Abstracts  by unknown
ABSTRACTS
1
Utilization of a new tissue expander in the closure of a large Mohs surgical defect
A Bajoghli,1,2,3 J Yoo1 and D Faria4 1 Dermatology, Fairfax Hospital, Falls Church, VA, 2
Dermatology, George Washington University, Washington, DC, 3 Dermatology, Skin & Laser
Surgery Center, Tyson’s Corner, VA and 4 Dermatology, Excel Dermatology, Vienna, VA
Malignant proliferating trichilemmal tumor (MPTT) is an uncommon lesion originating in the
outer sheath of a hair follicle that often presents as a slowly enlarging, painful, subcutaneous scalp
nodule. We describe a case of malignant proliferating trichilemmal tumor (MPTT) in an elderly
65-year-old Asian male who presented with a 5.5 x 5.0 cm mass on the posterior scalp. There was
no noted bleeding or ulceration, with the lesion slowly enlarging over the past ten years. Histopathol-
ogy depicted a solid cystic epithelial neoplasm composed of cells without distinct intercellular
bridges but abundant eosinophilic cytoplasm consistent with the diagnosis. Mohs’ micrographic
surgery was used to excise the tumor in three stages. H&E stains were used for all microscopic
sections, with achievement of clear margins. The resulting irregular wound measured 6.3 x 5.6
cm, and was repaired with the DermaClose RC™ device. The area was prepped and 1% xylo-
caine with epinephrine was infiltrated. Following the application of the DermaClose RC ™ device,
the wound reduced in size to 1.5 to 1.0 cm. The wound was dressed with Aquaphor healing oint-
ment and a pressure dressing. The device was then removed and the wound was surgically closed
utilizing 4.0 Vicryl sutures. Postoperatively, the patient had no evidence of recurrent disease at 7
months. Mohs’ micrographic surgery has evolved as a superior option for treating MPTT over wide
excision due to its tissue sparing technique and the increased ability to assess microscopically the
exact tissue margins and extensions, and thus increased probability of eliminating malignancy. Use
of the DermaClose RC™ tissue expander following Mohs’ surgical procedure provides an effec-
tive functional and cosmetic alternative to a skin graft, which not only creates a donor site wound
but also engenders a more complicated, time consuming procedure.
3
The effect of magnolia on VEGF regulation: an in vitro vascular permeability assay and pos-
sible implications
M Stotland,1 D Collins,2 Y Ee,1 AR Shalita1 and WS Lee1 1 Dermatology, SUNY-Downstate Med
Ctr, Brooklyn, NY and 2 BioResearch, Estee Lauder Companies, Melville, NY
The purpose of our study was to investigate the effect of magnolia extract on VEGF regulation and
to test the ability of a novel fluorescence based in vitro assay to detect changes in the permeabil-
ity of a vascular cell layer to fluid flux. To test the novel fluorescence based in vitro permeability
system normal human endothelial cells were grown to confluence on collagen coated inserts effec-
tively occluding the pores that exist in the insert membrane. These monolayers are treated with
known inducers of VEGF (and permeability) such as TNFα, platelet activating factor (PAF), UVA
or UVB either in the presence or absence of known or suspected inhibitors of VEGF. “Vascular”
permeability was determined through the application of either 10 kDa or 70 kDa FITC labeled dex-
tran particles to the media above the endothelial cell monolayer and measuring the appearance
of the fluorescent particles in the media below the insert. Preliminary data showed a dose response
relationship between the induction of VEGF (and the resultant permeability) and TNFα, PAF, UVA
and UVB. Results indicated that the system responded positively to permeability inducing factors
such as VEGF and PAF (2-5 fold increase in fluorescence). In addition, this induced permeability
was found to be inhibited by our positive control, endostatin (a known inhibitor of VEGF), hypoestox-
ide and the magnolia extract. The preliminary data indicate that this novel assay provides a sen-
sitive and reproducible system to detect changes in the permeability of vascular cell layer. We have
also been able to identify a magnolia extract as an effective inhibitor of VEGF release and of vas-
cular permeability.
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Opposing roles of angiogenesis and lymphangiogenesis in inflammation
R Huggenberger,1 K Alitalo2 and M Detmar1 1 Institute of Pharmaceutical Sciences, Swiss
Federal Institute of Technology, Zurich, Switzerland and 2 Molecular/Cancer Biology
Laboratory, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland
The chronic inflammatory skin disease psoriasis is characterized by extensive (lymph)angiogene-
sis. Whereas there is increasing evidence that inhibiting angiogenesis may serve as a novel strat-
egy to treat psoriasis, the implications of lymphatic vessels in cutaneous inflammation are unclear.
Lymphatic vessels contribute to the regulation of immune responses through their role in antigen
transport and leukocyte migration to draining lymph nodes, and they drain edematous tissue fluid
and inflammatory cells from inflamed skin. We investigated the relative contribution of each indi-
vidual VEGF receptor, and of lymph- versus angiogenesis in the pathogenesis of skin inflamma-
tion. To this end, we induced delayed-type hypersensitivity (DTH) reactions in the ears of K14-
VEGF-A and K14-VEGF-A/C transgenic mice. To dissect the effects of the VEGF receptors on
(lymph)angiogenesis, we blocked the three VEGF-receptors - individually or in combination - in
VEGF-A transgenic mice which develop a chronic, psoriasis-like skin inflammation. We found
that inhibition of angiogenesis via blockade of VEGFR1 and VEGFR2 resolved the psoriasis-like
skin inflammation, epidermal hyperplasia and abnormal epidermal differentiation in the VEGF-A
transgenic mouse model. In contrast, blockade of VEGFR3 prolonged the course of inflammation.
Conversely, stimulation of lymphatic function by VEGF-C counteracted the proinflammatory role
of VEGF-A in the double transgenic K14-VEGF-A/C mice, leading to the resolution of psoriasis.
Together, these findings indicate that inhibition of angiogenesis and/or stimulation of lymphan-
giogenesis might serve as novel strategies to treat chronic skin inflammation/psoriasis.
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Epinephrine increases keratinocyte migration by activating the α2B-adrenergic receptor
P Steenhuis, AP Glucksman, Z Gurenko and RR Isseroff Department of Dermatology, University
of California Davis, Davis, CA
Keratinocyte migration into skin wounds is required for the final step of the healing process. Our
lab previously found that activation of the β2-adrenergic receptor by 1μM epinephrine decreases
keratinocyte migration and consequently delays wound healing in cultured human skin and in
mice. Blocking of the β2-adrenergic receptor with antagonists reverses this effect and accelerates
both migration and wound healing in vitro, making the β2-adrenergic receptor an interesting ther-
apeutic target. We have now determined that keratinocytes also express α2-adrenergic receptors
and in the present study, we investigated the effects of α2-adrenergic receptor activation on ker-
atinocyte migration and scratch wound healing. Normal human keratinocytes were isolated from
foreskins and cultured in serum-free growth medium with 60μM calcium. Activation of α2-adren-
ergic receptors by 0.1nM epinephrine increases keratinocyte migration and scratch wound heal-
ing. After co-treatment with 0.1nM epinephrine and various α2-adrenergic receptor subtype-spe-
cific antagonists, it was determined that only the α2B-adrenergic receptor antagonist ARC239 can
reverse the epinephrine-induced increase in keratinocyte migration, indicating that α2B-adrener-
gic receptor activation by 0.1nM epinephrine increases keratinocyte migration. Phosphorylation
of AKT, ERK1/2 and p38 MAPK was also increased upon α2B-adrenergic receptor activation by
0.1nM epinephrine, suggesting that these 3 signaling pathways are involved in this process. Phos-
phorylation of the EGF receptor was not affected by treatment with 0.1nM epinephrine indicating
that there is no cross activation of this receptor. These results suggest that catecholamines can
induce opposite migratory effects by activating different adrenergic receptors. Therapeutic activa-
tion of the α2B-adrenergic receptor may have benefits for patients with non-healing wounds.
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Beta-arrestin1 mediates nicotinic acid induced flushing, but not its antilipolytic effect
RW Walters,1 AK Shukla,2,5 JJ Kovacs,2,3 JD Violin,4 SM DeWire,5 CM Lam,2 JR Chen,5
MJ Muehlbauer,6 EJ Whalen2 and RJ Lefkowitz2,4,5 1 Medicine, Division of Dermatology, Duke
University, Durham, NC, 2 Medicine, Duke University, Durham, NC, 3 Immunology, Duke
University, Durham, NC, 4 Biochemistry, Duke University, Durham, NC, 5 Howard Hughes
Medical Institute, Duke University, Durham, NC and 6 Sarah W. Stedman Nutrition and
Metabolism Center, Duke University, Durham, NC
Nicotinic acid, which stimulates the G protein-coupled receptor GPR109A, and Gi/Go proteins,
is one of the most effective agents for both lowering triglycerides and raising high-density lipopro-
tein. However, cutaneous flushing severely limits patient compliance. We investigated the roles of
G proteins and the adaptor proteins, beta-arrestins, in nicotinic acid-induced signaling and phys-
iological responses. Nicotinic acid stimulation leads to: Pertussis toxin sensitive lowering of cAMP;
recruitment of beta-arrestins to the cell membrane; activating conformational change in beta-arrestin;
beta-arrestin dependent signaling to ERK MAP kinases; binding of beta-arrestin1 to activated cytoso-
lic phospholipase A2; and beta-arrestin1 dependent activation of cytosolic phospholipase A2 and
release of arachidonate, the precursor of prostaglandin D2, the vasodilator responsible for the flush-
ing response to nicotinic acid. Moreover, beta-arrestin1 is required for nicotinic acid induced flush-
ing in vivo, but not for salutary serum free fatty acid lowering effects. Since the adverse side effect
of cutaneous flushing is mediated by beta-arrestin1, and lowering of serum free fatty acids is not,
“G protein biased ligands” (i.e. – ligands which activate GPR109A in a beta-arrestin independent
fashion) may provide novel therapeutic agents for the treatment of dyslipidemia.
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Rate of cutaneous wound healing is dependent on MAPKAPK-2-mediated macrophage acti-
vation
T Thuraisingam,1,4 Y Xu,2 K Eadie,2 M Heravi,2 R Greemberg,4 G Matthias,5 M Guiot3 and
D Radzioch1,2 1 Human Genetics, McGill University, Montreal, QC, Canada, 2 Medicine,
McGill University, Montreal, QC, Canada, 3 Pathology, McGill University, Montreal, QC,
Canada, 4 Medicine, University of Montreal, Montreal, QC, Canada and 5 Biochemistry,
Hannover Medical School, Hannover, Germany
Cutaneous wound healing is a complex process, which is heavily dependent on successful inflam-
matory action. MAPKAPK-2 (MK2), a major substrate of p38 MAPK, has been shown to be a major
player in multiple inflammatory diseases, but its role in cutaneous wound healing has not yet been
explored. In this study, by comparing excisional wounds made on the backs of MK2 KO and MK2
WT mice, we found that the kinetics of wound healing are significantly affected by the absence of
MK2 (p=0.010 to p<0.001). Histological examination showed a higher level of acanthosis of the
migrating wound keratinocyte layer as well as a higher level of collagen deposition and angio-
genesis in the granulation tissue of the wounds from MK2 WT mice compared to those of MK2 KO
mice. Interestingly, although MK2 did not influence macrophage and neutrophil infiltration of the
wounds, the expression of many cytokines and chemokines was significantly affected at different
days post-wounding. Furthermore, the delayed healing rate of wounds in MK2 KO mice can be
significantly improved by passive transfer of macrophages with intact MK2. Overall, these results
demonstrate a critical role for MK2 gene expression in macrophages participating in the process
of cutaneous wound healing.
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Differential keratin expression during epiboly in an organotypic model of injury
S Luo,1 T Yufit,1 P Carson1 and V Falanga1,2 1 Department of Dermatology and NIH Center of
Biomedical Research Excellence, Roger Williams Medical Center, Providence, RI and 2
Departments of Dermatology and Biochemistry, Boston University, Boston, MA
Various keratin intermediate filaments are critical to the different stages of keratinocyte migration
and differentiation. These keratins, or cytokeratins, may be used as markers to elucidate the intri-
cacies of the wound healing process. This study demonstrates the variable expression patterns of
cytokeratins through an in vitro model of epiboly in a bilayered living skin construct (LSC). Six-
mm biopsy specimens were taken from LSC and transferred to cell culture plates in DMEM and
5% CO2, 95% air, where epiboly growth from the cut edge began and was followed up to 72 hours.
For in vivo comparison with human wounds, we obtained biopsies of chronic venous leg ulcers
to represent chronic wounds, and biopsies of normal skin at baseline and at Day 3 to simulate acute
wounds as they heal. All the specimens, including LSC cultured in vitro, were fixed and immunos-
tained for the various cytokeratins. We also compared our results in this model to the expression
previously reported. We found that K1 and K10 were fully expressed in the epidermis of the com-
pletely epibolized surface, and thus truly represent markers of differentiation. As expected, K1 was
also faintly present in the migrating edge of the healing LSC and acute wounds, while K10 was
absent. K16 and K6 were evident in normal skin and in the epibolized component of LSC; K6 was
markedly present in the migrating edge. Importantly, K17 was distinctly limited to the epibolized
surface of LSC and the migrating edge, and like the K6 and K16, may represent a more significant
marker for migration. Differential expression of keratins in this epiboly model appears to reflect in
vivo studies and supports keratin specificity in the processes of migration and differentiation of new
epidermis. Therefore, these findings provide further and important validity for the study of epithe-
lialization in this epiboly model of a bilayered organotypic culture.
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Apelin attenuates UVB-induced inflammation by promoting the stabilization of lymphatic
vessels
M Sawane,1 K Kajiya,1 H Kidoya,2 F Muramatsu2 and N Takakura2 1 Shiseido Innovative Science
Research and Development Center, Yokohama, Japan and 2 Department of Signal
Transduction, Research Institute for Microbial Diseases, Osaka University, Suita, Japan
Apelin is a bioactive peptide known as the ligand of the G protein-coupled apelin receptor, known
as APJ. Apelin has been shown to be involved in the regulation of cardiovascular functions, fluid
homeostasis, and vessel formation. Recent report showed that apelin secreted from endothelial
cells associated the regulation of caliber size of blood vessel through APJ (Kidoya et al, EMBO J
(27) 522-534, 2008). However, the function of apelin in lymphatic vessels has been completely
unclear. Here we first describe that apelin attenuates the ultraviolet-B (UVB)-induced inflamma-
tion in the skin by promoting the stabilization of lymphatic vessels. First, we have confirmed that
APJ was expressed by human lymphatic endothelial cells (LECs) as well as blood vascular endothe-
lial cells and also showed that apelin induced migration and cord formation of LECs dose-depend-
ently in vitro. To determine the functional role of apelin in cutaneous lymphatic vessels in vivo,
the transgenic mice of apelin under the control of keratin 14 (K14-apelin) were exposed to 200mJ/cm2
of UVB. Interestingly, the attenuated edema formation was found in the dermis of K14-apelin mice
associated with a decreased number of CD11b-positive macrophages as compared to the wildtype
(WT) mice irradiated with UVB. Moreover, double immunofluorescent staining for the blood and
lymphatic markers, revealed that UVB induced enlargement of lymphatic vessels as well as blood
vessels of WT mouse ears, whereas K14-apelin mice inhibited enlargement of lymphatic vessels.
Finally, we demonstrated that UVB resulted in the leaky and hyperpermeable lymphatic vessels of
WT mouse ears, whereas, K14-apelin mice blocked the hyperpermeability of lymphatic vessels.
These results indicate that apelin plays a functional role in the stabilization of lymphatic vessels in
inflamed tissues and that apelin might be a suitable target for the prevention of UVB-induced inflam-
mation.
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MAPK-dependent CCL21 expression by lymphatic endothelial cells
T Miyagaki,1,2 M Sugaya,1,2 H Okochi,2 A Blauvelt3 and K Tamaki1 1 Department of
Dermatology, University of Tokyo, Tokyo, Japan, 2 Department of Regenerative Medicine,
Research Institute, International Medical Center of Japan, Tokyo, Japan and 3 Department of
Dermatology, Oregon Health & Science University, Portland, OR
CCL21 expression by lymphatic endothelial cells is essential for migration of CCR7+ immune cells
from skin to regional lymph nodes, although the mechanisms that regulate CCR7 expression are
unclear. We investigated the importance of MAPK signaling in CCL21 expression by endothelial
cells in vitro and in vivo. Using cDNA microarray chips, we first revealed that oncostatin M (OSM)
treatment of primary human dermal microvascular endothelial cells led to enhanced expression of
a large number of lymphatic endothelial cell-specific genes, including CCL21. When purified lym-
phatic endothelial cells (LEC) were stimulated in vitro with IL-6, OSM, or IL-31 (1-100 ng/ml), only
cells stimulated with OSM (10 and 100 ng/ml) expressed high amounts of CCL21 mRNA. CCL21
protein expression by LEC was also markedly increased by OSM compared to unstimulated cul-
tures (207.8 ± 72.9 pg/ml vs. 56.8 ± 26.6 pg/ml at 72 hr). Phosphorylation of STAT3 was detected
in LEC stimulated by IL-6 or OSM, whereas marked phosphorylation of Akt and Erk1/2 were detected
only in LEC stimulated by OSM. CCL21 expression by LEC was blocked by a JAK1 inhibitor and
MEK inhibitors in vitro, all of which blocked phosphorylation of Erk1/2. In addition, injection of
PD98059 (a MEK inhibitor) into murine skin significantly decreased CCL21 mRNA expression. In
summary, these results suggest that the MAPK pathway is important for CCL21 expression by LEC
in vitro and in vivo. Blocking MAPK signaling within skin may interrupt migration of immune
cells, and thus may offer a novel approach to treatment of inflammatory skin diseases.
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Enrichment of tissue-engineered skin with Schwann cells improves cutaneous nerve regen-
eration 
M Blais, M Grenier and F Berthod Université Laval, Quebec, QC, Canada
The use of autologous reconstructed skin appears to be a promising treatment for the permanent
coverage of extensive burns. However, the capability of reconstructed skin transplanted on wounds
to promote recovery of sensory perception is a major concern. Our aim was to develop a tissue-
engineered skin that stimulates nerve regeneration after transplantation on extensive burns. We
developed a tissue-engineered skin made of fibroblasts and keratinocytes cultured in a collagen-
chitosan sponge. First, to study in vitro the influence of Schwann cells on nerve migration, we
added sensory neurons(freshly obtained from dorsal root ganglia of mice embryos at E12) in the
reconstructed skin enriched with or without Schwann cells (isolated from mouse sciatic nerves).
Second, to study in vivo the effect of Schwann cells on nerve regeneration, we grafted on nude
mice our tissue-engineered skin enriched or not with Schwann cells. The current perception thresh-
old of A-beta, A-delta and C nerve fibers in the graft was evaluated using a Neurometer® 90 days
after transplantation. Schwann cells induced in vitro the migration of 2 times more neurites 14 days
after the seeding of neurons, compared to the control (p < 0,02; n = 5). They secreted a basal
membrane of laminin around axons and formed myelin sheaths. In vivo, their presence induced a
2 times increase in the number of neurites in the graft 60 days after transplantation. Moreover, 90
days after graft, the sensibility of the mice grafted with reconstructed skin containing Schwann cells
was similar to that of normal mouse skin for the large myelinated A-beta cutaneous nerve fibers,
but was decreased in mice grafted with a reconstructed skin without Schwann cells. We con-
cluded that Schwann cells induced faster and greater nerve regeneration in the tissue-engineered
skin both in vitro and in vivo. This enhanced innervation achieved an efficient recovery of tactile
sensation similar to the normal mouse skin only 90 days after graft.
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Development of a standardized chronic wound in a diabetic (db/db) mouse by application
of biofilm
P Hochwalt,1 G Zhao,1 R Underwood,1 M Usui,1 P Singh,2 P Stewart,3 G James,3 J Olerud1 and
P Fleckman1 1 Medicine/Dermatology, University of Washington, Seattle, WA, 2 Microbiology,
University of Washington, Seattle, WA and 3 Center for Biofilm Engineering, Montana State
University, Bozeman, MT
Chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers are a serious
medical problem. Systematic study of chronic wound therapies is difficult due to wound hetero-
geneity. Our goal is to develop a standardized chronic wound model for testing potential wound
healing therapies. Recent data have shown that microbial colonies known as biofilms are present
in the chronic wounds of humans. The microorganisms in biofilms have several protective mech-
anisms that make them difficult to eradicate by common means. For this reason, biofilm infections
persist and may be a major contributor to poor wound healing. We hypothesize that application
of biofilm to standardized wounds on a diabetic (db/db) mouse may create a reproducible chronic
wound. Bacterial biofilm was developed by inoculating planktonic Pseudomonas aeruginosa (PAO-
1) onto polycarbonate membrane filters resting on LB agar plates and culturing for 3 days. Tega-
derm™ was applied to the dorsal skin of diabetic mice and full-thickness wounds (6mm diameter)
were created through the Tegaderm™, skin, and panniculus carnosus. The biofilm was transferred
to the wounds of mice two days after wounding. Wounds were then covered with a secondary
dressing consisting of Maxorb® Extra (CMC/alginate) and Tegaderm™. The dressings were changed
twice a week. The mice were euthanized at 14, 21, and 28 days following wounding. Wounds of
control mice were almost completely closed by 14 days. Wounds of infected mice remained puru-
lent and slowly grew in size over a period of 28 days. Pseudomonas aeruginosa (10^8 CFU/wound)
was cultured from the biofilm-infected wounds at all time points. In addition, microscopy revealed
thick layers of Pseudomonas aeruginosa biofilm within and around the tissue of these wounds. Ulti-
mately, the development of a reproducible chronic wound infection will allow in vivo testing of
potential therapies targeting biofilm.
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Human lactoferrin stimulates keratinocytes proliferation, migration and protects cells from
death
L Tang,1 J Wu,1 Q Ma,1 N Huang2 and J Li1 1 Department of Dermatology, University of Miami,
Miami, FL and 2 Ventria Bioscience, Sacramento, FL
Human lactoferrin (hLF), a glycoprotein of the transferrin family, has recently been shown to stim-
ulate the wound repair through its antimicrobial and anti-inflammation modulation. hLF was also
demonstrated to stimulate the proliferation of various cell lines in other systems. To explore the
role of hLF in the wound healing, we used a rice-derived holo-recombinant human lactoferrin
(holo-rhLF) to examine the effects of hLF on cell proliferation, migration, attachment, and survival
in a normal epidermal keratinocyte culture system. This study demonstrated that holo-rhLF sig-
nificantly stimulated keratinocyte proliferation. Total numbers of cells cultured with 100 and
200μg/mL holo-rhLF were increased 8.3% (p<0.05) and 14.5% (p<0.05) respectively on day 5
compared with cells without holo-rhLF. When together with 2ng/mL of EGF, holo-rhLF showed
markedly synergistic effects with EGF on cell proliferation (p<0.01). Furthermore, using a scratch
migration assay, an in vitro incisional wound model, holo-rhLF significantly promoted keratinocyte
migration. At day 3, gap filling was increased 10.41% (p<0.01) and 10.25% (p<0.01) in cells cul-
tured with 10 and 100 μg/mL of holo-rhLF respectively. At day 4, cells treated with 100 μg/mL
holo-rhLF had significant higher gap filled (95.05% vs. 84.38% of the control, p<0.01). Strikingly,
holo-rhLF significantly increased cell viability when cells were stressed by serum depletion or
TPA exposure. TUNEL staining positive (apoptotic) cells were significantly decreased in cells treated
with holo-rhLF under serum depletion (33% vs. 5.5%; p<0.01) or TPA exposure (35% vs. 2.8%;
p<0.0001). No significant effect was observed on cell attachment. These findings revealed direct
effects of holo-rhLF on the functions of human keratinocytes and strongly implicated its high poten-
tial of clinical application in wounds through enhancing cell proliferation, migration and protect-
ing cells from cell death. Furthermore, this plant-derived recombinant protein is cost-saving and
safer than animal or microbial-derived products.
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The linear excisional wound: a new model for human ex-vivo wound healing studies.
AE Rizzo,1 LA Beckett,2 BS Baier1 and RR Isseroff1,3 1 Dermatology, University of California,
Davis, Davis, CA, 2 Public Health Sciences and the Division of Biostatistics, University of
California, Davis, Davis, CA and 3 Wound Service, Veterans Affairs, Northern California
Health Care System, Mather, CA
Wound healing is a complex process that involves multiple intercellular and intracellular processes
and extracellular interactions. Explanted human skin has provided a model for human wound heal-
ing under controlled, reproducible conditions that limit some of the extraneous sources of varia-
tion. The currently used standard technique employs a circular punch biopsy tool to make the ini-
tial wound. Despite its wide use, the geometry of round wounds makes them difficult to measure
reliably. Our group has designed a linear wounding tool, and compared the variability in ex vivo
human linear and circular wounds. An F test for differences in variances demonstrated that the lin-
ear wounds provided a population of wound size measurements that was fifty percent less vari-
able than that obtained from a group of matched circular wounds. This reduction in variability
would provide substantial advantages for the linear wound technique over the circular wound
punch technique, by reducing the sample sizes required for comparative studies of factors that
alter healing. This linear wounding tool thus provides method for wounding that is standardized,
provides minimal error in wound gap measurements, and is easily reproducible. We demonstrate
its utility in an ex vivo model for the controlled investigation of human skin chronic wounds.
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Molecular techniques: role in diagnosing microbial bioburden within a wound
S Kandula,1 JH Melendez,1 ME Shirtliff,2 JM Zenilman1 and GS Lazarus1 1 Johns Hopkins
Medical Institutions, Baltimore, MD and 2 University of Maryland School of Medicine,
Baltimore, MD
The purpose of the study is to quantify and localize microbial bioburden in chronic wounds using
cutting edge methodologies including qualitative cultures, quantitative cultures, quantitative Real
Time Polymerase Chain Reaction (RT-PCR) and Peptide Nucleic Acids- Fluorescence In Situ
Hybridization (PNA-FISH). Our first four patients with chronic wounds were recruited from a ter-
tiary care hospital wound center, age range 45-68 years, 2 male, 2 female. The wounds were
anesthetized and wedge biopsies were performed to include center and advancing rim. Tissue
was marked for orientation and probed with pan bacterial PNA-FISH that labels all bacteria or a
probe specific for Staphylococcus aureus (S. aureus). Wound base and advancing edge were curet-
ted with 3 mm curette. Tissue was also evaluated for qualitative cultures, quantitative cultures and
bacterial genomic load using RT-PCR technique. Microbial bioburden detected by qualitative cul-
ture, quantitative culture, FISH and PCR was consistent in all patients. The first patient had sub-
stantial bacterial load detected by all methods and highest density was noted at the advancing
rim. This patient was treated for S. aureus two weeks earlier and the S. aureus PNA-FISH probe
did not detect the organisms. By contrast the second patient had far fewer bacteria but did have
low density of S. aureus confirmed by multiple methods and the organisms were located at the
advancing rim. The third and fourth patients had minimal bacterial load by all methods. Pan bac-
terial PNA-FISH probe detected twice the bacterial load at the advancing edge of the wound than
the central wound bed. PNA-FISH confirms that microbial load is heavier at the advancing rim of
the wound. We demonstrated location of specific bacteria and their relationship with other bac-
terial species within the wound. These new molecular methods are powerful tools to define the
importance of specific bacteria in wound healing.
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A dual regulatory role of PEDF and its interplay with VEGF in human epidermal keratinocytes
and dermal fibroblasts: from normal skin to psoriasis
M Zheng, X Man, X Yang, C Li and S Cai Dermatology, Second Affiliated Hospital, Zhejiang
University, School of Medicine, Hangzou, China
Vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) have been
shown to balance angiogenesis activation and inhibition in normal and pathological conditions.
In this study, we examined the expression of VEGF and PEDF in keratinocytes and fibroblasts from
normal healthy skin and nonlesional, perilesional, and lesional psoriatic skin, to evaluate their
potential roles and interactions in the development of psoriasis. The results show that the expres-
sion of VEGF and PEDF were increased in the keratinocytes and fibroblasts from psoriatic skin as
compared with normal skin at the mRNA and protein levels. Treatment with different concentra-
tions of PEDF functioned differently. PEDF could decrease the overexpression of VEGF in psoriatic
keratinocytes and fibroblasts (at 10 ng/ml) and upregulate the lower level of VEGF in normal cells
(at 50 ng/ml). VEGF at 10 ng/ml could significantly induce the expression of PEDF within 48 h in
normal keratinocytes and fibroblasts. Moreover, PEDF had an inhibition effect on the proliferation
and migration of keratinocytes and fibroblasts at low concentration (at or lower than 25 ng/ml) but
had a stimulatory effect at high concentration (at or above 50 ng/ml). VEGF at 10 ng/ml restored
the inhibition effect of low concentration of PEDF and played a synergic role with a high concen-
tration of PEDF on cell proliferation and migration. Furthermore, PEDF increased phosphorylation
of p44/42 MAPK and enhanced VEGF-induced phosphorylation effect, but enacted a dual role in
inducing cleavage of inhibitor of caspase-activated DNase (ICAD) in keratinocytes and fibroblasts.
Taken together, our results suggest that PEDF acts as a multipotent factor in the skin and the imbal-
ance of PEDF and VEGF may be responsible for the transformation from normal skin to psoriasis.
14
Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and
lymphangiogenesis
J Asai, H Takenaka, A Moriyasu, N Katoh and S Kishimoto Dermatology, Graduate School of
Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
Impaired wound healing is one of the common complications of diabetes. Recent studies have
shown reduced lymphangiogenesis as well as angiogenesis is observed during diabetic wound
healing, and is thought to be the new therapeutic target. Statins, which are usually used systemi-
cally, have different effects beyond cholesterol reduction and stimulate angiogenesis. However, the
effects of topically applied statins on wound healing, especially on angiogenesis and lymphan-
giogenesis, have not been well investigated. The present study tested the hypothesis that topical
application of statin may promote angiogenesis and lymphangiogenesis during wound healing in
genetically diabetic mice. A full thickness skin wound was created on the back of diabetic (db/db)
mice. Animals were treated either simvastatin (50 μg per wound) or vehicle topically. % wound
closure, vascular density, and lymphatic vascular density were evaluated. Topical application of
simvastatin resulted in significant acceleration of wound recovery. The acceleration in wound heal-
ing was notable for increased vascularity and lymphatic vascularity. These findings suggest that a
simple strategy of topically applied statins may have therapeutic potential for enhanced wound
healing in patients with impaired microcirculation such as diabetic foot ulcer.
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Promotion of cutaneous wound healing with a fusion protein of hepatocyte growth factor
and collagen-binding domain of fibronectin
N Okiyama,1,2,3 T Kitajima,4 Y Ito,4 N Miyasaka,1 H Yokozeki2 and H Kohsaka1,3 1 Department
of Medicine and Rheumatology, Graduate School, Tokyo Medical and Dental University,
Tokyo, Japan, 2 Department of Dermatology, Graduate School, Tokyo Medical and Dental
University, Tokyo, Japan, 3 RCAI, RIKEN, Kanagawa, Japan and 4 ASI, RIKEN, Saitama, Japan
Hepatocyte growth factor (HGF) stimulates proliferation and migration of epidermal keratinocytes
and endothelial cells. Systemic or topical overexpression of the HGF transgene or daily topical
treatment with recombinant HGF expanded granulation and stimulated neovascularization in cuta-
neous wound healing. In the present study, fusion proteins of HGF and collagen-binding domain
of fibronectin (CBD-HGF) were used to enhance availability of HGF in the wound. Surface plas-
mon resonance sensorgrams disclosed that the CBD-HGF fusion protein had approximately 100
times stronger affinity to collagen than native HGF. It stayed bound to the collagen-coated plastic
wells better than native HGF. This modification did not attenuate growth promoting activity for der-
mal fibroblasts and epithelial cells. Moreover, activity of CBD-HGF lasted longer than HGF in cul-
ture medium at 37°C, suggesting that CBD-HGF is less susceptible to inactivation. Both types of
HGF were used to treat a full-thickness cutaneous wound in diabetic mice, which are impaired in
skin wound healing. Preliminary experiments showed that exogenous non-CBD-proteins placed
in the wound disappeared in six hours. When the wounds were treated once a week, their heal-
ing was significantly quicker in the CBD-HGF-treated mice than in the control or HGF-treated mice
(p<0.001, Two-way ANOVA). Mean duration of the wound closure was 14 days in the CBD-HGF-
treated mice, and 17 days in the HGF-treated mice, respectively (p<0.01). Addition of CBD might
be useful modification to enhance wound healing by HGF.
www.jidonline.org   S3
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CXCR4-selective antagonist AMD3100 accelerates impaired wound healing in diabetic mice
Y Nishimura,1,2,3 M Ii,2 J Asai,1 H Takenaka,1 N Katoh,1 H Hamada,4 G Qin,5 DW Losordo5 and
S Kishimoto1 1 Department of Dermatology, Kyoto Prefectural University of Medicine, Kyoto,
Japan, 2 Institute of Biomedical Research and Innovation of Kobe, Kobe, Japan, 3 Department
of Dermatology, Nishiyama Hospital, Kyoto, Japan, 4 Department of Pediatrics, Tokyo
Women’s Medical University Yachiyo Medical Center, Chiba, Japan and 5 Feinberg
Cardiovascular Research Institute, Northwestern University, Chicago, IL
Based on our previous data that AMD3100, a CXCR4-selective antagonist, has a beneficial effect
on ischemic tissue promoting neovascularization with bone marrow (BM)-derived endothelial
progenitor cell (EPC) recruitment. We hypothesized whether AMD3100 may accelerate diabeti-
cally impaired wound healing via a similar mechanism. Skin wounds were made on the back of
diabetic mice, treated with AMD3100 or saline (control), covered with a semipermeable dressing,
and examined macroscopically and histologically at subsequent time points. Fourteen days after
treatment, wound closure was significantly more complete in the AMD group than the control
group (87.0±2.6 vs. 33.1±1.8%, P<0.0001) with greater collagen-fiber formation, capillary den-
sity, and monocyte/macrophage (Mφ) infiltration; and higher numbers of arteriole. Number of cir-
culating EPCs and Mφs were more prevalent in the AMD group than the control group 7 days after
treatment, and quantitative RT-PCR analyses demonstrated that AMD3100 upregulated SDF-1α and
PDGF-B mRNA expressions in the wound bed. Interestingly, AMD3100 increased migration and
proliferation activities in CXCR4-null fibroblasts, upregulating SDF-1α and PDGF-B mRNA, and
also enhanced proliferation and phagocytosis activities of BM-derived Mφ with MCP-1 mRNA
upregulation. These results suggest that not all of the AMD3100-mediated effects on wound heal-
ing evolved via CXCR4 antagonism. AMD3100 promoted wound healing in diabetic mice by
stimulating fibroblast and Mφ activities; mobilizing EPCs from BM; and increasing cytokine pro-
duction thereby enhancing neovascularization. These results may give rise to a novel therapeutic
approach by AMD3100 to delayed wound healing in diabetic patients.
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Epidermal caspase-8 regulates a wound healing response
P Lee,1 D Lee1 and C Jamora1,2 1 Department of Cell and Developmental Biology, University
of California, San Diego, La Jolla, CA and 2 Department of Medicine (Division of
Dermatology), University of California, San Diego, La Jolla, CA
Regulation of epidermal regeneration and homeostasis is achieved by balancing the distinct processes
of proliferation vs. differentiation and cell death vs. survival. Disruption of epidermal integrity ini-
tiates a cascade of signals leading to the release of factors that alter these balancing acts. During
homeostatic conditions, we found expression of caspase-8 confined to the granular layer. Upon
cutaneous trauma caspase-8 mRNA and protein levels are decreased. In order to investigate the
contributions of caspase-8 modulation in response to wounding, we generated mice deficient in
caspase-8 in the skin. Analysis of the caspase-8 conditional knockout (cKO) epidermis revealed an
increase in the number of proliferating keratinocytes, resulting in a thickened epidermis. Since the
cells in the stratum corneum display characteristics of programmed cell death and caspase-8 is
known to initiate apoptosis, we hypothesized that caspase-8 abrogation would interfere with the
proper formation of the stratified layers of the epidermis. Surprisingly, immunohistochemical analy-
sis revealed that the thickening observed in the caspase-8 cKO epidermis was due to increased
proliferation of basal cells as opposed to a blockade in cell death during the terminal differentia-
tion process. Downregulation of caspase-8 in the cKO and wounded skin corresponded to an
increase of secreted IL-1α which stimulated epithelial-mesenchymal interactions leading to the
enhanced proliferation of basal keratinocytes. Elevated levels of phospho-NFκB were observed by
immunoblotting and in the nuclei of suprabasal cells of the caspase-8 cKO skin and quantitative
RT-PCR analysis of caspase-8 cKO and wounded skin revealed increased expression of NFκB tar-
get and pro-inflammatory genes. Taken together, we have uncovered a molecular mechanism for
sensing epidermal perturbations that rely on the modulation of caspase-8 levels thereby initiating
an essential epithelial-mesenchymal-leukocytic interaction as a response.
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Breaking the “harmony’ of signaling via TNFR1/p55 or TNFR2/p75 for cancer treatment
S Sasi,1 H Gilbert,1 M Silver,1 C Coleman,2 L Hlatky,1 G Qin,3 R Kishore3 and DA Goukassian2,1
1 Center of Cancer System Biology, TUSM, Boston, MA, 2 Department of Dermatology,
BUSM, Boston, MA and 3 Northwestern University, Chicago, IL
Tumor necrosis factor-α (TNF) binds two receptors TNFR1/p55 and TNFR2/p75 and is produced
continuously in all tumors and tumor microenvironment affecting many tumor-associated processes.
We hypothesized that inhibition of signaling via one or the other of TNF receptors may inhibit
tumor growth. To test our hypothesis we injected WT, p55KO and p75KO mice with 5x105 mouse
lung carcinoma line (LLC) or human melanoma MMAN line into the flank. Compared to 7d(days),
by 14d and 21d LLCs in WTs grew ~343% and ~933% larger, while LLC growth was inhibited in
p75KO and p55KOs ~50% and ~40% (p<0.05). Compared to 7d, MMAN tumors in WTs on 14d
were ~1195% larger, while melanoma growth was inhibited in p75KOs and p55KOs by 53%
(p<0.03). TNF levels were significantly (6-10-fold) higher within genotype in normal skin vs tumor
tissue in WT(p<0.01), p75KO(p<0.01) and p55KO(p<0.03). Compared to WTs, CD31 staining in
tumors revealed 80% (p75KO, p<0.001) and 60% (p55KO, p<0.02) decreases in capillary density.
There was a ~50% increase in TUNEL (+) apoptotic cells in p75KO and p55KO tumors. VEGF
expression was decreased by more than 50% (p75KO, p<0.01) and 40% (p55KO, p<0.02). Com-
pared to WT and p55KOs there was ~50% (p<0.05) decrease in BM-derived EPCs incorporation
into the functional capillary network in p75KOs. Gene array analysis showed that compared to
WTs, in p75KO and p55KO tumors the absence of the signaling via these receptors in the host tis-
sue decreased the gene expression in several crucial pathways that regulate tumor angiogenesis
and cell survival, such as: VEGF-A, Akt, Ctgf, Cxcl1 and 10, IL12b, Angpt14, Mmp9, IL18, Nrp1,
Hif1a (2-4-fold) and p38 MAPK, VEGF-D, Cxcl2, IL1b, Pgf (5-10-fold). Gene array results were con-
firmed by qRT-PCR. We conclude that in vivo inhibition of TNFR p55 or p75 in tumor tissue may
deliver “double hit” by affecting survival and function of ECs and tumor cells, while persistent
high levels of TNF in tumor tissue will have self-destructive effect.
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Rosacea: Physiology and regulation principles
F Chanteloube,1 A Loiseau1 and G Tenca2 1 Bayer Santé Familiale - Division Serdex, LONS,
France and 2 BioAlternatives, Gençay, France
To date, few therapeutic treatments cope with a real improvement of rosacea, for instance for inflam-
matory or even acneic cases. Many scientific searches and publications have tried to explain the
rosacea causes, which are mainly: 1) an over-expression of active forms of antimicrobial peptides
such as cathelicidins, involved in the maintenance of an infectious status leading to skin chronic
inflammation, 2) a vascular defect, which contributes to impaired capillary neoangiogenesis with
frequent hemorrhagic characteristics, leading to the weakening of a skin that naturally tends to be
thin and reactive,3) inflammation, initially elusive but steadily increasing to become persistent with
flush and blush phenomena,and 4) an inflammatory process depending on environmental condi-
tions such as UVs or free radicals. The madagascan plant Tambourissa trichophylla has been selected
for rosacea modulation evaluation owing to its traditional use in healthcare and its phytochemical
composition – in particular the presence of catechuic tannins renowned for anti-inflammatory and
anti-hemorrhagic properties. A titrated extract of leaves of Tambourissa trichophylla has been shown
to impact the main pathways of rosacea etiology thanks to: 1) infection modulation owing to the
significant reduction of LL-37, the active form of cathelicidin in epidermis, and of the related
enzymes (e.g. kallikreins) 2) the global anti-inflammatory activity with the modulation of both
prostaglandins (COX) and leucotriens (LOX) pathways 3) an improvement of the neo-angiogene-
sis due to VEGF inhibition and to the reinforcement of capillary structures for hemorrhagic char-
acteristic limitation and 4) a protection against deleterious effects of free radicals. An in-use test
versus excipient on slight to moderate rosacea cases has confirmed the activity in vivo of Tam-
bourissa trichophylla with the significantly reduction of the capillary flux (Doppler® measurements)
and the visible diminution of the skin redness. Based on these results, a new mechanism dealing
with regulation cycle can be considered for interrelating rosacea causes.
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CLIC4 regulates TGF-β dependent myofibroblast conversion of dermal fibroblasts
A Shukla, S Madanikia and SH Yuspa Laboratory of Cancer Biology and Genetics, National
Cancer Institute, NIH, Bethesda, MD
The activation of dermal fibroblasts to myofibroblasts is an essential function in skin wound heal-
ing and is associated with a number of other alterations in cutaneous homeostasis including can-
cer development. Myofibroblasts are characterized by the expression of alpha smooth muscle actin
and the elaboration of a number of growth and angiogenic factors. Previous studies in skin and
other tissues indicate that TGF-β is fundamental to the conversion of fibroblasts to the myofibrob-
last phenotype. CLIC4 (Chloride intracellular channel 4) is a member of a family of intracellular
chloride channel proteins that are ubiquitously expressed in multiple tissue types. It is a dimorphic
protein that exists in both soluble and membrane bound forms. CLIC4 is multifunctional, traffics
between the cytoplasm and nucleus and participates in cell cycle control and differentiation. CLIC4
is the single most upregulated transcript during conversion of breast fibroblasts to myofibroblasts
and is coexpressed with alpha smooth muscle actin in tumor associated fibroblasts. Recent stud-
ies in our laboratory have shown that CLIC4 modifies TGF-β signaling in skin keratinocytes alter-
ing TGF-β dependent gene regulation and cell proliferation. Here we show that CLIC4 also par-
ticipates in TGF-β signaling in the dermis. RNAi mediated knockdown of CLIC4 in dermal fibroblasts
inhibits TGF-β dependent expression of alpha smooth muscle actin. Fibroblast transdifferentiation
by TGF-β is ERK 1⁄ 2 dependent. CLIC4 overexpression enhances phosphorylation of ERK1/2 and
synergizes with TGF-β in activating ERK1/2. Furthermore CLIC4 knockdown abrogates TGF-β
dependent ERK activation in dermal fibroblasts. Thus CLIC4 plays an important role in both epithe-
lial and mesenchymal cell biology by altering TGF-β signaling. Participation in TGF-β signaling
might also explain the reciprocal nature of CLIC4 expression in tumor epithelium and stroma. In
this light, CLIC4 may serve as a target for modifying TGF-β under conditions where this pathway
is involved in pathological changes.
24
Rapamycin inhibits tumor angiogenesis in a xenograft model of tuberous sclerosis complex
S Li,1 J Wang,1 S Rajesh,1 J Moss2 and T Darling1 1 Dermatology, USUHS, Bethesda, MD and
2 Translational Medicine Branch, NHLBI, Bethesda, MD
Tumors in patients with tuberous sclerosis complex (TSC) decrease in size during treatment with
rapamycin. This inhibitor of growth-stimulatory signaling through mTORC1 could have direct effects
on tumor cells or suppress angiogenesis in these highly vascular tumors. To study the potential
utility and mechanism of action of rapamycin in the treatment of TSC skin tumors, we adminis-
tered rapamycin to nude mice grafted with human TSC skin tumor cells. Earlier, we had shown
that fibroblast-like tumor cells grown from TSC angiofibromas, periungual fibromas, and forehead
plaques sustain biallelic mutations in the tumor suppressor gene TSC2, resulting in loss of TSC2
expression and increased signaling through mTORC1. Here, we incorporated tumor cells or fibrob-
lasts from patient normal-appearing skin into collagen gels overlaid with normal human neonatal
keratinocytes, and grafted these constructs to the backs of nude mice. Rapamycin (2mg/kg) or
vehicle was administered by intraperitoneal injection on alternate days for 12 weeks beginning 5
weeks after grafting (8 mice for each condition). Tumor cells persisted in rapamycin-treated grafts,
since microdissected grafts showed the presence of a tumor-specific, second-hit mutation in TSC2.
Moreover, sections stained with a pan-human HLA class I antibody showed that the number of
human tumor cells in the dermis decreased only slightly with rapamycin treatment. Changes in vas-
cularity were measured by digital analysis of vessel area relative to total area in sections stained
for the endothelial cell marker CD31. The vessel area of grafts containing tumor cells was 6-fold
greater than that of grafts containing normal fibroblasts (p<0.0001). Rapamycin decreased the ves-
sel area of grafts containing tumor cells to one-third that of vehicle-treated animals (p=0.0003),
but did not significantly decrease the vessel area of grafts containing patient normal fibroblasts.
These results suggest that a major mechanism of action for rapamycin is though anti-angiogenic
effects rather than eradicating TSC skin tumor cells.
S4 Journal of Investigative Dermatology (2009), Volume 129
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Change of fate of epidermal stem cells contributes to pathogenesis of chronic wounds
O Stojadinovic,1,3 I Pastar,3 A Krzyzanowska,3 S Vukelic,3 K Zimmerman,2 H Brem2 and
M Tomic-Canic1,3 1 Dermatology and Cutaneous Surgery, University of Miami Miller School
of Medicine, Miami, FL, 2 Surgery, NYU School of Medicine, New York, NY and 3 Hospital
for Special Surgery, New York, NY
The epidermis of non-healing edge of chronic wounds is hyper-proliferative but non-migratory,
indicating absence of appropriate input of epidermal stem cells (ESCs). It was shown previously
that down-regulation of BMPR1 results in decreased GATA3, activation of the Wnt pathway, and
a loss of stem cell quiescence. However, the fate of ESCs in human chronic wounds has not been
extensively studied. Using microarray analysis of non-healing edges from 5 venous ulcers (VUs),
we identified changes in expression of genes harboring regulation of ESCs cells and their fate.
Specifically, transcription of BMPR1 and GATA3 were suppressed, which was confirmed by real-
time PCR for total of 10 VUs. In addition, we found up-regulation of Wnt-signaling pathway as
evident by decrease of phosphorylated GSK3β and nuclearization of β-catenin. In turn, c-myc, a
putative transcriptional target of β-catenin, was over-expressed in VUs. Furthermore, we found
Lrig1, a gene important for maintaining epidermal stem cells in a quiescent non-dividing state,
down-regulated in VUs. Finally, K15, a marker of the basal stem cell compartment, was absent in
non–healing edges of VUs. These data suggest that epidermal stem cells at the non–healing edge
of chronic wounds undergo frequent cycling due to down-regulation of GATA3, BMPR1 and Lrig1
and activation of β-catenin/c-myc. Deregulation of signals controlling the quiescent stem cell niche,
may lead to their cycling and local depletion at the non-healing edges of VUs contributing to the
enlargement of the wound and lack of healing-competent epidermal tissue.
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Acute animal model of radiation-altered wound healing
M Jourdan,1 E Olasz,1 J Moulder,2 B Fish,2 M Mader,2 A Schock,2 A Lopez1 and Z Lazarova1 1
Dermatology, Medical College of Wisconsin, Milwaukee, WI and 2 Radiation Oncology,
Medical College of Wisconsin, Milwaukee, WI
Skin exposure to ionizing radiation, whether therapeutic or accidental, disrupts the normal wound
healing process and has great impact on prognosis and survival of affected individuals. Most of
the current models use either total body radiation injury where animals need to be rescued with
bone marrow transplants, or use a small, localized area of body to inflict skin radiation damage.
To better understand the pathology of wound healing in irradiated skin, we developed an animal
model of combined radiation and wound injury with radiation injury affecting 30% of total body
surface. The WAG/Rij/MCW rats (n=47) were irradiated on the back with a 15kVp x-ray beam with
a steep dose gradient. The single dosage ranged from 10 to 40 Gy and was defined at the skin level.
Within one hour after irradiation, two whole thickness circular wounds were inflicted on the back
of the animals. Control animals (n=11) were sham irradiated and then wounded. Duration of the
experiment was 30 days. Our studies show that experimental animals developed, in a dose depend-
ent manner, cutaneous radiation reactions such as erythema (onset day 3), alopecia (onset day 10,
duration entire period of study) and/or moist desquamation (onset day 19, duration entire period
of study). The peak of acute skin reactions were between days 19 to 21. Wound measurement of
non-irradiated animals showed a rapid wound closure within 14 days after wounding. In contrast,
14 days after irradiation, in animals receiving 10 Gy, the unhealed area represented 27.6%; at 20
Gy=52.7%; at 30 Gy=59.5%; and at 40 Gy=64.7% of the original wound size. At the day 30 only
rats irradiated with 10 Gy had a complete wound closure. Immunohistochemical evaluation of
the irradiated skin showed decreased staining for laminin 332, severe fragmentation of the colla-
gen fibrils and atypical fibroblasts within 14 days after irradiation. These studies establish an ani-
mal model that can be used to assess mechanism of radiation-altered wound healing and treat-
ment modalities.
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Proteomic analysis of human dermal microvascular endothelial cells after UVB irradiation
and intense pulsed light treatment
S Oh, J Noh, N Chang, K Lee and J Lee Department of Dermatology & Cutaneous Biology
Research Institute, Yonsei University College of Medicine, Seoul, Korea, South
The research on the aging of vascular endothelial cells is of help in elucidating the mechanism of
aging of the skin. Exposures of the human skin to ultraviolet radiation (UVR) result in inflamma-
tion, and also in premature aging, and even skin cancer. On the other hand, intense pulsed light
(IPL) is a widely-used rejuvenating method that improves photodamage. The objective of this study
was to search aging-related proteins using human dermal microvasuclar endothelial cells (HDMECs)
after UVR and IPL treatment. Irradiation with UVB at a dose of 20mJ/cm2 and three passes of IPL
using a 590 nm cut-off filter at a fluence of 15J/cm2 were applied to each group of HDMECs. These
treated cells were harvested 24 hr following treatment and 2-D difference gel electrophoresis (2-
D DIGE) coupled with MS was used to investigate a panel of proteins found to be differentially
expressed between UVB and IPL treatment. Six proteins including beta-tubulin and vimentin were
found to have decreased abundance levels in IPL-treated HDMECs comparing non-treated HDMECs.
UVB-irradiated HDMECs showed decreased levels for 10 proteins including superoxide dismu-
tase and increased levels for 34 proteins including heat shock protein 70, moesin, and matrix met-
alloproteinase compared with non-treated HDMECs. Vimentin which was decreased after IPL treat-
ment is known as the specific target of advanced glycated end products (AGEs) that accumulate
during normal aging. The expression of Nε-(carboxymethyl) lysine (CML), a major antigenic AGEs
in HDMECs was measured by flow cytometric analysis according to serial subcultures. HDMECs
at late passages showed higher expression of CML comparing to early passages, and the expres-
sion of CML in HDMECs at late passages decreased after irradiation of IPL. Although practical sig-
nificance remains to be confirmed by in vivo research, this discovery may provide a basis for under-
standing the mechanism of aging and age-related diseases.
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Carboxymethyl lysine as a biomarker for the senescence of human dermal microvascular
endothelial cells
J Noh, S Oh, J Lee, N Chang and K Lee Department of Dermatology & Cutaneous Biology
Research Institute, Yonsei University College of Medicine, Seoul, Korea, South
Human dermal microvascular endothelial cells (HDMECs) between blood and tissues maintain
homeostasis through their interaction with serum. The research on the aging of vascular endothe-
lial cells is of help in elucidating the pathogenesis of diseases associated with cell aging. The aim
of this study was to discover proteins associated with senescence of HDMECs in serum with pro-
teomics techniques. Peripheral blood from 8 healthy donors in their twenties and 6 healthy donors
in their sixties was collected. Differential protein expression between pooled PBMCs in young and
old donors was compared by two-dimensional difference gel electrophoresis (2-D DIGE) coupled
with MS. Sixty-five proteins including vimentin and annexinV were upregulated and 75 proteins
including ras suppressor gene protein-1 downregulated in PBMCs of old donors when compared
with the same protein in PBMCs of young donors. We investigated the expression of Nε-(car-
boxymethyl) lysine (CML), a major antigenic advanced glycation end products, which accumu-
lates vimentin in skin glycation during normal aging, in serum was measured by ELISA. Serum in
old donors showed higher expression of CML comparing to young donors (p=0.003, 3.31±0.49 vs
2.13±0.48, respectively). In addition, HDMECs which had been treated with serum according to
ages were evaluated by FACS analysis and the expression of CML in HDMECs treated with serum
of old donors was higher than that in HDMECs treated with serum of young donors. In conclusion,
these data indicate that blood components including serum and PBMCs with age-related differ-
ences can influence the aging of endothelial cells and suggest that CML might serve as a potential
biomarker for aging.
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Isolation of directionally migrating human keratinocytes in an electric field
YC Liu,1 H Yang,1 JY Lee,2 A Revzin2 and RR Isseroff1 1 Dermatology, School of Medicine,
University of California, Davis, CA and 2 Biomedical Engineering, University of California,
Davis, CA
When skin is wounded, a low resistance pathway is created and an endogenous wound electric
flield (EF) of 50-100 mV/mm is generated. Our lab has demonstrated that EFs of this magnitude
can direct keratinocyte migration: >90% of keratinocytes exposed to an EF move toward the cath-
ode. Since the cathodal pole of the endogenous wound EF resides in the wound center, this EF
helps guide keratinocytes to re-epithelialize the wound. However, a small population <10% of ker-
atinocytes migrates anodally, away from the wound edge. Our study is aimed at defining the char-
acteristics of this population of migrating cells. Here we present a novel cell separation and col-
lection method that combines microfabrication and laser capture microdissection to allow the
capture and genetic profiling of individually migrating keratinocytes. First, a polydimethylsilox-
ane(PDMS) patterning mask was fabricated to create multiple linear cell plating channels, each
with width of 300 um. This was adhered to an indium tin oxide (ITO)-coated glass slide, to facili-
tate later laser catapult. The ITO was coated with type I collagen, to improve keratinocyte adher-
ence. Normal human keratinocytes were injected into the channels and allowed to attach to the
collagen substrate for 2 hours. Once cells attached, the PDMS mask was removed, and the ITO-
coated glass slide was placed into a chamber that allowed the application of an EF of 100 mV/mm
perpendicular to the orientation of the plating channels. After 6 hours, keratinocytes migrated away
from the channels in both cathodal and anodal directions. 100 keratinocytes that had migrated
toward the cathode were laser catapulted from the ITO-coated glass slide and RT-PCR of the col-
lected sample was used to detect the house keeping gene GAPDH. The recovery of a robust sig-
nal indicates that this method will allow the capture and genetic profiling of directionally migrat-
ing keratinocytes in an EF, providing clues to the unique characteristics that govern either anodal
or cathodal directional migration.
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Skin wounds actively generate endogenous electric fields and fluxes of Ca2+ and Na+
B Reid,1 D Graham,2 P Smith2 and M Zhao1 1 Dermatology, University of California, Davis,
Davis, CA and 2 BioCurrents Research Center, Marine Biological Laboratory, Woods Hole,
MA
Endogenous electrical fields are present at skin wounds and are a powerful signal that directs cell
migration in wound healing. To date, the underlying mechanisms of the generation of endogenous
electric fields remain elusive. We used a vibrating probe system to measure wound electric cur-
rents. Small wounds in human and mouse skin all produced dynamically-regulated electric fields.
In a skin epithelial slit cut of two millimeters in length on a human finger, inward electric currents
of ~2.3μA/cm2 were detected 5min after wounding. The electric currents then reversed direction
to become outward 10-20 min following injury. The size of the currents increased to 3.9μA/cm2
at 45 min, 7.3μA/cm2 at 90 min and 9.6μA/cm2 at 120min after injury. It has been assumed that
passive leakage of ions and charged particles out of the wound generates wound electric cur-
rents/fields. Our data challenge this paradigm and suggest that the wound electric fields are an
active response of the injured epithelium to injury because the current direction reversed after
wounding, and the current size increased to peak up to two hours following injury. If the current
is merely due to passive leakage, the direction of the current should be consistent immediately after
wounding, and the peak current should appear immediately upon or very soon after wounding.
We next used an ion selective probe system to measure the fluxes of specific ion fluxes at human
and mouse skin wounds. We detected large Ca2+ and Na+ effluxes at mouse skin wound immedi-
ately following wounding, which doubled in size in 60-90min after wounding, with a similar but
shorter rising phase as the wound electric currents. Elucidation of the ionic and molecular mech-
anisms of the electric currents will likely provide pharmacological targets to increase the endoge-
nous wound electric signaling, which can be used to accelerate wound healing and instigate heal-
ing responses in chronic and non-healing wounds.
www.jidonline.org   S5
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Fibronectin growth factor-binding peptides protect adult human dermal fibroblasts from
oxidative- and cytokine-induced death
L Macri,1 MG Tonnesen,1,2 F Lin1 and RA Clark1 1 Stony Brook University, Stony Brook, NY and
2 VAMC, Northport, NY
In acute burns and chronic wounds, oxidative stress and inflammatory cytokines induce tissue cell
death by necrosis and apoptosis, respectively. The persistence of these toxic agents leads to burn
injury progression and failure of chronic wounds to heal. We discovered that FN contains 4
fibronectin growth factor-binding (FN-GFB) peptides that bind PDGF and are required for fibrob-
last survival and proliferation. In other studies presented at this meeting we show mechanisms by
which fibroblasts failed to survive and grow in the absence of FN-GFB sites, by utilizing mouse
FN-null fibroblasts. Here we demonstrate that FN-GFB peptides prevented adult human dermal
fibroblast (AHDF) death induced by oxidative stress and/or tumor necrosis factor-α (TNF-α). Within
24 hrs, most (>90%) AHDF died by necrosis and none by apoptosis in the presence of ≥500 μM
H2O2, while 20-30% AHDF died by apoptosis and none by necrosis in the presence of ≥500 ng/ml
TNF-α. Little, if any, toxic effect was observed when AHDF were exposed to lower doses of these
agents: 50-300 μM H2O2 or 50-100 ng/ml TNF-α. In contrast, when AHDF were exposed to a
subtoxic level of H2O2 (200 μM) in combination with TNF-α (500 ng/ml), approximately 60% died
by necrosis and 40% died by apoptosis, indicating a synergistic effect. FN-GFB peptide (in con-
centrations as little as 15 μM) completely protected AHDF from cytotoxic doses of H2O2 alone,
or in combination with TNF-α, regardless of whether the death pathway was necrosis, apoptosis
or both. Therefore we propose that FN-GFB peptides may be cyto-protective in chronic wounds,
burns and other inflammatory disorders and thereby restore homeostasis and promote healing.
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Fibronectin contains four novel, evolutionarily conserved growth factor-binding peptides
required for fibroblast survival
RA Clark,1 F Lin1 and MG Tonnesen1,2 1 Stony Brook University, Stony Brook, NY and 2 VAMC,
Northport, NY
Chronic wounds and burns show an absence of fibronectin (FN) and demonstrate fibroblast apop-
tosis. Last year at the TriSociety meeting, we showed that fibroblasts in the absence of FN died by
apoptosis and that fibroblast survival and proliferation requires FN growth factor-binding (FN-
GFB) domains. Now we extend those studies by delineating 4 FN-GFB peptides within the FN-
GFB domains with binding KDs of 10 to 100 nM. The peptides have similar sequence patterns and
are evolutionarily conserved. To determine the biological activity of the peptides, FN-null fibrob-
lasts were utilized. Null- cells cultured in serum-free DMEM on recombinant RGD cell-binding
domains without FN-GFB domains or peptides, died by apoptosis within three days, in the pres-
ence or absence of 1 nM PDGF. Attachment, spreading and focal contact formation occurred within
1 hr and continued to appear morphologically normal for 24 hrs. However, the metabolic response
even in the presence of PDGF was minimal at 24 hrs and was associated with autophagy as judged
by the appearance of LC3II, a protein critical for autophagosome formation. At 48 hrs apoptosis
was first noted, and by 72 hrs most cells had died. In contrast, when FN-null cells were plated on
RGD cell-binding domain to which any one of the FN-GFB peptides had been coupled, they sur-
vived for 7 days without PDGF and proliferated in its presence. Importantly, FN-GFB peptides
decreased pro-apoptotic gene expression and increased anti-apoptotic gene expression. Thus to
survive fibroblasts required a FN-GFB peptide in addition to the RGD cell-binding domain. In the
absence of FN-GFB peptides, cells developed a starvation response including autophagy and finally
died by apoptosis. Such FN-GFB peptides have great therapeutic potential for FN-deficient wounds,
such as burns and chronic ulcers.
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Indigo naturalis and one of its pure components, indigo, exert anti-angiogenic effects both
in vivo and in vitro
Y Lin1,2 and J Su Pang2 1 Chang Gung Memorial Hospital, Keelung, Taiwan and 2 Chang Gung
University, Taoyuan, Taiwan
Psoriasis is a chronic skin disease for which only remissive, as opposed to curative, treatments are
currently available. In recent years, we developed a new method for treating psoriasis by using
indigo naturalis ointment and the clinic efficacy was better compared to other routine treatments.
Since the role of angiogenesis has been demonstrated to be important in the pathogenesis of pso-
riasis, this study was focused on investigating the effects of indigo naturalis and its pure acting com-
ponent(s) on the process of angiogenesis. The angiogenesis in the psoriatic lesions was first found
to be diminished in indigo naturalis–treated cured lesions as demonstrated by histological exami-
nation. We also demonstrated that indigo naturalis and one of its pure ingredient, indigo, exerted
anti-angiogenic effects as analyzed by in vivo chick CAM angiogenesis assay. The VEGF-induced
CAM angiogenesis could be inhibited by the addition of indigo naturalis or indigo by 67% or
87%, respectively. Indigo naturalis (up to 500 ug/ml) and indigo (up to 100uM) did not affect the
cell viability and cell migration of vascular endothelial cells, however, they significantly inhibited
matrix-induced tube formation. The matrix-induced tube formation could be inhibited by the
addition of indigo naturalis or indigo by 30% or 80%, respectively. Among the genes that were
known to be induced by VEGF in vascular endothelial cells, we analyzed the expressions of genes
such as angiogenin, PDGF-A &-B, IL-8, MMP-1 & 3. We found that both indigo naturalis and indigo
could effectively inhibit the gene expression of IL-8. Since the function of IL-8 was known to be
required for the angiogenesis, we concluded that indigo naturalis, possibly mediated by indigo,
could inhibit the angiogenesis, at least in part, by down-regulating the gene expression of IL-8.
Hopefully, with these research efforts, we can finally understand the mechanism underlying the
efficacy of indigo naturalis and help us to make improvements on preparing the drug in order to
obtain the best efficacy.
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Comparative assessment of molecular events involved in wound healing using a porcine
partial thickness wound model and real time RT-PCR
R Perez, Y Rivas, J Gil, J Valdes and SC Davis Dermatology and Cutaneous Surgery, University
of Miami, Miami, FL
The benefits of occlusion for wound healing have been well established by countless studies. How-
ever, the molecular events associated with these benefits are not clearly understood. Wound heal-
ing is a complex orchestration of cellular and molecular events which must be carefully balanced
in order to prevent catastrophic malfunctions leading to chronicity, inefficient scarring, or infec-
tion. Swine were used in our experiments due to their similar wound healing response and skin
physiology to that of humans. Using a well established porcine model for wound healing we eval-
uated the effects of occlusion on deep partial thickness wounds using an epidermal migration assay
and real-time RT-PCR with porcine specific oligonucleotides. Wounds were created and immedi-
ately occluded with a polyurethane dressing or left uncovered (air exposed) and assessed using an
epidermal migration assay beginning on day 4. Biopsies were taken for molecular analysis. Occluded
wounds initiated complete epithelialization and were 100% completely epithelialized, two days
earlier than air-exposed wounds. Gene expression analysis of interleukin 1α (IL-1α) and tumor
necrosis factor α (TNFα) indicated that occlusion results in an abbreviated but more intense inflam-
matory response. Earlier and more intense expression of these factors may be one of the key rea-
sons for accelerated tissue repair. Comparative analysis of matrix metalloproteinase-9 (MMP-9)
indicated that gene expression was greatly reduced by occlusion. Over expression of MMP-9 has
been associated with chronic wounds. Yet others have shown MMP-9 levels in acute wounds are
upregulated in scarless wound healing. Analysis of vascular endothelial growth factor (VEGF) indi-
cated that occlusion induces expression of the gene. VEGF is also expressed earlier in the occluded
wounds. VEGF is involved in angiogenesis and endothelial cell migration. A better understanding
of the progression of the cellular events during accelerated repair may provide novel therapeutics
for acute and chronic wounds.
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Media conditioned by human metastatic melanoma cells inhibits in vitro dermal fibroblast
migration
K Kobrin,1,2 T Kwak,1,2 T Yufit1,2 and V Falanga1,2,3 1 Department of Dermatology and Skin
Surgery, Roger Williams Medical Center, Providence, RI, 2 NIH Center of Biomedical
Research Excellence, Roger Williams Medical Center, Providence, RI and 3 Departments of
Dermatology and Biochemistry, Boston University, Boston, MA
In this report, we determined the effect of MEM conditioned by two separate strains of human
melanoma, primary or metastatic, on the in vitro migration of human dermal fibroblasts. This
study utilized a novel research tool that enables time lapse photography of cells directly in a stan-
dard incubator, and then calculates and graphs data such as cellular confluence and scratch wound
width. Fibroblast cells were grown to confluence in DMEM in 24-well plates for 24 hours. We
used a specialized wound-scratch module to make uniform scratches in every well. Fibroblasts
were then treated for 24 hours in MEM, MEM conditioned by metastatic melanoma cells, or MEM
conditioned by primary melanoma cells. Each culture was photographed every hour for 24 hours.
We used the percent wound confluence generated by the equipment’s software as a measure of
percent scratch wound coverage. All changes in migration were compared to control cultures. We
found that MEM conditioned by metastatic, but not primary, melanoma cells led to a steady (hour
by hour) decrease in fibroblast migration. At 24 hours, the decrease in migration was 27% (p <
.05; t-Test). Our results indicate that media conditioned by tumor cells, depending on the condi-
tioning cells’ biological behavior, can decelerate fibroblast migration, a parameter that is not nor-
mally investigated. This may have implications for tumor spread and growth.
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Overexpression of Hoxb13 in mouse skin results in delayed wound healing, dermatitis, and
upregulation of VEGF
JA Mack1,2 and EV Maytin1,2 1 Biomedical Engineering, Cleveland Clinic, Cleveland, OH and
2 Dermatology, Cleveland Clinic, Cleveland, OH
The Hox transcription factors are best known for their roles in embryonic patterning and specifi-
cation of cell fate. Hox gene expression continues throughout adulthood and we are just begin-
ning to understand how these highly conserved proteins function in the maintenance and repair
of adult tissues. We previously showed that loss of Hoxb13 from adult skin results in enhanced
cutaneous healing. To further elucidate the role of Hoxb13 in skin maintenance and repair, we gen-
erated transgenic mice that overexpress Hoxb13 in the basal layer of the epidermis via the K14
promoter (Hoxb13K14 mice). Full-thickness cutaneous excisional wounds were performed, and
the skin harvested for histological and molecular analyses in time course studies. Compared to
wild-type littermates, Hoxb13K14 mice demonstrated significantly delayed healing, exemplified
by persistence of the fibrin clot, a prolonged inflammatory response, enlarged blood and lymphatic
vessels, and grossly abnormal epidermal histology. In addition to delayed healing, Hoxb13K14
mice developed progressively worsening skin lesions as they aged, manifested by histological
changes and inflammatory abnormalities very similar to those of aging mice overexpressing VEGF
via the K14 promoter. We evaluated VEGF expression in Hoxb13K14 unwounded skin and deter-
mined that it is significantly upregulated compared to VEGF in the skin of wild-type littermates.
Overall, we have shown that overexpression of Hoxb13 in skin results in impaired healing and der-
matitic skin lesions in aging mice, both of which may be due in part to VEGF upregulation. VEGF
plays a central role not only in wound healing but also in tumor growth. Therefore it is notewor-
thy that Hoxb13 upregulation has been reported in several types of cancer. In conclusion, our cur-
rent data suggest that Hoxb13 may be an important clinical target in a number of pathological
conditions.
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Candida albicans infections: A porcine skin model to evaluate treatment efficacy
R Perez, J Gil, J Valdes, Y Rivas and SC Davis Dermatology and Cutaneous Surgery, University
of Miami, Miami, FL
Candida albicans is the most common cause of opportunistic mycoses worldwide and can be a
major player in wound infections. The aim of this study was to examine the effects of an antifun-
gal agent on the proliferation of 3 strains of Candida albicans using a porcine model. Second degree
burns were created on pigs and inoculated with one of three different strains of Candida albicans:
ATCC 10261, ATCC 64550 fluconazole-resistant and ATCC 26310 fluconazole-sensitive. After
inoculation, wounds were covered with a polyurethane dressing for 4 hours to allow fungal wound
colonization. After 4 hours, the polyurethane dressings were removed and wounds either treated
with daily application of topical terbinafine hydrochloride or left untreated. At 24, 48 and 72 hours
post inoculation, three wounds from each treatment group were flush and scrub cultured and quan-
tified using the Spiral Plater System. Candida albicans was grown on BIGGY agar at 25°C for 48–72
hours. Colonies on the plates were counted and the colony forming units per mL (CFU/ml) calcu-
lated. At 24 hours, wounds inoculated with the most sensitive strain (26310) were the only group
which showed a significant reduction in challenge pathogen with treatment. At the 48 hour assess-
ment time, wounds which were inoculated with ATCC strain 10261 showed a reduction in fungal
cell counts with treatment. A significant reduction in the colony counts was seen in all 3 strains at
72 hours with active as compared to the non-treated wounds. Overall, the most sensitive strain
was 26310 and the most resistant strain was 64550. Once a day application of the antifungal was
able to reduce counts of C. albicans. However, it was never able to completely eradicate the organ-
ism. Further studies are needed to determine if additional treatments (i.e. twice daily or more pro-
longed) would eliminate this organism from the wounds.
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Delayed cutaneous wound repair in Pyk2 knockout mice
A Hindes,1 CJ Burns,1 BL Marmer,1 G Goldberg,1 M Blumenberg2 and T Efimova1 1
Dermatology/Medicine, Washington University, St. Louis, MO and 2 Dermatology, NYU,
New York, NY
The proline-rich protein tyrosine kinase 2 (Pyk2) is a member of the focal adhesion kinase family
of tyrosine kinases. We studied a role for Pyk2 in cutaneous wound repair using Pyk2-deficient
mice. Histological analysis showed that Pyk2-null epidermis was normal. However, the rate of
wound closure in Pyk2-deficient mice was delayed compared with that of control mice. To exam-
ine whether the impaired wound healing of Pyk2-null mice is caused by compromised keratinocyte
function, primary keratinocytes from wild-type (WT) and Pyk2-null mice were isolated and cul-
tured, and their ability to heal scratch wounds in vitro was compared. We found that the rate of
scratch wound repair by Pyk2-null keratinocytes was decreased compared with that by WT cells.
Moreover, cultured normal human epidermal keratinocytes (NHEK) in which Pyk2 function was
inhibited by overexpression of a dominant-negative mutant of Pyk2, failed to heal scratch wounds.
Thus, in the absence of Pyk2, epidermal keratinocytes show a cell-autonomous defect in migra-
tion. Conversely, stimulation of Pyk2-dependent signaling via overexpression of WT Pyk2 in NHEK
induced a markedly accelerated scratch wound closure, and was associated with increased expres-
sion of genes encoding matrix metalloproteinases (MMPs) 1, 9, and 10, the important enzymes
that regulate extracellular matrix remodeling during wound healing process. The Pyk2-stimulated
increase in the rate of scratch wound repair was blocked by co-expression of the dominant-neg-
ative mutant of Protein Kinase C δ (dnPKCδ), indicating that PKCδ is essential for this regulation.
Zymographic analysis showed that Pyk2-stimulated increase in MMP9 activity was abolished by
co-expression of the dnPKCδ in NHEK. Taken together, these data suggest that Pyk2 is essential for
skin wound reepithelization in vivo, and regulates epidermal keratinocyte migration via a path-
way that involves PKCδ and MMPs 1, 9, and 10 in keratinocytes.
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Identification of minimum amino acid sequence in heat shock protein-90 as a novel moto-
gen for both human keratinocytes and fibroblasts during wound healing
W Li, C Cheng, J Fan, R Kim, M Chen and D Woodley Dermatology and Norris Comprehensive
Cancer Center, University of Southern California, Los Angeles, CA
Until recently, heat shock protein 90 (Hsp90) has been mostly known as an intracellular ATP-
dependent chaperon with more than 100 clients playing critical roles in various branches of the
intracellular signaling networks. Because of Hsp90’s reported higher protecting functions in can-
cer cells, chemical inhibitors that target Hsp90’s N-terminal ATPase function are currently in a
number of human clinical trials as anti-tumor drugs. However, emerging results of studies from
the past few years have demonstrated that certain cells secrete Hsp90α into extracellular envi-
ronment under either pathological conditions or stress. We showed that TGF-alpha (in serum, but
not available in plasma) and hypoxia potently cause keratinocytes and dermal fibroblasts to secrete
Hsp90α. Outside the cells, Hsp90α strongly stimulates motility of both dermal and epidermal cells.
The mechanism of extracellular Hsp90’s action is to bind and signal through the lipoprotein
receptor, LRP-1, present in all the cell types in skin. More intriguingly, unlike conventional growth
factors, Hsp90α-induced cell migration is refractory to the anti-motility effect of the TGF-beta
family cytokines (TGF-beta1 and TGFbeta3), which are abundantly present in wounds. Thera-
peutically, we further identified the functional domain of ~130 amino acids within the junction
between the middle domain and the charged linker region in Hsp90α. In contrast, the entire N’-
terminal ATPase and the C-terminal co-factor-interacting domains are dispensable. Topical appli-
cation of purified Hsp90α showed significant higher enhancement of wound healing in mice than
the only FDA-approved wound healing agent, PDGF-BB (Regranex). Thus, this 130 amino acid
peptide derived from Hsp90α could be a novel and more effective wound healing agent. We will
discuss why Mother Nature chooses extracellular Hsp90 to carry out extracellular, conventional
growth factor-like functions during wound healing.
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Parallel studies of cutaneous wound healing: IR imaging, confocal Raman microscopy, and
molecular biology
G Zhang,1 K Chan,2 M Tomic-Canic,3,4 O Stojadinovic,3 B Lee,5 CR Flach1 and R Mendelsohn1 1
Dept of Chemistry, Rutgers University, Newark, NJ, 2 Dept of Chemical Engineering, Imperial
College London, London, United Kingdom, 3 Tissue Engineering, Regeneration, and Repair
Program, Hospital for Special Surgery of the Weill Medical College of Cornell University, New
York, NY, 4 Dept of Dermatology, Weill Medical College of Cornell University, New York, NY
and 5 Genentech, South San Francisco, CA
The response of the human body to cutaneous wounding leads to a complex series of spatially and
temporally organized events in order to prevent infection and initiate healing of the injured tissue.
Wound closure involves proliferation and migration of keratinocytes over the wound bed, followed
by remodeling of connective tissue and re-establishment of the stratified epidermis. We have used
a human skin wound healing model to correlate changes in genotype and phenotype with infrared
(IR) and confocal Raman spectroscopic images during the re-epithelialization of excisional wounds.
IR images clearly delineate the keratin-rich migrating epithelial tongue from the collagen-rich wound
bed. The distinct spatial distribution of different keratin types exposed by immunofluorescent stain-
ing is correlated with IR imaging data revealing subtle spectral differences. Images constructed from
confocal Raman spectra identify elastin in the wound bed and complementary collagen-rich spa-
tial patterns. The temporal sequence of events is explored by comparing the results of gene microar-
ray analysis with confocal Raman microscopy. The current experiments demonstrate the feasibil-
ity of our experimental protocol. The spectroscopic methods complement the molecular biology
approaches by providing a molecular structure-based characterization of several factors, mostly
protein, in a single skin section.
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Podoplanin can influence the MAPK pathway and thereby regulate its own expression
T Schüler,1,2 L Bruckner-Tuderman1 and V Schacht1 1 Department of Dermatology, University
Medical Center Freiburg, Freiburg, Germany and 2 Institute of Biology I, University of
Freiburg, Freiburg, Germany
Podoplanin is a small transmembrane glycoprotein, used as a specific marker for lymphatic endothe-
lium. Podoplanin promotes cell development and cell migration by directly interacting with ezrin
and moesin, ERM proteins linking membrane proteins to the actin cytoskeleton. The expression of
podoplanin is induced by EGF, FGF2 and TNF-α and is upregulated in many different human can-
cers, e.g. squamous cell carcinomas. Recent studies have shown that the transcriptionfactor c-fos
binds to the promoter region of podoplanin and activates the transcription of podoplanin. Further
studies during the last years have shown that podoplanin is able to induce invasion of single cells
after loss of E-cadherin and to induce collective cell migration, because podoplanin is expressed
in the invasive front of the migrating cells. But the molecular mechanism is still unknown. We inves-
tigated podoplanin using the yeast-two-hybrid (Y2H) system to find new protein interacting part-
ners. The Y2H system is a widely accepted method for in vivo detection of binary protein interac-
tions. We screened podoplanin against the cDNA library of the human kidney and human ovary.
One interaction we found was between the endodomain of podoplanin and the β-subunit of the
sodium potassium pump. As it is known, the sodium potassium pump directly interacts with src,
probably by its α subunit, and activates it, which in turn activates the EGF receptor and leads to
the activation of the MAPK pathway resulting in the transcription of c-fos. So we conclude that the
interaction of podoplanin with the sodium potassium pump can influence the transcription of c-
fos and consequently also influences its own transcription. Additionaly we found in microarray
data of lymphatic endothelial cells, which have been treated with podoplanin siRNA, the sodium
potassium pump α1 subunit upregulated. This result leads to the assumption that the upregulation
of the α1 subunit of sodium potassium pump is a mechanism of compensation for the missing
podoplanin.
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Effect of transforming growth factor beta 3 on the proliferative phase of murine wound
healing
J Morrison,1 B Schutte2 and M Dunnwald1 1 Pediatrics, The University of Iowa, Iowa City, IA
and 2 Microbiology and Molecular Genetics, Michigan State University, East Lansing, MI
Many growth factors and cytokines are necessary for proper wound healing. Amongst them, the
transforming growth factor beta (Tgfb) family has been shown to have an important role in cellu-
lar differentiation and growth. However, the role of Tgfb3 in the epidermis during the proliferative
phase of wound healing has yet to be determined. Six mm bilateral full thickness wounds were
created on the dorsorostral back skin of adult mice. One day after wounding, mice were injected
with either saline, Tgfb3 or Tgfb3 neutralizing antibody. Animals were sacrificed 4, 7 and 11 days
after wounding and the wounded skin was harvested. Macroscopic observations revealed no dif-
ference between treatments at either 4, 7 and 11 day time points. Morphometric analyses of serial
histological sections indicate no statistical significant changes in wound volume, epidermal vol-
ume and wound surface between Tgfb3 and Tgfb3 neutralizing antibody treated animals 7 days
post wounding (n=3). Keratin 14 was absent from the neoformed epidermis, while stratifin and
interferon regulatory factor 6 were expressed in the suprabasal keratinocytes of the neoformed
epidermis. Keratin 17, which is normally absent from the interfollicular epidermis, was upregu-
lated in the neoformed epidermis. Together, these data suggest that the exogenous addition of Tgfb3
had no detectable effect on the proliferative phase of wound healing. As Tgfb3 is under clinical
trial for scar free wound healing, it remains to be seen if it has an effect on the extracellular matrix
and at different time points.
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Positive correlation between VEGF-A expression in melanocytic lesions and degree of histo-
logical atypia
C Curiel-Lewandrowski,1,2,3 JG Einspahr,2,3 K Saboda,2 M Krutszch,2 L Morrison1,2 and
RB Nagle2,3,4 1 Section of Dermatology, University of Arizona, Tucson, AZ, 2 Arizona Cancer
Center, University of Arizona, Tucson, AZ, 3 Department of Medicine, University of Arizona,
Tucson, AZ and 4 Department of Pathology, University of Arizona, Tucson, AZ
A significant body of evidence supports the concept that dysplastic melanocytic nevi (DN) repre-
sent either a precursor and/or surrogate marker of melanoma (MM). Therefore, identification of
relevant and reproducible melanocytic biomarkers that can accurately recognize individuals at sig-
nificant risk for melanoma are needed. The expression of vascular endothelial growth factor-A
(VEGF-A) and VEGFR2 by IHC technique was assessed in archival material from 17 begin nevi
(BN), 33 DN with mild atypia (DNM), 18 DN with severe atypia/MMIS (DNS/MMIS), and 30 inva-
sive MM. Specifically, VEGF-A and VEGFR-2 expression was evaluated at the junctional (JNM)
and dermal (DMM) melanocytic components, as well as keratinocytes (KC), with respect to both
the intensity of the IHC signal and percentage of positive cells at the nuclear (NU) and cytoplas-
mic (CT) level. Overall, VEGF-A expression in melanocytic cells demonstrated an increased expres-
sion from BN (mean ± SD, 242.9 ±166.0), to DNM (399.8 ± 206.8), DNS/MMIS (487.5 ± 156.1),
and MM (430.0 ± 182.6) while VEGFR-2 demonstrated minimal expression throughout the study
samples. Further analysis with respect to histological localization of VEGF-A expression among
melanocytic lesions categories demonstrated: JNM CT index p=0.20, JNM NU index p=0.88, DMM
CT index p=0.006, DMM NU p=0.008, KC CT index p=0.02, and KC NU index p=0.15. The trend
in VEGF-A expression was statistically significant (p=0.023) over the diagnostic categories. Cur-
rent results suggest that VEGF-A expression, particularly within the dermal melanocytic compo-
nent, represents a potential biomarker in the progression from benign melanocytic lesions to MM.
Further evaluation at the signaling pathway level will be required to further support the role of
VEGF as a potential biomarker in a subset of melanoma cases.
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The role of insulin-like growth factor-1 (IGF-I) in wound healing of human skin cells
S Chen, J Conte, S Yim, D Ptchelintsev and U Santhanam Global R&D, Avon Products, Inc.,
Suffern, NY
IGF-I stimulates a broad range of actions from early development and throughout life. Its role in
orchestrating and enabling the cellular process required for successful wound healing remains to
be elucidated. In this study, we used a scratch assay of primary human keratinocytes and primary
human fibroblasts as our model systems to examine the role of IGF-I on cell proliferation and migra-
tion during wound healing. A positive effect of IGF-1 on wound healing was discerned in the fibrob-
last scratch assay and we further compared IGF-I action in young vs. old human skin cells. To delin-
eate the mechanism of IGF-I action during the wound healing process, we also studied the IGF-I
signaling pathway to understand whether other growth factors mediate IGF-I effects during wound
healing. Finally, we developed a blend of novel plant extracts and synthetic compounds that can
mimic, in part, IGF-I action on skin cells in our human skin wound healing model systems.
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Stress-related catecholamines alter chemokinetics of hMSC in vitro
BR Lin,1,2 RS Bolaji,1 JA Nolta2 and RR Isseroff1 1 Department of Dermatology, UC Davis,
Davis, CA and 2 Department of Internal Medicine, UC Davis, Sacramento, CA
Bone-marrow derived human mesenchymal stem cells (hMSC) are recruited to the dermis and epi-
dermis during cutaneous wound healing. We previously found that epinephrine (EP) decreases ker-
atinocyte migration and delays skin wound re-epithelialization, indicating that conditions of stress
may hinder wound healing. Here we examined the effects of the stress-related catecholamines, EP
and norepinephrine (NE) on hMSC migration. hMSC were isolated from human bone marrow
aspirates and cultured in low glucose DMEM with 10% FBS. Using RT-PCR, we found expression
of transcripts for α2A, α2B, β1 and β2 adrenergic receptors in hMSC. Cells also expressed the α2A
and β2 receptor proteins. To determine functionality of the receptors, hMSC were incubated with
either EP or NE (at 0, 1, 10, 100 nM, 1 μM, doses mimicking physiologic levels in non-stressed and
stressed individuals) and cell migratory speeds measured. hMSC treated with EP exhibited a dose
dependent decrease in migratory rates with a maximal 20% decrease in migration speeds at 1 μM
EP. In contrast, hMSC treated with NE exhibited a dose dependent increase in migratory rates with
a maximal 25% increase in migration rates at 1 μM NE. The changes in migration rate could be
reversed by blockade of specific adrenergic receptors. Cotreatment of hMSC with Timolol, a com-
petitive antagonist of β1 and β2 receptors, reversed the EP-induced decrease in migration rate, while
cotreatment of hMSC with Yohimbine, a competitive α2 antagonist reversed the NE induced increase
in migration rate, demonstrating receptor subtype specificity for the EP and NE-induced alterations
in hMSC migration. Treatment of hMSC with 1 μM EP led to decreased phosphorylation of ERK
and AKT. These results indicate that catecholamines alter hMSC migration and possibly homing to
wound sites by receptor mediated mechanisms, and suggest that EP and NE released during stress
can contribute to decreased wound healing observed in stressed individuals. These findings offer
a model for developing novel treatment strategies for non-healing wounds.
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Noninvasive assessment of cutaneous microcirculation using functional diffuse reflectance
spectroscopy
I Seo, PR Bargo and N Kollias Models and Methods, Johnson and Johnson CPPW, Skillman, NJ
Diffuse reflectance spectroscopy (DRS) is a widely used noninvasive technique to diagnose bio-
logical tissues. In particular, strong absorption characteristics of blood in visible spectral range have
been used to assess physiological condition from DRS measurements. However, the DRS system
only provides information of blood content from the reflectance detected at a single exposure
time, and fails to demonstrate dynamic changes of blood flow inside the tissues. In the present
study, a prototype system for functional DRS (fDRS) has been developed for the sequential acqui-
sition of multiple reflectance spectra in the visible range at every 150 milliseconds. Fast acquisi-
tion of time-series reflectance enables us to detect blood pulsations at different skin sites. The new
system was examined on 12 individuals with skin phototype I-III by measuring erythema lesions
induced by UVB irradiation at a maximum of 2.5 minimum erythema dose. The light source for
irradiation was a Xenon arc solar simulator filtered by UG-11 and WG-335. The skin reactions were
evaluated on days 1, 3, and 7 after irradiation. Evaluations included conventional DRS, functional
DRS, and a laser Doppler flowmeter/imaging system. In a frequency analysis results, there were
two distinctive frequency components. A low-frequency component was found near 0.03-0.1 Hz,
and another high-frequency component near 0.9-1.2 Hz which is synchronous with heart pulsa-
tions. The magnitude of high-frequency component changed with the degree of minimum erythema
dose. Additional measurement with the conventional DRS revealed the increase of oxy- and deoxy-
hemoglogin concentrations with the level of irradiation dose. The result confirms the potential of
this technique for noninvasive diagnosis of cutaneous microcirculation.
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Melanoma cells trigger vascular leak via VEGF-independent activation of endothelial cell
matrix metalloproteinases
S Weng and M Kluger Department of Dermatology and Program in Vascular Biology and
Therapeutics, Yale University School of Medicine, New Haven, CT
Melanoma cells secrete factors that promote vascular hyperpermeability (leak) in order to create
an environment favoring angiogenesis and metastasis. Expression of VEGF-A increases with
melanoma progression, but expression of other vascular permeability factors (e.g., IL-8) suggests
leak may occur via different endothelial cell (EC) pathways. Because understanding these path-
ways could inform therapy, we studied how melanoma cells trigger vascular leak in two human-
based models. Melanoma cells (YUSIT) injected sub-cutaneously under human skin grafted onto
SCID mice increased vascular leak by 100% at 72 h post-injection via secreted factors. Similarly,
medium conditioned either by cultured YUSIT (CM) or by three different human melanoma lines,
increased leak across monolayers of human dermal microvascular EC (HDMEC) as measured by
transendothelial electrical resistance (TEER). Removing VEGF (but not IL-8) by antibody depletion
largely blocked leak in both models, suggesting a complete EC response requires VEGF. However,
YUSIT CM also promotes leak via factors different from VEGF, since lower VEGF concentrations
were needed to decrease TEER when HDMEC were first incubated in VEGF-depleted CM. Indeed,
matrix metalloproteinase (MMP) Inhibitor V (Calbiochem; specific to MMP-2 and MMP-9 at < 200
nM) inhibited TEER decreases in response to replete YUSIT CM, or to CM depleted of MMPs, but
did not inhibit TEER decreases in response to VEGF. Moreover, CM increased HDMEC MMP-2
mRNA in a VEGF-independent manner. Remarkably, CM depleted of VEGF, or CM depleted of
MMPs, could each increase enzymatic activity of HDMEC MMP-2 and MMP-9 by zymography
analysis. We conclude that melanoma cells secrete one or more unknown factors that activate EC
MMPs in a VEGF-independent manner. Once activated, HDMEC MMP-2 +/or -9 increase perme-
ability; melanoma derived MMPs may also contribute. These results invite further investigation into
EC MMP activation and vascular leak as potential therapeutic targets in melanoma.
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An IMIC-like current in normal human keratinocytes: Possible involvement in cell migration
SC Lee, EV Leaver, Z Gurenko, P Steenhuis and RR Isseroff Dermatology, University of
California, Davis, CA
Ion channels contribute to functions such as differentiation and migration in non-excitable cells.
To assess whether ion channels play a role in migration in keratinocytes, normal human neonatal
foreskin keratinocytes were voltage-clamped by whole-cell patch clamp methods. In Ca/Mg-con-
taining medium almost all cultured keratinocytes studied in ruptured patch mode expressed an out-
wardly-rectifying current consistent with the Magnesium-Inhibitable Current, IMIC, present in many
other cell types but not yet described in keratinocytes. This current is activated by depletion of
intracellular Mg2+ (Mg2+i) but exhibits little or no activity at normal [Mg
2+
i]. In some keratinocytes
IMIC-like current was present from the beginning of recording, but in most it developed slowly over
a period of minutes, reflecting the deliberate depletion of Mg2+i by the pipet fill solution. Cells dia-
lyzed with internal solutions supplemented with Mg to maintain high [Mg2+i] quickly lost any ini-
tial IMIC-like current and never developed any similar current. As with this current in other cell types,
the IMIC-like current in keratinocytes became largely non-rectifying in Ca/Mg-free media and was
blocked by externally-applied 2-aminoethoxydiphenylborate (2-APB) and Gd3+. To evaluate the
function of this current, we examined migratory speed of keratinocytes incubated with 2-APB.
Cell movement was completely and reversibly inhibited by 2-APB with an IC50 of ~50 μM—con-
centrations comparable to those that block the IMIC-like current under voltage clamp. IMIC is com-
monly identified with the nonspecific cation channel TRPM7, and indeed, we found TRPM7 expres-
sion in keratinocytes by both RT-PCR and Western blot analysis. Thus, we have uncovered a potential
role for the TRPM7 channel in keratinocytes in controlling cell migration. TRPM7 is believed to
function as a regulated uptake pathway for Ca2+ and/or Mg2+. Since wound concentrations of Mg2+
vary during skin wound healing, sampling of this ion by keratinocytes may be an important guid-
ance mechanism during wound repair.
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Overexpression of CD109 in the epidermis modulates inflammation during wound healing
J Vorstenbosch,1 C Gallant-Behm,2 R Fang,2 S Mathur,1 T Mustoe2 and A Philip1 1 Plastic
Surgery, McGill University, Montreal, QC, Canada and 2 Plastic Surgery, Northwestern
University, Chicago, IL
TGF-β is a multifunctional growth factor that affects many aspects of wound healing including
inflammation, angiogenesis, cell proliferation and migration. Excessive levels of TGF-β1 at the
wound site have been suggested to underlie the scar formation, and even higher levels have been
identified as a hallmark several fibrotic wound healing pathologies such as keloids and hyper-
trophic scars. CD109 has recently been identified as a TGF-β co-receptor that inhibits TGF-β sig-
naling in vitro. To identify the role of CD109 in wound healing, we generated transgenic mice
overexpressing CD109 in the epidermis and administered wounds on the back of these transgenic
mice and their wild-type littermates. In excisional wounds we demonstrate that the CD109 trans-
genic mice display enhanced keratinocyte migration and proliferation, and accelerated re-epithe-
lialization, when compared to wild-type littermates. Additionally, the transgenic mice exhibit
increased recruitment of inflammatory cells such as neutrophils to the wound margins as opposed
to wild-type mice which heal with moderate inflammation, identifying CD109 as a potent
immunomodulatory agent during wound healing. The effect of CD109 to promote reepithelial-
ization and enhance immune cell recruitment during wound healing may involve its ability to
regulate TGF-β signaling pathways. Understanding the mechanism by which CD109 modulates
reepithelialization and inflammation during wound healing may lead to the development of bet-
ter treatment strategies for impaired healing and excessive scarring.
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The role of extracellular superoxide dismutase in the molecular link between inflammation
and angiogenesis
H Lee, Y Kim, B Jeon, J Han and T Kim Catholic Research Institute of Medical Science, Seoul,
Korea, South
Ultraviolet light induces inflammatory process and the generation of reactive oxygen species (ROS).
ROS-mediated inflammation plays an important role in angiogenesis. One of antioxidant enzymes,
extracellular superoxide dismutase (EC-SOD) is primarily a tissue enzyme and has been implicated
in the regulation of the inflammatory response including angiogenesis. Studies in our laboratories
showed that overexpression of EC-SOD reduced edema, inflammatory cell infiltration and vessel
formation. EC-SOD transgenic mice revealed decreased expression of pro-angiogenic factor such
as vascular endothelial growth factor (VEGF) and NF-kB (p65) by UVB irradiation compared with
those of WT through phosphorylation of protein kinase C in mouse epidermis. The present study
extends our previous studies in the EC-SOD transgenic mice and shows that EC-SOD inhibits
endothelial cell proliferation and tube formation. To investigate the possibility that a treatment of
EC-SOD may have a therapeutic effect, we purified recombinant EC-SOD in HEK293E cells. In a
macrophage cell line and human umbilical vein endothelial cells (HUVEC), recombinant EC-
SOD inhibits expression of LPS-induced pro-inflammatory cytokines and VEGF. Leukocyte adhe-
sion assay indicated that recombinant EC-SOD significantly inhibited migration of leukocytes
towards endothelial cells. These data demonstrate that EC-SOD exhibits direct anti-inflammatory
and anti-angiogenic effects, providing a developing new therapeutic approach in inflammatory
skin diseases.
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Low strength of correlation between the intensity of neutrophil elastase expression in lesional
skin and the level of serum IgA antibodies to epidermal transglutaminase in dermatitis her-
petiformis
M Dmochowski,1 J Gornowicz,1 M Bowszyc-Dmochowska,1 A Seraszek2 and E Kaczmarek2 1
Dermatology, University School of Medicine, Poznan, Poland and 2 Pathology, University
School of Medicine, Poznan, Poland
As CD89 molecules are expressed on both neutrophils and eosinophils, and both cell types are
present in inflammatory infiltrate in dermatitis herpetiformis (DH) skin (eosinophils are usually far
less numerous than neutrophils), the activation of those cell types by IgA antibodies to epidermal
transglutaminase (eTG), an enzyme regarded as the most disease-specific autoantigen in DH, could
be responsible for cutaneous pathology in DH. We aimed here to analyse whether in DH cases
there are correlations between level of serum IgA antibodies to eTG and either expression of neu-
trophil elastase (NE) (activation marker of neutrophils) in lesional skin or serum level of eosinophil-
derived neurotoxin (EDN), also known as RNase 2, (activation marker of eosinophils). Altogether,
24 DH cases were studied. The diagnosis of DH was made when whichever pattern of possible 7
diagnostic patterns of granular IgA deposition was detected with direct immunofluorescence of
nonlesional skin. The levels of IgA antibodies to eTG and levels of EDN in sera were calculated
with ELISA. The expressions of NE were examined with immunohistochemical technique in sec-
tions of lesional skin using a mouse monoclonal antibody to human NE. The digital microscopic
image analysis with the appropriate software was then used to measure intensities of NE expres-
sion. The strength of correlation between the intensity of NE expression in lesional skin and the
level of serum IgA antibodies to eTG in DH was low. There was no significant correlation between
the serum level of EDN and the level of serum IgA antibodies to eTG in DH. Thus, it seems that
in DH cases the engagement of IgA autoantibodies to eTG on both neutrophils and eosinophils
might not be a principal stimulus to releasing both NE (with lesser conviction) and EDN (with
stronger conviction), enzymes involved in pathology of inflammatory diseases.
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Upregulation of Id1 in peripheral blood of psoriatic patients
C Ronpirin,1 T Tencomnao,2 J Wongpiyabavorn,3 M Arjariyakul4 and W Chaicumpa5 1
Preclinical Science, Faculty of Medicine, Thammasat University, Prathumthani, Thailand, 2
Department of Clinical Chemistry, Faculty of Allied Health Sciences, Chulalongkorn
University, Bangkok, Thailand, 3 Department of Microbiology, Faculty of Medicine,
Chulalongkorn University, Bangkok, Thailand, 4 Department of Clinical Science, Faculty of
Medicine, Thammasat University, Prathumthani, Thailand and 5 Department of Parasitology,
Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Although the precise causes of psoriasis are unclear, it is generally believed that psoriasis is a dis-
order in which factors in the immune system, enzymes, and other biochemical substances that
regulate skin cell division become impaired. This abnormal immune response causes rapid prolif-
eration of keratinocytes and incomplete keratinization (abnormal differentiation). The helix-loop-
helix transcription factor Id1 (inhibitor of differentiation/inhibitor of DNA binding) functions as an
inhibitor of differentiation. In this study, the Id1 mRNA expression in human peripheral blood lym-
phocytes of psoriatic patients and healthy controls was determined using reverse transcription-poly-
merase chain reaction (RT-PCR) technique if Id1 might be involved in the molecular mechanisms
leading to psoriasis. The normalized Id1 expressed transcripts in psoriatic patients were about 2-
fold significantly higher (P < 0.05) than those in healthy controls. Stimulation indices (SI) based on
PHA stimulation assay were not significantly different between patients and controls (P > 0.05). In
patients, there was no correlation between SI and disease activity as reflected by the Psoriasis Area
and Severity Index (PASI). Our finding suggested the association between Id1 and psoriasis, and
further studies should be carried out to elucidate the molecular role of Id1 in psoriasis.
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The lysosomal protease cathepsin K plays an important role in wound healing and scar for-
mation in the skin
TM Ruenger,1 A Sharov,1 T Sharova,1 D Zhang2 and D Broemme2 1 Dermatology, Boston
University, Boston, MA and 2 Oral Biological and Medical Sciences, University of British
Columbia, Vancouver, BC, Canada
Cathepsin K (catK) is a lysosomal protease with strong collagenolytic activities well known for bone-
degrading properties in osteoclasts. We recently described expression of catK in the dermis of young
surgical scars, while it was not expressed in normal skin. In order to substantiate our hypothesis
that catK’s collagenolytic activities counteract fibrosing during scar formation, we studied wound
healing and scar formation in 6 week-old catK-knockout mice and their catK-intact littermates
(mixed Bl6/J129 background). Four full dermal thickness wounds were created on the back of five
mice from each group using a four millimeter punch and wounds/scars were harvested 2, 6, 10,
15, and 20 days later. Macroscopic evaluation revealed hairless scars that were 2.6-, 1.9-, and 3.6-
fold larger in the catK knockout mice than in the catK-intact mice on days 10, 15, and 20 (p=0.02),
respectively. Microscopic evaluation (H&E stain) showed cell-rich dermal scars that were 2.3- to
4-fold wider in the catK knockout mice. Masson trichrome staining demonstrated a more intense
collagen staining in the scars of catK knockout mice. No differences were noted at the earlier time-
points. These data demonstrate an antifibrotic role of catK in wound healing and scar formation
which is most likely mediated through its prominent collagenolytic activities. We have previously
reported that extracellular collagen is internalized by cultured dermal fibroblasts to lysosomes
through endocytosis and then degraded by catK. As catK is stable and active only at very low pH,
its collagenolytic activities in the skin are likely limited to lysosomes within cells. Intracellular col-
lagen degradation, mediated at least in part by catK, therefore appears to be a critical player in
wound healing and scar formation. We suggest that collagen degradation during scar formation,
and likely during other processes of collagen metabolism as well, is the result of extra- and intra-
cellular proteases acting in concert with each other.
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ASB16165, a novel phosphodiesterase 7A inhibitor in development as a topical agent for pso-
riasis (2) - Effect on induction and function of cytotoxic T lymphocytes
K Kadoshima-Yamaoka,1 M Murakawa,1 M Goto,1 Y Tanaka,1 H Inoue,1 H Murafuji,1 Y Hayashi,1
K Nagahira,1 K Miura,1 T Nakatsuka,1 K Chamoto,2 Y Fukuda1 and T Nishimura2 1 Biomedical
Research Laboratories, Asubio Pharma Co., Limited, Osaka, Japan and 2 Division of
Immunoregulation, Section of Disease Control, Institute for Genetic Medicine, Hokkaido
University, Sapporo, Japan
Phosphodiesterase 7A (PDE7A) has been suggested to be involved in activation of T lymphocytes,
and ASB16165 is a potent and specific inhibitor for PDE7. In the present study, effect of ASB16165
on induction and function of cytotoxic T lymphocytes (CTL) was examined. ASB16165 inhibited
generation of CTL activity in mixed lymphocyte reaction (MLR), in which splenocytes from C57BL/6
mice were stimulated with those from BALB/c mice. Flow cytometric analysis revealed that ASB16165
suppressed induction of activated CD4+ as well as CD8+ T cells in MLR. In cell division analyses
using 5-carboxyfluorescein diacetate succinimide ester (CFSE), ASB16165 was shown to markedly
inhibit proliferation of CD4+ and CD8+ T cells. In addition, ASB16165 reduced effector function
of CTL, while the effect was less than that observed in CTL induction in MLR. Forskolin and dibu-
tyryl cAMP also inhibited both the induction and effector function of CTL. PDE4 inhibitor rolipram
showed similar but weaker inhibition for the development and proliferation of CD8+ T cells com-
pared with ASB16165, and failed to impair effector function of CTL. These findings suggest that
PDE7 but not PDE4 has the major role in induction and function of CTL in mice, and that the effect
might be mediated by elevation of intracellular cAMP level. Since CTL is known to have a patho-
genic role in psoriasis, our data indicate that ASB16165 will be useful as an agent for psoriasis.
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ASB16165, a novel phosphodiesterase 7A inhibitor in development as a topical agent for pso-
riasis (1) - Effect on function of T lymphoblasts
M Murakawa,1 K Kadoshima-Yamaoka,1 M Goto,1 Y Tanaka,1 H Inoue,1 H Murafuji,1
A Nagahira,1 Y Hayashi,1 K Nagahira,1 K Miura,1 T Nakatsuka,1 K Chamoto,2 Y Fukuda1 and
T Nishimura2 1 Biomedical Research Laboratories, Asubio Pharma Co., Limited, Osaka, Japan
and 2 Division of Immunoregulation, Section of Disease Control, Institute for Genetic
Medicine, Hokkaido University, Sapporo, Japan
Phosphodiesterase 7A (PDE7A) has been suggested to be involved in activation of T lymphocytes,
and ASB16165 is a potent and specific inhibitor for PDE7; the IC50 value for human PDE7A was
15 nM. In the present study, effect of ASB16165 on function of pre-activated T lymphocytes (i.e. T
lymphoblasts) was investigated. T lymphoblasts were prepared by stimulating mouse T cells with
anti-CD3 antibody, and the function of T lymphoblasts was examined by their ability to produce
IFN-γ in response to IL-12. In this experiment, ASB16165 was found to suppress the IL-12-induced
IFN-γ production by T lymphoblasts. A PDE4-specific inhibitor, rolipram, showed similar effect on
the IL-12-induced IFN-γ production, while calcineurin antagonist FK506 did not. Forskolin (an
adenylyl cyclase activator) and dibutyryl cAMP also inhibited the IL-12-induced IFN-γ synthesis.
Rp-8-Br-cAMPS, an inhibitor of protein kinase A (PKA), reduced the suppressive effect of ASB16165
on the IFN-γ production by T lymphoblasts. The rescue of IFN-γ production by Rp-8-Br-cAMPS was
also observed in the inhibition by rolipram and forskolin. These findings suggest that PDE7A may
regulate function of activated T cells in a cAMP/PKA-dependent manner, and that PDE4 might share
the role. The data in our study also indicate that ASB16165 will be beneficial for the patients with
immunological disorders such as psoriasis.
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ASB16165, a novel phosphodiesterase 7A inhibitor in development as a topical agent for pso-
riasis (3) - Effect on proliferation and function of NKT cells
M Goto,1 M Murakawa,1 K Kadoshima-Yamaoka,1 Y Tanaka,1 H Inoue,1 H Murafuji,1 Y Hayashi,1
K Miura,1 T Nakatsuka,1 K Nagahira,1 K Chamoto,2 Y Fukuda1 and T Nishimura2 1 Biomedical
Research Laboratories, Asubio Pharma Co., Limited, Osaka, Japan and 2 Division of
Immunoregulation, Section of Disease Control, Institute for Genetic Medicine, Hokkaido
University, Sapporo, Japan
Phosphodiesterase 7A (PDE7A) has been suggested to be involved in activation of T lymphocytes,
and ASB16165 is a potent and specific inhibitor for PDE7. In the present study, effect of ASB16165
on proliferation and function of NKT cells was examined using NKT cells isolated from mouse
spleen. Activation of mouse NKT cells with CD3/IL-2 co-stimulation resulted in induction of cell
proliferation as well as production of Th17 cytokines (IL-17 and IL-22) in addition to Th1/Th2
cytokines, and ASB16165 inhibited both the proliferation and cytokine production. Forskolin (an
activator of adenylyl cyclase) and dibutyryl cAMP also exhibited inhibitory effects on the cell pro-
liferation and cytokine production of NKT cells. In addition, Rp-8-Br-cAMPS, an inhibitor of pro-
tein kinase A (PKA), reversed the suppressive effects of ASB16165 against NKT cells. These results
suggest that PKA/cAMP as well as PDE7A is involved in regulation of cell proliferation and cytokine
production of NKT cells, and that the inhibitory effects of ASB16165 in NKT cells shown here are
mediated by increase in cellular cAMP level. Since NKT cells have been shown to have pathogenic
roles in psoriasis, our findings also raise the possibility that PDE7A inhibitor ASB16165 is useful
for treatment of psoriasis.
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ASB16165, a novel phosphodiesterase 7A inhibitor in development as a topical agent for pso-
riasis (4) - Effect in phorbol ester-induced mouse dermatitis model
R Yoshioka, K Kadoshima-Yamaoka, M Goto, M Murakawa, Y Tanaka, H Inoue, H Murafuji,
S Kanki, Y Hayashi, K Nagahira, A Ogata, T Nakatsuka and Y Fukuda Biomedical Research
Laboratories, Asubio Pharma Co., Limited, Osaka, Japan
Phosphodiesterase 7A (PDE7A) has been suggested to be involved in activation of T lymphocytes,
and ASB16165 is a potent and specific inhibitor for PDE7. In the present study, effect of ASB16165
on skin inflammation was examined using phorbol ester 12-O-tetradecanoylphorbol-13-acetate
(TPA)-induced mouse dermatitis model, so as to investigate the potential of ASB16165 as anti-pso-
riasis agent. An epicutaneous application of TPA to the mouse ear resulted in induction of skin
edema, and topical treatment with ASB16165 inhibited the induction of skin edema in a dose-
dependent manner. The ASB16165 treatment also reduced the skin content of TNF-α, the major
cytokine involved in the pathogenesis of psoriasis. In addition, ASB16165 suppressed the produc-
tion of TNF-α by human keratinocytes in vitro stimulated with TPA in conjunction with calcium
ionophore A23187. Forskolin, an activator of adenylyl cyclase, as well as dibutyryl cAMP also
showed inhibitory effect on the TNF-α production in the cells, suggesting involvement of cAMP in
TNF-α generation in the cells. These results demonstrate that PDE7A might regulate TNF-α pro-
duction in keratinocytes in a cAMP-dependent fashion. As an immunostaining analysis revealed
PDE7A is expressed in the epidermis of mouse skin and TNF-α is known to contribute to the TPA-
induced edema, it is possible that the inhibitory effect of ASB16165 on skin edema in mouse TPA-
induced dermatitis model is mediated by suppression of TNF-α production. Taken together, PDE7
inhibitor ASB16165 is thought to be useful as an agent for psoriasis.
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In vitro biologic activity of GABA rich Lactobacillus plantarum DSM19463 biomass, on recon-
structed human epidermis
G Giuliani,1 A Benedusi,1 M Meloni,2 L Béatrice3 and B Marzani1 1 Giuliani S.p.A, Milan, Italy,
2 VitroScreen Srl, Milan, Italy and 3 Links Ingénierie, Montélier, France
Human skin acts not only as a physical barrier but has been shown to be an important immune
organ displaying various defense mechanisms. Grape must was used as substrate for growth of Lac-
tobacillus plantarum in optimal conditions for synthetizing GABA (aminobutyric acid) and this new
biomass has been fully characterized. The biological activity of the biomass was assessed by top-
ical application (24, 48, and 72h at 1, and 3%) on reconstructed human epidermis (RHE, Skinethic®).
Cell viability was performed by MTT test and quantitative RT-PCR (DEFB4 and IL12B) by a Taq-
man assay®. The biomass 1% showed an interesting activity by upregulated the beta-defensin-2
transcription, an antimicrobial peptide which is integral component of the innate immune response
due to its broad spectrum activity against invading pathogens. The biomass topically applied at
1% for 24h on RHE in physiological conditions increased IL-12 mRNA, allowing keratinocytes to
promote type 1 T cell responses. IL-12,IL-10 is one of the major players involved in orchestrating
both innate and acquired immune responses. The new biomass enables a transcriptional modula-
tion by epidermal cells after topical application. A strengthening of the skin immune defense mech-
anisms appears to be induced by increasing beta-defensin-2 and IL-12 cytokine mRNA. Fillagrin
upregulation was observed after 24h and 72h by gene expresion (RT-PCR FLG by a Taqman assay®).
The biomass immunomodulating capacities should be useful for a therapeutical application in dis-
eases such as atopic dermatitis often complicated by an enhanced susceptibility to bacterial skin
infections and contribute to a better overall skin homeostasis.
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ASB16165, a novel phosphodiesterase 7A inhibitor in development as a topical agent for pso-
riasis (5) - preclinical toxicological studies
T Yotsumoto,1 S Kanki,2 T Matsumoto,2 R Nakamura,1 M Doi,1 T Ochiai,1 M Nakamoto,1
K Nakano,1 M Kobayashi,2 S Nakada,1 C Tamaki,2 T Tabata,2 Y Fujieda,2 T Iwata,1 A Ogata,2
H Ogasawara,2 Y Kanai1 and Y Nakanishi1 1 Biopharma Center, Asubio Pharma Co., Limited,
Gunma, Japan and 2 Biomedical Research Laboratories, Asubio Pharma Co., Limited, Osaka,
Japan
Phosphodiesterase 7A (PDE7A) has been suggested to be involved in activation of T lymphocytes,
and ASB16165 is a potent and specific inhibitor for PDE7. The in vitro and in vivo studies have
suggests that ASB16165 will be useful as a topical agent for psoriasis. In the present study, the tox-
icological profile of ASB16165 was analyzed. Topical application of ASB16165 (1, 5%) to the skin
of rabbits once a day for 14 days did not induce a skin irritation. Skin photosensitization study
with the adjuvant and strip test and phototoxicity test with 3T3 cells revealed that ASB161615 has
no ability to induce phototoxicity and photosensitization. In local lymph node assay in mice, anhy-
drate of ASB16165 did not induce lymphocytes proliferation, suggesting that ASB16165 has no
skin sensitizing activity. It was found, in addition, that ASB16165 does not induce gene mutation
in bacteria and chromosomal aberrations in CHL cells. ASB16165, which has an IC50 value of
26.1 μM in hERG assay, showed no effect on the electrocardiogram in QT assay of guinea pig by
intravenous infusion (Cmax: 0.6 μg/mL) as well as in 2-week repeated oral dose toxicity study in
dogs at the 20 mg/kg/day group (Cmax: 9.3 μg/mL). In the 2-week oral repeated dose toxicity stud-
ies in rats and dogs, the NOAELs of ASB16165 were 100 mg/kg/day and 20 mg/kg/day, respec-
tively. Systemic exposure of ASB16165 after topical application was thought to be extremely low
in dogs and pigs. These findings suggest that ASB16165 is safe enough to be applied to psoriasis
patients.
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Tolerance to mature but not precursor desmoglein 1 (Dsg1) in non-pemphigus patients: Impli-
cations for development of autoimmunity
J Yamagami,1 S Kacir,2 AS Payne,1 DL Siegel2 and JR Stanley1 1 Dermatology, Univ. of
Pennsylvania, Philadelphia, PA and 2 Pathology and Laboratory Medicine, Univ. of
Pennsylvania, Philadelphia, PA
In pemphigus foliaceus (PF), breakdown in immune tolerance results in Dsg1 autoantibodies that
cause epidermal blistering. One theory of autoimmunity is that autoreactive, but quiescent, B cells
present in normals are stimulated by tissue destruction or molecular mimicry to produce autoan-
tibodies, and, subsequently, somatic mutation of these natural autoantibodies produces disease.
To test whether B cells encode anti-Dsg1 antibodies in non-pemphigus patients we used antibody
phage display to isolate IgG anti-Dsg1 monoclonal antibodies (mAbs) from a healthy person and
two non-pemphigus autoimmune patients with thrombotic thrombocytopenic purpura. From these
three individuals, we found 14 unique mAbs against precursor (i.e. proprotein) Dsg1 (preDsg1)
but none against mature Dsg1 (matDsg1), as determined by immunoprecipitation. 13 mAbs used
heavy chain gene VH3-09 and one used closely related VH3-20. In two PF patients, we also cloned
anti-preDsg1 mAbs, of which 8 used VH3-09 and one used VH4-30; however, in addition, we
found anti-matDsg1 mAbs, none of which used the genes encoding anti-preDsg1 mAbs. By immuno-
fluorescence, mAbs against preDsg1 bound the cytoplasm but not cell surface of keratinocytes,
consistent with the location of preDsg1 compared to matDsg1. PreDsg1 mAbs, compared to matDsg1
mAbs, showed little somatic hypermutation, consistent with less antigen-driven stimulation of the
preDsg1 autoantibodies. These data suggest that B cells with receptors for preDsg1, present in nor-
mals, could present Dsg1 peptides to T cells but that such T cells and other B cells would have to
lose tolerance to matDsg1 for disease to occur, multiple unlikely events consistent with the rarity
of PF. These data show that PF clearly does not result from somatic mutation of naturally occur-
ring autoantibodies because matDsg1 antibodies use different VH genes than do preDsg1 anti-
bodies.
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Calcitonin gene-related peptide (CGRP) inhibits chemokine production by human dermal
microvascular endothelial cells (HDMEC)
J Huang, W Ding and RD Granstein Dermatology, Weill Cornell Medical College, New York,
NY
Dermal blood vessels are associated with nerves containing the sensory neuropeptide calcitonin
gene-related peptide (CGRP), suggesting that CGRP-containing nerves may regulate cutaneous
inflammation through effects on dermal vessels. Dermal endothelial cells contribute to cutaneous
inflammation through production of chemotactic factors. We asked whether CGRP regulated
stimulated production of the chemokines CXCL1 (growth-related oncogene alpha), CXCL8 (inter-
leukin-8) and/or CCL2 (monocyte chemotactic protein-1) by a human dermal microvascular endothe-
lial cell line (HMEC-1) and/or primary HDMEC. HMEC-1 cells or HDMEC were plated at a con-
centration of 0.25×106 cells/well in twelve-well plates in triplicate in 2 ml of depleted medium
per well. After overnight incubation for HMEC-1 cells or a 6-hour incubation for primary HDMEC,
cells were cultured with or without LPS (1 μg/ml) in the presence or absence of graded concen-
trations of CGRP. Supernatants were harvested at the indicated times and CXCL1, CXCL8 and CCL2
content was quantified by sandwich ELISA. CGRP (1-100 nM) inhibited LPS-induced production
of all 3 of the chemokines by both HMEC-1 and primary HDMEC in a dose- and time-dependent
manner. HMEC-1 cells were found to express mRNA for components of the CGRP and
adrenomedullin receptors [receptor activity-modifying protein (RAMP)1/calcitonin-receptor-like
receptor (CL), RAMP2/CL, and RAMP3/CL, though RAMP3 at substantially lower levels]. Further-
more, the RAMP1/CL-specific antagonists CGRP8-37 and BIBN4096BS blocked the effect of CGRP
in a dose-dependent manner. As H89 [a PKA inhibitor] and calphostin C [a PKC inhibitor] each
suppressed CGRP-mediated inhibition of chemokine induction, PKA and PKC appear to be involved
in this CGRP-mediated effect. Nerves containing CGRP may regulate cutaneous inflammation by
modulating chemokine production by dermal microvascular endothelial cells. Elucidation of this
pathway may suggest new avenues for therapeutic manipulation of cutaneous inflammation.
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Autoimmunity to desmocollin 3 in pemphigus vulgaris
X Mao,1 AR Nagler,1 LH Jackson,2 EJ Choi,1 KM Leiferman,2 M Amagai,3 JJ Zone2 and AS Payne1
1 Dermatology, Univ of Pennsylvania, Philadelphia, PA, 2 Dermatology, Univ of Utah, Salt
Lake City, UT and 3 Dermatology, Keio Univ, Tokyo, Japan
Pemphigus vulgaris (PV) is a blistering disease of the skin and mucous membranes associated with
autoantibodies to desmoglein 3 (Dsg3). Mice with a skin-specific deletion of desmocollin 3 (Dsc3)
demonstrate suprabasilar blisters histologically identical to those observed in Dsg3-deficient mice,
supporting a critical role for these two desmosomal cadherin isoforms in basal epidermal cell adhe-
sion. We have identified a patient with mucosal PV who has serum autoantibodies against Dsc3,
but not Dsg3. Mucosal biopsy demonstrated suprabasilar acantholysis with tombstoning of basal
keratinocytes. The patient serum showed intercellular staining of monkey esophagus at a titer of
1:2048 and was negative on Dsg3, Dsg1, BP180, and BP230 ELISA. The patient serum immuno-
precipitated the recombinant extracellular domain of human Dsc3 as well as Dsc3 endogenously
expressed in human keratinocytes. Recombinant Dsc3 but not Dsg3 adsorbed all cell surface bind-
ing from the patient serum, suggesting that Dsc3 is the primary target of serum cell surface autoan-
tibodies. Incubation of patient serum with human keratinocytes caused loss of cell surface Dsc3
but not Dsg3 by immunofluorescence (IF), suggesting specific pathogenic effects of serum autoan-
tibodies on Dsc3. To determine whether other pemphigus patients demonstrate serum autoanti-
bodies to Dsc3, we screened a panel of 35 human normal and autoimmune sera. Of 24 samples
positive for intercellular staining by IF on monkey esophagus, 10 were positive (2 indeterminate)
on Dsg3 ELISA, 2 were positive on Dsg1 ELISA, and 10 were negative on both Dsg3 and Dsg1
ELISA. 4 of the 10 Dsg3 ELISA-positive and 3 of the 10 Dsg ELISA-negative sera immunoprecipi-
tated Dsc3, in contrast to 0 of 11 intercellular IF-negative samples. Taken together, these clinical
and serologic data indicate that autoimmunity to Dsc3 phenocopies autoimmunity to Dsg3 and
suggest that Dsc3 may be a relevant target antigen in pemphigus vulgaris, either alone or in addi-
tion to Dsg3.
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Microarray analysis defines disease-, severity-, and inheritance-specific gene signatures in
Alopecia areata blood
AB Coda, V Qafalijaj Hysa, K Seiffert-Sinha and AA Sinha Center for Investigative Dermatology,
Dermatology and Cutaneous Sciences, Michigan State University, East Lansing, MI
Alopecia areata (AA) is an autoimmune hair loss disorder in which systemic disturbances have
been described, but are poorly understood. Moreover, the genetic basis of disease heterogeneity
is not known. To gain further insight into disease mechanisms, we examined global gene expres-
sion patterns in the blood of defined clinical subgroups (patchy AA, persistent type, AAP, n=5;
alopecia universalis, AU, n=4) and healthy control subjects (unaffected relatives, UaR, n=5; unaf-
fected non-relatives, UaNR, n=4) by microarray (Affymetrix U133 Plus 2.0). Unsupervised hier-
archical clustering distinctly separates all four patient and control groups. Functional classifica-
tion of differentially expressed genes (1% false discovery rate, Benjamini-Hochberg method with
a +/- 2.5 fold-change threshold) comparing disease (AAP, AU) vs. normal groups (UaR, UaNR)
reveals a significant upregulation in immune response (including IFN-induced genes), cytokine
signaling, signal transduction, cell cycle, proteolysis, and cell adhesion/migration pathways. Specif-
ically, we observed the activation of multiple genes related to NK cell mediated cytotoxicity, apop-
tosis, IL-1 and TNF response, MAP kinase, Wnt signaling, and B- and T-cell receptor signaling in
patients. Of note, we find a more robust expression of immune response related genes in AAP vs.
AU patients. The AU group clusters closer to healthy relatives than diseased individuals, which
may indicate that systemic immune response subsides in later, less acute phases of disease. We
also observe that unaffected relatives cluster more closely with AA patients than unaffected non-
relatives, supporting a genetic basis for immune dysregulation in AA.
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A desmoglein 3 pemphigus antibody signaling
A Chernyavsky, J Arredondo and SA Grando Dermatology, University of California, Irvine, CA
A loss of epidermal cohesion in pemphigus results from pemphigus autoantibody (PAb) action on
keratinocytes (KCs) causing their shrinkage, detachment from neighboring cells and rounding up
(acantholysis). PAb binding to the keratinocyte plasma membrane launches an array of downstream
signaling events that lead to cell death via apoptosis or oncosis. Pab signaling may be subserved
by signal transduction kinases, including Src, EGF receptor kinase, p38 MAPK and PKC. The pool
of PAb is heterogeneous, comprised by antibodies to the structural proteins, like desmoglein 3
(Dsg3), and cell surface receptors. Each patient has a unique composition of PAb which determines
the preferential signaling pathways downstream of targeted self-antigens. To dissect out the sig-
naling pathways elicited due to PAb binding of Dsg3, we utilized KCs grown from the skin of neona-
tal Dsg3-/- mice and their wild-type (WT) littermates. The keratinocyte monolayers were incu-
bated for different time periods with 1 mg/ml IgGs from 6 pemphigus vulgaris patients that did not
have anti-Dsg1 antibodies. PAb from individual patients elicited distinct signaling events. A time-
course analysis did not reveal significant differences between the responses observed in Dsg3-/-
and WT KCs, except for p38 MAPK activity. In the presence of Dsg3, PAb from 4 patients elicited
two peaks of activity at 15 and 240 min, whereas in Dsg3-/- KCs, an early activity peak has prac-
tically disappeared and the late peak significantly (p<0.05) decreased. While the late activity peak
is apparently related to the cytoskeletal alterations in the rapidly shrinking cells, the early Dsg3-
related signaling could be evoked secondary to interference of the PAb-Dsg3 complex with stoi-
chiometry and compartmentation of neighboring receptor proteins on the plasma membrane. Elu-
cidation of the primary signaling events downstream of PAb targets on the plasma membrane,
therefore, will be critical for the development of a more successful non-steroidal therapy of pem-
phigus patients.
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Eruptive pseudoangiomatosis lesions do not harbor Epstein-Barr virus but are associated with
characteristic intravascular neutrophils
S Jin,1 M Chang,2 H Shin,1 H Park3 and S Cho1 1 Dermatology, Seoul National University
Boramae Hospital, Seoul, Korea, South, 2 Pathology, Seoul National University Boramae
Hospital, Seoul, Korea, South and 3 Dermatology, Ilsan Paik Hospital, Ilsan, Korea, South
Eruptive pseudoangiomatosis (EPA) is a rare, relatively newly described cutaneous disorder char-
acterized by the sudden onset of a few to several bright red angioma-like papules surrounded by
a blanched halo. The etiology is unknown; however, viral infection or mosquito bites have been
speculated as possible causes. Twenty-five cases of EPA were studied retrospectively. The patients’
female-to-male ratio was 2.1:1 (17 female and 8 male subjects), and ages of the subjects ranged
from 5 to 79 (average, 46). In all but 3 patients the lesions appeared during the months of July thru
September. Skin biopsies demonstrated capillary ectasia with perivascular mononuclear cellular
infiltrates in the upper dermis. Most patients were otherwise healthy, and routine laboratory results
were all normal except in one patient with known diabetes. The skin lesions faded out without any
treatment in 1 to 2 weeks. In order to determine latent Epstein-Barr virus (EBV) infection, EBV-
encoded small RNA (EBER) in situ hybridization was performed in 18 subjects, and the results
were all negative. In comparison to 22 control cases of perivascular lymphocytic infiltration, no
differences were found in CD3, CD4, CD8, CD31 and c-kit staining patterns. The only histologic
distinguishing feature of EPA was the presence of intravascular neutrophils, which were present in
19 of 20 EPA cases (95%), in contrast to 3 of 22 control cases (14%) (p<0.0001). The sudden col-
lective onset of the lesions in the summer and the presence of intravascular neutrophils charac-
terize this probably underdiagnosed condition and support the concept of “paraviral eruption”.
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HLA-E profile is associated with susceptibility to Alopecia Areata
DG Bhanusali,1 A Sachdev,1 A Rahmanian,2 JA Gerlach2 and AA Sinha1 1 Center for
Investigative Dermatology, Dermatology and Cutaneous Sciences, Michigan State University,
College of Human Medicine, East Lansing, MI and 2 Biomedical Laboratory Diagnostics
Program, College of Natural Science, Michigan State University, College of Human Medicine,
East Lansing, MI
Non-classical human leukocyte antigen-E (HLA-E) plays a role in the down-regulation of immune
activity and has been proposed to be relevant in the regulation of autoimmunity. The HLA-E locus
is polyallelic; eight sequences have been defined. The HLA-E*0103 allele is thermally stable and
highly expressed at the cell surface. It has been shown to participate in the potent inhibition of NK
and CD8+ responses. *01032 is associated with an increased risk of Behcet’s disease, and the
*0101x/0103x genotype was found to cluster in Type 1 diabetes patients diagnosed before the age
of 10. Our group has recently found that *0103x is also associated with susceptibility to Pemphi-
gus vulgaris. In this study, we investigated the possible association between HLA-E polymorphisms
and alopecia areata. We examined HLA-E allele status in 72 alopecia areata patients, 42 related
controls, and 55 unrelated controls via amplification refractory mutation system (ARMS) analysis.
Statistical estimates were determined via Cochran Mantel Hanzel Chi squares and logistical regres-
sion. We find that the frequency of HLA-E* 01031/01032 is increased in alopecia patients versus
unrelated controls (p=0.0419). Additionally, we find that *0101/01032 is strongly associated with
risk of alopecia totalis (p=0.0098) and alopecia universalis (p=0.0042) versus unrelated controls.
However, *0101/01031 is strongly associated with unrelated controls versus alopecia patients (p=
0.0003) and related control subjects (p=0.0493). Population analysis using a combined
E*0101/0103x (presumed heterozygous) genotype did not result in significant findings. These find-
ings suggest that the HLA-E*01032 allele may be a risk factor for alopecia areata.
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Increased IFN-γ production from peripheral blood mononuclear cells in acne vulgaris patients
by Propionibacterium acnes : Host but not P. acnes species dependent production
H Sugisaki, K Yamanaka, M Kakeda, H Kitagawa, I Kurokawa and H Mizutani Mie University,
Tsu, Japan
Acne vulgaris is a multifactorial inflammatory disease of the sebaceous follicles. Initially, acne starts
as a non-inflammatory comedo, which subsequently evolves into inflammatory reactions such as
pustules or granulomatous lesions. In pathogenesis of this inflammatory changes, immunological
roles of Propionibacterium acnes (P.acnes) is particularly important. However, the host immune
response to P.acnes has not been fully elucidated. The present study aimed to evaluate the host
immune response to P.acnes and the bacteriological factor in the pathogenesis of acne. P.acnes iso-
lated from various acne lesions and healthy volunteers were cultured. The peripheral blood mononu-
clear cells (PBMC) from acne patients and healthy volunteers were stimulated with viable P.acnes,
and their cytokine productions were measured using RT-PCR and ELISA. IFN-γ, IL-12p40, and IL-
8 mRNA and their protein productions were significantly increased in PBMC from acne patients
compared with those from normal donors stimulated with the same P. acnes. However, these cytokine
productions from PBMC from acne patients and normal subjects were not influenced by differences
in P. acnes species: isolated from various acne lesions or normal subjects. The inflammatory response
of acne appears to be attributable to individual differences in host immune response rather than
differences in P.acnes species. These present results confirmed importance of extermination of P.
acnes in a patients with inflammatory lesions, and also suggest importance of immune response
modification in severe inflammatory acne cases.
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Escape of desmoglein 3-reactive T cell from central tolerance by expression of dual T cell
receptors
H Takahashi,1,2 M Kuwana3 and M Amagai1 1 Dermatology, Keio University, Tokyo, Japan, 2
Tokyo Electric Power Company Hospital, Tokyo, Japan and 3 Internal Medicine, Keio
University, Tokyo, Japan
Pemphigus vulgaris (PV) is an autoimmune bullous disease caused by anti-desmoglein 3 (Dsg3)
IgG and Dsg3-reactive T cells play a key role in this harmful autoantibody production. The pur-
pose of this study is to determine the tolerance mechanism of Dsg3-reacitve T cells using T cell
receptor (TCR) transgenic mice. We recently established several CD4+ T cell clones reactive to
Dsg3 from Dsg3-/- mice that do not acquire tolerance to Dsg3, and isolated cDNAs of their TCRα
and β chains. Epitopes for those TCRs were determined by analyzing transfected T cell hybirodomas
with overlapping Dsg3 peptides. We then generated Dsg3-reaective TCR transgenic mice using a
set of TCR that recognizes the peptide Dsg3301-315, and selected transgenic lines (Dsg3H1-TCR mice)
based on physiological expression timing of TCRβ chain on cell surfaces during T cell develop-
ment in the thymus. Dsg3H1-TCR mice were crossed with Rag2-/- mice in order to determine the
effects of endogenous TCR expression on the fate of Dsg3-reactive T cells in the thymus and periph-
eral lymphoid organs. Interestingly, Dsg3-reactive transgenic T cells were clonally deleted in
Dsg3H1-Rag2-/- mice. In contrast, the transgenic T cells were detected in the spleen and lymph
nodes of Rag2-sufficient Dsg3H1-TCR mice. Moreover they showed increased proportion of
CD44hiCD62Llo cells (memory/activated phenotype) indicating previous encounter with autoanti-
gen in vivo. Furthermore, those transgenic T cells from the spleen reacted with the peptide Dsg3301-
315, indicating that they were not anergic in vitro. Thus, Dsg3-reactive T cells can escape from cen-
tral tolerance in the thymus by expressing second TCRα chain in addition to the self-reactive TCR
in vivo. This novel TCR transgenic model provides a valuable tool to analyze both central and
peripheral tolerance against physiological epidermal autoantigen and will provide fundamental
bases to understand immunological mechanisms of tolerance and autoimmunity.
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Expression of the 27 kD and 90 kD heat shock proteins in psoriatic skin
D Mairhofer,1,2 RM Nazarian,3 A Lobo,3 RJ Geller,4 MC Mihm3 and F Trautinger1,2 1 Karl
Landsteiner Institute of Dermatological Research, St. Poelten, Austria, 2 Landesklinikum St.
Poelten, St. Poelten, Austria, 3 Department of Pathology, Massachusetts General Hospital,
Boston, MA and 4 Emerson Hospital, Concord, MA
Heat shock proteins (hsp) are a heterogeneous group of highly conserved proteins that are essen-
tial in cytoprotection and cell physiology. Although hsp have been shown to be involved in inflam-
mation and keratinocyte differentiation their role in psoriasis is largely unknown. In the current
study a collection of 16 archival samples from various stages and various clinical variants of pso-
riasis was investigated for the expression of hsp27 and hsp90 by immunohistochemistry. As in nor-
mal human skin hsp27 in psoriatic epidermis was associated with keratinocyte differentiation. In
addition, most samples showed highly positive staining in the basal cell layer and in subcorneal
areas of neutrophil aggregation. A striking finding in the dermis was the strongly positive staining
of endothelial cells that was specifically absent from the characteristic dilated and tortuous capil-
laries of the papillae. Hsp90 was found to be expressed throughout the epidermis with a mainly
nuclear staining pattern and increasing intensity towards the upper layers. In the dermis hsp90
was expressed in all nucleated cells including infiltrating leukocytes. Our findings indicate that
hsp27 and hsp90 might be induced in psoriatic skin in response to inflammation and - as specifi-
cally shown for hsp27 - probably also through reactive oxygen species released by neutrophils.
Furthermore, the differential expression of hsp27 in capillary versus postcapillary endothelium
points to a role of hsp27 in angiogenesis and the endothelial pathology associated with psoriasis.
Based on these findings further studies are warranted to investigate the functional role of these and
other hsp in psoriasis and the possible therapeutic use of hsp modifying agents.
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The molecular basis for increased dermal content of hyaluronic acid and chondroitin sulfate
in cutaneous lupus erythematosus
LM Chang,1,2 L Schaffer,3,4 SR Head3,4 and VP Werth1,2 1 Philadelphia VA Medical Center,
Philadelphia, PA, 2 Department of Dermatology, University of Pennsylvania, Philadelphia, PA,
3 Consortium for Functional Glycomics, La Jolla, CA and 4 The Scripps Research Institute, La
Jolla, CA
Based on Hale’s stain, skin lesions of cutaneous lupus erythematosus (CLE) exhibit an increased
dermal content of mucin, also known as glycosaminoglycans (GAGs). Hale’s stain, however, fails
to distinguish among different GAG species. Using more specific reagents, we previously reported
that different subclasses of CLE exhibit distinct accumulations of hyaluronic acid (HA), a GAG
whose fragments can activate dendritic cells and macrophages, and/or chondroitin sulfate (CS), a
GAG that has immunologic effects in vitro (Chang et al., JID, 128(S1):S19, 2008). We have now a
glycomic microarray to explore the molecular basis for the increased dermal content of GAGs in
these conditions. Dermal RNA was extracted from the skin of healthy controls (n=4) and from
lesional and non-lesional skin from subjects with DLE (n=3), SCLE (n=3), and TLE (n=4). The RNA
was hybridized to the human GLYCOv3 chip, a small, focused microarray developed using Affymetrix
technology that contains probes for only ~1,200 transcripts, all highly annotated and directly related
to glycobiology. Hits were validated using real-time quantitative PCR in a subset of CLE lesions.
Real-time RT-PCR confirmed increased expression in the combined groups of CLE lesions (n=8)
compared to controls (n=4) for HAS2 (4.1±0.9 vs. 1.0±0.1, p<0.01), CHSY1 (2.6±0.4 vs. 1.0±0.2,
p<0.02), and C4ST1/CHST11 (7.4±2.4 vs. 1.0±0.2, p<0.01). Other genes known to be involved in
the production of HA (HAS1, HAS3) and CS (CHSY2, CHPF, CSGlcA-T) as well as the CS sulfo-
transferase genes CHST1-3,5,8,9,13 were not differentially expressed on the microarray. Thus, the
increase in HA in CLE is likely due to an upregulation of HAS2, while CHSY1 and C4ST1 are likely
responsible for the increase in CS. Regulation of HA and CS production in CLE skin lesions may
be one mechanism for the aberrant production of HA and CS.
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Induced keratinocyte hyper-proliferation in alfa2beta1 integrin transgenic mice results in sys-
temic immune cell activation
I Teige, A Bäcklund, L Svensson, PH Kvist, TK Pedersen and K Kemp LEO Pharma, Ballerup,
Denmark
Alfa2beta1 integrins are normally confined to the basal layers of the epidermis. However, during
wound healing and in psoriasis, these integrins are expressed in supra-basal keratinocytes. Trans-
genic mice expressing alfa2beta1 integrins under the involucrine promoter have previously been
demonstrated to spontaneously develop an erratic skin disorder resembling psoriasis. Herein, we
show that mild wounding induces a uniform acanthosis and an influx of immune cells. The dis-
ease initiates as a normal wound healing process completely restored by day 14 in wildtype mice.
However, in integrin transgenics, a chronic inflammation develops comparable to the Koebner phe-
nomenon in psoriatic patients. Substantial keratinocyte hyper-proliferation, inflammatory infiltra-
tion, and high cytokine levels within the skin can still be observed in integrin transgenics five weeks
after wounding. Additionally, draining lymph nodes contained highly activated T cells and APCs
secreting large amounts of pro-inflammatory cytokines. Furthermore, the systemic immune response
was affected with increased spleen size, elevated serum cytokine levels, and altered lymphocyte
trafficking patterns. Finally, CD4+ T cell depletion was not able to affect the onset or progression
of skin inflammation. This suggests that altered keratinocyte differentiation and proliferation can
drive a psoriasis-like inflammation and cause chronic immune cell activation both at a local and
systemic level.
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Activating transcription factor 3 is expressed in inflamed human skin and is upregulated by
interferon-γ
B Sapkota1 and BP Pollack1,2 1 Dermatology, Emory University School of Medicine, Atlanta,
GA and 2 Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta,
GA
Activating transcription factor 3 (ATF3) is a member of the ATF/CREB family of transcription fac-
tors that has been implicated in cancer development, apoptosis and immune regulation. In addi-
tion to directly regulating transcription, ATF3 has been shown to bind to p53, block p53 degrada-
tion and increase p53 protein levels. To further define the role of ATF3 in human skin, we have
examined the expression of ATF3 in inflammatory skin disease. Epidermal ATF3 protein levels are
increased in cases of erythema multiforme and psoriasis. Because ATF3 has been reported to be a
negative regulator of Th2 responses and increased levels of interferon (IFN)-γ can be present in
erythema multiforme and psoriasis, we examined the impact of IFN-γ on ATF3 expression in HaCaT
cells. IFN-γ increases levels of ATF3 hnRNA, mRNA and protein in HaCaT cells. Histone acetyla-
tion at the ATF3 promoter is also altered by IFN-γ with an initial decrease in acetylation followed
by an increase to above basal levels that is present 24 hours after IFN-γ treatment. In addition to
increasing transcription, IFN-γ increases the stability of ATF3 mRNA suggesting a post-transcrip-
tional mechanism contributes to the elevated ATF3 mRNA and protein that we observe. Despite
having mutant p53, HaCaT cells treated with IFN-γ displayed an increase in p53 protein levels that
paralleled those of ATF3 protein. Thus, ATF3 may contribute to the cutaneous inflammatory response
and provide a novel mechanism through which p53 levels are augmented in the setting of cuta-
neous inflammation.
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Familial Mediterranean fever (FMF)-associated mutant B30.2 domain activates a NALP3-
independent inflammasome and induces autoinflammatory disease in mice
Y Cho,1 J Chae,2 J Linton,1 PP Liu,3 L Feigenbaum,4 DL Kastner2 and SI Katz1 1 Dermatology
Branch, NCI, Beth, MD, 2 Genetics and Genomics Branch, NIAMS, Beth, MD, 3 Genetics
and Molecular Biology Branch, NHGRI, Beth, MD and 4 Laboratory Animal Sciences
Program, NCI, Beth, MD
FMF is a recessively inherited autoinflammatory disease characterized by recurrent episodes of
fever and inflammation. Most patients carry missense mutations in the C-terminal B30.2 domain
of pyrin. To study the role of FMF-associated mutant B30.2 in FMF pathogenesis, we generated
knock-in (KI) mouse models by inserting the B30.2 of human pyrin with or without the FMF-caus-
ing mutations (M680I, V726A) into mouse pyrin that has no compatible B30.2 in the C-terminus.
While the homozygous KI mice with wild type (WT) human B30.2 are embryonic lethal, the mice
homozygous for human mutations showed growth retardation, spontaneous dermatitis and arthri-
tis with inflammatory cell infiltration, and increased CD11b+ cells (mainly neutrophils) in the blood.
Bone marrow (BM) cells of KI mice transferred all the phenotypes of the KI mice into WT mice,
and WT BM cells rescued the diseased KI mice, suggesting that BM-derived cells are critical and
sufficient for the disease. Lymphocytes are not required for inflammation since Rag-1 deficient KI
mice showed similar phenotypes as Rag-1 sufficient KI mice. The expansion of CD11b+ myeloid
cells is mediated by soluble factors. Pro-inflammatory cytokines, such as IL-1β, are significantly
increased in KI mouse sera. In the steady state, the inflammasome is constitutively activated in
CD11b+ cells in KI mice, and subsequently CD11b+ cells secrete active IL-1β when stimulated
with LPS alone without ATP in vitro. Also, the autoinflammatory phenotype did not appear when
KI mice were crossed with IL-1 receptor KO or ASC KO mice. On the other hand, NALP3 deficient
KI mice exhibited the autoinflammatory phenotype. Together, these results suggest that in FMF-
associated mutant B30.2 KI mice the underlying cause of the inflammation is the activation of a
NALP3-independent inflammasome that may, in humans, be a potential target for therapy.
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Increased IL-23 expression, but not IL-12, in individuals with hyperkeratotic hand dermati-
tis or palmoplantar psoriasis
JV Lillis, C Guo, J Lee and A Blauvelt Dermatology, Oregon Health and Science University,
Portland, OR
Hyperkeratotic hand dermatitis (HHD) is characterized by sharply demarcated, fissure-prone plaques
on the palms and soles. The cause of HHD is unknown and there is controversy as to whether it
represents an eczematous process or a variant of localized psoriasis. The purpose of this study
was to characterize IL-23 and IL-12 expression patterns in clinical cohorts of untreated patients
previously defined by clinical and histologic examination as having either HHD or palmoplantar
psoriasis, while utilizing untreated patients with typical chronic plaque psoriasis as controls. Punch
biopsies were obtained from lesional skin of HHD (n=4), palmoplantar psoriasis (n=4), and chronic
plaque psoriasis (n=6) as well as non-lesional skin from the latter group (n=6). Skin was snap frozen
in liquid nitrogen, stained with anti-human monoclonal antibodies directed against either IL-23
or IL-12, and the average numbers of positive cells in 8 high-power fields (hpf) were quantified.
For both IL-23 and IL-12, positive cells demonstrated a dendritic morphology, with the vast major-
ity of cells located within the tips of dermal papillae. IL-23+ cells were markedly increased in HHD
(24.3 cell/hpf), palmoplantar psoriasis (15.9 cells/hpf), and lesional psoriasis (16.4 cells/hpf) com-
pared to non-lesional psoriasis (2.42 cells/hpf) (p<0.05 for each group). There were no significant
differences in IL-23+ cells between the three disease groups. By contrast, IL-12+ cells were not
increased in any disease group compared to non-lesional psoriasis. These data demonstrate for
the first time that 1) IL-23, but not IL-12, is up-regulated in palmoplantar psoriasis, similar to chronic
plaque psoriasis and 2) patients diagnosed with HHD show a similar pattern of IL-23 expression
when compared to psoriasis. We conclude that HHD is likely a variant of palmoplantar psoriasis,
and that patients with palmoplantar disease that has clinical features of either psoriasis or HHD
would be excellent candidates for biologic therapy that targets IL-23.
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Regulation of CCL20 chemokine by Trim32 and Piasy, the contribution of keratinocyte in
psoriasis pathogenesis
Y Liu, J Lagowski and M Kulesz-Martin Dermatology, Oregon Health & Science University,
Portland, OR
There is a vicious circle in psoriasis that disrupts epidermal homeostasis through alterations in ker-
atinocytes (hyperproliferation, parakeratosis) and immunocytes (infiltration and activation). While
it is well known that uncontrolled keratinocyte proliferation is largely driven by pro-inflammatory
cytokines from the immunocytes, the functional role of keratinocytes in the regulation of immuno-
cytes is poorly understood. We have discovered intriguing links between Trim32 (an E3 ubiquitin
ligase), its substrate Piasy (an E3 SUMO ligase), and psoriasis. Trim32 is elevated in psoriasis tis-
sue samples compared to non-lesional control epidermis. Trim32 negatively regulates the pro-
apoptotic Piasy protein, a repressor of NF-kappaB, STAT, and SMAD transcription factors that
have been implicated in the pathogenesis of psoriasis. The Piasy gene resides in the PSORS6 sus-
ceptibility locus on chromosome 19p13, although the significance of this remains to be deter-
mined. We have found that Trim32 activates and Piasy inhibits keratinocyte production of CCL20,
a psoriatic chemokine responsible for the recruitment of CCR6 positive dendritic cells and Th17
lymphocytes to the skin. Systemic analysis CCL20 induction in response to cytokines revealed
that CCL20 is induced by Th17 cytokines but not Th1 or Th2 cytokines. Further molecular dis-
section of this pathway revealed that CCL20 regulation by Trim32/Piasy is mediated through NF-
kappaB by Piasy interaction with the RelA/p65 subunit of NF-kappaB. As CCL20 is activated by
Th17 cytokines and essential for Th17 recruitment and activation, the aberrant regulation of CCL20
by Trim32 and Piasy may contribute to the positive feedback loop of CCL20 overproduction by
keratinocytes and Th17 activation that fuel the vicious circle of psoriasis. This study was sup-
ported by OHSU 2007-08 Presidential Bridge Funding and OHSU Knight Cancer Institute
CA069533.
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Improvement of psoriasis-like lesions in transgenic mice overexpressing amphiregulin with
omega-3 supplementation
J Genebriera,1 M Pellizzon2 and M Pittelkow1 1 Dermatology, Mayo Clinic Foundation,
Rochester, MN and 2 Nutrition, Research Diets Inc., New Brunswick, NJ
Studies have suggested that supplementation with omega-3 fatty acids reduce the severity of pso-
riasis. We determined whether supplementation would affect the phenotype of the amphiregulin
(AREG) transgenic mouse that develops characteristic cutaneous and histopathological changes of
psoriasis. Further, we determined whether several known markers of inflammation and histopathol-
ogy of skin from this mouse model were modulated by omega-3 supplementation. Control diet con-
taining 12 kcal% fat as corn oil and a calorically matched diet with 30 kcal% fat as linseed and
menhaden (fish) oil (omega-3 diet) were used. Shortly after weaning, mice were fed each diet for
a total of 9 weeks. Blood was extracted and levels of essential fatty acids, cytokines, lipid profile
and immunoglobulins were quantitated. Skin samples were taken from the ear and tail of the con-
trol and experimental mice. CD3, Ki-67 and K-17 stains were performed. Omega-3 treated AREG
mice showed diminished staining and decreased positive cell biomarkers compared to those fed
the control diet, thus demonstrating less proliferation, hyperkeratinization and inflammation. Hema-
toxin-eosin staining showed decreased acanthosis, parakeratosis and other psoriasis related changes
in the skin of the omega-3 fed group. Omega-3 diet significantly increased plasma omega-3 fatty
acids and reduced omega-6 fatty acids in AREG mice, and there were trends for reduced levels of
IL-6 and increased levels of MIP-1a and IL-5 in plasma (p=0.12). Other cytokines centrally medi-
ating the inflammatory-immune reaction in the AREG mouse may be more significantly altered.
Increased blood levels of anti-inflammatory essential fatty acids and decreased levels of pro-inflam-
matory fatty acids decrease the severity of the psoriasis-like lesions in the treated mice and may,
with further specific dietary fatty acid restrictions, have beneficial effects in human psoriasis.
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Ceramide deficiency in epidermis results in development of dermatitis through Langerhans
cell maturation and expansion of IL-17-producing γδ T cells
K Nakajima,1 M Terao,2 H Azukizawa,2 I Katayama,2 J Takeda3 and S Sano1 1 Dermatology,
Kochi Medical School, Kochi University, Kochi, Japan, 2 Dermatology, Osaka University
Graduate School Medicine, Osaka, Japan and 3 Social and Environmental Medicine, Osaka
University Graduate School Medicine, Osaka, Japan
Ceramides in the stratum corneum are essential for skin barrier function to prevent skin inflam-
mation, but the underlying mechanism still remains elusive. Here, we generated Sptlc2 targeted
mice under the keratin 5 promoter, whose keratinocytes were devoid of serine palmitoyltrans-
ferase (SPT), the rate-limiting enzyme for de novo synthesis of sphigolipids. Ceramide levels were
reduced in the cornified layer of newborn K5-SPT-KO mice and proinflammatory cytokines from
their keratinocytes were upregulated. From 2 weeks after birth, barrier disruption and spontaneous
dermatitis developed, with histologic aberration such as hyperkeratosis, acanthosis and the infil-
tration of inflammatory cells in the dermis. Langerhans cells (LCs) in the epidermis of K5-SPT-KO
mice appeared mature and there were increased numbers of langerin+ dendritic cells in the skin-
draining lymph nodes compared to control mice. However, FITC painting revealed an impaired
antigen presentation capacity of LCs in K5-SPT-KO mice. In the skin-draining lymph nodes of
these mice, there were increased IL-17-producing γδ T cells and, to a lesser extent, Th17 cells. Fur-
thermore, IL-17 and IL-22 mRNAs in the lesional skin of K5-SPT-KO mice were increased. We
concluded that deficiency in de novo ceramide synthesis of keratinocytes resulted in increase of
proinflamatory signals in epidermis and subsequent barrier disruption, that promoted aberrant mat-
uration and migration of LCs, followed by expansion of IL-17-producing γδ T cells and develop-
ment of dermatitis. This animal model may represent an ‘innate dermatitis’ initiated by an aberrant
keratinocyte-LC crosstalk and help to understand the relationship between reduced epidermal
ceramides and inflammatory skin disease, such as atopic dermatitis.
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Roles of sphingosine-1-phosphate for eosinophil localization and function in mice
K Sugita,1 K Kabashima,2,1 J Sakabe,1 R Yoshiki1 and Y Tokura1 1 Department of Dermatology,
University of Occupational and Environmental Health, Kitakyushu, Japan and 2 Department
of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Increment of circulating and tissue eosinophils is frequently observed in patients with certain inflam-
matory skin diseases such as atopic dermatitis. The mechanisms underlying eosinophil circulation
and the precise roles of eosinophils in skin disorders remain unclear. An immunosuppressant drug,
FTY720, inhibits lymphocyte emigration from lymphoid organs. Phosphorylated FTY720 binds to
one of sphingosine-1-phosphate (S1P) receptors, S1P1, and downregulates S1P1, providing an
explanation for the mechanism of FTY720-induced sequestration of lymphocytes. However, the
effect of FTY720 on the function of eosinophils remains to be elucidated. Initially, we monitored
numerical alternations of eosinophils in IL-5 transgenic mice following FTY720 administration. The
number of circulating eosinophils was significantly decreased in the FTY720-treated IL-5 transgenic
mice, suggesting that eosinophils are S1P sensitive. Accordingly, eosinophils showed a weak but
substantial chemotactic response to S1P as assessed by transwell assay. We then addressed the roles
of eosinophils using a murine atopic dermatitis model induced by repeated hapten application.
BALB/c mice were sensitized by painting of TNCB on the abdomen on day 0, and the ears were
repeatedly challenged with TNCB at 3-day intervals from day 5 to day 20. FTY720 administered
12 h before the final challenge decreased an ear swelling response of the 6-8 hour post-challenge
corresponding to the late phase reaction. These data suggest that eosinophils are sensitive to S1P
and deeply participate in the late phase reaction of this atopic dermatitis model.
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Successful preventive and therapeutic approaches to CD8 T cell-mediated autoimmunity
using self-peptides
J Gutermuth, K Nograles, E Nelson, J Linton, F Miyagawa, Y Cho and SI Katz Dermatology
Branch, NCI, NIH, Bethesda, MD
While the pathogenic role of B cells and CD4 T cells has been studied extensively, less is known
about the role of CD8 T cells in autoimmunity and self-tolerance. To evaluate the role of CD8 T
cells in autoimmunity and their potential modulation, we utilized mice expressing ovalbumin under
control of the keratin-14 promoter in the skin, tongue, esophagus and thymus (sOVA mice). To
generate a spontaneous model of autoimmunity, sOVA mice were crossed to OT-I mice, whose
CD8 T cells carry a transgenic T cell receptor with specificity for the OVA257-264-peptide (OVAp).
83% (n=28) of these F1 (sOVAxOT-I) mice die by d21, due to inflammation in multiple organs and
diminished food intake. Prophylactic ip OVAp injections on both d5 and d9 after birth induced a
dose dependent increase of sOVA/OT-I survival of 98% (100μg OVAp; n=18), whereas 1μg OVAp
(n= 18) or PBS (n=33) led to 100% death. As well, therapeutic injections on day 10 of life, when
F1 mice already show overt signs of disease (growth restriction and neurological signs) still increased
survival to 58% (n=21) compared to solvent-treated mice that uniformly died (PBS; n=15). FACS
analysis of skin draining lymph nodes of healthy survivors (either spontaneous or OVAp-treated)
at d35 revealed reductions of (i) CD8 T cells (-95.4% to -98.5%), (ii) CD8 cell surface expression
(-63% to -68%) and (iii) CD8-Vα2 expression (47% to 60% of CD8 T cells were Vα2-negative), as
compared to OT-I controls or sick F1 mice. In addition, CD8 T cells from healthy mice failed to
proliferate when cultured with OVAp-pulsed splenocytes. Nor did these cells proliferate in the pres-
ence of IL-2. FACS analysis of pSTAT5 protein showed a block of IL-2/IL-7 mediated signaling, thus
providing a basis for low CD8 expression and failure of IL-2 to break anergy in CD8 T cells of
healthy F1 mice. Thus, prophylactic and therapeutic self-peptide injections trigger multiple toler-
ance mechanisms and attenuate disease in sOVA/OT-I mice, making this approach a potential par-
adigm for modulating autoimmune diseases.
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Apoptosis precedes desmoglein cleavage and keratinocyte dissociation in pemphigus: anti-
Fas Ligand neutralizing antibodies prevent acantholysis both in vitro and in vivo
R Lotti,1 E Shu,2 F Truzzi,1 E Palazzo,1 A Marconi,1 Y Kitajima2 and C Pincelli1 1 Dermatology,
University of Modena and Reggio Emilia, Modena, Italy and 2 Gifu University, Gifu, Japan
While anti-desmoglein (dsg) antibodies are essential for the development of pemphigus, the molec-
ular mechanisms underlying cell-to-cell detachment (acantholysis) are still to be fully clarified.
We had first proposed an important role for apoptosis in the pathomechanisms of blister forma-
tion. In this study, we have analyzed in details the apoptotic process in relation to acantholysis.
Here, we present evidence that the effector caspase-3 is activated in lesional and perilesional skin
of pemphigus. Moreover, untreated but not steroid-treated pemphigus sera induce apoptosis in nor-
mal human keratinocytes in culture, which is abrogated by caspase-8 inhibitor, indicating that the
extrinsic apoptotic pathway is involved in this process. Untreated pemphigus sera contain signifi-
cantly higher levels of Fas ligand (FasL) than sera from healthy controls and treated sera. Because
caspases can cleave adhesion molecules in many cell settings, we evaluated whether pemphigus
sera can cleave dsg. Indeed, sera from untreated patients induced the cleavage of both dsg-1 and
–3 in a time dependent manner starting at 4-6 hrs. Moreover, FasL cleaves dsg-1 and 3 in a dose
and time-dependent manner. Anti-FasL neutralizing antibodies and caspase-8 inhibitor prevent
both dsg cleavage and keratinocyte dissociation. Caspase-8 and caspase-3 activation occurs at 2
and 4 hrs, respectively, while dsg cleavage and keratinocyte dissociation take place at 6 and 24
hrs, respectively. indicating that apoptosis precedes acantholysis in vitro. Finally, using the “pas-
sive transfer” pemphigus mouse model, we were able to prevent caspase-3 activation and blister
formation, by injecting anti-FasL neutralizing antibody 3 hours after PVIgG administration, as meas-
ured by counting the number of clefts in histology sections from treated vs. untreated mice. This
strongly indicates that FasL plays a central role in blister formation.
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Impaired psoriatic CCR5+ regulatory T cells exhibit reduced migratory capacity toward CCR5
ligands
H Sugiyama,1 T McCormick,1 J Massari,1 S Shimada3 and K Cooper1,2 1 Dermatology, Case
Western Reserve University / University Hospitals Case Medical Center, Cleveland, OH, 2
VAMC, Cleveland, OH and 3 Dermatology, University of Yamanashi, Yamanashi, Japan
CCR5 expression on CD4+CD25+ regulatory T (Treg) cells is crucial for recruitment of Treg cells to
sites of ongoing Th1 type inflammation to avoid inordinate immune responses. Examples of CCR5
criticality on Treg have been shown in murine models of Leishmania major infection as well as
acute graft-versus-host disease. We previously reported that the proportion of peripheral blood cells
positive for both Treg-cell markers (CD4+CD25highFOXP3+) and CCR5 was significantly decreased
(~50%) in psoriatic patients compared to that of control subjects (n=9 and 8, respectively, P<0.05).
The current study explores the specificity and functional implications of this finding. CCR5 dimin-
ishment on psoriatic Treg appears specific to this chemokine receptor, since there was no defect
in various chemokine receptors including CD62L, CCR4, CCR6, CCR7, CCR8, CXCR3, CXCR4,
CXCR5, CXCR6 and β7 integrin. Functionally, the loss of the CCR5+ Treg subset is important because
these cells are highly suppressive: CCR5+ Treg exerted greater than five times the suppressive capac-
ity of CCR5- Treg when co-cultured with autologous responder T cells at ratios of 1:1 and 1:2 (n=5,
P<0.01). Compared to normal CCR5+ Treg cells, even artificially enriched psoriatic CCR5+ Treg
cells, in addition to numerical impairment, showed a significantly decreased migratory capacity
toward the CCR5 ligands MIP-1β and RANTES (n=3, P<0.05), chemokines known to be highly
expressed in psoriatic lesions. Combined with a decreased capacity to suppress effector/pathogenic
T cell proliferation, the impaired migratory capacity of psoriatic CCR5+ Treg cells may lead to fail-
ure of recruitment of these cells to the ongoing disease site thus exacerbating the pathogenesis of
psoriasis.
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Skin resident T cells producing IL-13 and TNFα: a possible role in the initiation of cutaneous
sclerosis
A Calarese, M Lichtman, TS Kupper and RA Clark Department of Dermatology, Brigham and
Women’s Hospital, Boston, MA
Skin fibrosis in localized scleroderma is preceded by dense T cell inflammation that starts in the
deep dermis and progresses more superficially, leaving fibrosis in its wake. There is accumulating
evidence that T cells may play a critical role in the early stages of fibrosis in generalized sclero-
derma. We have found that normal human skin contains nearly 20 billion memory T cells, nearly
twice as many as are found in the entire circulation. In mice, TNFα and IL-13 have been shown
to stimulate production of TGFβ by tissue macrophages, leading to the initiation of fibrosis. IL-13
is also increased in the serum of patients with scleroderma. We report now that 13% of T cells res-
ident in normal human skin co-produce IL-13 and TNFα, compared to <1% from the blood. Skin
resident IL-13/TNFα T cells expressed the skin addressins CLA and CCR4, had a diverse T cell reper-
toire and did not produce IFNγ. Treatment of human skin with IL-2 and IL-15 led to a 10-fold expan-
sion of these cells without loss of skin homing receptors or cytokine production. Autoreactive T
cells derived from this population may be capable of initiating skin fibrosis. To examine the cuta-
neous effects of IL-13, we treated human skin with recombinant human IL-13. We observed devel-
opment of a larger population of fibroblasts that expressed increased levels of the pro-fibrotic tran-
scription factor STAT3 and decreased levels of the anti-fibrotic STAT1. In summary, we have found
that a novel population of T cells expressing IL-13 and TNFα are present in high numbers in nor-
mal human skin. Autoreactivity of this T cell subset in the skin may lead to local production of IL-
13 and TNFα, two cytokines that can initiate tissue fibrosis in mice. We hypothesize that activa-
tion of autoreactive TNFα/IL13 T cells in the skin may initiate fibrosis and that dissemination of
these cells to other sites could spread fibrosis to other organs.
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Phenotypical and functional analyses of ectoenzyme CD39/CD73 expressing CD4+CD25high
regulatory T cells in human peripheral blood
L Han,1,2 J Massari,1 Z Zheng,2 J Xu,2 T McCormick,1 K Cooper1,3 and H Sugiyama1 1
Dermatology, Case Western Reserve University / University Hospitals Case Medical Center,
Cleveland, OH, 2 Dermatology, Fudan University / Huashan Hospital, Shanghai, China and
3 VAMC, Cleveland, OH
CD39 and CD73 are recently reported as two novel cell-surface markers in rodent CD4+CD25high
regulatory T (Treg) cells. Concordant expression of these two ectoenzymes generates pericellular
adenosine, which has been reported to suppress proliferation of activated T effector cells. Because
little is known about the pivotal role of these molecules in human Treg cells, we examined the pro-
portion and functional properties of CD39/CD73 expressing Treg cells in human peripheral blood.
Flow cytometric analyses (n=5) revealed that CD4+CD25highFoxP3+ Treg cells showed significantly
higher expression levels of CD39 (59.7±9.9%) compared to that of CD25midFoxP3- (7.6±2.1%)
and CD25- pool (6.5±1.0%, P<0.01). Conversely, the proportion of CD73 positive cells in Treg cells
(12.7±2.0%) was significantly less than that of CD25mid and CD25- cells (21.7±5.5% and 21.2±6.5%,
respectively, P<0.05). Only 6.0 ± 1.1 % of Treg cells exhibit both CD39 and CD73, while
CD4+CD25mid and CD4+CD25- fractions express 1.0±0.3% and 1.0±0.4% of CD39/73, respectively
(P<0.01). Next, we compared the functional regulatory properties of flow-sorted CD39+CD73- Treg,
CD39+CD73+ Treg, and Treg-cell pool in vitro using allo MLR. The inhibitory capacity of
CD39+CD73- Treg cells was significantly higher than that of the unfractionated Treg cell-pool when
co-cultured with autologous responder T cells at ratios ranging from 1:1 to 1:4 on a cell per cell
basis (n=5, P<0.01). On the other hand, interestingly, CD39+CD73+ Treg exhibited significantly less
suppressive capacity compared to that of Treg-cell pool at a 1:4 ratio (n=5, P<0.05). Our data sug-
gest that expression of CD73 on Treg cells leads to decreased suppressive capacity of these cells.
This loss of suppressive capacity may be attributed to alteration of cyclic AMP levels or an alter-
ation of an as yet unknown function of CD73.
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Specific immunoglobulin isotypes correlate with disease activity, morphology, duration,
and HLA association in Pemphigus vulgaris (PV)
MM Dhandha, K Seiffert-Sinha and AA Sinha Dermatology and Cutaneous Sciences, Michigan
State University, East Lansing, MI
The molecular basis of disease heterogeneity in autoimmune conditions such as PV is poorly under-
stood. While desmoglein 3 (Dsg3) is the primary target of immunoglobulin (Ig) autoantibodies in
PV, no previous studies have addressed Ig-subtype correlation with a comprehensive set of defined
variable (activity, morphology, age, duration) and constant (HLA-type, gender, age of onset) clini-
cal parameters. To systematically address the outstanding questions related to Ig-isotype speci-
ficity in PV, we analyzed IgA, IgM, IgG1, 2, 3 and 4 anti-Dsg3 levels by ELISA in 196 serum sam-
ples obtained from 95 patients with distinct clinical profiles and 70 serum samples from 59
HLA-matched and -unmatched controls. Patients with PV had significantly higher levels of IgG4
and IgG1 anti-Dsg3 antibodies than controls, but not of the subtypes IgM, IgA, IgG2 and IgG3. As
suggested previously, we found significantly elevated levels of IgG4 and IgG1 anti-Dsg3 antibod-
ies in active disease, when compared to remission (p=0.0001 and p=0.002, respectively; Kruskal-
Wallis test). Interestingly, anti-Dsg3 IgG2 levels were significantly elevated during active disease
phases as well (p=0.006). Furthermore, patients with a history of mucocutaneous and mucosal only
lesions had increased IgG4, but not IgG1 or 2, anti-Dsg3 antibody levels when compared to patients
with a history of cutaneous only lesions. While the age at sampling did not influence anti-Dsg3 Ig
levels, the levels of IgG4 significantly increased with increasing duration of disease (<2y vs. >10y;
p=0.03). In addition, patients carrying the disease associated HLA alleles DRB1*0402 and
DQB1*0503 had significantly higher anti-Dsg3 IgG4 levels, but not other Ig subtypes, than carri-
ers of other HLA alleles (p=0.034). Gender or age of onset did not influence anti-Dsg3 Ig-subtype
distribution. In summary, our data indicate that Ig subtype profiles can be used to substratify PV
patients and provide further insight into the immunoregulatory mechanisms that underlie disease
heterogeneity.
S14 Journal of Investigative Dermatology (2009), Volume 129
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Pregnant women have an increased incidence of IgE-class autoantibodies directed against
BP180
MH Noe,1,3 KA Messingham,1 DS Brandt1 and JA Fairley1,2 1 Dermatology, University of Iowa,
Iowa City, IA, 2 Dermatology, VA Medical Center, Iowa City, IA and 3 Tufts University School
of Medicine, Boston, MA
The development of IgG autoantibodies directed against BP180 (type XVII collagen) during preg-
nancy is associated with pemphigoid gestationis (PG), and the infants born of these mothers tend
to be small for gestational age. In a previous study, we identified BP180-specific IgE in 50% of PG
patients and also in a small number of pregnant controls who did not develop PG. The purpose
of the current study was to determine the frequency and specificity of antibodies to BP180 in a
larger cohort of pregnant women. De-identified sera were collected from pregnant women at the
time of alpha-fetoprotein testing (between 16 and 20 weeks gestation, n=299) and from healthy,
non-pregnant women of childbearing age (n=134). Sera were analyzed by enzyme-linked
immunosorbent assay (ELISA) for the presence of IgG and IgE autoantibodies directed against the
NC16A region of BP180, which harbors the major epitopes recognized by both IgG and IgE in PG
and bullous pemphigoid. 8.7% of pregnant women were found to have IgE antibodies directed
against NC16A, as compared to 2.2% of healthy controls (Mann Whitney U Test, p = 0.01). No
increase in IgG autoantibodies against BP180 was seen. Total serum IgE was measured in both
groups and found to be within the normal range. A subset of pregnant women (n=100) and con-
trols (n= 102) were also examined for IgG antibodies to BP230 and desmogleins 1 and 3, but no
reactivity was found. The sera that were positive in the NC16A IgE ELISA, labeled both the amnion
of normal placenta as well as the BMZ of normal skin in a pattern identical to that of a polyclonal
anti-BP180 antibody control. The development of these autoantibodies during pregnancy is intrigu-
ing and a larger, prospective study is underway to identify factors that may lead to the develop-
ment of these autoantibodies and to determine if they are a biomarker for adverse pregnancy out-
comes.
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Development of a novel chimeric fusion protein to identify CCR10+ cells
B Gammon,1,2 V Lee1 and ST Hwang1 1 National Cancer Institute, Bethesda, MD and 2
Internal Medicine, Tulane University, New Orleans, LA
Application of topical sensitizing agents to murine skin is known to result in rapid depletion of the
chemokine CCL27 from the skin and accumulation of CCL27 in skin-draining lymph nodes (LN).
This likely provides a chemotactic stimulus to CCR10+ T cells. RT-PCR data demonstrates that
CCR10 mRNA signal in LN is upregulated after application of topical sensitizing agents. Full char-
acterization of the cellular infiltrate by flow cytometry (FCM) was previously not possible due to
the lack of commercially available antibody with acceptable performance. Our aim was to gen-
erate a chimeric protein with which we could sensitively and specifically label murine CCR10+
cells for FCM. To achieve this, we constructed a fusion vector consisting of cDNA for the com-
plete sequence of murine CCL27 (mCCL27) ligated to the sequence of the Fc portion of human
IgG1. This vector was used to generate a secreted protein using a mammalial protein expression
system and transient transfection. Western blot assays using anti-mCCL27 antibody as the probe
revealed that the fusion protein retained its native conformation. The protein induced dose-depen-
dant chemotaxis of MBL2-hCCR10 cells that was inhibited by a CCR10 antagonist. Use of the pro-
tein allowed for differentiation of B16 cells transfected with CCR10 from those transfected with a
mock plasmid. The mean fluorescence intensity from B16-CCR10 cells decreased by 40% after
preincubation with recombinant CCL27. Cervical LN from Balb/C mice were harvested 6 hours
after application of either 0.5% DNFB or vehicle. LN were homogenized into single cell suspen-
sion and stained for FCM with chimeric protein as primary antibody and FITC-labeled goat anti-
human IgG protein as secondary antibody. Application of DNFB to the ears of Balb/C mice resulted
in a 2-fold increase in the number of CCR10+ cells migrating to cervical LN. This novel chimeric
protein can be used to identify CCR10+ cells by FCM. CCR10+ cells migrate to the skin-draining
lymph node after application of topical sensitizing agents.
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BP180-specific IgE directly affects keratinocyte structure and function
K Messingham,1 A DeGueme3 and J Fairley1,2 1 Dermatology, University of Iowa, Iowa City,
IA, 2 VA Medical Center, Iowa City, IA and 3 Dermatology, Medical College of Wisconsin,
Milwaukee, WI
Bullous pemphigoid (BP) is an autoimmune disease characterized by the development of patho-
genic autoantibodies directed against the hemidesmosomal protein BP180. Although BP180-spe-
cific IgG and IgE are detectable in the majority of BP sera, BP IgE has only recently been shown
to play a pathogenic role in the disorder, most likely by triggering degranulation of dermal mast
cells. It is not clear if BP180-specific IgE exerts direct effects on the skin by binding keratinocytes.
We addressed this by treating primary cultures of normal human keratinocytes (nKC) with IgE (60
ng/ml) purified from BP or control sera and evaluated changes in cell structure and function. First,
we determined if BP IgE could bind to the keratinocyte surface. Using flow cytometry, IgE was
detectable on the cell surface after incubation with BP, but not control, sera and that fluorescence
intensity was diminished with serum dilution. Confocal microscopy studies confirmed BP (but not
control) IgE binding to the cell surface and demonstrated rapid translocation of the bound anti-
body into the cytoplasm. Similarly, the addition of BP IgE results in a transformation in the appear-
ance of keratinocyte cultures when observed by phase contrast microscopy. To assess whether the
addition of BP IgE influenced the production of mediators known to be elevated in the sera and
blister fluid of BP patients, BP or control IgE (60 ng/ml) was added to keratinocyte cultures and
supernatants were collected over time and evaluated using a human cytokine Bioplex assay. BP
IgE treatment resulted in a significant increase in IL-8 and IL-6. Finally, evaluation of parallel cul-
tures using a MTT assay demonstrated decreased keratinocyte viability when treated with BP IgE,
compared to control. In summary, our findings reveal a potential new role for IgE autoantibodies
in BP through a direct effect of antibody binding on keratinocyte structure and function.
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The immune phenotype of therapeutic IL-12/IL-23 blockade in psoriasis patients treated with
ustekinumab
J Krueger,1 T Kikuchi,1 R Fidelus-Gort,2 A Khatcherian,1 I Novitskaya1 and C Brodmerkel3 1
Rockefeller University, New York, NY, 2 Incyte Corp., Wilmington, DE and 3 Centocor
Research and Development, Inc, Malvern, PA
Genes activated in psoriasis vulgaris skin lesions include lipocalin 2, defensins, S100 proteins,
and CCL20, all modulated by IL-17, the defining cytokine of Th17 T-cells. In the ACCEPT study,
patients were treated with 45mg or 90 mg of ustekinumab for 12wks. Skin biopsies were performed
at baseline, wks1, and 12 of treatment to assess the impact of p40 cytokine (IL-12/IL-23) blockade
on resident and inflammatory cells and on expression of gene circuits that may drive chronic immune
activation and inflammation in the skin. Two inflammation-associated dendritic cell subsets;TIP-
DCs (CD11c+BDCA1-) and mature/activated DCs (DC-LAMP (CD208+)) were highly expressed in
active psoriasis lesions and reduced to normal levels by ustekinumab (p < 0.01) as were infiltrat-
ing T cells. In contrast, resident populations of Langerhans cells (CD207+) and dendritic cells
(BDCA1+) were retained in skin lesions at normal levels during ustekinumab treatment. Activation
of inflammatory DCs, Th1, and Th17 T-cells, as well as keratinocyte response to IL-17 was assessed
by quantification of mRNAs for gene products (IL-20, IL-23, IL-17, IL-22, interferon-gamma,
lipocalin,defensins,CCL20, and MX-1). Genes in this axis may form a self-sustaining activation loop
for Th17 T-cells through Toll-like receptors 1 and 2 on inflammatory DCs. Treatment with ustek-
inumab modulated expression of genes in this “autoinflammatory loop” and reduced activation of
Th1 and Th17 T-cells to background levels found in non-lesional psoriatic skin (all effects p<0.01).
Modulation of inflammation-associated leukocyte subsets was confined to the skin, as circulating
levels of Th1, Th2, Th17, NK-T and Treg T-cell subsets was not significantly impacted during 12wks
of ustekinumab treatment. Overall, these results suggest that interruption of p40 cytokine signal-
ing in the skin causes collapse of pathogenic immune infiltrates and cytokines, but T-cells and DCs
of the normal skin immune system persist in treated skin.
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Sertaconazole nitrate mediates its anti-itch activity by inducing PGD2 via the p38 MAPK
pathway
S Kaur, R Sur, F Liebel and M Southall Pharmacology, Johnson & Johnson Consumer Products,
Skillman, NJ
Sertaconazole nitrate, a broad-spectrum anti-fungal agent, has recently been shown to exhibit anti-
itch activity; however, the signaling pathways that mediate this action are unknown. Therefore, to
elucidate the cellular mechanism behind this activity, the effects of sertaconazole nitrate were exam-
ined in-vitro and in-vivo. We used compound 48/80, an agent known to induce itch and promote
the release of histamine, in RBL-2H3 mast cells to mimic a pruritic response, and observed that
sertaconazole nitrate induced Prostaglandin- D2 (PGD2) production. PGD2 is known to have
anti-pruritic activity by suppressing histamine release. Similar results were obtained in the
macrophage cell line, RAW 264.7, when Lipopolysaccharide (LPS)-stimulated PGD2 levels were
further enhanced by sertaconazole. In order to further dissect the pathway involved in PGD2 pro-
duction, the inhibitor of p38-MAPK, SB203580, was used along with the above-mentioned secre-
tagogues. Blocking the p38-MAPK pathway eliminated PGD2 induction in both cell lines. Fur-
thermore, using a murine model of pruritus we showed that compound 48/80-induced scratching
was successfully reduced by the topical application of sertaconazole nitrate. This effect was reversed
by the addition of Ibuprofen or a PGD2 antagonist confirming that sertaconazole-induced PGD2
production was responsible for inhibiting the itch response. Thus, the anti-pruritic activity of ser-
taconazole nitrate is mediated by the induction of PGD2 through the p38-MAPK pathway.
90
Evolutionary conserved chemotactic activity of S100A7 (psoriasin) is mediated by RAGE
and potentiates inflammation with highly homologous but functionally distinct S100A15
R Wolf,1,6 H Dong,2 C Voscopoulos,1 J Winston,1 M Gunsior,5 P Goldsmith,5 C Cataisson,1
T Chavakis,3 O Howard,4 JJ Oppenheim4 and SH Yuspa1 1 Laboratory of Cancer Biology and
Genetics, NCI, Bethesda, MD, 2 SAIC Frederick, Division of Basic Sciences and Cellular
Immunology, NCI, Frederick, MD, 3 Experimental Immunology Branch, NCI, Bethesda, MD,
4 Laboratory of Molecular Immunoregulation, NCI, Frederick, MD, 5 Antibody and Protein
Purification Unit, NCI, Bethesda, MD and 6 Department of Dermatology and Allergology,
Ludwig-Maximilians-University, Munich, Germany
Human S100A7 and the homologous hS100A15 (93% sequence identity) are upregulated in pso-
riasis and other cutaneous inflammatory diseases. This study addresses why such closely related
proteins evolved and are co-regulated in disease. We show that both hS100A7 and hS100A15 are
differentially expressed by human skin cells and have different properties as chemoattractants.
Despite their nearly identical amino acid sequence, only hS100A7 binds and mediates chemo-
taxis through RAGE (receptor of advanced glycated end products). In contrast, hS100A15 promotes
chemotaxis through a Gi protein coupled receptor. While zinc is required for hS100A7 receptor
binding and chemotactic function, hS100A15 functions independently of zinc. The single mouse
ancestor to both hS100A7 and hS100A15 also binds RAGE and induces chemotaxis. In vivo, chemo-
taxis is potentiated by combined treatment with hS100A7 and hS100A15. Thus, the evolutionary
recent duplication of hS100A7/ hS100A15 produced biological diversification by which their inde-
pendent actions through distinct receptors regulate physiological functions but potentiate their
proinflammatory activities in disease.
www.jidonline.org   S15
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Prolactin enhances CCL20 production in human keratinocytes
N Kanda and S Watanabe Dermatology, Teikyo University School of Medicine, Tokyo, Japan
Psoriasis vulgaris is an autoimmune dermatosis with Th17 infiltration. Prolactin may participate in
the pathogenesis of psoriasis. The chemokine CCL20 recruits Th17 cells, and CCL20 production
by epidermal keratinocytes is enhanced in psoriatic lesions. We examined the in vitro effects of
prolactin on CCL20 production in human keratinocytes. Prolactin increased basal and IL-17-induced
CCL20 secretion, and mRNA expression in keratinocytes. CCL20 production by prolactin was
suppressed by antisense oligonucleotides against the AP-1 components c-Fos and c-Jun, while
that by IL-17 was suppressed by antisense NF-κB p50 and p65. CCL20 production induced by
prolactin plus IL-17 was suppressed by antisense c-Fos, c-Jun, p50, and p65. Prolactin alone
increased the transcriptional activity of AP-1, and c-Fos and c-Jun expressions; moderately enhanced
NF-κB activity and IκBα phosphorylation; and potently increased IL-17-induced NF-κB activity.
MEK and JNK inhibitors suppressed prolactin- or prolactin plus IL-17-induced CCL20 production
and AP-1 activities. MEK inhibitor suppressed prolactin-induced c-Fos expression, while JNK inhibitor
suppressed c-Jun expression. Prolactin induced ERK and JNK phosphorylation. These results sug-
gest that prolactin may enhance basal and IL-17-induced CCL20 production in keratinocytes by
AP-1 and NF-κB activation, which is partially mediated via MEK/ERK and JNK. Prolactin may pro-
mote Th17 infiltration into psoriatic lesions via CCL20.
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Carbazole modulates chemokine production by the transformed human microvascular
endothelial cell line HMEC-1 and antigen presentation by murine epidermal cells
C Culjis,1 J Huang,1 J Arbiser,2 W Ding1 and R Granstein1 1 Dermatology, Weill Cornell Medical
College, New York, NY and 2 Dermatology, Emory University School of Medicine, Atlanta,
GA
Carbazole (CZ) is a component of coal tar that has anti-angiogenic activity, inhibits IL-15 produc-
tion by human mononuclear cells, reduces the activity of inducible nitric oxide synthase and inhibits
signal transducer and activator of transcription (STAT)3-mediated transcription. CZ may be impor-
tant in the anti-psoriatic activity of coal tar. To examine the possibility that CZ modulates chemokine
production by endothelial cells, we used HMEC-1 cells as a surrogate for primary human dermal
microvascular endothelial cells. HMEC-1 cells (2 ml of medium containing 0.2 x 106 cells/well)
were cultured in graded concentrations of CZ for 2 hrs followed by stimulation with 100 μM
ATPγS (a long-lived, hydrolysis-resistant analog of ATP). After 24 hrs, supernatants were collected
and assayed for CXCL8, CXCL1 and CCL2 content by ELISA. CZ inhibited production of all 3
chemokines in a dose-dependent manner (0.1 μM to 10 μM). Cell viability in 10 μM CZ at 24 hrs
was 80% and 82% in the presence of 100 μM ATPγS; in these experiments viability in the pres-
ence of ATPγS alone was 82% and 89%, respectively. The ability of CZ to alter antigen presenta-
tion was assessed by comparing a single cell suspension of epidermal cells (EC) from BALB/c mice
treated with CZ with EC treated with medium alone. EC were cultured for 1.5 hrs in various con-
centrations of carbazole. Then, keyhole limpet hemocyanin (KLH) was added to 200 μg/ml. After
an additional 1.5 hrs of culture, EC were washed 3 times. They were then co-cultured with HDK-
1 cells (a Th1 clone that responds to KLH presented by I-Ad) for 72 hrs. Supernatants were then
collected and assayed for IFNγ content by ELISA. CZ dose-dependently inhibited antigen presen-
tation over the range of 0.1 to 10 μM. Inhibition of chemokine release and suppression of antigen
presentation by CZ may be therapeutically useful in skin disorders characterized by inappropriate
inflammation or immunity.
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Development of psoriasis is dependent on IL-12/23p40, but partially on IL-17A in a mouse
model
M Takaishi,1 K Nakajima,1 J DiGiovanni,2 Y Iwakura3 and S Sano1 1 Dermatology, Kochi
University, Nankoku, Japan, 2 MD Anderson Cancer Center, Smithville, TX and 3 Institute of
Medical Science, University of Tokyo, Tokyo, Japan
We previously found that Stat3 signaling of keratinocytes played an essential role in the develop-
ment of psoriasis with a distinct crosstalk to T cells. Recent studies revealed that Th17 contributed
to the crosstalk through their secreting IL-17A and IL-22, which activates Stat3 of keratinocytes.
Furthermore, it was found that IL-23, which promoted activation and maturation of Th17, was also
involved in the pathogenesis of psoriasis, evidenced not only by laboratory studies but also by the
clinical efficacy of treatment with anti-IL-12/23p40 antibody on patients with psoriasis. Here we
examined the contribution of the IL-23/Th17 axis to the development of psoriasiform lesions in
K5.Stat3C transgenic mice, which represented a model animal for psoriasis showing a distinct skin
phenotype following wound healing, topical TPA treatment and tape stripping. Administration of
K5.Stat3C mice with anti-IL-12/IL-23p40 antibody completely inhibited the development of lesions.
Real-time RT-PCR analysis using skin lesions clearly demonstrated that anti-IL-12/23p40 markedly
reduced the transcript levels of IL-17A, IL-17F, IL-22, S100A8, S100A9, and LL-37, but not IFN-γ.
Furthermore, K5.Stat3C mice in IL-17A-/- background presented a weak but not completely reversed
skin phenotype, which was further abolished by anti-IL12/23p40 treatment. We conclude that the
development of psoriatic lesions in our model completely depended on IL-12/23p40, but partially
on IL-17A. This result also suggested that full-blown psoriasis might require two pathways, IL-17A-
dependent and -independent pathways.
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Wnt5a causes hypersensitivity toward type 1 interferon and is aberrantly distributed in pso-
riasis
M Romanowska,1 S Donandt,4 A Evans,1 DB Kellock,3 SE Bray,3 K McLean3 and JP Foerster1,2 1
Division of Medical Sciences, University of Dundee, Dundee, United Kingdom, 2
Department of Dermatology, University of Dundee, Dundee, United Kingdom, 3 Tayside
Tissue Bank, Dundee, United Kingdom and 4 Charité Medical University, Berlin, Germany
Wnt5a protein belongs to the family of the wingless-type regulators of development. The expres-
sion of Wnt5a and its receptors frizzled (fzd) 3 and 5 in post-natal skin have not been compre-
hensively studied to date. We analyzed expression of Wnt5a and Fzd receptors in adult human epi-
dermis and psoriatic tissue using immunohistochemical staining. Next, we investigated Wnt5a
expression level in vitro in keratinocytes from psoriasis patients. Finally, we compared gene expres-
sion between primary keratinocytes from psoriasis patients and controls cultivated in the absence
or presence of the Wnt5a-mimic peptide using microarray-based expression profliling. We here
show that Wnt5a as well as fzd3, fzd5, and fzd6 are restricted to specific layers in adult human
epidermis, reminiscent of their zonal distribution in hair follicles. Wnt5a and fzd5 are both aber-
rantly expressed in the epidermis of psoriasis. In psoriasis, defective keratinocyte homeostasis is
coupled to activation of type 1 interferon signalling. We unexpectedly found that Wnt5a renders
keratinocytes hypersensitive towards type 1 interferon, suggesting a mechanism underlying IFN
hypersensitivity in psoriasis. Finally, we show that type 1 interferon and Wnt5a synergistically
induce two novel targets, nedd8 as well as the amyloid precursor APP, the latter of which has pre-
viously been implicated in psoriasis pathogenesis. The present data suggest that Wnt5a is critical
for keratinocyte dynamics in adult skin and define a novel function for Wnt5a in innate immunity.
Targeting Wnt5a signal transduction may reduce IFN hypersensitivity and harbour therapeutical
value.
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Th17 dependent psoriasis-like skin disease in transgenic mice upon activation of PPAR delta
M Romanowska,1 CN Palmer2 and J Foerster1 1 Division of Medical Sciences, University of
Dundee, Dundee, United Kingdom and 2 Biomedical Research Institute, University of
Dundee, Dundee, United Kingdom
The nuclear hormone receptor peroxisome proliferator activator receptor (PPAR) delta is overex-
pressed in psoriasis. Its activation by specific ligands stimulates keratinocyte proliferation and blocks
apoptosis in T cells. PPAR delta is a key regulator of adipogenesis, glucose metabolism, macrophage
function, and muscle metabolism. Here, we show that activation of PPAR delta in mice harbour-
ing transgenic PPAR delta driven by the CYP1A1 promoter causes a skin disease resembling pso-
riasis, including epidermal acanthosis, basal-cell hyperproliferation, endothelial activation, and T
cell influx. The phenotype is induced within 14 days upon administration of a PPAR delta-specific
agonist and shows maximal severity in areas of mechanical friction. Th17 cells are abundant in
the skin of transgenic mice and are involved in disease pathogenesis, since intraperitoneal injec-
tion of an IL12/23p40 antibody significantly reduces disease activity. Analysis of gene dysregula-
tion in PPAR delta transgenic mice uncovered a large overlap between genes dysregulated in human
psoriasis and in PPAR delta transgenic mice. Our data indicate that PPAR delta may contribute to
the pathogenesis of human psoriasis. Moreover, several features of the novel mouse model (rapid
onset, Th17 dependence, immunocompetent background, responsiveness to therapy, complete
reversability) suggest that it may be of use for the exploration of novel therapeutic strategies.
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Rapid suppression of receptors for IL-20-related cytokines by etanercept in psoriasis
F Wang,1 N Smith,1 S Kang,2 G Fisher1 and J Voorhees1 1 Department of Dermatology,
University of Michigan, Ann Arbor, MI and 2 The Johns Hopkins Department of Dermatology,
Baltimore, MD
Several “IL-20-related cytokines,” including IL-19, IL-20, IL-22, and IL-24, are implicated in stim-
ulating keratinocyte hyperproliferation in psoriasis. IL-19, IL-20, and IL-24 each bind a heterodimeric
receptor consisting of IL-20R1/IL-20R2 on keratinocytes, whereas IL-20 and IL-24 additionally bind
to a receptor consisting of IL-20R2/IL-22RA1. IL-22 binds to IL-22RA1/IL-10R2 on keratinocytes
and a soluble neutralizing receptor IL-22RA2. Previously, we found that mRNA expression of the
IL-20-related cytokines is rapidly suppressed within 1 to 3 weeks of etanercept therapy. To elabo-
rate on these findings, we obtained weekly biopsies from psoriasis patients (N=9) during the first
5 weeks of etanercept therapy and investigated whether the receptors for the IL-20-related cytokines
change with treatment. Compared with uninvolved skin at baseline, mRNA expression of IL-20R1
and IL-20R2 in untreated lesional skin was downregulated by 49% and 28%, respectively, while
IL-22RA1 was upregulated by 27% (all P≤0.05). During therapy mRNA expression of IL-20R2, IL-
20R1, and IL-22RA1 returned to near-baseline levels at week 1, 3, and 5, respectively (all P<0.05).
Interestingly, the soluble receptor IL-22RA2 became upregulated by 57% at week 2 (P<0.05). No
alterations of IL-10R2 were found before or during therapy. Our data firstly indicate that the recep-
tor subunits IL-20R1, IL-20R2 and IL-22RA1 are normalized with early etanercept therapy. These
findings further support a role for their cognate ligands (IL-19, IL-20, IL-22 and IL-24) in influenc-
ing early responses to etanercept. Secondly, the observed increase of IL-22RA2 with early therapy
suggests that etanercept may suppress the pro-inflammatory effects of IL-22 by upregulating its sol-
uble inhibitory receptor. Lastly, rapid modulation of IL-20-related cytokines and their receptors by
etanercept therapy implies an important role for these mediators in psoriasis pathogenesis. Thus,
targeting the IL-20-related cytokines or their receptors has likely therapeutic potential.
S16 Journal of Investigative Dermatology (2009), Volume 129
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Mapping pathogenic epitopes recognized by herpes gestationis autoantibodies using human-
ized BP180NC16A mice
L Heimbach,1 N Li,1 W Huang,1 G Guidice,2 J Fairley,2 P Marinkovich,3 L Diaz1 and Z Liu1 1
Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2 Dermatology,
University of Iowa, Iowa City, IA and 3 Dermatology, Stanford University, Stanford, CA
Herpes gestationis (HG) and bullous pemphigoid (BP) are autoimmune subepidermal blistering
diseases associated with autoantibodies against BP180, a transmembrane collagen and major com-
ponent of the hemidesmosome. Both BP and HG autoantibodies target multiple BP180 epitopes
clustered within the non-collagen linker domain, NC16A. Using humanized NC16A mice
(NC16A+/+), in which the murine BP180NC14A was replaced with the homologous human
BP180NC16A region, we previously determined that pathogenic BP autoantibodies recognize the
BP180NC16A2.5 epitope. In this study, we used NC16A+/+ mice to map the BP180 epitope reac-
tive with HG pathogenic autoantibodies. HG patients’ sera were purified with affinity-columns
conjugated with BP180NC16A or BP180NC16A deletion mutants, and the affinity-purified epi-
tope-specific autoantibodies were tested for pathogenicity. Like BP, NC16A+/+ mice injected with
anti-BP180NC16A autoantibodies purified from HG sera developed subepidermal blisters, and
disease development depends on complement activation, mast cell degranulation and neutrophil
infiltration. IgG passive transfer experiments identified one pathogenic epitope (BP180NC16A2)
and one nonpathogenic epitope (BP180NC16A3). BP180NC16A2-specific autoantibodies induced
subepidermal blisters in NC16A+/+ mice, but were no longer pathogenic in NC16A+/+ mice pre-
treated i.p. with recombinant BP180NC16A2. In contrast, BP180NC16A3-specific autoantibodies
bound to BP180 in vitro and in vivo, but failed to induce subepidermal blisters in NC16A+/+ mice.
Both anti-BP180NC16A2 and anti–BP180NC16A3 autoantibodies activated complement in skin
cryosections, but only anti-BP180NC16A2 IgG-injected NC16A+/+ mouse skin exhibited in situ
deposition of complement C3 at the basement membrane zone. Our findings represent the first
identification of a pathogenic epitope in HG, and suggest that the pathogenic epitope could be a
new therapeutic target to treat HG.
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The systemic lupus erythematosus susceptibility locus Sle3 is associated with heightened
contact hypersensitivity and hyperstimulatory dermal dendritic cells
M Tomihari,1 J Chung,1 J Zhu,2 PD Cruz,1 C Mohan2 and K Ariizumi1 1 Dermatology, UT
Southwestern Med Ctr, Dallas, TX and 2 Dept of Internal Medicine, UT Southwestern Med
Ctr, Dallas, TX
Sle3 is a susceptibility locus for systemic lupus erythematosus (SLE) identified in the SLE-prone
NZM2410 mouse strain. Studies using B6 mice congenic for the Sle3 locus (B6.Sle3) have shown
dendritic cells (DC) from bone marrow and spleen to have greater antigen presenting cell (APC)
capacity for activating T cells and producing anti-nuclear antibodies than their counterparts from
parental B6 mice. Little however is known about their skin APC. In contact hypersensitivity assays,
we found B6.Sle3 mice to develop 2-fold greater ear swelling responses associated with an increased
ratio of CD4 to CD8 cells (1.7 vs. 1.3) in draining lymph nodes. This phenotype can be transferred
adoptively by injecting lymph node cells from hapten-sensitized B6.Sle3 mice into naive B6
recipients. To determine whether heightened CH in B6.SLe3 mice is due to intrinsic properties of
skin APC, we first compared epidermal Langerhans cells (LC) from B6.Sle3 and B6 mice. LC from
both mice expressed similar levels of CD40 and CD80, although Sle3-LC exhibited greater CD86.
There was no significant difference in epidermal density of LC, their T-cell stimulatory capacity,
or ability to induce UVB-immunosuppression. These results plus failure of epidermal tape-strip-
ping to abrogate the strong CH in B6.Sle3 mice led us to focus on dermal DC as the distinguish-
ing element. Using ovalbumin-reactive mice, we noted dermal DC (CD8-/CD11c+/Langerin-) puri-
fied from draining lymph nodes of B6.Sle3 (vs. B6) mice to have a 2-fold higher capacity to activate
CD4+ and CD8+T cells. These results indicate that the Sle3 locus endows dermal DC (but not epi-
dermal LC) with a hyperstimulatory phenotype responsible for greater CH responses and which
may contribute to the pathogenesis of LE.
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Systemic profile of psoriasis: The effects of ustekinumab and etanercept following 12 weeks
of treatment
C Brodmerkel,1 K Li,1 T Kikuchi,2 R Fidelus-Gort,3 A Khatcherian,2 I Novitskaya,2 F Baribaud1
and J Krueger2 1 Biomarkers, Centocor Research and Development, Inc, Malvern, PA, 2
Laboratory of Investigative Dermatology, Rockefeller University, New York, NY and 3 Clinical
Research and Development, Incyte Corporation, Wilmington Delaware, DE
Serum proteins and subsets of inflammatory cells are potential biomarkers associated with psori-
asis and its comorbidities, and variation in these may correlate with response to biologic therapy.
Blood samples from patients (n=145) in ACCEPT, which compared the efficacy of etanercept (ETA)
and ustekinumab(UST) in moderate-to-severe psoriasis, were analyzed for a panel of 91 proteins
using a Luminex-based-platform. Serum CCL22, a chemokine produced by macrophages and den-
dritic cells, significantly correlated with disease severity based on the Psoriasis Area and Severity
Index (PASI) and body surface area (BSA) of involvement (r>0.5, p<0.001). Serum leptin signifi-
cantly correlated with BMI (r>0.7, p<0.001). No consistent changes in normalized serum protein
profiles were identified based on treatment response (PASI 75) at wk4 or wk12 across all groups.
Significantly reduced serum IL-8, CRP and CCL4 levels were observed for ETA-treated patients.
UST had minimal impact on serum CCL4; trends for decreased serum levels of IL-8 and CRP were
noted. Median numbers of circulating lymphocytes remained unchanged across all groups (n=69).
There were no significant changes in percentages of CD4+ T-cells (naïve and memory); CD8+ T-
cells (naïve, memory, and effector), regulatory T-cells; CLA+ cells; NK cells; NKT cells following
12 wks of UST or ETA; or in cytokine production (IFNg, TNF, IL-17, and IL-22) in response to
CD3:CD28 stimulation ex vivo following UST or ETA. In summary, these data demonstrate lim-
ited effects on the circulating serum protein profile as well as the normal complement of circulat-
ing immune cells after 12 weeks of treatment with either UST or ETA.
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Abnormal in vitro keratinocyte-T cell interactions during psoriasis 
M Rosa Fortin,1,2,3 PE Poubelle3 and R Pouliot1,2 1 Faculté de Pharmacie, Université Laval,
Québec, QC, Canada, 2 Laboratoire d’Organogénèse Expérimentale (LOEX), Hôptal du
Saint-Sacrement du CHA, Québec, QC, Canada and 3 Centre de Recherche en
Rhumatologie et Immunologie (CRRI), CRCHUL, Québec, QC, Canada
The study was aimed at deciphering the functional interactions between keratinocytes and T cells
during active cutaneous psoriasis. The in vitro model used a monolayer of healthy or psoriatic
keratinocytes co-cultured for two weeks with human blood T cells obtained from healthy donors.
Controls were healthy or psoriatic keratinocytes and T cells alone. The culture medium was regu-
lar keratinocyte growth medium with or without addition of IL-2. Cell-to-cell interactions were
studied by the production of 22 cytokines/chemokines (Luminex xMap technology) and by changes
of apoptosis (flow cytometry with Annexin V-FITC and propidium iodide). Psoriatic keratinocytes,
compared to healthy keratinocytes, generated higher concentrations of IL-6, GM-CSF, IP-10 and
eotaxin and lower concentrations of IL-1Ra, VEGF and FGF-2. During co-culture of T cells with
keratinocytes, the production of IFN-γ, IL-15, GM-CSF, sIL-2 Rα and TNF-α was increased with
psoriatic keratinocytes compared to healthy keratinocytes. Fractalkine was strongly elevated when
psoriatic keratinocytes were co-cultured with T cells and IL-2. T cell survival was significantly
increased when they were added to healthy keratinocytes (5-fold) and to psoriatic keratinocytes
(8-fold). Neither the co-culture nor the addition of IL-2 affected the survival of keratinocytes.
These data indicate functional interactions between the two kinds of cells, and persistence of patho-
logical characteristics of psoriatic keratinocytes during in vitro culture. This experimental co-cul-
ture model will be useful to understand in depth immune cutaneous disorders like psoriasis and
their pharmacological approach.
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The presence of cutaneous autoantibodies in scabies
MM Wong,1,3 KA Messingham,1 E Boddicker,1 L Arlian,4 KB Yancey5 and JA Fairley1,2 1
Dermatology, University of Iowa, Iowa City, IA, 2 VA Medical Center, Iowa City, IA, 3 SUNY
Downstate, Brooklyn, NY, 4 Wright State University, Dayton, OH and 5 UT Southwestern,
Dallas, TX
Infestation with Sarcoptes scabiei typically leads to a pruritic eruption caused by sensitization to
mite antigens. A small subset of patients develop bullous scabies, characterized by subepidermal
bullae and antibody deposition at the basement membrane zone (BMZ), similar to bullous pem-
phigoid (BP). In BP, IgG and IgE autoantibodies directed against BP180 have been identified as key
causative agents. BP230-specific autoantibodies are also observed but their pathogenic relevance
remains unclear. The histological and immunofluorescent (IF) similarities between bullous scabies
and BP suggest an immunologic link. To explore this, we screened sera from patients with non-
bullous scabies (n=12) and normal controls (n=30) for the presence of IgG and IgE specific for
BP180 (NC16A region) and BP230 by ELISA. Three archival sera from bullous scabies patients were
also screened for cutaneous IgG-class autoantibodies. BP180-specific IgG was detected in a higher
percentage of scabies sera (5/12, 42%) compared with controls (3/30,10%) by ELISA. No differ-
ences were seen between scabies and control sera when testing for anti-BP230 IgG or for IgE against
either BP180 or BP230. Total IgE levels were elevated in 3/10 patients. Of the bullous scabies sera,
1/3 had IgG class autoantibodies specific for NC16A, 2/3 were positive for BP230 IgG by Western
Blot. Direct IF was positive for linear C3 and IgG in 2/3 patients. Interestingly, the blistering sub-
sided with mite eradication in the patient with negative direct IF and the remaining two went on
to develop true BP. These studies demonstrate that some patients with both ordinary scabies and
bullous scabies develop autoantibodies of the same specificity as those in BP. Better understand-
ing of the immune response to scabies could provide insights into the development of cutaneous
autoimmunity.
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The microRNAs regulate CD4+CD25+FoxP3+ Treg cell and iNKT cell development
L Zhou,1 K Seo,1 H He,1 R Pacholczyk,2 D Meng,2 J Xu2 and Q Mi1 1 Dept of Dermatology,
Henry Ford Hospital, Detroit, MI and 2 Medical College of Georgia, Augusta, GA
microRNAs (miRNAs), non-coding small RNAs, function as endogenous translation repressors of
protein-coding genes in animal by binding to target sites in the 3’ UTR of mRNAs. The accumu-
lated evidences indicate that miRNAs are differentially regulated in developmental hematopoietic
organs. CD4+CD25+FoxP3+ regulatory T (Treg) cells and invariant natural killer T (iNKT) cells are
potent regulators of diverse skin immune responses and maintain the skin homeostasis. The role
of miRNAs in Treg and iNKT cell development is unclear. Here we tested if lack of Dicer, the miR-
NAs-processing enzyme, will affect Treg and iNKT cell development. We generated mouse strains
with tissue-specific disruption of Dicer. The mice that were homozygous for Dcier-loxP (F allele)
with Cre (C allele) expression controlled by Tie-2 [in the bone marrow (BM) and endothelial cells]
or CD4 (in thymus) promoters were conditional Dicer knockout and designated as Tie2-CFF or
CD4-CFF. Significantly fewer iNKT cells and Treg cells were found in the thymus, spleen, and liver
from Tie2-CFF and CD4-CFF mice. Bone marrow from Tie2-CFF mice poorly reconstituted iNKT
cells compared to BM from WT mice, while transferred WT iNKT cells were poorly migrated to
liver and spleen in Tie-2-CFF mice compared to WT mice, indicating miRNAs expressed in BM and
endothelial cells both contribute to the defective iNKT cell development and migration. The fre-
quencies of mature CD44hiNK-1.1+ iNKT cells were significantly decreased in Tie2-CFF and CD4-
CFF, suggesting that miRNAs may regulate iNKT cell maturation. Furthermore, miRNA-deficient
peripheral iNKT cells displayed profound defects in a-GalCer-induced activation and cytokine pro-
duction, while Treg cells from Tie2-CFF and CD4-CFF mice had a normal immune suppressive
function in vitro. Thus, miRNAs are potent regulators of Treg and iNKT cell development. The iden-
tification of specific miRNAs required for the proper development of Treg and iNKT cells will fur-
ther illuminate the molecular mechanisms underlying CD4+Treg and iNKT cell development.
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Surgical denervation of skin using the KC-Tie2 mouse model of psoriasis eliminates den-
dritic cells and markedly improves acanthosis and angiogenesis
SM Ostrowski,1,2 JA Wolfram,1 AM Belkadi,2 DA Hatala,1 W Fu,1 D Diaconu1 and NL Ward1,2 1
Dermatology, University Hospitals Case Medical Center and Case Western Reserve
University, Cleveland, OH and 2 Neurosciences, Case Western Reserve University, Cleveland,
OH
Human psoriatic lesional skin has increases in the number of nerve fibers and numerous clinical
observations have noted plaque resolution following accidental denervation, suggesting that the
nervous system is necessary for the maintenance of psoriasis. Previously we reported the genera-
tion of a new murine model of human psoriasis, the KC-Tie2 mouse. Using this murine system, we
now demonstrate that beginning at 8 weeks of age KC-Tie2 mice have 76% more PGP9.5+ nerve
fibers in back skin (p=0.047) and have a 4.1 and 9.2 fold increase in substance P (SP) and neu-
ropeptide Y (NPY), respectively. To examine the influence of nerve-derived factors on psoriasis
maintenance, we unilaterally surgically denervated the dorsal cutaneous nerves at their anatomi-
cal entry into back skin. Ten days post-surgery, denervation was confirmed using PGP9.5 immuno-
histochemistry and measurement of protein expression of PGP9.5 and synaptophysin. We also
determined that the nerve derived molecules SP, NPY and IGF-1 were decreased in denervated
compared with innervated skin. Remarkably, 10 days following cutaneous denervation we observed
a 36% decrease in acanthosis (p=0.02), an increase in the keratinocyte (KC) terminal differentia-
tion marker loricrin, and a 25% decrease in the number of blood vessels (p=0.048). CD4+ and
CD8+ T cells, and Th1 and Th17 cytokine expression remain unchanged at this time point, whereas
CD11c+ dermal DCs decreased significantly (61%, p=0.035), returning to control mouse levels in
denervated skin. These data suggest that nerve derived factors influence DCs, KCs, and blood ves-
sels contributing to inflammation and acanthosis observed in psoriasis. Elucidation of the mecha-
nisms underlying these findings may lead to novel therapeutic approaches for the treatment of
psoriasis.
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CD4+CD45RO+CCR4+ memory T cells activate keratinocytes to produce the proinflama-
tory cytokine IL32γ in a cell-cell contact manner: Implications for the pathogenesis of pso-
riasis
SO Francis,1 L Hu,1 R Asokan,1 M Fujita,1 S Kim,2 CA Dinarello,2 DA Norris1 and CK Edwards1,2
1 Dermatology, University of Colorado Denver, Aurora, CO and 2 Infectious Disease,
University of Colorado Denver, Aurora, CO
A newly described cytokine, interleukin-32γ (IL32γ), induces Tumor Necrosis Factor-α (TNFα), a
cornerstone in the pathogenesis of psoriasis. We investigated the role of IL32γ in psoriasis using
IHC, qRT-PCR, and eletrocheminescence (ECL) cytokine measurements from human skin biopsy
tissues obtained from patients with active psoriasis and healthy human volunteers. Additionally
we used FACs and ECL to measure stimulated and unstimulated subpopulations of T cells from
human whole blood and their ability to stimulate cytokine production (IL32γ, TNFα, IL1β) after
indirect and direct cell-cell contact assays with primary human keratinocytes (Hka). Our results
demonstrate that IL32γ is expressed in basal Hka and DC in the dermis of psoriatic skin. Induction
of IL32γ and its isoforms IL32α was detected in Hka lysates, but not supernatants, after stimulation
with rhuTNFα or rhuIL1β. ECL and qRT-PCR results demonstrated that IL32γ, as well as TNFα/IL1β,
were significantly increased in psoriatic skin compared to healthy human skin. Inhibition of siRNA
data indicate that IL32γ induces TNFα, but reciprocally, TNFα does not induce IL32γ. Finally, we
show that both human H9 and CLA+CD4+CD45RO+CCR4+ T cells stimulate Hka through direct
cell-cell contact to up-regulate IL32γ at significantly increased levels compared to non-stimulated
H9 T cells or CD4+CD45RO+CCR4-, CD4+CD45RA+CCR4+ and CD4+CD45RA+CCR4- mem-
ory T cells. These findings demonstrate for the first time that the proinflamatory cytokine IL32γ is
upregulated in Hka after T cells:Hka cell-cell contact and support the hypothesis that this novel
cytokine may be involved in the early stages of the pathogenesis of psoriasis.
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A role for BP180 in the keratinocyte pro-inflammatory response
F Van den Bergh,3 BT Burmeister,1 SL Eliason1 and GJ Giudice1,2 1 Dermatology, University of
Iowa, Iowa City, IA, 2 Biochemistry, University of Iowa, Iowa City, IA and 3 Dermatology,
Medical College of Wisconsin, Milwaukee, WI
Subepidermal blistering in bullous pemphigoid (BP) is caused by autoantibodies to BP180, a basal
keratinocyte (KC) surface protein. Experiments on both BP patients’ samples and experimental mod-
els have established that an inflammatory reaction is an essential step in the pathogenesis of BP
and have identified key roles for specific cytokines, such as IL-1α, IL-6 and IL-8. It was also previ-
ously shown that the treatment of normal human keratinocytes (NHK) with anti-BP180 autoanti-
bodies results in the up-regulation and secretion of IL-6 and IL-8. To further investigate the role of
BP180 in a pro-inflammatory response, we cultured NHK and BP180-deficient KC [derived from
a patient with non-Herlitz junctional epidermolysis bullosa (JEB-nH)] under various conditions and
assayed for expression of a panel of cytokines. We observed that after trypsinization and plating
there was a transient increase in the secretion of high levels of IL-8 protein by the JEB-nH KC, but
not by NHK. This cytokine expression peaked at about 9 hours post-plating and returned to a basal
level by 24 hours. Plating on uncoated plastic or in wells coated with various matrix proteins
(laminins 1 and 5, fibronectin) did not affect this response. More moderate increases in IL-1α and
CCL5 were also observed in the JEB-nH KC following plating. We then tested IL-8 expression in
these same cells after exposure to various external stimuli known to induce cytokine production
in KC (ultraviolet radiation, DFNB, PMA, SDS, ethanol, croton oil). Interestingly, an enhanced up-
regulation of IL-8 expression was detected in the JEB-nH KC, compared with NHK, for all of these
treatments except croton oil and PMA. These findings suggest that BP180 plays an important reg-
ulatory role in the expression of certain pro-inflammatory cytokines. Future experiments will
probe the mechanism of this control.
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Galectin-3 negatively regulates TCR-mediated CD4+ T cell activation at the immunological
synapse
H Chen,1 A Fermin,1 S Vardhana,2 I Weng,1 K Lo,1 E Chang,3 R Yang,1 D Hsu,1 M Dustin2 and
F Liu1 1 Dermatology, UC Davis School of Medicine, Sacramento, CA, 2 Skirball Institute of
Biomolecular Medicine, New York University School of Medicine, New York, NY and 3 La
Jolla Institute for Allergy and Immunology, San Diego, CA
We have investigated the function of endogenous galectin-3, a member of an animal lectin fam-
ily, in T cells. Galectin-3-deficient (gal3-/-) CD4+ T cells secreted more IFN-g and IL-4 than
gal3+/+CD4+ T cells after TCR engagement. Galectin-3 was recruited to the cytoplasmic side of
the immunological synapse (IS) in activated T cells. In T cells stimulated on supported lipid bilay-
ers, galectin-3 was primarily located at the peripheral supramolecular activation cluster (pSMAC).
Gal3+/+ T cells formed central SMAC (cSMAC) on lipid bilayers less effectively and adhered to
antigen-presenting cells less tightly than gal3-/- T cells, suggesting that galectin-3 destabilizes the
IS. Galectin-3 expression was associated with lower levels of early signaling events and phospho-
tyrosine signals at the pSMAC. Additional data suggest that galectin-3 potentiates downregulation
of TCR in activated T cells. By yeast two-hybrid screening we identified as a galectin-3-binding
parter, Alix, which is a component of the endosomal sorting complex required for transport (ESCRT)
known to regulate cell surface of expression of certain receptors. Co-immunoprecipitation per-
formed with transfected Jurkat T cells confirmed galectin-3-Alix association. We conclude that
galectin-3 is an inhibitory regulator of T cell activation and functions intracellularly by promoting
TCR downregulation, possibly through modulating Alix’s function at the IS.
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Autoantibodies in scurfy mice recognize keratins
EN Huter, K Natarajan, DD Glass and EM Shevach Laboratory of Immunology/NIAID, National
Institutes of Health, Bethesda, MD
Scurfy mice have a deletion in the forkhead domain of Foxp3 and fail to develop thymic-derived
Foxp3+ regulatory T cells. Early in life, Scurfy mice develop a fatal lymphoproliferative syndrome
with multi-organ inflammation and the generation of autoantibodies. In humans, loss-of-function
mutations in the foxP3 gene lead to a similar disease, termed the IPEX syndrome (Immune dys-
regulation, Polyendocrinopathy, Enteropathy, X-linked). The skin is affected in all Scurfy mice and
most IPEX-patients and histology shows a lymphocytic infiltration in the dermis and epidermis. The
goal of this study was to identify the target antigen(s) in the skin recognized by autoantibodies in
serum from scurfy mice. On Western blot analysis, Scurfy serum, but not WT littermate serum,
recognized several bands in total skin lysate from a RAG-/- mouse. Immunohistochemistry on frozen
sections of RAG-/- skin revealed that the antibodies in the serum recognized a target in the epi-
dermis. These data were confirmed by Western blot using a murine keratinocyte lysate. Further
analysis using 2D-Western blot technology followed by Mass spectrometry identified several ker-
atins as targets recognized by the autoantibodies in Scurfy serum. One of the targets was keratin-
14. To confirm this observation and to identify the epitopes recognized by the autoantibodies on
keratin-14, we utilized a bacterial expression system to express three polypeptides encompassing
the N-terminal, middle, and C-terminal portions of the keratin-14 protein. By Western blot, we
found that Scurfy serum predominantly recognized the C-terminal fragment. Our results indicate
that keratins, especially keratin-14, are antigenic targets for autoantibodies developing in autoim-
mune skin disease in the scurfy mouse. This data should facilitate the investigation of the speci-
ficity of autoreactive T cells in scurfy mice and in other autoimmune skin diseases.
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An IL13 polymorphism that associates with psoriasis and protects from risk of psoriatic arthri-
tis is abrogated by smoking
I Freeny,1,4 B Feng,1 B Wong,1,3 R Solatani-Arabsahi,1 DE Goldgar,1 SJ Schrodi,2 GG Krueger1 and
KC Duffin1 1 Dermatology, University of Utah, Salt Lake City, UT, 2 Celera, Oakland, CA, 3
College of Nursing, University of Utah, Salt Lake City, UT and 4 Dermatology, Drexel
University, Philadelphia, PA
Psoriatic arthritis (PsA) is an inflammatory arthritis occurring in ~25% of patients with psoriasis (Ps).
Recently we reported that three IL13 single nucleotide polymorphisms (SNPs), rs1800925, rs20541
and rs848, on chromosome 5q31 conferred a modest risk for Ps. IL13 encodes interleukin-13, a
cytokine that plays a role in Th2-mediated disorders, and IL13 SNPs rs1800925 and rs20541 are
associated with risk of asthma and COPD. Since smoking is considered a risk factor for the devel-
opment of Ps, we conducted this study to examine association between IL13 SNPs, smoking, and
phenotypic features of Ps and PsA. Subjects included 700 psoriasis patients and 460 controls in
the Utah Psoriasis Initiative genotyped for rs1800925, rs20541, and rs848. 334 patients with Ps for
≥10 years who had not developed PsA and 181 patients with PsA were included. We found that
the minor allele of rs1800925 (T) was protective for PsA (OR 0.43, 95% CI 0.25-0.72, allelic
p=0.001). We then determined the prevalence of PsA in smokers and non-smokers who carried at
least 1 copy of the minor, protective allele (CT or TT) and the prevalence of PsA in patients who
did not carry a protective allele (CC). Analysis showed that the minor allele conferred protection
in the non-smokers, but smoking abrogated this effect (CT/TT/non-smoker, prevalence of PsA
13%, OR 0.20, p=0.0001; CT/TT/smoker, prevalence 38%, OR 0.88, p=0.74; CC/non-smoker,
prevalence 42% [reference]; CC/smoker prevalence 47%, OR 1.21, p=0.47). This study shows
that smokers with the protective allele are almost as likely to develop PsA as individuals with the
risk allele, suggesting that smoking negates the protective effect. This study is the first to show that
the development of PsA can be influenced by an interaction between a genetic risk factor and the
environment.
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Antioxidants in psoriasis: a preliminary in vivo analysis
JA Kado,1 CN Young1,2 and L Savoy1,2 1 Wayne State Department of Dermatology, Wayne State
University, Detroit, MI and 2 Dermatology, John D. Dingell VA Medical Center, Detroit, MI
The imbalance between ROS generation and cellular antioxidant capacities is known to contribute
to the pathogenesis of psoriasis. However, results from these studies are inconsistent when com-
paring independent enzyme activitiy levels. In this study we assessed the activities of several antiox-
idant enzymes, including catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase
(GPx) and glutathione reductase (GRx) in the blood (plasma and erythrocytes) from 10 psoriatic
patients and 9 healthy controls. We attempted to find whether or not discernible differences exist
with respect to the levels or activities of these enzymes in the mentioned populations. Our study
was approved by the institutional review board from Wayne State University School of Medicine
and showed: i. The erythrocyte activity of CAT and GPx were lower in patients with psoriasis as
compared to control patients by a statistically significant standard deviation (SD) of 3.72 and 0.21
respectively (p <0.01). ii. The erythrocyte activity of SOD and GRx were also shown to be lower
than controls by a SD of 0.69 and 0.17 respectively, but did not differ sufficiently to be statistically
significant. iii. Plasma CAT, GPx and GRx activities were not significantly different between patients
and control populations. In conclusion, psoriatic patients showed statistically significant decreases
of enzymatic activity in CAT and GPx erythrocytes populations, however this result was not repli-
cated in plasma enzymatic activity levels. Expanding the sample sizes in future work would more
carefully discriminate between the two populations of cellular vs. plasma antioxidant levels and
may direct vehicles of psoriatic antioxidant treatments in future.
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Rapid downregulation of LL-37 and β-Defensins in psoriasis with etanercept therapy.
NR Smith,1 F Wang,1 S Kang,2 GJ Fisher1 and JJ Voorhees1 1 Dermatology, University of
Michigan, Ann Arbor, MI and 2 Dermatology, Johns Hopkins University, Baltimore, MD
Psoriatic lesions contain an abundance of anti-microbial peptides (AMPs) relative to healthy and
atopic skin. This elevated expression may explain, in part, the lack of cutaneous infections observed
in patients with psoriasis. Additionally, recent data suggest that self-DNA coupled with cathelicidin
(LL-37) may stimulate plasmacytoid dendritic cells in non-lesional psoriatic skin, thereby initiat-
ing an inflammatory cascade that could generate overt psoriatic lesions. While it remains unclear
exactly how AMPs are regulated in psoriasis, increased levels of pro-inflammatory cytokines, such
as TNF-α, may stimulate the production of LL-37 and β-defensins within lesional skin. To exam-
ine this hypothesis, we investigated the expression of LL-37 and β-defensins in psoriasis patients
treated with the TNF-α inhibitor etanercept (Enbrel®). Biopsies of non-lesional and lesional pso-
riatic tissue were obtained at baseline, with additional lesional biopsies taken at weeks 1, 2, 3,
and 4 of therapy. Reverse-transcriptase polymerase chain reaction was used to quantify mRNA
expression of LL-37 (N=14), human β-defensin-3 (HBD-3, N=8), and human β defensin-2 (HBD-
2, N=13). Expression of LL-37, HBD-3, and HBD-2 was increased in untreated lesional skin by 6,
100, and 1551 fold, respectively, compared with non-lesional skin (all P<0.05). At week 1 of ther-
apy, expression of these AMPs decreased by 40%, 45%, and 45%, respectively, compared with
untreated lesional skin (all P<0.05). Expression of these AMPs continued to decrease at all subse-
quent time points, ultimately decreasing at week 4 of therapy by 66%, 72%, and 80%, respec-
tively (all P<0.001). These findings indicate that etanercept rapidly suppresses the expression of
LL-37, HBD-3, and HBD-2, thus suggesting that TNF-α plays an important role in the upregula-
tion of AMPs in psoriasis. Furthermore, since LL-37 has been implicated in the pathogenesis of
psoriasis, rapid downregulation of LL-37 mRNA by etanercept may be one mechanism by which
TNF-α blockade improves psoriasis.
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Severe irritant contact dermatitis and loss of epidermal LC in zinc deficient mouse
T Kawamura, Y Ogawa and S Shimada Dept. of Dermatology, Univ. of Yamanashi, Yamanashi,
Japan
Acrodermatitis enteropathica (AE) is caused by zinc deficiency. However, the pathogenesis of AE
is unknown. We have previously reported that irritant contact dermatitis (ICD) to croton oil (CrO)
in mice fed by zinc deficient diet (ZD) was significantly increased and prolonged, when com-
pared to that in mice fed by zinc adequate diet (ZA). Since nucleotides released from chemically
injured keratinocytes serve as a causative mediator for ICD, we hypothesized that the increased
ICD observed in ZD mice may be related to aberrant extracellular ATP concentrations in the epi-
dermis. We first tested whether zinc deficiency affected ATP release from keratinocytes upon expo-
sure to irritant chemicals. Pam-212 keratinocytes rapidly released ATP after in vitro exposure to
CrO. However, the zinc-chelating reagent TPEN did not affect ATP levels detected in supernatants
of CrO-treated Pam-212 keratinocyte cultures. To examine the potential of extracellular ATP to
trigger skin inflammation in vivo, soluble NTPDase (apyrase) was locally injected before and after
CrO application. Local injections of apyrase marginally diminished ICD response in ZA mice. Inter-
estingly, severe ICD response in ZD mice was dramatically attenuated by local injections of apyrase.
As Langerhans cell (LC) is known to play a protective role against ATP -mediated inflammatory
signals by hydrolyzing extracellular nucleotides, we next assessed the number of epidermal LC by
a flow cytometric analysis of epidermal cell suspensions obtained from ZD and ZA mice. Surpris-
ingly, the number of IA+, CD11c+ epidermal LC in ZD mice was found to be decreased by 67-
90% compared to that in ZA mice. The number of DC in the draining lymph nodes or spleen was
not significantly different between ZA and ZD mice. These findings suggest that loss of LC and
impaired LC-dependent hydrolysis of nucleotides may be an important mechanism involved in
severe ICD in ZD mice and AE.
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Characterization of functions and egress mechanism on skin regulatory T cell using Kaede-
transgenic mice
T Honda,1 M Tomura,2 H Tanizaki,1 O Kanagawa,2 Y Miyachi1 and K Kabashima1,3 1
Dermatology, Kyoto University, Kyoto, Japan, 2 Laboratory for Autoimmune Regulation,
RIKEN, Yokohama, Japan and 3 Center for Innovation in Immunoregulative Technology and
Therapeutics, Kyoto University, Kyoto, Japan
Skin immune response is caused by dynamic immune cell movements and interactions. However,
it remains unknown whether skin-derived lymphocytes move from skin into draining lymph nodes
(DLN) under pathophysiological conditions, since it remained impossible to label lymphocytes
located exclusively in the skin. We have recently made transgenic mice expressing the Kaede pro-
tein, which is photoconvertible from green to red upon violet light exposure without effects on
cellular functions (PNAS. 2008;105:10871-6). Here we succeeded in analyzing the physiological
cell movements by monitoring the skin-photoconverted red (Kaede red) cells, and found that CD4+
T cells migrated from skin to DLNs in steady states. In addition, most of the migrated T cells were
CD4+Foxp3+ phenotype, indicating that regulatory T cell (Treg) selectively migrated. Cell move-
ments under inflammatory conditions were also evaluated using DNFB-induced contact hyper-
sensitivity model. The drastic increase in CD4+Foxp3+ Kaede red cells was noted in DLNs migrated
from the inflammatory skin where Tregs were noted to be dividing. We then evaluated the func-
tional activity of Kaede red Tregs. The addition of non-Kaede red Tregs into that culture inhibited
DNBS-induced DNFB sensitized lymph node cell proliferation. This inhibition was more promi-
nent when Kaede red Tregs migrated from the DNFB-stimulated skin were added. Moreover, this
suppressive effect was antigen-specific, since the inhibition by DNFB-sensitized Kaede red cells
was much less prominent when added in TNBS-induced TNCB-sensitized cell proliferation. These
results suggest that under antigen exposure, Tregs in skin divide in situ, and egress from the skin
into DLNs to suppress inflammation not only in skin but also in DLNs in an antigen specific man-
ner.
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Development of a spontaneous, TCR transgenic mouse model of human vitiligo
S Mehrotra,1 IC Le Poole,2 M Li,1 GE Lyons,3 N Spivey,1 T Martins da Palma,1 OS Naga,1
HR Norell,1 CM Diaz,4 DJ Cole1 and MI Nishimura1 1 Surgery, Medical University of South
Carolina, Charleston, SC, 2 Pathology, Loyola University Chicago, Chicago, IL, 3 Surgery,
University of Chicago, Chicago, IL and 4 Hematology/Oncology, University of Miami, Miami,
FL
Tyrosinase is a target antigen shared by melanocytes and melanoma cells. High avidity CD4+, MHC
class I restricted T cells reactive with human tyrosinase-derived peptide YMDGTMSQV were cloned
from tumor infiltrating lymphocytes (TILs) of a patient with metastatic melanoma. The TCR from
these TILs recognized cultured normal human HLA-A2+ but not HLA-A2- melanocytes following
introduction into cultured Jurkat cells. The cloned TCR served to develop a transgenic mouse model.
T cells bearing the HLA-A2 restricted TCR passed thymic selection in C57BL/6J (H2-Kb) mice and
were detectable in the periphery, with ~25% of circulating CD4+ T cells and >75% of the CD8+
T cells expressing the transgenic TCR in peripheral blood, spleen and lymph nodes. TCR transgenic
T cells were functional in vitro and secreted cytokines upon stimulation with the cognate epitope.
Subsequently, HLA-A2+ TCR+ double transgenic mice were generated by breeding TCR and HLA-
A2 transgenic mouse strains. Among double transgenic offspring, more than 90% of TCR trans-
genic CD3+ T cells expressed a CD3+CD4-CD8- phenotype. Interestingly, resulting double trans-
genic mice develop rapid spontaneous autoimmune vitiligo from 4 weeks of age onward. In resulting
h3TA2 mice (for human TCR transgenic Tyrosinase reactive T cells), depigmentation is associated
with loss of melanocytes from hair follicles and a redistribution of skin T cells, similar to human
vitiligo. The presence of human class I restricted TCR on both CD4+ and CD8+ T cells in C57BL/6J
mice and appearance of transgenic TCR positive double negative T cells in the periphery is intrigu-
ing. The h3TA2 model provides an important tool for translational studies attempting to interfere
with T cell mediated melanocyte cytotoxicity in vitiligo.
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Anti-inflammatory effects of newly synthesized PAR-2 antagonist, NP-003 in oxazolone-
induced chronic dermatitis animal model
J Jeon,1 M Kwon,1 S Jeong,1 H Kim,2 H Kwak,1 B Park1 and S Lee2,3 1 Research Division,
NeoPharm Co., Ltd., Daejeon, Korea, South, 2 Department of Dermatology, Yonsei University
College of Medicine, Seoul, Korea, South and 3 Human Barrier Research Institute, Yonsei
University College of Medicine, Seoul, Korea, South
Currently, a lot of pathophysiological roles are known to be exerted by protease-activated recep-
tor (PAR)-2 in skin. Notably, increased expression and activation of PAR-2 in epidermis was reported
in lesional skin of atopic dermatitis (AD), which suggests that potential therapeutic application of
PAR-2 specific antagonist for AD. In this study, using the oxazolone mice model, we have investi-
gated the anti-inflammatory effects of PAR-2 antagonists. PAR-2 specific antagonism of NP-003 was
verified by intracellular calcium mobilization assay using PAR HCT-15. Treatment of PAR-2 acti-
vators, either the PAR-2 specific activating peptides (APs) or trypsin, induced the calcium influx in
HCT-15 cell lines, and these calcium influxes were dose dependently inhibited by treatment of NP-
003. Whereas the treatment of trypsin inhibitor prevented the calcium influx by trypsin, APs-induced
calcium influx was not prevented by trypsin inhibitors. PAR-2 specific desensitization experiments
confirmed that NP-003 is a PAR-2 specific antagonist. In order to prepare the oxazolone-induced
AD model, CD-1 mice was sensitized by topical application of oxazolone on the dorsal area. 1
week after sensitization, chronic inflammation was induced by topical application of oxazolone
on the both ear twice a day for 2 weeks. Inflammation was accessed by measuring the ear thick-
ness and weight change was measured. Histological observation was also performed. As a result,
significant reduction of ear thickness was observed in NP-003 applied site, which suggested that
NP-003, as a PAR-2 specific antagonist has an anti-inflammatory activity in AD model. Histologi-
cal observation also confirmed the anti-inflammatory activity. As a conclusion, these results sug-
gest that PAR-2 is involved in inflammatory reaction in AD model, and PAR-2 specific antagonist,
NP-003 can be used as a potential anti-inflammatory agent in AD.
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PAF induces Th17 lymphocytes through activation of monocyte-derived Langerhans cells
A Drolet,1,2 M Thivierge,1 S Turcotte,1 D Hanna,2 B Maynard,2 J Stankova1 and M Rola-
Pleszczynski1 1 Allergy and Immunology, Université de Sherbrooke, Sherbrooke, QC, Canada
and 2 Dermatology, Université de Sherbrooke, Sherbrooke, QC, Canada
Platelet Activating Factor (PAF) has been reported in increased concentration in psoriatic skin. Aber-
rant T cells type 1 immune responses have also been linked to the pathogenesis of psoriasis. T
helper cells producing IL-17 (Th17) have been shown to play a major role in this disease. Th17
cells express RORγt transcription factor and IL-23 is essential for their expansion. IL-23 is now a
target for therapy in psoriasis. The aim of this study is to determine whether PAF can induce Th17
cells by stimulating IL-23 production. In this study, monocyte-derived Langerhans cells (LCs) were
produced by culturing them with GM-CSF, IL-4 and TGF-β for 5 days. They were then stimulated
with graded concentrations of PAF. IL-23 mRNA levels were measured. Moreover, LCs were pre-
treated with PAF and then co-cultured with autologous anti-CD3- and anti-CD28-activated T
cells. After 10 days, these co-cultures were analysed for the presence of RORγt by FACS analysis.
We found that PAF-stimulated LCs showed a 3-fold increase in the levels of IL-23 mRNA with
maximal effects at 4 hours. Following co-culture of PAF-stimulated LCs with activated lympho-
cytes, CD4+ lymphocytes showed a 4-fold increase of RORγt expression compared to controls at
PAF concentrations of 10-1000 pM. Our data suggest that PAF can stimulate LCs to produce IL-23,
which in contact with activated CD4+ T cells can trigger the development of Th17. This may con-
stitute a previously unknown stimulus for psoriasis and a potential therapeutic target.
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IL-12/IL-23p40 small interfering RNA establish protective immunity against autoimmune dis-
ease in vivo
J Brück, C Weigert, S Pascolo, I Glocova, K Fuchs, K Ghoreschi and M Röcken Department of
Dermatology, Eberhard-Karls Univerity, Tübingen, Germany
Experimental autoimmune encephalomyelitis (EAE) is a prototypic organ-specific autoimmune
disease, mediated by pro-inflammatory T helper (Th) cells. Destructive inflammation within the
central nervous system is initiated by the infiltration of interferon (IFN)-g-producing Th1 cells and
interleukin (IL-)17-producing Th17 cells after immunization with brain-specific peptides like PLP
in complete Freund’s adjuvant (CFA) and pertussis toxin. CFA stimulates dendritic cells (DC) through
Toll-like receptors (TLR), and induces pro-inflammatory mediators such as IL-6, IL-23 and IL-12
that promote the differentiation of naïve Th cells into Th1 or Th17 cells. IL-12 and IL-23 are het-
erodimers sharing the IL-12/IL-23p40 subunit. Experiments with knock-out mice revealed that the
IL-12/-23p40 subunit is crucial for the development of EAE. We therefore asked, whether siRNA
allows establishing protective immunity when applied at the time of DC maturation. Naïve SJL-
mice were immunized with PLP in CFA and received either PBS or siRNA at the time of immu-
nization. Immunizing mice with PLP and CFA in the presence of IL-12/IL-23p40 siRNA impaired
IL-12 production by DC in vivo and in vitro, and deviated the development of Th1/Th17 responses
into a Th2 phenotype in vivo. Simultaneously, immunization in the presence of IL-12/IL-23p40
siRNA significantly improved the clinical course of EAE. After active immunization only 20% devel-
oped EAE in the siRNA group while in the control group 100% developed the disease. Si-RNA treat-
ment did not induce anergy or detectable regulatory Th cells. The IL-12/23p40 siRNA can be used
to deviate the development of harmful Th1/h17 responses into Th2 responses and to establish pro-
tective immunity against encephalomyelitis. This may provide the basis for new vaccination strate-
gies that establish protective immunity against organ-specific inflammatory autoimmune diseases,
including psoriasis.
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Amphiregulin induces T cell activation through complex cytokine circuits in psoriasis-like
transgenic mouse model
J Lu, K Squillace and MR Pittelkow Department of Dermatology, Mayo Clinic, Rochester, MN
In addition to fundamental functions in mediating survival, proliferation and migration of ker-
atinocytes, increasing evidence suggests that amphiregulin (AREG) / EGFR pathway has a major
impact on cutaneous inflammation. We have shown that transgenic expression of AREG in the
epidermis of mice induces skin pathology with striking phenotypic similarity to both psoriasis and
psoriatic arthritis. Also, prominent T cell and dendritic cell infiltrates are observed in the lesional
skin from these mice. In this study, we further identify the effect of AREG on recruiting and acti-
vating dendritic cells and T cells during cutaneous inflammation through examining relevant
cytokines in the lesional skin as well as draining lymph nodes. Tissue samples of involved skin and
draining lymph nodes were harvested from both AREG transgenic mice and wild type mice. After
overnight in vitro culture, supernatants from different groups were collected for multi-cytokine
ELISA assay. We found that AREG transgenic mice has significantly increased secretion of cytokines
involved in inflammation (MIP-1α, IL-1α and TNFα) and dendritic cell activation (GM-CSF and IL-
12) compared with wild-type mice. In addition, we compared the cutaneous expression of T cell
cytokines in AREG transgenic mice with wild type mice using quantitative PCR, which demon-
strated upregulation of IFNγ and VEGF as well as IL-4 in AREG transgenic mice. Our study sug-
gested that AREG in the epidermis not only induces keratinocyte proliferation but also induces den-
dritic cell and T cell activation during cutaneous inflammation through a complex circuit of multiple
cytokines. The role of AREG on the generation, interaction and Th balance among different T cell
subsets is currently being investigated.
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Possible coordinated involvement of p120catenin and Rho A in pemphigus intracellular sig-
naling
Y Aoyama, Y Isa, K Murase and Y Kitajima Dermatology, Gifu University School of Medicine,
Gifu, Japan
Pemphigus-IgG and monoclonal-antibody (mAb) binding to desmoglein (Dsg) 3 induces a decrease
in Dsg3-protein expression in the membrane fraction and formation of Dsg3-depleted desmosomes
by endocytosis and degradation in cultured keratinocytes. Recently, we found that p120catenin
(ctn) association to Dsg3 stabilizes Dsg3 at cell surface. The association of p120ctn with Dsg3 func-
tions to stably pool Dsg3 at the cell membrane, and appears to involve in the regulation of the
amount of Dsg3 in desmosomes. Basing on our hypothesis that p120ctn and it’s related molecules
may possibly be key molecules to regulate Dsg3 stability in keratinocytes and especially in cell-
cell detachment of keratinocytes in patients with pemphigus, we examined the association between
Dsg3, p120ctn and Rho A, and the activity of Rho A after treatments with anti-Dsg3-mAbs in cul-
tured keratinocytes. Human squamous cell carcinoma cell line, DJM-1 cells, were treated with
AK23 mAb (a pathogenic anti-Dsg3 mAb) for 10 min. DJM-1 cells for controls were incubated
with ice-cold PBS, followed by incubation with AK23 mAb on ice for 60 min, in order to recover
Dsg3, that were exposed only on the surface without endocytosis. Cells were lysed in Brij buffer
and immunoprecipitaed by proteinA beads to pull down Dsg3, which was expressed on cell sur-
face during IgG treatment. Immnoprecipitates were subjected to westernblotting with anti-p120ctn,
Rho A and Dsg3 antibodies. Rho A activity assay was performed by using GST-Rhotekin pulldown
method. AK23 mAb reduced the amount of Dsg3-associated p120ctn after 1- to 3-min treatments.
Rho A activity in total cell lysate was increased during 10- to 30-min treatment, and returned to
the basal level after 120-min treatment. Treatment with C3 toxin to inhibit Rho A increased the
amount of non-desmosomal Dsg3. The amount of Rho A associated with Dsg3 did not change
during AK23 mAb treatment. These results suggest that p120ctn and Rho A may be involved in
pemphigus signaling possibley linked to endocytosis of Dsg3.
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The impact of tonsillectomy on patients with chronic plaque psoriasis – a controlled study
RH Thorleifsdottir,1,2 A Johnston,3 SL Sigurdardottir,1 JH Olafsson,2 B Sigurgeirsson,2 H Petersen,4
JE Gudjonsson3 and H Valdimarsson1 1 Department of Immunology, Landspitali, University
Hopsital, Reykjavik, Iceland, 2 Department of Dermatology, Landspitali, University Hopsital,
Reykjavik, Iceland, 3 Department of Dermatology, University of Michigan, Ann Arbor, MI and
4 Department of ENT, Landspitali, University Hopsital, Reykjavik, Iceland
We have proposed that the palatine tonsils may generate effector T cells that recognize strepto-
coccal M-protein determinants in the tonsils and homologous keratin determinants in the skin,
and are pathogenic in psoriasis. We are therefore studying psoriatic patients after tonsillectomy
(TX) and matched non-TX controls. They will be followed for 2 years and monitored by PASI, and
also by a number of immunologic parameters, including enumeration of blood T cells that respond
by IFN-γ or IL-17 production to short homologous M-protein or keratin peptides. We have now
recruited 25 patients. After 2 months a mean PASI reduction of 38% was observed in the TX patients
(n=13, p=0.024) but there was no PASI change in the controls (n=12). After 6 and 12 months the
mean PASI reduction remained at about 40% in the TX group (n=13 and 8, p= 0.012 ) compared
with a slight baseline PASI increase in the controls (n=12 and 5). After 2 months the improvement
of the TX patients coincided with a marked decrease in the frequency of circulating cross-reactive
CLA+CD8+ T cells in 10 of 12 TX patients compared with 1 of 10 controls, and this decrease has
persisted for 12 months. These preliminary findings indicate that TX has at least a temporary ben-
eficial effect on chronic psoriasis, and is associated with a striking reduction in the frequency of
circulating skin homing CD8+ T cells that are specific for peptides with amino acid sequences that
are present in both streptococcal M-proteins and human keratins. These amino acid sequences
might therefore represent antigen determinants that are relevant in psoriasis.
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Local and systemic inflammation are a consequence of targeted deletion of epidermal EGFR
F Mascia, G Souto Adeva and SH Yuspa LCBG, NCI/NIH, Bethesda, MD
The blockade of EGFR strongly up-regulates keratinocyte chemokine expression and causes an
enhanced inflammatory responses in mouse models and individuals undergoing anti-EGFR ther-
apy for epithelial cancers. In this study a mouse model was developed to better understand the
role of EGFR in the control of skin inflammation. By crossing Keratin 5 driven Cre recombinase
transgenics with EGFR floxed mice, EGFR was ablated in the epidermis. The double transgenic
mice did not display a clear phenotype at birth. After the first week of life, double transgenics
showed a strong skin phenotype with aberrant hair growth. During the following weeks the skin
of these mice became progressively more inflamed, scaly, dry and less elastic and underwent cycles
of hair growth and hair loss. Double transgenic mice experienced a strong pruritus through their
entire life, and their scratching behavior caused skin erosions. Tissue samples isolated from non
lesional skin of adult double transgenics contained high levels of CD45 antigen and increased
mRNA levels of a subset of inflammatory mediators namely MIP-2, MIP-3alpha, MCP-1, TNF-alpha,
IL-6, IL-17, IL-18, TARC, TGF-beta, and G-CSF. These targeted knockout mice also displayed hema-
tological abnormalities with a higher number of circulating neutrophils, eosinophils and basophils
associated with higher plasma levels of IL-17, IL-6, IP-10, MCP-1, and TGFbeta1. These data indi-
cate that the absence of EGFR triggers local and systemic inflammatory responses. Therefore, this
model represents a valuable tool to further investigate the control of EGFR in the maintenance of
a balanced immuno-homeostasis of the skin.
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Essential role of hypoxia-induced angiogenesis in experimental arthritis
K Fuchs,1,2 BJ Pichler,2 S Wiehr,2 M Judenhofer,2 D Bukala,2 H Wehrl,2 G Reischl,3 M Kneilling1
and M Röcken1 1 Dermatology, Eberhard Karls University, Tuebingen, Germany, 2 Laboratory
for Preclinical Imaging of the Werner Siemens-Foundation, Radiology, Eberhard Karls
University, Tuebingen, Germany and 3 Radiopharmacy, Radiology, Eberhard Karls University,
Tuebingen, Germany
Auto-antibodies against Glucose-6-phosphat-isomerase (GPI) induce arthritis in mice that closely
resembles human rheumatoid arthritis (RA). Inflammation is associated with tissue hypoxia and
can induce angiogenesis via stabilization of the transcription factors hypoxia inducible factor (HIF)-
1α and HIF-2α in resident and infiltrating cells. As the role of hypoxia-induced angiogenesis in
RA is still poorly understood, we investigated tissue hypoxia using 18F-fluoroazomycin-arabinosid
(FAZA) or 18F-Fluoromisonidazole (FMISO) and positron emission tomography (PET) in arthritis.
To induce arthritis, mice received either GPI-serum or control-serum. After 5-7 days mice under-
went in vivo PET investigation using [18F]FLT, [18F]FDG to analyze inflammation and [18F]FAZA,
[18F]FMISO to investigate hypoxia. Subsequently, we performed H&E-staining, pimonidazole
immunohistochemistry, RT-PCR and Western blot analysis of arthritic and healthy joints. In vivo
PET images confirmed a 2.9 fold increased [18F]FLT and a 3.6 fold increased [18F]FDG uptake in
arthritic joints indicating an enhanced cell proliferation and glucose metabolism. Importantly, a
2.8 fold increase of [18F]FAZA and a 3.6 fold increase of [18F]FMISO uptake was detected specif-
ically in arthritic joints directly visualizing hypoxia. Western blot analysis of arthritic ankles showed
an increased HIF-1α and HIF-2α protein expression, RT-PCR analysis a 6-3000 fold enhanced
HIF1α/HIF2α, IL-1β, IL-6 and TNF expression on mRNA and pimonidazole staining confirmed
our in vivo PET data. Thus, non invasive in vivo examination of hypoxia-induced angiogenesis
using [18F]FAZA or [18F] FMISO provides a new powerful tool to quantitatively evaluate hypoxia
in vivo and the initial phases of angiogenesis in autoimmune diseases such as psoriasis or RA.
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Functional and Phenotypic Characterization of LRRC32+ and LRRC32- Regulatory T Cells
DV Chan,1 A Somani,1 A Young,1 J Massari,1 E Garaczi,1 H Sugiyama,1 K Cooper1,2 and
T McCormick1 1 University Hospitals of Cleveland & Case Western Reserve University,
Cleveland, OH and 2 Louis Stokes VA Medical Center, Cleveland, OH
CD4+CD25hi regulatory T cells (Treg) express elevated levels of intracellular FoxP3 and are criti-
cal for normal immune homeostasis. Lack of cell surface markers has hampered characterization
of Tregs. Previously, we reported that mRNA expression of leucine rich repeat containing 32 (LRRC32)
protein is specifically upregulated in human Tregs and demonstrated cell surface expression of
GFP-tagged LRRC32 on transfected HEK293 cells (JID, 128(S1) 2008: A684). Using a newly cre-
ated antibody specific to LRRC32, we demonstrate that although unstimulated Tregs express high
levels of LRRC32 mRNA, they express negligible surface LRRC32 (3.8% ± 1.13%, n = 9). How-
ever, these cells do contain LRRC32 (48.5% ± 7.2%, n = 6), suggesting that LRRC32 may be
sequestered. Upon polyclonal stimulation of Tregs, LRRC32 surface expression is significantly
upregulated (27.1% ± 2.6%, n = 9, p < 0.0001). Compared to LRRC32- Tregs, LRRC32+ Tregs
show no significant difference in the expression of previously characterized Treg surface markers
(CD69, CD62L, GITR, CTLA4, HLA-DR, and CD45RO). Following polyclonal activation of CD25hi
Tregs, LRRC32 was expressed on both FoxP3+ and FoxP3- subsets (19.4% ± 5.2% and 7.0% ± 1.3%,
respectively). Next, we polyclonally activated CD4+CD25hi cells for 15 hours and sorted LRRC32+
and LRRC32- CD4+CD25hi cells and mixed them with allogeneic antigen presenting cells and syn-
geneic CD25- effector T (Teff) cells. LRRC32+ Tregs are at least twice as suppressive compared to
LRRC32- Tregs at Teff:Treg cell ratios up to 1:16. In summary, LRRC32 mRNA and surface expres-
sion do not appear to comport; however, LRRC32 may be sequestered, as expression of LRRC32
on the surface of Tregs is evident upon activation. Furthermore, surface LRRC32 marks CD25hi cells
that have potent suppressive capabilities.
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Evidence for the expression of type 1 interferons in scalp lesions of Alopecia Areata
M Ghoreishi, JP Dutz and M Martinka Dermatology & Skin Sciences, University of British
Columbia, Vancouver, BC, Canada
The exact mechanisms involved in the genesis of alopecia areata (AA) remain unknown. Infiltrat-
ing T lymphocytes have been shown to play essential role in the hair follicle (HF) injury that occurs
in AA. Type 1 interferons (IFNs) are known to enhance a Th1 immune response and are able to
recruit T-cells expressing CXCR3+. However little is known about the role of Type1 IFNs and
CXCR3+ cells in lesions of AA. We examined the expression of IFNα inducible myxovirus protein
A (MxA) and CXCR3+ T cells in paraffin embedded sections of scalp lesions from total of 8 patients
with AA and compared those with lesions from 2 discoid lupus erythematosus (DLE), 2 lichen
planopilaris (LPP) and 2 androgenic alopecia (androgenic A). We observed strong expression of
MXA in follicular epithelial cells and epidermal keratinocytes and appearance of CXCR3+ cells
surrounding the bulbar regions of HF in early AA similar to lesions from DLE and LPP. In contrast,
chronic (non-inflammatory) lesions of AA and lesions of androgenic A failed to show the expres-
sion of MXA or CXCR3. Granzyme B (GrB) and T-cell restricted intracellular Ag1 (TiA-1) are both
cytotoxic granule proteins and induce apoptosis and tissue damage. However TiA-1 has been
shown to be a marker of resting as well as activated T cells possessing cytolytic activity, whereas
GrB expression is restricted to activated T lymphocytes and other inflammatory cells such as mast
cells. Lesions of AA in our study showed expression of (TiA-1) but not GrB. In contrast, lesions of
scarring alopecia (DLE and LPP) demonstrated expression of both TiA-1 and GrB cytotoxic mole-
cules. These results suggest that type 1 IFN mediated induction of Th1 inflammatory immune
responses and recruitment of CXCR3+ T cells may play role in early lesions of AA. Furthermore,
cytotoxic cells in AA lesions are functionally different than in DLE or LPP.
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Leaf-encapsulated acne vaccines: agroinfiltration and transient expression of Propionibac-
terium acnes CAMP virulence factor as an antigen in radish leaves
P Liu, T Nakatsuji, R Gallo and C Huang Division of Dermatology, University of California San
Diego, San DIego, CA
Acne vulgaris afflicts more than fifty million people in the United State. Propionibacterium acnes(P.
acnes) is known as a key pathogen involved in the progression of inflammatory acne vulgaris. Pre-
viously, we have developed a subunit vaccine targeting a cell wall-anchored sialidase of P. acnes.
The protective immunity of this vaccine has been demonstrated in a mouse acne model established
in our laboratory. Here we develop a leaf-encapsulated acne vaccine to avoid the transgene intro-
gression that is a major concern associated with transgenic plant-based vaccines. Agroinfiltration
can be used to selectively transform non-reproductive organs and avoid introgression. A P. acnes
secreted protein, co-haemolytic Christie-Atkins-Munch-Peterson (CAMP) factor was selected as
an antigen. The CAMP genes are agroinfiltrated into radishes (Raphanw sativus L.), transiently
express and accumulate in planta. ICR mice immunized intranasally with radish leaf extracts express-
ing CAMP antigens elicit specific anti-CAMP antibodies. An amount of 25μL aliquots of living P.
acnes (1x107 CFU) was intradermally injected in the central portion of the ear. As a result, CAMP-
immunized mice provided about 20 % in vivo protective immunity against P. acnes induced inflam-
mation in ear thickness. Moreover, passive immunization of CAMP-specific antibodies protects
naive animals from ear inflammation by 70 % compared to negative groups. Thus, plant based-
CAMP vaccination and immunotherapy may prevent P. acnes-caused inflammation in acne vul-
garis.
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CD127low/- and FoxP3+ expression levels characterize different regulatory T cell popula-
tions in human peripheral blood
S Klein,1 C Kretz,1 PH Krammer1 and A Kuhn1,2 1 Tumor Immunology Program, Division of
Immunogenetics, German Cancer Research Center, Heidelberg, Germany and 2 Department
of Dermatology, University of Muenster, Muenster, Germany
Recently, it has been suggested that a lack of CD127 expression can be used to identify human
CD4+ regulatory T cells (Treg), especially when combined with CD25. Therefore, we were inter-
ested to analyze CD4+CD25+CD127low/- cells and compare their frequency and expression pat-
tern to FoxP3+ Treg using multiparameter flow cytometry analysis. We obtained human peripheral
blood mononuclear cells from 20 normal healthy donors and determined the number of
CD25+CD127low/- cells as percentage of the CD4+ T cells in the same panel used for
CD4+CD25+FoxP3+ cells. In contrast to CD4+CD25+FoxP3+ cells, gating of a clear
CD4+CD25+CD127low/- population was difficult. Moreover, we demonstrate that there was a
high percentage (34.0% ± 15.1%) of CD127low/- cells that did not express FoxP3, and conversely,
that there was a high percentage (30.3% ± 7.4%) of CD127+ cells that expressed FoxP3, suggest-
ing that these markers did not represent the same population of Treg. These data were also con-
firmed in blood samples from 12 patients with systemic scleroderma (SSc). In addition, statistical
analysis revealed that the number of CD4+CD25+CD127low/- cells (7.4%, range 5.7% to 17.7%)
in the SSc patients was slightly lower compared to the number of CD4+CD25+FoxP3+ cells (8.2,
range 4.5% to 14.0%); however, this was not statistically significant (p=0.3793). Thus, isolation of
pure Treg populations for in vitro functional studies is a challenge, explaining the various results
by different groups in clinical studies. The data of this study have important implications for car-
rying out a quantitative analysis of Treg in human samples.
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Isoprenylcysteine analogs: a novel class of non-steroidal anti-inflammatories show specificity
to different inflammatory endpoints 
E Perez,1 JB Stock,1,2 AV Gonzalez,1 S Lee,1 MV Voronkov,1 K Rapole,1 J Barrera-Oro,1
K Rouzard,1 JS Gordon1 and MB Stock1 1 Signum Biosciences, Monmouth Junction, NJ and 2
Princeton University, Princeton, NJ
G proteins participate in eliciting inflammatory responses such as the release of pro-inflammatory
mediators, and the migration and activation of inflammatory cells. Isoprenylcysteine (IPC) analogs
are structural mimics of the lipidated C-termini of the Gγ subunit of all heterotrimeric G proteins,
as well as that of small molecular weight GTPases such as Ras, Rho and Rac. Using mouse mod-
els for acute dermal inflammation and allergic contact hypersensitivity we have previously demon-
strated that the IPC analog, N-acetyl-S-farnesyl-L-cysteine (AFC) is an effective topical anti-inflam-
matory in vivo comparable in activity to glucocorticoids and standard non-steroidal anti-inflammatory
drugs (NSAIDs), but lower in potency (Gordon et al, 2008, JID, 128: 643). AFC’s effects, unlike
glucocorticoids, are restricted to the site of application and do not cause adverse effects such as
skin thinning. To assess the anti-inflammatory potential of novel IPC analogs, a total of 126 chem-
ically-diverse IPC analogs were synthesized with structural modifications made to four distinct
regions: 1) the cysteine α-carboxyl, 2) the farnesyl side chain, 3) the sulfur and 4) the cysteine α-
amino. Analogs were screened for three endpoints in mice: inhibition of TPA-induced ear thick-
ness (edema), neutrophil infiltration (myeloperoxidase - MPO) and erythema (redness). Several
analogs substantially more potent than AFC were identified for all three endpoints and compounds
exhibiting specificity for only one endpoint were identified. Structure activity relationships indi-
cated that specific modifications at the cysteine α-amino elicited the greatest diversity of effects.
Thus, IPC analogs could yield novel pharmaceutical leads for the treatment of specific inflamma-
tory skin conditions.
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Long-term topical treatment with anti-inflammatory N-acetyl-S-farnesylcysteine (AFC) avoids
the skin thinning and inhibition of wound healing associated with glucocorticoids
JS Gordon,1 J Barrero-Oro,1 J Fernandez,1 AV Gonzalez,1 K Rouzard,1 E Perez,1 JB Stock2,1 and
MB Stock1 1 Skin Research, Signum Biosciences, Monmouth Jnctn, NJ and 2 Molecular
Biology, Princeton Univ., Princeton, NJ
Topically applied N-acetyl-S-farnesylcysteine (AFC), a G-protein coupled receptor signaling mod-
ulator, has been shown to substantially inhibit edema and neutrophil infiltration induced in the
acute chemical irritation and allergic contact sensitivity mouse ear models (Gordon et al, 2008,
JID, 128: 643). The restriction of AFC’s anti-inflammatory activity to the site of application, unlike
that of glucocorticoids, has lead to the conclusion that it would have minimal if any systemic adverse
effects, a problem with glucocorticoid use. Since long-term glucocorticoid use also results in adverse
skin effects, we have compared topical AFC and the standard anti-inflammatory glucorticoid, clo-
betasol. We demonstrate here that long-term treatment of mouse skin with AFC does not cause
either skin thinning or inhibition of wound healing. Hairless Skhr-1 mice were treated topically on
the flank daily with 10% AFC and 0.5% clobetasol in a PEG/EtOH vehicle. While clobetasol treated
skin showed a 50% decrease in both epidermal and total skin thickness, no change was seen in
either parameter after AFC treatment compared to vehicle treatment. To determine the compara-
tive effects on wound healing, 8-week old, depilated, CD-1 mice were treated daily for 2 weeks
with both agents and once immediately after which their epidermis was selectively removed mechan-
ically. Neutrophil infiltration as measured by myeloperoxidase (MPO) activity was reduced by 30%
in AFC treated mice. AFC treated and untreated mice completed reepithelialization at 48 hours.
None of the clobetasol treated mice completed reepithelialization at 48hrs and 50% did by 96
hours. Thus, long-term use of AFC for inflammation potentially avoids both the systemic or skin
adverse effects of glucocorticoids.
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Dissecting the roles of Th1 versus Th2 cells in cutaneous inflammation
E Robinson, K Yasui, L Xu, C Ko and C Herrick Dermatology, Yale School of Medicine, New
Haven, CT
To decipher the roles of individual T cell subsets in various skin diseases, we developed a new
model using DO11.10 T cell receptor (TCR) transgenic mice, whose CD4+ T cells express a TCR
that is directed against OVA peptide (pOVA) and recognized by the antibody KJ1-26. Th1 and Th2
cells were generated in vitro (DO11 CD4 T cells + pOVA under cytokine skewing conditions) and
injected (5x106 i.p.) into BALB/c mice. Similar numbers of KJ1-26+ cells were detected in blood
of Th1 vs. Th2 recipients on day 4 (5.3±0.6 vs. 4.5±0.3%). Mice were then epicutaneously (e.c.)
exposed to pOVA (10 μg). Skin was harvested 1-5 days later and H&E stained sections examined.
Th1 recipients had significantly more inflammation in skin on all days than did recipients of either
Th2 or no cells, with a mixed infiltrate, acanthosis and parakeratosis. Isolation of cells by enzy-
matic digestion of skin 4 days after e.c. pOVA challenge showed significantly higher numbers of
KJ1-26+ cells present in skin of Th1 recipients (6.5±3.4 x104), compared to Th2 recipients (0.8±0.3
x104). Increased numbers of KJ1-26+ cells were also present in local lymph nodes (LN) following
challenge of Th1 recipients compared to Th2 recipients (9.8±2.3 vs 2.3±0.2 x105). Thus, Th2 cells
appeared relatively weak in their ability to mediate inflammatory responses in skin following e.c.
pOVA challenge. When Th1 cells were transferred into IFN-γ receptor deficient (IFN-γR -/-) mice,
no significant inflammatory response was seen in skin following e.c. pOVA challenge, and there
was no increase in KJ1-26+ cells in LN, supporting a role for IFN-γ in the Th1-mediated responses.
Addition of exogenous IFN-γ during e.c. pOVA exposure of Th2 recipients in turn, resulted in a
significant increase in KJ1-26+ cells recovered from skin digests compared to Th2 recipients exposed
to pOVA alone (3.6±0.3 vs. 0.9±0.2 x104). The data indicate that in contrast to Th1 cells, which
are capable of mediating significant cutaneous inflammatory responses on their own, Th2 cells
may be more reliant upon proinflammatory cytokine signals provided by other cell types.
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Defining and targeting CXCR2 signaling during skin inflammation
C Cataisson,1 L Wright,1 D Maloney,2 C Thomas2 and SH Yuspa1 1 Laboratory of Cancer Biology
and Genetics, NCI, Bethesda, MD and 2 NHGRI, Bethesda, MD
We and others have previously demonstrated that transgenic mice that overexpress the conven-
tional PKCα in basal keratinocytes exhibit an acute intraepidermal inflammatory response when
topically exposed to the PKC activator 12-O-tetradecanoyl-phorbol-13- acetate (TPA). Driving the
inducible cutaneous inflammation is a PKCα dependent upregulation of CXCR2 ligands such as
MIP-2 attracting neutrophils into the epidermis, forming intraepidermal neutrophilic microabscesses,
sloughing of the epidermis and a regenerative hyperplastic response emanating from the intact
hair follicle epithelium. We also confirmed that CXCR2 is expressed by keratinocytes and demon-
strated that transformation by oncogenic ras (a hallmark of tumor initiation) or TPA exposure induced
all CXCR2 ligands. Ras induction of CXCR2 ligands was mediated by autocrine activation of EGFR
and NF-kB and potentiated by PKCα. Activation of CXCR2 on ras transformed keratinocytes has
both pro-migratory and pro-tumorigenic functions. Collectively those results suggest that CXCR2
is an attractive target in cutaneous inflammation and during carcinogenesis. The aim of the cur-
rent work was to define signaling pathways activated downstream of CXCR2 in keratinocytes. Treat-
ment of keratinocytes with the CXCR2 ligand MIP-2 activated the ERK and Akt pathways. Pre-
treatment of keratinocytes with PP2 or a selective Src kinase inhibitor (PD 173958) completely
abolished ERK phosphorylation in response to MIP-2. We next demonstrated that ERK activation
by MIP-2 did not require EGFR expression by keratinocytes. Finally, a previously reported CXCR2
antagonist (N-(3-bromo-4-cyano-2-hydroxy-phenyl)-N’-(2bromophenyl) urea) effectively blocked
ERK phosphorylation in response to MIP-2 in vitro. The same compound was also able to reduce
TPA-induced skin inflammation in K5-PKCα mice when administered systemically in vivo. Col-
lectively, those results suggest that CXCR2 itself or possibly other signaling molecules downstream
of CXCR2 (like src) are potential anti –inflammatory targets in the skin.
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Clinical and histopathological analysis of subjects treated with lenalidomide for refractory
chronic cutaneous lupus erythematosus
M Rosenbach,1 J Okawa,1,2 M Krathen,1 I Braunstein,1,2 C Kovarik1,2 and VP Werth1,2 1
Dermatology, University of Pennsylvania, Philadelphia, PA and 2 VAMC, University of
Pennsylvania, Philadelphia, PA
Lenalidomide is a thalidomide analogue that in vitro studies have shown to be many times more
potent than the parent drug. We investigated the use of lenalidomide for chronic cutaneous lupus
erythematosus, enrolling five patients with refractory disease in a prospective, open-label study.
Four of the five patients showed disease improvement; the patient who failed to respond and one
patient who improved but developed arthralgias and proteinuria were withdrawn from the study.
Here we report the clinical and histopathological findings of those five patients. The cutaneous
lupus activity and severity index (CLASI) was used to objectively rate patient skin findings. CLASI
activity scores improved from mean 21.4 at week 0 pre-treatment to 10.8 at week 6 of treatment
(P=0.004). Physicians’ global assessment scales improved from mean 6.4 at week 0 to 3.6 at week
6 (P=0.002). Patients also completed a number of subjective measures, including itch and pain
questionnaires as well as the Skindex survey. Patient scores for pain and itch improved from week
0 to week 6 (4 to 2.4, 3.2 to 0.8, P=ns). Skindex survey data showed improvement in emotional,
symptom, and functioning scores between week 0 and week 6 (37.2 to 29.6 [P=0.15], 23 to 14
[P=0.17], and 32.2 to 26.6 [P=0.02], respectively). In vivo response to therapy was assessed by
analyzing punch biopsy specimens taken from lesional and non-lesional skin. The four responders
all showed decreased tissue lymphocytes by week 6 of drug treatment. The patient who failed to
respond did not show a reduction in tissue lymphocytes during treatment. Tissue analysis also
demonstrated decreased dermal hyaluronic acid after treatment in four of five patients. Flow cyto-
metric analysis was performed on peripheral blood from these patients during drug treatment and
is reported separately. This preliminary study suggests a potential role for lenalidomide in the treat-
ment of chronic cutaneous lupus erythematosus.
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Proteasome inhibition with bortezomib ameliorates acute and chronic cutaneous graft-ver-
sus-host disease after allogeneic bone marrow transplantation
WJ Murphy,1,2 LA Welniak1 and K Sun2 1 Department of Dermatology, University of California
Davis, School of Medicine, Sacramento, CA and 2 Department of Microbiology and
Immunology, University of Nevada School of Medicine, Reno, NV
The occurrence of graft-versus-host disease (GVHD) is a major complication after allogeneic bone
marrow transplantation (BMT). The etiology of GVHD is complex but essentially is attack of host
tissues by donor T cells. GVHD occurs in two forms, acute and chronic which differ in timing,
pathobiology and mechanisms of attack. The skin is one of the major target organs in both forms
of GVHD. Proteasome inhibition has been successful in B cell lymphomas and has immunomod-
ulatory effects in part through inhibition of NFkB. We have previously shown that systemic pro-
teasome inhibition with bortezomib can markedly inhibit acute GVHD affecting the gut and liver
in mice. Both inflammatory cytokine production and alloreactive donor T cells were suppressed.
We now show that cutaneous GVHD in both the acute GVHD model of C3H.SW donor bone
marrow and spleen cells transplanted into C57BL/6 recipients, and the chronic GVHD model of
B10.D2 donor cells into BALB/c recipients, can be ameliorated by bortezomib administration. Over-
all survival was significantly improved in both strain combinations. Toxicities were mild even with
continuous administration and donor engraftment was not adversely affected. These results demon-
strate that bortezomib may be clinically protective in both acute and chronic GVHD and may pro-
vide additional anti-tumor effects when allogeneic BMT is used in the treatment of cancer.
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Epidermal growth factors synergize with the psoriasis-associated inflammatory cytokines
IL-1, IL-17 and IL-22 promoting keratinocyte antimicrobial peptide and chemokine expres-
sion
A Johnston, JE Gudjonsson and JT Elder Dermatology, University of Michigan, Ann Arbor, MI
Multiple ligands of the epidermal growth factor (EGF) family are overexpressed in psoriasis, and
cytokines such as IL-1, IL-17A and IL-22 promote epidermal hyperplasia and/or leukocyte infiltra-
tion by the induction of chemokines such as CCL20 and antimicrobial peptides like HBD2 and
S100A7. Given that these cytokines and growth factors are co-expressed in inflamed skin, we inves-
tigated the potential for synergism between the EGFR ligands EGF, HB-EGF, TGF-α, AREG, BTC,
EREG and EGN and the inflammatory cytokines IL-1α, IL-17A and IL-22 in 4 day post-confluent
(differentiated) monolayer cultures of normal human keratinocytes (NHK) and organotypic cultures
of reconstituted human epidermis (RHE). Culture supernatants were assayed by ELISA, and mRNA
levels were determined using real-time quantitative RT-PCR. EGFR ligands alone were ineffective
in inducing HBD2, S100A7, S100A8, S100A9, CCL20 mRNA or HBD2 and CCL20 protein by NHK.
In combination with IL-1α, however, EGFR ligands provoked on average 250x more DEFB4 and a
9-fold rise in S100A7 mRNA relative to the ligand alone. This was also reflected in the levels of
HBD2 and CCL20 secreted into the medium. IL-17A also synergized with EGFR ligands to induce
CCL20 and HBD2 secretion (3-4 fold). IL-22 had little effect on HBD2 or CCL20, either alone or
in combination with EGFR ligands; however IL-22 increased the effects of IL-17A on DEFB4 mRNA
(9-fold) and secreted HBD2 protein (5-fold). Synergism was also apparent in RHE cultures, where
we saw a 3-fold increase in HBD2 secreted into the underlying medium when either TGF-α or IL-
22 was combined with IL-17A. Based on these results, we conclude that EGFR ligands are impor-
tant modifiers of the activity of IL-1α and IL-17A, and that IL-17 and IL-22 strongly synergize to
stimulate epidermal production of chemokines and antimicrobial peptides.
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Expression of vitamin A metabolism components are altered in both mouse and rat models
of alopecia areata
HB Everts,1 C Johnson,1 KA Silva,2 DE Ong,3 LE King,4 KJ McElwee5 and JP Sundberg2,4 1
Nutrition, The Ohio State University, Columbus, OH, 2 The Jackson Laboratory, Bar Harbor,
ME, 3 Biochemistry, Vanderbilt University Medical Center, Nashville, TN, 4 Medicine
(Dermatology), Vanderbilt University Medical Center, Nashville, TN and 5 Medicine
(Dermatology), The University of British Columbia, Vancouver, BC, Canada
Alopecia areata (AA) is a non-scarring hair loss affecting up to 2 % of humans during their life-
time. Previously we found retinoic acid (RA) synthesis proteins increased in human skin samples
and mouse models of scarring alopecia. Gene microarray analysis revealed that genes involved in
RA synthesis were increased, while RA degradation genes were decreased in the graft-induced
and spontaneous C3H/HeJ mouse model of AA compared to controls. These results were initially
confirmed by immunohistochemistry (IHC) for four of these proteins. To determine if this was unique
to the graft-induced C3H/HeJ model of AA we ran IHC on a tissues array of numerous other mouse
models of AA as well as samples from DEBR rats, another rodent model for AA. We also tested
more proteins involved in vitamin A metabolism. Immunoreactivity was increased for Cellular
retinol binding protein (Crbp), Lecithin:retinol acyltransferase (Lrat), Dehydrogenase/reductase
(SDR family) member 9 (Dhrs9), and cellular retinoic acid binding protein 2 (Crabp2) in dystrophic
follicles from all models of AA. Expression of retinal dehydrogenase 1-3 was variable, with increases
seen in only some models. These data suggest that elevated RA within the dystrophic hair follicles
may contribute to hair loss in AA.
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Deposition of granular immunoglobulin in dermal papillae of human skin by passive trans-
fer of anti-epidermal transglutaminase antibody to SCID mice bearing normal human skin
J Zone,1 L Schmidt,2,1 M Sotiriou,1 T Taylor,1 C Hull1 and L Meyer2,1 1 Dermatology, University
of Utah, Salt Lake City, UT and 2 Internal Medicine, Salt Lake City Veterans Administration
Medical Center, Salt Lake City, UT
Granular IgA deposition in dermal papillae is the hallmark of dermatitis herpetiformis(DH). The
mechanism by which this antibody is deposited is unknown. Sardi et al reported the presence of
epidermal transglutaminase(eTG) antigen that co-localized with IgA, concluding that eTG was the
autoantigen in DH and that circulating immune complex deposition was likely. We have hypoth-
esized that passive transfer of antibodies to eTG will produce a pattern of antibody deposition in
dermal papillae similar to that seen in DH. To test the hypothesis we first immunized a goat with
purified eTG as described previously. We then administered intraperitoneal goat IgG fraction
reactive with human eTG to 10 SCID mice bearing normal human skin. A total of 6 mg of protein
was administered over 21 days. IgG from a non-committed goat was used as a control in 10 mice.
Biopsies and serum were obtained weekly over a 7 week period. All mice developed detectable
levels of goat IgG which was maintained for the 7 week duration of the experiment. 10 mice receiv-
ing eTG antibody demonstrated deposition of goat IgG in dermal papillae in a granular pattern
immunopathologically similar to that seen in DH. Control mice demonstrated no goat IgG depo-
sition. We conclude that the pattern of deposition of immunoglobulin in dermal papillae in DH
can be reproduced by passively transferring eTG antibody making it likely that antibody binds to
eTG antigen after it reaches the skin. Using indirect immunofluorescence with this newly produced
antibody, we also confirmed the presence of eTG antigen in human DH skin and the absence of
eTG reactivity in skin from patients with linear IgA disease and granular IgA deposition associated
with lupus erythematosus.
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IL17C is a pro-inflammatory cytokine up-regulated in lesional psoriatic skin induced by IL-
17A and IL-22
M Riblett, A Johnston, AT Bruce, X Xing, JJ Voorhees, JT Elder and JE Gudjonsson Department
of Dermatology, University of Michigan, Ann Arbor, MI
The IL-17 family is comprised of six pro-inflammatory cytokines; IL-17A through IL17-F. Several
members of this family are produced by T-cells, including IL-17A and IL-17F by Th17 cells and IL-
17E (IL-25) by Th2 cells, but much less is known about the other members of this family, such as
IL17C. IL-17C has 27% amino acid homology to IL-17A and its function appears to be distinct from
that of both IL-17A and IL-17F. IL-17C has been shown to have a restricted expression pattern and
although the receptor for IL-17C is unknown, IL-17C has been shown to induce synthesis and secre-
tion of TNF-alpha in monocytes. To evaluate IL-17C expression in psoriasis we performed QRT-
PCR for IL17C on 10 normal, 10 uninvolved and 10 lesional psoriatic samples. IL17C was 30-fold
up-regulated in lesional psoriatic skin relative to normal (p<0.01). IL17C expression was strongly
induced by IL-17A (>6-fold, p<0.05) in a dose-dependent manner in both proliferating and dif-
ferentiated normal human keratinocytes (NHKs) (p<0.01) to levels comparable to that seen in
lesional skin, whereas much lower expression were seen in response to TNF-alpha or IL-22 and
no dose response observed (ns). However, IL-22 had a synergistic effect with IL-17A in the induc-
tion of IL17C expression by NHKs. Interestingly, anti-TNF treatment of psoriasis patients resulted
in decreased expression of IL17C within one week of treatment (>2-fold, p<0.05, n=8). Treatment
of NHKS by IL-17C induced expression of beta-defensin 2 (DEFB4) in a dose-dependent manner,
although the level of expression was lower than that seen with either IL-17A or IL-22. Our results
expand our knowledge on the expression and induction of this cytokine and provide further insights
into its biological function. Furthermore, our results indicate that IL17C may be part of a positive
feedback loop involving Th17 cells, monocytes and keratinocytes and thus have an essential role
in maintaining inflammation in psoriatic lesions.
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Psoriatic patient cardiovascular event surrogates in relation to markers of systemic inflam-
mation, lipids and disease severity
LY Cao,1,2,3 I Grozdev,1,3,2 RL Feig,1,2 TL Carman,2 DC Babineau,1,3 EF Kern,3 BR Bohaty,1,3,2
TS McCormick,1,3 KD Cooper1,2,3 and NJ Korman1,2,3 1 Murdough Family Center for Psoriasis,
Cleveland, OH, 2 University Hospitals Case Medical Center, Cleveland, OH and 3 Case
Western Reserve University, Cleveland, OH
We performed a cross-sectional study of 32 psoriasis patients and 16 controls without inflamma-
tory skin disease, and utilized surrogate cardiovascular (CV) markers to assess the propensity of
psoriasis patients to develop cardiovascular disease (CVD). Carotid intima-media thickness (CIMT)
correlated with age (p≤.0001), while brachial artery flow-mediated dilation (FMD) correlated with
gender (p=.006) and menopausal status (p=0.013), validating our assays relative to published lit-
erature. Serum myeloperoxidase (MPO) levels were significantly higher in psoriasis patients than
controls (p<.0001). Higher numbers and durations of current (p=.0411) and cumulative lifetime
(p=.0321) psoriasis therapies significantly lowered MPO levels. Increasing MPO levels were asso-
ciated with increasing average of maximum CIMT (p=.0069), as measured in the common carotid
artery 1 cm proximal to the bifurcation. MPO levels increased with increasing body mass index
(p=0.0116), a known risk factor for CVD; increasing high sensitivity C-reactive protein (p=.0004),
a strong and specific marker for future CV events; decreasing high density lipoprotein (HDL) (p=.0169)
and adiponectin (p=.0135), both factors known to be protective against CVD. Serum adiponectin
levels were significantly lower in psoriasis patients than controls (p=.0308). Adiponectin levels pos-
itively correlated with HDL levels (p=.0005), and negatively correlated with waist-to-hip ratios
(p=.0243). Thus, the inflammation of psoriasis may contribute to systemic levels of MPO, a known
risk factor for CV events. By contrast, low adiponectin levels may provide decreased protection for
CV events in psoriasis. Since MPO levels correlate with several surrogate markers of CVD and
appear to be lowered by increasing numbers and durations of psoriasis therapies, MPO may serve
as a marker for predicting CV events in psoriasis patients.
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Successful treatment of patients with bullous pemphigoid (BP) with rituximab despite per-
sistent anti-BP180 antibody
RP Hall,1 RD Streilein,1 D Hannah,1 PD McNair1 and MC Levesque2 1 Dermatology, Duke
University, Durham, NC and 2 Medicine, Univ Pittsburgh, Pittsburgh, PA
Six BP patients with persistent disease activity on 17.5 mg or more of prednisone per day for at
least 8 weeks were treated with rituximab (1000 mg on day zero and day 14). Patients were fol-
lowed for 1 year and prednisone was tapered as dictated by clinical disease. B cell subsets were
analyzed using flow cytometry and IgG anti-BP180, anti- BP230, anti-VZV levels and serum BAFF
and APRIL levels were determined by ELISA. 4 females and 2 male were studied (mean age 64
years; mean disease duration 3.6 years; mean starting prednisone 31 mg/day). No serious adverse
events occurred. Patients achieved a dose of prednisone below 10 mg/day at a mean of 106 days
(range 55 – 162) after the first infusion. IgG anti-BP180 was present in 5 of 6 subjects (64, 35, 198,
112, 40 u/ml) and was 48% of baseline (range 8% to 84%) at month 9(p<.03). IgG anti-BP230 was
present in 3 of 6 subjects (14, 59, 61 u/ml) and was 29 % of baseline at month 9. IgG anti-VZV
antibodies were unchanged at 9 months. CD19+ B cells were 4% of baseline at the time of the
second infusion and were 35% of baseline at month 12. Serum BAFF levels were elevated in all
patients at time 0 and further increased 6.9 times baseline at 6 months(p<.02). Serum APRIL lev-
els were normal at baseline and showed no increase. The reconstituted B cell population at month
9 was composed of less memory (CD38-/IgD-) and more transitional (CD38++/IgD+) B cells than
at baseline (p<.04). These studies demonstrate that rituximab is a successful therapy for patients
with bullous pemphigoid who are unable to taper systemic corticosteroids. The improvement occurs
despite persistent BP antibody titers, a striking increase in BAFF levels and is associated with a B
cell repopulation with an increased proportion of CD38++/IgD+ transitional B cells.
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Homoisoflavanone, an extract of Cremastra appendiculata Makino, inhibits UVB-induced
skin inflammation
S Hur and T Kim Laboratory of Dermato-Immunology, Catholic Research Institute of Medical
Science, Seoul, Korea, South
Ultraviolet B (UVB) irradiation on skin induces an acute inflammation, by the generation of reac-
tive oxygen species (ROS) and release of cytokines via activating cyclooxygenase-2 (COX-2). In
this study, we investigated an anti-inflammatory action and underlying molecular mechanisms of
homoisoflavanone in UVB-induced inflammation. Pretreatment of homoisoflavonone inhibited the
production of intracellular ROS by UVB irradiation in HaCaT cells. Simultaneously, homoisofla-
vanone also inhibited UVB-induced matrix metalloproteinase (MMP-1) expression and produc-
tion of prostaglandin E2 in human dermal fibroblast (HDF). Analysis of UVB-irradiated keratinocytes
showed decrease in COX-2 level, cytosolic phospholipase A2 (cPLA2) and p38 activation by
homoisoflavonone. The expression of pro-inflammatory cytokines, IL-6, IL-8 and TNF-α, was con-
currently decreased by homoisoflavanone, which is associated with inhibition of NF-kB nuclear
translocation. Moreover, topical treatment of homoisoflavanone inhibited ear edema in response
to different agents including phorbol 12-myristate 13-acetate (TPA), arachdonic acid, UVB, and
croton oil over 50 % in mice. These data demonstrates that homoisoflavanone has a strong pro-
tective effect against inflammatory response via down-regulation of COX-2, cPLA2, p38 and NF-
kB, providing the possibility of therapeutic application in skin inflammatory diseases
www.jidonline.org   S23
ABSTRACTS
139
Profiling of recently-identified IL-1 family cytokines in psoriasis
X Xing, A Johnston, M Riblett, AT Bruce, M Shum, JJ Voorhees, JT Elder and JE Gudjonsson
Department of Dermatology, University of Michigan, Ann Arbor, MI
The IL-1 cytokine family consists of 11 members, the best characterized of which are IL-1a, IL1b,
IL-RA and IL-18. Six novel members have recently been identified: IL-1F5, which antagonizes IL-
1F6 and IL-1F9, IL-1F7, an attenuator of IL-18 activity; the pro-inflammatory cytokines IL-1F8 and
IL-1F9; IL-1F10 whose function is unknown, and IL-F11 (IL-33) a Th2-inducing cytokine. The reg-
ulation and function of these new IL-1 family members in the skin is poorly understood. It was
recently shown that overexpression of IL-1F6 in IL-1F5 knockout mice leads to a psoriasiform phe-
notype and that expression of these two cytokines is elevated in psoriatic skin. To better define the
role of this family in psoriasis pathogenesis, we assessed the expression of all known IL-1 family
ligands and their receptors in healthy controls, symptomless psoriasis and psoriatic plaques by QRT-
PCR. Expression of the IL1B, IL1RA, IL1F5, -F6, -F8, and -F9 genes was significantly increased in
plaque versus symptomless skin, whereas expression of the anti-inflammatory IL1F7 gene was
decreased. This was supported immunohistologically, with IL-1F5, -F6, -F8 and -F9 being up-reg-
ulated and IL-1F7 being down-regulated in psoriasis plaques. IL1F6 was up-regulated at the mRNA
level to a much greater degree than its antagonist cytokine IL1F5. To begin to understand the induc-
tion of IL-1 cytokines in psoriasis skin, we treated normal human keratinocytes (NHK) with IL-1a,
IL-17A, IL-22 and TNF-a. Stimulation of NHK with IL-1a lead to increased expression of IL1A and
B, IL1F5, -F6, -F8, -F9, -F10 and -F11. IL-17A induced IL1F6 and -F9 expression. While IL-22
alone was ineffective, it potentiated the effects of IL-17A. TNF-a dose-dependently induced IL1RA,
-F5, -F7, -F8 and -F9 expression, while IL-1F7 was suppressed by IL-1a, IL-17A and IL-22. While
these results suggest important participation of newly-identified IL1 family members in the patho-
genesis of psoriasis, the exact interactions and roles of these novel cytokines in skin inflammation
remains to be elucidated.
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CD109 is an important regulator of extracellular matrix production in dermal fibroblasts of
systemic sclerosis
X Man,1 KW Finnson,1 A Iorga,1 M Baron2 and A Philip1 1 Surgical Research, McGill University,
Montreal, QC, Canada and 2 Rheumatology, McGill University, Montreal General Hospital,
QC, Canada
Increasing evidence indicates that dysregulation of transforming growth factor β (TGF-β) signaling
contributes to the excessive extracellular matrix (ECM) synthesis and deposition in the skin and
internal organs of systemic sclerosis (SSc) patients. Recent results from our laboratory have shown
that the TGF-β co-receptor, CD109, a membrane bound glycosylphosphatidylinositol (GPI)-anchored
molecule, plays an important role in regulating TGF-β action. Our specific objective is to deter-
mine whether CD109 plays a role in regulating TGF-β activity and the fibrotic process in SSc. Skin
fibroblasts from the arm or abdomen of 10 SSc patients and 8 normal controls were examined.
CD109 expression in fibroblasts was determined by immunofluorescence and Western blot. The
functional role of CD109 was determined by blocking its expression in fibroblasts using a CD109-
specific siRNA. Our results show that CD109 is expressed in fibroblasts and localizes to the cel-
lular membrane and cytoplasm. Importantly, CD109 expression is upregulated in SSc fibroblasts,
both at the mRNA and protein levels. Blocking the expression of CD109 by CD109-specific siRNA
results in marked upregulation of the synthesis of (basal and TGF- β-induced) fibronectin, colla-
gen type I and connective tissue growth factor (CTGF) as compared to control siRNA treated cells,
in both normal and SSc dermal fibroblasts. Furthermore, basal and TGF- β-induced activation of
the phospho-Smad1/5 pathway, which is known to be upregulated in systemic sclerosis, is decreased
by the CD109 siRNA. The increased expression of CD109 in SSc fibroblasts may represent an adap-
tive response to dysregulated TGF-β signaling in SSc cells. Taken together, our findings suggest
that CD109 may play a critical role in the pathophysiology of systemic sclerosis. Understanding
the mechanism by which CD109 regulates the various TGF- β signaling pathways may lead to novel
approaches to decrease the excessive fibrotic process in SSc.
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Deficient deletion of apoptotic cells by macrophage migration inhibitory factor (MIF) over-
expression accelerates photocarcinogenesis
A Honda,1,2 R Abe,2 Y Yoshihisa,1 T Makino,1 K Matsunaga,1 H Shimizu2 and T Shimizu1 1
Dermatology, University of Toyama, Toyama, Japan and 2 Dermatology, Hokkaido University
Graduate School of Medicine, Sapporo, Japan
Chronic UV exposure can increase the occurrence of p53 mutations, thus leading to a dysregula-
tion of apoptosis, the expansion of mutated keratinocytes and the initiation of skin cancer. There-
fore, it is extremely important that apoptosis is induced quickly after UV irradiation, without any
dysregulation. MIF is a pluripotent cytokine that stimulates the proinflammatory functions of immune
cells. Recent studies have suggested a potentially broader role for MIF in growth regulation because
of its ability to antagonize p53-mediated gene activation and apoptosis. To further elucidate the
possible role of MIF in UV induced cell apoptosis (carcinogenesis), the acute and chronic UVB
effect in the skin was examined using MIF transgenic and wild type mice. The mice exposed to
chronic UVB irradiation began to develop skin tumors after approximately 14 weeks in MIF Tg
mice, whereas WT mice began to develop tumors after 18 weeks. A higher incidence of tumors
was observed in the MIF Tg in comparison to the WT mice after chronic UVB irradiation. Next, to
clarify whether the acceleration of photo-induced carcinogenesis acceleration in MIF Tg mice was
mediated by an inhibition of apoptosis; the UV-induced cell apoptosis process was investigated.
The mice were UVB irradiated on the skin to induce acute UV dermatitis. There were fewer sun-
burned cells in the epidermis of the MIF Tg mice than WT mice 24 hr after UVB exposure and
TUNEL staining showed a significantly smaller number of TUNEL positive nuclei in MIF Tg mice
than WT mice. Western blotting showed the epidermis derived from MIF Tg mice to exhibit sub-
stantially decreased levels of p53, bax and p21 after UVB exposure in comparison to WT mice.
These findings suggest that chronic UVB exposure enhances MIF production, which may inhibit
the p53-dependent apoptotic processes and thereby induce photocarcinogenesis in the skin.
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Frequency of BRAFV600E mutation in atypical genital nevi
LP Nguyen,1 A Emley,1 N Wajapeyee2 and M Mahalingam3 1 Boston University School of
Medicine, Boston, MA, 2 Program in Gene Function and Expression, Howard Hughes
Medical Institute, University of Massachusetts Medical School, Worcester, MA and 3
Dermatopathology Section, Department of Dermatology, Boston University School of
Medicine, Boston, MA
BRAFV600E, the most common mutation in benign and malignant nevomelanocytic proliferations,
has been associated with intermittent sun exposure. Nevi arising on the vulva of young women
may or may not exhibit cytologic atypia. The former, designated atypical genital nevi (AGN), exhibit
expansile nests of dyshesive nevomelanocytes with varying degrees of cytologic atypia and con-
sumption of the epidermis. The primary purpose of this study was to ascertain the utility of BRAF
mutational status as a diagnostic adjunct in AGN with histologic features that are insufficient for a
diagnosis of malignant melanoma. Given our recent experience with expression of the tumor sup-
pressor IGFBP7 in BRAFV600E positive nevomelanocytic proliferations with BRAFV600E positive
nevi expressing high levels of the IGFBP7 and BRAFV600E positive melanomas lacking significant
expression of IGFBP7, an additional aim was to determine the biological significance of IGFBP7
in genital nevi with the BRAFV600E mutation. Genomic DNA from 13 AGN and 7 genital nevi
without atypia was isolated per protocol, and the BRAF mutational status was ascertained. We iden-
tified the BRAFV600E mutation in 3/13 (23%) AGN and 3/7 (43%) genital nevi without atypia
(p=0.64). In BRAFV600E positive nevi, IGFBP7 expression was maintained in 2/3 AGN and 2/3
genital nevi without atypia. These findings indicate that the BRAFV600E mutational status cannot
be used as a histologic adjunct to distinguish genital nevi that exhibit atypia from those that do not
and suggest that the melanocytic proliferation in atypical nevi might not be RAF-MEK-ERK path-
way-induced. Further in favor of this is maintenance of the tumor suppressor IGFBP7 in 2/3 cases
of BRAFV600E positive AGN. The prevalence of BRAFV600E in AGN is unusual given their sun-
protected location and suggests that UV exposure is not essential for generating BRAFV600E muta-
tions.
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Controlled study on the relationship between vitamin D levels in tissue and blood in patients
with non melanoma skin cancer
BH Mahmoud,1 A Unnikrishnan,2 S Siddiqui,1 DJ Kouba,1 HW Lim,1 A Heydari2 and IH Hamzavi1
1 Dermatology, Henry Ford Hospital, Detroit, MI and 2 Nutrition and Food Science, Wayne
State University, Detroit, MI
Studies have shown that vitamin D plays a role in development of a wide spectrum of cancers
including colorectal, lung and prostatic cancers. However, although skin cancer is the most com-
mon type of cancer, its relationship with vitamin D has not been established. Assessment of the
serum vitamin D level alone is inadequate to explain the relationship with skin cancer. The pur-
pose of our case-control study was to compare levels of vitamin D as well as cancer susceptibility
genes expression in nonmelanoma skin cancer tissues (cases) against normal skin (controls) in the
same patient, as well as its level in serum. Our results showed significant difference in levels of
vitamin D activating enzymes and vitamin D receptor as well as in expression of genes responsi-
ble for apoptotis such as caspase-3, anti-apoptotis such as bcl-2, and tumor suppressor genes
between skin cancer and normal tissues. Our group has been able to correlate between tissue and
serum vitamin D activity and their impact on pathogenesis of skin cancer.
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Stem cell gene module map guides creation of epidermal cancer stem cells
DJ Wong,1 H Liu,1 TW Ridky,1 D Cassarino,2 E Segal3 and HY Chang1 1 Program in Epithelial
Biology, Stanford University, Stanford, CA, 2 Department of Pathology, Stanford University,
Stanford, CA and 3 Department of Computer Science and Applied Mathematics, Weizmann
Institute, Rehovot, Israel
Self-renewal is a hallmark of stem cells and cancer, but the existence of a shared stemness pro-
gram even among normal stem cells remains controversial. We constructed a gene module map
to systematically relate transcriptional programs in embryonic stem cells (ESCs), adult tissue stem
cells, and human cancers. This map reveals two predominant gene modules that distinguish ESCs
and adult tissue stem cells. The ESC-like transcriptional program is activated in diverse human
epithelial cancers and strongly predicts metastasis and death. c-Myc, but not other oncogenes, is
sufficient to reactivate the ESC-like transcriptional program in normal and cancer cells. In primary
human keratinocytes transformed by Ras and IκBα, c-Myc increases the fraction of tumor-initiat-
ing cells by 150-fold, enabling tumor formation and serial propagation with as few as 500 cells.
c-Myc-enhanced tumor initiation is cell-autonomous and independent of genomic instability. Thus,
activation of an ESC-like transcriptional program in differentiated adult cells may induce patho-
logic self-renewal characteristic of cancer stem cells. Experimental creation of cells with many
properties of cancer stem cells may offer numerous opportunities to improve cancer diagnosis and
therapy.
S24 Journal of Investigative Dermatology (2009), Volume 129
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Interleukin-12-deficiency enhances 12-O-tetradecanoylphorbol-13-acetate-induced skin
tumor promotion and malignant progression of papillomas to carcinomas in DMBA-initiated
mouse skin
SK Katiyar,1,2 N Katiyar,1 H Xu1 and SM Meeran1 1 Dermatology, University of Alabama at
Birmingham, Birmingham, AL and 2 Dermatology, Birmingham VAMC, Birmingham, AL
The cytokine interleukin (IL)-12 has been shown to have anti-tumor activity in preclinical animal
tumor models, therefore has stimulated interest in the therapeutic use of this cytokine. To exam-
ine the role of IL-12 in chemical carcinogenesis, IL-12p40 knockout (IL-12 KO) mice on C3H/HeN
background were subjected to a two-stage chemical carcinogenesis protocol. Mice were initiated
with 7,12-dimethylbenz(a)anthracene (DMBA) and one week later treated with 12-O-tetrade-
canoylphorbol-13-acetate (TPA) twice a week for 26 weeks. It was found that the development of
tumors was rapid and the tumor multiplicity was significantly higher in IL-12 KO mice (p<0.01)
than in their wild-type (WT) mice. Moreover, the rate of malignant transformation of skin papillo-
mas to carcinomas was higher in IL-12 KO mice compared to their WT. As, TPA-induced inflam-
matory responses, such as, edema, cyclooxygenase-2 (COX-2) expression and PGE2 production
are conventionally used as markers of skin tumor promotion, we assessed the effect of IL-12-defi-
ciency on TPA-induced these biomarkers of inflammation. The data from immunostaining and
western blot analysis revealed that TPA-induced expressions of COX-2, PGE2 and PCNA in DMBA-
initiated mouse skin tumors were higher in IL-12 KO mice than their WT mice. The IL-12-defi-
cient mice were also more susceptible to other structurally different skin tumor promoters (mez-
erein, anthralin and benzoylperoxide)-induced skin inflammatory responses. Together, these data
indicate that IL-12-deficiency in mice enhances TPA-induced tumor promotion and malignant
transformation of papillomas to carcinomas in DMBA-initiated skin, and that IL-12-deficient mice
are more susceptible to tumor promoter-induced inflammation than their WT mice. This study
raises the possibility that in vivo stimulation or exogenous administration of IL-12 may prove ben-
eficial in prevention of chemical carcinogenesis in humans.
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Role of SWI/SNF chromatin remodeling complex in nucleotide excision repair in human
melanoma cells
L Lin, R Wong and G Li Dermatology and Skin Science, University of British Columbia,
Vancouver, BC, Canada
Melanoma is a life-threatening skin cancer, for its ability to metastasize rapidly and its resistance
to radiotherapy and chemotherapy. Ultraviolet (UV) radiation is the major environmental factor
for development of melanoma. It induces DNA lesions such as cyclobutane pyrimidine dimers
(CPDs). UV-damaged DNA is repaired by nucleotide excision repair (NER) pathway, which involves
up to thirty polypeptides. For this number of repair factors to gain access to the lesion sites, chro-
matin’s compact structure needs to be relaxed. It is proposed that the relaxation process, or chro-
matin remodeling, precedes NER in order to provide favorable environment for recruitment of
repair factors. Chromatin remodeling is allowed through SWI/SNF ATP-dependent chromatin remod-
eling complex. Previous studies have shown that SNF5, a core subunit of SWI/SNF complex, is
down-regulated in malignant rhabdoid tumors (MRT). Overexpression of SNF5 is able to reduce
MRT cell proliferation and migration. To design effective strategies for melanoma prevention, the
molecular mechanism of NER needs to be understood. We recently found that SNF5 mRNA level
is down-regulated in five human melanoma cell lines by at least 60% compared to melanocytes.
We also found that overexpression of SNF5 is able to increase DNA repair efficiency by three to
four folds in host cell reactivation assay (P = 0.01, t-test). To further study the role of SNF5 in NER,
we established stable HEK293-cell line with SNF5 knockdown using adenoviral shRNA infection,
and observed 10 to 20% lower repair rates in SNF5 knockdown cells compared with vector con-
trol in slot-western analysis of CPD (P < 0.03, t-test). Finally, we found that UV-induced chromatin
relaxation was abrogated in cells with SNF5 knockdown using Micrococcal nuclease digestion
assay. Our data show the importance of SWI/SNF complex as chromatin remodeling factors in NER
in melanomas. This sheds light on the molecular mechanisms of how UV-damaged DNA is repaired
which may eventually enable us to design effective strategies for skin cancer prevention.
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The expression of CD1a and CD83 molecules in cervical lesions caused by human papilloma
virus infection
T Lai and D Luo Department of Dermatology, the First Affiliated Hospital of Nanjing Medical
University, Nanjing, China
Our objective was to research the expression and mutual relationship of molecules CDla and CD83
in different Cervical lesions caused by Human papilloma virus(HPV). In this study,immunohisto-
chemical method was used to examine the expression of CD1a and CD83 molecules in 30 patients
with squamous cell carcinoma of the cervix,30 patients with cervical condyloma accuminatum
(CA) and 30 patients with normal cervix. In the development of cervical neoplasm,there is a decline
in the number of immature CD1a+ dendritic cells in CA and a further decline in population in car-
cinoma as compared to the normal ectocervix(normal ectocervix:3.45 cells/HPF, CA:2.89
cells/HPF,cancer:2.41 cells/HPF). However there is a significant increase in the mature CD83+
dendritic cells population in CA as compared to the normal ectocervix(CA:0.056cells/HPF,normal
ectocervix:0.019 cells/HPF). There is also an increase in the mature CD83+ dendritic cell popu-
lation in the neoplastic lesion(cancer:0.039cells/HPF). We discovered that the existence of a cer-
tain immune response in the CA and Cervical Cancer lesions,hence,preventing the progression of
the lesions to invasive carcinoma. While compares with CA the expression of mature Dendritic
cells in Cervical Cancer is lower,this shows that the presence of antigen presenting cells within
the carcinoma population is insufficient to mount adequate immune response to prevent invasion
into the stroma.
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Detection of human papilloma virus type 16 in bowenoid papulosis and Bowen’s carcinoma
S Mii,1 S Niiyama,1 H Takasu,1 Y Amoh,1 S Kosaka,2 K Hara,2 H Kitasato,2 Y Sato3 and K Katsuoka1
1 Department of Dermatology, Kitasato University School of Medicine, Sagamihara, Japan, 2
Department of Environmental Microbiology, Graduated Scool of Medical Science, Kitasato
University, Sagamihara, Japan and 3 Department of Molecular Diagnostics, Kitasato
University School of Allied Health Sciences, Sagamihara, Japan
Human papillomavirus (HPV) have been thought to be etiologic agents for cutaneous SCC. We
report cases of bowenoid papulosis and poorly differentiated SCC (Bowen’s carcinoma) detected
HPV type 16. Case 1: A 24-year-old man noticed multiple black and keratotic nodules on his glans
penis. The skin biopsy specimen from the nodule showed acanthosis, atypical cells in the whole
epidermis with nuclear atypism, clumping cells and dyskeratotic cells. We had a diagnosis of
bowenoid papulosis and treated with liquid nitrogen, these nodules disappeared completely. Case
2: A 44-year-old man noticed a irregular verrucous hyperkeratotic nodule with ulceration partially
on his right giant toe, the size of nodule was also 2,5cm diameter. He refused any therapy. 8 months
later from first consultation, his disease had progressed gradually. The tumor had glowed further,
the right leg presented a marked lymphedema, and there were numerous nodules of new skin metas-
tases. The skin biopsy specimen from the tumor showed irregular masses of epidermal cells pro-
liferated in the dermis and the subcutaneous fat tissue. The tumor cells appeared highly atypical
and composed clumping cells, dyskeratotic cells. We made a diagnosis Bowen’s carcinoma. Unfor-
tunately, he died from the obstructive pneumonia two weeks after hospitalization. We examined
of HPV with polymerase chain reaction and sequencing from samples of bowenid papulosis and
Bowen’s carcinoma, we found HPV DNA, and the result of DNA sequencing identified the type of
HPV were type 16 respectively. Right now, we are examining HPV-DNA in 10cases of Bowen’s
disease and 5cases of Bowen’s carcinoma. We present the case reports and results of the investi-
gation of HPV-DNA.
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Polymorphisms of FAS and FAS ligand genes and risk of skin cancer
MA Dyer,1 H Nan,2,3 DJ Hunter,2,3 J Han2,3 and A Qureshi1,2 1 Department of Dermatology,
Brigham and Women’s Hospital (BWH) and Harvard Medical School (HMS), Boston, MA, 2
Channing Laboratory of the Department of Medicine, BWH and HMS, Boston, MA and 3
Program in Molecular and Genetic Epidemiology, Harvard School of Public Health, Boston,
MA
FAS and FAS ligand (FASL) genes are involved in the extrinsic signaling pathway that causes cells
that have been irreparably damaged by UV radiation to undergo apoptosis. Polymorphisms in these
genes may prevent UV-damaged pre-cancerous cells from going into apoptosis, and therefore, may
contribute to risk of skin cancer. In this nested case-control study within the Nurses’ Health Study,
we assessed whether two polymorphisms in the promoter region of the FAS gene (FAS -1377 G>A
and FAS -670 A>G) and two polymorphisms in the FASL gene, one in the promoter region (FASL -
844 C>T) and one in the second intron (FASL INV2nt -124 A>G), contribute to susceptibility to
skin cancer (300 cases of basal cell carcinoma, 285 cases of squamous cell carcinoma, 218 cases
of melanoma, and 870 controls). Previous functional studies showed that both of the FAS minor
alleles diminish promoter activity and therefore decrease FAS expression, and the FASL -844 T
(minor) allele decreases baseline expression of FASL. We observed that the FAS -1377 A (minor)
allele was associated with increased risk of basal cell carcinoma. The odds ratio (OR) for the addi-
tive model was 1.43 (95% confidence interval (CI) = 1.07-1.92). The FAS -1377 A / -670 G hap-
lotype (both minor alleles) was associated, with borderline statistical significance, with an increased
risk of basal cell carcinoma (OR = 1.30; 95%CI = 0.98-1.73; p for Global test = 0.08). We found
an inverse association between the FASL -844 T (minor) allele and basal cell carcinoma (additive
OR = 0.81; 95%CI = 0.65-1.00). No associations were observed for these four polymorphisms with
the risk of squamous cell carcinoma or melanoma. Our data suggest that functional polymorphisms
in the promoter regions of the FAS and FASL genes that decrease baseline expression of FAS and
that increase baseline expression of FASL may be associated with an increased risk of BCC.
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Indoleamine-pyrrole 2,3-dioxygenase expression may contribute to immunoprotection in
basal cell carcinomas
BK Lo,1 N Sidhu,1 D Zloty,1 RB Jalili,2 A Ghahary,2 B Cowan,1 J Shapiro1 and KJ McElwee1 1
Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada and
2 Surgery, University of British Columbia, Vancouver, BC, Canada
Basal cell carcinoma (BCC) is the most prevalent malignancy found in the Caucasian population.
It has been suggested that immunoprotection may be involved in BCC tumorigenesis; however,
the nature of such putative immunoprotective mechanisms has yet to be established. In this study,
we profiled the expression of genes associated with immune privilege (IP) and immunoregulation
in BCCs by real-time RT-PCR using human nodular BCC samples (n=10) as compared to non-lesional
skin epithelium control tissue (n=10). BCC samples exhibited significant upregulation in 9 of 19
immunoregulatory genes including IDO (1.96-fold), TGFβ1 (2.49-fold), and TGFβ2 (5.43-fold),
along with IL10 (3.40-fold), CCL2 (2.86-fold), and MIF (2.25-fold). Notably, Fas expression was sig-
nificantly decreased (0.34-fold). Indoleamine-pyrrole 2,3-dioxygenase (IDO) promotes T cell sup-
pression and tolerance induction and is used as an immune subversion strategy by several tumors.
Immunohistochemistry (IHC) and Western blot confirmed the IDO protein was present in relatively
high concentrations in nodular BCCs. IDO was mainly localized in the tumor nests while a weak,
non-specific staining was distributed in the stromal region of the BCC biopsies. There was some
immuno-labeling in the normal skin biopsies, especially in sweat glands, hair follicle outer root
sheath, and sebaceous glands. IDO proteins were present at low levels in the non-follicular epithe-
lium of both BCC and control tissue biopsies. In conclusion, the data suggest BCCs may employ
IP and immunoregulatory mechanisms to avoid targeting by the host immune system. Of several
differentially expressed genes, IDO may be a key factor. The results may ultimately shed light on
the impact of IDO and other IP associated genes on BCC growth.
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The possibility of personalized medicine in CTCL: Transcriptional analysis of lesioned patient
skin reveals three clusters with distinct clinical outcomes
I Litvinov,1 D Jones,2 D Sasseville1 and T Kupper2 1 Dermatology, McGill University Health
Centre, Montreal, QC, Canada and 2 Dermatology, Harvard/Brigham and Women’s Hospital,
Boston, MA
Average survival after diagnosis of CTCL is associated with clinical stage at diagnosis: Stage IA
patients have normal life expectancies, while patients with Stage IIb and higher succumb to their
disease within 5 years. Unfortunately, a subset of patients with IA or IB stage disease will have a
progressive and fatal clinical course, while a minority of patients with advanced disease will sur-
vive for much longer than 5 years. Early identification of patients at risk of progression would
allow the earlier use of more aggressive therapies. Our previous work used microarray analysis of
skin biopsies from 62 CTCL patients at various clinical stages to perform an unsupervised analysis
of gene expression, which revealed 3 distinct transcription profile clusters (1,2 and 3) associated
with different clinical courses (Shin et al, Blood, 2007). During the initial three year follow up, clus-
ter 2 genes associated with the best clinical outcome, while cluster 1 and 3 genes associated with
the worst and intermediate clinical outcomes, respectively. In the present study, we successfully
confirmed gene expression in the 3 cluster model derived from the microarray analysis by RT-PCR.
These data were further correlated with an additional 2 years of clinical follow up, which docu-
mented that all of the cases of stage IA or IB CTCL that progressed to stage II or higher disease were
in clusters 1 and 3. The RT-PCR analysis also identified certain genes that are preferentially expressed
in a heterogeneous manner in each of the three clusters. These RT-PCR data allow us to document,
in a limited set of patients, an association between WNT signaling (WIF-1 expression) and favor-
able outcome, and an association of the Th17 cytokine IL-17F expression with disease progression
and poor clinical outcome. This work suggests that it may be possible to identify CTCL patients at
risk for disease progression by gene expression profiling through a controlled prospective analy-
sis.
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A chemical genetic screen reveals novel ATR/ATM pathway inhibitors that sensitize p53-defi-
cient cells to DNA-damaging agents
M Kawasumi,1 H Sloan,1 J Bradner2 and P Nghiem1 1 Dermatology/Medicine, University of
Washington, Seattle, WA and 2 Chemical Biology, Broad Institute of Harvard & MIT,
Cambridge, MA
Suppression of cellular DNA damage responses may promote the selective killing of malignant cells
in cancer therapy. To discover potential tools to elucidate and manipulate this pathway, we per-
formed a chemical genetic screen to identify small molecules that suppress a key aspect of the DNA
damage response: induction of Chk1 phosphorylation on Ser345 (“P-Chk1”). This is an early event
after DNA damage that is dependent on the ATR/ATM kinase pathways. A total of 9195 compounds
were screened at low micro-molar concentration by automated immuno-fluorescent microscopy
for their ability to block P-Chk1 induction by hydroxyurea (HU). Of the compounds screened, 33
(0.36%) suppressed P-Chk1 more potently than caffeine (3 mM) a known, non-selective ATR inhibitor.
These 33 compounds were tested in secondary assays to yield 12 that suppressed P-Chk1 in a dose-
dependent manner. Of those, 5 blocked P-Chk1 induction by either HU or UV irradiation in west-
ern blot studies. In vitro kinase assays were used to test whether these compounds acted directly
as ATR kinase inhibitors. Strikingly, even at high concentrations, none of these 5 compounds had
any effect on the in vitro kinase activity of ATR. In order to determine if these compounds affected
ATR/ATM activity more broadly than P-Chk1, we established cellular assays that were specifically
dependent on either kinase. All 5 compounds inhibited both ATM- as well as multiple ATR-depend-
ent phosphorylation events. In the absence of the test compounds, several classical DNA damag-
ing chemotherapeutic agents were less able to kill p53-/- cells than isogenic p53+/+ cells. Four of
the 5 compounds, when given in combination with a chemotherapeutic agent, selectively sensi-
tized p53-/- cells to death (synergy of 20-55% via ‘excess over Bliss’ analysis). Studies are ongoing
to define the targets of these small molecules both to learn more about the pathway and to further
evaluate this approach to selectively sensitize p53-deficient cells to death.
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Downregulating ΔNp63 causes skin squamous cell carcinomas
JR Quante and MI Koster University of Colorado Denver, Aurora, CO
Skin squamous cell carcinoma (SCC) is one of the most common cancers in humans resulting in
approximately 2,500 deaths per year in the United States. One gene that may play a role in skin
SCC development and progression is p63, a transcription factor that is critical for normal epider-
mal development and differentiation. However, the role for p63 in skin carcinogenesis remains to
be elucidated. We initially determined the expression pattern of p63 in skin SCCs by performing
immunostaining for p63 and keratin K14, a marker for epithelial cells, on samples of human skin
SCCs. Whereas p63 and K14 were co-expressed in many skin SCCs, we observed patches of cells
which expressed K14, but not p63, in about 50% of the tumors (n=52). Of the six p63 isoforms,
only ΔNp63 isoforms are expressed at detectable levels in postnatal skin, suggesting that loss of
ΔNp63 occurs in p63-negative carcinoma cells that are present in SCCs. To determine if ΔNp63
downregulation contributes to SCC development, we generated inducible epidermal-specific ΔNp63
knockdown (ΔNp63 i-kd) mice in which epidermal ΔNp63 expression can be downregulated by
topical application of RU486. Transient downregulation of ΔNp63 expression in postnatal epider-
mis resulted in impaired keratinocyte differentiation and impaired basement membrane forma-
tion, two known contributing factors for SCC development. Upon chronic ΔNp63 downregula-
tion, ΔNp63 i-kd mice developed visible tumors as early as 3 weeks after ΔNp63 downregulation,
and 78% of ΔNp63 i-kd mice had developed at least one SCC after 12 weeks of ΔNp63 down-
regulation. Interestingly, all SCCs regressed upon withdrawal of RU486. Further, despite the rapid
development of SCCs in ΔNp63 i-kd mice, these SCCs did not metastasize. Together, our data
demonstrate that ΔNp63 can function as a tumor suppressor gene and might thus play an impor-
tant role in skin malignancies.
154
Dinitrofluorobenzene (DNFB) promotes the development of a high-grade, aggressive lym-
phoma by MBL2 murine T cells in skin
X Wu and S Hwang Dermatology, NCI/NIH, Bethesda, MD
Cutaneous T cell lymphomas (CTCL) display features of both inflammatory skin disease and malig-
nant neoplasms. The contribution of host immunity (innate or acquired) in controlling or promot-
ing lymphomagenesis in these rare lymphomas is unclear. To develop a murine model to address
this question, we utilized the MBL2 cell line: a Moloney MuLV-induced T cell line that expresses
the gag antigen, which may induce host immune resistance to transplanted tumors. We injected
up to 400k MBL2 cells into the ear skin or flank of syngeneic C57BL6 or immunocompromised
SCID-beige mice with and without topical application of 0.5% DNFB (~20 ul) in acetone/olive oil.
With vehicle treatment, MBL2 cells did not form tumors in ears of C57BL6 mice but did form tumors
in SCID-beige mice. Strikingly, topical application of DNFB following inoculation of MBL2 cells
in WT C57BL6 mice resulted in progressive erythema with scaling (beginning at 4 days) and mas-
sive thickening of mouse ears (15-fold increased over normal) over 2 weeks. Histologically, sheets
of high-grade lymphoma cells with accompanying inflammatory cells filled the dermis and sub-
cutis, resembling tumor stage CTCL. Tumor formation was observed in >90% of inoculated mice
that were treated with DNFB. By flow cytometry, DNFB treatment alone without MBL2 inocula-
tion in WT ears resulted in enhanced infiltration of CD45+ leukocytes comprised of 56% GR1+
granulocytes (vs 1.5% in vehicle-treated mice). Application of topical DNFB also resulted in IL-1β
activation (i.e., cleavage) in skin that was confirmed by Western blot with IL-1β Ab. Co-injection
of recombinant IL-1β (70 ng/site) with MBL2 cells in flank skin increased the resulting tumor vol-
ume by 4.4 fold (vs. no IL-1β), suggesting that IL-1β was sufficient to mimic the tumor-promoting
effects of topical DNFB. In summary, we established a skin-localized murine T cell lymphoma
model using MBL2 cells that is dependent on inflammation driven by topical DNFB or IL-1β. This
model may be useful for exploring the contribution of inflammatory pathways to the progression
(or control) of CTCL in humans.
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CD133 identifies human cutaneous squamous cell carcinoma tumor initiating cells
GK Patel,1,2 CL Yee,2 A Montemarano,3 K Maggio4 and JC Vogel2 1 Dermatology, School of
Medicine Cardiff University, Cardiff, United Kingdom, 2 Dermatology Branch, National
Cancer Institute, Bethesda, MD, 3 Rockledge Skin Cancer Clinic, Bethesda, MD and 4
Dermatology Services, Walter Reed Army Medical Center, Washington DC, MD
To test the hypothesis that a subset of primary human cutaneous squamous cell carcinoma (SCC)
cells function as cancer stem cells (CaSC) and possess tumor-initiating capacity (TIC), functional
assays are needed to characterize SCC subsets defined by cell surface markers. In our in-vitro assay,
SCC cells were cultured on a NIH 3T3 feeder layer and in contrast to normal human keratinocytes,
formed spheroidal colonies (>100 cells) tethered to the 3T3 cells. Colonies were formed in a dose
responsive manner to number of input SCC cells and results from serial passage of the tethered
spheres indicated that there were only a few TIC cells per sphere. In vivo human SCC xenografts
in immunocompromised mice were only possible if the engraftment site was extensively “human-
ized” by implantation of a glass disc or Gelfoam™ dressing with primary human fibroblasts to cre-
ate a fibrovascular stromal bed. Human SCC growth in the in vivo assay was dependent upon the
number of unsorted total SCC cells implanted, with reproducible tumor growth when >3x10*6 SCC
cells were engrafted but no tumors forming if < 10*5cells were implanted. When assessing differ-
ent cell surface markers, we found that CD133 expression was localized to a small subset of SCC
cells both by immunohistochemistry and FACS analysis. In our vitro assay, CD133+ sorted cells
showed a >7-fold enrichment in colony forming efficiency compared to unsorted and CD133- cells.
Using our in vivo assay, CD133+ sorted cells had reproducible tumor growth with as few as 10*2
cells in 24 of 28 different human SCC. Self-renewal ability of CD133+ enriched human SCC cells
was demonstrated by their ability to initiate and serially transfer new SCC. Small numbers (10*2)
of sorted CD133+ cells from primary xenografts were able to form secondary SCC xenografts (10/14).
Consistent with CD133+ CaSC, CD133- SCC cells were unable to initiate SCC xenografts.
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Ectodysplasin receptor Edar is highly expressed in nodular basal cell carcinomas
M Yu, S Ma, D Zloty, B Cowan, J Shapiro and K McElwee Dermatology and Skin Science,
University of British Columbia, Vancouver, BC, Canada
In the hair follicle skin appendage, the Sonic hedgehog (Shh), Wnt, and Edar pathways play pri-
mary roles in development and growth. Studies with mice either lacking the functional proteins of
Edar pathway or overexpressing the ligand or receptor suggest that Edar signaling has multiple roles
in ectodermal organ development regulating their initiation, morphogesis, and differentiation. Basal
cell carcinomas (BCCs) can be regarded as aberrant skin appendages where Shh and Wnt have
been shown to have primary roles. Pervious microarray analysis of BCCs also suggested an active
Edar pathway. We further investigated components of Edar signaling in nodular BCCs versus nor-
mal skin epithelium and hair follicles. Quantitative PCR (qPCR) of nodular BCCs (n=8), normal skin
epithelium (n=8), and microdissected hair follicles (n=8, ten hair follicles per donor sample) revealed
possible increased EDA and significantly increased EDAR (43-fold increase in BCCs over hair fol-
licles). In contrast, XEDAR (0.17-fold), and TRAF6 (0.27-fold) exhibited statistically significant
suppression in BCCs as compared to hair follicles. Immunohistology revealed distribution of Eda,
Edar, and Xedar in BCC keratinocytes consistent with cell membrane expression and with strongest
expression in those cells at the periphery of tumor cell nests. In contrast, positive expression in
hair follicles was evenly distributed in the non-bulbar outer root sheath. This preliminary investi-
gation suggests that, in addition to Shh, and Wnt signaling, other hair follicle appendage signaling
pathways, including Edar, may be active in BCC growth. The potential role of Edar pathway in BCCs
may correlate with its ability to regulate ectodermal organ development.
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Profile of immunoregulatory cells in human cutaneous squamous cell carcinoma and pre-
cancerous lesions
S August,1 C Pickard,1 SV Dixon,1 JM Theaker,2 MR Ardern-Jones,1 SD Gadola3 and E Healy1 1
Dermatopharmacology, University of Southampton, Southampton, United Kingdom, 2
Department of Histopathology, Southampton University Hospitals NHS Trust, Southampton,
United Kingdom and 3 Infection, Inflammation and Repair Division, University of
Southampton, Southampton, United Kingdom
The immune system plays a crucial role in preventing development of squamous cell cancer
(SCC) of the skin as evidenced by the hugely increased risk of this tumour in immunosuppressed
organ transplant recipients. On histology, cutaneous SCCs are typically surrounded by an immune
cell infiltrate which would appear to be dysfunctional given that these tumours do not usually
regress spontaneously. There is some evidence to suggest that immune cells which can suppress
anti-tumour responses (such as FoxP3+ T regs and Natural Killer T (NKT) cells) may play a role in
SCC development. We have thus characterised the immune infiltrate within human cutaneous SCC
(n=24) and pre-cancerous lesions (actinic keratosis (n=6) and Bowen’s disease (n=6). Numerous
T regs were present in all SCCs, with 28% (SD±12.5%) of peritumoral T cells expressing FoxP3 on
immunohistochemical analysis. Fluorescence activated cell sorting (FACS) analyisis demonstrated
greatly increased proportions of FoxP3+ T regs in the SCC samples compared to that of normal
skin and peripheral blood. Lesional T regs were also observed by FACS and immunohistochem-
istry in actinic keratosis and Bowen’s disease, indicating that influx of these cells may permit per-
sistence of pre-malignant lesions and the subsequent progression of these lesions to skin cancer.
We have also identified Vα24 positive cells within the infiltrate surrounding human cutaneous
SCCs, suggesting the presence of peritumoural NKT cells at this site. Further work is ongoing to
characterise the function of these immunoregulatory cells in SCC development, however the data
so far suggest that lesional immunosuppressive cells play an important role in skin carcinogene-
sis.
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Overexpression of ΔNp63α negatively regulates multiple protease inhibitors in keratinocytes
KE King,1 D Muraleedharan,1 RM Ponnamperuma,1 MJ Gerdes2 and WC Weinberg1 1 Office of
Biotechnology Products, FDA Center for Drug Evaluation and Research, Bethesda, MD and
2 GE Global Research Center, Niskayuna, NY
The p53 homologue, p63, is critical for normal epidermal development. While overexpression of
p63, in particular ΔNp63α, has been reported in many squamous cell cancers including those of
the skin, the role of p63 in cancer pathogenesis remains unclear. We performed microarray analy-
ses of ΔNp63α-overexpressing primary murine epidermal keratinocytes to identify target genes
impacted by dysregulated ΔNp63α. Our studies revealed a coordinated downregulation of RNA
transcripts for multiple protease inhibitors, including tissue inhibitor of metalloproteinase-3 (TIMP-
3), as well as two members of the serpin family of serine protease inhibitors, plasminogen activa-
tor inhibitor-2 (PAI-2) and maspin. By western blot analysis, TIMP-3 was detected in keratinocyte
conditioned medium but not in whole cell lysates, supporting a primarily extracellular function
for TIMP-3. Secreted levels of TIMP-3 declined with elevated ΔNp63α and correlated with decreased
pro-MMP-9 and a slight increase in active MMP-9. The serpins, PAI-2 and maspin, were detected
in both whole cell lysates and conditioned medium. Intracellular levels of PAI-2 and maspin were
negatively regulated by ΔNp63α. Like TIMP-3, secreted levels of PAI-2 declined with overexpressed
ΔNp63α, whereas maspin levels remained stable. The mechanism of action by which ΔNp63α
down-regulates these proteins, as well as the biological impact on cellular invasiveness and motil-
ity are currently under investigation. We have previously shown that elevated levels of ΔNp63α
aberrantly maintain keratinocyte proliferation under differentiating conditions. The current data
suggest additional, complementary roles for ΔNp63α in cancer pathogenesis by down–modulat-
ing protease inhibitors, thereby promoting keratinocyte invasiveness.
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Heterogeneity in mutant Ha-ras expression within cutaneous papillomas in mice
S Li,1 H Park,1 CS Trempus,2 D Gordon,3 LC King,4 G Cotsarelis5 and RJ Morris1 1 Department
of Dermatology, Columbia University, New York, NY, 2 Lab. Mol. Toxicol., NIEHS, Research
Triangle Park, NC, 3 Dept. Genetics, Rutgers, Piscataway, NJ, 4 EPA, Research Triangle Park,
NC and 5 Department of Dermatology, University of Pennsylvania, Philadelphia, PA
The purpose of our investigation was to study expression of the activated Ha-ras oncogene by cuta-
neous papillomas in Krt1-15CrePR1;R26R transgenic mice where the Cre recombinase was tran-
siently induced in hair follicle stem cells shortly after tumor initiation with DMBA followed by
tumor promotion with TPA. Resulting papillomas were blue, non-blue, or a mixture of blue and
non-blue regions after x-gal histochemistry. We performed laser capture microdissection of papil-
lomas followed by DNA extraction and sequencing to detect the signature mutation in codon 61
of the Ha-ras oncogene. LCM disclosed an unexpected heterogeneity in activated Ha-ras expres-
sion with 73% of bulge-progeny being wild type and 27% being mutated in individual papillo-
mas. Among non-blue papilloma cells, 34% were wild type and 66% mutated. Tumor-adjacent
hyperplastic epidermis was wild type whether blue or non-blue. P32 postlabeling of FACS sorted
bulge and non-bulge cells revealed similar adduct profiles between the two groups. Hence, hair
follicle stem cells do form the primary lesion after carcinogen exposure, but based on the lower
percentage of mutant cells in bulge-derived progeny, it is possible that transition from adduct to
mutation in codon 61 may not be as efficient. We conclude that K15-expressing stem cells con-
tribute to skin tumors, but highlight the complexity of tumor development in the (relatively) sim-
ple model of chemically induced carcinogenesis, and point towards unanticipated cellular het-
erogeneity in developing papillomas and in expression of the Ha-ras signature mutation.
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Plakophilin 3 acts as a tumor suppressor gene in oral cancer
J Chen,1 C O’Shea,1 A Schmidt2 and PJ Koch1 1 Dermatology, University of Colorado Denver,
Aurora, CO and 2 Pathology, University of Marburg, Marburg, Germany
Plakophilin 3 (PKP3) belongs to the armadillo family of cell adhesion and signaling molecules found
in desmosomes of simple and stratified epithelia. In contrast to the other plakophilins, mutations
in PKP3 have not been associated with human diseases. We recently generated Pkp3 null mice
and found that loss of Pkp3 leads to ventral hair loss and mild acantholysis in the oral cavity, sug-
gesting that Pkp3 plays a role in cell-cell adhesion. In addition, we found that loss of Pkp3 leads
to increased plakoglobin and beta-catenin expression in stratified epithelia, suggesting that Pkp3
may play a role in modulating Wnt signaling. Although several in vitro studies have suggested a
role for Pkp3 in tumor development, in vivo models to assess the function of Pkp3 in tumorigene-
sis have not been described. To test if Pkp3 affects tumor development, we generated mice in which
expression of an activated Ras oncogene (K-rasG12D) is focally induced by RU486. We activated
Ras either in the back skin or the oral cavity of Pkp3 null (K5.CrePR1/K-rasG12D/Pkp3-/-) and
control mice (K5.CrePR1/K-rasG12D/Pkp3+/-). Mutant mice showed an increased susceptibility to
develop tumors, which was reflected by a higher proportion of mice carrying tumors as well as a
greater tumor load of mutant mice. The effects of the Pkp3 null mutation were most pronounced
in the oral cavity; 21 weeks after activation of the Ras oncogene in the oral cavity, 5% of the con-
trol mice (n=16) and 55% of the mutant mice (n=17) had developed tumors. It remains to be deter-
mined whether these effects are due to reduced cell adhesion, altered cell signaling caused by
increased expression of beta-catenin and/or plakoglobin, or an as yet unidentified function of PKP3.
In summary, our results demonstrate that Pkp3 functions as a tumor suppressor gene in vivo. Our
animal models are ideally suited to elucidate the molecular mechanism underlying Pkp3-facili-
tated carcinogenesis.
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Keratinocyte migration and squamous cell carcinoma invasion is enhanced by microRNA-
205
RM Lavker, Q Ruan, S Getsios and J Yu Dermatology, Northwestern Univ., Chicago, IL
MicroRNAs (miRNAs) regulate diverse cellular processes including proliferation, differentiation
and apoptosis. Deregulation of miRNAs is increasingly noted in human malignancies with miR-
NAs functioning as tumor suppressors or oncogenes. However, their mechanism(s) of action in neo-
plastic processes are, in general, poorly understood. Our previous studies indicated that one of the
roles of the epithelial microRNA-205 (miR-205) is to directly regulate the levels of the lipid phos-
phatase SHIP2 and thereby suppress PI3K-Akt signaling. Notably, SCC cell lines are characterized
by elevated levels of miR-205, a marked reduction in SHIP2 and enhanced Akt activation. Since
the Akt pathway has been implicated in regulating the actin cytoskeleton and keratinocyte migra-
tion, we investigated whether the upstream regulation of SHIP2 levels by miR-205 plays a role in
keratinocyte migration and SCC invasiveness. Suppression of miR-205 in normal human epider-
mal keratinocytes (HEKs) following 48hr treatment with an antagomir to miR-205 (antago-205)
increased SHIP2 protein expression, reduced Akt phosphorylation and inhibited these cells from
sealing linear scratch wounds compared with irrelevant antago-treated HEKs. Conversely, HEKs
transfected with SHIP2 siRNA sealed wounds more rapidly than controls. Treatment of HEKs with
antago-205 resulted in a marked diminution of filamentous actin as well as a redistribution of
focal adhesion components. Consistent with the idea that miR-205 regulates actin-based cell motil-
ity pathways, treatment of orally-derived SCC68 and CAL27 cell lines with antago-205 resulted in
a >two-fold decrease in trans-well invasion through a matrigel-coated membrane. Collectively,
these results suggest that miR-205 targeting of SHIP2, a potential tumor suppressor gene, regulates
cell migration and tumor invasiveness. Targeting miR-205 is sufficient to limit tumor cell invasion
in vitro in a manner that is likely to involve associated changes in actin cytoskeleton and focal
adhesions, leading us to propose that suppression of miR-205 may be a novel approach for the
treatment of aggressive SCCs.
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Identification of novel biomarkers for keratinocyte malignant transformation by analysis of
cutaneous squamous cell carcinoma degradome
R Ala-aho,1 J Joutsa,1 A Stokes,4 C Pennington,4 R Grenman,2 J Peltonen,3 D Edwards4 and
V Kähäri1 1 Dermatology, University of Turku, Turku, Finland, 2 Otorhinolaryngology,
University of Turku, Turku, Finland, 3 Anatomy and Cell Biology, University of Turku, Turku,
Finland and 4 Cell Biology, University of East Anglia, Turku, United Kingdom
The degradome consists of the complete set of proteases expressed by a cell, tissue, or organism
at a given time. Here, we performed global expression profiling of cutaneous squamous cell car-
cinoma (SCC) cell lines and normal human epidermal keratinocytes (HEKs) to identify novel bio-
markers within degradome for malignant transformation of HEKs and for SCC progression. Expres-
sion profiling of cutaneous SCC cell lines established from primary tumors (n=5) and from metastases
(n=3) and of HEKs established from the skin of normal adults (n=5) was performed using the
Affymetrix GeneChip microarray. Altogether 2259 genes were upregulated at least 2-fold and
1178 genes were downregulated by at least 50% in SCC cells as compared to HEKs. Of these, 179
genes were found to encode proteinases or their inhibitors. Additional expression profiling for
metalloproteinases (MMPs, ADAMs and ADAMTSs) and TIMPs in SCC cells, keratinocytes, and in
tissue samples from cutaneous SCCs (n=10) and normal skin and oral epithelium (n=13) was per-
formed by quantitative RT-PCR. The results indicated that the expression of MMP-1, -2, -7, 10, -
13, ADAM-8, -9, ADAMTS-8, and TIMP-2 were highest and most elevated in both cutaneous SCC
cell lines and in SCC tumors as compared to HEKs and normal epithelium. Increased expression
of these metalloproteinases by SCC cells was also verified by western blotting. In metastatic SCC
cell lines, the expression of the two collagenolytic MMPs (MMP-1 and -13) was the highest of all
metalloproteinases. These results suggest important roles for a number of proteases in malignant
transformation of epidermal keratinocytes. Specifically, these results identify a cluster of metallo-
proteinases as novel biomarkers for the progression of cutaneous SCCs and as candidates for tar-
geted therapy of these tumors.
www.jidonline.org   S27
ABSTRACTS
163
JunB and c-Jun display opposite effects on epidermal growth and neoplasia.
JY Jin, B Leshin, H Ke and JY Zhang Medicine, Duke University, Durham, NC
JunB and c-Jun are members of the Jun group of AP-1 family transcription factors which have been
recognized as important regulators in tissue homeostasis of various organs. In this study, we explored
the functional significance of JunB and c-Jun in epidermal homeostasis and neoplasia by using
human cell and tissue models. We found that JunB and c-Jun display functional diversity in human
epidermis. JunB increases epidermal cell senescence and inhibits cell growth, which occurs in a
dose-dependent and cell-autonomous manner. Consistent with the negative growth effect, JunB
inhibits epidermal neoplasia driven by Ras and decreases soft agar colony formation of A431, a
spontaneous SCC cell line. Conversely, a JunB mutant lacking the N-terminal transactivation domain
is able to team with oncogenenic Ras to induce malignant tumor growth. In contrast to JunB, c-Jun
is highly activated in human keratinocytes in response to EGF, and displays increased binding to
the gene promoters of positive cell growth regulators, including cdk4 and egfr. In addition, a con-
stitutively active mutant of c-Jun is sufficient to couple with Ras to transform normal epidermal cells
into malignancy, whereas a c-Jun mutant lacking the N-terminal transactivation domain inhibits
epidermal neoplasia driven by Ras or spontaneous SCC cell lines. These findings indicate that
JunB and c-Jun have opposite effects on epidermal growth and neoplasia. Regarding differentia-
tion, however, both JunB and c-Jun display increased binding to gene promoters of profilaggrin, a
differentiation marker, in response to Ca++-treatment; and consistently, simultaneous inhibition
JunB and c-Jun results in defects in epidermal stratification in 3-dimensional skin culture. These
findings underscore a functional importance for JunB and c-Jun in human epidermal homeostasis,
and suggest that they are functionally antagonistic in epidermal growth and neoplasia and redun-
dant in differentiation.
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Multiple dermatofibrosarcoma protuberans (DFSP) in patients with adenosine deaminase
deficiency associated severe combined immunodeficiency (ADA-SCID)
EW Cowen,1 C Kesserwan,2 R Sokolic,2 E Garabedian,2 K Baird,1 A Wayne,1 S Pittaluga,1
D Lopez-Terrada,3 J Bridge4 and F Candotti2 1 National Cancer Institute, Bethesda, MD, 2
National Human Genome Research Institute, Bethesda, MD, 3 Baylor College of Medicine,
Houston, TX and 4 University of Nebraska, Omaha, NE
DFSP has been associated with the immunodeficient state, including HIV-AIDS and immunosup-
pression following renal transplantation. In this study, 8 consecutive patients with ADA-SCID were
examined at the NIH Clinical Center. Skin biopsies of suspicious lesions were performed, followed
by H&E and staining for CD34 and Factor XIIIa. Molecular analyses (FISH and/or RT-PCR) and cyto-
genetics were performed in several cases. One or more DFSP were identified in 6/8 patients (age
2, 2, 5, 9, 12 and 22). Multiple lesions (range 4-12) were identified in 5/6 affected patients. Most
lesions were small (<1cm) tan/brown indurated oval plaques consistent with morphea-like non-
protuberant variant DFSP. Nodular lesions were present in 3 patients. All lesions showed a spin-
dle cell proliferation in the dermis, extending into the subcutaneous fat. A storiform histologic pat-
tern was detected only in the adult patient. In all cases, CD34 expression was diffusely positive
and FXIIIa was negative. Cytogenetics in the 2 patients in whom it was performed showed
t(17;22)(q22;q13). FISH was positive for COL1A1-PDGFB in 2/4 patients studied. RT-PCR showed
a COL1A1-PDGFB fusion transcript in one case in which FISH was inconclusive. DFSP is a rare
malignant skin tumor with characteristic cytogenetic findings (t(17;22)(q22;q13)) resulting in a
COL1A-PDGFB fusion gene. We describe a high prevalence of DFSP in the NIH ADA-SCID pop-
ulation. Two cases of ADA-SCID associated DFSP have previously been described, however this
is the first report of multicentric lesions, a rare finding in sporadic DFSP. The biologic behavior of
multiple DFSP lesions in the setting of ADA-SCID is unknown, but may provide insight into the
pathogenesis of DFSP.
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Stable overexpression of ΔNp63α blocks senescence and supports long-term proliferation
in keratinocytes
L Ha, R Ponnamperuma and W Weinberg DMA/OBP/CDER, FDA, Bethesda, MD
P63 plays a central role in squamous epithelial development. Although p63 is not commonly
mutated in cancer, the gene locus is amplified in squamous cell lung cancers, and elevated levels
of the p63 isoform ΔNp63 have been observed in squamous cell cancers of the head, neck, skin,
lung and cervix. Our lab has previously shown that transient overexpression of adenoviral ΔNp63α
in primary mouse epidermal keratinocytes is associated with enhanced cell proliferation and inhi-
bition of morphological and biochemical differentiation. However, the long-term biological effects
of ΔNp63α overexpression remain unknown. Lentiviruses were developed to drive long-term over-
expression of ΔNp63α. Under optimized conditions, the infection efficiency of lentivirus encod-
ing green fluorescent protein (lenti-GFP) was 92.05% in primary keratinocytes at day 5 post infec-
tion. Lenti-ΔNp63α expression was stable for at least 15 days and was distributed uniformly across
the cell population, as seen by western blotting and immunocytochemistry. Proliferation status
was assessed by BrdU uptake and analyzed by FACS. The S-phase population was consistently
higher in lenti-ΔNp63α cultures as compared to control cultures. S-phase populations of lenti-
ΔNp63α cells were 18.18%, 11.12% and 5.12% at days 5, 10, and 15, respectively, compared to
17.58%, 4.12% and1.59% in lenti-GFP control cultures. Cell senescence was identified using het-
erochromatin protein 1 (HP1) and SA-β-GAL as markers. Lenti-GFP keratinocytes undergo spon-
taneous senescence by day 15, as evidenced by the presence of nuclear foci of HP1γ; such foci
were absent in lenti-ΔNp63α cells at day 15. Lenti-ΔNp63α also blocked oncogene-induced senes-
cence typically seen within 15 days following introduction of v-ras-Ha. Our findings suggest that
long-term overexpression of ΔNp63α, as seen in human squamous cell cancers, promotes primary
keratinocyte proliferation and inhibits senescence, thereby facilitating keratinocyte transformation.
166
Repression of protein kinase C delta gene expression in human squamous cell carcinomas
by a novel RasÇNF-κB signaling pathway
V Yadav,1,2 NC Yanez2 and MF Denning1,2,3 1 Molecular Biology Program, Loyola University
Chicago, Maywood, IL, 2 Stritch School of Medicine, Loyola University Chicago, Maywood,
IL and 3 Department of Pathology, Loyola University Chicago, Maywood, IL
The delta isoform of PKC (PKC-δ) has a critical role in UV-induced apoptosis, and PKC-δ protein
levels are frequently low in chemically or UV-induced mouse skin tumors, as well as in human
cutaneous squamous cell carcinomas (SCC). Furthermore, re-expression of PKC-δ in human SCC
lines is sufficient to induce apoptosis and suppress tumorigenicity, making PKC-δ a potential tumor
suppressor gene for SCCs. To determine if PKC-δ loss in human SCCs is at the RNA level, we used
Laser Capture Microdissection to isolate cells from 3 normal epidermises and 14 human SCCs
with low PKC-δ protein. Analysis by quantitative RT-PCR revealed that PKC-δ RNA was reduced
an average of 90% in the SCCs tested, consistent with PKC-δ down-regulation at the level of gene
expression. To further explore the mechanism of PKC-δ down-regulation, we studied Ras-trans-
formed HaCaT cells (HaCaT-Ras), which have selective down-regulation of the PKC-δ isoform at
both protein and mRNA levels. Ras significantly repressed human PKC-δ promoter activity in HaCaT
cells (85% reduction, p<0.05). Mutagenesis and ChIP studies of the PKC-δ promoter revealed that
Ras activation represses PKC-δ promoter activity by activation of nuclear factor kappa B (NF-κB)
and recruitment of repressive NF-κB subunits (p50 and c-Rel). We also found that Fyn tyrosine
kinase activation was necessary and sufficient for NF-κB activation and PKC-δ repression. In addi-
tion, Fyn, but not Src, was over-expressed and had increased activity in HaCaT-Ras cells. Further-
more, activation of PI3K/AKT pathway was necessary and sufficient for Ras-induced up-regulation
of Fyn expression in HaCaT cells. Thus, a RasÇPI3KÇFynÇNF-κB pathway leads to PKC-δ repres-
sion in human keratinocytes. Our results have implications for the development of therapeutic
strategies abrogating this signaling pathway to trigger the re-expression of pro-apoptotic PKC-δ to
induce apoptosis in SCCs.
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Oral and topical small molecule hedgehog antagonists reduce BCCs in Ptch1+/- K14Cre-
ER2 p53 fl/fl mice
JY Tang,2,1 T Tang,3 TZ Xiao,1 A Wu,1 E Shpall,1 C Callahan,3 F de Sauvage3 and EH Epstein1 1
Children’s Hospital of Oakland Research Institute, Oakland, CA, 2 Stanford University
Medical Center, Stanford, CA and 3 Genentech Inc, South San Francisco, CA
Constitutive Hedgehog (Hh) signaling underlies basal cell carcinoma (BCC) carcinogenesis. The
Patched1 (Ptch1) gene encodes a transmembrane receptor for the Hh ligand and is the key inhibitor
of Hh signaling. Mutational inactivation of Ptch1 commonly drives the development of BCCs and
p53 gene mutations also are frequently found in human BCCs. We have used BCC-susceptible,
Ptch1+/- K14Cre-ER2 p53 fl/fl mice as a model for testing small molecule inhibitors of the Hh
pathway. We have found that two Smo inhibitors (Cur-61414 and Hh-Antag) reduce the expres-
sion of the Hh target gene Gli1 by at least 16-fold in murine cell lines. In vivo these mice develop
multiple, large BCC tumors at 5 months of age after treatment with ionizing radiation (IR) and tamox-
ifen. We conducted a placebo-controlled preclinical trial of topical Cur-61414 applied daily to the
dorsal skin of Ptch1+/- K14Cre-ER2 p53 fl/fl mice for 35 days and found significant reduction and/or
elimination of BCCs. Placebo treated BCCs increased by 40% in tumor area while BCCs treated
Cur-61414 decreased in size by 40% (p<0.001) and this correlated with a significant reduction of
Gli1 expression. Approximately 10% of BCCs did not decrease in size following topical Cur-
61414 treatment and did not show a reduction in Gli1 mRNA level. Upon histologic examination,
we found a subset of Cur-61414 treated tumors that appeared to differentiate into cyst-like struc-
tures that stained positive for CK 14 and were negative for CK 10. In a second preclinical trial we
tested an orally available Smo inhibitor (Hh-Antag). BCCs in Hh-Antag treated mice, as compared
to those in placebo-treated mice, had a dramatic reduction of tumor size after 8 days of treatment
(p<0.001). These results suggest that Smo inhibitors directly inhibit BCC proliferation and may alter
BCC differentiation. Thus, small molecule Hh antagonists may provide an effective targeted ther-
apy for the treatment of BCCs.
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Impaired lariat-loop formation causing abnormal XPC pre-mRNA splicing resulted in xero-
derma pigmentosum
SG Khan,1 K Oh,1 H Inui,1 S Emmert,1 D Tamura,1 JJ DiGiovanna,1,3 T Shahlavi,1 CC Baker,4
TD Schneider2 and KH Kraemer1 1 Basic Research Laboratory, NCI, Bethesda, MD, 2
Nanobiology Program, NCI, Frederick, MD, 3 Dermatology, Brown Med School, Providence,
RI and 4 Extramural Program, NIAMS, Bethesda, MD
The lariat-loop formation involving branch point sequence (BPS) near the 3’ end of introns is cru-
cial for precise processing of the pre-mRNA. We previously reported that mutations within -4 and
-24 branch point sequences (BPS) in intron3 of the XPC gene differentially affects the XPC pre-
mRNA splicing by disrupting lariat-loop formation in xeroderma pigmentosum (XP) patients (Hum.
Mol. Genetics, 13: 343 (2004)). Here we studied two related XP patients, XP14BE and XP377BE,
with multiple skin cancers and reduced DNA repair. Their cells had the same 9 base-pair deletion
(-13 to -21) that lies 3 bases downstream of the -25 ‘A’ of the mapped BPS in intron6 of the XPC
gene. This deletion mutation moved the BPS closer to intron6/exon7 junction and abolished lar-
iat-loop formation. This change reduced the information content of the intron6 splice acceptor from
12.3 to 6.2 bits. These cells exclusively expressed XPC mRNA with an in-frame exon7 deletion.
The cells had reduced amounts of mutant XPC protein. This mutation abolished DNA repair activ-
ity since an expression vector containing XPC cDNA devoid of exon7 failed to correct DNA repair
defect in other XP-C cells in a post-UV host cell reactivation assay. The mutant XPC protein did
not localize to UV-induced DNA-lesions in the patient’s cells. Thus, the 30 amino acid sequence
derived from exon7 of the XPC gene is an important motif for localization of XPC protein to the
site of damaged-DNA. Abolishing lariat-loop formation resulted in expression of mutant XPC pro-
tein with reduced nucleotide excision repair function that resulted in multiple sunlight-induced
skin cancers in these XP-C patients.
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High definition clonal analyses of human melanoma
A Sekulic,1 A Miller,2 A Mengos,1 M Barrett3 and M Pittelkow2 1 Dermatology, Mayo Clinic,
Scottsdale, AZ, 2 Dermatology, Mayo Clinic, Rochester, MN and 3 Pharmaceutical
Genomics, Tgen Institute, Scottsdale, AZ
This project focused on development of flow cytometry assays to identify and purify clonal cell
populations from melanoma tumors and provide samples suitable for high definition genomic stud-
ies. Genomic analyses of clinical tissues are highly dependent on the cellular composition of the
specimens. Clonal heterogeneity and admixtures of genomically normal cells within a single tumor
can obscure the detection of clinically significant molecular changes occurring in a functionally
important cellular subset within the tumor. Therefore, efficient and objective purification of the
cells of interest is essential. Our approach relied on isolation of cellular nuclei, followed by mul-
tiparameter flow cytometric purification of tumor nuclei from non-melanoma nuclei (e.g. fibrob-
lasts) using melanocyte-directed antibodies. Separation of individual melanoma subpopulations
was carried out based on the differences in the DNA content. DNA extracted from the sorted clonal
populations was subjected to high-resolution array-based comparative genomic hybridization
(aCGH). We initially tested several melanocyte-specific antibodies by multiparameter flow cytom-
etry and demonstrated distinct separation of cultured melanoma cells from primary fibroblasts
and successful aCGH analysis of the isolated DNA. This method was further optimized for analy-
sis of melanoma specimens from frozen clinical tissues. In this setting, genomic analysis of the
purified tumor subpopulations identified focal chromosomal aberrations often not detected in
unsorted, bulk tumors analyzed by the same high-resolution aCGH approach. Finally, we demon-
strated adaptation of this method for analysis of paraffin embedded clinical tissues. Our results out-
line a feasible approach for in-depth analysis of melanoma tumor tissues. The method has poten-
tial for use in analysis of both primary and metastatic melanoma tissues for molecular studies of
clonal populations arising during tumor progression as well as identification of potential prognostic
markers.
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Epigenetic effects of manufactured human extra cellular matrix (hECM) on tumor cell phe-
notype
E Pinney, A Schenone, M Montes-Camacho, F Zeigler, RS Kellar and G Naughton R&D,
Histogen Inc., San Diego, CA
Our purpose was to assess a tissue engineered human extracellular matrix for its ability to inhibit
tumor growth. Neonatal dermal fibroblasts were seeded on dextran spheres and cultivated in a
stirred bioreactor for eight weeks. The cells were water lysed and washed out then the dextran
was digested away with dextranase, the resulting hECM was lyophilized as a powder. This process
generates a material enriched in fetal ECM proteins and proteoglycans. Cancer cell lines were
placed on the chorioallantoic membrane (CAM) of the fertilized chicken egg. The cells prolifer-
ated to form a solid tumor. In this study hECM was co-introduced to the CAM with the cells. After
one week the tumors was excised and the weights compared with controls. Tumor inhibition was
reported as a function of reduced tumor weight. A sub-cutaneous nude mouse model was employed
to assess the hECM’s activity in a mammalian system. Cells and treatments were mixed and injected
sub-cutaneously. Tumor growth was assessed by width and length measurements of the mass over
the course of the study as well as excised tumor weights at the end of the studies. Standard his-
tology was also used as an endpoint. Our results showed that in the CAM model, significant tumor
inhibition was seen across a number of tumor lines: B16 melanoma was reduced 67%, C6 glioma
58% and MD435 breast cancer 78%. Histology indicates that where the cells are in contact with
hECM the cells appear apoptotic and condensed indicating programmed death. In the nude mouse
models similar inhibition was seen with: B16 melanoma reduced 61%, C6 glioma 60% and MD435
breast cancer reduced 58%. In conclusion, recent work on epigenetics and tumor biology has
demonstrated the role and effects of ECM molecules in tumor growth and cancer cell phenotype.
A number of these molecules have shown tumor inhibition activity through various pathways.
These data indicate that an ECM rich in fetal proteins is capable of retarding tumor growth and
may point to a therapeutic application.
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Novel approach to genomic profiling in Sezary Syndrome
RG Pomerantz,1 ED Mirvish,1 G Erdos,1 AD Donnenberg,2 LD Falo, Jr1 and LJ Geskin1 1
Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA and
2 University of Pittsburgh Cancer Institute, Pittsburgh, PA
The objective of this study was to identify specific genetic differences between malignant and
nonmalignant CD4+ T cells in a patient with Sezary Syndrome (SS). Previous microarray hybridiza-
tion studies have attempted comparisons of T lymphocytes from SS patients to those of normal con-
trols, yielding widely inconsistent results. Major limitations of this design are (1) significant inher-
ent genetic variability of lymphocyte populations between individuals, which could produce
differences in gene expression unrelated to disease state, and (2) heterogeneity of SS patients’ cir-
culating T lymphocytes, which do not consist exclusively of the malignant cell population. We
addressed these limitations through the use of a novel comparative schema, in which highly puri-
fied malignant cells were compared to control T cells from the same patient. Peripheral blood
mononuclear cells were obtained by Ficoll-Paque density centrifugation, stained with T cell mark-
ers (CD3, CD4, CD45RO) and anti-T cell receptor-Vβ (TCR-Vβ) antibodies, and sorted by multi-
parameter flow cytometry. Malignant cells expressed the dominant TCR-Vβ, as confirmed by PCR
and histopathologic evaluation; control T cells lacked the dominant TCR-Vβ but were otherwise
phenotypically identical (CD3+ CD4+ CD45RO+). These cell populations were compared using
the Illunina Inc. Sentrix Human-6 expression BeadChip system. Preliminary analysis of microar-
ray data showed changes in the expression of a number of genes known to be associated with car-
cinogenesis and immunologic dysfunction. The results of this study suggest the feasibility of this
novel approach to genomic profiling in SS, in which malignant T cells are compared to control T
cells from the same SS patient.
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Ras driven genetically defined invasive human carcinomas generated from primary human
epidermal, head and neck, cervical, esophageal, prostate, and breast epithelial cells estab-
lished within in a three-dimensional organotypic human tissue platform
TW Ridky, J Chow and PA Khavari Dermatology, Program in Epithelial Biology, Stanford
University, Stanford, CA
Despite accelerating growth in genome-scale data associating specific genetic changes with human
malignancies, progress toward assigning functional significance to these individual genetic alter-
ations has been relatively slow. This results from a relative lack of physiologically relevant three-
dimensional experimental human tissue models to recapitulate in vitro critical steps in tumor pro-
gression, such as local invasion across tissue boundaries including the epithelial basement membrane
(BM). To address this, we have developed a broadly applicable experimental platform for the study
of human epithelial neoplasms, the site of the vast majority of human malignancies. Primary human
epithelial cells isolated from normal epidermal, head and neck, cervical, esophageal, prostate and
breast tissues were transduced in one step with a single retroviral vector driving expression of onco-
genic Ras and an additional element to loosen G1 cell cycle restraints. This proved sufficient to
transform the primary cells in situ from all six different tissues into invasive carcinoma. Three-
dimensional organotypic human tissues were established in which epithelial cells were grown on
an intact fully formed BM in the presence of a living cell-populated stroma. While primary untrans-
duced cells differentiated normally and respected the normal epithelial-stromal tissue boundary,
Ras-expressing cells rapidly degraded BM proteins opening portals through which epithelial can-
cer cells invaded into supporting stroma. The presence of living stroma proved critical for poten-
tiating the invasive phenotype. This experimental platform provides the ability to quickly interro-
gate the functional significance of individual and combinatorial tumor-associated genetic alterations
in a large number of human epithelial cancers.
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Identification of the core gene expression signature and key cell-signaling pathways associ-
ated with Ras driven squamous cell carcinoma invasion
TW Ridky, D Wong and PA Khavari Dermatology, Program in Epithelial Biology, Stanford
University, Stanford, CA
Ras is one of the most commonly mutated genes in human cancers and its activity is upregulated
in epidermal squamous cell carcinoma (SCC). Expression of oncogenic Ras within the context of
loosened cell-cycle restraints transforms primary human keratinocytes into invasive SCC. Ras acti-
vates several broadly acting downstream cell-signaling pathways including Raf MAP kinase, PI3K,
and Ral GEF, and the elements and associated signaling networks most critical for mediating the
invasive phenotype were not clear. Using a three-dimensional human organotypic in vitro tissue
platform and specific pharmacologic inhibitors of downstream pathways, we have identified Raf
MAPK as the key downstream pathway mediating Ras effects and have defined an associated core
invasion gene set. This in vitro derived gene signature proved to be highly correlated with gene
expression changes seen in spontaneously occurring human head and neck carcinoma. Analysis
of the expression signature using comprehensive annotated pathway analysis tools identified cen-
tral cell-signaling, and protein interaction networks with specific individual protein hubs engaged
during carcinoma invasion. In addition to Ras itself, this analysis identified potentially key hubs in
cell cycle, metabolism, proteolytic, epidermal differentiation, interleukin, and integrin signaling
networks. Many of these include cell surface and secreted elements that may be potential targets
for cancer therapeutics.
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Increased tumor burden and tumor progression in mice lacking the PAF receptor
RL Konger,1,2 A Kozman,2 Y Yao,2 JB Travers2 and SJ Warren1,2 1 Pathology, Indiana University,
Indianapolis, IN and 2 Dermatology, Indiana University, Indianapolis, IN
Platelet activating factor (PAF) is a well-known mediator of platelet aggregation and acute inflam-
mation that acts by binding to a G-protein coupled receptor (PAF-R). Previous evidence also sug-
gests a potential role for PAF and the PAF-R in neoplasia, particularly in tumor angiogenesis, motil-
ity, and metastatic behavior. However, no definitive evidence exists that demonstrates that the PAF-R
is coupled to neoplastic development. Using C57Bl/6 mice with germ-line deletion of the PAF-R
(KO mice), we provide compelling evidence that the PAF-R plays a role in suppressing cutaneous
chemical carcinogenesis. Following a single application of 7,12-dimethylbenz(a)anthracene (DMBA),
mice were treated twice weekly with TPA (Phorbol-12-Myristate-13-Acetate). Tumor incidence (%
of mice with tumors) and multiplicity (Avg # tumors/mouse) were assessed at weekly intervals. After
25 weeks, KO mice exhibited a marked and significant (p<0.0001, ANOVA) increase in tumor mul-
tiplicity (88% increase) and a modest increase in tumor incidence relative to wildtype (WT) mice.
KO mice also exhibited a significant increase in tumor size measured at 25 weeks, with approxi-
mately 27% of the tumors on KO mice and 0% of the WT mouse tumors exhibiting a size ≥ 6 mm
in greatest dimension (p<0.05, Chi-Square Test). In addition, loss of the PAF-R resulted in a signif-
icant increase in tumor progression: 32% of KO tumors and 0.6% of WT tumors were classified as
squamous cell carcinomas (p<0.05, Chi-Square). In short-term studies, we next verified that a dou-
ble application of TPA induces a 7.6-fold increase in PAF-R agonist activity (observed 1 hr after the
2nd TPA dose). Surprisingly, KO mice also exhibited an augmented inflammatory response com-
pared with WT mice (as measured by a 64% increase in skin thickness) following twice weekly
applications of TPA over 3 weeks. In conclusion, our data indicates that the PAF-R plays an impor-
tant role in suppressing cutaneous tumor development and tumor progression during two-stage
chemical carcinogenesis.
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Beta human papillomvirus (beta-HPV) types are common in persistent warts in HAART treated
HIV positive individuals
R Meys,1 KJ Purdie,2 MN de Koning,3 QG Wim,3 C Alison,1 M Atkins,1 FM Gotch,1 CA Harwood2
and CB Bunker1 1 Departments of Dermatology, Virology, Genitourinary Medicine, and
Immunology, Imperial College School of Medicine, London, United Kingdom, 2 Centre for
Cutaneous Research, Barts and the London School of Medicine and Dentistry, Queen Mary
University of London, London, United Kingdom and 3 DDL Diagnostic Laboratory, Voorburg,
Netherlands
To date, the HPV types found in cutaneous warts of HIV positive individuals have not been well
characterised. Beta-HPV types have been implicated as cofactors in the pathogenesis of non-
melanoma skin cancer (NMSC) particularly in immunosuppressed organ transplant recipients, in
whom they are also over-represented in viral warts. Although the incidence of warts and NMSC
are increased in HIV, the contribution of beta-HPV types to either is not known. The purpose of
this study was to establish the prevalence and spectrum of beta-HPV in HIV positive HAART treated
patients with persistent warts. Cutaneous warts from HIV positive HAART treated patients persist-
ent for at least twelve months were excised (39 specimens from 26 patients). Persistent cutaneous
warts from HIV negative patients were also available (12 specimens from 7 patients). DNA from
these warts was analysed with a commercial beta-HPV reverse hybridisation line probe assay (Dias-
say). Beta-HPV types were commonly detected in HIV positive patients; 35/39 (90%) lesions were
beta-HPV positive compared with 8/12 (66%) lesions from HIV negative patients (p=0.08). Onco-
genic beta-HPV types 5 or 8 were detected in 18/35 (51%) of HIV positive individuals but only 2/8
(25%) of HIV negative. Multiple beta-HPV types were significantly more common in HIV positive
individuals (mean 6 types compared with mean of 2 types in HIV negative individuals, p=0.003).
The prevalence and spectrum of beta-HPV types detected in this study are comparable to previ-
ous studies examining NMSCs in which beta-HPV types are a risk factor for NMSC development.
Further work is now required to establish whether these beta-HPV types are involved in HIV-asso-
ciated NMSCs.
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Langerhans cells are necessary for chemical mutagenesis
J Neustadter,1 S Roberts,1 R Filler,1 B Kwong,1 J Lewis,1 A Galan,1 S Reddy,1 R Tigelaar,1 P Fu,2
D Kaplan,3 A Hayday4 and M Girardi1 1 Derm., Yale Univ., New Haven, CT, 2 Toxicol., FDA,
Jefferson, AR, 3 Derm., Univ. of Minn., Minneapolis, MN and 4 Immunobio., King’s Col.,
London, United Kingdom
Polyaromatic hydrocarbons (PAHs) are among the most potent carcinogens in industrial societies,
and DMBA is a model PAH used to study effects on epithelial tissues. We recently demonstrated
that mice genetically deficient in epidermal Langerhans cells (LC-def) are highly resistant to tumor
development invoked by two-stage carcinogenesis with DMBA and TPA. Thus, we sought to gain
insight into this phenomenon and the mechanisms by which LC might promote cancer. Having
previously shown that γδ+ T cells exert a major anti-tumor effect, we assessed whether they are
required for the tumor resistance observed in LC-def mice. While both TCRδ-/- (116.2±11.9 mm2)
and TCRβ-/-δ-/- mice (62.4±12.3 mm2) were highly susceptible to tumor development, corre-
sponding LC-def.TCRδ-/- (2.8±1.7 mm2) and LC-def.TCRβ-/-δ-/- (0.0±0.0 mm2) mice were almost
completely resistant (P<0.000001). To determine whether LC might influence the mutagenic capac-
ity of DMBA, we developed a novel genomic DNA methodology to quantify the H-ras codon 61
DMBA signature mutation with a sensitivity of 1 mutant/>106 normal alleles. Control mouse skin
showed markedly higher levels of H-ras mutations than LC-def mice (>150x; P<0.0001). We next
utilized an LC line to assess the metabolism of DMBA in vitro. HPLC analysis revealed the poten-
tial of LC to internalize and metabolize DMBA, and identified six known DMBA metabolites. DMBA-
containing media cultured overnight with the LC line, but neither DMBA-containing media alone
or cultured with keratinocytes, was capable of inducing H-ras mutations in primary keratinocyte
lines after 24 h (>16x; P<0.01). These data reveal that LC are essential for the emergence of cuta-
neous H-ras mutations induced by DMBA, and provide evidence that this effect occurs inde-
pendently of T lymphocytes and largely as a result of LC conversion of DMBA to more mutagenic
metabolites. Such findings may have implications for tumor development in epithelial tissues
more generally.
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Psph is a protein phosphatase that stimulates UVB-induced apoptosis and is dysregualted in
cutaneous squamous cell carcinoma
MA Bachelor,1 D Ratner,1 EB Desciak,1 YD Eliezri1 and DM Owens1,2 1 Dermatology, Columbia
University, New York, NY and 2 Pathology, Columbia University, New York, NY
L-3-phosphoserine phosphatase (Psph) is a widely expressed member of the haloacid dehaloage-
nase superfamily and primarily thought to function in L-serine biosynthesis. We previously found
Psph expression to be uniquely upregulated in transgenic mouse epidermis exhibiting aberrant inte-
grin expression and predisposed to hyperplasia and squamous cell carcinoma (SCC) formation
implicating a novel function for Psph in epidermal homeostasis. Since ultraviolet radiation (UV) is
a primary etiological agent for SCC development in humans, we evaluated the status and function
of Psph in normal and UV-irradiated keratinocytes. Psph is expressed throughout the proliferative
layer of the epidermis and hair follicles in normal cutaneous epithelium and is found primarily
localized to the endoplasmic reticulum at the subcellular level. Primary mouse keratinocytes sta-
bly expressing Psph exhibited substantially increased sensitivity to UV-induced apoptosis, as indi-
cated by increased PARP cleavage and Annexin V binding, and partial knockdown of Psph dra-
matically reduced the levels of UV-induced apoptosis. Importantly, we have identified a novel
role for Psph as a protein phosphatase and found that mutation of Asp20 to Asn20 in the catalytic
domain of Psph completely abrogated endogenous phosphatase activity and attenuated UV-induced
apoptosis in cells expressing the phosphorylation deficient Psph mutant collectively indicating
that Psph protein phosphatase activity may be an essential component of UV-induced apoptotic
pathway. Interestingly, reduced Psph expression was observed in 70% of human SCC analyzed and
correlated with poor differentiation status in those lesions. Overall, these data suggest that the func-
tion of Psph extends beyond serine metabolism, to regulate the ability of keratinocytes to respond
to apoptotic stimuli such as UV-irradiation, a function that may be critical for the prevention of UV-
induced skin cancer.
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Srcasm inhibits Fyn-induced skin carcinogenesis-a role for Notch 1
L Zhou,1 W Li,1 C Marshall,1 R Hick,1 T Dentchev,1 A Werth,1 E Williams,1 C Miller,1 W Pear2 and
J Seykora1,2 1 Dermatology, Univ. of Penn., Philadelphia, PA and 2 Pathology, Univ. of Penn.,
Philadelphia, PA
Src tyrosine kinases (SFKs) are key regulators of cell proliferation, and are activated in carcinomas.
The goal of this study was to model the elevated SFK activity in human skin squamous cell carci-
nomas (SCCs) using a keratin 14-Fyn Y528F transgenic model and to determine how Srcasm reg-
ulates carcinogenesis. Increased Fyn activity promotes the formation of scaly plaques and tumors
histologically consistent with carcinoma in situ and squamous cell carcinoma (SCCs_ (p < 3.7 x
10-18). This model mimics human cutaneous neoplasia as small precancerous lesions resembling
actinic keratoses were identified, and the SCCs exhibited no evidence of metastasis within 8 months.
Immunohistochemistry and western blotting demonstrated increased levels of activated SFKs, PDK-
1, STAT-3, and Erk1/2 in the murine lesions; similar findings were observed in human SCCs. Increased
Fyn activity decreased Notch 1 transcript and protein levels in precancerous lesions and carcino-
mas, demonstrating that Fyn negatively regulates Notch 1. Double transgenic mice harboring
K14-Fyn Y528F and K14-Srcasm transgenes demonstrated no squamous cell carcinomas (p < 4.9
x 10-5). Double transgenic lines expressing the K14-Fyn Y528F and a non-phosphorylatable Srcasm
mutant demonstrated a phenotype similar to the parental lines (p = 0.77). Molecular analysis demon-
strates that Srcasm normalizes levels of Fyn, activated SFKs, PDK-1, STAT-3, and Erk1/2, and it also
restores Notch 1/NICD levels. These data show that Srcasm is an anti-oncogene that downregu-
lates SFKs. Since Notch 1 and Srcasm are highly expressed in differentiating keratinocytes, a
potential regulatory relationship was evaluated. Human keratinocytes treated with gamma-secre-
tase inhibitors show a robust correlation between lower NICD and Srcasm levels that is dose-
dependent. K14-Fyn Y528F mice represent a skin carcinogenesis model with pre-cancerous and
cancerous lesions. These data reveal a novel regulatory relationship between Fyn, Srcasm, and
Notch 1, including that Srcasm may be a Notch target.
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Hairless Is repressed by tumor necrosis factor-alpha via activation of NFκB
H Kim,1 A Casta,1,3 MA Bachelor,1 A Englehard,1 DM Owens1 and AM Christiano1,2,3 1
Dermatology, Columbia University, New York, NY, 2 Genetics and Development, Columbia
University, New York, NY and 3 Institute of Human Nutrition, Columbia University, New York,
NY
Hairless (HR) is a key factor in the regulation of the hair cycle of mammals. The phenotype result-
ing from Hr mutations in human and mouse skin manifests at catagen, indicating that HR is criti-
cal for epidermal proliferation and differentiation. However, a specific role for HR and the nature
of HR regulation in epidermal homeostasis are largely unknown. TNFα is an essential regulator of
hair follicle development and cycling, particularly at catagen, the hair follicle cycle phase with pre-
dominant HR expression. TNFα has recently been shown to be required for the transition of ana-
gen to catagen, and TNFα-/- mice show a delayed entry into catagen. Furthermore, exogenously
supplied TNFα can trigger entry into catagen. Here, we asked whether there is a mechanistic link
between the TNFα/NFκB signaling pathway and transcriptional regulation of the HR promoter in
the interfollicullar epidermis. We recently investigated the relationship between HR and TNFα
and found TNFα signaling transcriptionally represses HR gene expression in human keratinocytes.
Furthermore, we determined the TNFα-dependent repression of HR to be mediated through spe-
cific activation of NFκB, which is known to induce tumor progression in initiated or immortalized
keratinocytes. NFκB is recruited to the HR promoter region at a specific NFkB response element,
which mediates the TNFα effect. In addition, TNFα-dependent repression of HR transcription is
enhanced when cells are pre-treated with Trichostatin A, a potent HDAC inhibitor and activator of
NFκB. Finally, HR overexpression blocks the TNFα-induced survival of HaCaT cells in suspension
culture, a hallmark of malignant transformation. Collectively, our data suggests HR repression by
TNFα is required for tumor progression in immortalized human keratinocytes, and that constitu-
tive HR expression is sufficient to attenuate pro-survival signaling via TNFα.
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Increased expression and ectodomain shedding of Dsg2 in skin carcinomas
D Brennan and MG Mahoney Dermatology and Cutaneous Biology, Thomas Jefferson
University, Philadelphia, PA
Invasion and metastasis of malignancies is partially facilitated through the disruption or loss of cel-
lular adhesion as illustrated by the E- to P/N- cadherin switch. Although desmosomal adhesion has
been considered in a similar context, the nature of this deregulation is less defined. Desmoglein 2
(Dsg2) is normally expressed at low levels in the proliferative basal layer of the epidermis and hair
follicles. Here we show a dramatic up-regulation of Dsg2 in human epithelial malignancies, includ-
ing basal cell carcinomas, squamous cell carcinomas, carcinomas of sebaceous and sweat glands,
and adenocarcinomas. Dsg2 expression was absent in malignant fibrosarcomas and melanomas.
We recently demonstrated that Dsg2 overexpression in keratinocytes deregulates multiple signal-
ing pathways associated with increased growth rate, anchorage-independent cell survival, and
tumor development. Here we show that transgenic mice overexpressing Dsg2 developed sponta-
neous skin tumors. Within the tumor mass Dsg2 was expressed in ectopic locations and under-
went extensive proteolytic processing, similar to the processing observed in several metastatic car-
cinoma cell lines. Some of these fragments correspond with expected products of ADAM17 (TACE)
mediated ectodomain shedding. This shedding is enhanced with chemically induced apoptosis
and abrogated with TAPI-2 and GM6001, suggesting that shedding may be the result of metallo-
proteinases, such as ADAM17. We further demonstrate a correlation between Dsg2 shedding,
ADAM17 activation, and EGF receptor phosphorylation. Taken together these results give insights
into the potential mechanisms by which Dsg2 activates cell-signaling pathways and provide evi-
dence that Dsg2 is a multi-functional protein that plays complex roles in cell adhesion, growth
and survival.
S30 Journal of Investigative Dermatology (2009), Volume 129
ABSTRACTS
181
In vivo cell origin of basal cell carcinomas (BCCs) in Ptch1+/- p53fl/fl mice
GY Wang and EH Epstein Research, Children’s Hospital & Research Center, Oakland, CA
BCCs are keratinocyte tumors with histologic resemblance to the basal layer of the interfollicular
epidermis (IFE) and hair follicles. Therefore, it has long been believed that normal basal cells give
rise to BCCs. Indeed, our lab has found that conditional deletion of p53, which is believed to act
cell autonomously, in basal K14-expressing cells of Ptch1+/- mice dramatically enhances ioniz-
ing radiation (IR)-induced murine BCC tumorigenesis. To localize the basal keratinocyte popula-
tion from which BCCs arise, we compared the acceleration of BCC carcinogenesis in mice in which
p53 was deleted in K14-expressing basal keratinocytes vs. that in mice in which p53 was deleted
specifically from the keratin 15-expressing hair follicle bulge region in which stem cells reside.
Our hypothesis is that if BCCs originate from K15-expressing cells, the acceleration of BCC car-
cinogenesis will be similar irrespective of whether p53 is deleted in all basal keratinocytes or only
in K15-expressing basal keratinocytes. Specifically, Cre-mediated deletion of p53 was induced at
age 7.5 weeks by intra-peritoneal injection of Tamoxifen or RU486 in Ptch1+/- K14-CreER2 or
Ptch1+/- K15-CrePR1 mice, immediately followed by ionizing irradiation at age 8 weeks. Our
results indicated that both mice formed visible BCCs from age 5 to 8 months, which is markedly
earlier than the 12 months and later age of onset of visible BCCs in p53 wild type Ptch1+/- mice.
These results strongly suggest that K15- expressing hair follicle bulge stem cells can give rise to
murine BCC upon environmental mutagenesis.
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Reduced skin tumor formation in CHOP/GADD153 deficient mice exposed to chemical car-
cinogens
S Anand,1 A Paliwal1 and E Maytin2,1 1 Biomedical Engineering, Cleveland Clinic, Cleveland,
OH and 2 Dermatology, Cleveland Clinic, Cleveland, OH
The CCAAT/Enhancer Binding Proteins (C/EBPs) are leucine zipper transcription factors that con-
trol growth and differentiation. Involvement of C/EBPalpha and C/EBPbeta in cancer has been
described, with a loss of C/EBPalpha commonly reported in neoplasia. Our current interest was to
investigate the role of another C/EBP family member, C/EBP Homologous Protein (CHOP)/gadd153,
in carcinogenesis. Although roles for CHOP in regulation of apoptosis and in endoplasmic retic-
ulum (ER) stress have been previously reported, involvement in the development of tumors has
not been widely explored. To investigate the role of CHOP in skin tumor formation, CHOP null
and CHOP heterozygous mice, along with wild type controls, were subjected to a chemical car-
cinogenesis regimen (initiation by DMBA and promotion by TPA for 20 weeks, followed by 5 weeks
of observation prior to final tumor counts). At 25 weeks, CHOP mice showed an attenuated response
to the carcinogen. Only 0.66 vs. 9.25 tumors/mouse developed in CHOP null versus wildtype
mice, respectively. Mice heterozygous for CHOP deletion exhibited an intermediate response (4.0
tumors/mouse). The average size of skin tumors in CHOP knockout mice was significantly smaller
than the wild type controls, as well. These results indicate that CHOP functionally participates in
tumor initiation, tumor progression, or both. Different C/EBP isoforms exert cross-regulatory effects
upon each other, either through regulation at the gene promoter level or through protein het-
erodimerization. To explore whether CHOP might be acting directly or via interaction with other
C/EBPs, mice received a single exposure to DMBA, followed by histological analysis at 24 and 48
hr post-application. In CHOP knockout mice, a progressive increase in expression of C/EBPalpha
was observed relative to wild type controls. In conclusion, CHOP-deficient mice develop fewer
and smaller skin tumors than do normal mice in response to chemical carcinogens. Counterregu-
lation by C/EBPalpha may be part of the mechanism behind this observed phenotype.
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Transcriptional repression of ODC by Hairless
C Luke,1 A Casta,2 H Kim,1 S Gilmour3 and A Christiano1,2,4 1 Dermatology, Columbia
University, New York, NY, 2 Human Nutrition, Columbia University, New York, NY, 3
Genetics & Development, Columbia University, New York, NY and 4 Lankenau Institute for
Medical Research, Wynnewood, PA
Hairless (Hr) is a transcriptional corepressor critical for hair cycling which has been implicated in
several different pathways, including NFkB. Hr mutant mice are hairless with large dermal cysts
and dramatic skin mass enlargement accompanied by wrinkling and folding. Hr mutant mice are
also highly susceptible to both chemical and UVB induced tumorigenesis. Previous work in our
lab has shown that this phenotype is strikingly similar to that of K6-ODC transgenic mice. Addi-
tionally, tumorigenesis in Hr mutant mice can be blocked by the ODC inhibitor DFMO. When
taken together, this data points to a possible mechanistic relationship between ODC and Hr. ODC
is responsible for the biosynthesis of the polyamine putrescine, which is a rate-limiting step in the
creation of other polyamines that regulate cellular proliferation and differentiation. The reverse
reaction to create putrescine from higher polyamines is mediated by the enzyme SSAT. The SSAT
overexpressing transgenic mouse also shares phenotypic similarities with Hr mutant and K6-ODC
mice, thus indicating that the common mechanism leading to these phenotypes is increased
putrescine levels. Here we show that that human hr -/- keratinocytes also have an increased basal
level of ODC transcription when compared to normal human keratinocytes. The increased ODC
promoter activity seen in hr-/- keratinocytes was abolished by the reintroduction of Hr and the
promoter region necessary for this regulation was defined using luciferase assays. Hr is known to
regulate the NFkB pathway and here we show through inhibitors studies that Hr also regulates the
ODC pathway via NFkB and c-myc. These data indicate that Hr acts as a transcriptional co-
repressor of ODC, thereby indirectly regulating putrescine and higher polyamine levels. We sug-
gest that Hr mutations result in the deregulation of ODC, and subsequent increases in polyamine
levels which alter cellular proliferation and contribute to susceptibility to tumorigenesis.
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Multiple signaling pathways contribute to apoptosis induced by ABT-737 and Mcl-1 siRNA
in melanoma cell lines
AM Keuling,1 VA Tron2 and SE Andrew1 1 Medical Genetics, University of Alberta, Edmonton,
AB, Canada and 2 Pathology and Molecular Medicine, Queen’s University, Kingston, ON,
Canada
Malignant melanoma responds poorly to chemotherapy, which may relate to the overexpression
of proteins that promote cell survival and prevent apoptosis. Overexpression of anti-apoptotic Bcl-
2 family proteins Bcl-2, Bcl-xl and Mcl-1 is well-documented in melanoma. Previous work in our
laboratory has demonstrated that ABT-737, a small-molecule inhibitor of Bcl-2, Bcl-xL and Bcl-w,
induces apoptosis in melanoma cells when Mcl-1 levels are reduced by RNA interference. The
objective of the present study was to identify apoptotic mechanisms involved in the induction of
cell death by the combination treatment of ABT-737 and Mcl-1 siRNA. We used two approaches
to address this question. First, we used western immunoblotting to examine levels of Bcl-2 family
proteins before and after treatment. Second, as a more general screen, we used a custom cDNA
microarray to identify genes that are significantly up- or down-regulated with treatment. Both exper-
iments were performed in six different melanoma cell lines. Based on the western blot analysis,
we demonstrated dramatically altered processing of pro-apoptotic proteins Bid and PUMA fol-
lowing treatment. From the array data, we identified 23 genes significantly up-regulated in at least
three of the six cell lines, including not only Bcl-2 family genes but also genes involved in the imme-
diate-early response, the death receptor apoptotic pathway and the endoplasmic reticulum stress
response. Our results suggest that multiple signaling pathways may contribute to the induction of
apoptosis following treatment with ABT-737 and Mcl-1 siRNA. By elucidating the pathways involved
in treatment response, we aim to identify additional genetic targets that could increase treatment
efficacy.
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Retinoid inhibition of IGF/PI3K/Akt signaling is a likely mechanism of its anti-Basal cell car-
cinoma effects
P So and EH Epstein Children’s Hospital Oakland Research Institute, Oakland, CA
Basal cell carcinoma (BCC), the most common cancer, is caused by hyperactive Hedgehog (HH)
pathway signaling, most frequently due to loss of Patched1 (Ptch1), a major suppressor of HH sig-
naling. We have previously shown in irradiated Ptch1 heterozygous mice that the retinoid tazarotene
can prevent BCC carcinogenesis in vivo by approximately 85% and that its tumor suppressive effects
are likely mediated by specific activation of retinoic acid receptor (RAR)γ signaling in BCC tumor
cells. To identify downstream target pathways of tazarotene’s action, we treated the murine BCC
cell line ASZ001 with 10 μM tazarotene, a concentration that inhibits ASZ001 cell proliferation,
or DMSO vehicle and carried out Affymetrix gene expression analysis on cells treated for 10 h or
24 h. Analysis of the global gene expression changes indicated that over 200 genes were differ-
entially-expressed at 10 h and 24 h: functional cluster and connectivity analyses of differentially
expressed genes at 10 h suggest that the IGF/PI3K/Akt pathway may be a key downstream target
pathway of tazarotene’s action. Therefore, we first confirmed the presence of activated (phospho-
rylated) Akt in ASZ001 cells by western blotting and then confirmed that small molecule inhibitors
of IGF and PI3K, AG1024 and LY294002 respectively, could similarly inhibit ASZ001 cell prolif-
eration. Since we find that small molecule inhibitors of IGF/PI3K signaling inhibit growth of our
murine BCC cell line, we suggest that inhibition of this pathway may well be one mechanism for
tazarotene’s anti-BCC effect and that this pathway may be a previously unrecognized target for pre-
vention and treatment of this cancer.
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Silencing of FAK and Src kinases normalizes human, 3D tissue models of squamous cell car-
cinoma harboring E-cadherin-deficient tumor cells
A Alt-Holland,1,2 A Sowalsky,3 Y Szwec-Levin,2 Y Shamis,1 L Feig3 and JA Garlick1 1 Division of
Cancer Biology & Tissue Engineering, Oral Pathology, School of Dental Medicine Tufts Univ.,
Boston, MA, 2 Endodontics, School of Dental Medicine Tufts Univ., Boston, MA and 3
Biochemistry, School of Medicine Tufts Univ., Boston, MA
Advanced stages of epithelial carcinogenesis are linked to loss of E-cadherin function, yet the link
between abrogation of cell-cell adhesion and acquisition of enhanced cell motility during prema-
lignant stages of squamous cell carcinoma (SCC) progression remain unclear. We have shown that
3D, human skin equivalents that mimic SCC and harbor E-cadherin-deficient tumor cells (H-2Kd-
E-Cad-II-4), undergo transition from precancer to cancer in vitro and develop highly aggressive SCC
in vivo. As FAK and Src kinases play key roles in cell adhesion, migration and invasion, we ana-
lyzed their expression and activation in E-cadherin-deficient-II-4 cells. These cells showed single
cell scattering and enhanced migration that were associated with increased FAK expression and
elevated tyrosine phosphorylation of FAK and Src. Pharmacological inhibition of these kinases
resulted in a reversible inhibition of cell migration. To study the contribution of FAK and Src to the
migratory and invasive behavior of E-cadherin-deficient cells in 3D tissues, we targeted these kinases
with lentivirus-mediated gene silencing. Downregulation of FAK and Src in 2D cultures was asso-
ciated with increased E-cadherin expression, formation of adhesive colonies and inhibition of cell
migration. 3D tissues comprised of these cells showed increased localization of E-cadherin at cell-
cell borders, suppression of tumor cell invasion and tissue normalization. Furthermore, surface
transplantation of these tissues to nude mice resulted in a switch from high-grade, highly invasive
tumors to low-grade, well-differentiated SCCs. Thus, E-cadherin suppression is linked to upregu-
lation and activation of FAK and Src, which in turn, directs a highly motile tumor cell phenotype
that contributes to the transition from precancer to malignancy during incipient SCC develop-
ment.
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Aquaporin-3 and phospholipase D2 protein expression in basal and squamous cell carcinoma
K Voss,1 N Fussell,1 C By,1 RJ Bollag,2 DJ Sheehan1,2 and WB Bollag1 1 Department of Medicine,
Medical College of Georgia, Augusta, GA and 2 Department of Pathology, Medical College
of Georgia, Augusta, GA
Skin cancer, including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), is the
most common cancer in humans. SCC and BCC result from abnormal differentiation of keratinocytes,
the major cells in the epidermis. We have previously shown that aquaporin-3 (AQP3) and phos-
pholipase D2 (PLD2) work together to generate phosphatidylglycerol, a prodifferentiative signal-
ing lipid, suggesting that AQP3 should be down-regulated in these cancers. However, Verkman
and colleagues have reported that AQP3 is increased in SCC. The goal of this study was to deter-
mine whether AQP3 (and PLD2) levels are altered in SCC and BCC. Paraffin-embedded skin blocks
from patients diagnosed with SCC or BCC were obtained from the Pathology archives. Sections
(10 μm) were cut, and immunohistochemistry was performed using antibodies recognizing AQP3,
PLD2 or Ki67 (a marker of proliferating cells). AQP3 was predominantly localized in the plasma
membrane of basal keratinocytes in the overlying normal-appearing epidermis observed in many
BCC sections. In the BCC itself, AQP3 was down-regulated and often completely absent. AQP3
immunoreactivity was “patchy” in SCC, with some areas staining well and others with almost no
staining, particularly at the SCC borders. In serial SCC sections Ki67 expression was increased in
these border areas, suggesting that proliferation correlated with down-regulation of AQP3. PLD2
expression was predominantly perinuclear and diffusely distributed throughout the epidermis. PLD2
was also decreased in BCC, and unchanged in SCC, as compared to normal epidermis. Our results
suggest that the AQP3/PLD2 signaling module may be anti-proliferative, since both are down-reg-
ulated in BCC, and AQP3 is reduced in areas of SCC that are proliferating, as marked by Ki67. The
potential for these two proteins to act to inhibit growth suggests that further studies should be con-
ducted in other hyperproliferative skin disorders, such as psoriasis, to investigate possible changes
in AQP3 and PLD2 levels.
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Hedgehog signaling of BCC is inhibited by Vitamin D: Implication for a chemopreventive
agent against BCC carcinogenesis
TZ Xiao, JY Tang, A Wu, E Shpall, I Khaimsky, P So and EH Epstein Children’s Hospital of
Oakland Research Institute, Oakland, CA
Constitutive Hedgehog (Hh) signaling underlies several human tumors, including basal cell carci-
noma (BCC). Patched1 (Ptch1) gene encodes a transmembrane receptor for the hedgehog ligand
and is the key inhibitor of Hh signaling. Mutational inactivation of Ptch1 commonly drives the
development of BCCs. In addition, p53 gene mutations are frequently found in human BCCs. We
are using BCC-susceptible, Ptch1+/- mice with conditional deletion of keratinocyte p53 as a
model for testing potential chemopreventive agents. We have found that vitamin D decreases the
expression of the Hh target gene, Gli1 by 4-fold and that 5-10μM vitamin D specifically inhibits
the proliferation of our two murine BCC cell lines. These effects of vitamin D on Gli1 expression
and on BCC proliferation are comparable to the effects of 10μM of cyclopamine, a known inhibitor
of the Hh pathway. These results appear to be specific for vitamin D, since the precursor 7-dehy-
drocholesterol and the downstream products 25-hydroxy and 1,25-dihydroxy vitamin D are con-
siderably less effective in reducing both Gli1 mRNA and cellular proliferation. Moreover, these
effects seem to be independent of the vitamin D receptor (VDR) since shRNA for VDR does not
abrogate the effects despite reducing expression of the VDR target gene 24-hydroxylase. Our data
support the working model in which vitamin D3 directly inhibits the Hh pathway by binding to
Smoothened (Smo). Finally, topical vitamin D treatment of existing murine BCC tumors significantly
decreases Ki67 expression without activating apoptosis. For a chemoprevention study, we applied
topical vitamin D3 daily to the dorsal skin of Ptch1+/-K14-Cre-ER2 p53fl/fl mice treated with ion-
izing radiation (IR) and tamoxifen. We found that topical vitamin D3 reduces visible BCC tumor
number and size by 50% (p<0.05) in mice monitored until age 8 months. Thus, vitamin D may
hold promise as an effective chemopreventive agent against BCC.
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The reciprocal roles of cellular senescence on the UVB response of the skin
D Spandau, Q Yi and D Lewis Indiana University School of Medicine, Indianapolis, IN
Cellular senescence is defined as an irreversible arrest in cellular replication in otherwise meta-
bolically active cells. In the skin, the number of senescent fibroblasts in the dermis of primate skin
increases with advancing age, reaching up to 80% of the total number of fibroblasts found in the
skin. A similar phenotype of senescence, called stress-induced senescence, can be observed in
cells following exposure to many types of noxious agents including ultraviolet light, gamma-irra-
diation, and inducers of oxidative stress. Tissues use stress-induced senescence as a tumor evasion
mechanism as the proliferative potential of cells that have been damaged and are at risk of malig-
nant transformation is permanently arrested. By extrapolating data derived from experiments using
cells grown tissue culture, we hypothesize that cellular senescence affects the UVB response of
keratinocytes in the epidermis through two distinct and reciprocal mechanisms that are depend-
ent on the IGF-1/IGF-1R signaling pathway; one mechanism suppresses UVB-induced transfor-
mation of keratinocytes and the second mechanism promotes keratinocyte carcinogenesis. Using
normal human keratinocytes grown in vitro, we demonstrate that activation of the IGF-1R promotes
stress-induced senescence in UVB-irradiated keratinocytes through increased generation of reac-
tive oxygen species and by maintaining the expression of the cyclin-dependent kinase inhibitor
p21. If this mechanism occurs in vivo, the induction of senescence in UVB-irradiated keratinocytes
could repress carcinogenesis. In contrast, the induction of cellular senescence in cultured human
dermal fibroblasts suppresses the expression of IGF-1. In the epidermis, the IGF-1R on keratinocytes
is activated by IGF-1 produced by dermal fibroblasts; therefore, the silencing of IGF-1 expression
by senescent fibroblasts could suppress IGF-1R activation on epidermal keratinocytes resulting in
an aberrant UVB response and may contribute to an increased initiation of transformed keratinocytes.
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Decreased T cell expression of the anti-apoptotic protein Ku70 in CTCL skin lesions
K Ferenczi,1 J Ohtola,1 P Aubert,1 M Kessler,1 H Sugiyama,1 S Matsuyama,2 T McCormick1 and
KD Cooper1 1 Dermatology, University Hospitals Case Medical Center, Cleveland, OH and 2
Division of Hematology and Oncology, Case Medical Center, Cleveland, OH
Primary cutaneous T cell lymphomas (CTCL) are malignancies of the skin homing T cells. While
clonal lymphocytes in CTCL have prolonged lifespan -in part- due to lack of/or dysregulation of
apoptosis, they are highly responsive to apoptosis inducing therapies, such as ultraviolet treatment.
In this study we analyzed the expression of Ku70/80 heterodimeric protein with cytoprotective
functions, known to play a role in DNA repair (Ku70 and Ku80) and inhibition of apoptosis (Ku70)
in CTCL lesions (n=6) and normal skin (n=6) using three color laser confocal microscopy. Quan-
titative assessment of Ku expression in CD3+ T cells in CTCL and normal skin was performed
using Metamorph software. Confocal analysis of staining with CD3, Ku and Hoechst in normal skin
revealed co-localization of Ku and CD3+ T cells and constitutive nuclear Ku70/80. We also demon-
strate in this study that Ku70 expression was significantly down-regulated in lesional T cells in CTCL
patients relative to control skin (average fluorescence intensity of 602.9 versus 1243. 26, respec-
tively; P=0.03). Five out of the six patients tested had reduced levels of Ku70, with a reduction of
78% in Ku70 expression. Interstingly, within CTCL skin lesions, decreased Ku70 staining was most
dramatically noted in association with epidermal T cells compared with dermal lymphocytes,
consistent with the presence of a higher proportion of reactive T cells in the dermis as in the epi-
dermis. Diminished expression of the cyto-protective and anti-apoptotic Ku70 in CTCL lesional T
cells may account for increased susceptibility of the malignant T cells to apoptosis-inducing treat-
ment modalities, and response to ultraviolet light treatment. Indeed, UV treatment of CTCL T cells
treated with histone deacetylase inhibitor, which acetylates intracellular Ku70, resulted in enhanced
apoptosis. Deficient expression or lack of Ku70 may also result in genomic instability and play a
role in tumorigenesis.
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The immunosuppressive surface ligand CD200 regulates immune privilege in metastatic squa-
mous cell carcinoma
M Stumpfova,1 D Ratner,2 EB Desciak,2 YD Eliezri2 and DM Owens1,2 1 Pathology, Columbia
University, New York, NY and 2 Dermatology, Columbia University, New York, NY
CD200 is a widely expressed cell-surface glycoprotein known to suppress immune cell function
through its receptor CD200R in order to maintain tissue homeostasis. CD200 is a prognostic fac-
tor in a number of malignant tumor types, whereby CD200 is thought to stimulate metastasis by
suppressing anti-tumor immune surveillance. In the skin, CD200 expression is confined to the hair
follicle, where CD200 provides immune privilege to epithelial keratinocytes. CD200 expression
has also been observed in chemically induced tumorigenic epidermal keratinocytes; however, any
potential role of CD200 in the formation and pathogenesis of epithelial neoplasms, including
cutaneous squamous cell carcinoma (SCC) remains elusive. Here we show that CD200 expression
was largely absent in chemically induced murine benign squamous papillomas and primary SCCs.
However, CD200 was induced in focal areas of invasive SCCs and was present in all SCC metas-
tases to the lymph node and lung. Similarly, CD200 expression was also absent in primary human
cutaneous SCCs but was present in all (6/6) of human lymph node metastases derived from cuta-
neous and head and neck SCCs. CD200+ SCC cells were closely associated with CD200R+ immune
cells in vivo that were primarily CD11b+Gr-1+, suggesting that CD200 expression in SCC cells may
suppress anti-tumor myeloid cell function. Importantly, ablation of CD200 expression in metasta-
tic SCC cells did not interfere with primary SCC formation but i) completely blocked the ability of
SCC cells to metastasize and seed secondary tumors and ii) dramatically altered the production of
GCSF and GM-CSF pro-inflammatory cytokines in the presence of CD200R+ immune cells. Col-
lectively, our findings implicate CD200 as an essential component of epithelial metastasis that
suppresses anti-tumor immune responses in neoplastic skin initiated by CD200R+ myeloid cells.
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Genomic instability and cMyc amplification are associated with the p53R172H gain of func-
tion mutation in mouse skin SCCs
EC Torchia,1 S Acin,2 C Caulin2 and DR Roop1 1 Dermatology and The Charles C. Gates
Regenerative Medicine and Stem Cell Biology Program, University of Colorado Denver at
Anschutz Medical Campus, Aurora, CO and 2 Head and Neck Surgery, University of Texas,
M.D. Anderson Cancer Center, Houston, TX
We previously reported that co-activation of a KrasG12D and a gain of function p53R172H mutant alle-
les in mouse skin resulted in highly malignant and metastatic Squamous Cell Carcinomas (SCC)
compared to SCCs with activation of the KrasG12D allele in the presence of wt (p53+/+ or p53+/-) or
homozygously deleted p53 (p53-/-) (Caulin et. al, JCI(2007)117:1893). We performed comparative
genomic hybridization (CGH) analysis using Agilent’s 244K murine array CGH platform on these
SCCs to assess global genomic changes associated with p53R172H expression. Amplification in regions
of Chr 6 was observed in SCCs regardless of p53 status, whereas gains in Chr 3 and 15 occurred
preferentially in p53R172H tumors. Additionally, p53R172H tumors showed gains in more probes com-
pared to wt, p53+/-, or p53-/- tumors, confirming that p53R172H SCCs have more unstable genomes.
Examination of altered loci on Chr 6 and 15 revealed Kras amplification in 40-55% of wt, p53R172H,
p53+/-, and p53-/- tumors. In contrast, cMyc amplification was observed in 40% of p53R172H tumors,
but not in wt, p53+/-, or p53-/- tumors. Validation by expression array analysis showed that SCCs
with Kras or cMyc amplification had elevated Kras or cMyc mRNA levels, respectively, compared
to tumors without Kras or cMyc alterations and to either newborn skin or benign papillomas. Our
CGH experiments clearly implicate cooperativity between mutant p53 and cMyc in the develop-
ment of highly malignant SCCs, and suggest that the Myc pathway is a target of elevated genomic
instability associated with the p53R172H gain of function mutation. These results are consistent with
the common amplification of the cMYC region of Chr8q in human SCCs, and demonstrate the rel-
evance of the p53R172H skin tumor model for the preclinical assessment of novel therapeutics for
human SCCs.
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Recruitment and redistribution of nucleotide excision repair factors in XP-E cells
K Oh,1 K Imoto,1 S Emmert,2 D Tamura,1 JJ DiGiovanna1,3 and KH Kraemer1 1 Basic Research
Laboratory, NCI, Bethesda, MD, 2 Dept of Derm, Goettingen Univ, Goettingen, Germany
and 3 Dept of Derm, Brown Med School, Providence, RI
Xeroderma pigmentosum (XP) is a rare autosomal recessive disease with increased susceptibility
to skin cancer in association with defective DNA repair. There are 7 complementation groups
(XPA–G) and a variant. The XPE DNA damage binding (DDB) protein complex (127 kDa (DDB1)
and 48 kDa (DDB2)) is involved in early recognition of DNA damage. Mutations in the DDB2 gene
have been reported in only 7 families. Here we report 4 new XP-E patients with multiple skin can-
cers in 3 different families: XP408BE and 2 affected siblings XP37BE and XP66BE from US and
XP1GO from Germany. We assigned these cells to XP-E by host cell reactivation. We found that
these cells have normal UV sensitivity but the repair of cyclobutane pyrimidine dimers (CPD) and
6-4 photoproducts (6-4PP) was delayed. We identified mutations in DDB2: homozygous p.R273H
mutation in XP37BE which was previously described in XP2RO from Europe and heterozygous
mutations (L350P and a 3 bp deletion p.N349del) in XP408BE previously reported in GM01389
from the US. We also found a new homozygous p.T305N mutation in XP1GO cells. The levels of
p53 and p21 were reduced in XP-E cells compared to normal cells suggesting that mutations in
DDB2 found in XP-E cells result in reduced level of p53 and its downstream-regulated proteins.
Using localized UV damage through 5 micron filters, the nucleotide excision repair proteins (NER),
XPC, XPB, XPG, XPA and XPF, co-localized to the CPD and 6-4PP positive regions immediately
after localized UV irradiation in cells from normal and XP-E patients. Interestingly, these NER pro-
teins rapidly redistributed in XP-E not in normal cells within 0.5h after local UV damage. Our
results suggest that UV-DDB2 is not required for the rapid recruitment of NER proteins but normal
persistence of these proteins depends on DDB2. XPE plays major role in prevention of skin can-
cer and recruitment of NER proteins to sites of UV damage.
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Human papilloma virus increases skin cancer risk in organ transplant recipients by substi-
tuting for somatic alterations of the CDKN2A locus
K Ridd,1 S Vemula,1 G Palmedo,2 H Kutzner,2 R Roy,1 RJ Akhurst,1 A Balmain,1 E Epstein1 and
BC Bastian1 1 Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA
and 2 Dermatopathologische Gemeinschaftspraxis, Friedrichshafen, Germany
Organ transplant recipients (OTRs) have an increased risk of developing cutaneous squamous cell
carcinoma (SCC). UV exposure is a risk factor for SCC in OTRs and non-OTRs but does not explain
the increased risk in OTRs. The incidence of human papillomavirus (HPV) is increased in SCCs of
OTRs, but its role is unclear, as it is also found in non-lesional skin. In non-melanoma skin can-
cer (NMSC)the RB and p53 pathways are often mutated. These pathways are also inhibited by the
oncogenes of HPV-types associated with cervical cancer (high-risk types) and possibly partially by
low-risk types. If HPV plays a causal role in tumors, its oncogenes should obviate the need for fur-
ther somatic mutations in these pathways. To test this, we determined the presence of HPV and
the mutation status of targets in the RB and p53 pathways in 205 NMSCs from OTRs (n=117) and
non-OTRs (n=98). HPV was found more frequently in tumors from OTRs (30.8% (36/117)) than
non-OTRs (18.3% (18/98; p<0.035) and was due to an increase in low-risk HPV types, which were
found in 25.5% of OTRs compared to 12.2% of non-OTRs (p<0.013), while the proportion of
tumors positive for high-risk types was similar (8.5% v 6.1%,p<0.49). The frequency of p53 muta-
tions between HPV-positive (52%) and negative tumors (42%, p<0.31) was similar, however array
CGH detected more frequent losses at the CDKN2A locus in HPV negative tumors (45.7%) com-
pared to HPV positive tumors (24%, p<0.045). Furthermore, mutations in CDKN2A were more fre-
quent in HPV-negative tumors (27% vs 10.4%, p<0.04). These findings suggest that low risk HPV
contributes to the increased cancer incidence in OTRs by substituting for somatic alterations in
the RB-pathway but not the p53-pathway. We propose that immunosuppression increases infec-
tion of the skin with low-risk HPV types, which can cooperate with UV-induced p53 mutations,
partly explaining the increased rate of SCC in OTRs.
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Loss of immune function genes and gain of non-lymphoid genes in Sezary Syndrome
TM Germeroth, HM Gibson, AJ Wilson, BF Chong and HK Wong Dermatology, Henry Ford
Hospital, Detroit, MI
Mycosis fungoides(MF)/Sezary Syndrome(SS) are the most common forms of cutaneous T cell
lymphoma (CTCL), characterized by a proliferation of memory CD4+, CD45RO+, CLA+ T cells
that traffic to the skin. We previously described increased CTLA-4 expression and a loss of acti-
vating cytokine genes in advanced MF/SS. To comprehensively study gene expression abnormal-
ities in MF/SS, we analyzed the transcriptome of resting and stimulated purified CD4+, CD45RO+
T cells from normal and SS patients. Combined supervised and unsupervised analysis were per-
formed to identify genes expressed at least 10-fold higher in normal T cells (183) and genes at
least 10-fold higher in SS (88) T cells. Gene ontogeny analysis of genes from each list revealed a
significant loss of genes associated with inflammatory response and immune function, and an
increase in genes associated with muscle development and structural function in SS T cells. When
genes higher in SS were analyzed by qRT-PCR in PBMCs from SS(n=8), normal (n>7), and psoria-
sis patients (n=5), 13 genes showed a significant difference (p<0.05). A subset of these genes was
abnormally expressed in all SS patients, suggesting an important signature for SS. We also found
a profound defect in the expression of additional chemokine genes highly expressed in normal
PBMCs that are markedly reduced in SS PBMCs. The findings support that SS T cells have a gene
expression profile different from normal memory T cells, and have functional differences upon
stimulation. These findings indicate that SS T cells are not typical activating T cells. Furthermore,
these genes can serve as biomarkers in PBMCs for the diagnosis and treatment of MF/SS. Future
studies into the mechanism for altered regulation of these genes may provide insight into the patho-
genesis of MF/SS.
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Genetic abnormalities associated with FAS-low CTCL
J Wu and GS Wood University of Wisconsin Madison, Madison, WI
We determined previously that CTCL cells often express low levels of FAS (CD95) and, like nor-
mal T cells, exhibit a direct relationship among FAS transcript levels, cell surface FAS protein expres-
sion and sensitivity to FAS-mediated apoptosis. In the current study, karyotypic and FISH analysis
of CTCL lines indicated the presence of the chromosome 10 pair and FAS gene (10q24.1) in FAS-
hi MyLa, absence of one 10q region in FAS-lo HH, and complete absence of FAS gene in FAS-neg
SeAx. To explore the possibility of abnormal protein structure, we sequenced the coding regions
of the FAS gene in 20 cases of CTCL and found structurally significant mutations in 3 (15%). To
determine if regulatory defects in the FAS gene could reduce FAS expression, we generated mutant
AP1, GABP and GAS elements in luciferase reporter constructs and transfected them into CTCL
and Jurkat cell lines. They resulted in decreased luciferase expression, indicating that mutated tran-
scription factor binding sites can reduce FAS promoter function. To determine if similar mutations
exist in CTCL, we then sequenced a 1781 bp promoter region of the FAS gene upstream of the start
codon. We identified heterozygous and homozygous germline single nucleotide polymorphisms
(SNPs) in SP1, AP1, YY1, GAS and UEF-1/ER-α, β elements. Their individual prevalence was sim-
ilar to that of the general population. However, 6/29 samples had multiple SNP combinations that
ranged from 2.5X to 35X the estimated allelic frequency in the general population. In aggregate,
these findings in 11/30 CTCL samples (37%) suggest that the low FAS protein expression often seen
in CTCL can be associated with gross chromosome 10 defects or FAS coding region mutations.
Multiple SNPs in FAS promoter binding sites might be an additional mechanism for decreased
transcription in cases with normal FAS coding regions.
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A novel role for Bid in promoting UV-induced cell cycle checkpoint function and suppres-
sion of skin carcinogenesis
H Kim,1,2 Y Tsuruta,1,2,5 CM Martin,1 J Wu,1 AA Andea,1,2,3 WE Grizzle,2,3 NS Fineberg,4
SK Katiyar,1,2 CA Elmets,1,2 M Athar1,2 and L Timares1,2,5 1 Dermatology, University of Alabama
at Birmingham, Birmingham, AL, 2 Skin Diseases Research Center, University of Alabama at
Birmingham, Birmingham, AL, 3 Pathology, University of Alabama at Birmingham,
Birmingham, AL, 4 Biostatistics, University of Alabama at Birmingham, Birmingham, AL and
5 Division of Human Gene Therapy, University of Alabama at Birmingham, Birmingham, AL
UV-induced skin carcinogenesis results from DNA damage sustained by epidermal cells. The “BH3-
only” Bcl-2 family member Bid is well known as a pro-apoptotic molecule. Recently a novel pro-
survival S/G2 cell-cycle checkpoint function, dependent on ATM-mediated phosphorylation of Bid
at serine 78 (pBid), has been identified. Because epidermal keratinocytes (KC) are physiologically
relevant UV-targets, we hypothesized that prosurvival functions of Bid may have a role in UV-
induced cell recovery and skin carcinogenesis. We demonstrate that human (h) and murine (m)
KCs, as well as hSCC lines, induce expression of the prosurvival isoform, pBid, upon UV exposure
and is not p53 dependent. Immunofluorescence and western blots show that pBid is induced specif-
ically in the nuclei of mKC and hKCs, but is absent in Bid knockout (KO) mKCs. In addition, immor-
talized (i) WT KCs, but not Bid KO iKCs accumulated in S/G2 in a UV dose responsive manner,
supporting a role for Bid in mediating ATR-dependent cell-cycle regulation. Bid’s role in carcino-
genesis was tested in cohorts of C57BL/6 (WT) and Bid KO mice exposed to chronic UVB over 35
weeks and followed up to a year. Significant decreases in tumor latency and increases in inci-
dence and multiplicity of tumors were observed for the Bid KO cohort. In addition, Bid KO tumors
were chiefly high-grade tumors, whereas the majority of WT tumors were low-grade or benign.
These studies provide new evidence that Bid prosurvival functions are induced by UVB exposure
in epidermal KCs and may be critical to Bid’s observed tumor suppressor function. pBid may be a
new target for development of diagnostic or therapeutic applications for skin cancer.
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The role of p53 in melanoma tumor suppression
T Terzian,1 S Robinson,1 R Stiegmann,1 G Lozano,2 D Roop,1 W Robinson1 and N Box1 1
Dermatology, University of Colorado at Denver, Aurora, CO and 2 Cancer Genetics, MD
Anderson Cancer Center, Houston, TX
Pharmacologic activation of the p53 tumor suppressor through inhibition of its binding to the neg-
ative regulator Mdm2, is a chemotherapeutic strategy that is currently being explored in many
cancer types. The fact that p53 mutations rarely occur in human melanomas suggests that this tumor
type may be particularly suited for chemotherapies that aim at activating p53. In order to study the
role of p53 in melanocyte transformation in vivo, we have examined melanoma development in
a mouse model expressing activated HRASV12G under the control of the tyrosinase promoter
(TPRAS). Using a DMBA carcinogenesis protocol, multiple melanomas appeared in TPRAS/+ mice
beginning at 100 days after treatment. Around 40% of these mice developed metastatic lesions. In
addition, we examined melanoma formation in TPRAS/+ mice inheriting a heterozygous deletion
of the Mdm4 locus. Mdm4 is a major negative regulator of p53 and Mdm4 heterozygous mice are
extremely sensitive to carcinogen induced p53 activation. A similar number of tumors and age of
onset were observed in Mdm4+/-:TPRAS/+ mice versus TPRAS/+ alone. However, none of the
Mdm4+/-:TPRAS/+ mice developed metastatic lesions compared to 40% of the TPRAS/+ mice.
We conclude that the p53 tumor suppressor acts to prevent malignant conversion in these mice
without impacting the initiation of pre-malignant lesions. This genetic model of p53 activation
also suggests that the pharmacological activation of p53 in human melanomas may be an effec-
tive chemotherapeutic strategy. Therefore we used the Mdm2 inhibitor, Nutlin-3a, on human
melanoma cell lines, and on colonies grown from primary and metastatic tumors in a Matrigel 3D
culture system to demonstrate that p53 activation may be an important chemotherapeutic strategy
for malignant melanoma.
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Cyclosporine A (CsA), an immunosuppressant, transforms squamous cell carcinoma (SCC)
to a more invasive phenotype: a non-immunological effect
SE Beatrous,1 J Xu,1 H Xu,1 AR Kurundkar,2 A Maheshwari,2 L Kopelovich,3 CA Elmets1 and
M Athar1 1 Dermatology, University of Alabama at Birmingham, Bimingham, AL, 2
Neonatology, University of Alabama at Birmingham, Bimingham, AL and 3 NCI, Bethesda,
MD
Organ transplant patients often develop multiple skin cancers, which are known to be more aggres-
sive and metastatic than those induced in normal populations. However, the underlying mecha-
nism causing this enhanced invasiveness and aggression remains undefined. In this study, we
show that xenograft squamous cell tumors developed in nude mice by A431 cells grow much faster
and become much larger in size following treatment with CsA. The mean tumor volume in the CsA-
treated group was 1854.7± 379.7mm3 as compared to 703.9±133.4mm3 in the vehicle-treated
controls (p<0.03). To determine whether the observed CsA-related alterations are reversible fol-
lowing cessation of CsA treatment, we isolated tumor keratinocytes of both CsA- and vehicle-treated
groups, passaged them for 4 cycles in culture in normal medium and then re-injected them in
nude mice. Cells from the CsA-treatment group continued to form larger tumors than those iso-
lated from the vehicle-treated control animals (1150.7±140.8 mm3 verses 604.5±116.7mm3 respec-
tively). As compared to controls, tumors in the CsA group manifested enhanced cellular prolifera-
tion (increased PCNA staining & G1/S populations on FACS) and tumor vascularity with high
VEGF expression. These tumors also showed increased expression of fibronectin, α-SMA, vimentin,
N-cadherin, MMP-9/-2, snail, slug, and twist with a concomitant decrease in E-cadherin which
are biomarkers of epithelial-mesenchymal transition. Consistently, CsA increased TGFβ1 expres-
sion and –dependent signaling in these tumors. In A431 cells, CsA treatment increased cell migra-
tion/invasion and decreased apoptosis. The mechanism of these changes involves CsA-mediated
activation of MAP kinases (both ERK1/2 and p38) and Akt signaling pathways. Our data demon-
strate that CsA alters the phenotype of skin SCCs independent of its immunosuppressive effects to
an invasive and aggressive tumor-type.
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TRPV1, the transient receptor potential type V1, interacts with and down-regulates the epi-
dermal growth factor receptor (EGFR) and suppresses skin carcinogenesis
ME Ericson,1 BM Bode,2 C Yong-Yeon,2 Z Duo,2 F Zhu,2 W Ma,2 K Yao2 and Z Dong2 1
Dermatology, University of Minnesota, Minneapolis, MN and 2 Hormel Institute, University
of Minnesota, Austin, MN
The transient receptor potential channel vanilloid subfamily 1 (TRPV1) belongs to a family of pro-
teins comprised of non-selective cation channels. The TRPV1 is not only expressed in neuronal
tissues, but is detected in epidermis, dermal blood vessels, normal human keratinocytes, mast cells,
appendage epithelial structures, human cultured fibroblasts, human hair follicles, human lung
BEAS-2B cells, and HaCaT cells. The function of TRPV1 in non-neuronal cells and tissues is unclear.
TRPV1 interacts with capsaicin, the pungent ingredient of hot peppers. The role of capsaicin in
cancer development is controversial and little is known about other physiologic effects that might
occur from long-term blockade of this receptor. The epidermal growth factor receptor (EGFR) is a
widely expressed receptor tyrosine kinase that plays an important role in regulating epidermal
development. It is overexpressed in many human epithelial cancers and is a target for anticancer
drugs. We show that TRPV1 interacts with EGFR, which facilitates EGFR ubiquitylation by Cbl, an
ubiquitin ligase, resulting in subsequent EGFR degradation through the lysosomal pathway. TRPV1
knockout (TRPV1-/-) mouse skin expressed higher levels of the EGFR compared to TRPV1 wild-
type (TRPV1+/+) mouse skin and had a marked increase in papilloma development. EGFR protein
level in TRPV1-/- mouse skin was markedly increased compared with the amount of EGFR expressed
in normal skin from TRPV1+/+ mice. Overall, results indicated that TRPV1 is a membrane recep-
tor exhibiting a tumor-suppressing effect that is associated with the down-regulation of another
membrane receptor, the EGFR, known to be important in skin cancer development.
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MicroRNA profiling of squamous cell carcinomas of the skin: miR-21 expression is inversely
correlated with SATB1 expression
L Luan,1 M Teta,2 J Seykora,2 SE Millar2 and T Andl1 1 Medicine, Vanderbilt University,
Nashville, TN and 2 Dermatology, University of Pennsylvania, Philadelphia, PA
microRNAs (miRNAs) are a class of non-coding genes that regulate a myriad of biological processes
by adjusting and stabilizing gene expression patterns through binding to the 3’untranslated regions
(3’UTR) of mRNAs. miRNAs have been implicated in the regulation of cancer-associated processes
such as immortalization/senescence, telomere regulation, stem cell maintenance, metastasis and
angiogenesis. There are high hopes that therapies targeting miRNAs will have a great impact on
the treatment of many diseases including cancer. However, surprisingly little is known about their
role in skin carcinogenesis. To understand the impact of miRNAs in the formation of squamous
cell carcinomas (SCC), we micro-dissected normal epidermis and tumor tissue from fomalin-fixed,
paraffin-embedded tissue and extracted total RNA for miRNA microarray analysis. A broad spec-
trum of miRNAs is expressed in normal epidermis and tumors. Three miRNAs, miR-21, miR-31 and
miR-375, were markedly up-regulated in SCCs compared with normal skin. We confirmed these
data in a second cohort of tumor samples and identified an inverse correlation between miR-21
expression and a highly predicted target, SATB1 mRNA. By contrast the mRNA levels of the related
SATB2 gene and the predicted miR-21 target CHD7 were not significantly altered in SCCs and did
not inversely correlate with miR-21 expression. SATB1 is a global regulator of gene expression and
chromatin organization. SATB1 generally acts a repressor and its overexpression is associated with
the metastatic potential of breast cancer. Thus low levels of SATB1 in SCC of the skin may con-
tribute to the low metastatic potential of these tumors.
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Squamous cell carcinoma cell lines deficient in p53, p63 and global genomic DNA repair
TK Dong1,2 and DH Oh1,2 1 Department of Dermatology, University of California, San
Francisco, San Francisco, CA and 2 Dermatology Research Unit, VA Medical Center, San
Francisco, CA
We recently demonstrated that human epidermal keratinocytes, unlike other cell types, require
both p53 and p63 to maintain global genomic nucleotide excision repair of cyclobutane-pyrimi-
dine dimers (CPDs), the major ultraviolet radiation-induced DNA lesion. p53 is commonly mutated
in non-melanoma skin cancers, but a role for p63 is unclear. We hypothesized that squamous cell
carcinomas deficient in p53 and p63, but not p53 alone, would be associated with impaired
repair of CPDs. We examined four squamous cell carcinoma cell lines—A431, SCC12B2, SCC12F2,
and SCC25—all known to harbor p53 mutations. Relative to normal human keratinocytes, three
of the four cell lines exhibited elevated p53 protein levels, consistent with p53 inactivation, and
reduced protein levels of the most common p63 isoform, ΔNp63α. When damaged with ultravio-
let radiation and assayed for global repair using an immunoblot assay for CPDs, all SCC cell lines
with reduced ΔNp63α were impaired in repair of CPDs by at least 50% by 24 hours post-irradia-
tion. One p63-deficient cell line, A431, also exhibited slower repair kinetics of the other major
ultraviolet radiation-induced DNA photoproduct, pyrimidine(6-4)pyrimidone photoproducts (6-
4PP). In contrast, the fourth cell line, SCC25, possesses a p53 mutation that renders the p53 pro-
tein unstable and undetectable, yet had ΔNp63α levels that were comparable to normal ker-
atinocytes. Interestingly, SCC25 cells exhibited normal global genomic repair of both CPDs and
6-4PPs by 24 hours post-irradiation. When XPC, an important DNA damage recognition protein
required for initiation of global genomic repair, was examined in SCC12 and SCC25 cell lines, its
levels correlated more closely with p63 than with p53 levels. These results further confirm that both
p53 and p63 are important in the regulation of global nucleotide excision repair, and suggest that
dual loss of their activity may be a source of genomic instability that contributes to the evolution
of squamous cell carcinomas.
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Stem cell origin and microenvironment contributions for NF1-associated dermal neurofi-
bromas
LQ Le,1,2 T Shipman,2 C Liu,1 DK Burns3 and LF Parada2 1 Dermatology, The University of Texas
Southwestern Medical Center, Dallas, TX, 2 Developmental Biology, The University of Texas
Southwestern Medical Center, Dallas, TX and 3 Pathology, The University of Texas
Southwestern Medical Center, Dallas, TX
The tumor predisposition disorder Neurofibromatosis type I (NF1) is one of the most common
genetic disorders of the nervous system. It is caused by mutation in the NF1 tumor suppressor gene,
which encodes a GTPase Activating Protein (GAP) that negatively regulates p21-RAS. The devel-
opment of malignant nerve tumors and neurofibromas, the most frequent tumors in NF1, is a seri-
ous complication of the disease. However, little is known about the molecular mechanisms medi-
ating the initiation and progression of these complex tumors, as well as the identity of the specific
cell type that gives rise to dermal or cutaneous neurofibromas. In this study, we identify that a pop-
ulation of stem/progenitor cells residing in the dermis termed Skin Derived Precursors (SKPs), through
loss of NF1, form neurofibromas. We propose that SKPs, or their derivatives, are the cell of origin
of dermal neurofibroma. We also provide evidence that additional signals from the non-neoplas-
tic cells in the tumor microenvironment play essential roles in neurofibromagenesis. These unique
interactions between the neoplastic cell (the Schwann cells) and its microenvironment are absolutely
required for neurofibroma formation. These novel findings provide an innovative approach to gain
a greater understanding of the molecular pathogenesis of neurofibroma and exploit new therapeutic
approach in clinical trial to treat NF1-associated neurofibromas. In addition, while focused on neu-
rofibroma, this work raises the exciting possibility that the non-neoplastic cells in the tumor envi-
ronment may impact the growth of other tumor types. An increased understanding of the role of
non-neoplastic tumor-associated cells may lead to new directions for cancer therapy and preven-
tion.
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Resveratrol suppresses ultraviolet B (UVB)-induced basal cell carcinoma (BCC) growth via
cyclin D1 modulation in Ptc1+/-/SKH-1 mice
X Tang,1 Y Zhu,1 JH Back,1 L Kopelovich,3 M Athar,2 AL Kim1 and DR Bickers1 1 Dermatology,
Columbia University, NY, NY, 2 University of Alabama at Birmingham, Birmingham, AL and 3
Division of Cancer Prevention, National Cancer Institute, Bethesda, MD
BCCs and squamous cell carcinomas (SCCs) are the most common type of human malignancies.
Solar ultraviolet radiation can induce reactive oxygen species (ROS) and other free radicals that
are involved in various stages of experimental skin carcinogenesis. In this study, we tested whether
resveratrol, a potent ROS scavenger, manifests chemopreventive effects against UVB-induced BCCs
in Ptc+/-/SKH-1 hairless mice. Ptc+/-/SKH-1 mice were irradiated twice a week at a dose of 180
mJ/cm2 UVB. Resveratrol was administered by gavage twice a week (400 mg/kg body weight in
0.5% methyl cellulose). Mice treated with resveratrol showed approximately 30% of the tumor bur-
den of UVB-irradiated/vehicle (0.5% methyl cellulose)-treated control mice. At week 34, both the
number and size of the microscopic BCCs were reduced in the resveratrol-treated Ptc+/-/SKH-1
mice. Resveratrol also attenuated the enhanced levels of proteins involved in regulation of cell pro-
liferation and cell cycle progression in chronically irradiated skin bearing microscopic BCCs. The
levels of cyclins A and D1, proliferating cell nuclear antigen (PCNA), and ornithine decarboxylase
(ODC) were significantly lower in microscopic BCCs harvested from resveratrol-treated mice than
those from control animals. Moreover, cyclin D1 overexpression occurred throughout both the
basal and suprabasal layers of the epidermis in chronically UVB-irradiated non-resveratrol-treated
skin, whereas its expression was confined to the basal layer in skin harvested from resveratrol-
treated animals. Cyclin D1 expression in microscopic BCCs was significantly reduced following
resveratrol treatment. Our data indicate that resveratrol effectively suppresses the growth of UVB-
induced BCCs in Ptc+/-/SKH-1 mice.
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Nicotinic acid receptors in skin differentiation and skin cancer
Y Bermudez1 and EL Jacobson1,2 1 Cancer Prevention and Control, Arizona Cancer Center,
Tucson, AZ and 2 Department of Pharmacology and Toxicology, College of Pharmacy,
University of Arizona, Tucson, AZ
Nicotinic acid has a protective effect against nonmelanoma skin cancer (NMSC) in preclinical
models by inhibiting photocarcinogenesis and photoimmunosuppression induced mainly by ultra-
violet (UV) radiation. However, the molecular mechanisms by which nicotinic acid exerts its pro-
tective effects are not well understood. We have studied the recently identified orphan human G-
protein-coupled receptors for nicotinic acid, HM74 and HM74A, to determine their potential
involvement in skin cancer prevention. We evaluated the mRNA and protein expression of HM74
and HM74A in skin cell lines, full thickness skin reconstructs, and in normal, benign, and malig-
nant human skin tissues by qRT-PCR, Western blot, and immunostaining analyses. We find that
nicotinic acid receptors are expressed in epidermal keratinocytes at both the mRNA and protein
levels and that the expression of both receptors is greatly upregulated in immortalized and trans-
formed cultured cells. We then compared the relative levels of HM74 and HM74A message expres-
sion in normal skin to that present in squamous cell carcinoma (SCC) lesions. Both receptors are
expressed in normal human skin, however the high affinity receptor (HM74A) is expressed at
more than 2-fold higher levels. HM74A expression is upregulated progressively from SCC stage I
to stage III, up to about 20 fold. HM74 expression in SCC stages I to II remains unchanged when
compared to normal human skin. As the disease progresses to stage IIB and III and becomes inva-
sive, HM74 expression is significantly upregulated. These data support the hypothesis that nico-
tinic acid receptors are present in skin keratinocytes, have altered expression in immortalized
cells and SCC, and warrant further investigation as potential targets for skin cancer prevention.
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Differential proteomic analysis of the effects of immunosuppressant, Cyclosporine A and
rapamycin, on squamous cell carcinoma by 2D difference gel electrophoresis and mass spec-
trometry
C Wang,1,2 S Barnes,2,3 S Beatrous,1 R Herring,3 L Wilson,3 C Elmets1,2 and M Athar1,2 1
Dermatology, Univ Alabama Birmingham, Birmingham, AL, 2 skin diseases res center, UAB,
Birmingham, AL and 3 Mass Spec Facility, UAB, Birmingham, AL
Organ transplant patients have a dramatically increased incidence of aggressive malignancies as
compared to normal population, with non-melanoma skin cancers being the most common post-
transplant malignancy. This increase in malignancies has been linked to the immunosuppressive
agents given to these patients to prevent organ rejection. Some agents, including azathioprine and
cyclosporine, have been found to promote carcinogenesis by mechanisms independent of their
immunosuppressive effects. Rapamycin (Rapa), a newer potent immunosuppressant, has been
report to constrain tumor growth and metastatic progression, and has approved by the FDA for use
in organ transplantation in conjunction with cyclosporine. In this study, we evaluate the effects of
CsA and Rapamycin on xenograft squamous cell tumors developed in nude mice by A431 human
epithelial carcinoma cells with the treatments of CsA alone or co-treatment of CsA with Rapa. The
mean tumor volume in the CsA-treated group (1854.7 mm3) is the largest followed by the mean
volume in the control group (703.9 mm3) and the CsA/Rapa co-treatment group (81.7 mm3), which
indicates that CsA may promote SCC tumor progression and the Rapa may reduce SCC progres-
sion even with co-administration of CsA. Differential proteomic changes of these tumors with dif-
ferent treatments were quantitatively analyzed by 2D Fluorescence Difference Gel Electrophore-
sis. Expression of 8 protein spots were found regulated with average ratio ≥ ±1.5 (p<0.05) between
tumors from the CsA treated group and from control group. 39 protein spots were recognized
expressed differently (average ratio ≥ ±1.5, p<0.05) between the tumors from the CsA/Papa group
and the control group. Identification of these differential protein spots by nanoLC-mass spectrometry
will provide helpful knowledge to elucidate the molecular mechanisms of CsA and Rapa toward
SCC progression.
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Hyaluronan (HA) fragment-CD44 interactions selectively regulate keratinocyte proliferation,
differentiation, wound healing and permeability barrier homeostasis in aged verus young
epidermis
LY Bourguignon,1 W Xia,1 G Wong,1 G Wei,1 E Gilad,1 J Youm,2 P Elias2 and W Holleran2 1
Medicine, University of California-San Francisco & VA Med. Center, San Francisco, CA and 2
Dematology, University of California-San Francisco & VA Med. Center, San Francisco, CA
Interaction between hyaluronan (HA), the major glycosaminoglycan of extracellular matrix (ECM)
and its receptor, CD44 has been shown to regulate keratinocyte activities and epidermal functions.
In this study we investigated the effects of the HA-CD44 interaction on epidermal structure and
function in aged vs. young murine epidermis. Initially we established that keratinocyte functions
(e.g., proliferation, migration and differentiation), and lamellar body (LB) formation/secretion are
significantly downregulated in aged epidermis, associated with marked epidermal thinning and
slower wound healing/barrier recovery. Further analyses indicate that epidermal aging is associ-
ated with abnormal HA-size changes (i.e., reduction in small-size HA fragments). In addition, spe-
cific epidermal functions are impacted differently by distinct sizes of HA fragments (small vs. large
HA); i.e., small HA fragments (~25-100kDa) stimulate proliferation and migration, while larger-
HA fragments (>600kDa) regulate differentiation in cultured keratinocytes. Topical applications of
small HA fragments promote keratinocyte proliferation, skin thickness and wound healing, but fail
to upregulate keratinocyte differentiation, LB formation or permeability barrier repair in aged mouse
skin. However, topical treatment with large HA fragments restores keratinocyte differentiation and
improves permeability barrier function in aged epidermis. The fact that both small and large HA
fail to correct epidermal defects observed in either aged and young CD44 knock-out (k/o) mice
suggests the importance of selective HA fragment-CD44 binding in the epidermis observed in aged
vs. young mice. Thus, manipulation of the HA fragment-CD44 interaction could provide a novel
therapeutic approach for the treatment of various aging-related skin disorders.
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Cell-type specific RAGE signaling drives carcinogenesis by sustaining inflammation and tumor
angiogenesis
C Gebhardt,1,2 A Riehl,2 J Németh,2 J Hess,2 K Müller-Decker,2 F Kiessling,2 PP Nawroth,1
A Bierhaus,1 B Arnold,2 A Enk1 and P Angel2 1 University Hospital Heidelberg, Heidelberg,
Germany and 2 German Cancer Research Center (DKFZ), Heidelberg, Germany
The central role of chronic inflammation in promoting tumor development is highlighted by a broad
range of experimental and clinical evidence. However, the mechanisms that sustain a tumor-pro-
moting microenvironment remain largely elusive. We have demonstrated that mice deficient for
the receptor for advanced glycation end-products (RAGE) are resistant to DMBA/TPA-induced skin
carcinogenesis. Furthermore, RAGE-deficient mice showed severely reduced inflammatory response
to treatment with TPA accompanied by impaired infiltration with subsets of innate immune cells
such as neutrophils, macrophages, mast cells and myeloid-derived suppressor cells (MDSCs) and
impaired upregulation of pro-inflammatory genes, such as Ptgs2, MIPs, S100a8 and S100a9 using
confocal microscopy and gene expression analysis. S100a8 and S100a9, representing activating
ligands of RAGE, were induced in TPA-treated skin and overexpressed in advanced stages of mouse
and human skin tumors using RQ-PCR and tissue microarrays. Since ligand expression is RAGE-
dependent, we propose the existence of an S100/RAGE-driven feed-forward-loop in chronic inflam-
mation and tumor formation. Most importantly, TPA-induced dermal infiltration and epidermal
hyperplasia was restored in wildtype bone marrow chimeric RAGE-deficient mice revealing that
RAGE expression on immune cells is essential for sustaining inflammation. Moreover, we present
novel data on a prominent endothelial-specific role of RAGE in driving tumor-angiogenesis under-
lining the importance of a specific RAGE-dependent microenvironment for effective tumor pro-
motion. In conclusion, we demonstrate the complex role of RAGE signaling in driving the strength
and maintenance of an inflammatory reaction during tumor-promotion and in sustaining tumor
angiogenesis and thereby we provide direct genetic evidence for novel cell type-specific functions
of RAGE in promoting inflammation-induced skin cancer.
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p53-modulating compounds inhibit ultraviolet B (UVB)-induced skin cancer development
in genetically engineered murine models
DR Bickers,1 X Tang,1 Y Zhu,1 ME Daly,1 WJ Liu,1 L Kopelovich,3 AL Kim1 and M Athar2 1
Dermatology, Columbia University, New York, NY, 2 University of Alabama at Birmingham,
Birmingham, AL and 3 Division of Cancer Prevention, National Cancer Institute, Bethesda,
MD
BCCs (basal cell carcinomas) are known to be induced by environmental exposure to solar UVB.
Both p53 and patched (PTCH) tumor suppressors are major target genes known to be mutated in
both UVB-induced murine BCCs and sporadic human BCCs. CP-31398, a styrylquinazoline and
2,2-bis(hydroxymethyl)-1-azabicyclo[2,2,2]octan-3-one (PRIMA-1) have been shown to restore
wild-type conformation and transcriptional activity to mutant p53. In this study we determined
whether CP-31398 or PRIMA-1 is able to suppress the growth of murine BCC cells (ASZ001 cells)
in vitro and in vivo, using relevant BCC murine model. Treatment of ASZ001 cells derived from
murine BCCs, with various concentrations of either CP-31398 (0-50 μg/ml) or PRIMA-1 (0-100
μM), dose-dependently increased their apoptosis 24 hrs after treatment. Both CP-31398 and PRIMA-
1 increased the level of pro-apoptotic Bak. CP-31398 and to a lesser extent PRIMA-1 caused ASZ001
cells to accumulate in the G2 phase of the cell cycle before undergoing apoptosis. In addition, CP-
31398 treatment increased the transcriptional activity of p53 in ASZ001 cells carrying mutant
p53, but decreased NF-κB activity, as measured by luciferase reporter assays. This was accompa-
nied by a slight decrease in the proliferation as assessed by [3H]-thymidine incorporation. The
parenteral administration of CP-31398 to Ptc1+/-/SKH-1 mice for 33 weeks reduced both the
number and size of UVB-induced microscopic BCCs by 40% and 60%, respectively. Our results
indicate that pharmacological agents capable of restoring wild type conformation are effective
chemopreventive agents. Increased transcriptional activity of p53 with a concomitant decrease in
NF-κB activity likely contributes to chemical inhibition of the growth of BCCs in Ptc1+/-/SKH-1
mice.
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SERCA2, the intracellular calcium pump targeted in Darier’s disease, is necessary for proper
regulation of PKC signaling, keratin organization and desmosome assembly
RP Hobbs,1 LM Godsel,1 MF Denning2 and KJ Green1 1 Department of Pathology,
Northwestern University, Chicago, IL and 2 Division of Cellular and Molecular Biochemistry,
Cardinal Bernardin Cancer Center, Loyola University, Chicago, IL
Desmoplakin (DP) provides resistance to mechanical stress in epithelial and myocardial tissues by
anchoring the intermediate filament (IF) cytoskeleton to intercellular junctions known as desmo-
somes. Desmosome assembly is known to be dependent on extracellular calcium, though our
understanding of how intracellular calcium (CaInt) regulation influences the assembly of these cell-
cell junctions is limited. We perturbed the levels of CaInt by treating epithelial cell monolayers
with either BAPTA-AM, a CaInt chelator, or thapsigargin (TG), a specific inhibitor of the SERCA
(sarco[endo]plasmic reticulum calcium ATPase) family of calcium storage pumps and analyzed
junction status by immunofluorescence microscopy. Both treatments dramatically impaired DP
recruitment to cell borders without affecting E-cadherin localization or total DP protein levels.
Furthermore, we utilized siRNA oligo pools to silence the expression of the SERCA2 isoform, which
is genetically compromised in the human skin blistering disorder Darier’s disease, and observed a
similar impairment of DP border localization. From our previous studies, DP recruitment to junc-
tions was impaired by either expressing a DP phosphoserine point mutant within a PKC consen-
sus site in the C-terminal IF-binding domain (Ser2849ÇGly) or by inhibiting PKCα activity. Inter-
estingly, cells transfected with siSERCA2 oligos exhibited decreased levels of PKCα signaling, as
assessed by a reduction of activated PKCα (phospho-Thr638), in addition to a reorganization of
the keratin IF pattern at the cell periphery. We propose that the SERCA2-dependent control of CaInt
homeostasis contributes to PKCα-dependent regulation of DP-IF association, which is in turn required
for proper IF organization and desmosome assembly. Moreover, we predict that alterations in DP
phosphorylation status may be an underlying factor in Darier’s disease pathogenesis.
www.jidonline.org   S35
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Factors modulating a directional hypermotility response that is a feature of keratinocytes and
all p63+/K14+ epithelial cell types
W Wei, S Dabelsteen, P Barron and JG Rheinwald Dermatology, Brigham and Women’s
Hospital, Boston, MA
When reepithelializing a wound or initiating malignant invasion, keratinocytes at the migrating
fronts of these lesions display increased expression of TGFβ and Laminin-322. As a cell culture
model of this type of motility, primary human keratinocytes plated at low density respond with
sustained directional hypermotility accompanied by growth arrest ~20 hr following treatment
with TGFβ or immediately upon plating on a surface coated with the γ2-unprocessed form of
Laminin-332 (Lam332’). We have extended this analysis to three p63+/K14+ epithelial cell types
of endodermal origin: urothelial, tracheobronchial, and prostate epithelial cells, and to p63+/K14+
cells derived from hES cells. These cell types proliferate and can be studied in certain nutrition-
ally-optimized media, such as K-sfm, supplemented with pituitary extract and EGF, KGF, or HGF.
All of these cell types express Laminin-332 and all proved to be induced to hypermotility by Lam332’
and TGFβ. Some common variables in culture medium formulations markedly affected the hyper-
motility response of two of these cell types that we studied in detail: keratinocytes and prostate
epithelial cells. TGFβ-induced hypermotility proved to be inhibited by some production lots of
pituitary extract and by a substratum-binding component of serum. Both cell types specifically
required EGF in the medium in order for TGFβ to induce hypermotility. The migration rate in
response to TGFβ was inversely proportional to Ca++ concentration. None of the above variables
affected the ability of either cell type to proliferate under control conditions, to be growth-inhib-
ited by TGFβ, or to display hypermotility in response to Lam322’. Our results reveal that the large
family of p63+/K14+/Lam332+ epithelial cell types possesses a common hypermotility and growth
arrest response to TGFβ and to Lam332’, the former which is subject to substantial modulation in
culture by factors that are present in wound and neoplastic tissue in vivo.
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Enhancements of a composite skin equivalent using acellular dermal matrix as the scaffold
for full-thickness burns
J Lee,3,2 D Lee,2 I Kim,2 H Jeong,1,3 M Lee,3 T Sohn,3 C Yoon,4 J Lee,5 J Lee1,3 and K Kang1 1 Hans
Biomed Corporation, Daejeon, Korea, South, 2 Biological Science, Hannam Univ, Daejeon,
Korea, South, 3 B&H Therapeutics, Seoul, Korea, South, 4 Bestian Hospital, Seoul, Korea,
South and 5 Department of Dermatology, School of Medicine, Chungbuk National
University, Cheongju, Korea, South
Tissue-engineered skin equivalents composed of epidermal and dermal components have been
widely investigated for coverage of full-thickness burn. We have evaluated tissue-engineered
composite skin equivalent using dermal matrix (ShebaTM) as the scaffold in an animal model. Sheba
is processed powdery form of acellular dermal matrix from human origin and contained most der-
mal compositions. Sheba was added to collagen and fibroblast mixture to construct a dermal sub-
stitute for human skin engineering. Human keratinocytes were seeded on to the dermal substitute
and cultured for a week. Immunohistochemical study showed that it was more similar to normal
skin than the artificial skin equivalent using collagen alone as the scaffold. Histologically, ker-
atinocytes were firmly attached to the dermal substitute and differentiated in epidermal sites. We
also assessed its preliminary clinical application in an animal model of full-thickness burn. Burn
healing occurred more effectively by the composite skin equivalent containing Sheba than artifi-
cial skin equivalent using collagen only. In addition, this composite skin equivalent could protect
contraction in burn defect. We conclude that this three-dimensional skin equivalent can be used
to hold the wound sites and effectively enhance wound healing including burn and chronic ulcer
in vivo.
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Hormonal regulation of hyaluronate synthesis in a human dermal equivalent
T Pouyani and BH Sadaka Pharmaceutical Sciences, Northeastern University, Boston, MA
Human dermal fibroblasts cultured under serum-free conditions without the use of a three dimen-
sional scaffold produce an organized extracellular matrix in vitro. This matrix bears marked resem-
blance to the human dermis and is capable of producing large amounts of Hyaluronic Acid
(hyaluronate, HA). We have investigated the effect of the hormone triiodothyronine (T3) in differ-
ing concentrations on the behavior of human dermal fibroblasts cultured in vitro. Specifically, the
effects of this hormone on extracellular matrix production in vitro by the human dermal fibroblasts
have been studied. Our results indicate that higher amounts of T3 (10X and 100X) are capable of
selectively inhibiting hyaluronate production in the Human Dermal Matrix. Collagen production
was not affected by an increase in T3 concentration. Transmission Electron Microscopy indicates
that the morphology of the constructs is not altered by an increase in T3.
214
Platelet mediated adhesion of tumor cells promotes metastasis of B16 melanoma cells
AS Lonsdorf,1 AH Enk1 and HF Langer2 1 Department of Dermatology, University of
Heidelberg, Heidelberg, Germany and 2 Department of Cardiovascular Medicine, University
of Tuebingen, Tuebingen, Germany
Fundamental aspects determining the molecular basis for the reciprocal relationship between metas-
tasizing tumor cells and soluble components of the coagulation cascade have recently been elu-
cidated. However, the involvement of platelets, the cellular component of thrombus formation, in
the pathogenesis of cancer metastasis is still poorly understood. Here, we show that platelets are
an important contributing factor in the early phase of the formation of lung metastasis in vivo.
Depletion of platelets after i.v. injection of luciferase-transduced murine B16 melanoma cells (B16M-
luc) into syngeneic C57BL/6 mice resulted in a more than 30 % reduction of micrometastasis to
the lung, as determined by in vivo luciferase bioluminescence imaging and in vitro biolumines-
cence analysis of lung tissue. Thus, we hypothesized that platelets may be critically involved in
the multistep process of tumor metastasis. Evaluating tumor cell rolling (parallel-plate flow cham-
ber), chemotaxis (wound assay) and migration (transwell chamber) we found no significant platelet
mediated effect on B16M behavior in vitro. However, we determined that the adhesion of melanoma
cells under static conditions was augmented up to 50fold on immobilized platelets. Moreover,
platelets substantially mediated adhesion of human melanoma cells under physiological sheer stress
conditions. The observed increase in tumor cell adhesion was significantly abolished by blocking
monoclonal antibodies (mAb) to αV integrin, an adhesion molecule highly expressed on B16
melanoma cells (B16M). Likewise, blocking mAb to GPIIbIIIa, the most abundant platelet adhe-
sion receptor, and the integrin blocking peptide RGD significantly impaired the platelet-mediated
increase in B16M adhesion. We conclude that platelets promote early metastasis of melanoma cells
to the lung and suggest that the specific targeting of adhesion molecules involved in this process
may represent a promising strategy for therapeutic intervention.
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Critical roles for EpCAM (epithelial cell adhesion molecule) for early embryogensis and pla-
cental development
K Nagao,1,5 J Zhu,2 J Hanson,2 MI Morasso,4 L Tessarollo,3 S Mackem2 and MC Udey1 1
Dermatology Branch, National Institutes of Health, Bethesda, MD, 2 Pathology, National
Institutes of Health, Bethesda, MD, 3 Mouse Cancer Genetics Program, National Institutes of
Health, Bethesda, MD, 4 Developmental Skin Biology Unit, National Institutes of Health,
Bethesda, MD and 5 Dermatology, Keio University School of Medicine, Tokyo, Japan
EpCAM (CD326) is encoded by the tacstd1 gene and expressed by a variety of normal and malig-
nant epithelial cells, as well as some leukocytes, including Langerhans cells. In vitro experiments
have suggested that EpCAM is an intercellular adhesion molecule. EpCAM has been extensively
studied as a potential tumor marker and immunotherapy target, and more recent studies suggest
that EpCAM expression may be characteristic of cancer stem cells. To gain insights into EpCAM
function in vivo, we generated EpCAM -/- mice utilizing an embryonic stem cell line with a tac-
std1 allele that had been disrupted. Gene trapping resulted in a protein comprised of the N-termi-
nus of EpCAM encoded by 2 exons of the tacstd1 gene fused in frame to βgeo. EpCAM +/- mice
were viable and exhibited no gross abnormalities. In embryos, EpCAM was expressed in epithe-
lial structures including otocysts, branchial arches, gut, apical ectodermal ridges, lungs, pancreas,
and hair follicles. EpCAM was co-expressed with E-cadherin, but was reciprocally expressed with
P-cadherin in placenta and many embryonic epithelia. EpCAM -/- mice died in utero at approxi-
mately E9.5, and were small, developmentally delayed, and displayed placental abnormalities.
EpCAM was expressed in developing placentas throughout the labyrinthine layer. Placentas of
EpCAM -/- embryos were compact, with thin labyrinthine layers lacking prominent vascularity. Tro-
phoblast giant cells are required for invasion of embryonic tissue into maternal tissue, and were
dramatically reduced in EpCAM -/- placentas. These results indicate that EpCAM is required for
differentiation of trophoblast giant cells, normal development of the placental labyrinth and estab-
lishment of a competent maternal-fetal circulation.
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Effects of hyaluronan on collagen synthesis and MMP-1 activity in stress-induced premature
senescent dermal fibroblasts
N Boubekeur, M Charveron, N Castex-Rizzi and P Bogdanowicz Pierre Fabre Dermo-
Cosmétique, Toulouse, France
Alterations of skin observed during skin aging are both due to an increase of MMP activity and a
decrease of collagen synthesis. The aim of this study was to evaluate the effects of hyaluronan
(HA) on matrix metalloproteinase-1 (MMP-1) activity, and collagen I synthesis, which are dysreg-
ulated during skin aging. We have developed an in vitro model of stress-induced premature senes-
cence fibroblast (SIPS), which is closely related to chronological-aging. This model represent a valu-
able in vitro model to evaluate anti-aging compounds. We showed that MMP-1 activity is
up-regulated in SIPS fibroblasts. Moreover, we also showed that pre-incubation of SIPS fibroblasts
with HA reduced senescence effects, since we measured an inhibition of MMP-1 activity. On the
other hand, we showed that procollagen I neosynthesis is inhibited in SIPS fibroblasts and prein-
cubation with HA partially restaured procollagen I neosynthesis. Our findings demonstrated the
anti-aging properties of HA. Indeed, HA is able to reduce the exacerbated catabolic activity (MMP-
1) and to stimulate the anabolic activity (collagen I) in SIPS dermal fibroblast.
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p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acan-
tholysis
P Jolly,1 P Berkowitz,1 H Lee,1 M Chua,2 L Diaz1 and DS Rubenstein1 1 Dermatology, UNC-CH,
Chapel Hill, NC and 2 Cell & Molecular Physiology, UNC-CH, Chapel Hill, NC
Pemphigus vulgaris (PV) is an autoimmune blistering disease in which pathogenic anti-desmoglein
(dsg) 3 autoantibodies induce blistering. A variety of mechanisms have been proposed to explain
the ability of pemphigus IgG to cause loss of keratinocyte cell-cell adhesion, including steric hin-
drance, activation of intracellular signaling, and dsg endocytosis. Previously, we observed PV IgG
induced activation of p38 mitogen activated protein kinase (MAPK). The ability of p38 inhibitors
to block PV IgG induced cytoskeletal changes in vitro and blistering in vivo suggested a mecha-
nistic role for p38 activation in PV IgG induced acantholysis. In addition, data from a number of
labs has demonstrated that pemphigus IgG induces depletion of dsg from the cell surface suggesting
a model in which loss of adhesion results from depletion of membrane associated dsg. In this cur-
rent study, we sought to investigate the potential relationship between PV IgG triggered signaling
and dsg3 redistribution in primary human keratinocytes. Keratinocyte cultures were (i) pre-treated
with vehicle or the p38MAPK inhibitor SB2020190 for two hours and (ii) then treated with PBS,
normal human IgG (NH IgG) or PV IgG. Shifts in dsg3 localization were examined by (i) confocal
immunoflourescent microscopy, (ii) immunoblot of detergent soluble and insoluble fractions, and
(iii) employing biotin cell surface labeling as a cell specific assay for dsg3 in the cell membrane.
In each assay used, and consistent with previous reports, PV IgG triggered loss of dsg 3 from the
cell membrane and dsg3 endocytosis. Significantly, PV IgG triggered dsg3 internalization was
blocked in cells treated with the p38 inhibitor SB202190. Taken together, the data suggests a model
of pemphigus acantholysis in which (i) PV IgG triggered p38 signaling and dgs3 internalization
are linked events and furthermore, (ii) that pemphigus IgG triggered p38 activation is upstream of
dsg internalization.
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Enhanced skin elasticity with Cotinus coggygria extracts
R Zhao,1 E Bruning,1 D Rossetti,1 B Starcher,2 M Seiberg1 and V Iostova-Stone1 1 The Johnson
and Johnson Skin Research Center, Johnson & Johnson CPWW, Skillman, NJ and 2 Health
Center at Tyler, University of Texas, Tyler, TX
Elastin fibers are essential extracellular matrix components of the skin, contributing to its resilience
and elasticity. The integrity and functionality of dermal elastic fibers are reduced upon aging. This
decrease is due to reduced elastin synthesis, as well as to the disintegration of existing elastic fibers.
We have identified a Smoke tree (Cotinus coggygria) extract, which can induce elastin promoter
activity and thereby enhance elastin synthesis. Moreover, this extract inhibits a number of elastin-
degrading enzymes, known to increase upon chronological aging and sun exposure, therefore pro-
tecting the existing elastic network from degradation. Treatment of cultured dermal fibroblasts with
Cotinus extracts enhanced the expression of tropoelastin. Cotinus-treated mouse and swine skins
showed enhanced network of elastic fibers upon histological staining. Similar results were docu-
mented in human skins transplanted onto SCID mice, as revealed by the increased expression of
tropoelastin and other elastin-accessory genes involved in elastin fiber assembly. Preliminary human
studies showed that topical applications of Cotinus extracts enhanced skin elasticity as measured
by cutometer. These results suggest that extracts from Cotinus coggygria can restore skin elastic-
ity and provide an effective, natural skin care product for reducing the sagging and wrinkles of
aged skin.
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Collagen XVII participates in keratinocyte adhesion to collagen IV, and in p38-MAPK-depend-
ent migration and cell signaling
H Qiao, A Shibaki, HA Long, G Wang, Q Li, W Nishie, R Abe, M Akiyama, H Shimizu and
JR McMillan Department of Dermatology, Hokkaido University Graduate School of
Medicine, Sapporo, Japan
Collagen XVII (COL17), a transmembrane collagen, is thought to be involved in keratinocyte adhe-
sion and possibly migration, as COL17 defects disrupt keratinocyte-basal lamina adhesion and
underlie the disease non-Herlitz junctional epidermolysis bullosa (n-HJEB). COL17 is involved in
keratinocyte adhesion and migration. Using siRNA to knockdown COL17 expression in HaCaT
cells, we assessed cell characteristics including adhesion, migration and signaling. Control and
siRNA transfected keratinocytes showed no difference in adhesion on plastic dishes after incuba-
tion for 8 hours in serum-free keratinocyte-growth medium, however when grown on collagen IV
alone or BD matrigel (containing collagen IV and laminin isoforms) COL17 deficient cells showed
significantly reduced adhesion compared to controls (P<0.01), and MEK1/2 and MAPK demon-
strated reduced phosphorylation in COL17 depleted cells. Furthermore, COL17 deficient HaCaT
cells plated on plastic exhibited reduced motility that was p38MAP kinase dependent (after addi-
tion of the p38MAPK inhibitor SB203580). Conversely, keratinocyte adhesion was independent of
p38MAPK signaling. Taken together, these results suggest COL17 has significantly wider signaling
roles than were previously thought, including the involvement of COL17 in keratinocyte adhesion
to collagen IV, in p38MAP kinase-dependent cell migration, and multiple cell signaling events per-
taining to MEK1/2 phosphorylation.
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Fetal dermal fibroblasts cultured in vitro produce an organized extracellular matrix
T Pouyani Pharmaceutical Sciences, Northeastern University, Boston, MA
Neonatal human dermal fibroblasts cultured under serum-free conditions without the use of a three
dimensional scaffold produce an organized extracellular matrix in vitro. This matrix bears marked
resemblance to the human dermis and may have potential in promoting dermal regeneration. We
have investigated the ability of fetal dermal cells to produce an organized extracellular matrix (ECM)
in vitro and have conducted a comparison of the ECM produced by fetal cells of 18 and 22 weeks
of gestation with that produced by neonatal dermal cells. We find that fetal dermal cells cultured
in vitro under serum free conditions produce an organized ECM with similarities to human skin.
We present a detailed characterization of the ECM components.
218
Sodium butyrate inhibits hyaluronate synthesis in a human dermal equivalent
T Pouyani and BH Sadaka Pharmaceutical Sciences, Northeastern University, Boston, MA
Human dermal fibroblasts cultured under serum-free conditions without the use of a three dimen-
sional scaffold produce an organized extracellular matrix in vitro. This matrix bears marked resem-
blance to the human dermis and is capable of producing large amounts of Hyaluronic Acid
(hyaluronate, HA). We have investigated the effect of the fatty acid, sodium butyrate (NaB) in dif-
fering concentrations on the behavior of human dermal fibroblasts cultured in vitro. Specifically,
the effects of NaB on hyaluronic acid and extracellular matrix production in vitro by the human
dermal fibroblasts have been studied. Our results indicate that sodium butyrate is a potent inhibitor
of hyaluronate synthesis, but that this inhibition is not selective as inhibition of collagen synthesis
and cell replication is also observed. Higher concentrations of sodium butyrate result in dermal
equivalents with smaller fibril diameters as compared to those grown in the absence, or in the
presence of low concentrations of NaB.
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The elastin receptor mediates endocytosis of elastin to lysosomes and the subsequent degra-
dation of elastin by cathepsin K
SD Gan, K Codriansky and TM Ruenger Dermatology, Boston University, Boston, MA
Degradation of the extracellular matrix proteins collagen and elastin is commonly regarded to be
mediated by secreted proteases, including matrix metalloproteinases and elastases, in the extra-
cellular space. Recently, internalization of extracellular collagen to lysosomes and its degradation
by the lysosomal protease cathepsin K (catK) has been described in dermal fibroblasts. Elastin bind-
ing to a cell’s surface is mediated through the elastin receptor. This interaction has been implicated
in cell adhesion and intracellular signaling, but not with internalization or intracellular degrada-
tion of elastin. As the lysosomal catK is the protease with the strongest elastolytic activity known,
we examined endocytosis and lysosomal degradation of elastin and the role of the elastin recep-
tor in these processes. Using fluorescence microscopy and co-staining with the lysosomal marker
Lamp1, we observed binding of elastin to the cell surface followed by internalization to lysosomes
over a period of 1 to 4 days. Western blotting showed that incubation of cells with elastin induces
and activates catK. Both the internalization of elastin and the induction of catK by elastin were
inhibited by lactose. This demonstrates that these two processes are mediated through the elastin
receptor, as lactose specifically inactivates this receptor through negative cooperativity. Degrada-
tion of internalized elastin in lysosomes was shown using a labeled elastin that only fluoresces
upon degradation. Inhibition of catK using a specific catK inhibitor significantly reduced lysoso-
mal elastin degradation. This demonstrates that catK degrades elastin in lysosomes. We believe that
the elastin receptor-mediated internalization and subsequent intracellular degradation by catK com-
plements extracellular elastin degradation. This may play important roles in maintaining normal
homeostasis of the elastin metabolism and in skin disease with altered elastin turnover.
www.jidonline.org   S37
ABSTRACTS
223
Effect of L-4-Thiazolylalanine, a non-proteogenic amino acid, on biological processes essen-
tial for maintaining skin elasticity and improving the appearance of the skin
D Ptchelintsev, S Chen, JW Lyga, U Santhanam, R Wyborski and Q Zheng Avon Products, Inc.,
Suffern, NY
Elastic fibers, the essential extracellular matrix molecules which provide elasticity and resilience
to the skin, are made up of elastin polymer surrounded by fibrillin-rich microfibrils. Production of
mature and functional elastic fibers depends on a multi-step process, a key step being the crosslink-
ing of tropoelastin through a process catalyzed by one or more members of the lysyl oxidase fam-
ily of enzymes. Fibrillin-containing microfibrils aid in the assembly of elastin by serving as a scaf-
fold to ensure proper alignment of the fibers. Recent studies indicate that expression of lysyl oxidase
like-1 (LOXL1), a major lysyl oxidase enzyme in skin, declines in skin fibroblasts with age. We ini-
tiated a program to identify novel leads capable of stimulating LOXL1 and fibrillin with antici-
pated benefits of improving the appearance and resiliency of aged or photodamaged skin. Amino
acids have become increasingly important ingredients in anti-aging cosmetic formulations. Non-
proteogenic amino acids, although commonly used as intermediates and leads for modern drug
discovery, have received little attention in cosmetics research. They have greater structural diver-
sity over the 20 common natural amino acids and are not normally used in nature as building blocks
for protein synthesis. L-4-thiazolylalanine, a non-proteogenic amino acid, was identified in a research
program as having efficacy on several biochemical processes, including LOXL1 and fibrillin, tar-
geting the production of quality elastin fibers. We will present on both the chemical properties and
in vitro and in vivo efficacy of L-4-thiazolylalanine as a novel cosmetic ingredient for anti-aging
skin treatment.
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The ultrastructure of acantholysis in pemphigus vulgaris
MF Jonkman, GF Diercks, G van der Wier and HH Pas Dermatology, UMCG, Groningen,
Netherlands
The pathogenesis of the blister formation in pemphigus vulgaris (PV) is a matter of debate. The
major electron microscopic studies of pemphigus skin in human date back to the 60s and 70s of
the previous century, and did not take into account of the recent insights of cell signaling by
desmogleins. Here, we examined skin and mucosa of two patients with mucocutaneous PV and
mucosal PV by electron microscopy. Patient 1 had ELISA indices for anti-desmogleins 1 and 3 IgG
of 91 and 186 fitting with mucocutaneous PV, and patient 2 had anti-desmogleins 1 and 3 IgG of
16 and 247 U/ml fitting with mucosal PV. Punch biopsies were taken from Nikolsky positive (N+)
normal appearing skin in patient 1, and from N+ mucosa in patient 2. Electron microscopy of the
N+ skin and N+ mucosa showed widening of the intercellular cement susbstance (ICS) resulting
in gaps between cells, that were bordered by desmosomes pulling at the plasma membrane that
was stretched to its limits. In these partial acantholytic keratinocytes retraction of tonofilaments
was present. In the most advanced stage we saw incomplete acantholysis of keratinocytes with
pinched off desmosomes. The level of cleavage was intracellularly behind the desmosomal plaque
or in the tonofilaments. We could not find signs of splitting of desmosomes into two half-desmo-
somes. The early widening of the ICS and the absence of half desmosomes in acantholytic N+ skin
strongly argues against the theory that acantholysis in pemphigus is the result of direct steric hin-
drance of desmosomal cadherins. The intracellular cleavage behind the desmosomal plaque as
seen in this study agrees with the concept that intracellular mechanisms after outside-in signaling
weaken the bond between plaque and tonofilaments and precedes loosening of the desmosome
from the cytoskeleton. The early sign of widening of the interdesmosomal intercellular space in
N+ skin suggests that PV is initially not a desmosomal disease.
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Extracellular nucleotides inhibit EGF-induced hemidesmosome disassembly in keratinocytes
E Faure,1 F Garrouste,1 F Parat,1 S Taboubi,1 S Monferran,1 G Pommier,1 JC Hubaud2 and
M Lehmann1 1 Faculté de Pharmacie, INSERM UMR 911, Centre de recherche en oncologie
biologique et oncopharmacologie, Université Aix Marseille;, Marseille, France and 2 DIPTA,
Aix-en-Provence, France
Hemidesmosomes (HD) allow basal epithelial cell attachment to the underlying basement mem-
brane. Growth factors such as EGF regulate HD disassembly, a critical step for keratinocyte migra-
tion during wound healing. We recently identified extracellular nucleotides as new signaling mol-
ecule that can inhibit keratinocyte migration and in vitro wound healing by activating the Gq-coupled
purinergic (P2Y2) receptor (Taboubi, FASEB J, 2007). Here, we investigate purinergic signaling
implication in HD dynamics. Immunolabelling of HD components (plectin/HD1, α6β4, CD151)
revealed that extracellular UTP reversed the EGF-induced HD disruption in HaCat keratinocytes.
Pharmacological inhibition of Gq protein impeded UTP-induced HD stabilization, suggesting
thus that P2Y2/Gq pathway regulated HD dynamics. Moreover, studies performed in presence of
pharmacological inhibitors indicated that the Raf1/MEK1/Erk1/2 pathway might be required for
EGF-induced HD disassembly. As we previously showed that UTP activates P2Y2/Gq pathway to
inhibit Erk1/2 activation by growth factors (Taboubi, FASEB J, 2007), we thought to decipher the
crosstalk signaling between EGF and UTP. We showed that UTP inhibited the EGF-induced MEK1,
Erk1/2 and p90 Ribosomal S6 Kinase phosphorylation in a Gq-dependent manner. This inhibitory
effect did not affect the phosphorylation level of upstream MAP kinase cascade components such
as Raf1 and EGFR. Moreover, UTP failed to inhibit Erk1/2 phosphorylation in keratinocytes express-
ing a constitutively activated form of MEK. Together, these experiments suggest that UTP modu-
lates the EGF-induced MEK1 activation. To conclude, in keratinocytes, MEK1 appears to be a key
intermediate between EGF and UTP signalling pathways that oppositely regulate HD dynamics.
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Fate of the subepidermal nerve plexus of human skin in culture
CM Reinisch1 and E Tschachler1,2 1 Department of Dermatology, Medical University of
Vienna, Vienna, Austria and 2 Centre de Recherches et d’Investigations Épidermiques et
Sensorielles (CE.R.I.E.S.), Neuilly, France
The subepidermal nerve plexus constitutes the most distal part of the peripheral nervous system.
Being composed of nerve fibers ensheated by Schwann cells, it is a highly complex structure embed-
ded in the papillary dermis. Structural and functional changes of the subepidermal nerve plexus
have been shown in a variety of diseases, like diabetes and polyneuropathies. Yet, the evaluation
of the therapeutic benefit of treatments is limited to extensive clinical studies, as no applicable in
vitro model exists. Therefore, we separated split skin in dermal and epidermal sheets and cultivated
the dermal sheets for 3, 6, 9 and 12 days. In parallel, we cultured complete split skin for 12 days.
The complete split skin was separated in a dermal and epidermal sheet at day 12. As control
served a dermal sheet from day 0. Fixed dermal sheets were immunofluorescently processed for
Nerve Growth Factor Receptor, Neurofilament and Protein Gene Product 9.5 and analysed on a
Laser scanning microscope. As image analysis software Imaris was used. In cultured dermal sheets,
a progressive loss of staining for Neurofilament and PGP9.5 could be observed from day 3 on. At
day 12, there were neither Aδ-fibers nor C-fibers present any more. The Schwann cell scaffold in
contrast, was completely preserved at all time points. Moreover, Schwann cells showed a pro-
gressing increase in arborization from day 3 to day 12 compared to the control. In cultured com-
plete split skin, at day 12 nerve fibers were still present, amounting to approximately 29% of the
numbers found in the control sheet. However, no morphological changes of Schwann cells were
visible. Hence, our study demonstrates that the presence of the epidermis leads to a sustained sur-
vival of nerve fibers in dermal sheets in culture. In addition, we provide the first model system to
test the effects of therapeutic strategies on components of the subepidermal nerve plexus in vitro.
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MMP-2, but not MMP-9, is required for pemphigus foliaceus induction in mice
N Li,1 Z Liu,1 M Park,1 Z Werb2 and LA Diaz1 1 Dermatology, University of North Carolina,
Chapel Hill, NC and 2 Anatomy, University of California, San Francisco, CA
Pemphigus foliaceus (PF) is an autoimmune skin blistering disease characterized by IgG autoanti-
bodies to desmoglein-1. Acantholysis (cell-cell detachment) and intraepidermal blisters in PF are
restricted to the subcorneal layer of the epidermis. PF autoantibodies are pathogenic as shown in
the IgG passive transfer mouse model. The pathogenic mechanisms underlying the pemphigus
autoantibody-induced acantholysis and skin blistering are not fully elucidated. Several mechanisms
may be involved in pemphigus pathogenesis, such as direct interference with the desmoglein adhe-
sive function (steric hindrance), desmoglein depletion, desmosome assembly and disassembly,
intracellular signalings, keratinocyte apoptosis, and proteolysis. Previously we have shown that
caspase activation is critically involved in pemphigus skin blistering. In this study we investigated
the role of matrix metalloproteinases MMP-2 and MMP-9 in PF pathogenesis using the IgG pas-
sive transfer mouse model and commercially available MMP inhibitors. Administration of an inhibitor
specific for both MMP-2 and MMP-9 blocked acantholysis and the skin disease induced by path-
ogenic PF autoantibodies. In contrast, vehicle-treated mice developed subcorneal blisters. Inter-
estingly, a MMP-9 specific inhibitor showed no protective effect on skin disease induced by path-
ogenic PF autoantibodies. Furthermore, pathogenic PF autoantibodies induced PF-like acantholysis
and skin blisters in both wild-type mice and MMP-9 knock out mice. These results suggest that
MMP-2, but not MMP-9, may play a critical role in PF acantholysis and blistering.
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Catenin control of desmocollin gene expression
E Tokonzaba, X Cheng and PJ Koch Dermatology, University of Colorado Denver, Aurora, CO
A critical step in epidermal appendage formation is the invasive growth of placode keratinocytes
into the underlying dermis and the subsequent differentiation of these cells into the various cells
and tissues that constitute appendages. Invasive growth and differentiation both require extensive
remodeling of desmosomes which connect keratinocytes, a process which is characterized by a
change in the expression of desmosomal cadherins (e.g. desmocollins, Dsc). Of particular interest
to us is the mechanism that controls the switch from Dsc3 to Dsc2 that occurs in invading placode
keratinocytes. We began by testing whether catenins (plakoglobin, Pg; and beta-catenin, b-cat) and
associated factors (LEF, TCF3/TCF4) regulate the proximal Dsc promoters in transfection assays
using a simple epithelial cell line (MDCK cells). B-cat and TCF/LEF factors are components of the
Wnt pathway, which is required for appendage development. Our studies were performed using
a combination of reporter gene assays, ChIP assays, and biochemical studies. We show that catenins
differentially regulate the Dsc2 and Dsc3 promoters in vitro. First, we found that Pg can stimulate
both the Dsc2 and the Dsc3 promoters. However, in the presence of Lef-1, a co-activator which
is critical for appendage development, Pg activates the Dsc2 promoter, but inhibits the Dsc3 pro-
moter. Conversely, in the absence of Lef-1, only the Dsc3 promoter is active. Surprisingly, although
Pg can activate Dsc3 reporter constructs, it does not bind to the Dsc3 proximal promoter. In con-
trast, we found that both Lef1 and β-catenin can individually bind to the Dsc3 promoter. We are
currently testing a regulatory model in which Pg activates the Dsc3 promoter by counteracting b-
cat-mediated repression of the proximal promoter. In summary, our experiments reveal a catenin-
based gene regulatory network that differentially regulates the proximal Dsc2 and Dsc3 promot-
ers. Our results are consistent with the hypothesis that Pg signaling plays a critical role in remodeling
desmosomes during appendage formation.
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Type VII collagen enhances the osteogenic potential of human mesenchymal stem cells
through an ERK-dependent pathway
X Wang, J Cogan, H Zhou, Y Hou, W Li, D Woodley and M Chen Dermatology, University of
Southern Califirnia, Los Angeles, CA
Mesenchymal stem cells (MSCs) are pluritipotent cells that can differentiate into osteoblasts and
provide an excellent source for bone regenerative repair. The canonical Wnt-beta catenin, bone
morphogenetic protein (BMP), and extracellular matrix-mediated Ras-Erk signaling pathways have
all been implicated in playing a critical role in MSC osteoblast differentiation and bone formation.
We previously showed that type VII collagen (C7) dramatically enhances in vitro osteogenesis dif-
ferentiation of MSCs and promotes bone formation in vivo. In this study, we sought to identify the
signal pathway that mediates the C7-induced osteogenic potential of MSCs. We showed that
incubation of human MSCs with osteogenic medium supplemented with recombinant C7 resulted
in robust and sustained activation of ERK, demonstrated by increased ERK phosphorylation. This
ERK activation was associated with increased alkaline phosphatase activity, bone nodule forma-
tion, and calcium accumulation. The enhanced bone-forming ability of MSCs correlated with
increased expression of osteoblast markers including alkaline phosphatase, bone sialoprotein II,
Runx 2, osteopontin, and osteocalcin. Inhibition of ERK activation by U0126, a potent ERK1/2
inhibitor, blocked C7-induced osteogenic differentiation and bone formation of MSCs in a dose-
dependent manner, as did infection of MSCs with a lentivial vector expressing dominant negative
form of MAP kinase (MEK-1). In contrast, treatment of MSCs with recombinant DKK1, an inhibitor
of the canonical Wnt pathway, had no effect on C7-mediated MSC osteogenesis. Most interest-
ingly, inhibition of BMP signaling by treatment of MSCs with noggin, a BMP antagonist, increased
MSC osteogenic differentiation mediated by C7. Taken together, these results indicate that C7 pro-
motes the osteogenic differentiation of MSCs via an ERK signaling pathway, suggesting a potential
target for bone regeneration and repair.
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Embryonic trafficking of T cells to skin is dependant on E/P selectin ligands and CCR4
X Jiang,1 JJ Campbell,1 C Gerard2 and TS Kupper1 1 Brigham and Women’s Hospital, Boston,
MA and 2 Children’s Hospital, Boston, MA
Dendritic epidermal T cells (DETC) express invariant Vγ5/Vδ1 TCRs and reside in epidermis. Their
temporal development in thymus and important roles in tissue homeostasis, wound healing and
tumor immunosurveillance have been studied extensively. However, little is known about the
mechanisms and relevant molecules involved in the embryonic and neonatal epidermal traffick-
ing of thymic DETC precursors to skin. We hypothesized that DETC would use the same homing
molecules as adult αβ T cells to home to skin. We first showed that DETC within the epidermis of
the intact adult skin, as well as the DETC precursors in day 15 fetal thymus, stably expressed E
selectin ligand (E-lig) and P selectin ligand (P-lig). Mice deficient in the α1,3 fucosyl transferases
VII and IV do not express E-lig and P-lig. Compared to wild type mice, DETC within the epider-
mis of Fuc T-VII/VI -/- mice were dramatically reduced. However, the development of Vγ5 DETC
precursors in fetal thymus was indistinguishable in normal and Fuc T-VII/IV-/- mice, suggesting that
DETC precursors were produced in Fuc T-VII/IV-/- mice but could not effectively traffic to skin.
We tested this hypothesis by daily injection of specific blocking antibodies against E-selectin and
P-selectin into pregnant normal mice from gestational days 14 through 20. Mice born from anti-
E- and P-selectin treated dames, but not isotype control treated ones, had significantly diminished
DETC in skin. To test the role of chemokine receptors in DETC homing, we examined skin from
CCR4-/- and CCR10-/- mice, respectively. Skin DETC bearing Vγ5 were significantly reduced in
CCR4-/- mice, but were unaltered in CCR10-/- mice. Our results present the first evidence for the
crucial role of E-lig, P-lig and CCR4 in embryonic migration of DETC precursors to skin, indicat-
ing that fetal thymus provides a specific environment for the imprinting program of skin-selective
γδ T lymphocytes. This trafficking pathway is preserved in adult life and mediates both constitu-
tive and emergency T cell homing to skin.
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An acellular dermal equivalent derived from fibroblast cultures alone
D Lee and J Yang Dermatology, Sunkyunkwan University Samsung Medical Center, Seoul,
Korea, South
To construct dermal equivalents, various materials such as bovine collagen, human dead dermis,
and synthetic polymers have been used. Recently, we developed a new dermal equivalent by cul-
turing fibroblasts alone in special culture medium. In this study, we evaluated the usefulness of an
acellular dermal equivalent derived from fibroblast cultures alone. After the fibroblasts reached a
confluence, EGF and insulin were added. The dermal equivalent was produced in culture dish
over three weeks for the post-confluent cultures. In order to remove the living fibroblasts in the
dermal equivalent, repeated freezing and thawing was performed. Then, the acellular dermal equiv-
alent was placed with three layers superimposed in a polycarbonate filter chamber in the culture
dish. Epidermal keratinocytes were seeded on the top of the dead dermal equivalent. The cultures
were maintained at an air-liquid interface. Histologically, a multilayered epidermis with granular
and horny layers was formed on the acellular dermal equivalent in hematoxylin and eosin stain-
ing. It was very similar to the epidermis reconstructed on living dermal equivalent, which was
previously reported. Immunohistochemically, keratin 1 and 10 were expressed in the suprabasal
layers similarly to that in normal skin in vivo. The results of this study showed that normal look-
ing epidermis developed on the acellular dermal equivalent, suggesting that an acellular dermal
equivalent, derived from fibroblast cultures alone, may be useful for skin equivalent. As the dead
fibroblasts do not produce any new active ingredients, extracellular matrix in an acellular dermal
equivalent seems to be important for constructing skin equivalent. The advantages of our model
system are that the dermal equivalent can be constructed by culturing fibroblasts alone without
exogenous materials, a large volume of the dermal equivalent can be obtained from fibroblast cul-
tures, it can be stored for long periods because it is dead tissue and it is available at any time. Fur-
ther studies are necessary to evaluate its usefulness.
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Involvement of increased versican expression in the pathogenesis of keloids
E Araki,1 M Naitoh,1 S Aota,2 S Matsui,1 S Suzuki,1 Y Miyachi1 and A Utani1 1 Kyoto University
Graduate School of Medicine, Kyoto, Japan and 2 Center for developmental biology, RIKEN,
Kobe, Japan
Keloids are a refractory disease characterized by excessive deposition of extracellular matrices
(ECMs) whose etiology remains to be elucidated. We previously found that increased expression
of versican, a large chondroitin sulfate proteoglycan, was one of the key features that characterize
keloid tissues as well as cultured keloid cells (KL cells). In this study, factors regulating versican
expression KL cells and normal dermal fibroblasts were investigated using RT-PCR and luciferase
assay. KL cells showed two-fold higher transcription level. Screening of Wnt, β-catenin, TGF-β,
androgen, IL-1β and PI3K showed the latter two signals were involved in versican gene regulation.
Versican expression in normal skin wound healing process was also studied using C57BL mice.
Immunohistochemistry showed transient versican expression in the wounded dermis which reached
the maximum at 5 days post-wounding. To trace the destination of versican-expressing cells, we
generated transgenic mice expressing versican promoter-Cre recombinase/rosa26. The number of
LacZ positive cells peaked at 5 days post-wounding, thereafter decreased and disappeared within
14 days. We hypothesized that persistent survival and proliferation of these versican-expressing
cells might be involved in the keloid pathogenesis. In order to establish the experimental model of
keloids, we implanted KL cells with collagen sponge scaffolds in nude mice. Sponges with KL cells
(KL sponges) appeared thicker and more opaque and weighed significantly heavier than those
with normal fibroblasts (normal fb sponges) after 4 weeks. KL sponges deposited more versican
than normal fb sponges did, which suggested that this model reflected the ECMs-producing char-
acteristics of keloids. Administration of IL-1β and chondroitinase ABC to KL sponges for 4 weeks
successfully suppressed the deposition of glycosaminoglycans as well as the increase in weight.
This in vivo model could provide a valuable tool for the evaluation of therapeutic reagents tar-
geted for keloids.
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Type VII collagen promotes osteogenic differentiation of human dermal fibroblasts: poten-
tial application to bone tissue engineering.
D Woodley, J Cogan, X Wang, J Burnett, T Wu and M Chen University of Southern Califirnia,
Los Angeles, CA
Bone tissue engineering has emerged as a promising strategy for the repair of skeletal fractures.
However, clinical application of this approach has been hindered by the availability of a robust
mineralizing cell source. Non-osteogenic cells, such as skin dermal fibroblasts (HDFs), are an attrac-
tive cell-source because they are easy to harvest from autologous donor skin biopsies and have a
high capacity for in vitro expansion. HDFs have been shown to undergo “osteoinduction” when
stimulated with bone morphogenetic proteins (BMP) or vitamin D3. In this study, we tested the
feasibility of using type VII collagen (C7) to induce osteogenic differentiation of HDFs. We showed
that incubation of HDFs with medium supplemented with recombinant C7 induced the osteogenic
differentiation of HDFs, as demonstrated by increased matrix mineralization, bone nodule forma-
tion, and expression of osteogenic differentiation markers, including alkaline phosphatase, bone
sialoprotein II, Runx 2, osteopontin, and osteocalcin. Similarly, we found that genetically engi-
neered HDFs over-expressing C7 also could be readily induced into osteogenic differentiation.
Interestingly, overexpression of C7 in HDFs was sufficient to promote functional osteogenesis with-
out the presence of dexamethasone in the inductive medium. In contrast, DEB fibroblasts that
entirely lack C7 failed to differentiate along an osteoblastic lineage. Further, the C7-mediated
osteogenic differentiation of HDFs was completely abolished by a potent ERK signaling inhibitor,
U0126, or over-expression of the dominant negative mutant of MAP kinase (MEK-1) in HDFs. How-
ever, neither recombinant DKK1, an inhibitor of the canonical Wnt signaling pathway, nor nog-
gin, a BMP antagonist, had any effects on the C7-induced osteogenic potential of HDFs. These
results suggest that ERK signaling plays a role in C7-mediated osteogenic induction of HDFs. The
ability of C7 to induce an osteogenic potential in HDFs has potential for use in bone regeneration
and repair.
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Collagen XXIII - novel ligand for integrin α2β1 in epidermis
G Veit,1 B Eckes,2 J Käpylä,3 A Ishada-Yamamoto,4 T Krieg,2 J Heino,3 JA Eble5 and M Koch1,2 1
Biochemistry, University of Cologne, Cologne, Germany, 2 Deramtology, University of
Cologne, Cologne, Germany, 3 University of Turku, Turku, Finland, 4 Asahikawa Medical
College, Asahikawa, Japan and 5 Frankfurt University Hospital, Frankfurt, Germany
Collagen XXIII is a transmembrane collagen that exists in a membrane-bound and a shed form. It
is expressed in the epidermis and hair follicles predominantly as full-length protein. Cellular recep-
tors for collagens are β1-integrins. In epidermis, the only integrin binding native collagens is
α2β1. Its expression is restricted to basal keratinocytes. While α2β1 receptors at the basal surface
interact with basement membrane collagen IV and laminin 332, interaction partners for receptors
at lateral and apical surfaces have remained elusive. We demonstrate that collagen XXIII shows
high affinity direct interaction with integrin XXIII in an ion and conformation dependent manner,
using recombinant collagen XXIII ectodomain and integrin α2 I-domain or soluble α2β1 het-
erodimeric ectodomain. Solid phase binding studies were confirmed by surface plasmon resonance
spectroscopy, yielding a KD of 3x10-8 M. Would collagen XXIII be the elusive ligand of integrin
α2β1 in epidermis, contributing an unusual cell-extracellular matrix interaction that is - due to the
membrane-anchored localization of the ECM molecule - at the same time a cell-cell interaction?
HaCaT keratinocytes adhered to collagen XXIII in a Mg and Mn dependent manner and induced
assembly of focal adhesions. Neutralization of α2β1 in HaCaT or deficiency of α2 in primary ker-
atinocytes almost abrogated adhesion. In vivo, collagen XXIII and integrin α2β1 co-localized at
keratinocyte surfaces in non-desmosomal areas. In normal skin, the collagenous domains of mem-
brane-anchored collagen XXIII (370 amino acids) form a collagen fold of ca 110 nm length, which
is well capable of bridging the gap between adjacent cells. Taking this together with the localiza-
tion of collagen XXIII at sites of cell-cell contacts, we postulate a role for the collagen XXIII – inte-
grin α2β1 interaction in epidermal homeostasis by conferring cell-cell adhesion.
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BPAG1e regulates β4 integrin dynamics at the leading edge of migrating keratinocytes
KJ Hamill, SB Hopkinson, PJ DeBiase and JC Jones Cell and Molecular Biology, Northwestern
University, Chicago, IL
Integrin dynamics is well established as being important in cellular adhesion and migration. In
scratch wounded or migrating keratinocytes α6β4 integrin relocates from a primarily perinuclear
localization to the leading front where it colocalizes with BPAG1e (bullous pemphigoid antigen
1e, BP230). Utilising retroviral infection of human keratinocytes we have established cell lines
expressing GFP tagged β4 integrin and used these lines to investigate the role of BPAG1e in β4
dynamics in both migrating and stationary cells. Through fluorescence recover after photobleach-
ing experiments we demonstrate that at the leading edge of keratinocytes moving into a scratch
wound, β4 integrin is dramatically more dynamic than in stably adhered cells. Cells in which
BPAG1e expression has been targeted for knockdown by shRNA show reduced β4 integrin dynam-
ics at the leading edge relative to controls. In contrast, fluorescence recovery rates are unchanged
in stationary BPAG1e deficient cells. Moreover, in BPAG1e deficient cells the association of β4
integrin with the small GTPase Rac1 along with the activity levels of Rac1 and its downstream effec-
tor, the actin severing protein cofilin, are reduced. BPAG1e deficient cells also display aberrant
motility patterns relative to controls. These data suggest that reduced β4 integrin dynamics in
BPAG1e knockdown cells is a result of an inhibition in actin remodelling. Furthermore, they empha-
sise the importance of dynamic regulation of β4 integrin in determining keratinocyte migration dur-
ing wound healing.
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Type VII collagen increases invasion and migration of squamous cell carcinoma keratinocytes
isolated from patients with recessive dystrophic epidermolysis bullosa.
C Pourreyron, C Hogan, C Cole, K Purdie, L Bruckner-Tuderman, J McGrath, I Leigh and A South
University of Dundee, Dundee, United Kingdom
Recessive dystrophic epidermolysis bullosa (RDEB) is a mechano-bullous disease caused by muta-
tions in the COL7A1 gene which encodes type VII collagen (C7). There is currently no cure for this
disease and different strategies are being investigated to deliver C7 to patients. Because patients
are at risk of developing highly aggressive squamous cell carcinomas (SCC) we have assessed
whether C7 influences invasion and migration in RDEB-SCC keratinocytes. We have established
keratinocyte cultures from three separate RDEB patient SCC and compared their behaviour in the
presence or absence of either fibroblast delivered C7 (using an organotypic model of invasion), or
recombinant, retroviral delivered, C7 (using transwell and scratch wound assays). RDEB SCC ker-
atinocytes show on average a 2.3 fold increase (p=0.0047, TTEST) in invasion into collagen/ Matrigel
organotypic cultures populated with fibroblasts expressing functional C7 (12 separate fibroblast
populations derived from normal skin and SCC) when compared with RDEB derived fibroblasts
which do not express functional C7 (again, 12 separate skin and SCC populations). This increase
was not seen during the same experiment using non-RDEB SCC keratinocytes. We next performed
transwell assay, scratch assay and organotypic cultures using RDEB-SCC keratinocytes transduced
with full-length COL7A1 cDNA or vector controls. Expression of recombinant C7 induced a sig-
nificant increase in migration in all 3 RDEB SCC keratinocyte populations using the transwell
assay (n>4, p=3.0E-05, p=1.0E-05, p=9.3E-07, TTEST). Expression of recombinant C7 increased
scratch wound migration in 2/3 RDEB SCC keratinocyte populations (n=2) and increased invasion
in organotypic culture in 2/3 RDEB SCC keratinocyte populations (n=2). In conclusion type VII
collagen increases the migration and invasion of RDEB SCC keratinocytes.
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α6 integrin supports keratinocyte motility
KR Kligys, Y Wu, SB Hopkinson and JC Jones Cell and Molecular Biology, Northwestern
University, Chicago, IL
Keratinocyte migration is an important step for the proper closure of wounds as well as a key fac-
tor for tumor dissemination in skin cancer. Previous data demonstrate that the migration pattern of
keratinocytes, in vitro, depends on an α6β4 integrin-mediated signaling cascade to Rac1/Sling-
shot/cofilin. α6β4 integrin deficient keratinocytes display aberrant migration, in vitro, and delayed
wound healing, in vivo, when compared to wildtype cells. However, this phenotype may be due
to cell surface expression of α6β1 integrin, since the formation of this heterodimer is induced in
β4 integrin deficient keratinocytes. Therefore, to assess whether α6β1 integrin functions to impede
cell migration or alters the linear migration pattern of keratinocytes, we knocked down expression
of both α6β4 and α6β1 integrins in human keratinocytes using shRNA targeted specifically against
the α6A integrin subunit. A loss of α6 integrin expression leads to a concomitant decrease in β4
integrin surface expression, whereas β1 integrin surface level is unchanged. Cellular distribution
of BP230, BP180, and plectin are mislocalized in cells lacking α6 integrin expression compared
to wildtype keratinocytes. Interestingly, knockdown of α6A integrin expression results in a com-
plete loss of migration. Specifically, keratinocytes deficient in the α6 integrin display a fluttering
of their lamellipodia, and remain stationary. These data strengthen the concept that α6β4 integrin
signaling in keratinocytes determines cell polarization and directed migration. In the absence of
α6β4 integrin, α6β1 integrin supports keratinocyte motility but is incapable of mediating signals
required for directed migration.
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Synergistic action of a triple peptide complex (TPC) on an essential extracellular matrix (ECM)
protein exhibits significant anti-aging benefits
A Laloeuf,1 T AL-Bader,1 A Byrne2 and AV Rawlings3 1 Oriflame Skin Research, Stockholm,
Sweden, 2 Oriflame R&D, Dublin, Ireland and 3 AVR Consulting, Northwich, United
Kingdom
Basement membranes (BM) are thin structures present in the ECM that provide a supporting struc-
ture on which cells reside. Type IV Collagen (COL IV) is present in all BM and plays an important
role in cell adhesion, migration differentiation and growth. In this study, the ability of TPC to stim-
ulate the production of COL IV in human skin fibroblasts (FB) was investigated. FB matured to rep-
resent ‘aged’ cells were stimulated for 72h with TPC as well as the 3 individual peptides consti-
tuting TPC. COL IV production by the FB was determined by ELISA. The results show that stimulation
with the individual peptides at doses found in 1% (v/v) of TPC did not result in soluble COL IV pro-
duction above levels detected by the unstimulated cells. However, after stimulation with 1% (v/v)
of TPC, COL IV was produced by the cells when compared to control unstimulated cells. This
indicates that the combination of the individual peptides is necessary to synergistically stimulate
COL IV production. These findings suggest that TPC plays a role in the strengthening of the BM
through its ability to produce COL IV. In order to determine whether these results translated into
significant effects in vivo, we performed a 4 week, double blind, fully randomized clinical study.
This placebo-controlled study was performed on 22 healthy Caucasian volunteers displaying
moderate periorbital wrinkles. Product (3% (w/w) of TPC vs. placebo) application was performed
twice daily for 4 weeks. Alterations in wrinkle number were monitored by the application of sili-
cone replicas taken at baseline and after 4 weeks. Results were analysed by means of a students
paired t-test. A significant reduction in global aging aspects over the 4 week period in comparison
to placebo (6.88%, p<0.05) was observed in subjects applying the product containing TPC. More-
over, none of the volunteers experienced irritation or stinging during the study. These results show
how TPC can be used for anti-aging applications.
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Effects of a selected peptidic fragment from Dermatopontin on cultured human dermal fibrob-
lasts
G Menon,1 J Botto,2 C Serre,2 C Plaza,2 N Garcia,2 C Gondran,2 N Domloge2 and DJ Moore1 1
R&D, ISP, Wayne, NJ and 2 R&D, ISP Vincience, Sophia Antipolis, France
Dermatopontin (DPT) is a small molecular weight protein, widely distributed in the ECM, with
homologues known in several mammals and invertebrates. In the skin, it is located mainly on the
collagen fiber surfaces, but also found in cytoplasm of fibroblasts in vitro, and their culture medium.
Several functions of this protein have been discovered in the recent years, including its ability to
bind decorin and TGF beta - modulating the function of this cytokine. Targeted disruption of DPT
results in a phenotype of Ehlers-Danlos Syndrome, and the levels of DPT are reduced in Keloid
scars, pointing to its role in wound healing as well. In light of these interesting roles for this pro-
tein, we synthesized several peptidic sequences derived from DPT, and tested them on cultured
human fibroblasts, evaluating the treated cells using transmission electron microscopy. Of the var-
ious biopeptides tested in these initial studies, one has been identified to have significant effects
on the ultrastructural profile of the cells after 48 hours of treatment. Fibroblasts exhibited a signif-
icant increase in caveolae, endoplasmic reticulum, and Golgi complex. Additionally, some cells
demonstrated a high level of secretory activity, secreting an extracellular component into the cul-
ture medium. These experimental observations are presented and their potential significance will
be discussed. Additionally, treated cells also expressed enhanced ability for wound healing com-
pared to untreated controls, as seen in a “scratch wound” in culture. Potential effects of this biopep-
tide on epidermal keratinocytes are also under investigation in our lab.
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Differentiation of mouse bone marrow-derived stem cells and iPS cells into keratinocytes
and other skin components
M Itoh and AM Christiano Dermatology, Columbia University, New York, NY
Recessive dystrophic epidermolysis bullosa (RDEB) is a severe inherited blistering skin disease
caused by mutation in type VII collagen gene (COL7A1). The absence of type VII collagen pro-
duction leads to the loss of adhesion at the basement membrane zone due to the lack of anchor-
ing fibrils, which are comprised of type VII collagen. Patients with RDEB develop severe blisters
and open wounds from minor trauma to their skin. It has previously been shown that bone mar-
row-derived stem cells have pluripotency to differentiate into the other cell types, and further, that
bone marrow cells can contribute to skin remodeling during the process of wound healing. Recently,
several groups have demonstrated that bone marrow transplantation can provide the clinical improve-
ment of the RDEB mouse model (col7a1-/-), which suggests that bone marrow-derived stem cells
can home to skin, generate several cell types of skin components, and produce extracellar matrix
including type VII collagen. However, it is unclear which population of bone marrow-derived
cells can most efficiently generate skin components, and the mechanisms of differentiation into
skin components are not well understood. Additionally, in vitro methodology to generate skin com-
ponents, either from bone marrow-derived cells or iPS cells has not yet established. Our study
examined whether bone marrow-derived cells can be differentiated into keratinocytes and the other
skin components in vitro. We are working to identify which population of bone marrow cells gen-
erates skin cells with greatest efficiency. These studies will enhance our understanding of the cel-
lular dynamics which operate when bone marrow cells home to skin and participate in repair and
regeneration.
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Oxidative stress impairs TGF-β responsiveness by coordinate down-regulation of Type II TGF-
β receptor and Smad3 in primary human skin fibroblasts
T He, T Quan, JJ Voorhees and GJ Fisher Dept. of Dermatology, University of Michigan, Ann
Arbor, MI
Evidence indicates that oxidative damage plays a major role in age-related decline of tissue func-
tion, and contributes to cellular transformation leading to oncogenesis. The TGF-β pathway is the
primary regulator of extracellular matrix (ECM) production by human skin fibroblasts. Acute repet-
itive exposure to low level (200μM) hydrogen peroxide permanently causes loss of TGF-β respon-
siveness and down-regulates ECM synthesis in human skin fibroblasts. We have investigated mech-
anisms by which oxidative exposure reduces TGF-β responsiveness. Oxidative exposure specifically
reduced protein levels of type II TGF-β receptor (TβRII) (78%, n=6, p<0.05) and its down stream
effector transcription factor Smad3 (82%, n=6, p<0.05). Levels of other components of the TGF-
β receptor complex or Smad proteins were not altered. Consistent with impairment of the TGF-β
pathway, basal levels of two well established TGF-β-regulated genes, type I procollagen (COLI)
and Connective Tissue Growth Factor (CTGF) were also substantially reduced. Addition of TGF-
β1 (2ng/ml) to control fibroblasts for one hour significantly induced Smad3 phosphorylation (5-
fold, n=5, p<0.05) and nuclear translocation, as shown by Western analyses and immunofluores-
cence, respectively. Furthermore, TGF-β treatment stimulated COLI and CTGF protein levels 3.4-fold
and 5.6 fold, respectively (p<0.01, n=8). In contrast, oxidative exposure caused complete loss of
TGF-β induction of Smad3 phosphorylation, COLI, and CTGF. Separate restoration of TβRII or
Smad3 protein levels by transfection did not confer TGF-β responsiveness. However, expression
of TβRII and Smad3 together restored TGF-β-induced Smad3 protein phosphorylation (3-fold, n=5,
p<0.05), induction of COLI (2.4-fold n=5, p<0.05), and induction of CTGF (2.8-fold n=5, p<0.05).
These data demonstrate that oxidative exposure impairs TGF-β responsiveness and consequent
ECM production through coordinate reduction of TβRII and Smad3 in human skin fibroblasts.
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Plakophilin 2 integrates intracellular signals required for actomyosin remodeling necessary
for desmosome assembly and focal adhesion dynamics in epithelial cells
L Godsel,1,2 A Bass-Zubek,1 R Hobbs,1 V Todorovic´,1 N Garcia1 and K Green1,2 1 Pathology,
Northwestern University, Chicago, IL and 2 Dermatology, Northwestern University, Chicago,
IL
Members of the plakophilin (PKP) subfamily of armadillo proteins are components of desmosomes,
intercellular junctions essential for maintaining tissue integrity. Mutations in PKP family members
have been linked to skin and heart diseases, illustrating their importance in desmosome function.
PKP2 associates with the intermediate filament (IF) anchoring protein desmoplakin (DP) in cyto-
plasmic junction precursors. PKP2 knock down (KD) results in aberrant DP precursor dynamics
and junction translocation, dependent on regulation by PKP2-scaffolded PKCα. Cytochalasin D
blocks precursor translocation, so we investigated a role for PKP2 in actin remodeling events
required for desmosome assembly. Our data show that either pharmacological inhibition of myosin
II or PKP2 KD interferes with DP junction incorporation without affecting E-cadherin border accu-
mulation. PKP2 KD resulted in an altered temporal program of actomyosin rearrangements trig-
gered by cell-cell contact with retention of radially oriented stress fibers and a failure to reorgan-
ize into the normal, mature cortical distribution. RhoA accumulated at borders during early stages
of contact formation in controls; however, this recruitment was impaired in the PKP2 KD cells,
suggesting that RhoA mislocalization could affect membrane-proximal signaling. In support of
this hypothesis, activated focal adhesion proteins normally observed at leading edges during con-
tact formation were decreased upon PKP2 loss, suggestive of focal adhesion immaturity and a
lack of cell polarity. PKCα-dependent biochemical indicators of contractile signaling were ele-
vated in PKP2 KD cells, including an increase in myosin phosphatase inactivation and a corre-
sponding increase in myosin phosphorylation. The data support a model whereby PKP2 functions
as a scaffold to integrate PKCα and small G protein signaling for coordinating the dynamic cytoskele-
tal rearrangements necessary to drive desmosome assembly.
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How to improve quality of life in patients with recurrent genital herpes
G Taldibaeva,1 M Gomberg2 and L Bardenshteyn3 1 Central Research Institute for Skin and
Venereal Diseases, Moscow, Russia, 2 Department of Skin and Venereal Diseases, Moscow
State University of Medicine and Dentistry, Moscow, Russia and 3 Department of Psychiatry
and Narcology, Moscow State University of Medicine and Dentistry, Moscow, Russia
Genital herpes (GH) affects the quality of life (QoL) in patients, resulting in psycho-emotional and
depressive disorders. Strategy to suppress viral replication with nucleoside analogues seems to be
the most effective, but it may not prevent recurrences in all cases. The increased incidence of GH
makes it necessary to develop new methods for preventing it recurrence. Our objective was to
evaluate effect of complex therapy with nucleoside analogues and SSRI in preventing of GH
recurrences and in improving of health related QoL in these patients. We observed 73 patients
with frequent recurrences of GH. Health related QoL was measured using the MOS-SF-36. The
normal values for scale is >50. All patients were consulted by psychiatrist (ICD-10). All patients
received valacyclovir (500 mg twice daily for 5 days) during clinical recurrences of GH. Patients
with depressive disorders received also antidepressant Sertraline from the SSRI-group (50 mg
once daily orally for 24 weeks). Our results showed that scores for 6 out of 8 domains of the SF-
36 were significantly lower in those respondents who were most psychologically and sexually
disturbed by GH outbreaks and found it difficult to discuss the problem with their partner. After
24 weeks of Sertraline was started, mental status normalized in 52 (71.2%) of patients. There were
only 2 recurrences of GH during 1st and 2nd months of treatment and no recurrences for the next
4 months in these 52 patients. The scores of estimated QoL became more than 80 in 70 out of 73
patients (95.8%). In conclusion, complex therapy with episodic specific antivirals and SSRI is an
effective strategy for improving the QoL of patients with recurrent genital herpes. Newer thera-
peutic modalities, including the SSRIs, may further decrease the psychological morbidity of recur-
rent genital herpes and enhance the clinical benefit in the long term management of this condi-
tion.
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Characterization of cellular environment in post-therapeutic disease recurrence associated
with efalizumab
CA Pensabene,1,2 K Pierson,1 T Kikuchi,1 M Sullivan-Whelan,1 P Gilleaudeau,1 I Novitskaya,1
A Khatcherian,1 AE Cruz-Inigo,1,3 M Suárez-Fariñas,1 JG Krueger1 and MA Lowes1 1 Laboratory
for Investigative Dermatology, The Rockefeller University, New York, NY, 2 School of
Medicine, Stony Brook University, Stony Brook, NY and 3 Weill Cornell Medical College, New
York, NY
Efalizumab (Raptiva, Genentech Inc) is an FDA-approved biologic agent for moderate-to-severe
psoriasis vulgaris that is effective in 30-50% of patients. Efalizumab is a fully humanized mono-
clonal antibody to CD11a, the α-chain of lymphocyte function-associated antigen (LFA-1), which
is present on many leukocytes. LFA-1 interacts with intracellular adhesion molecules (ICAMs) for
leukocyte trafficking into tissues, antigen-presentation to T cells, and interaction with keratinocytes.
The mechanism of action of efalizumab in psoriasis may involve blockade of all these mechanisms.
Conversely, psoriasis recurs in most patients within 12 weeks of stopping efalizumab treatment.
Some recurrent lesions are highly inflammatory plaques. To better characterize recurrent/inflam-
matory psoriasis lesions, we conducted a clinical trial with a 12-week course of efalizumab, and
8 of 20 psoriasis patients developed new psoriatic lesions within 2-5 weeks of ceasing treatment.
Half of these 8 patients were responders, and half were either partial or non-responders (defined
histologically). Immunohistochemistry revealed a marked increase in leukocytes (DCs, macrophages,
and T cells) from the end of the treatment period until the onset of disease recurrence. In addition,
serveral types of leukocytes (CD3+ T cells, BDCA-1+ DCs, and CD11c+ DCs) are present in higher
numbers in disease recurrence compared to untreated, baseline lesions. The presence of these cells
suggests that releasing the CD11a blockade upon cessation of efalizumab treatment creates a
rapid influx of immune cells resulting in the development of new psoriatic lesions in some patients.
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Classical cadherins as key regulators of keratinocyte intercellular junctions
C Michels,1 T Buchta,1 W Bloch,2 T Krieg1 and CM Niessen1 1 Department of Dermatology,
University of Cologne, Cologne, Germany and 2 German Sport University, Cologne, Germany
Tight intercellular adhesion contributes to the skin barrier and requires the cooperative activity of
intercellular junctions like desmosomes, adherens and tight junctions. In vitro results have sug-
gested a primary and specific role for E-cadherin in the establishment and maintenance of not only
adherens junctions but also tight junctions and desmosomes. We recently found that in vivo epi-
dermal loss of E-cadherin did disturb tight junctions but not desmosomes. Together with older results
this raises the question whether classical cadherins are dispensable for desmosome formation or
whether the other classical cadherin in the epidermis, P-cadherin, can functionally compensate
for the loss of E-cadherin. To examine this, we lentiviral transduced control or E-cadherin-/- ker-
atinocytes with P-cadherin cDNA or hairpin RNAs against P-cadherin. Whereas junction forma-
tion was unaffected by P-cadherin knockdown in control cells, no obvious intercellular junctions
were formed upon downregulation of P-cadherin in E-cad-/- cells. Interestingly, expression levels
of desmosomal or tight junctions remained similar, suggesting that classical cadherins regulate junc-
tion formation on a posttranslational level. Overexpression of either E- or P-cadherin rescued
junction formation in P-cadkd/E-cad-/- keratinocytes. Similarly, P-cadherin was able to rescue
tight junctional barrier function in E-cad-/- cells. Desmosome formation requires the presence of
the classical cadherin extracellular domain. Our results show that classical cadherins are impor-
tant in the initiation of intercellular junction formation and that regulation of desmosomes and tight
junctions depends not on an E-cadherin specific function but on total levels of classical cadherins.
These findings are clinically relevant in light of recent observations that E-cadherin is a target of
pemhigus auto-antibodies and that P-cadherin is mutated in hypotrichosis associated with juve-
nile macular dystrophy.
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Rosacea unresponsive to oral zinc sulfate, a randomized controlled clinical trial
JT Bamford,1 CE Gessert,1 IV Haller1 and K Kruger2 1 Dermatology/Research, SMDC, Duluth,
MN and 2 Family Practice, Duluth Family Practice Clinic, Duluth, MN
Our objective was to confirm oral zinc sulfate as an effective rosacea treatment. A placebo-con-
trolled cross-over study found rosacea improved with oral zinc sulfate(69.3 mg elemental zinc
daily). We used research subjects that were adults with a diagnosis of roseacea with severity “greater
than mild” at enrollment. Patients were excluded if they had used zinc dietary supplements of >25
mg per day or any rosacea treatments during the prior 3 months. Our study design was prospec-
tive, double-blind, randomized, placebo-controlled. Informed consent, then baseline demographic
information was obtained. Beginning and end of therapy evaluations included: QOL, photographs,
blood samples and rosacea severity evaluations. Subjects were randomized to receive either oral
zinc sulfate 220 mg capsules, twice daily for 90 days (101.6 mg elemental zinc per day) or placebo.
Severity was assessed using an instrument adapted from “Rosacea Standard Grading System”. Qual-
ity of life was assessed using a rosacea-specific quality-of-life instrument(RosaQoL), blood was used
to determine zinc, copper and hemoglobin levels. Our results showed that the protocol called for
an accrual goal of 80 subjects. Because an interim data analysis of 53 subjects demonstrated zinc
sulfate use was not associated with improved outcomes based on pre-post rosacea severity scores,
the trial was discontinued. There were no differences in frequency of side effects between active
and placebo groups. In conclusion, taking 100 mg elemental zinc/day for 90 days was not asso-
ciated with improvement of rosacea severity. Additional analysis will be directed at examination
of subjects’ before-and-after photographs and self-reported quality of life, to identify trends and to
guide further research. The implication is that the use of zinc in the management of facial rosacea
is not supported by these findings.
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A prospective clinical trial of open label etanercept for the treatment of hidradenitis sup-
purativa
E Dommasch,1 RA Lee,1 J Treat,1 J Sciacca-Kirby,3 S Chachkin,1 J Williams,1 DB Shin,1 J Leyden,1
C Vittorio1 and JM Gelfand1,2 1 Dermatology, University of Pennsylvania School of Medicine,
Philadelphia, PA, 2 Center for Clinical Epidemiology and Biostatistics, University of
Pennsylvania School of Medicine, Philadelphia, PA and 3 Dermatology, Penn State Milton S.
Hershey Medical Center, Hershey, PA
Medical therapies for hidradenitis suppurativa are often ineffective. TNF-alpha inhibitors may be
a potential treatment for patients with moderate to severe hidradenitis suppurativa. We sought to
evaluate the safety and efficacy of etanercept for patients with severe hidradenitis suppurativa. A
prospective clinical trial of etanercept 50 mg subcutaneously per week was conducted in patients
with moderate to severe hidradenitis suppurativa. Efficacy was measured using a Physician’s Global
Assessment (PGA) and secondary physician and patient reported outcome measures including Der-
matology Life Quality Index (DLQI) scores, patient pain scores, and number of lesions. Respon-
ders were classified as those achieving at least a 50% reduction on the PGA at week 12 compared
to baseline. Only 3 out of the 15 patients who entered the study were classified as responders
(response rate of 20%; 95% CI: 4.3-48.1) based on the intention to treat analysis. DLQI scores
improved slightly from a median of 19 to 15 (P=0.02). Comparison of baseline to week 12 PGA
scores, as well as secondary outcome measures of lesion counts and patient pain scores, failed to
show statistically significant improvement. Etanercept was generally well tolerated; however, 2
patients discontinued the study due to skin infections at the site of hidradenitis lesions requiring
oral antibiotics. Our study demonstrated minimal evidence of clinically significant efficacy of etan-
ercept 50 mg SC once weekly in the treatment of hidradenitis. Future studies using higher doses of
etanercept are indicated, however, patients need to be carefully monitored for infection and other
adverse events. Randomized, controlled trials will be necessary to demonstrate the risk to benefit
ratio of TNF-α inhibitors in the treatment of hidradenitis.
248
4-Hydroxy-oxindole-3-acetic acid: A new natural skin whitener
JJ Wille1 and MA Berhow2 1 Cell Biology, Bioderm Technologies, Inc, Eastampton, NJ and 2
Natural Products, ARS/USDA, Peoria, IL
The search for new natural skin whiteners with improved safety and efficacy commands a high pri-
ority in world-wide personal and skin care markets. To meet this challenge and satisfy the need for
green/ecocitizenship, cosmetic companies have scoured the planet for more exotic plants and
places. Our search began nearer home with such ubiquitous commercial food plants as corn. The
story begins with the discovery that corn tassels produce a fragrant odor during pollination. Over
the past decade, corn tassel extracts have been prepared and examined in our laboratory to ana-
lyize their primary constituents and perform biochemical and biological assessments which have
demonstrated their anti-irritant, anti-oxidant and anti-microbial activities. Here, we report another
biological activity present in corn tassels, a natural skin whitener. HPLC analyses of hydroalcoholic
fractions of corn tassels, reveal many phenolic compounds among which is a predominant com-
ponent we have isolated and identified as 4-hydroxy-oxindole-3-acetic acid. This proprietary com-
pound was purified and its exact chemical composition determined by preparative HPLC and LC-
MS. Earlier, we made the observation that partially purified corn tassel extracts inhibit melanin
formation in common bread mold cultures. We have now completed studies showing that our puri-
fied indole compound is an effective inhibitor of mushroom tyrosinase, a key enzyme in melanin
synthesis pathway. Current efforts are focused on scale-up production and commercialization of
this prospective natural skin whitener.
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Hair care practices and the development of Central Centrifugal Cicatricial Alopecia
AO Kyei, W Bergfeld, S Harrison and M Piliang Dermatology/A61, Cleveland Clinic
Foundation, Cleveland, OH
Central Centrifugal Cicatricial Alopecia (CCCA) is the most common type of scarring alopecia, pri-
marily affecting black women. It has been linked to hair care practices. Although there is agree-
ment that hair care practices contribute to the development of CCCA, there have been few epi-
demiological studies to investigate this relationship. The purpose of this study is to investigate
potential factors that may be contributing to the development of CCCA. A questionnaire about hair
care practices, standardized by the North American Hair Research Society (NAHRS) for evaluation
of CCCA was administered to 37 African American women at a local church. This was followed
by a scalp exam using NAHRS CCCA hair loss scales to grade hair loss. Answers to the question-
naire were compared with the graded hair loss scales to determine if there is a relationship between
hair care practices and the development of CCCA. Of the 37 responders, 34 (92%) relaxed their
hair by chemical means. Only 3 out of the 37 (8%) responders were found to have CCCA using
NAHRS hair loss scales. All 3 used chemical relaxers in their hair. Of the 34 patients who used
chemical relaxer and did not have CCCA, 62% had some central hair loss (but did not meet crite-
ria for CCCA) and 75% had temporal/parietal hair loss. The responders’ perceived hair loss corre-
lated positively with the clinical assessment of hair loss (P<0.001 and correlation coefficient is 0.5).
Other associations include family history of hair loss (70%), adult acne (38%), and facial hair (32%).
There were no associations with diabetes, thyroid anomalies or fungal infection of the scalp. In
conclusion, the use of chemical relaxers is widespread among black women. It is thus important
to determine what relationship if any, this practice has with the development of CCCA. It is unclear
how much of the hair loss in this population can be attributed to the use of chemical relaxers since
only 2 people in this study did not use chemical relaxers. Larger studies are needed to better eval-
uate the factors causing CCCA.
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Sentinel node biopsy and post-surgical adjuvant therapy in metastatic melanoma
E Minutilli,1 U Trefzer,2 E Stockfleth2 and W Sterry2 1 Catholic University of Sacred Heart,
Rome, Italy and 2 Charitè University, Berlin, Germany
To correlate the size of sentinel node (SN) metastasis and therapeutic results obtained by post-sur-
gical adjuvant treatment in cutaneous melanoma. Sentinel node biopsy has to be performed for
cutaneous melanomas with Breslow’s thickness ≥ 1 mm or IV-V Clark’s level. Patients with sen-
tinel node metastasis (micrometastases = stage IIIA, macrometastases = stage IIIB, clinically pal-
pable metastasis = stage IIIC) will be treated with high-dose pegylated interferon-alpha (3-6 μg/kg/wk)
and tailored multitarget tyrosine kinase inhibitors (MTKIs) for more than one year, evaluating
recurrence-free survival (RFS) and overall survival (OS) in comparison with the different stages
IIIA-B-C of the metastatic melanoma. Patients with stage IIIA melanomas take advantages of the
most effective post-surgical adjuvant treatment, such as high-dose pegylated interferon-alpha ther-
apy (6 μg/kg/wk for 8 weeks and 3 μg/kg/wk for further 10 months), in terms of RFS rather than OS,
with acceptable toxicity, unlike patients with stage IIIB and IIIC. Higher doses of pegylated inter-
feron-alpha (3 μg/kg twice weekly) for a quite long period could permit to achieve better results in
terms of OS in stage IIIA and, eventually in combination with MTKIs, in stage IIIB and IIIC.
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Development and assessment of onion extract cream with sun protection factor for the
improvement of the appearance of post surgical scars
ZD Draelos,1 B Hardas,2 M Kaur,2 W Jones2 and W Murray2 1 Dermatology Consulting
Services, High Point, NC and 2 Research and Development, Merz Pharmaceuticals, LLC,
Greensboro, NC
Scars are sensitive to sunlight and sunburn faster than healthy skin and thus becoming discolored
and cosmetically unacceptable. Physicians recommend these patients to limit sun exposure and
use a sunscreen to prevent worsening of the overall appearance of the scar. With this medical need,
a new onion extract cream formulation was developed with added UVA and UVB sun protection
to help protect scars from sun exposure. With two onion extract formulations (gel and cream) con-
taining the same therapeutic ingredient, this study proves the newer cream formulation exhibits
comparable efficacy to that of the original gel formulation for the reduction of post surgical scar-
ring. Twenty subjects with symmetrical seborrheic keratosis on the upper chest were randomized
to evaluate the efficacy of the onion extract cream with SPF formulation on post surgical scars. The
surgical sites were allowed to heal for two weeks. At the end of week 2, subjects returned to the
research center for randomization to either the onion extract gel treatment group or onion extract
cream group. At this visit, all subjects underwent scar photography, a subject scar assessment and
an investigator scar assessment (via separate 4-point ordinal scales) and transepidermal water loss
(TEWL) measurement.Study subjects applied the onion extract gel and cream 3 times daily for 8
weeks. In summary, with two onion extract formulations (gel and cream) containing the same ther-
apeutic ingredient, it is important to prove the newer cream formulation exhibits comparable effi-
cacy to that of the original gel formulation for the reduction of post surgical scarring. Both the gel
formulation and the cream with SPF formulation showed comparable improvement in the appear-
ance of scars. e conclude that the onion extract cream with SPF 30 formulation is as effective as
the original gel formulation for the improvement of the cosmetic appearance of post surgical scar-
ring.
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LBH-589 inhibits NF-κB signaling pathway and synergizes with bexarotene to induce apop-
tosis in CTCL cell lines and patients’ Sézary cells
C Zhang, X Zhang, T Trynosky, S Molavi, E Gupta, A Villa-Prados and M Duvic Dermatology,
The University of Texas MD Anderson Cancer Center, Houston, TX
Although the pan histone deacetylase (HDAC) inhibitor, LBH-589 (Panobinostat) is currently in
clinical trials for cutaneous T-cell lymphomas (CTCL) and other hematologic malignancies, its mech-
anism of action is not fully known. The transcription factor, NF-κB, is constitutively activated and
therefore a potential therapeutic target in malignant T-helper cells. In this study, we investigated
whether LBH-589 modulates the NF-κB signaling pathway and whether there is synergism in com-
bination with bexarotene in CTCL cell lines and patients’ Sézary cells compared to normal CD4+
T cells. Cell viability was examined by the MTS assay. Apoptosis was determined by flow cytom-
etry analysis of annexin V/PI binding and sub-G1 populations. The NF-κB signaling pathway was
analyzed by EMSA and Western blots. LBH-589 (10-100 nM for 24 and 48 hrs) decreased cell via-
bility and induced apoptosis in a time- and dose-dependent manner in both vorinostat-sensitive
(HH) and -resistant (MJ) CTCL cell lines. LBH-589 (10-100 nM for 24 hrs) also caused significantly
more apoptosis of patients’ Sézary cells compared to normal CD4+ T-cells (p < 0.05). LBH-589
suppressed DNA binding of NF-κB, and decreased protein expression of the NF-κB activator RANK
and NF-κBp65 in CTCL cells. LBH-589 also modulated NF-κB-regulated proteins, including those
linked with apoptosis (bcl-2, bcl-xL, bax, and survivin), proliferation (c-myc), angiogenesis (VEGF),
and invasion (MMP-9). In addition, LBH-589 at lower doses (2 and 5 nM) combined with bexarotene
(1-10 μM) induced up to 5-fold more apoptosis than either alone. In summary, LBH-589, at clini-
cally relevant concentrations, inhibits the NF-κB signaling pathway and synergizes with bexarotene
to induce apoptosis in both vorinostat-resistant and -sensitive CTCL cell lines, and SS patients’ cells.
These translational studies support the ongoing clinical trial of LBH-589 and provide the rationale
for studying the combination of LBH-589 and bexarotene in CTCL.
S42 Journal of Investigative Dermatology (2009), Volume 129
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Modification of the cutaneous dermatomyositis disease area and severity index, an out-
come instrument
M Yassaee,1,2 D Fiorentino,3 L Taylor,4 C Coley,4 AB Troxel4 and V Werth1,2 1 VAMC,
Philadelphia, PA, 2 Derm, Univ. of Pennsylvania SOM, Philadelphia, PA, 3 Stanford Univ.,
Palo Alto, CA and 4 Biostatistics & Epidemiology, Univ. of Pennsylvania SOM, Philadelphia,
PA
A reliable and partially validated measure of skin disease severity in dermatomyositis known as
the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) has been developed
(Klein RQ, Br J Dermatol 2008). To simplify and improve the tool for clinical use, we modified the
outcome measure and validated the new version. The skin disease of twenty patients with der-
matomyositis was evaluated by the same dermatologist at each clinic visit between July and Novem-
ber 2008 using both the original and the modified CDASI. Physician global measures (PGMs)
were implemented to assess overall skin disease state, skin disease activity and skin damage. Spear-
man’s rho was used to determine the correlation between the total, activity, and damage scores
from both the original and the modified CDASI and their correlation with the three PGMs. The
correlation of the total, activity and damage scores between the original and the modified CDASI
were rsp= 0.99 (p<.0001), 0.99 (p<.0001) and 1.00, respectively. Comparing the physician over-
all skin scale to the scores of the original and the modified CDASI, the rsp= 0.76 (95% CI:0.60–0.92,
p<.0001) and 0.80 (95%CI:0.67-0.93,p<.0001) for the total score; 0.75 (0.58-0.92,p<.0001) and
0.77 (0.60-0.93,p<.0001) for the activity score; and 0.14 (-0.21-0.49,p=0.4515) and 0.10 (-0.27-
0.46,p=0.6022) for the damage score, respectively. However, comparing the PGM activity scale
to the activity score of the original and the modified CDASI, the rsp were 0.78 (0.61-0.95,p<.0001)
and 0.79 (0.63-0.95,p<.0001), respectively. Similarly, comparing the PGM damage scale to the
damage score of each version, the rsp were the same, 0.85 (0.75-0.94,p<.0001). We demonstrate
that the modified CDASI is perfectly correlated with the original CDASI and has equally good
concurrent validity with the PGMs. We also suggest that PGMs of skin disease activity and dam-
age should be assessed separately for greater value.
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Psoriatic patients with positive psychological factors have high serum level ofβ-endorphin
and poor sleep quality
Y Li, D Li, H Ma and X Yang Department of Dermatology, General Hospital of Air Force,
Chinese PLA, Beijing, China
Psoriasis is generally thought to be worsened by psychological factors. This presumption has been
supported primarily by retrospective studies using questionnaires. No controlled prospective study
on this issue has been performed. To detect the levels of serum β-endorphin (β-EP) and to explore
quality of sleep in psoriasis patients, 70 patients with psoriasis were divided into two groups:
those involving psychological factors or with abnormal results of self-rating anxiety scale (SAS) and
self-rating depression scale (SDS) were labeled as psoriatic patients Ι, and the others as psoriasis
patients Π. Meanwhile 32 normal healthy controls were grouped in the same way, respectively
labeled as normal controlsΙand Π. The levels of serum β-EP in all subjects were detected by radioim-
munoassay. The sleep quality of 12 patients with psoriasis and 19 normal healthy controls were
examined by polysomnography (PSG) . All results showed that the difference of β-EP level between
patients with psoriasis and normal controls was not significant (P>0.05). The level of β-EP in pso-
riasis patients Ιand normal controls Ιwas significantly higher than that of psoriasis patients Π and
normal controls Π respectively (P<0.01). The level of β-EP in post-treatment psoriatic patients was
significantly lower than that of patients before treatment (P<0.05). Hypopnea index, apnea-hypop-
nea index, lowest saturation in arterial blood, <90% oxygen desaturation index and SIT90 of pso-
riasis group were significantly higher than those of normal control group. The values of rMSASD
in psoriasis group were significantly lower than that of normal control group. Arrhythmia of non-
rapid eye movement sleep of psoriatic group was significantly higher than rapid eye movement
sleep. It suggests that there is the correlation between serum β-EP level and psychological factors.
β-EP may be participate in the processing of adjusting the whole body state. Sleep quality and lev-
els of respiratory disturbance index are all on the poor condition in psoriasis patients.
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Changes in the circulating leukocyte profile of subjects on lenalidomide for cutaneous
lupus erythematosus
I Braunstein,1,3 NG Goodman,2 M Rosenbach,3 J Okawa,3 C Kovarik,3 ET Luning Prak2 and
V Werth1,3 1 Dermatology, Philadelphia VA Medical Center, Philadelphia, PA, 2 Pathology &
Laboratory Medicine, University of Pennsylvania, Philadelphia, PA and 3 Dermatology,
University of Pennsylvania, Philadelphia, PA
Lenalidomide is a thalidomide analogue with potentially fewer side effects than thalidomide. Five
subjects with refractory CLE were treated with lenalidomide in an off-label trial and four of the
five subjects demonstrated skin improvement. One subject with skin improvement developed wors-
ening arthralgias and new-onset proteinuria and was withdrawn from the study. Here we report
trends in the circulating leukocyte subsets in four subjects with skin improvement and multiple
unique features of the leukocyte profile in the subject who developed arthralgias and proteinuria.
Flow cytometry was performed for dendritic cell, T-cell, B-cell, NK-cell, regulatory T-cell (Treg),
and T-cell activation markers at baseline and at weeks 2 and 6 of treatment. In the subjects show-
ing skin improvement the following trends were observed: decreased percentage of plasmacytoid
dendritic cells (pDCs) (mean±SEM: -74% ± 7%); progressive decline in circulating CLA+ lympho-
cytes at weeks 2 and week 6 (-74% ± 17% at week 6); and at least a 3-fold increase in Tregs from
baseline to week 6. Results for the non-responding subject did not follow these trends. The sub-
ject who developed arthralgias and proteinuria revealed many unique and robust changes in the
leukocyte profile, including elevated numbers of resting memory B cells at baseline (~14%), a 46-
fold increase in activated pDCs at week 6, and a 37-fold increase in plasmablasts at week 6. A
larger sampling of subjects is needed for further study; however, this descriptive longitudinal analy-
sis of peripheral blood leukocyte subsets suggests that circulating Tregs, CLA+ lymphocytes and
pDCs may serve as markers of clinical response in some CLE patients. Furthermore, these prelim-
inary data suggest that lenalidomide may activate pDCs and promote plasmablasts, potentially trig-
gering systemic disease in a subset of susceptible CLE patients.
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Diversity profile of the human skin microbiome
HH Kong,1 EA Grice,2 SP Conlan,2 C Deming,2 AC Young,2 GG Bouffard,2 RW Blakesley,2
ED Green,2 PR Murray,3 L Mijares,2,3 ML Turner1 and JA Segre2 1 Dermatology, NCI, NIH,
Bethesda, MD, 2 NHGRI, NIH, Bethesda, MD and 3 Microbiology Service, Department of
Laboratory Medicine, Clinical Center, NIH, Bethesda, MD
The skin serves as a primary defense against invading microbes and is also the site of complex host
and commensal microbe interactions that may be important to health and disease. A coordinated,
systematic effort to characterize the microbes residing in and on humans is underway. Current
genome technology allows determination of microbial diversity and abundance, enabling a more
comprehensive identification of resident microbes than routine culture-based methods. We previ-
ously identified Janthinobacteria and Pseudomonas as the dominant microbes in the antecubital
fossae of healthy volunteers using 16s rRNA phylotyping. To comprehensively analyze the micro-
bial variability of different cutaneous microenvironments and to determine if a core skin micro-
biome exists, we extended our survey to 20 skin sites on ten healthy volunteers. These skin sites
included sampling of hair-bearing/non-hair-bearing, sebaceous/non-sebaceous, and moist/dry
surfaces; comparable sites with bilateral symmetry to examine intrapersonal variation; and body
regions affected by common dermatologic disorders. Our initial analysis suggested that certain bac-
terial species predominate in cutaneous microenvironments sharing similar characteristics: Propi-
onibacterium predominated in sebaceous sites, Staphylococcus species predominated in moist and
sebaceous sites when compared to dry sites, and Corynebacterium species predominated in moist
sites. The degree of interpersonal variation was dependent upon the particular site. Each of the sites
surveyed harbored a unique bacterial community structure with differing ratios of dominant and
rare species. Our long term goal is to elucidate the contribution of the cutaneous microbiome to
skin disorders and translate this into novel treatments.
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Pityriasis versicolor: A systematic review of interventions
SW Hu1 and M Bigby2 1 Harvard Medical School, Boston, MA and 2 Dermatology, Beth Israel
Deaconess Medical Center, Boston, MA
Pityriasis versicolor is a common, well-known condition with a wide array of therapeutic options,
yet a current summary and consensus on their comparative efficacy is lacking. The purpose of this
study is to systematically review all published controlled trials of topical or systemic agents used
in the treatment or prevention of pityriasis versicolor and to synthesize available evidence in terms
of efficacy, tolerability, and adverse effects. Data sources included the Cochrane Skin Group Spe-
cialized Register (to June 2008), Cochrane Central Register of Controlled Trials, Medline (1950 to
June 2008), Embase (1974 to June 2008), sources for registered trials (to November 2008), and the
gray literature. Reference lists of all retrieved trials and reviews were checked for additional trials.
Controlled trials in children or adults with a microscopic or clinical diagnosis were included. The
primary outcome measure was achievement of negative direct microscopy of skin scrapings. Results
in 7,888 participants in 86 controlled trials revealed that studies investigating treatment efficacy
for pityriasis versicolor are poorly reported and low in quality. Most topical therapies are effective
when compared to placebo with NNT’s of 1-3. Studies comparing one agent or regimen with another
had significant heterogeneity in design that prevented combination into a meta-analysis, but data
suggest that longer duration of treatment and higher concentrations of active agents produce greater
cure rates. Extensive disease can be successfully and safely treated with the oral imidazole anti-
fungals. Data suggest that ketoconazole 200 or 400 mg daily for 5-10 days, itraconazole 200 mg
daily for 5-7 days or 100 mg daily for 2 weeks, or fluconazole 300 mg weekly for 2-4 weeks are
effective. Data on prevention of recurrences are sparse. Optimal regimens for topical or oral treat-
ment or prevention of pityriasis versicolor have not been established, and randomized, controlled
clinical trials are needed to establish relative efficacy of topical and systemic agents used in the
management of pityriasis versicolor.
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Anti-fungi property of China-Hemp fiber and its texture against Dermatophyte
Y Dang, Y Li, D Li, H Ma and X Yang Department of Dermatology, General Hospital of Air
Force, Chinese PLA, Beijing, China
Recently, people are attracted by the antibiosis property of China-Hemp fibers. Some experiments
reveal that China-Hemp fibers have antibacterial effects. but the anti-fungi property of China-Hemp
fibers remain unclear. There is even no method to evaluate their anti-fungi effects.Based on the pre-
vious tests which were used for testing the antibacterial property of anti-bacterial fabrics, we choose
Flask-shaking test and Quinn test as the methods for our experiments through adjusting and select-
ing the right test parameters. Flask-shaking test can keep fungus and fibers in contact with each
other completely. After shaking 72h in the flask and then examining the antibiosis rate by colony
numeration. In Quinn test, Trichophyton rubrum, T.mentagrophytrs and Microsporum canis had
been inoculated in the China-Hemp fibers texture and cotton respectively. It involves cultivating
60h and then comparing the size of their coenobium.Flask-shaking test shows that the antibiosis
rate of China-Hemp fibers and its texture are much higher than those of Cotton fiber and cotton
fabric (P<0.01). The antibiosis rate of China-Hemp fibers against Trichophyton rubrum, T.menta-
grophytrs and Microsporum canis are 61%,68% and 70% respectively. The antibiosis rate of China-
Hemp texture against the three Dermatophytes are 49%,53% and 44% respectively. The result
also shows that the antibiosis rate of China-Hemp fibers is higher than its texture (P<0.01). Quinn
test reveals that the coenobium of Trichophyton rubrum, T.mentagrophytrs and Microsporum
canis on China-Hemp texture is much smaller than the cotton contrast after growth of 60h.The
results above suggests both of China-Hemp fibers and its texture have refrain impact on Trichophyton
rubrum, T.mentagrophytrs and Microsporum canis. China-Hemp fibers refrain Dermatophyte more
seriously than its texture.
www.jidonline.org   S43
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Topical 5-FU improves photoaging
D Sachs,1 S Kang,2 C Hammerberg,1 Y Helfrich,1 D Karimipour,1 J Orringer,1 T Johnson,1
T Hamilton,1 G Fisher1 and J Voorhees1 1 Dermatology, University of Michigan, Ann Arbor, MI
and 2 Dermatology, Johns Hopkins University, Baltimore, MD
It has been observed that patients undergoing topical 5-fluorouracil (5-FU) for actinic keratoses
(AKs) have improvement in photoaging. Epidermal wounding results in a wound healing cascade
which culminates in dermal collagen remodeling. We investigated whether an FDA approved twice
daily two week course of topical 5-FU triggered wound healing events and associated collagen
remodeling. Twenty-one subjects, ages 56-85, with AKs and photodamage completed treatment to
the face. This was a non-randomized, open label study followed by clinical and molecular evalu-
ations. Skin biopsies were performed 1 day and 2, 8, and 22 weeks after the last application of 5-
FU. Gene and protein expression of molecular effectors of epidermal injury, inflammation, and
extracellular matrix remodeling were quantified by reverse transcriptase real-time PCR technology
and ELISA. Clinical improvement was measured by evaluators, photography and questionnaires.
One day following final 5-FU treatment, gene expression of keratin 16, a marker of epidermal injury,
was increased by 7-fold (p<.05, n=16), and mRNA of the primary inflammatory mediator, IL-1β,
more than doubled (p<.05, n=16). MMP-1 and MMP-3 mRNA levels were significantly increased
at 1 day following the last 5-FU application by 480-fold and 180-fold (p<.05, n=16). Types I and
III procollagen mRNA were induced at week 2 by 7-fold and 3-fold (p<.05, n=15). Type I procol-
lagen protein levels were increased two-fold at week 22 (p<.05, n=10). At 22 weeks the mean num-
ber of AKs was reduced from 11.6 to 1.5 (p<.05), and the global severity rating of photoaging was
reduced from 5.38 to 4.63 (p<.05). Following topical 5-FU significant clinical improvement was
associated with increased procollagen and was noted in skin without AKs. In summary, topical 5-
FU causes epidermal injury which stimulates wound healing and dermal remodeling resulting in
improved appearance. 5-FU evokes a wound healing response similar to laser treatment and aggres-
sive microdermabrasion for photoaging.
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Poor correlation between specific IgE values and food reactions in young children with atopic
dermatitis
LE Keck, EL Simpson, TM Berry and JM Hanifin Dermatology, Oregon Health & Science
University, Portland, OR
True food allergy prevalence among university clinic patients with atopic dermatitis (AD) is 30-
40%. Controversy exists on 1) the accuracy of IgE tests in predicting food reactions and 2) the rela-
tionship of food allergy to AD. Predictive values of specific IgE levels vary with age and severity
making risk assessment imprecise. We assessed 1) the frequency of reported type I food reactions
in a 3-5 yo AD cohort and 2) the correlation between Type I Reactions and specific IgE levels. Infants
3-18 mo with AD but no history of food or respiratory allergy were enrolled in a prospective, lon-
gitudinal flare prevention trial. Specific serum IgE levels for 6 foods (RAST) were determined at 3-
5 yo. Parents were interviewed regarding past/current food-specific reactions (skin, gut or respira-
tory) within 30-120 minutes of ingestion. Data were entered into Excel for calculations of sensitivities,
specificities, PPV’s, and NPV’s using a standard 2x2 table. Results in 40 patients revealed one or
more Type I reactions from exposure to egg white in 7/38 (18%), peanut in 4/37 (11%) and milk,
2/39 (5%). None reacted to wheat, soy or fish. Overall, 24% of these children had developed food
allergy during the study but 72% had specific IgE above the normal level (0.34 IU/ml). Many patients
with elevated IgE had no clinical reactions from current exposure to the food. Predictive values
varied widely, leaving risk-assessment uncertain over a 20- to 40-fold range between weak and
high, “definitely allergic” probability levels. Peanut was the only allergen to delineate between low
versus high IgE and true clinical reactions with PPV of 85%. The prevalence of food allergy in
these mild to severe patients with AD presents a more representative spectrum than the “highly
atopic” patients previously studied and used for allergy prediction. This study suggests that diag-
noses and prevalence estimates of food allergy in infants and children with AD may be consider-
ably inflated and that population-based cohorts may provide a more realistic model for risk assess-
ment.
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Treatment of melomental fold rhytides with nonanimal sourced hyaluronic acid combined
with botulinum toxin A compared with nonanimal sourced hyaluronic acid alone
T Custis,1 D Beynet,1,2 D Carranza,1 G Lask1 and J Kim1,2 1 Dermatology, David Geffen School
of Medicine at the University of California Los Angeles, Los Angeles, CA and 2 Dermatology,
Greater Los Angeles Healthcare System Veterans Affairs, Los Angeles, CA
The combination therapy of nonanimal sourced hyaluronic acid (NASHA) and botulinum toxin A
(BTX-A) for glabellar furrowing has been shown to have higher clinical effectiveness than BTX-A
treatment alone. While injectable filler monotherapy has been noted effective in the perioral region,
the clinical effectiveness of combination treatment with NASHA and BTX-A to melomental fold
rhytides is not well documented. The purpose of this study was to compare the efficacy of BTX-A
and intradermal NASHA combination therapy with the efficacy of NASHA monotherapy in patients
with melomental fold rhytides. 23 patients with melomental fold rhytides were randomized for
this double blind, placebo controlled, prospective study. Thirteen of the patients received the
combination therapy to their right melomental fold area and 10 to their left. Each subject also
received NASHA and a placebo saline injection to the contra-lateral side. Responses were assessed
both clinically and photographically at 2 weeks, 1 month, 3 months, 6 months, 9 months, and 12
months. The BTX-A plus NASHA group showed a significantly better response compared to the
NASHA alone group at 2 weeks and 1 month by photographic review. The median time for return
to pretreatment rhytide was at 32.5 weeks in the NASHA alone group compared to 39 weeks for
the combination therapy group. In conclusion, melomental fold rhytides were treated more effec-
tively by BTX-A and intradermal NASHA combination therapy than NASHA monotherapy.
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Treatment of cutaneous malignant myoepithelioma on the nasal ala using mohs micrographic
surgery in a two and a half year old child
A Bajoghli1,2 and J Limpert1 1 George Washington University, Washington, DC and 2 Inova
Fairfax Hospital, Falls Church, VA
To demonstrate the efficacy of Mohs micrographic surgery in the treatment of a facial cutaneous
malignant myoepithelioma in the pediatric population. A two and half year old female presented
to her pediatrician for a growing “cyst” on the right side of her nose for the past several months.
She was referred to a plastic surgeon who performed the initial skin biopsy on the right nasal ala
which revealed a cutaneous malignant myoepithioloma. The lesion was treated by local excision
which confirmed the initial diagnosis. The tumor was incompletely excised. The patient was sub-
sequently referred for Mohs micrographic surgery. The tumor was excised using the Mohs fresh tis-
sue technique requiring one stage. The resultant defect was reconstructed at the same time. There
has been no evidence of recurrence at the 4 year follow up visit. We report the first case of Mohs
micrographic surgery for the treatment of a malignant cutaneous myoepithelioma in the pediatric
population with a small resultant defect, excellent cosmetic follow up and no recurrence at four
year follow up. Mohs micrographic surgery is a safe treatment in the pediatric population for the
treatment of rare skin cancers such as cutaneous malignant myoepithelioma. This represents an
alternative option over wide excision due to its accuracy in assessing exact tissue margins. The
physician can be sure at the time of the procedure that clear margins have been established. This
method also allows for an excellent cosmetic result.
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Th17 T-cells are reduced in atopic dermatitis (AD) lesions compared to psoriasis vulgaris
K Nograles,1 LC Zaba,1 A Shemer,2 T Kikuchi,1 M Ramon,3 I Cardinale,1 R Bergman,3 JG Krueger1
and E Guttman-Yassky1,4 1 Investigative Dermatology, Rockefeller University, New York, NY,
2 Dermatology, Tel-Hashomer Medical Center, Ramat Gan, Israel, 3 Dermatology, Rambam
Medical Center, Haifa, Israel and 4 Dermatology, Weill-Cornell Medical College, Cornell
University, New York, NY
Psoriasis and atopic dermatitis (AD) are common inflammatory skin diseases. Up-regulated Th17/IL-
23 pathway was recently demonstrated in psoriasis. Although potential involvement of Th17 T-
cells in AD was suggested during acute disease, the role of these cells in chronic AD remains unclear.
To allow an interpretation of differences in IL-23/Th17 signal between these diseases and establish
relative frequencies of these cell subsets in AD, skin biopsies and peripheral blood were collected
from chronic AD (n=12) and psoriatic (n=14) patients. Relative frequencies of Th1, Th2 and Th17
cells within these two compartments were examined by intracellular cytokine staining and flow
cytometry. In peripheral blood, no significant difference was found in percentages of Th1, Th2 or
Th17 T-cells between the two groups. In contrast, psoriatic skin had significantly increased fre-
quencies of both Th1 and Th17 cells compared with AD. Th2 cells in skin were significantly
higher in AD compared to psoriasis. A significantly higher percentage of IL-4+IL-22+ CD4+ T-cells
was shown in AD skin compared to psoriasis, suggesting that IL-22 production is not exclusive to
Th17 cells. Our findings of decreased Th17 T-cells in AD skin compared to psoriasis, together with
previous data showing reduced IL-17/IL-23 mRNA expression in AD skin, supports a relative defi-
ciency of Th17/IL-23 pathway in chronic AD skin. Given the number of emerging biological ther-
apies that directly target components of the Th17/IL-23 pathway, further elucidation of the role of
Th17 T-cells in acute AD, as well as factors that suppress the Th17/IL-23 pathway in this disease,
are warranted.
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A clinical and mycological assessment of patients with Tinea Pedis receiving topical treat-
ment of anti fungal drugs using newly developed medium which contains deactivator drugs
toward antifungal agents
M Adachi Dermatology, Kanto Rosai Hospital, Kawasaki, Japan
Using newly developed medium, combined deactivators supplemented agar medium(CDSAM),
the viability of dermatophytes in the scales was clinically evaluated. Culture studies were carried
out using both CDSAM and normal Sabouraud`s dextrose agar(SDA) for skin scales taken from 44
patients of tinea pedis, treated with topical antifungal drugs for two weeks. 64% of cases wewe
mycological positive on CDSAM, while only 23% of cases were positive using SDA, convention-
ally used agar medium. And 36% of all cases were negative on both CDSAM and SDA. The exper-
imental data from this clinical study showed that CDSAM was more useful than SDA for evaluat-
ing the efficacy of anti-fungal drugs correctly, because combination of deactivators would support
the fungal recovery by minimizing the effect of specimen associated drugs residues.
S44 Journal of Investigative Dermatology (2009), Volume 129
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Increased Syndecan4 expression in malignant T-lymphocytes is associated with progression
in Mycosis Fungoides
A Dougherty,1 L Shiue,1 V Prieto,2 R Bassett,3 X Ni1 and M Duvic1 1 Dermatology, University
of Texas MD Anderson Cancer Center, Houston, TX, 2 Dermatopathology, University of Texas
MD Anderson Cancer Center, Houston, TX and 3 Biostatistics, University of Texas MD
Anderson Cancer Center, Houston, TX
Following antigen-mediated TCR stimulation, CD4+ T-cell activation/inhibition is governed by
receptor-ligand interactions with antigen presenting cells(APCs). Mycosis Fungoides (MF),the most
common form of cutaneous T-cell lymphoma (CTCL), is hypothesized to arise from unknown per-
sistent antigens driving an expansion of clonal, epidermotropic, CD4+/CD45RO+ memory T lym-
phocytes. Syndecan4 (SD4),a proteoglycan expressed on normal T-cells, is up-regulated by anti-
gen-mediated TCR stimulation and attenuates T-cell activation once it is ligated to dendritic
cell-associated heparin sulfate proteoglycan-dependent integrin ligand (DC-HIL)on APCs. To study
the role of SD4 in CTCL, we evaluated SD4 expression by immunohistochemistry in lesional skin
biopsies from 22 patients with histopathologically suspicious lesions, lymphomatoid papulosis
(LyP), and MF lesions across T1-T4 stages. Skin lesions were divided into 3 stage-dependent groups:
early-suspicious lesions (n=2), LyP (n=3), &MF stageIa (n=2); mid-MF stageIb (n=8); and late-MF
stageIIb (n=2), stageIII (n=1), &stageIVb (n=4). SD4 expression was determined using semi-quan-
titative assessment of both intensity and frequency of positively staining in lymphocytes. We also
studied protein expressions in CTCL lines (HH,Hut78,MJ) using Western blotting. In MF lesions,
most intense staining was observed in late-stage lesions (T3-T4) in both epidermal
(mean=1.48;N=22;F=4.34;p=0.02) and dermal lymphocytes (mean=2.14;N=22;F=13.3;p<0.001)
among all stages. Likewise, highest percentage of positively staining was found among dermal lym-
phocytes in late-stage lesions (mean=58.3%;N=22;F=3.91,p=0.03) although the percentage of pos-
itive cells in epidermal lymphocytes were similar among all 3 stages (p=0.67). SD4 protein was
also detected in cultured CTCL lines. Our results suggest that SD4 expression may be up-regu-
lated with malignant transformation and could serve as a potential therapeutic target.
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Development of a good manufacturing practice (GMP) facility
T Yufit,1,2 P Carson,1,2 T Kwak,1,2 S Iwamoto,1,2 D Fiore1,2 and V Falanga1,2,3 1 Dermatology and
Skin Surgery, Roger Williams Medical Center, Providence, RI, 2 NIH Center of Biomedical
Research Excellence, Roger Williams Medical Center, Providence, RI and 3 Department of
Dermatology and Biochemistry, Boston University, Boston, MA
The FDA is now requiring investigators to receive their approval in the form of Investigational
New Drug (IND) or Investigational Device Exemption (IDE) for existing therapeutic agents being
used for different non-approved clinical applications or for any manipulation of the drug or agent.
Generally, and certainly for any new products or in vitro manipulation of cells, this requires Good
Manufacturing Process (GMP) facilities. GMP is different and its creation and maintenance requires
more stringent quality control and assurance than a Good Laboratory Practice (GLP) facility. The
use of GMP is particularly important in the field of tissue repair and wounds, where products are
likely to be applied topically after in vitro production or manipulation. We have recently gone
through this process from the very beginning and report the work, inclusive of performing FDA-
mandated dry runs on the final living cell product. This very stringent process consists of the fol-
lowing components: 1) creation of the actual GMP facilities and certification (anti room, ceiling
with HEPA filter, clean room architecture, and compliance with Class 10K); 2) development of pro-
tocols and standard operating procedures (SOPs are required for all procedures conducted in the
GMP facility. This includes equipment together with calibration and validation; SOPs are generic
(applied to equipment and reagents) and specific (a function of the product being created); 3)
quality control and assurance, which requires annual training of GMP personnel and internal audit-
ing of the process; 4) maintenance of GMP status, including semiannual environmental certifica-
tion of GMP rooms, annual calibration of all equipment. In this report, we outline the steps that
are required for developing an IND submission to the FDA and discuss the challenges and how to
overcome them.
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Mechanism of suppressive effect of lipoic acid on the UVB-induced erythema reaction in
vivo
T Bito,1,2 S Fukamachi,1 T Mori,1 R Yoshiki,1 T Shimauchi,1 M Nakamura,1 C Nishigori2 and
Y Tokura1 1 Dermatology, University of Occupational and Environmental Health, Kitakyushu,
Japan and 2 Dermatology, Kobe University Graduate School of Medicine, Kobe, Japan
Biological thiols can play a typically defensive role to the external stress, leading to metabolic
maintenance of the cells in vivo. Although various therapeutic effects of α-lipoic acid (LA) have
been reported, only a few studies have been performed to elucidate the in vivo effect. We aimed
to investigate the biological effect of reactive oxygen species on ultraviolet (UV)-induced skin dam-
age in vivo with LA. Twenty-one healthy volunteers were enrolled in the study under the informed
consent. Before and after oral administration of LA or placebo, minimum erythema dose (MED) of
UVB was assessed by dermatologists with colorimetric measurements. The LA group showed a sig-
nificant reduction of erythema reaction and an increase of MED compared to the placebo group.
To further elucidate the molecular mechanisms of the LA effect, human primary keratinocytes (HEK)
were utilized for the following experiments. The pretreatment with LA prevented UVB-induced
apoptosis in HEK via the modulation of capase-3 pathway. In addition, LA pretreatment augmented
Stat3 activation after UVB irradiation in HEK, indicating the involvement of apoptotic pathway in
its molecular mechanisms. The results suggest that LA has a protective ability on UVB-induced
skin damage by modulating the signaling pathway to apoptosis in epidermal keratinocytes.
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Aberrant toll-like receptor signaling increases kallikrein in rosacea
K Yamasaki,1,2 K Kanada,1 S Morizane,1 AL Cogen,1 T Nakatsuji1,2 and RL Gallo1,2 1
Dermatology, UCSD, San Diego, CA and 2 VA San Diego, San Diego, CA
The epidermis of patients with rosacea has increased and abnormally processed Cathelicidin antimi-
crobial peptides that are generated by serine proteases kallikrein 5 (KLK5). These peptides lead to
an inflammatory and vascular reaction in mice that resembles the characteristic histopathological
changes in rosacea. Here we sought to explain the abnormal Cathelicidin and KLK5 expression in
rosacea. We hypothesized that innate immune events would be involved since this system is respon-
sive to factors that exacerbate rosacea, and peptides like Cathelicidin have previously been shown
to be induced by innate immune elements such as toll-like receptors (TLRs). Quantitative RT-PCR
and immunostaining showed higher TLR2 expression in rosacea skin (P=0.04, N=11). Consistent
with elevated TLR2, TNFα was also elevated in rosacea skin (P=0.01, N=11). To test the signifi-
cance of elevated TLR2 in keratinocytes we overexpressed TLR2 by adenovirus (Ad-TLR2) in nor-
mal human keratinocytes, and this resulted in increased KLK5 protein (Ad-TLR2-treated:104.3±36.06
vs non-treated:0.07±0.02 ng/ml, P<0.01) and total protease activity (2-fold increase, P<0.001) sim-
ilar to findings in rosacea. Furthermore, Ad-TLR2 and the addition of a TLR1/2 ligand (Pam3CSK4),
or addition of P.acnes, augmented KLK5 release from differentiated human keratinocytes in culture
(1120±217.9 ng/ml, P<0.01). KLK5 was also induced 3-fold by P.acnes in mouse skin but this
increase was not observed in the skin of TLR2-deficient mice. Because KLK5 is also involved in
skin barrier formation, we examined transepidermal water loss (TEWL) of Tlr2–/– mice and found
that the mice showed delayed TEWL recovery after the skin barrier disruption by chemical abra-
sion. These data suggested that TLR2 signaling is important to protease activity involved in acti-
vation of the chemical barrier produced by antimicrobial peptides as well as the physical skin bar-
rier of the stratum corneum. Thus, increased TLR2 and susceptibility to innate immune stimuli
further explains aberrant expression of Cathelicidin and kallikrein in rosacea.
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A priming in vitro step greatly enhances the repertoire of key genes involved in epidermal
proliferation and migration in bioengineered skin
T Kwak,1,2 T Yufit,1,2 P Carson,1,2 A Michalowska3 and V Falanga1,2,4 1 Dermatology and Skin
Surgery, Roger Williams Medical Center, Providence, RI, 2 NIH Center of Biomedical
Research Excellence, Roger Williams Medical Center, Providence, RI, 3 Laboratory of Cancer
Biology and Genetics, National Institutes of Health, Bethesda, MD and 4 Department of
Dermatology and Biochemistry, Boston University, Boston, MA
A bilayered living skin construct (BSC), consisting of neonatal foreskin fibroblasts and keratinocytes,
has been extensively used for the treatment of difficult-to-heal chronic wounds. We have been
studying in vitro conditions that could “prime” the BSC, activate key genes, and render it more
efficient in human chronic wounds. Total RNA was isolated from the BSC in each of three exper-
imental groups: A) control; B) incubation in DMEM for 24 hours; and C) meshing and incubation
in DMEM for 24 hours. Gene expression analysis was performed using Affymetrix HG-U133 Plus
2.0 Array and the Ingenuity Pathway Analysis program. Results were confirmed by quantitative
real-time PCR. We identified dramatic expression differences (more than 1,000 genes) by incu-
bating the construct in DMEM for 24 hours at 37°C with or without meshing, when compared to
control conditions. Gene expression analysis was filtered according to Log2 ratio (> 1.75). In all,
807 and 782 genes were differentially expressed in Group B and C, respectively. Comparative func-
tional analyses (Benjamini-Hochberg corrected p-value <0.05) showed that the expression level
of genes related to cellular migration and proliferation was most statistically different in Groups B
and C, with more dramatic differences in cell migration noted when the construct was also meshed
(Group C). Our study has demonstrated that numerous genes related to wound healing functions,
such as cellular migration, were significantly induced by this novel in vitro priming of the BSC.
These findings could lead us in a new direction in which the treatment efficacy of the BSC could
be maximized by in vitro manipulation prior to application to human wounds.
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Predictors of retinoid dermatitis
KC Lee1 and MA Weinstock2 1 Northwestern University, Chicago, IL and 2 Brown University,
Providence, RI
Topical tretinoin is widely prescribed, and the resulting retinoid dermatitis is well-documented. We
evaluated predictors of retinoid dermatitis after use at high-dose for 6-months based on the VA
Topical Tretinoin Chemoprevention (VATTC) Trial. The VATTC Trial was a double-blind, random-
ized trial of tretinoin 0.1% cream or vehicle-control cream for prevention of keratinocyte carci-
noma (KC). Patients applied the cream up to twice daily as tolerated. Sunscreens and moisturizers
were provided without charge. At baseline, data on the following were collected: sun-sensitivity,
photodamage, gender, age, marital status, education, smoking, past 5-fluorouracil use, and history
of KCs verified by medical records. At 6-months, symptoms of dermatitis (burning, itching, or numb-
ness/tingling), and frequency of usage were self-reported. Study dermatologists counted actinic ker-
atoses on the face and ears at baseline and 6-months. The χ2 test, and univariate and multivariate
regressions were used. The 726 participants recruited at 4 centers with adequate data were 97%
male, with a mean age of 71 years. Prior analysis found dermatitis in 61% of tretinoin and 42% of
placebo users (p<.001). In the tretinoin group, our study found that typical frequency of use, and
number of applications in the past week and the past 2 days were associated with dermatitis (p=.02,
.001, <.001, respectively). Number of applications in the past 2 days was also associated among
controls (p=.012). In a multivariate model, applications in the past 2 days was significant in tretinoin
users (p<.01); it was not associated in placebo users after controlling for marital status. Dermatitis
were also associated with decreased sunscreen use in the tretinoin group (p<.01), and decreased
moisturizer use in tretinoin (p=.013) and control (p<.001) groups. No other variables were asso-
ciated. Usage patterns in the past 2 days is an important predictor of dermatitis in tretinoin users,
but actinic keratoses count, age, photodamage, and sun-sensitivity are not, and tretinoin users had
more dermatitis overall.
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Increased levels of CD4+25high regulatory T cells in patients with cutaneous T-cell lymphoma
after extracorporeal photopheresis
LH Shiue, E Aakhus, P Arias-Mendoza, M Duvic and X Ni Dermatology, UT MD Anderson
Cancer Center, Houston, TX
Extracorporeal photopheresis (ECP), a systemic treatment involving the reinfusion of UVA-pso-
ralen treated lymphocytes, is used effectively to treat Sézary Syndrome (SS), the leukemic variant
of cutaneous T-cell lymphoma (CTCL). ECP is thought to control SS in part through direct induc-
tion of lymphocyte apoptosis, but its effects on the immune system beyond apoptosis remain unchar-
acterized. In a prospective trial, we have studied 5 SS patients undergoing ECP treatment and cor-
related the clinical response by skin-weighted assessment tool (SWAT) with the induction of regulatory
T cells (T-reg). Freshly isolated peripheral blood mononuclear cells (PBMCs) were evaluated for
the levels of CD4+CD25high T cells by flow cytometry at baseline and post-ECP on Day 2, 1 month,
3 months, and 6 months. Total RNA extracted from PBMCs was used to measure CD25 (IL-2Rα)
and Foxp3 mRNA by QT-RT-PCR. The numbers of CD4+CD25high T cells, and the expressions of
CD25 and Foxp3 mRNA varied among SS patients at baseline. Compared to baseline, at 6 months
post-ECP, 5 of 5 patients had increased percentages and absolute numbers of CD4+CD25high T
cells. The highest increase was found in the clinical responder, Pt#2, from 0.31% to 27.3%. Com-
pared to baseline, the expression of CD25 and Foxp3 mRNA also increased at 6 months post-ECP
in 3 of 4 examined CTCL patients (Pt#1, #2, and #4). Continuous rising levels of both CD25 and
Foxp3 mRNA were seen in responders, Pt#1 and Pt#2, during the treatment course. The highest
levels were detected at 6 months post-ECP with 8.4- and 9.8-fold increase in CD25 expression,
and 13.1- and 17.4-fold increase in Foxp3 expression, respectively. These two patients experienced
partial clinical responses and decreased circulating tumor cells with ECP. These results indicate
that CD4+CD25high regulatory T cells are induced in some of the CTCL patients by ECP, and could
suppress the malignant clone leading to disease improvement. The ongoing studies are recruiting
more patients to support our findings.
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Obesity increases the risk of psoriatic arthritis among psoriasis patients
R Soltani-Arabshahi,1 B Wong,2 B Feng,1 S Ahmed,1 DE Goldgar,1 K Callis Duffin1 and
GG Krueger1 1 Dermatology, University of Utah, Salt Lake City, UT and 2 College of Nursing,
University of Utah, Salt Lake City, UT
Obesity is a risk factor for psoriasis and is associated with more severe disease. We set out to study
whether obesity increases the risk of psoriatic arthritis (PsA) in a large psoriasis cohort. Patients
enrolled in the Utah Psoriasis Initiative from November 2002 to October 2008 (943 subjects; 50.2%
female, 49.8% male) were included. Cox regression analysis was used to study the relationship
between obesity and PsA. The association of obesity and other clinical features was tested by t-test
for parametric variables and chi square test for nonparametric variables. At age 18, prevalence of
being classified as overweight (25≤BMI<30) or obese (BMI≥30) was 14.1% and 5%, respectively;
these numbers increased to 33.5% and 35.5% at enrollment (mean age of 47.89±16.69 years-old).
Psoriatic arthritis was seen in 250 (26.5%) of patients. Patients who were overweight or obese at
age 18 had a higher hazard of PsA (HR=1.536, p=0.021 for overweight and HR=2.495, p=0.001
for obese compared to normal BMI). Also, the mean time interval from development of psoriasis
to the development of PsA was shorter in patients with a higher BMI at age 18 (Pearson correla-
tion, r=-0.143, p=0.036). BMI at enrollment was not correlated with the hazard of PsA. Patients
with BMI≥25 at age 18 were more likely to experience severe psoriasis (p=0.012) and report
Koebner phenomenon in the course of their disease (p=0.025). Overweight patients at enrollment
were more likely to report psoriatic nail changes (p=0.001) and inverse psoriasis (p=0.030). This
study suggests that obesity increases the risk of developing PsA. In addition, overweight patients
might develop psoriatic arthritis earlier in the course of their psoriasis. Increased adiposity is asso-
ciated with higher levels of inflammatory cytokines known to be associated with psoriasis. This
inflammatory milieu could increase the risk of psoriatic arthritis. Thus it is predicted that the pre-
vention and treatment of obesity may decrease the risk of PsA.
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Clinical efficacy and tolerability of repeat course of total skin electron beam therapy (TSEBT)
in mycosis fungoides (MF)
YS Levin,1 D Navi,1 N Riaz,2 NC Sullivan,1 RT Hoppe2 and YH Kim1 1 Dermatology, Stanford
Cancer Center, Stanford, CA and 2 Rad Oncology, Stanford Cancer Center, Stanford, CA
Patients with refractory MF may become candidates for a second course of TSEBT. We completed
a retrospective review of Stanford’s experience with MF patients who received more than 1 course
of TSEBT. Only patients who were treated with TSEBT to dose >30 Gy at their first course were
included in this analysis. Patients were considered for a second course if they had good objective
response, response duration, and/or exhausted other therapy options. 17 patients were identified.
Four patients were stage IB, 5 were stage IIA, 6 stage IIB, 1 stage IVA, and 1 stage IVB. The mean
dose for the first treatment was 34.7 Gy. Following their first course, 13 of the 17 had a cutaneous
complete response (CR), with mean relapse-free interval (RFI) of 11 mo (median 6.5 mo, range 2-
40 mo). Median interval prior to the second course of TSEBT was 44 mo (range 9-95 mo). Updated
staging prior to second course of treatment yielded 10 patients at higher stage, 6 at equal stage,
and 1 at lower stage than at time of first treatment. Eight of 17 patients had extracutaneous disease
prior to the second course, 5 of whom had visceral involvement. The mean dose for the second
treatment was 22.7 Gy. Following the second TSEBT course, 6 patients achieved a cutaneous CR
and 11 achieved a partial responses (PR). The median RFI for pts who achieved a cutaneous CR
after second treatment was 6 mo, (range 2-40 mo). Of the 16 patients who have died, 13 died of
MF, 1 of a secondary cancer, and 2 of causes unrelated to MF or its treatment. Median time to
death after second course of TSEBT was 15 mo (range 2-192 mo). One patient is alive with disease
14.6 years following second TSEBT. These results demonstrate that a second course of TSEBT is
well-tolerated and effective in the management of refractory MF, including palliative skin control
in those with extracutaneous disease. Its role in combination therapy to improve durability of
response should be further explored.
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Sudden skin appearance change in skin aging; skin elasticity tipping model as a key indica-
tor of the skin aging progression
K Miyamoto,1 O Kuwazuru2 and N Yoshikawa3 1 Research and Development, Procter &
Gamble Japan KK, Kobe, Japan, 2 Nuclear Power and Energy Safety Engineering, University
of Fukui, Fukui, Japan and 3 Industrial Science, University of Tokyo, Tokyo, Japan
Understanding bio-elasticity of human tissues is important to maintain human health and wellness
including skin substrates against aging. It has been considered signs of skin aging are appeared
gradually, while we discovered sudden skin condition change occurred in the aging process. A
new skin elastic model was proposed as a new skin aging progression, by characterizing multi-
layered skin physical properties. From mathematical simulation of this skin model by changing
each layer’s thickness and elasticity, it was suggested sudden change of skin condition may occur
in the skin aging process, which leads sudden visible change of skin wrinkling and sagging. Our
objective was to show a demonstration of sudden change in the skin aging process with a newly
developed skin imaging system in the human clinical assessments. Skin surface deformation was
measured by compressing the skin at the periorbital region on the face with a newly developed
skin compression imaging system among 92 Asian healthy females aged 25 to 55. The skin com-
pression system compresses the skin by 1mm step, up to 6mm compression. Skin images were
captured at each compression and analyzed skin deformation (wrinkling) area by the image analy-
sis algorithm. The gradient of skin deformation was then calculated from 0 to 6mm compression.
The gradients were then plotted by the function of the age to evaluate progression of skin aging.
Our results showed that skin surface deformation was quantified with this method in this clinical
study. There are significant difference in skin deformation between age 20’s and 30’s, and 30’s and
40’s (p<0.001), and such sudden change of skin deformation was observed in age 30’s. Skin defor-
mation was, however, not significant difference between age 40’s and 50’s. The clinical results are
consistent with the theoretical skin model and successfully demonstrated sudden skin changes in
the aging process.
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Sequential therapy with cyclosporine and adalimumab in patients with severe plaque psori-
asis: a series of five cases
S Gattu,1,2 JJ Wu3 and JY Koo2 1 University of California Irvine, Irvine, CA, 2 Dermatology,
University of California San Francisco, San Francisco, CA and 3 Dermatology, Kaiser
Permanente Los Angeles Medical Center, Los Angeles, CA
Cyclosporine, an inhibitor of T cells, is an effective treatment for severe psoriasis however its dura-
tion of use is limited to one to two years due to its risk of organ toxicity while its discontinuation
raises concern for relapse. Dermatologists are often reluctant to initiate cyclosporine due to the
absence of a safe long term agent to transition patients to after treatment with cyclosporine. Adal-
imumab, a tumor necrosis factor inhibitor, may be a safe option for transition. An experience of
using sequential therapy to help prevent relapse in patients transitioning from cyclosporine to adal-
imumab is described. Patients were informed of the off-label nature of concomitant use of two
immunosuppressants for the treatment of psoriasis. Five patients with severe generalized psoriasis
ages 17, 20, 21, 31, and 41 transitioned from therapy with cyclosporine alone to adalimumab alone
with a transition period of 12, 12, 11, 6 and 8 weeks respectively. During the transition period
cyclosporine was individually tapered and adalimumab was self administered 40 mg every other
week. There was no significant change in Psoriasis Area Severity Index scores from the time of ini-
tiating the transition phase to 12 weeks after initiation. One patient experienced a mild return of
psoriasis on the face which was treated successfully with topical 0.1% triamcinolone acetate oint-
ment. Serum labs and blood pressure readings remained normal for all five patients during the tran-
sition period and no adverse events were noted. Patients may be transitioned from cyclosporine to
adalimumab through sequential therapy to minimize risk of recurrence of psoriasis. The short dura-
tion of three months or less in healthy individuals may minimize risk of additive immunosuppres-
sive side effects. Safety and efficacy of sequential therapy with cyclosporine and adalimumab needs
to be validated by randomized controlled studies.
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D1-like dopamine receptor-mediating activation of mast cells and Th2 cells and augmenta-
tion of immediate and late-phase cutaneous reactions
T Mori, K Kabashima, K Sugita, R Yoshiki, J Sakabe, S Fukamachi, M Kobayashi and Y Tokura
Dermatology, University of Occupational and Environmental Health, Kitakyusyu, Japan
DA (DA) is a representative neurotransmitter in the CNS. DA mediates signals via five subtypes of
G protein-couplet receptors, D1 to D5. D1 and D5 from the D1-like group are coupled to Gs, while
D2, D3 and D4 form the D2-like group that couples to Gi. DA is also produced by lymphocytes
and holds immunomodulatory effects, and D2-like-R antagonists may exert a Th2-skewing action.
However, the roles of DA for the skin constituents remain unknown. To investigate this issue, we
examined the effect of D1-like-R antagonist SCH23390 on a murine Th2 type model induced by
repeated hapten challenges to the skin. Initially we confirmed that D1-like-Rs were expressed by
LC and BMMC as well as KC using RT-PCR. For the Th2 models, BALB/c mice were sensitized with
TNCB on the abdomen, followed by repeated challenges on the both sides of each ear with TNCB.
A significantly lower ear swelling response was observed in mice orally administered with SCH23390
during elicitation, when measured at 1 and 4 hours after challenge. This suggests that the imme-
diate and late phase skin reactions were impaired by blockade of D1-like-R. A real-time PCR analy-
sis of mRNA expression for cytokines in the ears demonstrated that SCH23390-treated mice had a
higher level of IFN-γ expression and a lower IL-4 expression level than non-treated mice. Thus, the
D1-like-R seem to be involved in the immediate or Th2 type immune responses in vivo. Since
mast cells and Th2 cells participate in those responses, we examined the effects of DA and the
antagonist on BMMC. The addition of DA induced degranulation of mast cells, as assessed by the
release of β-hex from BMMC. Furthermore, the passive cutaneous anaphylaxis reaction was sig-
nificantly reduced in SCH23390-treated mice. These findings suggest that signaling through the
D1-like-R mediate the activation of mast cells and Th2 cells, leading to enhancement of the imme-
diate and late phase skin reactions.
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Atopic dermatitis (AD) keratinocytes exhibit normal Th17 cytokine responses
KE Nograles,1 M Suarez-Farinas,1 A Shemer,2 LC Zaba,1 I Cardinale,1 T Kikuchi,1 M Ramon,3
R Bergman,3 JG Krueger1 and E Guttman-Yassky1,4 1 Laboratory for Investigative Dermatology,
The Rockefeller University, New York, NY, 2 Department of Dermatology, Tel-Hashomer
Medical Center, Ramat-Gan, Israel, 3 Department of Dermatology, Rambam Medical Center
and the Technion, Haifa, Israel and 4 Department of Dermatology, Weill Cornell Medical
College, New York, NY
Cytokines produced by Th17 T cells, particularly IL-17, are major regulators of antimicrobial pro-
teins (AMPs) in keratinocytes. Decreased expression of IL-17-induced AMPs was recently reported
in chronic AD skin lesions compared to psoriasis, possibly accounting for the increased risk of
infections in AD patients. To investigate whether this deficiency in AMPs in AD as compared to
psoriasis may be due to defective signaling, deficiency in cognate receptor or a lack of ligand,
skin biopsies were obtained from AD patients (n=5) and normal volunteers (n=5) and assessed for
expression of IL-17R and IL-22R by immunohistochemistry. Additionally, primary keratinocytes
from AD and normal skin were cultured, treated with IL-17, IL-22 or control (media), and fol-
lowed by Affymetrix arrays and RT-PCR analysis. A strong pattern of IL-17R and IL-22R protein
expression was observed in both AD patients and normal skin. Similarly, both AD and normal IL-
17-treated keratinocytes showed significant up-regulation of AMPs and neutrophil chemoattrac-
tants, including CCL20, β-defensin-2, lipocalin and IL-8. The same pattern of gene modulation was
observed with IL-22-treated AD and normal keratinocytes. Our data suggests that the relative defi-
ciency of AMPs in AD does not stem from a defect in IL-17 or IL-22 receptor or signaling, but
likely from a relative deficiency of the ligand. This may have important therapeutic implications
as interventions that upregulate the expression of IL-17 can potentially increase the AMP levels
thus decreasing the rate of skin infections in AD.
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Photochemical tissue bonding for closure of excision wounds: a first-in-human clinical trial
S Tsao,1 M Yao,1,2 FP Henry,2 H Tsao,1,2 RW Redmond1,2 and IE Kochevar1,2 1 Dermatology,
Massachusetts General Hospital, Harvard Medical School, Boston, MA and 2 Wellman
Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School,
Boston, MA
We have developed a novel technology for sealing surgical wounds that relies on light-initiated
covalent cross-linking between tissue proteins on the wound surfaces to form an immediate water-
tight seal. Photochemical Tissue Bonding (PTB) does not heat the tissue, in contrast to laser weld-
ing, and does not damage skin cells. Rose Bengal dye (RB) is applied to the apposed wound edges
and activated by green light to initiate the bonding reactions. We compared PTB with sutures for
superficial closure of fusiform excisions. Thirty-one skin cancers or atypical nevi were excised fol-
lowed by deep closure with coated Vicryl sutures. In a randomized split-lesion design, half of
each wound was closed with nylon sutures and the other half was sealed using PTB (0.1% RB in
PBS, 532 nm KTP laser, 100 J/cm2, 0.5 W/cm2, 200 seconds). At 2 weeks, 3 and 6-months the
excision wound was evaluated by the patient and two physician observers and photographed. Two-
week results are available from all patients. No dehiscence occurred after either treatment. Three
dermatologists viewing the photos scored the difference between outcomes as 4.7 ± 0.6 on a 9-
point scale. The observers ranked PTB better than sutures in 75% of wounds. Patients scored the
overall appearance of PTB-treated wounds as better than sutured closure (18 of 28). On photos
the overall appearance after PTB was judged better than sutures (p <0.002). The major difference
was greater erythema after sutures than PTB (p <0.005). Patients were more satisfied with the
appearance of wounds after PTB (p <0.01), and the observers ranked the scar less visible after PTB
(p <0.02). No differences in pigmentation, thickness, itch, pain or oozing were observed. These
results indicate that PTB provides sufficient tensile strength to prevent dehiscence and causes less
inflammation than standard sutures, suggesting that PTB may cause less scarring.
281
Wound edge biopsy sites in chronic wounds heal rapidly and do not result in delayed wound
healing
J Panuncialman,1 S Hammerman,1,2 P Carson1,2 and V Falanga1,2,3 1 Department of
Dermatology and Skin Surgery, Roger Williams Medical Center, Providence, RI, 2 NIH Center
of Biomedical Research Excellence, Roger Williams Medical Center, Providence, RI and 3
Departments of Dermatology and Biochemistry, Boston University School of Medicine,
Boston, MA
Wound biopsies are an essential component in the management of chronic wounds. First, the
possibility of malignancy or infection within the wound often requires sampling of the wound edge
and its bed. Secondly, several practice guidelines recommend biopsying wounds that have not
responded to treatment after 2-6 weeks. However, there has always been a concern that the
biopsy may worsen the wound and delay healing. In this report, we investigated the safety and
effects of wound biopsies on healing rates (advance of wound edge per week) before and after the
biopsy was performed. In a cohort of 14 consecutive patients with chronic wounds of the lower
extremity, we found that post-biopsy healing rates (0.99 mm/week ± 0.31; mean±SEM) were not
decreased and were actually higher than pre-biopsy healing rates (0.49 mm/week ± 0.23;
mean±SEM); (p<0.05). In addition, we documented healing of the biopsy sites up to the original
wound edge in 11 of the 14 subjects within 6 weeks. Therefore, we conclude that chronic wounds
do not worsen after being biopsied and that wound biopsies are a safe procedure that does not
delay healing.
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NF-κB- and STAT3-dependent cytokine production by circulating CCR6+CD4+ Th17 cells is
increased in psoriasis, and decreases with effective therapy
S Kagami,1 H Rizzo,1 J Lee,1 Y Koguchi2 and A Blauvelt1 1 Dermatology, Oregon Health &
Science University, Portland, OR and 2 Molecular Microbiology and Immunology, Oregon
Health & Science University, Portland, OR
Both Th17 and Th1 cells have been implicated in psoriasis pathogenesis, but the relative impor-
tance of each cell type is unclear. The purpose of this study was to evaluate Th17 and Th1 cytokine
production by circulating CD4+ T cells in untreated and treated psoriatics. CD4+ T cells were iso-
lated from 10 untreated psoriatics, 5 patients receiving infliximab, and 11 healthy individuals,
placed into culture overnight with PMA/ionomycin, and assessed by 7-color flow cytometry (extra-
cellular expression: CCR6, IL-23R, CD161; intracellular expression: IFN-γ, IL-17A, IL-22, TNF-α).
Based upon IL-17A and IL-22 production, CCR6 was a more reliable marker for Th17 cells com-
pared to IL-23R or CD161. CCR6+CD4+ (p<0.01), IL-23R+CD4+ (p<0.05), CCR6+IL-17A+CD4+
(p<0.01), CCR6+IL-22+CD4+ (p<0.01), and IL-17A+IFN-γ-CD4+ (p<0.01) cells were markedly
increased in psoriatics, indicating elevations in circulating Th17 cells utilizing a number of crite-
ria to define these cells. IL-17A-IFN-γ+CD4+ (p<0.05) and IL-17A+IFN-γ+CD4+ (p<0.05) cells were
also increased in psoriatics, indicating elevations in Th1 and double-positive Th17/Th1 cells, but
to a lesser extent compared to Th17 cells. CCR6+CD4+ (r>0.45), IL-17A+CD4+ (r>0.35), and TNF-
α+CD4+ (r>0.45) cell numbers correlated well with clinical disease activity. Infliximab therapy
over time led to decreases in CCR6+CD4+ and CCR6+TNF-α+CD4+ cell numbers. NF-κB inhibi-
tion by parthenolide and STAT3 inhibition by Stattic blocked cytokine production in CD4+ cells
in a dose-dependent manner. This study reveals several novel observations with potential clinical
implications: 1) both circulating Th17 and Th1 cells are elevated in psoriasis, with greater eleva-
tions observed in Th17 cells; 2) cytokine production by these cells can be blocked by inhibiting
either NF-κB or STAT3; and 3) CCR6, IL-17A, and TNF-α represent the best blood markers for dis-
ease activity in psoriatics.
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Compression regimen for venous leg ulcer patients requiring dressing changes at least once
a day
S Hammerman,1 P Carson,1,2 J Panuncialman,1 D Herring1 and V Falanga1,2,3 1 Dermatology
and Skin Surgery, Roger Williams Medical Center, Providence, RI, 2 NIH Center of Biomedical
Research Excellence, Roger Williams Medical Center, Providence, RI and 3 Dermatology and
Biochemistry, Boston Univeristy, Boston, MA
The aim of this study was to determine ways to apply effective compression in the home setting to
patients with venous leg ulcers (VLU) when using a topical ulcer treatment once or twice a day.
This high frequency of dressing changes generally interferes with the use of multi-layer bandages.
5 patients with VLU > 2 cm sq. in size, longer than one year in duration and resistant to treatment
with conventional compression were followed on a weekly basis for 8 weeks. All of the patients
required once or twice self-administered topical treatment. Self-applied compression was achieved
with a latex-free tubular elastic bandage. At each visit during the 8 weeks, ulcers were examined,
traced for planimetry, and photographed. The NIH Image J Program was used to calculate the wound
healing rate (Gilman formula), which was the primary end point. During the 8 week period of the
study, all 5 patients had positive wound healing rates. One of the patients achieved complete wound
closure. None of the patients developed additional ulcers or other adverse events while using the
latex-free tubular elastic bandage. The mean ± SEM of healing rates at Week 4 and 8 for all patients
was 0.762 ± 0.355 and 0.42 ± 0.176 mm/week, respectively. In three of the patients, the healing
rate was greater than .75mm/week, which we have previously found to be 80% sensitive and spe-
cific for predicting ultimate wound closure. This study indicates that compression with the latex
free tubular elastic bandage can be safely used in patients with VLU requiring frequent dressing
changes. The healing rate obtained with this compression regimen suggests that the ultimate heal-
ing of the ulcer may not be compromised, and that this regimen can be used in experimental pro-
tocols.
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Structure-activity studies of novel oxaborole dual inhibitors of PDE4 and IL-23 release
T Akama,1 J Antunes,1 Y Freund,1 R Kimura,1 C Dong,1 V Sanders,1 G Graves,1 X Lu,2 R Sharma,2
M Sales,2 J Nieman,2 R Singh,2 C Ding1 and J Plattner1 1 Anacor Pharmaceuticals, Inc., Palo
Alto, CA and 2 NAEJA Pharmaceuticals, Edmonton, AB, Canada
AN2898 (5-(3,4-dicyanophenoxy)-1-hydroxy-1,3-dihydro-2,1-benzoxaborole) is a broad spectrum
anti-inflammatory compound that is currently under development for the topical treatment of plaque
psoriasis and atopic dermatitis. AN2898 inhibited phosphodiesterase 4 (PDE4) enzyme activity
(IC50 0.06 μM) and the release of several cytokines including TNF-α (IC50 0.16 μM) from periph-
eral blood mononuclear cells (hPBMCs) stimulated by lipopolysaccharide or phytohemagglutinin.
AN2898 was also found to inhibit IL-23 release (IC50 1.1 μM) from THP-1 cells stimulated by LPS
and IFN-γ. This activity was also observed in human dendritic cells cultured from hPBMCs. Inves-
tigation of the structure-activity relationship around this compound was carried out to identify a
more potent dual TNF-α/IL-23 inhibitor. The cyano group at the 4’-position was important for activ-
ity against both cytokines. Substituting the cyano group at the 4’-position with a group such as
methoxycarbonyl was tolerated for PDE4 and TNF-α release inhibition, while the activity against
IL-23 release was drastically diminished. Combination of a cyano group at the 4’-position with a
halogen, methyl, or methoxy group at the 2’- or 3’-position on the same phenyl ring retained activ-
ity against TNF-α. Replacement of the phenyl ring with a 2-pyridinyl ring bearing cyano and either
methoxy or ethoxy groups enhanced the potency against both TNF-α and IL-23. One of the potent
compounds showed IC50 values of 0.06 μM and 0.35 μM against TNF-α and IL-23 release, respec-
tively. Since no clear correlation has been reported between PDE4 activity and IL-23 release, IL-
23 release inhibition was considered to be mediated by a different mechanism from that of TNF-
α. Typical PDE4 inhibitors, such as rolipram and roflumilast, did not show significant inhibition
against IL-23 release up to 100 μM. These compounds are expected to be promising leads for the
topical treatment of plaque psoriasis.
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CCL26 and CCL11 produced by lesional fibroblasts increase CCR3+ lymphocytes both in
the lesional skin and in the peripheral blood in patients with CTCL
T Miyagaki, M Sugaya, H Fujita, H Ohmatsu, T Kakinuma, T Kadono and K Tamaki Department
of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan
CCL26 and CCL11 belong to the CC chemokine family and are secreted by endothelial cells, fibrob-
lasts and bronchial epithelial cells. CCR3, a sole receptor for CCL26 and CCL11, is preferentially
expressed on eosinophils, basophils, and Th2 cells. In Hodgkin’s disease, tumor cells induce fibrob-
lasts to secrete CCL11 resulting in Th2 cells- and eosinophils-rich condition. In this study, we inves-
tigate whether CCL26 and CCL11 are involved in pathogenesis of cutaneous T cell lymphoma
(CTCL). We first revealed that both serum CCL26 and CCL11 levels of patients with advanced
(plaque, tumor, and erythroderma) stages of CTCL were significantly higher than those of controls
(31.5 ± 20.8 pg/ml vs. 11.0 ± 2.5 pg/ml and 182.3 ± 55.9 pg/ml vs. 121.0 ± 50.0 pg/ml, respec-
tively). The concentrations of these chemokines were correlated with serum sIL-2R levels. In each
patient, serum levels of CCL26 and CCL11 showed good correlation with disease activity. Immuno-
histochemistry showed that keratinocytes, endothelial cells, and dermal fibroblasts expressed CCL26
and that lesional skin of CTCL expressed this chemokine more strongly than normal skin. Cultured
fibroblasts from lesional skin of CTCL expressed higher amount of CCL26 and CCL11 mRNA by
quantitative RT-PCR, compared with those from normal skin. In some cases of CTCL, CCR3+ lym-
phocytes were detected in the lesional skin by immunohistochemistry. CCR3 mRNA expression in
the lesional skin of CTCL was higher than that of normal skin. In addition, the percentage of
CCR3+ cells in peripheral mononuclear cells was increased in patients with CTCL, compared to
that in normal control. Our study suggests that CCL26 and CCL11 produced by dermal fibroblasts
in the lesional skin of CTCL increase CCR3+ cells both in the skin and in peripheral blood, which
may be involved in the pathogenesis of CTCL.
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Histologic and clinical evaluation of hidradenitis suppurativa following treatments with the
long-pulsed Nd:YAG 1064nm laser
D Rucker Wright,1 L Xu,1 B Mahmoud,1 D Mehregan,2 D Ozog1 and I Hamzavi1 1 Dermatology,
Henry Ford, Detroit, MI and 2 Dermatology, Wayne State University, Detroit, MI
Hidradenitis Suppurativa (HS) is a chronic, painful, suppurative condition that affects intertriginous
areas and is part of the follicular occlusion tetrad. It is a disorder of the hair follicle and apocrine
glands, although the exact pathological origin has been debated. Treatments are limited with rad-
ical surgical excision reported as the most effective but resulting in high morbidity. Recently, our
group has published data on the clinical effectiveness of the long-pulsed Nd:YAG 1064 nm hair
removal laser for the treatment of HS. The primary goal of this study is to examine histological
changes occurring after Nd:YAG laser treatment in 20 patients of various skin types. The second-
ary goal is to clinically asses effects of the laser on HS. Two Nd-YAG laser treatments were per-
formed 30 days apart. Punch biopsies were obtained from an active lesion before laser treatment,
at day 1, day 7 and day 60. An active lesion from an untreated site was biopsied as control on day
60. All H&E slides were reviewed by a dermatopathologist (D.M.). Total mean percent change using
a modified Hidradenitis Suppurativa Lesion, Area and Severity Index including patient symptoms
(based on the Sartorius scale) from baseline to month two was −20.5%, SD 9.2, p <0.016. Histo-
logical findings varied by type of lesion biopsied and time points. Preliminary findings show fol-
licular plugging, follicular rupture, folliculocentric mixed inflammation with sparing of apocrine
glands when they were present in the sample and folliculitis moving towards fibrosis over the time
points. In 2/7 (29%) patients, the superficial inflammation cleared after the second laser treatment.
Histologic changes specifically due to the Nd:YAG laser on HS lesions are still being investigated,
however this study supports previous data that the Nd:YAG laser is effective in decreasing HS activ-
ity per patient and physician assessment. We also have provided histological evidence that the con-
dition is primarily folliculocentric and can spare apocrine glands.
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Epilepsy as an initial presentation in bullous systemic lupus erythematosus
M Pan, R Shi and J Zheng Dermatology, Rui Jin Hospital, School of Medicine, Shanghai Jiao
Tong University,, Shanghai, China
BSLE is a rare clinical manifestation of SLE patients. It associated with epilepsy has not been explored
in the field. We recently encountered a case presenting epilepsy as an initial presentation. A 22-
year-old woman came to our clinic because of severe headache. EEG demonstrated epilepsy waves
with multiple spikes. Brain MRI was normal. Based on clinical presentation and above laboratory
findings, epilepsy was diagnosed. Patient developed erythema on her face, neck and chest a week
later. Rapidly, many vesicles and large bullae with clear contents arose on those erythematous
lesions. The Nikolsky’s sign was negative. There was no fever, mouth ulceration, or joint pain.
Skin biopsy from representative lesions showed subepidermal vesicles with liquefactive degener-
ation and extensive neutrophil infiltration in the papillary dermis. No signal was detected by IIF.
However, DIF showed IgG and IgM linear deposition along the basement membrane zone. Fur-
thermore, IgG deposition was also present on the dermal side of peri-lesional skin. Patient’s WBC
was low (3.2 x 109/L, twice) and positive for anti-nuclear antibody (1:640), anti-Sm antibody, and
anti-dsDNA antibody. BSLE was diagnosed and the patient was treated with daily 30mg of pred-
nisone and the lesions were completely cleared in a week. Meanwhile, the terrible headache was
disappeared. Repeated EEG showed no abnormality. In addition to the blistering eruption, patients
with BSLE may exhibit any of the symptoms associated with SLE, especially severe lupus nephri-
tis. However, the onset and course of cutaneous lesions may or may not parallel the activity of the
systemic involvement. In our case, the patient had epilepsy as an initial presentation and then devel-
oped bullae on inflamed skin. Although the patient had classic sero markers of SLE, she had no
other common SLE symptoms. We believe this represents a case of BSLE associated with epilepsy,
which has previously never been reported. Collection of more such cases may help us to have a
better understanding the disease process.
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Ubiquitin-proteasome system activation protects from UV damage. In vivo study
Y Guerif,1 G Oberto,1 C Gondran,1 E Bauza,1 J Botto,1 A Berghi,1 K Cucumel,1 C Dal Farra2 and
N Domloge1 1 Vincience, ISP Global Skin Research Center, ISP, Sophia-Antipolis, France and
2 ISP Corporate Research Center, ISP, Wayne, NJ
The ubiquitin-proteasome system is an essential mechanism for maintaining cell integrity, due to
its role in eliminating abnormal and damaged cell proteins. Through aging, the synthesis and
activity of this system decrease, leading to the accumulation of damaged proteins that impair cell
function, which accelerates aging. In this study, we evaluated the beneficial effects of activating
the ubiquitin-proteasome system, using a previously described inducer (IV08.013). 12 volunteers
participated in this double-blind study. They applied, twice a day, the inducer-containing cream,
or placebo, on a defined zone of the thigh for a week, followed by full solar spectrum irradiation
of 2 MED. Volunteers continued to apply creams for 3 more weeks. Skin condition was evaluated
by TEWL, in vivo confocal microscopy (vivascope) assessment, and by clinical examination. From
day 8 on the induced side, TEWL studies revealed a significant decrease of TEWL measures (p =
0.0323), indicating better barrier function. Interestingly, this effect was also seen after UV stress.
TEWL was significantly reduced on the irradiated-induced side (p = 0.0113) at D16 and (p = 0.0225)
at D23, suggesting significant UV protection of epidermal functions and integrity on the ubiquitin-
proteasome activated side. Vivascope study revealed that UV damage was remarkably reduced on
the induced side at all time points, as demonstrated by stratum corneum thickness, and stratum
granulosum cell shape and morphology. Observation and quantification of sunburn cells showed
significant reduction on the induced side, and similar results were obtained with other signs of UV
damage, such as vacuoles and oedema, which were significantly reduced. Clinical examination
revealed a significant increase in the healthy appearance of the skin, as well as hydration and radi-
ance, which were visible after 2 weeks of study on 83% of volunteers. These results confirm the
ubiquitin-proteasome system’s key protective roles in skin biology and photoaging.
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Psoriatic predisposition protects against acne in cross-national comparison
JM Yost,1 DL Sachs,1 M Ramos-e-Silva,3 TA Hamilton,1 JJ Voorhees1 and S Kang2 1 Dermatology,
University of Michigan, Ann Arbor, MI, 2 Dermatology, Johns Hopkins Medicine, Baltimore,
MD and 3 Dermatology, Universidade Federal, Rio de Janeiro, Brazil
While acne and psoriasis are two of the most common dermatologic disorders, the relationship
between these conditions has not been formally studied. Individuals with psoriasis have been shown
to be less susceptible to many cutaneous infections, presumably due to increased epidermal expres-
sion of antimicrobial peptides (AMPs). Since some of the AMPs have bacteriocidal activity against
Propionibacterium acnes, a key component in acne pathogenesis, we hypothesized that psoriasis
patients may be less affected by acne. This cross-sectional study characterizes the prevalence of
acne vulgaris in psoriasis patients and healthy controls. Study volunteers were recruited from gen-
eral dermatology clinics at the University of Michigan and Universidade Federal do Rio de Janeiro,
Brazil. Data regarding personal history of acne, subjective acne severity, acne lesion type, and
previous acne treatments were collected via a written questionnaire. In total, 310 individuals par-
ticipated in the study, of which 158 were psoriatics and 152 were non-psoriatic controls. Overall,
compared to controls, psoriatics had a significantly lower prevalence of acne (47.5% vs. 69.1%,
p = .0001). Furthermore, in participants with a history of acne, individuals with psoriasis had sig-
nificantly reduced rates of inflammatory lesions than in controls (29.1% vs. 48.7%, p =.0004). Inter-
estingly, when stratified by location, the prevalence of acne was significantly higher among psori-
atics in Rio de Janeiro than in Ann Arbor (55.8% vs. 31.5%, p = 0.003). Differences in UV exposure,
diet, genetics, and other environmental factors may be responsible. Our results further substanti-
ate the theory that the skin of psoriatics may be less hospitable to P. acnes colonization.
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Topical application with DHMEQ, a novel NF-kB inhibitor, improves atopic dermatitis in
murine model
R Abe,1 A Hamasaka,1 N Yoshioka,1 S Kishino,4 K Umezawa,5 M Ozaki,2 S Todo3 and H Shimizu1
1 Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan, 2
Molecular Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan, 3
First Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan, 4
Medication Use Analysis and Clinical Research, Meiji Pharmaceutical University, Tokyo,
Japan and 5 Applied Chemistry, Keio University, Yokohama, Japan
Growing evidence has demonstrated the crucial role of NF-kB activation on disease severity in
allergic disorders. We recently developed a novel NF-kB inhibitor, dehydroxymethyle-
poxyquinomicin (DHMEQ) which has been found to inhibit TNF-α-induced NF-κB activation by
suppressing nuclear translocation but not IκB-phosphorylation or degradation. Molecular weight
of DHMEQ is less than 300 so that can penetrate into the skin. In this study, we examined the clin-
ical relevance of DHMEQ for atopic dermatitis (AD) by its topical application. First we showed
that DHMEQ significantly inhibited contact hypersensitivity reactions in dose-dependent manner.
To investigate the efficacy to AD in murine model, 1% DHMEQ ointment was applied daily to
NC/Nga mice with severe dermatitis, which served as a model for human AD. During 2 weeks of
treatment, clinical skin scores (itch, erythema, edema, excoriation/erosion, scaling/dryness) sig-
nificantly reduced in mice treated with DHMEQ (n=10, score; 6.6) as well as betamethasone (n=10,
score; 6.8) and tacrolimus (n=10, score; 5.1) compared to control (n=10, score; 13.2), without
diverse effects. Based on histological examinations, the hyperplasia of keratinocytes and infiltra-
tion of inflammatory cells including CD3+ T cells, eosinophils, and mast cells were significantly
reduced in the skin of DHMEQ-treated mice compared to vehicle-treated mice. Thus, a drug that
interferes with NF-kB activity may provide an alternative therapeutic strategy for the treatment of
AD.
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Diagnostic accuracy of using telemedicine to evaluate vesicular or pustular rash illnesses
M Yassaee,1,2 J Albrecht,3 S Hutchins,4 J Okawa,2 Z Bonilla Martinez,5 S Moghadam-Kia,2
L Taylor,6 C Coley6 and V Werth1,2 1 VA Medical Center, Philadelphia, PA, 2 Dermatology,
University of Pennsylvania School of Medicine, Philadelphia, PA, 3 John H Stroger Jr. Hospital
of Cook County, Chicago, IL, 4 Centers for Disease Control and Prevention, Atlanta, GA, 5
University of Miami Miller School of Medicine, Miami, FL and 6 Biostatistics and
Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA
The CDC developed an algorithm to prevent overdiagnosis of smallpox in patients who present
with vesicular or pustular rash syndrome (VPRS). Physicians representing different specialties are
often consulted via telemedicine to evaluate these patients. We used data from a study to evalu-
ate the smallpox algorithm to compare the accuracy in diagnosing various VPRSs using digital pho-
tographs. The study was conducted during and after national mass mailings and training of physi-
cians and public health professionals for smallpox and its differential diagnoses. Six VPRS cases
that included patient photographs and case histories were presented via a web-based survey to
three physician groups (infectious disease specialists, dermatologists, and public health physicians;
n=13-25 per group). Based on the given information, the physicians suggested a likely diagnosis
for each case. In two cases, a high proportion of physicians diagnosed the disease accurately: small-
pox (94.00%, 95% confidence interval (CI): 87.18% - 100%) and erythema multiforme (75.41%,
95% CI: 64.29% - 86.53%). Diagnostic accuracy for the remaining cases was lower: Steven John-
son Syndrome/Toxic Epidermal Necrolysis (67.74%, 95% CI: 55.77% - 79.71%); varicella (66.18%,
95% CI: 54.64% - 77.71%); disseminated herpes (38.60%, 95% CI: 25.56% - 51.63%); and eczema
herpeticum (31.48%, 95% CI: 18.69% - 44.28%). We concluded that coupled with mailings and
training of physicians, the use of telemedicine may assist with the recognition of smallpox and
other VPRSs.
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Effect of Rhus verniciflua Stokes (RVS) water extracts on the photoaged skin
M Jung1 and E Choi1,2 1 Department of Dermatology, Yonsei University Wonju College of
Medicine, Wonju, Korea, South and 2 Wonju Rhus Project Team, Yonsei University Wonju
College of Medicine, Wonju, Korea, South
Rhus verniciflua Stokes (RVS) has long been used as a food additive and a traditional herbal med-
icine in Korea; however, this sap contains a toxic compound ‘urushiol’, inducing severe allergic
contact dermatitis. RVS water extract without urushiol contains many polyphenols or flavonoids
known as anti-aging agents. In this study, we prepared a water extract from RVS which does not
contain the urushiol, i.e., RVS water extract, to investigate its effects on the skin of photoaged
mice by oral administration and on UVB-irradiated primary human fibroblasts. In RVS water extract-
administrated photoaged mice, dermal collagen density and dermal thickness increased through
the increases in collagen production compared to regular water-administered mice. Furthermore,
RVS water extract significantly promoted the proliferation of human fibroblasts in MTT dye assay,
and the procollagen mRNA level of UVB-irradiated primary human fibroblasts in real-time RT-PCR.
Our results indicate that RVS water extract improves photoaged skin by enhancing fibroblast pro-
liferation and subsequent increase in collagen density.
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The effect of topical application and intraperitoneal injection of oregonin on atopic der-
matitis (AD) in NC/Nga mice
M Jeong,2 J Park1 and S Seo1 1 Dermatology, Chung-Ang University Hospital, Seoul, Korea,
South and 2 Dermatology, Chung-Ang Medical Research Center, Seoul, Korea, South
The diarylheptanoid series chemical of Oregonin (ORE) separated from the bark of the Alnus genus
plant of Alnus japonica Steudel which is natively growing in Korea has been known to have antiox-
idative, anti-inflammatory, anti-cancer, and immune response inhibitory effects. So, it is expected
to have an effect on the treatment of AD. The in-vivo activity study of pharmaceutically active ORE
on AD has not been made yet. So, we tested the in vivo AD animal model by applying ORE onto
the NC/Nga mice through the two types of application pathways of skin application and intraperi-
toneal injection. As the treatment effect evaluation of ORE, the clinical observation by following
the SCORE method was used to score the effect, the Th2 cytokine IL-4, 5, 13 were measured from
the serum and lymphocytes, and IgE and eosinophil was measured from serum. Additionally, the
expressions of mRNA and protein were estimated by real-time PCR and western blotting method.
For the following categories of clinical evaluation, Th2 cytokine IL-4, 5, 13 values, serum IgE,
serum eosinophil, expressions of iNOS mRNA and protein, and the expressions of COX-2 mRNA
and protein, each evaluation category was evaluated from the ORE application groups. The effect
of ORE on AD in NC/Nga mice were confirmed as similar to the positive control group and a sig-
nificant difference with negative control group was observed. The results presented in this report
suggest that ORE might be beneficial for the treatment of AD.
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99mTc-ethyl cysteinate dimer (ECD) single photon emission computed topmgraphy (SPECT)
with acetazolamide administration revealed hyperfusion to the frontal lobe of patients with
primary hyperhidrosis
T Tanaka, T Satoh and H Yokozeki Dermatology, Tokyo Medical and Denatol University,
Tokyo, Japan
Primary hyperhidrosis (PH) is a disorder of excessive, bilateral, and relatively symmetric sweating
occurring in the axillae, palms, soles, or craniofacial region without obvious etiology. The patho-
physiology of PH is not completely understood but may result from hyperstimulation of eccrine
glands by the central sympathetic nervous system. Single-photon emission computed tomography
(SPECT) using 99mTc ethyl cysteinate dimer (ECD) is an established method for measuring cere-
bral blood flow with or without acetazolamide (Diamox) challenge in patient with alzheimer’s dis-
ease, stroke or carotid diseases . To examine alteration in regional cerebral blood flow in the patients
with PH, we compared 99mTc ethyl cysteinate dimer (ECD) brain scans with SPECT after aceta-
zolamide administration with and without emotional stimulation (mental arithmetic) between 6
normal control subjects (mean age: 30.6, 6 female) and 9 patients with PH (mean age: 20.7, 4 male,
5 female) . Both normal subjects and patient with PH underwent magnetic resonance imaging (MRI)
which revealed no deformity of the skull and no tumor in the brain. SPECT using 99mTc ECD in
patients with PH revealed increased uptake in frontal lobe both with and without emotional stim-
ulation in comparison with normal control subjects (p<0.01). These data indicated that excessive
mental sweating in PH is related to frontal lobe of brain dysfunction.
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Colorimetric and spectroscopic analysis of postinflammatory pigmentation
J Zhao,1,2,3 H Alkhayat,1,3 A Al Robaee,1,3 H Zeng2,1,3 and H Lui1,3,2 1 Department of
Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada, 2
Cancer Imaging Department, BC Cancer Research Centre, Vancouver, BC, Canada and 3
Photomedicine Institute, Vancouver Coastal Health Research Institute, Vancouver, BC,
Canada
Post-inflammatory hyperpigmentation (PIH) is a common acquired cause of cutaneous dyspig-
mentation that is often disfiguring. Melanin has been thought to be the major chromophore respon-
sible for the skin darkening. The natural history and detailed biophysical basis of PIH have not yet
been studied in detail. Our study objectives are to develop a system for quantifying and monitor-
ing PIH, to measure and model the time course and clinical factors that influence the spontaneous
resolution, and to identify the underlying biophysical properties. The CIE L*a*b* skin color was
quantified using a hand-held colorimeter and the physical properties of selected chromophores
were studied using diffuse reflectance spectroscopy. Sixty-seven (67) patients participated in this
study. Most of them had skin type III (36) and IV (15). The causes of PIH were dermatoses (36),
trauma (17), laser therapy (5) and burn (9). All (100%) PIH lesions had lower L*, 94% had higher
a*, and only 46% had higher b* than adjacent normal skin. The differences in L*, a*, and b* between
PIH and normal skin, as well as the corresponding Wilxocon tests were -7.4 ± 4.1 (p < 0.001), 2.3
± 1.9 (p < 0.001), and -0.3 ± 2.7 (p = 0.496), respectively (mean ± SD); the total color difference
was 8.2 ± 4.3 (p<0.0001). Spectral analysis showed that oxy-hemoglobin (p = 0.004) and deoxy-
hemoglobin (p = 0.002) in addition to melanin (p < 0.001) were significantly higher in PIH than
normal surrounding skin. Our results demonstrate that PIH over time can be monitored and stud-
ied using colorimetry and diffuse reflectance spectroscopy. Furthermore we found that besides
melanin, hemoglobin contributes significantly to the darker skin color of PIH.
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Adipose-derived stem cell would be a new therapeutic modality for the aged skin
J Kim,1 M Jung,2 H Kim3 and E Choi4 1 Department of Dermatology, Yonsei University Wonju
College of Medicine, Wonju, Korea, South, 2 Department of Dermatology, Yonsei University
Wonju College of Medicine, Wonju, Korea, South, 3 Department of Hematology and
Oncology, Yonsei University Wonju College of Medicine, Wonju, Korea, South and 4
Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Korea,
South
Stem cell is an undifferentiated cell which has the properties of self-renewal and differentiation.
Adipose-derived stem cells (ADSC) have relative advantages in the accessibility and abundance
compared to other kinds of stem cells. Regeneration therapy using ADSC has received attention in
the treatment of various dermatologic diseases. In the previous studies, ADSC were shown to have
antioxidant, whitening and wound-healing effects in the skin through secretion of growth factors
and by activating fibroblasts. We investigated whether ADSC could be used as an anti-aging ther-
apy, especially in the aspects of dermal collagen synthesis and angiogenesis. Collagen synthesis
significantly increased by the subcutaneous injection of ADSC in hairless mice. Dermal thickness,
collagen density and fibroblast number also increased in the ADSC skin. In addition, the expres-
sions of protein and mRNA of procollagen type I were increased by ADSC, which accounts for the
increased dermal collagen density. Angiogenesis which was visualized by CD31 and NG2 immuno-
fluorescence stains also increased in ADSC-treated skin. Our results implicated that ADSC therapy
would be useful in the aged skin. Its effects are mainly mediated by stimulating the collagen syn-
thesis in dermal fibroblasts and increasing angiogenesis.
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Clinical efficacy of wrinkle decrement in functional serum application
G Yeom,1 J Kwon,1 D Yun,1 I Kang,2 Y Kim2 and T Yoon3 1 Skin Science Lab., iPEERES Cosmetic
Ltd., Anseong, Korea, South, 2 Basic Product Lab., iPEERES Cosmetic Ltd., Anseong, Korea,
South and 3 R&D Center, iPEERES Cosmetic Ltd., Anseong, Korea, South
We could identify wrinkle decreasing effect in serum. We think main source that this serum is con-
tained effective raw materials: palmitoyl-oligopeptide (glycerin-butylene glycol-carbomer-olysor-
bate20-palmitolyl oligopeptide-palmitoyl-tetrapeptide-3, matrixyl 3000, Sederma, France) and
adenosine (adenosphere, Biospectrum, Korea). Serum is added palmitoyl-oligopeptide of 1% and
adenosine of 0.04%. Adenosphere is containing adenosine of 2% and some lecithin. We were used
adenosphere of 2% in this work. We analyzed depth and volume of whole-wrinkle and main (thick)
wrinkle by real-time 3-dimensional in vivo microphotography of human skin replica (MZ 16A,
Leica stereomicroscope, Germany). Twelve female subjects with average ages of 42.6 were included
in the study. We let her treat serum each twice per day for 30 days. We prepared replica of wrin-
kle every 7 days. We measured depth & volume comparing before treatment and after treatment
and then observed decreasing rates. We also evaluated subjective question. In case of whole-
wrinkle, it was decreased 31.73% in depth and 25.96% in volume. In case of main-wrinkle, it was
reduced 33.11% in depth and 23.93% in volume. We observed improvement by replica and
observed facial images by macrography (DSC – F717, Sony, Japan). In case of subjective question,
they replied to us that serum was shown wrinkle improvement of 67% in final day. We all know
that effective oligo-peptide have an anti-aging effect. Therefore we applied to cosmetic products
and observed. It was appeared only 30 days as we thought. Therefore if we are used steady for
expect of anti-wrinkle, we will identify improvement effect obviously.
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The possibility of valproic acid as a therapeutic agent against natural killer (NK) lympho-
proliferative disorders
K Fujii, N Suzuki, T Yamomoto, Y Hirai, T Kaji, K Tsuji and K Iwatsuki Department of
Dermatology, Okayama University Graduate School of Medicine, Dentistry and
Pharmaceutical Sciences, Okayama, Japan
Cutaneous lymphomas expressing natural killer (NK) phenotype are characterised in most cases
by a highly aggressive clinical course and remain still incurable to date. It is thus necessary to seek
new therapeutic agents. Histone deacetylase (HDAC) inhibitors have demonstrated therapeutic
benefit as monotherapy in cutaneous T-cell lymphoma (CTCL), however, its effects in NK cell lym-
phoproliferative disorders are still unclear. The purpose of this study is to clarify the possibility of
HDAC inhibitors as therapeutic agents against NK cell neoplasms. We have observed the growth
inhibitory and apoptogenic potential of valproic acid (VPA) on NK cell lines. Three cell lines (KAI3
and NKED were established from patients with chronic active EV virus infection, KHYG-1 was
established from a patient with aggressive NK cell leukemia) were used. Treatment with VPA resulted
in a dose and time-dependent inhibition of cell growth in all cell lines correlated with histone hyper-
acetylation. Anti-proliferative effects were observed even in therapeutic concentration for seizures
(< 1mM). VPA induced apoptosis in KHYG-1 with cleaved-PARP expression, downregulated Bcl-
2 transcript expression and mitochondrial membrane depolarization. On the other hand, VPA
induced G1 cell cycle arrest and upregulation of p53-independent p21 expression in KAI3 and
NKED. These results suggest the possibility of HDAC inhibitors as novel and effective treatment
agents in management of NK lymphoproliferative disorders.
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Effects of vitamin D products in a psoriasis plaque test and a psoriasis xenograft mouse model
– comparison of biomarker responses
PH Kvist,1 K Kemp,1 L Svensson,1 O Hagberg,2 V Hoffmann3 and MA Røpke4 1 Disease
Pharmacology, LEO Pharma A/S, Ballerup, Denmark, 2 Biostatistics, LEO Pharma A/S,
Ballerup, Denmark, 3 Clinical Operations, LEO Pharma A/S, Ballerup, Denmark and 4
Translational Research, LEO Pharma A/S, Ballerup, Denmark
The aim of the present study was to analyse the effects of vitamin D products on clinical score and
biomarker responses in the Scholtz-Dumas psoriasis plaque assay and to compare these results
with those obtained in a psoriasis xenograft mouse model. Twenty four patients with psoriasis
were treated daily with Daivobet®, calcipotriol and an ointment vehicle topically once daily for
three weeks. Clinical responses were scored twice weekly and biopsies taken at the end of the study
to analyse for skin biomarkers. The grafted animals were treated daily for four weeks and the bio-
marker responses analysed by histology and immuno-histochemistry in skin biopsies. The results
of the plaque test study demonstrate clear effects on both clinical signs and biomarkers. At the end
of the study the total clinical score was reduced 84 % and 61% by Daivobet® and calcipotriol,
respectively. Both treatments reduced epidermal thickness, Ki-67 and keratin 16 expression. T cell
infiltration was significantly reduced by Daivobet® but only marginally by calcipotriol treatment.
Both treatments showed strong effects on the epidermal psoriatic phenotype (e.g. extent of corneum
and parakeratosis), although Daivobet® clearly was the most effective of the two treatments. Results
from the in vivo mouse model were generally in good agreement with the results from the plaque
test. However differences were observed when investigating subtypes of T cells, indicating limita-
tions to the mouse model when compared to the plaque test. The study demonstrates that data
obtained with the psoriasis plaque test model is in accordance with results obtained from clinical
studies. Furthermore, it shows the feasibility of obtaining robust biomarker data from biopsies taken
from a psoriasis plaque test model and that these data correlate to some extent with biopsy data
from the grafted mice.
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Toll-like receptor (TLR) agonists synergize with interleukin-15 (IL-15) and interferon gamma
(IFN gamma) to boost cell mediated immunity (CMI): relevance to treatment of cutaneous
T-cell lymphoma (CTCL)
M Wysocka,1 LC Showe,2 B Benoit,1 AB Troxel,1 JM Gelfand1 and AH Rook1 1 University of
Pennsylvania, Philadelphia, PA and 2 Wistar Institute, Philadelphia, PA
CTCL is a malignancy of skin trafficking T-cells that is highly responsive to immune augmentative
therapies, including interferons and possibly TLR agonists. We have previously demonstrated syn-
ergy between agonists for TLR 2, 4 and 9 and IFN gamma and IL-15 in regard to enhancing CMI
of patients with advanced CTCL. In preparation for a phase II clinical trial, we determined whether
a synthetic agonist for TLR 7&8 also produced synergistic enhancement of CMI in vitro with either
IFN gamma or IL-15. Peripheral blood cells (PBMC) from patients with Sezary syndrome, the
leukemic variant of CTCL, were studied for enhancement of activation of NK and CD8+ T-cells,
cell-mediated cytotoxicity and cytokine production in response to priming with either IFN gamma
or IL-15, followed by exposure to the TLR 7/8 agonist. Exposure of patients’ PBMC to the TLR ago-
nist alone increased percent CD8+ T-cells that were activated, assessed by CD69 expression, from
4% to 32% with a further increase to 43% and 51% with IFN gamma and IL-15 priming, respec-
tively. Similarly, percent NK cells activated increased from 20% at baseline to 50% with the TLR
agonist and to 65% and 82% following priming with IFN gamma and IL-15. These results were
reflected in a 1.5 fold and a nearly 2 fold increase in cell-mediated cytotoxicity when primed with
IFN gamma and IL-15, respectively. One mechanism for these boosting effects may be the enhance-
ment of cytokine production as both IFN gamma and IL-15 priming resulted in a 2-fold increase
in IFN alfa production over TLR agonist stimulation alone while priming also resulted in marked
augmentation of IL-12 production over the TLR agonist alone. The in vitro data indicates a pro-
found degree of synergistic interaction between IFN gamma, IL-15 and the TLR 7/8 agonist. Such
results typically translate into relevant therapeutic benefit to patients with advanced CTCL and
suggest a novel approach to future therapy.
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Topical Ammonium-trichlorotellurate (AS101) in the treatment of mild plaque- type psoria-
sis; double-blind placebo controlled study
L Akerman,1 B Sredni,2 M Albeck2 and M David1 1 Dermatology, Beillinson Hospital, Petach-
Tikva, Israel and 2 Life Science Faculty, Bar-Ilan University, Ramat-Gan, Israel
Psoriasis is an organ-specific autoimmune disease that is triggered by an activated cellular immune
system. Psoriatic epidermal cells continuously produce enormously wide spectrum of cytokines
showing distinct biological functions, such as IL-4, IL-10, IL-12 as well as IL-11, IL-17, IL-18, and
TNF alpha. AS101 has an inhibitory effect on IL-17 secretion from activated mice spleen cells, as
well as inhibition of caspase 1 and subsequently decreasing IL-18 expression. AS101 had also been
found as an anti-angiogenetic factor by inhibition of VLA-4. Our objective was to evaluate the effi-
cacy of topical therapy with 4% AS101 in 5% Propylene glycol, in Polyethylen-glycol for mild
plaque-type psoriasis. Twenty four patients were included in the study. Patients were randomly
selected for 2 groups: 16 patients received 4% AS101 and 8 patients were given vehicle only. The
AS101 was applied twice daily for 8 weeks. All patients applied 3% Salicylic acid for the first three
days. Patients were checked every two weeks and evaluated for efficacy and side effects. The out-
come measure was modified PASI. Each psoriatic lesion was graded from 0 to 4 (0=clear 1=mild,
2=moderate, 3=moderate to severe, 4=severe) for the following parameters: scaling, erythema and
thickness. The score of the modified PASI parameters of each lesion was averaged, and a total
average of all lesions score was calculated. At the end of week 8, 5 patients (31%) had 75-100%
improvement in modified PASI and 5 patients (31%) had 50-75% improvement in the AS101 group;
compared to 0 and 12% (1 patient) respectively in the placebo group (p<0.04). Mild pruritus was
observed in 12 patients; no serious adverse effects have been observed. These preliminary results
suggest that topical AS101 4% might have a therapeutic effect on psoriatic lesions. It is well toler-
ated and is not associated with significant side effects. Further studies are needed to establish these
results.
300
A noninvasive clinical method to assess biomarkers in human skin
M Garay, H Kenney, P Lyte and M Southall Pharmacology, Johnson & Johnson Consumer
Products, Skillman, NJ
Clinically, there exists a need for sensitive, non-invasive techniques to assess skin inflammation
and oxidative stress as well as skin differentiation. In addition, quantification of antimicrobial pep-
tides present on the skin can provide insight on innate immunity, particularly as it relates to acne.
Inflammatory skin diseases are among the most common cutaneous disorders and are currently
primarily evaluated by visual assessment or histology. However visual assessment cannot detect
sub-clinical irritation. In addition, measurements of oxidative stress can be invasive and require
cumbersome instrumentation. Measurement of skin biomarkers via non-invasive tape-sampling as
compared to other biophysical tools is highly sensitive and allows for meaningful evaluation of a
variety of dermal endpoints. We can demonstrate that non-invasive tape-sampling via either D-
squamesâ or Sebutapesâ is an effective way to quantify biomarkers from the skin of subjects in clin-
ical studies of various skin conditions associated with diaper rash, aging, and the measurement of
antimicrobial peptides present on facial skin. This quantification has been validated in freshly
acquired clinical samples as well as after prolonged storage at subzero temperatures. Since these
noninvasive methods can also be used to evaluate skin in vivo as a function of age, regional site
variations, and external challenges this technique is ideal for clinical assessment and as an inves-
tigative tool as it is simple, non- invasive and versatile.
S50 Journal of Investigative Dermatology (2009), Volume 129
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Exploiting the DC-HIL/syndecan-4 pathway to treat cutaneous T cell lymphoma
J Chung,1 L Shiue,2 M Tomihari,1 M Duvic,2 PD Cruz1 and K Ariizumi1 1 Dermatology, UT
Southwestern Medical, Dallas, TX and 2 Dermatology, MD Anderson Cancer Center,
Houston, TX
We discovered a novel inhibitory pathway, in which DC-HIL receptor on antigen presenting cells
attenuates TCR-activation of T cells by binding the ligand syndecan-4 (SD-4) on activated effec-
tor/memory T cells. Because cutaneous T cell lymphoma (CTCL) cells display effector/memory T
cell phenotype, we posited these cells to also express SD-4. mRNA analysis revealed heteroge-
neous SD-4 expression by 3 CTCL lines (high for HUT-78; intermediate for MJ; and nil for HH),
and FACS analysis of peripheral blood T cells showed high-level cell-surface expression of SD-4
in 2 of 3 CTCL patients. By contrast, SD-4 was not expressed by non-CTCL leukemia lines (Jurkat,
Molt-4, PEER); and other inhibitory molecules (PD-1, BTLA, CTLA-4, CD160) were not expressed
by any of the cells (CTCL or non-CTCL) tested. We next questioned whether the inhibitory capac-
ity of SD-4 (mediated by ligation to DC-HIL) is functional in CTCL cells. As predicted by level of
SD4 expression, DC-HIL bound greatest to HUT-78, some to MJ, but not to HH. We then stimu-
lated CTCL cells with immobilized anti-CD3 Ab plus DC-HIL or control protein; and measured
activation using the markers IL-2 or CD69. DC-HIL markedly inhibited the anti-CD3 response by
HUT-78 (but not HH); it also blocked entry of HUT-78 cells into the cell cycle. Finally, to test the
possibility that SD-4 on CTCL cells may serve as a therapeutic target, we examined effects of toxin
(saporin)-conjugated DC-HIL in vitro. Saporin-DC-HIL (but not saporin-control) killed HUT-78 and
MJ (but not HH) cells (70% lethality at 40nM). These findings indicate that toxin-conjugated DC-
HIL can be developed as a treatment for patients with SD-4+ CTCL.
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Dermatology through the eyes of family practice: A regional survey
LL Rosamilia, SA Klepeiss and JJ Miller Dermatology, Penn State Milton S. Hershey Medical
Center, Hershey, PA
Primary care physicians are more likely to refer than manage skin disorders compared to other
medical problems, and importantly, wait time in dermatology is a constant concern and exceeds
that of other specialties. Therefore, we conducted a survey of 188 regional family physicians to
determine their diagnostic, treatment, and referral patterns for skin problems; assess their attitudes
toward dermatology and the care their patients receive; and synthesize the above findings into
areas of improvement in our patient care, communication, and education in reference to our pri-
mary care colleagues. Our results showed that family physicians are least comfortable treating skin
cancer and psoriasis, as only around 50% manage these problems without referral. We also pin-
pointed areas of medication and procedural inexperience for family physicians, such as rare use
of high potency steroids and topical wart therapies. The comment/free text portion of the survey
revealed candidly that access to dermatology and patient wait time were salient concerns. For
instance, the most commonly reported patient wait time for dermatology was 3 to 4 months. Almost
to a vulgar extent, the free text section depicted dissatisfaction of family physicians with the cos-
metic focus of some dermatology settings as it relates to medical dermatology access difficulties.
Additionally, family physicians compellingly request improved communication from us, such as
clearer letters of explanation of patient diagnosis, treatment, and follow-up plans. This regional
survey provides data to improve our referral base relationships so as to broadly advocate cooper-
ative care, targeted education efforts for primary care curricula, and ultimately, improved primary
care understanding of and access to dermatology.
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Nonablative collagen remodeling In photoaged skin: A comparative study
M El-Domyati,1 W Medhat,1,2 T El-Amawi,1 O Moawad,3 D Brennan,2 MG Mahoney2 and
J Uitto2 1 Dermatology, Al-Minya University, Al-Minya, Egypt, 2 Dermatology and Cutaneous
Biology, Thomas Jefferson University, Philadelphia, PA and 3 Moawad Skin Institute for Laser,
Cairo, Egypt
Multiple therapies have been described for skin rejuvenation, including ablative and non-ablative
modalities. Nonablative photorejuvenation has become an integral procedure in laser dermato-
logic surgery. In order to compare the effects of these modalities we evaluated the changes induced
by different nonablative procedures on various structures of the skin using computerized histo-
metric and immunohistochemical techniques. Patients (36) of Fitzpatrick skin type III-IV and class
I–II wrinkles were subjected to different nonablative techniques for treatment of skin aging, employ-
ing 4 approaches with 6 different devices. The first approach included light-based technologies
where discrete chromophores are targeted via photothermal mechanisms as intense pulsed light
(IPL) and E-Light (combined IPL and RF); the second approach involved modalities with water as
the primary chromophore, i.e., 1320 nm Nd:YAG and 1540 nm Erbium:YAG lasers; the third
approach uses the creation of stress waves at the skin surface for rejuvenation as radiofrequency
(RF) device; as a control, poly-vitamin complex application as mesotherapy injection was used.
Standard photographs and skin biopsies were obtained at base line as well as 3 and 6 months after
the start of treatment. Blinded photographs were independently scored for wrinkle improvement.
E-Light, RF, 1540 nm Erbium:YAG and 1320 nm Nd:YAG produced clinical results, with high patient
satisfaction and corresponding facial skin improvement. This was accompanied by increasing
collagen content and by improved morphologic appearance of collagen and elastic fibers. Mini-
mal improvement was obtained with IPL and mesotherapy. In conclusion, although the results may
not be as impressive as those obtained by ablative treatments, selected nonablative procedures
are effective in the treatment of photoaging skin with fewer side-effects and downtime.
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Statins, inhibitors of cholesterol synthesis, accelerate wound healing via farnesyl pyrophos-
phate
S Vukelic,2 O Stojadinovic,1,2 I Pastar,2 S Das,3 H Samuels,3 A Krzyzanowska,2 H Brem3 and
M Tomic-Canic1,2 1 Dermatology and Cutaneous Surgery, University of Miami Miller School
of Medicine, Miami, FL, 2 Hospital for Special Surgery, New York, NY and 3 Surgery, NYU
School of Medicine, New York, NY
Statins are widely clinically used as cholesterol synthesis pathway inhibitors that act through inhi-
bition of HMG-CoA-reductase. However, these compunds also show additional cholesterol-inde-
pendent effects, including immunomodulatory effects and decrease of oxidative stress. Here we
show that statins accelerate wound healing through novel mechanism involving farnesyl pyrophos-
phate (FPP), a key intermediate in cholesterol synthesis pathway and protein farnesylation. Previ-
ously, we reported that FPP acts as an agonist for nuclear hormone receptors. Now we show that
elevation of endogenous FPP results in activation and nuclear translocation of the glucocorticoid
receptor (GR). To functionally test the effects of FPP-GR we used keratinocyte migration assay and
skin organ culture wound model. FPP-GR inhibited keratinocyte migration and wound epithelial-
ization. Furthermore, using chromatin immunoprecipitation (ChIP) and transfection assays we show
that this inhibition occurs by FPP-GR binding to keratin K6/K16 promoters leading to suppression
of their transcription. These data suggest that endogenous FPP levels may influence clinical out-
come of wound healing. Therefore, we used topical application of mevastatin, a HMG-CoA reduc-
tase inhibitor that blocks FPP formation. We found that mevastatin promotes epithelialization in
acute wounds. In addition, mevastatin reverses the inhibitory effects of endogenous FPP. In sum-
mary, our findings suggest new mechanism of action for statins in which they may act to promote
wound healing. Many patients are currently treated by various modulators of cholesterol synthe-
sis, which may impact their ability to heal wounds, which is particularly important among elderly
and/or diabetic patients whose healing capabilities may be compromised.
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Workflow tracking of dermatopathology consultation cases
LM Drogowski,1 J Martina1 and DM Jukic1,2 1 Dermatology, University of Pittsburgh,
Pittsburgh, PA and 2 Pathology, University of Pittsburgh, Pittsburgh, PA
The existing dermatopathology second opinion consultation process in place in most of the insti-
tutions, academic as well as private, relies on physical transport of paperwork and glass-slides.
The steps required to obtain a consultation on a case is not well documented; more so, to date, no
study documents the time required for completion of each step of this process (from initial acces-
sioning to final sign-out). Delay is usually source of frustration for submitting clinician and/or pathol-
ogist as well as the patient. We hypothesize that most of the delay in occurs during the diagnostic
workup, and this delay is exacerbated by inefficiencies in the consultation process. We tracked
the time required for completion of each step of the consultation process. Information was recorded
in an Excel spreadsheet and obtained from shipping documents, CoPath (anatomic pathology lab-
oratory information system) and measurements by study participants. Consultation requests were
tracked for forty-five days (fifty-nine consultations). The data needed for evaluation included the
date the consultation was shipped, method of transport, date and time received, number of parts,
number of blocks and slides, original diagnosis, time to accession, time of the signed-out in CoPath,
as well as final diagnosis and final date and time it was faxed to the requesting office. The average
time between original accession (usually 1 to 2 days after the procedure date) and consulting
office accession was 13.5 days. The average time to transport a case was 1.2 days. Time to acces-
sion the consultation averaged only 10.6 minutes. The time from consultation receipt to sign-out
by a dermatopathologist in our institution averaged 6 days. As seen above, out of two main sources
of delay and increase of turnaround time, the initial delay was more than double to the actual
workup time. This is one of the areas addressable via tele(dermato)pathology - to give guidance in
the initial workup of a challenging case and allow for additional materials to be requested early in
the process.
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Curcumin improves radiation dermatitis in breast cancer patients: Interim analysis of ran-
domized, double-blind, placebo-controlled clinical trial
JL Ryan,1,2 L Marsh,1 M Ling,2 J Williams,2 P Okunieff,2 GR Morrow2 and AP Pentland1 1
Dermatology, University of Rochester Medical Center, Rochester, NY and 2 Radiation
Oncology, University of Rochester Medical Center, Rochester, NY
Radiation dermatitis occurs in nearly 95% of cancer patients receiving radiation therapy. Currently,
there are no useful treatments for these skin reactions. Curcumin, a component of turmeric, is a
potent anti-inflammatory and antioxidant. Published preclinical studies by our group showed that
intragastric administration of curcumin reduced radiation skin toxicity by 50% in mice. Currently,
we are conducting a randomized, double-blind, placebo-controlled clinical trial to assess the effi-
cacy of curcumin to reduce radiation dermatitis in breast cancer patients. After randomization, all
patients take twelve 500mg capsules of curcumin or placebo daily during their prescribed course
of radiation treatment. Weekly assessments include Common Toxicity Criteria score for dermati-
tis, erythema measurement, Symptom Inventory survey, and McGill Pain Questionnaire. The goal
of the study is to determine if curcumin reduces radiation-induced redness, tenderness, or desqua-
mative dermatitis in breast cancer patients. Interim statistical analyses, using two-independent t-
tests with significance level of 0.05, were performed on the first nine patients to successfully com-
plete the study. Initial results showed no significant differences in dermatitis, redness, or pain at
treatment site between curcumin and placebo groups. Further analyses were performed solely on
six patients who received whole breast irradiation. Curcumin significantly reduced the severity of
dermatitis (p=0.018), but not redness (p=0.884), in patients receiving whole breast irradiation com-
pared to placebo. Additional analyses suggest that curcumin may relieve pain at treatment site
(p=0.055). In conclusion, curcumin is a promising non-toxic intervention for radiation dermatitis
in breast cancer patients receiving whole breast irradiation.
www.jidonline.org   S51
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African Americans display a significant lack of hyperalgesia and neurogenic inflammation in
response to topical capsaicin
H Wang,1 A Papoiu,1 R Coghill,2 T Patel1 and G Yosipovitch1 1 Dermatology, Wake Forest
University Health Sciences Center, winston salem, NC and 2 Department of Neurobiology
and Anatomy, Wake Forest University Health Sciences Center, winston salem, NC
Topical application of capsaicin commonly produces burning, stinging and itching as well as hyper-
algesia to heat stimuli via activation of transient receptor potential vanilloid subtype 1 (TRPV1).
Our study was intended to evaluate if there were differences in sensory response and neurogenic
inflammation to topical capsaicin in four different ethnic populations with different skin types.
This study was performed on 40 healthy subjects consisting of 10 African Americans, 10 East Asians,
10 Hispanics and 10 Caucasians, 5 males and 5 females in each group. Warmth detection and
heat pain thresholds, as well as pain sensation intensity were measured before and after applica-
tion of capsaicin or placebo cream on forearms along with skin blood flow data and the extent of
the local flare reaction. In African Americans the heat pain threshold, pain intensity and skin blood
flow did not change significantly after capsaicin application whereas in the other 3 ethnic groups,
a significant change occurred characterized by hyperalgesia and vasodilatation. Post-capsaicin
warmth detection threshold significantly increased only in African American group. Another strik-
ing finding was that only the Hispanic group reported itch sensation after topical capsaicin appli-
cation. No differences were noted in baseline measurements between African Americans and other
3 ethnic groups. Our observations show that African Americans display a striking lack of hyper-
sensitivity to topical capsaicin, compared to other ethnic groups. The efficacy of topical capsaicin
in treatment of neuropathic pain in African Americans becomes a question requiring further inves-
tigation.
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Development of novel calcium carbonate-coated tretinoin nanoparticles
E Hsia, J Therrien, M Larm, E Millerman, W Chern and H Hofland Stiefel Laboratories Inc., Palo
Alto, CA
Retinoids are natural and synthetic analogues of vitamin A (retinol) which are known to regulate
epidermal proliferation and differentiation. The efficacy of topical retinoids such as tretinoin (all-
trans-retinoic acid) in the treatment of keratinizing disorders is well established, but local side effects
such as erythema, dryness, peeling and scaling, limit their use. Novel vesicular and particulate
topical drug delivery systems are proposed to reduce these undesirable effects of retinoids while
preserving their efficacy. Here we describe the development of CaCO3-coated tretinoin nanopar-
ticles (CCTN) and their characterization with respect to: 1) particle formation as assessed by
microscopy and 2) potential dermal irritation and retinoid activity in vitro using reconstructed
human epidermis (RHE) cultures. CCTNs were generated by reacting CaCl2 with Na2CO3 in the
presence of tretinoin, forming CaCO3-encapsulated tretinoin particles. Final particle size was esti-
mated to be <1 μm, and aggregation was reduced by addition of a chelating agent (EDTA). CCTNs,
with and without EDTA, were incorporated into an aqueous vehicle that was suitable for topical
delivery. In RHE cultures, potential irritation was evaluated by release of pro-inflammatory cytokines,
and activity was assessed histologically by changes in cell morphology and expression of bio-
markers of cell differentiation. In comparison to commercially available tretinoin formulations, both
IL-1α and IL-8 release from cultures treated with CCTNs without EDTA were similar to a commer-
cial micro-sponge formulated tretinoin and approximately 2-fold lower than that of a commercial
tretinoin gel. Histology revealed that RHE treated with CCTN formulations showed a loss of kera-
tohyalin granules, decreased expression of keratin 10, and increased expression of keratin 19. These
profiles were comparable to commercially available tretinoin preparations. In conclusion, these
results suggest that CCTNs formulated in an aqueous vehicle may be less irritating but equally active
compared to other currently available topical tretinoin formulations.
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ABT-737 synergizes with Paclitaxel and Bortezomib to kill melanoma cells by neutralizing
multiple anti-apoptotic defenses
YG Shellman, NB Goldstein, LA Miller, S Smith, M Fujita and DA Norris Dermatology, UC
Denver, School of Medicine, Aurora, CO
The BH3 mimetic ABT-737 is a potent small molecule inhibitor of the anti-apoptotic proteins Bcl-
2, Bcl-XL, and Bcl-w. The expression of Bcl-2 family proteins plays an important role in modulat-
ing sensitivity to anticancer drugs in melanomas. In this report, we examined whether ABT-737 is
effective in killing human melanoma cells when combined with Paclitaxel (a microtubule stabi-
lizing agent) or Bortezomib (a proteasome inhibitor), and we further evaluated the mechanisms of
action. Viability and apoptosis assays showed that ABT-737 alone induced little cytotoxicity in
melanoma cells, yet it displayed strong synergistic lethality when combined with either Paclitaxel
or Bortezomib. In addition, siRNA-mediated inhibition of the anti-apoptotic proteins Bcl-2, Bcl-
XL, and Mcl-1 indicated that Mcl-1 is the main mediator of melanoma cell resistance to ABT-737
treatment. Furthermore, Western Blot analyses demonstrated that Paclitaxel decreased Mcl-1 pro-
tein expression whereas Bortezomib increased expression of Noxa (a pro-apoptotic Bcl-2 member
that antagonizes Mcl-1’s function). These results indicate that both Paclitaxel and Bortezomib
neutralize Mcl-1 function through different mechanisms. Finally, preliminary studies suggested that
siRNA-mediated inhibition of Noxa expression protected melanoma cells from cytotoxicity induced
by the combination treatments of ABT-737 with either Paclitaxel or Bortezomib. These findings
suggest that drugs that neutralize Mcl-1 function are good candidates for combination therapy with
the BH3 mimetic ABT-737 for treating melanomas. In summary, this study indicates the promising
therapeutic potential of ABT-737 in treating melanomas, and it validates rational molecular
approaches to targeting multiple anti-apoptotic Bcl-2 members in developing cancer treatments.
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Development of the CLASI as a tool to measure responsiveness to therapy in cutaneous lupus
erythematosus
RS Klein,1,2 S Moghadam-Kia,2 J LoMonico,2 K Chilek,2 E Gaines,2 L Taylor,3 C Coley,3 J Okawa2
and VP Werth1,2 1 VAMC, Phil, PA, 2 Dermatology, U. of Pennsylvania, Phil, PA and 3 Biostat
and Epi, U. of Pennsylvania, Phil, PA
The CLASI (cutaneous lupus erythematosus disease area and severity index) is a quantitative tool
that measures both disease activity and damage in patients with cutaneous lupus erythematosus
(CLE). The purpose of this study was to determine how the CLASI activity score could be used to
determine whether or not patients responded to therapy, and if this score changed for patients with
different underlying disease severity. At each clinic visit, both the CLASI and the physician’s skin
score were calculated. A change ≥ 2 in the physician’s skin score was considered the gold stan-
dard for improvement. A subset of patients were also categorized into “mild”, “moderate,” and
“severe” disease, based on the physician’s subjective assessment. This data was used to generate
a range of CLASI activity scores corresponding to mild (0-4), moderate (5-18) and severe (>18) dis-
ease. A total of 150 patients were included in the analysis, all of whom were screened for improve-
ment over the course of several clinic visits, for a total of 511 assessments. The preliminary results
indicate that the CLASI activity score can detect improvement in patients with moderate and severe
disease; for moderate disease, a mean 38% decrease (t=-3.03, DF=208, p<0.0028) corresponded
with a clinical improvement, whereas for severe disease, a mean 51% decrease (t=-5.55, DF=33.3,
p<0.0001) corresponded with a clinical improvement. Alternatively, a mean decrease of 5 points
(t=-3.98, DF=208, p<0.0001) corresponded with a clinical improvement in patients with moder-
ate disease, while a mean decrease of 12 points (t=-5.24, DF=33.1, p<0.0001) was seen in patients
with severe disease. Of note, there was no significant change in the CLASI activity score amongst
patients that did not improve clinically or for patients with mild disease. These preliminary results
suggest that the CLASI may be a useful tool in determining response to therapy for patients with
moderate and severe CLE.
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The role of infant skin care in atopic dermatitis development
SF Baig-Lewis, TM Berry, ME Rendell, MA Denny, PA Brown, BM Simpson, SJ Tofte, JM Hanifin
and EL Simpson Dermatology, Oregon Health & Science University, Portland, OR
Studies of filaggrin reveal that a genetically-determined defect in the skin barrier may initiate atopic
dermatitis (AD). We hypothesize that the routine exposure of infant skin to water, soap, and some
lotions may be additionally detrimental to the skin barrier, thus promoting AD development. We
performed two independent studies examining the effect that early skin care practices may have
on AD development. Results from a case-control study (n=225) revealed that skin care practices
potentially harmful to the skin barrier are common in both infants who do, and do not, develop
AD. Seventy percent of parents used an emollient on their infant’s skin on a regular basis prior to
the development of AD. Lotions from a pump were the most commonly used emollients in all
groups. Over 70% of parents bathed their infant more than 3 times per week prior to AD devel-
opment. Because of the high use of skin care products in the control groups, no one skin care
practice could be identified that increased the risk for AD development. Results from a separate
interventional pilot study of 24 infants at high-risk for AD revealed that a petrolatum-based emol-
lient used from birth was a safe and feasible approach to AD primary prevention. There were no
adverse events and compliance was excellent. Transepidermal water loss (TEWL) and skin hydra-
tion values were equivalent to that expected of normal skin. Two of twenty-four infants were diag-
nosed with AD during a mean follow-up time of 406 days. The preliminary results from this novel
approach to AD prevention suggest a protective effect and controlled studies should be pursued.
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Effects of bath-PUVA on circulating regulatory T cells and malignant lymphoma cells in
patients with mycosis fungoides
C Saito, H Kato, A Maeda, Y Shintani and A Morita Department of Dermatology, Nagoya City
University Graduate School of Medical Sciences, Nagoya, Japan
Photochemotherapy with psoralen and UVA (PUVA) is widely used as an effective treatment for
cutaneous T-cell lymphoma (CTCL). Mycosis fungoides (MF) and Sézary syndrome (SS) represent
the most frequent forms of CTCL. In the majority of cases, both are characterized by skin infiltrat-
ing and/or circulating malignant cells displaying a CD4+CD7– phenotype. We previously reported
that bath-PUVA therapy induces circulating regulatory T cells (Treg) in patients with psoriasis. In
the present study, we examined whether bath-PUVA affects circulating Treg and malignant cells in
the peripheral blood of 14 patients with MF. Bath-PUVA was well tolerated and the lesions regressed
with pathologic improvement in all patients (total session number: 25.8±14.0). We analyzed
CD4+CD25+Foxp3+ Treg and CD4+CD7(-)cells in the peripheral blood of the 14 MF patients
before and after bath-PUVA therapy. Peripheral blood mononuclear cells (PBMCs) were obtained
by density gradient centrifugation and stained with fluorescence-conjugated antibodies against
human CD4, CD25, FoxP3, CD4, CD3, and CD7, followed by fluorescence–activated cell sorting
analysis. We assessed the percentages of CD4+CD25+FoxP3+Treg in CD4+T cells isolated from
MF patients. Treg did not differ between MF patients (8.39 ± 6.54%) and healthy volunteers (4.98
± 1.16%). Further, bath-PUVA therapy did not significantly change the percentage of Treg (7.97 ±
5.97%). Next, the percentages of CD4+CD7(-) cells in CD3+T cells in PBMCs isolated from CTCL
patients were evaluated. CTCL patients has significantly more malignant cells before bath-PUVA
therapy (9.29 ± 6.32%) than did healthy volunteers (4.06 ± 1.44%, n=10, p < 0.05). PUVA-bath
therapy did not, however, significantly decrease the number of CD4+CD7(-) cells (8.98 ± 7.30%)
in the CTCL patients. Although the study was conducted with a limited number of patients, bath-
PUVA therapy did not affect FoxP3+ Treg and CD4+CD7(-) lymphoma cells in the peripheral blood.
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Polysomnography of patients with psoriasis show prolonged Stage I sleep and lower oxygen
levels compared to controls
B Wong,3,1 T Downing,2 R Simpson,2 GG Krueger1 and KC Duffin1 1 Dermatology, University
of Utah, Salt Lake City, UT, 2 Medicine, University of Utah, Salt Lake City, UT and 3 College
of Nursing, University of Utah, Salt Lake City, UT
Psoriasis is an immune-mediated disorder manifest by cutaneous plaques and associated arthritis
that is known to disrupt sleep. We compared polysomnography (PSG) results of 13 psoriasis patients
from the Utah Psoriasis Initiative with 1338 non-psoriatic controls at the University of Utah
Sleep/Wake Center. Total sleep time, sleep efficiency, latency, time spent in sleep stages 1-4 and
REM, apnea-hypopnea index, mean oxygen saturation, and periodic limb movement index were
compared using independent samples t-test. Of the 13 psoriasis patients, 7 were male, 4 (31%)
had psoriatic arthritis, and 6 (46%) were smokers. The patients had a mean age of 57.9, and mean
BMI of 37.7. Compared to controls, the psoriasis patients statistically spent more time in Stage 1
sleep (24.1% vs. 17.1%, p = 0.046). The psoriasis patients had a lower mean oxygen saturation
(89.7%+/-0.027 vs. 91.3%+/-0.028, p = 0.037). Although not significant, the psoriasis patients also
trended to lower total sleep time (358.8+/-90.2 minutes vs. 393.7+/-90.5 minutes, p = 0.167) and
a higher periodic limb movement (PLM) index (44.5 +/-48.7 vs. 22.2 +/-27.1, p = 0.208). This
data suggests psoriasis patients may have more severe overnight hypoxemia compared to non-pso-
riatic patients referred for sleep study. Co-morbidities seen in psoriatic patients such as high body
mass index, tobacco use, underlying cardiopulmonary disorder, and sleep apnea may be con-
tributing to more severe hypoxemia. Our patients also had more significant early stage sleep dis-
ruption. We hypothesize that itch and discomfort from psoriasis and arthritis could contribute to
excess movement leading to prolonged stage I sleep; this combined with increased PLM can con-
tribute to fragmented sleep. These observations make it apparent that further research will be needed
to tease out cause and effect for psoriasis, psoriatic arthritis, sleep disorder, cardiovascular risk,
and quality of life.
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The morphologic and immunohistochemical overlap between cutaneous marginal zone lym-
phoma and cutaneous chronic lymphocytic leukemia
C Levin,1,2 N Mizramani,1 J Zwerner,3 Y Kim3 and U Sundram1,3 1 Pathology, Stanford
University, Stanford, CA, 2 Dermatology, University of Minnesota, Minneapolis, MN and 3
Dermatology, Stanford University, Stanford, CA
Leukemic infiltrates in the skin due to chronic lymphocytic leukemia (CLL) is a common initial
presentation of this disease. There can be histologic and immunohistochemical overlap with
other low grade B cell lymphomas, specifically marginal zone lymphoma (MZL). We wished to
document the overlap between cases of cutaneous CLL and MZL, since CLL can demonstrate light
chain restriction, similar to MZL. We studied 13 cases of patients with cutaneous CLL and 14
cases of primary cutaneous MZL (PCMZL), and compared histologic features as well as immuno-
histochemistry. We found that the histologic findings in these two entities can be very similar. The
majority of both show nodular involvement of the skin (69% CLL, 64% PCMZL), with a minority
demonstrating diffuse (23% CLL, 29% PCMZL) and patchy perivascular patterns (8% CLL, 7%
PCMZL). Both can have monocytoid cells (61% CLL, 50% PCMZL). However, PCMZL is more
likely than CLL to have reactive germinal centers (8% CLL, 86% PCMZL) and plasma cells (31%
CLL, 71% PCMZL). While the cases of CLL did have a characteristic immunohistochemical pro-
file (CD79+CD5+CD23+CD43+), interestingly, 4/13 cases (31%) also showed light chain restric-
tion. The cases of PCMZL also had a characteristic profile (CD79+CD5-CD43-) and all were light
chain restricted (14/14, 100%). Our results indicate that as there can be significant histologic
overlap between these two entities, it is important to test cases with CD79, CD5 and CD43, as
these are the most reliable markers to make this distinction. The presence of light chain restriction
should not prompt the incorrect diagnosis of MZL without the demonstration of CD5 and CD43
negativity.
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Low-dose total skin electron beam therapy (TSEBT): A revisited paradigm in management of
mycosis fungoides (MF)
J Young,1 D Navi,1 N Riaz,2 RT Hoppe2 and YH Kim1 1 Dermatology, Stanford Cancer Center,
Stanford, CA and 2 Rad Onc, Stanford Cancer Center, Stanford, CA
Although response rates to conventional dose (>30 Gy) TSEBT in MF are high, relapse is likely
within 3 yrs and retreatment must be given with caution. Strategic use of low-dose TSEBT is an
attractive option as it would allow more frequent retreatment, extending the benefit of total skin
irradiation over a much longer time span. The goal of this study was to identify a lower dose range
of TSEBT that has favorable efficacy profile. Retrospective review of Stanford pts with T2-T4 MF
treated with initial course of TSEBT to a dose ≤ 25 Gy identified 102 pts (51 T2, 29 T3, 22 T4).
Actuarial survival curves were generated using the Kaplan-Meier method and differences deter-
mined by log-rank test. In the T2 subgroup, overall response rate (ORR) (≥ 50% improvement
involved skin) was 87% in 5-10 Gy cohort, and 100% in both 10.1-20 Gy and 20.1-25 Gy cohorts.
Similarly high ORRs were seen in T3/T4 subgroups. Complete clinical response (CCR) rates in the
T2 were 14% in 5-10 Gy cohort and 40% in both 10.1-20 Gy and 20.1-25 Gy. In the T3, CCR
rates were 15% in each of the dose cohorts while in the T4 they were 9% in 5-10 Gy, 29% in
10.1-20 Gy and 50% in 20.1-25 Gy cohorts. Freedom from relapse (FFR) was analyzed among
complete responders. The median duration of FFR was 12 mo in both T2 and T3 vs. 4 mo in T4
(p=0.050). No significant difference in FFR was noted among the dose cohorts. Median time to
progression (TTP) was similar in T2 (283 mo) and T4 (205 mo), while significantly shorter in T3
(32 mo) (p=0.002). Stratified by dose, median TTP in 5-10 Gy and 10.1-20 Gy cohorts was 27 mo
and 205 mo, respectively (p=0.024) and that in 20.1-25 Gy was 80 mo. Radiation-induced toxi-
cities were mostly limited to mild acute dermatitis, nail loss and alopecia. Our findings identified
the 10.1-20 Gy range of low-dose TSEBT to be associated with high ORR and favorable FFR/TTP
in T2-T4 MF and be optimal dose range for further study in a prospective clinical trial alone
and/or in combination with other therapies.
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The importance of dendritic cells in the clearing of psoriatic skin lesions by Adalimumab
RE Schopf and G Ceri Dermatology, Johannes Gutenberg Univ., Mainz, Germany
We examined dermal dendritic cells (DCs) during a 12-week anti-TNF treatment with Adalimumab
in 15 patients with psoriasis (5 female, 10 male, aged 25 to 68 years). Clinical severity was deter-
mined by the psoriasis area and severity index (PASI), skin biopsies were taken from gluteal skin
at weeks 0 from uninvolved and lesional skin and at week 12 from lesional skin. Skin sections
were stained by H&E and monoclonal antibodies (visualized by biotin/streptavidin alkaline phos-
phatase) against HLA-DR (MHC class II), CD123 (IL3-Ra, plasmacytoid DCs), Langerin (CD207,
cell surface receptor of Langerhans cells), CD11c (myeloid DCs), and CD83 (activated and fully
mature DCs). After 12 weeks, the PASI decreased from 21.9 +/- 2.4 to 2.7 +/0.9 (mean +/- SE), the
epidermal thickness (as measured by a micrometer grid, Leica Application Suite) from 358 +/- 36
in lesional skin to 179 +/-14 micrometers (97 +/- 4 in uninvolved skin at week 0). As counted micro-
scopically, HLA-DR+ cells in epidermis and dermis did not differ between the various biopsies;
neither did CD123+ cells between weeks 0 and 12 For Langerin we found a decreased number of
epidermal DCs in involved epidermis at week 0 vs. week 12 and uninvolved skin (p<0.001; 2-
tailed Wilcoxon test). By contrast, CD11c+ and CD83+ cells were significantly increased at week
0 in involved skin (p<0.01) and returned to normal values at week 12 as in uninvolved skin at
week 0. Our findings indicate that MHC-class II+ and plasmacytoid DCs remain constant during
anti-TNF treatment whereas Langerhans cells quickly increase in number in the epidermis. More-
over, myeloid (CD11c+) and activated (CD83+) DCs rapidly dwindle in the epidermis after suc-
cessful therapy with Adalimumab. We conclude that the reverse shift of Langerhans cells and acti-
vated myeloid DCs during clearing of skin lesions is of pathogenic importance for psoriasis.
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Actinic keratoses are intermittently present during the natural course of their disease
W Cantrell,1 JW Turnham,1 AA Andea1,2,3 and CA Elmets1,2,3 1 Dermatology, University of
Alabama at Birmingham, Birmingham, AL, 2 Skin Diseases Research Center, University of
Alabama at Birmingham, Birmingham, AL and 3 Pathology, University of Alabama at
Birmingham, Birmingham, AL
Actinic keratoses (AKs) are exceptionally common dysplastic epidermal lesions occurring on chron-
ically sun-exposed skin. Despite the prevalence, little is known about their natural history. In this
study, the AKs of 27 subjects between the ages of 39 and 79 with extensive sun damage were fol-
lowed. A total of 610 lesions were mapped and then examined on 5 separate visits over 11 months.
The mean number of lesions per patient at baseline was 23.5 ± 7.9. At the end of the study, there
were 37 ± 24.6 AKs per subject (57% increase from baseline). Of the AKs clinically present at the
commencement of the project, 29.7% regressed by month 11; 32.6 %, present at baseline regressed
at one of the follow-up visits, but then recurred by the end of the study; 10.6 % of AKs originally
present regressed twice during the course of the study; 24.3% of the AKs were present throughout
the study period and never regressed. To evaluate whether those AKs that had regressed clinically
had also done so histologically, some AKs were randomly selected at baseline. The site was biop-
sied at month 9 whether the AK was present or not. In every instance of clinical regression, there
was no evidence of an AK histologically. Over the 9 month period, there did not appear to be sta-
tistically significant progression in the severity of the AKs histologically. These data indicate that
in normal individuals, AKs are present intermittently, suggesting a dynamic interplay between intrin-
sic forces within the keratinocyte that accentuate growth and host defense mechanisms that result
in their regression.
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A unique case of an erythrodermic TCRγδ+ peripheral T cell lymphoma with TH2 phenpo-
type
W Bauer,1 D Spazierer,1 I Klein,1 G Stary,1 S Woehrl,1 S Wagner,1 L Müllauer2 and G Stingl1 1
Dermatology, DIAID, Medical University of Vienna, Vienna, Austria and 2 Pathology, Medical
University of Vienna, Vienna, Austria
Peripheral T cell lymphomas expressing the γδTCR represent rare cases of non-Hodgkin lymphomas
and most often originate at extranodal sites. We report on a 78 year old patient with a peripheral
TCRγδ+ T cell lymphoma who initially presented with a sudden onset of erythroderma, massive
pruritus and eosinophilia. Within one month the patient developed generalized lymphadenopathy
with the presence of tumor cells staining positive for CD3, CD4, CD5 and TCRVδ1 and lacking
expression of CD2, CD7, CD8, CD30 and of cytotoxic molecules (granzyme B, perforin). These
cells were also present in the peripheral blood (CD4/CD8 ratio up to 12), bone marrow and skin
whereas involvement of liver or spleen could not be observed. Upon in vitro stimulation the cells
readily produced IL4, IL5 and IL13, thus displaying a TH2 phenotype. This is in sharp contrast to
the vast majority of TCRγδ+ lymphomas showing a cytotoxic phenotype. The disease was not
associated with HTLV1 or EBV infection. Due to the known aggressive course of γδ T cell lym-
phomas we initiated systemic chemotherapy with CHOP, which was complicated by severe recur-
rent infections and stopped after five cycles because of disease progression. After short stabiliza-
tion with extracorporeal photopheresis and systemic glucocorticoids the patient died 8 months after
initial diagnosis due to disease progression. To the best of our knowledge this TCRγδ+ peripheral
T cell lymphoma is unique for the expression of a TH2 phenotype and its clinical presentation as
erythroderma.
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The natural healing ability of chronic pressure ulcer – the demonstration of VEGF165 in its
exudate and slough
M Takayama,1 Y Kuramoto2 and S Aiba1 1 Department of Dermatology, Tohoku University
Graduate School of Medicine, Sendai, Japan and 2 Osaki Citizen Hospital, Sendai, Japan
So far it is believed that chronic pressure ulcer (PU) has a limited potential to heal. Recently, how-
ever, the efficacy of simple polyvinylidene film dressing without any dressing products for PU has
been reported, which suggests that PU itself owns natural healing ability. To clarify the mechanism
for it, we measured the concentration of vascular endothelial growth factor (VEGF 165) and fibrob-
last growth factor 2 (FGF2) in the exudates and sloughs of chronic PU. We measured the concen-
tration of these factors in 11 samples of exudates from 11 PU of 8 patients and 4 samples of fibri-
nous slough from 4 PU of 4 patients. We recovered exudates as much as possible using 1 cm2
square filter papers spread on the bottom of PU. After we calculated the weight of absorbed exu-
dates or fibrinous sloughs, we extracted growth factors in 1 ml of PBS and measured the concen-
tration of VEGF165 and FGF2 by ELISA. All 11 samples of exudates contained a substantial con-
centration of VEGF165 (5.7 +/- 2.5 μg/ml), irrespective of the grade of PU severity. In contrast, only
two samples of exudate had a barely measurable amount of FGF2. Similarly, all the fibrinous sloughs
from PU contained a substantial amount of VEGF165 (4.0 +/- 2.1 μg/ml), while 3 fibrinous sloughs
contained much less FGF2 (less than 0.3 μg/ml). These studies demonstrating that the exudates
and sloughs of chronic PU contain VEGF165, which is well known to function as endothelial cell
growth factor, suggest the natural healing ability of chronic PU.
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Differences in facial sensitive epidermal nerves between Japanese and French women with
sensitive skin
O De Lacharriere,1 F Salas,1 C Saito,2 K Kawashima,2 C Bredoux,1 O Jammayrac,1 P Bastien1 and
A Morita2 1 L’Oréal, Clichy, France and 2 Nagoya City University, Nagoya, Japan
Self Perceived Sensitive Skin (SPSS) is a common condition observed in about 50% of the women
in Europe; it is suspected to be observed with a higher prevalence in Japan. SPPS is supposed to
be linked to a neuron-sensitive reactivity, we conduct a study to check if there is a specific epi-
dermal sensitive nerves pattern according to population and to SPSS or Non-SPSS in both popula-
tions. In Japan and in France, volunteers (women,18yrs-29yrs) were selected using the same clin-
ical questionnaire. According to the answers, a SPSS score was built to select in each country two
groups of 12 volunteers (Severe SPPS vs Non-SPSS). In addition, each subject was characterized
by his skin reactivity to Lactic acid Stinging Test and Capsaicin Test. Lactic acid Stinging test was
performed on the naso-labial fold using a 10% Aqueous Lactic Acid solution. Capsaicin Test was
done on the angle of the jaw with a 0.075% emulsion. On alla volunteers, 2mm punch-biopsies
were done on the angle of the jaw of all volunteers, before and after Capsaicin test. Immuno-stain-
ing was performed on the biopsies using pgp9.5. Histological scoring were done on the slides and
compared between groups. Our results indicated that (i) Epidermal sensitive nerve fibers densities
were found very significantly higher for French women compared to Japanese women. (ii) What-
ever the country, the comparison of the nerve densities between SPSS to Non-SPSS subjects does
not show any significant difference, (iii) Capsaicin reactivity test increases the intensity of nerves
immuno-staining with pgp9.5. We also have the following comments: a) The higher sensitive nerve
density observed on French compared to Japanese is surprising and to our knowledge, has never
been reported. We hypothesize that the epitope of the monoclonal antibody (pgp9.5) between both
populations could be different. (b) Regarding the absence of significant difference in nerve den-
sity, between SPSS and non SPSS, it could indicate that the observed differences are rather quali-
tative than quantitative. (c) Additional studies are needed.
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Trafficking of 8-MOP/UVA treated leukocytes after photopheresis in humans
U Just,1 E Dimou,2 R Knobler,1 G Klosner,1 H Greinix,3 A Becherer4 and F Trautinger5 1 Dept of
Special&Environmental Dermatology, Univ of Vienna, Vienna, Austria, 2 Dept of Nuclear
Med, Univ of Vienna, Vienna, Austria, 3 Dept of Internal Med, Univ of Vienna, Vienna,
Austria, 4 Dept of Nuclear Medicine, LKH Feldkirch, Feldkirch, Austria and 5 Karl Landsteiner
Inst for Dermtol Res, LKH St Pölten, St Pölten, Austria
Photopheresis is an established treatment for cutaneous T-cell lymphoma, systemic sclerosis, GvHD
and other autoimmune diseases. During photopheresis a leukocyte fraction of the peripheral
blood (buffy coat) is extracorporeally exposed to 8-MOP and UVA before reinfusion into the patient.
The precise mechanisms of photophesesis are not yet known. The aim of the present study was to
investigate the fate of UVA irradiated cells after reinfusion. Therefore a fraction of UVA-irradiated
buffy coat was sampled prior to reinfusion, separated into lymphocytes (LC) and polymorphonu-
clear leukocytes (PMN) and labelled with Indium-111 before being reinjected. Scans were acquired
at 10min, 3h and 24h after injection. Regions of interest were drawn over liver, spleen, spine, right
lung and heart. Pixel-normalised ratios of organ to background were calculated with correction for
physical decay. Each patient was investigated separately for migration of labelled LC and PMN.
Ten patients have been included in the study. Using trypan blue we found that viability of 8-
MOP/UVA treated LC and PMN was only minimally affected by labelling and that our technique
results in a sufficiently strong signal to follow the labelled cells for 24h. These results show for the
first time that specific radiolabelling of blood cells after photopheresis in humans is feasible. Dif-
ferent kinetics of major white cell fractions after reinjection after photopheresis can be proven by
this method. From our observation it appears that LC show higher retention in the capillary bed of
the lungs and are more rapidly sequestered from bloodstream than PMNs. The technique described
here can be used to further investigate organ specific leukocyte homing in specific diseases and
initiate functional studies on the effects of ECP on mechanisms of leukocyte migration.
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Mutation-specific siRNA resolves callus in a pachyonychia congenita patient
SA Leachman,1 RP Hickerson,2 ME Schwartz,3 EE Bullough,1 SL Hutcherson,4 KM Boucher,1
CD Hansen,1 MJ Eliason,1 GS Srivatsa,5 DJ Kornbrust,6 FD Smith,7 W McLean,7 LM Milstone8 and
RL Kaspar2 1 University of Utah, Salt Lake City, UT, 2 TransDerm, Inc., Santa Cruz, CA, 3 PC
Project, Salt Lake City, UT, 4 Visionary Therapeutics Corporation, Richmond, VA, 5
ElixinPharma, Encinitas, CA, 6 Preclinsight, Reno, NV, 7 University of Dundee, Dundee,
United Kingdom and 8 Yale University, New Haven, CT
Few therapeutic agents have been developed to target known molecular defects in dominant neg-
ative hereditary disorders. However, mutation-specific siRNAs have the potential to target a mutant
allele, thereby inhibiting the dominant negative effect. Using pachyonychia congenita (PC) as a
prototype, we have completed the first Phase Ib siRNA clinical trial for a dominant negative genetic
disorder, also the first siRNA trial in skin, in a single PC patient. The siRNA has been shown in tis-
sue culture and animal models to specifically and potently target the keratin 6a N171K mutant
allele carried by the trial participant. Following IND and IRB approval, the siRNA (TD101) or vehi-
cle control was injected into symmetric plantar calluses on opposite feet in a 17-week, prospec-
tive, double-blind, split-body, placebo-controlled, dose-escalation trial. The highest dose (2 mL of
8.5 mg/mL solution) was tolerated without adverse events. Significant pain was associated with
intradermal injection of both TD101 and vehicle, precluding enrollment of additional patients.
Prominent regression of the siRNA-injected callus, but not the vehicle-injected callus was observed.
Spontaneous regression of this type has not been noted in PC patients. This finding appears suffi-
ciently promising to warrant additional studies of siRNA in this and other dominant negative skin
diseases. Because of the pain associated with injection, IND-enabling studies with a topical for-
mulation (GeneCream™) are underway in anticipation of topical siRNA clinical studies.
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Safety and tolerability of topical botulinum toxin type A in healthy adults
T Jones,1 J Scott,1 D Tranowski2 and T Joshi2 1 J&S Studies, Inc, College Station, TX and 2
Revance Therapeutics, Inc, Newark, CA
The objective of this study was to evaluate the safety and tolerability of a topical formulation of
Botulinum Toxin Type A (BoNT-A) in healthy adult volunteers to determine any potential to cause
skin irritation or sensitization or systemic immunogenicity. Topical BoNT-A is comprised of a puri-
fied 150kD form of BoNT-A formulated in a poloxamer gel containing a proprietary peptide that
enables the percutaneous delivery of BoNT-A to the underlying muscle. This double-blind, con-
trolled study enrolled 42 subjects, who received topical BoNT-A 300U and placebo to defined
areas on their forearms. Subjects were randomized as to which arm received which treatment.
Treatments were applied on Days 0, 14, & 28 (induction phase), followed by retreatment on a new
area of each forearm on Day 42 (challenge phase). Safety evaluations, including adverse events
(AEs), clinical laboratory tests, skin irritation and sensitization evaluations, serum BoNT-A anti-
bodies, ECGs, and muscle grip strength, were performed on Days 2, 16, 30, 44, & 56. Blinded
data are available for 41 subjects. The population included 31 females and 10 males, aged 18-63
years, of whom 35 were Caucasian and 6 were Hispanic. Only 2 subjects had AEs that were con-
sidered related to treatment. One subject had moderate bilateral papular rash and pruritus of the
treatment area on Day 28, which were related to study treatment and 1 subject had mild arthral-
gia of the right wrist on Days 14 & 28, which was possibly related to study treatment. All events
were resolved within 24 hours and there were no serious AEs. There was no evidence to suggest
a trend for skin sensitivity, and no cumulative skin irritation with either treatment. In addition,
there were no clinically significant changes or decreases in muscle grip strength and no clinically
significant abnormalities or changes from baseline in clinical laboratory values at any time. In sum-
mary, topical BoNT-A was well tolerated with no evidence to suggest a trend for skin sensitivity or
cumulative irritation with repeat treatment.
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Malignant clonal T cells in Leukemic (L-)CTCL/Sezary Syndrome (SS) exhibit a unique cell
surface profile: high and uniform expression of CCR4 and central memory markers CCR7,
L-selectin, and CD27
JJ Campbell, D Soler, R Clark and T Kupper Harvard/BWH, Boston, MA
It has been suggested that L-CTCL, including SS, has a distinct molecular basis from mycosis fun-
goides (MF), a variant of CTCL favoring skin. We performed a careful analysis of the clonal malig-
nant population from 11 patients with L-CTCL in whom we could identify the neoplastic clone in
peripheral blood using specific TCR-V beta antibodies and flow cytometry. We assessed expres-
sion of relevant chemokine receptors, cell trafficking/adhesion molecules, and maturation/differ-
entiation markers on these cells. All clones assessed were CD4+CD8-. Among markers associated
with skin homing, we found consistent high expression of CCR4, but very heterogeneous expres-
sion CCR6, CCR10 and CLA. The function of CCR4 was intact, as confirmed by chemotaxis assays.
In all L-CTCL patients studied, the lymph-node homing molecules CCR7 and L-selectin were con-
sistently and highly expressed; this CCR7 was confirmed to be functional by chemotaxis. Surpris-
ingly, the ratio of cell-surface CD45RA to CD45RO, which typically distinguishes non-neoplastic
naïve from antigen-experienced CD4 T cells, was highly variable from patient-to patient, with some
clones being strongly CDR5RA+/RO- and others strongly CD45RA-/RO+. However, CD27, whose
expression is lost upon differentiation of CD4 T cells to effector cells, was consistently expressed
at high levels on L-CTCL cells. These findings suggest that L-CTCL/SS are malignancies of central-
memory CD4 T cells that, with the exception of uniformly expressed CCR4, have variable expres-
sion of skin homing markers. This is in direct contrast to MF, wherein clonal cells isolated from
skin lesions uniformly express the skin homing markers CLA and CCR4, and have variable or low
expression of central memory markers CCR7 and L selectin. Expression of functional CCR4, how-
ever, appears to be uniform, high, and consistent in both MF and L-CTCL/SS, suggesting it may be
an attractive therapeutic target in both variants of CTCL.
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The cyclooxygenase-2 inhibitor celecoxib effectively suppresses the development of non-
melanoma skin cancers: results of a phase II/III clinical trial
CA Elmets,1 JL Viner,7 AP Pentland,9 W Cantrell,1 H Bailey,2 S Kang,3 KG Linden,4 M Heffernan,5
D Madeleine,6 B Elewski,1 A Umar,7 H Lin,1 W Bell1 and G Gordon8 1 Dermatology, University
of Alabama at Birmingham, Birmingham, AL, 2 Medicine, University of Wisconsin, Madison,
WI, 3 Dermatology, University of Michigan, Ann Arbor, MI, 4 Dermatology, University of
California Irvine, Irvine, CA, 5 Dermatology, Washington University, St. Louis, MO, 6
Dermatology, M.D. Anderson Cancer Center, Houston, TX, 7 Cancer Prevention, National
Cancer Institute, Bethesda, MD, 8 G.D. Searle, Inc, Skokie, IL and 9 Dermatology, University
of Rochester, Rochester, NY
Cutaneous squamous cell and basal cell carcinomas, classified together as nonmelanoma skin can-
cers, are among the most common human malignancies. There is considerable experimental evi-
dence that the enzyme cyclooxygenase-2 (COX-2) is involved in the pathogenesis of nonmelanoma
skin cancers. The purpose of this study was to determine whether the COX-2 inhibitor celecoxib
might have chemopreventive activities in actinic keratoses, cutaneous squamous cell and basal
cell carcinomas. A total of 238 subjects, Fitzpatrick types I, II or III, with extensive actinic damage
and 10-40 actinic keratoses received 200 mg of celecoxib or placebo twice a day for nine months
in this randomized, double blind, placebo, controlled trial. Over a nine month period of time, no
difference in the number of actinic keratoses was observed in the celecoxib treatment and control
groups. In contrast, there was a 58% reduction in the incidence of non-melanoma skin cancers in
the celecoxib group compared to the group that received placebo (p=0.002). Celecoxib signifi-
cantly inhibited the development of both basal cell carcinomas and squamous cell carcinomas.
The incidence of adverse events including serious adverse events was not statistically different
when the celecoxib group and the placebo treated group were compared. These results indicate
that pharmacologic agents such as celecoxib, that inhibit the enzyme cyclooxygenase-2, may be
potent chemopreventive agents for non-melanoma skin cancers.
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Polymorphisms in TNFAIP3 as a predictor of response to TNF blockade in psoriasis
T Tejasvi, PE Pstuart, RP Nair, JJ Voorhees and JT Elder Dermatology, University of Michigan,
Ann Arbor, MI
The tumor necrosis factor-alpha-induced protein 3 (TNFAIP3) gene has been associated with rheuma-
toid arthritis (RA), type 1 diabetes mellitus, systemic lupus erythematosus and psoriasis. It encodes
A20, a TNF-α-inducible zinc finger protein that temporally limits immune responses by inhibiting
NF-κB activation and terminating NF-κB mediated responses. In the CD18 hypomorphic PL/J mouse
model, a region of mouse chromosome 10 encompassing Tnfaip3 promoted psoriasis in a TNF-α
dependent manner and reversal of these changes were brought about by etanercept. Another recent
study also revealed that early downregulation of expression of TNFAIP3 levels secondary to TNF
neutralization was associated with good clinical responses in RA. So far, there has been no study
evaluating the role of polymorphisms in TNFAIP3 as predictors of clinical response to TNF block-
ers. To address this question, we studied 343 patients who received TNF blockers (144 males and
199 females, mean age 52.8 years). Treatment response was self-evaluated using a 0-5 visual ana-
logue scale. Responses were characterized as good vs. poor (3-5 and 0-2, respectively). The ratios
of good vs. poor responders were as follows: adalimumab 43/16, etanercept 240/62 and inflix-
imab 55/14. Data were analyzed for linear trend of association between drug response and geno-
types or haplotypes of two SNPs in TNFAIP3—one in exon 7 T/G SNP rs2230926 (MAF = 0.029)
and another in intron 3 T/G SNP rs610604 (MAF= 0.338). A moderate association was observed
between dosage of the G allele of rs610604 and good response to either etanercept (OR = 1.64,
p = 0.030) or combined response to all TNF blockers (OR= 1.83, p= 0.0090). The rs2230926
T–rs610604 G haplotype was also associated with good response to etanercept (OR = 1.68, p =
0.048) and good combined response to all TNF blockers (OR=1.88, p = 0.015). These preliminary
results suggest that A20 may be mechanistically involved in the actions of TNF in psoriasis, and
that TNFIAP3 polymorphisms may be predictors of treatment response.
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Increased vitamin D deficiency in cutaneous T-cell lymphoma: From theory to therapy
KM Cox,1 R Talpur,1 P Liu2 and M Duvic1 1 Dermatology, MD Anderson Cancer Ctr, Houston,
TX and 2 Biostatistics, MD Anderson Cancer Ctr, Houston, TX
Vitamin D (Vit D) analogues exert pluripotent, dose-dependent effects on the immune system.
Low Vit D is a risk factor for some cancers and relevant for prevention. CTCL pts respond to pho-
totherapy, an inducer of 1,25(OH)2 Vit D. To study Vit D levels and response to therapy, we prospec-
tively measured baseline and follow-up serum 25(OH)D3 levels in 203 CTCL pts whose demo-
graphics, body surface area (BSA) involvement, and therapies were collected under an IRB approved
protocol. Control pts with other cancer (N=169) or no history (N=69) were compared by Chi square,
Wilcoxon or Kruskal-Wallace tests. Vit D status was defined as deficient (<20 ng/ml), insufficient
(20-29 ng/ml), or sufficient (≥30 ng/ml). Vit D deficiency was more prevalent in CTCL pts (53.7%)
vs all controls (40.3%), cancer controls (36.7%)(p=0.003) or benign controls (49.3%) (p=0.002).
Only 15.3% of CTCL pts had sufficient levels. No relation between 25(OH)D levels and age, sex,
BSA, stage of CTCL, or concurrent therapy was observed. Lowest Vit D levels were associated
with morbid obesity (p=0.02), skin type >III (p<0.0001), and 3 children. There were 64 pts with
deficient or insufficient baseline levels and were supplemented with Vit D2 (50,000 IU/2 x wk) or
with Vit D3 (1000 IU/d) with repeat levels available at 1-6 months. Thirty-six of 64 pts’ (56%) lev-
els normalized; 9 of 36 (25%) experienced disease improvement of >50% BSAÑ (partial response
PR). Twenty-eight of 64 pts (44%) failed to normalize but 15/28 (54%) also had PRs. In 45 pts with
up to 10 ng/ml increase levels, 49% (22/45 pts) had >25%Ñ in BSA with 14 PRs. Of 17 erythro-
dermic pts, 13 pts’Vit D normalized, 7 had PRs, and 9 had stable disease. In conclusion, we demon-
strate for the first time that Vit D deficiency is more common in CTCL pts than normal or cancer
controls, even with correction for sex and skin type by multivariate analysis. Clinical improve-
ment in BSA, with concomitant therapy including Vit D supplementation, was observed regard-
less of normalization.
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Adult stem cells for treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
JE Wagner,1 A Ishida-Yamamoto,2 JA McGrath,3 D Keene,4 M Hordinsky,5 BR Blazar1 and J Tolar1
1 Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN, 2
Asahikawa Medical College, Asahikawa, Japan, 3 King’s College, London, United Kingdom, 4
Shriners Hospital for Children, Portland, OR and 5 Dermatology, University of Minnesota,
Minneapolis, MN
RDEB is a severe inherited blistering skin disorder secondary to mutations in the collagen VII (C7)
gene. Having previously demonstrated ‘proof of concept’ in the C7 deficient murine model by
showing that infusion of wild-type marrow stem cells resulted in biochemical improvement and
prolonged survival, we initiated a human trial to evaluate the safety and effectiveness in RDEB chil-
dren. As of January 13, 2009, 12 patients (pts) have been evaluated with 4 between the ages of 0.9
to 6 years enrolled on the trial consisting of busulfan (12.8-16 mg/kg), fludarabine (FLU 75 mg/m2)
and cyclophosphamide (200 mg/kg) followed by the infusion of bone marrow (BM) or umbilical
cord blood (UCB). Pt 2 who presented with significant renal impairment (GFR 26 mL/min/1.73 m2)
secondary to perinatal cardiac arrest necessitated a 50% FLU dose reduction but died of car-
diomyopathy prior to BM infusion. Three of 4 pts completed the treatment plan and demonstrated
marked clinical improvement with a gradual decrease in blister formation. Results of immunoflu-
orescence (IF) for C7 and electron microscopic studies for anchoring fibrils (AFs), and proportion
of donor cells in a 2mm punch skin biopsy at last follow up are as follows: Pt 1 is alive 434 days
after HLA-matched sibling BM/UCB with ÉC7 IF+, ÉAFs, 16% chimerism; Pt 3 died 183 days after
mismatched unrelated UCB with ÉC7 IF+, ÉAFs, 23% chimerism; and Pt 4 is alive 33 days after
matched sibling BM with tests pending. Presence of increasing C7 IF intensity and AF number and
maturity was observed by blinded reviewers, suggesting that a BM and UCB cell population is capa-
ble of ameliorating RDEB. This represents the first successful use of allogeneic adult stem cells to
correct RDEB and first clinical improvement of an extracellular matrix disorder by this type of cell
therapy.
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Effective utilization of cyclosporine in an efalizumab-associated generalized inflammatory
flare unresponsive to adalimumab
R Pugashetti,1 E Becker,1 R Greenberg2 and J Koo1 1 Dermatology, University of California, San
Francisco, San Francisco, CA and 2 Private Practice Dermatology, East Bay Psoriasis
Treatment Center, San Ramon, CA
Efalizumab, a recombinant monoclonal antibody which inhibits T-cell activation in sites of cuta-
neous inflammation, is an effective therapy for chronic plaque psoriasis; despite its demonstrated
safety and efficacy profile, generalized inflammatory flares (GIF) occur in an estimated 1-3% of
psoriatic patients treated continuously with weekly efalizumab. Here, we report the case of a patient
with chronic plaque psoriasis who initially demonstrated excellent clinical response to efalizumab
(1 mg/kg/week subcutaneous injection) but subsequently developed a severe, erythrodermic gen-
eralized inflammatory flare following 7 weeks of therapy. Efalizumab was continued at 1 mg/kg/week
and a loading dose of the TNF-α antagonist adalimumab (80mg subcutaneous injection) was admin-
istered. However, the patient’s condition exacerbated; cutaneous examination was remarkable for
erythrodermic psoriasis involving 85% of total body surface with extensive desquamation and fis-
suring. Facial involvement included severe erythema, scaling, and significant eyelid edema.
Cyclosporine was initiated at 100mg three times daily, in addition to topical corticosteroids. By
day 6 of cyclosporine administration, the patient demonstrated a dramatic clinical response, with
striking reduction in erythema and marked plaque clearance. Efalizumab was continued through-
out this time period. This psoriatic flare was not only clinically unresponsive to a loading dose of
adalimumab, but subsequently worsened following its administration, with spreading of the highly
inflammatory lesions and exfoliative erythroderma. This is the only reported case to date in which
adalimumab was used, and subsequently failed to control, an efalizumab-associated generalized
inflammatory flare. However, these results demonstrate the rapid efficacy and utility of cyclosporine
in the acute management of severe generalized inflammatory flares, without necessitating discon-
tinuation of efalizumab treatment.
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Immunotherapy of solid tumors utilizing PLGA/ tumor lysate nanoparticles to stimulate TIL
and circulating CD8+ tumor-specific T cells
DJ Hanlon,1 S Prasad,3 V Patriub1 and M Saltzman2 1 Dermatology, Yale School of Medicine,
New Haven, CT, 2 Biomedical Engineering, Yale University, New Haven, CT and 3 Laryngeal
Research Group, University of Bristol, Bristol, United Kingdom
Dendritic cell (DC)-based therapies for solid tumors have failed to achieve large-scale clinical uti-
lization because at present no unified technology exists to overcome two fundamental obstacles.
These are the lack of known tumor-associated antigens (TAA) from most solid malignancies and
the lack of efficient methodologies to transfer antigen from tumor to DC. Here we describe the
development of an alternative technology for antigen delivery that appears to transfer a broad spec-
trum of tumor antigens to DC with extremely high efficiency. We used this methodology, termed
“nanoparticle (NP)- mediated tumor delivery”, to encapsulate whole melanoma and HNSCC pro-
tein lysates into PLGA biodegradable microspheres and targeted these conjugates to dendritic APC.
Optimization of Ag delivery was achieved by experimental determination of which polymer for-
mulation, Ag source and release characteristics led to most potent DC antigen presentation. In both
murine and human T-cell stimulation assays, DC loaded with NP/tumor conjugates were superior
to other Ag forms in stimulating anti-tumor T cells- including murine gp100-specific naïve T-cells
from pmel transgenics and human TIL and blood CD8+ T-cells from cancer patients. Analysis of
cytokine production by DC and T cell by cytometric bead array (CBA) assays indicated that NP-
loaded DC drove increased production of Th1 and proinflammatory cytokines such as IFN-g and
IL-2 and greatly diminished the production of IL-10, indicating the potential for these reagents to
overcome pre-existing T cell tolerance when used in an anti-tumor vaccination strategy. Two major
advantages of NP-based antigen delivery are the targeting of multiple undefined antigens and the
clinical biocompatibility of the reagents, and these results indicate that treatment of virtually any
solid malignancy through personalized immunotherapy is now a possibility.
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Interactions of IL-17, IL-22 and TNF in regulation of keratinocyte-mediated inflammatory
networks
A Chiricozzi,1,2 KE Nograles1 and JG Krueger1 1 Laboratory for Investigative Dermatology, The
Rockefeller University, New York, NY and 2 Department of Dermatology, University of Rome
Tor Vergata, Rome, Italy
Psoriasis is a complex inflammatory state where IL-17, IL-22, and TNF participate in disease patho-
genesis by altering expression of inflammatory gene products in epidermal keratinocytes. In turn,
these inflammatory products induce downstream or feed-back loops with leukocytes to augment
cell-mediated inflammation and potential keratinocyte responses. Curiously, anti-TNF or anti-IL-
17 antibodies can reverse psoriasis disease activity, although different inflammatory pathways
should be regulated by these cytokines. To help dissect potential interactions between “innate” and
T-cell derived inflammatory cytokines, we studied the response of human epidermal keratinocytes
to single, and mixtures of, cytokines IL-17, IL-22, and TNF by RT-PCR. Initial target genes evalu-
ated include IL-8, a strong chemoattractant for neutrophils, and S100A7, an innate defense pro-
tein with chemotactic activity for leukocytes. Treatment of human keratinocytes for 24h with TNF
alone (1-10ng/ml) induced a 10-fold increase of IL-8 mRNA, IL-17 alone (200ng/ml) was less active,
whereas IL-22 alone (200ng/ml) did not induce the expression of IL-8 mRNA. While the combi-
nation of IL-17 and IL-22 did not lead to significant IL-8 induction, mixtures of IL-17 and TNF
resulted in strong, synergistic induction of IL-8 even with TNF concentrations as low as 0.1 ng/ml.
This synergism was not observed in mixtures of IL-22 and TNF in most keratinocyte lines. While
individually, IL-17, IL-22 and TNF increased S100A7 mRNA in keratinocytes, a strong, synergistic
induction of S100A7 occurred with TNF + IL-17 or TNF + IL-22 combinations. These data estab-
lish important “cross-talk” between innate and adaptive immune cytokines for inflammatory path-
ways relevant to natural and pathologic skin immunity. These data also establish potential mech-
anisms for highly selective therapeutic targeting of psoriasis with cytokines (e.g., anti-IL-17 or
anti-TNF) that work in synergism to amplify pathogenic inflammatory circuits.
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Digital pathology diagnosis of melanocytic lesions via conventional and immunohistochem-
ical techniques
LM Drogowski,1 J Ho,2,3 A Radfar2,3 and DM Jukic2,3 1 Department of Dermatology, University
of Pittsburgh, Pittsburgh, PA, 2 Department of Dermatology, University of Pittsburgh School
of Medicine, Pittsburgh, PA and 3 Department of Pathology, University of Pittsburgh School
of Medicine, Pittsburgh, PA
Digital pathology’s utility in evaluating melanocytic lesions via immunohistochemistry (IHC) and
conventional hematoxylin and eosin (HE) sections has not been established. This study assesses its
potential in diagnosing melanocytic lesions remotely and assesses consistency of the diagnoses.
Three dermatopathologists evaluated 80 cases of dysplastic nevi and early melanomas on HE and
IHC stained slides. Digital and glass sets of cases were evaluated in two phases with a washout
period. Digital slides were hosted remotely and evaluated via a network camera and a Java-enabled
web-browser. Intraobserver variability for each medium (glass and digital) was compared and con-
cordance rates were consistent whether diagnoses were made conventionally or digitally. Intraob-
server consistency for digital diagnoses ranged from 64-88% for lesions viewed on HE sections
only and from 75-93% for lesions first viewed on HE and then on IHC. Likewise, consistency for
glass diagnoses ranged from 84-100% for lesions viewed on HE sections only and from 86-100%
for lesions viewed first on HE and then on IHC. Time spent assessing cases digitally exceeded time
for glass-based cases, but overall turnaround time was less as materials did not need to be trans-
ported (time to evaluate remotely versus 48 hours for physical transport plus time to evaluate). Eval-
uators did not feel totally comfortable when the slide was moved at the remote site, because an
area of interest was often omitted or would come in and out of focus; in particular a slow time to
focus was an issue. While additional training and improved level of comfort on both client and
server side are necessary, this method is ideal for consultation as diagnoses can be reached faster.
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Dynamic area telethermometry determines the skin inflammatory response intensity induced
by imiquimod on human basal cell carcinoma treatment
RC Souza,1 M Cimbalista,2 VO Carvalho3 and HC Lima3,4 1 Faculdade Evangelica do Parana,
Curitiba, Brazil, 2 Thermotronics, Curitiba, Brazil, 3 Universidade Federal do Paraná, Curitiba,
Brazil and 4 Massachusetts General Hospital, Boston, MA
Study purpose was to evaluate inflammatory effects in the course of Imiquimod for Basal Cell Car-
cinoma (CBC) treatment based on skin temperature variation measured by Dynamic Area Telether-
mometry (DAT). Imiquimod (IMM) is a topical cream used to treat CBC. It activates immune cells
inducing inflammatory cytokines. Areas treated with IMM become inflamed and heated due to
increased blood flow. Changes in temperature can emit different infrared radiation. DAT monitors
infrared (IR) emission intensity. We could measure the inflammatory response induced by IMM
treatment and found a new CBC immune system evasion mechanism. This research was an exper-
imental follow-up study of inflammatory severity based on monitoring the CBC temperature change
treated with IMM. The protocol was approved by national and local Research Ethics Committee.
Twelve patients were evaluated before treatment and 15 days later. The temperature on CBC was
in comparison to healthy adjacent normal skin after thermal challenge stimulation. Temperature
kinetics was recorded by Flir Thermovison SC 2000 ®, and determined by ThermaCam researcher
® 2001 software. To compare the evolutionary kinetics of each stimulus, we performed ANOVA
for repeated measurement. To compare the temperature data Student’s t test was used. Statistical
difference was considered significant when p<0.05 for all data. The data were analyzed by JMP
6.0 software (SAS Institute, USA). All patients showed an inflammatory reaction at the treated site.
The median tumor temperature was 0.5° C below the healthy skin. After 15 days of treatment a
significant increase of 1° C over normal skin, and 1.5° C from lesion before treatment was observed.
This study confirms and measured the inflammatory IMM anti-tumor activity. Also, this study reveals
that CBC avoids inflammation at the tumor site by reducing the local temperature a new immune
system evasion mechanism.
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A comparison of key photochemical marker compounds in pomegranate variety ‘wonderful’
from mid and late season harvest
J Leverett, J Balles, J Rana and G Seehra Amway Corporation, Ada, MI
Many important pharmaceuticals have been developed from botanical sources. Hence, botanically
derived treatments for topical application are a major focus for many researchers in Academia and
Industry alike. Standard investigative procedure is to procure a suitable feedstock (root, stem or
aerial), macerate it and submit to a series of solvent extractions. The obtained extracts can then be
analyzed for efficacy in a variety of ways, from simple chemical ID of known compounds, to in
vitro techniques for determination of activity in a defined biochemical pathway. However, due to
the complex chemical makeup of botanical extracts there is often a synergistic or even confound-
ing interplay between the constituents. Further, it has been documented that growth conditions,
harvest time and environmental stressors can significantly alter the chemical composition of the
botanicals. We have investigated the impact of mid vs. late season harvest of the Pomegranate
variety ‘Wonderful’ which was grown in Lakeview, CA. Fruit was collected in August and Sep-
tember 2008 and separated into 6 size ranges. The dehydrated, milled whole fruit were extracted
with either a hydro-ethanolic or aqueous solvent system. All extracts were analyzed for brix, total
acidity, total polyphenols and punicaligins A and B. In summary, there was a significant decrease
in total brix and a 40% decrease in total polyphenol content in the late season fruit. Of particular
note were total levels of punicaligins A and B, the “key” marker compounds present in pomegranate,
were decreased by 2 fold in the late season fruit. In conclusion it is evident that chemical compo-
sition which can be monitored by HPLC may vary greatly even in the same species, grown in the
same location. Therefore, tightly controlled growth conditions for source materials and their phy-
tochemical compositional analyses are required for meaningful botanical research and discovery.
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Automatic detection, quantification and tracking of emerging acne vulgaris lesions
GO Cula, PR Bargo and N Kollias Methods and Models, Johnson and Johnson, Skillman, NJ
The current study presents an imaging method for early detection of emerging acne and a com-
putational algorithm to automatically follow the evolution of the lesions to check if they progress
or regress in time. Cross-polarized imaging, where linear polarizers at the camera and the illumi-
nation are oriented perpendicular to each other, is used to document the skin. This technique
eliminates the specular reflectance from the skin, enhancing the appearance of early inflammatory
lesions, which are the focus of the current work. An inflammation map has been generated out of
the color image by linearly combining the red, green and blue channels to enhance the redness of
lesions. The resulting inflammation map is guaranteed to preserve redness of skin, while other
type of pigmentation is canceled out. Starting from this inflammation map, a computational tech-
nique for automatic detection of the lesion was developed based on separating the background
normal skin from the acne lesions, based on the hypothesis that the background normal skin and
the foreground inflammatory lesions can be modeled on the inflammation map by distinct Gauss-
ian distributions. This dichotomy between background skin and inflammation lesions makes the
approach independent on the skin color of the subject, as long as the inflammatory lesions appear
at least slightly distinct from the background. Moreover, an algorithm to track and quantify the
evolution of lesions, in terms of the degree of progress or regress of the lesion, has been devel-
oped. Using cross-polarized imaging, different types of acne lesions from a group of 30 individu-
als, were documented over 72 hours at 4 different time points. The proposed algorithms were
applied to this data set and the results showed the ability of the proposed computational approach
to detect emerging lesions and to track their behavior. Moreover, the results suggest that the com-
putational approach correlates well with clinical observation of acne lesions by trained graders.
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Reduced intensity conditioning and allogeneic stem cell transplantation in Recessive Dys-
trophic Epidermolysis Bullosa
AM Christiano,1 JA McGrath,7 E Hillman,3 E Philipone,4 K Ventura,5 A Ishida-Yamamoto,6
D Keene,8 S Foley,2 E Smilow,2 E Morris,2 C Fanelli,2 K Morel,1 J Uitto9 and MS Cairo2 1
Dermatology, Columbia University, New York, NY, 2 Pediatrics, Columbia University, New
York, NY, 3 Biomedical Engineering, Columbia University, New York, NY, 4 School of Dental
Medicine, Columbia University, New York, NY, 5 School of Nursing, Columbia University,
New York, NY, 6 Asahikawa Medical College, Asahikawa, Japan, 7 King’s College, London,
United Kingdom, 8 Shriner’s Hospital, Portland, OR and 9 Dermatology, Thomas Jefferson
University, Philadelphia, PA
Recessive dystrophic epidermolysis bullosa (RDEB) is a severe mechanobullous disorder resulting
from mutations in the type VII collagen gene (COL7A1). Several groups have demonstrated cor-
rection of the RDEB phenotype in col7a1-/- mice using transplanted bone marrow stem cells. Since
myeloablative conditioning is associated with significant morbidity and mortality, we recently pio-
neered a lower risk approach of reduced intensity conditioning (RIC) to induce long term donor
chimerism in children with non-malignant diseases, such as sickle cell disease, following allo-
geneic stem cell transplantation (AlloSCT) utilizing unrelated cord blood (UCB) donors (Bradley/Cairo
et al, BMT, 2007). We have embarked upon a clinical trial using RIC and AlloSCT in selected patients
with RDEB. We aim to demonstrate that it will 1) be safe and well tolerated; 2) induce long term
donor chimerism of the blood and skin, with expression of COL7A1 and the presence of anchor-
ing fibrils measured by non-invasive skin imaging and EM; and 3) improve the quality of life in
RDEB patients. We will utilize a RIC regimen of busulfan, fludarabine and alemtuzumab and AlloSCT
from HLA matched family or UCB donors. To date, we have consulted with 7 RDEB patients, of
which searches have been performed in 3 patients and a matched UCB (6/6 or 5/6) has been cal-
culated. This investigation will test the feasibility of a new potential curative therapy for RDEB,
while reducing the risks and ethical concerns associated with myeloablative conditioning prior to
AlloSCT in the setting of a non-malignant disease.
S56 Journal of Investigative Dermatology (2009), Volume 129
ABSTRACTS
337
The human cutaneous SCC microenvironment is associated with CD163+ macrophages, IL-
10 and MMPs 1, 3, 9, 10, 11, 13 and 14
A Pitts-Kiefer,1 MJ Bluth,1 L Fan,1 MA Lowes2 and JA Carucci1 1 Dermatology, Weill Medical
College of Cornell, New York, NY and 2 Investigative Dermtology, Rockefeller University,
New York, NY
Cutaneous SCC affects approximately 300,000 patients in the United States each year. Although
most cases can be treated by surgical removal, select cases can cause extensive local tissue dam-
age and metastasize to lymph nodes and distant organs. We studied tumor-associated macrophages,
associated cytokines and macrophage-influenced matrix metalloproteinases focusing on their poten-
tial effects on dermal invasion. We evaluated samples of SCC, peritumoral skin and normal skin
for the presence of M2-polarized macrophages by immunohistochemistry for CD163. Screening
microarray analysis and RT-PCR were performed to study gene expression, and cytokine and
chemokine levels were evaluated by Luminex assay. We found higher numbers of CD163+ cells
in the juxta-tumoral dermis adjacent to SCC compared to normal papillary dermis. Even higher
numbers of tumor-associated macrophages were found in the juxta-tumoral dermis adjacent to
SCC from transplant recipients, who generally demonstrate a more aggressive phenotype. Microar-
ray analysis showed increased expression of MMPs in SCC and SCC from transplant recipients.
RT-PCR confirmed increased expression of MMPs 1, 3, 9, 10, 11, 13 and 14. IL-10, an inducer of
M2-polarization, was increased in supernatants from SCC and peritumoral skin explants. The results
suggest a potential role for M2-polarized macrophages and associated MMPs in facilitating inva-
sion of primary cutaneous SCC.
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Human cutaneous squamous cell carcinoma is associated with increased density of lym-
phatics in the tumor microenvironment and upregulated lymphangiogenic genes
D Moussai,1 S Mayte,2 C Irma2 and JA Carucci1 1 Dermatology, Weill Medical College of
Cornell, New York, NY and 2 Investigative Dermatology, Rockefeller University, New York,
NY
Squamous cell carcinoma (SCC) is the second most common human cancer affecting 300,000 indi-
viduals in the United States each year. SCC is locally invasive and has the potential to metastasize
to regional lymph nodes and distant organs. We studied lymphangiogenesis in human SCC because
of the role of local lymphatic vessels in metastasis. Human SCC samples were stained for lym-
phatic vessel marker LYVE-1 and LYVE-1 positive lesions were counted in tumors and compared
with normal skin. Gene chip microarray analysis was performed on tumor, peritumoral non-lesional
tissue and normal skin to evaluate potential differential expression of factors promoting lymphan-
giogenesis. RT-PCR was performed on tumor, peritumoral non-lesional tissue and normal skin to
determine levels of mRNA for VEGF-C, VEGF-D, VEGF-A, Flt-4, and IL-8. We found that SCC was
associated with elevated numbers of LYVE-1 positive (1.5-fold) lymphatic vessels within 100 um
circumferential to epithelial tumor nests. We detected elevated levels of IL-8 in SCC tissue com-
pared to normal (12-fold) and adjacent peritumoral tissue (6-fold). Microarray analysis demon-
strated upregulation of CCL21, PDPN, PROX1, FLT4, NRP2 and FOXC2 genes in SCC compared
to normal skin. These genes mediate crucial roles in lymphatic vessel development and consid-
ered as putative lymphatic vessel markers. Furthermore, we found elevated mRNA levels of VEGF-
A, VEGF-C, VEGF-D and Flt-4 in peritumoral adjacent samples compared to normal skin. In sum-
mary, human SCC appears to induce proliferation of lymphatic vessels, which may facilitate eventual
invasion to regional lymph nodes. Clarification of mechanisms governing SCC mediated lym-
phangiogenesis may identify novel targets for therapeutic intervention.
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Antimicrobial activity of chitosan against cutaneous pathogens
J Champer,1 X Ye,1 NB Fernando,1 JG Patel1 and J Kim1,2 1 Dermatology, David Geffen School
of Medicine at the University of California, Los Angeles, Los Angeles, CA and 2 Dermatology,
Greater Los Angeles Healthcare System Veterans Affairs, Los Angeles, CA
With the emergence of antibiotic-resistant cutaneous bacteria, there is considerable incentive in
developing alternate frontline treatments. Chitosan, derived from chitin, a natural polymer, has
been shown to have promising antimicrobial activity against various pathogens. Here, we show
that chitosan is highly bactericidal against two common gram-positive cutaneous pathogens, P.
acnes and S. aureus. Of clinical importance, chitosan was also effective against multiple isolates
of P. acnes derived from skin samples of patients. Chitosan was maximally bactericidal at pH 6,
and retained most of its effectiveness at physiological sodium concentrations. In addition, chitosan
was shown to have additive antibacterial effects against S. aureus with benzoyl peroxide, sug-
gesting that a chitosan-benzoyl peroxide combination may be useful in the treatment of cuta-
neous pathogens.
340
Myeloid dendritic cells from human squamous cell carcinoma are poor stimulators of T cell
proliferation
MJ Bluth,1 LC Zaba,2 D Moussai,1 M Suarez-Farinas,2 A Pitts-Kiefer,1 L Fan,1 KC Pierson,2
E Guttman-Yassky,2 JG Krueger,2 MA Lowes2 and JA Carucci1 1 Dermatology, Weill Medical
College of Cornell, New York, NY and 2 Investigative Dermatology, Rockefeller University,
New York, NY
In order to determine the phenotype and function of myeloid DCs from human cutaneous squa-
mous cell carcinoma (SCC), we studied their surface marker expression and allo-stimulatory poten-
tial ex vivo. There were abundant CD11c+ myeloid DCs, as well as TNF and inducible nitric oxide
synthase (iNOS)-producing DCs (TIP-DCs), in and around SCC tumor nests. Although myeloid DCs
from SCC, adjacent non-tumor bearing skin, and normal skin, were phenotypically similar by flow
cytometry, and there was a pronounced genomic signature of mature DCs in SCC, they showed
different T cell stimulatory potential in an allo-MLR. Myeloid DCs from SCC were less potent stim-
ulators of allogeneic T cell proliferation than DCs from non-tumor bearing skin. Culture with a
DC-maturing cytokine cocktail (IL-1β, IL-6, TNF, and PGE2) enhanced stimulatory potential in DCs
from non-tumor-bearing skin, while SCC associated DCs remained poor stimulators of T cell pro-
liferation. The microenvironment associated with SCC showed expression of TGFβ, IL-10 and VEGF-
A, factors capable of suppressing DC function. These findings indicate that CD11c+/HLA-DRhi DCs
from SCC are mature, but are not potent stimulators of T cell proliferation compared with pheno-
typically similar DCs isolated from non-tumor-bearing skin. Identification of mechanisms respon-
sible for suppression of tumor-associated DCs may provide insight into evasion of immunosur-
veillance by SCC.
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Method of assessing the pre-clinical drying/scaling effects occasioned by alcohol-based hand
disinfectants
I Sadiq, M Crossby, J Nicholson and MV Shelanski Product Investigations, Inc., Conshohocken,
PA
Alcohol-based hand rubs and rinses are experiencing widespread acceptance as the means to
control nosocomial infections. Alcohols in the concentration range of 70 to 90% exert a desiccant
effect on the skin. Long term, frequent daily use of alcohol-based hand disinfectants may result in
irritation and skin damage. The degree of scaliness and dryness depends on the type of alcohol
and the concentration of alcohol. In the very early stages of its desiccant activity, an alcohol elic-
its dryness and scaliness that is not discerned by the naked eye. We have evaluated a variety of
methods to detect the pre-clinical changes. We have found that videomicroscopy, using either vis-
ible or UV light for imaging the skin surface, was capable of revealing the very subtle changes
depicting the initial stages of the drying/scaling effect. An image analysis procedure was also devel-
oped to quantify the scaliness effect. A number of studies were undertaken to evaluate the short-
term effects of exposure to alcohols and alcohol-based hand disinfectants. We evaluated a num-
ber of single and repeated application methods, to wit: cotton pads (repeated applications), occlusive
patching devices (single and repeated applications), glass well (single application). Videomicroscopy
of the skin after a 24-hour patch of ethanol 90% revealed gross scaliness/dryness. A 5-minute expo-
sure to ethanol 90% in a glass well produced moderate scaliness (fine scales). Repeated applica-
tions of ethanol 90% resulted in statistically significant increase in scaliness, calculated by the
image analysis program. The effect of adding emollients to alcohol was assessed using a repeated
application model. The effect of a formulation containing 70% 1-propanol and emollient excipi-
ent (3% glycerol and 2% polyethylene glycol) was compared to that of a 70% 1-propanol solu-
tion. The skin showed demonstrably less scaliness for the formulation with the emollient than it
did for the 1-propanol solution. The methods we have described are easy to use and will help the
researchers in the early stages of product development.
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Differences in c-Kit mutations may dictate different treatments for adult-onset mastocytosis
I Chan and MD Tharp Dermatology, Rush University Medical Center, Chicago, IL
Autoactivating mutations of the Kit receptor are associated with adult-onset mastocytosis. Previ-
ous studies from our laboratory has shown that the growth of mastocytosis mast cell line express-
ing the kit mutation V560G (HMC-1) was more sensitive to the treatment with the JAK3 specific
inhibitor, Whi-P131, whereas a mastocytosis mast cell line expressing Kit-D816V (HMC-1.2) was
more sensitive to rapamycin growth inhibition. Treatment of HMC-1 and HMC-1.2 cell lines with
the JAK3/STAT pathway specific inhibitor, WHI-P131 (20 μM), effectively reduced the growth of
these cell lines by 82±14% and 53±5%, respectively. Inhibition of the mTOR pathway with the
specific inhibitor, rapamycin (20 nM), reduced the growth of HMC-1 by 47±9% and HMC-1.2 by
76±15%. Western blot analysis for proteins associated with the JAK3 and mTOR pathways revealed
that JAK3/STAT3 is the predominant signaling pathway for Kit-V560 whereas mTOR/STAT3 is the
major growth promoting pathway for HMC-1.2. STAT3 was found to be constitutively activated in
HMC-1 and HMC-1.2 cells. Treatment of the HMC-1 and HMC-1.2 cells with the JAK3 inhibitor,
Whi-P131 (20 μM), for 1 hr effectively diminished the phosphorylation of STAT3 in HMC-1, but
had no effect on STAT3 phosphorylation in HMC-1.2 cells. Treatment of both cell lines with the
mTOR inhibitor, rapamycin (20 nM) for 1 hr. effectively inhibited phosphorylation of STAT3 in
HMC-1.2 cells, but much less effective for HMC-1 cells. These results indicate that mastocytosis
mast cells with different activating mutations of c-Kit, such as Kit-V560G and Kit-D816V, have dif-
ferent intracellular signaling mechanisms that control mast cell growth. Thus, the identification of
different Kit mutations may be a critical step in tailoring the effective therapies for the treatment of
mastocytosis patients. Since nuclear phosphorylated STAT3 appears to be the common downstream
target of activated Kit mutations, inhibitors to the nuclear specific phosphor-STAT3 may prove to
be another therapeutic approach to mastocytosis.
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Safety and efficacy of a non-steroidal anti-inflammatory agent (WBI-1001) as a novel topi-
cal treatment for psoriasis and atopic dermatitis
R Bissonnette,1 M Lyle,2 Y Wanggui,2 B Li,2 G Chen,2 L Tang2 and J Webster2 1 Innovaderm
Research inc., Montreal, QC, Canada and 2 Welcihem Biotech Inc., Burbaby, BC, Canada
WBI-1001 is a new chemical entity that is currently being developed as a topical treatment for
psoriasis and atopic dermatitis (AD). In preclinical studies, WBI-1001 was shown to inhibit inflam-
matory cytokines, T-cell viability and the infiltration processes. Two clinical studies were completed
to assess the safety and efficacy of WBI-1001 in patients with psoriasis or AD. In the Phase I dose
ascending study, a total of 36 patients with mild to moderate plaque psoriasis were recruited in
groups of 6. Each group received 0.5, 1.0 or 2.0% WBI-1001 cream either once or twice daily on
one side of the body and the placebo on the other side. In the second study, 36 patients with mild
to moderate atopic dermatitis were randomized (1:1:1) to receive either 0.5 or 1.0% WBI-1001 or
the placebo cream twice daily. In both studies the 0.5% and 1.0% WBI-1001 cream doses exhib-
ited excellent skin tolerance. The 2.0% WBI-1001 cream caused a few temporary mild skin-
related adverse events (AE) in the psoriasis study. No subjects discontinued treatment from these
studies due to any AEs in any group. The pharmacokinetic studies showed that WBI-1001 was
only minimally absorbed following topical application and no evidence of WBI-1001 accumula-
tion was detected in the blood over the 28 day period. In the psoriasis study, improvement in physi-
cian’s global assessment, induration, erythema and scaling was more important on the side treated
with WBI-1001 as compared to the side treated with the placebo cream. In the AD study patients
randomized to 0.5 or 1.0% WBI-1001 had statistically significant improvements in all of the major
efficacy assessments including eczema area and severity index, SCORAD, investigator’s global
assessment, and body surface area, when compared with placebo cream. In conclusion, WBI-1001
cream at 0.5% and 1.0% was well tolerated by patients with psoriasis and AD, minimally absorbed
into the blood system and efficacious on both psoriasis and AD as a novel topical therapy.
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Characterization of VBY-129, a cathepsin S inhibitor efficacious in a mouse model of psori-
asis
LJ Holsinger,1 S Mocci,3 JO Link,2 K Elrod,1 MJ Green,1 R Booth1 and SA Dalrymple1 1 Virobay,
Menlo Park, CA, 2 Gilead Sciences, Foster City, CA and 3 Elan, South San Francisco, CA
Cathepsin S is a cysteine protease that catalyzes the final proteolytic step in the processing of invari-
ant chain in specific antigen presenting cells, essential in the maturation and loading of MHC
Class II with antigenic peptides and subsequent activation of CD4+ T cells. Continuous presenta-
tion of antigenic self-peptides is thought to be involved the maintenance of chronic disease in
autoimmune disorders including psoriasis. Inhibition of cathepsin S is likely to result in a reduc-
tion in humoral immune processes without an impact on innate immunity. Virobay has developed
a novel oral cathepsin S inhibitor, VBY-129, which may provide a new therapeutic option to treat
psoriasis and other autoimmune diseases. VBY-129 is a neutral, competitive reversible inhibitor of
cathepsin S with a mean inhibition constant (Ki) of 0.24 + 0.046 nM. VBY-129 is greater than 1500-
fold selective against other human cathepsins. VBY-129 inhibited cathepsin S activity and subse-
quent invariant chain processing in a human B cell line, as well as primary human peripheral blood
mononuclear cells (PBMCs), resulting in the accumulation of the Iip10 intermediate in the pro-
cessing of invariant chain with an IC50 and IC90 of 159 + 24nM and 294 + 40nM respectively.
VBY-129 was efficacious in reducing disease in therapeutic dosing of the mouse adoptive transfer
SDI™ model of psoriasis. Two weeks of once-a-day dosing with VBY-129 at 50mg/kg reversed
established disease as measured by changes in inflammation-induced ear thickness and ear his-
tology. Sustained inhibition of cathepsin S was required for maximal efficacy. VBY-129 entered
human clinical testing in a Phase I single-ascending-dose and multiple-dose trial in healthy sub-
jects. These data indicate that VBY-129 may be an efficacious and novel oral therapeutic for the
treatment of psoriasis with a unique mechanism of action.
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Foreign body granuloma due to injectable polymethylmethacrylate microspheres
CF Estes1 and AA Bajoghli2 1 The George Washington University, Washington, DC and 2
Dermatology, Inova Fairfax Hospital, Falls Church, VA
We report a case of foreign granulomatous lesions caused by injectable polymethylmethacrylate
(PMMA) microspheres. A 72-year-old female presented with mildly erythematous, mostly hyper-
pigmented, firm nodules that were tender to palpation in the infraorbital wrinkles four months
after PMMA microsphere injection into the infraorbital lines. She began to notice the lesions one
month after injection. No confirmation of prior aesthetic implants could be elicited from the patient.
A biopsy was performed, and histological examination of the lesions showed aggregates of lym-
phocytes, histiocytes, and multinucleated giant cells with numerous clear cystic spaces consistent
with PMMA microsphere foreign body granuloma. Since sarcoidosis is ranked highly on the dif-
ferential diagnosis for this presentation, a chest radiograph was performed, which, however, failed
to show any evidence supporting this diagnosis. PMMA microspheres are suspended in 3.5% col-
lagen. Once injected, collagen rapidly surrounds the microspheres, preventing phagocytosis. It is
rare that this process is not successful and that granulomatous reactions to the microspheres occur,
based on the literature. To our knowledge, this is the first report of foreign body granuloma due to
injectable PMMA microspheres in the infraorbital lines. It is suggested that the possibility of gran-
ulomatous reaction to PMMA microspheres be communicated to the patient, and also that this be
mentioned on the informed consent form prior to administering these injections.
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Treatment of epidermal growth factor-induced rash with colloidal oatmeal extract: An
extended follow-up
DT Alexandrescu,1,2 LC Kauffman2 and CA Dasanu3 1 Division of Dermatology, University of
California at San Diego, San Diego, CA, 2 Georgetown Dermatology, Washington, DC and 3
Hematology/Oncology, St Francis Hospital, Hartford, CT
The therapeutic armamentarium for epidermal growth factor (EGFR) positive cancers includes the
use of antibodies and small-molecule tyrosine kinase inhibitors (TKI) which block signaling through
the EGFR. The rash which occurs during the use of EGFR inhibitors, while correlating with an anti-
neoplastic response, acts as a limiting factor for the administration of treatment, affecting 60-70%
of patients. Present management modalities for this toxicity are of limited efficacy and require inten-
sive surveillance and the use of treatment strategies that further add cutaneous and systemic side
effects. Colloidal oatmeal lotion demonstrates multiple anti-inflammatory properties with known
effects on arachidonic acid, cytosolic phospholipase A2 (cPLA2), and tumor necrosis factor alpha
(TNF-α) pathways, along with an excellent side-effect profile. Treatment with colloidal oatmeal
was applied three times daily until response for a maximum period of 21 days to 28 patients with
a maculo-papular erythematos (“acneiform”) eruption induced by cetuximab (n=15), erlotinib (n=5),
panitumumab (n=3) and sorafenib (n=5). A full resolution was seen in 18 patients (64.3%), and par-
tial improvement in 10 patients (35.7%), of which one patient dramatically improved over 90%.
The overall response rate was 100%, with no associated toxicities. All patients experienced sub-
stantial relief from their cutaneous symptoms. In conclusion, treatment with colloidal oatmeal lotion
is efficient in controlling the rash associated with EGFR and multiple TKI and allows continuation
of the antineoplastic treatment.
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Upregulation of pro-inflammatory markers in open and closed comedones in acne vulgaris
W Lee,1,2 T Do,1 F Wang,1 G Fisher,1 J Voorhees1 and S Kang3 1 Department of Dermatology,
University of Michigan, Ann Arbor, MI, 2 Department of Dermatology and Immunology,
Kyungpook National University, Daegu, Korea, South and 3 The Johns Hopkins Department
of Dermatology, Baltimore, MD
Although there are various factors involved in the pathogenesis of acne, the direct causes of this
common inflammatory condition are still unknown. Recent studies have focused on the interplay
of follicular hyperkeratinization, colonization with P. acnes, increased sebum production, and
inflammation. Additionally, recent data suggest that comedones undergo different stages of devel-
opment, with some lesions developing into inflammatory lesions such as papules and pustules. The
goal of this study was to investigate the molecular mechanisms that may be involved in determin-
ing the biological behavior of comedones. Biopsies of closed comedones (N=7) and open come-
dones (N=4) were obtained from 9 patients with mild comedonal and inflammatory acne. All come-
dones clinically appeared non-inflamed at the time of biopsy. Using real-time PCR, the mRNA
expression of various inflammatory mediators was measured. Comparing all comedones (N=11)
with adjacent uninvolved skin, we found that IL-8 was elevated 35±26 fold, CCL20 12±9 fold,
human β defensin-2 86±41 fold, MMP-1 11±4 fold, MMP-3 15±9 fold, and MMP-9 8±3 fold (all
P<0.05). Comparing closed versus open comedones, there were no significant differences in the
expression of these markers. Overall, these data suggest that some comedonal lesions produce pro-
inflammatory mediators, a concept that contrasts with long-held beliefs that comedones are, by
definition, non-inflammatory. In turn, we propose that biochemical inflammation in comedones
may lead, in some cases, directly to the development of clinical inflammation (papules and pus-
tules). In particular, upregulated expression of chemokines (IL-8, CCL20) may stimulate the influx
of leukocytes, while upregulated expression of MMPs may lead to rupture of the follicular epithe-
lium. Future studies that correlate the expression of inflammatory markers with the natural history
of comedones may further support these conclusions.
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Measuring negative body image among patients with acne vulgaris: Validation of the Body
Image Disturbance Questionnaire in a clinical population
WP Bowe,1 A Doyle,1 C Crerand,2 DJ Margolis3,4 and AR Shalita1 1 Dermatology, SUNY
Downstate, Brooklyn, NY, 2 Plastic Surgery, Children’s Hospital of, Philadelphia, PA, 3
Dermatology, Univ of Penn, Philadelphia, PA and 4 Biostatistics & Epidemiology, Univ of
Penn, Philadelphia, PA
Psychosocial outcome measures have become increasingly important in dermatology research.
These measures attempt to examine acne from the patient’s perspective. One such measure is the
Body Image Disturbance Questionnaire (BIDQ), which measures body image disturbance: the
persistent report of dissatisfaction, concern and distress that is related to an aspect of appearance,
and results in some degree of impairment in social relations, social activities, or occupational
functioning. We conducted a cross-sectional investigation designed to validate the BIDQ in a clin-
ical population of patients with acne vulgaris. Participants included 52 consecutive acne patients,
aged 13 to 54 years, presenting to an outpatient dermatology clinic. All subjects completed self-
report questionnaires including the Body Image Disturbance Questionnaire (BIDQ), a series of
established measures of body image and psychosocial functioning, and the Skindex-16. Results
confirmed that the BIDQ was internally consistent (Cronbach’s alpha = 0.92) and converged appro-
priately with other body image indices including the Multidimensional Body Self-Relations Ques-
tionnaire (MBSRQ)-Body Areas Satisfaction Subscale (r=-.354, p=.010), the MBSRQ-Appearance
Evaluation (r=-.369, p=.007), and the Center for Epidemiologic Studies-Depressed Mood Scale
(r=.390, p=.004). BIDQ scores also correlated with Skindex-16 scores (r=.562, p<.001), confirm-
ing that quality of life and body image are related psychosocial constructs. Based on these results,
the BIDQ appears to be an accurate instrument that can be used to assess appearance-related dis-
tress and impairment in patients with acne vulgaris. This user-friendly instrument can serve as an
outcome measure in clinical research to help investigators assess whether a given therapy has a
meaningful effect on acne study patients.
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Increasing burden of melanoma in the United States
E Linos,1 S Swetter,1 M Cockburn,2 G Colditz3 and C Clarke1 1 Dermatology, Stanford
University, Stanford, CA, 2 Preventive Medicine, University of Southern California, Los
Angeles, CA and 3 Siteman Cancer Center, Washington University School of Medicine, St
Louis, MO
It is controversial whether worldwide increases in melanoma incidence represent a true epidemic
or simply increased detection of biologically indolent tumors due to screening expansion. Under-
standing melanoma incidence trends can be aided by examining them jointly by tumor thickness,
which reflects severity at diagnosis and by socioeconomic status, a proxy for access to physician
screening. Our aim in this analysis was to update recent melanoma incidence and mortality
trends and evaluate them according to tumor thickness and socioeconomic status. We used pop-
ulation-based data from the United States SEER cancer registry database and subset of this data-
base (California) for which small-area socioeconomic measures were available. Diagnoses of inva-
sive melanoma among non-hispanic whites were obtained from nearly 291 million person-years
of observation. A total of 70,596 cases of malignant melanoma were included in this analysis.
Melanoma incidence increased at 3.1% (p<0.001) per year. Significant rises occurred across all
tumor thickness levels, including those thicker than 4mm irrespective of histologic subtype.
Melanoma incidence doubled in all socioeconomic groups over a 10- year period, especially
among persons of low socioeconomic background. Mortality from melanoma did not increase
significantly over the same period. We conclude that overdiagnosis of thinner melanomas, can-
not entirely explain the increasing rates of thick melanomas among persons of low socioeco-
nomic status who may have poor access to physician screening.
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Cutaneous lymphoma incidence patterns in the United States: a population-based study of
3,884 cases
P Bradford,1 SS Devesa,2 WF Anderson2 and JR Toro1 1 Genetic Epidemiology Branch, Division
of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD and 2
Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer
Institute, Bethesda, MD
There have been no prior large population-based studies focusing on cutaneous lymphomas (CL)
in the United States. Using the Surveillance, Epidemiology and End Results (SEER) program, we
analyzed age-adjusted CL incidence rates (IR) and survival rates by gender and race/ethnicity. There
were 3,884 CLs diagnosed during 2001-2005. Cutaneous T-cell lymphomas (CTCLs) accounted
for 71% (IR 7.7/1,000,000 person-years), while cutaneous B-cell lymphomas (CBCLs) accounted
for 29% (IR 3.1/1,000,000 person-years). Males had a statistically significant higher IR of CL than
females [14.0 vs. 8.2/1,000,000 person-years, respectively; M:F incidence rate ratio (IRR)
1.72p<0.0001]. The M:F IRR ranged between 1.28-2.55 for the various CTCLs and CBCLs. Age-
adjusted CL IR were highest among Non-Hispanic Whites and Blacks (both 11.5/1,000,000 per-
son-years), followed by Hispanic Whites (7.9) and Asian/Pacific Islanders(7.1). CTCL IR were high-
est among Blacks (IR 10.0/1,000,000 person-years), while CBCL IR were highest among
Non-Hispanic Whites (3.5). Hispanic Whites and Asian/Pacific Islanders had higher rates of cuta-
neous diffuse B-cell lymphoma-leg type than Non-Hispanic Whites. CTCL and CBCL 5-year rela-
tive survival rates were highest among Non-Hispanic Whites (both 87%) and lowest in Asian/Pacific
Islanders (77% and 79%, respectively). CL rates vary markedly by race, gender, and histologic sub-
type, supporting the notion that they represent distinct disease entities.
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A cohort study of vitamin D intake and melanoma risk
MM Asgari,1,2 SS Maruti,4,3 LH Kushi1 and E White4,3 1 Division of Research, Kaiser Permanente
Northern California, Oakland, CA, 2 Department of Dermatology, University of California
San Francisco, San Francisco, CA, 3 Cancer Prevention Unit, Fred Hutchinson Cancer
Research Center, Seattle, WA and 4 Department of Epidemiology, University of Washington
Medical Center, Seattle, WA
Data suggest that vitamin D intake may have chemopreventive efficacy against melanoma, but
there have been no published epidemiologic studies examining the association between vitamin
D intake and melanoma risk in a large prospective cohort. We examined whether dietary and sup-
plemental vitamin D intake was associated with melanoma risk among 68,611 men and women
who were participants of the Vitamins and Lifestyle cohort study. Participants reported dietary
vitamin D intake over the past year and 10-year use of multivitamin and individual vitamin D sup-
plements on a baseline questionnaire. After follow-up through 2006, 455 incident melanomas
were identified through linkage to the Surveillance, Epidemiology, and End Results (SEER) cancer
registry. Cox proportional hazards regression models were used to estimate relative risks (RR) and
95% confidence intervals (CI) for vitamin D intake after adjustment for melanoma risk factors. Com-
pared to the lowest quartile, we did not detect a risk reduction of melanoma in the highest quar-
tiles of dietary vitamin D intake (RR=1.31, CI=0.94-1.82), 10-year average supplemental vitamin
D intake (RR=1.13, CI=0.89-1.43), or combined dietary and supplemental intake (1.05, CI=0.79-
1.40). In this large prospective cohort, we did not find an association between vitamin D intake
and melanoma risk.
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Itch and perceived self-efficacy among adolescents. Results from a cross-sectional study
F Dalgard1,3 and R Stern2 1 Judge Baker Children Center, Harvard Medical School, Boston,
MA, 2 Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA and 3
Institute of General Practice and Community Medicine, University of Oslo, Oslo, Norway
Itch is the most common dermatological symptom among adults and adolescents, mostly accom-
panying chronic inflammatory skin diseases, triggered by stress and often difficult to treat. Self-effi-
cacy has been shown important in the management of other chronic diseases. The purpose of this
study was to describe the relation of itch and perceived self-efficacy among 18 years old individ-
uals. The design of this study is cross-sectional and questionnaire-based, collecting information on
psycho-social factors and skin symptoms. The questionnaire was administrated to a representative
sample of late adolescents in the general population in Oslo, a major city of Norway. The response
rate was 80% and 2489 responders. Girls had significantly lower self-efficacy than boys (5.8%
compared to 1.7%). Adolescents reporting itch had significantly lower self-efficacy (9.1% com-
pared to 3.4) than those who did not itch. In the logistic regression model adjusted for major explana-
tory factors for itch the OR for low self-efficacy was 2.19 (1.23; 3.88). In conclusion low perceived
self-efficacy is explanatory for reporting itch.
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A genetic epidemiologic investigation of gestational outcomes associated with the DNA repair
disorder, trichothiodystrophy
R Moslehi,1,2 C Signore,3 D Tamura,1 JL Mills,3 JJ DiGiovanna,1 MA Tucker,1 J Troendle,3
A Goldstein1 and KH Kraemer1 1 NCI, NIH, Bethesda, MD, 2 SUNY at Albany, Albany, NY and
3 NICHD, NIH, Bethesda, MD
Trichothiodystrophy (TTD) is a rare recessive disorder caused by mutations in a number of genes,
some with known functions involved in the nucleotide excision repair (NER) pathway. The pro-
teins coded for by these NER genes are also components of the basal transcription factor, TFIIH.
Based on our clinical observations, we conducted a genetic epidemiologic study in order to inves-
tigate pregnancy and fetal developmental outcomes associated with TTD. We interviewed 15 moth-
ers with at least one TTD-affected child and collected information on all 49 of their pregnancies.
We compared the births of TTD-affected offspring (N=24) with those of their unaffected siblings
(N=18), accounting for correlation. Significantly higher incidence of small for gestational age
(SGA<10th percentile) (RR=9.3, 95%CI:1.4-60.5, P=0.02), SGA<3rd percentile (RR=7.2, 95%CI:1.1-
48.1, P=0.04), and neonatal intensive care unit (NICU) hospitalization (RR=6.4, 95%CI:1.4-29.5,
P=0.02) were found among TTD-affected neonates compared to their unaffected siblings. Com-
pared to reference values from general obstetrical population, pregnancies that resulted in TTD-
affected infants were significantly more likely to be complicated by hemolysis, elevated liver
enzymes, and low platelets (HELLP) syndrome (RR=35.7, 95%CI: 7.6-92.5, P=0.0002), elevated
mid-trimester maternal serum human chorionic gonadotropin (hCG) levels (RR=14.3, 95%CI: 7.0-
16.6, P<0.0001), small for gestational age (<3rd percentile) (RR=13.9, 95%CI:7.4-21.1, P<0.0001),
preterm delivery (<32 weeks) (RR=12.0, 95%CI:4.9-21.6), P<0.0001), pre-eclampsia (RR=4.0,
95%CI:1.6-7.4, P=0.006), and decreased fetal movement (RR=3.3, 95%CI: 1.6-5.2, P=0.0018).
Abnormal placentation may explain the constellation of complications noted in TTD-affected preg-
nancies in our study. Thus, we hypothesize that TTD genes may be important in normal placenta-
tion and human fetal development.
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Global access to dermatopathology services
MW Tsang1 and CL Kovarik2 1 Dermatology, University of Minnesota, Minneapolis, MN and
2 Dermatology, University of Pennsylvania, Philadelphia, PA
The availability of dermatopathology services varies across the world. Many developing countries
have limited to no access to dermatologists, pathologists, or histology and laboratory services. To
address the healthcare needs of underserved areas, medical specialists are increasingly providing
care to patients in remote areas of the developing world, either through establishing local clinics
or through telemedicine. This growth in clinical services has led to a rising need for the histologic
assessment of cutaneous diseases that cannot be diagnosed solely on a clinical basis. Novel solu-
tions to provide pathologic correlations to diagnoses include the international shipment of wet tis-
sue samples to expert laboratories, or establishing ‘virtual dermatopathology’ through electronic
transfer of photomicrographs or scanned slides. This study characterizes the presence of der-
matopathology services within developing countries in sub-Saharan Africa, where many patients
are evaluated clinically but laboratory services are especially scarce. We performed a search of
international professional databases, query of local physicians, and inquiry to the Ministries of
Health within these countries. Eighty-six percent of countries report histology services in their bor-
ders; only 14% report a dermatopathologist. The availability of dermatopathology services in Sub-
Saharan Africa is limited. While physicians have access to histology in the majority of countries
surveyed, long wait times make it difficult to rely on this diagnostic tool when patients are ill and
treatment is determined by the results of biopsy. Medical providers and health care members demon-
strated overwhelming interest and excitement at the possibility of teledermatology and teleder-
matopathology services. This study illustrates the differences in access to and availability of der-
matopathology in Sub-Saharan Africa and establishes a starting point from which to base any future
plans to address the challenge of expanding access to dermatopathology services.
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Patient preferences for dermatology visits
JY Yoo,1 DL Pancir1 and AB Kimball2 1 Dermatology, Mount Sinai Medical Center, New York,
NY and 2 Dermatology, Massachusetts General Hospital, Boston, MA
In recent years, evidence has demonstrated an undersupply of dermatologists despite an increas-
ing need for dermatologic services. Long wait times in major metropolitan cities across the US have
been well-documented through anecdotal evidence and telephone surveys. However, little infor-
mation has been collected pertaining to patient perceptions of wait times and consumer prefer-
ences for dermatology visits. Written survey distributed to over 600 individuals in public areas in
Boston and New York. 334 and 362 individuals were surveyed in Boston and New York, respec-
tively. Among survey participants, 281 (40.37%) had seen a dermatologist within the past five years.
Uniformly, Boston respondents were more likely to have experienced longer wait times for new
patient, non-emergency and emergency appointments compared to New Yorkers, consistent with
data provided from physician practices in other studies. 126 respondents (37.84%) in Boston and
155 respondents (42.82%) in NYC had seen a dermatologist within the past 5 years. The average
waiting time for a new patient dermatology visit in Boston was 28.2 vs.17.55 days in New York
City (P<0.001). There was a significant difference in the expected wait times for routine yearly skin
checks (20.25 vs 12.79 days), changing mole (7.18 vs 5.43 days) and cosmetic (23.78 vs 16.62
days) appointments, with Boston respondents having higher values than New Yorkers in each of
these areas. Having seen a dermatologist within the past 5 years had no significant difference on
expected wait times for routine, changing mole, chronic or cosmetic appointments. Respondents
overwhelmingly preferred to see a dermatologist for routine yearly skin checks, a changing mole,
chronic skin condition and cosmetic appointments over other kinds of health care providers. In
conclusion, this survey identifies discrepancies between patient experiences and preferences for
dermatology visits in two large metropolitan areas and may provide the basis for practice bench-
marks.
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Reliability and validity of the Patient Report of Extent of Psoriasis Involvement (PREPI) for
determining psoriasis severity
E Dommasch, DB Shin, AB Troxel, DJ Margolis and JM Gelfand Dermatology, University of
Pennsylvania, Philadelphia, PA
The development of a simple, reliable, and valid method for measuring the extent of skin involve-
ment in psoriasis is important for use in epidemiologic studies. We sought to investigate the relia-
bility and validity of the Patient Report of Extent of Psoriasis Involvement (PREPI), a single ques-
tion method for classifying disease severity in which the patient estimates the percentage of their
body surface area affected by psoriasis. This was a prospective study of consecutive patients with
a prior diagnosis of psoriasis (n =140) being seen in routine follow-up. To assess test-retest relia-
bility, we examined the agreement between the PREPI administered over the phone and re-admin-
istered at an outpatient visit 2-3 days later. Criterion validity was evaluated by comparing the PREPI
score to a dermatologist’s assessment who was not aware of the patient’s score. Both were ana-
lyzed using intra-class correlation coefficients (ICCs; 95% CI). To assess construct validity, we com-
pared Skindex-29 domain specific scores to the PREPI using Spearman correlation coefficients (ρ;
95% CI). The test-retest reliability of the PREPI was excellent (ICC = 0.99 (0.97, 0.99)), and the cri-
terion validity analysis showed substantial agreement between patient and physician assessments
(ICC = 0.82 (0.75, 0.87)). Spearman correlation coefficients for the PREPI score and Skindex-29
domains of emotions, symptoms, and functioning were 0.48 (0.33, 0.61), 0.41 (0.25, 0.55), and
0.64 (0.51, 0.73), respectively. The patient’s self-assessed PREPI correlated more strongly than the
physician’s assessment with all quality of life measures. Our study demonstrated that the PREPI is
a valid and reliable measure of psoriasis severity and may be useful for future epidemiologic research.
Further studies are indicated to determine if these results are generalizable to other patient popu-
lations.
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Assessment of dermatology-domain specific term coverage in ICD-9 and SNOMED-CT using
a dermatology textbook index
N Shah and M Pittelkow Dermatology, Mayo Clinic, Rochester, MN
The International Classification of Diseases 9th edition, ICD-9, is a medical terminology that is used
to record clinical information for a variety of applications including research on mortality, health-
care outcomes and reimbursement systems. SNOMED-CT is a more comprehensive and complex
medical terminology currently used primarily for research purposes. In this study the index of a
widely referenced dermatology textbook was used to assess dermatological term coverage in ICD-
9 and SNOMED. Using a set of lexical matching tools 1299/5576 index terms were found in ICD-
9 while 4920/5576 terms were found in SNOMED-CT. Despite its widespread use, ICD-9 lacks a
majority of terms which are present in a popular dermatology text. SNOMED-CT was superior to
ICD-9 in dermatology-domain specific term coverage. Inclusion of all or a portion of specialty-spe-
cific lexicons, such as the Dermatology Lexicon Project (DLP) and British Association of Derma-
tology (BAD) Index, would further enhance dermatology term coverage in SNOMED-CT.
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Exposure to particle pollution is associated with skin aging in elderly women
A Vierkötter,1 T Schikowski,1 U Ranft,1 D Sugiri,1 M Matsui,2 A Morita,3 U Krämer1 and
J Krutmann1 1 IUF, Düsseldorf, Germany, 2 The ESTÉE Lauder Companies Inc., Melville, NY
and 3 Dept. of Dermatology, Nagoya City University, Nagoya, Japan
For decades, extrinsic skin aging has been thought to result from exposure of human skin to solar
radiation and, more recently, to tobacco smoke. We now report that traffic-related, airborne par-
ticles may represent a third environmental factor which contributes to premature skin aging. In
this study, the influence of air pollution on skin aging was assessed in a cohort of 402 German
women aged 70 to 80 years living in industrialized and rural areas of North Rhine-Westphalia.
Aging symptoms were evaluated by SCINEXA, a validated score that assess and differentiate between
intrinsic and extrinsic skin aging (Vierkötter et al., 2008). As potential confounding factors, UV
exposure and smoking habits were assessed by questionnaire. Exposure to airborne particles was
determined by measurements of ambient PM10 (particulate matter with Ø < 10 μm) concentrations
at fixed monitoring sites and traffic exposure by distance of residency to a major road by employ-
ing Geographic Information System (GIS). The impact of air pollution on skin aging was analyzed
by linear regression and adjusted for potential confounding variables (age, UV exposure, smoking).
The following significant results emerged: Women who lived ≤ 250m from a major road had 55%
more pigment spots on their faces (95% Confidence interval (CI) 10%-120%) than women who
lived further away. These women also showed stronger tissue slackening in form of more pro-
nounced nasolabial folds (5% (95% CI 1%- 8%)). In addition, we observed a significant impact of
long-term PM10 exposure on skin aging: Per 5 μg/m
3 increase in the 5-year-means of PM10 spots
on face increased by 89% (95% CI 24%-190%) and nasolabial folds by 4% (95% CI 0%-8%). These
results indicate that extrinsic skin aging is not only determined by exposure to UV radiation and
tobacco smoke, but also by exposure to particles. Further studies will have to clarify the mecha-
nism of PM-induced skin aging and subsequently develop cosmetically acceptable preventive strate-
gies.
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Advanced glycation end products crosslinks breaker: A new approach for improvement of
aged skin
A Tada, A Kanamaru, M Oyobikawa, T Maeda and H Oshima POLA Chemical Industries, Inc.,
Yokohama, Japan
Research has confirmed a marked increase in advanced glycation end products (AGEs) during aging
in normal human skin, along with greater accumulation in photoaged skin. Accumulation of AGEs
in skin is associated with reduced softness and elasticity and increased yellow-brown coloration.
Inhibiting AGEs production may thus slow the rate of skin aging. However, this approach does not
eliminate AGEs already present in the skin and cannot prevent further damage from these mole-
cules. Our novel approach involves removing AGEs that have already accumulated in the skin by
devising a new method of breaking AGEs crosslinks, thereby promoting healthy skin. The objec-
tive of this study was to identify safe and effective methods of breaking AGEs crosslinks. We screened
128 botanical extracts for promising active ingredients that would be safe and effective for our
purpose, and identified Compound Y from NMR spectral analysis from mugwort (Yomogi in Japan-
ese) using an assay for cleavage of AGEs crosslinks in vitro. We prepared an extract that we termed
Yomogi AGEs Clearing (YAC) extract, incorporating a significant amount of Compound Y. We then
evaluated the effects of YAC extract in reducing AGEs accumulation using a collagen gel in vitro
model. To further substantiate the results, we tested YAC extract on human subjects by evaluating
skin softness, elasticity and yellow-brown coloration in a double-blind study of two groups of female
volunteers with application for 6 months, using samples with or without YAC extract. Results demon-
strated significant improvements in skin AGEs content after treatment with YAC extract. This change
is believed to be due to the YAC extract breaking AGEs crosslinks, reducing the accumulation of
AGEs in skin and resulting in increased skin softness and elasticity and decreased yellow-brown
coloration. From our experimental results, we believe that the elimination of accumulated AGEs
in skin is as important as preventing formation, and must be considered when formulating effec-
tive anti-aging strategies for maintaining youthful skin.
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Effects of chronic pruritus on depression, activities of daily living, and quality of life
L Kamalpour, PD Harvey, E Veledar, S Kini, M McIlwain, L Van, R Berrios, T Finch, L Delong and
SC Chen Emory University, Atlanta, GA
Our aim was to evaluate the impact of chronic pruritus on depression, quality of life (QOL) and
activities of daily living (ADL). Adult patients with chronic pruritus (> 6 weeks) were recruited
from the Emory dermatology clinic between June and December 2007. Each subject was surveyed
using the Beck Depression Inventory-2 (BDI-2), the EuroQoL (EQ-5D), and questions related to pru-
ritus severity and demographics. The “Usual Activities” question from the EQ-5D was employed
as a gauge of ADL performance and the EQ-5D utility score was used to measure QOL. BDI-2
scores determined severity of depression. Regression analysis was used to evaluate predictors for
QOL and ADL performance. Of the 73 patients with chronic pruritus, 44.8% were male, 70%
were Caucasian, 84% had ≥ college-level education, and the mean age was 55.3 years (SD 16.8).
Univariate regression showed a significant correlation between severity of pruritus and level of
depression (r = 0.354, p=0.003). In multivariate regression analysis, after accounting for severity
of depression, age, race, gender, education level, ADL performance, and pruritus severity, only pru-
ritus severity (B = -0.361, p = 0.002) and ADL performance(B = -0.463, p<0.0001) were found to
be significant predictors for QOL, accounting for 53.6% of the variance. Pruritus severity was also
found to a significant predictor for ADL performance (B = 0.875, p = 0.029) independent of demo-
graphics and depression severity. We have shown that increasing severity of pruritus has a signif-
icant negative impact on QOL and ability to perform ADL. The mechanisms by which pruritus
causes these effects are unknown, but may be related to underlying psychiatric conditions or per-
sonality temperaments. Further studies are warranted to investigate the relationship between pru-
ritus, quality of life, and the ability to perform activities of daily living.
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Pyoderma gangrenosum: A tertiary care experience
AM Binus,1 AA Qureshi,1 VW Li1,2 and LS Winterfield1,2 1 Dermatology, Brigham and Women’s
Hospital, Boston, MA and 2 Pyoderma Gangrenosum Clinic, Angiogenesis & Wound Healing
Center, Dept of Dermatology, Brigham and Women’s Hospital, Boston, MA
Pyoderma gangrenosum is a rare, painful ulcerative disease commonly associated with other inflam-
matory diseases. The pathogenesis and epidemiology are poorly understood, and treatment can
be challenging. Using a set of major and minor criteria based on the characteristics described in
the medical literature, we retrospectively identified 111 cases of pyoderma gangrenosum treated
in 2 large academic hospitals in Boston from 2000-2007. Medical records were reviewed to eval-
uate patient demographics, disease parameters, comorbid conditions, and treatments. Our find-
ings included a male:female ratio of 1:3, predominance of ulcer location on the leg (79.3%), and
pathergy phenomenon documented in 28.8% of cases. Notably, the vast majority of patients who
were treated with gentle ulcer debridement tolerated this without induction of the pathergy response.
There was a high frequency of comorbid conditions, including inflammatory bowel disease (36%),
hematologic disorders (25%), seronegative arthritis (19.8%), psoriasis (9.9%), and hepatitis (8.1%).
We also found documented major depression in 12.6%, an association which has not been reported
in other large series. In this study, 27.9% of the patients had one, 36% had two, and 12.6% had
three comorbidities. Systemic steroids were the most commonly prescribed treatment, and 27%
of patients required 3 or more systemic drugs. The mortality rate was 14.4% in the 8-year period
of the study. This represents the largest series of patients with pyoderma gangrenosum reported to
date, and our data are largely in concordance with previously reported series. We have also iden-
tified an association with hepatitis and major depression.
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Tumor infiltrating lymphocytes are a prognostic marker for survival in patients who develop
melanoma metastases
CC Wriston, AB Troxel, DB Shin, A Schaffer, AI Rubin, JA Brauer and ME Ming University of
Pennsylvania, Philadelphia, PA
Although the presence of tumor infiltrating lymphocytes (TILs), thought to be a marker of active
host immune reponse, has been shown to be an independent prognostic marker for survival in
melanoma patients as a whole, there are no previous studies that have established whether TILs
surrounding the primary tumor are still a marker for survival once patients have developed metasta-
tic disease. To address this shortcoming, we examined the presence of TILs and 14 other clinical
and pathologic prognostic characteristics in 508 patients seen at the Pigmented Lesion Clinic of
the University of Pennsylvania who presented with local disease only but developed melanoma
metastases. Of the 508 patients, 330 (65.0%) were male, with a median age at the time of metas-
tasis of 55.2 years. The initial presentation of metastases was as in transit metastases in 63 (12.4%)
patients, in regional lymph nodes in 235 (46.3%) patients, and at more distant sites in 210 (41.3%)
patients. Survival analysis was carried out using Cox proportional hazards regression. 370 (72.8%)
patients died from melanoma with a median survival of 1.4 years after metastases were discov-
ered. Multivariate analysis determined that the presence of TILs (Hazard ratio (HR)=0.74; 95% con-
fidence interval (95% CI)=0.59, 0.93; p=0.01), initial presentation as in transit metastases (HR=0.28;
95% CI=0.20, 0.41; p<0.0001) or regional lymph node metastases (HR=0.36; 95% CI=0.28,
0.45, p<0.0001) as compared to distant metastases, the presence of solar elastosis (HR=0.58;
95% CI=0.46, 0.72; p<0.0001), the absence of ulceration (HR=0.74; 95% CI=0.58, 0.93; p=0.01),
and younger age at time of metastasis (HR for every 10-year decrease in age=0.91; 95% CI=0.84,
0.98; p=0.02) were independently associated with survival. Even among patients who develop
metastases, initial host immune response, as measured by the presence of TILs, seems to be an
important factor in melanoma survival.
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Depression and incident diabetic foot ulcers: a prospective cohort study
LH Williams,1 CM Rutter,2 WJ Katon,3 GE Reiber,4,5,6 P Ciechanowski,3 SR Heckbert,2,5 EH Lin,2
EJ Ludman,2 MM Oliver,2 BA Young7,8 and M Von Korff2 1 Dermatology, University of
Washington, Seattle, WA, 2 Group Health Center for Health Studies, Seattle, WA, 3
Psychiatry, University of Washington, Seattle, WA, 4 VA Health Services Research &
Development, Seattle, WA, 5 Epidemiology, University of Washington, Seattle, WA, 6 Health
Services, University of Washington, Seattle, WA, 7 VA Epidemiologic Research and
Information Center, Seattle, WA and 8 Nephrology, University of Washington, Seattle, WA
Our objective was to test whether major and minor depression are associated with an increased
risk of incident diabetic foot ulcers. The Pathways Epidemiologic Follow-up Study is a popula-
tion-based prospective cohort study of patients with diabetes from nine Group Health Coopera-
tive primary care clinics in Western Washington State. It took place between 2000 and 2007. The
present analysis included a sample of 3515 adults with type 2 diabetes and no prior foot ulcers or
lower limb amputations. Major and minor depression, as measured by the Patient Health Ques-
tionnaire-9 (PHQ-9), were the exposures of interest. The outcome of interest was incident diabetic
foot ulcers. We computed the hazard ratio (HR) and 95% confidence intervals (CI) for incident
diabetic foot ulcers, comparing patients with major and minor depression to those without depres-
sion, and adjusting for sociodemographic characteristics, diabetes severity, medical comorbidity,
and self-care. Mean follow-up was 4.1 years. Compared to patients without depression, patients
with major depression had a two-fold increase in the risk of incident diabetic foot ulcers (adjusted
HR 2.0, 95% CI: 1.3, 3.2). The HR for incident diabetic foot ulcers associated with minor depres-
sion was not statistically significant (adjusted HR 1.3, 95% CI: 0.76, 2.4). Major depression is
associated with a two-fold higher risk of incident foot ulcers in patients with type 2 diabetes. Fur-
ther research is needed to identify the mediators of this relationship and to evaluate possible pre-
ventive strategies.
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United States patients with severe psoriasis have an risk of increased all cause but not increased
cardiovascular mortality
RS Stern1,2 and A Huibregtse2 1 Dermatology, Beth Israel Deaconess Medical Center, Boston,
MA and 2 Harvard Medical School, Boston, MA
Recent work based on analysis of ambulatory records from British general practitioners suggested
that patients who have utilized systemic or ultraviolet therapies for psoriasis have higher risk of
myocardial infarction and stroke. We have conducted a 30 year prospective study of 1376 patients
with severe psoriasis (92% had ≥10% body surface area (BSA) affected at enrollment). From 1977
to 2005, 617 patients died compared to 542 expected (Standard Mortality Ratio SMR 1.1, 95% CI
=1.04 to 1.20). Using standard algorithms, we determined cause of death for 97% of patients.
Observed cardiovascular mortality was nearly identical to that expected 246 vs. 241 deaths (SMR
=1.02, 95% CI = 0.90-0.16). A Cox Proportional hazard model estimates cardiovascular death
(CVD) among cohort patients in the highest quartile of disease severity (BSA ≥42%) compared to
patients in the lowest quartile (BSA <16%, mean BSA=11%) is increased (Hazard Ratio (HR) = 1.44,
95% CI =1.00-2.09). After adjustment for known confounding factors, no significant increase risk
in CVD is observed among those with greatest psoriasis (adjusted HR 1.30, 95% CI 0.85-1.99).
The point estimate of risk of death due to CVD in the most severely affected patients is less than
that observed for this group for death from all other causes (adjusted HR=1.51, 95% CI=1.19 to
1.91). Overall, cohort patients with severe psoriasis had slightly higher mortality rates than observed
in the general population. Among patients with severe psoriasis, very severe psoriasis (>42% BSA)
is associated with significantly higher all cause mortality. However, this association is less appar-
ent for CVD than deaths from other causes. Our findings do not support the hypothesis that severe
psoriasis is an independent risk factor for fatal cardiovascular disease. Among those with extremely
extensive and severe disease, excess mortality attributable to cardiovascular disease appears to be
less than that due to other causes of death.
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The safety and efficacy of the scoop-shave for pigmented lesions of the skin
G Mendese,1 J Bordeaux2 and M Maloney3 1 Dermatology, Boston Medical Center and Tufts
Medical Center, Boston, MA, 2 Dermatology, Case Western Reserve, Cleveland, OH and 3
Dermatology, UMass Memorial Health Care, Worcester, MA
The scoop-shave is a biopsy into the deep dermis used for complete removal. Concern over
melanoma transection has inhibited many practitioners from using this technique. We hypothe-
sized that when performed appropriately, this technique can be safe and efficacious. Pigmented
lesions removed from September 2006-June 2007 were included. A survey was completed at the
time of the procedure, which included the technique used, intent and diagnosis. Patients rated their
experience (on a scale of 1-5) within 2 weeks of the procedure. Results: 333 lesions were removed.
Diagnoses included dysplastic nevi, other nevi, melanomas (invasive and in situ) and other lesions.
Of the dysplastic nevi, 62.2% were completely removed by scoop shave. Of the melanomas, 35.3%
were completely removed by scoop-shave, compared to 64.7% by standard excision. Of the 204
total lesions that were completely excised, 48% were by scoop-shave (p<0.0001). 13 in-situ
melanomas were identified. All had adequate depth but 8 (61.5%) had positive peripheral mar-
gins, 50% of which were scoop-shaved. 16 invasive melanomas were identified, and 33.1% were
scoop-shaved. All had adequate depth but 25% had positive margins and 2 were scoop-shaved.
Of the 88 dysplastic nevi removed in this study, 56.8% were scoop-shaved. Two cases showed pos-
itive deep margins: one moderately dysplastic nevus (scoop-shaved) and one intradermal nevus
(shaved). 208 patients were contacted within 2 weeks of the procedure, and 85% were satisfied
(>3 on 5 point scale) with their experience. Of the satisfied patients, 38.6% had a scoop shave. Of
the 32 patients who were unsatisfied, 69% had scoop shaves (p=0.003). In conclusion, the scoop-
shave is an effective technique for diagnosis and treatment of melanocytic lesions. Most patients
were satisfied regardless of method used. Of the unsatisfied patients, there was a higher propor-
tion who underwent scoop-shave. Perhaps lesion location might be considered prior to using this
technique.
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What form of informed consent?
B Stoff, J Shih, E Veledar and SC Chen Dermatology, Emory University, Atlanta, GA
Informed consent (IC) is an ethical obligation for all physicians and is required by common law
prior to treatment in most states. We sought to determine the method by which practicing derma-
tologists in the US obtain IC for common procedures, with the expectation that most dermatolo-
gists pursue some method of IC prior to most procedures. A random selection of 150 practicing
dermatologists in the US received a mailed survey, on which 19 common procedures were listed.
For each procedure, participants were asked to select the method of IC – none, verbal only, writ-
ten only, or written and verbal – representing their usual practice. We grouped the procedures into
(1) “Destructive treatment of non-malignant lesions” (i.e. cryosurgery and intralesional injections)
(2) “Biopsy” by any method (3) “Excision” (including Mohs surgery) and (4) “Cosmetic.” Of 29
responders, 59.3% were male and 92.6% Caucasian. The most common practice duration was 5-
15 years (40.7%), subspecialty was medical dermatology (59.3%), and practice setting was solo
private practice (51.8%). There was a statistically significant (p=0.0001) difference in the propor-
tion of dermatologists reporting failure to obtain IC between the four different types of procedures,
with “Destructive treatment of non-malignant lesions” having the highest number reporting no IC
(30%, 16/54), followed by “Biopsy” (12%, 20/162). Very few dermatologists reported failure to
obtain IC for “Excision” (1.2%, 1/81) and “Cosmetic” procedures (0%). The constructs of law
10(37%) and ethics 11(41%) influenced responses more than medicine 6(22%) by self report. Those
previously sued documented verbal IC less often (25% vs 55%) than those not sued, but supported
published guidelines regarding IC (62% vs 42%) more often. Limitations include small sample, low
response rate, and inability to assess the content of IC when done. We conclude that a substantial
number of dermatologists in the US fail to obtain IC for certain procedures, a violation of ethical
obligation and often common law. Further, the likelihood for which informed consent is obtained
appears to be greater for more invasive and cosmetic procedures.
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Prevalence and effects of adult atopic dermatitis in Taiwan: A pilot study on validation of
diagnostic questionnaires and impacts of life quality
CE Lan,1,2 H Yu,1,2 C Wu3 and G Chen1,2 1 Department of Dermatology, Kaohsiung Medical
University, Kaoshiung, Taiwan, 2 Department of Dermatology, Kaohsiung Medical University
Hospital, Kaoshiung, Taiwan and 3 Department of Biomedical Laboratory Science, Kaohsiung
Medical University Hospital, Kaoshiung, Taiwan
Atopic dermatitis (AD) is a chronic, relapsing dermatosis. Previous studies have mostly focused on
pediatric patients, and investigations emphasizing on adult AD have been limited. We set out to
determine the prevalence and evaluate the validity of International study for Asthma and Allergies
in Childhood (ISAAC) and UK working party’s AD questionnaires on adult AD in Taiwan. The
impacts of disease on life quality were also evaluated. We conduct a cross-sectional study among
nursing staff in a university hospital. The prevalence of AD was assessed by ISAAC and UK work-
ing party’s questionnaires. Subsequently, the dermatologists’ diagnosis based on Hanifin and Rajka
criteria was used as a reference for validation. In addition, short form-36 (SF-36) was used for eval-
uation for impacts on life quality. The overall response rate was 93%, equivalent to 1131 complete
questionnaires. Ninety adult AD patients (8%) were identified by dermatologists’ diagnosis while
ISAAC and UK working party criteria identified 107 and 42 AD patients, respectively. Using the
receiver-operator characteristic (ROC) curve analysis, the UK working party’s criteria performs sig-
nificantly better than its ISAAC counterpart. In addition, McNemar’s test indicated that certain mod-
ification of UK criteria may result in improvement of its diagnostic efficacy. As expected, adult AD
has significant negative impact on life quality of those affected. In summary, currently available
questionnaire instruments do not perform well in identification of adult AD patients, whom have
significantly lower quality of life. Modification of the original questionnaires may allow for future
large-scale epidemiologic studies.
368
Development and acceptability of a new international quality of life instrument specific to
physical appearance: BeautyQoL
A Beresniak,1 P Auquier,2 G Duru,6 GG Krueger,4 S Talarico,5 K Tsutani,3 Y de Linares7 and
G Berger8 1 Data Mining International, Geneva, Switzerland, 2 Université de la Méditerranée,
Marseille, France, 3 University of Tokyo, Tokyo, Japan, 4 Dermatology, School of Medicine,
SLC, UT, 5 Dermatology, Federal University of Sao Paulo, Sao Paulo, Brazil, 6 National Centre
of Scientific Research, Lyon, France, 7 R&D, L’Oréal International, Paris, France and 8
University Pierre Marie Curie, Paris, France
Many studies have observed the impact of physical appearance on Quality of life (QOL) but no
specific instrument has been validated at an international level. Our objective was to develop
such an instrument and to test its acceptability across a broad spectrum of cultures. BeautyQol is
a multidimensional QOL questionnaire specific to cosmetology and physical appearance. Semi
directive interviews were conducted by clinical pychologists simultaneously in 10 countries in 309
users, men and women aged 18 to 70. Then an acceptability study in 13 countries representing 16
cultures was conducted in France, UK, Germany, Spain, Sweden, Italy, Russia, USA, Brazil, Japan,
India (Hindi and English) China and South Africa (Zulu, Sotho and English). 62 questions were
selected in the prototype questionnaire. The acceptability phase was conducted on 874 subjects.
General acceptability was very good according to the low rate of no answer. Mean time duration
was 11 minutes. Statistical analyses for redundant questions led to a 48 question version. The next
study currently underway is a global validation study involving no less than 3200 subjects world-
wide. In conclusion, BeautyQol is the first user centered instrument specific in cosmetics and phys-
ical appearance that is being developed simultaneously in 13 countries. BeautyQol will be a valu-
able tool for national and international assessment in Dermatology, Cosmetic dermatology, Cosmetic
surgery, and Cosmetology. It is anticipated that BeautyQoL will become the gold standard for the
measurement of QoL as affected by cosmetic products, techniques and agents that alter physical
appearance of disease.
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Agreement between pruritus patients’ self-reports of medications and doctor visits when
compared with electronic medical records.
RL Berrios, LK Delong, E Veledar, A Seidler and SC Chen Dermatology, Emory University
School of Medicine, Atlanta, GA
The advent of the electronic medical record (EMR) has tamed many of the frustrations surround-
ing patients’ recall of medications, dosages, and physician visits. However, due to several factors
including cost, unfamiliarity, and information security, many outpatient facilities have been slow
to adopt the technology, and have had to rely on patient recall alone. Our aim was to evaluate the
degree of agreement between patients’ self-reports of medications and physician visits with those
in the EMR. During December of 2006 and April of 2007, adult patients with chronic pruritus (CP,
>6 weeks duration) were recruited from the Emory dermatology clinic. Patients were asked to fill
out paper surveys detailing the medications they were currently on and the number of physician
visits they had accrued in the last three months because of their pruritus. Responses were then com-
pared with the Emory EMR; individual medications were said to agree if they at least fell within
the same drug class (antihistamine, topical/oral steroid, etc.). Levels of agreement were deter-
mined by the weighted kappa coefficient and intraclass correlation coefficient (ICC, Shrout-Fleiss
fixed set) using the SAS 91® statistics program. Of 21 patients with the CP, 43% were female, 71%
were Caucasian, 67% were married, and the mean age was 60.7 (13) years. For medication agree-
ment, the weighted kappa coefficient was 0.68 (p=0.0015), and the ICC was 0.69 (p=0.0002); for
physician visits, the weighted kappa coefficient was 0.35 (p=0.0062), and the ICC was 0.55
(p=0.0042). Methods were limited by an inability to verify medications and visits accrued outside
of the Emory EMR system. Our data show that, in an outpatient dermatology setting, there is a sub-
stantial and statistically significant level of agreement between patients’ recall of medication and
visit history and the EMR.
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Assessment of quality of life of patient members of a web-based hydroa vacciniforme sup-
port group
RH Huggins,1 LA Leithauser,3 MJ Eide,1,2 CL Hexsel,1 G Jacobsen2 and HW Lim1 1 Dermatology,
Henry Ford Hospital, Detroit, MI, 2 Biostatistics and Research Epidemiology, Henry Ford
Hospital, Detroit, MI and 3 School of Medicine, Wayne State University, Detroit, MI
Hydroa vacciniforme (HV) is a rare pediatric photodermatosis characterized by pruritic blisters
which heal with scarring. The purpose of this study was to investigate the effect of HV on quality
of life (QoL) and to compare our results with life quality indices reported for other dermatoses. A
disease-specific questionnaire was developed, and participants recruited from a web-based, inter-
national HV support group. Impact of HV on QoL was measured using the Dermatology Life Qual-
ity Index (DLQI) or the Children’s DLQI. Fifteen HV patients participated: 9 (60%) males and 6
(40%) females. Median age at onset was 7 years, and 11/15 (73%) were younger than 18 years.
Most patients self-identified as Caucasian (93%). The mean CLDLQI and DLQI scores for HV were
12.1 and 8.5, respectively, which suggests equal or greater impact on patient QoL compared to
previously reported indices for childhood psoriasis (9.2) and generalized eczema (9.1), and atopic
dermatitis in adults (4.5). Children cited QoL as being negatively impacted most by an inability to
play outdoors while adults noted QoL influences due to limitations on choice of clothing. Embar-
rassment associated with their skin condition was also noted by children and adults surveyed, but
personal relationships were not reported as being significantly impacted by either group. Patients
with HV have significant impairment of QoL. When compared to other common childhood der-
matoses, HV appears to have an equal or greater impact on patients’ QoL. Dermatologists should
be aware of the substantial psychosociologic impact of this disease.
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Identification of patients with nonmelanoma skin cancer using HMO claims data
MJ Eide,1,2 R Krajenta,2 D Johnson,2 J Long,2 G Jacobsen2 and CC Johnson2 1 Dermatology,
Henry Ford Hospital, Detroit, MI and 2 Biostatistics & Research Epidemiology, Henry Ford
Hospital, Detroit, MI
US cancer registries usually exclude nonmelanoma skin cancer (NMSC) and secondary data analy-
sis has been limited. Our aim was to define and compare algorithms for identifying NMSC using
available health system administrative databases of a large health maintenance organization (HMO).
A computerized claims database of a large HMO was used to identify NMSC patients diagnosed
between January 1988 to December 2007. Three algorithms were examined: use of International
Classification of Disease (ICD-9) codes (ICD-9 of 173.0-173.9), use of Current Procedural Termi-
nology (CPT) code for treatment of malignant lesions, or use of both ICD-9 and CPT codes. A sub-
set was reviewed to verify NMSC diagnosis. Positive predictive values were calculated. Analyses
of data from 1988-2007 identified NMSC by either ICD-9 or CPT codes in 32,184 patients. A ran-
dom sample of 647 cases were selected, and NMSC was validated in 74% of ICD-9-identified
patients (95% CI: 70-78), 95% of CPT-identified patients (95% CI: 93-97), and 97% with both codes
(95% CI: 96-99). All charts from cases identified in a single year (2007) were reviewed (N=1771),
and NMSC cases were confirmed in 97% of ICD-9 group (95% CI: 96-98), 98% of CPT group
(95% CI: 98-99), and 99% with both codes (95% CI: 98-99). HMO computerized claims data can
be used to identify NMSC. The use of an algorithm which requires that both a CPT and ICD-9 code
be recorded is only slightly better when compared to CPT code alone. These algorithms should be
validated in a population captured by a reputable tumor registry to determine sensitivity and
specificity.
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Eczema prevalence in the United States: Data from the 2003 National Survey of Children’s
Health
TE Shaw, GP Currie and EL Simpson Dermatology, Oregon Health & Science University,
Portland, OR
Atopic dermatitis (AD) is a global public health concern given its increasing prevalence and mount-
ing financial costs to health systems. Studies of AD prevalence have primarily been performed in
European populations. There have only been three previous studies of AD prevalence in the United
States, two of which were limited to data from one state. We conducted a cross-sectional study
determining the national prevalence of eczema in the U.S. pediatric population using data from
the 2003 National Survey of Children’s Health (NSCH). The NSCH surveyed parents of 102,353
children aged ≤17 years of age from all 50 states. A single question that addressed parent recall of
physician-diagnosed eczema was used to define AD. A similar question has been validated and
used in previous prevalence studies showing high concordance with a clinical diagnosis of AD.
Overall, 10.7% of children in the U.S. were diagnosed with eczema by a physician in the 12 months
prior to the survey. AD prevalence ranged from 8.69% to 18.05% between states, with the high-
est prevalence reported in many of the East Coast states, as well as Nevada, Utah, and Idaho. A
higher disease prevalence was found among black and multi-race populations, a finding not pre-
viously reported in the U.S. One third of patients with eczema also reported symptoms of hay fever;
and 22.8% were diagnosed with asthma. These findings were similar to previous reports from
Europe. Other disease associations were confirmed such as an increased prevalence found in higher
socioeconomic groups. These data represent the largest study of AD prevalence in the U.S. to
date. They confirm previously reported associations found in Europe and identify populations at
risk. Geographic areas with high population densities appear to suffer from higher prevalences of
eczema for unclear reasons.
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Resource utilization and quality of life in the congenital ichthyoses
L Kamalpour,1 BL Gammon,2,1 KH Chen,3,1 E Veledar,1 Z Rice,1 M Pavlis1 and SC Chen1 1 Emory
University, Atlanta, GA, 2 Tulane University, New Orleans, LA and 3 ChungTai Univ of Med
and Tech, Taichung, Taiwan
We explored resource utilization and quality of life (QOL) associated with the congenital ichthyoses
(CI). Subjects were recruited, aided by the Foundation for Ichthyosis and Related Skin Types (9-
12/2008) to complete an online survey related to clinical severity, demographics, resource uti-
lization (ResUtil), and QOL as measured by Dermatology Life Quality Index (DLQI). Validated
Likert scales were used to evaluate severity of hyperkeratosis (scale) and erythema. ResUtil was
determined by time spent daily treating CI symptoms (TimeTx) and number of ichthyosis-related
dermatology visits (visits) per year. We used linear regression to investigate a transformed DLQI
(sqrtDLQI) and logistic regression for ResUtil. Of 230 subjects, 63.5% were adults (≥18 yrs), 39.6%
were male, 80.9% were Caucasian, 61.5% were married and 42.8% had a family history of
ichthyosis (FH). Classification by CI type was 11.9% x-linked, 29.1% lamellar, 11.9% epidermolytic
hyperkeratosis, 4.4% Netherton’s Syndrome, and 42.7% other. In multivariate regression, account-
ing for scale, erythema, adult/child, CI type, demographics, FH, and DLQI score, only DLQI
score(odds ratio 1.07, 95% CL 1.01-1.13) and erythema(OR 1.50, CL 1.14-1.96) were significant
predictors for TimeTx. DLQI score(OR 1.09, CL 1.04-1.14) and adult/child (OR 2.39, CL 1.31-4.38)
significantly predicted visits, independent of scale, erythema, CI type, demographics or FH. Sig-
nificant QOL predictors were scale (Beta: 0.27 p<0.001), erythema (0.24, p<0.001), ichthyosis
type(0.07 p<0.001), race (0.09, p=0.018), adult/child (0.356, p=0.003) and TimeTx (0.19, p<0.001).
We have shown that increased severity of hyperkeratosis and erythema as well as ichthyosis type,
non-white status, child status, and increased TimeTx negatively impact QOL. Resource utilization
in ichthyosis is increased in patients with lower QOL, increased erythema, and children. Effective
treatments for CI would help minimize disease burden on QOL and reduce disease-associated
costs.
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Alcohol intake and risk of incident psoriasis in US women: A prospective study
AA Qureshi,1,2 PL Dominguez,1,2 G Curhan1,3 and HK Choi1,4 1 Medicine, Channing
Laboratory, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, 2
Dermatology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, 3
Epidemiology, Harvard School of Public Health, Boston, MA and 4 Rheumatology, Boston
University, Boston, MA
The association between alcohol consumption and risk of developing psoriasis has long been sus-
pected but has not been prospectively evaluated. Additionally, a potential risk of psoriasis associ-
ated with different types of alcoholic beverages has not been previously assessed. We sought to
determine if alcohol intake is an independent risk factor for new onset psoriasis in the Nurses Health
Study 2, a cohort study in the United States consisting of 82,869 female nurses aged 27 to 44 at
baseline. We evaluated risk for incident psoriasis among participants who reported amount and
type of alcohol intake. We excluded participants with a history of psoriasis prior to 1991. Over 14
years (1991-2005) we used biennial questionnaires to assess type and amount of alcohol con-
sumption. Self-reported incident physician-diagnosed psoriasis was the main outcome measure.
We documented 955 incident cases of psoriasis. Compared with women who did not drink alco-
hol, the multivariate relative risk (RR) of psoriasis was 1.59 (95% CI 1.02-2.49) for alcohol con-
sumption ≥ 30 g/week. When examined by type of alcoholic beverage, non-light beer consump-
tion showed the only independent association with the risk of psoriasis (multivariate RR for ≥5
drinks/wk 1.83; 95% CI 1.16-2.86); Light beer, red wine, white wine, and liquor consumption were
not significantly associated with psoriasis risk. In conclusion, non-light beer intake is associated
with an increased risk of psoriasis in this population of US women. Light beer, wine, and liquor
did not increase risk for psoriasis.
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Associated conditions in psoriasis and inflammatory bowel disease
AM Binus,1 AA Qamar,2 EA Mody,2 LS Winterfield1 and AA Qureshi1 1 Dermatology, Brigham
and Women’s Hospital, Boston, MA and 2 Medicine, Brigham and Women’s Hospital,
Boston, MA
Psoriasis and Inflammatory Bowel Diseases (IBD) have previously been linked with several comor-
bidities. We determined retrospectively (January 1, 2000 – June 30, 2008) associated conditions
in a set of clearly defined patients who were diagnosed with both psoriasis and IBD. Patient data
and controls were taken from teaching hospitals in Boston, MA. After going through the medical
records of interest and excluding all patients that did not meet our selection criteria for a clear diag-
nosis of psoriasis and ulcerative colitis or Crohn’s disease, we had a total of 146 patients. There
were 60 (41.1%) individuals diagnosed with seronegative arthritis, 35 (24%) with type 2 diabetes
and four (2.7%) with type 1 diabetes, ten (6.8%) with autoimmune thyroiditis, nine (6.2%) with
hepatitis, nine (6.2%) with malignant melanoma, and seven (4.8%) with lymphoma. The average
CRP and ESR at the last visits in our clinics were significantly elevated. This study has demonstrated
a high association of particular comorbidities in individuals with both psoriasis and IBD. The con-
stant state of inflammation, common genetic predispositions for specific patterns in the immune
response as well as immunomodulatory anti-inflammatory drugs may play an important role in
the evolution of associated conditions.
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Risk of cardiovascular mortality in patients with severe psoriasis
RS Azfar,1,2 AL Neimann,3 DB Shin,1 AB Troxel2 and JM Gelfand1,2 1 Dermatology, University of
Pennsylvania, Philadelphia, PA, 2 Center for Clinical Epidemiology and Biostatistics,
University of Pennsylvania, Philadelphia, PA and 3 Dermatology, Albert Einstein College of
Medicine, New York, NY
Psoriasis is a common TH-1/17 mediated skin disease that is associated with an increased risk of
cardiovascular (CV) disease. We conducted a cohort study using the General Practice Research
Database to determine if patients with severe psoriasis have an increased risk of cardiovascular
mortality. Severe psoriasis was defined as patients who received a psoriasis diagnostic code and
systemic therapy consistent with severe psoriasis (N=3603). Up to 4 controls without psoriasis were
selected from the same practices and start dates for each psoriasis patient (N=14330). The elec-
tronic medical records of all patients who died (N=1236), stripped of entries that could indicate
psoriasis, were independently reviewed by up to three physicians to determine the cause of death.
Cardiovascular death was defined as diagnoses consistent with stroke, cardiovascular disease, heart
disease, arrhythmia, or thrombus entered on or very close to the entry of death. Agreement on cause
of death among the reviewers was excellent (96%). Cox proportional hazards models adjusted for
age, sex, smoking, BMI, diabetes, hypertension, hyperlipidemia, history of MI, stroke or TIA revealed
that patients with severe psoriasis had an increased risk of CV mortality (HR 1.55; 95% CI 1.24,
1.94) independent of traditional CV risk factors. The relative risk of CV death was modified by
patient age. For example, the HRs comparing CV mortality for severe psoriasis vs controls were
2.65 (1.42, 4.95) at age 40 and 1.90 (1.39, 2.58) at age 60. The adjusted excess risk of CV mor-
tality in a 40- and 60-year-old psoriasis patient was 5.78 deaths/10,000 person-years and 5.89
deaths/1000 person-years respectively. These results suggest patients with severe psoriasis have an
increased risk of cardiovascular mortality that is independent of traditional CV risk factors.
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Validation of psoriasis self-reports and phenotypes in the nurses health study 2
PL Dominguez,1,2 HK Choi,1,4 G Curhan1,3 and AA Qureshi1,2 1 Medicine, Channing
Laboratory, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA, 2
Dermatology, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA, 3
Epidemiology, Harvard School of Public Health, Boston, MA and 4 Rheumatology, Boston
University, Boston, MA
There is a need to validate psoriasis self-reports and to collect information on psoriasis phenotypes
in epidemiological studies. To meet this need, we have developed the Psoriasis Screening Tool
(PST). In this study we confirmed psoriasis self-reports using the PST in the Nurses’ Health Study 2
(NHS 2), an ongoing cohort study of over 116,000 women. The PST has eight questions that require
a ‘yes’ or ‘no’ response and a scoring algorithm that assigns a diagnosis of psoriasis (sensitivity
98% and specificity of 95%). Color images of skin, nail, and scalp changes were included. The
responses from returned PST questionnaires form the basis of the following analysis. After IRB
approval, we mailed the PST to 1886 NHS 2 participants who had self-reported a physician-diag-
nosis of psoriasis in 2005. A total of 1538 (82%) women responded with a completed PST. Of these,
1425 (93%) were confirmed to have psoriasis according to the PST scoring algorithm. Of the con-
firmed cases of psoriasis, 253 (18%) reported plaque-type psoriasis alone, 49 (3.4%) reported nail
changes alone, 208 (15%) reported scalp psoriasis alone, 30 (2%) reported inverse psoriasis alone,
and 686 (48%) reported having a combination of these phenotypes. Of the participants reporting
a combination of phenotypes, 66 (5%) reported having nail and plaque type psoriasis. No pheno-
type was reported in 199 of (14%) confirmed cases. We found that psoriasis self-reports had >90%
validity in this study of US women. Additionally, the PST is a valid method to confirm psoriasis in
a remote population. Investigators may choose to use the PST in epidemiological studies to also
capture data on psoriasis phenotypes.
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Association between serum vitamin D3 levels and non-melanoma skin cancer
JY Tang,1,2,3 N Parimi,4 A Wu,2,3 J Boscardin,2 M Chren,2 SR Cummings,2,4 EH Epstein3 and
DC Bauer2,4 1 Stanford University Medical Center, Stanford, CA, 2 University of California,
San Francisco, San Francisco, CA, 3 Children’s Hospital Oakland Research Institute, Oakland,
CA and 4 California Pacific Medical Center Research Institute, San Francisco, CA
Basal cell carcinoma (BCC) risk is correlated with UV exposure. BCC risk correlates better with
intermittent UV than with cumulative lifetime exposure. The pivotal molecular abnormality in BCCs
is inappropriate activation of the hedgehog (HH) signaling pathway. In vitro and murine experi-
ments have shown that vitamin D3 inhibits BCCs by decreasing the HH pathway. To determine the
relationship between serum 25(OH) vitamin D3 and non-melanoma skin cancer (NMSC) we per-
formed a cross-sectional study from the MrOS cohort. The Osteoporotic Fractures in Men Study
(MrOS) is a prospective, observational study of senior men that recruited subjects from six clinical
sites in 2000-02. History NMSC was determined by subject self-report. In men older than 65 years
of age, the majority of skin cancers are the BCC type (5:1 ratio). UV exposure was controlled by
clinic site and self report of walking. 25(OH)D levels were measured from serum collected at
baseline from a random sample (N=1608), and adjusted for clinic site, subject age, and season of
blood draw. Control and skin cancer cases were similar in age (73 ± 5), self-report of health sta-
tus, physical activity, and mean 25(OH)D levels (23 ± 8 ng/ml). The average age of skin cancer
development in cases was 61±12. Among the 126 white men with a history of NMSC, there was
a trend of decreasing skin cancer risk with increasing 25(OH)D. In categorical analysis using the
lowest quintile (16 ng/ml) as the reference, the odds ratio for each subsequent quintile were 1.2,
0.93, 0.86 and 0.55 (P=0.04 for trend). When the analysis was adjusted for walking and oral vita-
min D intake, each higher 25(OH)D quintile was associated with a reduced skin cancer risk by
0.87 (95%CI: 0.75-1.0, P=0.05). Our results suggest that high circulating levels of vitamin D may
be associated with a decreased prevalence of skin cancer.
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Length-of-wait: A novel measure for access to ambulatory care in dermatology
P Agarwal,1 T Lugdon,2 L Wang,1,2 M Rubenstein,1,2 H Haynes,1,2 T Kupper1,2 and A Qureshi1,2 1
Harvard Medical School, Boston, MA and 2 Brigham & Women’s Hospital, Boston, MA
Previous surveys have documented a dermatologic workforce shortage in the United States, result-
ing in prolonged wait times for new patients. In this study, we describe a novel length-of-wait (LOW)
metric to measure access to medical dermatology care at a major academic medical center. We
analyze risk factors affecting LOW such as time-of-year, number of new patients, clinical space
availability, number of MDs, and number of clinic sessions. LOW data, measured as the number
of days a new patient must wait for an appointment, was collected for 21,481 patients between
March 2003 and September 2008. Data regarding physician practice patterns and clinical-space
utilization were also collected over the same period. The practice employed 12-16 MDs, and the
number of half-day clinical sessions ranged from 26.5-50.5 sessions/week (mean=37.5, median=36).
Weekly clinical-space utilization ranged from 53%-101% (mean=75%, median=72%). We iden-
tified risk factors affecting LOW using univariate and multivariate analyses, and incorporated
these factors into a regression model. The mean and median LOW for new patients was 64 and 55
days respectively. Significant predictors of LOW (p<0.05) were the number of new patients/quar-
ter, the number of half-day clinical sessions, and space utilization; the number of MDs and time-
of-year were not significant (p>0.05). In multivariate analyses, number of new patients/quarter
and number of half-day clinical sessions predicted 74.5% of the variability in mean LOW/quarter.
As expected, space utilization was collinear with the number of half-day clinical sessions/week.
Our results suggest that the LOW for a medical dermatologic appointment can be reduced. Our
study highlights the importance of workforce management and suggests that reprioritization of med-
ical and non-medical dermatologic work can mitigate the impacts of the documented workforce
shortage. Our study also highlights the importance of clinical space management: as more der-
matologists are hired and trained, clinical space must also grow.
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Resistance to microbial penetration by acellular dermal matrices
M Alam,1 E Fahrenbach,4 JY Kim2 and C Qi3 1 Dermatology, Northwestern University, Chicago,
IL, 2 Plastic Surgery, Northwestern University, Chicago, IL, 3 Microbiology, Northwestern
University, Chicago, IL and 4 Loyola University, Maywood, IL
Acellular dermal matrices are skin and subcutaneous substitutes that are used for skin repair and
surgical reconstruction. Compared to autologous grafts, acellular materials do not require creation
of a donor site defect and enable the coverage of large defects. Since such acellular dermal sub-
stitutes may be implanted permanently, their susceptibility to infection is a relevant feature. The
purpose of this study is to investigate how commercially available dermal matrices compare to
one another in their ability to act as barriers to microbial penetration in vitro. A pilot study was
performed to determine the appropriate microbial concentrations for an in vitro comparison of the
ability to serve as a barrier to microbial penetration of 4 commercially available dermal matrices:
Alloderm (LifeCell), FelxHD (MTF), Neoform (Mentor Corp), and Strattice (LifeCell). Twenty 1 x 2
cm pieces of each dermal substitute were placed on top of blood agar culture medium, yielding
80 plates. As our pilot study identified 106 CFU/ml as the appropriate bacterial dose, four solu-
tions of this concentration were created for Staplylococcus aureus, Pseudomonas aeruginosa, Strep-
tococcus pyogenes, Candida albicans. For each of the 4 acellular dermal materials, 5 plates were
inoculated with 1 microliter of 106 CFU/ml each for each of the 4 bacterial solutions; thus 20 plates
were prepared for each acellular dermal material. Alloderm acted as the best barrier to bacterial
penetration. S. aureus and S. pyogenes were unable to penetrate Alloderm, and P. aeruginosa pen-
etrated two out of five pieces of Alloderm. Flex HD followed Alloderm, functioning as a good bar-
rier to penetration by S. aureus and S. pyogenes. However Flex HD was not able to prevent pen-
etration of P. aeruginosa. There appear to be differences among commercially available acellular
dermal matrices regarding their microbial barrier function.
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Treatment of rare and uncommon nonmelanoma tumors by Mohs surgery: A meta-analysis
of 1232 cases
M Alam,1,2 C Wickman,1 D Danahey,2 NA Kim,1 S Yoo1,2 and A Rademaker3 1 Dermatology,
Northwestern University, Chicago, IL, 2 Otolaryngology, Northwestern University, Chicago, IL
and 3 Preventive Medicine, Northwestern University, Chicago, IL
The purpose of this study was to characterize the utility of Mohs surgery in the treatment of uncom-
mon and rare nonmelanoma skin cancers of various types. Meta-analysis of case reports and case
series from MEDline, 1950-2007, and older articles obtained from bibliographic searches. Uniform
fields, including demographic information (patient age, sex), tumor characteristics (anatomic loca-
tion, apparent clinical surface area), and treatment-specific variables (treatment type, post-opera-
tive defect size, duration of post-treatment follow-up, recurrence, death from disease) were extracted
from published reports. Means and variation of descriptive variables were recorded. Association
of demographic and tumor characteristics with likelihood of recurrence was assessed. Data was
extracted for 1232 tumors, including (in parentheses after each tumor type: median preoperative
size in sq. cm.; ratio of post-operative size to preoperative size, median; % recurring during fol-
low-up period): atypical fibroxanthoma (1.8, 2.8, 13.3); angiosarcoma (5.8, 3.6, 12.5); dermatofi-
brosarcoma protuberans (7.1, 9.7, 1.5); extramammary Paget’s disease (36.7, 2.1, 20.3); eccrine
porocarcinoma (1.1, 2.4, 0.0); granular cell tumor (1.2, 1.4, 0.0); lymphoepithelioma-like carci-
noma of the skin (2.1, 9.4, 0.0); leiomyosarcoma (7.6, 5.6, 14.3); microcystic adnexal carcinoma
(0.5, 3.2, 21.1); sebaceous carcinoma (0.6, 4.7, 11.1); trichilemmal carcinoma (1.0, 4.0, 16.7).
Overall, mean follow-up in months was 39 months, by which point 3.6% were alive with disease
and 1.4% were dead with disease. However, for Merkel cell carcinoma, after just 27 months of fol-
low up, 11.3% were alive with disease and 14.4% were dead of disease. On average, for tumors
studied preoperative tumor size was 3.6 sq. cm.; postoperative tumor size was measured by the
final Mohs defect was 4.4 times larger in area. Mean recurrence rate was 9.4% during 3.5 years of
follow-up.
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Treatment of primary mucinous carcinoma of the skin: Meta-analysis of 189 cases
M Alam,1 R Trela,1 N Kim,1 S Yoo1 and A Rademaker2 1 Dermatology, Northwestern University,
Chicago, IL and 2 Preventive, Northwestern University, Chicago, IL
The purpose of this study was to estimate the likelihood of recurrence and matastasis after treat-
ment of primary mucinous carcinoma by various methods. A secondary objective was to provide
demographic data regarding incident cases. Meta-analysis of case reports and case series from
MEDline, 1950-2008. Uniform fields, including demographic information (patient age, sex, race),
tumor characteristics (anatomic location, apparent clinical surface area), and treatment-specific
variables (months prior to treatment when lesion was first noticed, treatment type, duration of
post-treatment follow-up, recurrence, metastasis) were extracted from published reports. Means
and variation of descriptive variables were recorded. Association of demographic and tumor char-
acteristics with likelihood of recurrence and metastasis was assessed. The average patient (mean)
was 64 years old, female (51.5%) and white (53.2%; 22.1% black; 23.4% Asian). Anatomic site
was associated with risk of metastasis (p=0.002), with 40% of axillary lesions, 18% of trunk and
extremity lesions, and fewer than 5% of lesions at all other locations developing metastases. The
association between treatment type and risk of recurrence approached significance (p=0.06) with
recurrence after Mohs or excision (3.4%) being nominally much less than recurrence after non-
surgical modalities (33%). Similarly, the association between lesion size and risk of metastasis was
near-significant (p=0.08), with lesions that did not metastasize having a mean surface area of 3.88
sq. cm., and lesions that did of 18.87 sq. cm. Primary mucinous carcinoma is amenable to surgi-
cal resection, which provides a good outcome, with approximately 20% risk of recurrence and
5% risk of metastasis during 3 years of follow-up. Axillary tumors account for a small proportion
(5.3%) but are much more liable (40%) to metastasize than tumors at other locations.
383
Co-morbidity of psychiatric conditions skin disease in the United States: A population-based
cross-sectional analysis of the 2007 National Health Interview Survey
N Smith and F Tausk Dermatology, University of Rochester, Rochester, NY
Our purpose was toestimate the prevalence of psychiatric conditions among adults with skin dis-
ease. A cross-sectional analysis of the 2007 National Health Interview Survey (NHIS) was con-
ducted. The NHIS uses a multistage clustered sample design to produce nationally representative
estimates. All estimates were weighted using the sample adult record weights which were modi-
fied by adjusting them to 2000 Census control totals for sex, age and race. Logistic regression
models were used to obtain odds ratios for associations between psychiatric conditions and skin
disease while controlling for various demographic characteristics (age, race, sex). Estimates were
compared using two-tailed statistical tests at the 0.05 level or the binomial Wald 95% confidence
interval. Data were analyzed using STATA 9.0 (College Station, Tex). The survey response rate was
87.1% yielding 23,393 observations (adults). The prevalence of depression/anxiety in the general
population was 15.3% (CI 14.7-15.9) vs. 29.7% (CI 27.9- 31.5) among those with skin disease.
The prevalence of psychosis in the general population was 5.4% (CI 5-5.8) vs. 11.9% (CI 10.6-
13.2) among those with skin disease. When adjusting for age, sex and race the odds ratio for depres-
sion/anxiety among those with skin disease was 2.8 (CI 2.5- 3.2); the odds ratio for psychosis was
2.9 (CI 2.5-3.4). In contrast, the odds ratio for depression/anxiety among adults with skin cancer
(melanoma and non-melanoma combined) was .76. Additionally, the odds ratios for depres-
sion/anxiety among those with myocardial infarction, any type of cancer, and hypertension were
1.2, 1.5 and 1.5 respectively. In conclusion, the prevalence of depression or anxiety among adults
with skin disease is approximately 30%. The prevalence psychosis among adults with skin disease
was approximately 12%. In contrast, the odds ratios for depression/anxiety and psychosis for adults
with myocardial infarction, hypertension and cancer (including skin cancer) are much lower.
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Tumor recurrence after treatment of keratinocyte carcinoma
MM Chren,1,2 JS Torres,2 SE Stuart,2 RJ Labrador,2 D Bertenthal2 and WJ Boscardin1,2 1 University
of California at San Francisco, San Francisco, CA and 2 San Francisco Veterans Affairs Medical
Center, San Francisco, CA
The most common treatments for primary basal cell carcinoma and squamous cell carcinoma of
the skin (keratinocyte carcinoma, KC) are tumor destruction by electrodessication and curettage
(ED&C), excision, and Mohs surgery. Because few data exist from prospective studies, our goal
was to determine tumor recurrence long-term after treatment of primary KC. This prospective cohort
study followed all patients with primary KC treated with ED&C, excision, or Mohs surgery in a Vet-
erans Affairs hospital in 1999-2000. Data were collected by medical record review. A tumor was
defined as recurrent if it was described by a dermatologic clinician in the medical record as recur-
rent or previously treated. Survival analysis techniques were used to compare tumor recurrence by
treatment type and to adjust for likely risk factors for recurrence. The cohort consisted of 495 patients
with 616 primary KCs in 1999 and 2000. Follow-up data were available for 480 patients with 599
tumors (97%), at a median of 6.6 years later [interquartile range (IQR) 4.2 years]. The mean age
was 71 years; 97% were men. Over the course of the study, 22 (3.6%) tumors recurred; the median
time of detection of recurrence was 4.2 years after treatment (IQR 3.4 years). With respect to the
treatment types, 2 of the recurrences (1.6%) were after ED&C, 15 (4.7%) after excision, and 5 (3.0%)
after Mohs surgery. The recurrence rate among treatments was not significantly different (P=0.29).
No significant effect on recurrence rate differences was seen from multiple risk factors in patients
or tumors, including age, body location or size of tumor, or basal cell vs. squamous cell histology.
We conclude that recurrence of primary keratinocyte carcinoma long-term after treatment occurred
in 3.6% of tumors, and was not significantly different after ED&C, excision, or Mohs surgery.
These results must be validated in larger samples from different practice sites before they can be
used to affect clinical care.
S64 Journal of Investigative Dermatology (2009), Volume 129
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Vitamin D Levels and photoprotective behavior in patients with NMSC
N Hill,1 L Delong,2 V Tangpricha,2 B Gammon,2 M Kumari,2 E Veledar2 and SC Chen2 1 Boston
University School of Medicine, Boston, MA and 2 Dermatology, Emory University School of
Medicine, Atlanta, GA
Despite the evidence of health benefits of sun avoidance much controversy surrounds the role
that sun avoidance may play in vitamin D (vitD) insufficiency. We explored the levels of vitD and
the relationship between photoprotective behavior and vitD levels in individuals diagnosed with
non-melanoma skin cancer (NMSC), since they would be motivated to protect their skin. From the
Emory Clinic, 37 patients with past NMSC were recruited and queried for demographics, skin
cancer history, sun protection habits and dietary vitD. Sun protection was captured with the
Glanz Sun Protection Habits (SPH) instrument. We dichotomized the scores using the median (2.5)
of our population to group them into NonAdherent (≤2.5) and Adherent (>2.5). Serum 25-hydrox-
yvitamin D was determined by ELISA and insufficiency was defined as a vitD< 32ng/ml. Of the 37
patients, 51% were male, 100% were Caucasian, 92% had at least completed college. VitD lev-
els ranged from 12.6-99.0 ng/ml with a mean of 32.8ng/ml (+/-15.2); prevalence of vitD insuffi-
ciency was 54%. The NonAdherent group reported a mean of 3.78 hrs/wk (+/-2.87) outside and
had a mean vitD of 30ng/ml (+/-8.9) compared to 2.89 (+/-1.6) hrs/wk and 34ng/ml (+/-18.7) in
the Adherent group. Univariate regression showed no significant correlation between vitD levels
with SPH score (p=0.67) or with hrs/wk outside (p=0.5). In multivariate regression, with SPH score,
age, gender, education, enteral vitD, and skin cancer type, no variable significantly predicted vitD
levels. Although majority of the patients were borderline sufficient, we were unable to find a sig-
nificant relationship between the vitD levels and sun protection adherence or time spent outside.
Limits in our study included a small sample size. In our NMSC patient cohort, the majority had
borderline vitD levels which might not be secondary to sun protection but from other reasons that
require further investigation.
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Three case reports of metastatic basal cell carcinoma
AA Bajoghli,1,3 O Olowoyeye,3 N Dash,2 N Sadeghi3 and V Giannelli4 1 Dermatology, INOVA
Fairfax Hospital, Falls Church, VA, 2 Otolaryngology, Mary Washington Hospital,
Fredericksburg, VA, 3 George Washington University School of Medicine, Washington, DC
and 4 Dermatology, Washington Hospital Center, Washington, DC
We present three cases of metastatic basal cell carcinoma (MBCC), all of which have been con-
firmed by final pathology reports. Case No. 1: A 52-year-old female presented with a basal cell
carcinoma (BCC) of the right lateral cheek with perineural invasion of the marginal mandibular
branch of the facial nerve. The tumor was removed, utilizing Mohs micrographic surgery fresh tis-
sue technique, requiring two stages. During the second stage, tumor invasion of the marginal
mandibular nerve was noted. The patient then underwent a deeper resection of the gross disease
with facial nerve preservation. She later presented with multiple nodules on the back. PET-CT
revealed innumerable foci of skeletal and soft tissue metastases of BCC with no pulmonary or major
organ involvement. Case No. 2: A 72-year-old male presented with a BCC of the left antecubital
fossa. The patient had a ten year history of multiple incidences of several BCC’s excised from the
left chest and a recurrent infiltrative BCC of the right nasal wall. None of his BCC’s were over 2
cm wide. During an evaluation of congestive heart failure, a solitary nodule was discovered in the
left posterior lung. A new pulmonary nodule in the left upper lobe was discovered the following
year. Computed tomography-guided lung biopsy of the tumor showed similar histological features
to the first pulmonary nodule and the infiltrative BCC excised from the right nasal wall ten years
prior. Case No. 3: A 44-year-old male presented with BCC of the forehead. The lesion had par-
tially eroded through the outer table of the frontal bone. During a follow-up evaluation, a CT scan
of the neck and parotids revealed three nodules in the right parotid gland and one in the left
gland, all of which were confirmed as MBCC by fine needle aspiration cytology. Although, the
overall incidence of MBCC is rare, in cases with perineural invasion or involvement of bone, a
metastatic work up is warranted.
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Psoriasis is associated with disruption in religious affiliation and marital status during early
adulthood
EM Seidler and AB Kimball Clinical Unit for Research Trials in Skin, Massachusetts General
Hospital, Boston, MA
Cross-sectional research has demonstrated that many psoriasis patients have a quality-of-life decre-
ment which is greater than the general population, regardless of the severity of the psoriasis. Patients
may learn to cope with their chronic skin disease over time, but in learning to cope, they may make
certain decisions which have irreversible effects on their lives. We sought to determine the degree
to which patients use social connection and support networks as potential coping mechanisms by
determining the rates of religious affiliation and non-affiliation in psoriasis patients compared to
the general population by age cohort. Additionally, we used marital status in these age cohorts as
a surrogate measure of social connectivity. We examined rates of religious non-affiliation and
marital status in the Partners HealthCare system, consisting of 3,509,083 patients aged 18 and
older at Massachusetts General and Brigham and Women’s Hospitals. We compared rates in three-
year age cohorts from 20 to 49 years old. The rate of religious non-affiliation in psoriasis patients
was significantly higher in the 29-31 age cohort (p < 0.001) than in the general population. Fur-
ther, the divorce rates (divorced / total) in psoriasis patients were significantly higher in the 29-31
(p < 0.05) and 32-34 (p < 0.001) age cohorts than corresponding divorce rates in the general pop-
ulation. And, divorce to married ratios in psoriasis patients for the 29-31 and 32-34 age cohorts
were almost double the ratios in the general population in the corresponding age cohorts. In all
other age cohorts, religious affiliation and marital status in psoriasis patients were similar to the
general population. We conclude that during early adult years, ages 29-34, higher religious non-
affiliation and divorce rates may demonstrate a degree of disruption or absence of social connec-
tivity. Although social connections may be reclaimed in later years, effects of disconnection, such
as divorce, from this time period may have long-lasting effects on the overall quality of patients’
lives.
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Topical tretinoin and prevention of keratinocyte carcinoma
MA Weinstock,1,2 SF Bingham,3 R Hall,3 D Eilers,3 R Kirsner,3 M Naylor,3 J Kalivas,3 G Cole,3
K Marcolivio,1 JJ DiGiovanna2 and JE Vertrees3 1 Dermatology, V A Medical Center, Providence,
RI, 2 Dermatology and Community Health, Brown University, Providence, RI and 3 V A
Medical Center, various, AE
Systemic retinoids such as acetretin and isotretinoin have been demonstrated to reduce the inci-
dence of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) in high risk populations,
and hence topical retinoids are sometimes used for this purpose. We sought to determine whether
the topical retinoid tretinoin at the highest commercially available concentration, and dosed twice
daily if tolerated, would indeed be successful at reducing BCC and SCC risk. We recruited 1131
veterans from 6 V A Medical Centers who were at very high risk of keratinocyte carcinoma (KC,
i.e. BCC or SCC) by virtue of having at least 2 KCs in the prior 5 years. They were randomized to
apply tretinoin 0.1% or a vehicle control cream to their face and ears; no other treatments were
applied to those areas. All participants were followed with semiannual dermatologic examinations
for the occurrence of BCC and SCC over 1.5 to 5.5 years. The primary outcomes were time to BCC
and to SCC, and secondary outcomes included time to BCC and to SCC at least 2 years after ran-
domization. All diagnoses were established by central dermatopathology review. The log-rank test
(two-tailed) was the primary statistical test. BCCs occurred in 493 (44%), including 237 (42%) of
the tretinoin group and 256 (45%) of the controls (p=.3). With the two year lag, these proportions
were 25% and 28% (p=.2). SCCs occurred in 256 participants (23%), including 121 (21%) in the
tretinoin group and 135 (24%) in controls (p=.5). These proportions were 12% and 13% (p=.8)
after the two-year lag. We conclude that topical tretinoin at high doses over long periods of time
was ineffective for preventing keratinocyte carcinomas in this high risk population, and that simi-
lar substances may have very different clinical effects when administered topically as opposed to
orally.
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Health care delivery system effect on disparities in melanoma outcomes among medicare-
aged hispanic patients
P Rouhani,1,2 K Arheart2,3 and RS Kirsner1,2,3 1 Dermatology & Cutaneous Surgery, Miller
School of Medicine, University of Miami, Miami, FL, 2 Epidemiology & Public Health, Miller
School of Medicine, University of Miami, Miami, FL and 3 Sylvester Comprehensive Cancer
Center, Miller School of Medicine, University of Miami, Miami, FL
The health care delivery system and race/ethnicity has been associated with differences in the stage
at diagnosis and in survival. Our objective was to evaluate the effect of Hispanic ethnicity and
health care delivery systems, fee-for-service (FFS) and health maintenance organizations (HMO),
in the stage at diagnosis and survival for melanoma of Medicare aged patients in US (1991-2005).
Using SEER-Medicare data to evaluate socio-demographic data, stage at diagnosis, and median
survival for melanoma in two subsets of analyses: (1) HMO vs. FFS groups by race/ethnicity and
(2) non-Hispanic white (NHW) vs. Hispanic patients by health care delivery plans. Our results
included a population of 40,633 patients (74.5% FFS; 98.3% NHW). Among NHW, we found an
earlier stage of diagnosis for the HMO group compared with the FFS group. Among Hispanic
patients, HMO patients were significantly less likely than FFS patients to receive a diagnosis at a
regional (later) stage versus earlier stages (OR=0.50; 95% CI=0.31-0.81). Among HMO patients,
there were no statistically significant differences with regard to stage at diagnosis or survival by
race-ethnicity. Among FFS patients, Hispanic patients were 2.07 times significantly more likely to
receive a diagnosis at distant stage versus earlier stages (OR=2.07; 95% CI=1.36-3.16) relative to
NHW patients. Similarly, Hispanic patients were 2.31 times significantly more likely (OR=2.31;
95% CI=1.75-3.03) to receive a diagnosis at regional stage versus earlier stages then their NHW
counterparts. Despite later stage of diagnosis, median survival time for all stages was slightly longer
among FFS than for HMO patients; 45.0 and 43.0 months (P<0.01). In conclusion, differences
exist in stage at diagnosis and survival between patients in HMOs compared with those in FFS
health care plans as well as by race/ethnicity.
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Pemphigus vulgaris differs among males and females
A Sachdev, DG Bhanusali, L Gill, J Shah, K Seiffert-Sinha and AA Sinha Center for Investigative
Dermatology, Dermatology and Cutaneous Sciences, Michigan State University, East Lansing,
MI
A female predominance in many autoimmune diseases, including Pemphigus vulgaris (PV), is well
established. The genetic and physiological basis for this gender bias is not well understood. More-
over, it is unclear whether disease profiles differ between males and females in terms of defined
clinical parameters. To address this issue, we performed a comprehensive analysis of clinical dis-
ease among primarily Caucasian and Ashkenazi Jewish PV patients (n=123) and matched controls
(n=105). We compared multiple constant (age of disease onset, HLA-DR, -DQ, and –E type, fam-
ily history of autoimmunity) and variable (lesion morphology, anti-desmoglein (Dsg) 1 and 3 autoan-
tibody levels) clinical parameters between male and female PV patients and healthy controls. Sta-
tistical estimates were determined via Cochran Mantel Hanzel Chi squares and logistical regression.
We report that patients diagnosed under the age of 30 (p=0.0392) and 40 (p=0.0829) tended to be
male. Males diagnosed under the age of 40 were more likely to have a family history of autoim-
mune disease (p=0.0455), present with mucocutaneous lesions (p=0.0343), and test positive for
anti-Dsg 3 autoantibodies (p=0.0862) when compared to matched female PV patients. Variable
and gender specific disease presentation supports a multifactorial description of autoimmune sus-
ceptibility.
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Accuracy of teledermatology for pigmented neoplasms
E Warshaw,1,2 F Lederle,1,2 J Grill,1 A Gravely,1 A Bangerter,1 L Fortier,1 K Bohjanen,2 K Chen,1
P Lee,2 H Rabinovitz,3 R Johr,3 V Kaye,2 S Bowers,4 R Wenner,2 S Askari,5 D Kedrowski1 and
D Nelson1,2 1 VAMC, Minneapolis, MN, 2 University of MN, Minneapolis, MN, 3 University
of Miami, Miami, FL, 4 Southern Illinois University, Springfield, IL and 5 St Louis University,
St. Louis, MO
Our objective was to compare accuracy of store and forward teledermatology for pigmented neo-
plasms with standard clinic dermatology. We conducted a repeated-measures equivalence trial
involving veterans with pigmented skin neoplasms. Each lesion was evaluated by an clinic der-
matologist and a teledermatologist; both generated a primary diagnosis, up to two differential
diagnoses, and management plan. The primary outcome was aggregated diagnostic accuracy
(percent correct matches of any chosen diagnosis with histopathology). We enrolled 542 patients,
most were male (96%) and Caucasian (97%). The aggregated diagnostic accuracy rates for teled-
ermatology (macro images, polarized light dermatscopy, and contact immersion dermatoscopy)
were not equivalent (95% CI for difference within +/-10%) and were inferior (95% CI lower bound
<10%) to clinic dermatology. Results were similar for benign and malignant subgroups. However,
teledermatology management plan accuracy rates (all image types: all lesions, and benign lesions)
were superior and/or equivalent to clinic dermatology. For the subgroup of malignant lesions, the
rate of appropriate management was significantly worse for teledermatology than clinic derma-
tology (all image types). 4-9 melanomas were mismanaged via teledermatology. Our limitations
included a non-diverse study population and relatively small number of melanomas. In conclu-
sion, the aggregated diagnostic accuracy of teledermatology was inferior to clinic dermatology for
all lesions (and benign or malignant subgroups). While overall teledermatology management was
better than clinic dermatology, this was not the case for malignant lesions. Especially concerning
was that nine (22%) melanomas were mismanaged via teledermatology.
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Accutane and Botox video information on YouTube
KK Vance,1 W Howe1 and RP Dellavalle1,2 1 Dermatology, University of Colorado and Health
Sciences Center, Aurora, CO and 2 Dermatology, Department of Veterans Affairs, Denver, CO
More than 120 million people visit social media websites, such as MySpace, Facebook, and YouTube.
More than 60% of young adults visit these sites frequently, and 34% use social media websites as
a source of health information. For topics such as human papilloma virus vaccination and tobacco
cessation, YouTube has influenced health care decisions and cheaply and widely spread public
health messages. To sample dermatologic information currently on YouTube, we performed com-
puterized searches for videos concerning two popular dermatologic medications: “Accutane” and
“Botox”. From the website, www.youtube.com, 188 videos were identified using the search word
“Accutane” and 2750 videos were identified using the search word “Botox.” While Accutane videos
were most commonly positive patient testimonials, Botox videos commonly depicted health care
providers performing Botox injections on a patient. The top 3 Accutane videos (determined by a
YouTube proprietary algorithm for relevance) had each been viewed more than 11,000 times since
being posted 4 to 24 months prior and generated up to 249 comments from viewers. The top 3
Botox videos had each been viewed more than 24,000 times since being posted 15 to 21 months
prior and generated up to 70 comments from viewers. One of the top Botox videos contained a
patient using adult language in response to the pain of injections. While many different opinions
were presented in these videos and related commentary, input from professional dermatology groups
such as the SID and AAD were absent. These finding spurred us to obtain funding from the Sulzburger
Institute of Dermatologic Education to initiate an open, public video contest to promote YouTube
videos delivering skin cancer prevention messages. Furthermore we urge professional dermatol-
ogy organizations to consider their role in promoting reliable dermatology information in this new,
popular health information arena.
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Cardiovascular risk factors and stroke are increased in psoriasis patients compared to the
US population
I Grozdev, LY Cao, DC Babineau, EF Kern, TS McCormick, KD Cooper and NJ Korman
Murdough Family Center for Psoriasis, University Hospitals Case Medical Center and Case
Western Reserve Univ, Cleveland, OH
Recent studies show that psoriasis is a systemic disease however, little integrated psoriasis data-
base information is available from US populations. We gathered comprehensive patient data with
an emphasis on cardiovascular disease (CVD) and stroke from 170 psoriasis patients in the Mur-
dough Family Center for Psoriasis (MFCP) and compared our results to the 1999-2004 National
Health and Nutrition Examination Survey (NHANES). We compared patients aged 35 -74 in our
MFCP database to the same age group in the NHANES database, and evaluated the prevalence of
obesity, current smoking and elevated cholesterol. We found that 83% of psoriasis patients in the
MFCP database were overweight or obese {body mass index (BMI)>25}, as compared to 66% of
NHANES controls. Similarly, relative to NHANES controls, MFCP psoriasis patients had higher
prevalence of hypercholesterolemia (41% vs 16%), and smoking (27% vs 21%). Despite the only
modest difference in smoking prevalence between psoriasis patients and controls, we found a
markedly increased prevalence of stroke in psoriasis patients. Stroke prevalence among each group
was higher in psoriasis than in controls: 35-44 year old males (MFCP:17%; NHANES:1%); 45-54
year old males (MFCP:13%; NHANES:1%); 35-44 year old females (MFCP:23%; NHANES:1%);
45-54 year old females (MFCP:31%; NHANES:2%). Remarkably, we found that 7/31 (23%) psori-
asis patients aged 18-34 had a history of stroke and 6/7 of these had a BMI >25. Although NHANES
does not report stroke history in this age group, NHANES data shows increasing rates of stroke
with age and the rate of stroke in the 18-34 age group is likely to be < 1%. Our data confirm and
extend previous findings that psoriasis patients have risk factors for CVD and suggest that younger
psoriasis patients have a higher incidence of stroke. Our findings suggest that stroke education,
detection, and prevention measures may need to be instituted for young and middle-aged patients
with psoriasis.
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Decreased cutaneous resonance running time in cured leprosy subjects
S Song,1 PM Elias,2 Q Hou,3 C Lv,1 Y Shi,1 KR Feingold2 and M Man2 1 Dermatology, UCSF, San
Francisco, CA, 2 Dermatology, Dalian Skin Disease Hospital, Dalian, China and 3 Center for
Disease Prevention and Control, Zhangjiajie, China
Leprosy involves both the skin and peripheral neural tissue. In addition to neuropathy, cutaneous
abnormalities, such as decreased stratum corneum (SC) hydration, elevated skin surface pH, hyper-
pigmentation, and ulcerations, remain significant problems in “cured” leprosy. Moreover, alterna-
tions in dermis have been reported in leprosy. The purpose of present study was to determine
whether there is change in cutaneous resonance running time (RRT), a parameter that is influence
by both hydration and collagen properties, in cured leprosy subjects. Reviscometer was used to
measure the cutaneous RRT on the dorsal hand and the flexor forearms in 76 cured leprosy and
68 normal subjects at various clockwise directions. In comparison to normal subjects, cutaneous
RRTs on both the hands and the forearms of cured leprosy were abnormal in all directions, except
in the directions of 1-7, 2-8 and 3-9 o’clock on the forearms. Cutaneous RRTs at both the 4-10 and
5-11 o’clock directions were reduced significantly on the forearm in lepromatous and borderline
lepromatous types as compared with normal. On the hand, cutaneous RRTs at all directions, except
that at 4-10 o’clock directions on the hands were also significantly reduced in lepromatous and
borderline lepromatous types in comparison with normal control. No significant differences in cuta-
neous RRT at any direction were found among the various subtypes of leprosy. In conclusion,
cutaneous RRTs were abnormal in cured leprosy subjects as a whole, but varied among leprosy
subtypes. These results suggest RRT measurement could be a useful approach to quantify the extent
of abnormality and to monitor the response to treatment.
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Variation of skin surface pH, sebum content, and stratum corneum hydration with age and
gender in Chinese population
S Gong,1 C Lv,1 KR Feingold,2 X Zhang,3 S Xin,1 C Tu,4 L Sui,1 PM Elias2 and M Man2 1 Dalian
Skin Disease Hospital, Dalian, China, 2 Dermatology, UCSF, San Francisco, CA, 3
Dermatology, Zunyi Medical College, Zunyi, China and 4 Dermatology, Dalian Medical
University, Dalian, China
Evidence suggests the importance of skin biophysical properties in predicting diseases and in devel-
oping appropriate skin care. The results to date of studies on skin surface pH, stratum corneum
(SC) hydration, and sebum content in various gender and ages have been inconclusive in part due
to small sample size. Additionally, little is known about skin physical properties of Asian, espe-
cially Chinese, subjects. In the present study, we assess the difference in skin surface pH, sebum,
and SC hydration at various ages and both genders in a large normal Chinese population without
skin diseases. Total of 328 males and 385 females, aged 0.5 to 94 years old were enrolled in this
study. Subjects were divided by age into three groups, i.e. 0-12, 13-65, and over 65 years. A mul-
tifunctional skin physiology monitor was used to measure SC hydration, SS pH, and sebum con-
tent on both the forehead and the forearms. In both males and females, the highest sebum content
is found on both the forearms and the forehead in the age 13-65 group; Forehead sebum content
is higher in males aged 13-65 than in age-matched females; Sebum content on the forehead in both
males and females is higher than that on the forearm. Skin surface pH on the forehead of both males
and females age over 65 years is higher than that in younger groups. SC hydration on the forehead
in both males and female is lower above age 65; SC hydration on the forehead in males aged 13-
65 is higher than that in females. SC hydration on the forehead in both genders does not differ sig-
nificantly from that on the forearm. In a larger Chinese cohort, the skin surface pH, sebum con-
tent, and SC hydration vary with age, gender and body site. This information could be useful in
predicting skin disease susceptibility in certain subgroups, and in optimizing skincare products.
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The presence of N ε- (Carboxymethyl) lysine in the epidermis
K Kawabata,1 H Yoshikawa,2 K Saruwatari,1 Y Akazawa,1 T Inoue,1 T Sayo1 and Y Sugiyama1 1
Basic Research Laboratory, Kanebo Cosmetics Inc, Odawara, Japan and 2 Products Science
Research Laboratory, Kanebo Cosmetics Inc, Odawara, Japan
It is well known that advanced glycation end products (AGEs) are formed in long-lived dermal
proteins such as collagen and elastin, and their formation is related to skin aging. However, there
are few reports about the distribution of AGEs in skin. To examine the distribution in human and
rat skin of N ε- (Carboxymethyl) lysine (CML), one of the AGE structures, we performed immuno-
histochemical studies on human buttock and HWY-rat dorsal skin. The CML signals were, unex-
pectedly, observed in both human and rat epidermis. Moreover, the intensity of CML staining on
rat epidermis was increased with age. The presence of CML in the epidermis was confirmed by liq-
uid chromatography-electrospray ionization time-of-flight mass spectrometry (LC-ESI-TOF-MS)
methods under our developed conditions. Concordance with the retention times of a compound
in rat epidermal hydrolysates and authentic CML as well as the concordance with the specific
mass transition of CML (205.12Ç84.08) was given for the signals identified as CML in the rat epi-
dermal hydrolysates, indicating that CML is present not only in the dermis but also in the epider-
mis. In order to characterize the CML-modified proteins in the epidermis, protein samples were
prepared from rat epidermis and analyzed by two-dimensional electrophoresis followed by amino
acid sequence analysis. The clarified peptide sequences derived from the positive spots revealed
by immuno-blotting with anti-CML antibody covered approximately 45% of amino acid sequences
of cytokeratin 10 (K10). In the separate western blotting analyses using epidermal protein samples
from the human skin-equivalent cultures, the molecular size of the major CML-positive band was
the same that of the K10. Taken together these results suggested that epidermal proteins are mod-
ified by CML, and K10 is one of the target molecules for the CML-modification in the epidermis.
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TGF-β1 upregulates Semaphorin 7A on keratinocytes, which promotes Interleukin-8 pro-
duction from monocytes through β1-integrin
M Kamata, H Uratsuji, T Kawashima, Y Tada and K Tamaki Dermatology, University of Tokyo,
Tokyo, Japan
Semaphorins are secreted and transmembrane proteins, initially described as regulators of devel-
opment in neuronal axons. Recently it is becoming clear that Semaphorins are also critical in
immune system. Semaphorin 7A (Sema7A), which was first reported to promote axon outgrowth,
has been shown to be expressed on activated T cells and stimulate cytokine production in mono-
cytes and macrophages through α1β1 integrin. In skin, Sema 7A is expressed in keratinocytes and
fibroblasts both in vitro and in vivo, and reported to promote spreading and dendricity in melanocytes
through β1-integrin. However, the regulation and function of Sema7A in skin immune system is
not known yet. We confirmed that Sema 7A is expressed on the cell surface of normal human epi-
dermal keratinocytes (NHK) and examined the regulation of its expression under various cytokine
stimulation by flow cytometry and immunoblot. Secreted form of Sema7A was not detected under
these stimulations. IL-4 decreased expression of Sema7A protein of NHK, and IFN-γ, TNF-α, TGF-
β1 increased its expression. Among these stimulations, TGF-β1 strikingly increased the Sema7A
expression on NHK, thus, we further examined the function of Sema7A on TGF-β1-stimulated NHK
in keratinocyte-monocyte interaction. NHK were stimulated with or without TGF-β1 and
paraformaldehyde-fixed, and co-cultured with Human monocyte cell line, THP-1 cells. When
THP-1 cells were cultured with TGF-β1-stimulated NHK, IL-8 production from THP-1 cells were
increased, compared to THP-1 cells cultured with non-stimulated NHK. Interestingly, this upreg-
ulation of IL-8 production from THP-1 cells was inhibited when THP-1 cells were pre-treated with
β1-integrin blocking antibody. These results suggest that Sema7A on NHK might increase IL-8
production from THP-1 cells via β1-integrin. Our study gives clinical significance of Sema7A-β1-
integrin interaction between keratinocytes and inflammatory dendritic epidermal cells derived from
monocytes, which are identified in the epidermis of diseases such as psoriasis vulgaris or atopic
dermatitis.
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LaPlace’s Law and its potential relevance in comedo formation
C Kroodsma Central Illinois Dermatology, Peoria, IL
It is widely accepted that comedo formation is a process which begins secondary to yet unresolved
abnormalities involving the deeper, typically wider infrainfundibulum portion of the sebaceous
follicle lumen, with the narrower acroinfundibulum region (containing the pore/ostium) consid-
ered noncontributory. This assumption is supported by histological studies which concluded that
the first visible changes, including distension, occur in the infrainfundibulum. Also, it is stated
(Plewig and Kligman, 1975, 1993, 2000) that acne beliefs based on obstruction at the level of the
pore or acroinfundibulum cannot be correct because only the infrainfundibulum is involved in for-
mation of the closed comedo. Pliable latex material was used to create a distensible cylindrical
lumen of decreasing diameter, meant to resemble the lumen of the sebaceous follicle, wider prox-
imally and narrower distally. Water was allowed to flow through the lumen and the narrower dis-
tal end was blocked. As intralumenal fluid pressure increased, the proximal portion of the lumen
distended dramatically, without corresponding dilation of the distal lumen. These findings are
predicted by LaPlace’s Law, which holds that T=(ΔP×R)/M (T=wall tension, ΔP=transmural pres-
sure, R=radius, M=wall thickness) for a cylindrical lumen. Tension, as defined by LaPlace’s Law,
is a force directed along the circumference of the lumen which tends to induce distension and
stretch. In vivo, the greater radius (R) and lesser wall thickness (M) of the infrainfundibulum, rela-
tive to the acroinfundibulum, each likely contribute to increased wall tension (T) and thus disten-
sion in this region. It is therefore speculated that partial or complete occlusion at the level of the
acroinfundibulum, by any means, impedes sebum flow and results in distension and stretch of the
infrainfundibulum, without similar corresponding changes of the acroinfundibulum region. Given
that stretch of keratinocytes has been found to induce changes associated with comedo forma-
tion, such as IL-1α release, increased DNA synthesis, and differentiation, simple occlusion should
be considered a potential cause of the comedo.
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Epidermal lipids: differences between age, region and color skin in Brazilian voluntaries
LB López,2 MB Roedel,2 R Borojevic,2 FC Guma,3 SH Medina,1 VM Sá-Rocha1 and JL Gesztesi1
1 Skin Technology, Natura, Cajamar, Brazil, 2 Skin, Excellion Serviços Biomédicos S/A, Rio
de Janeiro, Brazil and 3 Chemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre,
Brazil
The purpose of this study was analyze epidermal lipids in face (f), abdomen (a) and breast (b) in
White and Black women voluntaries in three age band: 27-40; 41-50 and 51-66 years old. The
permeability barrier is required for terrestrial life and is localized at the stratum corneum. The
impairing of barrier homeostasis is a well know cause of a several skin disorders. 22 skin slices
from different body region of White and 6 skin slices of Black voluntaries were used. All correc-
tive plastic surgery were made in hospitals and voluntaries agreed with the donation term from
skin material. The slices were collected in medium culture and send to a center to process them.
Epidermal lipids in skin as ceramide (cer) I, III, VI(1) and VI(2), Gliceryl/lactosylceramide (Gli),
phospholipids (PL), cholesterol (CHO) and fatty acids (TG) were analyzed by High Performance
Thin Layer Chromatography (HTPLC). When we compared the region of skin the results (% dis-
tribution) showed that there were not differences in ceramides I (a:6,7±0,8; m: 7,5±0,9; f: 7,5±1,2),
cer III (a: 8,9±1,0; m: 9,2±1,4; f: 18±8,2), cer VI(1) (a:8,06±0,7; m: 9,0±0,9; f: 8,05±2,4), cer VI(2)
(a:8,7±0,7; m: 8,8±0,9; f: 8,0±1,2) phospholipids (a:50,1±6,1; m: 58,2±3,9; f: 48,3±8,2) and
Gliceryl/lactosylceramide (a: 8,05±1,2; m: 5,2±1,1; f: 10,5±7) between face, abdomen and breast
of voluntaries respectively. A significant reduction in cer I after 40 years old was observed (9,9±0,9
in 27-40 year old group, 4,7±0,5 in 41-50 year old group, 4,7±0,3 in 51-66 year old group).
When skin color was compared, a significant less quantity in cer I (black: 3,8±0,1; white: 7,5±0,3)
and Gli (black: 4,0±0,1; white: 7,5±0,5) were found in black and a significant less quantity in cer
III was found in white skin (black: 20,1±1; white: 10,1±0,6). This study showed physiological dif-
ference in lipid profile between white and black skin and a changes of cer I after 40 years old.
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Are advanced glycation (AGEs) and oxidation products (OP) measured by skin fluorescence?
P Beisswenger,1 S Howell,1 T Mackenzie,1 H Corstjens,3 N Muizzuddin2 and MS Matsui2 1
Dartmouth Medical School, Hanover, NH, 2 Estee Lauder Co’s, Melville, NY and 3 Estee
Lauder Co’s, Oevel, Belgium
AGEs and OP have been implicated in the aging and photoaging of skin, and some AGEs and OP
are fluorescent. Measurement of skin fluorescence has been promoted as a non-invasive tech-
nique to measure skin AGEs. We have measured levels of AGEs and oxidative biomarkers in skin
biopsies concurrent with skin fluorescence. The correlation of fluorescence and biomarkers, and
the impact of aging and sun exposure were analyzed. Skin fluorescence (SF) was measured by
fiberoptic spectrometer (SkinSkan, Jobin Yvon, USA) on the upper inner arm (non-exposed) and
lower outer forearm (exposed) in 40 normal subjects. Four excitation/emission intensities were
measured :295/344 (Tryptophan), 335/385 (Pentosidine), 370/440 (Collagen cross-links), and 440/520
(Elastin-collagen cross-links). Skin color was measured with a Minolta Chromameter. Punch biop-
sies from the measured sites were digested enzymatically. Pentosidine (Pent), carboxymethyllysine
(CML), carboxyethyllysine (CEL) and methionine sulfoxide (MetSO) were measured in digests by
LC-MS/MS. SF was corrected for pigment by multivariate regression analysis by the generalized
estimating equations method. CML, Pent, and MetSO all showed significant correlations with age,
while CEL did not. Sun exposure significantly increased CML, Pent, and MetSO, but not CEL. Only
Pent (p=0.01) showed significant correlation with fluorescence at 370/440, and no AGE correlated
with fluorescence at 335/385. Fluorescence measured at 440/520 showed positive correlations
with the AGEs Pent, CML and CEL (p = 0.02, 0.02 and 0.01 respectively), and the OP, MetSO
(p=0.04). Therefore, CML, Pent, and MetSO correlated with aging and sun exposure, but only Pent
correlated with a known AGE crosslink fluorescence of 370/440 nm, while no AGEs correlated
with fluorescence at 335/385. Only a less well studied fluorescence intensity of 440/520, possibly
reflecting elastin/collagen crosslinks, showed significant correlations with all AGEs and OP meas-
ured.
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Expression profile of a profilaggrin-like protein, hornerin, in oral mucosa
T Makino,1 T Yamakoshi,1 S Inoue,2 M Noguchi,2 N Huh3 and T Shimizu1 1 Department of
Dermatology, University of Toyama, Toyama, Japan, 2 Department of Oral and Maxilla-Facial
surgery, University of Toyama, Toyama, Japan and 3 Department of Cell Biology, Okayama
University Graduate School of Medicine, Okayama, Japan
Recently we identified human hornerin gene on chromosome 1q21 by homology search using a
sequence covering the EF-hand domain of mouse hornein. Human hornerin consists of an EF-
hand domain at the N-terminus followed by a large repetitive domain. These structural features of
human hornerin are most similar to those of human profilaggrin, an essential protein for kera-
tinization. The hornerin protein was detected in the granular cells of regenerating skin and psori-
atic skin, but not in the normal skin (J. Biol. Chem. 280: 4696-4703, 2005). In the present study,
we investigated expression of human hornerin in oral mucosa using antibodies against the repeti-
tive domain of hornerin. Hornerin was slightly expressed in the epithelium of hard plate, but not
in buccal mucosa and tongue. On the other hand, profilaggrin was expressed in epithelium of in
buccal mucosa, hard plate and tongue. Furthermore, we examined the expression of hornerin in
oral mucosa with the disorders. The expression of human hornerin was markedly increased in the
epithelium of oral mucosa with leukoplakia, lichen planus and dysplasia. The positive signals of
hornerin were observed as granules, some of which were also positive for profilaggrin as revealed
by a double staining method. These results showed that hornerin was expressed in oral mucosa
under the pathological conditions similar to the expression profile in skin, and might be involved
in the pathogenesis of some disorders of oral mucosa.
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The changes of the stratum corneum constituents in the skin barrier dysfunction model
mice
T Midorikawa,1 F Yamaguchi,1 K Ishida,1 M Yumoto,1 T Asanuma,1 T Yoshino,1 M Ohdera1 and
Y Kitajima2 1 Biological Science Research Laboratories, LION Corporation, Odawara, Japan
and 2 Dermatology, Gifu University School of Medicine, Gifu, Japan
Chronic skin barrier dysfunction is considered to be one of the causes of skin disorder character-
ized by itch and dry skin. When HR-1 hairless mice are fed with a special diet, HR-AD, itch and
dry skin are induced. But the componential changes in the skin stratum corneum of these model
mice have not been sufficiently analyzed. In this study, we show that the penetration of exogenous
substance was increased as well as transepidermal water loss. Furthermore, we show the decrease
of some components of stratum corneum lipid and the acceleration of desmocollin-1 degradation
in these model mice skins. These results indicate that chronic skin dysfunction in these model
mice is accompanied with the structural changes of stratum corneum in the skins.
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Effects of retinoic acid on keratinocyte proliferation and differentiation in a psoriatic skin
model
J Jean,1,2 J Soucy,3 FA Auger2,4 and R Pouliot1,2 1 Faculté de Pharmacie, Université Laval,
Quebec, QC, Canada, 2 Laboratoire d’Organogénèse Expérimentale (LOEX), Hôpital du St-
Sacrement, Quebec, QC, Canada, 3 Département de Dermatologie, Hôpital de l’Enfant-
Jésus, Quebec, QC, Canada and 4 Faculté de médecine, Université Laval, Quebec, QC,
Canada
Psoriasis is a chronic skin disease known as a retinoid-sensitive pathology. Retinoids can modu-
late epidermal proliferation in different ways in vivo; they can cause an antiproliferative potential
in hyperproliferative systems or an induction of hyperproliferation in normoproliferative systems.
The aim of this study was to compare the development of psoriatic skin substitutes cultured in a
retinoic acid supplemented medium to those cultured in medium receiving no supplement, in order
to define the effects of this growth factor on keratinocyte proliferation and differentiation. Healthy
and psoriatic skin substitutes, from Caucasian males and females, aged between 39 and 65, were
produced using the self-assembly method. Biopsies were taken 21 days after being raised to the
air-liquid interface and they were examined by histology and immunohistochemistry. Macroscop-
ical and histological observations showed that the epidermis of psoriatic skin substitutes cultured
in a medium supplemented with retinoic acid were thinner than the controls. Epidermal thickness
measurements using the MetaVue Imaging software have confirmed these observations. Differen-
tiation markers such as filaggrin and loricrin are underexpressed in psoriatic skin as well as in our
pathological skin substitutes. In presence of retinoic acid, the expression of these two markers was
restored appearing much more similar to the controls. Cell proliferation, analyzed by the presence
of ki67 positive cells, showed a significant decrease when the psoriatic substitutes were cultured
with retinoic acid. In brief, results suggest that retinoic acid can modulate epidermal proliferation
and differentiation of keratinocytes in a new psoriatic skin model.
404
Vitamin D receptor and coactivators SRC 2 and 3 regulate barrier sphingolipid production
and epidermal permeability barrier formation
Y Uchida,1 Y Oda,2 S Moradian,1 D Crumrine,1 PM Elias1 and DD Bikle2 1 Dermatol, UCSF &
VAMC, San Francisco, CA and 2 Med & Endocrinol, UCSF & VAMC, San Francisco, CA
The vitamin D receptor (VDR) is a nuclear hormone receptor that regulates transcription of target
genes. VDR exerts its biological effects through transcriptional coactivators. VDR-interacting pro-
tein (DRIP) 205 and p160 family members SRC 2 and SRC3 modulate VDR transactivation in ker-
atinocytes (KC) during differentiation. DRIP 205 plays a major role in the early stages of differen-
tiation while SRC2 or SRC3 serve as coactivators later in the differentiation process. Here, we
investigate the roles of VDR and its coactivators in major barrier lipid production; i.e., ceramides
(Cer), cholesterol and free fatty acids (FFA), and epidermal permeability barrier formation. Lipid
analysis of glucosylCer (GlcCer), immediate precursors of Cer in the stratum corneum, demon-
strated that silencing of VDR, SRC2 or SRC3 expression by siRNAs decreases specific GlcCer species,
including acylGlcCer (precursors of acylCer, required for barrier formation) in fully differentiated
cultured human KC. However, cholesterol and FFA content were not altered. qRT-PCR analysis
showed decreased transcription of GlcCer synthase and fatty acid elongases (ELOVL3 and ELOVL4),
which are critical for the synthesis of epidermis-unique GlcCer species. Moreover, ultrastructural
analysis revealed defects in lamellar body (LB) formation associated with decreased mRNA expres-
sion of the lipid transporter ABCA12. Finally, Vdr null mice exhibit abnormal barrier features, includ-
ing LB formation and secretion, and extracellular lamellar membrane structures in the stratum
corneum. Pertinently, barrier lipid composition is significantly changed, with decreases in the
ratio of the Cer to cholesterol or FFA, and acylCer to Cer 2. These results demonstrate that VDR,
and its coactivators SRC2 and SRC3, are critical for specific species of Cer production required for
barrier formation. In contrast, DRIP silencing had no apparent effect on these processes indicating
that the two classes of coactivators are differentially utilized.
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Ceramide metabolites in epidermal permeability barrier function and atopic dermatitis
N Loiseau,1,2 S Moradian,1 PM Elias,1 WM Holleran1 and Y Uchida1 1 Dermatology, UC San
Francisco & VA Med Ctr, San Francisco, CA and 2 UR66, Pharmacologie-Toxicologie, INRA,
Toulouse, France
Ceramides (Cer), major constituents of stratum corneum (SC) permeability barrier structures, are
hydrolyzed to free fatty acids (FFA) and sphingoid base metabolites by ceramidases, the latter hav-
ing demonstrated antimicrobial activities. However, the roles of sphingoid base in epidermal bar-
rier structures and function remain unknown. Due to its chemical properties, we hypothesize that
sphingoid bases modulate barrier SC membrane permeability and stability, and changes in spe-
cific content with disease alter SC functions. Since changes in Cer metabolism occur in atopic der-
matitis (AD) skin, we compared skin from normal to AD mouse (by repeated hapten [oxazolone]
challenge; Man MQ, et al., JID, 128: 79-86, 2008). Similar to human AD and consistent with prior
studies, decreased Cer, particularly acylCer, occurs in AD mouse epidermis, while Sphingosine
(d17/18:1, So) and Sphinganine (d17/18:0, Sa) are the major SC sphingoid base species (>95% of
total sphingoid bases) in both normal- and AD-mice. Importantly, the total sphingoid base content
is increased 1.5-fold, while the So-to-Sa ratio is markedly increased (from 5.5 to 15.2) in AD
mouse SC. To assess the effects on this altered sphingoid base content on SC membrane perme-
ability, a liposome system consisting of the major SC lipids (Cer, FFA, & cholesterol) +/- So and/or
Sa was used. Either So or Sa increased carboxyfluorescein (CF) release from liposome (i.e., increased
permeability), while inclusion of both Sa and So in the liposome formulation decreased CF release
vs. that with each sphingoid base alone. However, an increase in the So-to-Sa ratio from 5.5 to
15.2 (similar to that in AD) further increased CF release. These results demonstrate not only that
sphingoid bases can alter membrane permeability, but also that the ratio of sphingol species is a
critical determinant of membrane stability. Thus, changes in sphingol content/species, in addition
to the Cer deficiencies, likely contribute to the barrier defects in AD skin.
406
Pemphigus vulgaris antibodies (PV IgG and AK23) antagonize differentiation-dependent onset
of Wnt signaling via constitutive c-Myc in keratinocyte cultures
A Galichet,1 L Williamson,1 C Kolly,1 K Schulze,1 H Posthaus,1 E Boitier,2 MM Suter1 and
EJ Müller1 1 Molecular Dermatology, Vetsuisse Faculty, University of bern, Bern, Switzerland
and 2 Sanofi-Aventis, Anthony, France
We recently reported that Pemphigus vulgaris (PV) antibodies promote constitutive c-Myc expres-
sion in cultured mouse keratinocytes and in patients, resulting in sustained proliferation at the
expense of terminal differentiation. To gain further insight into the consequences of constitutive c-
Myc in PV, we performed a DNA microarray analysis of PV antibody-treated mouse keratinocytes
versus normal terminally differentiating cells. Two days after exposure to PV antibody, Wnt 4 was
the most down-regulated gene. Concomitantly, the expression level of other Wnt pathway related-
genes such as disheveled 2 and Tcf4 was also reduced in PV antibody-treated cells. Quantitative
RT-PCR confirmed the differentiation-dependent increase in steady-state levels of several Wnt tran-
scripts during the terminal differentiation process and activation of Wnt signaling as suggested by
the increase in axin2 gene expression and de-phosphorylation-induced β-catenin activation. In
contrast, under PV antibody conditions, expression of Wnt genes and Wnt signaling was impaired.
Because the increase in c-Myc precedes the decrease in Wnt signaling in PV antibody-treated mouse
keratinocytes, we wondered whether constitutive c-Myc could be involved in this negative regu-
lation. To investigate this possibility, we specifically blocked c-Myc activity and its upstream acti-
vator GSK3. We demonstrate the PV antibody-induced down-regulation of Wnts gene expression
is reverted by c-Myc and GSK3 inhibition. Taken together, these data show that Wnt genes are
expressed in terminally differentiating keratinocyte cultures resulting in activation of the canoni-
cal Wnt pathway. In addition, sustained c-Myc expression at onset of terminal differentiation, as
seen in PV antibodies-treated keratinocytes, directly or indirectly impedes on terminal differentia-
tion-induced Wnt signaling.
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Caspase-14 is associated with DNA degradation in differentiated keratinocytes
M Yamamoto,1,2 J Hosoi,1 C Katagiri1 and T Hibino1 1 Shiseido Research Center, Shiseido Co.
Ltd., Yokohama, Japan and 2 Dermatology, Tokyo Medical University, Tokyo, Japan
Caspase-14 is expressed only in the epidermis and its activation occurs at the onset of cornified
cell formation. Recent studies suggest that caspase-14 is able to degrade filaggrin, however, its phys-
iological roles are not fully understood. We have previously purified human caspase-14 from corni-
fied cells and determined cleavage sites for the activation. Based on this information, we prepared
constitutively active caspase-14 by reverse genetics. The recombinant protein showed similar
hydrolytic activities on synthetic and protein substrates with the purified enzyme. In addition, we
developed a cleavage-site directed antibody (D146 Ab), which recognized only the active caspase-
14, and a monoclonal antibody to procaspase-14, 6B2. We also constructed two kinds of active
caspase-14 expression vectors driven by the CMV promoter and the involucrin promoter. HA-tag
and fluorescence protein Azami-Green was also inserted for the detection. These constructs were
introduced into keratinocytes using FuGENE. When active caspase-14 was expressed in a grow-
ing phase of cultured keratinocytes, it did not show any detectable changes assessed by TUNEL
and immunocytochemical studies. Time lapse study with confocal microscopy revealed that fluo-
rescence of caspase-14 appeared from 6 hours after transfection and lasted thereafter without any
different cell behavior compared to untransfected cells. On the other hand, when keratinocytes
were cultured until confluency and further differentiated by addition of calcium, involucrin-driven
active caspase-14 emerged in the tranfected cells. Interestingly only those cells stained with anti-
HA antibody and D146 Ab were found to be TUNEL positive, indicating that DNA degradation
occurred in active caspase-14 expressing keratinocytes after differentiation. Later those cells showed
features like individual cell keratinization. Our results indicate that caspase-14 is involved in DNA
degradation, although it plays a role under the environment that only exists in the last stage of ter-
minal differentiation.
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STRA6 a potent novel transporter for the active influx of retinol in human epidermal ker-
atinocytes
C Skazik, R Heise, S Joussen, Y Marquardt, HF Merk and JM Baron Dermatology, University
Hospital RWTH, Aachen, Germany
Retinoids play key roles in cell proliferation and differentiation. Retinylesters and β-carotene are
ingested and stored mainly in stellate cells of the liver. Demand for retinol results in the release of
retinol-retinol binding protein complexes which are taken up by human skin. Recently the novel
transport protein STRA6, which is a high-affinity cell surface receptor for retinol-RBP has been
detected in bovine retinal epithelium cells. STRA6 removes retinol from RBP and transports it across
the plasma membrane. To demonstrate whether similar transport processes take place in human
skin cells, we analyzed expression of human STRA6 in normal human epidermal keratinocytes
(NHEK), murine PAM212 cells and human dermal fibroblasts. qRT-PCR analysis detected a con-
stitutive expression of STRA6 in NHEK, PAM212 cells and dermal fibroblast and expression could
be significantly upregulated by ligands of the different nuclear retinoic receptors such as 9-cis-RA,
13-cis-RA, all-trans-RA and targretin as well as retinol itself. In contrast we could not observe an
increased STRA6 expression after stimulation with ligands of other class II nuclear receptors such
as phenobarbital, dexamethasone and benzanthracene. To characterize the influx transport of retinol
in NHEKs we established a functional uptake-transport assay and demonstrated that retinol uptake
in keratinocytes depends on expression level of STRA6 as well as time of incubation. Gene regu-
lation studies revealed that RAR/RXR- as well as EGFR signaling pathways are involved in the upreg-
ulation of STRA6 in NHEKs. In conclusion we were able to demonstrate that skin cells express
STRA6, a novel transporter for active influx transport of retinol.
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The profilaggrin N-terminus interacts, and is co-expressed, with two novel nuclear proteins
in keratinocytes
RB Presland,1,2 OT Lawrence,1 J Huard1 and H Kortgere1 1 Oral Biology, University of
Washington, Seattle, WA and 2 Medicine (Dermatology), University of Washington, Seattle,
WA
Profilaggrin, a protein expressed in epidermal granular cells, undergoes specific processing dur-
ing keratinocyte terminal differentiation to generate two end-products, filaggrin and the N-termi-
nus. While the role of filaggrin as a keratin-aggregating protein and in water retention (as free amino
acids in the stratum corneum) is well established, the potential function of the profilaggrin N-ter-
minal domain (PND) in keratinocyte differentiation is unknown. We have previously shown that
the PND localizes to both the nucleus and cytoplasm of granular layer cells. The PND consists of
an S100 calcium-binding domain (A domain) and a B domain that facilitates nuclear accumula-
tion. The mouse and human PND interacts with a number of proteins, as shown by yeast two-
hybrid assays and in vitro binding studies. Among the interacting proteins are annexin II/p36, corni-
fied envelope/cytoskeletal proteins including loricrin and an SPRR-like protein, and two
predominantly nuclear proteins, BRD1 and AATF. AATF has multiple functions, including a role
in cell cycle regulation and as a nuclear receptor co-activator, while the function of BRD1 is
unknown. Both BRD1 and AATF interact specifically with the S100 A domain of mouse PND. BRD1
and AATF are present in the nuclei of granular cells, while the PND is cytoplasmic and nuclear in
granular and transition cells, respectively. These results suggest that the PND modulates the func-
tion of these nuclear proteins, which in turn may regulate late transcriptional events and/or chro-
matin remodeling during keratinocyte terminal differentiation.
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THP-1 cells as an in vitro model for subacute toxicity assay
I Garcia, C Pouzet, M Arcioni, E Bauza and N Domloge Vincience, ISP Global Skin Research
Center, ISP, Sophia-Antipolis, France
Monitoring the chronic and subacute toxicity of chemical substances is essential in the develop-
ment of new active ingredients. However, Cosmetics Directive 2003/15/CEE has established a pro-
hibition of repeated dose toxicity testing of cosmetic ingredients on animals after March 11, 2013.
To date, only a few long-term in vitro toxicity methods have been proposed, and none have been
validated yet. In the current study, we propose the THP-1 cell line as a model for repeated dose
toxicity testing. We focused on non-organ-specific parameters used in acute testing, such as cyto-
toxicity endpoints (mitochondrial function). Cultured in suspension, THP-1 cells can be maintained
in culture over long periods of time, under stable conditions. Subacute toxicity studies were per-
formed by applying active ingredients during a 14-day period with a frequency of 3 applications
per week. As a first step, a positive control (SDS 0.001% and 0.005%) was established. Cells were
then treated with three different doses (5, 10 and 20%) of placebo (H2O) or with one of 4 com-
pounds. Results showed very low cell viability rates at 20% doses, even when cells were treated
with placebo. To prevent this osmotic shock, a calculated volume of reconstituted RPMI 5X medium,
supplemented with FBS, was used to equilibrate the osmolarity. Next, cell viability results were
compared statistically, and showed that when equilibrated with this reconstituted medium, water
concentration had no influence on cell viability. The osmotic shock is mitigated, allowing us to
compare long-term toxicity of compounds, following cell viability, without interference. In the next
step, compounds classified with different degrees of toxicity will be tested, in order to carry out a
concordance study. Using THP-1 as a model for long-term non-organ-specific toxicity testing has
the advantage of being inexpensive, fast, and reproducible.
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Involvement of Aquaporin-3 in cold stress resistance in normal human keratinocytes and
human skin
L Mur,1 F Labarrade,1 C Serre,1 C Gondran,1 J Botto,1 F Portolan,1 C Dal Farra2 and N Domloge1
1 Vincience, ISP Global Skin Research Center, ISP, Sophia-Antipolis, France and 2 ISP
Corporate Research, ISP, Wayne, NJ
One of the main functions of the skin is to protect the organism against environmental threats, such
as thermal stress. Aquaporin-3 facilitates water and glycerol transport across cell membranes, and
therefore regulates osmotic balance in different situations of stress. This mechanism seems to be
particularly important for the resistance of different organisms to cold stress. Consequently, we
were interested in investigating the effect of cold stress on AQP3 expression in normal human ker-
atinocytes (NHK) and human skin, and its role in cold stress resistance. RT-PCR studies were per-
formed in order to evaluate the expression of aquaporins 3, 5, and 7 in different human cell types
(NHK, HaCaT, and fibroblasts). Then, NHK were submitted to a cold stress of 4°C for 4 hours, with
or without pre-treatment with the AQP3-inducing active ingredient IV08.002. AQP3 expression
was then analyzed by immunoblotting and immunofluorescence staining. This study revealed
that cold stress up-regulated AQP3 expression in all the cells. Moreover, we examined the effect
of cold stress on cell morphology. Our results indicated that cold stress induced rounding of the
cells, and that pre-induction of AQP3 helped to preserve cell shape in cold-exposed cells. Fur-
thermore, actin staining showed that induction of AQP3 by IV08.002 maintained the actin cytoskele-
ton in cold-stressed NHK, preserving cell morphology and preventing cells from rounding. These
results were also confirmed by transfecting NHK with AQP3-specific si-RNA. Ex vivo studies showed
that, in human skin samples exposed to a cold stress at 4°C for 4 h, with or without pre-treatment
with IV08.002, AQP3 expression increased. However, AQP3 pre-induced skin exhibited less dam-
age, compared to control cold-stressed skin. The implication of AQP3 in thermal stress resistance
suggests that it plays an essential role in environmental stress resistance and in protecting the skin
from cold-induced damage.
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Modulating aconitase expression and activity reduces oxidative stress and skin damage
G Oberto,1 Y Guerif,1 C Gondran,1 E Bauza,1 J Botto,1 G Bressier,1 A Berghi,1 K Cucumel,1 C Dal
Farra2 and N Domloge1 1 Vincience, ISP Global Skin Research Center, ISP, Sophia-Antipolis,
France and 2 ISP Corporate Research Center, ISP, Wayne, NJ
Oxidative stress generates mitochondrial DNA alterations and damage, therefore compromising
the cellular respiration process. In response to oxidant accumulation, cells have developed an
“oxidative stress response” in which aconitase seems to play an important role by triggering sur-
vival functions. We evaluated hydrogen peroxide (H2O2) cytotoxicity on human skin fibroblasts
in culture, grown for 48h with or without 1% of the IV08.001 compound, which has been previ-
ously shown to enhance total cellular aconitase expression and activity. After 30 minutes of 5 mM
H2O2 treatment, fibroblasts were allowed to recover for 2h in medium containing or not containing
compound IV08.001. Free radical production was then evaluated by dihydroxy-ethidium staining
and subsequent analysis by flow cytometry. Aconitase-stimulated cells showed a significant reduc-
tion in the production of free radicals when fibroblasts were pretreated for 48h before the appli-
cation of H2O2. In this study, the observed level of ROS production was less (-16%) than that of
the control condition. An 8-day in vivo study was also conducted with IV08.001 compound, ver-
sus placebo, on 12 healthy volunteers. In vivo confocal microscopy (Vivascope) at D0, D6, and
D7, 24h after UV (2 DEM of full spectrum solar light), allowed comparison between placebo and
aconitase-induced epidermis. At D6 and D7, we observed nice conserved structure with an improve-
ment of granular cell morphology on the aconitase-induced side, demonstrating skin with a health-
ier appearance, compared to the placebo-treated side. Moreover, UV-generated damage, such as
sunburn cells, vacuoles, and oedema, was less apparent on the aconitase-induced side. A Vivas-
cope was used to quantify results and revealed a 61% decrease of sunburn cells on the aconitase-
induced side, which confirmed the overall protective role of aconitase against UV damage.
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The tight junction protein Claudin-1 is a susceptibility gene in Atopic Dermatitis with rele-
vance for cutaneous barrier function
A De Benedetto,1 A Ivanov,1 S Vidyasagar,1 M Bolognino,1 KW Bundy,1 M Boguniewicz,2 T Hata,3
L Schneider,4 J Hanifin,5 R Gallo,3 NM Rafaels,6 C Cheadle,6 P Gao,6 KC Barnes,6 DY Leung2 and
LA Beck1 1 University of Rochester Medical Center, Rochester, NY, 2 National Jewish Health,
Denver, CO, 3 University of California San Diego, San Diego, CA, 4 Children’s Hospital
Boston, Boston, MA, 5 Oregon Health & Science University, Portland, OR and 6 Johns
Hopkins University, Baltimore, MD
Barrier disruption is a cardinal feature of atopic dermatitis (AD). The stratum corneum (SC) is the
first level of defense followed by the tight junctions (TJ), which are found at the level of the stra-
tum granulosum. TJs control the diffusion of fluid, electrolytes, macromolecules and pathogens.
We evaluated the expression and function of the TJ protein, claudin-1 in skin from AD and nonatopic
(NA) subjects. Expression profiles of nonlesional epithelium from AD (n=5) and NA (n=5) subjects
were generated using Illumina’s HumanRef-8 BeadChips. Claudin-1 expression was evaluated by
tissue staining (n=12/group). We screened 27 haplotype-tagging SNPs in CLDN1 in two independent
groups of AD and NA (European American, EA; n=404 and African American, AA; n=323). The
role that claudin-1 expression plays in TJ function was assessed using a knockdown approach
(siRNA) in undifferentiated and differentiated primary human keratinocytes (PHK). Claudin-1 expres-
sion was reduced in AD nonlesional skin, which we confirmed at both the mRNA and protein lev-
els. In both AA and EA populations, individual CLDN1 SNPs were associated with AD (p<0.04)
and AD severity (p<0.02). In vitro, we noted claudin-1 protein expression and membrane local-
ization in Ca+2-differentiated PHK coincident with an increase in transepithelial electrical resist-
ance (TEER) and reduced permeability. Claudin-1 knockdown significantly reduced TEER
(49±3.2%;p<0.035) and increased sodium fluorescein permeability (2.3±0.5 fold), without affect-
ing the expression of other TJ proteins. Claudin-1 is a crucial component of the epidermal barrier
and is a novel susceptibility gene for AD and AD severity.
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Skin protection by modulation of peripheral proteins implicated in circadian rhythms
E Bauza,1 J Botto,1 R Chabert,1 F Labarrade,1 C Gondran,1 G Bressier,1 I Imbert,1 C Dal Farra,2
N Pernodet,3 D Maes3 and N Domloge1 1 Vincience, ISP Global Skin Research Center, ISP,
Sophia-Antipolis, France, 2 ISP Corporate Research Center, ISP, Wayne, NJ and 3 Estee Lauder
Research Laboratories, Estee Lauder, Melville, NY
Circadian rhythms are physiological, biochemical and behavioural processes governed by a group
of genes called “biological clock genes” which allow organisms to prepare against environmental
changes. At the molecular level, several gene products are implicated in the central regulation of
circadian rhythms: Clock, BMAL and Period proteins. Our preliminary studies have shown that the
biological clock genes were expressed in the skin. In order to determine cutaneous benefits from
modulating the expression of these biological clock genes, we developed an active ingredient that
specifically target these genes. Keratinocytes and Fibroblasts treated with 1% of the newly devel-
oped molecule IV08.014 showed an increase in Per-1 and Clock proteins expression after 18h of
application. On ex-vivo skin this up-regulation was also observed after 62 h of treatment, in cor-
relation with a great improvement of skin morphology. These results were confirmed by immunoblot-
ting on fibroblasts: clock protein expression reached +54.4% (p=0.044) in presence of IV08-014.
The transfection of normal human keratinocytes with Per1-specific siRNA allowed the silencing of
PER-1 gene expression. This knockdown was partially restored by treatment with IV08.014 com-
pound, suggesting a direct implication in Per-1 expression. Treatment of fibroblasts for 2-7 weeks
with 1% IV08.014 showed a very important decrease in senescent cells number. Studies on irra-
diated ex-vivo skin (100mJ/cm2 UVB), showed a depletion of Clock and Per-1 proteins; this effect
was reversed by treatment with 1% IV08-014 and the benefit was seen as a net decrease in sun-
burn cells number and by a significant protective effect of fibroblasts DNA by comet assay (-39%,
p=0.03). These results suggest strongly that maintenance of biologic rhythms proteins helps the
skin to preserve its youth potency and to protect it from UV stress.
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Use of IL-1alpha release in HaCaT cells for skin irritation evaluation
S Duveau, I Garcia, M Arcioni, E Bauza and N Domloge Vincience, ISP Global Skin Research
Center, ISP, Sophia-Antipolis, France
In terms of the alternative validation process, reconstructed human epidermis model (RHE) is an
expensive and labor intensive test. In the present study, we propose HaCaT cells as a comple-
mentary in vitro model for chemical irritancy testing. The use of immortalized stable HaCaT cells
eliminates a source of the inter-individual variability of the RHE model (different human donors).
As in the RHE model, we focused on interleukin-1 alpha release, one of most important inflam-
matory response markers. First, sodium dodecyl sulfate (SDS), an irritant usually used in skin irri-
tation tests, was chosen as a positive control. We tested a large range of SDS concentrations and
measured IL-1alpha levels secreted in the extracellular medium. Based on the results, we defined
a range of SDS concentrations (0.07%-0.1%) in which high IL-1alpha levels were observed. Asso-
ciated with the ELISA method, intracellular protein levels were measured by a BCA assay in order
to evaluate cell viability. Then, the SDS concentration inducing 50% of cell death (IC50) was estab-
lished. After IL-1alpha release analysis of several assays, the difficulty in segregating between irri-
tants and non-irritants became rapidly apparent. To facilitate the classification of products, an SDS
concentration that comes very close to inducing IC50 was selected, and the corroborated level of
released IL-1alpha was taken as a reference. This value was then compared to IL-1alpha secretion
induced by a test compound. In order to clarify and simplify the interpretation of results, a per-
centage of irritancy (PI) was calculated. A background of several assays allowed us to classify
compounds with a PI<10% as “non-irritant” and those with a PI>10% as “irritant.” The use of this
model, which is more sensitive and less expensive than the RHE model, seems reliable and advan-
tageous as a preliminary and complementary method for pre-clinical skin irritancy testing.
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Modulation of transglutaminase isoform expression and activity in human keratinocytes and
skin biopsies
L Mur,1 A Perrin,1 C Gondran,1 J Botto,1 N Garcia,1 F Portolan,1 C Dal Farra2 and N Domloge1 1
Vincience, ISP Global Skin Research Center, ISP, Sophia-Antipolis, France and 2 ISP Corporate
Research Center, ISP, Wayne, NJ
Transglutaminases (TGases) are calcium-dependent enzymes that catalyze the formation of ε-(γ-
glutamyl) lysine bonds, conferring stability of cross-linked proteins. Among the TGases expressed
in the skin, TGases 1, 3, and 5 take part in the formation of the cornified envelope, whereas TGase
2, is implicated in matrix remodeling and the wound healing. In these studies, we tried to modu-
late the expression of these different types of TGases and their main substrates in human ker-
atinocytes (NHK) and human skin biopsies. Analyses were performed by immunoblotting and
immunofluorescence staining (IF). Our results indicated that IV08.008, a newly developed active
to selectively modulate TGases expression, increased the synthesis of transglutaminases 1, 3, and
5, as well as the substrate molecules involucrin and loricrin, confirming their relatedness. Inter-
estingly, an increase in TGase 1, involucrin and loricrin staining was also observed in cultured
human skin biopsies induced in a similar fashion. Moreover, on the basis of the implication of
TGase 2 in wound healing, fibroblast migration capacity was observed at different time points in
a two-compartment chamber. This study revealed that fibroblast treatment with the TGase-induc-
ing active ingredient could enhance fibroblast migration and wound healing. In order to evaluate
the effect of TGase selective induction on TGase activity, NHK were incubated in the presence of
fluorescein-labelled cadaverine, which acts as an amine donor for the TGase reaction. This study
showed a significant increase in TGase activity, with a 24 to 48 hour treatment. si-RNA approach
for TGase 1 showed that incubation with IV08.008 in the presence of si-RNA could, in part, reverse
the si-RNA effect on TGase 1 expression, as confirmed by IF. In conclusion, these studies showed
a positive modulation of TGases that suggests a beneficial effect on cornified envelope assembly
and skin barrier function, as well as matrix stability in wound repair.
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Role of telomere-associated protein TRF2 in cell aging
A Amoyel,1 L Bergeron,1 C Gondran,1 J Botto,1 N Garcia,1 I Imbert,1 C Dal Farra2 and
N Domloge1 1 Vincience, ISP Global Skin Research Center, ISP, Sophia-Antipolis, France and
2 ISP Corporate Research Center, ISP, Wayne, NJ
Telomeres behave like “virtual aging clocks” by determining the number of times cells can divide.
Some proteins associated with telomeres can stabilize the loss of genetic material by capping
chromosome ends. This protection prevents deleterious events due to chromosome instability,
which can lead to apoptosis or cellular senescence. The complex of telomeric proteins maintains
the structure of telomere in the T-loop, the protective form of telomeres. Our studies focused on
the expression of the TRF2 protein, which plays an important role in telomere stabilization. Through
RNA silencing experiments, using si-RNA directed to the TRF2 protein, we observed that TRF2
silencing led to an increase in p53 expression in human fibroblasts, as well as increased senes-
cence-associated beta-galactosidase marker expression. However, we also observed that selective
TRF2 induction by the newly developed active IV08.007 could partially restore TRF2 expression,
in fibroblasts transfected with TRF2 si-RNA, and hence, could compensate for increased senes-
cence induced by TRF2 RNA silencing. Furthermore, we used a model of human dermal fibrob-
lasts, aged in vitro by repeated subcultures, and treated with a TRF2-inducing agent throughout
their aging in culture. By comparing these fibroblasts at different stages, we observed a decrease
in TRF2 immunostaining as the aging of the fibroblasts progressed. Interestingly, TRF2 expression
in these aged cells was restored by selective treatment with IV08.007. These results were confirmed
by western blot. Moreover, staining of the senescence-associated beta-galactosidase marker, which
increased in aged fibroblasts, also decreased when TRF2 was induced. In conclusion, our results
indicate that modulation of TRF2 telomeric protein expression in cells may play a key role in cell
aging.
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Mitochondrial mass is related to a protective effect against UV-induced apoptosis
J Botto,1 E Bauza,1 G Menon,2 R McMullen,2 G Bressier,1 C Gondran,1 C Dal Farra2 and
N Domloge1 1 Vincience, ISP Global Skin Research Center, ISP, Sophia-Antipolis, France and
2 ISP Corporate Research Center, ISP, Wayne, NJ
In eukaryotic cells, mitochondria are essential organelles in charge of ATP production through
oxidative phosphorylation and lipid oxidation. Acquired or induced dysfunction of mitochondrial
metabolism can participate in initiating cell programmed death and apoptosis. As oxygen metab-
olism generates reactive oxygen species and free radicals, mitochondria have developed several
essential antioxidant systems, both enzymatic and non-enzymatic, such as MnSOD, catalases,
and cytochrome C. When cytochrome C capacity to trap O(2) is reduced, for example, after stress
or hypoxia, the cellular redox potential is altered, thus leading to the accumulation of electrons
that induce the formation of ROS. Thus, we studied the effect of UV stress on cultured human skin
fibroblasts, by measuring mitochondrial mass and membrane potential, as well as apoptotic cell
death. We evaluated the mitochondrial mass of a population of skin fibroblasts by Fluorescence
Activated Cell Sorting (FACS) after 10 nonyl acridine orange staining of mitochondria. We observed
that the IV08.005 compound, already known for its ability to stimulate cytochrome C expression
and cytochrome C oxidase activity, was able to increase mitochondrial mass. For apoptosis induc-
tion, fibroblasts were UVB irradiated (150 mJ/cm2, corresponding to 55% of induced apoptotic
cells, 12h after UV irradiation), incubated for 36h in culture, with or without the cytochrome C
inducer, and then cultivated for 16h, with or without cytochrome C induction. Cells were labeled
with Annexin V-FITC and propidium iodide and then submitted to flow cytometry analysis. The
percentage of apoptotic cells corresponded to the total of Annexin V positive and Annexin V/PI
double positive cells. Significant protection from UV-induced apoptosis was observed in cells where
cytochrome C was induced by IV08.005 treatment. In conclusion, increase in mitochondrial mass
correlated with better cell resistance to UV-induced apoptosis in skin fibroblasts.
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Flow cytometric assessment of protection of skin fibroblasts from oxidative stress and UV-
induced apoptosis
J Botto,1 E Bauza,1 C Gondran,1 R Chabert,1 N Garcia,1 C Dal Farra2 and N Domloge1 1
Vincience, ISP Global Skin Research Center, ISP, Sophia-Antipolis, France and 2 ISP Corporate
Research Center, ISP, Wayne, NJ
Oxidative stress and UV irradiation are implicated in the alteration of cutaneous mitochondrial
metabolism, leading to premature cell death. Moreover, coenzyme Q10 is known to play an
essential role in mitochondrial energy synthesis and antioxidative stress protection. In this study,
we further investigated the deleterious effects of hydrogen peroxide (H2O2) on mitochondrial res-
piratory functions and UV irradiation on skin fibroblast apoptosis. Additionally, we compared the
chemopreventive effects of the IV08.004 compound, which we previously described to possess an
effect on mitochondrial redox metabolism and apoptosis. We evaluated hydrogen peroxide cyto-
toxicity on cultured cells by following the level of the free radicals produced. Human skin fibrob-
lasts were grown for 48h, treated for 30 minutes with H2O2, and then allowed to recover for 2h.
For apoptosis induction, fibroblasts were UVB-irradiated (150 mJ/ cm2) after 36h, and then main-
tained in culture for 16h for recovery. In parallel, the same treatments were applied in the pres-
ence of the IV08.004 compound. After H2O2or UV treatment, cells were harvested and then sub-
mitted to ROS measurement with dihydroxy-ethidium, or to cell death measurement by annexin
V-FITC labeling. Analyses were performed by flow cytometry. To evaluated apoptosis, cells were
labeled with recombinant annexin V-FITC. Then, propidium iodide was added and samples were
analyzed immediately by flow cytometry. The percentage of apoptotic cells corresponded to the
total of annexin V positive and annexin V/PI double positive cells. The IV08.004 compound exhib-
ited the property of significantly reducing the level of free radicals produced in response to the
H2O2application (-22%) and also of protecting from UV-induced apoptosis (-27%), compared to
the control. These studies shed more light on the effects of oxidative stress and the essential role
of mitochondrial protection
420
Modulation of caspase-14 expression plays a key role in DNA repair and protection
L Bergeron,1 F Labarrade,1 A Amoyel,1 C Serre,1 C Gondran,1 J Botto,1 N Garcia,1 C Dal Farra2
and N Domloge1 1 Vincience, ISP Global Skin Research Center, ISP, Sophia-Antipolis, France
and 2 ISP Corporate Research Center, ISP, Wayne, NJ
Caspase-14 is involved in keratinocyte terminal differentiation cell death program of cornification.
Caspase-14 is involved in the processing of profilaggrin into filaggrin, which is further degraded
into free amino acids, constituting the NMF. Therefore, caspase-14 plays a crucial role in protect-
ing skin from dehydration, and from the harmful effects of UV. In the present study, caspase-14
expression in different cell lines was investigated by RT-PCR studies. Caspase-14 transcripts were
detected in HaCaT cells and normal human keratinocytes (NHK), but not in human fibroblasts and
melanocytes. Immunofluorescence (IF) studies on NHK and human skin biopsies showed that cas-
pase-14 expression could be induced selectively within 24 hours of treatment with our newly devel-
oped IV08.003 active. By using si-RNA on caspase-14, we observed an inhibition of 30.6% in cas-
pase-14 expression that was significantly restored by the induction of caspase-14 by IV08.003.
Because profilaggrin is considered a direct substrate of caspase-14, IF staining studies for profi-
laggrin were performed on human skin biopsies, treated with caspase-14 inducing active ingredi-
ent for 24 to 72 hours. We observed an increase in profilaggrin staining at the different time points
studied. This increase could be the result of a compensation mechanism, resulting from an increase
in profilaggrin cleavage by caspase-14. Our studies also investigated the effects of UVB-irradiation
on caspase-14 expression. As previously described, caspase-14 expression was up-regulated in
NHK irradiated with a dose-effect of UVB. Comet assays showed that caspase-14 induction pro-
moted DNA protection and repair, depending on whether the induction was performed before or
after UVB irradiation. In conclusion, these results indicate that caspase-14 can play an important
role in preventing and repairing UVB-induced DNA damage, in addition to its effect on skin bar-
rier function.
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SNAP29, a protein deficient in CEDNIK syndrome, is expressed in the lamellar granules and
is regulated during epidermal differentiation in a PPAR-γ dependent fashion
D Fuchs,1 J Lugassy,2 M Indelman,3 H Stewart4 and E Sprecher1 1 Department of Dermatology,
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2 Faculty of Medicine, Technion – Israel
Institute of Technology, Haifa, Israel, 3 Department of Dermatology, Rambam Health Care
Campus, Haifa, Israel and 4 Department of Clinical Genetics, Churchill Hospital, Oxford,
United Kingdom
Cerebral dysgenesis, neuropathy, ichthyosis and keratoderma (CEDNIK) syndrome is a rare geno-
dermatosis which has been shown in one family to result from a loss-of-function mutation in
SNAP29, encoding a member of the SNARE family of proteins. Decrease in SNAP29 expression
was found to result in abnormal lamellar granule maturation ensuing in aberrant epidermal dif-
ferentiation and ichthyosis. In the present study, we systematically screened families affected by
atypical neurocutaneous disorders. We identified a homozygous insertion in SNAP29 (c.486insA)
in two sibs presenting with ichthyosis and agenesis of the corpus callosum. To further investigate
this unique phenotype, we studied the sub-cellular localization and regulation of SNAP29 in human
keratinocytes. We found that SNAP29 co-localizes with trans-Golgi (e.g. galactosyltransferase) and
lamellar granule (e.g.cathepsin D) markers. In addition, we showed that SNAP29 is up-regulated
by a number of agents known to induce keratinocyte differentiation (e.g. high calcium and PPARγ
agonists). Interestingly, inhibition of the PPAR-γ pathway prevented calcium-induced SNAP29 up-
regulation at the RNA and at the protein level, indicating that calcium up-regulates SNAP29 through
the PPAR-γ pathway. In line with these results, calcium induced up-regulation of a SNAP29 pro-
moter-luciferase reporter construct activity was abolished in the presence of a PPAR-γ inhibitor. In
conclusion, our present results (1) establish CEDNIK syndrome as a novel clinical entity associ-
ated with defective SNAP29 expression, (2) position SNAP29 as an essential component of the epi-
dermal differentiation machinery, and (3) suggest the importance of PPAR-γ in the biogenesis of
the lamellar granules.
423
Glucocorticoid receptor enhances the keratinocyte differentiation in a ligand-independent
manner
H Yoon,1 K Sohn,1 D Choi,1 C Hwang,1 Y Lee,1 T Yoon,2 Y Lee,1 C Kim1 and J Lee1 1 Chungnam
National University, Daejeon, Korea, South and 2 Gyeongsang National University, Jinju,
Korea, South
Glucocorticoid receptor (GR) is a member of nuclear receptors that exerts its role as a transcrip-
tion factor. In addition, GR affects the cytoplasmic signal pathway by crosstalk with various sig-
naling molecules, thereby modulating the downstream gene expression. To investigate the role of
GR in epidermis, we first performed immunohistochemistry analysis. Interestingly, GR expression
was highly increased in upper granular layer of skin tissues. Consistent with, GR expression was
markedly increased by calcium treatment of normal human epidermal keratinocytes cultured in
vitro, suggesting that GR may be involved in keratinocyte differentiation process. We made the
adenovirus expressing GR, and then examine the effect of GR overexpression on keratinocyte dif-
ferentiation. Results showed that the expression of involucrin, an early differentiation marker of
keratinocyte, was markedly increased by GR overexpression. However, treatment of dexametha-
sone, a GR agoinst, did not increase the involucrin expression. Interestingly, overexpression of GR
led to the phosphorylation of JNK and ERK in the absence of glucocorticoid, suggesting that GR
effect on keratinocyte differentiation may be related with activation of intracellular signaling cas-
cades. This notion was supported by the fact that GR-mediated involucrin induction was abolished
by the treatment of JNK and ERK inhibitors. In addition, GR mutants lacking the ligand binding
domain also increased the involucrin expression in the absence of glucocorticoid. Together, these
results suggest that GR modulates the keratinocyte differentiation by regulating the intracellular
signaling network in a ligand-independent manner.
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Role of Brn2 in keratinocyte differentiation
G Shi,1 K Sohn,1 D Choi,1 N Kim,1 K Lee,1 Y Lee,1 T Yoon,2 Y Lee,1 C Kim1 and J Lee1 1
Chungnam National University, Daejeon, Korea, South and 2 Gyeongsang National
University, Jinju, Korea, South
The epidermis, the outer layer of the skin composed of keratinocytes, is a stratified epithelium that
functions as a barrier to protect the organism from dehydration and external insults. Much of this
protective function is provided by highly sophisticated and tightly regulated process of keratinocyte
differentiation. In this study, we investigated the role of Brn2, a POU domain transcription factor,
using in vivo and in vitro test models. The expression of Brn2 was remarkably increased in upper
granular layer of skin tissue, and also highly induced by calcium treatment of normal human epi-
dermal keratinocytes cultured in vitro. To examine its putative role, we made the recombinant ade-
novirus expressing Brn2, then transduced into the cultured human keratinocytes. Interestingly,
overexpression of Brn2 led to the increase of gene expression for several differentiation-related
genes, such as filaggrin, loricrin and involucrin. These results suggest that Brn2 exerts its role as a
differentiation-related transcription factor. Actually, chromatin immunoprecipitation assays revealed
that Brn2 bound to the promoters of loricrin and involucrin, indicating that Brn2 is an authentic
transcription factor directly involved in keratinocyte differentiation. When the recombinant ade-
novirus expressing Brn2 was intradermally injected into the rat skin, it provokes the thickening of
epidermis and highly increased expression of differentiation markers. Together, these results sug-
gest that Brn2 is an important transcription factor regulating the keratinocyte differentiation posi-
tively.
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Sequential down-regulation of the skin barrier homeostasis in Otsuka Long-Evans Tokushima
Fatty (OLETF) rat, type 2 diabetes animal model, with age
H Park,1 M Jung,1 C Chung2 and E Choi1 1 Dermatology, Yonsei University Wonju College of
Medicine, Wonju, Korea, South and 2 Internal Medicine, Yonsei University Wonju College of
Medicine, Wonju, Korea, South
Type 2 diabetes mellitus (DM) is a highly prevalent disease and induces many skin problems such
as xerosis, pruritus, skin infection and delayed wound healing. However, little is known about the
skin barrier state in diabetic patients. In this study, we investigated whether type 2 DM down-reg-
ulates skin barrier homeostasis relative to disease duration, and its pathomechanism. We used
Otsuka-Long-Evans-Tokushima-Fatty (OLETF) rats as an animal model of human type 2 diabetes
and Long-Evans-Tokushima-Otsuka (LETO) rats as a control strain. At the ages of 15, 20, 30 and
45 weeks, metabolic changes and skin barrier homeostasis were evaluated. Body weight and hemo-
globin A1c were significantly increased in OLETF rats with age. Glucose level was significantly
higher in OLETF rats by intraperitoneal glucose tolerance test. These results represent that OLETF
rat is a useful animal model for human type 2 DM. In terms of skin barrier state, there was no dif-
ference between two groups until 20th week; however, OLETF rats demonstrated delayed barrier
homeostasis from 30th week on. In conclusion, type 2 DM down-regulates the skin barrier home-
ostasis relative to disease duration, which becomes one of the main pathophysiologies underlying
cutaneous problems of DM.
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IGFBP7, a biomarker deficient in psoriatic plaques and induced by UVB phototherapy, reg-
ulates keratinocyte proliferation, differentiation and apoptosis
J Nousbeck,1 O Sarig,2 N Avidan,1 M Indelman,3 R Bergman,3 M Ramon,3 C Enk4 and E Sprecher2
1 Translational Genetics, Technion – Israel Institute of Technology, Haifa, Israel, 2 Department
of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 3 Department of
Dermatology, Rambam Health Care Campus, Haifa, Israel and 4 Department of
Dermatology, Hadassah Hebrew University Medical School, Jerusalem, Israel
Insulin-like growth factor (IGF)-binding protein (IGFBP) 7 has been shown to function as a potent
tumor suppressor gene. Recently, a global gene expression study revealed that IGFBP7 is down-
regulated in the psoriatic epidermis, with UVB phototherapy restoring its expression to normal. In
a large series of biopsies, we confirmed these results at the protein level. These data suggest that
IGFBP7 may be involved in the pathogenesis of psoriasis, and more generally, in the regulation of
keratinocyte proliferation and differentiation, which are abnormal in psoriasis. To model IGFBP7
down-regulation in vitro, we used lentiviral vectors expressing IGFBP7-specific shRNA and con-
trol shRNA in HaCat cells and in primary human keratinocytes. Down-regulation of IGFBP7 was
found to enhance keratinocyte proliferation in both systems as assessed by MTT and BrdU incor-
poration assays. In addition, IGFBP7 down-regulation was associated with a marked decrease in
keratinocyte susceptibility to TNF-α-induced apoptosis but lacked any effect on senescence. Down-
regulation of IGFBP7 was also found to block calcium-induced differentiation of human keratinocytes
as assessed by KRT10 and involucrin expression and morphometry. Moreover, we found out that
IGFBP7 down-regulation caused a global block in the differential expression of more than 300
genes associated with calcium-induced keratinocyte differentiation. Finally, recombinant IGFBP7
was found to significantly inhibit keratinocyte proliferation. These data position IGFBP7 as a
major regulator of keratinocyte proliferation and differentiation, suggesting a potential role for this
protein in the treatment of psoriasis and other hyperproliferative dermatoses.
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Cannabinoïd receptors 1 and 2 oppositely regulate permeability barrier status and epider-
mal differentiation
T Roelandt,1 S Bedrif,2 C Heughebaert,1 C Giddelo,1 C Baudouin,2 P Miska,2 PM Elias,3
D Roseeuw1 and J Hachem1 1 Dermatology, Vrije Universiteit Brussel, Brussels, Belgium, 2
Laboratoires Expanscience, Epernon, France and 3 University of California San Francisco, San
Francisco, CA
Since both cannabinoïd receptors (CB) 1 and 2 are expressed within the suprabasal levels of the
epidermis, and more specifically at the stratum granulosum (SG)/ stratum corneum (SC) interface,
we addressed their participation in permeability barrier homeostasis and epidermal differentia-
tion. Permeability barrier abrogation was induced by sequential tape stripping of the SC and assessed
in both CB1 and CB2 knockout mice (-/-) in comparison with wild type littermates (+/+). Unlike
CB2 -/-, absence of CB1 delays permeability barrier recovery. The ultrastructural basis for accel-
erated barrier recovery in CB2 -/- was assessed by electron microscopy and shows enhanced pro-
cessing of SC lamellar bilayers. Contrariwise CB1 animals respectively display strong alteration in
these lamellae. Markers for epidermal differentiation assessed by western immunoblotting (i.e. filag-
grin, loricrin and involucrin) and terminal differentiation (i.e. TUNEL assay and western immunoblot-
ting for caspase-14) were respectively decreased or increased in CB1 and CB2 -/- mice. All the
same, mRNA levels of Keratin 1/10 were decreased and Cyclin D1/P21 increased when specific
CB1 agonists were applied on cultured human keratinocytes. Finally, the epidermis of CB1 -/-
mice displays a propensity towards epidermal hyperplasia (i.e. increased epidermal thickness and
PCNA assay). All together, these observations put forward the importance of cannabinoïd signal-
ing for the regulation of permeability barrier and epidermal differentiation and consequently may
become a pharmaceutical target for diseases with abnormal epidermal structure and function.
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Sweat is the origin of natural moisturizing factors such as lactate and potassium. A study on
the patients with localized anhydrosis
A Watabe,1 M Ozawa,1 K Kikuchi,1 T Sugawara,2 S Sakai2 and S Aiba1 1 Department of
Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan and 2 Kanebo
Cosmetics Inc, Odawara, Japan
Amino acids (AAs) have been established to play important roles in maintaining the optimal hydra-
tion state of stratum corneum (SC) as a natural moisturinzing factor (NMF). Recently, we have
reported that, other than AAs, lactate and potassium significantly affect the hydration state of SC.
In this study, to explore the source of lactate and potassium in SC, we compared the concentration
of various NMFs such as AAs, pyrrolidone carbonic acid (PCA), lactate, sodium, and potassium in
the SC between anhydrotic area and adjacent hydrotic area of the patients with localized anhy-
drosis. We examined 5 anhydrotic areas with adjacent control skin of 4 different patients. We first
determined anhydrotic and hydrotic areas of the patients by iodine starch method. Then we deter-
mined the hydration state of SC by measuring the high-frequency conductance. We also measured
the content of sodium, potassium, lactate, and AA in the SC obtained from anhydrotic and adja-
cent hydrotic areas by stripping with adhesive tape. The cation content, the lactate content, and
the AA content of the SC were analyzed by an ion chromatography, a commercial kit using lactate
dehydrogenase, and our developed method using o-phthaladehyde, respectively. Anhydrotic areas
showed significantly low hydration state of SC. Among various NMFs we examined, only lactate,
Na, and potassium were significantly decreased in the SC of anhydrotic areas compared with
those in the SC of hydrotic areas. On the other hand, free AAs and PCA were rather increased in
the SC of anhydrotic areas. These data suggest that NMFs other than AA, lactate and potassium are
derived from sweat, suggesting the crucial role of sweating in maintaining the physiological hydra-
tion state of SC.
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Localization of MFG-E8 (milk fat globule-associated protein with EGF- and Factor VIII-like
domains) in normal murine skin
S Motegi, C DeWitt, W Leitner, K Nagao and MC Udey Dermatology Branch, Center for Cancer
Research, National Cancer Institute, NIH, Bethesda, MD
MFG-E8 is a secreted glycoprotein with at least 2 functional domains and at least 2 functional activ-
ities. The amino-terminus of MFG-E8 binds to αvβ3/5 integrins and the carboxy-terminus binds to
negatively charged phospholipids. These domains facilitate opsonization of apoptotic cells for
uptake by phagocytes as well as enhancement of VEGF-dependent angiogenesis. Although it has
been demonstrated that MFG-E8-deficient mice are prone to develop autoimmune disease and are
resistant to tumor formation, it is uncertain what, if any, function MFG-E8 performs in skin. To begin
to address this issue, we developed a high affinity, highly specific rabbit polyclonal antibody reac-
tive with native murine MFG-E8 that was vastly superior to four monoclonal antibodies that we
also generated, and utilized this reagent to examine the distribution of MFG-E8 in normal BALB/c
mouse ear skin. Consistent with some, but not all, previous reports, staining of epidermal sheets
revealed that MFG-E8 co-localized exclusively with epidermal Langerhans cells. Staining of cor-
responding dermal sheets allowed comprehensive surveys of dermal vasculature. In the dermis,
accumulations of MFG-E8 were found around CD31 positive blood vessels, but not lymphatics.
MFG-E8 deposits frequently occurred in approximation to vascular branch points where they may
be associated with pericytes. We also identified subcellular punctate staining in linear arrays jux-
taposed and external to podoplanin and S-100 positive nerve fibers. Our results are consistent
with previous studies implicating MFG-E8 in leukocyte and vascular physiology, and also suggest
that this enigmatic protein may play a role in peripheral nervous system function.
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Abnormal lamellar body formation and secretion in Sjögren-Larsson syndrome is responsi-
ble for the defective epidermal water barrier
WB Rizzo,1 D S’Aulis,1 MA Jennings,2 D Crumrine,3 ML Williams3 and PM Elias3 1 Pediatrics,
University of Nebraska Medical Center, Omaha, NE, 2 Genetics, Cell Biology and Anatomy,
University of Nebraska Medical Center, Omaha, NE and 3 Dermatology, University of
California, San Francisco, CA
Sjögren-Larsson syndrome (SLS) is a genetic disease characterized by ichthyosis, mental retarda-
tion and spasticity. It is caused by mutations in the ALDH3A2 gene coding for fatty aldehyde dehy-
drogenase (FALDH), an enzyme necessary for oxidation of fatty aldehydes and fatty alcohols. Cul-
tured SLS keratinocytes accumulate fatty alcohols and related lipids. We investigated the cutaneous
abnormalities in SLS to better understand how the enzymatic deficiency results in epidermal dys-
function. The histopathology of the skin was investigated in 8 SLS patients (5 M, 3 F) ranging in
age from 1 yr to 34 yrs. All patients had deficient FALDH activity in cultured skin fibroblasts and
carried pathologic ALDH3A2 mutations. Light microscopy of skin biopsies showed epidermal hyper-
plasia, spongiosis, hyperkeratosis and scattered vacuolated granular cells. Histochemical staining
for FALDH enzyme activity was profoundly reduced in the epidermis. Ultrastructural studies of the
skin using ruthenium/OsO4 post-fixation revealed a normal abundance of lamellar bodies (LB),
many of which had disrupted limiting membranes and were empty or possessed non-lamellar
contents. The stratum granulosum-stratum corneum (SC) interface was occupied by non-lamellar
material that displaced or replaced secreted lamellar membranes. There were decreased lamellar
bilayers in the SC and evidence of lamellar/non-lamellar phase separation. Entombed LB were pres-
ent in the periphery of the outer SC cells suggesting blockade of LB secretion. Colloidal lanthanum
perfusion studies showed abnormal movement of tracer into the extracellular spaces of the SC
consistent with a leaky water barrier. These studies suggest that abnormal lipid metabolism in SLS
is responsible for a global disruption of LB formation and secretion, resulting in a defective SC and
impaired water barrier.
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Did stress to the barrier influence the development of pigmentation in humans?
PM Elias,1 G Menon2 and JW Williams3 1 Dermatology, VA Med Ctr/UCSF, San Francisco, CA,
2 Global R&D, ISP Corp, Wayne, NJ and 3 Geography Dept., Univ of Wisconsin, Madison,
WI
Since current explanations for the development of epidermal pigmentation during human evolu-
tion are not tenable as stand-alone hypotheses, we propose instead that xeric- and UV-B-induced
stress to the permeability barrier could have ‘driven’ cutaneous pigmentation, because: 1)
Megadroughts prevailed in central Africa when hominids expanded into open savannahs [≈1.5-
0.8 mya]), resulting in sustained exposure to both extreme aridity and erythemogenic UV-B, cor-
relating with genetic evidence that pigment developed ≈ 1.2 mya. 2) Pigmented skin is endowed
with enhanced permeability barrier function, stratum corneum integrity/cohesion, and less sus-
ceptibility to infections. Enhanced cutaneous function can be attributed to the lower pH of outer
epidermis, which is linked to the persistence of more-acidic melanosomes and the conservation
of genes associated with eumelanin synthesis and melanosome acidification (e.g., TYR, OCA2,
MATP, p protein). Five keratinocyte-derived signals (stem cell factorÇKIT; FOXn1ÇFGF2; IL-1α,
NGF, and p53) are candidates which may have stimulated the sequential development of epider-
mal pigmentation.
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Topical imiquimod and calcipotriol stimulate antimicrobial peptide expression in mouse epi-
dermis
M Rodriguez-Martin,1,2 M Hupe,1 M Man,1 J Naya3 and PM Elias1 1 Dermatology, VA Med
Ctr/UCSF, San Francisco, CA, 2 Dermatology, Hospital Univ de Canarias, Tenerife, Spain and
3 ISDIN, Barcelona, Spain
Conventional therapy for infectious diseases, which relies on the administration of microbicidal
antibiotics/antiseptics, appears to be in a losing battle due to the rapid emergence of antimicrobial
resistance. An intriguing alternate approach is to enhance innate immunity by upregulation of
endogenous antimicrobial peptide (AMP) expression. We assessed here whether two commonly-
deployed, topical therapeutic agents (imiquimod [IMQ] and the 1,25(OH)2D3 analogue, cal-
cipotriol), with known activity as immune response modifiers, upregulate epidermal AMP expres-
sion. Commercially-available formulations of IMQ, calcipotriol, and their vehicles were applied
twice-daily to normal hairless mouse epidermis for 7 days. Changes in immunostaining for mouse
cathelicidin AMP (CAMP) and mouse beta-defensin 3 (homologue of human LL-37 and hBD2,
respectively) were assessed by immunofluorescence. IMQ and calcipotriol both increased expres-
sion of CAMP and mBD3, but the changes were more ‘patchy’ following calcipotriol treatment.
Increased immunostaining further localized in a vesicular pattern to the outer stratum granulosum,
consistent in its known localization to lamellar bodies and the stratum corneum. These results could
explain the benefits of IMQ for the treatment of cutaneous viral infections, and conversely, the low
incidence of secondary infections in iatrogenic, IMQ-induced ulcerations. These results demon-
strate properties of these two commonly-deployed agents that could substantially broaden their
therapeutic applications.
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Barrier injury to the stratum corneum by acetone causes a marked increase in hyaluronan
that is mediated via the EGF receptor pathway in a 3-D epidermal keratinocyte model
J Monslow, G Ajani and EV Maytin Biomedical Engineering, Cleveland Clinic, Cleveland, OH
Superficial barrier injury in vivo results in a marked increase in the ubiquitous matrix molecule
hyaluronan (HA) together with increased epidermal hyperplasia. Treatment with hyaluronidase
blunts this response, implying that HA functionally participates in injury-induced hyperplasia. In
order to better understand the molecular mechanism(s) of this response in the epidermis, we used
an in vitro bioengineered 3-D model of acetone-induced injury using rat epidermal keratinocyte
(REK) cultures. Fully stratified cultures were treated with 1, 2 or 3 doses of acetone over a period
of 24 hours. Samples were fixed and stained for histological and immunohistochemical analysis.
Total HA content was measured using the FACE technique, and HA size was determined using
agarose gel analysis. The levels of the HA synthetic enzymes (Has1, 2 and 3) along with their HA-
degrading counterparts (Hyal1, 2 and 3) were measured by RT-PCR. Involvement of the EGF recep-
tor (EGFR) pathway was determined using media-transfer experiments from acetone-treated cul-
tures. Finally, a lentiviral vector encoding the Hyal2 gene was introduced to the REK cultures prior
to acetone barrier injury. Two and three acetone treatments caused a marked increase in epider-
mal hyperplasia, a thickened stratum corneum and parakeratosis. HA production was increased,
and size analysis showed an increase in high molecular weight HA. This was coupled with an
upregulation of Has2 and Has3, as observed by RT-PCR. Media transfer experiments from ace-
tone-treated cultures induced HA synthesis in uninjured cultures. This response was blocked by
the EGFR inhibitor AG1478 in a dose dependent manner. Overexpression of Hyal2 (introduced by
lentivirus) disrupted normal epidermal morphology showing a reduced stratum corneum and
increased apoptosis in untreated samples, and blocked acetone-induced hyperplasia by 50 per-
cent.
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Epidermal barrier dysfunction in HIV: Relationship to immune status, antiretroviral therapy,
and atopy
R Gunathilake,1 M Schmuth,2 TC Scharschmidt,1 TM Mauro,1 TA Maurer,1 LS Kieron1 and
PM Elias1 1 Dermatology, UCSF, San Francisco, CA and 2 Dermatology, Univ of Innsbruck,
Innsbruck, Austria
Patients infected with human immunodeficiency virus (HIV) often experience xerosis, pruritus, and
eczematous dermatitis, which reportedly occur more common in patients receiving antiretroviral
therapy. Although it has been proposed that these complications reflect a worsening of pre-exis-
tent atopic dermatitis, HIV infection itself provokes a TH2 immunophenotype, suggesting the alter-
native possibility that a primary immune abnormality drives subsequent epidermal changes. Accord-
ingly, we assessed cutaneous permeability barrier status in 42 HIV+ and 12 age/ethnicity matched
control subjects with no prior or current history of atopic dermatitis. Most of the HIV+ patients
were receiving antiretroviral therapy, including a protease inhibitor. HIV+ patients displayed abnor-
mal basal barrier function, assessed as a modest increase in basal TEWL rates (p = <0.001), an
abnormality that became more prominent in a subgroup of HIV+ patients with xerotic eczema.
CD4+ cell nadirs (<150) correlated significantly with prominent skin dryness, as noted both by
physicians and patients. In contrast to prior reports, antiretroviral therapy did not aggravate xero-
sis, and stratum corneum (SC) hydration also remained normal, suggesting that this complication
could occur preferentially in patients with prior or current atopic dermatitis. Moreover, since the
barrier abnormality is not linked to atopic dermatitis, our results suggest an initial TH2-driven,
‘inside-to-outside’ pathogenesis of the barrier abnormality in HIV disease. Since barrier function
worsens in patients that develop xerotic eczema, the ‘inside-to-outside’ pathogenesis may then be
followed by a cytokine cascade, which promotes the development of inflammation in HIV+ patients.
435
Keratin network mediates the stiffness of human keratinocytes
V Lulevich,1 H Yang,2 RR Isseroff2 and G Liu1 1 Chemistry, UC Davis, Davis, CA and 2
Dermatology, UC Davis, Davis, CA
Skin is required for resisting the physical pressure of the body movements. Daily activities like
walking and sitting generate contact pressure, which is directly transferred to the keratinocytes in
the epidermis. The physical properties of keratinocytes play an important role in resisting these
pressures, but are poorly understood. Here we use atomic force microscopy-based cell compres-
sion to study the physical properties of normal human keratinocytes (NHK) at the single cell level.
Cell compression on adherent NHK revealed a high resistance of physical pressure (4-7 μN force
for 80% deformation) compared to T-cells (0.2-1 μN, Lulevich et al., 2006) and cells formed plasma
membrane blebs to release the hydrostatic pressure from the compression. By introducing a sim-
ple analytical model, we estimate that the Young’s modulus of keratinocyte is as high as 120-340
kPa. Since nuclear composition is highly conserved and the nuclear compression only accounts
for a negligible force (estimate Young’s modulus 1-5 kPa, Dahl et al., 2005), we propose that the
unique physical stiffness of human keratinocytes may result from their cytoskeleton networks. To
further investigate the contribution of cytoskeleton of NHK stiffness, we performed the cell com-
pression on keratinocytes with defective actin, microtubules or keratin networks. We selectively
disrupted F-actin by latrunculin A, or microtubules by nacodazole, before compression. Both treat-
ments did not alter the stiffness of NHK during compression. In F-actin depleted NHK, the plasma
membrane completely detached from cells after compression, suggesting blebbing may occur at
the non-actin associating regions of membrane. Compression of a keratin-mutant cell line, KEB-7
demonstrated a 50% decrease of the compression force of 1-1.6 μN at 80% deformation when
compared with the control of immortalized NEB-1 (1.4-2.8 μN). The results suggest that the ker-
atin network, but not actin or microtubule networks, is the major factor contributing to the unique
stiffness of keratinocytes.
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Detection of calcium gradients in live ex vivo human epidermis using a novel approach based
on phasor analysis of two-photon excitation Fluorescence Lifetime Imaging (FLIM)
A Celli,1 SA Sanchez,2 M Behne,3 T Hazelet,2 E Gratton2 and T Mauro1 1 Dermatology, VAMC-
UCSF, San Francisco, CA, 2 Biomedical Engeneering, University of California Irvine, Irvine,
CA and 3 Dermatology and Venerology, University Hospital Hamburg-Eppendorff,
Hamburg, Germany
Ionic gradients are found across a variety of tissues, and control vital functions in skin. It has been
difficult to accurately measure whole tissue ionic gradients in vivo, as previous methods have been
ill-suited to address problems of tissue thickness, concentration artifacts, and calibration across
inhomogeneous tissue. Here we show that a novel, minimally invasive, experimental and analytic
imaging approach accurately quantifies and localizes the free Ca2+ gradient in ex vivo epidermis
and dermis, and allows simultaneous analysis of epidermal morphology and Ca2+ concentrations
in the same samples. This method is based on the combination of two-photon excitation fluores-
cence lifetime imaging (FLIM) and a novel data analysis technique based on the phasor represen-
tation of the FLIM data (Digman et al 2008). Skin samples from adult patients were incubated with
the fluorescent calcium sensitive dye Calcium Green 5N (CG5N) whose lifetime is sensitive to vari-
ation in calcium concentrations. The use of two-photon excitation provides high axial and lateral
spatial resolution, deep tissue penetration, and low out of focus photodamage, while the phasor
plot analysis allows calibrating the response of the dye to calcium directly in tissue. The high spa-
tial resolution offered by this method and the data analysis performed allowed us to measure
intracellular average calcium concentrations directly in tissue and detect a previously unknown
bimodal distribution of Ca2+ concentrations in the proliferative epidermal basal layer. This approach
reveals that the extracellular space in epidermis is much narrower than previously thought, local-
izes most epidermal Ca2+ to intracellular stores. These new findings suggest that long-held hypothe-
ses addressing Ca2+ control of differentiation and barrier formation require revision.
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Ovol2 inhibits transient expansion and terminal differentiation of epidermal progenitor
cells by repressing c-Myc and Notch1
J Wells,1 B Lee,1 A Cai,2 W Lee,1 L Rugg,3 S Sinha,4 Q Nie2 and X Dai1 1 Biological Chemistry,
University of California, Irvine, Irvine, CA, 2 Mathematics, University of California, Irvine,
Irvine, CA, 3 Dermatology, University of California, Irvine, Irvine, CA and 4 Biochemistry,
SUNY, Buffalo, NY
Although molecular mechanisms that control the growth and/or differentiation of epidermal ker-
atinocytes are being unfolded, how these cellular processes are coordinately regulated to main-
tain a proliferation-competent and differentiation-resistant progenitor cell state remains to be fully
elucidated. The Ovo gene family encodes evolutionarily conserved zinc-finger transcription fac-
tors that reside downstream of key developmental signaling pathways such as Wg/Wnt and BMP/TGF-
β. While Ovol1 has been shown to regulate cell cycle exit of epidermal progenitor cells, the func-
tion of Ovol2/OVOL2 in keratinocyte homeostasis has not been studied. In this work, we use
well-established human keratinocyte culture systems to explore the function of OVOL2 in epider-
mal cells. We show that Ovol2 regulates several independent yet related aspects of keratinocyte
homeostasis, namely suppressing transient amplification and terminal differentiation but promot-
ing long-term proliferation. When OVOL2 is knocked down, we observe a transient cell expan-
sion followed by a loss of cells with long-term proliferation potential. Our experimental findings
along with mathematical modeling suggest that both faster cycling of the transit amplifying (TA)
cells and precocious stem-to-TA cell transition underlie the phenotype. We also show that knock-
down of OVOL2 leads to premature terminal differentiation. We present evidence that OVOL2
inhibits transient proliferation and terminal differentiation by directly repressing two critical down-
stream targets, c-Myc and Notch1, respectively. These findings shed light on how epidermal cells
coordinately control proliferation and differentiation to maintain a progenitor cell fate.
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Ceramide stimulates ABCA12 expression via PPAR-beta in human keratinocytes
Y Jiang,1 Y Uchida,2 B Lu,1 P Kim,1 C Mao,3 M Akiyama,4 PM Elias,2 WM Holleran,2,5
C Grunfeld1,6 and KR Feingold1,6 1 Metabolism, VA Med Ctr, San Francisco, CA, 2
Dermatology, VA Med Ctr/UCSF, San Francisco, CA, 3 Med Univ S. Carolina, Charleston, SC,
4 Dermatology, Hokkaido Univ, Sapporo, Japan, 5 Pharm Chem, UCSF, San Francisco, CA
and 6 Medicine, UCSF, San Francisco, CA
ABCA12 is a membrane transporter that facilitates the delivery of glucosylceramides to lamellar
bodies (LB) in keratinocytes, a process critical for epidermal permeability barrier formation. Fol-
lowing LB secretion, glucosylceramides are metabolized to ceramides, which comprise ~50% of
stratum corneum lipids. ABCA12 gene mutations underlie harlequin ichthyosis, a devastating skin
disorder characterized by abnormal LBs and a severe barrier abnormality. Recently we reported
that PPAR and LXR activators increase ABCA12 expression in cultured human keratinocytes (CHK)
(Jiang Y., et al. JID 128:104, 2008). Here we demonstrate that exogenous ceramide (C2-Cer and
C6-Cer), but not C8-glucosylceramides, sphingosine, or ceramide-1-phosphate, increased ABCA12
mRNA expression in a dose- and time-dependent manner in CHK. In addition, inhibitors of glu-
cosylceramide synthase, sphingomyelin synthase, and ceramidase, as well as siRNA knock-down
of human alkaline ceramidase, which all increase endogenous ceramide levels, also increased
ABCA12 mRNA levels. Moreover, simultaneous treatment with C6-Cer and each of these same
inhibitors additively increased ABCA12 expression, indicating that ceramide is an important inducer
of ABCA12 expression, and that its conversion to other sphingolipid metabolites is not required.
Finally, both exogenous and endogenous ceramides preferentially stimulated PPAR-delta expres-
sion (but not other PPARs or LXRs), while PPAR-delta knock-down by siRNA transfection specifi-
cally attenuated the ceramide-induced increase in ABCA12 mRNA levels, indicating that PPAR-
delta is a mediator of the ceramide effect. Thus ceramide, an important stratum corneum lipid
component, up-regulates ABCA12 expression via PPAR-delta-mediated signaling pathway, pro-
viding a substrate-driven, feed-forward mechanism for regulating this key lipid transporter in the
epidermis.
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Activation and translocation of PKCβII in response to pro-differentiative AQP3/PLD2 sig-
naling in primary mouse keratinocytes
L Bailey and WB Bollag Department of Medicine, Medical College of Georgia, Augusta, GA
We have previously found that in primary mouse keratinocytes phospholipase D2 (PLD2) associ-
ates with aquaporin 3 (AQP3), an efficient glycerol transporter, to regulate the synthesis of phos-
phatidylglycerol (PG) in response to elevated extracellular calcium levels. We have proposed that
this PLD2/AQP3/PG signaling cascade, in which AQP3 mediates the transport of glycerol into ker-
atinocytes followed by the PLD2-catalyzed generation of PG from glycerol, represents a novel lipid
signaling pathway involved in induction of keratinocyte differentiation. Indeed, manipulations to
enhance the activity of this module result in keratinocyte differentiation. We hypothesize that pro-
tein kinase CβII (PKCβII), which contains a PG-binding domain, functions as an effector enzyme
mediating the response to the PLD2/AQP3/PG signaling module. We established the presence of
PKCβII protein in primary cultures and freshly isolated mouse keratinocytes as well as in homog-
enized epidermis. Using immunocytochemistry, we found that PKCβII redistribution was induced
by treatment of the cells with elevated calcium and TPA and by direct addition of glycerol or PG.
In the unstimulated state, PKCβII was primarily cytosolic. Treatment with elevated calcium or PG
led to the translocation of PKCβII to the perinuclear region of the cell. Treatment with the phorbol
ester, 12-O-tetradecanoylphorbol 13-acetate (TPA) resulted in a shift of the majority of PKCβII into
the nucleus. In the unstimulated state phospho-PKCβII was found primarily in the perinuclear area
also. Activation of the signaling pathway resulted in increased phospho-PKCβII localization in the
perinuclear area, consistent with the idea that translocation to this site represented activation. Stud-
ies in which soluble and particulate cell fractions were analyzed by western blot showed an increase
in phospho-PKCβII in the particulate fraction upon activation of the cascade. These results suggest
that the PG produced by the PLD2/AQP3 signaling module functions, at least in part, by inducing
the redistribution and activation of PKCβII.
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Analysis of tight junction function in explanted and xenografted human skin
T Yuki,1 A Hachiya,2 P Sriwiriyanont,3 M Vissher3 and Y Sugiyama1 1 Basic Research Laboratory,
Kanebo Cosmetics Inc., Odawara, Japan, 2 Kao Biological Science Laboratories, Haga, Japan
and 3 Skin Sciences Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
There is to date no direct evidence for the existence of TJs responsible for the intercellular perme-
ability barrier in human skin. To clarify this issue, we performed immunohistochemical studies for
TJ components and a TJ permeability assay using normal human skin obtained from abdominal
plastic surgery. Occludin was expressed in the granular layer, where occludin colocalized with
ZO-1, claudin-1 and -4. A subcutaneously injected tracer (NHS-LC-Biotin) was halted due to the
presence of TJs, marked by occludin staining between the cells of the granular layer. Furthermore,
incubation with ochratoxin A for 24 hours decreased the expression level of claudin-4 and the inter-
cellular permeability barrier of TJs in the explanted human skin deteriorated. These results demon-
strated for the first time that human skin possesses TJs responsible for the intercellular permeabil-
ity barrier. To assess the involvement of TJs in skin barrier, ochratoxin A was injected into human
skin grafted onto SCID-mice. Two days after the injection, the expression level of claudin-4 decreased
and the intercellular permeability barrier of TJs was abrogated. Elevated TEWL (transepidermal
water loss) was simultaneously observed in ochratoxin A-injected skin compared to PBS-injected
skin. In addition, one day after a single UVB irradiation of 200 mJ/cm2 on the grafted skin, decreased
claudin-4 expression, deteriorated TJs function and increased TEWL were detected, as was the case
when the ochratoxin A was administered. These findings suggested that TJs and TJ proteins are
involved in the human skin barrier.
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(Neuro-)endocrine control of keratin expression in human skin in situ
Y Ramot,1,2 K Foitzik,3 E Gáspár,1 E Bodó,1 S Tiede,1 V Goffin,4 L Langbein5 and R Paus1,6 1
Department of Dermatology, University of Lübeck, Lübeck, Germany, 2 Department of
Dermatology, Hadassah- Hebrew University Medical Center, Jerusalem, Israel, 3 Children’s
Hospital Wilhelmstift, Hamburg, Germany, 4 Inserm Unit 845 and University Paris Descartes,
Faculty of Medicine, Paris, France, 5 German Cancer Research Center, Heidelberg, Germany
and 6 University of Manchester, Manchester, United Kingdom
Keratins play a major role in skin and hair physiology and pathology. In addition to their structural
functions, selected keratins have also important regulatory functions, e.g. in hair cycle control.
While some information is known on the regulation of keratin expression by steroid hormones, the
neuroendocrine regulation of keratin expression in human skin is essentially unknown. Since the
human hair follicle (HF) expresses functional receptors for thyrotropin releasing hormone (TRH),
thyroid stimulating hormone (TSH) and prolactin (PRL), and may even express all three neuroen-
docrine modulators, we have studied whether TRH, TSH, and/or PRL exert any effect on keratin
expression in normal human skin. Human scalp skin or microdissected HFs were treated for 5 or
6 days under serum-free organ culture conditions with TSH (10 or 100 mU/ml), TRH (1-100 ng/ml)
or PRL (400 ng/ml). By microarray analysis, PRL, TSH and/or TRH differentially regulated a large
subset of keratins and keratin-associated proteins. By immunhistology, TRH downregulated K6
immunoreactivity (IR) in epidermal and HF keratinocytes in situ, while TSH upregulated K5 IR in
the epidermis. In organ-cultured HFs, PRL upregulated K15 and K19 IR, two proposed markers of
HF progenitor cells, and additionally upregualted K5 IR. Keratin 6 IR was downregulated. The effects
of PRL were blocked by a pure competitive PRL receptor antagonist. Interestingly, the latter by
itself changed keratin expression, supporting inhibition of the autocrine/paracrine actions of PRL
secreted by HF. In summary, our study provides the first evidence for neuroenedocrine controls of
keratin expression in normal human skin/HFs, and introduces TSH, TRH and PRL as differential
regulators of human keratin expression in situ.
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Up-regulation of serpin SCCA1 disrupts barrier function
C Katagiri, M Sugahara, T Iida, M Kaneko, M Ooguri and T Hibino Shiseido Research Center,
Yokohama, Japan
During the transition phase from granular to cornified cells, keratinocytes lose their nuclei to form
the cornified layer. Disordered differentiation frequently leads to the persistent presence of nuclei
in the cornified layers, a condition known as parakeratosis that seriously disrupts the barrier func-
tion of the skin. Previously, we purified caspase-14 from human cornified cells and determined
cleavage sites of the activation. Based on this information we prepared recombinant caspase-14
which was enzymatically active. This preparation degraded inhibitor of caspase-activated DNase
(ICAD) effectively and SCCA1 suppressed this reaction. We tested another close relative serpin,
PAI-2, and found that PAI-2 did not show any effect on ICAD degradation by caspase14. These data
suggest that SCCA1 may be an endogenous inhibitor for caspase-14 responsible for parakeratosis.
The double staining demonstrated that ICAD and SCCA1 coincided with undigested nuclei in parak-
eratotic areas, using a confocal microscopy. We then established an ELISA system for SCCA1, and
investigated its contents in various parakeratotic skin conditions. SCCA1 showed strong up-regu-
lation in psoriatic skin (466-fold), pollinotic skin (232-fold) and sun-exposed skin (90-fold) com-
pared to normal sun-protected skin. The levels of SCCA1 were strongly correlated with markers of
skin barrier function such as TEWL, number of parakeratotic cells in the cornified layer and tex-
ture of the skin. Furthermore, we found that the person who had high levels of SCCA1 in the epi-
dermis was highly susceptible to external stimuli and easily led to barrier disruption due to the fur-
ther up-regulation of SCCA1. These lines of evidence suggest involvement of caspase-14 and SCCA1
in the final stage of keratinocyte differentiation in order to establish epidermal barrier function.
SCCA1 might be a key factor of barrier disruption in the epidermis.
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Anti-itching properties of a natural extract
S Bredif, C Baudouin and P Msika R&D Center, Laboratoires Expanscience, Epernon, France
Itch is defined as an unpleasant sensation evoking the desire to scratch. Cross-talk between C neu-
ron terminals and the spatially closely related dermal mast cells seems to play an important part
in the pathophysiology of itch. Indeed, mast cell mediators such as histamine and tryptase (via
PAR2) are able to stimulate C neuron terminals, thus inducing the sensation of itch. Moreover, PAR2
is also expressed by keratinocytes, where its activation initiates inflammation. Although the patho-
physiology of itch in dry skin is not fully understood, the clinical association between itch and dry
skin is well established. In this study we investigated the anti-itching and moisturizing properties
of a natural extract (Exp09/01). Mast cells were treated with calcium ionophore or substance P in
order to induce release of tryptase and histamine, respectively, measured according to spec-
trophotometric and spectrofluorometric methods. Gene expression of PAR2 was analysed in a
reconstructed human epidermis model using DNA arrays. Epidermal lipids neo-synthesis in a recon-
structed human epidermis model was followed thanks to lipids radiolabelling and thin layer chro-
matography analysis. Hyaluronic acid release by normal human epidermal keratinocytes (NHEK)
was measured by ELISA. Glycosaminoglycans (GAGs) synthesis by NHEK was evaluated by meas-
uring incorporation of 35S-sulfate. Exp09/01 was able to significantly inhibit the release of hista-
mine (up to -53%, p<0.01) and tryptase (-30%, p<0.01) by mast cells. Epidermal gene expression
of PAR2 was reduced by 52% following treatment with Exp09/01. Exp09/01 positively affected epi-
dermal ceramides and free fatty acid synthesis. Finally, Exp09/01 significantly enhanced NHEK pro-
duction of hyaluronic acid and GAGs by 31% (p<0.05) and 34% (p<0.05), respectively. The anti-
itching activities of this natural extract have been shown on mast cells, which are at the heart of
pruritus reaction. Moreover, its moisturizing and relipidizing properties were suggested by in vitro
assays. Exp09/01 could therefore be of particular interest in the management of cutaneous disor-
ders associated with itchy and dry skin.
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Knock-down of (pro)-filaggrin in an organotypic skin model reproduces some of the features
observed in atopic dermatitis and Ichthyosis vulgaris
J Jin,1 M Mildner,1 L Eckhart,1 D Födinger,1 V Mlitz,1 C Ballaun1 and E Tschachler1,2 1
Dermatology, Medical University of Vienna, Vienna, Austria and 2 CE.R.I.E.S., Centre de
Recherches et dInvestigations Epidermiques et Sensorielles, Neuilly, France
Loss-of-function mutations in the filaggrin gene have been shown to be associated with skin dis-
eases displaying impaired terminal keratinocyte differentiation such as ichthyosis vulgaris and atopic
dermatitis. We have thus investigated whether knock-down of filaggrin in an organotypic skin model
would also lead to morphological phenotypes reminiscent of these diseases. In addition, we asked
whether filaggrin knock-down in this system would have an impact on keratin-condensation/soubil-
ity. Human primary keratinocytes were transfected with siRNAs specific for filaggrin, and seeded
onto fibroblast-collagen suspensions to generate a multilayered epidermis. By H&E-staining we
observed a complete loss of keratohyalin granules in filaggrin knock-down organotypic skin cul-
tures, whereas the stratum corneum was formed regularly. However, ultra-structural investigations
showed that keratohyalin granules, although still present, were strongly reduced in size. We did
not observe significant differences in the expression of other important epidermal differentiation
associated genes, including loricrin, involucrin, matriptase-1, caspase-14, and several keratins by
Western blot analysis and immunostaining. In addition the solubility of keratin-1 and keratin-10
was not affected by filaggrin knock-down, indicating a proper aggregation of keratin intermediate
filaments. Our findings show that filaggrin knock-down in an organotypic skin model does not
affect the expression and solubility of other differentiation associated proteins, and that morpho-
logical alterations of the epidermis are restricted to the granular layers, without influencing stra-
tum corneum formation.
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A potential regulatory role for cathepsin V and its cognate inhibitor cystatin M/E in epider-
mal desquamation
T Cheng,1 C Dolk,1 C Caubet,2 M Simon,2 C Watts,3 M Kamsteeg,1 G Serre,2 J Schalkwijk1 and
PL Zeeuwen1 1 Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2
University of Toulouse III-CNRS UMR5165, Toulouse, France and 3 University of Dundee,
Dundee, United Kingdom
Desquamation is the physiological process of shedding dead corneocytes from the stratum corneum
of the epidermis. This process requires degradation of corneodesmosomes, intercellular junctions
that provide strong cell-cell adhesion. Recently, we reported that cathepsin V and its natural inhibitor
cystatin M/E co-localize in the stratum granulosum and the stratum corneum of the epidermis. In
the extracellular space of the upper stratum corneum layers both proteins are closely associated
with corneodesmosomes, indicating a potential role for these molecules in epidermal desquama-
tion. In the present study we analyzed the ability of cathepsin V to cleave recombinant and natu-
ral forms of corneodesmosomal components. Cathepsin V proteolyses desmoglein-1, desmoglein-
3, and corneodesmosin at pH 5.5, which resembles the acidic environment of the upper stratum
corneum layers. At a neutral pH of 7.0, which is the pH environment of the lower stratum corneum
layers, little proteolysis was observed and the corneodesmosomal proteins remained largely unaf-
fected. Furthermore, we found that legumain, another physiological target protease of cystatin M/E,
is able to process active single-chain cathepsin V in vitro into a previously unknown active two-
chain form. Subsequently, we determined the cleavage site by N-terminal sequencing and MALDI-
MS analysis. Immunoblotting of cathepsin V in human epidermal extracts shows that the two-chain
form of cathepsin V exists in vivo. Altogether, we propose a regulatory role for cystatin M/E in
desquamation by controlling cathepsin V protease activity in the stratum corneum.
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Acute and chronic skin barrier disruption leads to increased expression of murine β-defensin-
1, -3, and -14
K Hinrichsen,1 J Meingassner,2 J Harder1 and E Proksch1 1 Dermatology, University of Kiel, Kiel,
Germany and 2 Novartis Institute for BioMedical Research, Vienna, Austria
Protection of the skin against microbiological infection is provided by the permeability barrier
and by antimicrobial proteins. We asked whether the expression of murine β-defensins mBD-1, -
3 and -14 which are orthologs of human β-defensins hBD-1, -2 and -3, respectively, is stimulated
by acute (tape-stripped or acetone treatment) and chronic (essential fatty acid, EFA diet) skin bar-
rier disruption. Defensin expression was determined by RT-PCR and by immunohistology using
specific antibodies. Also, the stimulation of defensins by cytokines and growth factors was exam-
ined in primary murine keratinocyte culture. Acute and chronic permeability barrier disruption
led to an upregulation of all three defensins, but the levels of increase were different. We found a
slight induction of mBD-1, a moderate induction of mBD-14 and a pronounced induction of mBD-
3 after acute barrier disruption. After chronic disruption mBD-14 expression was also markedly
increased. This may be due to the upregulation of mBD-3 by cytokines TNF-α, IL-1β and IFN-γ,
which is probably an acute response, whereas mBD-14 is stimulated by growth factor TGF-α,
which may be a chronic response. Similar upregulation by cytokines and growth factors, respec-
tively, has been shown previously for the human orthologues hBD-2 and -3. Artificial barrier repair
by occlusion reduced the increase in defensin expression supporting interrelation between per-
meability and antimicrobial barrier. Together we demonstrate upregulation of murine β-defensins
mBD-1, -3 and -14 orthologs of important human β-defensins hBD-1, -2 and -3, respectively. The
upregulation may be an attempt to increase defense in the case of a reduced physical barrier which
alleviates the invasion of bacteria and fungi. A stimulation of the innate immune barrier may sub-
side for the loss in the permeability barrier function.
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Upregulation of hyaluronan synthases during phorbol ester (TPA)-induced hyperplasia with
potential functional compensation by Has2 in Has1/Has3 double knockout mice
R Feldman,1 J Monslow,2 N Itano,3 K Kimata4 and E Maytin1,2 1 Dermatology, Cleveland Clinic,
Cleveland, OH, 2 Biomedical Engineering, Cleveland Clinic, Cleveland, OH, 3 Shinshu
University, Nagano, Japan and 4 Aichi Medical University, Aichi, Japan
Hyaluronic Acid (HA) is an abundant extracellular molecule in skin, implicated in inflammation,
wound healing and carcinogenesis. Elevated HA levels in the epidermis are associated with ker-
atinocyte proliferation. We sought to further characterize the mechanism for enhanced HA expres-
sion during in-vivo epidermal proliferation and hyperplasia. Topical treatment of wildtype (WT)
mice with 12-0-tetradecanoylphorbol-13-acetate (TPA) caused significant upregulation of epider-
mal and dermal HA. The HA receptor CD44 was also increased. The size of HA species in skin (>
1 million Dalton), as analyzed on agarose gels, was unchanged by TPA. Increased HA levels were
associated with increases in all three hyaluronan synthase transcripts. Has3 (4-fold) was induced
more than Has2 (1.5-fold), while low levels of Has1 were detected. Transcript levels of HA degrad-
ing enzymes, hyaluronidases, were unchanged. In-vitro stimulation of cultured human keratinocytes
by TPA caused changes in cellular morphology and similar induction of Has2 and Has3. To fur-
ther characterize the role of HA synthases in-vivo, we studied mice harboring functional null alle-
les for Has1 and Has3. Double knockout (Has1/3) mice are healthy, with clinically normal skin.
TPA treatment of Has1/3 and WT mice led to comparable inflammatory hyperplasia, elevated
hyaluronan and proliferation (Ki67) with no change in apoptosis (TUNEL). TPA accelerated epi-
dermal differentiation, with increased keratin 14, downregulated keratin 10, and increased filag-
grin expression, all qualitatively similar in Has1/3 and WT mice. Has2 transcripts were inducible
similar to WT mice, while hyaluronidases were unchanged. Overall, the data suggest that during
increased epidermal proliferation and hyperplasia, HA may be generated by all three Has enzymes.
However, Has2 can functionally compensate in the absence of Has1 and Has3.
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Urea revisited: a well known molecule with previously unrecognized gene regulatory prop-
erties
S Grether-Beck,1 I Felsner,1 H Brenden,1 K Reinhold,1 T Jaenicke,1 C Trullas,2 PM Elias3 and
J Krutmann1 1 IUF, Duesseldorf, Germany, 2 Isdin, Barcelona, Spain and 3 VA Medical Center,
San Francisco, CA
Urea, because of its capacity to serve as a natural moisturizing factor (NMF), has been used for
many decades to improve the surface properties of healthy and diseased human skin. Here we
show that this well known molecule possesses previously unrecognized gene regulatory activities
which can be used to enhance the barrier function of human skin. Accordingly, in-vitro stimula-
tion of primary human epidermal keratinocytes (KCs)with clinically relevant concentrations of urea
induced an increased transcriptional expression of the differentiation markers transglutaminase-1
(TG1), involucrin (INV), filaggrin (FIL) and loricrin (LOR). These effects were of in-vivo relevance
because in a placebo-controlled, double-blinded study with 21 healthy human volunteers, a 4-
week application of a 20% urea containing topical preparation significantly increased the expres-
sion of these KC differentiation markers in human skin. Increased KC gene expression was asso-
ciated with an improvement of skin barrier function, as indicated by a significant decrease of
transepidermal water loss in urea treated skin areas. At a mechanistical level, urea induced gene
expression in KCs was not due to a urea induced shift in osmolarity, but mediated by specific urea
transporters. Primary human keratinocytes expressed the human urea transporters UTA2 and UTA1
and the urea transport inhibitors thiourea or phloretin (i) decreased 14C labelled urea uptake in
KCs by 43% or 25%, respectively, and, even more important, (ii) completely prevented urea induced
expression of TG1, INV, FIL and LOR. Similary, KC expressed the aquaglyceroporin AQP-3 and
inhibition of aquaporins with HgCl2 or CuSO4 caused a decrease by 65% or 30% in KC urea
uptake, respectively, and a 50% inhibition of urea induced upregulation of skin differentiation
markers. These studies show for the first time that urea, in addition to its passive role as a NMF,
actively improves the properties of human skin by virtue of its capacity to modulate KC gene expres-
sion.
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A randomized, double-blind, vehicle-controlled, bilateral comparison trial of calcitriol vs
vehicle in Pityriasis alba
B Moreno Cruz, B Torres-Alvarez, J Castanedo-Cazares and B Moncada Dermatology,
University of San Luis Potosi, San Luis Potosi, Mexico
Pityriasis alba (PA) is a frequent cause for consultation in dark-skin populations due to its chronic
course, trend to relapse and aesthetic impact. At this time, there is not reliable treatment for this
condition, but topical corticosteroids and sunscreens are frequently used. Calcitriol efficacy in the
treatment of childhood PA was compared with petrolatum in twenty individuals of phototype IV-
V, aged 3-13 years with symmetrical lesions on the face. Both treatments were randomly assigned
to each half side. Sunscreens were avoided, and any hygienic pattern was not modified. Hypopig-
mented areas were evaluated at baseline and at weeks 3, 6 and 9 by means of transepidermal water
loss (TEWL), colorimetric measurements and photographic controls. Petrolatum and calcitriol
induced similar repigmentation on PA plaques. A defect of barrier in this entity was noticed based
on increased TEWL on plaques compared with perilesional skin. A remarkably fact was the absence
of erythema on PA plaques at baseline. Restoration of stratum corneum integrity in this entity
could be enough to observe clinical improvement. Dermal erythema is not an important factor
implicated in the development of this condition
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Increased stratum corneum serine protease activities in acute eczemateous atopic skin
R Voegeli,1 AV Rawlings,2 S Doppler1 and JW Fluhr3,4 1 DSM Nutritional Products Ltd Branch
Pentapharm, Basel, Switzerland, 2 AVR Consulting Ltd, Northwich, United Kingdom, 3
Department of Dermatology, Friedrich Schiller University, Jena, Germany and 4 bioskin
GmbH, Hamburg, Germany
The activities of key inflammatory and desquamatory serine proteases on forearm tape-strippings
of acute eczematous lesions in patients with atopic dermatitis (AD), non-lesional atopic and healthy
skin were determined, corresponding activity depth profiles in the stratum corneum (SC) were
generated and the correlations of the individual protease activities with non-invasive bio-physical
instrumental data were calculated. Six healthy subjects (HS), six patients with non-lesional AD (NL),
and six patients with mild to moderate acute atopic eczema (LS) were enrolled. SC integrity was
determined by sequential tape-stripping and infrared densitometry. TEWL, corneometry and chro-
mametry were assessed. Activities of serine proteases on tape-strippings were quantified with flu-
orogenic peptide substrates and HPLC. Elevated basal TEWL and reduced skin capacitance were
observed in LS skin. Skin irritation and TEWL levels after tape-stripping were also elevated in LS.
Conversely, the amount of SC removed by sequential tape-stripping was decreased in LS. Elevated
serine protease activities were measured in LS in the order: SC tryptase-like enzyme (44X), plas-
min (30X), urokinase (7X), trypsin-like kallikreins (6X), and chymotrypsin-like kallikreins (4X). Leuko-
cyte elastase activity was not detected in HS and NL but was observed in LS SC samples. All enzymes
were elevated in the deeper layers of the SC compared with NL and HS SC samples. Equally, all
consistently elevated SC protease activities were significantly correlated with the bio-instrumental
data. These changes were associated with impaired barrier function, irritation, and reduced skin
capacitance. As these proteases are elevated in the SC, they will also be elevated in the epidermis
where they can be involved in neurogenic inflammation and epidermal barrier impairment via acti-
vation of the protease-activated receptors. These results indicate the need for specific serine pro-
tease inhibitors.
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Notch ligands, jagged 1 and jagged 2 as well as the notch target gene, hes-1 are expressed
in human epidermis, hair follicle and sweat gland
M Cleaton, F Ruge, TE Easter and PE Bowden Dermatology, Cardiff University, Cardiff, United
Kingdom
Notch (N), delta-like (DLL) and jagged (J) genes are essential for embryonic development but more
recently, they have been implicated in playing a key role in cell fate determination in adult tissues.
There are four notch receptor genes (N1-N4), three delta ligand genes (DLL1, DLL3 and DLL4) and
two jagged genes (J1 and J2). Active signalling by this pathway can be detected by assessing Notch
target genes such as Hes and Hey (HERP family). We have now examined the expression of J1, J2
and Hes-1 in human epidermis, hair follicle and sweat gland. We have found prominent nuclear
staining with a Hes-1 rabbit antibody in basal and suprabasal cells of the epidermis, hair follicle
outer root sheath (ORS), cortical and cuticle cells of the hair bulb and the sweat gland. Frozen sec-
tions of skin were treated with antibodies to keratins (K5, K14, K1, K10, K16 and K17) and notch
pathway components (N1, N3, J1, J2, DLL1, DLL4 and Hes-1). Primary antibody binding was
detected by immunoperoxidase staining and sections were counterstained with haematoxylin, eosin
or light green SF yellowish. Primary antibodies were also detected by immunofluorescence (IMF)
using Alexa 488 (green) and/or Alexa 594 (red) fluorescence and were characterised by western
blotting. J1 showed prominent expression at the plasma membrane of all epidermal cells (basal
and suprabasal), hair follicle ORS, sweat gland and hair fibre cortical cells but little or no expres-
sion in hair follicle IRS. However, J2 expression was only found in basal cells of the epidermis, ORS
and sweat gland with more widespread expression in the hair follicle IRS. Hes-1 was localised to
the nuclei of basal and lower spinous cells in epidermis, ORS and sweat gland but cytoplasmic
localisation in cortical and cutical cells of the hair bulb. We therefore conclude that Notch recep-
tor signalling via both jagged ligands (J1 and J2) and the target gene, Hes-1, appears to contribute
to the maintenance of the epidermis and it appendages.
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The aging secretome of skin cells
M Stichenwirth,1 M Mildner1 and E Tschachler1,2 1 Department of Dermatology, Medical
University Vienna, Vienna, Austria and 2 Centre d Investigations Epidermiques et Sensorielles
(CE. R. I. E.S.), Neuilly, France
Aging cells develop specific changes in their complement of secreted proteins. Senescence-asso-
ciated secreted proteins of fibroblasts and epithelial cells include inflammatory cytokines, immune
modulators and enzymes degrading the extracellular matrix. As senescent cells accumulate with
age, their secretome induces changes in tissue microenvironment which can disrupt the tissue struc-
ture and consequently decrease tissue function and eventually stimulate age-associated tissue degen-
eration. Here we investigated the changes in the secretory profile, here referred to as the secre-
tome, of skin cells that occur when cells become senescent. Proteins secreted by pre-senescent
and senescent human dermal fibroblasts and epidermal keratinocytes during 24 hours of culture
in serum-free medium were analyzed by 2-D fluorescence difference gel electrophoresis (DIGE).
Multiplexed proteomics using stains for phosphoproteins and glycoproteins was used to identify
senescence-associated changes in the post-translational modifications of secreted proteins. Dif-
ferences in secretory profile of senescent human dermal fibroblasts and epidermal keratinocytes
were qualitatively and quantitatively determined using the DeCyder 7 software. Differentially
secreted proteins are identified by ESI-MS/MS. The senesce-associated changes in the secretome
of fibroblasts and keratinocytes may expand our understanding of skin aging and provide insight
to changes in tissue microenvironment during aging.
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Investigation of the relation between different parameters of skin barrier function
T Reuther, L Mose, S Schroeder and M Kerscher Division of Cosmetic Sciences, Departmet of
Chemistry, University of Hamburg, Hamburg, Germany
The aim of the present study is to analyse the interrelationship among standard skin barrier param-
eters as well as between these parameters and the amount of ammonium-ions on the skin surface.
The data of 37 consecutive female volunteers aged 18-30 were included. Assessments were per-
formed in winter and spring as well as in summer. Room temperature was 20-22°C. Relative humid-
ity was 40 to 73%. On the forearm (FA) and on the forehead (FH) transepidermal water loss (TEWL),
skin capacitance (SC), skin surface pH (pH) and the amount of ammonium-ions (AI) (after rinsing
ca. 3cm 2 of the skin surface with 6ml ion-free water, the amount of AI was determined using the
Berthelot-Reaction) were assessed. The interrelationship of the values was analysed by correlation
analysis (significance: p≤0,05). The TEWL [g/m2h] ranged from 3,2 to 15,9 on the FA and from 6,6
to 23,6 on the FH. SC [AU] ranged from 23,67 to 67 on the FA and from 26,33 to 74 on the FH.
PH ranged from 4,50 to 6,66 on the FA and from 4,40 to 6,30 on the FH. AI [μg/6ml] ranged from
0,71 to 3,69 on the FA and from 0,76 to 2,82 on the FH. A significant negative correlation both on
the FA and on the FH was found between SC and TEWL (p=-0,454, p=0,005; r=-0,563, p<0,001),
between pH and Co (r=-0,408, p=0,012; r=-0,326, p=0,049) and between AI and pH (r=-0,539,
p=0,001; r=-0,407, p=0,012). Moreover, a positive correlation between pH and TEWL was found
on the FH (r=0,353, p=0,032). The expected highly significant negative correlation between TEWL
and SC at both sites of investigation confirms a constant relation between TEWL and SC within the
full range of values assessed. The weaker but significant negative correlation between SC and pH
indicates some kind of relation between skin hydration and pH. A potential relation between TEWL
and pH on the FH remains to be investigated. From the correlation between AI and pH it is con-
cluded that skin surface pH is a major influence on the amount of AI on the skin surface. Further
studies are required to confirm the findings.
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Clinicopathologic and molecular significance of intra-epidermal type VII collagen in inher-
ited skin blistering
N Almaani,1 L Liu,2 PJ Dopping-Hepenstal,2 PA Lovell,2 JE Mellerio1,2 and JA McGrath1 1 St
John’s Institute of Dermatology, King’s College London, London, United Kingdom and 2 The
National Diagnostic Epidermolysis Bullosa Laboratory, The Guy’s and St Thomas’ NHS
Foundation Trust, London, United Kingdom
In skin biopsies from subjects with inherited blistering skin diseases, the immunohistochemical
finding of intra-epidermal type VII collagen (C7) is often thought to be pathognomonic of bullous
dermolysis of the newborn (BDN), a rare variant of dystrophic epidermolysis bullosa (DEB) in which
the skin blistering usually presents around birth and which often improves markedly or even resolves
thereafter. In this study, we performed a 5–year retrospective review of skin biopsies sent to our
diagnostic EB laboratory to determine the clinical and molecular implications of these skin biopsy
findings. Of ~250 skin biopsies assessed, intra-epidermal C7 was observed in 24 individuals (21
families). Clinically (with follow-up data), only 7 cases (5 families) had BDN and complete reso-
lution of all physical signs only occurred in 4 cases. The other diagnoses were recessive DEB
(n=8), EB simplex (n=4), junctional EB (n=3), aplasia cutis (n=1) and one case was undiagnosed.
For the BDN families, 2 were autosomal dominant (COL7A1 mutations p.G1522E and IVS73-3del6)
and 3 were autosomal recessive (p.R2008H/p.R2008H, p.G2781S/p.R1632X, p.G2372V/p.G2372V).
This study demonstrates that intra-epidermal C7 is not specific for BDN but also occurs in other
variants of DEB and even other forms of EB. Thus intra-epidermal C7 can have diverse diagnostic,
phenotypic and prognostic implications.
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Desmoglein 1 interacts with erbin: a putative mechanism for inhibiting Erk signaling during
epidermal differentiation and morphogenesis
R Harmon, C Simpson, S Getsios and K Green Pathology and Dermatology, Northwestern
University Feinberg School of Medicine, Chicago, IL
Desmosomes mechanically link epithelial cells in the skin by connecting cadherin-based adhe-
sions to the keratin network. Desmosomal cadherin isoforms are expressed in a differentiation-
dependent manner in the epidermis; however,the functional significance of this pattern remains
unclear. Using organotypic cultures to model stratified epidermis, our lab recently demonstrated
that knocking down desmoglein 1 (Dsg1), disrupts suprabasal tissue architecture and differentia-
tion. Toward a mechanism, we found that cultures lacking Dsg1 exhibit aberrant signaling from
the EGF receptor and ErbB2 via the Raf-Mek-Erk/MAP kinase pathway, which is normally sup-
pressed during epidermal differentiation. Using chemical inhibitors to limit the increase in
EGFR/ErbB2 or Erk activity, we rescued differentiation in Dsg1-deficient cultures. However, ques-
tions concerning the mechanism by which Dsg1 may directly regulate this pathway remain. The
intracellular region of Dsg1 harbors domains unique to desmogleins and extends well beyond clas-
sic cadherin tails. The best characterized cytoplasmic partner is plakoglobin (PG), an armadillo
protein. This interaction does not fully explain the requirement for Dsg1 in our model as a PG-
binding mutant of Dsg1 rescues differentiation in silenced cultures as well as the wild-type cad-
herin. Thus, we aimed to identify novel proteins which interact with the Dsg1 cytodomain. A yeast
two-hybrid screen identified Erbin (ErbB2-interacting protein) as a Dsg1 binding partner. Previously
localized to desmosomes and known to inhibit Erk, epidermal Erbin re-localizes from the cyto-
plasm to intercellular borders as keratinocytes differentiate, matching the pattern of Dsg1 local-
ization. We show that Erbin knockdown mimics Dsg1-depletion with impaired differentiation and
increased Erk signaling. In summary, we propose that Dsg1 interacts with Erbin and enhances its
inhibition of the Raf-Mek-Erk pathway to allow for proper epidermal differentiation.
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Bath emollients prevent atopic dermatitis lesions in the NC/Nga mouse model
J Lenn, W Chern and H Hofland Center for Skin Biology, Stiefel Laboratories, Inc., Palo Alto,
CA
The NC/Nga mouse is a well published model for atopic dermatitis. It is typically used to assess
the treatment effects of systemic and topical products containing active pharmaceutical ingredi-
ents (API). This study investigates if pre-treatment with commercially available bath emollients can
prevent the spontaneous development of atopic dermatitis lesions in this model. The study also
compared the effects of bath emollients with (BE+) and without antimicrobial agents (benzalko-
nium chloride and triclosan) (BE-) to gain insight into the potential mechanism of action of these
products. The BEs (Oilatum) were diluted 1,000 fold with sterile water to resemble real use con-
ditions. The diluted BEs were applied to the dorsa of the NC/Nga mice, twice daily, for 4 weeks.
Tacrolimus ointment served as a positive control. Water served as a negative control. The dermatitis,
which develop spontaneously in this model, was given a “dermatitis intensity score” by assessing
1) erythema, 2) edema or papules and 3) oozing, crusts, or hemorrhage weekly. The dermatitis
intensity score ranges from 0 to a possible highest score of 9. During the first weeks, Tacrolimus
Ointment and the BEs prevented the atopic dermatitis regardless of the presence of anti-microbial
agents. This suggests that the early effects are not due to a reduction in pathogens, but may be due
the BE preventing antigens from entering the skin by providing an improved barrier. However, at
day 28, BE+ reduced the mean dermatitis intensity score slightly over that of the BE- (p<0.06). This
suggests that antimicrobial agents may be needed to have a longer lasting, or more pronounced
effect when used chronically. The efficacies of BEs were comparable to that of tacrolimus ointment.
In a separate study, an ointment without tacrolimus had no effect on reducing the dermatitis scores.
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Bad fur: a mutation affecting skin development that restores B cells to IL-7 deficient mice
BE Rich Dermatology, Brigham and Women’s Hospital, Boston, MA
A spontaneous autosomal recessive mutation affecting coat development was identified in a strain
of inbred mice and named bad fur (bdfr). Analysis of progeny from an F2 intercross has mapped
the gene to a region of 9.2 million base pairs on Chromosome 12. The phenotype of affected mice
is most prominent during the first period of anagen fur growth, when they appear nearly free of fur.
In subsequent cycles, affected mice grow fuller coats, but they remain more sparse and disordered
than those of unaffected littermates. Thicker hairs appear less affected while the thinner zigzag hairs
are greatly reduced. Although the difference between affected mice and their unaffected littermates
diminishes with age, they remain distinguishable. Histological examination of the skin of young
affected mice reveals prominent perturbations involving thickening of the epidermis and perifol-
licular hypercellularity in the dermis. The cutaneous phenotype is associated with increased per-
meability and trans epidermal water loss. The bdfr phenotype is also associated with modest increases
in thymic and splenic cellularity. Surprisingly, the bdfr phenotype restores splenic and peritoneal
B cell populations to mice deficient in IL-7 or JAK3 kinase, while T cells are not restored. This may
be explained by elevated levels of TSLP mRNA that are found in the skin of bdfr mice.
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Japanese cheek skin has greater ASIC and heightened sensory thresholds compared to hair-
line skin
B Maddison,1 V Foy,2 J Stocks,1 S Singleton1 and F McGlone3 1 Unilever R&D, Colworth,
Sharnbrook, United Kingdom, 2 Unilever R&D, Trumbull, CT and 3 Unilever R&D, Port
Sunlight, United Kingdom
Cutaneous sensitivity varies between body sites as well as individuals. In addition, strong facial
sensory responses to some cosmetic ingredients (e.g. alpha hydroxy acids) have been reported. We
investigated the hypothesis that sting correlates with a difference in epidermal acid sensing ion
channel 1 (ASIC1) expression between cheek and hairline skin from Japanese (n=23) women. Study
populations were segmented into stingers (S) and non-stingers (NS) based on their response to gly-
colic acid-induced sting (4%, half face, 7 minutes) and assessed with quantitative sensory tech-
niques (QST; hot pain, cold pain, von Frey hair). Biopsies (2mm) were collected and ASIC1 was
immunolocalised. ASIC1 quantity in Japanese cheek was 36-fold higher than hairline (p=0.0001).
When looking at the sub-populations of stingers and non-stingers between the two sites, Japanese
cheek consistently had more overall ASIC1 quantity than the hairline for each respective sub-pop-
ulation (p=0.0001 & 0.0001, respectively), (Stinger Cheek=1.51 pi vs. hairline=0.03 pi; Non-stinger
cheek=0.79 pi vs. hairline=0.03 pi). ASIC1 density (immunostained quantity/distribution area) was
31-fold greater in cheek compared to hairline (p=0.0001). Likewise, ASIC1 density was higher in
cheek than hairline for both stingers (p=0.0001) and non-stingers (p=0.0001). Sensitive skin is
perceived to be a multifactorial condition and in this study we have identified objective measures
that have linked through to subjective responses. Here we propose that ASIC’s are potentially a
group involved in mediating heightened sensory sensations at Japanese cheek, especially around
cold sensation. That these receptors are known to be located on nerve fibers would suggest that
this type of nerve fiber sub-population is important in determining facial site sensitivity.
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Proteome changes in human epidermis induced by UVB irradiation
E Benlhabib,1 MK Hordinsky,1 IG Panoutsopoulou,1,3 G Wendelschafer-Crabb,3 WR Kennedy3
and GL Wilcox1,2 1 Dermatology, University of Minnesota, Minneapolis, MN, 2 Neuroscience,
University of Minnesota, Minneapolis, MN and 3 Neurology, University of Minnesota,
Minneapolis, MN
Long-term sun exposure, principally UVB, induces skin cancer, premature skin aging and cuta-
neous immunosuppression. Comprehensive analysis of UVB-induced changes in human epider-
mal cell protein expression may assist in discovery of UVB-induced damage biomarkers. This study
determined changes in the human epidermal proteome at 2, 7 and 24h after UVB (40 mJ/cm2)
using iTRAQ and 2D LC-MS/MS. Expression of ~100 distinct proteins identified with >95% con-
fidence was altered by UVB: 108 at 2h, 93 at 7h, 108 at 24h. At 2h, expression of 61 proteins
increased: diazepam binding inhibitor, fatty acid binding protein 5, several metabolic proteins.
Expression of 47 proteins decreased: several keratins (1, 5, 10, 14), apoptotic (calpain and lamin
A) and calcium binding (S100A14) proteins, the neurite growth inhibitor reticulon 4 (RTN4). At
7h, expression of 50 proteins increased, mostly those highly expressed at 2h. Expression of 43
proteins decreased: proteins involved in cell metabolic or structural components, calcium bind-
ing protein (S100A11) and neuron-related proteins (RTN4, GABA-B receptor 1 (GABABR1). At 24h,
expression of 64 proteins was increased: several involved in glycolysis/gluconeogenesis, inositol
metabolism, regulation of actin-based motility. Expression of 44 proteins decreased: several
cytoskeletal constituents (keratins 9, 15) and myosin, proteins RTN4 and GABABR1. Across all
time points, metabolic protein expression was highly increased while keratins and RTN4 expres-
sion decreased. At 2h, expression of antioxidant proteins greatly increased. At 7 and 24h, expres-
sion of proteins involved in metabolism and motility greatly increased. Confocal microscopy of
naive human skin biopsies confirmed the presence of RTN4 in epidermis and select dermal cells.
These results suggest that during the first 24h after UVB challenge, human epidermal cells alter
protein expression to protect the skin from oxidative damage and invite neurite extension.
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Functional analysis of Pecanex, a Drosophila neurogenic gene, during epidermal morpho-
genesis
C Cela,1,2 K Fantauzzo,2 H Bazzi1 and AM Christiano1,2 1 Department of Dermatology,
Columbia University, New York, NY and 2 Department of Genetics & Development,
Columbia University, New York, NY
Pecanex (Pcxn) is a highly conserved heptaspan transmembrane protein with homologs found in
multiple organisms ranging from flies to humans. Pcnx was described several years ago in Drosophila
as a maternal-effect neurogenic gene, such that when the gene is not expressed maternally, the
embryos display hyperneuralization, indicating that its function is to promote epidermal cell fate.
The neurogenic phenotype also suggests that pcnx may encode a new component of the Notch
signaling pathway. In order to identify the function of Pcxn during skin development, we performed
experiments in two model organisms: mouse and Drosophila. To define the role of Pcnx during
hair follicle and epidermal morphogenesis, we first analyzed Pcnx expression in developing mouse
epidermis by quantitative RT-PCR, and found that expression peaked at E14.0-E14.5. Whole mount
in situ hybridization revealed that pcnx mRNA is expressed in the epidermis, developing limb, tail
and muzzle area. Immunofluorescence analysis with a Pcnx antibody showed a dynamic protein
expression pattern throughout hair follicle morphogenesis and postnatal cycling. Since pcnx is
highly conserved during evolution, we used Drosophila genetics to place it in the context of the
Notch signaling pathway and to determine genetic interactions. Drosophila pecanex (pcx) is widely
expressed during embryogenesis, in both the growing imaginal discs and ovaries. We confirmed
the hyperneuralization phenotype of embryos laid by homozygous EMS mutant females, and in
addition, we observed extra bristles in the maxillary palps, a previously undescribed phenotype
in pcx mutants. These data suggest that pcnx it alsoplays an important role in epidermal morpho-
genesis, and moreover, that its function is related to the Notch signaling pathway.
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In vivo screening of cosmetic actives for enhanced effects of Vitamin A
J Lee, M McKinney, C Horbacewicz, J Bajor, W Lathrop, M Yeh, H Chen and H Meldrum
Unilever R&D, Trumbull, CT
Vitamin A and its derivatives have been shown to provide a variety of skin benefits such as improve-
ment of naturally aged skin. There is an opportunity to improve skin benefits from cosmetically
acceptable forms of Vitamin A, by modulating retinol metabolism in skin and inhibiting the con-
version of retinol into the inactive ester. This can be achieved by the use of technologies that increase
retinoid levels in vivo as measured by CRABPII. In this report, we report our improved approach
for screening retinol boosters in in vivo assays. Specifically, we will report the development of an
epidermal abrasion technique which allows higher throughput epidermal sampling and we will
describe the protocol for application and retinol booster screening in panellists. In vivo analysis of
the biomarker CRABPII, a retinoic acid responsive marker, was used to validate the effects of the
positive compounds from the in vitro assay. The results of this investigation showed that CRABPII
was induced in a dose dependent manner in skin treated with retinol for four days via open appli-
cation. The effects of compounds that modulate retinoid metabolism in vitro on retinol biocon-
version as measured by CRABPII in vivo will also be reported. The success of this approach is pos-
sible by the availability of a novel minimal invasive epidermal biopsy technique allowing rapid
analysis of CRABPII from in vivo samples.
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Effect of overexpression of the N-Terminus of profilaggrin on epidermal biology In geneti-
cally modified living skin equivalent
S Aho, J Lee, H Meldrum and C Bosko Unilever R&D, Trumbull, CT
Natural moisturization factors (NMF) are derived from filaggrin and are important for SC and bar-
rier function. Profilaggrin is proteolytically cleaved to generate filaggrin monomers and this cleav-
age also releases N-terminal AB-domain. As a homolog to calcium binding S100 proteins, the AB-
domain has been hypothesized to function as a nuclear transcription regulator promoting keratinocyte
differentiation in the upper granular cell layer of epidermis. The nuclear localization of the AB-
domain has been well documented, but its functional role in epidermis lacks experimental evi-
dence. A Living Skin Equivalent model was set up using human keratinocytes and fibroblasts to
study the effects of the AB-domain on epidermal maturation. Lentiviral vector encoding AB-domain
and a control vector were used to infect keratinocytes. LSE samples were collected at various time
points after air-exposure and subjected to western blot analysis and IHC with relevant markers.
Overexpression of the AB-domain impaired the quality of stratum corneum as evidenced by the
leakage of medium through the model. IHC revealed a thinner epidermis with lower number of
proliferating cells as assessed by Ki67 positive cells. Also profilaggrin/filaggrin expression was
delayed by several days and down-regulated in AB-domain over-expressing cultures. Although cas-
pase-14 proform was present, the active form was barely detectable by western blotting. These
results suggest a defect in proliferation and late differentiation events. Based on observed results,
we hypothesize that profilaggrin AB-domain impacts on differentiation at the granular layer where
profilaggrin is expressed and has a further effect on proliferation at the basal layer.
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Cleansing without compromise: A novel lipid-rich moisturizing body wash technology
KP Ananthapadmanabhan, L Tsaur, V Villa, L Yang, S Mukherjee, C Vincent, K Vetro, V Foy,
S Zhang, A Ashkenazi, E Pashkovski and V Subramanian Unilever R&D, Trumbull, CT
The traditional approach to minimize cleanser induced stratum corneum protein damage has
been the use of a combination of anionic and amphoteric surfactants in a liquid cleanser. In con-
trast, the lipid damage potential of liquid cleansers has not received much emphasis in the past.
In this study, we have explored the effect of incorporating long chain (C16-C18) lipids (fatty acids)
into a typical anionic- amphoteric surfactant containing cleanser on skin lipid damage. The hypoth-
esis is that the fatty acids in the formulation will act as a buffer against removal of skin lipids as
well as deposit fatty acids on skin to replenish the fatty acids lost during cleansing. In-vivo clini-
cal studies confirm that introduction of fatty acids into the formulation at a constant level of anionic
or anionic –amphoteric combination reduces both skin dryness and trans-epidermal water loss
(TEWL), and deposition and penetration of fatty acids was in the upper layers. Oils were also eval-
uated for their skin benefits from a cleanser. Previously reported studies showed that polar oils such
as triglyceride oils, as opposed to hydrocarbon oils, protect corneocyte proteins by reducing sur-
factant binding to proteins. In-vivo patch tests with the same surfactant system with different polar-
ity oils confirmed reduced irritation with increase in polarity of the oil. Using the above new insights,
a new lipid-rich moisturizing body wash (LRMBW) with fatty acids and soybean oil as moisturiz-
ers has been developed. Evaluation of the LRMBW in standard patch tests showed significantly
lower irritation compared to typical anionic-amphoteric surfactant containing cleansers as well as
to an identical formulation with petrolatum as the moisturiser. In-vivo clinical studies under nor-
mal use conditions showed significant improvements in skin hydration and dryness and provided
perceivable appearance benefits. These results demonstrate that LRMBW technology provides pro-
tection to both skin proteins and lipids leading to healthy, hydrated skin.
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Development of genetic modification capability in the living skin equivalent model to under-
stand gene function
J Adamus, S Aho, J Lee, H Meldrum and C Bosko Unilever R&D, Trumbull, CT
To understand the relevant pathways involved in epidermal homeostasis, we have developed a
genetically modified living skin equivalent model in-house using human primary keratinocytes.
Stable expression of a target gene or oligonucleotide, and the use of keratinocytes from different
age adult donors rather than traditionally used primary neonatal cells, are key aspects of this capa-
bility. Our initial investigation monitored GFP expression throughout maturation of the epidermis.
Using Open Biosystem’s pGIPZ-based vector we successfully expressed GFP in all epidermal lay-
ers after air lifting, and found that transgene expression can be selectively directed to the upper liv-
ing layers of epidermis or across all viable layers by excluding or including the WPRE sequence in
the construct. We observed no phenotypic differences between the infected and normal model as
determined by the overall morphology of the viable epidermis, the number of cell layers and its
structural integrity. GAPDH was chosen to demonstrate successful transgene knockdown in a
chimeric lentiviral GAPDH shRNAmir-GFP construct. This recombinant was able to silence GAPDH
expression as shown by a quantitative reduction in mRNA transcription. We observed no adverse
effects as compared to non-silenced models. To further our understanding of PPARγ’s role in main-
taining healthy skin, a non-GFP lentivirus overexpressing PPARγ was used to infect our model.
This overexpression resulted in total structural loss of integrity, suggesting that PPARγ is integral to
epidermal function and that the expression level needs to be carefully controlled in order to resolve
protein function. These genetic modification capabilities provide a set of powerful tools not only
to screen for key targets or pathways for skin benefits but also to understand the fundamentals of
skin biology, such as maturation of keratinocytes in the epidermis.
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In-vitro skin penetration of novel antimicrobial nanoemulsion formulations containing anti-
fungal agents
S Ciotti,1 R Eisma,1 L Ma1 and JR Baker2,1 1 NanoBio Corporation, Ann Arbor, MI and 2
University of Michigan, Ann Arbor, MI
NB-002, a novel oil-in-water nanoemulsion formulation, is currently under development for the
treatment of onychomycosis. The aim of this study was to investigate the potential of a combina-
tion product containing NB-002 and an anti-fungal agent. Thus, the ability of NB-002 + antifun-
gal agents to penetrate into skin was assessed and compared with the skin penetration of com-
mercially available anti-fungal products. In vitro skin permeation studies with two different NB-002
/ terbinafine hydrochloride (TBHC) formulations or a NB-002 /miconazole (MCZ) formulation were
performed using diffusion cells with swine skin. Twenty-four hours after topical application, the
skin surface was swabbed to remove residual test article and skin tissues separated, weigh and
assayed for the anti-fungal agent. THBC levels were determined by HPLC, and MCZ levels deter-
mined by HPLC/MS/MS. Levels of TBHC in the epidermis were 18.6 and 15.1 times higher for 1%
TBHC/0.3% NB-002a and 1% TBHC/0.3% NB-002b, respectively, as compared to the LamisilAT
Cream formulation. The levels of TBHC in the dermis were 10.9 and 20 times higher for 1%
TBHC/0.3% NB-002a and 1% TBHC/0.3% NB-002b, respectively, as compared to the LamisilAT
Cream formulation. The levels of MCZ in the epidermis were 30 times higher for 2% TBHC/0.3%
NB-002 compared to the Lotrimin®AF Spray Solution. The levels of MCZ in the dermis were 9
times higher for 2% MCZ/0.3% NB-002 as compared to the Lotrimin®AF Spray Solution. Thus,
there appears to be an increased delivery of either antifungal agent into epidermal and dermal tis-
sues using the nanoemulsion formulation as compared to commercially available products. A novel
antimicrobial nanoemulsion formulation with encapsulated anti-fungal agents can diffuse into
skin at significantly higher levels as compared to commercially available products.
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Lateral diffusion of a novel nanoemulsion containing terbinafine hydrochloride
S Ciotti,1 R Eisma,1 L Ma1 and JR Baker2,1 1 NanoBio Corporation, Ann Arbor, MI and 2
University of Michigan, Ann Arbor, MI
Nanoemulsions(NB-00X) are oil-in-water emulsions composed of nanometer-sized droplets, sta-
bilized by surfactants. We previously demonstrated permeation and lateral diffusion of NB-00X
into epidermal and dermal tissues following topical application to human cadaver skin. The aim
of this study was to determine whether nanoemulsion droplets containing terbinafine hydrochlo-
ride (TBHC) could diffuse laterally from the site of application. In vitro studies were carried out
using excised human cadaver skin in a modified diffusion apparatus. NB-00X incorporated with
1%TBHC and LamisilAT cream (1% TBHC) were applied onto human cadaver skin enclosed by
two concentric glass cylinders. Twenty-four hours post application, residual formulation was removed
and epidermis and dermis of the dosing areas were separated, weighed and assayed for TBHC using
HPLC. A punch biopsy of the inner non-dosing area (inner area) and middle non-dosing area (mid-
dle area) were processed in similar fashion. Due to apparatus design, TBHC can only reach the
middle or inner tissues by permeation of the test formulation into skin underlying the dosing area
and traversing laterally into the non-dosing areas. Levels of TBHC found in the outer, middle and
inner epidermis were 14, 35 and 310 times higher (μg/g tissue levels) when incorporated with the
NB-00X formulation as compared to the same areas (outer, middle inner) for the LamisilAT cream.
TBHC levels found in the outer, middle and inner dermis were 27, 28 and 118 times higher (μg/g
tissue levels) for the 1% TBHC/0.3 % NB-00X formulation as compared to the same areas for the
LamisilAT cream. These results confirm that nanoemulsion containing an antifungal agent, terbinafine
hydrochloride, diffuses laterally under the stratum corneum to tissues over a centimeter away from
the site of application. This suggests that, when combined with NB-00X, antifungal agents can dif-
fuse under human nails from adjacent skin sites to kill the fungus that causes onychomycosis.
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A novel ABCA12 mutant mouse model provides new insight into the pathological mecha-
nisms of Harlequin Ichthyosis
L Zhang, W Feng, L Niswander, D Roop and T Williams University of Colorado Denver, Aurora,
CO
Harlequin Ichthyosis (HI) is a severe congenital skin disease caused by mutations in the gene encod-
ing Abca12, a member of the ABCA transporter family. Abca12 is thought to regulate the transfer
of lipids into lamellar bodies in the epidermis. However, it remains unclear how ABCA12 mutants
affect normal epidermal development and the pathogenesis of HI. From a mouse ENU mutagene-
sis screen, we have isolated and characterized a novel ABCA12 mouse mutant that recapitulates
many of the pathological features of HI including: loss of barrier function, defects in lipid deposi-
tion in stratum corneum, hyperkeratosis, and parakeratosis. ABCA12 mutant mice were born with
taut skin and die shortly after birth due to severe dehydration. In the mutant epidermis, immuno-
fluorescence staining showed aberrant keratin 6 expression in the suprabasal layers, and ectopic
expression of keratin 10 and desmoplakin in the stratum corneum, Ultrastructural analysis revealed
the absence of lamellar bodies and lipid lamellae, and the retention of corneodesmosomes in the
stratum corneum. Moreover, the stratum corneum from the mutant epidermis remained unexpect-
edly intact after harsh cornified envelope purification procedures. Interestingly, we found that
both kallikrein 5 and 7, two major proteolytic enzymes involved in epidermal desquamation,
were decreased in the mutant stratum corneum and their enzymatic activities were significantly
decreased as determined by immunofluoresence analysis and in situ zymography, respectively. In
vivo BrdU-labeling showed no signs of enhanced proliferation of keratinocytes, indicating that the
thickened stratum corneum in the mutant epidermis results from a lack of desquamation rather than
enhanced proliferation. Taken together, these findings suggest essential roles for Abca12 in trans-
ferring not only lipids, which are required for formation of multilamellar structures in the stratum
corneum, but perhaps more importantly, proteolytic enzymes, which are essential to allow normal
desquamation.
467
Functional pathways of NAD biosynthesis in human keratinocytes
L Signorello, R Azar, N Giridharan, DL Coyle and MK Jacobson PhD University of Arizona,
Tucson, AZ
Epidermal keratinocytes must continually proliferate and differentiate in the presence of chronic
genotoxic stress caused by UV exposure. NAD is an important cellular component in both epi-
dermal proliferation/differentiation and maintenance of genomic integrity in a number of different
ways that include NAD as a cofactor in hydride transfer reactions central to cellular energy gen-
eration and utilization of NAD as a substrate for two classes of enzymes involved in the response
of cells to genotoxic stress, poly(ADP-ribose) polymerases and NAD-dependent protein deacety-
lases (sirtuins). Enhancement or optimization of keratinocyte NAD content represents an approach
to enhance function and in this study we have determined the functional pathways of NAD biosyn-
thesis in human keratinocytes (HaCaT). Culture of cells in the absence of preformed pyridine ring
precursors of NAD demonstrated demonstrating that functional de novo pathways are not present
in HaCaT cells. Functional pathways of NAD biosynthesis from nicotinamide and nicotinic acid
are present in HaCaT cells. HaCaT cells also efficiently convert nicotinamide riboside to NAD by
two different pathways. We have examined the alternative NAD precursors for effects on sirtuins
1, 2, and 3. Sirtuins are inhibited by nicotinamide, albeit with different potency, that nicotinamide
riboside causes sirtuin inhibition but with less potency than nicotinamide, and that nicotinic acid
did not show inhibitory activity. Our results indicate that nicotinic acid can be used to enhance or
optimize NAD content without raising the possibility of sirtuin inhibition, which may benefit ther-
apeutic approaches targeting skin cell NAD content.
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Grainyhead-like factor Get1/Grhl3 is a shared transcriptional regulator for epidermal and
urothelial differentiation
Z Yu,1,2 J Mannik,1,2 A Soto,2 K Lin1,2 and B Andersen1,2 1 Medicine, University of California
Irvine, Irvine, CA and 2 Biological Chemistry, University of California Irvine, Irvine, CA
Skin and bladder epithelia form effective permeability barriers through the activation of distinct dif-
ferentiation gene programs. To gain insights into common and unique transcriptional regulatory
programs during skin and bladder differentiation, we profiled global gene expression in mouse dor-
sal skin and bladder at E14.5, E16.5, and E18.5. At E18.5, a total of 1540 transcriptional regula-
tors are expressed in both skin and bladder while there are 532 and 264 transcriptional regulators
uniquely expressed in skin and bladder, respectively. We also identified transcriptional regulators
whose expression correlates highly with expression patterns of differentiation markers both in skin
and bladder. Among this group of factors is the Grainyhead factor Get1/Grhl3, already known to
be important for epidermal barrier formation. Furthermore, through chromatin immunoprecipita-
tion assays, we showed that Get1/Grhl3 directly regulates a bladder specific differentiation gene,
Uroplakin II (UpkII), and that this activation was not seen in primary keratinocytes. In order to elu-
cidate how this transcription factor could be acting in a tissue specific manner, we then investi-
gated the chromatin landscape of this gene in both skin and bladder. We found that histone mod-
ifications associated with repression are present in keratinocytes at the UpkII promoter while histone
modifications associated with gene activation were present in bladder cells. Therefore, our results
suggest that epigenetic mechanisms allow Get1 to selectively activate different gene targets in a
cell-specific manner. We speculated that such mechanisms may be widely used to allow cell-spe-
cific activity of a developmental transcription factor which plays a role in distinct tissues.
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Potential role of TRPV5 and 6 in the formation of epidermal calcium gradients and ker-
atinocyte differentiation
H Kim,1,3 S Jeong,2 J Kim,1,3,4 M Jeong1,3,4 and S Lee1,3 1 Dermatology, Yonsei University College
of Medicine, Seoul, Korea, South, 2 Research Division, NeoPharm Co., Ltd., Daejeon, Korea,
South, 3 Human Barrier Research Institute, Yonsei University College of Medicine, Seoul,
Korea, South and 4 Brain Korea 21 Project for Medical science,Yonsei University, Seoul,
Korea, South
TRPV5 and 6, which belong to the superfamily of transient receptor potential channels, constitute
the apical Ca2+ entry mechanism in active Ca2+ transport in kidney and intestine. Considering
the calcium gradient in viable epidermis, it is interesting that the extracellular calcium ion at the
SG-SC junction is abruptly disappeared. Currently, it is unclear which receptors or ion channels
are underlying the acute loss of calcium ions at SG-SC junction. In this study, we have investi-
gated the potential role of TRPV5 and 6 in the regulation of epidermal calcium ion concentration.
Firstly, epidermal expressions of TRPV5 and 6 were observed in the suprabasal layer of normal
skin, whereas in the lesional skin of atopic dermatitis and psoriasis, epidermal expression of TRPV5
and 6 were lost. Treatments of psoriasis, however, resulted in the re-appearance of TRPV5 and 6
expressions in epidermis. In an animal model, acute disruption of epidermal permeability barrier
induced the decrease of TRPV 5 and 6 expressions, and the recovery of those proteins was paral-
lel to that of calcium gradient. The occlusion after barrier disruption, which inhibits the recovery
of calcium gradient, also inhibited TRPV5 and 6 expressions. These results suggested that TRPV5
and 6 are closely related with the epidermal calcium gradient, as well as keratinocyte differentia-
tion. Since the extracellular pH environment regulates the expressions of TRPV5 and 6, it can be
suggested that TRPV5 and 6 are potential sensor for pH environment, which controls calcium
movement and keratinocyte differentiation.
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The amiloride controls the antimicrobial peptide expressions of human primary keratinocyte
H Kim,1,3 J Kim,1,2,3 S Jeong4 and S Lee1,3 1 Dermatology, Yonsei University College of
Medicine, Seoul, Korea, South, 2 Brain Korea 21 Project for Medical Science,Yonsei
University, Seoul, Korea, South, 3 Human Barrier Research Institute, Yonsei University
College of Medicine, Seoul, Korea, South and 4 Research Division, NeoPharm Co., Ltd.,
Daejeon, Korea, South
The ‘acid mantle’ of the stratum corneum seems to be important for both permeability barrier for-
mation and cutaneous antimicrobial defense. However, the origin of the acidic pH, measurable
on the skin surface, remains still unfolding. The Na+/H+ antiporter (NHE1) is an essential endoge-
nous pathway responsible for stratum corneum (SC) acidification and amiloride, the nonselective
inhibitor of NHE1, was effective for increasing the skin surface pH and disrupted the normal skin
barrier function. Recent studies have shown the co-regulation of permeability and antimicrobial
barriers. We want to know the effect of the amiloride on the expression of antimicrobial peprides,
which is co- related to various epidermal barrier functions, in human keratinocytes. The differen-
tiated human keratinocyte are cultured in medium which are switched to pH buffered by either
6.3 or 8.3. A control group was left in the medium without changing pH (pH 7.3). After the amiloride
treatment, we analyzed the expression levels of human beta defensin2 and LL-37 using RT-PCR
and ELISA. We also used the microarray after the amiloride treatment for identifying what mech-
anisms are medicated. The treatment of amiloride changed the intracellular pH and calcium
level. It also decreased the hBD2 expression and this effects are somewhat inhibited in acidic
conditions. The amiloride as a potent skin pH disruptor also affects on the expressions of AMP.
Further studies are needed to reveal the exact relationships among intracellular pH, acid sensing
receptors, amiloride sensitive channels involving NHE1 and TRPV 5and 6 and intracellular cal-
cium for the expression of AMP in different pH status.
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Characterization of human kallikrein-8, a keratinocyte-specific protease implicated in epi-
dermis physiology and pathobiology
A Eissa1,2 and E Diamandis1,2 1 Department of Laboratory Medicine and Pathobiology,
University of Toronto, Toronto, ON, Canada and 2 Department of Pathology and Laboratory
Medicine, Mount Sinai Hospital, Toronto, ON, Canada
Kallikrein serine proteases (KLKs), in particular KLK5 and KLK7, regulate important homeostatic
skin barrier functions harbored in the outer stratum corneum (SC) layer, such as skin desquama-
tion and antimicrobial defense. The dysregulated activity of KLK5 and KLK7 is implicated in nether-
ton syndrome, acne rosacea, and psoriasis pathology. We and others have shown that additional
KLKs are localized in normal human epidermis, among which is KLK8. In human and mouse skin,
KLK8 is localized from the upper stratum spinosum to the stratum corneum, and is linked to epi-
dermal proliferation, differentiation, desquamation, and response to UVB, but the mechanistic
details are largely elusive. The aim of this study is to characterize KLK8 functions in human skin
by detecting its expression in primary skin cell cultures and characterizing its skin-specific sub-
strate targets. To this end, we examined KLK8 and other KLK expression by qRT-PCR and ELISA
methods in HaCat keratinocyte cell line, primary human epidermal keratinocyte, epidermal
melanocyte, and dermal fibroblast cultures. Our results show that immunoreactive KLK8 is abun-
dantly secreted by HaCat and primary human keratinocyte cultures, while epidermal melanocyte
and dermal fibroblast cultures produce negligible amounts. For biochemical and kinetic studies,
we cloned and expressed both inactive KLK8 precursor (pro-KLK8) and active mature KLK8 (mat-
KLK8) proteases in Pichia Pastoris yeast strains. Recombinant KLK8 proteases expressed in yeast
culture media were purified by cation exchange chromatography. Active mat-KLK8 was N-glyco-
sylated having a molecular weight of ~ 31 kDa and a pI of ~ 6.0. This protease degraded gelatin,
collagen, and fibronectin, and exhibited trypsin-like substrate specificity towards fluorogenic AMC
substrates in vitro, with preference towards arginine versus lysine. This study provides the foun-
dation for a deeper investigation into KLK8 roles in human skin.
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A novel role for Nrf2 in restoration of epidermal barrier function in utero
AJ Huebner,1 P Koch,1 S Werner2 and D Roop1 1 Dermatology and Charles C. Gates
Regenerative Medicine and Stem Cell Biology Program, University of Colorado Denver,
Aurora, CO and 2 Institute of Cell Biology, Swiss Federal Institute of Technology, Zurich,
Switzerland
The epidermis serves as a functional barrier between the body and the outside environment. Devel-
opment and maintenance of the epidermis is a dynamic process requiring several distinct steps of
differentiation. A final step in epidermal differentiation is the replacement of the keratinocyte plasma
membrane with the cornified envelope (CE), an insoluble protein/lipid matrix necessary to provide
a functional barrier. The main component of the CE is loricrin (Lor), a structural protein that com-
prises up to 85% of the CE. Unexpectedly, Lor -/- mice are born with a functioning, intact epider-
mis, unveiling a compensatory mechanism that is activated in utero. Preliminary data suggests that
several members of the recently identified late cornified envelope gene family along with mem-
bers of the short proline rich gene family are upregulated to compensate for the loss of loricrin.
Microarray analysis on Lor -/- skin revealed the transcription factor, NF-E2 related factor 2 (Nrf2),
as a possible candidate for orchestrating this compensatory response. To test this, we have gener-
ated a transgenic mouse line that drives expression of a dominant negative form of Nrf2 (dnNrf2)
in late differentiating keratinocytes, where the compensatory mechanism is activated. When we
cross the dnNrf2 into the Lor -/- background we see a significant reduction in transcription of the
compensatory genes and the mice are no longer able to survive after birth. These findings suggest
that Nrf2 can orchestrate the compensatory response seen in the Lor -/- mouse and can activate the
transcription of several genes important in the later stages of epidermal differentiation. Thus, reveal-
ing the Nrf2 signaling pathway as a potential target for accelerating epidermal barrier function in
premature infants.
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Folate metabolism in skin cells subjected to folate deficiency and ultraviolet radiation expo-
sure
JD Williams and MK Jacobson University of Arizona, Tucson, AZ
It is hypothesized that inadequate levels of folate in skin cells may be caused by either nutrient
deficiencies or environmental exposure to ultraviolet (UV) radiation and that conditions of intra-
cellular folate deficiency impair proliferation, differentiation, DNA repair, and error-free DNA syn-
thesis. Intracellular folate concentrations and the mechanisms of folate metabolism are examined
in cultured human keratinocytes (HaCaT) before and after folate nutrient deprivation and/or expo-
sure to UV radiation in the form of solar simulated light. Nutrient deficiencies were generated
through restriction of folate in the culture medium. Changes in intracellular concentrations of indi-
vidual folate species including 5-methyltetrahydrofolate, 5-formyltetrahydrofolate, and tetrahy-
drofolate are measured by HPLC MS/MS techniques. DNA repair and error free synthesis are assessed
utilizing both standard and DNA glycosylase modified alkaline comet assays. Mechanisms of folate
transport and intracellular retention are investigated by RT-PCR. Folate restriction alone and in com-
bination with UV exposure resulted in a significant decrease in the intracellular concentrations of
measured folate species. Folate restriction of HaCaT cells inhibited proliferation in a dose depen-
dant manner, resulted in morphological alterations, and caused S phase cell cycle accumulation.
Proliferation, morphology, and cell cycle alterations were all reversible upon folate replenish-
ment. Cell cycle blockage in the S phase is a scenario in which skin cells may be sensitized to the
adverse effects of UV induced DNA damage and insufficient DNA damage repair. From these results
it is concluded that alterations in folate metabolism resulting from folate deficiency and UV expo-
sure can predispose normal skin cells to neoplastic transformation by an increased sensitivity toward
DNA damage and insufficient DNA damage repair.
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Modeling of molecular properties leads to the development of a novel humectant system
with enhanced stratum corneum hydration benefits
C Vincent, P Chandar, N Lu and G Nole Unilever R&D, Trumbull, CT
Skin moisturizers are commonly applied to remedy dry skin conditions via increasing the hydra-
tion level in stratum corneum (SC). To do this, current moisturizers typically contain humectant
and occlusive ingredients, with the former being a highly hygroscopic molecule, such as glycerol.
However, any increase in the hygroscopicity of a molecule will by nature reduce its ability to pen-
etrate the lipid barrier of the stratum corneum. Therefore, to be effective, a humectant must bal-
ance competing lipophilic (lipid solubility) and hygroscopic (water-liking) properties. To explore
new skin moisturization technology, we have developed a model which couples the SC barrier
property, local transport and physicochemical phenomena of water and (natural and exogenous)
moisturizers, and external environmental conditions with hydration profiles across the stratum
corneum (SC) depth and the rate of transepidermal water loss. The model predicts that a single
humectant approach results in a trade-off between water binding and permeability. The model
also suggests an opportunity to potentially target moisturization to the very dry, outermost part of
the SC by reducing lipophilic properties of the humectant. This could lead to developing combi-
nations of materials with different physio-chemical properties, providing complementary contri-
butions to hydration performance. In a series of controlled studies with volunteers the perform-
ance of moisturizing products containing a novel humectant system was compared to lotions
containing glycerol. Formulations containing these novel humectants were superior to matched
formulations with conventional humectant systems and also superior to a wide range of commer-
cially available skin moisturizing products. These results were in agreement with predictions of
the model.
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Transglutaminase-1 gene mutations in autosomal recessive congenital ichthyosis: A report
of 23 novel mutations and modeling of TGase-1
ML Herman,1 S Farasat,1 PJ Steinbach,2 M Wei,1,3 O Toure,1 P Fleckman,4 PW Blake,1,5 SJ Bale6
and JR Toro1 1 Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics,
National Cancer Institute, Bethesda, MD, 2 Center for Molecular Modeling, Division of
Computational Bioscience, Center for Information Technology, National Institutes of Health,
Bethesda, MD, 3 Basic Research Program, SAIC-Frederick Inc, Frederick, MD, 4 Dematology
Branch, Division of Medicine, University of Washington, Seattle, WA, 5 Research Scholars
Program, Howard Hughes Medical Institute, Bethesda, MD and 6 GeneDx, Inc, Gaithersburg,
MD
Autosomal recessive congenital ichthyosis (ARCI) is a heterogeneous group of rare cornification
diseases. Germline mutations in TGM1 are the most common cause of ARCI in the US. TGM1
encodes for the TGase-1 enzyme that functions in the formation of the cornified cell envelope. We
review the clinical manifestations as well as the molecular genetics of ARCI. In addition, we char-
acterized 115 TGM1 mutations reported in 234 patients. In addition, we report 23 novel mutations:
71 (62%) missense; twenty (17%) nonsense; nine (8%) deletion; eight (7%) splice-site and seven
(6%) insertion. The c.877-2A>G was the most commonly reported TGM1 mutation accounting for
34 % (147/435) of all TGM1 mutant alleles reported to date. It had been shown that this mutation
is common among North American and Norwegian patients due to a founder effect. Thirty-one
percent (36/115) of all mutations and 41% (29/71) of missense mutations occurred in arginine
residues in TGase-1. Forty-nine percent (35/71) of missense mutations were within CpG dinu-
cleotides, and 74% (26/35) of these mutations were C> T or G>A transitions. We constructed a
model of human TGase-1 and showed that all mutated arginines that reside in the two beta-barrel
domains and two (R142 and R143) in the beta-sandwich are located at domain interfaces. In con-
clusion, this study expands the TGM1 mutation spectrum, summarizes the current knowledge of
TGM1 mutations. The high frequency of mutated arginine codons in TGM1 may be due to the
deamination of 5′ methylated CpG dinucleotides.
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CYLD missense mutations occur in USP domain and are associated with multiple familial
trichoepithelioma
PW Blake,1,2 PJ Steinbach3 and JR Toro1 1 Genetics and Epidemiology, National Cancer
Institute, Bethesda, MD, 2 Research Scholars Program, Howard Hughes Medical Institute,
Bethesda, MD and 3 Center for Molecular Modeling, Division of Computational Bioscience,
Center for Information Technology, National Institutes of Health, Bethesda, MD
Germline mutations in the cylindromatosis (CYLD) gene have been described in families with
Brooke-Spiegler syndrome, an autosomal dominant predisposition to skin appendageal neoplasms
including cylindromas, trichoepitheliomas, and/or spiradenomas. CYLD encodes a deubiquitinat-
ing (DUB) enzyme that negatively regulates the NF-kappaB and c-Jun N-terminal kinase path-
ways. We investigated the clinical, molecular, and genetic features of BSS cases reported in the lit-
erature. Of the 49 mutations reported, 43% (21) are frameshift, 37% (18) are nonsense, 12% (6)
are missense, and 8% (4) are putative splice site. Eighty-eight percent (43/49) of the mutations are
predicted to result in truncated proteins. Our investigation revealed that the six missense muta-
tions reported to date occur only within the ubiquitin-specific protease (USP) domain of the CYLD
protein and 5/6 mutations are associated exclusively with multiple familial trichoepithelioma. The
structure of the USP domain of the native CYLD enzyme determined by X-ray diffraction (PDB
code: 2VHF) was inspected using molecular-graphics software to identify possible structural effects
of the CYLD missense mutations. Four of the mutated residues (G596, D681, P904, and D941) are
arranged in a ring around, and relatively close to, the catalytic site. The G596D, D681G, and D941V
mutations involve the addition or removal of an ionizable side chain. The P904L mutation may
well affect the mobility of the loop in which it resides. The E747G mutation is located in a cleft
with other negative charges nearby and might disrupt protein-protein interactions. In summary,
CYLD mutations disrupt the USP domain, either through premature protein truncation or missense
mutation. The location and type of CYLD mutation may be important in the clinical phenotype in
patients with BSS.
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Identification of a nonsense ATP2C1 mutation in a Chinese family with Hailey–Hailey dis-
ease
G Zhang,1,2 H Shi,1,2 M Shao,2,1 X Du,2,1 H Mu3 and P Xie3 1 Department of Dermatology, The
Wuxi First Affiliated Hospital of Nanjing Medical University, Wuxi, China, 2 Department of
Dermatology, Wuxi People’s Hospital, Wuxi, China and 3 Department of Central Laboratory,
Wuxi People’s Hospital, Wuxi, China
The objective of this study is to detect the ATP2C1 gene mutation in a Chinese familiy with Hai-
ley–Hailey disease (HHD, OMIM 16960). Hailey–Hailey disease, otherwise known as familial
benign chronic pemphigus, is a rare cutaneous disorder inherited as an autosomal dominant trait,
with an incidence of 1:50,000. It is characterized by recurrent vesicles, crusted erosions, and warty
papules usually involving intertriginous areas and first occurring after puberty, mostly in the third
or fourth decade. Recent studies have revealed that Hailey–Hailey disease is caused by mutations
in the ATP2C1 gene on chromosome 3q21-24, encoding the human secretory pathway Ca2+/Mn2+
ATPase protein 1 (hSPCA1) which localizes to the Golgi apparatus and pumbs Ca2+ from the cytosol
to the Golgi. In this study, we reported clinical and molecular findings of a Chinese multi-genera-
tion family and identified a recurrent mutation 163C>T, which was previously identified in two
other ethnic families with HHD, in the ATP2C1 gene in the affected individuals of this family. The
163C>T results in arginine codon 55 (CGA) being substituted for a stop codon (TGA). ATP2C1
with this mutation will encode abnormal gene products of prematurely truncated mutant hSPCA1
proteins. This may cause an inability to maintain structurally intact desmosomes, leading to the
acantholysis characteristic of HHD. The results suggest the molecular basis of HHD in this Chi-
nese family and provide further evidence that the mutation in ATP2C1 underlie Chinese HHD.
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Phase I trial of H5.020CMV.PDGF-b for treatment of venous leg ulcer
DJ Margolis,1 L Weinberg,1 M Curran,1 L Morris2 and T Crombleholme2 1 Dermatology,
University of Pennsylvania, Philadelphia, PA and 2 Cincinnati Children’s Hospital, Cincinnati,
OH
Despite promising basic research, no cytokine growth factor has been approved for the treatment
of venous leg ulcer. This failure may be related to delivery. In order to assure the delivery to chronic
wound target tissue, we explored the novel use of gene-transfer. The goals of this study were to
explore the initial safety and proof of concept of H5.202CMV.PDGF-b, which is a replicate defi-
cient adenovirus (H5) containing cDNA for platelet derived growth factor (PDGF-b). We enrolled
15 subjects in a 3-6 dose escalation study. Subjects received either 3x107, 1.1x108, 3x108, or 1.1x109
particles per ulcer of H5.020CMV.PDGF-b as a single ulcer-edge intradermal injection. They were
closely followed for 28 days (safety window) and then for one-year. The average age of the par-
ticipants was 46 years. Eleven were male (73%) and 9 were Caucasian (60%). No dose limiting
toxicity was observed. Antibodies to H5 (adenovirus vector) were noted in all tested subjects. At
the start of the study, the average wound was 24.4 cm2. With respect to wound improvement, a
decrease in wound size was noted in 14 of 15 subjects (93%) and 11(73%) had day 28 changes in
wound size previously associated with good prognosis. Two subjects healed by day 28. Seven
subjects (47%) healed by week 24. A large cohort-based projection for healed wounds from sim-
ilarly severe patients treated in a wound care system was 31%. Immunohistology of wound biop-
sies obtained just before administration, at 48 hours, and at day 28 for CD133 and CD31 (mark-
ers of angiogenesis) showed CD31 counts elevated near the site of injection (P<0.001) and a
statistically significant increased number of CD133 cells were observed (p=0.002) at the wound
edge at 48 hours. In conclusion, this is the first completed human study using the gene-transfer of
a cytokine-growth in a venous leg ulcer. We showed that a dose exists that is safe enough to be
explored in a phase II study that a single injection of H5.020CMV.PDGF-b appears to encourage
wound repair.
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Reduced FRAS1 expression underlies epithelial fragility in AEC syndrome
SE Clements and JA McGrath St John’s Institute of Dermatology, The Guy’s, King’s College and
St. Thomas’ School of Medicine, London, United Kingdom
AEC (ankyloblepharon-ectodermal dysplasia-clefting) syndrome results from mutations in the
transcription factor p63: most cases involve heterozygous amino acid substitutions in the sterile-
alpha motif (SAM) domain. In contrast, mutations in the DNA-binding domain of p63 typically lead
to EEC (ectrodactyly-ectodermal dysplasia-clefting) syndrome. One common clinical feature in AEC
syndrome is skin erosions (especially scalp), which is not usually seen in EEC or other p63 ecto-
dermal dysplasia syndromes. To investigate this, we first performed immunolabeling of eroded
and intact AEC skin (n=4) using a panel of anti-basement membrane antibodies but observed no
differences from normal control skin. Next, we undertook Illumina Human-6 v2 microarray expres-
sion profiling using cDNA from biopsies of intact skin from 4 individuals with AEC syndrome (muta-
tions: p.G505T, p.L514F, p.I537T, and p.G561D) and 12 normal controls. Greater than two-fold
changes were noted in AEC syndrome skin for 404 down-regulated and 7 up-regulated genes,
including a ~3-fold reduction in FRAS1, which encodes an extracellular matrix protein involved
in embryonic dermal-epidermal adhesion and which is normally expressed in the sub-lamina densa
zone. Validation by real-time RT-PCR confirmed a 40-60% reduction in FRAS1 in cDNA from tis-
sue sections of non-blistered full thickness AEC skin as well as a 60% reduction in expression in
basal keratinocytes isolated from AEC frozen skin sections by laser capture microdissection. Immuno-
fluorescence microscopy of scalp and trunk skin from the AEC subjects showed a marked reduc-
tion of FRAS1 protein at the dermal-epidermal junction, in contrast to FRAS1 immunolabeling in
EEC syndrome skin which showed no differences from normal control skin. Collectively, our find-
ings show that epithelial fragility in AEC syndrome is associated with reduced FRAS1 expression,
thus providing new insight into one of the clinicopathologic features of this particular ectodermal
dysplasia syndrome as well as the role of the p63 SAM domain in embryonic epidermal adhesion.
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Gene expression profiling as a tool to characterize the response of epidermal keratinocytes
towards cholesterol depletion
C Mathay,1 M Pierre,2 M Pittelkow,3 E Depiereux2 and Y Poumay1 1 Cell and Tissue Laboratory
- URPhyM, University of Namur (FUNDP), Namur, Belgium, 2 Research Unit in Molecular
Biology, University of Namur (FUNDP), Namur, Belgium and 3 Dermatology Research, Mayo
Clinic, Rochester, MN
Cholesterol depletion carried out with methyl-beta-cyclodextrin (MBCD) in normal epidermal
keratinocytes perturbs membrane lipid rafts and induces several morphological changes. Choles-
terol depletion activates the EGF receptor and p38MAPK pathways, induces the gene expression
of heparin-binding EGF-like growth factor (HB-EGF) and involucrin and suppresses the gene expres-
sion of keratin 10. Wishing to better characterize the observed alterations, we performed a whole
genome-based expression profiling (Affymetrix HG_U133 Plus 2.0) of keratinocytes subjected or
not to cholesterol depletion. Samples were analysed immediately after cholesterol depletion, or
after 1h or 8h of recovery in order to identify early and later responses to the treatment. Subse-
quently to analysis of the raw microarray data, we obtained a list of differentially regulated genes
(0.5 > fold change > 2, p-level < 0.05). Our observations confirm the previously reported induced
expression of HB-EGF and involucrin and the reduced expression of keratin 10 in cholesterol-
depleted cells, and they further allowed us to identify new highly regulated targets of cholesterol
depletion, such as for instance interleukin-8 (IL-8) expression. Real-time PCR analysis validates this
array-detected increase in IL-8 mRNA, and using ELISA assays, we also prove a stimulated IL-8
release from MBCD-treated keratinocytes. Several genes involved in inflammatory mechanisms,
notably IL-1 receptor, IL-1 alpha, IL-8, COX-2 and SOCS3, are differentially up-regulated in response
to cholesterol depletion. Gene clustering of the various regulated genes will deduce biological
functions from groups of altered genes. This analysis is helping us in answering the question whether
cholesterol depletion is actually related to a general inflammatory response in keratinocytes.
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Fibroblast cell therapy for Dystrophic Epidermolysis Bullosa: Long-term skin stability despite
limited cell viability
JS Kern,1 S Loeckermann,1 A Fritsch,1 ML Müller,1 I Hausser,2 P Ruther1 and L Bruckner-
Tuderman1 1 University Medical Center and University, Freiburg, Germany and 2 University
Hospital, Heidelberg, Germany
Recessive dystrophic epidermolysis bullosa (RDEB) is an incurable skin fragility disorder caused
by mutations in the collagen VII gene. Pilot experiments suggested that topical injections of allo-
geneic fibroblasts may show promise as a treatment for RDEB. Here we investigated long-term
efficacy, mechanisms and safety of this cell therapy approach in the collagen VII hypomorphic
mouse model for RDEB. Five week-old mice were injected twice with 20 x 106 EGFP+ fibroblasts
intradermally into a 2x3 cm area of dorsal skin. After 1 - 120 days, the skin was subjected to
(immuno)histopathological, EM and RNA-expression analysis and to functional tests. 24 h post-
injection, EGFP+ fibroblasts were found throughout the dermis within the injected area, they had
migrated up to 10 mm into adjacent areas, but did not proliferate. Gradually, they became apop-
totic within 28 d. In the first weeks, the fibroblasts actively synthesized collagen VII, with strongly
increased mRNA levels at 7 d after injection and a return to basic levels within 28 d. Collagen VII
protein, as measured with semiquantitative confocal laser scanning microscopy, was significantly
increased at the dermal-epidermal junction. Intriguingly, the levels remained high for >100 d, and
EM demonstrated increased anchoring fibril-like structures. The mechanical stability and resist-
ance to shearing forces of treated skin areas was improved for 100 days, as assessed with a newly
developed micromechanical force sensor. The therapy appeared safe, as the fibroblast injections
lead to a transitory mild inflammatory infiltrate, but not to specific immune response to collagen
VII or to fibrotic processes. This study clearly demonstrates that intradermal injection of allo-
geneic fibroblasts increases dermal-epidermal stability in the RDEB mouse for >3 months and that
no significant adverse effects are to be expected, thus paving way to development of a clinically
feasible and safe causal therapeutic regimen for human RDEB.
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Conditional collagen VII inactivation allows analysis of anchoring fibril stability and func-
tion in vivo and reveals a major role of fibroblasts in collagen VII expression
A Fritsch,1 JS Kern,1 S Loeckermann,1 D Velati,1 R Fässler2 and L Bruckner-Tuderman1 1
University Medical Center Freiburg, Freiburg, Germany and 2 Max-Planck-Institute of
Biochemistry, Martinsried, Germany
Anchoring fibrils (AF) are essential mediators of dermal-epidermal stability in the skin. They con-
sist of collagen VII, and mutations in the COL7A1gene cause recessive dystrophic epidermolysis
bullosa (RDEB) with loss of AF and extensive blistering and scarring of the skin and mucosa. To
analyse disease mechanisms and develop novel therapies we generated several transgenic mod-
els for RDEB. A collagen VII hypomorph with only 10% residual protein led to discovery of con-
tinuous inflammation and contractile fibrosis as a cause for scarring. In these mice, skin stability
was strongly improved after intradermal injection of fibroblasts, demonstrating the feasibility of
cell therapy for RDEB. Major questions in therapy development concern the quantity of collagen
VII required for a therapeutic effect and the stability of AF in vivo. We designed a Col7a1 allele
for inactivation by a tamoxifen-inducible Cre-recombinase. Ubiquitous gene inactivation in Col7a1
fl/fl mice lead to strong reduction of collagen VII levels and microblistering in skin and lingual
mucosa within 5 weeks. In contrast, keratinocyte-restricted Col7a1 inactivation using a K14 pro-
moter-driven Cre-recombinase caused a clearly slower loss of AF function. Microblisters occurred
only after 10-12 weeks, demonstrating that both keratinocytes and fibroblasts are significant sources
of the AF. Quantification of collagen VII in the skin showed, irrespective of the localization of the
Cre-recombinase, that about 35% of normal collagen VII levels are required for skin stability;
microblisters occurred at lower levels. Interestingly, in the tongue, about 50% reduction of colla-
gen VII already produced microblisters, suggesting different demands for AF in different organs and
localizations. Moreover, our data show that collagen VII is highly stable in vivo, thus providing an
important basis for design of molecular and cellular therapy protocols for RDEB.
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Transcriptional coactivator DRIP/Mediator is involved in VDR function and regulates ker-
atinocyte proliferation and differentiation
Y Oda,1 RJ Chalkley,2 AL Burlingame2 and DD Bikle1 1 Medicine and Endocrinology,
University of California San Francisco and Veterans Affairs Medical Center San Francisco, San
Francisco, CA and 2 Pharmaceutical Chemistry, University of California San Francisco, San
Francisco, CA
DRIP/Mediator is multi-subunit coactivator complex that facilitates transcription of nuclear recep-
tors. We investigated the role of the DRIP/Mediator complex as a coactivator for Vitamin D recep-
tor (VDR) in primary keratinocytes. Using GST-VDR affinity beads, the DRIP/Mediator complex
was purified from primary keratinocytes, and its subunit composition was determined by mass
spectrometry. The complex included core subunits, such as DRIP205/MED1, that directly bind to
VDR and activate VDR function. Additional subunits were identified that are components of the
RNA Polymerase II complex. The function of DRIP/Mediator was investigated by silencing its sub-
units. The core subunit DRIP205/MED1 facilitates VDR activity and regulating keratinocyte pro-
liferation and differentiation. An additional subunit MED21/hSrb7 plays a role in keratinocyte
proliferation, whereas MED10/hNut2 has an inhibitory role. Blocking DRIP205/MED1 expression
increased proliferation of keratinocytes, accompanied by increases in mRNA expression of the cell
cycle regulator Cyclin D1 and Gli 1. Blocking DRIP205/MED1 expression also resulted in defects
in calcium-induced keratinocyte adhesion and differentiation, as indicated by decreased adherens
junction formation and decreased expression of differentiation markers. These results demon-
strate that keratinocytes utilize the transcriptional coactivator DRIP/Mediator to regulate VDR func-
tions and further to regulate keratinocyte proliferation and differentiation.
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Novel mutations in the oncostatin M receptor-β underlie familial primary localized cuta-
neous amyloidosis
A Tanaka,1 JE Lai-Cheong,1 N Nagy,1 P Van Den Akker,2 F Palisson,3 G Millington4 and
JA McGrath1 1 St.John’s Institute of Dermatology, King’s College London (Guy’s Campus),
London, United Kingdom, 2 Department of Genetics, University Medical Center Groningen,
Groningen, Netherlands, 3 Depertment of Dermatology, University of Chile, Santiago, Chile
and 4 Dermatology Depertment, Norfolk and Norwich University Hospital, Norwich, United
Kingdom
Familial primary localized cutaneous amyloidosis (FPLCA) is an autosomal dominant disorder asso-
ciated with chronic skin itching and deposition of epidermal keratin filament-associated amyloid
material in the upper dermis. In 2008, the genetic basis of FPLCA was shown to involve mutations
in the OSMR gene, which encodes oncostatin M receptor-β (OSMRβ). OSMRβ forms part of the
oncostatin M (OSM) type II receptor and the interleukin (IL)-31 receptor, dimerizing with gp130 or
IL31RA, respectively. The published mutations (p.G618A and p.I691T) comprised heterozygous
amino acid substitutions within the extracellular fibronectin type III-like (FNIII) domains, regions
critical for receptor dimer formation and function. These mutations may interfere with receptor
coupling, as evidenced by decreased signal activation following stimulation with the ligands OSM
and IL-31 in FPLCA keratinocytes. We have now sequenced OSMR in 4 further FPLCA pedigrees
and identified 3 novel heterozygous missense mutations (p.V631L, p.D647Y and p.P694L) and 1
recurrent mutation (p.G618A). Haplotype analysis of all individuals with the mutation p.G618A
showed evidence for a common ancestral allele. None of the amino acid substitutions were observed
in sequencing 200 ethnically-matched control chromosomes. This study expands the molecular
pathology of FPLCA. Five different mutations in OSMR have now been elucidated: all mutations
are located in the FNIII domains of OSMRβ, data that provide intriguing new insight into the
pathophysiology of FPLCA, and which may have broader biological relevance to mechanisms of
skin itching and keratinocyte apoptosis.
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Mutations in FERMT1 in Kindler syndrome implicate a role for fermitin family homolog 1 in
epidermal stem cell maintenance and integrin activation
JE Lai-Cheong,1 A Tanaka,1 M Parsons2 and JA McGrath1 1 St John’s Institute of Dermatology,
King’s College London, London, United Kingdom and 2 Randall Division of Cell and
Molecular Biophysics, King’s College London, London, United Kingdom
Loss-of-function mutations in the FERMT1 gene which encodes the focal adhesion protein, fermitin
family homolog 1 (FFH1), underlie the autosomal recessive blistering and poikilodermatous gen-
odermatosis, Kindler syndrome (KS). Precisely how these mutations lead to basement membrane
disruption and skin atrophy, however, is unclear. In this study, we investigated the epidermal base-
ment membrane and keratinocyte biology abnormalities in KS. Broad reticular labeling for types
IV, VII and XVII collagens as well as a new finding of reduced and fragmented staining for α6 and
β4 integrins in KS skin were identified by indirect immunofluorescence microscopy. Furthermore,
reduced immunostaining for the epidermal stem cell markers, β1 integrin and cytokeratin 15, was
noted. Next, using confocal microscopy visualization of cultured KS keratinocytes, we observed
abnormal deposition of the extracellular matrix components, laminin-332 and type IV collagen, in
keeping with the saltatory migratory behavior of these cells. To investigate keratinocyte-extracel-
lular matrix interactions, we assessed the activation status of β1 integrin in KS keratinocytes and
found a marked reduction in active β1 integrin levels but similar total protein levels. This study
thus provides the first evidence that FFH1 is linked to β1 integrin activation. Loss of FFH1 there-
fore leads to pathology beyond the actin cytoskeleton and focal adhesions with disruption of sev-
eral hemidesmosomal proteins as well as reduced expression of keratinocyte stem cell markers.
These findings collectively illustrate the role of FFH1 in human skin and provide new insight into
the clinicopathological abnormalities of KS.
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A functional enhancer in the first intron contributes to the control of PADI1 transcription
S Ying,1 T Kojima,1 A Kawada,2 M Méchin,3 S Chavanas,3 G Serre,3 M Simon3 and H Takahara1
1 Department of Applied Life Sciences, Ibaraki University, Ami, Japan, 2 Department of
Dermatology, Kinki University, Osaka, Japan and 3 CNRS-Toulouse III University, Toulouse,
France
Peptidylarginine deiminase (PAD), which has five isoforms (PAD1-4,6), catalyzes the conversion
of protein-bound arginine residues to citrulline residues in a Ca2+-dependent manner. Three of them
are expressed in the epidermis. PAD1 is detected throughout the whole epidermis; PAD2 is located
in stratum spinosum and granulosum. PAD3 is restricted to the granular and the lower cornified
layers. In order to investigate the mechanism of PADI1, PADI2 and PADI3 transcriptions in the
human epidermis, previous studies revealed the basic transcritional regulation of human PADI1,2,3.
In present study, the result of in silico analysis indicates that there is an about 1000bp fragment in
the first intron of PADI1 which has very high conserved in several mammalians’ known genomes.
We explored the potential regulatory function of the fragment, like locus control region (LCR), was
confirmed by real-time PCR DNase I hypersensitivity assay in cultured keratinocytes. Further-
more, this fragment was showed both enhance the core-promoter activities of PADI1 gene and
SV40 in keratinocytes by luciferase reporter analyses. Additionally, mutation of NF-κB or Elk-1
putative sites which we identified by P-match motif program in this fragment markedly reduced
PADI1 promoter activity. Eukaryotic gene transcription is controlled not only by promoters but
also by intragenic cis-elements. In this study, we found the high conserved element, which is prob-
able a functional enhancer within the first intron, contributes to the control of PADI1 transcription.
www.jidonline.org   S81
ABSTRACTS
487
Study by qRT-PCR of the epidermal differentiation of human keratinocytes after evaluation
of candidate housekeeping genes using geNorm algorithm
F Minner, F Herphelin and Y Poumay Cell and Tissue Laboratory, URPHYM, University of
Namur (FUNDP), Namur, Belgium
In serum-free autocrine culture conditions, confluence of cultured human keratinocytes corre-
sponds to a strong commitment towards epidermal differentiation. Quantification of mRNA encod-
ing epidermal markers of differentiation such as keratin14 (KRT14), keratin 10 (KRT10), involucrin,
loricrin, filaggrin or transglutaminase-1 has been usually performed by Northern blotting in order
to characterize the precise phenotype of these cells. The expression of a gene is quantified by cal-
culating a value that is expressed relatively to the measurement performed on the same sample for
the expression of a housekeeping gene (HKG). HKG are genes with stable expression independ-
ently of any particular cell phenotype. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
ribosomal protein large P0 (RPLP0), actin or tubulin have been chosen for studies of keratinocytes
by Northern blotting. Today, real-time qRT-PCR is becoming a generalized technique to study the
mRNA expression of markers of differentiation, expressed as a ratio between the gene of interest
and a stably expressed HKG. However, the high sensitivity of qRT-PCR requires particular atten-
tion on data normalization and processing. In this study, we present analysis of multiple markers
of epidermal differentiation by qRT-PCR, with emphasis on the right choice of HKGs. The mRNA
expression of GAPDH, alpha-Tubulin1B (TUBA1B), RPLP0, TATA-binding protein (TBP), ribosomal
protein large 13A (RPL13A) and KRT14, an exclusively epidermal gene presenting a stable expres-
sion in the culture model, was measured to evaluate HKGs. Data were analyzed using geNorm
algorithm. Results obtained support the selection of TBP, RPL13A and RPLP0 as HKGs in order to
study cell density-induced differentiation of keratinocytes by real-time qRT-PCR and highlight that
HKGs used in studies of gene expression in keratinocytes must be evaluated in regard of precise
experimental conditions before their use to normalize expression of regulated genes.
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Identification of five new mutations in ABCA12 gene of three Japanese cases of non-bullous
congenital ichthyosiform erythroderma, suggesting a genotype-phenotype correlation
S Fukuda,1 T Hamada,1 S Sakaguchi,1 K Sakai,2 S Yasumoto,1 M Akiyama,2 H Shimizu2 and
T Hashimoto1 1 Department of Dermatology, Kurume University School of Medicine,
Kurume, Japan and 2 Department of Dermatology, Hokkaido University Graduate School of
Medicine, Sapporo, Japan
Non-bullous congenital ichthyosiform erythroderma (NBCIE; MIM 242100) is a heterogeneous
group of autosomal recessive congenital ichthyoses (ARCI) characterized by generalized superfi-
cial scales and erythroderma without blister formation. NBCIE results from mutations in several
genes, including ABCA12, ALOXE3, ALOXE12B, CYP4F22, ichthyin, and TGM1. ABCA12 is a
member of the ATP-binding cassette transporter, involved in lipid transport from lamellar granules
to the keratinocyte surface of the granular layer. So far, only four ABCA12 mutations in three NBCIE
cases have been reported. In this study, we examined the ABCA12 gene in five unrelated Japan-
ese patients with NBCIE and identified five new mutations and one recurrent mutation in three
patients. All three cases had compound heterozygosity of a truncation mutation (either splice site
or deletion mutation) and a missense mutation: i.e., c.[5940-1G>C]+p.[Arg986Trp],
c.[5128+3A>G]+p.[Asn1380Ser] and c.[6031delG]+p.[Thr1575Pro]. Among these mutations, only
p.Asn1380Ser is a recurrent mutation. Mutations in ABCA12 are also known to result in lamellar
ichthyosis type 2 (LI2; MIM 601277) and harlequin ichthyosis (HI; MIM 242500). In general, a
homozygous or compound heterozygous missense ABCA12 mutation leads to an LI2 phenotype,
and a homozygous or compound heterozygous truncation mutation exhibits an HI phenotype.
Adding to these previous results, our study clearly suggests that NBCIE phenotype is caused by a
combination of truncation and missense mutations. Although the molecular pathology of ABCA12
remains unclear, our study strengthens the genotype-phenotype correlation in ARCI patients with
ABCA12 mutations. The findings also provide clinicopathological evidence for the role of ABCA12
in keratinocyte differentiation.
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Analysis of the HLA-Cw1–B46 psoriasis risk haplotype reveals allelic heterogeneity with HLA-
Cw6
RP Nair,1 PE Stuart,1 R Hiremagalore,1 P Kullavanijaya,2 T Tejasvi,1 JJ Voorhees1 and JT Elder1 1
Dermatology, Univ Michigan, Ann Arbor, MI and 2 Institute of Dermatology, Bangkok,
Thailand
In Caucasians, HLA-Cw6 is the most likely risk allele at the chromosome 6 psoriasis susceptibility
locus PSORS1 (Nair et al, Am J Human Genet 78:827, 2006). In Asians, in addition to HLA-Cw6,
the HLA-B46-Cw1 haplotype is also associated with psoriasis. To examine whether these two risk
haplotypes share a disease allele identical by descent from a common ancestor, we sequenced a
Thai B46–Cw1 homozygote across the ~300 kb PSORS1 risk region. Comparison with previously
sequenced Cw6-B57 and Cw6-B50 risk haplotypes revealed 3 regions of sequence similarity. How-
ever these regions also shared equivalent sequence similarity with one or more haplotypes that
were clearly non-risk, and they contained no polymorphisms unique to Cw1-B46 and Cw6 risk
haplotypes, suggesting allelic heterogeneity at PSORS1. In a sample of 206 Thai cases and 114 con-
trols, we confirmed that Cw1 (p = 0.0011, OR = 2.16) and Cw6 (p = 3.2x10-6, OR = 4.79) are sig-
nificantly associated with psoriasis. The difference in risk between the two alleles, along with greater
nail involvement and later age at onset for Cw1-carrying psoriatics, further support allelic hetero-
geneity. In a sample of 1467 Caucasian cases and 1458 controls, Cw6 was strongly associated (p
= 2.8x10-45, OR = 2.77), but Cw1 was unassociated (p = 0.17, OR=0.83) even though the sample
had >99.9% power to detect association under a multiplicative model (α = 0.05, RR = 2.0). Hap-
lotype analysis in Thais showed strong association for the B46-Cw1 haplotype (p = 0.0019, OR =
2.22), but not for Cw1 haplotypes lacking B46 (p = 0.56, OR = 1.33). There were no B46 carriers
among the 270 Caucasian Cw1 carriers. These results strongly suggest that HLA-Cw1 is not a
direct determinant of psoriasis. Since HLA-B and -C are highly homologous, B46 could possibly
be a psoriasis susceptibility determinant in Asians, a notion supported by a previous report that B46
is the result of a gene conversion event in which a segment of Cw1 was transferred to HLA-B62.
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Immunogenetics of HIV associated HPV disease after HAART
R Meys,1 F Fowles,2 A Little,2 SG Marsh,2 D Asboe,1 DA Hawkins,1 FM Gotch1 and CB Bunker1
1 Departments of Dermatology, Genitourinary Medicine & Immunology, Imperial College
School of Medicine, London, United Kingdom and 2 Anthony Nolan Research Institute &
UCL Cancer Institute, Royal Free Campus, London, United Kingdom
The purpose of this study was to determine the immunogenotypic basis for HPV immune recon-
stitution (IR) associated disease (IRAD) in HIV. Persistent and florid cutaneous and anogenital HPV
infection poses a significant clinical problem in HAART treated HIV patients despite apparently
adequate IR. Such persistent/emergent HPV disease might be viewed as a form of cutaneous IRAD.
Some clinical scenarios in HIV are related to host immunogenotype eg psoriasis (HLA-Cw*0602)
and abacavir hypersensitivity (HLA–B*5701) and others are postulated eg IRAD due to
cytomegalovirus, tuberculosis and herpes simplex virus. HLA associations have been identified for
HPV related disease, including respiratory papillomatosis, non-melanoma skin cancer and cervi-
cal cancer so might characterise HPV IRAD. HIV patients with persistent HPV IRAD were
immunogenotyped. HLA alleles were determined in white (European) HIV positive HAART treated
males with persistent (greater than twelve months) HPV related disease (n=32) and HIV positive
HAART treated controls with no history of persistent HPV disease (n=18). HPV diseases studied
include cutaneous warts, genital warts and anogenital intra-epithelial neoplasia. The HLA types
were compared at eight loci using a Luminex-based system. A significant association was found
for the allele HLA-DQB1*06, which conferred protection against HPV related diseases (12 of 32
cases compared with 14 of 18 controls, p=0.01, Chi Square test). After correction for multiple test-
ing, however, the difference was not significant (p=0.09; Bonferroni correction). The alleles HLA-
DRB1*03 (p=0.07) and HLA-DRB1*11 (p=0.08) were associated with persistent HPV disease,
although the allele frequency differences between cases and controls was not significant (Fishers
exact test). HLA alleles of potential interest have been identified that may be relevant to an
immunogenotypic basis for HPV IRAD in HAART treated individuals.
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Proximal transcription factor binding sites in the loricrin promoter are essential for regulat-
ing its expression in vivo
M Kawase,3 J Chen,1 Y Kawachi,4 D Dai,2 M Longley,2 AJ Huebner,1 K Yamada,4 PJ Koch1 and
DR Roop1 1 Department of Dermatology and Charles C. Gates Regenerative Medicine and
Stem Cell Biology Program, University of Colorado Denver, Aurora, CO, 2 Program in
Developmental Biology, Baylor College of Medicine, Houston, TX, 3 Dermatology, Jikei
University School of Medicine, Tokyo, Japan and 4 Dermatology, University of Tsukuba,
Tsukuba, Japan
Loricrin is the major protein component of the cornified cell envelope (CE), comprising up to 85%
of its mass. It has been demonstrated that the expression of the mouse loricrin gene (Lor) is strictly
regulated at the transcriptional level. The distal promoter region between position –14 kb and –6.5
kb contains differentiation-specific regulatory elements that restrict the expression of Lor to the
upper spinous and granular keratinocytes. A proximal AP-1 site has been shown to be essential for
Lor promoter activity. Here, we identified a putative Sp-1 transcription factor binding site which is
within 20 bp upstream of the AP-1 site. These elements are conserved between mouse and human.
To further characterize the proximal regulatory region of Lor, we generated BAC transgenic mice
in which the coding sequence of Lor was replaced with a LacZ reporter gene (Lor-LacZ-BAC). The
BAC transgene was flanked by 175.8 kb (46.2 kb upstream and 126.6 kb downstream) endoge-
nous Lor sequence. Initially, we confirmed that the retention of the large flanking sequences and
the preservation of the intron in the BAC transgenic vector reproduced the endogenous expression
profile of Lor in transgenic mice. We then introduced mutations into the proximal transcription
factor binding sites in the Lor promoter in the context of the Lor-LacZ-BAC and generated addi-
tional transgenic lines. We report here that the AP-1 site and putative Sp-1 site immediately upstream
of the transcription start site of Lor are essential for the transcriptional activity of Lor both in vitro
and in vivo. Thus, confirming the importance of these proximal regulatory elements for transcrip-
tional control of the Lor gene.
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Targeted ex vivo gene therapy for epidermolytic hyperkeratosis
J Chen and DR Roop Department of Dermatology and Charles C. Gates Regenerative
Medicine and Stem Cell Biology Program, University of Colorado Denver, Aurora, CO
Epidermolytic hyperkeratosis (EHK), also known as bullous congenital ichthyosiform erythroderma
(BCIE), is an autosomal dominant form of ichthyosis caused by point mutations in the keratin 1 or
keratin 10 genes. These mutations lead to defective suprabasal keratinocytes, resulting in blister-
ing and hyperkeratosis. Gene therapy approaches represent an attractive option for a permanent
corrective therapy for this monogenic disease. Our laboratory has previously developed a condi-
tional “knock-in” mouse model that mimicked EHK at both genetic and phenotypic levels. Obser-
vations based on this mouse model revealed that partial suppression of the mutant allele (Krt10)
might be sufficient to eliminate the clinical phenotypes. We have developed a lentivirus-based
delivery system so that mutant Krt10-specific siRNAs can be delivered to keratinocytes isolated
from the EHK mouse model. We demonstrate that dissociated primary keratinocytes isolated from
the EHK mouse skin were able to regenerate the scaly skin phenotype of EHK when grafted on
immune compromised mice to reconstitute a new skin. Therefore, the ability to genetically mod-
ify EHK keratinocytes ex vivo by lentivirus-mediated delivery of mutant-specific siRNA and sub-
sequently to reconstitute skin with these keratinocytes provides us with an in vivo model to test
the efficacy of these therapeutic strategies for EHK.
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Kindlins: Novel proteins involved in epidermal adhesion, cell-matrix interactions and skin
aging
Y He, B Maertens, L Bruckner-Tuderman and C Has Dermatology, University Medical Center,
Freiburg, Germany
Kindlins are essential regulators of integrin activation and cytoskeletal reorganization in cell-matrix
adhesion. Kindlin-1 and -2 are expressed in human skin. It’s not clear, however, how they con-
tribute to skin integrity and stability and whether their functions correlate. Defects of kindlin-1 are
the cause of Kindler syndrome (KS), a rare autosomal recessive disorder with an evolving pheno-
type: initial skin blistering is followed by photosensitivity, early progressive poikiloderma, atrophy
and skin cancer, features also seen in aged skin. In this study, we combined genetic, recombinant
expression, siRNA and antibody studies to investigate expression and functions of kindlin-1 and -
2 in the skin. Kindlin-1 is an epidermal-specific protein facing the basal surface in basal ker-
atinocytes. In contrast, kindlin-2 is expressed at high levels in all major skin cell types - keratinocytes,
fibroblasts and melanocytes. In the epidermis, it appears at the entire cell periphery of basal ker-
atinocytes, partially co-localizing with E-cadherin and α6 integrin, but not with laminin 332. In
dermal fibroblasts, kindlin-2 is found partially colocalized with vinculin. Its expression is regulated
by paracrine signals, both PDGF and FGFb, but not TGF-beta, suppress kindlin-2 expression sig-
nificantly within 24 h. siRNA mediated downregulation of kindlin-2 impeded multiple functions
of dermal fibroblasts, including adhesion and spreading on collagen I and fibronectin, contraction
of collagen gels, proliferation and migration in in vitro wound healing assays. It appears that kindlin-
2 cannot compensate for the absence of kindlin-1 since in KS cells and skin no changes in the
expression level or in the distribution of kindlin-2 were found. Here, we demonstrate differential
expression and functions of kindlin-1 and -2 in the skin and show that they play important roles
in maintaining skin integrity and homeostasis between the epidermis and the dermis. These data
lay a basis for further studies on the roles of kindlins, not only in KS, but also in common condi-
tions, such as skin aging.
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Inherited absence of dermal ridges – the immigration delay disease
B Burger1,2 and P Itin1 1 Dermatology, University Hospital, Basel, Switzerland and 2
Biomedicine, University Hospital, Basel, Switzerland
Since the 19th century the fingerprints are used for individual identification. From this time point
on a large number of human fingerprints have been collected and the usage of biometric finger-
print identification is expanding recently. Up to now only four families without fingerprints as a
prominent feature are described in the English literature, most of them exhibit more distinctive
characteristics, e.g. congenital facial milia, blisters and fissures associated with heat or trauma.
Now we describe an unknown family with the phenomenon of missing fingerprints without fur-
ther abnormalities. The index patient applied for investigation at the Clinic of Dermatology because
of recurring trouble at the entry to the US with identity check using fingerprints. Her fingers, toes,
palms, and soles are missing the friction ridges completely. The family history showed that the
absence of dermal ridges is inherited in an autosomal-dominant pattern over four generations, male
and female are affected similarly. Development of dermal ridge patterns is supposed to be influ-
enced by different embryologic processes, but controlling factors are not totally identified. A hint
is given by Naegeli-Franceschetti-Jadassohn syndrome with missing fingerprints where a mutation
in keratin 14 is the cause of disease. We present the clinical features of the index patient which
provides us an insight into the embryology of development of fingerprints and discuss the actual
hypothesis of the dermal ridge development.
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Over-expression of fetuin-A counteracts ectopic mineralization in a mouse model of pseu-
doxanthoma elasticum
Q Jiang, F Dibra, MD Lee and J Uitto Dermatology and Cutaneous Biology, Jefferson Medical
College, Philadelphia, PA
The pathologic hallmark of pseudoxanthoma elasticum (PXE) is ectopic mineralization of soft
connective tissues. Recent studies have suggested that PXE is a metabolic disease, and perturba-
tions in a number of circulatory factors have been postulated. One of them is fetuin-A, a 60-kDa
glycoprotein synthesized in the liver and secreted into blood. Observations in targeted mutant mice
(Ahsg-/-) and in cell culture model systems have demonstrated that fetuin-A is a powerful anti-min-
eralization factor in circulation, and the serum levels of fetuin-A both in patients with PXE as well
as in a mouse model of PXE (Abcc6-/-)have been shown to be reduced by up to 30 percent. In this
study, we tested the hypothesis that over-expression of fetuin-A in Abcc6-/- mice counteracts the
ectopic mineralization. Delivery of an expression construct containing liver-specific promoter
(albumin) and full-length mouse fetuin-A cDNA, linked to a His-tag, to the liver of these mice
resulted in elevated serum levels of this protein. As a consequence, soft tissue mineralization, a
characteristic of Abcc6-/- mice, was reduced by ~70 percent at 12 weeks of age. The results sug-
gest that normalization of serum fetuin-A, either through gene therapy approaches or by direct pro-
tein delivery to the circulation, may offer novel strategies to treat PXE and perhaps other heritable
disorders of soft tissue mineralization.
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Increased pachyonychia congenita severity with concurrent keratin and filaggrin mutations
R Gruber,1 FJ Smith,2 PO Fritsch1 and M Schmuth1 1 Dermatology, Innsbruck Medical
University, Innsbruck, Austria and 2 College of Life Sciences, Division of Molecular Medicine,
University of Dundee, Dundee, United Kingdom
Pachyonychia congenita (PC), a rare autosomal-dominant keratin disorder invariably character-
ized by plantar keratoderma and hypertrophic nail dystrophy, is caused by mutations in keratin
genes K6a/b, K16 or K17. Loss-of-function mutations in the filaggrin (FLG) gene underlie the most
prevalent skin disorder of cornification, ichthyosis vulgaris (IV), and also show a strong associa-
tion with atopic dermatitis. Recently FLG mutations have been reported to increase phenotype
severity of X-linked ichthyosis and alopecia areata. We here report a mother and her son present-
ing with painful plantar keratoderma, follicular hyperkeratosis of the knees and lower legs, hyper-
trophic nail dystrophy and oral leukokeratosis consistent with PC. The son showed palmar hyper-
linearity and was much more severely affected than his mother. In addition, the father exhibited
mild IV with fine scaling of the extensor surfaces of the extremities and palmoplantar hyperlinear-
ity. Mutation analyses revealed a heterozygous missense mutation in K6a in the mother and her
son. In addition, the son and his father carried the heterozygous FLG mutation R2447X. For the
first time we here report that co-inheritance of mutations in keratin and FLG aggravates the PC
phenotype, suggesting that FLG is a genetic modifier of PC.
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Kindlin-1 is required for RhoGTPase-mediated lamellipodia formation in keratinocytes
C Has,1 C Herz,1 E Zimina,1 H Qu,2 Z Zhang,2 T Wen,2 Y Gache,3 M Aumailley2 and L Bruckner-
Tuderman1 1 University Medical Center, Freiburg, Germany, 2 University of Cologne, Cologne,
Germany and 3 U385 INSERM, Nice, France
Kindlin-1 is a focal adhesion phosphoprotein mainly expressed in epidermal keratinocytes. Muta-
tions in its gene cause the Kindler syndrome (KS), a human disorder characterized by skin blister-
ing, progressive poikiloderma and photosensitivity. Here, we uncovered new functions for kindlin-
1 in the control of cell shape and lamellipodia formation in keratinocytes. In primary KS keratinocytes,
in a KS cell line and in HaCaT cells treated with KIND1 siRNA, kindlin-1 deficiency lead to abnor-
mal elongated cell shape and lack of stable lamellipodia. Absence of kindlin-1 was partially com-
patible with focal adhesion formation at the periphery of the cells, but centrally placed, β1 inte-
grin-dependent focal adhesions were almost absent. In vitro wound healing assays demonstrated
that KS cells do not move as a front, but in scattered manner, and clearly slower than control cells.
Time lapse video microscopy revealed their inability to migrate by extending lamellipodia. The
functional role of kindlin-1 in the regulation of cell motility is associated with the signaling plat-
form of β1 integrin, which is a protein ligand for kindlin-1, similarly to α-actinin, migfilin and
focal adhesion kinase, as shown by co-immunoprecipitations. A genetic approach comparing
kindlin-1 negative and normal human keratinocytes revealed that kindlin-1 maintains activity of
the Rho family GTPases, key regulators of cell polarity and directional migration. In particular, loss
of kindlin-1 led to a decrease in the pool of GTP-bound, active Rho GTPases, and to reduced
phosphorylation of their downstream effectors PAK1, LIMK and of cofilin. We conclude that kindlin-
1 has important physiological functions in regulating cell migration, specifically the formation of
focal adhesions and of β1 integrin - and Rho GTPase-dependent extension of lamellipodia.
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The Pseudoxanthoma Elasticum phenotype in the Abcc6-/- mice is modified by the Ggcx
gene and the genetic background (129X1)
Q Li, AE Grand-Pierre and J Uitto Dermatology and Cutaneous Biology, Thomas Jefferson
University, Philadelphia, PA
Pseudoxanthoma elasticum (PXE) is an autosomal recessive disorder characterized by ectopic min-
eralization of connective tissues, and shows considerable intra- and interfamilial phenotypic vari-
ability. PXE is caused by mutations in the ABCC6 gene, and targeted ablation of Abcc6 in mouse
recapitulates PXE. In this study, we examined the hypothesis that reduced γ-glutamyl carboxylase
(GGCX) activity may synergistically catalyze the mineralization process in Abcc6-/- mice. Thus,
Abcc6-/- and Ggcx+/- mice were generated on 129S1 and 129S1/129X1 genetic background, respec-
tively, and backcrossed with C57BL/6 for 5 generations. Thus, these strains differ by the 129X1 con-
tribution to the background of the Ggcx-/- mice. We then generated Abcc6-/-; Ggcx+/+, Abcc6+/-;
Ggcx+/- and Abcc6-/- Ggcx+/- mice by crossing Abcc6-/- and Ggcx +/- mice. The degree of mineral-
ization of connective capsule of vibrissae, a biomarker of the mineralization process in PXE, was
quantified colorimetrically by calcium and phosphate levels in tissues. The mineralization of the
vibrissae in Abcc6-/- mice takes place at ~5-6 weeks of age and is significantly enhanced at 3 months
of age in comparison to wild-type mice (10-fold, p<0.001). However, the onset of mineralization
in Abcc6-/-;Ggcx+/+ mice was delayed until between 3-4 months of age, suggesting that the genetic
background plays a role in modifying the mineralization process. The mineralization in the Abcc6-
/-;Ggcx+/- mice was accelerated in comparison with age-matched Abcc6-/-;Ggcx+/+ mice, with 2.5-
fold difference at 3 and 4 months of age (p<0.01). These findings suggest a role for both the GGCX
gene and the genetic background in modulating the phenotypic severity of PXE caused by loss-of-
function mutations in ABCC6.
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Characterization of the mouse Samd9L gene and its promoter region
B Quaynor,1 Q Jiang,1 Q Li,1 E Sprecher2 and J Uitto1 1 Dermatology and Cutaneous Biology,
Jefferson Medical College, Philadelphia, PA and 2 Tel-Aviv Sourasky Medical Center, Tel-Aviv,
Israel
Familial tumoral calcinosis (FTC) is a rare autosomal recessive disease characterized by progres-
sive buildup of periarticular calcium-phosphate deposits. Normophosphatemic familial tumoral
calcinosis (NFTC), where the calcium-phosphate buildups are present despite normal plasma phos-
phate levels, has been shown to be the result of mutations in the sterile alpha motif domain 9 gene
(SAMD9). However, very little is known about SAMD9 and its paralogous gene, SAMD9L. We
investigated the transcriptional regulation and tissue-specific expression of mouse Samd9L. To
examine the transcriptional regulation of the gene, the region 1.5 kb upstream of the transcription
start site was cloned and a series of 5’-serially truncated constructs were linked to a firefly luciferase
reporter gene. These constructs were transiently transfected into diverse cultured cell lines and
assayed for activity. All tested constructs displayed significant activity above background with the
highest activity in NIH/3T3 cells, suggesting the presence of regulatory cis-elements as close as 87
bp upstream of the transcription start site. Both computational analysis of this sequence and pro-
tein-DNA binding array results suggested transcription factor binding in the region, most notably
Ras-responsive element binding protein (RREB-1), a regulator of calcitonin gene expression. Cal-
citonin treatment of NIH/3T3 cell cultures was shown to lead to a significant increase of RREB-1
mRNA after 24 hours and a subsequent significant increase of Samd9L mRNA after 96 hours. Tis-
sue-specific qRT-PCR analysis of Samd9L revealed near-ubiquitous but the highest level of expres-
sion in the kidney, a major organ subject to calcium-phosphate regulation and site of calcitonin
hormonal action. Immunofluorescent staining of sectioned mouse kidney confirmed localization
in both proximal and distal tubules. These findings assist in elucidation of the mechanisms respon-
sible for extraosseous calcification in NFTC.
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Parabiotic heterogenetic pairing of Abcc6-/- and wild-type mice halts progression of ectopic
mineralization in a murine model of pseudoxanthoma elasticum
Q Jiang,1 R Oldenburg,1 S Otsuru,2 A Grand-Pierre,1 EM Horwitz2 and J Uitto1 1 Dermatology
and Cutaneous Biology, Jefferson Medical College, Philadelphia, PA and 2 Division of
Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA
Pseudoxanthoma elasticum (PXE), a pleiotropic heritable disorder, is characterized by ectopic min-
eralization of the connective tissues in the skin, eyes and the cardiovascular system. This disease
is caused by mutations in the ABCC6 gene, which is expressed primarily in the baso-lateral sur-
face of hepatocytes. Abcc6-/- mice develop progressive mineralization mimicking human PXE. To
investigate the hypothesis that PXE is a metabolic disorder, potentially caused by the absence of a
plasma factor(s) physiologically responsible for prevention of aberrant mineralization of periph-
eral connective tissues, we have utilized parabiotic pairing, i.e., surgical joining of two mice, to
create a shared circulation between various Abcc6 genotypic mice. Shared circulation between
the parabiotic animals was confirmed by quantitative PCR of blood cell genotypes and by Evan’s
blue dye injection into the tail vein of one of the mice one week after surgery. Pairing of Abcc6-/-
mice with their wild-type counterparts halted the connective tissue mineralization in the knock-
out mice. Wild-type and knock-out homogenetic pairing serving as controls were phenotypically
unaffected by parabiosis. Consequently, the observations on the parabiotic mice support the notion
that PXE is a metabolic disease, potentially due to absence of a systemic anti-mineralization fac-
tor(s). These observations suggest that re-introduction of these factors into circulation could yield
a potential treatment for this, currently intractable, disease.
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Experimental diet with mineral modifications accelerates connective tissue mineralization
in Abcc6-/- mice - a model for testing PXE treatment strategies
Q Jiang, R Oldenburg, A Grand-Pierre and J Uitto Dermatology and Cutaneous Biology,
Jefferson Medical College, Philadelphia, PA
Pseudoxanthoma elasticum (PXE) is characterized by progressive ectopic mineralization of con-
nective tissues, potentially regulated by various environmental factors. This study examined (1) a
possible acceleration of ectopic mineralization process; (2) organ-specific mineralization of con-
nective tissues; and (3) factors involved in the mineralization process, by utilizing a murine model
(Abcc6-/-) for PXE, fed either with a standard rodent diet or with an experimental custom-designed
mineral modification diet beginning at the age of 4 weeks. At 2 and 4 weeks after feeding, the min-
eralization of connective tissues was evaluated using quantitative morphometric image analysis
and by chemical assays of calcium content of the vibrissae. The results indicated increased min-
eralization in the Abcc6-/- mice fed a diet low in magnesium and high in phosphate, as compared
with those fed standard diet. Survey of mineralization in other organs by histopathologic observa-
tions revealed significant mineral deposits also in the kidneys and heart of the Abcc6-/- mice fed
the experimental diet, but no evidence of such mineralization was found in the corresponding mice
fed standard diet. Feeding Abcc6+/- or Abcc6+/+ mice with the experimental diet did not result in
any mineralization. This study revealed that mineral modified diet enhances mineralization in the
murine PXE model in a time- and genotype- dependent patterns and suggests that daily mineral
consumption may affect the mineralization process in PXE. This experimental model will also be
useful to test treatment strategies aimed at decreasing the pathologic mineralization process in PXE.
502
Morpholino “knockdown” of the Abcc6a gene impairs zebrafish development – a model
system for PXE
S Sadowski,1 Q Li,1 A Varadi,2 SY Ho,3 M Dean4 and J Uitto1 1 Dermatology and Cutaneous
Biology, Jefferson Medical College, Jefferson Institute of Molecular Medicine, Philadelphia,
PA, 2 Hungarian Academy of Sciences, Budapest, Hungary, 3 Biochemistry and Molecular
Biology, Thomas Jefferson University, Philadelphia, PA and 4 Human Genetics Section, NCI-
FCRDC, Frederick, MD
The ABCC6 gene encodes the ABCC6 protein, a member of the ATP binding cassette (ABC) trans-
porter superfamily. Although the physiological function and natural substrate transported by ABCC6
are currently unknown, mutations in the human ABCC6 gene result in a heritable disorder, pseu-
doxanthoma elasticum (PXE), characterized by ectopic mineralization of soft connective tissues in
the blood vessels, the eyes and the skin. The development of an Abcc6-/- mouse that recapitulates
features of PXE has suggested that the function of this transporter is conserved. The zebrafish (Danio
rerio) has nearly the same complement of ABC genes as mammals and has an accessible and well-
characterized embryo. To study the function of ABCC6 during zebrafish development, the full-
length cDNA sequence of the zebrafish abcc6a gene was determined and the mRNA expression
levels in embryos over the first week of development were measured using real-time qRT-PCR. The
abcc6a expression profile showed a very high level of expression at 5 days post fertilization. Two
morpholinos were designed to the abcc6a gene, one at the ATG site to block translation and one
at a splice donor site to prevent pre-mRNA splicing. Injection of the oligos into 1-4 cell zebrafish
embryos was performed and the embryos followed for a visible phenotype. The ATG site and the
splice donor site morpholinos were found to decrease abcc6a expression by 54 and 81%, respec-
tively. Both morpholinos induced a similar phenotype, cardiac edema and curled tail, and the splice
donor site morpholino resulted in a more severe phenotype consistent with the expression levels.
These results, which suggest that abcc6a is an essential gene for zebrafish development, provide
novel insight into the function of ABCC6, the gene mutated in PXE.
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Skin and adnexa diseases in the aging mouse: analysis of 31 inbred strains
JP Sundberg, KA Silva, V Kennedy, L Petell, B King, R Yuan, B Paigen and D Harrison The
Jackson Laboratory, Bar Harbor, ME
Little is known about spontaneous skin and adnexal diseases in aging mice. Inbred mice develop
strain specific diseases which can provide new models or genetic tools to investigate chronic dis-
ease. They are particularly useful when many inbred strains are evaluated and compared. The Jack-
son Aging Center set up cohorts of the 31 most important inbred strains used today in biomedical
research maintained under strict specific pathogen free barrier conditions. Groups of 15 females
and 15 males were aged to 12 and 20 months of age at which time complete necropsies were per-
formed. In addition, 65 females and 35 males of each strain were aged to determine maximum
lifespan. Few spontaneous skin and adnexa lesions were seen in these mice, possibly due to their
controlled environment which prevented exposure to sunlight. However, new spontaneous mod-
els for pseudoxanthoma elasticum and a severe nail dystrophy were identified. Cases of sponta-
neous basal cell carcinoma, subungual squamous cell carcinoma, and mast cell tumors were found
in some strains. Alopecia areata was confirmed in strains in which it was previously reported. Using
gene association studies and haplotype mapping strategies based on single nucleotide polymor-
phisms (SNP analyses) candidate genes were identified and sequenced to confirm any polymor-
phisms. Life span and physiological data are available on the Mouse Phenome Database (http://phe-
nome.jax.org); histopathologic images are on the Mouse Tumor Biology Database
(http://tumor.informatics.jax.org) and Pathbase (http://pathbase.net).
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Fluorescence labeled reporter genes provide useful tools to investigate cutaneous innerva-
tions
CM Webb, C Rosales, K Seburn, R Burgess and JP Sundberg The Jackson Laboratory, Bar
Harbor, ME
Although a variety of neurological markers, both traditional histochemistry and more currently
immunohistochemistry, have been useful for evaluation of cutaneous innervation, a number of
transgenic mice were created for the study of neuromuscular disease that can also be used for
evaluating innervation of the skin. B6.Cg-Tg(Thy1-YFP)16Jrs/J (YFP16, JR#3709) and B6.Cg-Tg(Thy1-
YFPH)2Jrs/J (YFPH; JR#3782) mice were created to express the yellow fluorescence protein gene
driven by a mouse Thy1 promoter which resulted in a panel of mouse tools that cause motor and
sensory neurons to fluoresce such that individual nerves could be followed. We used these strains
to evaluate patterns of nerves in the skin and adjacent structures. Whole mounts clearly demon-
strated without fixation nerves innervating the panniculus carnosus muscle. These results demon-
strate the value of these mice, which are readily available at The Jackson Laboratory, for studying
innervations of the skin.
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Narrowing the quantitative trait locus interval Alaa1 in the C3H/HeJ mouse model for Alope-
cia Areata
C McPhee,1 V Kennedy,1 B King,1 L Rowe,1 L King,2 D Roopenian1 and J Sundberg1 1 The
Jackson Laboratory, Bar Harbor, ME and 2 Department of Dermatology, Skin Disease
Research Center, Vanderbilt University, Nashville, TN
Alopecia areata (AA) is an autoimmune disease targeting anagen stage hair follicles that affects 1-
2 percent of the United States population. AA also affects a number of other species including dogs,
horses, chickens, rats, and mice. The C3H/HeJ mouse has been extensively studied as a model for
this disease. Alaa1 is a major histocompatibility complex (MHC)-linked major Quantitative Trait
Locus (QTL) that confers risk for AA to C3H/HeJ mice. Human AA gene association studies sug-
gested that NOTCH4, which is tightly linked to the MHC, was a potential candidate gene for AA
risk. To test this candidate gene, we created congenic C3.129-Notch4tm1Grid mice after back-
crossing C3H/HeJ females with B6;129-Notch4tm1Grid males for ten generations. These congenic
mice, which carry an interval including the 129-derived H2b MHC and the Notch4tm1Grid knock-
out allele, were totally resistant to AA at a year of age compared to 25% affected mice in the con-
trol C3H/HeJ+/+ mice. There were no crossovers to separate Notch4tm1Grid from the 129-derived
MHC, making it difficult to distinguish resistance caused by a deficiency in Notch4 from other
MHC-linked 129 alleles. However, mapping the limits of the interval containing Notch4 elimi-
nated other genes outside the interval containing these two genes. The A/J inbred strain also
develops AA. C3H/HeJ is the H2k haplotype while the A/J strain is H2a, a hybrid of H2k and H2d.
A comparison of genotypes for all available single nucleotide polymorphisms (SNPs) for C3H/HeJ,
A/J, and the unaffected strain, C57BL/6J, was used to identify regions that are identical by state to
exclude multiple probable susceptibility regions within this major QTL. Narrowing Alaa1 will allow
us to focus on a smaller pool of candidate genes and therefore speed identification of key genes
involved in this disease.
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Using the C3H/HeJ mouse model for Alopecia Areata in biomedical research
KA Silva,1 C McPhee,1 LE King2 and JP Sundberg1,2 1 The Jackson Laboratory, Bar Harbor, ME
and 2 Skin Disease Research Center, Vanderbilt University, Nashville, TN
The C3H/HeJ inbred mouse strain develops alopecia areata (AA) has a spontaneous background
disease at a frequency of around 20%. Although this is the most studied C3H substrain for AA, all
substrains of C3H evaluated to date develop AA at comparable rates. This form of alopecia waxes
and wanes and is due to a T cell infiltration in and around late anagen and early catagen stage fol-
licles. Full thickness skin grafts to immuncompetent histocompatible C3H/HeJ mice result in mice
developing AA in a predictable, highly reproducible manner, making this a useful tool to investi-
gate the pathogenesis of AA and to serve as a preclinical model. The skin graft procedure will be
described in detail as well as various approaches to using the mice for drug efficacy testing. Pro-
tocols will be presented for drug application using topical, oral (gavage and mixed in the feed),
subcutaneous implant, and injectable routes. More importantly, other skin diseases that are often
misinterpreted to be AA in this strain, such as barbering (trichotillomania) will be presented to assist
investigators in the proper interpretation of their experimental results.
509
Characterization of molecular mechanisms underlying mutations in dystrophic epidermol-
ysis bullosa using site-directed mutagenesis.
M Chen, Y Hou, E Cua, G Henderson, S Andrews and D Woodley Dermatology, University of
Southern Califirnia, Los Angeles, CA
Type VII collagen (C7), composed of a central triple helical domain flanked by globular non-hel-
ical domains, NC1 and NC2, is the major component of anchoring fibrils. COL VII gene (COL7A1)
mutations cause dystrophic epidermolysis bullosa (DEB). The biological consequences of specific
COL7A1 mutations leading to DEB clinical phenotypes are unknown. In this study, we generated
9 substitution mutations associated with recessive DEB, S48P, G1616R, G1664A, P1699L, R1957Q,
G2025A, G2031S, G2034W, and C2875F and purified the recombinant mutant proteins. All but
S48P and C2875F, mutations within NC1 and NC2, synthesized and secreted a 290 kDa mutant
C7 at levels similar to the wild type C7. Biochemical characterization of the purified mutant C7s
and structural and functional comparisons with wild type C7 demonstrated: (1) The S48P muta-
tion, the only reported missense mutation within NC1, resulted in a mutant C7 that was extremely
unstable and failed to form trimers. (2) The G1616R, G1664A, and P1699L mutations all pro-
duced mutant C7s with an increased sensitivity to protease and a decreased ability to form trimers.
These C7 mutants failed to promote keratinocyte and fibroblast migration in vitro or enhance the
closure of skin wounds in vivo. (3) Limited proteolytic digestion of mutant G2034W, G2025A,
and G2031S proteins yielded aberrant fragments and a triple helix with reduced stability. These
mutations, next to the 39 amino acid helical interruption (the “hinge region”), all reduced C7’s
ability to drive skin cell migration. (4) The R1957Q mutation within the hinge region yielded an
abnormal, incompletely folded mutant C7 with increased sensitivity to protease digestion and
reduced triple helix stability. (5) The C2876F mutation within NC2 caused an intracellular accu-
mulation of C7 and reduced C7’s ability to form antiparallel dimers. We conclude that mutations
within COL7A1 are located within motifs critical for the function of C7 such as protein process-
ing, folding, stability, cell migration and cell-matrix binding.
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Fox2 proteins parallel the effect of TIAs that enhance exon inclusion to give the alternatively-
spliced long transcript of lysyl hydroxylase 2 that is increased in Scleroderma
HN Yeowell,1,2 P Seth1,2 and LC Walker1 1 Dermatology, Duke University Medical Center,
Durham, NC and 2 Center for RNA Biology, Duke University Medical Center, Durham, NC
Specific lysines in collagen are hydroxylated by lysyl hydroxylases to give hydroxylysines that are
required in the crosslink formation that contributes to collagen tensile strength. The long form of
the alternatively-spliced lysyl hydroxylase 2 (LH2) includes an extra exon 13A that is excluded in
the short form. Since studies indicate that overexpression of LH2(long) is associated with the increased
crosslinking in the overaccumulated collagen that is a characteristic of scleroderma, it is impor-
tant to identify factors that regulate LH2 alternate splicing. We have shown that both Fox2 (femi-
nizing on X) and TIA (T-cell-restricted intracellular antigen) binding proteins regulate LH2 splicing
by enhancing inclusion of exon 13A. Using an LH2 minigene, overexpression of Fox2 and TIAs
gave increased LH2(long) expression, whereas knockdown of Fox2 and TIAs with siRNAs in murine
embryonic fibroblasts and HEK293 cells, respectively, decreased exon inclusion. In scleroderma
fibroblasts, a knockdown of Fox2 decreased the LH2(long) mRNA that is increased in sclero-
derma. This effect paralled that of TIA proteins. We have mutated the 4 Fox cis elements, both singly
and in combination, in the introns flanking exon 13A to show that the 2 upstream motifs are required
for expression of LH2(long). In contrast, mutation of the 2 downstream motifs had little effect on
LH2 splicing. This could demonstrate a positional requirement for Fox2 binding. Manipulation of
regulatory factors that control the splicing of scleroderma-associated LH2(long) may suggest a ther-
apeutic approach to fibrotic intervention.
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Mouse models for Cicatricial Alopecia
K Wolk,1,3 KA Silva,1 C McPhee,1 LE King2 and JP Sundberg1,2 1 The Jackson Laboratory, Bar
Harbor, ME, 2 Skin Disease Research Center, Vanderbilt University, Nashville, TN and 3 The
Ohio State University College of Veterinary Medicine, Columbus, OH
Cicatricial alopecias in humans are a group of poorly understood diseases in which the hair folli-
cles are replaced by scar tissue. By the time patients come for evaluation of their alopecia, their
scalp is inflamed with focal or extensive irreversible scarring . Cicatricial alopecias are classified
as being due to lymphocytic, neutrophilic, or mixed type of inflammation as well as nonspecific
forms with minimal inflammation associated with scarring. Cicatricial alopecias have been iden-
tified in mice with spontaneous and induced mutations in at least 7 single genes (Scd1, Gsd3, Hpt,
Foxn1, Pparg, Pfz, and several new unnamed loci) and one complex polygenic disease (B6 alope-
cia and dermatitis). The scarring response in these mice all start as structural defects of the hair fol-
licle. Once the follicle ruptures there is an inflammatory reaction, the nature of which depends on
the stage and evolution of the response and ultimately resolves with scarring of the hair follicle.
Unlike human patients, these mouse models can be studied from conception to adulthood. As the
defective genes are known for most of these models, the homozygous mutant mice can be identi-
fied (genotyped) and differentiated from heterozygous and wild type normal mice to determine the
specific events evolving into cicatricial alopecia long before the inflammatory process begins. In
addition to these primary cicatricial alopecias, a number of blistering skin diseases may result sec-
ondarily into cicatricial alopecias as part of the healing process. Reproducible mouse models for
these blistering skin diseases that induce scarring alopecias are also available. Almost all of these
models of primary or secondary cicatricial alopecias are or soon will be available from The Jack-
son Laboratory.
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Multiple independent loci within the major histocompatibility complex confer risk of psori-
asis
B Feng,1 R Soltani-Arabsahi,1 AM Bowcock,2 RP Nair,3 JT Elder,3 SJ Schrodi,4 AB Begovich,4
GR Abecasis,3 KP Callis-Duffin,1 DE Goldgar1 and GG Krueger1 1 Dermatology, University of
Utah, Salt Lake City, UT, 2 Washington University, St. Louis, MO, 3 University of Michigan,
Ann Arbor, MI and 4 Celera, Alameda, CA
The aim of the present study was to search for psoriasis (Ps) susceptibility genes in addition to
HLA-C within the Human Leukocyte Antigen (HLA) region. Recently we carried out a genome-
wide association study (GWAS) on psoriasis; 1359 cases and 1400 controls were genotyped for
447,249 SNPs. Using the phased CEPH dataset as a reference, we inferred the Cw*0602 status in
all samples with high accuracy. After adjustment for Cw*0602, additional signals in the HLA region
were noted. We first identified SNP rs9295993 as an independent Ps risk locus (p=0.000005,
OR=1.3); rs9295993 is located near the MICA gene whose product could be involved in Ps patho-
genesis by virtue of its interaction with CD8+ T cells and natural killer cells. After adjustment for
HLA-C and rs9295993, an additional locus with a protective minor allele was indicated by rs2073048
(p=0.00000002, OR=0.60). This locus is located 1.1 Mb centromeric of HLA-C, within the c6orf10,
a potential downstream effector of TNF-alpha. When both of the newly identified putative sus-
ceptibility loci and Cw*0602 were included in a logistic regression model, each of them was highly
associated with disease and both reached genome-wide significance (p<0.0000001). Individuals
carrying risk genotypes at HLA-C, rs9295993 and rs2073048 were estimated to be at a nine-fold
increased risk of psoriasis compared to those carrying low risk genotypes at all three loci. These
findings, which are currently being tested in a Han Chinese population, suggest that there are at
least two additional susceptibility loci within MHC that act independently of HLA-C in conferring
risk of psoriasis.
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Keratin 5 mutations in Epidermolysis Bullosa Simplex: Mutation-related differences in cel-
lular fragility and the protective effects of trimethylamine N-oxide (TMAO) on heat-stressed
EBS keratinocytes
J Chamcheu,1 M Virtanen,1 P Bowden,2 H Navsaria,3 A Vahlquist1 and H Törmä1 1 Medical
Sciences, Uppsala University, Uppsala, Sweden, 2 Dept of Dermatology, School of Medicine,
Cardiff, United Kingdom and 3 Centre for Cutaneous Research, Bart’s and London, Queen
Mary’s School of Medicine and Dentistry, London, United Kingdom
Epidermolysis bullosa simplex (EBS) is characterized by cytolysis of basal keratinocytes leading to
intra-epidermal blistering and skin fragility and is caused by mutations in keratin (K5 or K14) genes.
Cytoplasmic keratin aggregate is a characteristic of EBS cells in vitro upon stress. Our purpose was
(i) to investigate KRT mutations in a group of Swedish EBS patients, (ii) to evaluate the genotype-
phenotype relationship in vivo and in patient’s primary keratinocytes, and (iii) to analyze whether
heat-stressed EBS keratinocytes can be used to evaluate the effect of a chemical chaperone (TMAO)
as a protective agent for this disease. Here we describe the mutations in four Swedish EBS families
with mild to severe phenotypes. We identified V186L, I183M and E475G substitutions due to muta-
tions in the KRT5 gene. EBS-derived keratinocytes exhibited neither keratin aggregates nor cell loss,
except in cells derived from the patient with the pI183M mutation who showed ≈3% aggregates
and 2% cell loss. Upon transient heat-stress the number of aggregate-containing cells increased to
21%, 27% and 13% respectively in cells with the pI183M, pE475G, and pV186L mutations. Inter-
estingly, pre-treatment with TMAO (50-100 mM) prior to heat-stress, dose-dependently reduced
the number of aggregate-containing cells and cell loss in all cell types. These results demonstrate
that KRT5 mutant cells in culture are sensitive to heat stress, revealing a genotype-phenotype cor-
relation, and that TMAO protects EBS keratinocytes against the effects of the stress. These obser-
vations posit that a new therapeutic strategy may involve the use of chemical chaperones as
important pharmacological agents for the treatment of protein conformation skin disorders.
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Marie Unna hereditary hypotrichosis is caused by mutations of an upstream open reading
frame in the human hairless gene
X Zhang,1,2 Y Wen,1 Y Liu,2 Y Xue,1 Y Zhao,3 R Hua,1 K Wang,2 M Sun,1 W McLean3 and C He2
1 Peking Union Medical College, Beijing, China, 2 China Medical University, Shenyang, China
and 3 University of Dundee, Dundee, United Kingdom
Marie Unna hereditary hypotrichosis (MUHH; OMIM 146500), an autosomal dominant form of
genetic hair loss, is characterized by sparse or absent hair at birth, growth of coarse and wiry hair
during childhood, and progressive hair loss at puberty. The MUHH locus had been mapped to
8p21, the same chromosomal region harboring the hairless gene (HR). However, the gene respon-
sible for MUHH has not yet been discovered.The purpose of the study is to identify the culprit
gene for MUHH. We performed genetic linkage mapping and mutation screening in a large Chi-
nese MUHH family, and identified a pathogenic initiation codon mutation in U2HR, an inhibitory
upstream open reading frame (uORF) in the HR 5’-untranslated region (5’UTR). U2HR is predicted
to encode a 34 amino acid peptide that is highly conserved among mammals. In 18 additional
MUHH families from different ancestral groups, we identified a spectrum of defects in U2HR,
including loss-of-initiation, delayed termination codon, and nonsense and missense mutations. Our
functional analysis showed that these different classes of mutations all result in increased transla-
tion of the main HR physiological ORF. Our results establish the link between MUHH and U2HR;
show that fine-tuning of HR protein levels is important in control of hair growth; and, identify a
potential mechanism for either preventing hair loss or promoting hair removal.
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Inflammation in Bullous Congenital Ichthyosiform Erythroderma (BCIE) is composed of mast
cell infiltrarion, possibly through bFGF and PGE2 enhancement by mechanical stimuli
M Komine,1 Y Hanakawa,2 K Wakatabi,1 H Yokokura,1 K Hashimoto,2 K Tamaki3 and M Ohtsuki1
1 Dermatology, Jichi Medical University, Shimotsuke, Japan, 2 Dermatology, Ehime
University, Tohon, Japan and 3 Dermatology, Tokyo University, Bunkyo-ku, Japan
BCIE is caused by keratin gene mutation, disrupting keratin filament network by dominant nega-
tive effect. The skin of BCIE patients shows hyperkeratosis with erythroderma, suggesting cutaneous
inflammation; however, the mechanism of inflammatory processes in BCIE has not been fully inves-
tigated. In order to clarify the nature of inflammation in BCIE, we carefully investigated the
histopathology of BCIE, revealing numerous mast cells and enlarged vessels in addition to epider-
mal hyperplasia and hyperkeratosis. The number of mast cells per high power field was higher in
BCIE patients than that in normal controls. To assess the effect of keratin gene mutation on these
histological changes, we transfected normal human keratinocytes (NHKs) with construct carrying
keratin K1 with or without mutation causing BCIE, and stimulated cells with mechanical stretch-
ing, then performed cDNA arrays. DNA arrays revealed that mechanical stretch caused upregula-
tion of prostaglandin (PG) E2, and vascular endothelial growth factor (VEGF) in control NHKs,
both of which are mast cell chemoattractants, and interleukin (IL) 8 and 18 in NHKs specifically
with mutant K1, known to induce mast cell activation. ELISA experiments with supernatants revealed
that NHKs carrying mutated K1 showed higher production of bFGF than those with normal K1.
ELISA and real time PCR revealed that mechanical stretch induced higher production of bFGF and
PGE2, which was suppressed by inhibitors of ERK and p38 MAP kinases. These results indicate
that the cutaneous inflammation of BCIE is composed mainly of mast cell infiltration, which may
be induced through several mast cell chemoattractants and activators including bFGF and PGE2
induced by mechanical stimuli, and IL-8 and IL-18 specifically induced in KCs with K1 mutation,
and that inhibition of ERK or p38 MAP kinases could be used as therapeutic purposes.
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Inflammation mediates epidermal proliferation in Netherton syndrome through transform-
ing growth factor β1 and metalloprotease 9
M Lacroix, C Deraison, A Briot, C Bonnart, A Robin, C Besson, C Danne and A Hovnanian
INSERM U563, TOULOUSE, France
Netherton syndrome (NS) is a rare autosomal recessive skin disease characterized by congenital
ichthyosiform erythroderma and atopic manifestations. We previously identified SPINK5 as the
defective gene in NS, encoding the serine protease inhibitor LEKTI. Spink5-/- (KO) mouse skin repro-
duces key features of NS including abnormal desquamation with a severe skin barrier defect,
impaired keratinisation, inflammation and hyperproliferation. Histological analysis of LEKTI-defi-
cient skin in NS patients also shows lack of granular layer, epidermal thickening and hyperplasia
suggesting enhanced proliferation. Here, we show that the epidermis of KO mice displays an
increased number of Ki67 and p63 positive cells, induction of keratin 6 and down-regulation of
keratin 15 (K15) which are consistent with in vivo epidermal proliferation. However, human and
mouse LEKTI-deficient keratinocytes were not hyperproliferative in culture, indicating that epi-
dermal hyperproliferation is not an intrinsic property of these cells. As several studies have identi-
fied TGFβ1 signaling in K15 regulation but also in proliferation, differentiation and inflammatory
processes, we analyzed the expression pattern of this cytokine at the transcriptional and protein
level. TGFβ1 expression was increased in the Spink5-/- mouse model and in skin cross-section of
NS patients, and correlated with increased expression of metalloprotease 9 (MMP9) mRNA and
protein as previously demonstrated in other epithelial cells. Interestingly, gel zymography showed
enhanced MMP9 activity specifically in the epidermis, but not in the dermis of Spink5-/- mice,
suggesting that protease activities directly regulated by LEKTI, could modulate MMP9 activity
through pro-form cleavage. Taken together, these results suggest that hyperproliferation in NS is
not a cell-autonomous process, but is secondary to inflammatory events mediated by TGFβ1 and
MMP9 activation, which appear as new potential therapeutic targets.
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Atopic inflammation is an epidermal cell autonomous process in Netherton syndrome
A Briot, C Deraison, M Lacroix, C Bonnart, A Robin, C Besson and A Hovnanian INSERM U563,
Toulouse, France
Netherton syndrome (NS, MIM 256500) is a rare autosomal recessive ichthyosis, whose main clin-
ical features include generalized congenital erythroderma and recurrent atopic manifestations.
We have shown that NS is due to loss of expression of the SPINK5 gene encoding the serine pro-
teinase inhibitor LEKTI. LEKTI is preferentially expressed in the granular layer of the epidermis, in
mucosa and in Hassall’s corpuscles of the thymus. We have demonstrated that LEKTI plays a cru-
cial role in the skin barrier function by regulating the activity of epidermal proteases including
kallikrein 5 (KLK5). As Spink5-/- (KO) mice undergo rapid postnatal lethality, newborn mouse skin
was grafted on athymic mice to study phenotypic changes in KO adult skin. KO grafts developed
alopecic, scaly and erythematous lesions. In contrast to newborn KO mice, eosinophils and acti-
vated mast cells infiltrate were detected in KO grafted skin, associated with overproduction of proin-
flammatory and proTh2 molecules. Only few Langerhans cells were detected in KO grafted epi-
dermis, which is consistent with their activation and migration out of the epidermis. These features
were associated neither with infection, nor with the presence of mature T cells. These data sup-
port the notion that grafted KO skin by itself induces a cutaneous inflammatory response inde-
pendently of the adaptive immune system. Analysis of KO epidermis from mouse embryos deliv-
ered by caesarean and in vitro study of keratinocytes from NS patients revealed that overexpression
of proinflammatory and proallergic molecules is an early event thus confirming an intrinsic prop-
erty of LEKTI-deficient keratinocytes in promoting a proTh2 cascade independently of a skin bar-
rier defect. Using siRNA strategy on human primary keratinocytes we showed that in the absence
of LEKTI control, KLK5 initiates proinflammatory and proTh2 cascade through PAR2 cleavage. These
results identify KLK5 as a key protease leading to skin barrier defect and cutaneous allergic inflam-
mation, and a pertinent target for NS treatment using new potent protease inhibitors.
516
Assessing the risk of an immune response to type VII collagen gene therapy in recessive dys-
trophic epidermolysis bullosa
V Pendaries,1 G Gasc,1 M Titeux,1 C Leroux,4 Z Vitezica,1 J Mejia,1 A Decha,1 P Loiseau,3
C Bodemer,5 C Prost-Squarcioni4 and A Hovnanian1,2,6 1 U563, INSERM, Toulouse, France, 2
Paul Sabatier, Université, Toulouse, France, 3 Saint Louis Hospital, Paris, France, 4 Avicenne
Hospital, Bobigny, France, 5 Necker Hospital, Paris, France and 6 Purpan Hospital, Toulouse,
France
Recessive dystrophic epidermolysis bullosa (RDEB) is a severe genodermatosis caused by loss-of-
function mutations in COL7A1 encoding type VII collagen, the component of anchoring fibrils. To
assess the immunologic risk in RDEB patients during gene therapy restoring type VII collagen expres-
sion, we developed ELISA and ELISPOT tests based on recombinant, full-length type VII collagen
with a correct triple-helical conformation. The ELISA and ELISPOT were first performed in a cohort
of 41 untreated patients suffering from epidermolysis bullosa acquisita (EBA), an autoimmune dis-
ease characterized by circulating autoantibodies against type VII collagen. The ELISA detected anti-
type VII collagen antibodies with high specificity (95%) and sensitivity (70%). The ELISPOT detected
a Th1 response against type VII collagen, which correlated with EBA manifestations. We subse-
quently tested 7 RDEB patients with different patterns of type VII collagen expression. The ELISA
detected anti-type VII collagen antibodies in one of the 2 patients who expressed no detectable
type VII collagen. ELISPOT results showed a Th1 response against type VII collagen in 3 of the
patients. Of these, those who expressed no type VII collagen showed a strong ELISPOT reactivity.
The third patient, who expressed a 65-kDa truncated protein, showed a weak Th1 response. ELISPOT
results for the 4 remaining patients, who expressed low levels of a full-length mutated protein or
a 280-kDa truncated form, were negative. The ELISPOT results correlated with expression of the
type VII protein in RDEB patients. These tests of the B and T response to type VII collagen will be
helpful for the selection of RDEB patients to be treated by gene transfer or protein replacement.
They will also be essential to the immunological follow-up of treated RDEB patients during these
trials.
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Level of type vii collagen at the basement membrane does not always correlate with clini-
cal severity in a cohort of 13 mexican patients with recessive dystrophic epidermolysis bul-
losa
J Garza-Gómez,1 J Salas-Alanis,2 M Gómez-Flores,1 A Campbell,3 C Pourreyron,3 J Ocampo-
Candiani1 and A South3 1 Dermatology, Universidad Autonoma de Nuevo Leon, Monterrey,
Mexico, 2 Dermatology, ITESM, Monterrey, Mexico and 3 Surgery and Molecular Oncology,
University of Dundee, Dundee, United Kingdom
The purpose of this study was to correlate clinical severity with the amount of type VII collagen
measured at the basement membrane in 13 Mexican patients with recessive dystrophic epider-
molysis bullosa (RDEB). Clinical severity was scored according to recent guidelines (Fine et al,
JAAD. 2008). Skin biopsies from 7 Mexican patients with severe generalized RDEB (RDEB-sev gen)
and 6 Mexican patients with generalized other RDEB (RDEB-O) were compared with normal con-
trol skin. We used confocal microscopy to measure the amount of fluorescent immunostaining
localized to the basement membrane of skin sections after incubation with a monoclonal anti-
body specific for type VII collagen (LH7.2). All samples were processed under identical conditions,
and the images were obtained with a Zeiss confocal microscope on the same day using the same
settings and exposure times. We measured the amount of fluorescent immunoreactivity from col-
lected images using Adobe Photoshop software. Mutation analysis had previously identified all but
5 patients’ genotypes, 3 of which had one mutation identified. Six patients shared genotypes with
one or more other patient. We found that type VII collagen immune reactivity varied between 26
- 81.2% of control. Individuals with the same genotype displayed similar levels of type VII colla-
gen compared with control yet presented with different disease severities (5 RDEB-O and 1 RDEB-
sev gen). Patients with RDEB-sev gen varied from 26 to 67% of control type VII collagen levels
while patients with RDEB-O varied between 28 to 81.2% of control type VII collagen levels. Our
data shows that in this cohort of RDEB patients there are other possible modifying genetic or envi-
ronmental factors that influence the clinical severity of the disease regardless of the levels of type
VII collagen expression.
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Filaggrin-deficient mice exhibit enhanced percutaneous antigen priming
AD Irvine,2 PG Fallon,2 T Sasaki,3 A Sandilands,1 JJ Callanan,4 RB Presland,5 P Fleckman,5
J Kudoh,3 M Amagai3 and W McLean1 1 University of Dundee, Dundee, United Kingdom, 2
Trinity College Dublin, Dublin, Ireland, 3 Keio University, Tokyo, Japan, 4 University College
Dublin, Dublin, Ireland and 5 University of Washington, Seattle, WA
Loss-of-function mutations in the filaggrin gene (FLG), cause the semi-dominant keratinizing dis-
order, ichthyosis vulgaris, and convey a major genetic risk to atopic dermatitis (eczema), eczema-
associated asthma and other allergic phenotypes. Several low frequency FLG null alleles occur in
European and Asian populations, with a cumulative frequency of ~9% in Europe, and are associ-
ated with a significant cumulative burden of atopic disease. Here we report complete sequencing
and assembly of the murine profilaggrin/filaggrin gene, flg and detection of a 1-bp deletion muta-
tion in filaggrin repeat 6 in the spontaneous mouse mutant flaky tail (ft), allowing rapid genotyp-
ing and backcrossing onto C57BL/6. This mutation is highly analogous to common human FLG
mutations. Biochemical analysis showed that the defect leads to failure of profilaggrin-to-filaggrin
processing, destabilization of the truncated profilaggrin protein and ultimately, complete absence
of mature filaggrin in the epidermis. Importantly, we demonstrate that topical application of aller-
gen to mice homozygous mutant mice results in significantly increased cutaneous inflammatory
infiltrates and enhanced cutaneous allergen priming with development of allergen-specific anti-
body responses compared to heterozygous and wild-type littermates. These data validate ft as a
useful model of filaggrin-related ichthyosis and provide experimental evidence for the hypothesis
that antigen transfer through a defective epidermal barrier is a key mechanism underlying ele-
vated IgE sensitization and initiation of cutaneous inflammation in humans with filaggrin-related
atopic disease.
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Identification of downstream molecular targets of Trps1 during murine hair follicle mor-
phogenesis
KA Fantauzzo,1 CA Jahoda3 and AM Christiano1,2 1 Genetics and Development, Columbia
University, New York, NY, 2 Dermatology, Columbia University, New York, NY and 3
Biological Sciences, University of Durham, Durham, United Kingdom
Trichorhinophalangeal syndrome I (TRPS1) is a vertebrate transcription factor containing a GATA-
type zinc finger and two Ikaros-like zinc fingers. Patients with TRPS I have sparse scalp hair in
addition to craniofacial and skeletal abnormalities. The mouse ortholog of Trps1 is a transcriptional
repressor expressed in the mesenchyme-derived dermal papilla cells and the highly proliferative
epithelial cells of adult mouse hair follicles. Mice in which the GATA domain of Trps1 has been
deleted (Trps1Δgt/Δgt) have a reduced number of pelage follicles and lack vibrissae follicles postna-
tally. We performed microarray hybridization analysis comparing expression patterns in the whisker
pads of E12.5 wild-type versus Trps1Δgt/Δgt mice and identified Lhx2, Prdm1, Sox18 and Dkk4 among
transcripts downregulated in the mutant animals. In addition, we found that Sox9 and Runx2 are
conversely upregulated in the Trps1Δgt/Δgt whisker pad samples. Trps1 colocalizes in vivo with Prdm1
in the dermal papilla and inner root sheath precursors; with Sox18 in the mesenchyme surround-
ing developing vibrissae follicles; with Dkk4, Lhx2 and Sox9 in the epidermis at the onset of hair
follicle morphogenesis; and with Runx2 in the dermal papillae of hair follicles and in bone. Fur-
thermore, the expression of Lhx2, Prdm1, Sox18 and Dkk4 is reduced in Trps1Δgt/Δgt mutant ani-
mals. In an endogenous ChIP experiment using 293T cells, we found that TRPS1 binds at least one
canonical GATA binding site in the LHX2, SOX18, DKK4 and SOX9 promoters. Interestingly, Lhx2
and Sox9 have opposite trends of expression in Trps1Δgt/Δgt mice. Lhx2 has previously been shown
to be expressed at the leading edge of invaginating follicles, while Sox9 is expressed in the more
suprabasal cells. Since Sox9 and Lhx2 either specify or maintain hair follicle stem cells, respec-
tively, our findings suggest that Trps1 may be involved in the regulation of early hair follicle pro-
genitors.
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The Darier’s Disease phenotype may be modulated by changes in sphingosine and calcium
signaling pathways
DS McKenzie, A Celli, Y Uchida, W Holleran, C Tu, D Bikle and T Mauro Dermatology, VAMC-
UCSF, San Francisco, CA
Autosomal dominant mutations in the ATP2A2 gene, which encodes the sarco/endoplasmic retic-
ulum (ER) Ca2+ ATPase isoform 2 (SERCA2 protein), cause the acantholytic skin disorder Darier’s
disease (DD). Understanding DD pathogenesis provides invaluable information on Ca2+ regulated
processes in skin and other tissues, and may allow the development of novel therapies. Mutations
in the SERCA2 pump result in a marked decrease in the Ca2+ sequestration into the ER. To simu-
late the phenotype of DD, normal keratinocytes were treated with ATP2A2 siRNA or thapsigargin,
which specifically and irreversibly inhibits SERCA pumps. We examined the resulting regulation
of various keratinocyte mRNA and proteins believed to be affected by the ATP2A2 mutations using
quantitative PCR analysis and immunoblotting. We found that the induction of ER stress (similar to
that in DD keratinocytes) signals upregulation of ATP2A2, Golgi Ca2+ ATPase ATP2C1, keratinocyte
Ca2+ receptor, desmoglein 3, stromal interaction molecule 1, and two transient receptor potential
cation channels TRPC4 and TRPV6, while conversely, involucrin, vitamin D (1,25-dihydroxyvita-
min D3) receptor, and sphingosine kinase 1 isoform 2 mRNA levels are decreased. These experi-
ments reveal that signaling pathways that are known to control proliferation, differentiation and
apoptosis are activated by the depletion of ER Ca2+. The decrease of functional ER Ca2+ ATPase
pumps in DD keratinocytes illuminates the intricate pathways involved in Ca2+ regulated processes,
and our findings may provide new insights into treatment approaches for Ca2+ homeostatic dis-
eases.
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Compound heterozygous mutations in desmoplakin result in novel phenotypes of ectoder-
mal dysplasia
MG Mahoney,1 S Sadowski,1 D Brennan,1 P Pikander,2 P Saukko,2 JK Wahl,3 H Aho,4
K Heikinheimo,2 L Bruckner-Tuderman,5 A Fertala,1 J Uitto1 and S Peltonen2,4 1 Thomas Jefferson
Un, Philadelphia, PA, 2 Un of Turku, Turku, Finland, 3 Un of Nebraska Medical Center,
Omaha, NE, 4 Turku Un Central Hospital, Turku, Finland and 5 Un Medical Center, Freiburg,
Germany
Desmoplakin (DP), the most abundant desmosomal protein that anchors the intermediate filaments
to the cadherins, provides structural stability to tissues that undergo extensive physical stress. Muta-
tions in the DP gene are linked to palmoplantar keratoderma (PPK) and arrhythmogenic right ven-
tricular cardiomyopathy (ARVC). Here we present a patient with extensive skin and mucocutaneous
blisters, growth retardation, epidermolytic PPK, nail dystrophy, enamel dysplasia, and sparse woolly
hair. She died at the age of 14 from ARVC. We identified two mutations in exon 24 in the DP gene.
The maternal mutation, c.7964 C to A, results in an Asp for an Ala substitution (A2655D). Com-
puter modelling demonstrated that this mutation does not alter the 3D structure of DP but changes
the electrostatic potential of the mutated region, possibly altering functions that depend on inter-
molecular interactions. The paternal mutation, c.6310delA results in a frameshift and creates a
downstream PTC resulting in a truncated and presumably non-functional gene product. Non-con-
sanguineous parents and siblings are mutation carriers but showed no clinical phenotype suggesting
an autosomal recessive mode of inheritance. Histology and EM of the skin revealed hyperplasia
and acantholysis in the epidermis but with intact appearing desmosomes. Masson’s trichrome stain-
ing of the heart showed dysplasia in both ventricles, loss of cardiomyocytes with fibrofatty replace-
ment, and extensive fibrosis with increased connective tissue deposition. Immunofluorescence with
DP specific antibodies showed reduction in the skin, esophageal epithelium, and heart. This is the
first report of a combination of novel phenotypes caused by compound heterozygous mutations in
the DP gene affecting the C-tail of both DP isoforms and resulting in abnormalities in diverse tis-
sues.
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A new role for Cockayne Syndrome A and B in protection from mitochondrial aging of sub-
cutaneous fat
Y Kamenisch,1 M Fousteri,2 J Knoch,1 A von Thaler,1 R Kuiper,3 M Schaller,1 H van Steeg,3
M Röcken,1 J Krutmann,4 LH Mullenders2 and M Berneburg1 1 Department of Dermatology,
Eberhard Karls University, Tuebingen, Germany, 2 MGC-Department of Radiation Genetics
and Chemical Mutagenesis, Leiden University Medical Center, Leiden, Netherlands, 3 MGO,
RIVM, Utrecht,, Utrecht,, Netherlands and 4 IUF, Duesseldorf, Germany
Defects in the DNA repair mechanism nucleotide excision repair (NER) either promote skin tumors
in the rare disease Xeroderma pigmentosum (XP) or premature aging in Cockayne syndrome (CS).
Aging-associated reduction of subcutaneous fat is a hallmark of physiological aging and of CS and
many other progeroid syndromes. While mutations of mitochondrial (mt)DNA have also been linked
to aging, the functional involvement of NER-associated proteins in mtDNA mutagenesis and aging
has not been shown. We could previously demonstrate the localization of CSA and CSB proteins
in mitochondria and their mitochondrial enrichment upon oxidative stress as well as premature
induction of mtDNA mutations in cells from patients missing CS-A and CS-B. Removal of oxida-
tive mitochondrial DNA damage was impaired in cells of CS patients. This could be normalised
by coincubation with quenchers (vitamin E) and stable transfection of CSA and CSB. Furthermore,
we could show binding of the CSA protein to mtDNA in a complex by gelelectrophoresis mobil-
ity shift assays and coimmunoprecipitation upon oxidative stress. Aged csb m/m-mice show a strong
increase of mtDNA mutations in age-dependently reduced subcutaneous fat tissue which was not
observed in other DNA repair deficient mice - also not showing reduced subcutaneous fat. These
data disclose a link between the clinical premature aging symptom loss of subcutaneous fat in CS
patients, enhanced oxidatively induced mtDNA mutagenesis and the mitochondrial localization
of CS proteins directly interacting with mtDNA. This indicates a hitherto undescribed role of the
NER-associated CS-proteins in protection from oxidatively induced premature aging of subcuta-
neous fat.
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SHARPIN is a critical regulator of NFKB and MAPK signaling
Y Liang,1 R Seymour,1 V Kennedy,1 KA Silva,1 H HogenEsch2 and JP Sundberg1 1 The Jackson
Laboratory, Bar Harbor, ME and 2 Pathobiology, Purdue University School of Veterinary
Medicine, West Lafayette, IN
The chronic proliferative dermatitis mouse (cpdm) phenotype is a multi-organ inflammatory dis-
ease characterized by psoriasiform dermatitis that is due to a spontaneous null mutation in the
mouse Sharpin gene (allele symbol: Sharpincpdm). Mutant mouse epidermis becomes progres-
sively acanthotic with diffuse orthokeratosis and focal parakeratosis with age. There is an increased
number of eosinophils, neutrophils, macrophages, and mast cells in the dermis. To determine how
SHARPIN deficiency results in disease we performed Affymetrix microarray and QPCR analyses at
2, 4, 6, 8, and 10 weeks of age on dorsal skin from mutant and control mice. These studies revealed
constitutively dysregulated NFKB signaling presumably due to stimulation by IL1 in Sharpincpdm
skin as compared to controls. Concurrent with keratinocyte proliferation, increased keratinocyte
apoptosis was observed associated with mitochondrial abnormalities, cytochrome c release,
BAX/BCL2 shift, caspase-3 and poly (ADP-ribose) polymerase cleavage, p38 phosphorylation, and
TUNEL+ DNA fragmentation in Sharpincpdm mutant mice. Apoptosis was quantified by FACS using
Annexin V. Lectin, galactose binding, soluble 7 (LGALS7, galectin 7), which induces keratinocyte
apoptosis through the mitochondrial damage pathway, was significantly upregulated at both the
RNA and protein levels. Taken together, our findings suggest that Sharpin regulates epidermal hyper-
proliferation and dermal inflammation through the NFKB pathway which in turn stimulates ker-
atinocyte apoptosis via the mitochondria damage pathway involving p38-MAPK phosphorylation
and caspase-3 activation.
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Dietary magnesium modulates connective tissue mineralization in a mouse model of pseu-
doxanthoma elasticum (Abcc6-/-)
J LaRusso, Q Li, Q Jiang and J Uitto Dermatology and Cutaneous Biology, Jefferson Medical
College, Philadelphia, PA
Pseudoxanthoma elasticum (PXE) is an autosomal recessive multi-system disorder characterized
by ectopic connective tissue mineralization, with clinical manifestations primarily in the skin,
eyes and the cardiovascular system. There is considerable, both intra- and inter-familial, variabil-
ity in the spectrum of phenotypic presentations. Previous studies have suggested that mineral con-
tent of the diet may modify the severity of the clinical phenotype in PXE. In this study, we utilized
a targeted mutant mouse (Abcc6-/-) as a model system for PXE. We examined the effects of changes
in dietary phosphate and magnesium on the mineralization process using calcification of the con-
nective tissue capsule surrounding the vibrissae as an early phenotypic biomarker. Mice placed on
custom-designed diets either high or low in phosphate did not show changes in mineralization,
which was similar to that noted in Abcc6-/- mice on standard rodent diet (control). However, mice
placed on diet enriched in magnesium (5-fold) showed no evidence of connective tissue mineral-
ization in this mouse model of PXE. The inhibitory capacity of magnesium was confirmed in a
cell-based mineralization assay system in vitro. Conversely, diet deficient in magnesium (one-fifth)
accelerated the mineralization process. Collectively, our observations suggest that assessment of
dietary magnesium in patients with PXE may be warranted.
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Gene expression/qRT-PCR analysis in psoriatic disease: Translational approaches to identify
responder from non-responder psoriasis patients treated with Anti-TNFα biologics
SO Francis,1 M Fujita,1 R Dellavalle,1 DA Norris1 and CK Edwards1,2 1 Dermatology, UCD,
Aurora, CO and 2 Infectious Diseases, UCD, Aurora, CO
Psoriasis (Ps) affects 1.5 to 2% of the population and is a hereditary disorder of the skin. T cells and
cytokine involvement have led to Anti-TNFα therapies. Inflammation-related genes and changes
with therapy is not well defined in Ps. Therefore, (1) normal healthy volunteers (NHV), (2) patients
with “stable/well controlled” Ps (SCPs), and (3) patients with “unstable” psoriasis being treated with
Etanercept therapy (UPs-E) were chosen as treatment arms(COMIRB #06-0303) to provide com-
parisons between gene expression changes in whole blood (WB). qRT-PCR results for 32 SCPs WBS
(N=32) were compared against NHV WBS (N=20) using a 59-gene Precision ProfileTM for Ps(SMDx,
Inc., Boulder, CO). No 1 or 2 gene models were found to meet a preset (minimum 75%) classifi-
cation criteria for distinguishing SCPs from NHV. Only 4 individual target genes were found to have
statistical significance below the 0.05 level including HLA-C, CCND1, ITGAE and EGR2. How-
ever, several 2-gene models were found to be just below the threshold of 75% correct classifica-
tion criteria including 1) HLA-C and IL13RA1 (Rsq = 0.19), resulting in 65% and 66% correct clas-
sification of NHV and SCPs subjects, respectively, 2) HLA-C, on its own, demonstrated the most
significant differences between the SCPs and NHV (p = 0.0114), 3)IL13RA1, on its own, was not
found to be significant (p= 0.93), however when combined with HLA-C it did provide additional
discriminatory power for the 2-gene model, 4) ANXA3 and IL1RN (Rsq = 0.18), resulting in 70%
and 75% correct classification of HNV and SCPs, respectively, and 5) IL1RN, on its own, demon-
strated marginal significance between the SCPs and HNV(p-val = 0.06). Inclusion of ANXA3 in the
2-gene model provided additional discriminatory power despite the fact that this target gene was
not found to be statistically significant on its own (p-val = 0.38). More patients are now required
to “better identify” psoriasis patients entering our clinic with “stable disease”.
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Evidence for a founder mutation in the cathepsin C gene in two families with Papillon Lefevre
Syndrome
L Bach,1 M Kurban,1 M Wajid,1 Y Shimomura,1 R Bahhady,3 A Kibbi3 and A Christiano1,2 1
Dermatology, Columbia University, New York, NY, 2 Genetics and Development, Columbia
University, New York, NY and 3 Dermatology, American University of Beirut, Beirut, Lebanon
Papillon Lefevre Syndrome (PLS; OMIM 245000) is a rare autosomal recessive disorder with an
incidence of 1 to 4 persons per million. Clinically, PLS is characterized by hyperkeratosis involv-
ing palms, soles, elbows, and knees which sometimes resembles psoriasis. This is followed later
on by periodontitis, destruction of alveolar bone and loss of primary and permanent teeth. Some
patients are also predisposed to recurrent skin infections. The condition is caused by mutations in
the cathepsin C (CTSC) gene, also known as dipeptidyl peptidase I (DDRI), on chromosome 11q14.
CTSC is a lysosomal proteinase that functions in removing aminopeptides from the N-terminus of
its substrate and is expressed in many tissues including the epithelia, osteoclasts and immune cells
among others. Thus, a disturbance in the function of CTSC is expected to lead to pathology in sites
where it is highly expressed. Currently, more than 50 distinct mutations in CTSC have been reported
in PLS. Here, we analyzed the DNA of members from two consanguineous families from Pakistan
and Lebanon for mutations in the CTSC gene through direct sequencing analysis. We identified
the identical recurrent missense mutation,R272P, in both families. This missense mutation has been
reported previously in families from Lebanon, Turkey, France, Holland, Saudi Arabia, and Euro-
peans, therefore it is among the most common mutations in CTSC gene. Microsatellite markers
analysis around the cathepsin C gene revealed the same haplotype on the mutation-carrying allele
in both families. The presence of this common mutation in two families from different geographi-
cal areas provides evidence for a founder effect for CTSC mutations in PLS.
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Mutations in the keratin 85 (KRT85/hHb5) gene underlie pure hair and nail ectodermal dys-
plasia: evidence for clinical overlap with monilethrix
M Zhang,1 Y Shimomura,1 M Wajid,1 M Kurban,1 N Sato3 and A Christiano1,2 1 Department of
Dermatology, Columbia University, New York, NY, 2 Department of Genetics &
Development, Columbia University, New York, NY and 3 Department of Dermatology,
Niigata University School of Medicine, Niigata, Japan
Pure hair and nail ectodermal dysplasia (PHNED; OMIM 602032) is a congenital disorder char-
acterized by hypotrichosis and nail dystrophy. The disease can show either an autosomal domi-
nant or recessive inheritance pattern. Recently, a homozygous mutation in the basic hair keratin
gene, keratin 85 (KRT85), previously known as basic hair keratin hHb5, has been identified in a
single Pakistani family with autosomal recessive PHNED. However, molecular basis of the disease
remains largely undefined. In this study, we identified two consanguineous Pakistani families with
PHNED. Genotyping suggested linkage of both families to the type II keratin cluster on chromo-
some 12q13. Direct sequencing analysis led to the identification of two distinct homozygous muta-
tions in the KRT85 gene in both families, 1448_1449delCT (Pro483ArgfsX18) and 233G>A
(Arg78His), respectively. It is noteworthy that one of these families has fragile hair shafts. Surpris-
ingly, under scanning electron microscopy, the hair shows characteristic features of monilethrix,
characterized by hairs which consist of node and internode formation, and is occasionally asso-
ciated with nail anomalies. Monilethrix can similarly be inherited in either an autosomal domi-
nant (OMIM 158000) or recessive (OMIM 252200) pattern. To date, it has been shown that muta-
tions in other hair keratin genes KRT81 (hHb1), KRT83 (hHb3), and KRT86 (hHb6) genes cause the
autosomal dominant form, whereas DSG4 mutations underlie the autosomal recessive forms of
monilethrix. Our results not only expand our understanding of the molecular basis of PHNED, but
also suggest that PHNED exhibits clinical overlap with monilethrix.
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Identification of mutations in the SLURP1 gene in three Pakistani families with Mal de Meleda
H Lam,1 Y Shimomura,1 M Wajid1 and AM Christiano1,2 1 Department of Dermatology,
Columbia University, New York, NY and 2 Department of Genetics & Development,
Columbia University, New York, NY
Mal de Meleda (OMIM 248300) or keratosis palmoplantaris transgrediens of Siemens is a rare auto-
somal recessive skin disorder characterized by transgressive palmoplantar keratoderma, keratotic
skin lesions, perioral erythema, brachydactyly and hyperhidrosis. The disease has previously been
shown to be caused by mutations in SLURP1 gene. The SLURP1 gene encodes a secreted mem-
ber of the LY6/PLAUR family of proteins, and is abundantly expressed in the granular layer of human
epidermis. The SLURP1 protein potentiates the action of acetylcholine on a nicotinic receptor,
which plays a critical role in terminal differentiation of the epidermis. To date, a total of 11 muta-
tions in the SLURP1 gene have been identified in several families with Mal de Meleda from around
the world. It has previously been shown that most mutations in SLURP1 gene affect the expres-
sion, integrity, or stability of the mutant protein, which results in the abnormal keratinization and
hyperhidrosis. In this study, we identified three consanguineous Pakistani families with several
affected individuals showing classical features of Mal de Meleda. Direct sequencing analysis in all
three families led to the identification of one novel mutation, Ivs1+1G>A, as well as two recurrent
mutations, G86R and R96X, in the SLURP1 gene. This is the first report of SLURP1 mutations in
families from Pakistan. Our findings not only expand the allelic series of mutations in the SLURP1
gene, but also enhance our understanding of the role of SLURP1 protein in epidermal keratiniza-
tion.
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Compound heterozygotes in consanguineous families? A cautionary tale from lipase H muta-
tions in autosomal recessive woolly hair
M Wajid,1 L Petukhova,1 Y Shimomura,1 P Gorroochurn,4 SE Hodge3,4,5 and AM Christiano1,2 1
Dermatology, Columbia University, New York, NY, 2 Genetics and Development, Columbia
University, New York, NY, 3 Psychiatry, Columbia University, New York, NY, 4 Biostatistics,
Columbia University, New York, NY and 5 Epidemiology, NY State Psychiatric Institute, New
York, NY
Autozygosity mapping in consanguineous families is a powerful method for identifying recessive
disease genes. Using this technique with whole genome SNP data generated from low density map-
ping arrays, we previously identified two genes that underlie autosomal recessive woolly hair
(ARWH), specifically P2RY5 and Lipase H (LIPH). In this study, we sought to identify a novel dis-
ease locus for ARWH by analyzing two large consanguineous families who had initially been
excluded for mutations at either of these disease loci by haplotype analysis with microsatellite
markers. A genome-wide analysis of 10 members from each of the two families failed to identify
significant regions of autozygosity or linkage. Upon genotyping an additional 10 family members
in one of the families, parametric linkage analysis identified a region on chromosome 3q27 with
evidence for linkage (Z=2.5). Surprisingly, this region contains the LIPH gene. Microsatellite mark-
ers located within the LIPH gene were used for haplotype analysis and unexpectedly demonstrated
that not one, but two haplotypes were segregating in each of these families. DNA sequencing iden-
tified two distinct LIPH mutations (280_369dup90 and 659_660delTA). Each affected individual
(n=38) was either homozygous for one mutation (n=7 and 16 respectively), or compound het-
erozygous (n=15). A review of the literature identified several reports of compound heterozygotes
in consanguineous families. Prompted by this finding, we determined the probability that a patient
affected with a recessive disease is carrying two mutations at the disease locus and demonstrate
that the validity of the IBD assumption may be challenged in large consanguineous families.
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Proteasome inhibitor differentially targets Rel-transcription factors to suppress type 1 genes
and stimulate type 2 genes
HM Gibson,1,2 TM Germeroth1 and HK Wong1 1 Dermatology, Henry Ford Health System,
Detroit, MI and 2 Immunology & Microbiology, Wayne State University, Detroit, MI
T cells play an important role in the control of the immune response. Upon activation, CD4 helper
T cells differentiate into specific subsets defined by the profile of cytokines expressed. The Th1 T
cell is defined by IL-2 and Ifn-g, while Th2 is defined by IL-4, IL-5 and IL-13. Dysregulation of these
T cell subsets can lead to a proinflammatory immune response resulting in chronic immune dis-
ease. Immunosuppressive compounds such as cyclosporin A can be used to abrogate T cell acti-
vation, but the effect is not specific to either Th1 or Th2. Proteasome inhibitors target NF-kB-depend-
ent gene expression by blocking the degradation of Ik-B, but what role the proteasome has on the
Rel transcription factor NFAT is unclear. Differential effects on NF-kB and NFAT may lead to altered
immunoregulation as both factors are involved in cytokine expression. To determine whether NFAT
is regulated by the proteasome, we study the regulation of cytokine genes in the presence of the
proteasome inhibitor bortezomib. Pretreatment of normal human PBMCs with bortezomib leads
to a profound alteration of cytokine expression. Bortezomib induces a concentration-dependent
suppression of Th1 genes IL-2 and Ifn-g, and stimulates the Th2 genes IL-4, IL-5 and IL-13.
Immunoblot assays show bortezomib treatment increases Ik-B and NFAT protein, thereby inhibit-
ing NF-kB function while enhancing NFAT function. To further clarify the regulation of NFAT by
bortezomib, the CTLA-4 gene, which is highly dependent on NFAT, was analyzed. We found that
CTLA-4 is increased in the presence of bortezomib by immunofluorescence and by analysis of
gene expression, supporting a critical role of proteasome in regulating NFAT function. These find-
ings suggest a model whereby shifting the balance of NFAT and NF-kB protein levels with borte-
zomib, T cell cytokine expression can be altered to yield a stronger Th2 than Th1 response. The
ability to modulate T cell gene expression may potentially serve to treat Th1 mediated diseases
such as psoriasis.
533
Genetic architecture of Alopecia Areata: Common pathways among autoimmune diseases
L Petukhova,1 A Sinha,3 A Lee,4 J Freudenberg,4 M Olsen,3 M Hordinsky,5 D Norris,6 V Price,7
M Duvic,8 PK Gregersen4 and AM Christiano1,2 1 Dermatology, Columbia University, New
York, NY, 2 Genetics and Development, Columbia University, New York, NY, 3 Dermatology
and Cutaneous Sciences, Michigan State University, East Lansing, MI, 4 The Feinstein Institute
for Medical Research, Manhasset, NY, 5 Dermatology, University of Minnesota, Minneapolis,
MN, 6 Dermatology, University of Colorado, Denver, CO, 7 Dermatology, University of
California, San Francisco, CA and 8 Dermatology, MD Anderson Cancer Center, Houston, TX
Alopecia areata (AA) is a genetically determined autoimmune disorder of the hair follicle affect-
ing 1-2% of the US population. With the recent advent of genome-wide association studies, great
advances have been made in understanding the genetic architecture of autoimmune diseases (ADs).
Currently, at least 23 susceptibility genes are shared by two or more ADs. To identify alleles asso-
ciated with AA that are common to autoimmune processes, an Illumina iSelect™ chip was designed
to interrogate a panel of ~7000 SNPs in loci related to several ADs, as well as an additional panel
of ~5000 SNPs to capture ancestry information. This chip was used to genotype a cohort of 665
AA patients and 780 controls. There were 11 SNPs within the top 0.1% of the score distribution
which fell in 10 genes: HLA-DQA1(p=1x10-7), HLA-G(p=3x10-6), ARHGAP25(p=2x10-5),
LOC387939(p=2x10-5), STAT5B(p=3x10-5 and 5x10-5), PTPN22(p=5x10-5), BCLN(p=5x10-5),
IRF8(p=5x10-5), TRAF1(p=1x10-4), RSBN1(p=1x10-4). Interestingly, three of these are among the
23 genes shared in ADs: HLA-DQA1 (celiac disease, inflammatory bowel disease, and lupus),
PTPN22 (Crohn’s disease, rheumatoid arthritis, type I diabetes), and TRAF1 (rheumatoid arthritis).
Furthermore, three genes fall into critical pathways common to ADs: T-cell differentiation (STAT5),
immune cell activation (PTPN22), and innate immunity/ TNF signaling (TRAF1). Placing AA within
the context of shared genetics and common pathways among ADs promises to elucidate the under-
pinnings of disease pathogenesis and illuminate novel therapeutic avenues for the treatment of AA.
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Haplotype analysis implicates MICA*002 in susceptibility to psoriatic arthritis
RP Nair,1 PE Stuart,1 JJ Voorhees1 and JT Elder1,2 1 Dermatology, Univ of Michigan, Ann Arbor,
MI and 2 VA Hospital, Ann Arbor, MI
HLA-B38 and -B39 have been associated with psoriatic arthritis (PsA) for many years. Haplotype
analysis demonstrated that these alleles are carried on the same ancestral chromosomal segment
(AJHG 66:1833, 2000). It has been proposed that HLA-B38/39 associations with PsA are due to
linkage disequilibrium (LD) with the A9 allele of MICA (MHC Class I-related gene A), which maps
47 kb centromeric to HLA-B and specifies an extended MICA transmembrane segment (Arth Rheum
42:1010, 1999). More recently, Korendowych et al. reported a PsA-specific association with
MICA*002, a split of MICA-A9, whereas patients with early-onset psoriasis without arthritis (PsC)
were associated not with MICA*002 but with MICA*017, another split of HLA-A9 that is in LD with
HLA-B57 and HLA-Cw6 (BJD 154 suppl 1, 2006). In an effort to confirm this result, we analyzed
620 pedigrees with phased microsatellite haplotypes extending from D6S273 (360 kb centromeric
of HLA-B) to M6S181 (85 kb telomeric of CDSN). HLA-C and CDSN were typed and phased in all
samples, along with several SNPs and indels between them (AJHG 78:827, 2006). Based on the
report of Korendowych et al., we defined the MICA*002 allele as any chromosome carrying MICA-
A9, except for those also carrying HLA-B57 and HLA-Cw6. Based on this definition, we found a
43% higher frequency of arthralgia among MICA*002 carriers compared to non-carriers, whereas
it was 20% lower among HLA-Cw6 carriers relative to non-carriers. Importantly, the frequency of
arthralgia was also increased in MICA*002-positive haplotypes carrying HLA-B35 and HLA-Cw4,
explaining the increased risk of arthralgia in MICA*002 carriers (43%) relative to HLA-B38/B39
carriers (33%). The only other gene located in the region identical by descent between all MICA*002
haplotypes is HCP5, a poorly-characterized gene related in sequence to human endogenous retro-
viruses. While requiring confirmation by case-control analysis of rheumatologist-diagnosed PsA,
this study confirms the work of Korendowych et al. and suggests that MICA*002 may be a genetic
determinant of PsA.
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SNP linkage scan in Alopecia Areata families confirms susceptibility loci and identifies two
novel regions
J Chen,1 L Petukhova,2 WV Chen,3 A Lee,5 CI Amos,3 M Hordinsky,6 D Norris,7 V Price,8
M Duvic,4 PK Gregersen5 and AM Christiano1,2 1 Genetics and Development, Columbia
University, New York, NY, 2 Dermatology, Columbia University, New York, NY, 3
Epidemiology, MD Anderson Cancer Center, Houston, TX, 4 Dermatology, MD Anderson
Cancer Center, Houston, TX, 5 The Feinstein Institute for Medical Research, Manhasset, NY,
6 Dermatology, University of Minnesota, Minneapolis, MN, 7 Dermatology, University of
Colorado, Denver, CO and 8 Dermatology, University of California, San Francisco, CA
With a lifetime risk of approximately 2%, Alopecia Areata (AA) [MIM 104000] is one of the most
common human autoimmune diseases, affecting approximately 4.6 million individuals in the US,
including males and females of all ages and across ethnic groups. To identify causative genes in
AA, we previously conducted a genome-wide linkage screen with microsatellite (ms) markers in a
cohort of 20 US and Israeli families. We demonstrated strong evidence for linkage on chromo-
some 6q (Z=3.6) and suggestive evidence (Z>1.5) on 6p near HLA and on an additional five chro-
mosomes (1, 2, 9, 10, and 16). Finemapping was then performed in an expanded cohort of 38
families for six regions with ms markers. Linkage evidence was upheld on chromosomes 6q (Z=2.89)
and 16 (Z=3.12), and evidence strengthened on chromosome 18 (max multipoint LOD=3.93). We
conducted a genome-wide linkage scan using SNPs on a cohort of 38 US families, utilizing a high
density SNP genotyping array (Illumina 317K). Linkage analysis identified eight regions with LOD
scores >1.5, six of which positionally coincide with regions identified in our first scan, most notably
on chromosomes 2 (Z=4.17), and two regions on chromosome 6q (Z=2.31 and 2.18). Two novel
regions were identified, on chromosomes 5 (Z=1.71) and 20 (Z=1.52). Interestingly, the region on
5 coincides with psoriasis and atopic dermatitis linkage regions. These findings significantly advance
our efforts in systematically defining the genetic architecture of AA, and establish the foundation
for comparison between linkage and genome-wide association studies in the future.
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Regulation of Desmoglein 4 by transcription factors implicated in hair shaft differentiation
H Bazzi,1,2 S Demehri,3 CS Potter,4 A Getz,1 A Awgulewitsch,4 R Kopan3 and AM Christiano1,2 1
Genetics and Development, Columbia University, New York, NY, 2 Dermatology, Columbia
University, New York, NY, 3 Developmental Biology, Washington University School of
Medicine, St. Louis, MO and 4 Medicine and Cell Biology, Medical University of South
Carolina, Charleston, SC
The hair fiber is comprised of trichocytes that primarily express hair keratins which are cemented
by a multitude of keratin-associated proteins (KAP). The hair keratins form the intermediate fila-
ment cytoskeleton of trichocytes and are linked to abundant cell-cell adhesion junctions, called
desmosomes. Desmoglein 4 (DSG4) is the major desmosomal cadherin expressed in the hair shaft
cortex where these hair keratins are expressed. In humans, mutations affecting either the hair ker-
atins or DSG4 lead to beaded hair phenotypes with features of monilethrix. In this work, we hypoth-
esized that the regulatory pathways governing the expression of hair shaft components, such as
hair keratins and DSG4, are similar. Therefore, we studied the transcriptional regulation of DSG4
by transcription factors/pathways that are known regulators of hair keratin or KAP expression. In
particular, we focused on the Wnt and Notch pathways downstream effectors as well as transcription
factors such as HOXC13/12, FOXN1 and MSX2. Our data suggest that HOXC13, LEF1 and FOXN1
repress DSG4 transcription. In search of factors which positively regulate Dsg4, we turned our atten-
tion to the Notch pathway based on the phenotypic similarities of Dsg4 and Notch pathway mutant
mice. We show that the Notch intracellular domain upregulates a DSG4 reporter in HaCaT ker-
atinocytes, and further, that DSG4 expression is absent in the hair shafts of mice that lack γ-secre-
tase activity that is essential for Notch signaling. Our findings provide in vitro and in in vivo evi-
dence correlating the Notch pathway with the activation and/or maintenance of DSG4 expression
in the hair follicle.
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A genome-wide association study of gene expression in skin and psoriatic lesions
JE Gudjonsson,1 J Ding,2 RP Nair,1 L Liang,2 JJ Voorhees,1 GR Abecasis2 and JT Elder1 1
Department of Dermatology, University of Michigan, Ann Arbor, MI and 2 Department of
Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI
Psoriasis is an immune-mediated hyperproliferative skin disease with strong genetic basis. Lesional
psoriatic skin has marked changes in the expression of hundreds of genes. Recently, gene tran-
script levels have been used as an intermediate phenotype that bridges genotypes and more com-
plex clinical phenotypes. We carried out whole genome genotyping and gene expression analysis
in a set of skin biopsies from 110 individuals; 57 controls and 53 psoriatic patients with chronic
plaque psoriasis. 428,570 single nucleotide polymorphisms (SNPs) were genotyped for all study
subjects using the Perlegen Sciences microarray platform and approximately 2 million additional
SNPs were imputed using HapMap information. Gene expression was performed using Affymetrix
U133 Plus 2.0 Arrays to query 54,675 transcripts in control (n=57), uninvolved (n=53) and lesional
psoriatic (n=53) skin. By genotype trend test, 887 gene expression traits were identified and asso-
ciated with at least one SNP at p<5x10-8 in normal control and uninvolved psoriatic skin com-
bined. 73 gene expression traits were found to be similarly associated with at least one SNP in
lesional psoriatic skin. Only 4 (5.5%) traits were uniquely observed in psoriatic skin, while 69
traits were found in both normal and psoriatic skin. Enriched processes in the expression traits over-
lapping between psoriatic and normal skin included “antigen processing and presentation”, involv-
ing components of the class I antigen-processing pathway, and “protein metabolic process”. Of
the 1,562 SNP-transcript pairs in our dataset, around 80% were identical to those from an inde-
pendent survey of gene expression in lymphoblastoid cell lines (Dixon et al, Nat Genet. 39, 1202,
2007). The results provide a genome-wide look at regulation of gene expression in normal and pso-
riatic skin and suggest association between the genetic control of expression of components involved
in antigen processing and psoriasis.
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Identification of cis-regulatory elements in the epidermal differentiation complex (EDC)
C de Guzman Strong,1 K Sears2 and JA Segre1 1 National Human Genome Research Institute,
Bethesda, MD and 2 University of Illinois at Urbana-Champaign, Urbana, IL
The purpose of this study is to identify cis-regulatory elements in the Epidermal Differentiation Com-
plex (EDC) Locus (1q21). The EDC harbors 4 gene families (FLG-like, SPRR, LCE, and S100) that
are expressed during epidermal differentiation and barrier formation. Both atopic dermatitis (AD)
and psoriasis share independent genetic linkage to the EDC underscoring a potential role for these
genes in the etiologies of these diseases. Null mutations in filaggrin (FLG) strongly linked to famil-
ial ichthyosis vulgaris are also highly associated with cases of AD that often advance to asthma
(atopic march). AD familial studies excluding FLG continue to demonstrate EDC linkage suggest-
ing additional genetic variants within the EDC in AD pathogenesis. The density and tandem arrange-
ment of the paralogous genes within the FLG-like, SPRR, LCE, and S100 families and their spatial
and temporal expression in the epidermis suggest a coordinated network of cis-regulatory elements.
Here we utilize a multidisciplinary approach to identify regulatory activity residing within the EDC.
A comparative genomics approach by a multi-mammalian species alignment of syntenic EDC loci
(MultiPipMaker) identified 42 conserved noncoding sequences (CNS) as potential cis-regulatory
elements in the EDC. Incorporation of the metatherian Monodelphis domestica (opossum) genome
as a stringent criterion in annotating CNS in the EDC has been validated based on our evo-devo
analysis of the evolutionary conservation of dorsal to ventral patterning of epidermal barrier acqui-
sition in the opossum. To test the regulatory activity of the CNS, we employed dual luciferase
reporter assays in differentiating and proliferating keratinocytes and identified either enhancer or
repressor activity in roughly 50% of the CNS. Taken together, our results suggest a high proportion
of regulatory activity in the CNS that may coordinate expression of the genes in the EDC and could
pose as genetic variants contributing to either AD or psoriasis.
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Further pre-clinical characterization of TD101 – the first siRNA to enter clinical trials for a
skin disorder
RP Hickerson,1 SA Leachman,2 LN Pho,2 F Smith,3 W McLean,3 D Leake,4 LM Milstone5 and
RL Kaspar1 1 TransDerm, Santa Cruz, CA, 2 University of Utah, Salt Lake City, UT, 3 University
of Dundee, Dundee, United Kingdom, 4 ThermoFisher Scientific, Dharmacon Products,
Lafayette, CO and 5 Yale University, New Haven, CT
RNA interference offers a novel approach for treating genetic disorders including the rare mono-
genic skin disorder pachyonychia congenita (PC). PC is a caused by mutations in keratins K6, K16
or K17, resulting in keratoderma and blistering, which leads to debilitating pain at or near the
pressure points of the foot. We have identified an siRNA (K6a_513a.12; PBS-formulated GMP
K6a_513a.12 is known as TD101, which was recently evaluated in a Phase 1b clinical trial, see
Leachman et al. abstract) that demonstrates specific and potent inhibition of N171K mutant K6a
in a variety of cell lines, including a patient-derived immortalized keratinocyte (PC-10) cell line,
with no effect on wildtype expression, despite only a single nucleotide difference. Treatment of
PC-10 cells with K6a_513a.12 siRNA resulted in 98% knockdown of the mutant K6a mRNA with-
out affecting the wild-type mRNA level (assayed by allele-specific reverse transcriptase quantita-
tive PCR (RT-qPCR)). Importantly, sequential treatment of PC-10 cells resulted in continued inhi-
bition of N171K mutant K6a expression, suggesting that repeated treatment of patients with TD101
is a viable approach. To further investigate the mechanism of siRNA action, 5’ RACE analysis of
mRNA isolated from PC-10 cells treated with K6a.513a.12 siRNA was performed. This assay maps
the siRNA-mediated cleavage site of the mRNA. Sequencing of 5’ RACE products identified partial
mRNAs consistent with K6a_513a.12-mediated cleavage by RISC. If patient-friendly delivery meth-
ods can be developed, therapeutic siRNA holds great promise for treating dominant genetic skin
disorders, including PC.
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Characterization of a transgenic GFP mouse skin model for development of siRNA delivery
technologies
EG Gonzalez,1 H Ra,1 RP Hickerson,2 Q Wang,1 W Piyawattanametha,1,3 MJ Mandella,1
GS Kino,1 D Leake,4 AA Avilion,5 O Solgaard,1 TC Doyle,1 CH Contag1 and RL Kaspar2 1
Stanford, Stanford, CA, 2 TransDerm, Santa Cruz, CA, 3 NANOTEC/NECTEC, Phatum Thani,
Thailand, 4 ThermoFisher Scientific, Dharmacon Products, Lafayette, CO and 5 Barts and the
London School of Medicine and Dentistry, London, United Kingdom
The first skin clinical trial utilizing a small interfering RNA (siRNA) was recently completed with
encouraging results for pachyonychia congenita (PC) using TD101 (see Leachman et al abstract).
Although several siRNAs including TD101 have entered clinical trials, the development of siRNA
therapeutics as a new drug class will require the development of improved delivery technologies.
In this study, a reporter mouse model (Tg CBL/hMGFP) was developed to enable the study of siRNA
delivery to skin. In this model, reporter gene (GFP) expression localized predominantly in the
granular layer of the epidermis as well as the stratum corneum. Importantly, intradermal injection
of siRNAs targeting the reporter gene resulted in marked reduction of GFP expression in the local-
ized treatment areas as measured by histology, RT-qPCR and intravital imaging using a recently
developed dual-axes confocal fluorescence microscope. Although intradermal injection of siR-
NAs is likely the most efficient delivery method, the recently completed PC Phase 1b clinical trial
clearly demonstrated that the intense pain associated with intradermal injections into diseased skin
will severely limit this mode of administration in the clinic, and underscores the need for devel-
opment of alternative delivery technologies. This transgenic mouse model, coupled with intravi-
tal imaging, will be useful for development of efficient and “patient-friendly” siRNA delivery tech-
niques that should facilitate the translation of siRNA-based therapeutics to the clinic for treatment
of skin disorders.
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ABCA12 maintains the epidermal lipid barrier
Y Zuo,1,2 DZ Zhuang,1,2 R Han,3 G Isaac,5 JJ Manning,1,2 M McKee,4 R Welti,5 JL Brissette,3
ML Fitzgerald1,2 and MW Freeman1,2 1 Lipid Metabolism Unit, Dept of Medicine,
Massachusetts General Hospital, Boston, MA, 2 Center for Computational & Integrative
Biology, Massachusetts General Hospital, Boston, MA, 3 Cutaneous Biology Research Center,
Massachusetts General Hospital, Boston, MA, 4 Center for Membrane Biology, Massachusetts
General Hospital, Boston, MA and 5 Division of Biology, Kansas State University, Manhattan,
KS
Harlequin ichthyosis (HI) is a congenital scaling syndrome of the skin. Affected infants have epi-
dermal hyperkeratosis and a defective permeability barrier. Mutations in the gene encoding a mem-
ber of the ABCA transporter family, ABCA12, have been linked to HI. To investigate ABCA12’s activ-
ity, we generated Abca12 null mice and analyzed the impact on skin function and lipid content.
Abca12-/- mice survive to late term at near Mendelian frequency but die rapidly after birth. These
mice have a thickened epidermis from which water rapidly evaporates. In vivo skin proliferation
measurements, including bromodeoxyuridine incorporation and immunoblotting for expression
of Ki67 and Keratin 6, gave no indication of accelerated cell division, suggesting that a lack of
desquamation of the skin cells, rather than enhanced proliferation of basal layer keratinocytes,
accounts for the five-fold thickening of the Abca12-/- stratum corneum. Electron microscopy demon-
strated a severe disruption of the lamellar permeability barrier in Abca12-/- skin. This was associ-
ated with a profound reduction in skin linoleic esters of long chain ω-hydroxy-ceramides and a
corresponding increase in their glucosyl ceramide precursors. Studies of glucocerebrosidase did
not indicate any defect in its functional activity. As ω-hydroxy-ceramides are required for the bar-
rier function of the skin, these results indicate that ABCA12 activity is required for the generation
of long chain ceramide esters that are essential for the development of normal skin structure and
function.
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Lysophosphatidic acid-evoked calcium fluxes promote keratinocyte migration through Orai1,
lipid rafts and NFAT
R Jans, AM Brown, K Ross and NJ Reynolds Dermatological Sciences, Institute of Cellular
Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
Skin injury exposes keratinocytes to serum, which contains lysophosphatidic acid (LPA) and mil-
limolar concentrations of extracellular calcium ([Ca2+]o). LPA evokes intracellular calcium ([Ca
2+]i)
fluxes in keratinocytes, however the physiological mechanisms and targets of these fluxes are poorly
understood. Here we tested the hypothesis that LPA-activated [Ca2+]i fluxes are modulated by [Ca
2+]o,
involve Orai1 and lipid rafts and affect the activity of NFAT transcription factors and the motility
of keratinocytes. As monitored by Fluo-4 imaging, LPA stimulation of keratinocytes in 0.06 mM
[Ca2+]o evoked [Ca
2+]i transients due to store release, while in 1.2 mM [Ca
2+]o, LPA stimulation
triggered store release coupled to store-operated Ca2+ entry (SOCE). SOCE was blocked by the
SOCE inhibitor diethylstilbestrol (DES), by transient expression of dominant/negative Orai1R91W and
by lipid raft disruption using methyl-β-cyclodextrin treatment. NFAT activity was assessed using a
luciferase reporter assay and by monitoring the nuclear translocation of GFP-tagged NFAT2. Both
assays revealed significant activation of NFAT by LPA-evoked store release in 0.06 mM [Ca2+]o.
LPA-induced NFAT activation was blocked by pre-treatment with cyclosporin A (CsA). In 1.2 mM
[Ca2+]o, NFAT activation by LPA was substantially stronger than in 0.06 mM [Ca
2+]o. Moreover, in
1.2 mM [Ca2+]o, addition of DES and lipid raft disruption impaired LPA-induced NFAT activation.
The effect of LPA on cell motility was assessed using a 2-dimensional scratch assay and a 3-dimen-
sional chemotactic migration assay. In 0.06 and 1.2 mM [Ca2+]o, LPA significantly promoted both
2- and 3-dimensional cell migration, which was impaired upon pre-treatment with CsA. Our data
thus indicate that LPA- and [Ca2+]o-evoked [Ca
2+]i fluxes trigger a NFAT-activating signalling cas-
cade via Orai1 and lipid rafts which promotes keratinocyte migration, suggesting an involvement
of NFAT in epidermal reepithelialization.
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Requirement of G protein αi1 and 3 for UV radiation-induced activation of AKT/mTOR and
MAPK signaling in cultured human skin keratinocytes
C Cao,1,2 S Lu,1 W Wang,3 S Sarkisian,1 R Kivlin,1 W Chu,2 A Xu4 and Y Wan1 1 Providence
College, Providence, RI, 2 Brown University, Providence, RI, 3 Zhejiang University,
Hangzhou, China and 4 The 3rd Hospital of Hangzhou, Hangzhou, China
Activation of AKT/mTOR (mammalian target of rapamycin) and MAPK (p38/JNK/MEK/ERK) path-
ways is critical for UV-induced skin cell damage, skin aging and skin cancer. However, the molec-
ular mechanism underlying the activation of these pathways by UV remains elusive. Here we report
a novel and critical role of the G-proteins αi1 (Gi1) and Gi3 proteins in this activation process.
Using mouse embryonic fibroblasts (MEFs) lacking Gi1/3, we observed that UV-induced phos-
phorylation of MAPK (p38/JNK/MEK and ERK) as well as phosphorylation of AKT and downstream
targets of mTORC1, p70S6K, S6 and 4E-BP1, are largely impaired in doubly deficient cells, but
not in cells singly deficient for either Gi1 or Gi3. Furthermore, specific siRNA knockdown of both
Gi1 and Gi3 mimics the Gi1/3 deficiency phenotype in MEFs. Also, Gi1/3 are also expressed in
cultured human skin keratinocytes cell line (HaCaT cells) and primary human skin keratinocytes,
knockdown both Gi1 and Gi3 using specific siRNA in HaCaT cells largely impairs UV-induced
AKT/mTOR and MAPK activation. Further studies have shown that Gi1/3 are critical for UV-induced
Gab1 activation. Gab1 serves as a critical adaptor protein and mediator for UV-induced signal-
ing, Gab1 knockout almost abolishes UV-induced AKT/mTOR and MAPK activation. Importantly,
Gi proteins assemble with Gab1 in response to UV radiation, this interaction is critical for Gab1’s
adaptor function. UV-induced Gab1 phosphorylation and binding with EGFR are seen in wild type
but not in Gi1/3 double knockout MEFs. Finally, ablation of Gi1 and Gi3 largely enhances UV-
induced cell apoptosis and cell death. Collectively, our results suggest that Gi1 and Gi3 act down-
stream of EGFR, but upstream of Gab1-mediated activation of AKT/mTOR and MAPK, revealing
a novel role of Gαi proteins in UV signaling pathways and possibly in skin aging and cancer.
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In vitro characterization of Src phophorylation of a physiological substrate, cortactin revealed
intriguing features
X Lin,1,2,3 Y Wang3 and G Sun3 1 Dermatology and Skin Surgery, Roger Williams Medical
Center, Providence, RI, 2 Center of Biomedical Research Excellence (COBRE), Roger Williams
Medical Center, Providence, RI and 3 Cell and Molecular Biology, Unviersity of Rhode Island,
Kingston, RI
Src-family protein tyrosine kinases (SFKs) are important regulators of mammalian signal transduc-
tion. They play critical roles in the pathogenesis of cancer and several hyperproliferative epider-
mal disorders. More intensive study of SFKs is needed for skin disease prevention and treatment;
however, many molecular mechanisms of SFKs still remain unclear, including regulation and sub-
strate specificity. Biochemical characterizations of Src kinase activity have employed artificial sub-
strates; however, properties observed with such substrates may be misleading. In this study, we
reconstituted Src phosphorylation of a physiological protein substrate, Cortactin, in vitro, and bio-
chemically characterized this phosphorylation system. Several intriguing features of Src regula-
tion and function are revealed: First, the recognition of Cortactin by Src is shown to be specific,
in contrast with Csk, another soluble protein tyrosine kinase that shares similar structures with Src,
and does not phosphorylate Cortactin. Second, the activity of the un-autophosphorylated Src is
highly suppressed toward Cortactin, but is strongly activated by autophosphorylation on the Y419
residue. The extent of the suppression and the activation is far greater than previously reported
with artificial substrates. Third, both the deletion of the Src SH3 domain and the introduction of a
specific SH3 domain ligand significantly stimulate Src autophosphorylation on the Y419 residue,
leading to a greatly enhanced activity toward Cortactin. Finally, Src phosphorylates cortactin mainly
on three residues, Y421, Y446 and Y482, and the phosphorylation does not have an obligatory
order. These observations represent a first but critical step toward a thorough understanding of the
regulatory and catalytic mechanisms of Src phosphorylation of downstream protein substrates,
adding valuable information to the knowledge pool of SFKs.
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Novel mechanism of downstream signaling from keratinocyte nicotinic receptors
A Chernyavsky, J Arredondo, J Qian, V Galitovskiy and S Grando Dermatology, University of
California, Irvine, CA
The nicotinic class of keratinocyte acetylcholine receptors (nAChRs) mediates the nicotinergic arm
of ACh signaling that controls a plethora of cellular functions, including motility, adhesion and
differentiation, via alterations in gene expression, and also mediates carcinogenic effects of tobacco
nitrosamines. The nAChRs are comprised by five subunit proteins that form ACh-gated ion chan-
nels mediating Na+ and Ca2+ influx and K+ efflux, leading to membrane depolarization, opening
of voltage-operated Ca2+ channels and engagement of calcium calmodulin kinase. Activation of
α7 nAChR upregulates α2-intergrin expression via the Ras/Raf-1/MEK1/ERK signaling pathway. It
has been recently demonstrated that downstream signaling from α7 nAChR may involve Src acti-
vation due to formation of the membrane-associated multiprotein complex. Since, in contrast to
neurons and myocytes, keratinocytes are not excitable cells, we hypothesized that regulation of
gene expression by nAChRs in this cell type involves the receptor-mediated non-ionic events. To
test this hypothesis, we measured by the real-time PCR and in-cell western assays the effects of
Zn2+ and Cd2+—inhibitors of Ca2+ influx through nAChRs—on the ability of the α7 agonist AR-
R17779 to upregulate expression of the α2-integrin gene at the mRNA and protein levels, respec-
tively. The gene expression was reduced by Zn2+ and Cd2+ by approximately 50%, and com-
pletely blocked by MEK inhibitor, indicating that downstream signaling involved both ionic and
non-ionic events. Elimination of extracellular Ca2+ and treatment with Zn2+ and Cd2+ also signifi-
cantly (p<0.05), yet incompletely, decreased ERK activity, but not JAK-2 phosphorylation. There-
fore, the downstream signaling from α7 nAChR coupled to regulation of the α2-integrin gene expres-
sion apparently proceeds via at least two complimentary pathways initiated by: 1) Ca2+ influx and
2) direct activation of signaling kinases in receptor protein complexes. Both pathways may play
important roles in auto/paracrine control of epithelial and other types of non-neuronal cells by
ACh.
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Epidermal Growth Factor Receptor is internalized following stress condition in keratinocytes
S Lambert, A Frankart, M Hérin and Y Poumay Medecine - Cell and Tissue Lab, University of
Namur (FUNDP), Namur, Belgium
Keratinocyte is the major epidermal cell type and its proliferation is tightly regulated by the Epi-
dermal Growth Factor Receptor (EGFR) present in its plasma membrane. In absence of ligand, the
EGFR is mainly located in membrane micro-domains called lipid rafts, which act as traps for the
receptors and inhibit its downstream signalling. In keratinocytes, we have first shown that lipid raft
disruption induced by cholesterol depletion with methyl-beta-cyclodextrin activates the EGFR in
a ligand-independent manner. Secondly, the activation of EGFR is followed by a delayed re-local-
isation inside the cell cytoplasm, a phenomenon linked to the p38 MAPK activation as its specific
PD169316 inhibitor is able to slow down the process. We have also shown that keratinocytes are
able to recover from cholesterol depletion and restore their cholesterol content simultaneously with
inhibition of the stress signalling. Currently, we wonder if the ligand-independent internalization
o EGFR takes place under other physiological or chemical stress conditions. To assess this ques-
tion, we performed scratch wound assay and studied the activation state and localization of the
EGFR by Western blotting and immunofluorescence. In these conditions, EGFR was found inter-
nalized all along the cells neighbouring the scratch wound and this internalization was found
dependent on p38 MAPK since the use of PD169316 suppressed this phenomenon. We further
analysed the sensitizing chemical dinitrofluorobenzene and the inflammatory cytokine IL-1α or
physiological stress such as scratch and burn (by heat or cold). We found that all these conditions
induce internalization of the EGFR in absence of ligand addition in cultured keratinocytes. Taken
together, our results suggest that after stress conditions, keratinocytes temporarily internalize EGFR
without addition/participation of a ligand, providing a potentially beneficial process that impedes
keratinocytes to proliferate under stress conditions.
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G-protein αi1 and 3 are critical for arsenite-induced AKT/mTOR and MEK/ERK signaling in
cultured human skin keratinocytes
S Lu,1 C Cao,1,2 W Wang,3 S Sarkisian,1 R Kivlin,1 B Wallin,1 A Bagdasarian,1 T Tamakloe,1
W Chu,2 A Xu4 and Y Wan1 1 Providence College, Providence, RI, 2 Brown University,
Providence, RI, 3 Zhejiang University, Hangzhou, China and 4 The 3rd Hospital of
Hangzhou, Hangzhou, China
Inorganic arsenic is an environmental contaminant, associated with the increased risk of human
skin cancer. Arsenic has been reported to activate a variety of cellular signaling pathways which
have effects on cell growth, differentiation and apoptosis. However, the molecular mechanisms of
these arsenic-induced biological effects are not completely understood. Previous studies have shown
that EGFR-Shc-Grb2 complex plays critical role in arsenite-induced AKT/mTOR MEK/ERK signal-
ing pathway. Our most recent study using genetic depletion methods reveals an unexpected but
very exciting result that G-protein αi1 and 3 (Gi1 and 3) are critical for EGFR signaling and Gi pro-
teins serve upstream of Gab1. Here we show that arsenite (AsCl3 and As2O3)-induced AKT/mTOR
and MEK/ERK pathway is almost abolished in Gi1 and 3 double knockout MEFs (mouse embry-
onic fibroblasts). Further, siRNA knockdown of both Gi1 and Gi3 impairs arsenite-induced signal
transduction in cultured skin keratinocytes (HaCaT cell line and primary human keratinocytes). We
found that in response to arsenite, these Gi proteins assemble with Gab1, which severs as a key
adaptor protein for EGFR and arsenite signaling. Gab1 knockout largely impairs arsenite- induced
AKT/mTOR MEK/ERK activation. The association between Gab1 and Gi proteins is critical for Gab1
function, since Gab1 in Gi1/3 double knockout MEFs fails to be phosphorylated or bind to EGFR
after arsenite treatments. Finally, Gi1/3 deficient (knockout MEFs or siRNA knockout skin ker-
atinocytes) cells are more sensitive to arsenite-induced cell death. This is the first genetic evidence
showing the critical role of Gi proteins in arsenite- induced signaling. Our study helps us better
understand the molecular mechanisms underlying arsenite-induced signaling and skin cancer.
546
ER signaling is activated to protect human keratinocytes from UVB-induced ER stress
K Mera,1,2 K Kawahara,2 I Maruyama2 and T Kanekura1 1 Dermatology, Kagoshima University,
Kagoshima, Japan and 2 Laboratory of Molecular Medicine, Kagoshima University,
Kagoshima, Japan
Proteins are folded properly in the endoplasmic reticulum (ER). Various stresses such as hypoxia,
ischemia, or starvation interfere the ER function leading to the ER stress defined by accumulation
of unfolded protein (UP) in the ER. ER stress is avoided by UP response (UPR) and ER-associated
degradation (ERAD). Signaling pathways to avoid UP are activated by PERK, IRE-1, and ATF6. PERK
is activated to suppress protein synthesis. IRE-1 and its downstream mediator XBP-1 are activated
to induce ER chaperones to refold UP. ATF6 that activates proteins involved in UPR transcription-
ally is translocated to nuclei. These processes are UPR. Excess UP that cannot be processed by UPR
is degraded by ERAD; elimination of UP from ER to cytosol, ubiquitination and subsequent degra-
dation by proteasome. We investigated the ER signaling in ultraviolet B (UVB)-irradiated human
keratinocyte (KC) cell line, HaCaT. Whether UVB provokes ER stress was assessed by MTT assay
and immunoblot of Ero1-Lα that is expressed in the early stage of ER stress to refold UP. Phospho-
rylation of PERK and expression of XBP-1, ATF6, and calnexin, an ER chaperone that recognizes
UP and initiate ubiquitination, are studied by Western blot. RT-PCR was used for XBP-1 expres-
sion. Translocation of ATF6 was determined by a confocal microscope. Ubiquitination of UP was
detrermined by Western blot using an anti-ubiquitin antibody. UVB irradiation at 40 mJ/cm2 resulted
in significant growth retardation of HaCaT and induction of Ero1-Lα expression at 4 to 8 hrs, indi-
cating that UVB provoked ER stress in HaCaT cells. Expression of XBP-1 and ATF6 was induced
by 40 mJ/cm2 UVB. Nuclear translocation of ATF6 was observed after UVB irradiation. Calnexin
expression and ubiquitination of UP were induced by 40 mJ/cm2 UVB. PERK was not phosphory-
lated by UVB. These results demonstrate that UVB irradiation generates UP in human KC and UPR
and ERAD systems are activated to protect cells from UVB-induced ER stress. This is the first pres-
entation of ER signaling in UVB-irradiated KC.
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Insulin growth factor-1 regulates age-related gene expression in skin
Y Chen and R Wyborski Bioscience, Global R&D, Avon Products, Inc., Suffern, NY
Aging is a complex process manifested by profound changes in numerous organs, including nerv-
ous system degeneration, osteoporosis, immune system dysfunction and endocrine system hypo-
function. The most dramatic change we can observe is on the skin. The exact mechanisms of
aging are still elusive; however, the decline of growth hormone (GH) and insulin growth factor -1
(IGF-1) level in the serum has been associated with intrinsic aging (Rudman et al., 1981). The rela-
tionship between the decreased IGF-I serum levels and skin changes are not known. In the pres-
ent study, we identified genes in skin cells that are regulated by the IGF-1 signaling pathway. Gene
chip analysis (Affymetrix) of human dermal fibroblasts and epidermal keratinocytes treated with
IGF-I revealed numerous changes in gene expression. Among the 30,000 genes examined, activin
A, a member of the transforming growth factors (TGFβ) superfamily, was found to be upregulated
about 3 fold by IGF-1 in keratinocytes. This upregulation has been confirmed by qPCR. In fibrob-
lasts, the microfibril protein Fibrillin-1 level is upregulated by IGF-1 as measured by Western blot
analysis, although the mRNA level remains unchanged. These results suggest IGF-1 regulates the
expression of key functional proteins in the skin, and a crosstalk between the IGF and TGF sig-
naling cascades may contribute to intrinsic aging process in human skin.
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Regulation and function of kallikrein related peptidase 6 in malignant melanomas
S Krenzer,1 B Klucky,1 C Mauch,3 V Umansky,2 P Angel1 and J Hess1 1 Signal Transduction and
Growth Control, DKFZ, Heidelberg, Germany, 2 Skin Cancer Unit, DKFZ, Heidelberg,
Germany and 3 Dermatology and Center for Molecular Medicine, University, Cologne,
Germany
The malignant melanoma is a benign tumor, which arise from melanocytes that normally reside
within the basal layer of the epidermis. The development of malignant melanoma is divided into
four steps – the nevus, the radial and the vertical growth phase of primary melanoma and metas-
tasis. During normal homeostasis, melanocyte growth and behavior is tightly controlled by the
surrounding keratinocytes. The premise for the invasion of tumor cells in the surrounding tissue is
a reduced cell-adhesion, accelerated migration and degradation of the extracellular matrix. It is
known that proteases are involved in all three processes. Recently enhanced expression of the
kallikrein-related peptidase 6 (Klk6; mouse orthologue of human KLK6) was identified in advanced
tumor stages of the chemically-induced tumor model of mouse back skin and human skin cancer.
KLK6 belongs to a large family of kallikrein-related peptidases, representing secreted chymotrypsin-
and trypsin-like serine proteinases with diverse expression patterns under physiological and patho-
logical conditions, including common types of human cancer. Ectopic KLK6 expression in mouse
keratinocyte cell lines induces a spindle-like cell morphology with impaired cell-cell adhesion and
accelerates cell proliferation, migration, as well as invasion. Moreover, we found altered KLK6 pro-
tein expression in premalignant and malignant lesions of human melanomas. However, enhanced
KLK6 protein levels were not detected in melanoma cells, but in adjacent epidermal keratinocytes
and infiltrating immune cells of the tumor microenvironment suggesting a functional crosstalk
between these cell types and a potential paracrine role of the secreted proteinase in melanoma
formation and malignant progression. This assumption was supported by enhanced KLK6 expres-
sion in mouse epidermal keratinocytes in a B16 melanoma xenotransplantation model and induced
KLK6 expression in a co-culture model of human keratinocytes and melanoma cells.
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Protein phosphatase 1 is required for extracellular calcium-induced keratinocyte differenti-
ation
Z Xie, SD Pennypacker and DD Bikle Endocrine Unit, VA Medical Center, NCIRE and UCSF,
San Francisco, CA
Extracellular calcium (Cao) is a major regulator of keratinocyte differentiation in vitro, and appears
to play that role in vivo, but the mechanism is not well understood. We have previously demon-
strated that following calcium stimulation, phosphatidylinositol 4-phosphate 5-kinase 1α (PIP5K1α)
is recruited by the E-cadherin-catenin complex to the plasma membrane where it provides the
substrate phosphatidylinositol 4,5-bisphosphate for both phosphatidylinositol 3-kinase and phos-
pholipase C-γ1 (PLC-γ1). This signaling pathway is critical for Cao-induced generation of the sec-
ond second messengers inositol triphosphate and intracellular calcium and keratinocyte differen-
tiation. In this study we sought to determine the upstream regulatory mechanism by which calcium
activates PIP5K1α and the role of this activation in calcium-induced keratinocyte differentiation.
We found that treatment of human keratinocytes in culture with 1.2 mM Cao resulted in an increase
in serine dephosphorylation of PIP5K1α. This dephosphorylation occurs as early as 5 min follow-
ing the addition of calcium and is accompanied by increased activity of PIP5K1α. Knockdown of
protein phosphatase 1 (PP1) in human keratinocytes blocked Cao-induced increases in serine
dephosphorylation and activity of PIP5K1α, and induction of keratinocyte differentiation markers
keratin 1, involucrin and transglutaminase 1. Knockdown of PLC-γ1, the downstream effector of
PIP5K1α, in these cells blocked upstream dephosphorylation and activation of PIP5K1α induced
by Cao. Co-immunoprecipitation revealed that Cao induced recruitment of PP1 to the E-cadherin-
catenin-PIP5K1α complex in the plasma membrane. These results indicate that PP1 is recruited to
the Cao-dependent E-cadherin-catenin-PIP5K1α complex in the plasma membrane to activate
PIP5K1α, which is required for PLC-γ1 activation leading to keratinocyte differentiation. Activated
PLC-γ1 induces a feed-forward circuit that is responsible for the activation of PIP5K1α to maintain
signaling necessary for differentiation.
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Inhibition of Propionibacterium acnes-induced inflammation by a selective inhibitor of p38α
mitogen-activated protein kinase.
L Zhang, W Li, P Lyte, D Cavender, M Southall and M Eisinger Skin Research Center, Unit of
Johnson and Johnson Consumer Companies, Inc., Skillman, NJ
The outermost layers of human skin, mostly composed of epidermal keratinocytes, provide a pro-
tective barrier to various external stimuli. P. acnes, an ubiquitous skin bacterium, stimulates ker-
atinocytes to produce a number of proinflammatory cytokines and is believed to be a significant
contributing factor to the inflammatory stage of acne. In the current set of experiments, exposure
of in vitro cultures of human keratinocytes to live P. acnes resulted in rapid phosphorylation of mul-
tiple members of the MAPK family; Western blot analyses demonstrated that both p38 and ERK1/2
were rapidly, but transiently, phosphorylated, while there was a relatively slow but sustained
phosphorylation of JNK1/2. Increased secretion of interleukin-1α (IL-1α), tumor necrosis factor-α
(TNF-α), and IL-8 was documented by ELISA. Phosphorylation of p38 and production of cytokines
were inhibited by SCIO-469, a relatively selective inhibitor of the α isoform of p38. SCIO-469 also
inhibited P. acnes-induced infiltration of neutrophils into the skin in a mouse model of bacterial-
induced inflammation. In a second in vivo model, P. acnes-induced inflammation in human
skin/SCID mouse chimeras, SCIO-469 inhibited the increased phosphorylation of p38 in human
keratinocytes. Finally, increased levels of activated p38 were observed in acne lesions from human
patients, predominantly in follicular and perifollicular keratinocytes. These data indicate that P.
acnes may contribute to the inflammatory responses observed in acne patients, and that p38 may
be an excellent therapeutic target for inflammatory acne.
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Rho-mediated regulation of Ca2+-induced cell-cell adhesion and differentiation in keratinocytes
C Tu, W Chang and D Bikle VA Medical Center, San Francisco, CA
Extracellular Ca2+ (Ca2+o) induces E-cadherin mediated cell-cell adhesion, which is critical for coor-
dinating cellular signals mediating cell survival and differentiation in keratinocytes. Previous stud-
ies indicate that E-cadherin-mediated cell-cell adhesion and differentiation are regulated by the
calcium-sensing receptor (CaR) via Fyn tyrosine kinase–mediated signaling. Besides the Fyn/Src
tyrosine kinases, Rho-like GTPases are implicated as positive regulators of E-cadherin-mediated
cell-cell adhesion. To determine whether Rho is a part of the CaR-mediated signaling cascade, we
examined whether Ca2+o activates Rho and the impact of CaR knockdown on endogenous Rho
activity. Raising [Ca2+]o to 2 mM rapidly induced membrane-translocation of CaR and Rho to
adherens junctions (AJ) and increased endogenous Rho activity. Inactivation of CaR gene by expres-
sion of a CaR antisense cDNA inhibited these processes, indicating the importance of CaR in acti-
vation of the Rho pathway. To define the role of Rho in the E-cadherin-mediated cell-cell adhe-
sion, we examined the effect of Rho inactivation on AJ formation. Selectively silencing Rho A
expression by siRNA suppressed the Ca2+-induced membrane translocation and complex forma-
tion of E-cadherin, β-, γ-, and p120-catenin, blocked the Ca2+-induced activation of Fyn, and con-
sequently inhibited the ability of Ca2+o to promote the tyrosine phosphorylation of β-, γ-, and
p120-catenin, an essential step for the formation of adhesion complex. Furthermore, Rho A silenc-
ing suppressed the Ca2+-induced expression of terminal differentiation markers, signifying the impor-
tance of Rho- and E-cadherin-mediated signaling for differentiation. Finally, pull-down assays
demonstrated that CaR, Rho and E-cadherin formed a signaling complex at the cell membrane via
the scaffolding protein filamin in response to elevated Ca2+o, suggesting that CaR activates Rho
through direct protein interaction. These results indicate that Rho is a downstream mediator of
CaR and upstream of Fyn in the regulation of Ca2+-induced E-cadherin mediated cell-cell adhe-
sion and keratinocyte differentiation.
552
Neutrophil-dominant psoriasis-like skin inflammation induced by epidermis-specific Raf
expression in mice
M Tarutani,1 Y Imai,2 T Tsuda,1 K Nakanishi2 and K Yamanishi1 1 Dermatology, Hyogo College
of Medicine, Nishinomiya, Japan and 2 Immunology and Medical Zoology, Hyogo College of
Medicine, Nishinomiya, Japan
Raf is one of the downstream effectors of signal transduction mediated by Ras GTPases. In trans-
genic mice bearing the 4-hydroxytamoxifen (4OHT)–responsive mutant ER ligand binding domain-
Raf fusion gene under the control of keratin 14 promoter, the epidermis-specific Raf expression
induced by topical 4OHT application caused not only epidermal hyperplasia but also neutrophil-
dominant inflammation of the skin. The expression of IL-18, IL-15 and MCP-1 and the infiltration
of inflammatory cells into the skin were observed as early as 8 hr after the treatment. Administra-
tion of an anti-Gr-1 antibody reduced the numbers of those infiltrating cells and partially reversed
the epidermal hyperplasia. These results suggest that Raf might be involved in the formation of
psoriasiform skin inflammation via the recruitment of Gr-1 positive cells.
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Constitutive activation of STAT5A regulates the expression of VEGF family in human ker-
atinocytes
H Kim, H Lee, J Yang and G Park Dermatology, Sungkyunkwan University Samsung Medical
Center, Seoul, Korea, South
STAT (signal transducers and activators of transcription) family is involved in cytokine signal trans-
duction pathways controlling inflammation and immune response. Among the seven members of
family, STAT5 activation is involved in prolactin dependent casein production in mammary gland
cells. In this study, we examined the functional consequences of STAT5a activation in human ker-
atinocytes. Immunohistochemical analyses showed that activated form of STAT5a resulted from
phosphorylation and translocation to the nucleus, was found in hyperplastic epidermis such as
psoriasis, but, not in the normal epidermis. GMCSF and IFNgamma triggered the activation of
STAT5 in human keratinocytes. We established HaCaT, transformed human keratinocytes, cell
line expressing constitutive activated form of STAT5a. With this cell line, we analyzed the expres-
sion levels of cytokine expression using the cytokine array analysis. The result revealed that the
released VEGF protein level was dramatically induced in the established cells. RTPCR analysis on
stable cell line showed the induced levels of VEGFA, and VEGFC mRNA. Constitutive activation
of STAT5A increased the promoter activity of VEGFA and VEGFC, which include the putative
STAT5A binding site. And alternatively, MAPK signaling pathways involved in this regulation. These
results suggest that STAT5a activation triggered by cytokines, such as GMCSF and IFNgamma in
human keratinocytes involve in the regulation of VEGF expression and might participate in the
pathogenesis of inflammatory diseases of epidermis.
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The direct binding of insulin-like growth factor-1 (IGF-1) to integrins plays a role in IGF sig-
naling
S Yamaji, J Saegusa, K Ieguchi, YK Takada and Y Takada Dermatology, University of California
Davis School of Medicine, Sacramento, CA
Insulin-like growth factor 1 (IGF-1) is one of the major regulators of cellular proliferation and dif-
ferentiation in skin. IGF-1 acts through binding to the type I IGF receptor (IGF-IR), a receptor tyro-
sine kinase. Integrins are a family of cell adhesion receptors that mediate cell-extracellular matrix
interaction and cell-cell interaction. It has been proposed that ligand occupancy of integrin αvβ3
with extracellular matrix ligands (e.g., vitronectin) plays a critical role in IGF-1 signaling. We demon-
strated that αvβ3 specifically bound to IGF-1. We localized the amino acid residues of IGF-1 that
are critical for integrin binding by docking simulation and mutagenesis. We found that a mutation
in the C-domain of IGF-1 effectively reduced integrin binding. Interestingly, the mutant was defec-
tive in inducing IGF-1R phosphorylation, AKT and ERK1/2 activation, and in inducing cell prolif-
eration, while the mutant still bound to IGF-1R. Notably we demonstrated that the mutant sup-
pressed proliferation of NIH 3T3 cells induced by WT IGF-1, suggesting that it is a dominant-negative
mutant. These results suggest that the direct binding to IGF-1 to integrin αvβ3 plays a role in IGF-
1 signaling, and integrin-IGF-1 interaction is a novel target for drug discovery.
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VEGF decrease adhesion of HaCaT cells through activation of MAP kinases and inhibition
ofα6β4 integrin expression
S Cai, C Li, W Li, J Zhou, X Man, X Yang and M Zheng Dermatology, Second Affiliated
Hospital, Zhejiang University, School of Medicine, Hangzhou, China
Cell adhesion is an important process during morphogenesis, differentiation and homeostasis in
cell biology. In our previous study, we found significant decrease of the adhesion of HaCaT (Human
keratinocyte cell line ) cells induced by vascular endothelial growth factor (VEGF), but the exact
mechanism remains unclear. Since integrins play important roles in cell–matrix interaction and
regulation of cell adhesion, further study on whether VEGF affects expression of these adhesion
molecules on HaCaT cells were therefore examined. The results showed that abundant and con-
stitutive integrins such asα2β1, α3β1,α6β4 and etc.were expressed on both mRNA and protein
level respectively on HaCaT cells by RT-PCR and westing blotting assay. We further investigate
whether VEGF could affect the protein expression of these integrins on HaCaT cells during the
adhesion process. Results from the western bloting analysis showed that VEGF significantly decreased
the expression of adhesion molecules of α6β4 integrin at 4h and regressed to the base line at 12h.
However, the protein expression ofα2,α3 andβ1 integrin subunits could not be downregulated by
VEGF. We further explored the MAPK signal transduction pathways in HaCaT cells induced by
VEGF. Enhanced phosphorylation of ERK1/2 by VEGF was found as early as 5 min and sustained
at 15 min, but regressed to the baseline at 30 min. VEGF could also phosphorylate JNK from 15
min after stimulation, which reached the maximal level at 45min, as in comparison to cells with-
out VEGF (0 min). The activation sustained until 90 min. However, VEGF did not induce phos-
phorylation of p38. These results suggest that VEGF may decrease HaCaT cells adhesion through
inhibition ofα6β4 integrin expression and activation of MAP kinases.
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Effect of bevacizumab on proliferation, migration, adhesion and apoptosis in HaCaT cells
C Li, W Li, X Yang, X Man, S Cai and M Zheng Dermatology, Second Affiliated Hospital,
Zhejiang University, School of Medicine, Hangzhou, China
Vascular endothelial growth factor (VEGF) is expressed and secreted by epidermal keratinocytes
and overexpressed in skin disorders such as psoriasis. Our previous study showed VEGF increased
proliferation and migration of HaCaT cells and decreased their adhesion ability. Bevacizumab is
a VEGF monoclonal antibody which inhibits the signal transduction of VEGF receptors via directly
binding with VEGF. Since VEGF can alter the biological function of epidermal keratinocytes and
HaCaT cells, we therefore examined the biological effects of bevacizumab on cellular function by
using HaCaT cells in vitro. The proliferation of HaCaT cells stimulated by bevacizumab were deter-
mined by MTT assay. The effect of bevacizumab on migration of HaCaT cells was studied using
the Boyden chamber assay. Cell adhesion ability was assessed by cell adhesion assay. Annexin V-
FITC cell staining with flow cytometry analysis was used to determine early-stage apoptosis. Lad-
der formation of oligonucleosomal DNA and expression of inhibitor of CAD protein were identi-
fied for late-stage apoptosis. The results showed that bevacizumab decreased HaCaT cells
proliferation and migration in a dose-dependent manner. However, bevacizumab increased HaCaT
cells cell adhesion in a dose-dependent manner. We further explored whether bevacizumab can
induce apoptosis. Our results showed that serum-free (12h) medium induced apoptosis in HaCaT
cells. When the cells had been treated with bevacizumab at 0.5mg/ml for 12 h, the percentage of
HaCaT cells apoptosis was significantly increased to 11.3% from 3.52% in the group with serum
deprivation. Ladder formation of oligonucleosomal DNA and reduced expression of ICAD ( inhibitor
of CAD) protein were identified in HaCaT cells treated with 0.5mg/ml bevacizumab for 24h.
These findings may help us understand the biological activity of bevacizumab on HaCaT cells,
and provide evidence that bevacizumab may be a promising therapeutic agent for the treatment
of inflammatory skin diseases like psoriasis.
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Cyclic AMP suppresses TNF-alpha-induced matrix metalloproteinase-1 expression through
inhibition of MAPK and GSK-3beta
C Park, Y Moon, C Shin and J Chung Department of Dermatology, Seoul National University
College of Medicine, Laboratory of Cutaneous Aging Research, Clinical Research Institute,
Seoul National University Hospital; Institute of Dermatological Science, Medical Research
Center, Seoul National University, Seoul, Korea, South
Matrix metalloproteinase-1 (MMP-1) has been shown to play an important role in various physio-
logical and pathological processes. The expression of MMP-1 is stimulated by various stimuli includ-
ing tumor necrosis factor (TNF)-alpha. Although many studies have shown that mitogen-activated
protein kinase (MAPK) pathways are critical in the MMP-1 expression, other signaling pathways
are also likely to regulate MMP-1 expression. Cyclic AMP (cAMP) is widely known to act as a sec-
ond messenger for a variety of extracellular stimuli and to be involved in the regulation of cell pro-
liferation, apoptosis, and inflammatory reactions. Here we investigated the effect of cAMP eleva-
tion on TNF-alpha-induced MMP-1 expression and the molecular mechanisms involved in the
process in human skin fibroblasts. TNF-alpha-induced MMP-1 expression was suppressed by sev-
eral cAMP-elevating agents in a dose-dependent manner and the inhibition of MMP-1 expression
by cAMP was mediated through protein kinase A (PKA) pathway. Furthermore, we found that
cAMP/PKA pathway inhibited TNF-alpha-induced activation of ERK and JNK which played an
important role on MMP-1 expression. However, our further studies indicated that there might be
other targets which mediate cAMP-mediated suppression of MMP-1 expression. Then we found
that glycogen synthase kinase-3 (GSK-3) beta was inactivated by cAMP/PKA pathway and that GSK-
3beta played a critical role in TNF-alpha-induced MMP-1 expression. In addition, overexpression
of a constitutively active mutant form, but not of the wild type, of GSK-3beta abolished the cAMP-
mediated suppression of TNF-alpha-induced MMP-1 expression, independent of the regulation of
ERK and JNK by cAMP. Taken together, our results show that cAMP/PKA pathway may suppress
TNF-alpha-induced MMP-1 expression through inhibition of GSK-3beta as well as ERK and JNK.
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Promotion of stem cell proliferation by vegetable peptone
J Lee, J Lee, E Jung, S Huh and D Park Skin Disease Research Team, Biospectrum Life Science
Institute, Gunpo, Korea, South
Technical limitations and the evolution of therapeutic applications for cell culture-derived prod-
ucts have accelerated the elimination of animal-derived constituents from such products to mini-
mize inadvertent introduction of microbial contaminants, such as fungi, bacteria or viruses. This
study was conducted to investigate the proliferative effect of vegetable peptone on adult stem cells
in the absence of serum and its possible mechanisms of action. Cell viability and proliferation
were determined by MTT assay and a Click-iT EdU flow cytometry assay, respectively. In addition,
changes in the expression of cytokine genes were analyzed using a MILLIPLEX Human cytokine
ELISA kit. The viability of cord blood-derived mesenchymal stem cells (CB-MSCs) and adipose-
derived stem cells (ADSCs) treated with peptone increased significantly. In addition, the median
value of the group treated with peptone shifted to the right when compared with the untreated
control group. Furthermore, quantitative analysis of the cytokines revealed that the production of
vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF-β), and interleukin-
6 (IL-6) increased significantly in response to treatment with vegetable peptone in both CB-MSCs
and ADSCs. Our findings revealed that vegetable peptone promotes the proliferation of CB-MSCs
and ADSCs. In addition, the results of this study suggest that the induction of stem cell prolifera-
tion by vegetable peptone is likely related to its induction of VEGF, TGF-β, and IL-6 expression.
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Chronic heat treatment induced skin wrinkling, MMP-13 expression and depletion of antiox-
idant enzymes in hairless mice
M Shin, J Jung, J Seo, Y Kim and J Chung Seoul National University College of Medicine, Seoul,
Korea, South
We have shown previously that heat shock could induce expressions of matrix metalloproteinases
(MMPs) via activation of MAPKs pathways in skin cells. These results implicated that chronic heat
treatment may cause skin aging. Therefore, in present study, we investigated the effects of chronic
heat treatment (43°C, 30min, 3 times/week, 6weeks) on skin aging in the hairless mice. We found
that chronic heat treatment induced skin wrinkles after the 6 weeks of heat exposure in hairless
mice. Histologically, heat treatment increased the thickness of the epidermis and dermis. And the
repetitive heat treatment increased the expression of MMP-13 protein and mRNA significantly, but
not MMP-2 and -9 expression in hairless mouse skin. Furthermore, we investigated whether chronic
heat treatment altered the antioxidant enzymes in the mouse skin tissue or not. The activities of
antioxidant enzymes, including catalase and superoxide dismutases (SOD), were reduced by chronic
heat treatment. Oxidative damage such as protein oxidation was slightly increased in skin of chronic
exposure to heat shock. Taken together, our results suggested that chronic heat exposure to the
skin can cause the skin wrinkling and skin aging. And, alterations of antioxidants enzymes by heat
treatment may play an important role in the development of heat shock-induced skin aging.
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Anthralin inhibits store-operated calcium entry and STIM1 translocation through a super-
oxide-dependent mechanism
S Milner, K Ross and NJ Reynolds Newcastle University, Newcastle upon Tyne, United
Kingdom
The normal calcium gradient across epidermis is lost in psoriasis and store operated calcium entry
(SOCE) is dysregulated in cultured psoriatic keratinocytes (Karvonen SL et al, J Invest Dermatol
2000 114:693-700). Anthralin is an effective topical drug which localises to mitochondria, inter-
feres with electron flow at the level of the ubiquinone pool and disrupts mitochondrial membrane
potential (McGill A et al, FASEB J 2005 19:1012-1014). As mitochondria play a key role in the reg-
ulation of SOCE, we investigated the effect of anthralin on intracellular calcium ([Ca2+]i) signalling
and SOCE. Live cell confocal imaging of Fluo-4 loaded HaCaT keratinocytes showed that anthralin
inhibited store operated calcium entry (SOCE) induced by UTP or thapsigargin by 81% and 51%
respectively. In contrast, dithranol did not affect the amount of Ca2+ discharged from the endo-
plasmic reticulum (ER). On release of Ca2+ from the ER, STIM1 translocates to the plasma mem-
brane, and associates with the channel protein Orai1 to mediate SOCE. Anthralin significantly
inhibited the translocation of STIM1 and its subsequent association with Orai1. Neither anthrone
or danthrone, two clinically ineffective analogues, inhibited thapsigargin-induced translocation of
STIM1. Oxidation of anthralin results in the formation of reactive oxygen species. Live cell imag-
ing of MitoSox-loaded cells showed that anthralin induced a 292% increase in mitochondrial super-
oxide over 45 min. Notably, pre-treatment with Tiron, a superoxide dismutase mimetic, inhibited
anthralin-induced superoxide formation and restored STIM1 translocation and SOCE in the pres-
ence of anthralin. These data implicate superoxide in the regulation of STIM1 translocation and
SOCE and the relative specificity of anthralin compared to anthrone or danthrone suggests that
inhibition of STIM1 translocation may be relevant to the therapeutic mode of action of anthralin.
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Genetic deletion of Egfr delays catagen entry associated with defective cell cycle regulation
KJ Bichsel, D Porto, C Foote and LA Hansen Biomedical Sciences, Creighton University,
Omaha, NE
Treatment of cancer patients with epidermal growth factor receptor (EGFR) inhibitors causes peri-
follicular inflammation in the skin. Analysis of mouse models with deficient EGFR signaling pre-
dicted this folliculitis and revealed that abrogation of EGFR disrupts hair follicle cycling. The mech-
anisms through which EGFR regulates the hair cycle were investigated using a skin-targeted Egfr
mutant model (Egfr fl/fl/K14 Cre recombinase+ mice), which has reduced Egfr expression in the cuta-
neous epithelium. Hair cycle stage was assessed in Egfr mutant and littermate control skin obtained
at daily time points between 14d and 21d. Histological examination of these samples revealed syn-
chronous catagen onset at 17d in the control mice. In contrast, mutant follicles asynchronously
entered catagen between 18 and 20d. Follicular proliferation, as measured by bromodeoxyuridine
incorporation, ceased by 18d in control skin, but was maintained in mutant skin. Phospho-histone
H3 immunofluorescence indicated follicular bulb cells accumulated in late G2 and M phases prior
to the cessation of DNA synthesis in control but not mutant mice. To identify EGFR-dependent sig-
naling regulating cell division in catagen, transcriptional profiling was performed in Egfr mutant
and control hair follicles at 17d, the time of normal catagen onset, using follicular RNA obtained
from laser capture microdissection. In silico analysis of these data identified 88 genes that were
significantly altered, including genes that regulate proliferation, differentiation, and inflammation.
Three cell cycle related genes; Nupr1, Rcc2, and Sfi1; were upregulated by 2.3, 1.6, and 1.9 fold,
respectively, in Egfr mutant follicles. Real time RT-PCR was used to validate changes in gene expres-
sion. These data reveal EGFR-mediated signaling triggers catagen entry by regulating cell cycle pro-
gression in the hair follicle.
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Nerve growth factor, brain-derived neurotrophic factor and their high-affinity receptors are
overexpressed in extramammary Paget’s disease
S Takeuchi,1 Y Qian,1,2 S Chen,1,2 L Dugu,1 G Tsuji,1 T Nakahara,1 Y Moroi,1 Y Tu2 and M Furue1
1 Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan and
2 Dermatology, Union Hospital, Tongji Medical College, Huazhong University of Science and
Technology, Wuhan, China
Nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and their high-affinity recep-
tors (TrkA and TrkB, respectively) appear to play important roles in the pathogenesis of several
tumors, but their expressions in extramammary Paget’s disease (EMPD) have not been investigated
yet. Thus, the purpose of the study is to investigate the possible contribution of the major neu-
rotrophins/receptors to the development of EMPD. Thirty-four paraffin-embedded EMPD speci-
mens were subjected to immunohistochemical staining for NGF, BDNF, TrkA, TrkB, and the com-
mon low-affinity receptor, p75 neurotrophin receptor (p75NTR). The immunohistochemical analysis
revealed that all the 34 EMPD specimens, including 13 dermal invasive EMPD and 2 lymph node
metastasis (LNM), showed cytoplasmic overexpression of NGF, BDNF, TrKA and TrKB. The expres-
sion level (% positive cells) of NGF, BDNF, TrKA and TrKB in EMPD (78.3±20.8%, 84.4±11.4%,
83.0±14.4% and 86.2±11.7%, respectively) were significantly higher than in normal skin (21.6±6.5%,
27.6±4.5%, 25.0±5.3% and 25.4±6.4%). The expression level of NGF, BDNF, TrKA and TrKB in
invasive EMPD with LNM (92.2±11.2%, 93.8±4.3%, 95.8±3.2% and 95.8±2.4%, respectively) and
in invasive EMPD without LNM (85.0±11.8%, 90.3±7.9%, 88.1±8.4% and 90.2±7.8%) were sig-
nificantly higher than in non-invasive EMPD (74.1±13.6%, 77.7±8.5%, 75.8±13.9% and
80.5±11.3%) and the expression level tended to be associated with tumor stage of EMPD. Inter-
estingly, Paget cells were utterly negative for p75NTR in all the 34 EMPD, while keratinocytes,
mostly those of epidermal basal layer, were positive for p75NTR (17.7±5.0%). These results indi-
cate that overexpression of NGF, BDNF and their major high-affinity receptors and the absence of
p75NTR may play a role in the pathogenesis of EMPD.
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CD109, a TGF-β co-receptor, regulates TGF-β receptor internalization and degradation in
keratinocytes
AA Bizet,1 K Liu,1 N Tran-Khanh,2 A Saksena,1 M Buschmann2 and A Philip1 1 Surgery, McGill
Unversity, Montreal, QC, Canada and 2 Chemical Engineering, Ecole Polytechnique,
Montreal, QC, Canada
Tranforming Growth Factor β (TGF-β) is a multifunctional cytokine that plays a critical role in cell
growth, differentiation and extracellular matrix synthesis. Disruption of its action has been impli-
cated in several human disorders such as impaired wound healing and hypertrophic scarring. TGF-
β signals through the type I and type II receptors. These receptors internalize via two distinct com-
partments: the clathrin-coated pits which facilitates Smad-mediated signaling, and the caveolae,
which is associated with receptor degradation. Little is known regarding the factors regulating TGF-
β receptor compartmentalization and turnover. Previously, we have reported the identification of
CD109, a GPI-anchored protein that binds TGF-β 1 and forms a complex with the TGF-β signal-
ing receptors in keratinocytes. In addition, CD109 inhibits TGF-β signaling and responses in vitro.
Therefore, we explored the possibility that CD109 regulates TGF-β action by promoting TGF-β
receptor internalization into caveolae, thereby targeting TGF-β receptor for degradation. In ker-
atinocytes, we demonstrate that CD109 associates and co-localizes with caveolin, a key compo-
nent of the caveolae. Furthermore, CD109 promotes compartmentalization and internalization of
TGF-β receptor into the lipid-raft/caveolae. In addition, we show that CD109 enhances TGF-β
receptor degradation by the proteasome system, and that CD109 effects such as inhibition of TGF-
β -induced Smad signaling and fibronectin expression require TGF-β receptor degradation. Taken
together, our findings indicate that CD109 negatively regulates TGF-β signaling by promoting TGF-
β receptor internalization and degradation. In conclusion, CD109, by its ability to downregulate
TGF-β signaling receptors, is a promising target for the manipulation of TGF-β action in the skin
to improve wound healing outcome.
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EphA2-mediated cell-cell communication regulates human keratinocyte differentiation
SY Lin,1 LJ Sheu,1 KS Bryce,1 F Shahijanian,2 D Deb-Basu,2 DL Hirschberg,2 RM Lavker1 and
S Getsios1 1 Dermatology, Northwestern Univ., Chicago, IL and 2 Immunity, Transplant.,
Infection, Stanford Univ., Stanford, CA
EphA2 is a major epithelial receptor tyrosine kinase (RTK) that becomes activated by ephrin lig-
ands residing on adjacent cell surfaces. Normal human epidermal keratinocytes (NHEKs) abun-
dantly express EphA2 and ephrins but downregulate these juxtamembrane signaling complexes
upon terminal differentiation. These observations prompted us to test whether EphA2 transmits
signals between neighboring keratinocytes that control entry into terminal differentiation. In sup-
port of this possibility, EphA2 was rapidly recruited to nascent cell-cell contacts in a manner that
required E-cadherin-mediated adhesion. To define downstream signals specifically triggered by
EphA2, we incubated NHEKs with recombinant ephrin-A1 ectodomain peptides (efnA1-Fc) in low
calcium to limit the contribution of alternative juxtamembrane signaling pathways. EphA2 stimu-
lation led to a marked suppression of MAPK-Erk1/2 phosphorylation as revealed by conventional
immunoblotting techniques or with a novel, sensitive and quantitative nano-immunoassay system
(FireflyTM, Cell Biosciences) that combines isoelectric focusing with antibody-based detection. Pro-
longed incubation with efnA1-Fc caused receptor-mediated endocytosis resulting in a loss of EphA2
expression. To sustain these signaling complexes over extended time periods in differentiating
NHEKs, EphA2 was ectopically overexpressed in organotypic raft cultures of human epidermis. In
comparison to EGFP controls, forcing high levels of EphA2 reduced markers of differentiation, such
as keratin 10 and desmoglein 1. The kinase activity of this membrane receptor was most likely
responsible for these defects as a broad spectrum tyrosine kinase inhibitor (dasatinib) restored dif-
ferentiation in EphA2 overexpressing raft cultures. Collectively, our studies reveal a key role for
EphA2 in maintaining the differentiated state of keratinocytes, possibly through the coordination
of MAPK-Erk1/2 signaling.
S94 Journal of Investigative Dermatology (2009), Volume 129
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Induction of apoptosis of human melanoma cells through modulation of Wnt/NF-κB sig-
naling by a dietary triterpene lupeol
RS Tarapore, IA Siddiqui, M Saleem and H Mukhtar Dermatology, University of Wisconsin -
Madison, Madison, WI
A third of melanomas exhibit constitutive activation of Wnt signaling and this subset has very poor
prognosis. Recently, we demonstrated that suppression of Wnt signaling caused inhibition of NF-
κB signaling resulting in the apoptosis of human melanoma cells (Oncogene 27; 5069-74, 2008)
suggesting that targeting Wnt signaling could be a promising strategy for arresting the growth of
these human melanoma subtypes. We recently showed that Lupeol, a dietary triterpene signifi-
cantly decreases the viability of malignant melanoma cells while sparing normal melanocytes (Clin
Cancer Res 14; 2119-27, 2008). Current study was designed to investigate the effect of Lupeol on
Mel 928, Mel 1241 and Mel 1011 melanoma cells exhibiting varied Wnt status. Though Lupeol
inhibited the growth of all cells, the inhibitory effect was more pronounced in Mel 928 cells
which harbor constitutive Wnt activation. The inhibitory effect of Lupeol on clonogenic potential
of Mel 928 was more significant than in Mel 1011 cells. Lupeol was observed to cause a decrease
in the protein levels of downstream targets of Wnt, viz., CRD-BP, c-myc and MITF in melanoma
cells. Further, Lupeol inhibited the transcriptional activation of TCF responsive element (TOP-Flash),
a marker for Wnt signaling. Lupeol caused a decrease in nuclear β-catenin levels suggesting that
it inhibits the translocation of β-catenin to the nucleus, thus inhibiting the activation of downstream
Wnt targets. Since an association of Wnt signaling with NF-κB was previously established, we
next determined the effect of Lupeol on NF-κB signaling in melanoma cells. Lupeol caused a
decrease in the levels of BCl-2 protein and inhibited the translocation of p65-subunit of NF-κB to
the nucleus. Overall these data suggest that modulation of Wnt/NF-κB signaling by Lupeol results
in the growth inhibition and apoptosis of human melanoma cells. Lupeol could be used as a poten-
tial therapeutic agent for human melanomas exhibiting aberrations in the Wnt/NF-κB signaling
network.
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STAT4 and proliferation of epidermal keratinocytes
C Ferreli, C Pickard, S August, Y Buggy, M Ardern-Jones, PS Friedmann and E Healy
Dermatopharmacology Unit, University of Southampton, Southampton, United Kingdom
STAT proteins are a class of transcription factors which, upon phosphorylation, move from the cyto-
plasm to activate gene transcription in the nucleus. There is evidence that the STAT proteins are
expressed in human epidermis and that, in other cell types, some play a role in proliferation. Dur-
ing our initial investigations on STAT4 in keratinocytes, we observed that phosphoserine (pSer)-
STAT4 displayed a cellular distribution which varied during the cell cycle. Confocal microscopy
using markers for DNA, alpha-tubulin and pSerSTAT4 demonstrated a generalised pattern of pSer-
STAT4 staining throughout the cell from anaphase to telophase in HaCaTs and primary keratinocytes
(n=5 experiments). This differed from the localisation of phosphotyrosine (pTyr)-STAT4 which was
confined to the DNA compartment during this phase of the cell cycle. This altered pattern of pSer-
STAT4 was also observed in keratinocytes which were synchronised in mitosis using a mitotic
detachment (MD) approach and which had been halted during mitosis using the microtubule poly-
merization inhibitor, nocodazole. Fluorescence activated cell sorting (FACS) analysis demonstrated
increased levels of pSerSTAT4 and pTyrSTAT4 during M phase as compared with unsynchronised
cells. STAT4 can heterodimerise with STAT3 and STAT1, therefore the spatial expression of these
two phosphoproteins was also investigated. pSerSTAT1 was present in the DNA compartment
whereas pSerSTAT3 was throughout the cytoplasm during M phase (n=3), however, confocal
microscopy and FACS showed lower levels of pSerSTAT3 than pSerSTAT4 at this stage of the cell
cycle, suggesting that STAT4 is predominantly homodimerised during mitosis. Functional work is
continuing on the role of pSerSTAT4 during mitosis, but our in vitro observations have been repli-
cated in vivo, where we have seen increased and diffuse expression of pSerSTAT4 in mitotic cells
in normal epidermis and in cutaneous squamous cell carcinomas (n=10 cases). The data suggests
that pSerSTAT4 plays a role during mitosis of keratinocytes during normal and pathological con-
ditions.
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Physical contact appears to change nitric oxide levels in humans
VB Morhenn,1,2 J Park3 and P Zak3 1 Medicine, Division of Dermatology, UCSD, San Diego,
CA, 2 Therapeutics Clinical Research, San Diego, CA and 3 Department of Economics,
Claremont Graduate University, Claremont, CA
Knockout mice genetically incapable of producing nitric oxide (NO) are more aggressive than their
wild type littermates. The skin contains enzymes that can synthesize NO. We have found recently
that physical contact followed by a signal of trust significantly increases serum oxytocin levels in
humans as well as increasing the individuals’ willingness to sacrifice. This study sought to deter-
mine whether these results were influenced by release of NO, because the skin contains enzymes
that can synthesize NO. We compared the NO levels in individuals before and after i) receiving
a massage (N=24), ii) resting and being trusted by a stranger with real money (N=30), and iii) receiv-
ing a massage and being trusted by a stranger with real money (N=42). The trust task has been
reliably shown to induce oxytocin release. IRB approval and patient consent were obtained. Blood
was drawn from each subject at the start and the end of the procedure. In this way, the individual
served as his/her own control. Since NO is short lived and is converted to nitrate in serum, we
assayed the nitrate concentrations in the sera using the Griess reaction. We found that in both
groups receiving massages, nitrate levels decreased significantly whereas, in the individuals who
only rested and were trusted, the nitrate concentration increased significantly. We conclude that
touching/massaging inhibits the synthesis and/or release of NO. Thus, touching may influence
human behavior by changing NO levels.
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Activation of the canonical Wnt pathway in keratinocytes by Mcl-1
LA Sitailo,1 P Sethupathi2 and MF Denning1 1 Department of Pathology, Loyola University
Chicago, Maywood, IL and 2 Department of Microbiology and Immunology, Loyola
University Chicago, Maywood, IL
Mcl-1 is an anti-apoptotic Bcl-2 family member whose rapid down-regulation is required for UV
apoptosis. We recently showed that not only is Mcl-1 a major keratinocyte (KC) survival protein,
but it is required for proper KC differentiation, implicating a non-apoptotic function for Mcl-1
involved in regulating KC morphogenesis. To further explore the function of Mcl-1 in vivo, we
generated transgenic mice expressing human Mcl-1 under control of the K5 promoter. K5-Mcl-1
transgenic mice had >2-fold increase in the epidermal thickness (p<0.001), increased basal KC
BrdU incorporation, and altered expression of KC differentiation markers. In addition, several K5-
Mcl-1 mice developed benign follicular cysts. Since both proliferation and hair follicle morpho-
genesis are features of increased Wnt/β-catenin signaling, we analyzed components of the Wnt/β-
catenin pathway. K5-Mcl-1 mice had elevated phospho-GSK3β (Ser9, Ser21) and phospho-Akt
(Ser473), consistent with Wnt pathway activation. To assess Wnt pathway activation in more detail,
we over-expressed Mcl-1 in human KCs by retroviral transduction. Over-expression of Mcl-1, but
not Bcl-2 or Bcl-xL, also induced a significant increase in keratinocyte proliferation. Transduction
of Mcl-1 into human KCs increased the levels of total and active β-catenin, c-Myc, phospho-GSK-
3β, and phospho-Akt, as well as inducing TCF-4-dependent luciferase reporter activity (p<0.05).
Quantitative RT-PCR analysis of Wnt pathway genes identified Disheveled-1, Frizzled-1 and Cyclin
D3 as the most highly up-regulated genes common to both Mcl-1 transduced human KCs and K5-
Mcl-1 mice. These results demonstrate activation of the Wnt/β-catenin signaling by the Bcl-2 fam-
ily member Mcl-1. Since β-catenin signaling is activated in cutaneous squamous cell carcinomas
and involved in stem cell maintenance, this non-apoptotic function of Mcl-1 represents a novel
and potentially oncogenic role in addition to its well characterized anti-apoptotic function.
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Elucidation of the mechanisms by which SH2/SH3 adapters Nckα and Nckβ connect PDGF-
BB signaling to promote human dermal fibroblast migration
S Guan,1 J Fan,1,2 A Han,1 M Chen,1,2 D Woodley1,2 and W Li1,2 1 Dermatology and Norris
Comprehensive Cancer Center, University of Southern Califirnia, Los Angeles, CA and 2
Greater Los Angeles Veterans Administration Health System, Los Angeles, CA
PDGF-BB is a FDA-approved growth factor (Regranex), acting as a mitogen and motogen for der-
mal fibroblasts (DFs) in healing skin wound. Our laboratory studied the early signaling mechanism
by which PDGF-BB stimulates DF migration. We focused on two closely-related src-homolgy
domain (SH2 and SH3 domains) adaptor proteins, called Nckα and Nckβ. These adapters bind to
the cell membrane PDGF receptor via their C-terminal SH2 domain and interact with downstream
effectors through their N-terminal three SH3 domains, thereby connecting the PDGF receptor to
actin cytoskeleton-orchestrated cellular responses. In this study, we investigated side-by-side the
role of Nckα and Nckβ in PDGF-BB-stimulated human dermal fibroblast (HDF) migration, to address
the long-standing question of whether Nckα and Nckβ play distinct or redundant roles and how.
We report here that 1) cells expressing the PDGFRβ-Y751F mutant (preventing Nckα binding) or
PDGFRβ-Y1009F mutant (preventing Nckβ binding), 2) Murine DFs isolated from Nckα- or Nckβ-
knockout mice and 3) HDFs with RNAi knockdown of endogenous Nckα or Nckβ all failed to
migrate in response to PDGF-BB. The SH2 and middle SH3 domains were critical components of
the Nckα and Nckβ signaling. Re-introducing wild type Nckα or Nckβ genes rescued the defects
in Nckα- or Nckβ-knockout mouse DFs in a gene-specific fashion. Neither Nckα nor Nckβ was
required for PDGF-BB-stimulated activation of classical kinase pathways, including Pak1. Instead,
both Nckα and Nckβ translocated to cells’ leading edge, where Nckα appeared to mediate Cdc42
signaling for filopodium formation, whereas Nckβ mediated Rho signaling for stress fiber forma-
tion. This study elucidated the independent roles and mechanisms of action by Nckα and Nckβ in
PDGF-BB-stimulated HDF migration, which is critical for wound healing.
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The c-Jun N-terminal kinase 2 promotes human epidermal neoplasia
H Ke,1 RN Harris,1 J Coloff,1 JY Jin,1 B Leshin,1 P de Marval Miliani,1 S Tao,2 JC Rathmell,1
RP Hall1 and JY Zhang1 1 Duke University, Durham, NC and 2 Stanford University, Palo Alto,
CA
The c-Jun N-terminal Kinase (JNK) signaling cascade has been implicated in a wide range of dis-
eases, including squamous cell carcinoma (SCC). It is unclear, however, how an individual JNK
protein contributes to tumorigenesis. To address this, we transduced primary human keratinocytes
with retroviruses encoding JNK proteins along with or without oncogenic Ras, and used these cells
for in vitro cell culture analysis and in vivo skin regeneration. We found that JNK2, but not JNK1,
overcomes cell senescence induced by oncogenic Ras and couples with Ras to transform normal
human epidermal cells into malignancy with features resembling SCC. In addition, JNK2 blocks
Ras-induced NF-κB activation, while expression of exogenous RelA NF-κB subunit inhibits tumori-
genesis. In contrast to the inhibitory effect on NF-κB, JNK kinase activity is required for the Ras-
induced increase of glycolysis, an energy producing process commonly used by cancer cells. More-
over, JNK2 down regulates protein levels of CoXII, a key component of the mitochondria Cytochrome
C complex, and potentiates Ras-induced increase of glycolysis. Conversely, JNK2 inhibition by
expression of a dominant negative JNK2 mutant, shRNA-mediated gene silencing or a pharmaco-
logical inhibitor impairs anchorage-independent growth of spontaneous A431 SCC cells. These
findings indicate that JNK2 can couple with other oncogenes, such as Ras, to induce a collection
of molecular changes leading to malignancy, and thus represents a potential therapeutic target for
cancer.
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Regulation of ultraviolet irradiation induced epidermal growth factor receptor nuclear translo-
cation by Receptor Protein Tyrosine Phosphatase-kappa in human keratinocytes
Y Xu, Y Shao, J Zhou, JJ Voorhees and GJ Fisher Department of Dermatology, University of
Michigan, Ann Arbor, MI
Epidermal growth factor receptor (EGFR) plays a critical role in mediating ultraviolet irradiation
(UVR)-induced signal transduction and gene expression in human keratinocytes. Growth factor
binding to EGFR induces phosphorylation of specific tyrosine residues within its intracellular domain,
which triggers downstream signal transduction via activation of protein kinase cascades. In addi-
tion, growth factor binding induces EGFR translocation from the surface membrane to the nucleus,
where it may directly regulate gene transcription. We have investigated regulation of EGFR nuclear
translocation by UVR, in human keratinocytes. UVR stimulated rapid nuclear translocation of EGFR.
Maximal translocation occurred within 30 minutes post UVR, and resulted in a 10-fold increase
of EGFR in the nucleus, as determined by Western analysis of nuclear extracts and immunofluo-
rescence. Inhibition of EGFR tyrosine phosphorylation by specific kinase inhibitor (PD169540)
reduced UVR-induced EGFR nuclear translocation 50%. The role of specific phospho-tyrosines
was investigated by mutation to phenylalanine, which cannot be phosphorylated. Mutation of either
tyrosine 1148 or tyrosine 1173 reduced nuclear translocation 70%, while mutation of tyrosine 1068
was without effect. Receptor protein tyrosine phosphatase-kappa (RPTP-κ) specifically dephos-
phorylates EGFR tyrosines 1068, 1148 and 1173. Over-expression of RPTP-κ significantly decreased
UVR-induced EGFR nuclear translocation. This inhibition by RPTP-κ was abrogated by mutation
of tyrosine 1173, but not altered by mutation of tyrosine 1068. These data demonstrate that UVR
stimulates rapid EGFR nuclear translocation, which is dependent on phosphorylation of specific
EGFR tyrosine residues. Dephosphorylation of EGFR by RPTP-κ regulates both protein kinase cas-
cade-dependent and nuclear translocation-dependent signaling, which act in concert to mediate
UVR-induced responses in human keratinocytes.
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Downregulation of Src-family tyrosine kinases by Srcasm: the role of Grb2 and TSG-101
L Zhou, E Ayli, C Marshall, W Li, T Griffin, T Salah and J Seykora Dermatology, Univ. of Penn.,
Philadelphia, PA
Src-family tyrosine kinases (SFKs) are important regulators of cell growth and differentiation, and
cellular SFK activity is tightly regulated to prevent neoplasia. Although increased SFK activity is
prevalent in human neoplasia, activating mutations of SFKs are rarely found, suggesting that mech-
anisms for downregulating native SFKs may be important for inhibiting neoplasia. Srcasm is a Src
kinase substrate that downregulates Fyn and Src in a lysosomal-dependent manner that requires
kinase activity and Srcasm phosphorylation. In this study, we perform a structure-function analy-
sis to identify Srcasm mutants that are more efficient in downregulating SFKs than native Srcasm.
Srcasm contains conserved binding sites for Grb2, a regulator of EGF-dependent signaling, at tyro-
sine 392, and two binding sites for TSG-101, a regulator of multi-vesicular body function, in its
178PTAP and 310PSAP motifs. In this study, the ability of the following Srcasm mutants to down-
regulate Fyn, Src, and EGF-depedendent signaling is studied: Y392F, 178PTAP to 178AAAP, 310PSAP
to 310AAAP, and 178PTAP to 178AAAP/ 310PSAP to 310AAAP. The Srcasm Y392F molecule is 3-
5 fold more efficient in downregulating Fyn and Src relative to native Srcasm. The Srcasm Y392F
mutant also inhibits EGF-dependent phosphorylation of Akt and Erk 1/2 more strongly than native
Srcasm. The 178PTAP to 178AAAP and 310PSAP motif to 310AAAP Srcasm mutants downregu-
late Fyn, Src, and EGF-dependent signaling in a manner similar to native Srcasm. However, the
double mutation of 178PTAP to 178AAAP/ 310PSAP to 310AAAP yielded a Srcasm mutant that
markedly downregulated Fyn and Src to near undetectable levels. This mutant was the most potent
inhibitor EGF-dependent activation of Akt and Erk 1/2. These data demonstrate that there are mul-
tiple mutants of Srcasm that are more potent inhibitors of Src kinases and EGF-dependent signal-
ing and also implicate Grb2 and TSG-101 in regulating Srcasm function. Such Srcasm mutants may
function as potent anti-oncogenes in in vivo carcinogenesis models.
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Inhibition of human keratinocyte growth by amphiregulin-specific shRNA cannot be reversed
by EGFR ligands
SW Stoll, L Rittié and JT Elder Dermatology, University of Michigan, Ann Arbor, MI
Hyperactive autocrine EGFR signaling characterized by increased expression of multiple EGFR
ligands including amphiregulin (AREG), HB-EGF and TGF-α has been implicated in various skin
conditions, however it is still unclear why the EGFR signaling network relies on more than one lig-
and. We have previously shown that self-sustained KC proliferation and ERK phosphorylation can
be selectively blocked by antibody-mediated neutralization of secreted AREG and by shRNA-medi-
ated AREG knockdown. In this study, we asked whether we could override the growth inhibition
in response to AREG neutralization or knockdown by treating KC with EGFR ligands. Stable cell
lines of immortalized N-TERT KC with tetracycline (TET)-inducible expression of AREG shRNA
were plated at 1000 cells/cm2 and incubated for 6-8 days in basal KSFM medium +/- TET with and
without various EGFR ligands (AREG 10-100 ng/ml; EGF, EPGN, HB-EGF and TGF-α 2-20 ng/ml).
In the absence of TET, none of the EGFR ligands improved KC cell number (≤ 101.4 +/- 6.6% of
control with 100 ng/ml AREG; mean +/- SEM, n=5). TET-induced expression of AREG shRNA sig-
nificantly reduced AREG mRNA to 12.3 +/- 4.9% (p<0.05, n=6) and cell growth to 7.5 +/- 1.8%
of untreated controls (p<0.0001, n=8). Surprisingly, KC growth in AREG knockdown cells was
strongly inhibited, even in the presence of EGFR ligands (2-8% of controls, n=2-5). Interestingly,
addition of ligands to AREG knockdown cells markedly changed KC morphology with the appear-
ance of large, multinucleated cells. Treatment of N-TERT-KC with 5 μg/ml AREG neutralizing Abs
inhibited growth (60 +/- 5.3% of controls, n=4), with no further inhibition at 10 or 20 μg/ml. In
contrast, addition of 2 ng/ml EGF to cultures treated with 5–20 μg/ml anti-AREG markedly improved
cell growth (98.2 +/- 6.3% of control, n=5) and strongly reduced the appearance of differentiated
cells observed in cultures incubated with antibody alone. Taken together, our data strongly sug-
gest an important function of endogenous AREG precursor protein in the regulation of KC growth
and cell cycle progression.
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Small molecule suppression of ganglioside synthesis enhances keratinocyte wound healing
by promoting insulin and epidermal growth factor receptor
AS Paller, S McDaniel, N Gatla, A Arora, H Iordanov and X Wang Dermatology, Northwestern
University, Chicago, IL
Obesity and diabetes are major risk factors for impaired wound healing via insulin resistance.
Ganglioside GM3 is a critical intermediate in cytokine-induced insulin resistance in adipocytes.
We have recently found that the expression of GM3 synthase and its product, GM3, is increased
in the skin of ob/ob and high fat diet-induced diabetic mice in comparison with lean controls. Given
our previous demonstration that GM3 inhibits epidermal growth factor receptor (EGFR) activation
in carcinoma cells and the key role of both insulin receptor (IR) and EGFR signaling in keratinocyte
(KC) migration, we hypothesized that depletion of GM3 would enhance wound healing in vitro.
Using a small molecule inhibitor of glucosylceramide synthase (GCS), EtDO-P4, to deplete gan-
glioside production, we found that KC migration in scratch and modified Boyden chamber assays
is markedly increased in response to stimulation with insulin, transforming growth factor-alpha and
EGF. Staining of EtDO-P4 treated KCs (GM3-depleted) with phalloidin shows increased actin
microaggregation and reduced internal stress fibers, but an increase in transverse fibers and corti-
cal actin bundles at the periphery in comparison with vehicle-treated controls, suggesting that alter-
ations in cytoskeletal arrangement may contribute to the increased migration. Depletion of GM3
with EtDO-P4 increases the co-immunoprecipitation of insulin receptor substrate-1 with IR and
dramatically augments IR phosphorylation; the EtDO-P4 increase in IR phosphorylation is reversed
by treatment to increase GM3 expression. EtDO-P4-induced ganglioside depletion also signifi-
cantly increases EGF-induced KC EGFR phosphorylation. GCS inhibitors have been administered
orally to increase insulin sensitivity in diabetic mouse models and are in clinical trials for Fabry’s
disease. These studies suggest that oral or topical administration of small molecule inhibitors that
deplete ganglioside may accelerate wound healing, particularly in diabetic and obese patients.
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Role of ATP release and purinergic receptors in irritant-induced EGFR activation
KJ White,1,2 VJ Maffei,1 M Newton-West2,1 and RA Swerlick2,1 1 Dermatology, Emory University,
Atlanta, GA and 2 Dermatology, Atlanta Veterans Affairs Hospital, Atlanta, GA
Irritant contact dermatitis (ICD) occurs rapidly following exposure of the skin to irritant compounds.
Despite a significant body of clinical and biochemical research pertaining to ICD, information
regarding early events following exposure of skin to irritant compounds remains limited. Previously,
we reported on the role of metalloproteases and the epidermal growth factor receptor (EGFR) fol-
lowing stimulation with the model irritant sodium lauryl sulfate (SLS) in HaCaT cells. Treatment of
HaCaT cells with TGFα resulted in almost immediate ERK phosphorylation. However, p-ERK was
not immediately detectable after SLS stimulation, suggesting the requirement for secondary medi-
ators or signaling events. Previous studies have demonstrated irritant-induced release of cellular
ATP and assessment of ATP release following SLS treatment showed an increase in extracellular
ATP, consistent with previously published data. We hypothesized that ATP interaction with puriner-
gic receptors may result in EGFR activation. Supportive of this hypothesis, ATP-γ-S (300μM) resulted
in time-dependent ERK activation and de novo protein synthesis of early growth factor (egr)-1 in
HaCaT cells. ATP-mediated egr-1 induction was sensitive to the protease inhibitor marimastat and
the specific EGFR inhibitor PD168393. Moreover, IL-8, VEGF, and egr-1 mRNAs were also increased,
and similarly inhibited by protease and EGFR inhibitors. Neither AMP nor adenosine was capable
of inducing egr-1 or any of the pro-inflammatory genes of interest. Metabotropic P2Y purinergic
receptor inhibitors were examined for their effects on protein and mRNA induction. A3P5AS and
PPAD had no effect on SLS-induced pro-inflammatory genes. However, reactive blue 2 decreased
both SLS- and ATP-γ-S-, but not TGFα-induced, VEGF and egr-1 mRNAs. In contrast reactive blue
displayed no effect on SLS or ATP-γ-S induction of IL-8 mRNA. Our data suggest a role for irritant-
mediated ATP release driving protease dependent EGFR activation via P2Y purinergic receptors in
ICD.
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TNF-α activation of MAPK/ERK: Dependence on protease-mediated EGFR signaling and diver-
gence from NF-kB signaling
VJ Maffei,1 KJ White,1,2 M Newton-West2,1 and R Swerlick2,1 1 Dermatology, Emory University,
Atlanta, GA and 2 Dermatology, Atlanta Veterans Affairs Hospital, Atlanta, GA
In vitro models and in vivo responses to pharmacologic agents implicate the cytokine tumor
necrosis factor alpha (TNFα) as playing an important role in inflammatory skin disorders. Exposure
of skin cells to TNFα in vitro or in vivo results in the induction of a wide variety of genes, many
implicated in cutaneous inflammation and keratinocyte proliferation. The most well defined TNFα
signaling pathway is dependent upon TNFα-mediated degradation of the IkB complex resulting in
nuclear translocation of the active p65/p50 transcription complex and resultant gene activation.
However, TNFα also triggers broad activation of MAP kinase (MAPK) activity. Whether this acti-
vation is mediated via pathways distinct from or overlapping with NF-kB activation is not well
defined. In order to address this question, we examined the mechanisms involved in TNFα medi-
ated early growth response gene 1 (egr-1) induction in HaCaT keratinocytes. Egr-1 protein was
induced in HaCaT cells by either TGFα or TNFα in a dose- and time-dependent fashion. Induc-
tion by either TGFα or TNFα was inhibited by the EFGR inhibitor AG1478, implying a role for EGFR
activation by both cytokines. In order to address whether activation of EGFR by TNFα might be
mediated via proteolytic release of EGFR ligands, we examined whether induction of egr-1 was
protease inhibitor sensitive. Consistent with this hypothesis, TNFα-mediated induction of egr-1 was
blocked by the protease inhibitor marimastat. Furthermore, marimastat also blocked TNFα-medi-
ated ERK phosphorylation. Pretreatment of HaCaT cells with the proteasome inhibitor MG-132
blocked TNFα-mediated nuclear translocation of p65. However, it displayed no effect on TNFα-
mediated egr-1 induction or Erk phosphorylation. These data suggest TNFα-mediated ERK activa-
tion and egr-1 induction is strictly dependent on the protease-mediated activation of EGFR and
that this process is independent of TNFα-mediated nuclear translocation of NF-kB.
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Resveratrol regulates mTOR-dependent RhoA activity during induction of premature cellu-
lar senescence (PCS)
JH Back,1 Y Zhu,1 M Athar,2 DR Bickers1 and AL Kim1 1 Dermatology, Columbia University,
New York, NY and 2 University of Alabama at Birmingham, Birmingham, AL
DNA-damaging agents induce PCS in human cancer cell lines, and in vivo induction of PCS has
been suggested as an effective tumor suppressive mechanism in animal models. PCS induction is
associated with altered expression of genes involved in cell cycle progression. We have shown
that resveratrol treatment blocks cyclin D1 expression and induces PCS in human epidermoid squa-
mous cell carcinoma A431 cells. Prematurely senescent cells are characterized by distinct cellu-
lar phenotypes, such as enlarged and flattened cell shape and increased granularity, suggesting
dysregulated cytoskeletal structures. In this study, we show that resveratrol induces PCS and G1
cell cycle arrest in A431 cells by activating the ATM/ATR DNA damage pathway, leading to down-
regulation of cyclin D1. The Rho GTPase is known to regulate actin cytoskeletal structures and
alter the levels of the cell cycle regulatory proteins: cyclin D1, p21WAF1, and p27KIP1. Our results
show that resveratrol decreases GTP-binding RhoA activity in A431 cells. Resveratrol-mediated
decreases in RhoA activity lead to reduced/altered formation of actin cytoskeletons, as assessed
by immunofluorescent staining of F-actin. The mammalian target of rapamycin (mTOR) complex
2 (mTORC2) is known to regulate RhoA activity and actin cytoskeleton formation. We further show
that resveratrol significantly decreases the level of Rictor, a component of mTORC2, in A431 cells.
The addition of a copper specific chelator, neocuproine, which inhibits resveratrol-induced DNA
damage, was found to restore the level of Rictor, and prevent resveratrol-mediated downregula-
tion of RhoA activity and cyclin D1. Our data suggest that modulation of mTORC2-dependent
RhoA activity is involved in resveratrol-mediated cyclin D1 downregulation in A431 cells, and that
dysregulated RhoA activity may contribute to both the altered cell cycle progression and struc-
tural basis of PCS.
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Multipotent nestin-positive hair follicle stem cells can promote regeneration of impinged
peripheral-nerve injury
Y Amoh,1 M Kanoh,1 K Tanabe,1 S Mii,1 S Niiyama,1 K Kawahara,2 RM Hoffman3 and
K Katsuoka1 1 Dermatology, Kitasato University School of Medicine, Sagamihara, Japan, 2
Physiology, Kitasato University School of Medicine, Sagamihnara, Japan and 3 AntiCancer,
Inc., San Diego, CA
Nestin-positive and K15-negative multipotent hair follicle stem cells are located above the hair fol-
licle bulge (PNAS 102, 5530-4, 2005; Cell Cycle, 8, 2009, in press). We have termed this loca-
tion the multipotent hair follicle stem cell area (MHFSCA). We have previously shown that hair
follicle stem cells can form neurons, glial cells and other non-follicular cell types and can regen-
erate peripheral nerve and spinal cord injuries (PNAS 102, 17734-8, 2005; JID. 127: 11-5, 2007;
Cell Cycle, 7, 1865-9, 2008). In the present study, the hair follicle stem cells isolated from trans-
genic C57BL6-GFP mice and the human scalp were transplanted to the impinged area of the sci-
atic nerve in the nude mouse where they differentiated into CNPase-positive Schwann cells which
promoted the recovery of pre-existing axons. The regenerated sciatic nerve was functionary recov-
ered as demonstrated by its ability to stimulate the gastrocnemius muscle. These multipotent hair
follicle stem cells thereby provide a potential accessible, autologous source of stem cells for regen-
eration therapy of degenerative nerves caused by the compression between bony or other hard
surfaces.
581
13-cis Retinoic acid exerts an antibacterial effect through neutrophil gelatinase-associated
lipocalin
KR Lumsden,1 AM Nelson,1,2 DA De Cotiis,3 KL Gillilland,1,2 Z Cong,1,2 AL Zaenglein2 and
DM Thiboutot1,2 1 Jake Gittlen Cancer Research Foundation, Pennsylvania State University
College of Medicine, Hershey, PA, 2 Department of Dermatology, Pennsylvania State
University College of Medicine, Hershey, PA and 3 Department of Biochemistry,
Pennsylvania State University College of Medicine, Hershey, PA
Acne is a disease which affects a majority of the population at some point in their lives. For those
who suffer from moderate to severe acne, isotretinoin (13-cis RA) is the most effective agent, yet
there are potential side effects such as teratogenicity. A better understanding of mechanism of action
of 13-cis RA is warranted to help develop alternative therapies. The antimicrobial protein neu-
trophil gelatinase-associated lipocalin (NGAL) is a mediator of the apoptotic effect of 13-cis RA in
human sebocytes. The antibacterial affects of 13-cis RA have been attributed to a reduction in
sebum, which serves as a nutrient source for P. acnes. NGAL has antibacterial activity against E.
coli. We sought to determine if NGAL exerts antimicrobial effects against Propionibacterium acnes
(P. acnes) and whether the time course of induction of NGAL expression on the skin by 13-cis RA
correlates with reduction in P. acnes counts and sebum production in treated patients. We found
that: 1) NGAL reduces the number of colony forming units of P. acnes in vitro, 2) NGAL is increased
on the forehead skin of patients treated with 13-cis RA, 3) P. acnes levels decrease during the course
of treatment and 4) Sebum levels decrease during the course of treatment with the maximal decrease
occurring at 4 weeks. Furthermore, P. acnes itself can induce a 5-fold increase in NGAL expres-
sion in SEB-1 sebocytes compared to the 20-fold increase induced by 13-cis RA. These data indi-
cate that 13-cis RA can induce an innate immune response by increasing the antibacterial protein
NGAL. Although NGAL is effective in vitro against P. acnes, the in vivo reduction of P. acnes with
13-cis RA may be due to both increased NGAL and reduced sebum.
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Activation of WNT and BMP signaling pathways and forced cell aggregation enabled the gen-
eration of human dermal papilla equivalent with trichogenic activity
M Ohyama,1 T Kobayashi,1,2 A Shimizu1 and M Amagai1 1 Dept. of Dermatology, Keio Univ.
School of Med., Tokyo, Japan and 2 Dept. of Veterinary Internal Medicine, Tokyo Univ. of
Agri. and Tec., Fac. of Agri., Tokyo, Japan
Regeneration of human dermal papilla (DP) represents one of the indispensable techniques for the
investigation and the bioengineering of hair follicles. To achieve this goal, in vitro expansion and
re-aggregation of DP cells without impairing hair inductive capacity are required. In this study, we
attempted to generate human DP equivalent with trichogenic activity by ameliorating the condi-
tions of DP cell culture and aggregation. Microarray analysis identified the genes differentially
expressed between freshly-isolated and conventionally cultured human DP cells. The genes up-
regulated in fresh DP (DP genes) could contribute the maintenance of the biological distinctive-
ness of DP. Interestingly, the genes involved in WNT, BMP signaling pathways were significantly
down-regulated after culture, suggesting the importance of those pathways in the maintenance of
DP properties. Supplementation of WNT activator (BIO: 6-bromoindirubin-3’-oximin), or recom-
binant BMP2 into human DP cell culture sustained the expression of respective subsets of DP genes,
however, the growth of DP cells were negatively affected in a dose dependent manner. Thus, to
enhance proliferative capacity, bFGF was combined with both BIO and BMP2 to culture DP cells.
In this condition, the growth rate of DP cells was adequately maintained. Importantly, the expres-
sion levels of DP genes, including trichogenicity indicators, ALPL, WNT5A and Noggin, could be
sustained over passages. DP cells cultured with BIO, BMP2 and bFGF could be aggregated to form
DP-like spheres using low cell-binding plates. Of note, re-aggregation of the DP cells further restored
ALPL, WNT5A and BMP4 expression levels, comparable to that of freshly-isolated DP. The pres-
ent protocol could illustrate potential approaches to regenerate fully functional human DP. Evalu-
ation of trichogenic capacity of those regenerated human DP is in progress, using in vivo hair induc-
tion assays.
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History of atopy or autoimmunity and risk of Alopecia Areata
N Barahmani,1,3 MB Schabath2,3 and M Duvic1,4 1 UT-M.D. Anderson Cancer Center, Houston,
TX, 2 The H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, 3 UT- School of
Public Health, Hosuton, TX and 4 National Alopecia Areata Registry, Houston, TX
Background: Alopecia areata (AA), is an organ specific, T cell-mediated immune disease that tar-
gets anagen-stage hair follicles. The association between alopecia areata and self-reported autoim-
mune diseases is previously reported. However, it is not clear whether the associated autoimmune
disease increases or decreases the risk of AA. Objective: The goal of the study was to perform a
case-control analysis using the National Alopecia Areata registry database to investigate the asso-
ciation between history of self-reported atopic or autoimmune diseases and risk of AA. Methods:
A total of 2,055 self-registered sporadic alopecia areata patients and 558 control subjects were
studied. Multivariable logistic regression analyses were used to assess the association between a
self-reported history of atopic or autoimmune disease and AA. Patients with AA were classified
into three clinical subtypes: persistent patchy alopecia areata (AAP) if the duration of patchy hair
loss is longer than one year; alopecia totalis (AT) if total scalp hair loss lasts for more than one year,
and the alopecia universalis (AU) if entire body hair is lost for more than one year. Results: Among
the alopecia areata patients, 852 had persistent patchy alopecia areata, 343 had alopecia totalis,
and 860 had aloepcia universalis. A self-reported history of any atopic (OR=2.00; 95% CI 1.50-
2.54) or autoimmune disease (OR=1.73; 95% CI 1.10-2.72) was associated with an increased risk
of alopecia areata. We also found evaluated point estimates for self-reported history of hypothy-
roidism (OR= 2.96, 95% CI 1.43-6.19) and atopic dermatitis (OR=1.70, 95% CI 1.13–2.56). Con-
clusions: The common mechanisms of atopy and autoimmunity in AA remains understudied. Fur-
ther mechanistic and association studies, including an assessment of genetic susceptibility, may
yield new insights into the mechanisms of AA pathogenesis and identification of individuals who
will progress to severe subgroup (AT/AU).
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Embryonic hair follicle fate change by augmented β-catenin through Shh and Bmp signaling
K Suzuki,1,2 Y Yamaguchi,3 M Villacorte,1,2 M Akiyama,4 H Shimizu,4 MM Taketo,5 N Nakagata,1
S Kato6 and G Yamada1,2 1 CARD, Kumamoto Univ., Kumamoto, Japan, 2 Global COE “Cell
Fate Regulation Research and Education Unit”, Kumamoto Univ., Kumamoto, Japan, 3 Dep.
of Geriatric and Env. Dermatology, Nagoya City Univ., Nagoya, Japan, 4 Dep. of
Dermatology, Hokkaido Univ., Hokkaido, Japan, 5 Dep. of Pharmacology, Kyoto Univ.,
Kyoto, Japan and 6 IMCB, Univ. of Tokyo, Tokyo, Japan
β-catenin signaling is one of the key factors regulating the fate of hair follicles (HFs). To elucidate
the regulatory mechanism of embryonic HF fate determination during epidermal development/dif-
ferentiation, we analyzed conditional mutant mice with keratinocytes expressing constitutively
active β-catenin (K5-Cre Catnb(ex3)fl/+). The mutant mice developed scaly skin with a thickened
epidermis and showed impaired epidermal stratification. The hair shaft keratins were broadly
expressed in the epidermis but there was no expression of the terminal differentiation markers K1
or Loricrin. The hair placode and follicular dermal condensate markers were expressed through-
out the epidermis and the upper dermis, respectively. These results indicate the embryonic epi-
dermal keratinocytes have switched extensively to the HF fate. A series of genetic studies demon-
strated that the epidermal switching to HF fate was suppressed by introducing the conditional
mutations of K5-Cre Catnb(ex3)fl/+Shhfl/- or K5-Cre Catnb(ex3)fl/+BmprIAfl/fl. These results demon-
strate that Wnt/β-catenin signaling relayed through Shh and Bmp signals is the principal regula-
tory mechanism underlying the HF cell fate change. Assessment of the Bmp2 promoter activities
suggested a putative regulation by β-catenin signaling relayed by Shh signaling toward Bmp2. We
also found that Shh protein expression was increased and expanded in the epidermis of K5-Cre
Catnb(ex3)fl/+BmprIAfl/fl mice. These results indicate the presence of growth factor signal cross-
talk involving β-catenin signaling which regulates the HF fate.
www.jidonline.org   S97
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PPARγ agonists trigger a tissue-specific response in skin compared to adipose tissue in rats
M Rivier and A Jomard Galderma R&D, Biot, France
In the last ten years, many studies have been conducted to explore the role of PPARγ in the seba-
ceous gland function. In adipocytes, PPARγ controls the uptake of fatty acids and triglycerides.
Based on its role in adipocytes, and making a parallel between adipocytes and sebocytes, it was
expected that activation of PPARγ in sebocytes could lead to an increase in sebum excretion rate.
Unexpectedly, using different rat strains, we found that PPARγ agonists decreased strongly seba-
ceous gland volume and sebum excretion in vivo, whereas antagonists were inactive. Using a large
scale gene expression approach, we identified new specific markers modulated by PPARγ in seba-
ceous glands. The expression of these markers, as well as known adipose tissue PPARγ-specific
markers, has been monitored using qRT-PCR following oral or topical treatment with PPARγ ago-
nists. Modulations have been studied simultaneously both in rat’s subcutaneous adipose and skin
tissues. Gene-by-gene analysis highlighted tissue specific responses. A clustering approach allowed
us to determine specific patterns of genes up or down-regulated in response to the activators. Sur-
prisingly, we observed that only a small number of the genes are up-regulated in both tissues. Most
of the markers are up-regulated only in adipose tissue with no specific modulations in sebaceous
glands or displayed an opposite profile, being up-regulated in adipose tissue but strongly down-
regulated in the skin samples. Finally we also identified genes which were only down-regulated in
the skin. Taken altogether, these results demonstrate that PPARγ agonists are able to trigger a dif-
ferential expression profile on the same set of target genes in two different tissues. We conclude
that the control of lipid homeostasis in adipose tissue is strikingly different from what is observed
in sebaceous glands in vivo. The underlying mechanisms of regulation by PPARγ could therefore
not be extrapolated from adipocyte to sebocyte without considering other partners of nuclear recep-
tors such as co-activators or co-repressors.
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Evidence that Prostaglandin D2 contributes to development of Androgenetic Alopecia
LA Garza,1,5 B Alagesan,1 JA Lawson,2 SM Norberg,1 T Zhao,1 HB Blat,1 DC Stanton,3 L Carrasco,3
FM Susan,4 GA FitzGerald2 and G Cotsarelis1 1 Dermatology, University of Pennsylvania,
Philadelphia, PA, 2 Pharmacology, University of Pennsylvania, Philadelphia, PA, 3 ENT,
University of Pennsylvania, Philadelphia, PA, 4 Science Park, University of Texas M.D.
Anderson Cancer Center, Smithville, TX and 5 Dermatology, Johns Hopkins Medical School,
Baltimore, MD
To better understand the pathogenesis of androgenetic alopecia (AGA), we performed global gene
expression analysis on paired haired and bald scalp samples from 5 individuals undergoing hair
transplantation for male pattern baldness. The Lipocalin type of Prostaglandin D2 Synthase (L-PGDS)
was upregulated (p<0.01) in bald compared to haired scalp. RT-PCR (n=4, p<0.04) and western
blotting (n=4, p<0.01) confirmed increases in L-PGDS mRNA and protein expression respectively.
By ELISA (n=3, p<0.01) and mass spectrometry (n=17, p<0.01), we found increased PGD2, the
enzymatic product of L-PGDS, in bald versus haired scalp. PGE2, which often antagonizes PGD2
actions, was decreased in bald scalp (n=17, p<0.01). To investigate the role of prostaglandins in
hair follicle biology we studied changes in their expression during murine hair follicle cycling.
Using quantitative RT-PCR, we found that levels of L-PGDS mRNA peak in late anagen, coincident
with FGF-5 expression, a known marker of catagen onset. Immunohistochemistry localized L-PGDS
to dermal cells surrounding the bulge and hair follicle keratinocytes below the bulge during late
anagen. PGD2 and its breakdown product, 15d-PGJ2, were increased in K14-Cox2 transgenic mouse
skin, which develops alopecia and sebaceous hyperplasia reminiscent of that seen in AGA. In an
in vitro explant model (n=16, p<0.01), PGD2 and 15d-PGJ2 inhibit human hair growth. PGD2
and 15d-PGJ2 also inhibit mouse hair growth when applied topically (n=3, p<0.05). Topical 15d-
PGJ2 increased sebaceous gland size in mice (n=3, p<0.01). Together these data support a hair
growth inhibitory role for PGD2 and 15d-PGJ2 in normal hair follicle cycling and in the develop-
ment of AGA, thus providing new targets for possible hair loss treatments.
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Hair follicle RANK-ligand regulates epithelial growth via Bcl-3
V Duhéron,1 L Amoasii,1 M Decossas,1 J Klatte,2 R Paus2 and CG Mueller1 1 Laboratory of
Therapeutic Immunology and Chemistry, CNRS, IBMC, Université Louis Pasteur, Strasbourg,
France and 2 Department of Dermatology, University of Lübeck, Lübeck, Germany
The hair follicle is receiving increased attention for its renewal capacity and source of readily acces-
sible stem cells. It regulates the local immune and epidermal homeostasis and is source of tumour
cells. RANK-ligand, a TNF-family member, is expressed by osteoblasts and is required for the for-
mation of osteoclasts, specialized bone-absorbing macrophages. In view of certain similarities
between bone and skin, and because RANK-ligand is involved in mammary gland development,
we investigated if RANK-ligand and its receptor RANK play a role in hair follicle formation and
epithelial homeostasis of the mouse skin. We find that RANK is expressed at low levels in epithe-
lial cells but RANK-ligand is strongly expressed in growing hair follicles. Mice deficient in RANK-
ligand are unable to enter the hair follicle anagen (growth) phase and display reduced epidermal
thickness. On the other hand, mice overproducing RANK-ligand in the hair follicle show epider-
mal hyperplasia, demonstrating a requirement for RANK-ligand for epithelial growth. To under-
stand the signalling pathway triggered by RANK, we performed immunolabelling and western blot
analyses and found that RANK induces nuclear translocation of Bcl-3. Bcl-3 is a member of the
NF-κB inhibitor family, but is capable of promoting gene transcription when bound to p50 or p52
homodimers. As cylindromas show Bcl-3 nuclear translocation, it is possible that RANK-ligand is
implicated in the growth of these tumours.
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Novel formulation API31543 protects from chemotherapy-induced Alopecia
JJ Jimenez,1 JP McCook,2 LM Mauro3 and NN Narain1 1 Dermatology, University of Miami,
Miller School of Medicine, Miami, FL, 2 Cytotech Labs, LLC, Cambridge, MA and 3
Biochemistry and Molecular Biology, University of Miami, Miller School of Medicine, Miami,
FL
Alopecia is one of the most distressing side-effects of chemotherapy, with profound psychosocial
implications. The neonatal rat is an excellent model in which to study Chemotherapy-Induced
Alopecia (CIA) which has been shown to have correlation with human results. In the present
study, we used the secosteroid calcitriol in a proprietary delivery system, Cytotech Labs API31543.
The formulation or vehicle control was applied topically over the head area daily starting on day
5 for 6 consecutive days. Rats were isolated from their littermates and mother for 6 hours and
received 0.2μg or 0.3μg calcitriol or vehicle control. Subsequently, the treated area was cleaned
with soap and water and pups were returned to their litters. Rats received the following chemother-
apies: etoposide (1.5 mg/kg daily for 3 days), cyclophosphamide (37.5 mg/kg once), cyclophos-
phamide + doxorubicin (35mg/kg once /2.5 mg/kg daily for 3 days), cytarabine (25mg/kg daily for
7 days), cytarabine + doxorubicin (25mg/kg daily for 7 days /2.5mg/kg daily for 3 days). All
chemotherapies were given intraperitoneally. Alopecia was recorded 10 days after the last dose of
chemotherapy. In the rats treated with 0.2 μg of calcitriol, localized protection was observed in all
the animals. In the group receiving 0.3 μg, total body protection was achieved. In contrast, all the
rats receiving vehicle control became totally alopecic. In a separate experiment in which rats were
transplanted with chloroleukemia, there was no protection of the cancer cells from cyclophophamide
by API31543 while protection from CIA was achieved. In conclusion, pretreatment with calcitriol
with API 31543 offers novel protection against CIA without protecting cancer cells. The results
herein set a solid foundation for clinical investigation while creating a platform for further drug
discovery pathways.
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Modulation of different hair follicle markers: Studies on human scalp skin grafts
A Perrin,1 C Meyrignac,1 C Plazza,1 C Gondran,1 R Chabert,1 S Pinacolo,1 C Dal Farra2 and
N Domloge1 1 Vincience, ISP Global Skin Research Center, ISP, Sophia-Antipolis, France and
2 ISP Corporate Research Center, ISP, Wayne, NJ
Understanding the roles of different hair follicle components and the possibilities for acting on them
are key challenges in hair biology. Working with cells isolated from the different compartments of
the hair follicle fails to take into account the complexity of the interactions which take place
within it. For this reason, in the present study, we used a model of human scalp skin grafts, placed
in emersion on a culture insert, and fed with a previously described serum-free medium. In order
to test the reactivity of this model, we applied two molecules; one activates cAMP, and the other
ATP, on the top of scalp biopsies for 48 hours. At the end of the incubation, scalp grafts were paraf-
fin-embedded or frozen in OCT, to perform immuno-histochemical analyses. Our studies showed
that stimulating cAMP in the samples induced an increase in keratin 14, keratin 15, and keratin 16
in the outer root sheath (ORS). This outcome could be relevant for hair growth, as well as the qual-
ity of the anchoring of the hair. We also observed an increase in collagen IV and laminin-332,
indicating reinforcement of the basement membrane, and better communication between the
ORS and dermal sheath. A different set of markers, including beta-1 integrin, fibronectin, Ki67,
and P63, was modulated by ATP induction. These results suggest an optimized cell-matrix adhe-
sion and enhanced cell signaling in the hair follicle. Moreover, further study results on beta-1 inte-
grin and p63 (identified as potential markers for hair follicle stem cells) were in favor of a positive
effect of hair follicle ATP induction on hair renewal and growth cycle maintenance. Consequently,
this model of human scalp grafts seems appropriate to observe the modulation of different hair fol-
licle components, which could be essential for hair vitality and regeneration.
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Immunohistochemical studies and mapping of hair follicle markers in human scalp skin biop-
sies
C Meyrignac,1 R Chabert,1 C Gondran,1 N Garcia,1 A Amoyel,1 S Pinacolo,1 C Dal Farra2 and
N Domloge1 1 Vincience, ISP Global Skin Research Center, ISP, Sophia-Antipolis, France and
2 ISP Corporate Research Center, ISP, Wayne, NJ
The human hair follicle has a complex anatomical structure, which grows in a cyclic rhythm,
according to individual criteria. We were interested to determine, by immunohistochemistry, the
localization of different hair follicle markers which can be of interest in hair growth cycle. Thus,
we used biopsies of fresh human scalp skin using transverse and longitudinal sections, and a panel
of immunofluorescence stains. Parallel H&E studies were performed in order to precisely visual-
ize the location of the markers in the different zones of the hair follicle. The conjunctive sheath
was stained for type I and type III collagens, which were also present in the dermal papilla. Col-
lagen IV and laminin-332 were identified in the basement membrane, surrounding the outer root
sheath (ORS). Beta-1 integrin, which plays a role in hair growth control, revealed a staining pat-
tern in the outermost layer of the ORS. CD34, a human hematopoietic stem cell antigen, was found
to be expressed in ORS cells, and also in endothelial cells from microvessels in the dermal papilla.
Among the different keratins expressed in the ORS, keratins 14 and 15 showed different expres-
sion patterns. Moreover, additional staining studies were performed to observe the expression of
water-channel aquaporin-3 and tight junction marker claudin-1 in the hair follicle, though their
role in hair physiology is still undefined. Finally, the inner root sheath was characterized by the
staining of caspase-14. As cells from the hair follicle exhibit a high proliferative potential, we also
performed studies to evaluate markers such as Ki67, and p63, as well as the stem cell marker sur-
vivin. This panel of immunostains allowed us to better characterize the different compartments of
the hair follicle, and to develop a more global map of it, in order to focus on markers of interest to
hair follicle maintenance and structure.
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Survivin and other chromosomal passenger complex proteins are key regulators of adult epi-
dermal stem cell differentiation
F Labarrade,1 C Meyrignac,1 A Lableu,1 J Botto,1 C Gondran,1 C Dal Farra2 and N Domloge1 1
Vincience, ISP Global Skin Research Center, ISP, Sophia-Antipolis, France and 2 ISP
Corporate Research Center, ISP, Wayne, NJ
The epidermis and the hair follicle need to continuously generate new cells through proliferation
of progenitor cells and subsequent differentiation. This renewal is permitted by adult stem cells
(ASCs) originating from the bulge region of follicles. Under certain stimuli, ASCs are able to migrate
towards interfollicular epidermal regions and/or the hair follicle, in order to replenish the loss of
terminally differentiated cells (corneocytes and the hair shaft). This differentiation process is tightly
controlled and the underlying successive mitosis is strictly regulated, particularly by the chromo-
somal passenger complex (CPC). The CPC is the key regulatory complex which is responsible for
the correct development of cellular mitosis. The proteins survivin, borealin, aurora kinase B, and
INCENP are the interacting components of the CPC. Survivin is a member of the Inhibitor of
Apoptosis Proteins (IAPs) family. In order to study the role of CPC proteins in adult skin stem cell
maintenance and protection from various stresses, we prepared several fractions of primary cells
from human epidermis, corresponding to cellular enrichments at successive stages of differentia-
tion (mainly transient amplifying and differentiated adult epidermal stem cells). Cell morphology
observation, RT-PCR analysis, immunoblotting, as well as immunocyto, histological, and siRNA-
induced knockdown expression studies, were all approaches used to further evaluate and follow
the implications of the four studied CPC components in correct stem cell differentiation, their sub-
cellular localization, as well as several relevant markers (P63, beta-catenin, alpha-6 and beta-1
integrins, and KT15). In parallel, we investigated whether an induced upregulation of survivin
expression, or its translocation into the nucleus, could have a protective role in the mitosis phe-
nomenon. Together, these studies shed more light on the essential role and importance of ASC
protection.
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The hair growth-promoting effects of adipose tissue-derived stem cells
D Lee,1,2,3 C Won,4 H Yoo,1,2,3 O Kwon,1,2,3 Y Kang,1,2,3 J Chung,1,2,3 B Park,5,6 J Sung,6 W Kim7
and K Kim1,2,3 1 Department of Dermatology, Seoul National University College of Medicine,
Seoul, Korea, South, 2 Laboratory of Cutaneous Aging and Hair Research, Clinical Research
Institute, Seoul National University Hospital, Seoul, Korea, South, 3 Institute of
Dermatological Science, Seoul National University, Seoul, Korea, South, 4 Department of
Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea,
South, 5 Leaders Clinic, Seoul, Korea, South, 6 Division of Stem Cell Research, Prostemics
Research Institute, Seoul, Korea, South and 7 Department of Dermatology, Kangbuk
Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea, South
Mesenchymal stem cells within the stromal-vascular fraction of the subcutaneous adipose tissue
(adipose tissue-derived stem cells [ADSCs]), display multi-lineage developmental plasticity and
share similar characteristics with bone marrow-derived stem cells (BM-MSCs). In addition, ADSCs
are known to have various cytokine-secreting properties and to have beneficial paracrine effects
on surrounding cells or tissues. To determine whether these paracrine effects of ADSCs can pro-
mote hair growth, we investigated the effects of ADSC-conditioned media (CM) on hair growth.
The ADSC-CM was harvested and evaluated for the stimulatory effects on hair growth. ADSC-CM
increased the proliferation of dermal papilla cells (DPCs) and HaCaT cells. In a cell cycle analy-
sis, ADSC-CM shortened G1 arrest and prolonged the synthesis and mitosis phases in DPCs. ADSC-
CM induced the anagen phase and promoted hair growth in a C3H mouse model and enhanced
the elongation of hair shafts in ex vivo human organ cultures. The results presented in this study
suggest that ADSCs promote hair growth by increasing the proliferation of DPCs, and possibly
epithelial cells, through modulation of the cell cycle, and activating the anagen phase in hair cycles.
Therefore, the rational manipulation of ADSCs might be a promising tool for hair growth promo-
tion.
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Identification of four structural families of selective high affinity PPARγ agonists with tro-
pism for sebocytes
P Mauvais, P Collette, J Aubert, P Grundt, L Clary, J Boiteau and J Voegel Research, Galderma
R&D, Biot, France
Four structural families of small molecule ligands: propionic acids, acrylic acids, alpha-substi-
tuted carboxylic acids and thiazolidinediones have been evaluated in two cellular pharmacology
assay systems. The first was based on transactivation, using stably transfected PPARα, PPARδ and
PPARγ reporter cell lines. Efficacy, potency and selectivity of the compounds have been deter-
mined. Selective full PPARγ agonists have been selected for further profiling in a second assay,
based on the analysis of lipid synthesis (cholesterol esters and triglycerides) in rat preputial sebo-
cyte cultures. Compounds with strong potency in both assays systems (AC50 < 10nM) have been
identified for all four structural classes of PPARγ agonists. A strong correlation was observed between
induction of triglyceride and cholesterol ester synthesis in rat preputial sebocytes. We therefore
calculated the mean AC50 between these two parameters and compared it to the AC50 in the
PPARγ transactivation assay. Interestingly, we have been able to identify several compounds in
different structural classes with at least ten-fold stronger potency in sebocytes as compared to
their activity in the PPARγ transactivation assay. These molecules with an expected strong tropism
for the sebaceous gland are interesting drug candidates to treat pathophysiological processes involv-
ing sebaceous gland dysfunction, like e.g. acne vulgaris.
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Cross talk between p63 and IRF6 in the regulation of keratinocyte proliferation
F Moretti,1 B Marinari,1 N Lo Iacono,2 E Botti,1 G Spallone,1 G Merlo,3 S Chimenti,1 L Guerrini2
and A Costanzo1 1 Dermatology, University of Rome “Tor Vergata”, Rome, Italy, 2 Cellular and
Developmental Biology, University of Milan, Milan, Italy and 3 Molecular Biotechnology
Center, DTI, University of Torino, Torino, Italy
Mutations in irf6 and p63 genes lead to developmental syndromes characterized by defects in ecto-
derm-derived structures and in dysregulation of cell cycle exit during epithelial differentiation. We
have found that these genes belong the same genetic pathway being ΔNp63 an upstream activa-
tor of irf6 transcription in keratinocyte differentiation. ΔNp63 directly binds to irf6 promoter region
when keratinocytes are induced to differentiate and is necessary for irf6 transcription and protein
expression. Accordingly, p63 mutants unable to bind DNA block differentiation induced irf6 tran-
scription and p63 knockout mice show reduced irf6 levels in ectodrmal derived tissues. Once up-
regulated by ΔNp63, IRF6 induces ΔNp63 degradation, allowing cell cycle exit and reducing the
proliferative potential of keratinocytes. Our findings confirm the important role of irf6 in keratinocyte
differentiation and identify a novel feedback loop regulating cell cycle exit and keratinocyte pro-
liferative potential.
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Distinguishing mouse strains by proteomic analysis of pelage hair
RH Rice,1 DM Rocke,2 HS Tsai,3 KA Silva,4 YJ Lee5 and JP Sundberg4 1 Environmental
Toxicology, University of California, Davis, CA, 2 Division of Biostatistics, University of
California, Davis, CA, 3 Forensic Science Masters Program, University of California, Davis,
CA, 4 The Jackson Laboratory, Bar Harbor, ME and 5 Proteomic Core Facility, University of
California, Davis, CA
AKR/J mice all display a hair interior defect (hid) phenotype for which the molecular basis is
unknown. To investigate application of hair shaft proteomics to study of such diseases, pelage
from AKR/J and two other mouse strains without this defect were analyzed by shotgun proteomics.
The results permitted identification of 111 proteins from tryptic digests of total hair from AKR/J-
hid/hid mice, which were predominantly keratins and keratin-associated proteins. From the non-
solubilizable (cross-linked) fraction of the hair remaining after extensive detergent extraction, 58
proteins were identified. The majority were keratins and keratin-associated proteins, but junc-
tional and other membrane proteins, cytoplasmic proteins and histones were also identified. The
results indicate incorporation of a multitude of proteins into highly cross-linked material. Com-
parison of unique peptides generated among hair samples from AKR/J-hid/hid, FVB/NJ +/+, and
LP/J +/+ mice indicated these inbred strains could be distinguished by proteomic pattern. Trans-
mission electron microscopy after mild treatment in detergent and reducing agent permitted visu-
alization of projections of cortex cells, with characteristic filament patterns, into adjoining medulla
cells. Hair shafts from AKR/J mice were deficient in these projections and also exhibited relatively
low levels of trichohyalin, a possible contributor to or marker for the hid phenotype.
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A novel anti-catagen formulation
G Giuliani,1 B Marzani,1 A Benedusi,1 M Traversa,2 S Carelli,2 A Gorio2 and F Rinaldi3 1 R&D,
Giuliani S.p.A., Milan, Italy, 2 Laboratories of Pharmacology, Dept. Medicine, Surgery and
Dentistry, University of Milan, Milan, Italy and 3 Studio Rinaldi, Milan, Italy
The life cycle of the hair bulb can be reduced to three phases: anagen, catagen and telogen. We
are mostly interested in developing therapeutic strategies capable of counteracting the regression
phase (catagen), that is mostly caused by apoptosis of epithelial and melanocyte cells. We have
tested our working hypothesis on HFDPC-c cells, grown in culture in the Follicle Dermal Papilla
Growth Medium, and apoptosis was induced by 24 hours incubation with 1 μM staurosporin. This
treatment resulted in a marked activation of Caspase-3 accompanied by cytoskeletal degradation,
nuclear blebbing and cellular fragmentation. The addition of spermidine or rutine in the micro-
molar range concentration reduced staurosporin-induced caspase activity by over 50%, when the
two agents were added simultaneously the same extent of caspase-3 inhibition was achieved with
concentration 10 fold lower. Zeaxanthine alone was rather ineffective, however when it was added
to the combined treatment, made by spermidine and rutine, the staurosporin-induced caspase activ-
ity was almost totally counteracted and the enzymatic activity was much more significantly reduced.
These combined treatment was also very effective in preventing staurosporin-mediated cellular
damage. The extent of cell loss was greatly reduced, and, differently from untreated cells, there
was a total preservation and normal distribution of actin-tubulin cytoskeleton with normal cellu-
lar shape. Interestingly, our combined treatment counteracted also the over-expression of caspase-
3 induced by staurosporin. In conclusion, this novel formulation may pride an effective prevent-
ing treatment for the catagen phase of the hair bulb life cycle.
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DNase1L2 has an essential role in the degradation of nuclear DNA in hair and nails
H Fischer,1 K Jaeger,1 H Rossiter,1 M Ghannadan,1 M Buchberger,1 M Hermann,2 E Wagner,3
E Tschachler1,4 and L Eckhart1 1 Department of Dermatology, Research Division of Biology and
Pathobiology of the Skin, Medical University of Vienna, Vienna, Austria, 2 Max F. Perutz
Laboratories, Medical University of Vienna, Vienna, Austria, 3 Genes, Development and
Disease Group, Spanish National Cancer Centre (CNIO), Madrid, Spain and 4 Centre de
Recherches et d`Investigations Epidermiques et Sensorielles (CE.R.I.E.S.), Neuilly sur Seine,
France
The hair is formed by terminal differentiation of keratinocytes of the hair matrix. In the course of
this process nuclear DNA is degraded. We have reported recently that differentiated keratinocytes
of the hair, the nail and the epidermis express high levels of deoxyribonuclease 1-like 2 (DNase1L2),
an endonuclease specific to the skin. To assess the physiological role of DNase1L2, we generated
DNase1L2 knockout mice and characterized their phenotype. DNase1L2-/- mice were healthy, fer-
tile and macroscopically normal. Histological investigation revealed that the interfollicular epi-
dermis of DNase1L2-/- mice was orthokeratotic and morphologically not different from that of wild-
type mice. By contrast, all hair types investigated as well as the nails of the knockout mice differed
strongly from those of wild-type mice. Virtually all corneocytes of the hairs and nails of DNase1L2-
/- mice contained nuclear remnants that were strongly labeled with the DNA dye Hoechst 33342.
DNA extraction and quantification by real time PCR showed that hair of knockout mice contained
several hundred-fold more genomic DNA than hair of wild-type mice. Since the content of mito-
chondrial DNA was the same in hair of knockout and wild-type mice, DNase1L2 activity appeared
to be restricted to the nuclear compartment. Taken together, these data show that DNase1L2 is
essential for the breakdown of genomic DNA during hair formation and identify DNase1L2 as the
first specific mediator of differentiation-associated keratinocyte cell death in vivo. The DNase1L2
knockout mouse will be used to uncover the physiological role of nuclear DNA removal in the hair.
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Transgenic mice delineate the functional properties of p63 isoforms in regulating keratinocyte
differentiation
R Romano, K Ortt and S Sinha SUNY at Buffalo, Buffalo, NY
The transcription factor p63 plays a critical role in the development and differentiation of the epi-
dermis. Our understanding of the molecular mechanism by which p63 controls gene expression
in keratinocytes remains elusive, in part due to the myriad of naturally occurring isoforms of p63
with distinct transcriptional activities and biochemical properties. This includes p63 isoforms that
differ in their N-termini (ΔN or TA) because of alternate promoter usage or C-termini variants gen-
erated by alternative splicing resulting in longer p63α or shorter p63β and p63γ isoforms. It is con-
ceivable that the p63α proteins might possess unique functional properties due to the presence of
a protein-protein interacting SAM domain, a feature missing in p63β and p63γ isoforms. To test
this hypothesis and ascertain the specific functional properties of the ΔNp63α and ΔNp63β iso-
forms in vivo we have generated transgenic mice, which express these proteins in a Tet-inducible
fashion. By utilizing the K5 or involucrin-promoter based Tet-driver animals, we have targeted the
expression of ΔNp63α and ΔNp63β to proliferative and differentiated keratinocytes of the skin.
Our data shows that altered levels of specific isoforms of p63 cause profound changes in ker-
atinocyte lineage choices and differentiation status. To probe the differential effects of ΔNp63α and
ΔNp63β overexpression in mouse skin, we have performed global microarray analysis of effected
animals. These studies offer novel insights into the overlapping yet disparate ΔNp63α and ΔNp63β
regulated transcriptome and suggest that p63 influences several developmental and keratinocyte
maturation pathways including those governed by PPAR signaling. Finally, we have utilized our
transgenic mouse models to examine the functional efficacy of ΔNp63α and ΔNp63β in rescuing
the skin phenotype of p63 null animals. Collectively, these studies provide an unique glimpse into
the physiological properties of two major p63 isoforms in an in vivo setting.
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Role of vitamin D receptor in adult hair follicle cycling
AE Teichert, SM Chang, H Elalieh and DD Bikle Endocrine Unit, UCSF-VAMC, San Francisco,
CA
Hair follicle cycling describes rhythmically re-occurring phases of growth, regression and tissue
re-modeling events in a complex neuroectodermal-mesodermal interaction system. Hunting the
oscillator mechanism that drives these hair follicle transformations is one of the pre-eminent chal-
lenges of basic and clinically applied hair research. Among the large number of molecules play-
ing a role in the control of this oscillator system, one of the most interesting is the vitamin D recep-
tor (VDR). Lack or alteration of VDR in both human and mouse leads to an absence of adult hair
follicle cycling, with a defect in anagen re-initiation. This hair follicle cycling is accompanied by
a progressive hair loss. However, lack of VDR does not affect embryonic hair development and
differentiation of epidermal keratinocytes, showing the specificity of VDR action in adult hair fol-
licle cycling. The study objective was to identify genes involved in the control of hair follicle cycling
whose expression was affected by the lack of VDR in mice. Our studies using qRTPCR and Immuno-
histochemistry show that VDR deficient mouse hair follicles have a reduced expression of hair
specific markers and an increased expression of epidermal markers, suggesting a transformation
toward an epidermal structure. Moreover, the expression of multiple signaling pathways involved
in the control of hair follicle cycling, particularly at the telogen to anagen transition, is reduced in
VDR deficient mice. Of particular interest is the hedgehog (Hh) pathway, which shows increased
expression in the epidermis but decreased expression in the hair follicle. By using an agonist to
smoothened, a critical component of the Hh pathway we have been able to restore hair follicle
cycling and hair growth in VDR deficient mice, showing that the lack of this signaling plays a cen-
tral role in VDR deficient hair follicle cycling arrest.
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Mouse models of RAS/MAPK syndromes reveal opposing effects of RAS on hair and skin
development
A Mukhopadhyay,1 SR Krishnaswami,1 KM Haigis2 and BD Yu1 1 Division of Dermatology,
Department of Medicine, University of California, San Diego, CA and 2 Department of
Pathology, Massachusetts General Hospital Cancer Center, Charlestown, MA
RAS/MAPK syndromes represent a family of congenital syndromes with germline mutations in
RAS/MAPK genes. To study the role of RAS signaling in skin development, we investigated mice
bearing activating mutations in single alleles of KRAS or HRAS. We find that strong activating muta-
tions in HRAS or KRAS give rise to a cutaneous phenotype that resembles human Costello syn-
drome. These mice develop redundant skin, short hair, papillomas, and later hair loss. Redundant
skin is associated with increased basal keratinocyte proliferation and a 30% expansion of the nor-
mal body surface. Paradoxically, RAS inhibits hair polarity and growth. We find that hair follicle
defects are associated with a five-fold decrease in Sonic Hedgehog (SHH) levels and reduced acti-
vation of SHH-responsive genes. Furthermore, we find that this reciprocal regulation of SHH lev-
els in the matrix is normally triggered by fibroblast growth factor (FGF) signaling. These findings
along with observations from patients with RAS/MAPK syndromes suggest that different levels of
RAS activation, controlled in part through FGF, are interpeted by discrete cell populations and
molecular pathways to control the overall architecture of skin and hair.
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Regulation of bulge proliferation by RAS and its antagonists
A Mukhopadhyay, SR Krishnaswami and BD Yu Division of Dermatology, Department of
Medicine, University of California, San Diego, CA
Cardiofaciocutaneous (CFC) syndrome is a multi-organ disease associated with progressive hair
loss. The majority of CFC patients have now been found to bear activating mutations in BRAF,
MEK1/2, or KRAS. Our hypothesis is that activated RAS/MAPK signaling blocks hair cycle activa-
tion and prevents regeneration of hair in these patients. To test this hypothesis, we used tissue-spe-
cific activation of KRAS in the mouse and investigated its effects on hair cycle activation. We show
that KRAS inhibits hair cycle activation when expressed globally or specifically in bulge cells. More-
over, we find that mice lacking antagonists of the RAS/MAPK pathway called Sproutys also have
hair cycle defects. Analysis of cell cycle regulation and fate of bulge cells reveals that overactive
RAS signaling has both cell-autonomous and non-cell-autonomous effects on their proliferation.
These findings indicate that hair loss in CFC likely results from hair cycle defects and reveals that
regulation of RAS signaling is critical for the control of bulge activation and arrest.
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Inflammatory mediator TAK1 regulates hair follicle cycling
K Sayama,1 Y Shirakata,1 S Hirakawa,1 K Sugawara,2 P Chambon,3 S Akira,4 R Paus2 and
K Hashimoto1 1 Ehime University School of Medicine, Toon, Japan, 2 University of Hamburg,
Hamburg, Germany, 3 University Louis Pasteur, Illkirch Cedex, France and 4 Osaka
University, Suita, Japan
Transforming growth factor-β-activated kinase 1 (TAK1) is a member of NF-κB pathway and is
involved in IL-1 and TNF-α-induced activation of NF-κB and MAP kinases, and mediates innate
immunity. Recently, TAK1 and TAK1-binding protein 2 have been shown to be involved in EdaR
signaling. Previously, we generated keratinocyte-specific TAK1-deficient mice (Map3k7flox/floxK5-
Cre) and showed that TAK1 regulates keratinocyte differentiation and apoptosis, and hair mor-
phogenesis. To further study the role of TAK1 in hair cycling of postnatal mice, we newly gener-
ated tamoxifen-inducible keratinocyte-specific TAK1-deficient mice (Map3k7flox/floxK14-Cre-ERT2;
TAK1-CKO). In TAK1-CKO mice, Cre-ERT2 was expressed in the epidermis under the control of
K14 promoter and the site and timing of TAK1 deletion is easily controlled by topical application
of tamoxifen to the mouse skin. We applied tamoxifen to the back skin to delete TAK1 immedi-
ately after wax depilation or one week after depilation. There was no hair induction in the TAK1-
CKO mice in two weeks when tamoxifen was applied immediately after depilation and histologi-
cal analysis showed that the hair cycle progression of TAK1-CKO mice was delayed. When TAK1
was deleted one week after the depilation, hair re-growth was delayed compared with control mice,
and their hair elongation seemed to cease in TAK1-CKO mice. These data suggest that TAK1 is
essential for initiation and progression of the anagen phase in postnatal hair cycling.
S100 Journal of Investigative Dermatology (2009), Volume 129
ABSTRACTS
601
TAp63α initiates stratification in a cell context-dependent manner
D Dai,1,2 MI Koster,2 J Chen,2 FJ DeMayo,1 SD Reynolds3 and DR Roop2 1 Program in
Developmental Biology, Baylor College of Medicine, Houston, TX, 2 Department of
Dermatology and Charles C. Gates Regenerative Medicine and Stem Cell Biology Program,
University of Colorado Denver, Aurora, CO and 3 Department of Pediatrics, National Jewish
Medical and Research Center, Denver, CO
The transcription factor p63 is critical for epidermal stratification, as shown by the lack of a strat-
ified epidermis in p63-null mice. The p63 gene encodes six isoforms. Of these, TAp63α is the
only isoform that is expressed before the commitment to stratification, suggesting that this isoform
could be the master regulator of stratification. To test this hypothesis, we used inducible mouse
models to ectopically express TAp63α in different cell types in single-layered lung epithelia, and
determined if this would initiate stratification. We found that ectopic TAp63α expression in type-
II alveolar and distal Clara cells induced keratin 14 (Krt14) expression, a marker of epithelial cells
that have initiated stratification. In contrast, ectopic TAp63α expression in proximal Clara cells
did not induce Krt14 expression. These results suggest that the role of TAp63α in initiating strati-
fication is cell-context dependent. Normally, TAp63α protein is only detected at the early stages
of epidermal development, but not in mature adult epidermis. However, we discovered that wound-
ing the adult epidermis induced a dramatic increase in TAp63α expression. Therefore, we hypoth-
esized that a wound healing environment in the lung may cooperate with TAp63α in initiating
stratification. To test this hypothesis, we used naphthalene to induce injury in Clara cells that ectopi-
cally expressed TAp63α and found that this induced Krt14 expression and stratification. Together,
these data suggest that TAp63α may play a role in epithelial tissue repair and can initiate stratifi-
cation of lung epithelia in a cell context-dependent manner. Our results provide further insights
into the role of p63 in epidermal development and tissue repair.
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Circadian clock genes play a role in regulation of timing of anagen progression in mouse hair
follicles
KK Lin,1 M Geyfman,1 V Kumar,2 D Chudova,3 AT Ihler,3 P Smyth,3 R Paus,4,5 JS Takahashi2 and
B Andersen1 1 Medicine and Biological Chemistry, University of California, Irvine, Irvine, CA,
2 Center for Functional Genomics and Howard Hughes Medical Institute, Northwestern
University, Evanston, IL, 3 Computer Science, University of California, Irvine, Irvine, CA, 4
Dermatology, University of Luebeck, Luebeck, Germany and 5 School of Translational
Medicine, University of Manchester, Manchester, United Kingdom
Hair follicles undergo complex regenerative cycling consisting of active growth during anagen,
apoptotic regression of the lower two-third of the epithelial compartment during catagen, and a
period of relative quiescence in telogen. Many signaling pathways including Shh, Wnt and BMP
have been implicated in the control of hair follicle cycling. Taking a genomics approach to study
gene expression during synchronized mouse hair follicle cycling, we discovered that CLOCK-reg-
ulated genes are regulated during the hair growth cycle, including prominent expression in the
secondary hair germ during telogen and early anagen. Analysis of Clock and Bmal1 mutant mice
revealed a delay in anagen progression, and the secondary hair germ cells show decreased levels
of phosphorylated Rb and lack mitotic cells, suggesting the circadian clock regulates hair follicle
cycling via its effect on the cell cycle. While circadian clock mechanisms have been implicated
in a variety of diurnal biological processes, our data link circadian clock genes to biological oscil-
lation that is weeks in duration.
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Effect of glycyrrhizic acid on hair growth
J Ivosevic-Zaper,1,2 A Kakadjanova,1 J Pfeffer,1 S Kippenberger,1 R Kaufmann,1 J Bereiter-Hahn2
and A Bernd1 1 Department of Dermatology, Goethe University, Medical School, Frankfurt,
Germany and 2 Kinematic Cell Research Group, Goethe University, Frankfurt, Germany
Abnormal hair growth takes some risk of a significant negative impact on the psychosocial devel-
opment of affected people. So far, all known methods for hair removal are more or less effective
and show partly considerable side effects like pain, skin irritation, contact eczema, folliculitis,
and hyper-pigmentation. We found a new principle of painless and rapid hair removal based on
liquorice, a commonly used herbal extract of the tradition Asian medicine. We defined the liquorice
compound glycyrrhizic acid to be responsible for the epilatory effect. We dissolved glycyrrhizic
acid in an aqueous solution containing urea and ethanol and treated wistar rats in the neck region
twice a day. After 3 days first indications for hair loss became visible. After 6-12 days the treated
skin was nearly free of hairs without any sign of skin irritation. Even after a periodically long term
treatment over one year no abnormality of the skin surface was visible, but a permanent reduc-
tion in re-growing hair quantity by more than 50%. Histological analysis of hair follicles and scan-
ning electron microscopy of hairs revealed modifications in the hair cuticle and a detachment of
the hair shaft from the follicular wall. In situ TUNEL assay showed apoptotic cells in the bulge
region after treatment with glycyrrhizic acid. Based on these findings glycyrrhizic acid is a candi-
date molecule for the development of a powerful agent for painless and permanent hair removal.
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A role for p63 in establishing tissue-specific chromatin organization and high-order chro-
matin remodelling in epidermal keratinocytes during skin development
M Fessing,1 A Mardaryev,1 M Gdula,1 A Sharov,2 T Sharova,2 A Panteleyev,3 C Missero4 and
V Botchkarev1,2 1 Centre for Skin Sciences, University of Bradford, Bradford, United
Kingdom, 2 Dermatology, Boston University, Boston, MA, 3 University of Dundee, Dundee,
United Kingdom and 4 CEINGE Biotecnologie Avanzate, Napoli, Italy
During development, multipotent cells establish tissue-specific programmes of gene expression
that underlie a process of differentiation into specialized cell types. Increased evidence suggests
that gene activation or silencing are accompanied by significant changes in three-dimensional chro-
matin structure and may require gene repositioning towards or outwards the transcriptionally active
or inactive nuclear domains, respectively. We show here that during epidermal morphogenesis in
mice, increase of transcriptional activity of keratinocyte-specific genes forming the epidermal dif-
ferentiation complex (EDC) in gene-rich region of mouse chromosome 3 is accompanied by its
relocation from nuclear periphery towards nuclear interior into compartment containing nuclear
speckles and tissue-specific transcription factors Klf-4 and Arnt1. Process of the EDC relocation
towards nuclear interior is strongly altered in p63 knockout mice lacking epidermis and showing
decreased expression of the key genes (Satb1, Brg1) controlling high-order chromatin organization
and remodelling. Furthermore, expressions of the Satb-1 and Brg-1 proteins were strongly reduced
in the skin explants from heterozygous (+/-) p63 knockout mice treated with p63 siRNA, com-
pared to controls. Chromatin IP using extracts of primary epidermal keratinocytes revealed bind-
ing of the p63 to the Satb1 promoter and to the Brg1 intron regions, respectively, suggesting Satb1
and Brg1 as targets for p63 in keratinocytes. Thus, establishment of tissue-specific chromatin organ-
ization and proper EDC positioning in the keratinocytes is required for normal skin development.
p63 as a master regulator of epidermal morphogenesis promotes establishing the “permissive
environment” for efficient expression of tissue-specific genes via modulating high-order chro-
matin organization and remodelling.
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TGF-β2 is expressed in human dermal papilla cells and modulates folliculogenesis
K Inoue,1,2 N Aoi1 and K Yoshimura1 1 Department of Plastic Surgery, University of Tokyo,
Tokyo, Japan and 2 Departments of Dermatology and Genetics & Development, Columbia
University, New York, NY
For regenerative engineering of human hair follicles, it is indispensable to clarify the hair induc-
ing mechanism executed by hDPCs. To explore the hair inducing factors from human dermal papilla
cells (hDPCs), microarray and real-time RT-PCR analyses were performed comparing hDPCs and
human dermal fibroblasts (DF) both obtained from adult scalp skin. Substances which can up-reg-
ulate hDPC-specific genes were also explored. Functional properties of the genes in vivo were
assessed using an animal model generating rat-human or mouse-human chimeric hair follicles.
TGF-β2, but not TGF-β1, was among genes upregulated in hDPCs, and TGF-β2 expression from
hDPCs was further upregulated by a conditioned culture medium of human keratinocytes, which
is known to stimulate hDPC proliferation and minimize a time-dependent loss of hair inducing
capacity of hDPCs. Also found were some other substances which significantly upregulated TGF-
β2 mRNA and protein secretion from DPCs in vitro. One of them was 1,25- dihydroxy-vitamin D3
(1,25-VD3), the active form of vitamin D. Interestingly, 1,25-VD3 also upregulated gene expres-
sion from hDPCs of Wnt10b, a prominent morphogen of hair follicles. In animal models for fol-
liculogenesis, TGF-β2 was expressed in hDPCs of rat-human chimeric hair follicles, and a contin-
uous administration of a selective inhibitor for TGF-β signaling suppressed the number and maturity
of regenerated chimeric hair follicles. Immunohistochemistry of regenerated hair follicles against
several TGF-β signaling molecules revealed that hair follicle maturation was accompanied by trans-
portation of phosphorylated SMAD2 to nuclei of hair follicle epithelial cells and upregulation of
SMAD2 target genes, SMAD7 and PAI-1. These studies suggested that TGF-β2 is highly expressed
specifically in hDPCs, is upregulated by keratinocytes-derived soluble factors or Vitamin D, and
acts as a potent enhancer of folliculogenesis. Vitamin D may modulate folliculogenesis by upreg-
ulating expressions of TGF-β2 and/or Wnt10b in hDPCs.
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Red deer (Cervus elaphus) hair follicles express the genes for at least two forms of potas-
sium channels like human hair follicles
K Zemaryalai, MJ Thornton and VA Randall Medical Biosciences, University of Bradford,
Bradford, United Kingdom
Hair loss e.g. androgenetic alopecia or alopecia areata is psychologically distressing. Minoxidil,
currently the main, but limited, topical treatment for hair loss probably acts by opening ATP-sen-
sitive potassium (KATP) channels. These have recently been detected in human hair follicles (Shorter
et al 2008). Red deer hair follicles offer a model system for studying hair growth in vitro as they
are big follicles, readily available in large numbers without ethical difficulties from animals killed
for food. Various KATP channel openers and closers alter deer follicle growth in culture i.e. with-
out any blood supply, suggesting the presence of KATP channels in hair follicles themselves (Davies
et al., 2005). This study aimed to validate the deer follicle model further by investigating the expres-
sion of KATP channel subunit genes in red deer hair follicles. Skin samples from the neck/mane
region and other tissues of adult male red deer were collected in RNA stabilisation agent, RNA
later. Individual hair follicles were microdissected and pooled from each individual for poly(A)RNA
extraction, cDNA preparation and identification of 5 KATP channel subunit and b-actin genes by
RT-PCR. Gene identity was confirmed by size on gel electophoresis and gene product sequence
analysis. Four KATP channel subunits were detected in deer anagen follicles, SUR1, SUR2B, Kir6.1
and Kir6.2; SUR2A was not expressed in deer follicles although it was detected in the positive con-
trol red deer skeletal muscle and B-actin confirmed the cDNA integrity. These results indicate that
deer hair follicles express the genes for at least two KATP channels, only one of which would respond
to minoxidil. This mirrors the situation in human hair follicles (Shorter et al., 2008) and strength-
ens the use of deer hair follicles as a model system for understanding the biology of hair follicles.
Further investigations using this system should aid the development of better treatments for hair
disorders.
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Human scalp hair follicles express the genes for prostanoid FP receptor
KG Khidhir,1 NP Farjo,2 DF Woodward,3 SM Picksley1 and VA Randall1 1 Biomedical
Sciences/School of Life Sciences, University of Bradford, Bradford, United Kingdom, 2 Farjo
Medical Centre, Manchester, United Kingdom and 3 Department of Biological Sciences,
Allergan Inc, Irvine, CA
Hair growth disorders including hair loss (alopecia) and excessive hair growth (hirsutism), are cur-
rently poorly controlled. Prostaglandins regulate a wide range of physiological functions, but their
role in hair growth is unknown. A prostaglandin F2α analogue, latanoprost, used as a treatment
for patients with glaucoma (ocular hypertension) stimulated eyelash growth as a side effect. The
mechanism of action by which latanoprost increases eyelash length and pigmentation is unknown;
possibilities include direct action on the hair follicle or increasing the follicular blood flow. The
aim of this study was to determine whether human hair follicles contained target receptors for
latanoprost which would allow them to respond directly to the drugs. Therefore, the gene expres-
sion of prostanoid FP receptor was investigated in isolated human hair follicles using RT-PCR. Occip-
ital and parietal scalp skin samples were collected in the RNA stabilising solution, RNAlater, from
4 men and 1 woman aged 38-56. Hair follicles were individually microdissected and pooled for
each sample and poly(A) RNA extracted. RT-PCR was performed to detect the prostanoid FP recep-
tor gene in the human hair follicle using a specific primer set which was newly designed from the
human prostanoid FP receptor gene sequence. RT-PCR using control β-actin primers were carried
out to ensure that the cDNA was of appropriate quality. RT-PCR analysis showed expression of the
appropriate sized product, 1080bp for the prostanoid FP receptor gene and sequence analysis
showed 99% homology with the expected gene sequence. The results suggest that prostaglandin
F2α and its analogues may well be able to act on receptors within the human hair follicle to stim-
ulate growth. Better understanding of the mechanism of action of prostaglandin F2α on hair growth
could help in the development of future treatments for hair loss.
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Effect of adenosine on androgenetic alopecia in Caucasian
T Iwabuchi,1 R Ideta,1 R Ehama,1 M Iino,1 J Nakanishi,1 Y Tsuji,1 T Kobayashi,2 M Ohyama3 and
J Kishimoto1 1 Shiseido Res Ctr, Yokohama, Japan, 2 Dermatology, National Defense Medical
College, Tokorozawa, Japan and 3 Dermatology, Keio University School of Medicine, Tokyo,
Japan
Adenosine is effective for androgenetic alopecia (AGA) in Japanese clinical study. This compound
significantly increases the rate of thick hair in AGA. In this study, we analyzed the effect of adeno-
sine on AGA in Caucasian men. A single-blind, randomized, placebo-controlled study was con-
ducted on 38 Caucasian men aged 35 to 52 years (mean, 41.4 years) for 6 months. All subjects
received a full explanation of this trial and signed a written informed consent prior to the trial.
Subjects topically applied approximately 3 mL of a lotion containing 0.75% adenosine or a lotion
without adenosine (placebo), twice daily for 6 months. Data were obtained at the beginning of the
trial and 6 months thereafter. Scalp hairs of subjects were combed in the middle before taking pic-
tures, and top views of scalps were photographed. Nine well-trained investigators evaluated the
extent of hair loss in each subject by comparing the calibration standard photographs which is a
12-point scale from stage 1 (no hair loss) to stage 12 (severe hair loss). Hairs (approximate 6 mm
x 6 mm square) in the hair loss region were clipped using ophthalmologic scissors. And the area
was digitally imaged using a video microscope. The numbers of hair in this area were counted,
and hair density was calculated as the number of hair shafts/cm2. The density of hair in adenosine
group was significantly increased compared with that of placebo. Assessment by investigators on
hair loss stage in two groups was not significantly changed. These results suggested that adenosine
is effective for hair density in AGA. We will discuss regarding the difference of efficacy of adeno-
sine in Japanese and Caucasian men.
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Bimatoprost, a prostaglandin analog (PGF2α) for open-angle glaucoma, may have future
use to treat androgenetic alopecia
MN Nguyen,1 C Chiang,2 TR Hata1 and AR Shirazi1 1 Dermatology, University of California San
Diego, La Jolla, CA and 2 Dermatology, UCSF, San Francisco, CA
Androgenetic alopecia is a very distressing condition in patients which cause significant emo-
tional turmoil and low self-esteem. Bimatoprost ophthalmic solution 0.03%, a prostaglandin ana-
log (PGF2α), is an effective and widely used medication in the treatment of open-angle glaucoma
(Lumigan®) and has recently been FDA approved for lash lengthening and thickening (Latisse®).
This single-center, 12 month proof of concept trial is the first human study to determine whether
bimatoprost causes a pharmacological effect in stimulating hair growth, density, and thickening.
This was a single-blinded, placebo controlled study of 21 subjects (13 men, 7 women) with andro-
genetic alopecia. Subjects were randomly assigned into three groups: placebo (vehicle alone), low
dose therapy (0.2cc applied twice daily), and high dose therapy (0.4cc applied twice daily). Hair
density was calculated using Mirror Imaging Software© from Canfield Scientific™. At the 12 month
endpoint, the high dose group showed a nonsignificant (p=.15) increase in hair density of 18.5%.
The low dose group demonstrated a significant (p=.02) increase of 18.8%. Of note, the placebo
group showed a nonsignificant (p=.86) increase of only 1.1%. Subjects reported subjective hair
thickness and length on a 7 point scale; There was no significant change in subjective scoring at
12 months. This proof of concept trial suggests that further research is warranted for bimatoprost
as a possible new treatment for androgenetic alopecia.
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Endocrine modulation of human hair follicle epithelial progenitor cells in situ and in vitro:
effects of thyroid hormones, TSH, and calcitriol
S Tiede,1 JE Klatte,1 B Wenzel,2 K Lynaugh3 and R Paus1,3 1 Dept. of Dermatology, University of
Lübeck, Lübeck, Germany, 2 Department of Medicine I, University of Lübeck, Lübeck,
Germany and 3 School of Translational Medicine, University of Manchester, Manchester,
United Kingdom
Cloning of the human K15-promotor into a non-retroviral expression system and transfection of
microdissected, organ-cultured adult human scalp hair follicles generates specific K15-promoter-
driven GFP expression in their stem cell-rich bulge region. Vital progenitor cells can selected by
their green fluorescence, by adhesion to collagen IV and fibronectin, and by their geneticin resist-
ance. Propagated K15-GFP+ cells express common epithelial progenitor markers, show the dif-
ferential gene expression profile of human bulge cells, and form holoclones. Using this novel sys-
tem we provide the first evidence that thyroid hormones (T3, T4) up-regulate K15 promoter activity,
K15 transcription and protein in normal adult human hair follicle epithelial progenitor cells in situ
and in vitro, and show that these cells underlie profound hormonal regulation. Moreover, thyroid
hormones reduce strongly the colony forming efficiency (CFE), proliferation, cell number and via-
bility and induce apoptosis in cultured human K15-GFP+ cells. In culture, thyroid hormones also
induce morphological changes in these cells, possibly even incl. epithelial-mesenchymal transi-
tion (EMT) (as indicated e.g. by upregulation of vimentin). Under the influence of thyroid hormones,
K15-GFP+ cells start to express the TSH-beta-receptor and thus become sensitive to stimulation
with TSH, which completly down-regulates K15 promotor activity. For comparison, we also ana-
lyzed the effects of calcitriol. This steroid hormone also induced morphological changes, upregu-
lated VDR and CD200 expression, and impaired (CFE), in K15-GFP+ cells. These data provide
novel insights into the as yet largely obscure (neuro-)endocrine controls of normal human epithe-
lial progenitor/stem cells in general, and illustrate how primary human K15-GFP+ cells can be
exploited to further elucidate these crucial controls.
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Hedgehog signaling maintains hair follicle stem cell phenotype in young and aged human
skin in vivo
L Rittié, SW Stoll, S Kang, AA Dlugosz, JJ Voorhees and GJ Fisher Dept of Dermatology, Univ of
Michigan, Ann Arbor, MI
The bulge area of hair follicles (HFs) contains skin stem cells (SCs) that regenerate HFs during hair
cycles and repair skin epithelia after injury. Since natural aging decreases skin repair capacity in
humans, we have investigated the extent to which natural aging alters bulge cell properties in
human skin in vivo. To this end, we developed methodologies to isolate, count, and transcrip-
tionally profile living adult human bulge cells from occipital scalp biopsies of young (<40 yo) and
aged (>70 yo) healthy individuals. Consistent with previous reports, we find that human bulge ker-
atinocytes (KCs), enriched in HFSCs, are characterized by preferential gene and protein expres-
sion of CD200, KRT15, and KRT19, compared to differentiated HF KCs. In addition, we find that
natural aging does not alter expression or localization of these HFSC markers, nor does aging change
the number of CD200+/KRT15+/KRT19+ cells in scalp skin, whether SC number was calculated per
skin surface area or per HF (n=5-6, p<0.05). In other tissues or species, several developmental path-
ways govern SC maintenance or differentiation. We therefore quantified transcript levels of poten-
tially relevant developmental pathways’ target genes in human bulge and differentiated HF KCs.
Our results reveal that several Hedgehog (Hh) pathway components and target genes (including
Gli1, Gli2, Ptch1, and Smo) are selectively overexpressed in bulge cells compared to differenti-
ated HF KCs. Selective co-expression of Ptch and CD200 proteins in the bulge area of human HFs
was confirmed by immunofluorescence. In addition, direct comparison of young and aged bulge
KCs indicate that Hh target gene levels are maintained throughout life, suggesting an important
maintenance role. Consistent with this hypothesis, we find that Gli1 overexpression induces tran-
scription of human HFSC markers in KCs in vitro. Taken together, our data demonstrate that aging
does not alter HFSC number in human skin in vivo, and suggest a critical role for Hh signaling in
maintaining HFSC phenotype in human skin throughout life.
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Murine eyelashes as a study model for hypertrichology or alopecia of eyelashes
M Tauchi,1 TA Fuchs,1 DF Woodward2 and E Lütjen-Drecoll1 1 Institute of Anatomy II,
University of Erlangen-Nuremberg, Erlangen, Germany and 2 Department of Biochemistry,
Allergan, Inc., Irvine, CA
We aimed to develop a murine eyelash model for elucidating eyelash-specific mechanisms of hyper-
trichology or alopecia. First we undertook intensive morphological investigations to establish the
model. Upper eyelids from female C57/BL6 mice of various ages (0-6 weeks) were collected. Eye-
lid samples fixed with 4% paraformaldehyde were observed under a stereomicroscope. Eyelids
were then thin-trimmed, and observed under a light microscope. Eyelid samples fixed with Ito’s
fixative were embedded in epon resin. Sections with 1μm thickness were prepared, stained with
Toluidine blue, and observed under a light microscope. After characterizing murine eyelashes, we
applied a trichomeagaly-inducing agent, bimatoprost (3μl; LumiganTM, Allergan), and its vehicle
for 2 weeks to observe possible bimatoprost-induced trichomegaly. Murine eyelashes varied in
length, thickness, and pigmentation, such as small non-pigmented vellus eyelashes and long well-
pigmented eyelashes with medulla structures. The number of eyelashes was increased by 3 week
after birth and stayed the same for at least 6 weeks. The morphogenesis took a similar feature and
time course to that of dorsal skin hairs, followed by a synchronized growth cycle which pro-
gressed faster than dorsal skin hairs. Each follicle had only one completed eyelash, suggesting that
exogen occurs in every cycle. Bimatoprost application induced trichomegaly, which was not asso-
ciated with a formation of new follicles. Morphological abnormalities in follicles were not observed,
but more follicles presented anagen phase and the bulbs of early anagen phase were thicker. In
this study, we characterized murine eyelashes, which respond to a trichomegaly-inducing agent
in a similar manner to human eyelashes. Our data provide useful information on murine eyelashes
as a study model for hypertrichology or alopecia of eyelashes.
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Thyrotropin-releasing hormone (TRH) as a novel, potent modulator of human hair follicle
pigmentation and growth: Reminiscences of our amphibian past?
E Gáspár,1 E Bodó,1 C Hardenbicker,1 I Borbíró,3 T Bíró,3 A Kromminga4 and R Paus1,2 1
Dermatology, University of Lübeck, Lübeck, Germany, 2 School of Translational Medicine,
University of Manchester, Manchester, United Kingdom, 3 Physiology, University of
Debrecen, Debrecen, Hungary and 4 IPM, Hamburg, Germany
Thyrotropin-releasing hormone (TRH) is the most proximal member of the hypothalamic-pitu-
itary-thyroid (HPT) axis, and regulates thyroid hormone homeostasis. Recently, RNA transcripts of
many HPT axis related genes were detected in normal human skin and in isolated human skin cells
in vitro. TRH is also produced in large amounts in amphibian skin where it is thought to modu-
late pigmentation. Almost nothing, however, is known on whether and how TRH affects normal
mammalian skin functions. Here, we report that normal human scalp hair follicles (HF) express
both TRH and TRH-receptor on the mRNA and on the protein level. These receptors are functional,
since stimulation of microdissected, organ-cultured HF with TRH (1-100ng/ml) induces hair shaft
elongation, increases proliferation and decreases apoptosis of hair matrix keratinocytes, and pro-
longs anagen. TRH also exerts direct, pituitary-independent, pigmentation-stimulatory effects on
organ-cultured human scalp HFs: It significantly increases the melanin content, tyrosinase mRNA
expression, and enzyme activity, stimulates melanosome synthesis and dendrite formation of human
HF melanocytes in situ. Thus, human scalp HFs, surface from our study as both, sources and tar-
gets of TRH, which respond to TRH stimulation by well-defined changes in hair growth and pig-
mentation. Therefore, human HFs provide an excellent discovery tool for dissecting novel, non-
classical functions of TRH/TRH-receptor mediated signaling. Our study also reveals an evolutionarily
highly conserved neuroendocrine control system of human pigmentation that may date back to
amphibian skin biology and that deserves full exploration, e.g. as a potential target to prevent or
reverse hair graying. TRH-receptor stimulation may also become a novel hair growth promotion
strategy
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Sweat gland morphogenesis: classification of the developmental stages and expression pat-
terns of cell-type specific markers
T Sharova,1 A Sharov,1 A Mardaryev2 and V Botchkarev1,2 1 Dermatology, Boston University,
Boston, MA and 2 Centre for Skin Sciences, University of Bradford, Bradford, United
Kingdom
Skin development is a complex process in which two embryologically distinct cell layers (epithe-
lium and mesenchyme) interact with each other and give rise to a number of appendages includ-
ing hair follicles, teeth and glands. Here, we describe a process of sweat gland (SWG) morpho-
genesis in mouse foot pads and provide a classification of developmental stages based on the
analysis of expression patterns for markers specific for the secretory (aquaporin 5, AQP5) and
myoepithelial (keratin 5, K5) portions of the gland, respectively. SWG development begins at embry-
onic day 17.5 (E17.5) from the formation of K5-positive placodes in the foot pad epidermis sur-
rounded by homogenously distributed mesenchymal cells that show diffuse alkaline phosphatase
activity (stage 1). Similarly to the development of other types of skin appendages, K5-positive SWG
placodes show down-growth into the mesenchyme (stage 2) between E17.5 and postnatal day 0.5
(P0.5). The onset of coiling in the developing SWG (stage 3) is seen at approximately P1.5 and is
associated with marked decrease of K5 expression in central portion of the SWG epithelium,
while cells occupying more peripheral positions in the developing SWG remain K5-positive. At
P5.5, process of coiling continues and is associated with first appearance of AQP5 expression in
the K5-negative secretory cells, while peripherally positioned K5-positive cells become flattened
and form the myoepithelial portion of the gland (stage 4). Finally, SWG morphogenesis results in
a formation of matured AQ5-positive secretory epithelium surrounded by K5-positive myoepithe-
lial cells (stage 5) at about second week of postnatal life. Thus, these data describe the dynamics
of morphogenetic steps underlying SWG morphogenesis and provide a pragmatic guide for analy-
ses of alterations in SWG development in genetically engineered mouse mutants.
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Dynamic expression profiling of human dermal papilla signature during explant culture
C Higgins,1 K Fantuazzo,2 H Bazzi,2 G Richardson,3 R Bernstein,1 C Jahoda3 and A Christiano1,2
1 Dermatology, Columbia University, New York, NY, 2 Genetics and Development, Columbia
University, New York, NY and 3 Biological and Biomedical Sciences, Durham University,
Durham, United Kingdom
Dermal papillae represent a specialized stem cell niche within the hair follicle, distinct from both
dermal sheath and interfollicular dermal fibroblasts. Upon culturing dermal papillae, the gene
expression signature of dermal papilla cells is dramatically altered, as evidenced by the observed
loss of inductive potential in rodent dermal papilla cells at higher passages. In this study, our aim
was to establish the kinetics of gene expression changes in human dermal papillae during culture.
We first isolated dermal papillae from the scalp skin of three male subjects. RNA was extracted
from the freshly isolated human dermal papillae, then from early explant cultures, and dermal
papillae cells in culture from passages 1 through 5, all established from the same three donor tis-
sues. Using microarray hybridization to compare the dermal papillae cells from the three sub-
jects, we identified changes in gene expression between freshly isolated human dermal papillae,
early explants in culture, and those cultured from passages 1 and 5. We found a large number of
transcripts whose expression was altered significantly during the initial explant stage of dermal
papilla cell culture. Surprisingly, relatively few further changes were observed after passaging.
Genes whose expression was lost during explant culture included BMP, Wnt and FGF signaling
antagonists. One such gene was Noggin, with a proposed role in both hair follicle induction and
anagen initiation. Noggin mRNA was downregulated 10-fold in explanted dermal papilla com-
pared to freshly isolated dermal papillae. Another example is the BMP and Wnt signaling inhibitor,
Wise, which was downregulated 198-fold in explanted dermal papillae. We postulate that the
abrupt change in the expression signature between intact dermal papillae and papilla cells in
explant culture may reflect an early loss of inductive potential of human dermal papilla cells in
vitro.
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In vitro susceptibility of Propionibacterium acnes and skin permeation of NB-00X formula-
tions
J Pannu, S Ciotti, R Eisma, L Ma and J Sutcliffe NanoBio Corporation, Ann Arbor, MI
NB-00X, an oil-in-water topical nanoemulsion, has previously been shown to distribute preferen-
tially in hair follicles and sebaceous glands, the sites of acne pathogenesis. This study sought to
determine the susceptibility of P. acnes to NB-00X and comparator drugs and to evaluate the uptake
of NB-00X formulations into swine skin. Minimum inhibitory concentrations (MIC) and bacterici-
dal concentrations (MBC) to clinical isolates of P. acnes with defined resistance mechanisms to
erythromycin, clindamycin and tetracycline were determined using standard methodology (Clini-
cal and Laboratory Standards Institute). Skin permeation studies were performed using swine skin
in an in vitro Franz diffusion cell apparatus. NB-00X in the epidermis and dermis was quantified
by HPLC using an integral nanoemulsion component, cetylpyridinium chloride (CPC). The
MIC90/MBC90 values were 0.5/2.0 μg/ml for NB-00X and 1 μg/ml/2 μg/ml for NB-00X gel, respec-
tively. Both NB-00X formulations were bactericidal against all the isolates, including those that
were erythromycin-, clindamycin- and/or tetracycline-resistant. Benzoyl peroxide and salicyclic
acid had MIC90/MBC90 values of 50/200 μg/ml and 1000/2000 μg/ml, respectively. Both formula-
tions delivered similar amounts of CPC into the epidermal and dermal layers 24 hours after a sin-
gle application (~800 and 30 μg/g tissue, respectively). However, NB-00X gel delivered two-fold
more CPC into the epidermal layer compared to NB-00X at the 12 hour time point. Similar CPC
levels were found in the dermal layer. This study demonstrated that NB-00X formulations have rel-
evant antibacterial activities against recent clinical isolates of P. acnes, including multidrug-resist-
ant strains. The NB-00X gel delivered at a faster rate than NB-00X, but the same maximal skin lev-
els were achieved over 24 hours. Given the in vitro activity of NB-00X and that the nanoemulsion
preferentially reaches the site of infection via a transfollicular route, further evaluation of NB-00X
formulations for use in the treatment of acne vulgaris is warranted.
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Involvement of the Lhx2 transcription factor in the control of stem cells activity during epi-
dermal development, tumorigenesis and wound healing
A Mardaryev,1 A Sharov,2 T Sharova,2 M Fessing1 and V Botchkarev1,2 1 Centre of Skin Sciences,
University of Bradford, Bradford, United Kingdom and 2 Dermatology, Boston University,
Boston, MA
Lhx genes play essential roles in the morphogenesis and patterning of ectodermal derivatives. It
was shown previously that in the hair follicles, Lhx2 play an essential role in the control of activ-
ity of epithelial stem cells. We demonstrate here that during epidermal morphogenesis in mice,
Lhx2 shows placode-specific expression pattern and is seen exclusively in hair follicle placodes,
while is absent in the sweat gland placodes. In postnatal hair follicles, Lhx2-positive cells are located
in the bulge, secondary hair germ and outer root sheath and are likely to represent a subset of the
epithelial stem cells and/or their progenies. In K14-Noggin mice that show development of spon-
taneous trichofolliculoma-like hair follicle-derived tumours, numerous Lhx2-positive cells are seen
in the tumour placodes and follicular outer root sheath. Expression of the Lhx2 transcripts show
dynamic expression during the wound healing associated with expansion of the Lhx2-positive cells
from the follicular bulge towards the wound. In heterozygous (+/-) Lhx2 knockout mice, the wound
healing process is significantly retarded compared to the wild-type controls, thus suggesting a
contribution of Lhx2 to regeneration of the skin epithelium. By microarray and RT-PCR analyses,
expressions of genes involved in the control of keratinocyte proliferation/differentiation as well as
selected markers of epithelial stem cells (Sox9, Lgr5) were altered in Lhx2 knockout (-/-) mice ver-
sus wild-type controls. These data provide evidence that Lhx2 is involved in regulating the activ-
ity of epithelial stem cells and/or their progenies during epidermal development, wound healing
and tumorigenesis and suggest that modulating the Lhx2 activity may be useful for the develop-
ment of new approaches for therapy of a number of pathological skin conditions associated with
un-controlled activation or suppression of epithelial stem cells.
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Trichothiodystrophy patients with XPD mutations and features of COFS or features of Cock-
ayne syndrome
M Sarihan,1,2 SG Khan,1 NJ Mendelsohn,3 J Boyle,1 D Tamura,1 JJ DiGiovanna,1,4 BP Brooks,5
M Merideth6 and KH Kraemer1 1 Basic Research Laboratory, NCI, Bethesda, MD, 2 CRTP
Fellowship Program, NIH, Bethesda, MD, 3 Dept of Genetics, Children’s Hospitals and
Clinics of Minnesota, Minneapolis, MN, 4 Dept of Derm, Brown Med School, Providence, RI,
5 NEI, NIH, Bethesda, MD and 6 NHGRI, NIH, Bethesda, MD
Trichothiodystrophy (TTD), cerebro-oculo-facial-skeletal (COFS) syndrome, and Cockayne syn-
drome (CS) are rare, autosomal recessive disorders characterized by defective DNA repair but
with different clinical manifestations. Combinations of different DNA repair disorders have been
reported previously, such as xeroderma pigmentosum (XP)/CS complex and XP/TTD. We describe
two sisters with TTD/CS features and an infant with TTD/COFS. All three patients presented with
major features of TTD including abnormal hair (brittle hair, hair shaft defects, and tiger tail band-
ing on polarized microscopy), skin (ichthyosis, sun sensitivity without freckling), short stature, micro-
cephaly and low birth weight. TTD406BE and TTD407BE, 9 y/o and 7 y/o sisters, had features of
CS including microphthalmia, deep set eyes, pigmentary retinopathy and progressive neurologi-
cal degeneration. The third patient, TTD373BE, an 11month old girl, had features of COFS with
facial dysmorphism, microphthalmia, severe developmental delay and early death. Genomic DNA
sequencing revealed that these patients were compound heterozygotes with mutations in the XPD
nucleotide excision repair helicase. The TTD/CS sisters had an R112H mutation which was previ-
ously identified in TTD, XP, XP/CS and XP/TTD patients. Their L461V mutation was not associated
with the 15 base pair deletion previously described in TTD, XP and XP/CS patients. TTD373BE
had mutations R616W and D681W which were previously reported for another COFS patient.
These findings further illustrate the complexity of XPD gene defects and the diversity of pheno-
types. Further studies of these patients may provide more insights into the genotype-phenotype
relationship.
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Dissecting the role of cannabinoid receptor 1 (CB1) signaling in normal human skin mast
cell (MC) biology in situ
K Sugawara,1 T Biro2 and R Paus1,3 1 Dermatology, University of Luebeck, Luebeck, Germany,
2 Physiology, University of Debrecen, Debrecen, Hungary and 3 Dermatological Sciences,
University of Manchester, Manchester, United Kingdom
Recently, exo- and endocannnabinoids have been identified as yet another class of MC regulators
in cell culture. Predominantly, they appear to exert to inhibit MCs degranulation and may control
their proliferation in a specific cannabinoid receptor (CB) subtype-dependent manner. We have
previously shown that locally produced prototypic endocannabinoids (e.g. anandamide, AEA)
markedly inhibit the growth of organ-cultured human hair follicles (HFs) via CB1 (Telek et al, FASEB
J, 2007). We now have dissected the potential role of CB1-mediated signaling in human skin MC
in situ, studying exclusively connective tissue sheath MCs (CTS-MC) in microdiossected, organ-
cultured human HF. Double staining for CB1 and c-kit revealed that CTS-MCs express CB1 in situ.
AEA and the CB1-specific synthetic agonist ACEA did not significantly change the number or degran-
ulation of these MCs. In contrast, the CB1-specific antagonist AM251 markedly up-regulated the
number of MCs, stimulated their degranulation, and increased the number of c-kit+ cells within
the CTS. Since the above effects were effectively abrogated by the cannabinoid agonists, this sug-
gests an endogenously active inhibitory function of the endocannabinoid system in suppressing the
activation of normal resident human skin MC within their natural tissue environment. In accor-
dance with such a putative anti-inflammatory action of the endocannabinoid system of human skin,
examinantion of model MC lines (e.g. HMC-1, RBL) revealed that endocannabinoids effectively
abrogate the action of various pro-inflammatory MC secretagogues. Taken together, these results
suggest that CB1 signaling regulates not only human hair growth but also MC degranulation and
proliferation in normal human skin. In addition, we show that HF organ culture deserves to by dis-
covered and exploited by the mast cell research community as an excellent model system for study-
ing and manipulating primary human skin MCs within their natural tissue context.
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Disruption of LIPH/LPA/P2Y5 pathway in autosomal recessive woolly hair/hypotrichosis
M Kurban,1 Y Shimomura,1 M Wajid,1 A Zlotogorski,3 M Ito4 and A Christiano1,2 1 Dermatology,
Columbia University, New York, NY, 2 Genetics and Development, Columbia University, New
York, NY, 3 Dermatology and the Center for Genetic Diseases of the Skin and Hair, Hadassah-
Hebrew University, Jerusalem, Israel and 4 Dermatology, Niigata University, Niigata, Japan
Autosomal recessive woolly hair (ARWH)/hypotrichosis is a hereditary hair disorder which is char-
acterized by tightly curled hair, which usually progresses to sparse or absent hair. ARWH can be
caused by mutations in either the P2RY5 or lipase H (LIPH) gene. Here, we show extensive genetic
evidence that disruption of either gene results in phenotypes with features of both WH and hypotri-
chosis. In this study, we identified two Guyanese families with ARWH, both of which are of recent
Indian descent. Mutation analysis resulted in the identification of mutations in the LIPH gene in
both families. Affected individuals in the first family carry compound heterozygous mutations
Ex7_8del and 1303_1309dupGAAAACG in the LIPH gene, and those in the second family have a
homozygous mutation 659_660delTA in LIPH. Interestingly, the mutations Ex7_8del and
659_660delTA were previously identified in several Pakistani families with ARWH. Haplotype
analysis using microsatellite markers close to the LIPH gene defined a founder haplotype shared
in families from Pakistan and Guyana. In addition, we identified 8 consanguineous Pakistani fam-
ilies with ARWH, and found pathogenic mutations in the P2RY5 gene in all 8 families. Finally, we
analyzed a Japanese family with ARWH, and identified compound heterozygous mutations in the
LIPH gene. The LIPH gene encodes a phospholipase A1 family member and is a key enzyme in
the synthesis of lysophosphatidic acid (LPA) which is an extracellular mediator of many biological
functions. The P2RY5 gene encodes a G protein-coupled receptor known as P2Y5, which was
recently shown to be a LPA receptor. Our results underscore the crucial role of the LIPH/LPA/P2Y5
signaling pathway in hair growth in humans.
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Chemotherapy–induced alopecia in a novel adult rat model: Relation to the hair follicle cycle
T Cao,1 E Alvarez-Connelly,1 J Simon,1,3 LM Mauro,2 G Elgart,1 EV Badiavas,1 LA Schachner,1
B Roberts,1 CI Perez1 and JJ Jimenez1 1 Department of Dermatology and Cutaneous Surgery,
University of Miami, Miller School of Medicine, Miami, FL, 2 Department of Biochemistry,
University of Miami, Miller School of Medicine, Miami, FL and 3 University of Medicine and
Dentistry of New Jersey, Newark, NJ
Chemotherapy-induced alopecia (CIA) is a common and psychologically devastating side effect of
chemotherapy, currently with no preventive treatment. CIA occurs due to the cytotoxicity of anti-
neoplastic drugs on proliferating cells in anagen hair follicles. Here we report CIA in a novel pig-
mented rat model, in both juvenile and adult Long-Evans rats. Rats were injected with etoposide
daily for three consecutive days at 1.5μg/g intraperitoneally (i.p.) starting on day 7, 14, or 21, or
at 25μg/g i.p. on day 36 after birth. Alternatively, cyclophosphamide was injected once at 37.5μg/g,
i.p. on day 7,14, or 21, or at 150μg/g on day 36 after birth. Treated rats were subsequently moni-
tored for hair loss. Rats treated on day 7 to 9 developed total alopecia; rats treated on day 14 to
16 developed alopecia only on the trunk and limbs, but the scalp was protected against CIA; and
rats treated on day 21 to 23 showed no hair loss. Interestingly, rats treated on day 36 only devel-
oped alopecia on the dorsum if the hair was clipped on day 22 after birth. Histological analysis
confirmed that hair loss only occurred when the follicles were in anagen at the time of treatment.
Our observations support the notion that CIA in rats is anagen-dependent. This adult model of syn-
chronized anagen phase further validates the observations made in the young rat model of CIA.
Thus, this novel model may complement the neonatal rat model to study multiple courses of
chemotherapies, more closely mimicking the human setting.
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Identification of mutations in the hairless gene in Pakistani families with Atrichia and papu-
lar lesions
Y Kobayashi,1 M Kurban,1 M Wajid,1 Y Shimomura1 and A Christiano1,2 1 Dermatology,
Columbia University, New York, NY and 2 Genetics and Development, Columbia University,
New York, NY
Atrichia with papular lesions (APL; OMIM 209500) is an autosomal recessive disorder, character-
ized clinically by normal scalp hair phenotype at birth with subsequent irreversible hair loss
occurring during the first year of life. Patients also have absent facial, axillary and pubic hair. Dur-
ing childhood, patients develop papules over the face, arms, elbows, and knees. Clinically, the
condition is frequently misdiagnosed as alopecia universalis. Histology includes, empty hair folli-
cle infundibula, absence of the lower two thirds of the hair follicles that is often replaced by ver-
tically oriented irregular epithelial structures that are devoid of hair shafts but surrounded by a clear
layer of cells which is derived from the outer hair root sheath, and keratin cysts involving the der-
mis and demonstrating a granular cell layer often surrounded by normal sebaceous glands and
smooth muscles . APL is caused by mutations in Hairless gene located on chromosome 8p12.
Hairless plays a crucial role in the cell cycle and hair follicle regeneration through the regulation
of gene expression during catagen. To date, more than thirty different mutations including mis-
sense, nonsense, deletion, and insertion mutations have been reported. We recently identified seven
Pakistani families with classical features of APL, although some of them retained their facial, axil-
lary, and pubic hair. Mutation analysis led to the identification of three recurrent mutations, Q502X,
D1012N, and 1782-1783delAG in three families and four novel mutations, 3222-323 del15; ins5,
3373delC, R506G, and R1099P in the other four families. Our results expand the spectrum of muta-
tions in the HR gene which underlie APL.
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SWAMP, a novel inhibitor of Wnt signaling, is mutated in Hereditary Hypotrichosis Simplex
Y Shimomura,1 D Agalliu,2 A Vonica,3 V Luria,1 A Baumer,4 S Belli,5 L Petukhova,1 M Wajid,1
A Schinzel,4 BA Barres2 and AM Christiano1,6 1 Department of Dermatology, Columbia
University, New York, NY, 2 Departmant of Neurobiology, Stanford University, Stanford, CA,
3 The Laboratory of Vertebrate Embryology, The Rockefeller University, New York, NY, 4
Institute of Medical Genetics, University of Zurich, Zurich, Switzerland, 5 Consultorio
Genetico, Trento, Italy and 6 Department of Genetics & Development, Columbia University,
New York, NY
Hereditary hypotrichosis simplex (HHS; OMIM 605389) is a rare, autosomal dominant form of
hereditary hair loss. To identify a gene involved in HHS, we performed genetic linkage analysis in
two families of Pakistani origin with HHS, characterized by progressive loss and thinning of scalp
and body hairs. We identified a region of linkage on chromosome 18p11 in both families (Z=4.60).
Direct sequencing analysis of candidate genes in the interval led to the identification of a het-
erozygous missense mutation in the N-terminal signal peptide sequence in one of the candidate
genes, which encodes a protein of unknown function. We replicated this finding by sequencing
the gene in a third HHS family from Italy that had previously been linked to chromosome 18p, and
unexpectedly identified the identical missense mutation. Expression of the mutant protein demon-
strates that the mutation severely perturbs translational processing. The protein is intensely expressed
in the dermal papilla, the matrix, and the hair shaft of human hair follicles. Functional studies of
this gene in both frog and chick embryos showed that it inhibits Wnt signaling and is upstream of
beta-catenin. In chick spinal cord, overexpression of the gene results in a marked decrease of wnt-
dependent spinal cord neuronal populations. In frog, overexpression results in axis duplication and
blockade of downstream targets of Wnt signaling. Our findings uncover a novel component of the
Wnt signaling pathway, which we have designated SWAMP (Secreted Wnt Antagonist Mutated in
hyPotrichosis), with an essential role in human hair growth.
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Fibroblast growth factor 9 from dendritic epidermal T cells promotes hair follicle neogene-
sis after wounding in adult skin
O Kwon,1 M Ito,1 Z Yang,1 F Wang,2 DM Ornitz3 and G Cotsarelis1 1 Department of
Dermatology, Kligman Laboratories, University of Pennsylvania School of Medicine,
Philadelphia, PA, 2 Center for Cancer Biology and Nutrition, Institute of Biosciences and
Technology, Texas A&M University System Health Science Center, Houston, TX and 3
Department of Developmental Biology, Washington University School of Medicine, St Louis,
MO
To better understand the molecular events responsible for de novo hair follicle formation after
wounding, we analyzed gene expression changes in the epidermis around the time of hair follicle
neogenesis. We discovered that fibroblast growth factor 9 (FGF9) was upregulated by quantitative
Real Time PCR prior to new hair follicle formation. Surprisingly, by immunohistochemistry, FGF9
was expressed selectively by γδ T cell receptor-bearing dendritic epidermal T cells (DETCs) in the
regenerated epidermis. FGF9 expression was highly induced in vitro by stimulation of isolated
DETCs. These cells have been shown to play an important role in epidermal homeostasis and tis-
sue repair through local secretion of distinct factors such as KGFs and IGF-1. To test the role of
FGF9 in hair follicle neogenesis following wounding, we overexpressed FGF9 in the epidermis of
doxycycline-inducible transgenic mice (K14rtTA x TRE-Fgf9-IRES-eGfp) and demonstrated that
induced FGF9 expression immediately after reepithelialization increased the number and size of
hair follicles compared to controls. Exogenous FGF9 added to embryonic skin (E13.5) explant cul-
tures also resulted in increased numbers of hair follicles compared to controls. FGF9 neutralizing
antibodies injected into the reepithelialized wound suppressed new hair follicle development. Sim-
ilarly, hair follicle number and stage of development were significantly suppressed in mutant mice
carrying a deletion of the Fgf9 gene in DETCs (lck-cre x Fgf9flox/flox). Thus these data demonstrate
a novel role for FGF9 and DETCs in hair follicle neogenesis, and suggest manipulation of FGF9
expression as a tool to enhance this process.
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Transgenic expression of Smad1 in keratinocytes impairs postnatal hair follicle cycling, wound
healing and prevents tumorigenesis via functional restriction of epithelial stem cells
TY Sharova,1 AN Mardaryev,1,2 VA Botchkarev1,2 and AA Sharov1 1 Dermatology, Boston
University School of Medicine, Boston, MA and 2 Centre for Skin Sciences, Bradford
University, Bradford, United Kingdom
Bone morphogenetic proteins (BMPs) signaling plays pivotal roles in the control of skin develop-
ment and are also implicated in the control of skin carcinogenesis. Several lines of evidence sug-
gest that BMPs realizes its effects in the skin, at least in part, via the controlling activation and main-
tenance of epithelial stem cells and/or their progenies. To access the role of BMP-Smad pathway
in skin development, postnatal regeneration and tumorigenesis, K14-Smad1 transgenic (TG) mice
were generated. Despite a relatively normal hair follicle morphogenesis, TG mice demonstrated
strong retardation in the hair follicle entering new anagen phase and showed gradual hair loss post-
natally. Delayed telogen-anagen transition in TG mice was accompanied by decreased prolifera-
tion of hair follicle stem cells depicted by the significant retention of bromodeoxyuridine in the
hair follicle bulge. In addition, the healing process of full-thickness skin incisions was significantly
delayed in K14-Smad1 mice compared to controls. Furthermore, in double K14-Noggin/K14-Smad1
TG mice, overexpression of Smad1 protein was able to strongly inhibit formation of spontaneous
trichofolliculoma-like hair follicle-derived tumors. Immunohistochemical analysis demonstrated
that double TG animals have increased number of label-retaining, CD34 and Keratin 15 positive
cells in the bulge area compared to K14-Noggin littermates. Since activation of the hair follicle
cycling, wound healing and tumor formation require the involvement of epithelial stem cells, these
data suggest that BMP-Smad signaling pathway is indeed involved in the controlling the mainte-
nance and activity of stem cells and/or their progenies in postnatal skin.
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Role of Dlx3 in hair cycling
J Kim,1,2 J Hwang,1 J Suh1 and MI Morasso1 1 Developmental Skin Biology Section,
NIAMS/NIH, Bethesda, MD and 2 Dept. of Dermatology, Hanyang Univertisy College of
Medicine, Seoul, Korea, South
Ectodermal appendages such as hair and tooth are attractive models for understanding the mech-
anisms underlying epithelial-mesenchymal interactions. Dlx3 belongs to the Distal-less family of
homeodomain transcription factors, and an autosomal dominant mutation in DLX3 is responsible
for the ectodermal dysplasia termed Tricho-Dento-Osseous syndrome (TDO), characterized by
defects in hair, tooth, and bone development. Recently, we assessed the function of Dlx3 as a cru-
cial transcriptional regulator of hair formation and regeneration using a Cre-mediated knockout
mouse model. The most striking defect in those mice was complete alopecia due to failure in hair
morphogenesis and cycling. However, it is not clear that the failure of hair cycling is due to a direct
result from Dlx3 loss or a secondary effect from an incomplete first anagen in the Cre-mediated
knockout mouse. To further investigate the specific role of Dlx3 in the hair cycle, we are utilizing
a tamoxifen-inducible system by crosses of K14-CreERT mice with Dlx3-floxed mice. Knockout of
Dlx3 expression is accomplished by the topical application of tamoxifen during the first postnatal
catagen, especially to avoid the cumulative effect from an incomplete hair cycle as mentioned
above. Our preliminary results establish Dlx3 as an essential regulator of hair cycling, validated
by the permanent hair loss in the inducible knockout mice.
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Analysis of Scarf expression pattern in LacZ knockin mice
J Hwang, OE Kalinin, M Hwang and MI Morasso Developmental Skin Biology Section,
NIAMS/NIH, Bethesda, MD
Calcium is a ubiquitous intracellular messenger that regulates numerous cellular and develop-
mental processes including epidermal differentiation. In our previous studies, Scarf (Skin Calmod-
ulin related factor) was identified as a skin-specific calcium-binding protein expressed mainly in
the differentiated layers of the mouse epidermis. Binding target proteins of Scarf were determined
by affinity chromatography and mass spectrometry, and their functions were assessed during epi-
dermal barrier disruption and wound healing. These results determined that Scarf plays a critical
role as a calcium sensor, regulating the function of its binding target proteins in a calcium-depend-
ent manner. An in depth analysis of the expression pattern of Scarf is being performed using a
knockin mouse carrying the reporter of β-galactosidase (LacZ) gene under the control of endoge-
nous Scarf promoter. X-gal staining of embryos shows scarf expression in skin and hair follicles at
different developmental stages. Scarf expression is first detected in vibrissae at E13.5, and in skin
and hair follicle at E14.5. To determine the specific localization of Scarf expression in the hair fol-
licle, immunofluorescence staining is being carried out with antibodies against keratins K5, K14,
K15, K17 and K35, transcription factors such as Dlx3 and Hoxc13, and follicular signaling mole-
cules including Lef1, β-catenin, and Smads. The analysis of Scarf expression pattern will provide
insight into the function of Scarf in hair follicle and epidermal development.
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Delay of hair growth by oxidants in a neonatal rat model
JJ Jimenez,1 T Cao,1 J Simon,1,2 LM Mauro,3 CI Perez,1 B Roberts,1 G Elgart,1 E Alvarez-Connelly1
and LA Schachner1 1 Department of Dermatology and Cutaneous Surgery, University of
Miami Miller School of Medicine, Miami, FL, 2 University of Medicine and Dentistry of New
Jersey, Newark, NJ and 3 Department of Biochemistry, University of Miami Miller School of
Medicine, Miami, FL
Whereas there has been extensive research on the structural abnormalities of hair follicles (HFs)
induced by oxidants in cosmetic preparations such as hair dyes and bleaches, a possible correla-
tion between long-term use of these agents and alopecia remains to be investigated. In previous
studies, tert-Butyl hydroperoxide (tBHP), an organic peroxide, has been shown to cause reversible
damage to keratinocytes in vitro when administered short-term at low concentrations and irre-
versible damages with prolonged administration at higher concentrations. Here we analyze the
effects of tBHP on anagen HFs in vivo in a neonatal rat model. Sprague-Dawley and Long-Evans
pups were injected in the nape of the neck with tBHP (100μl of 20μl/ml in PBS s.c.) once daily
from day 5 to day 10 after birth, and monitored for hair growth. Oxidant treated rats showed a delay
in hair growth until shortly after withdrawal of treatment. Visible hair shafts were first observed 11
days post-treatment. Skin samples were collected upon treatment cessation every two days for
twelve days. Histological analysis confirmed the delay in anagen HF growth in treated rats. Sub-
sequent reentry of anagen HFs was first observed histologically three days after treatment cessa-
tion. This observation was confirmed by increased proliferating keratinocytes as shown by BrdU
incorporation within anagen HFs of treated rats. In conclusion, the rapid recovery upon oxidant
withdrawal suggests that the changes incurred in HFs by short-term use of high dose oxidants were
reversible in vivo. This neonatal rat model can be used in future studies to delineate the mecha-
nism of oxidant-induced damages in HFs.
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MicroRNAs (miRNA) in hair-cycle-dependent gene regulation, hair growth control, and asso-
ciated tissue remodeling
A Mardaryev,1 M Ahmed,1 A Sharov2 and N Botchkareva1 1 Centre for Skin Sciences, University
of Bradford, Bradford, United Kingdom and 2 Dermatology, Boston University, Boston, MA
The hair follicle (HF) is a cyclic biological system that progresses through stages of growth, regres-
sion and quiescence, each being characterized by unique patterns of gene activation and silenc-
ing. MiRNAs are critically important for gene silencing and delineating their role in hair cycle may
provide new insights into mechanisms of hair growth control and epithelial tissue remodelling.
Therefore, the aims of this study were i) to define changes in the miRNA profiles in skin during hair
cycle-associated tissue remodelling, and ii) to determine the role of miRNAs and their targets in
regulating gene expression programs that drive hair follicle growth, involution, and quiescence.
To identify miRNA signatures in the HF at distinct hair cycle stages, miRNAs were isolated from
the murine skin, and obtained samples were processed for evaluation of global miRNA expression
patterns using the microarray profiling approach. To validate data obtained from the microarray
profiling, real-time PCR analysis of specific miRNAs and in situ hybridization for selected miRNAs
were performed. Microarray analysis of HFs at distinct hair cycle stages revealed substantial hair
cycle-dependent changes in the expression of selected miRNAs. Low levels of miR-31 were detected
in telogen skin; however, its expression significantly increased during anagen and declined during
catagen. In contrast, high levels of miR-148a and miR-152 were found in telogen and their levels
dramatically decreased during anagen. Inhibition of these miRNAs in telogen skin using anti-sense
miRNA-specific inhibitors resulted in alterations of HF telogen-anagen transition. In primary epi-
dermal keratinocytes, inhibition of mir-31 resulted in substantial changes in expression of genes
involved in the control of keratinocyte proliferation/ differentiation. Thus, these data suggest a role
for miR-31, miR-148a and miR-152 in the control of gene expression programs driving hair folli-
cle growth and hair cycle-associated tissue remodelling.
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HSP-70 expression and Alopecia Areata development in C3H/HeJ mice
T Cao,1 E Alvarez-Connelly,1 J Simon,1,2 LM Mauro,3 G Elgart,1 LA Schachner,1 B Roberts,1
CI Perez,1 L Plano,4 J Chen4 and JJ Jimenez1 1 Department of Dermatology and Cutaneous
Surgery, University of Miami Miller School of Medicine, Miami, FL, 2 University of Medicine
and Dentistry of New Jersey, Newark, NJ, 3 Department of Biochemistry, University of Miami
Miller School of Medicine, Miami, FL and 4 Department of Pediatrics, University of Miami
Miller School of Medicine, Miami, FL
Alopecia areata (AA) is a common T-cell mediated autoimmune disease characterized by non-scar-
ring alopecia, which carries tremendous psychosocial implications in those affected. Earlier stud-
ies have shown an association between AA and stress. Heat shock protein 70 (HSP-70) primarily
functions as a molecular chaperone that is upregulated in response to heat shock and other types
of stress. HSP-70 has also been shown to trigger autoimmunity in vivo by stimulating T-cell medi-
ated responses. Previously, we have shown a statistically significant increase in incidence of AA
in heat-treated C3H/HeJ mice. In this study, we examined HSP-70 expression in heat treated mice
and mice with spontaneous AA. Eighteen-month old C3H/HeJ mice were heated at 48.5°C on the
trunk for 20 minutes once a week for six weeks. Skin samples from heated areas were collected
one day post-treatment. They were compared with samples from age-matched mice with sponta-
neous AA and location-matched samples from mice without AA. Histological analysis confirmed
AA by the presence of peri- and intrafollicular infiltration of anagen HFs by mononuclear cells.
Inducible HSP-70 (HSP-70i) expression was subsequently analyzed by Western blot. Untreated
mouse skin exhibited a low baseline level of HSP-70i expression, while skin samples from mice
with spontaneous AA and from heat-treated mice with and without AA showed an increased expres-
sion of HSP-70i. In conclusion, the elevated HSP-70 expression may be associated with the devel-
opment of AA in C3H/HeJ mice. The C3H/HeJ mouse model of heat shock treatment is a useful
tool to study the stress response in AA.
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Cross-talk between AHR and PPAR gamma signaling pathways in Cicatricial Alopecia
LF Xu,1,2 P Mirmirani,3 VH Price,3 TS McCormick,1,2 KD Cooper1,2 and P Karnik1,2 1
Dermatology, University Hospitals Case Medical Center, Cleveland, OH, 2 Dermatology,
Case Western Reserve University, Cleveland, OH and 3 Dermatology, University of California,
San Francisco, CA
We previously showed that Peroxisome Proliferator Activated Receptor Gamma (PPARG) is cru-
cial for healthy pilosebaceous units and loss of this function triggers the pathogenesis of lichen
planopilaris (LPP), a cicatricial alopecia (CA). However, the mechanisms responsible for loss of
PPARG signaling in CA are not understood. Microarray analysis of unaffected and affected scalp
biopsies from patients with lymphocytic and neutrophilic CA revealed upregulated Aryl Hydro-
carbon Receptor (AHR) signaling and xenobiotic metabolism by cytochrome P450 (CYPs). The
AHR is a ligand-activated transcription factor best known for mediating the toxicity of dioxin. The
CYP1A1 gene, a direct target of AhR-mediated transcription, is significantly upregulated (~20 fold)
in all paired unaffected and affected lymphocytic and neutrophilic CA. Ingenuity Pathway Analy-
sis (IPA) of microarray data revealed that AHR and PPARG signaling pathways converge on bio-
logical processes as diverse as growth response, metabolism, inflammation and tissue remodeling
by impinging on common cellular target genes. Treatment of hair follicle outer root sheath (ORS)
cells with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) showed a > 5-fold decrease in PPARG gene
expression and a significant increase in expression of CYP1A1 gene. This suggests that activation
of AHR directly inhibits PPARG gene expression as predicted from microarray and IPA analysis.
PPARG antagonist (GW9662) treatment of ORS cells caused a significant increase in CYP1A1
gene expression thus demonstrating that inhibition of PPARG activates the AHR signaling path-
way. Our data suggest a mutually antagonistic regulation between PPARG and AHR which likely
plays a central role in modulating inflammation and scarring in CA. Thus, PPAR gamma agonists
may provide novel therapeutic strategies in the treatment of CA.
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On the origin of hair: comparative analyses suggest that a common ancestor of modern rep-
tiles and mammals expressed hair keratins in the claws
L Eckhart,1 K Jaeger,1 S Szabo,1 L Dalla Valle,2 M Ghannadan,1 M Hermann,3 L Alibardi2 and
E Tschachler1,4 1 Research Division of Biology and Pathobiology of the Skin, Department of
Dermatology, Medical University of Vienna, Vienna, Austria, 2 Dipartimento di Biologia,
Università di Padova, Padova, Italy, 3 Max F. Perutz Laboratories, Medical University of
Vienna, Vienna, Austria and 4 Centre de Recherches et d Investigations Epidermiques et
Sensorielles (CE.R.I.E.S.), Neuilly, France
The presence of hair is one of the specific characters of mammals and, hence, the origin of hair
has been a central event in mammalian evolution. The main components of hair are the “hair ker-
atins”. These proteins contain multiple cysteine residues that are utilized to establish the hard prop-
erties of hair and nails by inter-molecular crosslinking. Hair keratins are encoded by genes with
characteristic exon-intron structures and conserved positions relative to neighboring genes. The
aim of this study was to get insights into the evolutionary history of hair by determining the evo-
lutionary history of hair keratins. We performed comparative genomics screenings and used the
unique properties of hair keratin genes to identify novel homologs. Indeed, the green anole lizard,
Anolis carolinenis, contained two genes orthologous to mammalian type I hair keratins and four
genes orthologous to type II hair keratins. The chicken contained an ortholog of type II hair ker-
atins. For studies of protein expression, antibodies were raised against a type I hair keratin homolog
and against a type II hair keratin homolog of the lizard. Immunohistochemistry demonstrated that
both proteins were specifically expressed in the claws of the lizard. In summary, this study shows
that hair keratins are not restricted to mammals and, therefore, must have evolved with an origi-
nal function that was not associated with the hair. We propose that the claws of the last common
ancestor of mammals and reptiles were the main sites of hair keratin expression before a change
in the expression pattern of these proteins facilitated the evolution of hair.
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Differences in the current perception thresholds (CPTs) of C nerve fibers in affected and
unaffected scalp of patients with alopecia areata
R Farah, H Guo, N Gallus, R Farah, A Junqueira, M Ericson, C Boeck and M Hordinsky
Department of Dermatology, Division of Biostatistics and Office of Clinical Research,
University of Minnesota, Minneapolis, MN
Alopecia areata (AA) is an immune mediated hair disease. Regardless of the degree of hair loss,
the psychological affects of AA can be devastating and the role of nerves and stress in this condi-
tion has long been discussed. Our objective was to study the function of cutaneous nerves in the
scalp of AA patients. A Neurometer CPT/C diagnostic stimulator was used to apply transcutaneous
electrical stimulation to shaved affected and unaffected scalp of 17 AA patients with patchy dis-
ease and 12 normal controls. The Neurometer generated stimuli at three different frequencies:
2000Hz, 250 Hz, and 5Hz, permitting assessment of CPTs of myelinated ABeta (touch) and ADelta
fibers (fast pain) and unmyelinated C nerve fibers (slow pain). CPTs represent the minimum amount
of electrical stimulus needed to consistently conduct a sensation. Two-sided paired t-tests were per-
formed to compare CPTs of affected ophiasis scalp and unaffected scalp outside the ophiasis
region in AA patients. Ophiasis and frontal scalp regions were also tested in the control subjects.
Results at 2000Hz and 250Hz in AA patients and at all three frequencies in normal controls were
not statistically significant. However, in AA patients mean CPTs at 5Hz (C fibers) were 24.65
microAmps (SD± 11.71 microAmps) for affected scalp in the ophiasis region and 13.82 microAmps
(SD±8.4 microAmps) for unaffected scalp outside the ophiasis region. Differences in CPTs at the
5Hz frequency in AA patients were statistically significant (p=0.0036). Thus, more current is nec-
essary for patients to consistently detect a sensation in affected scalp when compared to unaf-
fected scalp at 5Hz. This data is the first to demonstrate functional differences in C fibers in affected
and unaffected scalp of patients with patchy AA suggesting that C fiber sensory nerve dysfunction
is part of the pathophysiology of AA.
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The I-BAR protein Missing in Metastasis is required for primary cilia formation, Sonic Hedge-
hog signaling, and hair follicle regeneration.
M Bershteyn,1,2 W Woo,1 H Zhen1 and AE Oro1 1 Program in Epithelial Biology, Stanford
University School of Medicine, Stanford, CA and 2 Cancer Biology Graduate Program,
Stanford University School of Medicine, Stanford, CA
In perpetually renewing vertebrate hair follicle, we and others have shown that proper growth and
patterning requires continuous Sonic hedgehog (Shh) signaling between epidermal and dermal
cells. The spatial and temporal regulation of Shh signaling is critical as loss or gain of function
results in premature hair follicle arrest or susceptibility to cancer, respectively. Recent genetic and
cell biological studies suggest that the primary cilium (PC), a microtubule-based organelle, pro-
vides an essential point of regulation for Shh signaling and plays a key role in hair morphogene-
sis. However, the regulation and molecular function of PC during hair regeneration remain poorly
understood. In a screen for novel Shh target genes we previously identified the novel Bin/
Amphiphysin/Rvs (BAR)-domain protein Missing in Metastasis (MIM) (Callahan, Genes & Dev. 2004)
whose levels are altered in a variety of Shh-dependent tumors. Here, we used short hairpin RNAs
to knock down MIM and found that depletion of endogenous MIM using multiple independent
hairpins in a variety of cell types resulted in loss of PC. As a functional consequence of MIM knock
down and loss of PC, cells were no longer able to respond to Shh signal and displayed a signifi-
cant loss of target gene activation. Importantly, in an in vivo hair regeneration assay, we found that
MIM knock down blocked PC formation in dermal cells resulting in reduced hair follicle numbers
and immature hair follicles. Interestingly, staining with antibodies to endogenous MIM demon-
strates a previously uncharacterized localization of a subset of MIM to the basal body in cultured
cells as well as in skin tissues. MIM knockdown resulted in the inability of the basal body to dock
appropriately with the plasma membrane and facilitate ciliary elongation. Our results demonstrate
that MIM is part of a basal body complex required for PC formation, Shh signaling and hair folli-
cle regeneration.
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Inducible expression of Dickkopf1 reversibly inhibits hair growth without affecting stem
cell maintenance
Y Choi,1 T Andl2 and SE Millar1 1 Departments of Dermatology and Cell and Developmental
Biology, University of Pennsylvania, Philadelphia, PA and 2 Division of Dermatology,
Department of Medicine, Vanderbilt University, Nashville, TN
Wnt/β-catenin signaling is activated in hair follicles at anagen onset, and localizes to proliferating
matrix cells and differentiating hair shaft precursor cells. To determine whether Wnt/β-catenin sig-
naling is required for hair follicle cyclical growth in postnatal life, we used K5-rtTA tetO-Dkk1 bi-
transgenic mice in which expression of the secreted Wnt inhibitor Dickkopf1 (DKK1) can be induced
in the hair follicle outer root sheath including stem cells, by dosage with oral doxycycline. Induc-
tion of Dkk1 expression in mid-anagen prevented nuclear localization of β-catenin in epithelial
matrix cells but not in the dermal papilla, and caused cessation of proliferation and premature entry
into catagen. To determine whether Dkk1 also blocks anagen onset, Dkk1 expression was induced
in telogen, and hair shafts were plucked to initiate a new growth cycle. Unexpectedly, follicles
entered very early anagen, but epithelial proliferation and cyclin D1 expression, and BMP signal-
ing, which is required for hair follicle differentiation, were inhibited and the follicles did not express
differentiation markers or progress through subsequent stages of anagen. However, basic follicle
structures including the dermal papilla, and expression of the bulge stem cell marker K15 were
maintained even over long periods of Dkk1 expression. To determine whether the effects of Dkk1
were reversible, mice were maintained on doxycycline for up to 15 months, followed by removal
of doxycycline. Remarkably, hair follicles showed normal proliferation and differentiation follow-
ing doxycycline withdrawal, with or without hair plucking to initiate a new growth cycle. Spon-
taneous hair re-growth following doxycycline removal suggested that the follicles were primed for
hair re-growth rather than being maintained in a true telogen phase. These data suggest Wnt inhi-
bition as a promising method to reversibly inhibit growth of unwanted hair.
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Reciprocal requirements for Eda/Edar/NF-kB and Wnt/b-catenin signaling pathways in hair
follicle induction
Y Zhang,1 T Andl,1 ML Mikkola,2 P Overbeek,3 SE Millar1 and R Schmidt-Ullrich4 1 University
of Pennsylvania, Philadelphia, PA, 2 University of Helsinki, Helsinki, Finland, 3 Baylor College
of Medicine, Houston, TX and 4 Max-Delbrück-Center for Molecular Medicine, Berlin,
Germany
The Wnt/b-catenin and NF-kB pathways provide central controls in development and disease, but
how these pathways intersect is unclear. Using hair follicle induction as a model system, we show
that Wnt/b-catenin signaling is absolutely required for NF-kB activation, and that Edar is a direct
Wnt target gene. Wnt/b-catenin signaling is initially activated independently of Eda/Edar/NF-kB
signaling in primary hair follicle primordia, but requires NF-kB activity to achieve its final, refined
pattern. Localized Wnt/b-catenin signaling activity disappears from the skin of Eda/Edar/NF-kB
pathway mutants within 48 hours of its first appearance, indicating that maintenance of Wnt/b-
catenin signaling requires Eda/Edar/NF-kB activity. We show that localized expression of Wnt10b
and Wnt10a requires NF-kB signaling, providing a molecular explanation for this observation, and
identify Wnt10b as a direct NF-kB target. These data reveal a complex interplay and inter-depend-
ence of Wnt/b-catenin and Eda/Edar/NF-kB signaling pathways in initiation and maintenance of
primary hair follicle placodes.
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Partial proteasome inhibitors induce hair follicle growth by maintaining β-catenin signaling
JS Van Arnam, PC Means, EG Huntzicker and AE Oro Dermatology, Stanford University School
of Medicine, Stanford, CA
One of the central problems in stem cell biology is the mechanism and timing of stem cell acti-
vation during organ regeneration and tissue repair. The hair follicle, containing one of the best
studied stem cell niches, undergoes periodic growth and atrophy. While hair follicle stem cells
use Wnt / Shh signaling during anagen, and BMP/ NFAT to enforce quiescence during telogen, how
these pathways are integrated to control activation remains largely unknown. We and others have
shown that the Ubiquitin-Proteasome System (UPS) is a higher order integrator of numerous sig-
naling pathways, and is critical for the timing of diverse biological processes. Here we show the
UPS is required for proper hair cycling. Using hair cycle stage-dependent in vitro extracts, we find
that key substrates such as B-catenin have differential stabilities, with B catenin more stable in ana-
gen than telogen. Two different Partial Proteasomal Inhibitors (PaPI) applied to mice prevent the
destruction of ubiquitin-GFP throughout the epidermis. PaPI treatment leads to marked increase
in hair growth due to a dramatically shortened telogen, and increased rate of hair growth during
anagen. Analysis of signaling pathways using PaPI-treated reporter mice demonstrate B-catenin
stabilization and persistent Wnt signaling during telogen in CD34+, alpha-6 integrin+ hair follicle
stem cells. Surprisingly, Shh, BMP and NFAT signaling were minimally affected by PaPI treatment.
Telogen skin treated with adenovirus expressing wild type B-catenin and PaPIs restarted anagen
more rapidly than PaPI-treated or virus-treated skin alone. Our data demonstrates the critical role
the UPS plays in hair cycling by enforcing B-catenin destruction in hair follicle stem cells during
telogen and suggests that PaPIs represent a novel class of hair growth agents.
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Farnesyltransferase function is required for hair development
RC Lee,1 S Chang,2 SH Yang,2 C Coffinier,2 Y Tu,2 C Nobumori,2 M Allen,2 X Qiao,2 AC White,3
W Lowry,3 L Fong2 and SG Young2 1 Division of Dermatology, Geffen School of Medicine at
UCLA, Los Angeles, CA, 2 Division of Cardiology, Geffen School of Medicine at UCLA, Los
Angeles, CA and 3 Molecular, Cellular and Developmental Biology, UCLA, Los Angeles, CA
The role of farnesylation, the modification of a protein with a 15-carbon farnesyl group by the
enzyme farnesyltransferase (FTase), in skin development has never been explored. To address this
question, we generated skin specific constitutive and inducible conditional knockout mice for the
unique subunit of FTase, Fntb, using the Keratin 14 promoter driving expression of Cre recombi-
nase (K14-Cre & K14-CreER (tamoxifen-inducible)). K14-Cre FTase knockout mice are viable but
have severe hypotrichosis. Hair development is delayed and abnormal. On histology, hair folli-
cles are present but hair shafts are frequently fragmented with aberrant medulla architecture. We
conclude that FTase function is essential for normal hair development. Further characterization of
this defect, identification of the FTase protein substrates important for hair development, and deter-
mining the phenotype of tamoxifen treated K14-CreER FTase mice are underway.
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Immunomodulatory active ingredients for normalizing disrupted skin immune homeostasis
N Bechetoille and V André R&D, BASF Beauty Care Solutions, Lyon, France
The skin homeostasis involves numerous cell partners. Among them, skin dendritic cells play a
crucial role in the regulation of skin immune response. Environmental aggressions such as pollu-
tion can disrupt the skin immune balance and induce excessive responses. By targeting skin immune
cells and modulating their activation level, we would enable the normalization of the disrupted
skin immune homeostasis. Recently, we developed a culture model of skin dendritic cells derived
from blood monocytes (Bechetoille et al., 2006). We used this model to evaluate the ability of sev-
eral active ingredients to modulate dendritic cell activation level. For this, CD86 level was ana-
lyzed by flow cytometry after a 24 h incubation with active ingredients. Both cell recovery and
responsiveness following danger signals were then investigated after active ingredient treatment.
For each experiment, dexamethasone was used as positive control. Using this model as a screen-
ing protocol, we selected a plant extract from Cestrum latifolium for its ability to decrease CD86
expression on dendritic cells. Then, we checked that dendritic cells treated for 24 h with Cestrum
latifolium could still recover their CD86 basal expression when no longer treated with the active
ingredient. Finally, previously treated dendritic cells were then challenged by LPS/TNF-alpha and
were shown to: (1) display an increased CD86 expression (+250%), (2) migrate in response to MIP-
3 beta and, (3) stimulate T cell proliferation. Taken together these results demonstrate that the
selected active ingredient is able to decrease the activation level of skin dendritic cells without
disturbing their immune responsiveness when challenged by danger signals.
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Identification of novel dendritic cell maturation marker, mouse Transmembrane protein 123
T Takekoshi,1 Y Tada,1 T Watanabe,1,3 M Sugaya,1 M Komine,1,4 T Shimizu,1,5 A Asahina,1,6
T Yokomizo2 and K Tamaki1 1 Department of Dermatology, Graduate School of Medicine,
University of Tokyo, Tokyo, Japan, 2 Department of Medical Biochemistry, Graduate School
of Medical Sciences, Kyushu University, Fukuoka, Japan, 3 International University of Health
and Welfare Mita Hospital, Tokyo, Japan, 4 Graduate School of Medicine, Jichi Medical
University, Tochigi, Japan, 5 Teikyo University School of Medicine, Tokyo, Japan and 6
Sagamihara National Hospital, Kanagawa, Japan
We identified a novel gene, mouse Transmembrane protein 123 (Tmem123), as a dendritic cell
(DC) maturation marker. The open reading frame of Tmem123 encodes a type I membrane pro-
tein, and the extracellular domain of Tmem123 contains many O-linked glycosylation sites. We
carried out transcriptional profiling of immature and mature Langerhans cells (LC) by using a sup-
pressive subtractive hybridization method and found that Tmem123 mRNA expression was up-reg-
ulated in mature LC. We confirmed that Tmem123 was up-regulated not only in mature LC but also
in other mature DC such as bone marrow-derived DC (BMDC) and splenic DC in both mRNA and
protein levels by real time PCR, immunohistochemistry, flow cytometry and immunoblot. Inter-
estingly, expression of CD40 on the cell surface, together with Tmem123 expression, was up-reg-
ulated in mature BMDC cultured with colchicine, an inducer of BMDC maturation. Furthermore,
mouse BMDC derived cell line, DC2.4 cells, transfected with Tmem123 encoding vector showed
increased expression of CD40 on the cell surface compared with DC2.4 cells transfected with
empty vector. The expression of other co-stimulatory molecules, such as CD80 and CD86, was
not changed in these transfectants. After stimulation with anti-CD40 mAb plus IFN-γ, DC2.4 cells
transfected with empty vector did not produce detectable amount of IL-12p40 (<5 pg/ml); how-
ever, DC2.4 cells transfected with Tmem123 expression vector secreted detectable amount of IL-
12p40 (16.6±2.4 pg/ml) (n=3). Thus, our study demonstrates that Tmem123 can be used as a new
maturation marker of DC and that this molecule may be associated with CD40 expression on the
cell surface.
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Hedgehog signaling maintains the undifferentiated state of the follicle secondary hair germ
during telogen
ME Hutchin,1 M Grachtchouk,1 J Liu,1 J Waldinger,1 A Wang,1 AB Glick2 and AA Dlugosz1 1
Dermatology, University of Michigan, Ann Arbor, MI and 2 Penn State University, University
Park, PA
The Hedgehog (Hh) signaling pathway, operating through the Gli family of transcription factors,
drives proliferation of hair follicle epithelium during development and postnatal anagen growth
phases. Unexpectedly, recent studies have uncovered low-level Hh signaling in resting telogen hair
follicles, restricted to the secondary hair germ which comprises a subset of hair follicle stem cells
in close proximity to the dermal papilla. Using in situ hybridization for Ptch1, and Ptch1-lacZ and
Gli1-lacZ reporter mice, we have confirmed Hh signaling activity in the secondary hair germ and
hair follicle papilla during telogen. To test the potential function of Hh/Gli signaling in telogen fol-
licle epithelium, we used a doxycycline-inducible bitransgenic mouse model to conditionally
shut down epithelial Hh signaling in K5-expressing cells using a dominant-negative Gli2 mutant,
Gli2ΔC4. Induction of Gli2ΔC4 during telogen led to dramatic morphologic changes restricted to
the secondary hair germ and follicle papilla. Minute cystic lesions developed from secondary hair
germs, with cells in the remainder of the follicle stem cell compartment grossly unaltered. Gli2ΔC4-
expressing secondary hair germs contained a population of hair matrix-like cells (CDP-positive/K5-
negative) and cells expressing hair keratin. In addition, cells expressing differentiation markers nor-
mally localized to the uppermost follicle and epidermis, involucrin and keratin 1, were also detected
in Gli2ΔC4-expressing skin. Our findings reveal a previously unrecognized requirement for epithe-
lial Hh/Gli signaling in maintaining the undifferentiated state of stem cells of the secondary hair
germ during telogen, and thus identify an additional function for Hh signaling in skin beyond its
well-established role in regulating proliferation of hair follicle epithelium during anagen.
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Pituitary adenylate cyclase-activating peptide (PACAP) and vasoactive intestinal polypep-
tide (VIP) enhance Langerhans cell (LC) antigen presentation for an interleukin-17 (IL-17)
response
W Ding, L Stohl, M Michela and RD Granstein Dermatology, Weill Cornell Medical College,
New York, NY
IL-17 has been implicated in a variety of inflammatory conditions including psoriasis. It is produced
by a newly identified class of T helper (Th17 cells) as well as natural killer (NK) cells, NK T cells
and macrophages. Interestingly, there is evidence that nerves influence psoriasis. For example, there
are reports that psoriasis clears from denervated skin. We examined whether the neuropeptides
PACAP or VIP influence the ability of LC to present antigen for an IL-17 response. LC enriched to
~95% homogeneity were prepared from BALB/c mouse skin. LC were incubated in 10 nM PACAP,
VIP or medium alone for 2 hrs and then washed 4 times. Ten thousand LC were plated in 96-well
round bottom plates with 2 x 105 spleen cells from DO11.10 transgenic mice (BALB/c background).
These mice have T cell receptor transgenes that allow their T cells to recognize a fragment of chicken
ovalbumin (OVA323-335). Sets of wells were cultured for 48 hrs in the presence of graded con-
centrations of OVA323-335 and supernatants collected for assessment of cytokine content by ELISA.
PACAP or VIP treatment significantly increased IL-17 production while decreasing γ-interferon pro-
duction. Similar experiments were performed after removal of NK cells and NK T cells from respond-
ing DO11.10 splenocytes with the use of magnetic microspheres linked to anti-CD49b. The remain-
ing cells were negatively selected for CD4 expression using anti-mouse CD45R, anti-CD11b,
anti-Ter119, anti-CD/16/32 and anti-CD8 antibodies linked to magnetic microspheres. Supernatants
from an experiment utilizing the CD49b-depleted, CD4+ cells showed a similar pattern with IL-
17 production significantly enhanced by pre-treatment of LC with PACAP or VIP. These results
suggest that treatment of LC with PACAP or VIP biases them towards induction or stimulation of
Th17 cells. This may have implications for a further understanding of the mechanisms by which
products of nerves influence immunity within the skin.
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Systemic lupus erythematosis in China
C Ji,1 B Yang,1 Z Bi1 and Y Wan2 1 The First Affiliated Hospital of Nanjing Medical University,
Nanjing, China and 2 Providence College, Providence, RI
This study presents a clinical and laboratory characteristics of 408 patients with systemic lupus ery-
thematosis (SLE) from the First Affiliated Hospital of Nanjing Medical University between 2004
and 2008. There were 372 females (91.2%) and 36 males (8.8%), with a mean age of 34.83±13.56
years. The main clinical feature was renal disorder (82.1%), followed by hematologic disorder
(61.2%) and cardiac involvement (59.3%). Positive ANA (91.9%) was the most common labora-
tory manifestations, followed by anti-dsDNA (66.9%) and anti-SSA (50.8%). A comparison between
females and males demonstrated that men more frequently showed renal disorder and hypoalbu-
minemia, whereas women more frequently had photosensitivity. We also found out that old patients
(≥50 years) revealed a lower incidence of malar rash, discoid rash, renal disorder, photosensitiv-
ity, fever and positive anti-dsDNA, and younger patients (<50 years) showed less frequent charac-
teristics including pulmonary disorder and vision decline. Taken together, SLE is a multisystem dis-
ease with a wide spectrum of clinical and immunological abnormalities. These data will be helpful
for further clinical study of SLE.
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Plasticity of the T cell cholinergic system
J Qian, A Chernyavsky, V Galitovskiy and SA Grando Dermatology, University of California,
Irvine, CA
Specific T cell populations play central roles in immune-dependent skin diseases, and mouse mod-
els are used to develop new methods of selective immunocorrection. Recent discovery of anti-
inflammatory action of acetylcholine has opened a novel avenue for treatment of skin diseases with
cholinergic drugs that regulate immune reactions. The cholinergic effects are mediated by nico-
tinic and muscarinic acetylcholine receptors (nAChRs and mAChRs) that often render opposite
effects, so that the net response is determined by a unique combination of nAChRs and mAChRs
on a single cell. In this study, we mapped the expression patterns of nAChR and mAChR subtypes
in murine CD4 and CD8 T cells purified from BALB/c or C57BL/6J mouse splenocytes by magnetic
cell sorting followed by flow cytometry. We analyzed both freshly isolated T cells and T cells stim-
ulated by TCR cross-linking with CD3 and CD28 antibodies for five days. Reverse transcription-
polymerase chain reaction and western blotting revealed that CD4 and CD8 T cells express dis-
tinct nAChR and mAChR profiles. Both intact CD4 and CD8 T cells expressed α1, α2, α7, α9 and
β1 nAChR subunits and M3 mAChR. CD4 cells uniquely expressed α3, α4, α6 and β3 nAChR sub-
units and M2 mAChR, whereas CD8 T cells—α5 and β2 nAChR subunits and M5 mAChR. The TCR
stimulation altered repertoires of the cholinergic receptors in both T cell subpopulations. Acti-
vated CD4 cells lost their α9 and β3 nAChRs and switched the mAChR expression from M2/M3 to
M1/M2. Activated CD8 cells also lost α9 as well as β1 and β2 nAChRs, acquired α3 and α4 nAChRs,
and switched their mAChRs from M3/M5 to M4. These results demonstrated the plasticity of the T
cell cholinergic system. Changes in the profile of nAChRs and mAChRs on the plasma membrane
resemble a paradigm established for the cluster of differentiation markers. Learning the choliner-
gic pharmacology of immune response should allow to treat specific types of inflammatory der-
matoses by selectively activating or blocking cholinergic receptors expressed by the T cells medi-
ating specific immune reactions.
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Abdominal breathing training improve lesions of psoriasis by improving regulation function
of autonomic nervous system
Y Li,1 L Zhang2 and X Yang1 1 Department of Dermatology, General Hospital of Air Force,
Chinese PLA, Beijing, China and 2 Department of Dermatology, The Affiliated Hospital of
Aviation Medicine Research Center of Airforce, Chinese PLA, Beijing, China
Psoriasis is a skin disease associated with dysfunctional nervous system. It has been reported that
abdominal breathing, just like Biofeedback, can improve cutaneous problems that have an auto-
nomic nervous system component. To investigate the effects of abdominal breathing on psoriatic
patients, 60 patients with vulgaris psoriasis were randomly divided into two group. Group Ι were
conduct to do abdominal breathing with feedback abdominal breathing training apparatus for
30min twice everyday for 3 months and group Π were conduct to do calm and natural breathing
for 3 months. The heart rates, blood pressure and respiratory sinus arrhythmia (RSA) of the patients
were recorded after training. We found that heart rate in group Ι obviously decreased than that of
in group Π(P<0.01); RSA in group Ι significantly increased than that of in group Π(P<0.01); The
systolic pressure in first period of group Ι obviously declined than that of in group Π; while the
diastolic pressure of the patients in group Ι obviously declined than that of in group Π. The RSA of
13 cases who finished 3 month training were obvious increased from 31.36±6.86ms(before train-
ing) to 37.69±9.57ms(after training) (P<0.05). After treatment for 3 months in group Ι, there were
56.7% effective rate was got. However in group Π, we only got 10% effective rate. Abdominal
breathing may improve the regulating function of autonomic nervous system of psoriatic patients,
and sequentially improved the lesions of psoriasis.
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The establishment of animal model of psoriasis with streptococcal M6 protein : Implication
in onset of guttate psoriasis
D Li, G Zhao, W Liu and H Ma Department of Dermatology, General Hospital of Air Force,
Chinese PLA, Beijing, China
It has been shown that the strongest association among Group A streptococcus(GAS) infection and
onset of acute guttate psoriasis and aggravation of plaque psoriasis was exist. We have previously
shown that Streptococcal M6 protein may play an important role as a superantigen in the acute
form of psoriasis. But the real mechanism is largely unknown. To further study the real pathogen-
esis of the function of streptococcal M6 protein in triggering guttate psoriasis, we established the
psoriatic animal model of SCID mice with superantigen M6 protein. The uninvolved full-thickness
human skins (UFT skin) removed from the patients with acute guttate psoriasis and normal healthy
controls were respectively transferred onto SCID mices. The PBMCs of the patients with psoriasis
and healthy controls mixed with or without M6 protein were injected into the grafted human skin.
Biopsies were obtained from each samples 4 weeks later. Among 23 cases of tranplanted unin-
volved skin samples with acute psriasis, the psoriasis-like lesions were observed on the 12 cases
after injection with suspension of PBMC stimulated by M6 protein, and 10 cases after injection
with suspension of PBMC unstimulated by M6 protein were no found any psoriasis-like lesions.
No psoriasis-like lesions were founded on the 9 cases of normal controls skin samples after injec-
tion with suspensions of PBMC stimulated by M6 protein and 9 normal skin cases after injection
with suspension of PBMC un-stimulated by M6 protein. The significant difference was found between
the psoriasis group and the healthy control group(P<0.01).We have successfully established the
animal model of psoriasis with Streptococcal M6 protein. It is suggested that Streptococcal M6 pro-
tein may play an important role in the pathogenesis of acute guttate psoriasis.
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Bites of pathogen-free Ixodes ricinus ticks produce a prominent innate and a Th2-polarized
adaptive immune response in human skin
R Müllegger,1 M Glatz,2 K Jones,3 T Means,3 A Luster3 and AC Steere3 1 Dpt. of Dermatology,
State Hospital Wiener Neustadt, Wiener Neustadt, Austria, 2 Dpt. of Dermatology, Medical
University of Graz, Graz, Austria and 3 Center for Immunology and Inflammatory Diseases,
Harvard Medical School, Boston, MA
Ticks are among the most important arthropod vectors of human pathogens. We aimed to exam-
ine the influence of uninfected Ixodes ricinus ticks on the local immune response in human skin.
Using qRT-PCR, we determined mRNA expression of chemokines (CXCL1, 8; CCL20; CCL2, 3, 4;
CXCL9, 10, 11; CCL1, 22; CXCL13), cytokines (IL-1b, IL-6, TNF-a, IFN-g, IL-12, IL-4, IL-5, IL-10,
TGF-b), and leukocyte markers (CD11c, CD14, CD4, CD8, CD19) in biopsy samples of early tick
bite lesions from 22 individuals and from 9 control subjects. Infection with B. burgdorferi or A.
phagocytophilum was excluded by ospA or 16S rRNA PCR. Levels of mRNA expression were
compared between tick bite and control samples by a Mann-Whitney U Test. Tick bite lesions had
significantly higher mRNA levels of the macrophage chemokines CCL2, CCL3, and CCL4, and the
neutrophil chemokines CXCL1 and CXCL8 than normal skin. Also, the dendritic cell marker CD11c
and the macrophage marker CD14 were significantly elevated. mRNA levels of the T-cell active
chemokines CXCL9, CXCL10 and CXCL11, and the T cell markers CD4 and CD8 were compara-
bly high. mRNA levels of the Th2 cell chemokines CCL1, and CCL22, and the B cell chemokine
and marker CXCL13 and CD19 were low. Tick bite lesions had increased amounts of proinflam-
matory cytokines, particularly IL-1b and a compensatory expression of antiinflammatory cytokines,
particularly of the Th2 cytokine IL-5. We have portrayed for the first time the early local immune
response at the infestation site of pathogen-free Ixodid ticks in the skin of humans. It is character-
ized by a predominance of the innate immune response and a less significant activation of the
adaptive immune response with a slight Th2 cytokine prevalence. Further studies have to clarify
whether the influence of tick bites on the local human immune response facilitates the transmis-
sion of pathogens.
648
UV-induced regulatory T cells switch antigen-presenting cells from a stimulatory into a reg-
ulatory phenotype
A Schwarz, W Schuller and T Schwarz University Kiel, Kiel, Germany
UV-induced regulatory T cells (UV-Treg) inhibit sensitization in an antigen (Ag)-specific fashion.
The migratory behavior of UV-Treg can be reprogrammed by tissue-specific antigen-presenting cells
(APC) in an Ag-specific manner. We recently observed that UV-Treg in turn can influence APC,
since upon coincubation with activated UV-Treg hapten-coupled bone marrow-derived dendritic
cells (DC) lost their capacity to induce hapten-sensitization when injected subcutaneously (s.c.)
into naïve mice. The inhibitory effect of UV-Treg on DC was dependent on interleukin (IL)-10
since it could be prevented by a neutralizing anti-IL-10-antibody. UV-Treg but not DC appear to
be the relevant source of IL-10 as the inhibition was still observed when DC from IL-10 knock-out
mice were used. Despite the crucial role of IL-10 cellular contact is essential because the inhibitory
effect was not observed in transwell experiments. To determine how UV-Treg influence APC and
their Ag-presenting capacity, activated UV-Treg were cocultured with DC. After depletion of T cells,
FACS-analysis of DC was performed, revealing downregulation of B7-2 and MHC class II but induc-
tion of the inhibitory molecules B7-H3 and B7-H4. To analyze whether APC pretreated with UV-
Treg in turn are able to induce Treg, DC were coincubated with activated UV-Treg. DC were iso-
lated, hapten-coupled and injected s.c. into naïve mice. 5 days later ear challenge with DNFB was
performed. Splenocytes and lymph node cells were obtained from these recipients and injected
into naïve mice which were hapten-sensitized 24 hours later. Upon adoptive transfer, contact hyper-
sensitivity response was significantly suppressed in the secondary recipients, indicating the pres-
ence of Treg in the pool of transferred cells. Together, this demonstrates that UV-Treg can switch
APC from a stimulatory into a regulatory phenotype, which further induces Treg.
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Attenuation of cutaneous dendritic cell functions by prostaglandin E2-EP3 signaling.
N Shiraishi,1 K Kabashima2 and Y Tokura1 1 Department of Dermatology, University of
Occupational and Environmental Health, Kitakyusyu, Japan and 2 Department of
Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan
Cutaneous dendritic cells (DCs) regulate acquired skin immune responses. At present, the media-
tors to activate cutaneous DCs have been revealed such as TNF-α and IL-1, however, the mecha-
nism to keep skin immune homeotasis via DCs remained unknown. Prostaglandin (PG) E2 exerts
its physiological functions acting at four subtypes of receptors, EP1, EP2, EP3, and EP4. Previously
we reported that PGE2 initiates acquired immune responses by promoting cutaneous DC func-
tions through Gs-coupled cAMP elevating EP4 (Nat Med 2003). Although Gi-coupled cAMP-low-
ering EP3 is highly expressed in DCs, its role in cutaneous immune responses remains unknown.
To address these issues, we used an EP3 specific agonist (ONO-AE-248) and EP3-deficient (Ptger3-
/-) mice. Initially, we prepared bone marrow-derived DCs (BMDCs) by incubation of BM cells
with GM-CSF for 7 days. The EP3 agonist did not affect the total number, but significantly sup-
pressed maturation of BMDCs. The chemotaxis of BMDCs to a CCR7 ligand, CCL21, was attenu-
ated by the EP3 agonist and low dose PGE2. Consistently, the expressions of CD54, CD80 and
CD86 on epidermal Langerhans cells were suppressed by the EP3 agonist. We then evaluated the
in vivo roles of EP3 in the skin. FITC-induced migration of cutaneous DCs including Langerhans
cells and dermal DC into the draining lymph nodes was augmented in (Ptger3-/-) mice when FITC
was painted in low-dose but not in high-dose. In addition, the topical application of the EP3 ago-
nist during the sensitization impaired DNFB-induced contact hypersensitivity responses. In con-
clusion, in contrast to PGE2-EP4 signaling, Gi-coupled EP3 impairs initiation of skin immune
responses and rather keeps homeostasis of the skin by suppressing the cutaneous DC functions.
These dual functions of PGE2 may be due to differential affinity of PGE2 to EP receptors.
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IL-33 promotes dendritic cell development in a GM-CSF-dependent mechanism
N Mayuzumi, H Matsushima and A Takashima Medical Microbiology and Immunology,
University of Toledo College of Medicine, Toledo, OH
Several cytokines (GM-CSF, M-CSF, Flt-3 ligand, TNF alpha, IL-4, and IL-15) have been shown to
promote the development of dendritic cells (DCs). In an attempt to identify additional DC growth
factor(s), we employed a systematic screening approach. A total of 65 cytokines were tested indi-
vidually for their potentials to promote the generation of CD11c+ cells in standard bone marrow
cultures derived from C57BL/6 mice. In addition to the above listed cytokines known to promote
DC growth, IL-33 was found to augment DC development in a time- and dose-dependent man-
ner, with >100-fold increase in the number of CD11c+ cells achieved at 10 ng/ml on day 7. When
tested in combination with GM-CSF, IL-33 at 1-3 ng/ml augmented the expansion of CD11c+ cells
in a synergistic fashion. Although the resulting CD11c+ cells generated in the presence of IL-33
alone exhibited a characteristic DC morphology, they expressed only modest levels of MHC class
II, CD40, CD80 and CD86. IL-33-generated DCs also failed to vigorously respond to synthetic Toll-
like receptor ligands as measured by CD86 expression and cytokine production. Moreover, they
were far less functional than conventional DCs generated with GM-CSF in their abilities to acti-
vate immunologically naïve T cells, including CD3 T cells isolated from allogeneic BALB/c mice
and ovalbumin-reactive CD4 (and CD8) T cells from OT-II (and OT-I) transgenic mice. With regard
to mechanisms, IL-33-induced expansion of CD11c+ cells was blocked almost completely not only
by ST2-Fc (soluble IL-33 receptor), but also by anti-GM-CSF antibody, and significant amounts of
GM-CSF became detectable in IL-33-supplemented bone marrow cell culture supernatants within
24 hours, indicating that IL-33 promotes in vitro DC generation indirectly by triggering GM-CSF
production by bone marrow cells. To the best of our knowledge, this is the first report document-
ing any impact of IL-33 on DCs. Our results also illustrate that multiple cytokines support the devel-
opment of DC networks in highly interactive manners.
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Co-expression of HLA-DR and CD86 in skin resident T cells: implications for cutaneous
inflammation
M Lichtman,1,2 A Calarese,1 TS Kupper1 and RA Clark1 1 Department of Dermatology, Brigham
and Women’s Hospital, Boston, MA and 2 Department of Dermatology, UT Southwestern,
Dallas, TX
MHC II restricted antigen presentation has been studied primarily in professional APC. Unlike
murine T cells, human T cells can express MHC II but its functional significance is unclear. Stud-
ies of antigen presentation by αβ T cells have been limited to clones and did not include study of
the co-stimulatory molecule CD86. To evaluate a role for skin αβ T cells in antigen presentation,
we studied expression of HLA-DR and co-stimulatory molecules in T cells from human skin and
blood. HLA-DR was expressed by 17% of CD4 and 6% of CD8 T cells from normal human skin,
compared to 3% of CD4 and 8% of CD8 T cells from blood. Co-expression of CD86 was markedly
different. Skin resident HLA-DR+ T cells co-expressed CD86 on 50% of CD4 and 35% of CD8 T
cells, compared to 4% of CD4 and 2% of CD8 T cells isolated from blood. CD80 co-expression
was low in T cells from both tissues. HLA-DR expression is known to increase with T cell activa-
tion. When IL-2 and IL-15 were added to human skin cultures, half of CD4 and CD8 T cells expressed
HLA-DR and of these, 65% of CD4 and 32% of CD8 T cells co-expressed CD86. Skin T cells
enhanced IFNγ production in mixed lymphocyte reactions compared to blood T cells, suggesting
that HLA-DR/CD86 co-expression is functionally significant. To determine if these differences are
inherent to T cells or influenced by the skin microenvironment, we cultured human blood T cells
in IL-2 and IL-15 in the presence and absence of dermal fibroblasts. HLA-DR expression increased
to 30% of CD4 and 58% of CD8 T cells but CD86 co-expression remained low in the absence of
dermal fibroblasts. When dermal fibroblasts were included, CD86 was co-expressed on 35% of
CD4 and 30% of CD8 T cells. Our results suggest that elements of the skin microenvironment,
namely dermal fibroblasts, support the co-expression of co-stimulatory molecules by T cells. This
may enhance the ability of T cells to present antigen and augment immune reactions in the skin.
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CD44 regulated T cell proliferation: EGR-1 expression and the PI3K/Akt pathway play essen-
tial roles
L Zhang, H Ma, HJ Greyner, W Zuo and ME Mummert Dermatology, UT Southwestern Medical
Center, Dallas, TX
CD44 is a glycoprotein expressed by T cells. Previous investigations have introduced the concept
that CD44 can regulate T cell proliferation. However, the underlying mechanisms for how CD44
regulates T cell proliferation are unexplored. Thus, we sought to investigate the molecular and
biochemical pathways associated with CD44 mediated regulation of T cell proliferation using a
human T cell clone as a model. Briefly, we engineered the human E6.1 Jurkat T cell clone to express
CD44. Importantly, this clone does not express CD44 therefore allowing the functions of CD44 to
be investigated in permanently transfected T cells. Transfection of CD44 in T cells significantly
reduced the expression of the transcription factor, EGR-1. Moreover, T cells expressing CD44 had
a reduced rate of proliferation as compared with their counterparts lacking CD44 expression. Trans-
fection of control T cells with EGR-1 siRNA, but not a siRNA control significantly reduced T cell
proliferation mirroring T cells that expressed CD44. These results showed a role for EGR-1 in T
cell proliferation and further suggested that CD44 plays a role in regulating EGR-1 expression. Strik-
ingly, inhibition of the PI3K/Akt pathway in control T cells, but not ERK1/2 nor p38 reduced both
EGR-1 expression and cell proliferation recapitulating the properties of T cells expressing CD44.
Furthermore, Akt was hypophosphorylated in T cells expressing CD44 as compared with the con-
trol T cells lacking CD44 expression. These results showed that CD44 can modulate Akt phos-
phorylation. In conclusion, our results suggest that CD44 can regulate T cell proliferation via EGR-
1 expression and the PI3K/Akt pathway.
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The dermal microenironment regulates the migration of dendritic cells
A Saalbach,1 C Klein,1 C Schirmer,1 W Briest,2 U Anderegg1 and JC Simon1 1 Dermatology,
University Leipzig, Leipzig, Germany and 2 Carl-Ludwig-Institute of Physiology, University
Leipzig, Leipzig, Germany
Dendritic cells (DC) are potent antigen presenting cells that capture antigen in peripheral tissues.
Upon antigen capture DC mature and migrate to the lymph vessels and subsequently to the T-cell
areas of draining lymph nodes. There they initiate the immune response by activating T lympho-
cytes. On their way from skin to the lymph vessel DC have to cross the basement membrane as
well as the dermal extracellular matrix. In the present study we show that activated dermal fibrob-
lasts promote the migration of DC by stimulating the secretion of MMP-9 from DC. In vitro gener-
ated monocyte-derived DC were cocultured with activated dermal fibroblasts. In this coculture,
the secretion of matrix metalloproteinase-9 (MMP-9) from DC was significantly up-regulated within
6h compared to DC. Interleukin-6 and interleukin-8 were shown to initiate the fibroblast-stimu-
lated MMP-9 secretion from DC. In accordance, upon coculture with activated fibroblasts DC
migrated significantly more effectively through matrigel than TNFα/IL-1β stimulated DC. Selective
blocking of MMP-9 revealed the importance of MMP-9 for the migratory capacity of DC. Interest-
ingly, activation of DC via toll like receptors induced maturation of DC. However, maturation was
not mandatorily associated with stimulation of MMP-9 secretion. Taken together, at site of inflam-
mation pathogenic stimuli induce the maturation of DC. TNFα and IL-1β, present at high levels at
site of inflammation can directly stimulate MMP-9 secretion and subsequent migration of DC. On
the other hand the proinflammatory microenvironment activates resident stromal cells such as
fibroblasts which in turn will be activated resulting in the production of further proinflammatory
mediators such as IL-6 and IL-8. This microenvironment can directly support the migration of DC
by stimulation of MMP-9 secretion and thus can shorten the lag phase within the initiation of an
immune response.
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Imiquimod treatment of human squamous cell carcinomas enhances T cell IFNγ production
and effector function
S Huang,1 G Murphy,2 C Schanbacher,1 C Schmults,1 T Kupper1 and RA Clark1 1 Dept. of
Dermatology, Brigham and Women’s Hospital, Boston, MA and 2 Dept. of Pathology,
Brigham and Women’s Hospital, Boston, MA
Squamous cell carcinomas of the skin (SCC) are a leading cause of death in organ transplant recip-
ients and their development is linked to the use of T cell immunosuppressive medications. Most
patients have no history of skin cancer, suggesting that the immune system may control SCC in
healthy individuals. We reported previously that SCC lack vascular E-selectin, exclude CLA+ skin-
homing T cells and recruit FOXP3+ regulatory T cells (Treg). Imiquimod is a topical immune response
modifier and TLR7 agonist that induces the immunologic destruction of SCC. SCC treated with
imiquimod prior to excision showed induction of E-selectin on tumor vessels, recruitment of CLA+
CD8+ T cells, and reduction in the % and functional capacity of Treg. Because tumor destruction
and formation of immunologic memory are ultimately T cell mediated effects, we have studied the
effects of imiquimod on effector T cells in SCC. SCC treated with imiquimod contained dense CD8
T cell infiltrates that were associated with tumor cell apoptosis and histologic evidence of tumor
regression. Effector T cells from treated SCC produced more IFNγ, granzyme and perforin and less
IL-10 and TGFβ than T cells from untreated tumors. To separate the effects of imiquimod on T cell
homing vs. T cell activity, we studied the effect of imiquimod on T cells from normal human skin.
Imiquimod induced T cell activation and reduced IL-10 production but had no effect on IFNγ, per-
forin or granzyme. All effects were indirect. Our results suggest that imiquimod has two main effects
on T cells in SCC. First, imiquimod restores appropriate homing in SCC by induction of E-selectin
and recruitment of tumor-specific T cells that produce IFNγ, perforin and granzyme. Second,
imiquimod suppresses IL-10 and TGFβ production by both regulatory and effector T cells. Thus,
imiquimod stimulates tumor destruction both by recruiting cutaneous effector T cells from blood
and by inhibiting tonic anti-inflammatory signals within the tumor.
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Skin resident T cells producing TNFα but not Th1, Th2, or Th17 cytokines: their possible role
as immune sentinels in skin
RA Clark,1 I Mollet,2 D Hijnen,3 A Calarese,1 R Purwar,1 M Lichtman1 and TS Kupper1 1
Department of Dermatology, Brigham and Women’s Hospital, Boston, MA, 2 Ghent
University, Ghent, Belgium and 3 University of Utrecht, Utrecht, Netherlands
The skin of a normal individual contains nearly 20 billion memory T cells, nearly twice as many
as are present in the circulation. These T cells are polarized effector memory T cells that, from our
current understanding, have arisen from recognition of their antigens within the skin. We previ-
ously reported that human skin contains significant numbers Th1, Th17 and Th2 cells. We report
now that these T cell subsets are quiescent with respect to cytokine production when isolated from
unstimulated skin and that additional signals (e.g., cellular proliferation) are required to unlock
cytokine production. TNFα is a cytokine produced by both APC and subsets of effector T cells. We
describe here a novel and previously undescribed population of skin resident T cells that produces
TNFα alone, without concurrent production of IFNγ, IL-4 or IL-17. These cells comprise a mean
48% of the skin T cells resident in normal human skin. These T cells are CD45RO+ memory T
cells, express CLA, CCR4 and CCR6 and have a diverse TCR repertoire. This T cell subset differs
from the other cutaneous effector T cells in that half of these cells produce TNFα upon TCR trig-
gering without a requirement for additional activating signals. TNFα T cells are the most numer-
ous subset in normal human skin, outnumbering Th1, Th2 and Th17 T cells. TNFα has pleiotropic
effects in the skin. TNFα induces maturation of dendritic cells, enhancing antigen presentation,
and induces endothelial activation and chemokine production, leading to enhanced leukocyte
recruitment. Skin TNFα T cells, specific for pathogens previously encountered in skin, may serve
as antigen-specific immune sentinels. These T cells have the ability to rapidly produce TNFα upon
re-exposure to cognate antigen, leading to activation and recruitment of both innate immune cells
and other T cell subsets. Thus, they may serve to both initiate and amplify immune responses in
skin.
656
Initiation of inflammatory skin responses by promoting Th differentiation through prostaglandin
I receptor IP
S Nakajima,1 T Honda,1 H Tanizaki,1 G Egawa,1,2 C Moniaga,1 S Narumiya,3 Y Miyachi2 and
K Kabashima1,2 1 Department of Dermatology, Kyoto University Graduate School of
Medicine, Kyoto, Japan, 2 Center for Innovation in Immunoregulative Technology and
Therapeutics, Kyoto University Graduate School of Medicine, Kyoto, Japan and 3
Department of Pharmacology, Kyoto University Graduate School of Medicine, Kyoto, Japan
It has been demonstrated that a large amount of prostaglandin I2 (PGI2), which exerts its actions
via its specific receptor IP (Ptgir), is detected in the inflammatory sites, such as asthma and atopic
dermatitis. However, the roles of PGI2 in the cutaneous immune responses remain to be eluci-
dated. Therefore, we sought to address this issue by generating Ptgir-/- mice and a new IP-specific
agonist. Mice deficient in Ptgir exhibited significantly attenuated contact hypersensitivity response
induced by dinitrofluorobenzene (DNFB). This phenotype was recapitulated in wild-type mice by
adoptive transfer of T cells from sensitized Ptgir-/- mice. In addition, decreased amounts of IFN-
gamma and IL-17 in the culture supernatant of DNFB-sensitized lymph node cells after re-stimu-
lation were observed in Ptgir-/- mice. PGI synthase was detected in dendritic cells and its receptor
IP was identified in T cells by real time PCR analysis. We then purified naïve T cells and incubated
them with Th skewing condition. An IP selective agonist facilitated Th1 and Th17 differentiation
from naïve T cells by intracytoplasmic cytokine staining methods using flowcytometry. Taken
together, our data implicate that PGI2 produced by dendritic cells in the lymph nodes acts on IP
in naïve T cells to promote Th differentiation to initiate skin inflammatory responses.
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Functional IL-31 receptor activation in keratinocytes mediates beta-endorphin production
via STAT3 activation: A novel mechanism of IL-31 for development of pruritus in atopic der-
matitis
C Lee,1,2 C Hong,3 M Yu,1 H Chuang,1 G Chen,1 T Yoshioka,1 M Sakata,1 W Liao,1 Y Ko1 and
H Yu1 1 Kaohsiung Medical University, Kaohsiung, Taiwan, 2 Kaohsiung Municipal Hsaio-
Kang Hospital, Kaohsiung, Taiwan and 3 Kaohsiung General Veterans Hospital, Kaohsiung,
Taiwan
Atopic dermatitis (AD) is characterized by chronic and relapsing dermatitis, diagnosed in the con-
text of personal and family history of allergic diseases. Itch is the most prominent symptom in AD.
Several molecules might mediate the development of itch in AD, notably neuropeptides including
VIP, beta-endorphin, and CGRP. IL-31, mainly from activated CD4+ T cells, is actively involved in
the pruritus development in AD in both human and mice. In human skin, the IL-31 receptor is dis-
tributed in epidermal keratinocytes; however, its physiological function has never been addressed.
We have demonstrated that serum beta-endorphin is correlated with itch intensity of in patients
with atopic dermatitis. The aim of this study is to investigate the role of the IL-31 receptor in ker-
atinocytes upon the development of itch and the release of neuropeptides. The results show that
beta-endorphin, but not CGRP or substance P, is increased in the conditioned medium from IL-31-
treated keratinocytes. Further, IL-31 receptor activation results in receptor internalization and bipha-
sic calcium propagation. ERK, STAT3, and AKT but not MAPK p38, are activated in IL-31-treated
keratinocytes; blocking of STAT3 or space-operating calcium channel by pharmacologic inhibitors
abolished the increase of beta-endorphin by IL-31-treated keratinocytes. We conclude that the IL-
31 receptor in keratinocytes is functionally expressed, and upon activation, induces a STAT3-
dependent release of beta-endorphin, which subsequently results in the itch development in AD.
This study incorporates cutaneous immunology and neurobiology and proposes a novel patho-
mechanism in itch development in AD.
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Heat shock proteins-27 and -70 have a functional role in cutaneous cell-mediated immune
responses through effects on dendritic cells
N Yusuf,1 TH Nasti,1 AM Holzer,1 C Huang,2 L Timares,1 H Xu,1 M Athar1 and CA Elmets1 1
Dermatology, UAB, Birmingham, AL and 2 Dermatology, UCSD, San Diego, CA
Proteomic analysis of murine skin has demonstrated that a variety of heat shock proteins (HSPs)
are constitutively expressed in the skin, and immunohistochemical examination of skin specimens
has shown that HSP27 is present in the epidermis, while HSP70 is present in both the epidermis
and dermis. To determine the significance of these proteins with respect to the immunological func-
tion of the skin, neutralizing antibodies to HSP27 and HSP70 were administered to C3H/HeN
mice followed by application of a sensitizing dose of the contact allergen dinitrofluorobenzene
(DNFB). HSP antibody pretreatment produced a reduction in the contact hypersensitivity response
and resulted in the induction of antigen specific unresponsiveness. Addition of HSP27 to dendritic
cell cultures resulted in augmented production of IL-1beta, TNF-alpha, IL-6, and IL-12p70. More-
over, DNFB conjugated dendritic cells that were pretreated with HSP27 had an increased capac-
ity to initiate contact hypersensitivity responses. Similar results were obtained when the carcino-
genic polyaromatic hydrocarbon dimethylbenz(a)anthracene (DMBA), which also causes contact
hypersensitivity, was given to HSP treated mice. When anti-HSP27 and anti-HSP70 antibody treated
mice were subjected to a standard two-stage DMBA cutaneous carcinogenesis protocol, the per-
centage of mice with tumors was much greater (p<0.05) in anti-HSP27 and HSP70 treated mice
compared to control antibody treated animals. Similar results were obtained when the data were
evaluated as the cumulative number of tumors per group. These findings indicate that HSP27 and
-70 play an important functional role in the skin that is mediated at least in part by their effects on
dendritic cells and that modulation of the activity of these heat shock proteins is an effective method
of modulating cutaneous T-cell mediated immune responses.
659
Mutant ras proteins are capable of eliciting allergic contact hypersensitivity responses
CA Elmets, N Yusuf, TH Nasti, AM Holzer, H Xu, M Athar and L Timares Dermatology, UAB,
Birmingham, AL
Topical administration of selected environmental chemicals results in the development of T-cell-
mediated allergic contact hypersensitivity. It has been thought that the antigen specific T-cell response
that develops is directed at the hapten that is applied to the skin. The purpose of this study was to
determine whether the T-cell response for at least some contact allergens might be directed against
endogenous proteins. For this purpose, we examined contact hypersensitivity responses to 7,12-
dimethylbenz(a)anthracene. This polyaromatic hydrocarbon produces a specific activating muta-
tion in the H-ras oncogene, resulting in a protein that has a single amino acid substitution (leucine
for glutamine) at the 61st residue. C3H/HeN mice were contact sensitized by topical application
of DMBA. Six days later, attempts were made to elicit the response by injecting a peptide fragment
(AGLEEYSAM) containing the amino acid substitution into the ear. Panels of mice that were ear
challenged with the mutant peptide developed significantly greater ear swelling (50 ± 5 x10-3
mm) than mice that were only ear challenged with the mutant peptide (9 ± 1 x10-3 mm). A com-
parable contact hypersensitivity response could also be elicited in mice that were both sensitized
and ear challenged to the mutant H-ras peptide. In contrast to the the mutant ras peptide, elicita-
tion of contact hypersensitivity did not occur when mice were ear challenged with normal ras
peptide, indicating that elicitation of the response was specific for the mutant peptide. Mutant ras
peptide was also found to generate antigen specific IL-4, IL-10, IL-17, and IFN-γ production in
vitro when mutant ras peptide pulsed bone marrow denditic cells (BMDCs) were co-cultured with
DMBA sensitized lymphocytes compared to the normal ras peptide pulsed BMDCs. These findings
indicate that somatic mutations produced by chemicals applied to the skin can result in the pro-
duction of proteins to which T-cell mediated immune responses can develop and which in turn
can cause contact hypersensitivity responses.
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CD5 is expressed by dendritic cells and is a co-inhibitory molecule for T cell activation and
immune responses
D He, H Li, L Wu, CA Elmets, C Raman and H Xu University of Alabama at Birmingham,
Birmingham, AL
It is known that CD5 is a membrane protein expressed by T cells and a small portion of B cells.
CD5 mediates inhibitory signals for T cells and plays important roles in immune tolerance. It is
unexplored whether CD5 is expressed by dendritic cells (DC) and whether CD5 has a role in DC
induced T cell activation and immune responses. Here we show that CD5 was constitutively
expressed by CD11c+ DC in the thymus, lymph node, spleen and skin of mice. Interestingly, CD5
was expressed by myeloid and lymphoid but was not detectable in plasmacytoid DC. Targeted
disruption of CD5 gene (CD5-/-) did not have an effect on the development of DC. However,
CD5-/- DC had a significantly higher level of ability to activate CD4 and CD8 T cells than wild
type DC, both in vitro and in vivo. Immunization of mice with CD5-/- DC induced a higher level
of anti-tumor immunity than wild type DC. Moreover, hapten labeled CD11c+ DC from CD5-/-
mice induced a significant higher level of contact hypersensitivity responses than wild type DC.
Further analysis showed that CD5-/- DC induced higher levels of IL-2 and IFN-gamma production
by T cells than wild type DC and that hapten primed T cells from CD5-/- DC sensitized mice pro-
duced higher levels of IL-2 and IFN-gamma than those from wild type DC sensitized animals as
well. In cultures of CD5-/- DC with wild type T cells or wild type DC with CD5-/- T cells, the pro-
liferation of T cells was similarly increased compared to that in cultures of both wild type DC and
T cells. However, in cultures of CD5-/- DC with CD5-/- T cells, the proliferation of T cells was
slightly further increased compared to that in the cultures with either CD5-/- DC or CD5-/- T cells.
It suggests that CD5-CD5 homotypic interactions between DC and T cells may be a primary mech-
anism for CD5 mediated immune suppression. The study has demonstrated that CD5 is a DC derived
co-inhibitory molecule for suppression of T cell activation and immune responses. It provides novel
insights into mechanisms for DC induced T cell tolerance and immune suppression.
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PXR activation modulates SOCS-1, NF-kappaB and MEK1/2 signalling in T-lymphocytes
S Dubrac, A Elentner, E Susanne and M Schmuth Dermatology Department, Medical School,
Innsbruck, Austria
The transcription factor pregnane X receptor (PXR) regulates the xenobiotic response by modulat-
ing genes central to drug and hormone metabolism in the liver. The role of PXR in the skin and
the skin immune system is unknown. We here report that expression of PXR and its well-known
target genes, i.e. CYP3A11 is markedly up-regulated upon diverse inflammatory stimuli in mouse
T cells. In vitro, pharmacologic PXR activation inhibits T cell proliferation and anergizes T-lym-
phocytes by decreasing the expression of CD25, and the production of IFN-gamma. Conversely,
T-lymphocytes isolated from spleen and lymph nodes of PXR deficient mice display an exagger-
ated hyperproliferative response when co-cocultured with epidermal dendritic cells. Further-
more, in T-lymphocytes pharmacologic PXR activation decreases the active form of NF-kappaB
and MEK1/2, preceded by increased SOCS-1 expression in a PXR-dependent manner. In vivo, the
modulation of T cell function by PXR activation has anti-inflammatory effects in mouse models of
irritant dermatitis and allergic contact hypersensitivity. Together, these results reveal a novel immune-
regulatory role of PXR in T-lymphocytes and in the skin adaptive immune response.
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ATP dependent activation of naïve regulatory T cell in vivo during contact hypersensitivity
reactions
S Ring, AH Enk and K Mahnke Department of Dermatology, University of Heidelberg,
Heidelberg, Germany
Adoptively transferred naïve CD4+CD25+Foxp3+ regulatory T cells (Treg) suppress the sensitiza-
tion phase as well as the elicitation phase in a murine contact hypersensitivity (CHS) model. Since
only activated Treg are able to suppress immune reactions, we asked at what site of the body the
Treg become activated after injection. Therefore, we labelled freshly isolated naïve Treg with flu-
orescent dyes and injected the Treg either 2 h before sensitization or 15 min before challenging
into recipient mice. 24 h after sensitization or challenging, respectively, the re-isolated Treg showed
a significantly increased expression of the characteristic activation markers CD69 and CD44 whereas
CD62L expression decreased. Moreover, the activation was dependent on the site of hapten treat-
ment, i.e. Treg became activated in the draining lymph node after sensitization and in the blood
during the elicitation phase. Recently it was shown, that the suppressive function of Treg is partly
mediated by adenosine, generated by a CD39/CD73 ectonucleotidase pathway, where ATP is the
crucial substrate. We hypothesized that ATP, in addition to serving as substrate for adenosine pro-
duction, might also act as an activator for Treg. In first in vitro experiments we demonstrated that
ATP indeed induced the activation of naïve Treg as indicated by upregulation of CD69. Addition-
ally ATP-activated Treg, showed increased suppressive capacity, comparable to results obtained
with Treg activated by anti-CD3/CD28. Finally in vivo we could measure increased levels of ATP
at the sites of hapten application in vivo. In aggregate our data suggest that Treg get first recruited
to the site of action and then undergo activation. The underlying means of this activation are not
clear yet, however, our data suggest that ATP, which is released by cells during apoptosis and oxida-
tive stress may act as a potent trigger in this tissue-specific activation of Treg in vivo.
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The role of hapten-specific IL-10-producing CD4+CD25+ regulatory T cells in tolerance to
contact allergens
U Frankenberg, N Lorenz and K Steinbrink Department of Dermatology, University of Mainz,
Mainz, Germany
The development and mechanisms of tolerance to allergens are poorly understood. Using the
murine low zone tolerance (LZT) model, where contact hypersensitivity (CHS) is prevented by
repeated topical low dose applications of contact allergens, we showed that suppressor CD8+ T
cells of LZT inhibit the development of contact hypersensitivity (CHS). Here, the function of nat-
urally occurring CD4+CD25+FOXP3+ regulatory T cells (nTregs) in LZT was investigated. FACS
analysis of nTregs during LZT revealed a significant increase of CD4+CD25+FOXP3+ Tregs as com-
pared to controls. Depletion of CD4+CD25+ Tregs during tolerization (by anti-CD25-Ab or cyclophos-
phamide) resulted in an enhanced CHS reaction as revealed by a significant skin inflammation,
allergen-specific T cell proliferation and Tc1 cytokine production. Importantly, injection of CD8+
T cells purified from Treg-depleted and tolerized mice failed to transfer LZT, demonstrating an abol-
ished development of CD8+ suppressor T cells in the absence of CD4+CD25+ T cells. Transfer exper-
iments of CD4+CD25+ Tregs after tolerization into naïve mice that are subsequently sensitized
revealed that CD4+CD25+ T cells exhibited the regulatory capacity for the transfer of LZT. Fur-
thermore, sensitization of recipients of CD4+CD25+ Tregs with a second, unrelated hapten, com-
pletely abolished LZT, indicating an allergen-specific function of CD4+CD25+ Tregs in LZT. Our
data demonstrate that CD4+CD25+ Tregs are critical for tolerance to contact allergens and con-
tribute to the regulation of CD8+ T cell-related immunity.
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Targeting of a MOG-single chain fusion protein to DEC205+ dendritic cells in vivo amelio-
rates experimental autoimmune encephalomyelitis in C57BL/6 mice
S Schmitt, S Ring, TS Johnson, V Storn, K Mahnke and AH Enk Department of Dermatology,
University of Heidelberg, Heidelberg, Germany
For the purpose of tolerance induction, we have recently established a novel method to load steady
state dendritic cells (DC) in vivo with antigens, using biochemical coupling of antigens to DC-spe-
cific anti-DEC205 antibodies. The biochemical coupling is time consuming and not precise, as
different conjugation products may occur. Thus we aimed at generating recombinant fusion pro-
teins, containing a DEC205-specific single chain fragment variable (ScFv) fused to the autoantigen
MOG. The respective DNA sequences were cloned into His-Tag and Myc-Tag containing vectors
and the recombinant ScFvMOG fusion protein was purified. To assess its targeting capabilities,
cultivated DC were incubated with graded doses of ScFvMOG and stained thereafter with Myc-
Tag specific antibodies. Examination via fluorescence microscopy revealed effective loading of
MHC class II compartments with ScFvMOG. Likewise in vivo, we show that after injection of
ScFvMOG exclusively DC in the draining lymph nodes (LN) stained positive for Myc-Tag anti-
bodies. When analysing the T cell populations of ScFvMOG injected mice we detected increas-
ing numbers of CD4+CD25+FoxP3+ T cells in the LN. To test whether these Treg are able to pro-
tect mice from MOG-induced experimental autoimmune encephalomyelitis (EAE), we injected
ScFvMOG conjugates into the footpads of BL/6 mice, induced EAE 2 weeks later and assessed the
course of the disease. We found that in mice treated with ScFvMOG the onset of EAE was delayed
and only 20 % of the ScFvMOG treated mice developed symptoms. In contrast, in PBS-injected or
MOG peptide-injected groups 80% of the animals developed clinical signs of EAE. Thus, our data
show that specific targeting of steady state DC by DEC-specific ScFv fusionproteins, leads to induc-
tion of Treg and serves as a novel strategy to prevent autoimmunity.
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CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking adhe-
sion of T cells to vascular endothelium via a CD39, adenosine-dependent mechanism
S Ring,2 SJ Oliver,1 BN Cronstein,1 AH Enk2 and K Mahnke2 1 Department of Medicine, New
York University School of Medicine, New York, NY and 2 Department of Dermatology,
University Hospital of Heidelberg, Heidelberg, Germany
Injection of regulatory T cells (Treg) into mice sensitized with TNCB abrogates the elicitation
phase of contact hypersensitivity (CHS) reactions by blocking the adherence of leukocytes to vas-
cular endothelium. Likewise, injection of adenosine or its agonist NECA results in similar effects.
Therefore we set out to analyze whether adenosine, a newly identified suppressive factor released
by Treg accounts for the suppression of the effector T cell - endothelial cell (EC) interaction. In ini-
tial in vitro experiments, we superfused monolayers of activated EC with bulk T cells and recorded
substantial adherence of T cells to the EC monolayers. In contrast, pretreatment of the EC with
adenosine or Treg, respectively, abrogated adherence of the T cells and reduced the number of
adherent T cells by 80% as compared to untreated controls. Furthermore, we show that the expres-
sion of P- and E-selectin on the EC was downregulated by 50% in presence of Treg or adenosine,
respectively. Finally, the suppressive effects of the Treg on T cell – EC interactions were abrogated
by incubation of the EC with adenosine receptor antagonists. Thus these data indicate that Treg-
derived adenosine may play a role in suppressing the adhesion of T cells during CHS responses.
As adenosine can be generated by degradation of adenosine triphosphate (ATP) by the ectonu-
cleotidase CD39, we next tested Treg for expression of CD39. Here we show that nearly 90% of
the isolated Treg expressed CD39 and were able to produce adenosine via the degradation of ATP.
Moreover when we used Treg isolated from CD39 deficient mice in our CHS model, we observed
that these Treg failed to prevent adhesion of leukocytes to the endothelium and hence were unable
to abrogate the ear swelling reaction. Thus, our data indicate that adenosine generated by Treg via
CD39 is essential to block leukocyte adhesion to endothelium.
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Regulatory T cells expanded in skin-draining lymph nodes via RANK-RANKL-activated Langer-
hans cells suppress cutaneous inflammation and colitis
K Loser,1 A Luegering,2 T Sparwasser,3 TA Luger1 and S Beissert1 1 Department of Dermatology,
University of Muenster, Muenster, Germany, 2 Department of Internal Medicine, University
of Muenster, Muenster, Germany and 3 Department of Infection Immunology, Centre of
Experimental and Clinical Research, Hannover, Germany
CD4+CD25+ regulatory T cells (Treg) play an important role in suppressing immune responses but
the requirements for peripheral maintenance of Treg are incompletely understood. To identify the
site of expansion we crossed K14-RANKL transgenic (tg) mice with epidermal RANKL overexpres-
sion to DEREG mice, expressing a Foxp3-GFP fusion protein. Using a cutaneous contact hyper-
sensitivity (CHS) model we were able to show that Treg are expanded in skin-draining lymph
nodes by direct contact to RANK-expressing Langerhans cells (LC) before elicitation of CHS. After
elicitation, DEREG mice develop a normal ear swelling and Treg are detectable in inflamed ears
as well as in regional lymph nodes. In contrast, K14-RANKLxDEREG mice showed a significantly
reduced ear swelling upon challenge and the majority of Treg expressed increased levels of IL-10
but did not migrate to the inflamed ears suggesting that Treg in regional lymph nodes might inhibit
the migration of effector T cells to inflamed tissues. Additionally, we investigated if non-cutaneous
inflammation can be controlled by Treg expanded by cutaneous RANK-RANKL stimulated LC.
Therefore, K14-RANKLxDEREG mice were fed with dextrane sulfate to induce colitis. Strikingly,
all parameters pointing to a severe colitis such as weight loss or rectal bleeding were significantly
reduced in K14-RANKLxDEREG mice compared to DEREG controls. Together, these results indi-
cate that in K14-RANKL tg mice Treg are expanded in regional lymph nodes and seem to be acti-
vated but remain in draining lymph nodes upon cutaneous inflammation. Moreover, the suppres-
sive activity of Treg in K14-RANKL tg mice is not tissue specific since Treg expanded by epidermal
LC downregulate epithelial inflammation in the skin and the intestine.
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ECP generates large numbers of clinically relevant dendritic cells
CL Berger, JM Remington and RL Edelson Dermatology, Yale University, New Haven, CT
Extracorporeal photopheresis (ECP) has demonstrated clinically significant results observed in
patients with cutaneous T cell lymphoma (CTCL), graft versus host disease (GVHD) and other dis-
eases of immune dysfunction. Genomic microarrays demonstrated that ECP treated leukocytes incu-
bated overnight from CTCL, GVHD patients and normals significantly up-regulated RNA transcripts
of genes associated with dendritic cell (DC) differentiation from monocytes. We now extend these
results and demonstrate that large numbers of phenotypically homogenous, morphologic and func-
tional DC are rapidly generated by ECP, without exogenous cytokines, and irrespective of the leuko-
cyte source. Leukocytes were obtained from the ECP procedure on patients or by leukapheresis or
blood draw on normals. Normal leukocytes were treated in the ECP apparatus or in an in vitro
mimic of ECP. Cells were analyzed from the ECP and ECP overnight (O/N) fractions by flow cytom-
etry for DC markers, phase and electron microscopy, or tetanus toxoid recall antigen presentation.
The results demonstrate that in the ECP O/N sample large numbers of DC were generated (100-
350x106) that expressed CD83, CD80, CD86 or DC-LAMP. The DC displayed a characteristic
morphology with an eccentric ovoid nucleus and pseudopodia surrounding and ingesting apop-
totic lymphocytes. Significantly, increased presentation of tetanus toxoid (P<0.001) was demon-
strated when the ECP sample was incubated overnight in comparison to pre-treatment controls.
ECP treated cells incubated overnight are stimulated by the passage through a plastic plate and
apoptotic cell loading to assume the profile of maturing DC. The DC express the phenotype, mor-
phology and function as well as the transcriptional properties of mature immunocompetent DC,
providing a basis for the immunotherapeutic benefits achieved with ECP.
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Human skin langerhans cells and dermal dendritic cells show different capacity to initiate
Th17 responses
AR Mathers,1 BM Janelsins,1 JP Rubin,2 OA Tkacheva,1 WJ Shufesky,2 SC Watkins,3 AE Morelli2
and AT Larregina1 1 Dermatology and Immunology, University of Pittsburgh School of
Medicine, Pittsburgh, PA, 2 Surgery, University of Pittsburgh School of Medicine, Pittsburgh,
PA and 3 Cell Biology and Physiology, University of Pittsburgh School of Medicine,
Pittsburgh, PA
Inflammatory Th17 responses are associated with the development and progression of skin inflam-
matory and autoimmune diseases. Migratory human skin dendritic cells (smiDCs) have the ability
to prime and bias Th1 and Th2 CD4+ T lymphocytes. However, whether human epidermal
Langerhnas cells or dermal DCs (DDCs) have the ability to prime Th17 responses remains to be
addressed. Moreover, in humans, initiation of Th17 differentiation has been attributed to IL-1β
producing monocytes rather than DCs. Here, we employed a model of human skin epidermal-der-
mal explant cultures to collect total smiDCs, or separated epidermal and dermal sheets to collect
highly purified smiLCs and smiDDCs, which were used as stimulators of allogeneic naïve CD4T
cells. Total smiDCs stimulated naïve CD4+T cells to differentiate into two distinct effector Th17
and Th1 populations capable of homing to the skin and induce severe cutaneous damage. LCs
represented the main smiDC subset capable of inducing Th17 responses. This effect was depend-
ent on the combined effects of IL-15 and stabilized IL-6. Purified smiDDCs did not have the capac-
ity to synthesize IL-15 and were unable to bias Th17 responses. However, they acquired the abil-
ity to differentiate Th17 cells in cultures supplemented with IL-15 and stabilized IL-6. Overall, our
data demonstrate that human smiLCs induce Th17 responses by mechanisms different from those
previously described and highlight the need to target clinical treatments based on these variations.
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Monocyte interaction with adsorbed fibronectin initiates the ECP pathway to dendritic cell
differentiation
JM Remington, CL Berger and RL Edelson Dermatology, Yale University, New Haven, CT
Extracorporeal photochemotherapy (ECP) induces a large scale differentiation of dendritic antigen
presenting cells (DC) from peripheral blood monocytes. Genome microarrays demonstrated involve-
ment of the integrin-mediated adhesion pathway in ECP, which promotes cell cycle progression
and preserves cell viability in response to environmental stressors. In this study, we examine what
components within the plastic UVA exposure plate are necessary for DC differentiation and their
relationship to the integrin-mediated adhesion pathway. Western blot analysis of protein desorbed
from the plastic plate revealed the integrin ligands, fibronectin and osteopontin. FACS analysis of
the monocyte/DC population demonstrated a 36.8% + 7.2 (n=3) increase in the percentage of active
β1 integrins after ECP, which pair with αV, 4, or 5 to bind the RGD motif of fibronectin. To further
examine the role of fibronectin adhesion on monocyte activation, we compared conventional ECP
with ECP run through a fibronectin-coated plate (fibronectin-ECP). FACS analysis after overnight
incubation showed a higher percentage of cells bearing DC markers in conventional ECP
(CD80/86:32.9% + 8.5, DR/CD83:34.6% + 7.0, CD36/CD83:51.9% + 6.0, n=3) vs. fibronectin-
ECP (CD80/86:18.9% + 4.2, DR/CD83:19.9% + 2.3, CD36/CD83:25.7% + 0.9, n=2). Furthermore,
western blots of cell lysates from conventional ECP revealed a marked change in the phospho-
protein profile. These data indicate that fibronectin adsorbed onto plastic interacts with passaged
monocytes, triggering a cascade of events which culminate in DC differentiation.
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Signaling dendritic cells via the neurokinin 1 receptor synergizes with agonistic CD40 liga-
tion to promote dendritic cell survival and potent CTL responses
BM Janelsins,1 AR Mathers,1 OA Tkacheva,1 G Erdos,1 WJ Shufesky,2 AE Morelli2 and
AT Larregina1 1 Dermatology and Immunology, University of Pittsburgh School of Medicine,
Pittsburgh, PA and 2 Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA
As an immune competent organ the skin is richly innervated and pro-inflammatory neuropeptides
released by nerve endings regulate the initiation of skin dependent innate and adaptive immune
responses. By binding the neurokinin 1 receptor (NK1R), substance-P, the prototype pro-inflam-
matory neuropeptide, promotes survival of immune cells resulting in potent cellular immunity
responses relevant for skin inflammatory and autoimmune disorders. Dendritic cells express sur-
face NK1R and the priming of T cell responses requires Ag presentation by dendritic cells (DCs)
able to withstand apoptotic signaling. Therefore, we hypothesized that signaling DCs via the
NK1R prevents apoptosis of DCs and therefore a sustained DC-T cell interaction resulting in potent
CTL responses. Using murine bone marrow derived DCs (BMDCs) cultured with the NK1R agonist
[Sar9Met (02)11]-SP, (SarSP-DCs) we demonstrate that signaling via the NK1R utilizes the PI3K-Akt
pathway to prolong the expression of the anti-apoptotic Bcl-2 molecule. In addition, SarSP-DCs
showed increased expression of surface CD40. Adoptive transfer of Ag or hapten loaded SarSP-
DCs showed enhanced longevity in local draining lymph nodes vs. DC control, which was a result
of a combination of signaling via the NK1R and CD40 molecules. Importantly SarSP-DCs elicited
potent CTL responses compared to control DC. We conclude that agonistic signaling via the NK1R
and CD40 has a synergistic effect that enhances DC survival and favors the generation of potent
CD4+Th1and CTL Tc1 biased responses.
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The oxidative defense and antioxidant pathway is implicated in monocyte protection from
8MOP/UVA
K Mutyambizi, CL Berger and RL Edelson Dermatology, Yale University, New Haven, CT
Extracorporeal Photophoresis (ECP) is a clinically efficacious therapy for cutaneous T cell lym-
phoma, graft versus host disease and acute allograft rejection. During ECP, mononuclear cells are
treated with pro-apoptotic 8 methoxypsoralen and UVA (8MOP/UVA). Monocytes alone are spared.
Surviving monocytes become antigen presenting dendritic cells (DC), loaded with antigen derived
from diseased cells during overnight transimmunization, constituting a cellular vaccine on re-infu-
sion into the patient. After transimmunization, almost 3000 monocyte genes are up-regulated. We
propose that a cohort of up-regulated genes play a role in monocyte protection from apotosis on
exposure to 8-MOP/UVA. Leukapheresis of peripheral blood from CTCL patients or normal sub-
jects yielded mononuclear cells. To test the limits of monocyte resistance to apoptosis, pure mono-
cyte and lymphocyte populations were treated with 100ng/μl of 8MOP and 3 J UVA in an in vitro
setup analogous to ECP. Trypan blue staining distinguished viable from apoptosed cells. The apop-
tosis specific antibody, APO2.7 identified cells in early apoptosis. Transcriptional profiling was con-
ducted on monocyte populations exposed to standard ECP. In vitro studies (n=3) showed a cumu-
lative of 80% apoptosed lymphocytes and 30% apoptosed monocytes apoptosis by trypan blue
exclusion while APO2.7 staining showed 31% of monocytes and 41% of lymphocytes in early
apoptosis 24 hours after 8MOP/UVA treatment. PCR array profiling identified up-regulation of 12
genes, and down-regulation of 3 genes implicated in the oxidative stress and antioxidant defense
pathway, with a fold change >3. We show that monocytes are relatively protected from apoptosis
within the first 24 hours after 8MOP/UVA treatment. A proposed mechanism of protection is acti-
vation of the oxidative stress and antioxidant defense pathway.
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Specificity and dissemination of antigen-experienced, tissue-tropic T lymphocytes
JJ Campbell and NJ Tubo Dermatology, Brigham and Women’s Hospital, Boston, MA
The circulating T cell pool contains multiple antigen-experienced subpopulations bearing distinct
tissue tropisms. The two best understood are those associated with the skin or the small intestine.
Skin-homing cells express chemokine receptor CCR4 and E-selectin ligand (E-lig), while intestine-
homing cells express CCR9 and integrin α4β7. Here we explore the logistics and biological rele-
vance of tissue-specific T cell trafficking in vivo. We compared responses to a given antigen deliv-
ered through distinct routes: the skin, the small intestine or the peritoneum. We assessed the
accumulation of antigen-specific lymphocytes in a wide variety of lymphoid organs at d5 after
immunization. The response to skin or intestinal immunization occurred mainly within the lym-
phoid organs immediately draining the immunization site: cervical nodes for ear-skin immuniza-
tion, mesenteric nodes for gut immunization. In contrast, the response to peritoneal immunization
was massive in all lymphoid organs. In fact, this massive response was only moderately reduced
by inhibition of S1P receptors, which prevent lymphocytes from exiting lymphoid organs. Thus,
antigen introduced IP can be directly presented to naïve T cells in distal lymphoid organs through-
out the body. We next assessed generation of skin- or gut-homing phenotype for T cells within each
lymphoid organ. We found that skin immunization produced only skin-tropic T cells, while gut
immunization produced only gut-tropic cells. The small numbers of antigen-experienced T cells
found in distal lymphoid organs retained the homing phenotype appropriate to the site of immu-
nization. Thus, tissue-specific lymphocytes retain unrestricted access to secondary lymphoid organs,
a property normally associated with “central” rather than “effector memory cells. Direct immu-
nization into the peritoneal caused massive immunological insult, resulting in the expansion of
antigen specific cells throughout the body. This type of overarching response is not associated
with T cells in responses to antigen entry through natural barriers.
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Effects of activated T cells on multinucleated giant cells depend on how they are activated
K Mizuno, H Iwasaka, S Oe and H Okamoto Dermatology, Kansai Medical University,
Moriguchi, Japan
Since activated T cells predominantly infiltrated in sarcoidal lesions, T cells are emerging as impor-
tant regulators of granuloma formation. Multinucleated giant cells (MGCs) in various types of gran-
ulomas originate from the fusion of monocyte-macrophage lineage cells. Osteoclasts are a class
of these MGCs whose precursor cells are monocyte-macrophage lineage cells and co-cultures of
mitogen-activated T cells with osteoclast precursors result in the formation of multiple functional
osteoclasts. Here, we examined the role of activated T cells in granulomas using an in vitro MGC
formation model from human monocytes. T cells of healthy controls were stimulated for 3 days
with either concanavalin A (ConA), phytohemagglutinin (PHA), or Propionibacterium acnes (P.
acnes). Cultured supernatants were used as a conditioned medium for the induction of MGC for-
mation. We have previously reported that conditioned medium from ConA-stimulated peripheral
blood mononuclear cells has the ability to generate MGCs from monocytes. In the present study,
we observed that conditioned medium from P. acnes induces MGC formation, while that from
PHA-stimulated T cells does not. Co-cultures of T cells activated by ConA or P. acnes with mono-
cytes also induced MGC formation. There was no difference in formation rate between CD4+- and
CD8+- T cells activated by ConA and those activated by P. acnes. In contrast, co-cultures of PHA-
stimulated or freshly-isolated T cells with monocytes did not induce MGC formation. IFN-γ neu-
tralizing antibody completely blocked MGC formation. GM-CSF and IL-3 neutralizing antibodies
slightly inhibited formation. T cells activated by P. acnes, a possible etiological bacterium in sar-
coidosis, as well as those activated by ConA thus play an important role in granuloma formation;
in addition, IFN-γ is a major factor responsible for the induction of MGC formation by activated
T cells.
675
Effects of thymic stromal lymphopoietin on invariant natural killer T cell in atopic dermati-
tis
W Wu, J Noh, S Oh, N Chang and K Lee Department of Dermatology & Cutaneous Biology
Research Institute, Yonsei University College of Medicine, Seoul, Korea, South
Thymic stromal lymphopoietin (TSLP) is one of the most important cytokines regarded as trigger
of atopic dermatitis (AD). TSLP expression, which is specific in AD is highly increased in the epi-
dermis of AD patients. Although many studies showed the effect of TSLP on dendritic cells (DC)
activation, no reports have shown the effect on human invariant natural killer T (iNKT) cells
which are one of the potent immune modulators. The aim of this study is to investigate the differ-
ence between the population of iNKT cells in peripheral blood mononuclear cells (PBMCs) of
normal controls (NCs) and to AD patients, to confirm the expression of TSLP in the lesional skin
of AD patients and clarify the effect of TSLP on iNKT cells and the association of activated iNKT
cells in the pathogenesis of AD. In the flow cytometic analysis, the population of iNKT cells in
PBMCs was highly increased in AD patients. However, there’s no correlation between iNKT cell
population and severity of AD, also between iNKT cell population and IgE level in AD patients.
And the population of iNKT cells in PBMCs was not affected by TSLP-treated DC. High expres-
sion of TSLP was observed in the epidermis of the lesional skin of AD patients. iNKT cells expressed
high level of TSLP receptor and TSLP-treated PBMCs influenced on the IL-4 secreting iNKT cells.
The expression of IL-4 was increased when they were treated with TSLP. TSLP not only activated
DC but also activated iNKT cells to express TH2 cytokine such as IL-4. On the contrast, IFN-γ,
TH1 cytokine did not show significant changes by the treatment of TSLP. These results correspond
to the findings that AD patients have an increased number of cells expressing IL-4 and IL-13, but
not IFN-γ. In conclusion, expression of TSLP in AD might activate iNKT cells to secrete TH2 cytokine
IL-4 and thus activated iNKT cells might be involved in TH2 immune responses of AD.
677
The role of actin cytoskeleton formation through mDia1 in skin dendritic cells
H Tanizaki,1 G Egawa,1,2 S Narumiya,3 Y Miyachi1,2 and K Kabashima1,2 1 Department of
Dermatology, Kyoto University Graduate School of Medcine, Kyoto, Japan, 2 Center for
Innovation in Immunoregulative Technology and Therapeutics, Kyoto University Graduate
School of Medcine, Kyoto, Japan and 3 Department of Pharmacology, Kyoto University
Graduate School of Medcine, Kyoto, Japan
Antigen acquisition, migration, maturation, and immunological synapse formation of cutaneous
dendritic cells (DCs) are essential to initiate acquired immune responses. The critical mechanism
for cell machinery is formation of actin oligomers that serve as nuclei for further polymerization.
The actin nucleation and polymerization are facilitated by two groups of proteins, the mDia fam-
ily of formins and Wiskott-Aldrich syndrome protein (WASP). WASP is known to be important for
immunological synapse formation, but the role of mDia remains unknown. Initially, we examined
that mDia1 was dominantly expressed in bone marrow-derived dendritic cells (BMDCs) and Langer-
hans cells (LCs) among three isotypes, mDia1-3, using quantitative PCR. Therefore, we generated
mDia1-deficient mice to evaluate its roles. Although proliferation and maturation of BMDCs were
comparable between wild-type C57BL/6 mice and mDia1-deficient mice, phagocytosis of FITC-
dextran and chemotaxis to CCR7 ligand, CCL19, using transwell chamber coated with matrigel
were significantly impaired in mDia1-deficient mice. Moreover, the immunofluorescent staining
with phalloidin showed incomplete actin bundle formation in mDia1-deficient mice. Furthermore,
two-photon microscopy for three-dimensional time-lapse imaging revealed that immunological
synapse formation of mDia1-deficient DCs to OT-II CD4+ T cell and podosome formation in the
draining lymph nodes were impaired. Consistently, DNFB-induced sensitization through the skin
was impaired in mDia1-deficient mice in vivo. In conclusion, our findings suggest that actin poly-
merization through mDia1 is important for phagocytosis, mesenchimal movement, and immuno-
logical synapse formation of DCs to initiate skin acquired immune responses.
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Monosodium urate crystals induces IL-18 production from mouse Langerhans cells
T Kawashima, U Hideya, M Kamata, T Yayoi and T Kunihiko Dermatology, University of Tokyo,
Tokyo, Japan
Monosodium urate (MSU) crystals, which is the causative agents of gout and released from injured
or dying cells, has been demonstrated to activate macrophages and dendritic cells in a manner
dependent on the NALP-3-inflammasome. When cells are activated by MSU, the cytoplasmic recep-
tor NALP-3 recruits the adaptor molecule ASC and forms NALP-3-inflammasome, which in turn
binds procaspase-1 and leads to its autocatalytic processing and activation. Active caspase-1 cat-
alyzes cleavage of the pro-cytokines IL-1β and IL-18, leading to their activation. Epidermis is fre-
quently exposed to various stimulations, which could result in cell injury or death. Thus, we stud-
ied the effect of MSU on Langerhans cells (LC). LC were isolated from mouse epidermis by panning
method using anti-MHC-class II antibody. We confirmed that LC has NALP-3 mRNA and ASC pro-
tein by RT-PCR and immunoblot. LC were phagocytosing MSU crystals after 6 h culture with MSU
by electron microscopy. Immunoblot of LC cell lysate demonstrated that MSU stimulation yielded
active caspase-1. MSU stimulation did not change the cell surface expression of MHC-classII, CD80,
CD86, CD40 on LC and MSU did not affect IL-1β secretion from LC. However, MSU significantly
increased the IL-18 production from LC. IL-18 secreted into the cell culture supernatant of LC
induced IFNγ secretion from bulk spleen cells and this induction was inhibited by IL-18 blocking
antibody, which result indicated that MSU induced bioactive form of IL-18 from LC. We further
demonstrated that LC express both alpha chain and beta chain of IL-18 receptor by flowcytome-
try and immunoblot, which result indicated the possibility that IL-18 induced by MSU could affect
LC in an autocrine manner. IL-18 has been shown to promote LC migration, therefore, we studied
the effect of MSU on LC migration, in vivo. Our preliminary data suggested that CFSE labeled LC
cultured with MSU were promoted to migrate out of the skin to regional lymph node by MSU stim-
ulation. Thus, MSU would stimulate skin immune response via promoting LC migration.
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Stromal cell expression of Toll-like receptor 9 is required for the topical adjuvant effect of
CpG oligodeoxoynucleotides.
W Cheng and JP Dutz Dermatology & Skin Science, University of British Columbia,
Vancouver, BC, Canada
Current vaccine technologies remain inadequate to counter the risk of pandemics of viral infec-
tions. This is in part due to the poor ability to induce effective antiviral immunity mediated by
cytotoxic T lymphocytes (CTLs). We have demonstrated that topical administration of immunos-
timulatory CpG oligodeoxynucleotide (ODN), a Toll-like receptor 9 (TLR9) agonist, induces potent,
rapid and durable antigen (Agn)-specific CTL responses to locally injected protein Agn. However,
the subset of cells that are responding to this adjuvant effect remains to be elucidated and the expres-
sion of TLR9 in the skin is controversial. This study aimed to determine the expression of TLR9 by
real time-PCR in the skin and if TLR9 is required on stromal cells such as keratinocytes for the top-
ical adjuvant effect of CpG ODN in vivo using C57BL/6 mice. Bone-barrow chimeric mice with
TLR9 deficient stromal cells but TLR9 sufficient (WT) bone marrow (BM)-derived cells were gen-
erated. Real time-PCR results indicated that untreated WT mice expressed TLR9 compared to
TLR9 deficient mice in the skin. Tape stripping did not up-regulate TLR9 expression in WT mice
while CpG adjuvant up-regulated TLR9 expression in the skin. Topical CpG treatment enhanced
Agn-specific CTL responses in WT (TLR9 sufficient) but not stromal cell TLR9 deficient mice as
indicated by the percent of OVA-specific CTLs amongst CD8+ T cells in the spleen. Thus, skin
stromal cell expression of TLR9 is required for the topical adjuvant effect of CpG to increase the
efficacy of vaccines.
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Lymphocyte cooperation in T cell homing: CD4 T cells help CD8 T cells traffic to skin
X Jiang and TS Kupper Dermatology, Brigham and Women’s Hospital, Boston, MA
While CD4 T cells provide “help” to CD8 T cells with regard to activation/cytokine production, it
is unknown whether CD4 T cells can help CD8 T cells more efficiently home to skin during an
immune response. To test this possibility, we used a genetically modified vaccinia virus that expresses
full length ovalbumin(VV-OVA). We took advantage of transgenic T cells from two different strains
of mice. OT-I T cells are CD8+ and recognize the SINFEKL peptide of OVA in the context of Class
I H-2d. OT-II T cells are CD4, and recognize a distinct OVA peptide in the context of H-2d Class
II. Both respond to full length OVA processed and presented by dendritic cells. At 24 hours prior
to skin infection(scarification) with VV-OVA, normal mice were injected with naïve OT-I, OT-II, or
a 1:1 mixture of OT-I and OT-II cells. At various time points after skin infection in these mice, OT-
I or OT-II T cells were analyzed in draining LN and in infected skin. In OT-I mice, OT-I cells in LN
proliferated, rapidly upregulated ligands for E and P selectin, and were first detectable on day 2
after infection. They increased on day 3, and by day 5 comprised about 50% of recruited CD8 T
cells in the infected ear. In OT-II mice, upregulation of E and P selectin ligands was less robust, and
recruitment of OT-II T cells to infected skin followed the same kinetics, but was much less effi-
cient. However, in mice injected with both OT-I and OT-II T cells, OT-I cells more strongly upreg-
ulated E and P selectin ligands in LN. Recruitment of OT-I CD8 T cells to infected ear could be
detected as early as 24 hours after infection. By day 3, there was a dramatic increase in OT-I T
cells(>35% of total CD8 T cells). By day 5, OT-I T cells outnumbered non-transgenic CD8 T cells
by more than 3:1, while OT-II T cell homing was unaffected. These data were reproducible, and
strongly suggest that concurrent activation of OT-II CD4 and OT-I CD8 T cells in the draining LN
to VV expressed-OVA peptides strongly enhanced the homing of CD8 T cells to VV-OVA infected
skin. Thus, activated CD4 T cells enhance the homing of antigen specific CD8 T cells to skin.
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Phosphodiester-CpG-ODN-mediated prevention of atopic dermatitis through IL-4 inhibition
K Na, M Jeon and T Kim Laboratory of Dermato-Immunology, Catholic Research Institute of
Medical Science, College of Medicine, The Catholic University of Korea, Seoul, Korea, South
Atopic Dermatitis (AD) is a chronic and pruritic inflammatory disease of the skin characterized by
increased total IgE level, inflammatory cell infiltration, and the elevated expression of Th2 cytokines
such as IL-4. Synthetic oligodeoxynucleotides containing unmethylated CpG dinucleotides (CpG-
ODN) have been brought to an attention as immunomodulators that reduce Th2-mediated responses.
Previous works have demonstrated the clinical effectiveness of CpG phosphorothioate-ODN (PS-
CpG-ODN) for the management of AD in mice model. However, due to the unwanted side effects
such as increased B cell number, much increase of Th1-responses and pro-inflammatory cytokines,
the therapeutic use of PS-CpG-ODN might be limited. In this study, we investigated the preven-
tive effect of PO-CpG-ODN on AD using mouse model of ovalbumin (Ova)-induced skin inflam-
mation. Pretreatments of PO-CpG-ODN before the Ova sensitization prevented the development
of Th2-mediated responses such as less immune cell infiltration and low production of IgE and IL-
4. Our data indicate that PO-CpG-ODN might be possible candidates for the prevention of AD
without the unwanted side effects.
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α-Melanocyte stimulating hormone (α-MSH) treated CD8+ T cells control contact allergy
and anti-tumoral immunity
T Brzoska,1,2 TA Luger,2 S Beissert,2 C Abels1 and K Loser2 1 Dr. August Wolff GmbH, Bielefeld,
Germany and 2 Dept. of Dermatol., Univ. of Muenster, Muenster, Germany
The neuropeptide α-MSH is a potent immunomodulator. To investigate the mechanisms underly-
ing α-MSH induced immunomodulation we tested the effects of α-MSH on T cell function. Inter-
estingly, only CD8+ but not CD4+ T cells express the melanocortin receptor-1 (MC-1R). Accord-
ingly, treatment with α-MSH did not affect phenotype or function of CD4+ T cells. However, α-MSH
upregulates expression of activation markers, such as CD43 or CTLA-4, in CD8+ cells. To test
whether α-MSH-treated CD8+ T cells demonstrate altered functions in vivo PBS- or α-MSH-stim-
ulated CD8+ T cells were injected into DNFB sensitized mice. Upon ear challenge with DNFB,
mice treated with PBS-incubated CD8+ T cells mounted a normal contact allergy response. Injec-
tion of α-MSH-treated CD8+ T cells inhibited contact allergy suggesting a suppressive capacity of
α-MSH-stimulated CD8+ T cells in vivo. MC-1R-mediated signalling plays an important role in
induction of the suppressor phenotype since α-MSH stimulated CD8+ T cells from MC-1R defi-
cient mice were not able to reduce contact allergy responses upon adoptive transfer. The mecha-
nism underlying α-MSH induced suppressor activity was analysed further: qPCR and chromium
release assays suggested that the suppressive effect of α-MSH treated CD8+ T cells might be medi-
ated by increased kill activity as well as enhanced expression of cytotoxic molecules like granzyme
A, granzyme B or perforin. To further characterize the cytotoxic potency of α-MSH-treated CD8+
T cells C57BL/6 mice bearing B16-melanomas were injected with PBS or α-MSH treated CD8+ T
cells. Vaccination with α-MSH-stimulated CD8+ T cells reduced tumour growth dramatically. Adop-
tive transfer of α-MSH stimulated CD8+ T cells from MC-1R deficient mice into tumour-bearing
recipients did not result in reduced tumour growth indicating that MC-1R signalling is crucial for
α-MSH mediated induction of cytotoxicity in CD8+ T cells. Together, these findings indicate that
α-MSH induced increased cytotoxic activity in CD8+ T cells via MC-1R signalling.
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Stat1-dependent apoptosis of antigen-presenting cells by peptide-specific T helper 1 lym-
phocytes
H Braumueller, T Wieder, N Bauer and M Röcken Dermatology, Eberhard Karls University
Tuebingen, Tuebingen, Germany
Numerous studies have shown how antigen-presenting cells (APC) differentiate naive T helper cells
into Th1, Th2 or Th17 lymphocytes, but very little is known about how Th cells instruct APC. We
asked if and how differentiated antigen-specific IFN-gamma-producing Th1 lymphocytes can ren-
der APC function and signaling. IFN-gamma or Th1 cells are tumor protective under many condi-
tions but the mechanism is still unknown. One possible mechanism could be the direct anti-tumoral
influence of DC in the tumor draining lymphnode by Th1 cells. To address this question, we used
DC from wild-type as well as DC from Stat1 (a member of the Signal Transducer and Activator of
Transcription family) knockout mice. together with tumor-specific Th1 lymphocytes in an in vitro
approach and analyzed apoptosis, proliferation and cytokines/chemokines influencing the microen-
vironment. The apoptotic effects of Th1 cells were measured by TUNEL- and Annexin-V-staining.
Th1 lymphocytes induced apoptosis (up to 50%) in wild-type DC, but not in Stat1ko DC. This pro-
apoptotic effect was accompanied by a potent induction (up to 1,200 fold) of anti-angiogenic
chemokines, such as CXCL9 or CXCL10 in wild-type DC but not in Stat1ko DC. In a previous study,
we could show that Th1 cells can arrest tumor growth and proliferation of tumor cells in an endoge-
nous model of multistage carcinogenesis. Therefore, we analyzed Th1-mediated effects on the
proliferation of DC by 3H-thymidin uptake assays. Th1 cells reduced the proliferation of wild-type
DC dramatically, whereas in Stat1ko DC proliferation was not impared. In conclusion, peptide-
specific Th1 cells exert a strong negative feedback signaling on DC that leads to a loss of prolifer-
ation capacity and enhanced apoptosis in wild-type DC but not in DC that have lost the capabil-
ity of transducing IFN-gamma signaling. Our results show, that Th1 cell-mediated instruction of
DC is necessary for anti-tumoral immune responses.
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The RhoA effector mDia1 regulate motility and function of T lymphocytes in cutaneous
immune responses
G Egawa,1,2 H Tanizaki,2 T Okada,4 S Narumiya,3 Y MIyachi2 and K Kabashima1,2 1 Center for
Innovation in Immunoregulative Technology and Therapeutics, Kyoto University, Kyoto,
Japan, 2 Department of Dermatology, Kyoto University, Kyoto, Japan, 3 Department of
Pharmacology, Kyoto University, Kyoto, Japan and 4 Research Center for Allergy and
Immunology, RIKEN, Yokohama, Japan
Lymphocytes exhibit dynamic change in their receptor expression, cell polarity, and constitution
of cytoskeleton to reach their destination. Rho-GTPases (Rho, Cdc42, Rac) play a central role in
the modulation of cytoskeleton. We recently reported mDia1, one of the effectors of RhoA, is essen-
tial for T lymphocytes entry into the lymph nodes (J Exp Med.204:2031-8.2007), indicating a close
relation between the actin dynamics of T lymphocytes and their immunological functions. How-
ever, the precise underlying mechanism and the impact on skin immune response remains unknown.
To this end, we examined three-dimensional T lymphocyte motility in lymph nodes using two-pho-
ton microscope and found that the velocity and displacement of the movement in mDia1-defi-
cient T lymphocytes were impaired. In addition, they appeared round shape and their attachment
to stromal follicular reticular cells was disrupted. Moreover, treatment of Y-27632, a specific inhibitor
of other RhoA effectors, ROCK1/2, resulted in further T lymphocyte dysmotility, suggesting that
adequate actin nucleation by RhoA family molecules are essential for T lymphocytes motility. We
also characterized immunological ability of mDia1-deficient T lymphocytes. The adoptive trans-
fer of mDia1-deficient T lymphocytes sensitized with DNFB as a hapten showed an impairment of
their homing capacity to the local skin lesions challenged with DNFB, resulting in attenuation of
contact hypersensitivity response. Furthermore, we showed that while the chemokine responsive-
ness to a CCR7 ligand, CCL21, was impaired, their trans-endothelial migration capacity was com-
parable to that of wild type. Taken together, our findings indicate that the regulation of cytoskele-
ton via RhoA in T lymphocytes is essential for the establishment of acquired skin immune responses.
683
Interferon-gamma induces cellular senescence in primary tumor cells in vitro
T Wieder,1 H Braumüller,1 N Bauer,1 F Essmann,2 K Schulze-Osthoff2 and M Röcken1 1
Dermatology, University, Tübingen, Germany and 2 IFIB, University, Tübingen, Germany
The T antigen (Tag) of the simian virus 40 under control of the rat-insulin-promotor (RIP) leads to
the development of β-cell tumors in transgenic RIP1-Tag2 mice. Previous studies revealed that inter-
feron-gamma (IFN-γ)-producing, antigen-specific Th1 cells strongly inhibit tumor development in
the absence of significant β-cell destruction. Instead, Th1 cells reduce angiogenesis and decrease
proliferation of tumor cells in RIP1-Tag2 animals in a strictly IFN-γ-dependent manner. To eluci-
date the principles underlying the therapeutic efficacy of antigen-specific Th1 cells, we analyzed
the influence of IFN-γ on β-cell functioning, apoptosis and senescence in an ex vivo approach. For
this, islet carcinoma cells were isolated from RIP1-Tag2 mice. The isolated β-cell populations
were then treated in vitro with recombinant mouse IFN-γ, and senescence-associated β-galactosi-
dase was determined as a marker of senescent cells. To exclude cellular destruction of the cells,
TUNEL staining was performed in parallel. Furthermore, we immuno-stained the isolated cell pop-
ulations with an anti-synaptophysin antibody (which can be used as a primitive β-cell marker) to
discriminate between β-cells and tumor-associated fibroblasts. Our results showed an IFN-γ-depend-
ent induction of senescent cells in up to 40 % of the cell population. In sharp contrast, IFN-γ treat-
ment did not lead to detectable signs of apoptosis. The rate of apoptotic cells was below 5 % of
total cells and did not differ from control cultures. IFN-γ-mediated β-cell senescence was analyzed
in two additional experimental approaches: (i) β-galactosidase/synaptophysin double staining
revealed that senescence occurred in synaptophysin-positive β-cells and (ii) immuno-staining
with the antibody MeH3, which recognizes methylated Histone H3, confirmed senescence induc-
tion by IFN-γ. Thus, induction of β-cell senescence in the absence of apoptosis may represent a
central mechanism underlying the anti-tumoral effect of IFN-γ-producing Th1 cells.
684
T cell hyporesponsiveness is induced by efalizumab in vivo and in vitro
F Koszik, G Stary, N Selenko-Gebauer and G Stingl Department of Dermatology / DIAID,
Medical University of Vienna, Vienna, Austria
The use of the lymphocyte function associated-molecule-1 (LFA-1) α-chain (CD11a)-binding mon-
oclonal antibody (mAb) efalizumab (E) is a treatment option in moderate to severe psoriasis. Even
though LFA 1 is universally expressed on leukocytes of the peripheral blood, the general opinion
holds that E exerts its effects essentially on T lymphocytes by blocking their migration and by per-
turbing the immunological synapse. To test the validity of the latter assumption, we asked whether
E could interfere with T cell proliferation induced by qualitatively and quantitatively different
stimuli. Using PBMC of E treated patients, we observed that E, while unable to interfere with T cell
proliferation under optimal stimulation conditions (PHA), effectively blocks the allogeneic mixed
leukocyte reaction and anti-CD3-driven T cell proliferation induced under suboptimal conditions.
To understand the mechanism(s) underlying this phenomenon we exposed normal PBMC to E under
various conditions. Cells were subsequently stimulated via CD3. Whereas addition of E to the
medium alone did not modify the reactivity of PBMC to plate bound anti CD3, crosslinking via an
anti-E antibody rendered T cells less reactive to a following anti-CD3 stimulus. Our findings sug-
gest that binding of E to CD11a can induce molecular events that downmodulate T cell respon-
siveness/threshold to a T cell receptor-mediated stimulus. This may also provide an explanation as
to why E is highly effective in patients with stable psoriasis, but often fails to control disease flares.
These findings may further deliver insights into the immunosuppressive potential of E-treatment.
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Topical application of novel mitochondrial antioxidants mitigates skin damage from ioniz-
ing radiation
R Brand,1 M Epperly,2 A Radfar,1 NR Dodd,1 X Gao,3 S Li,3 S Huq,2 D Jukic,1 P Wipf,4 V Kagan,5
JS Greenberger2 and LD Falo1 1 Department of Dermatology, University of Pittsburgh School
of Medicine, Pittsburgh, PA, 2 Department of Radiation Oncology, University of Pittsburgh
School of Medicine, Pittsburgh, PA, 3 Department of Pharmacology, University of Pittsburgh
School of Medicine, Pittsburgh, PA, 4 Department of Chemistry, University of Pittsburgh,
Pittsburgh, PA and 5 Department of Environmental/Occupational Health, University of
Pittsburgh, Pittsburgh, PA
Cutaneous injury from ionizing irradiation and combined thermal/ionizing radiation damage is a
significant component of the tissue injury from radiological dispersion devices and fission bomb
terrorist events. There is a need to develop radio protective (delivered before radiation exposure)
and mitigating agents (delivered after irradiation) specific for ionizing irradiation induced cuta-
neous injury. To meet this need, we have developed novel mitochondrial targeted antioxidants that
act as potent radiation damage mitigators through stabilization of the mitochondrial cardiolipin
cytochrome C interaction. To address whether these novel mitochondrial targeted antioxidants can
mitigate radiation induced skin damage when applied topically, we irradiated naïve mice using a
6 MeV electron beam to delivery exposure doses known to cause significant radiation damage.
Specific antioxidants including targeted hemigramacidinnitroxide and triphenyl phosphonium
derivatives, were topically applied 1 hr after irradiation and daily for the remainder of the exper-
iment. Mice were photographed and skin damage was scored by clinically criteria. Skin samples
taken 3 and 7 days post irradiation for histological and enzymatic analysis. Analysis revealed that
the topically applied agents successfully reduced the severity of radiation-induced desquamation,
hydropic degeneration and follicular atrophy. Furthermore, these compounds significantly decreased
radiation induced apoptosis. Taken together, this data suggests that these novel mitochondrial tar-
geted antioxidants function as potent mitigators of radiation induced skin damage.
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Analysis of tumor-promoting CD8+ T cells reveals TH17 differentiation, regulatory capac-
ity, and growth-factor potential
B Kwong,1 S Roberts,1 T Silberzahn,2 R Filler,1 A Galan,1 J Neustadter,1 W Lin,1 S Reddy,1
A Hayday2 and M Girardi1 1 Dermatology, Yale University, New Haven, CT and 2
Immunobiology, King’s College, London, United Kingdom
We previously identified a novel population of CD8+ tumor-promoting, perforin-deficient T cells
(T-pro) in a model of inflammation-associated (2-stage chemical) carcinogenesis. To better under-
stand the role of these cells in driving tumor development and progression within epithelium, we
sorted by flow cytometry (>99.5% pure) TCRαβ+ CD8+ CD44+ CD62L(-) cells from the tumor-
infiltrating lymphocyte (TIL) and peripheral blood lymphocyte populations of multiple biologic
repeats of tumor-bearing mice, and studied them by full-genome expression analysis. Absolute
probe-hybridization values confirmed high-fidelity sorts devoid of non-CD8+ T cells, keratinocytes,
Langerhans cells, NK cells, or B cells. Cluster analysis indicated differentiation along the TH17
pathway, and a lack of cytolytic mediators, confirming that they were clearly distinct from anti-
tumor cytolytic lymphocytes. Real-time RT-PCR validated the following relative expression levels
in T-pro: TH17 differentiation (>100-fold up-regulation of RORγt, IL-17A, IL-17F, IL-10, IL-22; >25-
fold down-regulation of T-bet, EOMES, GATA-3); poor cytolytic potential (>100-fold down-regu-
lation of perforin, NKG2D, FasL, NKG7); and production of selective pro-inflammatory mole-
cules/growth factors (>100-fold up-regulation of AREG, GRO-1; yet >100-fold down-regulation of
RANTES). Further analyses on independent isolates from early vs late, and benign vs malignant,
tumors revealed that our ‘T-pro expression profile’ was associated with tumor progression to car-
cinoma. Two-color flow cytometric analysis confirmed the CD8+ IL-17+ T cells isolated from TIL.
Identification of putative mechanistic activities for tumor-promoting CD8+ T cells has major impli-
cations for inflammatory skin disease and carcinogenesis, and for the development of tumor pro-
phylactic and immunotherapeutic strategies. Investigators exploring therapies designed to broadly
stimulate CD8+ T cells might consider that such may stimulate tumor-promoting activities.
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Normal human lung is devoid of skin homing T cells, but like skin contains very large num-
bers of effector memory T cells at rest
R Purwar,1 RG William,2 R Clark1 and T Kupper1 1 Dermatology, Harvard Skin Disease
Research Center, Boston, MA and 2 Tissue Repository, BWH, Boston, MA
Our previous work has demonstrated that normal skin contains large numbers of effector memory
T cells (TEM). Therefore, by adulthood, T cell memory for antigens encountered through skin resides
largely in skin. Lung is another interface with the environment, where antigen encounter is fre-
quent and ongoing. We hypothesized that like skin,lung would contain large numbers of TEM cells
at rest. We took advantage of an established tissue procurement service at BWH in order to har-
vest normal undiseased portions of lungs electively resected for other indications. The integrity of
tissue was confirmed by pathology, which also confirmed the absence of acute or chronic inflam-
mation in the harvested tissue. Similar to skin, we cultured lung explants on Cellfoam grids, and
analyzed T cells derived from lung at various time points after culture. We were able to harvest
on average 4X109 T cells from each cubic centimeter of lung tissue, and demonstrated that they
were uniformly CD45RO memory phenotype, confirming lack of contamination with blood T cells.
Most memory T cells had a TEM phenotype. The vast majority of T cells were CD4 and CD8 TCR
αβ cells, with fewer than 5% TCR γδ cells, NK, or NK-T cells. The phenotype of lung TEM differed
from skin TEM in that they were uniformly negative for CLA, less than 50% positive for CCR4, but
expressed high levels of CCR5, CCR6, CXCR3, CXCR4, and PSGL-1. Like skin, many cells expressed
CD69, and a subset expressed CD4, high levels of CD25, and FoxP3, consistent with Treg cells.
Lung TEM produced significant IFNγ and TNFα, with little production of IL-4, IL-13, or IL-17. The
majority of cytokine secreting TEM were multifunctional, secreting combinations of IFNγ, TNFα,
and IL-2. We conclude that normal lung contains, in total, as many as 5X109 T cells at rest, and
that these TEM lack skin or gut homing markers. They produce multifunctional cytokines, and by
analogy to skin, may represent the reservoir for T cell immunity to antigens encountered through
airways.
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IL-15 regulates a critical checkpoint by stabilizing gene expression in autoreactive CD8 Tcells
F Miyagawa,1 A Terunuma,1 J Linton,1 A Player,2 D Edelman,2 S Davis,2 Y Wang,2 P Meltzer,2
Y Tagaya3 and S Katz1 1 Dermatology Branch, NIH, Bethesda, MD, 2 Genetics, NIH, Bethesda,
MD and 3 Metabolism, NIH, Bethesda, MD
We previously reported that autoreactive TCR-transgenic (Tg) CD8T cells (OT-I cells) adoptively
transferred into K14-mOVAhigh (high transgene copy number) Tg mice induced GvHD while K14-
mOVAlow Tg mice did not develop disease. Exogenous IL-15 induced disease in mOVAlow mice and
blocking endogenous IL-15 using anti-IL-15mAb or backcrossing into IL-15KO mice attenuated
GvHD in mOVAhigh mice. These results identify IL-15 as a critical costimulator that determines the
outcome of immune responses. To determine the precise mechanisms of IL-15 as a costimulator,
we established in vitro system that mimicked the in vivo system and determined the checkpoint
where the effect of IL-15 is critical as to whether effector function or unresponsiveness ensues. 0.3
pg/ml of OVA peptide was a suboptimal dose of antigen to induce OT-I proliferation. Combina-
tion treatment of 0.3 pg/ml of peptide and 15nM of IL-15 induced maximum responses, while IL-
15 alone induced only a minimal response. These results suggest that the effect of IL-15 is syner-
gistic with suboptimal doses of peptide. We then performed microarray analysis on OT-I cells
cultured with (1) combination (2) peptide alone or, (3) IL-15 alone at 6 hr and 12 hr culture. Sim-
ilar numbers of upregulated genes are detected at both timepoints in the combination treated
group.There is an 89% reduction in upregulated genes in the peptide-treated group and a 63%
reduction in the IL-15 treated group at 12hr compared to 6hr. This suggests that combination treat-
ment may stabilize gene expression since gene expression induced by combination is persistent.
There is a dramatic increase in upregulated genes induced only by the combination at 12hr sug-
gesting that the combination may induce unique gene sets. Pathway analysis of these newly induced
gene sets showed that various pathways including mitochondrial dependent, NF-kB,and Notch sig-
naling pathways are upregulated. Targeting these pathway may privide a greater understanding of
autoreactive CD8T cells.
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CD8+ T cells infiltrating human cutaneous squamous cell carcinomas display IL-10 produc-
tion and reduced cytotoxic potential
S Reddy,1 R Filler,1 SJ Roberts,1 J Neustadter,1 S Aasi,1 DJ Leffell,1 R Clark2 and M Girardi1 1
Department of Dermatology, Yale University School of Medicine, New Haven, CT and 2
Department of Dermatology, Brigham and Women’s Hospital, Boston, MA
The role of various T cell subsets within the tumor microenvironment of cutaneous squamous cell
carcinomas (SCC) remains to be fully elucidated. CD8+ cytotoxic T lymphocytes (CTL) may medi-
ate tumor cell destruction and the presence of CD8+ tumor-infiltrating lymphocytes (TILs) is seen
as prognostically favorable. However, we have previously identified in mice a subpopulation of
TCRαβ CD8+ T-cells (T-pro) that are associated with tumor progression. T-pro exhibit reduced cyto-
toxic effectors (e.g. perforin, FasL, and NKG2D) and increased levels of the immmunoregulatory
cytokine IL-10 and the proinflammatory cytokine IL-17. To begin to address whether a similar CD8+
T-pro population exists within human SCC, we analyzed six tumors following excision and culture
on three-dimensional cell matrices to facilitate T cell migration and collection. The isolated T cells
were analyzed by flow cytometry for CD8 expression, cytotoxic capacity (e.g. perforin, NKG2D,
FasL), and cytokine (e.g. IL-10) levels. While the CD8+ TIL consistently showed a pattern of high
NKG2D and low FasL expression, there were identified two distinct populations of CD3+ CD8+
perforin(lo) (mean 51.8%) and perforin(hi) T cells. Furthermore, a majority (mean 74.0%) of the
CD8+ TIL were positive for IL-10 production. In summary, these preliminary findings suggest that
CD8+ TIL within human cutaneous SCC contain a subpopulation with regulatory potential and
reduced cytotoxic capacity. Such human SCC CD8+ TIL are distinct from CTL, and show similar-
ities to the CD8+ T-pro identified in our experimental system of SCC induction.
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T cell-mediated immune memory, and not neutralizing antibodies, is necessary and sufficient
for successful vaccination against viral pathogens
L Liu,1,2 Q Zhong,1,2 K Dubin1 and TS Kupper1,2 1 Dermatology, Brigham and Women’s
Hospital, Boston, MA and 2 Dermatology, Harvard Medical School, Boston, MA
Generation of a robust neutralizing antibody response has been the goal of most vaccines for human
disease, including all that are currently FDA approved. The role of T cells, beyond providing help
for B cell antibody production, has been largely ignored. It has now become clear that memory T
cells are abundant in tertiary peripheral tissues such as skin, lung, and GI tract, where encounter
with pathogens typically occurs. We hypothesize that these cells may provide important first-line
defense against pathogen challenge. To test this hypothesis, we utilized vaccinia virus vaccination
in a murine model. Following immunization with attenuated vaccinia virus (VV) by skin scarifica-
tion, mice developed high titer VV-specific IgG and strong T cell memory, and were fully pro-
tected against subsequent respiratory and cutaneous VV challenge. We then immunized μMT mice,
which lack mature B cells and cannot produce antibodies, as well as normal mice, with VV virus,
either by skin scarification or intraperitoneal injection. Surprisingly, μMT mice were completely
protected against respiratory and cutaneous VV challenge, suggesting T cell memory in the absence
of neutralizing antibodies is sufficient to convey full protection. We next asked if depletion of T
cells interfered with protection against VV infection. Either CD4, CD8, or both populations of T
cells were depleted with specific antibodies from mice previously immunized against VV. When
both CD4 and CD8 T cells were depleted from these normal immune mice, protection against cuta-
neous viral challenge was completely abrogated, despite the persistent presence of circulating high
titer Ab. Together, these data strongly suggest that memory T cells play crucial and previously unap-
preciated role in protection against secondary challenge with viral pathogens. Development of
strong and long-lasting protective T cell memory should be an important goal for successful vac-
cination against cutaneous infectious diseases.
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Intrinsic properties of memory B cells
MM Tomayko,1 SM Anderson,2 NC Steinel,1 S Sadanand,2 CE Brayton,1 MP Cancro,3 T Migone,4
TW Behrens5 and MJ Shlomchik2 1 Dermatology, Yale University, New Haven, CT, 2
Immunobiology, Yale University, New Haven, CT, 3 Pathology, University of Pennsylvania,
New Haven, PA, 4 Human Genome Sciences, Rockville, MD and 5 Genentech, San
Francisco, CA
B cells are important for the pathogenesis of autoimmune disease, and memory B cells specifically
may play key roles determining disease chronicity. However, the properties that distinguish mem-
ory cells from their antigen inexperienced precursors are poorly understood. Using model systems
that overcome the lack of murine memory-specific markers and the low frequency of memory and
naïve cells characteristic of most murine systems, we undertook a global comparison of gene expres-
sion between memory and naïve B cells. We identified genes with differential expression and val-
idated the findings at the mRNA and protein levels. Our analysis revealed differential expression
of genes regulating signaling. Memory B cells differentially express genes that regulate adenosine
signaling and modulate cAMP responses. Furthermore, memory B cells upregulate receptors essen-
tial for stem cell self-renewal. One, leukemia inhibitory factor receptor, can initiate functional sig-
naling in memory but not naïve B cells. Memory B cells also upregulate cell surface proteins, includ-
ing PD-L2, CD80 and CD73 that distinguish them from the naïve population. These markers
define phenotypic subsets of memory cells, which differ functionally. For example, while memory
B cells as a whole are less dependent on BLyS/BAFF for survival in vivo than are naïve B cells, mem-
ory subsets differ notably from one another in their relative dependence on BLyS. Taken together,
these data indicate that memory B cells are poised to mount unique responses to environmental
stimuli and are dependent on different interactions for survival than are their precursors. Further,
they suggest specific pathways memory B cells might use to self-renew. The identification of phe-
notypic and functional subsets of murine memory B cells suggests complexity in how B cells
maintain long-term immunity in health and promote chronic autoimmunity in disease.
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Deficiency of Retinoid related Orphan Receptor (ROR)γ blocks the evolution of Th17 T cells
and abrogates the contact hypersensitivity response (CHS), despite intact immunity and IFNγ
production in response to CHS antigens
R Purwar,1 A Jetten2 and TS Kupper1 1 Harvard Skin Disease Research Center, Boston, MA and
2 Cell Biology, National Institutes of Health, NIEHS, Research Triangle Park, NC
Th17 T cells have joined Th1 and Th2 T cells subsets of T effector cells that produce distinct cytokine
profiles and play important roles in human immunphysiology. A recently identified T effector cell
subset, Th17, have been implicated in a number of autoimmune diseases, including psoriasis. While
Th1 and Th2 T cells are associated with the transcription factors T-bet and GATA-4, respectively,
early evidence suggests that Th17 T cells depend upon the function of RORγ. Mice deficient in
RORγ do not develop lymph nodes or other secondary lymphoid tissue, making it difficult to
assess their relative immunocompetence in vivo. In this study, we created RORγ-/-deficient chimeric
mice, where RORγ-/- bone marrow cells were transferred into sublethally irradiated RAG1-/-
recipients. RORγ-/- chimeric mice were compared to normal chimeric mice after 6 weeks. T cell
numbers in lymph node and spleen were comparable between these groups. CHS responses to
DNFB were tested in these mice. Compared to normal chimeric mice, which showed robust ear
swelling after challenge, RORγ-/- chimeric mice exhibited neglible ear swelling. This correlated
with greatly diminished T cell and neutrophil infiltration in the challenged ear. RORγ-/- T cells from
draining lymph nodes produced negligible IL-17 and significantly reduced TNFα, and increased
IFNγ compared to normal chimeric mice. TNFα-/- chimeric mice had intact ear swelling after
CHS. We conclude that RORγ-/- T cells are ineffective at eliciting CHS responses, despite their
capacity to make abundant IFNγ in response to antigen recall. These data support a role for Th17
T cells in the neutrophil and T cell infiltration, as well as tissue edema components that epitomize
murine CHS.
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Induction of regulatory T cells: A novel mechanism of glucocorticosteroid-induced immuno-
suppression?
G Stary,1 I Klein,1 S Kohlhofer,1 H Skvara,1 T Jung2 and G Stingl1 1 Dermatology, Medical
University of Vienna, Vienna, Austria and 2 Novartis Institute for Biomedical Research and
Institute for Exploratory Development, Basel, Switzerland
Although glucocorticosteroids have been used for many decades in autoimmune diseases and trans-
plantation, the exact mechanisms responsible for their immunosuppressive properties are not fully
understood. We therefore undertook a study with 24 nickel-allergic patients, performed epicuta-
neous patch tests (EPT) prior and after oral steroid or placebo treatment and took skin biopsies 72
hours after patch test application for immunofluorescence analysis. Expectedly, oral steroid treat-
ment led to a substantial reduction of clinical symptoms that was paralleled by a sizeable decrease
of infiltrating T cells. To our surprise, however, we found an absolute and, even more pronounced,
a relative increase of FoxP3+CD25+CD4+ T cells in the dermis of post-steroid ECT as compared to
the placebo control group. In addition, higher numbers of epidermal Langerhans cells (LC) were
observed after oral steroid treatment in comparison to pre-steroid lesions or the placebo group. In
contrast to LC from pre-steroid patch tests, those after steroid had an immature phenotype. Inter-
estingly, increased numbers of epidermal LC and dermal regulatory T cells were associated with
upregulated expression of TGF-β in skin biopsies after steroid treatment. Functional in vitro exper-
iments showed a dose-dependent increase of FoxP3+CD4+ T cells upon incubation of peripheral
blood mononuclear cells with dexamethasone. Our data support the concept that corticosteroid
can promote the generation of regulatory T cells and, thus, shed new light on the mechanisms of
glucocorticosteroid-mediated immunosuppression.
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Skin-specific homing imprinting requires T cell priming during early stage of cutaneous infec-
tion
Q Zhong,1,2 TS Kupper,1,2 K Dubin,1 M Wurbel1,2 and L Liu1,2 1 Dermatology, Brigham and
Women’s Hospital, Boston, MA and 2 Dermatology, Harvard Medical School, Boston, MA
Appropriate T cell trafficking to skin is critical for cutaneous immune surveillance. The signals driv-
ing T cell skin-homing imprinting are still unclear. We have recently demonstrated that within 60
hours after cutaneous infection with vaccinia virus (VV), antigen-specific T cells are imprinted
with skin-homing molecules such as E-selectin ligands (E-Lig) within skin-draining lymph nodes
(SDLN) after 3 division cycles. Intriguingly, this skin-homing imprinting was greatly diminished
when T cells were recruited and activated in SDLN at a later stage of the primary infection. We
hypothesized that signals required for T cell skin-homing are only present for a short period of
time following cutaneous infection. To test this hypothesis, we adoptively transferred Thy1.1+OT-
I CD8 T cells (recognizing OVA peptide OVA258-276) into Thy1.2+ mice either 1 day prior to, or
2 days after, cutaneous infection with recombinant VV expressing OVA258-276 (rVV-ova). Upon
activation in SDLN, OT-I cells transferred 1 day prior to the infection (early activation) expressed
high level of E-Lig and significantly down-regulated the LN-homing molecule CD62L. By three
days post infection, large number of OT-I cells were found in infected skin tissues. In contrast, OT-
I cells transferred 2 days after infection and then activated in SDLN (late activation) remained
CD62Lhi and did not express E-Lig, and resembled central memory T cells (Tcm). Very few of these
“late activated” T cells were found in infected skin tissue, but did circulate through blood and LN.
We next examined CD11c+ dendritic cells (DC) in skin and SDLN. Although DC in SDLN increased
steadily during the first 3 days of infection, CD11c DC were rapidly depleted from the infected
skin tissue by 48 and 64 hours after infection. We hypothesize that skin-derived DC may be the
primary source of signals for T cell skin-specific homing imprinting. After skin-derived DC are
reduced, T cells may be activated by other DC subsets and imprinted for LN-homing Tcm differ-
entiation.
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Efficient IL-4 therapy of psoriasis selectively abrogates IL-23 and Th17 responses in humans
E Guenova,1 K Ghoreschi,1 W Hötzenecker,1 G Weindl,2 K Sauer,1 K Schäkel,3 M Schaller,1
M Röcken1 and T Biedermann1 1 Dermatology, Eberhard Karls University, Tuebingen,
Germany, 2 Pharmacy, University of Berlin, Berlin, Germany and 3 Dermatology, Technical
University, Dresden, Germany
Over the last decade, psoriasis was characterized as prototypic Th1 disease mediated by IFN-y pro-
ducing Th cells. More recent data suggested that also Th17 cells and the Th17 driving cytokines
such as IL-23 are involved. Consequently, targeting the IL-12/23p40 subunit improved psoriasis.
Systemic IL-4 therapy also significantly improved psoriasis as shown in a dose escalation study.
This IL-4 treatment induced intra-lesional IL-4 expression, but did not significantly suppress IL-12
or IFN-y. Therefore, we investigated the in vivo effects of IL-4 therapy on the IL-23/Th17 pathway
in psoriasis. While IL-12p35 mRNA was rather increased following IL-4 therapy, this treatment dose
dependently suppressed cutaneous IL-23p19 and IL-17 mRNA expression to <10%. Accordingly,
immunohistology revealed IL-23+ APC and IL-17+ T cells in psoriasis skin prior to therapy, whereas
following 6 weeks of IL-4 therapy, IL-23 and IL-17 became almost undetectable. To uncover under-
lying mechanisms, we studied the effects of IL-4 on IL-12 and IL-23 production in human dendritic
cells (DC). In line with our previous data, IL-4 promoted IL-12p70 production, but in sharp con-
trast significantly suppressed the central Th17 inducing cytokines IL-1beta, IL-6, and IL-23. Con-
sequently, this IL-4 treatment allowed DC to prime Th cells for IFN-y production, while it strongly
inhibited their capacity to induce Th17 cells. In contrast to priming with conventional DC, Th
cells primed with IL-4-DC failed to produce IL-17 and IL-22. Thus, we show that IL-4 ameliorates
psoriasis by acting on the level of DC to selectively suppress IL-23 and consequently Th17 cells
but not by regulating IL-12 and IFN-y. These data demonstrate the dominant role of the Th17 path-
way in psoriasis and, consequently, that IL-4 treatment of psoriasis provides the unique opportu-
nity to suppress harmful IL-23/Th17 responses while preserving the IL-12/IFN-y responses for antimi-
crobial defenses.
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Regulated proenkephalin expression in human skin and cultured skin cells
AT Slominski,1 MA Zmijewski,1 B Zbytek,1 A Brozyna,2 J Granese,1 Z Janjetovic,1
A Szczesniewski3 and DJ Tobin4 1 Pathology and Laboratory Medicine, University of Tennessee
Health Science Center, Memphis, TN, 2 Department of Medical Biology, Nicolaus Copernicus
University, Torun, Poland, 3 Agilent Technologies, Schaumburg, IL and 4 Centre for Skin
Sciences, School of Life Sciences, University of Bradford, Bradford, United Kingdom
Proenkephalin is a large protein precursor, which is processed to produce several copies of Met-
enkephalin and Leu-enkephalin. We have demonstrated expression of both proenkephalin gene
and protein in normal and pathological skin, as well as in cultured normal and malignant
melanocytes, keratinocytes and dermal fibroblasts using RT-PCR, western blotting and immuno-
cytochemistry techniques. Mass spectroscopy (TOF-LCMS) analysis confirmed the presence of Leu-
enkephalin in skin and of Met-enkephalin in fibroblast extracts. By means of by real-time PCR we
have demonstrated that ultraviolet radiation B (UVB) stimulated proenkephalin mRNA production
in cultured melanocytes and keratinocytes. We have also investigated the effect of lipopolysac-
charide (LPS) on keratinocytes and fibroblasts, and found that LPS stimulates proenkephalin mRNA
in both cell types. Moreover, TLR2 agonist increased expression of proenkephalin gene in ker-
atinocytes. This effect was absent (or minimal) in fibroblasts perhaps due to high constitutive expres-
sion level. Using immunocytochemistry performed in skin biopsies proenkehalin-derived Met- and
Leu– enkephalin antigens were expressed in keratinocytes of the epidermis and hair follicle outer
root sheath, as well as in myoepithelial cells of eccrine glands and dermal sheath Proenkephalin
expression pattern was altered in the skin affected by pathology. Specifically, increased expression
was found in psoriasis and low or lack of detectable expression was seen in melanoma. In con-
clusion, adult human skin not only expresses proenkephalin, but this expression appeared to be
regulated by stressful stimuli and its pattern is altered in pathological conditions.
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Psoriasis lesions contain distinct populations of CD4+ and CD8+ T cells producing inter-
feron gamma, interleukin-17, and interleukin-22
CJ Rubin,1 I Kryczek,2 JE Gudjonsson,1 A Johnston,1 W Zou,2 JT Elder1,3 and AT Bruce1 1
Dermatology, University of Michigan, Ann Arbor, MI, 2 Surgery, University of Michigan, Ann
Arbor, MI and 3 Dermatology, VA Health System, Ann Arbor, MI
Psoriasis is a chronic inflammatory dermatosis mediated by interactions between T cells, ker-
atinocytes, and other inflammatory cells. Previous studies demonstrated increased interferon gamma
(IFN-γ)-secreting T helper 1 (Th1) cells in psoriatic plaques. However, recent genetic and phar-
macologic evidence strongly suggests a role for IL-23 in psoriasis. IL-23 supports the expansion of
CD4+IL-17+ (Th17) cells and production of IL-22, a cytokine commonly associated with Th17
cells. We recently quantified an increase in Th17 and CD8+IL-17+ (Tc17) T cells in psoriatic plaques.
In particular, we observed that CD8+IL-17+ T cells are enriched in psoriatic epidermis. We aimed
to define the populations of T cells producing IL-17, IFN-γ, and IL-22 in psoriatic plaques. We
therefore isolated immune cells directly from psoriatic plaques, unaffected psoriatic skin, or skin
from healthy individuals without the addition of exogenous cytokines and performed flow cyto-
metric analysis. We observed increased numbers of CD4+ and CD8+ T cells expressing IL-17, IFN-
γ, and IL-22 in psoriatic plaques. A majority of T cells produced just one of these cytokines, while
a minority co-expressed any two. However, most T cells producing IFN-γ, IL-17, or IL-22 also pro-
duced the pro-inflammatory cytokine, TNF-α. Thus, psoriatic plaques contain increased numbers
of CD4 and CD8 positive T cells expressing interferon gamma (Th1 and Tc1), IL-17 (Th17 and
Tc17), and IL-22 (possibly Th22 and Tc22), and various combinations thereof. The frequently
independent expression of IL-17 and IL-22 in T cells suggests that while these cytokines are induced
by common stimuli, e.g. IL-23, T cells producing IL-17 or IL-22 may have distinct physiologic activ-
ities and roles in psoriasis pathogenesis.
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Determining the roles of FKBP52 and CD147-EMMPRIN in stimulated human T cells lead-
ing to macrophage activation and proinflammatory cytokine production
KR Jonscher,1 L Li,2 E Eisenmesser,3 M Fujita,2 DA Norris2 and CK Edwards2,4 1 Anesthesiology,
University of Colorado Denver, Aurora, CO, 2 Dermatology, University of Colorado Denver,
Aurora, CO, 3 Biochemistry and Mol Genetics, University of Colorado Denver, Aurora, CO
and 4 Infectious Disease, University of Colorado Denver, Aurora, CO
Up-regulation of proinflammatory cytokines by activated macrophages (MΦ) has been shown to
drive the pathogenesis of chronic plaque psoriasis, most likely via direct cell-cell contact through
an immune synapse (IS) mechanism in the skin. The goal of our current research is to identify T
cell and MΦ proteins that may mediate adaptive immunity in this system. Differential two-dimen-
sional gel electrophoresis of stimulated and unstimulated human T cells was used to select upreg-
ulated protein candidates for subsequent identification by tandem mass spectrometry. Protein
expression was validated by Western blot, qRT-PCR and FACs analysis. Expression of proteins of
interest was inhibited using siRNA, and a cell-cell contact assay measuring cytokine levels was
used to establish protein functionality. Results from the proteomics study suggested that expres-
sion of FKBP52 was significantly increased following T cell activation by PMA/Ionomycin treat-
ment. FKBP52 is an immunophilin with cis/trans-prolyl isomerase activity that functions as a pro-
tein folding chaperone for proteins containing proline residues. It also binds the immunosuppressant
tacrolimus, used in treating patients suffering from autoimmune disorders. Cyclophilins are known
to bind to CD147 (EMPRINN) and we observed increased CD147 expression in stimulated T cells
as well as physiological binding of the immunophilin FKBP52 to CD147 in vitro by NMR. Although
siRNA knockdown of either FKBP52 or CD147 did not appreciably affect cytokine upregulation,
cytokine levels decreased by ~70% when expression was simultaneously inhibited for both pro-
teins. These results suggest that FKBP52 and CD147 may constitute part of a novel signaling path-
way leading to MΦ activation, secretion of proinflammatory cytokines, and chronic inflamma-
tion.
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Dermal microvascular endothelial cells enhance interleukin-17 production in an antigen-
specific immune response
M Manni, W Ding, L Stohl and RD Granstein Dermatology, Weill Cornell Medical School, New
York, NY
Dermal microvascular endothelial cells (DMEC) participate in immune and inflammatory activi-
ties through release of inflammatory cytokines and expression of adhesion molecules involved in
transmigration of leukocytes out of the vasculature. Interleukin (IL)-17 is the prototype of a family
of cytokines involved in immune reactivity. IL-17 has been proposed to have an important role in
psoriasis and several autoimmune disorders. We have tested the hypothesis that DMEC partici-
pate in the generation of an IL-17 response. DO11.10 mice have transgenes in the alpha and beta
chains of the T cell receptor such that these T cells recognize a fragment of chicken ovalbumin
(OVA323-339). We utilized these cells along with a transformed murine microvascular dermal endothe-
lial cell line (bEND.3, from BALB/c) for these experiments. One hundred thousand primary Langer-
hans cells from BALB/c mice were cultured in 96-well U-bottom plates with 2 x 105 nucleated
spleen cells from DO11.10 transgenic mice in 250 μl of complete medium in duplicate. A second
set of wells was cultured identically but with the addition of 1 x 105 bEND.3 cells. After incuba-
tion for 48-hours in the presence of 10 mM OVA323-339, supernatants were harvested for assess-
ment of IL-17 content. Addition of bEND.3 cells resulted in a significant increase in IL-17 pro-
duction. In separate experiments, bEND.3 cells stimulated with ATP or ATPγS (a long-lived,
hydrolysis-resistant analog of ATP) failed to produce measurable IL-17. In preliminary experiments,
the use of siRNA to knock down IL-6 production by bEND.3 cells led to a reduced production of
IL-17 in this system. DMEC may contribute to the generation of an IL-17 immune response.
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Th-17/Tc-17 infiltration and associated cytokine gene expression in elicitation phase of aller-
gic contact dermatitis
Y Zhao,1,2 A Balato,3 R Fishelevich,1 A Chapoval,4 DL Mann5 and AA Gaspari1 1 Dermatology,
University of Maryland, Baltimore, MD, 2 Dermatology, China Medical University, Shenyang,
China, 3 Dermatology, University of Naples Federico II School of Medicine, Naples, Italy, 4
Hematology, University of Maryland, Baltimore, MD and 5 Pathology, University of
Maryland, Baltimore, MD
Allergic contact dermatitis is a typical delayed-type hypersensitivity to sensitizing haptens medi-
ated by T cells. Th1/Tc1 cells are currently considered to be the primary effectors in allergic con-
tact dermatitis. There is little information concerning the role played in allergic contact dermatitis
in humans by Th-17/Tc-17 cells, a recently defined subpopulation of effector T cells. In the pres-
ent report we attempted to characterize Th-17/Tc-17 cells in the infiltrates of the skin in elicitation
phase of allergic contact dermatitis. Th-17 as well as Th1/Th2 cytokine gene expression was exam-
ined by semiquantitative real-time polymerase chain reaction in paired samples of positive patch
test biopsies and normal skins from 11 patients allergic to 9 different allergens. The in situ charac-
terization of IL-17-producing cells was carried out using anti-RORγ and anti-T cell subset antibodies
by double immunofluorescence. Compared to normal paired skins, gene expression of transcrip-
tion factor for Th-17 cells, RORγt, and Th-17-related cytokines IL-17A, IL-17F and IL-23 was sig-
nificantly increased in positive patch test biopsies. The mRNA for infiltrates, about 20 % of the infil-
trating cells were IL-17-producing cells as they expressed RORγt, and such RORγt expressing cells
were detected in both CD4+ (~30%) and CD8+ (~20%) subsets. This is the first demonstration of
Th-17/Tc-17 cells in the elicitation phase of human allergic contact dermatitis, showing that they
are a regular participant in the immunopathology of this common allergic reaction regardless of
the nature of the triggering allergens.
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Dissolving microneedle arrays effectively deliver soluble and particulate biologically active
molecules into the skin
G Erdos,1 H Toussaint,1 M Williams,1 J Zhang,1 BO Ozdoganlar2 and LD Falo1 1 Dermatology,
Univ of Pittsburgh School of Medicine, Pittsburgh, PA and 2 Mechanical Engineering,
Carnegie Mellon Univ, Pittsburgh, PA
Effective delivery of bioactive molecules into the skin would enable novel therapeutic approaches
for a broad range of skin and systemic diseases. To address this challenge, we fabricated dissolv-
ing microneedle arrays (DMA) with the goal of discovering a skin delivery platform applicable to
the efficient delivery of a broad range of bioactive molecules. DMAs were designed and fabricated
to have several advantages over existing skin delivery technologies including the potential to deliver
high quantities of bioactive materials, and the capacity to deliver a chemically and physically
diverse range of active components. To accomplish this, biocompatible carboxy-methylcellulose
(CMC) based DMAs were fabricated by molding. Male mastermolds were directly machined from
acrylic through micromilling and spincasted in Sylgard 184 to fabricate the female production
molds of the CMC-DMAs. The elements of the fabricated 10x10 CMC-DMAs are pyramidal, 0.6
mm high and 0.3 mm at base. Initially we formulated DMAs with integrated fluorescent tracers
and varying active ingredients to evaluate the physical penetration qualities of the DMAs in the
skin. Image analysis of DMA treated human and mouse skin demonstrated effective penetration in
both cases. We find that even at high active ingredient content, DMAs are physically able to pen-
etrate mouse and human skin, and able to deliver their active components to the skin. To test the
physiological effectiveness of the DMAs a model antigen (ovalubumin) in particulate or soluble
antigen form was incorporated into DMAs. DMA application to the skin of living mice induced
potent antigen-specific CTL immunity, comparable to immune responses induced by optimized
gene gun immunization protocols. These studies demonstrate the feasible and effective delivery of
a broad range of active materials including particulate and soluble biologicals for cutaneous immu-
nization, and suggest broad applicability for cutaneous drug delivery.
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Evaluation of antigen loading strategies for dendritic cell vaccines in patients with metasta-
tic melanoma
LJ Geskin,1,2 J Kirkwood,2 L Butterfield,2 W Storkus,1 T Whiteside2 and LD Falo1 1 Dermatology,
Univ of Pittsburgh School of Medicine, Pittsburgh, PA and 2 Univ of Pittsburgh Cancer
Institute, Pittsburgh, PA
Multiple DC vaccines are now being evaluated in clinical trials. While clinical improvement has
been observed in some trials, factors affecting efficacy of DC vaccines are complex and have not
yet been clearly defined. It is not known if certain immunization strategies are superior to others.
In the context of a phase I/II clinical trial, we conducted an analysis of dendritic cell vaccines con-
structed using 3 distinct strategies for delivery of antigens derived from autologous tumors. The
objectives of this study were to evaluate the safety of DC vaccine administration, to monitor clin-
ical effects of immunization and potential biological correlates of clinical responses including tumor
vaccine specific DTH reactivity and induction of tumor specific CD8+ T-cell activity. Patients with
metastatic melanoma with tumor tissue accessible for processing were randomized into 1 of the 3
arms according to uniform eligibility criteria. The 3 arms differed in vaccine composition and
included immunization with matured dendritic cells derived from adherent monocyte precursors
and loaded with tumor antigens derived from autologous tumor cells by: 1) coculture 2) fusion or
3) by coinculation with tumor lysate. A course of therapy consisted of 4 weekly ultrasound-guided
intra-lymph node administrations of vaccine. Our interim analysis suggests that all vaccines demon-
strated a mature DC phenotype with high levels of costimulatory molecules; all 3 methods of anti-
gen loading resulted in efficient tumor antigen transfer; vaccines produced various levels IL-12 with
lowest levels observed in the vaccine produced by fusion of tumor cells and DCs. Preliminary, in
vivo correlates (DTH responses) were observed in some patients. No Grade 3 adverse events were
observed. Some patients experienced mild Grade 1-2 flu-like illness within 24 hours following
immunization. In conclusion, qualitative and quantitative vaccine-associated changes in immune
responses were observed in all 3 arms of this study.
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Disorganization of sweat innate immunity is seen in Pustulosis Palmaris et Plantaris (Local-
ized palmoplantar pustular psoriasis)
M Murakami,1,2 T Ohtake,3 A Ishida-Yamamoto,2 RL Gallo4 and H Iizuka2 1 Dermatology,
Furano Kyokai Hospital, Furano, Japan, 2 Dermatology, Asahikawa Medical College,
Asahikawa, Japan, 3 Internal Medicine, Asahikawa Medical College, Asahikawa, Japan and 4
Dermatology, University of California San Diego, San Diego, CA
Sweat participates in innate immunity by production antimicrobial peptides (AMP) such as the
cathelicidins (hCAP-18/LL-37) that can kill certain bacteria, fungi and viruses (Murakami et al. JID
2002). Pustulosis Palmaris et Plantaris (PPP) (AKA palmoplantar pustular psoriasis) is a recurrent
dermatosis characterized by intraepidermal vesicles filled with neutrophils. We hypothesized that
a malfunction of sweat AMP processing may contribute to the pathophysiology of PPP. This hypoth-
esis was based on prior observations that abnormal enzymatic processing of cathelicidins by pro-
teinases SCTE (KLK-5) or SCCE (KLK-7) results in production of peptides that are pro-inflammatory
to the skin (Yamasaki et al. Nat Med 2007). To test this, Palmar sweat production was measured
by a portable sweat meter, polymorphonuclear leukocytes (PMN) from pustules and peripheral
blood were collected from normals and patients with PPP or acne vulgaris (AV) and analyzed by
real time PCR, ELISA, and Western blotting. Skin biopsies of PPP were also performed for immunos-
taining. Sweat production in PPP was lower than in non-lesional palmar skin (0.83 vs 1.62 mg/cm2/2
min) and acrosyringeal keratinous plugging was observed histopathologically. Immunostaining
showed that increased hCAP-18/LL-37 was found in the epidermal roof of the blister or pustule.
There was no difference in hCAP-18/LL-37 protein levels in peripheral blood PMNs between healthy
volunteers, PPP, or AV patients by ELISA. However, hCAP-18/LL-37 in the PPP pustule-derived
PMNs was considerably higher than that of AV (3.72 vs 3.01 ug/ml). Western blotting showed irreg-
ular 6Kd fragments in PPP pustular PMNs but not in AV PMNs. These results indicate that sweat
obstruction and disorganization of the PMN-innate immune system may contribute to the patho-
physiology of PPP.
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Expression of NO, TNFα, and IL-1α in a modified co-culture system: Effect of UVR on human
keratinocyte/monocyte
Y Ee, S Geen, AR Shalita and WS Lee Dermatology, SUNY Downstate, Brooklyn, NY
Cytokines have been demonstrated to play a critical role in the development of inflammatory
process. Ultraviolet (UVR) light has been reported to modulate the inflammatory process in differ-
ent inflammatory skin conditions. The purpose of the study was to construct an improved in vitro
model system that involved a co-culture of more than one cell type to study the effect of UVR on
the inflammatory process in the presence and absence of cytokines using NO, TNFα, and IL-1α as
markers for inflammation. The future goal will be to use this model to develop new therapeutic
agents for skin diseases related to inflammatory process. Normal human epithelial keratinocytes
(NHEK) were seeded in a 24-well tissue culture plate to reach sub-confluency. They were exposed
to UVA (up to 40 J/m2) and UVB (up to 200 mJ/cm2)using LPS (50 to 500 ng/ml) as a positive con-
trol. The supernatants of NHEK cells were co-cultured with SC cells, a cell line established from
human peripheral blood mononuclear cells, in a 24-well tissue culture plate. The supernatants of
both NHEK and SC cells were assayed for the nitric oxide (NO) expression and the cytokine level,
measured by modified Greiss assay and ELISA assay respectively. The results showed that under
these conditions, the “modified co-culture system” of NHEK cells and SC cells was not sufficient
to trigger NO responses. However, dose-related upregulation of TNFα and IL-1α were observed
from NHEK cells after UVR (A/B) treatment. The data showed that TNFα increased about three-
fold, whereas a 2-fold increase was associated with IL-1α when NHEK was treated with UV(A/B).
The increases of these cytokines were buffered when the supernatants from NHEK cells were added
to the SC cells indicating that the monocytes might impose some degree of surveillance by mod-
ulating the level of cytokine induction after UVR. The different effects of UVA and UVB on the IL-
1α and TNFα production in the NHEK/SC co-culture might explain the different action mecha-
nisms of UVR’s involvement in many cutaneous diseases.
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Identification of Bcl-3 as a novel modulator of antimicrobial peptide production in atopic
dermatitis
AS Büchau,1,2 DT MacLeod,1 S Morizane,1 PF Kotol,1 T Ruzicka,2 T Hata1 and RL Gallo1 1
Dermatology, University of California San Diego, San Diego, CA and 2 Dermatology and
Allergology, Ludwig-Maximilians-University, Munich, Germany
Innate immune responses involve the production of antimicrobial peptides (AMPs), chemokines
and cytokines. Here, we identified a novel IκB family member, B cell leukemia (Bcl-3), as a mod-
ulator of AMP production in keratinocytes. Sufficient AMP induction is defective in atopic der-
matitis (AD) compared to psoriasis and may explain susceptibility to infection. Bcl-3 was inducible
in normal human keratinocytes by the combination of interleukin (IL)-4 (50ng/ml) and IL-13 (50ng/ml)
(350% increase, p≤0.001), and was overexpressed in lesional skin of AD patients as analyzed by
RT-PCR (200% increase, p≤0.05) and immunofluorescence staining. Silencing of Bcl-3 by small
interfering RNA (siRNA) reversed the downregulatory effect of IL-4 on the expression of the AMP
beta-defensin-3 (70% decrease p≤0.05). The effects of Bcl-3 on the expression of the AMP cathe-
licidin by keratinocytes were more complex and only seen when studied in the context of 1,25OH
vitamin D3 (1,25D3), a potent cathelicidin inducer. Bcl-3 silencing enhanced 1,25D3 (10nM)
induced cathelicidin expression in keratinocytes (250% increase, p≤0.01). Furthermore, we have
previously found that oral administration of vitamin D3 (4000IU/day X 21 days) to individuals
with AD enhanced cutaneous cathelicidin expression in lesional skin. Thus, to evaluate if this may
also involve Bcl-3, we evaluated Bcl-3 expression by RT-PCR in lesional skin before and after D3
administration and observed a decrease of Bcl-3 (10-90% decrease) in lesional AD of most patients
tested (≥70%, n=7). Consistent with these clinical observations, stimulation of cultured keratinocytes
with 10nM 1,25D3 led to a moderate decrease of Bcl-3 expression (30%, p≤0.01). Together, these
observations suggest that Bcl-3 may be an important and previously unrecognized regulator of
innate host defense functions.
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Hyaluronan and CD44 direct specific inflammatory responses through TLR4
J Muto, K Yamasaki and RL Gallo Division of Dermatology,, University of California, San Diego
and VA San Diego Health Care System, San Diego, CA
Skin injury results in production of small molecular weight Hyaluronan (HA) that stimulates cytokine
release and signals the presence of tissue damage. We previously found that HA induces CXC
chemokines (human IL-8 and mouse MIP-2) through interaction with a unique complex of CD44,
TLR4 and MD2. Based on the unique binding of HA to TLR4 in a complex with CD44, we now
investigated if HA might change the response to bacterial endotoxin (LPS), shifting the inflamma-
tory response away from sepsis. This was confirmed in vivo as mice injected IP with HA prior to
LPS had greatly decreased serum IL6 measured by ELISA (77% decrease to 324 ± 184 pg/ml, p<0.01)
and TNFα decreased by 38.9%, (p<0.05). Importantly, HA also protected mice from symptoms of
sepsis seen when LPS was injected alone. Subcutaneous HA also decreased the local mRNA-expres-
sion of chemokines (IL-1, IL-6, MIP-2, TNFα) after LPS injection in skin as measured by real-time
PCR. The protective effect of HA was not due to adsorption of LPS as protection was not seen in
CD44 -/- mice injected with HA since these continued to show septic behavior and high serum IL6
and TNFα after HA and LPS. Consistent with our findings in vivo, addition of HA to macrophages
before LPS exposure significantly decreased the release of IL-6 (60.7% decrease, p<0.01), TNFα
(66.3% decrease, p<0.01) and this effect of HA was not seen in peritoneal macrophages from CD44-
deficient mice. The mechanism responsible for LPS tolerance appears to act through A20, a neg-
ative regulator of TLR signaling. Real-time PCR showed IP injection of HA in mice resulted in an
increase in peritoneal macrophage A20 mRNA-expression, and this was also significantly reduced
in CD44-deficient mice. Therefore, our results show that HA and CD44 trigger alternate innate TLR-
4 signaling events to initiate distinct cytokine responses to sterile injury or microbial ligands.
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Staphylococcus epidermidis antimicrobial peptide functions as a surface antibiotic and induces
keratinocyte TLR2-mediated expression of defensins and cathelicidin
AL Cogen,1 Y Lai,1 K Yamasaki,1 J Tanios,1 V Nizet2,3 and RL Gallo1,4 1 Medicine, UC, San
Diego, La Jolla, CA, 2 Pediatrics, UC, San Diego, La Jolla, CA, 3 Skaggs School of Pharmacy
and Pharmaceutical Sciences, UC, San Diego, La Jolla, CA and 4 Medicine, VA San Diego
Health Care System, San Diego, CA
We have shown that S. epidermidis (SE) produces antimicrobial peptides (AMPs) that may protect
the skin from pathogens. Similar to mammalian AMPs, we hypothesized that these SE AMPs pre-
vent pathogen survival in 2 ways: by killing bacteria directly, and by interacting with the host pep-
tides or host peptide regulation systems to kill pathogens. To investigate if SE induced host AMPs,
human keratinocytes were stimulated with the synthetic SE AMP, phenol soluble modulin-γ (PSMγ).
PSMγ induced expression with 500nM resulting in increased mRNA of hBD2 (4.95-fold increase
± 0.60), hBD3 (6.62 ± 4.06), and cathelicidin (30.39 ± 9.46) as measured by real-time PCR. Fur-
thermore, PSMγ enhanced responsiveness of keratinocytes to TLR ligands. The presence TLR lig-
ands for the 2/1 and 2/6 receptor induced AMP expression by 2.27 and 54.73-fold induction, respec-
tively. However, PSMγ in combination with TLR1/2 ligand Pam3CSK4 or TLR2/6 ligand Malp-2
caused 35.23±10.7, or 389.52±74.22 fold induction of hBD2 mRNA. LTA, PolyI:C, flagellin, or
immiquimod showed no enhancement of hBD2 with or without PSMγ. PSMγ also binds and coop-
erates with host AMPs. SE supernatant was incubated with LL-37. Precipitation of PSMγ but not
IgG control, showed that the presence of PSM:LL-37 complexes on a LL-37 immunoblot. Co-incu-
bation of PSMγ and LL-37 resulted in enhanced killing of skin pathogen Group A Streptococcus.
8μM of LL-37 completely inhibited GAS. The addition of 2μM of PSMγ rendered 4μM LL-37 suf-
ficient to completely inhibit GAS growth. Thus, SE PSMγ protects the skin by killing directly,
inducing host AMPs through TLR 2/1 and 2/6 and binding to and cooperating with LL-37 for max-
imal antimicrobial effect. These data suggest that a component of the skin microbiome, S. epider-
midis, is beneficial to the innate immune barrier of the skin.
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LL37 enhances TLR9 expression and activation in keratinocytes and is coordinately overex-
pressed in psoriasis
S Morizane,1 K Yamasaki,1 M Murakami,2 K Iwatsuki3 and RL Gallo1 1 Dermatology, University
of California - San Diego, San Diego, CA, 2 Dermatology, Asahikawa Medical College,
Asahikawa, Japan and 3 Dermatology, Okayama University, Okayama, Japan
Keratinocytes (KC) produce the antimicrobial peptide LL37 in psoriasis (PS) but its role in patho-
genesis is incompletely understood. TLR9 protein expression was highly elevated in PS KC (n=5),
and TLR9 mRNA was also increased (5.2 fold p=0.05). As LL37 can enhance the activation of
TLR9 in pDC, we hypothesized that KC TLR9 may also be influenced by LL-37. LL37 was con-
firmed as the peptide form of cathelicidin in PS by SELDI-TOF (n=5). Cultured human KC (NHEK)
treated with LL37 (6uM) increased TLR9 mRNA expression 7.4 fold p=0.0066. TLR9 was functional
in NHEK as CpG, a ligand for TLR9, induced increases in mRNA for IL-8 (3.6X, p=0.029), inter-
feron (IFN) alpha (4.1X, p=0.0007), IFN beta (3.5X, p=0.0008) and IL-23 (1.9X, p=0.026). LL37
alone induced IL-23 (36.8X, p<0.0001). However, the combination of CpG and LL37 synergisti-
cally induced IFN alpha (2666X, p<0.0001) and IFN beta (1226X, p=0.0001). Since LL37 and TLR9
colocalize in PS epidermis, these findings suggest that KC may participate in inflammation in PS
by the combined action of LL37 and TLR9.
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Arginine residues in the COOH-terminal of human beta-defensin-3 are essential for salt-
resistant, broad antimicrobial activities
Y Sakagami, Y Shirafuji, T Oono and K Iwatsuki Department of Dermatology, Okayama
University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama,
Japan
Human beta-defensin-3(HBD-3) has a broad spectrum of potent salt-resistant antimicrobial activ-
ities against both Gram-positive and -negative strains, while HBD-2 is sensitive to NaCl, and non-
bactericidal against Gram-positive strains. To clarify the differences in antimicrobial activities
between HBD-2 and HBD-3, we have focused on two Arginine(Arg) residues in the COOH-ter-
minal of HBD-3, a unique structure for HBD-3. We developed recombinant HBD-3 excluding
two Arg residues, designated desR HBD-3 by pET28a expression system, and purchased synthetic
HBD-2(sHBD-2) (41 aa) and sHBD-3(45 aa) as controls. Three strains of Staphylococcus(S.) aureus
and 3 strains of Pseudomonas(P.) aeruginosa were clinically isolated. These strains ranging from
10^5 to 10^6 colony forming units(CFU)/ml were incubated with 0 to 40μg/ml of each peptide
for 2 hours at 37degree, pH 7.4 in 10mM PBS with 1% TSB, and then cultured on plates. The
numbers of colonies were counted after overnight culture at 37degree. The concentration of 10μg/ml
of sHBD-3 completely suppressed the growth of S. aureus and P. aeruginosa. Antimicrobial activ-
ities of sHBD-2 and desR HBD-3 against P. aeruginosa were almost equal to those of sHBD-3,
whereas no bactericidal effects were observed against S. aureus. In order to evaluate the salt-sen-
sitivity of HBD-2 and HBD-3, we performed bacterial cultures in a similar fashion after treatment
of 20μg/ml of each with 0 to 250mM NaCl. Even though the NaCl treatment, sHBD-3 kept antimi-
crobial activities against both strains. By contrast, bactericidal activities of sHBD-2 and desR HBD-
3 were lost with treatment of 50mM NaCl. In conclusion, two Arg residues in the COOH-termi-
nal provide the salt-resistamce and a broad antimicrobial activity for HBD-3.
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Molecular taxonomy of trichophyton mentagrophytes complex
S Jee,1,2 P Sun3,4 and Y Ju5 1 Department of Dermatology, National Taiwan University
Hospital, Taipei, Taiwan, 2 Department of Dermatology, National Taiwan University College
of Medicine, Taipei, Taiwan, 3 Graduate Institute of Clinical Medicine, National Taiwan
University College of Medicine, Taipei, Taiwan, 4 Department of Dermatology, Mackay
Memorial Hospital, Taipei, Taiwan and 5 Institute of Plant and Microbial Biology, Academia
Sinica, Taipei, Taiwan
Trichophyton mentagrophytes complex, belonging to dermatophytes which can cause various
human skin infections such as tinea capitis, tinea faciei, tinea corporis, tinea manuum, tinea pedis
and onychomycosis. They have a wide range of hosts, including human, cats, dogs, rats, and hedge-
hogs. This is an important public health issue because they can transmit between humans and
between human and animals by direct or indirect contact. Traditionally, T. mentagrophytes com-
plex consists of three main species, T. mentagrophytes, T. interdigitale and T. erinacei. Due to
morphological similarity and existing intermediate forms and variants, there is a great confusion
in their taxonomic status. This confusion leads to trouble in the epidemiological study of fungal
infections by this group of fungi and further impeding our communicating about it. In this study,
we used 48 isolates of the T. mentagrophytes complex obtained from human and animals in Tai-
wan to perform clinical analysis and molecular taxonomy. We examined the correlation between
morphology of the isolates and the clinical presentations. We also used ITS1-5.8S-ITS2 andβ-
tubulin gene regions for molecular taxonomy according to the latest taxonomic definition of the
T. mentagrophytes complex proposed by Gräser et. al. By this definition, our result shows that
among 48 isolates, 21 isolates belong to the anthropophilic strain of T. interdigitale; 22 isolates
belong to the zoophilic strain of T. interdigitale; and 5 isolates belong to T. erinacei. No T. men-
tagrophytes was found. Because the new classification is quite different from what it used to be,
confusion in the nomenclature of the T. mentagrophytes complex will be expected. The applica-
bility of Gräser’s taxonomic concept requires further evaluation.
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Heat-treated vaccinia virus induces antiviral innate immunity and apoptosis in macrophages
P Dai,2 H Cao,1,2 F Wang,1,2 T Merghoub,3 A Houghton,3 A Rice,4 RW Moyer,4 S Shuman2 and
L Deng1,2 1 Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, 2
Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 3
Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY and 4
Microbiology and Immunology Program, University of Florida, Gainesville, NY
Macrophages play important roles in antiviral innate immunity. Macrophages detect pathogen-
associated molecular patterns (PAMPs) through Toll-like receptors (TLRs) and cytoplasmic nucleic
acid sensors. How macrophages sense poxvirus infection and generate antiviral immune responses
is not well understood. Poxviruses are large cytoplasmic dsDNA viruses. Vaccinia virus, a protypic
Orthopoxvirus, has been used successfully for the vaccination against smallpox worldwide.
Poxviruses employ many strategies to evade the host immune system. We have previously shown
that vaccina infection in murine dendritic cells attenuates innate immune responses and antigen-
specific T cell activation. Here, we show that vaccinia infection in murine macrophage RAW264.7
cell line, bone marrow-derived macrophages and human primary macrophages attenuates TLR-
induced immune responses. Interestingly, heat-treated vaccinia (55 0C for 1h) not only fails to
inhibit TLR-mediated induction but also induces the production of type I interferon, proinflam-
matory cytokines and chemokines in macrophages in the absence of other TLR agonists. We also
demonstrate that heat-treated vaccinia enters macrophages through the normal entry-fusion com-
plex. The induction of type I interferon by heat-treated vaccinia requires transcription factors IRF3
and IRF7, and independent of MAVS (mitochondrial antiviral signaling protein, an adaptor for cyto-
plsamic RNA sensors) and MyD88. Heat-treated vaccinia also induces apoptosis in macrophages.
Co-infection of macrophages with heat-treated vaccini and untreated wild-type vaccinia blocks
both antiviral immune responses and apoptosis, suggesting that vaccinia encodes inhibitors to
block poxviral sensing mechanisms in macrophages.
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Myxoma virus and heat-treated vaccinia induce type I interferon and TNF-alpha in human
plasmacytoid dendritic cells through an endosomal TLR-mediated, PI3K/AKT-dependent sig-
naling pathway
H Cao,1,2 P Dai,2 H Li,3 J Yuan,3 JW Young,4 R Condit,5 G McFadden,5 S Shuman2 and L Deng1 1
Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, 2 Molecular
Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 3 Immune
Monitoring Core Facility, Memorial Sloan-Kettering Cancer Center, New York, NY, 4 Division
of Hematology and Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY and 5
Microbiology and Immunology Program, University of Florida, Gainesville, FL
Plasmacytoid dendritic cells (pDCs) play important roles in antiviral innate immunity and adap-
tive immunity. Human pDCs selectively express TLR7 and TLR9 that recognize viral ssRNA and
DNA, and trigger type I interferon production. Poxviruses are large DNA viruses that replicate in
the cytoplasm of infected cells. How poxviruses are sensed by pDCs is not well understood. In this
study, we assess the immune responses of human plasmacytoid dendritic cells (pDCs) to two
poxviruses, vaccinia and myxoma. Vaccinia virus has been successfully used for vaccination against
smallpox, a highy contagious infectious disease with high mortality, caused by variola virus. Myx-
oma virus causes lethal myxomatosis in European rabbits, but is non-pathogenic in humans. We
find that myxoma virus induces IFN-α and TNF-α in human pDCs, whereas vaccinia virus infec-
tion alone fails to induce. Co-infection of pDCs with myxoma and vaccinia virus blocks myxoma-
induction effects. Heat-inactivated vaccinia virus gains its ability to induce type I interferon and
TNF-α. These results indicate that vaccinia virus encodes inhibitor(s) to block viral sensing path-
way in pDCs. We further observed that treatment of pDCs with chloroquine blocks myxoma induc-
tion of type I interferon and TNF-α, suggesting that myxoma virus sensing is mediated through
endosomal TLRs. Myxoma, heat-inactivated vaccinia and CpG induction effects can be blocked
by PI3K and Akt inhibitors. Therefore, our study revealed an endosomal TLR-mediated and PI3K/AKT-
dependent poxviral sensing pathway that is activated by myxoma but subverted by vaccinia virus.
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Optimal treatment approach in atopic dermatitis
M Langner and H Maibach Dermatology, University of California, San Francisco, San
Francisco, CA
This study seeks to determine the optimal treatment regimen for atopic dermatitis patients. Although
several treatment approaches are available, randomized, controlled, double-blinded studies have
not been done despite increased rates of atopic dermatitis in the United States population. Ade-
quate hygiene and skin hydration, corticoids, and topical calcineurin inhibitors (TCIs) represent
important components of atopic dermatitis therapy. TCIs are the first major advance in therapy since
the introduction of corticoids fifty years ago. Despite a decade of TCI use, however, atopic der-
matitis rates continue to increase and a worldwide research effort is underway to determine the
cause. One unexplored possibility is that TCIs may, in some cases, result in drug-induced irritant
contact dermatitis. In most cases, TCI therapy for atopic dermatitis results in clinical improvement
by decreasing inflammation through its depression of immunosurveillance. Thus, severe atopic der-
matitis shows improvement with TCIs, but long-term improvement is less common and recurrent
flares are typical. Hence, severe atopic dermatitis patients on TCIs might also benefit from skin
culture studies to determine antimicrobial susceptibility, as antibiotic-resistant bacterial strains are
known to colonize the skin of atopic dermatitis patients. Additional clinical studies addressing the
optimal treatment approach in atopic dermatitis patients are needed. This hypothesis is a working
hypothesis and initial work will involve literature searches using PubMed and Embase for addi-
tional information.
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Uric acid crystals induce inflammation in human keratinocytes through P2Y receptors
H Uratsuji, Y Tada and K Tamaki Dermatology, University of Tokyo, Tokyo, Japan
Uric acid crystals (monosodium urate crystals (MSU)) are reported to induce gouty inflammation
by macrophages, which depend on phagocytosis. MSU are recently identified as ‘danger signals’
released from dying cells. Hyperuricemia in psoriasis patients and MSU in the epidermis of psori-
atic lesions have been demonstrated. However, the significance of MSU in the pathophysiology of
psoriasis is totally unknown. Here we found that MSU stimulated normal human keratinocytes
(NHK) to produce large amount of IL-1α, IL-8/CXCL8, IL-6 and MIP-3α/CCL20, which are impor-
tant for pathogenesis of psoriasis. Moreover, an IL-1 receptor antagonist inhibited the production
of IL-8/CXCL8, IL-6 and MIP-3α/CCL20, which results suggested the importance of the IL-1α - IL-
1 receptor interaction pathway in MSU-induced skin inflammation. In sharp contrast to macrophage
cell line THP-1, this MSU-induced inflammation in NHK was not due to phagocytosis, because
electron microscopic observation failed to detect MSU in NHK, and cytochalasin D, a phagocy-
tosis inhibitor, did not suppress the production of inflammatory cytokines in MSU-stimulated
NHK. Therefore, we examined the role of P2 receptors in the MSU-induced inflammation on
NHK, since uric acid is the final metabolite of purines. Surprisingly, P2 and P2Y receptor antago-
nists completely inhibited the MSU-induced production of IL-1α, IL-8/CXCL8 and IL-6, suggesting
that P2Y receptors are essential for MSU-induced inflammation on NHK. Finally, in vivo, P2Y antag-
onist significantly inhibited the MSU-induced inflammation in mouse air pouch model. Thus, these
results provide new insights into the molecular mechanisms involved in the pathogenesis of inflam-
matory skin diseases such as psoriasis.
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Real-time in vivo imaging of IL-1 beta producing cells in inflamed murine skin
H Matsushima and A Takashima Medical Microbiology and Immunology, University of Toledo
College of Medicine, Toledo, OH
IL-1 is one of the prototypic inflammatory cytokines playing pathogenic roles in various skin dis-
orders. Although many cell types in mouse skin (e.g., keratinocytes) are known to produce IL-1
alpha under inflammatory conditions, limited information has been available with regard to the
identity of IL-1 beta producing cells. In this study, we employed our newly generated IL-1 beta
promoter-driven DsRed (pIL1-DsRed) transgenic mice to identify IL-1 beta producing cells in inflamed
skin. Topical application of 1.25% oxazolone (OX) induced robust (>10-fold) IL-1 beta mRNA
expression and DsRed fluorescent signals in skin extracts both in time dependent fashions. A macro-
zoom fluorescent microscope revealed emergence of DsRed+ cells within 12 hours after OX
painting. Interestingly, they were preferentially found around hair follicles. Numbers of DsRed+
cells increased thereafter, reaching to a plateau at 48 hours. Similar clusters of DsRed+ cells were
also observed under all tested inflammatory conditions induced by dinitrofluorobenzene (DNFB),
skin irritant chemicals, or tape stripping. Intravital confocal microscopic analyses of OX-painted
mice further unveiled the distribution of DsRed+ cells to both epidermal and dermal compartments,
as well as rapid movement of DsRed+ cells (time-lapse imaging). Cell suspensions prepared inde-
pendently from epidermis and dermis were analyzed for surface phenotype by flow cytometry:
DsRed+ cells uniformly expressed CD45 (>98%) and CD11b (>90%), while other markers (MHC
class II, F4/80, and Gr-1) were detectable only in certain fractions. Thus, we conclude that DsRed
expression, i.e., IL-1 beta promoter activation, is a functional hallmark of inflamed skin occurring
in multiple myeloid lineages, including Langerhans cells, dermal dendritic cells,
monocytes/macrophage, and granulocytes. The newly developed real-time, in vivo imaging sys-
tem represents a novel and useful tool for studying spatiotemporal regulation of IL-1 beta produc-
tion in skin.
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A beneficial effect of Staphylococcus epidermidisby induction of antimicrobial defense
through activation of TLR2 and P38 MAPK
Y Lai,1 K Radek,1 H Park,1 A Cogen,1 D Macleod,1 A Leichtle,2 AF Ryan,2 A Di Nardo1 and
RL Gallo1 1 Dermatology, UCSD, San Diego, CA and 2 Surgery/Otolaryngology, UCSD, San
Diego, CA
We hypothesized that S.epidermidis(SE) has a beneficial effect to prime keratinocytes to produce
antimicrobial peptides(AMPs), thus protecting the skin from infection. This hypothesis was sup-
ported in a mouse model of infection by Group A Streptococcus(GAS)that showed a sterile 10KDa
ultrafiltrate of SE-conditioned culture media(SECM)injected 24 hr prior to injection of live GAS
decreased survival of GAS in skin(33.4% decrease in lesion size, p=0.0152; 98.8% decrease local
GAS survival, p=0.0005), and dramatically inhibited systemic GAS 3 days later(89.5% decrease).To
identify if SECM could mediate this protection by inducing AMPs, normal human ker-
atinocytes(NHEK)were treated with SECM and real time RT-PCR used to measure cathelicidin, hBD2
and hBD3 expression. SECM significantly increased hBD3(73±7.74 fold increase)and hBD2(14±4.68
fold increase), but not cathelicidin. Intradermal injection of mice with SECM also induced mRNA
for mBD4(mouse ortholog of hBD2)(104±30.27 fold increase).This increase in mRNA correlated
with increased AMP activity as lysates from NHEK treated with SECM inhibited the growth of
GAS(57.4% decrease, p<0.001), S.aureus sa113(87.9% decrease, p<0.05), human papillomavirus
5 pseudovirus survival(49.1% decrease, p<0.01)and vaccinia virus(25.2% decrease, P<0.01)but
did not inhibit growth of SE itself.TLR2 was essential for induction of AMPs by SECM as treatment
of NHEK with TLR2 neutralizing antibody blocked induction of hBD2-3 and TLR2-deficient mice
did not show induction of mBD4. Furthermore, the inhibitor of P38 MAPK abrogated the expres-
sion of hBD2-3, while the activator of P38 MAPK (wortmannin)rescued and increased this expres-
sion (469±27.69 fold increase). Taken together, these findings reveal a novel role for the normal
commensal bacterium SE to activate TLR2 and P38MAPK signaling and induce AMPs. These find-
ings also support our novel hypothesis that the presence of SE enables the skin to mount an appro-
priate response to microbial infection.
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A central role for transcription factor C-EBP-beta in regulating CD1d gene expression in
human keratinocytes
H Sikder,1 Y Zhao,1 A Balato,1 R Fishelevich,1 P Gade,2 D Kalvakolanu,2 I Singh3 and A Gaspari1,2
1 Dermatology, University of Maryland, Baltimore, MD, 2 Microbiology-Immunology,
University of Maryland, Baltimore, MD and 3 Medicine, University of Maryland, Baltimore,
MD
CD1d is a non-classical antigen-presenting molecule that presents glycolipid antigens to natural
killer T (NKT) cells that are involved in immune defense and tumor rejection. The mechanisms con-
trolling the expression of CD1d are not well understood. Therefore, we cloned the CD1d gene
promoter and characterized its activities in primary human keratinocytes (KC) and other cell lines
of epithelial origin. We found that a CCAAT box in the CD1d promoter is required for its expres-
sion in KC. We show here that transcription factor CCAAT/enhancer binding protein-beta (C/EBP-
b binds to the CCAAT box in CD1d promoter in vitro and in vivo-EMSA and Chromatin Immuno-
precipitation). Consistent with these observations, deletion of the gene encoding for C/EBP-b caused
a loss of CD1d expression in gene targeted mice. The in vivo regulation of CD1d has significant
implications for the pathologic mechanisms of certain immunologic skin diseases in which NKT-
cells play a role, such as allergic contact dermatitis and psoriasis. Together, these data show a cen-
tral role for C/EBP-b in regulating CD1d transcription.
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The environmental contaminant, benzo(a)pyrene induced Interleukin-8 by normal human
epidermal keratinocyte
G Tsuji,1 T Masakazu,1 H Uchi,1,2 S Takeuchi,1 Y Moroi1 and M Furue1,2 1 Department of
Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan and
2 Research and Clinical Center for Yusho and Dioxin, Kyushu University, Fukuoka, Japan
Dioxins affect immune functions such as tumor immunity, autoimmune disease and allergic dis-
ease. However, the effects of dioxin toxicity especially to skin immune functions are still poorly
understood. Benzo(a)pyrene (BaP) is a kind of dioxins and is environmental contaminant contained
in exhaust gas from diesel cars and cigarette smoke. To examine adversely effects of exposure human
skin to BaP, we treated normal human epidermal keratinocytes with BaP and measured the pro-
duction of Interleuikin-8 (IL-8), well-established cutaneous inflammatory cytokine. BaP was shown
to induce IL-8 expression at both mRNA and secretion levels in a dose-dependent manner. Such
an up-regulation was likely linked to aryl hydrocarbon receptor (AhR)-activation since BaP-medi-
ated IL-8 induction was reduced after treatment with resveratrol that is a selective antagonist of
AhR. Overall, these data highlight an AhR-dependent regulation of IL-8 in response to BaP that
likely contributes to the cutaneous inflammatory effects of this environmental contaminant.
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Integrated pathways of neutrophil-mediated tissue injury in immune complex disease
DJ Lee,1 H Li,1 MT Ochoa,1 M Tanaka,2 RJ Carbone,1 R Damoiseaux,1 A Burdick,3 TH Rea4 and
RL Modlin1 1 UCLA, Los Angeles, CA, 2 Kyoto Univerisy, Kyoto, Japan, 3 University of Miami,
Miami, FL and 4 University of Southern California, Los Angeles, CA
We investigated the mechanisms of immune complex-mediated tissue injury in humans by bioin-
formatic pathways analysis of the gene expression profiles in the skin lesions of erythema nodosum
leprosum (ENL), an immune complex-mediated reaction in patients with lepromatous leprosy (L-
lep). The most overrepresented biologic functional group in ENL vs. L-lep lesions was “cell move-
ment,” which included mediators of neutrophil migration such as E-selectin, which correlated with
expression of both IL-1β and the IL-1 receptor (IL1R1). E-selectin localized to endothelial cells and
was more highly expressed in ENL than in L-lep lesions. IL-1β, together with IFN-γ, induced E-
selectin expression on, and neutrophil adhesion to endothelial cells in vitro. Thalidomide, an effec-
tive treatment for ENL, inhibited: 1) Fc Receptor (FcR) or TLR2/1 induction of IL-1β, 2) IL-1β and
IFN-γ upregulation of E-selectin; as well as 3) neutrophil binding, indicating that this pathway con-
tributes to inflammation in immune complex disease. The gene expression profile of ENL lesions
comprised an integrated pathway of macrophage activation, neutrophil migration and neu-
trophil/macrophage-mediated inflammation, providing insight into mechanisms of immune com-
plex-mediated tissue injury in humans.
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IL-5 regulates antibody response in human leprosy
MT Ochoa,1 D Lee,1 B Haas,1 D Zaghi2 and RL Modlin1 1 Dermatology, David Geffen School
of Medicine at UCLA, Los Angeles, CA and 2 Albert Einstein College of Medicine, New York,
NY
Leprosy is an infectious disease of the skin, in which the clinical manifestations correlate with the
type of immune response mounted to the pathogen, Mycobacterium leprae. To investigate which
biological pathways or gene sets are overrepresented in lepromatous (L-Lep) vs. tuberculoid (T-Lep)
patients that might be relevant in disease pathogenesis, we compared the gene expression profiles
of L-lep vs. T-lep skin lesions using knowledge-guided bioinformatic analysis, incorporating data
on likely biologic functions, including gene ontology information and regulatory data. Probe sets
comparatively increased in expression in L-lep vs. T-lep that met P-value < 0.05 and fold change
greater than 1.5 were included in the analysis. This analysis identified “B-cell receptor signaling”
as the 4th ranked canonical pathway (P < 0.005) and genes belonging to functional groups involv-
ing B cells (including B-cell proliferation, B-cell quantity, B-cell growth, B1 cell quantity, B-cell
survival, and B-cell maturation, P values all < 0.005) significant to the dataset. Further analysis of
gene expression profiles revealed a potential network involving the expression of IgM and IL-5. To
investigate the role of B cells in the progressive form of M. leprae infection, we examined L-lep
skin lesions and found approximately increased number of plasma cells and immunoglobulins (IgM
and IgA) compared to T-lep lesions . We hypothesized that the presence of IL-5 at the site of dis-
ease may contribute to the increased immunoglobulins present in L-lep. In vitro studies of periph-
eral blood mononuclear from healthy donors show an increased expression of immunoglobulins
when cultured with IL-5 and mycobacteria. This preliminary data suggests a potential role for IL-
5 and increased immunoglobulins present in L-lep skin lesions, providing a potential mechanism
for increased antibodies available to form immune complexes in the reactional states of leprosy
which develop in up to 50% of L-lep patients receiving multidrug therapy.
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IL-17A enhances vitamin D3 induced expression of cathelicidin antimicrobial peptide in
human keratinocytes
M Peric,1 S Koglin,1 S Kim,1 S Morizane,2 R Besch,1 J Prinz,1 T Ruzicka,1 RL Gallo2 and
J Schauber1 1 Dept. of Dermatology and Allergology, LMU Munich, Munich, Germany and
2 Dept. of Dermatology, UC San Diego, San Diego, CA
Cathelicidin is strongly expressed in lesional skin in psoriasis and may play an important role as
both an antimicrobial peptide and as an autoinflammatory mediator in this chronic skin disease.
The mechanism of increased cathelicidin in psoriatic keratinocytes is not known but recent obser-
vations have found that psoriasis has abundant Th17 cells which produce interleukin (IL-) 17A
and IL-22. We found that human keratinocytes stimulated with supernatants from T cells isolated
from lesional psoriatic skin increased expression of cathelicidin when stimulated in the presence
of 1,25-dihydroxyvitamin D3 (1,25D3). This increase was signalled through the IL-17 receptor A
(IL-17RA). In vitro, IL-17A, but not IL-22, enhanced cathelicidin mRNA and peptide expression in
keratinocytes dependent on the presence of 1,25D3. At the same time coincubation with 1,25D3
blocked induction of human β-defensin 2 (HBD2), IL-6 and IL-8, which are other target genes of
IL-17A. Act1, which is associated with IL-17RA and essential for IL-17A signaling, mediated cathe-
licidin induction, as its suppression by siRNA inhibited HBD2 and cathelicidin. Both, 1,25D3 and
IL-17A signalled cathelicidin induction through MEK-ERK. These results suggest that increased IL-
17A in psoriatic skin increases cathelicidin through a vitamin D3, Act1 and MEK-ERK dependent
mechanism. Therapies targeting this cathelicidin regulating system might be beneficial in patients
suffering from psoriasis.
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Indentification of Staphylococcal Protein A in infected atopic dermatitis lesions
JB Travers, A Kozman, Q Yi, M Al-Hassani and Y Yao Indiana University, Indianapolis, IN
Staphylococcus aureus infections are known triggers for skin inflammation and can modulate
immune responses. Patients with atopic dermatitis are particularly sensitive to staphylococcal
skin infections, which are known to worsen their skin disease. One mechanism by which staphy-
lococcal bacteria can worsen atopic dermatitis could involve bacterial products, including staphy-
lococcal protein A (SPA). Of note, SPA can bind to immunoglobulin, yet recent studies indicate
that it can also act as an agonist for the tumor necrosis factor receptor 1 (TNFR1). The objective
of the present studies was to assess quantitatively the amount of SPA present on clinically infected
atopic dermatitis lesions and compare with the amount of bacteria present and the amount of skin
inflammation. We enrolled over 80 patients with clinically impetiginized atopic dermatitis and
evaluated the amount of S. aureus bacteria, SPA, TNF-alpha and IL-8 in wash fluid from a quan-
titative culture of an infected lesion. The lesional inflammation was quantitated by Ezcema Area
and Severity Index (EASI), and the patient treated with appropriate care including oral antibiotics.
The patients were then re-evaluated after two weeks and the clinical EASI evaluation and wash
fluid studies repeated. These studies revealed that the clinical EASI score correlated with the amount
of staphylococcal bacteria and SPA levels. SPA levels also correlated with cytokines TNF-alpha
and IL-8. It should be noted that the effective concentration of SPA found in vivo on many of the
patients was adequate to induce skin inflammation when injected intradermally into the ears of
C57BL6 mice. These studies suggest that infected atopic dermatitis lesions contain biologically rel-
evant amounts of SPA which could in part provide a mechanism for the increased inflammation
and worening of dermatitis seen during a staphylococcal skin infection.
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Expression of molecules involved in the innate immunity is enhanced during lactation in
mammary epithelium
M Mildner,1 A Abtin,1 J Jin,1 R Gläser,2 JM Schröder,2 J Pammer,3 V Mlitz,1 M Schmidt1 and
E Tschachler1,4 1 Dermatology, Medical University of Vienna, Vienna, Austria, 2 Dermatology,
University Hospital Schleswig-Holstein, Kiel, Germany, 3 Pathology, Medical University of
Vienna, Vienna, Austria and 4 CE.R.I.E.S., Centre de Recherches et dInvestigations
Epidermiques et Sensorielles, Neuilly, France
Mastitis of the mammary tissue in response to invading bacteria is a serious problem in breast-feed-
ing women, and the innate immune system is of particular importance for rapid elimination of
pathogens in this setting. In the present study we have investigated the expression and regulation
of AMPs and TLRs in non-lactating versus lactating human mammary epithelial cells in vitro and
in vivo. We could demonstrate that during lactation the production of S100A7 (psoriasin), human
beta-defensin (HBD)-1 and calprotectin were strongly up-regulated in human mammary epithe-
lial cells, whereas HBD-2, cathelicidin, RNase 5 and RNase 7 were not induced. We could fur-
ther show that high amounts of S100A7, HBD1 and calprotectin were present in human breast
milk. In addition, the exposure of human mammary epithelial cells in monolayer culture to a cock-
tail inducing lactation sensitized these cells to TLR-mediated up-regulation of AMPs by bothTLR-
agonists and heat-inactivated Escherichia coli and pseudomonas aeruginosa cultures. We there-
fore investigated whether TLRs were also regulated by lactation. Western blot analysis of human
primary mammary epithelial cells in vitro and immuno-histochemical stainings of non-lactating
and lactating breast biopsy specimens revealed that TLR-1, -3, -6, -7, -8 and -9 were significantly
up-regulated during lactation. We conclude that an enhanced secretion of AMPs as well as an
enhanced production of TLRs by lactating mammary glands might represent an important step for
rapid elimination of invading pathogenic bacteria from the breast. Furthermore, the high concen-
trations of some AMPs in human breast milk might also represent an important protective factor
for breastfed babies.
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The functional spectrum of cytotoxic DCs: different roles of IFNα and MHC I in pDCs and
mDCs
M Kalb, G Stary, F Koszik and G Stingl Department of Dermatology, DIAID, Medical University
of Vienna, Vienna, Austria
Dendritic cells (DCs) do not only exhibit the unique capacity to evoke primary immune responses
by presenting antigens to naïve T cells, but may also acquire subtype-specific cytotoxic molecules
in response to stimulation with intracellular, but not extracellular Toll-like receptor (TLR) agonists.
We have previously shown that TLR7/8 and -9 stimulated plasmacytoid DCs (pDCs) express tumor
necrosis factor-related apoptosis-inducing ligand (TRAIL), while TLR7/8-stimulated myeloid DCs
(mDCs) express perforin and granzyme B, but not TRAIL. To gain a better understanding of the
mechanisms through which cytotoxic DCs elicit their killer activity, pDCs and mDCs isolated from
peripheral human blood were stimulated with a TLR7/8 agonist in the presence of IFNα/β anti-
bodies. Under these conditions the expression of TRAIL on TLR7/8-stimulated pDCs, but not
granzyme B and perforin on mDCs was completely abolished. Also, freshly isolated pDCs, but not
mDCs, that had been stimulated with IFNα alone expressed TRAIL and the mean fluorescence
intensity of TRAIL expression correlated with the dose of IFNα used. At a functional level both
TLR7/8- and IFNα-stimulated pDCs killed the tumor cell line Jurkat in a TRAIL-dependent fashion,
while tumor cell lysis was abolished in the presence of neutralizing IFNα/β antibodies. In contrast,
TLR7/8-stimulated mDCs lysed the MHC Ilow tumor cell line K562 and much less efficiently their
HLA-A*0201-transfected counterpart in a granzyme B- and perforin-dependent but IFNa-inde-
pendent fashion. Despite this killing pattern, TLR7/8-stimulated mDCs did not display the pheno-
typic profile of natural killer (NK) cells. In conclusion our data demonstrate two distinct mecha-
nisms by which pDCs and mDCs elicit their tumoricidal activity, pointing to an as yet
underappreciated powerful innate defense line in infectious and tumor immunity.
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Alternative pathway of IL-18 conversion by a lymphocyte-derived enzyme
Y Omoto,1 K Yamanaka,1 K Tokime,1 M Kakeda,1 H Kitagawa,1 I Kurokawa,1 K Yamanishi2 and
H Mizutani1 1 Dermatology, Mie University, Tsu, Japan and 2 Dermatology, Hyogo Medical
College, Nishinomiya, Japan
IL-18 is a multifunctional proinflammatory cytokine. With the presence of IL-12, IL-18 stimulates
Th1-mediated immune reaction to induce IFN-γ production. Without presence of IL-12, IL-18 has
the potential to stimulate Th2 cytokine production inducing IL-4 and IL-13. IL-18 is synthesized
and stored inside of cells as an inactive 24kDa proform. Upon stimulation, the known IL-18 pro-
ducing cells: dendritic cells, monocytes and Kupffer cells secrete IL-18 after processing at Asp35
by caspase-1. However, T cells, B cells, keratinocytes and fibroblasts have been believed active
IL-18 non-producers because of lacking functional caspase-1. We have already demonstrated that
IL-18 from keratinocyte causes atopic dermatitis-like lesions in caspase-1 and IL-18 transgenic mice.
Caspase-1 works very rapidly for processing of endogenous proIL-18. Its biological half time is very
short and its work as an extracellular enzyme is unlikely. Therefore, presence of an “exogenous
enzyme” that interacts with non-hematopoietic cells derived proIL-18 is expected. To detect the
enzyme that cleaves and activates proIL-18, we produced and purified recombinant His-tagged
proIL-18 protein with E.coli, and reacted with several enzymes. We have identified a lymphocytes
derived enzyme that cleaves and activate IL-18 proform. Analysis of amino acid sequence of the
processed peptide revealed accurate processing position at post Asp35 site, which was identical
to that of caspase-1. This reaction was completely blocked by its specific inhibitor. As expected,
this peptide showed biological activity compatible to that of mature IL-18. Thus, these results sug-
gest that this lymphocyte-derived enzyme is able to induce inflammation by secretion of active IL-
18 from proIL-18 reservoirs including keratinocytes. This may be a new pathway to activate IL-18
different from caspase-1.
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Propionibacterium acnes induces prostaglandin formation to auto-regulate inflammatory
responses
R Sur, P Lyte, A Vorobyeva-Schiano and M Southall Johnson & Johnson Consumer Companies,
Skillman, NJ
Acne vulgaris is a common multifactorial disorder of the pilosebaceous follicles, involving seba-
ceous hyperplasia, follicular hyperkeratinization, bacterial infection and immune hypersensitivity.
Part of the inflammation seen in acne is the result of the host response to Propionibacterium acnes
(P. acnes). P. acnes is a commensal microorganism found in sebum-rich skin and plays a role in
acne inflammation by stimulating keratinocytes to produce pro-inflammatory cytokines. In the cur-
rent set of in vitro experiments, exposure of cultures of human keratinocytes to live P. acnes resulted
in secretion of interleukin-1a (IL-1a), tumor necrosis factor-a (TNF-a), IL-8 and PGE2. Exposure of
human keratinocytes to P. acnes also resulted in the increased expression of COX-2, which is con-
sistent with the increased PGE2 formation. Production of PGE2 was inhibited by NS-398, a rela-
tively selective inhibitor of the COX-2, and by Ibuprofen, a non-selective COX-1/2 inhibitor. Inter-
estingly, inhibition of PGE2 formation resulted in the subsequent increase of TNF-a and IL-8 release
from P. acnes-treated human keratinocytes. These results suggest that P. acnes induces prostaglandin
production to negatively regulate the production of pro-inflammatory mediators from keratinocytes.
Finally, exogenous administration of PGE2 was found to decrease the P. acnes-induced release of
pro-inflammatory cytokines from keratinocytes. Taken together these results indicate that P. acnes
regulates acne inflammation through both pro- and anti-inflammatory pathways and therefore
demonstrates a new mechanism to potentially regulate acne inflammation.
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DC-HIL on dendritic cells is a pattern recognition receptor for dermatophytes and its down-
stream effects may condition innate immunity against these pathogens
J Chung,1 T Yudate,2 M Tomihari,1 PD Cruz1 and K Ariizumi1 1 Dermatology, UT Southwestern
Med Ctr, Dallas, TX and 2 Dermatology, Kinki University School of Medicine, Osaka, Japan
Having recently discovered a novel inhibitory pathway triggered by binding of DC-HIL on antigen
presenting cells (APC) to a heparin-like saccharide of syndecan-4 (SD-4) on activated T cells, we
posited that DC-HIL may also recognize microbial pathogens through a similar sugar moiety and
ignite signaling within APC. Using soluble recombinant DC-HIL, we performed binding assays:
DC-HIL bound the dermatophytes Trichophyton ruburm and Epidermophyton floccosum, but not
a variety of bacteria nor Candida albicans. Binding of DC-HIL to dermatophytes was abrogated
completely by the addition of heparin. Because DC-HIL has an ITAM-like intracellular sequence,
we posited that binding of DC-HIL to dermatophytes will transduce signals within APC. We tested
this possibility by performing tyrosine phosphorylation assays on immunoprecipitates of bone mar-
row-derived dendritic cells (DC) cultured with T. ruburm or hyphal C. albicans (0.5 or 1.0 mg
dried weight). T. ruburm induced tyrosine phosphorylation as early as 10 min, whereas C. albicans
failed to do so. Proof that the ITAM-like sequence is required for intracellular signaling was addressed
by transfection studies using a mutated (Tyr to Phe) sequence. Finally, we showed that ligation of
DC-HIL on DC upregulated transcription and translation of NF-κB, IL-1β and TNF-α (by gene
array and ELISA respectively), induced CD80/CD86 expression (by FACS), and augmented T cell-
stimulatory capacity (by IL-2 production of OVA-specific T cells). Our findings support a dual role
for DC-HIL: (previously) inhibition of adaptive immunity following ligation of SD-4 on activated T
cells; and (now) induction of innate immunity against dermatophytes.
728
HIV-1 induces Cdc42-dependent filopodia formation to facilitate Dendritic cell-T cell trans-
infection
DS Nikolic, M Lehmann, E Garcia, FP Blanchet and V Piguet Dermatology and Venereology,
Microbiology and Molecular Medicine, University Hospital and Medical School, Geneva,
Switzerland
Dendritic cells (DC), due to their unique localization at mucosal surfaces, coupled with their known
proficiency in capturing antigens, are among the first potential targets for HIV-1 during transmis-
sion. One of the limiting steps for HIV-1 propagation is the transfer of virus at an infectious synapse
(IS) between DC and CD4+ T cells. Bacterial pathogens can hijack the host actin cytoskeleton to
facilitate invasion and propagation. We report here the first evidence that a virus, HIV-1, induces
the formation of filopodia in DC through activation of the Rho GTPase Cdc42. We provide direct
evidence that filopodia are obligate components of the HIV-1 induced DC-T cell infectious synapse
and required for transfer of HIV-1 infection to target CD4+ T cells. HIV-1 at the surface and near
the tip of filopodia was observed by confocal microscopy, electron microscopy and live imaging.
Silencing of Cdc42, a key controller of filopodia formation, in DC by RNAi dramatically reduced
number of filopodia on DC and decreased HIV-1 transfer to CD4+ T lymphocytes but did not alter
infectious synapse formation. Finally, we show that filopodia play an essential role in the transfer
of virus when a low number of DC are co-cultured with T cells, a situation that mimics DC-T cell
ratios in mucosal tissues or lymph nodes. In conclusion we identify a critical role for Cdc42-depend-
ent filopodia induction by HIV-1 in the transfer of HIV-1 from DC to T cells thereby identifying a
novel pathway for HIV-1 cell-to-cell propagation.
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Langerhans cells regulate CHS responses via cognate CD4 interactions and LC-derived IL-
10
B Igyarto,1 MC Jenison,1 A Roers,2 PA Koni,3 MJ Shlomchik4 and DH Kaplan1 1 Dermatology,
University of Minnesota, Minneapolis, MN, 2 University of Cologne, Cologne, Germany, 3
Medical College of Georgia, Augusta, GA and 4 Yale University, New Haven, CT
We have previously demonstrated that Langerhans cells (LC) are not required for the development
of immune responses to cutaneous antigens. Rather, data from LC deficient mice (Langerin-DTA)
has revealed that the absence of LC at the time of sensitization but not challenge leads to enhanced
contact hypersensitivity (CHS) responses to cutaneously applied haptens. Since CHS responses
involve both CD4 and CD8 T cells, we generated mice in which MHC-II is selectively ablated
only in LC (Langerin-Cre x I-Aβ-flox). These mice have enhanced CHS responses indicating that
cognate interaction between LC and CD4 cells is required for regulation of CHS. LC-derived IL-10
also participates in this process since CHS responses were also enhanced in Langerin-Cre x IL-10-
flox mice. To further understand the details of LC-mediated regulation, we next examined hapten-
specific T cells by isolating LN cells from DNFB sensitized Langerin-DTA and Langerin-Cre x I-Aβ-
flox mice. These cells were then re-stimulated ex vivo with DNBS-haptenized spleen cells from
Rag1-/- mice. We observed a significant increase in the number of antigen-specific CD8 T cells
compared to WT. CD8 T cells produced increased amounts of IFNγ and IL-17 compared to cells
from WT mice. There was also an increase in the number of antigen-specific CD4 cells in Langerin-
DTA and Langerin-Cre x I-Aβ-flox mice. Levels of IFNγ, IL-17 and IL-2 were increased while lev-
els of IL-4, IL-5, IL-10, IL-13, and TGFβ were unchanged. The results in Langerin-DTA and Lan-
gerin-Cre x I-Aβ-flox mice were virtually identical. These data are consistent with a model in which
LC limit the development of antigen-specific CD8 and CD4 cells without altering Th-phenotype
through a mechanism that requires cognate CD4 interaction and involves the elaboration of LC-
derived IL-10.
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Antigen presenting cell depletion in the KC-Tie2 mouse model of psoriasis attenuates acan-
thosis, angiogenesis and leads to decreases in IL-23 and S100A8/9 but not IL-12
JA Wolfram,1 D Diaconu,1 PA Tessier,2 TS McCormick1 and NL Ward1 1 Dermatology, University
Hospitals Case Medical Center and CWRU, Cleveland, OH and 2 Univ Laval, Ste Foy, QC,
Canada
The IL-12 family of cytokines plays an important role in the initiation and regulation of cell-medi-
ated immunity with IL-12 and IL-23 having distinct roles in the pathogenesis of psoriasis. In addi-
tion, the calcium binding proteins S100A8/9 are also upregulated in skin and serum of psoriasis
patients, although the significance of this remains unclear. We hypothesized that S100A8/9 in
conjunction with IL-23 participates in the initiation, maintenance and propagation of the psoria-
sis phenotype. Utilizing our KC-Tie2 murine model of psoriasis, we depleted myeloid antigen pre-
senting cells (APC) using clodronate liposomes (CL) and found that acanthosis and dermal angio-
genesis returned to control levels in 7 of 10 mice after 6 weeks of treatment. In animals responsive
to CL treatment, immunocyte staining confirmed APC diminution and revealed decreased T cell
numbers intermediate to KC-Tie2 and control levels. Cytokine analysis post-CL treatment using
ELISA showed a significant reduction in IL-23 (p=0.016) but not IL-12, IL-17 or IFNγ. CL depletion
of myeloid APCs also lead to a 2.8 and 4.8 fold reduction of S100A8 and S100A9 expression respec-
tively, as well as returning expression of pro-inflammatory molecules IL-1α, IL-6 and TNFα to con-
trol levels. To address a potential role for S100A8/9 in the maintenance of psoriasis, we treated an
additional group of KC-Tie2 mice with function blocking antibodies specific for S100A8 and S100A9.
Interference with S100A8/9 failed to improve the psoriasis phenotype and surprisingly lead to a
further increase in IL-23 protein in treated vs untreated KC-Tie2 mice (p=0.021). These results
demonstrate that in a psoriatic cutaneous microenvironment, APC depletion leads to reduced IL-
23 expression and improves the phenotype despite sustained expression of IL-12, IL-17 and IFNγ.
Although APC depletion lead to decreased S100A8/9, specific neutralization of S100A8/9 failed
to reverse the psoriatic phenotype.
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Herpes simplex virus type 1 exploits scavenger receptors to infect human keratinocytes
DT MacLeod and RL Gallo Dermatology, University of California - San Diego, La Jolla, CA
Keratinocytes represent target cells in both primary and recurrent HSV-1 infections, but the mech-
anism used by the virus during this process remains incompletely understood. We previously
reported that Poly (I:C), a ligand for TLR3, protects keratinocytes from viral infection. Surprisingly,
however, this inhibitory effect did not require TLR3 activation. Based on this we hypothesized that
HSV-1 exploits cell-surface scavenger receptor A (SR-A), a receptor required for initial uptake of
Poly (I:C), and that infection is blocked due to competitive displacement. To test this we cultured
HSV-1 with normal human keratinocytes or HaCat and measured infection in the presence of mol-
ecules that bind SR-A at the cell surface but do not activate TLR3. These ligands dramatically
inhibited infection: Dextran Sulfate (Dxs) (99.99% inhibition, p<0.001), Fucoidan (Fn) (99.97%
inhibition, p<0.001), and Poly(I) (99.97% inhibition, p<0.001). In contrast, Poly(C) and other polyan-
ionic sugars that do not bind SR-A did not inhibit infection. Inhibition of infection was confirmed
independent of TLR3 as Dxs, Fn, Poly(I) did not induce IL-6 or IFN-β. Staining of HSV-1 adhering
to the cell surface directly demonstrated that Dxs, Fn, and Poly(I) blocked binding of viral parti-
cles by more than 90%. Additional support of our hypothesis was seen by measurement of viral
early gene (glycoprotein D) expression by qPCR, where Poly (I:C) inhibited 68% (p<0.05), and
Poly(I) inhibited 72% (p<0.05), while Poly(C) had no effect. Finally, confirmation for the role of
SR-A came after partial siRNA knockdown of SR-A which reduced HSV-1 gene expression 52%
(p<0.05) while a non-targeting siRNA, or control siRNA targeting LOX-1, an alternate scavenger
receptor, had no effect on HSV-1 infection. Therefore, we report for the first time identification of
SR-A as a receptor for HSV-1 on keratinocytes. These observations suggest a novel therapeutic
approach to control of HSV infections of the skin by blocking attachment to SR-A.
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Propionibacterium acnes benefits from a host enzyme that amplifies its pathogenicity: Syn-
ergy between microbial CAMP factor co-hemolysin and host acid sphingomyelinase toxic
properties
T Nakatsuji,1,2 RL Gallo1,2 and C Huang1,2,3 1 Dermatology/ Medicine, University of California
San Diego, San Diego, CA, 2 VA San Diego Healthcare Center, San Diego, CA and 3 Moores
Cancer Center, University of California San Diego, San Diego, CA
The initial event in typical inflammatory acne vulgaris is the disruption of follicular epithelium by
an over-growth of Propionibacterium acnes (P. acnes), which allows the bacteria in the comedo to
come in contact with the host immune systems. We have demonstrated that P. acnes secretes CAMP
factor, which is known to act synergistically with bacterial sphingomyelinase (SMase) to lyse ery-
throcytes. Recombinant P. acnes CAMP factor alone induced cell death in human keratinocyte
(HaCaT) and murine macrophage (RAW264.7) cell lines in a dose-dependent manner. Intradermal
injection of mouse ears with CAMP factor induced significant ear swelling. In addition, host acid
SMase (ASMase) was released/ secreted from HaCaT and RAW264.7 cells when the cells were co-
cultured with P. acnes. P. acnes-induced cytotoxicity in both cell lines was significantly neutral-
ized by including either a selective ASMase inhibitor or anti-CAMP factor antiserum. Intradermal
injection of mouse ears with live P. acnes attracted numerous macrophages, which strongly express
ASMase, resulting in an increase in soluble ASMase in the ear after P. acnes challenge. Most notably,
vaccination of ICR mice with CAMP factor yielded protective immunities against P. acnes-induced
inflammation and the development of skin lesions. In addition, the combination of vaccinating with
CAMP factor and locally injecting anti-ASMase IgG synergistically reduced P. acnes-induced ear
swelling. These data support our concept that P. acnes benefits from host enzymes that amplify its
pathogenicity; P. acnes may utilize host ASMase to enhance the toxicity of its CAMP-factor, which
may contribute to its evasion of host immune defenses, degrade host tissues, and spread the pathogen.
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Cholinergic activation decreases innate immune antimicrobial activity and barrier function
to increase susceptibility to bacterial infection
KA Radek,1 SK Mahata,1 L Taupenot,1 DT O’Connor1,2 and RL Gallo1 1 Medicine, University of
California, San Diego, CA and 2 Center for Molecular Genetics, University of California, San
Diego, CA
Stress increases susceptibility to infection and suppresses cutaneous innate immune functions,
including antimicrobial peptide (AMP) expression and epidermal permeability. We hypothesized
that this is partly attributed to cholinergic activation of nicotinic receptors (nAChR) on keratinocytes.
To test this, we applied nicotine (0.1-1ng/g) or vehicle to mouse skin for 3 days and found a 40%
reduction in AMP activity by radial diffusion against S. aureus using HPLC purified nicotine-treated
skin extracts. This confirmed our previous results in keratinocytes in vitro, as AMP gene expres-
sion (cathelicidin, hBD-2) was also reduced by nAChR activation (P<.05). Moreover, nicotine-
treated mouse skin had significantly higher barrier permeability measured by TEWL (1.3±0.7 vs.
5±1 g/m2h vehicle, P<.01). Our hypothesis was further confirmed in mice deficient in Chromo-
granin A (Chga) which lack the endogenous nAChR antagonist catestatin, and thus have unop-
posed cholinergic activation. Similar to nicotine-treated skin, Chga-/- mouse skin showed a 50%
reduction in AMP activity and increased barrier permeability (2±0.4 vs. 0.4±0.03 g/m2h, P<.01).
Susceptibility to Group A Streptococcus infection was increased in these mice, as lesions were
70% larger (35±4 mm vs. 21±2 mm, P<.05) and had 5x more surviving bacteria (8x10^8±3x10^8
vs. 4x10^9±1.4x10^9 CFU/ml, P<.05). In addition, Chga+/+ subjected to 3 days of stress (con-
stant crowding, noise, and light) to elevate endogenous cholinergic activity also had decreased
skin AMPs, barrier function, and increased susceptibility to infection identical to Chga-/- mice.
Stress did not further enhance these defects in Chga-/- mice. Thus, we have identified a novel mech-
anism of cutaneous immune defense and propose that cholinergic activation of epithelial cells sup-
presses immune defense by at least two detrimental effects by reducing AMP production and increas-
ing epithelial permeability.
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Free fatty lauric acid as an innate bactericide against propionibacterium acnes: In compli-
ance with evolutionary medicine for treatment of acne vulgaris
T Nakatsuji,1 MC Kao,1 CC Zouboulis,2 L Zhang,1 RL Gallo1 and E Huang1 1 Medicine,
University of California, San Diego, San Diego, CA and 2 Dessau Medical Center, Dessau,
Germany
Many agents such as benozoyl peroxide (BPO), anti-inflammatory isotretinoin and other antibi-
otics have been widely used in clinic for acne treatments. However, these antiacne drugs are not
in compliance with evolutionary medicine since they are synthetic chemicals which usually pro-
duce considerable local side effects. The strong bactericidal properties of lauric acid (LA), a mid-
dle chain free fatty acid commonly found in sebum, mother’s milk and natural products, have been
shown in a number of studies. However, it has not been demonstrated whether LA can be used for
acne treatment as a natural antibiotic against P. acnes, which promotes follicular inflammation.
This study evaluated for the first time the antimicrobial property of LA against P. acnes both in
vitro and in vivo. Incubation of the skin bacteria P. acnes, S. aureus, and S. epidermidis with LA
yielded minimal inhibitory concentration (MIC) values against the bacterial growth over 15 times
lower than those of BPO. The lower MIC values of LA indicate stronger antimicrobial properties
than that of BPO. The detected values of half maximal effective concentration (EC50) of LA on P.
acnes, S. aureus, and S. epidermidis growth indicate that P. acnes is the most sensitive to LA among
these bacteria. In addition, LA did not induce cytotoxicity to human sebocytes. Notably, both intra-
dermal injection and epicutaneous application of LA effectively decreased the number of P. acnes
colonized with mouse ears, thereby relieving P. acnes-induced ear swelling and granulomatous
inflammation. The obtained data highlight the potential of using LA as an alternative treatment for
antibiotic therapy of acne vulgaris. We will aslo present our current progress in engineering lau-
ric acid-encapsulated nanoparticles (LA-NPs). The LA-NPs significantly enhance the potency of
LA, circumvent the precipitation problem of water-insoluble LA,and improve the specificity of
delivery to acne microenvironment.
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Contrasting roles of the IL-1 and IL-18 receptors in myd88-dependent contact hypersensi-
tivity
PA Klekotka,1 L Yang2 and WM Yokoyama2 1 Dermatology, Washington University School of
Medicine, Saint Louis, MO and 2 Howard Hughes Medical Institute, Washington University
School of Medicine, Saint Louis, MO
Contact hypersensitivity (CHS) is a delayed-type hypersensitivity response that requires activation
of the innate immune system and results in an adaptive immune response. Many cells of the
innate immune system use Toll-like receptors (TLRs) to initiate an immune response to various
molecular pathogens. While most TLRs signal exclusively through the adaptor protein, MyD88, it
is also required for signaling by the IL-1 and Il-18 receptors. Herein we studied the role of several
constituents of the MyD88 signaling pathway in the CHS response to 2,4-dinitrofluorobenzene
(DNFB) because mice deficient in MyD88 were unable to mount a CHS response to DNFB. In con-
trast, mice deficient in Toll/IL-1R-containing adaptor inducing IFN-β (TRIF), TLR2, TLR4, TLR6 or
TLR9 had no defect in their ability to respond to DNFB whereas both IL-1R and IL-18R-deficient
mice showed a reduced CHS response. In bone marrow chimera and adoptive transfer experiments
with MyD88- and IL-18R-deficient mice, we found that MyD88 and IL-18R were required in a
radioresistant cell in the sensitization phase of the CHS response. In contrast, experiments with IL-
1R-deficient mice revealed that the IL-1R was required in a radiosensitive cell in the sensitization
phase of the CHS response. Taken together, these data indicate that signaling through the IL-18R
and MyD88 are required in a radioresistant cell during the sensitization phase while the IL-1R is
required on a radiosensitive cell in the sensitization phase. Thus, these data indicate that the roles
of IL-1 and IL-18 are mediated through distinct cells in CHS.
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Interference with the IL-1 network and cutaneous immunity to smallpox vaccine
T Tian,1 K Dubin,1 S Wong,1 L Liu,1 GF Murphy,2 TS Kupper1 and RC Fuhlbrigge1 1 Dermatology,
Brigham and Women’s Hospital, Boston, MA and 2 Pathology, Brigham and Women’s
Hospital, Boston, MA
Vaccinia virus (VV) scarification in a normal host results in specific and long-lasting immunity. But
in patients with atopic dermatitis viral replication can outstrip control leading to devastating mor-
bidity and mortality, a condition termed eczema vaccinatum (EV).The basis for this severe side
effect has not been clarified. It has been established that IL-1 is an important regulator of cuta-
neous inflammatory responses,but the role of IL-1 during smallpox vaccination is not well defined.
In a previous study we utilized transgenic mice with over-expressed IL-1α in the epidermis and
found that over-expression of IL-1α in skin differentially modulates the immune response to VV
scarification at different doses of virus. In this study we examined the skin reaction of IL-1 recep-
tor1-deficient (IL-1R1-/-) mice and found that the IL-1R1-/- mice developed markedly larger skin
lesions and exhibited multiple satellite lesions two weeks post VV scarification, similar to the
response seen in EV. Significant VV replication can be detected in the satellite lesions. To deter-
mine whether the larger lesions in the IL-1R1-/- mice were due to a defect of the adaptive immune
response, we analyzed VV-specifc Ab generation and T cell IFNγ production in IL-1R1-/- mice fol-
lowing VV scarification and found that IL-1R1-/- mice produced comparable VV-specifc Ab and
IFNγ as wild-type controls. The virus load at the inoculation site revealed that IL-1R1-/- mice har-
bored 10-fold more virus three days after VV scarification,a time point when the adaptive immune
response is not yet active. These results indicate that a defect of innate immune response in IL-
1R1-/- mice leads to their vulnerability of VV scarification. These studies will help to clarify the
role of IL-1 in the cutaneous immune response to vaccinia virus scarification and may lead to sub-
stantial insights that will benefit patients at risk for eczema vaccinatum.
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Gamma/delta T cells promote neutrophil recruitment in immunity against Staphylococcus
aureus skin infection
LS Miller,1 EM Pietras,2 J Cho,1 D Farzam,1 HR Monroe,1 NC Garcia,1 G Cheng2 and RL Modlin1,2
1 Division of Dermatology, University of California Los Angeles (UCLA), Los Angeles, CA and
2 Microbiology, Immunology and Molecular Genetics, University of California Los Angeles
(UCLA), Los Angeles, CA
Staphylococcus aureus skin infections represent a major public health threat in the United States
as a result of the dramatic and widespread emergence of virulent and antibiotic-resistant strains
such as methicillin-resistant S. aureus (MRSA). The ultimate objective of this study is to gain insight
into mechanisms of neutrophil recruitment against S. aureus skin infections. Here, we demon-
strate that gamma/delta T cell-deficient mice but not alpha/beta T cell-deficient mice developed
larger lesions (3 fold) with higher bacterial counts (up to 15-fold) and had decreased neutrophil
recruitment (histology and myeloperoxidase assays) and impaired production of neutrophil
chemokines (KC and MIP2) and neutrophil hematopoesis factors (GM-CSF) compared with wild-
type mice (p<0.05). Since the S. aureus-induced skin lesions are composed of resident cells and
bone marrow (BM)-derived recruited cells, we utilized techniques of BM reconstitution to delin-
eate which population of cells was important in promoting gamma/delta T cell-mediated host
defense and neutrophil recruitment. We found that host defense and neutrophil recruitment were
not dependent upon the presence of gamma/delta T cells in BM-derived recruited cells, suggest-
ing that resident skin gamma/delta T cells, likely the known skin resident dendritic epidermal T
cells (DETCs), are the primary mediators of neutrophil recruitment and host defense. Taken together,
this study provides evidence that gamma/delta T cells, which are resident in the skin, are impor-
tant in promoting neutrophil recruitment in immunity against S. aureus skin infection.
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Exploring natural killer cells resident in normal human skin
AE Gehad, RA Clark, SL King, TS Kupper and RC Fuhlbrigge Harvard Skin Disease Research
Center, Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical
School, Boston, MA
Human skin contains a broad collection of leukocytes that form an intricate network important for
immunosurveillance. In this study, we used a short term explant culture method for leukocyte iso-
lation to study the CD3-CD56+ Natural Killer (NK) cells present in normal (uninflamed) skin. Sam-
ples of human skin obtained from cosmetic surgery procedures were minced, and 1-2 mm frag-
ments were cultured on tantalum-coated carbon matrices in the absence and presence of various
cytokines including IL-2, IL-15, IL-18, IL-21, and FLT-3 ligand. Leukocytes that migrated out of the
matrices after 2-3 wk in culture were recovered and analyzed by flow cytometry. NK cells present
in normal skin represented a small fraction (2-12%) of total skin leukocytes recovered. A combi-
nation of IL-15 and IL-18 yielded maximal recovery of NK cells. The majority of skin NK cells
expressed CLA, and E- and P-selectin ligands, as well as both α4 and αL integrins. Skin NK cells
and skin T cells recovered in parallel did not express L-selectin or CCR7 consistent with a periph-
eral tissue homing phenotype. However, in contrast to skin T cells, only a small fraction of NK
cells expressed CCR4 and CCR6. Skin NK cells were negative for CCR10 and CXCR4. Skin NK cells
expressed the surface receptor NKG2D and intracellular perforin and granzyme B, molecules
required for NK cell cytotoxic function. With phorbol 12-myristate 13-acetate and ionomycin stim-
ulation, the majority of NK cells produced IFN-γ and TNF-α but not IL-10 or IL-6. Our data show
that NK cells in the skin represent a unique population with multiple capacities and functions, and
may play a critical role in cutaneous immunosurveillance and inflammatory responses.
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Association of Staphylococcus aureus exfoliative toxin A with a diminished local immune
response in infected skin lesions
LW Plano,1,2,3 CE Rolle,2 J Chen,1 TC Cardenas,1 R Perez3 and SC Davis3 1 Pediatrics, University
of Miami, Miller School of Medicine, Miami, FL, 2 Microbiology & Immunology, University of
Miami, Miller School of Medicine, Miami, FL and 3 Dermatology, University of Miami, Miller
School of Medicine, Miami, FL
Staphylococcus aureus, including MRSA, are common commensal bacteria capable of causing
multiple types of infections, chiefly of the skin and soft tissues. S. aureus produces a number of vir-
ulence factors that aid to establish and maintain infections by numerous mechanisms including
effects on the immune response. The repertoire of toxins carried by individual strains of S. aureus
varies widely and association of some virulence factors with the particular diseases they cause are
well established, for example, scalded skin syndrome and the exfoliative toxins (ETs). We recently
reported the association of the ETs and a low local WBC count in infected skin lesions from a sin-
gle geographic area. This investigation examines skin infecting S. aureus isolates from multiple
locations for the potential to produce associated virulence factors and assess their association with
the local immune response. Real-time PCR was used to determine the presence of toxin genes in
bacterial populations divided into groups according to the numbers of WBC in the lesions at the
time they were collected. All skin infecting S. aureus were considered as a single group and also
separated into MSSA and MRSA subsets. More of the 188 S. aureus isolates evaluated were capa-
ble of expressing ETA, ETB and the leukotoxin (PVL) than the expected community rates. MRSA
was higher for PVL and MSSA for the ETs. A correlation was observed between the gene for ETA
and low WBC count in the MSSA isolates, however no linkage between MRSA genes and WBC
was identified. We further investigated a potential link between the known activity of ETA, cleav-
age of the cadherin family member protein Dsg1 in epidermal keratinocytes, and the release of the
pleiotropic cytokine, IL-6. Additional studies on the role of these virulence factors and immuno-
logical responses may aid in the development of targeted therapies.
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Is there a ’gut-skin axis’?
PC Arck,1,2 B Handjiski,2 E Hagen,1,2 J Bienenstock1 and R Paus3,4 1 Brain Body Institute,
McMaster University, Hamilton, ON, Canada, 2 Center of Internal Medicine and
Dermatology, Charité, University Medicine Berlin, Berlin, Germany, 3 Department of
Dermatology, University of Schleswig Holstein, Campus Lübeck, Lübeck, Germany and 4
School of Medicine, University of Manchester, Manchester, United Kingdom
Emerging evidence arising from interdisciplinary research supports the occurrence of communi-
cation axes between organs, such as the brain-gut or brain skin axis. The latter is employed in
response to stress challenge, along which neurogenic skin inflammation and hair growth inhibi-
tion is mediated. We now show that ingestion of a Lactobacillus strain in mice dampens stress-
induced neurogenic skin inflammation and the hair growth inhibition. Since these findings suggest
the existence of a ‘gut-skin axis’, they reveal an important and clinically interesting new dimen-
sion of complexity of the effects exerted by probiotic nutritional supplements.
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The suppression of human keratinocyte Toll like receptor-mediated functional responses by
alpha-melanocyte stimulating hormone
S Ryu, AW Johnson, J An, Y Lu, CA Armstrong, PI Song and JC Ansel Dermatology, University of
Arkansas for Medical Sciences, Little Rock, AR
Alpha-melanocyte stimulating hormone (α-MSH) is a highly conserved 13-aa neuropeptide derived
from pro-opiomelanocortin by post-translational processing, which has been reported to exhibit
potent anti-inflammatory activity and a wide range of immunosuppressive activities in the skin.
However, the regulatory effect of α-MSH on skin TLR expression and function is not clear. Since
keratinocyte TLR is believed to play a pivotal role in cutaneous innate immunity, we determined
if α-MSH was capable of regulating keratinocyte TLR-mediated functional responses. Our results
indicated that the LTA-induced expression of both TLR2 as well as the chemokine IL-8 was nega-
tively regulated by α-MSH pretreatment in human keratinocytes. To investigate the mechanism of
this response, siRNA of IRAK-M, a negative regulator of TLR signaling, was utilized in these stud-
ies. Our results demonstrated that the α-MSH immunosuppressive effect on IL-8 production was
inhibited by transfection of cultured keratinocytes with IRAK-M siRNA prior to α-MSH. These
studies indicate for the first time that α-MSH is capable of suppressing keratinocyte TLR-mediated
functional responses, thus demonstrating another novel immunomodulatory activity of α-MSH in
normal human keratinocytes.
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Chromatin remodeling by Kaposi’s sarcoma-associated herpesvirus (KSHV) transcriptional
factors
Y Izumiya UC Davis Cancer Center, Sacramento, CA
KSHV is an etiologic agent of Kaposi’s sarcoma. Studies show that both latent and lytic viral cycles
contribute significantly to KS development. Although the molecular mechanisms of reactivation
have been extensively studied, a gap in knowledge concerns the process by which these viruses
rapidly regulate (i.e., turn on and off) their own transcriptional programs. Post-translational modi-
fications play key roles in chromatin remodeling, thereby impacting gene transcription via epige-
netic mechanisms. One of such post-translational modifications is the small ubiquitin-like modi-
fier (SUMO). SUMO regulates a wide variety of cellular processes including heterochromatin
formation by recruiting histone methytransferase, SETDB1. KSHV encodes over 80 genes, and K-
Rta is the first gene to be transcribed during viral reactivation from the latent state. Of the KSHV
genes, only K-Rta is both necessary and sufficient to activate the viral lytic cycle. Here we show
that K-Rta has dual roles as a transcriptional factor and a SUMO-dependent ubiquitin (Ub) ligase.
Overexpression of K-Rta drastically decreased SUMO-modified protein in transfected cells. In vitro
ubuquitination reaction demonstrated that K-Rta catalyzed Ub conjugation to SUMO peptides.
Accordingly, K-Rta expression changed KSHV local chromatin environment from heterochromatin
to euchromatin, evidenced by association with acetylated histones in chromatin immunoprecipi-
tation analysis. On the other hand, the KSHV transcriptional modulator, K-bZIP, increases SUMO
modified proteins by enhancing SUMO conjugation, thereby enhancing heterochromatin forma-
tion, which is accompanied by cellular gene silencing. These finding indicate that KSHV epige-
netically regulates gene expression by “hijacking” the cellular SUMO machinery. These functions
may play an important role in transition between latency and lytic replication of viral life cycle.
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Pseudomonas aeruginosa adhesion and cytotoxicity in keratinocytes and A549 pulmonary
epithelial cells
JY Jung,1,2 EW Wang,2 T Sinwell,2 LA Cornelius1 and RA Chole2 1 Dermatology, Washington
University, Saint Louis, MO and 2 Otolaryngology, Washington University, Saint Louis, MO
Pseudomonas aeruginosa (PA) is an important opportunistic pathogen and a common cause of cuta-
neous infections. These infections are often indolent and chronic rather than fulminant, as can be
seen in pulmonary infections. We hypothesized that PA may interact differently to keratinocytes
when compared to pulmonary epithelial cells in vitro and investigated the role of PA adhesion and
cytotoxicity in HaCaT keratinocytes and in A549 pulmonary epithelial cells. We also explored the
role of type 4 pili (TFP), which has been shown to an important virulence factor in PA pulmonary
infections. For these studies, we used PA strains PAK and OPPA8 and their isogenic type 4 pili
deletion mutants, PAK-NP and OPPA-NP. Adhesion was assayed on spontaneously immortalized,
HaCaT, normal human epidermal keratinocytes (NHEK) keratinocytes and A549 pulmonary epithe-
lial cells. Adhesion of OPPA8 and PAK were similar in A549 cells. However, binding of PAK was
significantly reduced in keratinocyte cell lines compared to OPPA8 (2 to 25 fold). Additionally, PAK
adhesion was TFP dependant whereas OPPA8 binding was independent of TFP. Cytotoxicity data
demonstrates that OPPA8 was significantly more destructive than PAK in both A549 and HaCaT
cells. One possible mechanism is the expression of exotoxin S in OPPA8, which is not expressed
in PAK. Additionally, the absence of TFP dramatically reduced cytotoxicity in HaCaT keratinocytes
but not A549 pulmonary epithelium. Taken together, these results demonstrate that PA has reduced
virulence mechanisms in keratinocytes compared to pulmonary epithelium. The reduced adhesion
and cytotoxicity of some PA strains suggests keratinocytes may have greater resistance to PA infec-
tion by modifying or interfering with PA virulence mechanisms. By comparing highly virulent to
attenuated PA strains, we hope to define important pathogenic mechanisms that can be targeted
by novel pharmacologic interventions.
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Cytotoxic activity of invariant NKT cells in human allergic contact dermatitis
A Balato,1,2 Y Zhao,1 R Fishelevich1 and AA Gaspari1 1 Dermatology, University of Maryland,
Baltimore, MD and 2 Dermatology, University of Naples Federico II, Naples, Italy
The role of cytotoxicity of NKT-cells in the skin is not defined. There are two prototypic skin dis-
eases in which epidermal Keratinocytes (KC) over-express CD1d, a MHC class-I-like molecule that
present antigens to NKT-cells, in all layers of the epidermis and which there is infiltration of NKT-
cells into the skin: allergic contact dermatitis (ACD) and psoriasis. In both diseases, NKT-cells are
found within skin lesions, and within the epidermis in close apposition to CD1d bearing KC. This
suggests that there may be direct KC-NKT-cell interactions that can affect the ongoing immune
mediated inflammatory response. Our goal was to investigate the cytotoxic activity of invariant
NKT cells in the skin and in human allergic contact dermatitis. Paired skin biopsies from patch test
reaction and normal skin were used for qPCR and immunohistochemistry. 51Cr release assay was
performed with NKT-cells as effector cells and KC as target cells. Invariant NKT-cells are enriched
in ACD reactions, but not in normal skin. Gene expression of cytotoxic effector molecules (per-
forin and granzymes)(qRT-PCR). Perforin and granzymes were found in invariant NKT-cells in patch
test reactions, where as these molecules were also expressed by other cells, such as CD8+ con-
ventional T-cells and NK-cells. Invariant gene expression of cytotoxic effector molecules is increased
when these cells are activated in vitro by glycolipid and potent APC such as CD1d bearing mono-
cytes, and KC in some cases as well. We concluded that human NKT-cells are in an activated state
in ACD, and contribute to the tissue damage of allergic inflammation. These findings indicate that
innate immunity plays an important role in the elicitation phase of ACD, and may represent a novel
therapeutic target in allergic skin inflammation.
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Homoisoflavanone, an extract of Cremastra appendiculata Makino, inhibits inflammatory
and allergic response in mast cell
S Hur and T Kim Laboratory of Dermato-Immunology, Catholic Research Institute of Medical
Science, SEOUL, Korea, South
The homoisoflavanone isolated from Cremastra appendiculata Makino was known to be involved
in anti-angiogenesis and cell cycle arrest. We investigated the anti-inflammatory and anti-allergic
effects of homoisoflavanone in mast cells. The human mast cell line (HMC-1) was activated by
phorbol 12-myristate 13-acetate (PMA) and calcium ionophore A23187 with or without homoisofla-
vanone to monitor release of preformed mediator and newly synthesized lipid products or cytokines.
The rat leukemic mast cell (RBL-2H3) was sensitized with dinitrophenyl (DNP) – specific IgE and
then challenged with DNP - human serum albumin (HSA) to induced mast cell degranulation.
Homoisoflavanone inhibited the release of histamine, interleukin (IL)-8 and production of leukotriene
B4, prostaglandin D2, IL-6 and tumor necrosis factor-alpha (TNF-a) over 50%. Inhibition of mast
cell degranulation was measured by the release of granular enzyme, β-hexosaminidase, and shown
by transmission electron microscopy (TEM). To analyze the in vivo effect of homoisoflavanone, the
ear of the mice was pretreated with compound 48/80 or anti-IgE antibody to induce ear swelling.
Homoisoflavanone suppressed markedly ear swelling by post-treatment. These data demonstrates
that homoisoflavanone inhibited inflammatory and allergic response by blocking histamine release
and pro-inflammatory cytokines or arachidonic acid products synthesis. Homoisoflavanone pro-
vides the possibility of therapeutic application in inflammatory and allergic skin diseases.
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Reversal of Ultraviolet B induced-immunosuppression via inhibition of extracellular signal-
regulated protein kinase : An in vivo study by ERK mitogen-activated protein kinase inhibitor
X Luo1 and H Leng2 1 Dermatology, Huashan Hospital, Fudan University, Shanghai, China
and 2 Huashan Hospital, Fudan Unviersity, Shanghai, China
Our objective was to investigate the mechanism of UVB-induced immunosuppression upon mice
skin related with MAPK by using their inhibitors for developing a potential of sunscreen design.
Based on the mouse model of UVB-induced immunosuppression the PD (PD98059, the inhibitor
for ERK MAPK) was applied on the mice skin 1 hour before, simutaneouly, and 6 hours after UVB
exposure respectively. The baseline of ear thickness was measured and the ear thickness remea-
sured 24 hours after the challenge of DNFB. The ear biopsies were taken for histopathology stud-
ies. Different doses of SB (SB203580, the inhibitor for P38 MAPK) with the PD were also performed
based upon the PD results. In the PD groups, the result of which PD applied 6 hours after UVB
exposure was significant compared with the controls. It was evidenced by the ear swelling response
and the histopathology studies. Interestingly, in PD+SB group, compared to the PD group there
was no statistically significant including the ear swelling response and histopathology studies. In
conclusion, ERK MAPK played a critical role in UVB-induced immunosuppression evidenced by
it’s specfic PD. It suggested that the PD inhibitor and its analogues may provide a potential of sun-
screen design for reducing the risk of UVB- induced immunosuppression.
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Trans-Zeatin inhibits UVB-induced matrix metalloproteinase-1 expression via MAP kinase
signaling in human skin fibroblasts
B Yang,1 C Ji,1 J Kang,1 W Chen,1 Z Bi1 and Y Wan2 1 The first affiliated hospital of Nanjing
Medical University, Nanjing, China and 2 Providence College, Providence, RI
Ultraviolet (UV) irradiation induces the expression of matrix metalloproteinases (MMPs), disturb-
ing the metabolism of extracellular matrix (ECM), and causes the characteristic changes of pho-
toaging in skin. Inhibition of the induction of MMPs has been suggested to alleviate photoaging
induced by UV irradiation. Zeatin, purified from Zea mays, is a member of the cytokinin group of
plant growth factors, the activity of which is attributed to its more stable trans form. In this study,
we attempted to investigate the effect of trans-Zeatin on UVB-induced matrix metalloproteinase-
1 (MMP-1) expression in cultured human skin fibroblasts (HSFs) and to further study the mecha-
nisms of its actions. We found that pretreatment with trans-Zeatin significantly inhibits UVB-induced
MMP-1 expression and c-Jun activation in a dose-dependent manner. We also observed that
trans-Zeatin inhibits UVB-induced phosphorylation of ERK, JNK and p38 MAP kinases (MAPKs)
dose-dependently. As expected, PD98059, an ERK inhibitor, SP600125, a JNK inhibitor and
SB203580, a p38 MAPK inhibitor effectively inhibits UVB-induced phosphorylation of ERK, JNK
and p38 MAPKs, respectively. Moreover, the inhibitory mechanism of trans-Zeatin was further
demonstrated in MMP-1 secretion using MAPKs specific inhibitors. PD98059, SP600125 and
SB203580 suppressed UVB-induced MMP-1 secretion, which is consistent with the above results.
Collectively, our results suggest that trans-Zeatin inhibit UVB-induced MMP-1 expression, which
may be mediated by inhibition of ERK, JNK and p38 MAPKs signaling pathways in HSFs. Trans-
Zeatin might be considered as a potential agent for the management of skin photoaging.
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Critical roles of EGFR and Gi proteins in infrared radiation-induced signal transduction and
skin cell damage
S Lu,1 C Cao,1,2 Z Chen,3 S Sarkisian,1 R Kivlin,1 A Bagdasarian,1 T Tamakloe,1 W Chu,2 J Zhang3
and Y Wan1 1 Providence College, Providence, RI, 2 Brown University, Providence, RI and 3
Beijing University, Beijing, China
Infrared radiation is non-ionizing, electromagnetic radiation with wavelengths between 760 nm
and 1 mm, which is further divided into IRA, IRB and IRC. While IRB and IRC do not penetrate
deeply into the skin, more than 65% of IRA reaches the dermis. Human skin is increasingly exposed
to IRA-radiation from sun exposure. Recent studies indicate that infrared radiation, along with or
without UV radiation, also induce skin aging or skin cell damage, probably by inducing ROS pro-
duction, MMP1 up-regulation and MAPK activation. However, the detailed mechanism involved
in this process remains unclear. Here we show that EGFR and its downstream proteins Gab1 and
Gαi 1 and 3 proteins are critical mediators for infrared radiation-induced signaling transduction
and skin aging. IFR induces EGFR tyrosine phosphorylation in cultured human skin keratinocytes
(HaCaT cell line and primary human skin keratinocytes) and mouse embryonic fibroblasts (MEFs),
EGFR inhibitor PD98059, AG 1478 or EGFR knockout (by using EGFR knockout MEFs) largely
impair infrared-induced signaling (AKT/mTOR/MAPK activation). By using knockout and specific
siRNA knockdown, we found that Gab1 and Gαi proteins, downstream of EGFR, mediate infrared-
induced signaling transduction. Finally, we found that EGFR and its downstream signals Gab1, Gαi
1 and 3 proteins are also involved in infrared-induced transient cell survival. Knockdown of EGFR,
Gab1 or Gi proteins makes cell more sensitive to infrared-induced cell death. Our study helps us
better understand molecular mechanisms underlying infrared-induced signaling and skin cell dam-
age and skin cancer.
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Differential regulation of P.Acnes in sebocytes compared to monocytes
CZ Fernandez and J Kim Medicine-Dermatology, David Geffen School of Medicine, UCLA,
Los Angeles, CA
A common site of Propionibacterium acnes infiltration and proliferation in the pathogenesis of acne
is the human pilosebaceous gland. Sebocytes within the sebaceous gland have been shown to react
to the P. acnes challenge with the production of antimicrobial genes which we hypothesize are
important in the immune defense of acne. Previous work demonstrated that TLR2/1 ligand can
induce antimicrobial peptide mRNA expression in monocytes with sufficient 25(OH)vitamin-D3.
We investigated the expression and mechanism of antimicrobial peptide genes DEFB4 and cathe-
licidin in sebocytes compared to monocytes, when challenged with a P.acnes sonicate solution,
given that P.acnes is believed to contain TLR2 ligand. Initial experiments demonstrated that both
sebocytes and monocytes responded to stimulation with P.acnes sonicate in similar fashion, in the
presence of adequate vitamin-D, inducing both DEFB4 and cathelicidin mRNA. However, with
physiologically insufficient levels of vitamin-D, mRNA expression of cathelicidin in monocytes was
inducible with high concentrations of P.acnes sonicate, but not in sebocytes. This leads us to believe
that vitamin-D plays a larger role in cathelicidin production in sebocytes than monocytes. On the
other hand, DEFB4 mRNA expression was seen to a similar degree in both cell types with or with-
out adequate vitamin-D levels, showing a vitamin-D independent response. Sebocyte-mediated
induction of antimicrobial peptides is highly regulated by vitamin-D levels, suggesting that per-
sons with high vitamin-D level may be able to resolve sebocytes infected with P.acnes in the patho-
genesis of acne.
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Photobiologic effects of long wavelength UVA and visible light on melanocompetent skin
BH Mahmoud,1 E Ruvolo,2 C Hexsel,1 Y Liu,2 M Owen,1 N Kollias,2 HW Lim1 and IH Hamzavi1
1 Dermatology, Henry Ford Hospital, Detroit, MI and 2 Consumer and Personal Products
Worldwide, Johnson & Johnson, Skillman, NJ
Many research studies looked extensively at the effects of ultraviolet (UV) radiation on the skin,
however, visible light (400-700 nm) has, until recently, been regarded to be without significant pho-
tobiological effect on the skin. Therefore, we designed a study to determine the impact of long
wavelength UVA (UVA1) and visible light on immediate pigmentation and delayed tanning of
melanocompetent skin and as a second parameter to compare between the quantity and quality
of pigmentation produced by each wavelength. Two targeted phototherapy devices were used to
irradiate the lower back: Pure visible light emitting device (400 to 700 nm) without any UV com-
ponent and a UVA1 emitting device (340 to 400 nm). The procedure was repeated until threshold
dose to produce visible pigmentation is determined, higher doses were then delivered to see if sat-
uration of pigment occurs. Pigmentation was assessed by visual exam, digital photography with
cross-polarized filter and diffuse reflectance spectroscopy at 7 timepoints over 2 weeks period;
confocal microscopy and skin biopsies with different stains were also performed after 24 hours to
show histopathologic changes following irradiation. We also studied the effects of those wave-
lengths on light-skinned volunteers. Results showed that both UVA1 and visible light can induce
pigmentation but that they are different in quantity and quality. Visible light pigmentation was darker
and more sustained than the one induced by UVA1 on dark skin but not on light skin. This has an
implication on the spectrum of sunscreens used for photoaggrevated dermatoses such as melasma
and for the use of visible light for treatment of hyopigmented disorders such as vitiligo.
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Delivery of Chlorella virus pyrimidine dimer glycosylase to skin cells to enhance repair of
UVB-induced DNA dimers
JL Johnson, B Lowell, R Lloyd and A McCullough Center for Research on Occupational and
Environmental Toxicology and Department of Molecular and Medical Genetics, Oregon
Health & Science University, Portland, OR
Ultraviolet (UV) light causes DNA damage in skin cells, leading to the more than one million cases
of non-melanoma skin cancer diagnosed in the United States yearly. Moreover, individuals affected
with Xeroderma Pigmentosum (XP) are 2000-fold more cancer prone than the general population
due to inherited deficiencies in enzymes responsible for DNA damage repair. Human cells pos-
sess only one mechanism (Nucleotide Excision Repair, NER) for repair of UV-induced DNA dam-
age. The cells are equipped with enzymes to complete another mechanism of DNA damage repair,
Base Excision Repair (BER), but lack the specific pyrimidine dimer glycosylase (pdg) needed to ini-
tiate BER in response to UV. Certain prokaryotes and viruses produce photo-damage-specific pdg
enzymes that can catalyze BER. Such a pdg was identified in Chlorella virus and termed Cv-pdg.
The exogenous delivery of a photoproduct-specific pdg protein to human skin has the potential to
enhance DNA repair following UV exposure. We have purified a Cv-pdg protein that has been
engineered to contain a nuclear localization sequence (NLS) and a cell membrane permeabiliza-
tion sequence (TAT from HIV) to enhance delivery. Here we show that the modified Cv-pdg-NLS-
TAT protein was effectively delivered to the nuclei of repair-proficient human keratinocytes and
fibroblasts and repair-deficient (XP) fibroblasts. Further, we show that Cv-pdg-NLS protein that has
been encapsulated in a lipid-based delivery vehicle can traverse the stratum corneum of a human
skin model (Mattek Epiderm-FT) and localize to the nuclei of basal and suprabasal keratinocytes.
Cv-pdg protein delivered to skin cells enhances repair of UVB-induced DNA damage. We are cur-
rently working to elucidate the biological impact of Cv-pdg delivery on skin cells in response to
UVB. Delivery of Cv-pdg protein to skin cells to aid repair of UV-induced DNA damage may be a
strategy for the prevention of skin cancer.
752
Inhibition of angiogenesis in UV-induced skin tumors by drinking green tea polyphenols
requires IL-12
SM Meeran,1 T Punathil,1 S Katiyar,1 CA Elmets1,2 and SK Katiyar1,2 1 Dermatology, University
of Alabama at Birmingham, Birmingham, AL and 2 Birmingham VAMC, Birmingham, AL
We have shown previously that administration of green tea polyphenols (GTPs) in drinking water
inhibits photocarcinogenesis in mice through stimulation of IL-12. As IL-12 possesses anti-angio-
genic activity, we investigated the possibility that GTPs inhibit tumor angiogenesis in UV-induced
skin tumors through an IL-12-dependent manner. To investigate this possibility, the effect of GTPs
was determined on tumor angiogenesis using IL-12p40 knockout (IL-12 KO) mice. At the termi-
nation of the photocarcinogenesis experiment, we found that the size of the skin tumors in IL-12
KO mice was significantly larger than in the skin tumors of wild-type (WT) mice, suggesting that
IL-12-deficiency promotes angiogenic program in tumors. Administration of GTPs significantly
reduced the growth of UV-induced skin tumors of WT mice, and that this effect of GTPs was not
seen in IL-12 KO mice, suggesting that inhibition of tumor angiogenesis by GTPs requires IL-12.
To further verify that the anti-angiogenic effect of GTPs is mediated through IL-12, the skin tumors
were analyzed for various biomarkers related to angiogenesis and data were compared between
IL-12 KO and their WT mice. Immunostaining, gelatinolytic zymography, real-time PCR and west-
ern blot analysis revealed that the expression of matrix metalloproteinase (MMP)-2, MMP-9, MMP-
3, MMP-7, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and
CD31 were significantly higher (p<0.001) in UV-induced tumors of IL-12 KO mice compared to
their WT. GTPs significantly reduced the levels of MMP-2, MMP-9, MMP-3, MMP-7, VEGF, bFGF
and CD31 in skin tumors of WT mice compared to non-GTPs-treated WT mice, but this inhibitory
effect of GTPs was less pronounced in the tumors of IL-12 KO mice. Together, these data indicate
for the first time that GTPs inhibit angiogenesis in UVB-induced skin tumors, and that the anti-
angiogenic effect of GTPs is mediated through IL-12 in mice.
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Antioxidant and photoprotective effects of CoffeeBerry® in human epidermis
J Therrien, E Millerman, H Hofland, W Chern and E Hsia Center for Skin Biology, Stiefel
Laboratories, Inc., Palo Alto, CA
CoffeeBerry® (CB) is a safe and natural extract derived from the fruit of the coffee plant, Coffea
arabica, which contains potent polyphenols such as chlorogenic acid, condensed proanthocyani-
dins, quicnic acid, and ferulic acid. Polyphenols are known to have strong antioxidant properties
by scavenging reactive oxygen species (ROS) generated by endogenous oxidative stress or ultra-
violet exposure. To assess the potential photoprotective effects of CB in human skin, reconstructed
human epidermis (RHE) cultures were topically treated with a formulation containing 1.5% CB one
hour before UVB exposure. Cultures were harvested at 2 and 24 hrs post-irradiation and assessed
histologically for skin morphology by H&E staining and the presence of DNA damage markers by
immunohistochemistry. When exposed to UVB, disruption of skin integrity was observed 2h post-
irradiation in both CB-treated and untreated RHE, but a complete restoration of the skin morphol-
ogy was observed at 24h post-irradiation only in CB-treated RHE. At the molecular level, amounts
of 8-hydroxy-2-deoxyguanosine (8OHdG) were decreased in both irradiated and non-irradiated
CB-treated RHE as compared to corresponding untreated RHE. This confirms the antioxidant prop-
erties of CB, since 8OHdG DNA damage is caused by ROS. As expected after UVB exposure,
cyclobutane pyrimidine dimer (CPD) formation and p53 expression were observed in untreated
RHE exposed to UVB at 2h post-irradiation, but not at 24h post-irradiation, confirming that DNA
repair mechanisms are functional in RHEs. Unexpectedly, both CPD and p53 were not detected
in UVB-exposed RHEs that were pre-treated with the CB formulation. Since these two markers are
a direct result from UVB exposure and are typically not reduced by antioxidants, this observation
suggests a new photoprotective property of CB. In summary, these results suggest that regular top-
ical use of CB formulation may reduce photo-aging by restoring the skin epidermis integrity and
protecting against DNA damage caused by sunlight exposure.
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Generalized chrysiasis improved with pulsed dye laser
JJ Wu,1 NG Papajohn,2 JE Murase,3,4 W Verkruysse5 and KM Kelly5,6 1 Dermatology, Kaiser
Permanente Los Angeles Medical Center, Los Angeles, CA, 2 University of South Alabama
College of Medicine, Mobile, AL, 3 Dermatology, University of California, San Francisco, San
Francisco, CA, 4 Palo Alto Foundation Medical Group, Mountain View, CA, 5 Beckman Laser
Institute and Medical Clinic, University of California, Irvine, Irvine, CA and 6 Dermatology,
University of California, Irvine, Irvine, CA
Chrysiasis is the phenomena of gray skin pigmentation induced by prolonged treatment with gold
salts. We present the first case of extensive, intense chrysiasis treated with pulsed dye laser. A 66
year old white female was diagnosed with rheumatoid arthritis in 1977. She received gold salts
100mg every week with a cumulative elemental gold dose of 33.8g, resulting in chrysiasis. Test
spots were performed on the left shoulder with the 755nm laser (10mm spot size, 3ms pulse dura-
tion) with radiant exposures up to 50 J/cm2. Cryogen spray cooling settings for test spots were 50ms
of cryogen with 30ms delay. Test spots on the arm were also performed with pulsed dye laser
(595nm; 7mm; 3ms pulse duration; 6-14 J/cm2); 30ms of cryogen with 20ms delay. The patient’s
facial telangiectases were treated with pulsed dye laser using a 7mm spot size, 3ms pulse dura-
tion, and radiant exposure starting at 8.5 J/cm2 and slowly moving up to 10 J/cm2. After a 6 week
observation period, there were no adverse effects with a slight improvement in the gray discol-
oration. Patient was satisfied and underwent a total of 9 full face treatments at 4-8 week intervals.
After the first 2 treatments, the neck and décolletage area was treated. She demonstrated improve-
ment in both her chrysiasis and telangiectases 13 months after the first treatment to the face (Fig-
ures 1 and 2). There was lightening of the 755nm left shoulder test spots at 16 month follow up
visit (Figure 3). Spectrum analysis showed difference between these test sites and untreated areas
(Figure 4).
755
Proteomic profile of ultraviolet B induced photodamage and interference of epigallocate-
chingallate in human epidermal keratinocytes
D Luo, W Min, B Lin and W Li Department of Dermatology, the First Affiliated Hospital of
Nanjing Medical University, Nanjing, China
The human skin is the main defense against ultraviolet(UV) radiation, we aimed to investigate the
proteomic change that induced by UVB irradiation and epigallocatechingallate(EGCG) interfer-
ence. In the present research, we used a proteomic method to study these responses. Human epi-
dermal keratinocytes (HEK) were kept on culturing for 24h after exposure to UVB, and 50μg/ml of
EGCG was added into the medium just after UVB irradiation. The total proteins were separated by
two-dimensional gel electrophoresis(2-DE). After that, differentially expressed proteins were
processed through mass spectrometric analysis and database searches. Among all the protein
spots detected, 76 were found to be different between the cells before and after UVB radiation. All
of them were identified by using mass spectrometry analysis. With the interference of EGCG, there
were 86 differential protein spots compare to the UVB group, when 16 of them were identified.
These identified proteins could be functionally classified into several aspects: cell structure and
cytoskeleton, gene or protein expression, cell division, cell defense, cell proliferation, apoptosis,
and unclassified. Some findings, including heat shock protein beta-1, interleukin-11 and prohibitin,
were further verified by western blot analysis. In this study, the comparative proteomic analysis
provides a map of human keratinocytes before and after UVB radiation, and some differential pro-
teins related to the effect of EGCG were found. These results will have advantages for the further
research of photodamage effect of UVB and photoprotective effect of EGCG.
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Prevention of short-term ultraviolet B radiation mediated damages by baicalin in mice skin
B Zhou and D Luo Department of Dermatology, the First Affiliated Hospital of Nanjing
Medical University, Nanjing, China
Solar UV irradiation, in particular UVB with a wavelength range between 290 and 320 nm, induces
different hazardous effects in skin, including sunburn, photoaging and cancer. Protection against
sun-induced damage is therefore a highly desirable goal. Chemoprevention is being investigated
as a potential approach for the management of UV damages including skin cancer. We have ear-
lier shown that baicalin, isolated from baical skullcap root, inhibits UVB exposure-mediated dam-
ages in HaCaT keratinocytes. In this study, to determine the relevance of our in vitro findings to in
vivo situations, we assessed the effects of baicalin on UVB-mediated damages in mice skin. Our
data demonstrated that a topical application of baicalin, either as a pretreatment (30 min prior to
UVB) or posttreatment (5 min after UVB), resulted in a significant decrease in UVB-mediated
increases in skin edema, skin hyperplasia and infiltration of leukocytes. Further, baicalin treatments
(pre and post) also resulted in a significant decrease in UVB mediated (1) generation of H2O2 and
(2) formation of DNA photolesions: cyclobutane pyrimidine dimers (CPDs). Based on this data, we
suggest that baicalin could be developed as an agent for the management of conditions elicited by
UV exposure including skin cancer.
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Topical application of a taurine precursor limits UVB-induced damages in reconstructed
human epidermis
M Fréchet, P Prouheze and J Nicolaÿ Exsymol S.A.M., Monaco, Monaco
A small heterocyclic molecule, 2-oxo-thiazolidine (OTZ), was designed for topical active photo-
protection. OTZ is endowed with antioxidant, free radical scavenging properties and “electrophilic
species” scavenging properties, e.g. detoxification of lipid peroxides breakdown products such as
malondialdehyde or 4-hydroxynonenal. A particular characteristic of this compound that may par-
ticipate to photoprotection, is its ability to release taurine upon reaction with some Reactive Oxy-
gen Species (ROS). OTZ percutaneous absorption, an important feature for effective topical active
photoprotection, has been evaluated on human skin explants (Kp = 6.1 cm.h-1). Here we demon-
strate the ability of OTZ to protect human keratinocytes from UVB-induced damages using recon-
structed human epidermis (RHE). Fully differentiated RHE were exposed to UVB (200 mJ. cm-2).
OTZ and controls solubilized in PBS were topically applied one hour before irradiation. Apopto-
sis was assessed by counting TUNEL-positive cells. General morphology and sunburn cells (SBC)
formation were evaluated following H&E staining. Pro-inflammatory cytokines release (IL-1α, IL-
8, TNF-α) was determined by ELISA. All endpoints were monitored 24h hours post-irradiation.
Morphological analysis of RHE topically treated with 0.1% OTZ (10 mM) revealed a clear limita-
tion of UVB-induced alterations compared to non-treated UVB exposed samples. SBC and TUNEL-
positive cell counts indicated that OTZ protects cells from UVB-induced apoptosis. Topical appli-
cation of taurine (up to 10 mM) provides a very limited photoprotection. Taken together, these
preliminary results support the possible usefulness of 2-oxo-thiazolidine for topical active photo-
protection. Contribution of in situ taurine formed upon reaction of OTZ with ROS, remains to be
determined.
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Endogenous survivin modulates survival and proliferation in normal human keratinocytes
and during UVB irradiation
A Marconi,1 K Dallaglio,1 E Palazzo,1 M Dumas,2 F Truzzi,1 R Lotti,1 F Bontè2 and C Pincelli1 1
Dermatology, University of Modena and Reggio Emilia, Modena, Italy and 2 LVMH
Recherche, St. Jean de Braye, France
Survivin is a bi-functional member of inhibitor of apoptosis protein (IAP) family, as it is able to
both inhibit apoptosis and to regulate cell cycle. We investigated the role of survivin in human
keratinocytes under normal conditions and during UVB irradiation. Silencing survivin mRNA under
normal condition results in a complete loss of protein from 24 to 120 h, and survivin siRNA-treated
keratinocytes loose their capacity of forming colonies in vitro. Survivin siRNA significantly decreases
proliferation and cell viability in a time-dependent manner from 24 to 120 h. Inhibiting survivin
also induces apoptosis in human keratinocytes at 48 and 120 h, in a mode consistent with the
mitotic catastrophe. This is also confirmed by activation of caspase-3 only in siRNA treated cells.
As UVB modulate survivin expression, we evaluated the role of survivin after UVB-irradiation.
Analysis of UVB-irradiated keratinocytes shows that low doses UVB (5 mJ/cm2) increase survivin
expression at 12 h, which tends to decrease at 24 h, going back to the control level. On the con-
trary, high doses (50 and 75 mJ/cm2) down-regulate survivin level both at 12 and 24 h. Low doses
UVB also induce cell cycle arrest in G2/M in synchronized keratinocytes at 12 and 18 h, while
high doses UVB cause apoptosis at the same times. Moreover, overexpression of survivin, using a
survivin retroviral vector, protects keratinocytes from UVB-induced apoptosis, as shown by the
lack of activation of caspase-8, whereas silencing of survivin renders keratinocytes more suscep-
tible to UVB-induced cell death, both at low and high doses. Finally, survivin siRNA increases
UVB-induced reduction of cell proliferation, as shown by MTT and 3H-thymidine incorporation.
Taken together, these results indicate that survivin plays a critical role in epidermal homeostasis
under normal conditions and during UVB exposure, with possible for skin carcinogenesis.
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Brown stem cell factor-transgenic (SCF-Tg) mice are useful for the research of skin damage
by ultraviolet radiation
F Yamazaki,1 S Ohe,1 H Iwasaka,1 T Kunisada2 and H Okamoto1 1 Dermatology, Kansai
Medical University, Moriguchi, Japan and 2 Regeneration Medicine and Bioethics, Gifu
University, Gifu, Japan
Melanin is known to be photoreactive and photoprotective, but its function in skin in vivo remains
controversial. Conventional experimental mice are not suitable for photo-biological tests because
of a defect in epidermal melanocytes and melanin. Recently established stem cell factor transgenic
(SCF-Tg) mice with epidermal melanocytes are not a suitable animal model for UV-induced car-
cinogenesis either, because these animals have heavily pigmented skin. We previously reported
that XPA gene-deficient (XPA (-/-)) SCF-Tg mice developed melanoma by UVB radiation alone and
did not develop melanoma spontaneously, mimicking the sporadic development of malignant
melanomas in humans. However, this mouse model requires repeated high-dose UVR exposure
(15000mJ/cm2/week) because of their heavily pigmented skin. Therefore, we developed a new
SCF-Tg mouse with brown skin. These mice have less epidermal melanin than black SCF-Tg mice.
The amounts of eumelanin and pheomelanin in the epidermis or dermis were measured. Pyrrole-
2, 3, 5-tricarboxilic acid (PTCA) 400ng/mg and aminohydroxylalanin (AHP) 30ng/mg were detected
in the epidermis of brown SCF-Tg mice, while there were 0.2ng/mg and <2ng/mg in albino mice
and >1000ng/mg and 20ng/mg in black SCF-Tg mice, respectively. Acute inflammatory reaction
to UVB irradiation was assessed by ear swelling after exposure to 300mJ/cm2 of UVB. Albino
mice showed 0.044±0.03cm of ear swelling 3 days after irradiation, while black SCF-Tg mice did
not show any significant ear swelling. Brown SCF-Tg mice showed 0.019±0.013cm of swelling.
Brown SCF-Tg mice showed redness and tanned skin after exposure to 300mJ/cm2 UVB 10 times.
There were over 100 TUNEL-positive epidermal cells per cm specimen in albino mice, 60.4±25.4
in new brown SCF-Tg mice, and 0.58±0.23 in black SCF-Tg mice after exposure to 300mJ/cm2
UVB 10 times. Our brown SCF-Tg mice are useful for research into skin damage by ultraviolet radi-
ation.
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DNA repair in skin fibroblasts as function of age and chronic photo-exposure
T Oddos,1 S Sauvaigo,2 F Odin,2 S Caillat,2 A Nkengne1 and C Bertin1 1 Pharmacology, Johnson
& Johnson Consumer France, Val de Reuil, France and 2 LCIB (UMR-E3 CEA-UJF), INAC,
CEA, Grenoble, France
DNA repair as a major defence against damage to cells is present in all living organisms. Abnor-
malities in DNA repair have been implicated in cancer and aging. Therefore the detection of the
functionality of DNA repair enzymes in skin is of the utmost interest as skin cells are exposed to
environmental challenges, e.g. solar light known to damage DNA through either the direct absorp-
tion of UV light by nucleotide bases or the generation of reactive oxygen species. We have devised
a miniaturized tool, DNA Repair Biochip, to characterize the repair capacities of a given cell extract
toward several lesion types allowing the simultaneous quantification of different repair systems
such as repair of UV-induced damage, oxidative damage, alkylated bases, abasic site and glycol.
We used this new technology to assess the evolution of DNA repair in human fibroblast from skin
biopsies issued from donors of different ages. For this, biopsies were taken on the dorsal forearm
(photo-exposed site) and the upper inner arm (photo-protected site) on each of the volunteers of a
cohort of 33 donors aged from 20 to 68 year old divided into 3 age groups (20-30 y.o., 40-50 y.o.
and 65+ y.o.). Fibroblasts from the biopsies were collected and cultivated. Level of DNA repair was
measured in the nuclear extract using the DNA Repair Biochip. A significant decrease of DNA repair
capacities with aging was observed although individual DNA repair levels were highly variable
within each age group. This clearly demonstrated that the capacity of skin cells to repair DNA
lesions decreased with age. This decrease was observed whatever the lesion considered although
the decrease profile was lesion dependent. Finally no statistical difference was observed in the
DNA repair activity between cells issued from photo-protected and photo-exposed sites suggest-
ing that the decrease in the DNA repair capacity of dermal fibroblasts was not linked to chronic
photo exposure.
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The protective effects of ultraviolet A1 irradiation on spontaneous lupus erythematosus-like
skin lesions in MRL/lpr mice
T Yoshimasu, N Mikita, N Kanazawa and F Furukawa Wakayama Medical University,
Wakayama, Japan
In skin lesions of systemic lupus erythematosus (SLE), the histamine-N-methyltransferase activity
is much lower than that of controls, and the decreased activity plays a particular role in the devel-
opment of immune-complex-mediated skin lesions (Furukawa, Dermatologica 1989). Furthermore,
we confirmed that histamine 2 receptor was expressed on infiltrated mast cells in spontaneous LE-
like skin lesions of MRL/lpr mice (Yoshimasu, Bentham Open J Dermatol 2008). The skin lesions
of LE are known to be exacerbated by ultraviolet B light (UVBL). It is still obscure the effects of
ultraviolet-A1 (UVA1) on LE lesions. We investigated the effects of UVA1 irradiation on the skin of
MRL/lpr mice, using a disease-prevention model. All mice were females and 4-6weeks old at the
start of an experiment, and 58 mice were randomly divided into 3 groups including non-treatment
(22 mice), 5 J/cm2 of UVA1 (18 mice) and 10 J/cm2 of UVA1 (18 mice). UVA1 was irradiated on
shaved dorsal skin of these mice at 5 times /week, and the irradiation was continued 4months. We
examined clinical changes, immunohistochemical staining of the skin and anti-nuclear antibody
in sera. LE-like skin lesions were developed at 27.3% (6/22) in non-treatment group of MRL/lpr
mice, whereas both UVA1 irradiation groups of 5 J/cm2 and 10 J/cm2 did not develop skin lesions
at 0/18 and 0/18 respectively. UVA1 irradiation significantly inhibited the development of LE-like
skin lesions (p<0.05). The number of mast cells in non-irradiated skin lesions was significantly
increased than those of UVA1-irradiated skin (p<0.05). Apoptotic cells were remarkably seen in
the dermis of UVA1-irradiated skin, whereas those cells were hardly detectable in non-irradiated
skin. Some of those apoptotic cells were mast cells. Thus, UVA1 irradiation might induce the
apoptosis of pathogenic mast cells, eventually attenuating the development of spontaneous LE-
like skin lesions. In conclusion, UVA1 irradiation may a good therapeutic maneuver for skin lesions
of lupus patients.
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Evidence for epidermal synergistic production of TNF- alpha in a patient with progression
of toxic epidermal necrolysis following tanning bed exposure
J Travers,1 N Gatson,2 M Al-Hassani,1 SJ Warren1 and JB Travers1 1 Indiana University,
Indianapolis, IN and 2 The Ohio State University, Columbus, OH
Tumor necrosis factor-alpha (TNF-alpha) is a primary cytokine that has been linked to both drug
reactions and photosensitivity. These studies describe a case of a 22 y.o. Caucasian female patient
who developed what appeared to be a mild cutaneous and mucosal eruption following ingestion
of ibuprofen. Unfortunately, the patient attempted to self-medicate by obtaining a treatment of her
face, chest and arms from a commercial tanning bed. Within 24 h of the tanning bed exposure,
the patient developed severe erythema and blisters in the UV-treated areas and worsening of her
oral involvement. The patient was admitted to our institution’s burn unit and skin biopsies con-
firmed the clinical diagnosis of toxic epidermal necrolysis (TEN). Immunohistochemical studies of
patient’s involved skin revealed high levels of TNF-alpha protein. The patient spent several weeks
in our burn unit and her TEN responded to cyclosporine and intravenous immunoglobulin. To begin
to understand this novel clinical case of how UVA exposure can synergize with a mild drug erup-
tion to induce TEN, we examined TNF-alpha production in the human epithelial cell line KB. Since
many cytokines and other stimuli use the protein kinase C (PKC) pathway, the PKC agonist 12-O-
tetradecanoylphorbol 13-acetate (TPA) was used in our studies. KB cells were treated with TPA fol-
lowed 30 min later by UVA irradiation (in a dose range experienced by the patient), and TNF-
alpha protein release measured by ELISA. These experiments demonstrate that the combination of
PKC and UVA (at the dosage experienced by the patient) resulted in more than a 5-fold increase
of TNF-alpha production over the individual stimuli alone. These studies suggest that PKC activa-
tion can synergize with UVA radiation to stimulate TNF-alpha production, which could have impor-
tant clinical implications.
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Comparative proteomic analysis of inhibitory effects of baicalin on ultraviolet B induced pho-
todamage in keratinocyte cell line
W Min, D Luo, B Lin and W Li Department of Dermatology, the First Affiliated Hospital of
Nanjing Medical University, Nanjing, China
In this study, we aimed to investigate the proteomic changes of human epidermal keratinocytes
(HEK) induced by baicalin, one kind of Chinese herbal medicine with anti-inflammatory and anti-
oxidant property, and UVB irradiation. We used a proteomic method to study these responses.
Keratinocytes were kept on culturing for 24h after that 200μg/ml of baicalin was added into the
medium and exposure to UVB irradiation. The total proteins were collected and separated by two-
dimensional gel electrophoresis(2-DE). Differentially expressed proteins were processed through
mass spectrometric analysis and database searches. Among all the protein spots detected, 38 were
found to be different between the cells before and after baicalin intervention. Of these spots, 18
were identified by using mass spectrometry analysis. With the UVB irradiation, there were 46 dif-
ferential protein spots compare to the simple baicalin group, when 17 of them were identified.
These identified proteins could be functionally classified into several aspects: cell structure, cytoskele-
ton, stress response, cell proliferation, apoptosis, and unclassified. Some findings, including tumor
protein D52 and interleukin-11, were verified by western blot analysis. In this study, some differ-
ential proteins related to the effect of baicalin and UVB radiation were found. These results strengthen
the notion that baicalin act as potential agent to reduce risk of photodamage effect of UVB.
764
UVB wavelength dependency of antimicrobial peptide induction for innate immunity in
human normal keratinocytes
K Torii,1 A Maeda,1 C Saito,1 Y Shirakata2 and A Morita1 1 Dermatology, Nagoya City University
Graduate School of Medical Sciences, Nagoya, Japan and 2 Dermatology, Ehime University
Graduate School of Medicine, Ehime, Japan
Sunlight, which includes UVB wavelengths, causes skin inflammation. In sunburn reactions, the
production of autoantigens stimulates the acquired immune system, potentially leading to autoim-
mune reactions. On the other hand, the induction of regulatory T cells and endogenous immuno-
suppressants, such as the soluble factors interleukin-10 and RANKL (receptor activator of nuclear
factor κB ligand), as well as the disappearance of cellular factors, e.g., epidermal Langerhans and
dermal dendritic cells, contribute to prevent autoimmune disease. In our previous study, delayed-
type hypersensitivity (DTH) responses were suppressed by UVB wavelengths (290 nm, 300 nm,
310 nm, and 320 nm), with a peak response at 310 nm. In a mouse model, the UVB-induced sup-
pression of DTH was associated with the induction of Foxp3-expressing T cells. Because UVB expo-
sure induces also antimicrobial peptides (AMPs), the innate immune system might be compensated
by the immunologic tolerance condition. To test this concept, we evaluated which UVB wave-
length induces AMPs. Normal human keratinocytes were irradiated with UVB wavelengths (280
nm, 290 nm, 300 nm, 310 nm, and 320 nm). AMPs, human β-defensin 2 (HBD2) and LL-37, were
analyzed by real-time PCR 24 h after UVB irradiation. HBD2 was significantly and dose-depend-
ently induced by all tested wavelengths with a peak response at 290 nm. LL-37 was similarly induced
by all wavelengths. In stratified keratinocytes (high Ca conditions), the maximum induction of HBD2
and LL-37 was observed at 290 nm. These observations suggest that longer UVB wavelengths induce
antigen-specific tolerance whereas shorter wavelengths induce innate immunity, possibly to defend
against pathogens without antigen specificity. UVB wavelengths may effectively harmonize the skin
immune response by inducing simultaneously antigen-specific tolerance and innate immunity.
765
IL10 is required for UVA1-induced suppression of delayed type hypersensitivity (DTH) but
not for suppression of contact hypersensitivity (CHS)
Y Shintani, A Maeda, K Torii, C Saito and A Morita Dermatology, Nagoya City University
Graduate School of Medical Sciences, Nagoya, Japan
The longer wavelengths of ultraviolet (UV) A1 phototherapy (340-400nm) penetrate the dermal lay-
ers more deeply than do the shorter wavelengths of UVB radiation (290-320 nm), and clear atopic
dermatitis lesions by inducing apoptosis of skin-infiltrating T helper cells. In addition to the induc-
tion of apoptosis in pathogenetically relevant cells, antigen-specific tolerance is thought to be an
important mechanism underlying narrow-band UVB and PUVA therapy. It remains controversial,
however, whether UVA1 also induces immune suppression. In our previous study, single exposure
to high-dose UVA1 did not suppress delayed-type hypersensitivity (DTH) or contact hypersensi-
tivity (CHS), but four consecutive high-dose UVA1 irradiations suppressed DTH and CHS. The sup-
pression was not caused by the induction of tolerance, which was assessed by adoptive transfer of
lymph node cells. These data suggest that the mechanisms underlying the clinical efficacy of UVA1
are different from those of UVB and PUVA. Therefore, in the present study, we investigated the
requirement for IL-10 in UVA1-induced suppression of DTH and CHS in a mouse model. The influ-
ence of IL-10 on UVA1-induced immune suppression was evaluated in IL-10 knockout (KO) mice.
IL-10KO mice were exposed to 100 J/cm2 UVA1 daily for four consecutive days. In mice sensi-
tized with 2,4-dinitrofluorobenzene 24 h after the last irradiation, CHS was elicited through the
UV-exposed dorsal skin after 5 days. CHS was significantly suppressed by repeated UVA1 irradi-
ation (sensitization alone: 117±28 μm, UVA1+sensitization: 46±13 μm), although tolerance was
not induced in a re-sensitization experiment (sensitization alone: 142±21 μm, UVA1+sensitization:
86±10 μm ). In contrast, DTH (sensitized with OVA-albumin) was not suppressed by repeated UVA1
irradiation (sensitization alone: 1410±36 μm, UVA1+sensitization 1360±64 μm). These observa-
tions suggest that IL-10 is required for UVA1-induced suppression of DTH, but not that of CHS.
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The effect of a new photodynamic therapy with glycoconjugated fullerene
E Otake,1 S Sakuma,1 A Maeda,1 H Ooi,2 S Yano2 and A Morita1 1 Department of Dermatology,
Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan and 2 Endowed
Research Section, Photomedical Science, Innovative Collaboration Center, Kyoto University,
Kyoto, Japan
Photodynamic therapy (PDT) has attracted attention as a less invasive treatment for cancer. In
PDT, the use of a tumor-localizing photosensitizer together with light exposure effectively and pref-
erentially induces apoptosis in cancer cells through the generation of reactive oxygen species (ROS).
Fullerene (C60) is a well known radical scavenger. In contrast, C60 has excitation wavelengths in
the ultraviolet region that generate ROS effectively upon excitation. Cancer cells endocytose glu-
cose more effectively compared to normal cells. Therefore, we hypothesized that glycoconjuga-
tion would improve tumor-localizability and glycoconjugated C60 may enhance PDT. To study the
cytotoxicity of PDT with these photosensitizers, HaCaT cells were cultured with 10 μM C60 (uncon-
jugated C60), C60-(Glc)1 (D-glucose residue pendant C60), and C60-(6Glc)1 (a maltohexaose residue
pendant C60) for 24 h and subsequently irradiated with 5 J/cm
2 UVA1. PDT with C60 was not cyto-
toxic. In contrast, % survival was significantly decreased when PDT was combined with C60-
(Glc)1 (1.4%) or C60-(6Glc)1 (70.1%). Similar effects were observed in various cancer cell lines.
Next, the effect of PDT on normal fibroblasts was evaluated. PDT exhibited no significant cyto-
toxicity against normal fibroblasts (%survival C60-(Glc)1: 99.5%, C60-(6Glc)1: 98.8%), indicating
that PDT with glycoconjugated C60 targets cancer cells. In addition, to investigate whether singlet
oxygen (1O2) is generated, 50 mM NaN3 was added during UV irradiation on 5637 cells. PDT-
induced apoptosis was extensively reinstated by NaN3 administration; from 1.6% to 45.4% [C60-
(Glc)1] and from 32.0% to 53.8% [C60-(6Glc)1], suggesting that PDT-induced cell death is due to
the generation of 1O2. These findings indicate that PDT with glycoconjugated C60 is extremely effec-
tive as a targeted therapy for cancer cells. This is the first report showing that glycoconjugated C60
is an excellent candidate PDT-enhancing drug.
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PUVA suppresses the initiation of EAE via inhibition of Th17-migration into CNS
T Furuhashi, A Maeda, K Torii, C Saito, Y Shintani and A Morita Department of Dermatology,
Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model of central nerv-
ous system (CNS) inflammatory demyelination, characterized by progressive paralysis and has
directly led to the development of treatments for Multiple Sclerosis. There is now growing evidence
implicating the newly characterized Th17 cells in the pathogenesis of EAE. Previous our study
shows that psoralen + UVA irradiation (PUVA) significantly suppresses the progression of EAE
although PUVA does not affect IL-17 mRNA expression in regional lymph nodes. To elucidate this
discrepancy, regional LNs obtained from PUVA-treated and untreated MOG-immunized mice were
analyzed before and after onset of EAE. The regional LNs obtained from PUVA-treated MOG-immu-
nized mice extremely enlarged 10days after immunization (Day10, before onset of EAE), while
those of immunized mice without PUVA treatment were significantly reduced in size compared to
naïve mice. Because pertussis toxin (PT) is known to facilitate the induction of EAE by opening up
the blood-brain barrier and thereby facilitating the migration of pathogenic T cells to the CNS, we
hypothesized that PUVA may suppress PT-induced migration of pathogenic Th17 cells. To confirm
this hypothesis, Th17 cells in regional LNs from PUVA-treated and untreated mice were analyzed
at Day10 (before onset) and Day17 (after onset). FACS analysis revealed significant expansion of
Th17cells in regional LNs from PUVA-treated immunized mice at Day10 (32.1% in CD4+ T cells)
compared to those of naïve (2.0%) and immunized mice without PUVA (8.0%). Th17cells on Day17
were significantly reduced (EAE: 1.6%, PUVA-treated EAE: 3.5% in CD4+ T cells) compared with
Day10, indicating that generation of Th17 after immunization and migration of Th17 from regional
LNs to CNS may be essential events in the initiation of EAE. Taken together, these findings indicate
that PUVA suppresses the initiation of EAE, presumably by inhibiting or delaying the migration of
Th17 cells into CNS in EAE mice.
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Possible involvement of Hsp27 oligomerization in UVB-induced apoptosis of keratinocyte
D Choi,1 K Sohn,1 Y Kwon,1 N Kim,1 A Cho,1 Y Lee,1 T Yoon,2 Y Lee,1 C Kim1 and J Lee1 1
Chungnam National University, Daejeon, Korea, South and 2 Gyeongsang National
University, Jinju, Korea, South
Hsp27 is a member of the small heat shock proteins. To investigate the expression of Hsp27 in epi-
dermis, we performed immunohistochemistry. Results showed that the expression of Hsp27 was
increased in a differentiation-dependent manner. Concomitantly, the phoshorylated Hsp27 was
also increased in upper granular layer. In calcium-induced keratinocyte differentiation in vitro,
Hsp27 expression was also increased in a temporally regulated manner. Since Hsp27 has been
known to act as molecular chaperone and to protect cells from environmental stress such as heat
shock, oxidative stress, heavy metals, osmotic pressure and metabolic poisons, we next investi-
gated the expression of Hsp27 against UVB insult. However, UVB irradiation did not induce and/or
reduce the Hsp27 expression remarkably in HaCaT keratinocytes, although the cell viability was
dose-dependently decreased. Previous study indicated that Hsp27 is phosphorylated by p38 MAPK
at three serine residues (serine 15, 78, 82) in response to various extracellular stresses, and these
phosphorylations affect the oligomerization of Hsp27 and the chaperone activity. Thus, we next
examined the oligomerization status of Hsp27 by the non-denaturing non-reducing polyacrylamide
gel electrophoresis. Interestingly, UVB irradiation reduced the Hsp27 oligomerization in a time-
dependent manner. Based on these results, we speculated that decreased oligomerization of Hsp27
renders not to function as a guardian for cell protection from environmental insults.
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UV increased the cis-11,14,17-eicosatrienoic acid to prevent UV-induced skin damages. 
J Jung, X Jin, E Kim, Y Kim, I Oh and J Chung Department of Dermatology, Seoul National
University Hospital, Seoul, Korea, South
Exposure to ultraviolet (UV) radiation up-regulates the synthesis of matrix metalloproteinase-13
(MMP-13), cyclooxygenase-2 (COX-2) and interleukine-1β (IL-1β), which induce inflammatory
responses in human skin. We recently found that the amount of cis-11,14,17-eicosatrienoic acid
(ETA), which is one of omega-3 fatty acids, was significantly increased in photoaged human epi-
dermis in vivo, and also in the acutely UV-irradiated human skin in vivo. Here, we investigated
the effects of topical treatment of ETA on UV-induced skin damages in hairless mice to elucidate
the roles of ETA on UV-induced skin inflammation and photoaging process. The dorsal skins of
female HR-1 hairless mice were irradiated with UV (250mJ/cm2) and then, were treated with top-
ical ETA (1%) or it’s vehicle (ethanol:propyleneglycol, 30:70) twice immediately after UV and at
24h after UV. Skin biopsy was carried out at 48h post-UV. The expressions of MMP-13, COX-2
and IL-1β were measured by real time-PCR and western blot analysis, and histological changes
were observed. Topical treatment of ETA (1%) significantly inhibited UV-induced epidermal thick-
ness and also prevented UV-induced trans-epidermal water loss and dehydration. Application of
ETA (1%) significantly prevented UV-induced MMP-13, COX-2, and IL-1β expressions at the mRNA
and protein levels. Our results suggest that ETA may be increased by acute and chronic UV irra-
diation to protect our skin from UV-induced skin damages. Therefore, ETA may be a good endoge-
nous photoprotective material and can be possible target for photoprotection in human skin in
vivo.
771
The proteasome is an integral part of the signaling cascade leading to solar UVA-induced
gene expression
B Catalgol,2,3 I Ziaja,1 N Breusing,2 T Jung,1,2 A Höhn,2 B Alpertunga,3 P Schroeder,1
N Chondrogianni,4 ES Gonos,4 I Petropoulos,5 B Friguet,5 LO Klotz,1 T Grune2,1 and J Krutmann1
1 IUF, Düsseldorf, Germany, 2 Inst of Biological Chemistry and Nutrition, University of
Hohenheim, Stuttgart, Germany, 3 Dept Pharmaceutical Toxicology, Istanbul University,
Istanbul, Turkey, 4 Inst of Biological Research and Biotechnology, National Hellenic Research
Foundation, Athens, Greece and 5 UMR CNRS 7079 Physiology and Physiopathology,
UPMC Univ Paris 06, Paris, France
Solar ultraviolet (UV) A radiation is a well-known trigger of signaling responses in human skin
fibroblasts. One important consequence of this stress response is the increased expression of matrix
metalloproteinase-1 (MMP-1), which causes extracellular protein degradation, thereby contribut-
ing to photoaging of human skin. In photoaged skin there is also an accumulation of oxidized pro-
tein in fibroblasts of the upper dermis, where collagen degradation is most prominent. Here we
report that such protein accumulation is of pathophysiological significance, as we identify the
proteasome and its interaction with oxidized protein as an integral part of the UVA-induced, intra-
cellular signaling cascade in primary human dermal fibroblasts. Accordingly, UVA-induced sin-
glet oxygen formation was accompanied by protein oxidation, the cross-linking of oxidized pro-
teins and an inhibition of the proteasomal system. This proteasomal inhibition subsequently led
to an accumulation of c-Jun, phospho-c-Jun and activation of AP-1, i.e. transcription factors known
to control MMP-1 expression. Increased transcription factor activation was also observed if the
proteasome was inhibited by cross-linked proteins or lactacystin, indicating a general mecha-
nism. Most importantly, inhibition of the proteasome was of functional relevance for UVA-induced
MMP-1 expression: overexpression of the proteasome or the protein repair enzyme methionine
sulfoxide reductase prevented the UVA-induced induction of MMP-1. These studies show that solar
UV radiation constitutes an environmental stimulus that can trigger a signaling pathway, which
links intracellular and extracellular protein degradation.
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Effect of Etanercept, TNF-α blocker on TNF-α-mediated photodamage/photoaging
MR Sharma,1,2 B Werth,1 J LoMonico1 and VP Werth1,2 1 Department of Dermatology,
University of Pennsylvania, Philadelphia, PA and 2 Philadelphia VA Medical Center,
Philadelphia, PA
Photodamage and photoaging is caused by UV light. Ultraviolet B (UVB) is a potent inducer of
cutaneous cytokines, particularly TNF-α. TNF-α stimulates release of chemokines and adhesion
molecules, as well as proteases that damage the cutaneous matrix and recruit other inflammatory
cell types. Mice deficient in TNF-α are resistant to UV-induced skin tumor formation. To select a
suitable mouse model for our photodamage and photoaging study, we compared Balb/c, C57BL/6J
and SKH-1 strains of mice. In these mice, we compared UV responses of cytokines and extracel-
lular matrix components relative to those known to occur in human skin and cells. In the acute
study, female mice were irradiated with UVB (100 mJ/cm2/day) for 5 days. Mice were sacrificed 3
and 20 h after the last exposure to UVB irradiation. We quantitated the total glycosaminoglycans
(GAGs) using Hale stain. Specific GAGs, including chondroitin sulfate and hyaluronic acid, were
assayed by immunohistochemical and molecular techniques. Collagen was quantitated by meas-
uring hydroxyproline content. Our results showed that UVB exposure increased the thickness of
epidermis, and increased the expression of total GAGs and chondroitin sulfate in the skin of C57BL/6J
mice, mirroring changes seen in human skin. Therefore, we chose C57BL/6J mice to study the
effects of mouse Etanercept (soluble receptor of TNF-α) on the TNF-α-mediated photodamage/pho-
toaging. Mice were treated with Etanercept (4mg/kg of body wt) for 4 days one hour prior to UVB
irradiation (100 mJ/cm2/day) for 5 days. On the 5th day mice were sacrificed 3h after the last
exposure to UVB irradiation. UVB + Etanercept-treated mice showed fewer inflammatory cells
homing to the skin, as well as a decrease in the expression of total GAGs and an increase in col-
lagen (p<0.001), when compared to UVB-treated mice. These results suggest that blockade of TNF-
α has significant effects on the cutaneous inflammatory and extracellular matrix response of mice
to UVB.
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The roles of free fatty acids and triglycerides in photoaging of human skin
E Kim,1,2 X Jin,1,2 C Park,1,2 Y Kim,1,2 J Kim1,2 and J Chung1,2 1 Department of Dermatology,
Seoul National University College of Medicine, Seoul, Korea, South and 2 Laboratory of
Cutaneous Aging Research, Clinical Research Institute, Seoul National University Hospital,
Seoul, Korea, South
Although fatty acids are known to be important in various skin functions, their roles on photoag-
ing in human skin are poorly understood. We investigated the alteration of lipid metabolism in the
epidermis by photoaging and acute UV irradiation in human skin. We observed that the amounts
of free fatty acids (FFA) and triglycerides (TG) in the epidermis of photoaged or acutely UV-irradi-
ated human skin were significantly decreased. The expressions of genes related to lipid synthesis,
including acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), stearoyl-CoA desaturase (SCD)
and sterol regulatory element binding protein (SREBP), were also markedly decreased. To eluci-
date the significance of these changes of epidermal lipids in human skin, we investigated the effects
of TG, FFA or various inhibitors for the enzymes involved in TG synthesis on the expression of
matrix metalloproteinase-1 (MMP-1) in cultured human epidermal keratinocytes. We demonstrated
that triolein (TG) reduced basal and UV-induced MMP-1 expression. In addition, each inhibitor
for various lipid synthesis enzymes, such as TOFA (ACC inhibitor), C75, cerulenin (FAS inhibitor)
and trans-10, cis-12-CLA (SCD inhibitor), increased the MMP-1 expression significantly in a dose-
dependent manner. We also demonstrated that triolein could inhibit cerulenin-induced MMP-1
expression. Furthermore, topical application of triolein (10%) significantly prevented UV-induced
MMP-13 expression in hairless mice. Taken together, our results suggest that TG and FFA may play
important roles in photoaging of human skin.
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New screening for photoprotective compounds using zebrafish as a vertebrate model. Vali-
dation with a Polypodium leucotomos extract. 
I Rodriguez-Martin,1 L Araujo-Bazan,1 L Palacios,1 J Guinea,1 E Reyes,2 S Gonzalez2 and
P Acebo1 1 ZFBiolabs, Madrid, Spain and 2 Cantabria Farmaceutica, Madrid, Spain
Skin overexposure to solar ultraviolet radiation (UVR) leads to deleterious effects such as pho-
tooxidative stress, sunburn, immune suppression, photoaging and skin cancer. Cells culture mod-
els have been mostly used to perform quantitative studies of radiation cytotoxicity; however, the
response of cells under culture conditions does not reflect the in vivo response of a whole organ-
ism. In recent years, zebrafish (Danio rerio) has increased its importance as a vertebrate model both
for toxicology assays and screening of therapeutic agents, due to its transparency, fast develop-
ment and easiness to handle in multiwell plates. Using zebrafish, a new screening for photopro-
tective compounds has been developed. The photoprotective effect of a hydrophilic extract of the
fern Polypodium leucotomos (PL) has been investigated besides another compounds, known for
their antioxidant and photoprotective properties, like Trolox and Vitamin C. Zebrafish embryos (24
hpf) were exposed to UVB radiation, with or without previous incubation with different concen-
trations of the compounds. Irradiated embryos treated with the different compounds were com-
pared with those untreated by evaluating the morphological abnormalities and viability up to 48
hpf. Our results, showing an increase in the viability and a decrease in the number of malformed
embryos, of the PL and Trolox treated irradiated embryos (1.4±2.4% viability of irradiated embryos
vs. 91.6±4.1% and 87.2±8.7% after treatment with PL and Trolox respectively; 97.2±2.4% of mal-
formed embryos after UV irradiation vs. 6.9±4.8 and 12.8±8.7 after treatment with PL and Trolox
respectively) seem to validate the use of zebrafish model to determine the effects of UVB radiation
in terms of oxidation and photodamage. No photoprotective effect was observed in irradiated
embryos treated with Vitamin C. This new approach provides a useful, rapid and easily to perform
method to detect photoprotection properties of natural extracts and other compounds.
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Protein network analysis of acutely UV-irradiated mouse skin and human samples repre-
senting the progression of cutaneous SCC
JG Einspahr,1 V Calvert,2 E Olson,1 C Curiel-Lewandrowski,1 C Longo,3 J Deng,2 L Lance,2
G Pellicani,3 DS Alberts,1 R Krouse,1,4 A Prasad,1,4 GT Bowden1 and EF Petricoin2 1 Cancer
Center, University of Arizona, Tucson, AZ, 2 Center for Applied Proteomics and Molecular
Medicine, George Mason University, Manassas, VA, 3 University of Modena and Reggio
Emilia, Modena, Italy and 4 Southern Arizona Veterans Affairs Health Care System, Tucson,
AZ
Ultraviolet light (UV) is an environmental carcinogen responsible for the high incidence of non-
melanoma skin cancers. It is imperative to evaluate the acute and chronic effects of UV. We assessed
acute solar simulated light (SSL) on signaling pathway activation using reverse phase protein microar-
ray (RPMA) in the epidermis of mice and in human samples representing the progression to SCC
(13 snap frozen SCCs and 4 AKs with matching normal) after microdisection. In mouse epidermis,
64 proteins were analyzed at 7 points following SSL. SSL activated Akt (S473) and stimulated
phosphorylation of downstream proteins mTOR (S2441, S2448), p70S6K (S371, T389), 4EBP1 (S65),
and eIF4G (S1108). RPMA also showed activation of MAPK signaling by increased phosphoryla-
tion of c-Raf (S338), ERK (T202/Y204), MSK1 (S360), and p90RSK (S380). For the human samples,
statistical analysis of 55 proteins found that 10 were significantly different (P<0.05) between AK
and advanced SCC (≥ 2 cm) including cleaved caspase-9 (D330), phosphorlation of ERK 1/2
(T202/Y204), EGFR (Y1173), MEK1/2 (S217/221), p38 MAP Kinase (T180/Y182), mTOR
(S2481,S2448), and NF-kappaB p65 (S536), total MEK1/2, and PTEN. Comparison of AK and nor-
mal showed that only phospho-IkappaB-alpha (S32/36) and phospho-CREB (S133) were significant
(P<0.05). We are currently analyzing additional human samples. Results demonstrate that while
over 55 signaling endpoints were analyzed, proteins that were significantly elevated were all con-
tained within a common linked network leading primarily through a common EGFR-driven sig-
naling network encompassing the MAPK family and AKT-mTOR activation in both acutely irradi-
ated mouse epidermis and in the transition of this small number of AK to SCC samples.
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Glycoconjugated chlorin effectively enhances photodynamic therapy
S Sakuma,1 E Otake,1 A Maeda,1 H Ooi,2 S Yano2 and A Morita1 1 Department of Dermatology,
Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan and 2 Endowed
Research Section, Photomedical Science, Innovative Collaboration Center, Kyoto University,
Kyoto, Japan
Photodynamic therapy (PDT) is a minimally invasive method of inducing apoptosis in cancer
cells. Typically used photosensitizers, such as NPe6, do not have adequate tumor selectivity and
induce photosensitivity. Cancer cells phagocytose glucose 3 to 20 times more than normal cells.
Therefore, we hypothesized that glycoconjugation may improve tumor-localizability and glyco-
conjugated chlorin may be a more suitable candidate PDT drug. To test the efficacy of PDT with
glycoconjugated chlorin, HaCaT cells were incubated with H2TFPC (unconjugated chrolin; tetra
(fluorophenyl) chlorin), H2TFPC-SGlc (glycoconjugated chrolin; glucose-linked tetra (fluorophenyl)
chlorin), and NPe6, followed by irradiation with 16 J/cm2 of 633 nm LED light. PDT with 1μM
H2TFPC-SGlc induced significant apoptosis 12 h after irradiation in HaCaT cells (annexinV
+ cells:
94.2%) compared to PDT with H2TFPC (annexinV
+ cells: 33.5%) and NPe6 (annexinV+ cells: 4.5%).
We then determined the IC50 24 h after PDT in various tumor cells. PDT with H2TFPC-SGlc (IC50:
0.2~0.8 μM) induced cell death more efficiently in all cell lines, compared to PDT with NPe6
(11~18 μM) and H2TFPC (0.6~2.8 μM). To confirm that PDT induced the production of reactive
oxygen species, sodium azide (NaN3) was added during irradiation to quench singlet oxygen.
PDT-induced apoptosis was significantly suppressed by NaN3 (%survival: 2.7%Ç54%). Further-
more, co-incubation with the singlet oxygen enhancer deuterium oxide (D2O) during irradiation
enhanced PDT efficiency (%survival: 110%Ç69%), indicating that PDT with glycoconjugated chlo-
rin had cytotoxic effects against cancer cells via the induction of singlet oxygen. Further, to eval-
uate in vivo efficacy of PDT, melanoma-bearing BL6 mice were intravenously injected with H2TFPC-
SGlc (0.14 μM), followed by irradiation with 150 J/cm2 633nm LED light. Tumors were significantly
reduced 48 h after irradiation in PDT-treated mice.
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Ultraviolet irradiation induces CYR61/CCN1, a novel mediator of collagen homeostasis, via
activation of transcription factor AP-1 in human skin fibroblasts
TH Quan, Z Qin, Y Xu, T He, JJ Voorhees and GJ Fisher Dept. of Dermatology, Univ. of
Michigan Medical School, Ann Arbor, MI
Solar ultraviolet irradiation (UV) stimulates degradation and reduces production of type I collagen,
the major structural protein in human skin. This altered collagen homeostasis is a major cause of
sun-induced skin aging (photoaging). Cysteine-rich protein 61 (CYR61/CCN1) is a member of the
CCN family of matricellular proteins, which participate in signal transduction between cells and
their extracellular matrix. CCN1 is significantly elevated in the dermis of photoaged human skin
(4-fold, N=6, p<0.05), and acute UV-irradiation induces CCN1 in human skin in vivo (6.5-fold,
N=6, p<0.05), and cultured human skin fibroblasts (4-fold, N=6, p<0.05). Inhibition of UV irradi-
ation-induced CCN1 by siRNA significantly attaneuates UV-induced inhibition of type I procolla-
gen and up-regulation of matrix metalloproteinase-1 (MMP-1), indicating CCN1 functions as a key
mediator of UV-induced aberrant collagen homeostasis. We have investigated regulation of CCN1
by UV, in primary human skin fibroblasts. UV significantly activates CCN1 promoter (3.6-fold, N=3,
p<0.05), without changing CCN1 mRNA or protein stability (N=3, p<0.05), indicating the primary
mechanism of CCN1 induction by UV is transcriptional. Analysis revealed that CCN1 proximal
promoter contains a putative AP-1 binding site. Investigation of proteins bound to the AP-1 site
revealed that UV increased binding of AP-1 family members, c-Jun and c-Fos (N=3, p<0.05).
Deletion or mutation of AP-1 binding site in the CCN1 promoter substantially abolished UV acti-
vation of CCN1 promoter (N=3, p<0.05). Furthermore, functional blockade of c-Jun by expression
of dominant negative mutant, or siRNA-mediated knockdown of c-Jun substantially reduced UV-
induced activation of CCN1 promoter and CCN1 expression (N=3, p<0.05). These data demon-
strate that CCN1 is transcriptionally regulated by UV via induction of transcription factor AP-1, and
that CCN1 is a novel mediator of solar UV irradiation-induced dermal connective tissue damage.
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Time-dependent generation of ROS in HaCaT keratinocytes after UVB-irradiation is modu-
lated by a Ca2+-dependent cascade
H Masaki and Y Okano Nikkol group Cosmos Technical Center, Tokyo, Japan
Generation of ROS by UVB-irradiation (UVB-R) is well recognized but the time-dependent kinet-
ics of ROS generation after UVB-R has not yet been identified. Although one study reported that
UVA-induced ROS generation is regulated by activated Nox due to Ca2+ influx, regulatory factors
involved in ROS generation have been unclear. The purpose of this study was to clarify the dynam-
ics of UVB-induced ROS generation after UVB-R and to identify regulatory factors focusing on intra-
cellular Ca2+ concentration. Intracellular Ca2+ concentration was measured using the fluores-
cence intensity of Fura-2AM. ROS generation was evaluated using a fluorescent probe,
2’,7’-dichlorodihydrofluorescein diacetate. IL-1α was quantified by a commercial ELISA kit. UVB-
R immediately increased ROS levels in HaCaT cells which was associated with intracellular Ca2+
concentration. Further, a re-elevation of ROS level was observed at 7 h after UVB-R, which coin-
cided with an increase of IL-1α secretion. These results indicate that UVB-R induces a biphasic
ROS generation which is expected to involve a cascade of UVB-induced ROS generation. A Ca2+
specific chelating agent suppressed ROS elevation immediately after UVB-R and also reduced IL-
1α secretion from UVB-irradiated HaCaT cells. In contrast, a Ca2+ ionophore and IL-1α stimulated
ROS production in HaCaT cells. Taken together, we propose a cascade which is initiated by the
elevation of intracellular Ca2+ and is promoted by IL-1α. UVB-R generally stimulates the secre-
tion of pro-inflammatory cytokines such as IL-1α, IL-1β and TNF-α For instance, IL-1α which is
stored in cells in an inactive form, is activated by Ca2+-dependent proteases such as calpain. These
facts suggest that the initial elevation of intracellular Ca2+ develops a biphasic ROS generation
through the conversion of IL-1α to its active form. This is the first report that the time-dependent
generation of ROS after UVB-R is modulated by a Ca2+-dependent cascade.
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Epidermal oxidative stress induces pro- and active MMP-1 production from fibroblasts through
cross-talk of keratinocytes and fibroblasts
K Shimizu,1 S Yahagi,1 Y Izutsu,1 K Obayashi,2 Y Yamashita,2 Y Okano1 and H Masaki1 1 Nikkol
Group Cosmos Technical Center Co., Ltd., Tokyo, Japan and 2 Nikoderm Reserch Inc., Osaka,
Japan
It was well recognized that the formation of deep wrinkles was caused by alterations and dys-
functions of dermal matrix structure. It has been reported that MMP-1 released from UV irradiated
dermal fibroblasts contributes to the dermal alterations. However, recent studies reported that epi-
dermal keratinocytes are also directly involved in dermal dysfunction in photoaged skin. The pur-
pose of the study is to clarify a relationship between keratinocyte - fibroblast on dermal alterations
focusing on MMP-1. MMP-1 expression was examined by the western blotting method. To iden-
tify the relationship, we examined MMP-1 production from fibroblasts treated with conditioned
medium (CM) from keratinocytes. A CM of UVB-irradiated keratinocytes up regulated not only
proMMP-1 production but also its active form from fibroblasts. These results indicate that UVB-
irradiated keratinocytes plays two roles on fibroblasts; 1) Induction of dermal MMP-1 production.
2) Activation of pro-MMP-1. On the other hands, it had been well established that ROS from UVB-
exposed skin causes excess production of MMP family in dermis. We examined whether an enforce-
ment of intracellular ROS scavenging in keratinocytes is effective for suppression of the keratinocyte-
effects on MMP-1. To enforce the intracellular ROS scavenging ability, we used zinc glycine complex
(Zn(Gly)2) as an inducer of GSH and MT. The CM of UVB-irradiated keratinocytes pre-treated with
Zn(Gly)2, showed the reduction of the pro- and active MMP-1 from fibroblasts. These results pro-
pose that the signals from UVB-irradiated keratinocytes initiate an aging process in dermis and in
addition, an enforcement of ROS scavenging ability in epidermis is an efficient blocking of the ker-
atinocyte-derived signals.
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Oxidized phospholipids mediate responses to UVA-1 via the redox – sensitive transcription
factor Nrf2
F Gruber,1,4 H Mayer,2 M Bilban,3 B Lengauer,1 JM Sanders,4 R de Martin,2 O Wagner,3
TW Kensler,5 N Leitinger4 and E Tschachler1,6 1 Dermatology, Medical University of Vienna,
Vienna, Austria, 2 Vascular Biology, Medical University of Vienna, Vienna, Austria, 3 KIMCL,
Medical University of Vienna, Vienna, Austria, 4 CVRC, University of Virginia, Charlottesville,
VA, 5 Environmental Health Sciences, Johns Hopkins University, Baltimore, MD and 6
CE.R.I.E.S, Neuilly, France
We have previously shown that the phospholipid 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phos-
phorylcholine (PAPC) is oxidized by UVA-1. The oxidation products mediate expression of heme
oxygenase-1 in skin fibroblasts (FB). We could identify oxidation products able to induce HO-1
that accumulate in FB immediately after UVA-1 irradiation. We thus hypothesized that UVA-1 oxi-
dized phospholipids regulate other UVA-1 response genes. To test this we carried out global expres-
sion analysis of dermal FB that were either untreated, UVA-1 irradiated or treated with oxidized
phospholipids. As much as 10% of the genes that were UVA-1 regulated were co-regulated in
lipid treated cells. Among these genes were HO-1, the glutathione synthesis gene GCLM, key
enzymes in the metabolism of oxidized lipids and of the thioredoxin and peroxiredoxin pathways
as well as IL8. Bio-informatics revealed that these genes contain antioxidant response elements
(ARE) in their promoters and are thus prone to regulation with the redox sensitive transcription fac-
tor Nrf-2. SiRNA mediated knockdown of this transcription factor left the co-regulated genes less
responsive to oxidized PAPC or UVA-1, while pro-inflammatory genes like IL6 and COX2 still
responded to the UVA-1 stimulus. In Nrf2 deficient mice the response to UV oxidized PAPC was
abrogated, demonstrating the relevance of this mechanism in vivo. Our data thus suggest that phos-
pholipid oxidation can account for a substantial part of an antioxidant response to UVA-1 and that
Nrf2 is a key regulator in this process.
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Soluble growth stimulation gene-2 (sST2) contributes to the immunosuppressive effects of
UV-radiation
V Mlitz,1 M Mildner,1 K Hötzenecker,2 H Ankersmit2 and E Tschachler1,3 1 Dermatology, Medical
University of Vienna, Vienna, Austria, 2 Surgery, Medical University of Vienna, Vienna, Austria
and 3 CE.R.I.E.S., Centre de Recherches et dInvestigations Epidermiques et Sensorielles,
Neuilly, France
ST2, a novel member of the IL-1-receptor family, has recently been identified as the receptor for
IL-33. In addition, a soluble form (sST2), comprising only the extracellular part of ST2, exists.
Whereas IL-33 activates Th2-cells, mast cells, eosinophils and basophils via binding to ST2, sST2
is known to have immunosuppressive properties by acting as a decoy receptor for this cytokine.
We have thus asked whether sST2 could contribute to the well-known, but poorly understood,
immunosuppression occurring in UV irradiated skin. Exposure of primary human keratinocytes
(KC) to UVB strongly induced the secretion of sST2. A similar effect was observed when KC were
stimulated with hepatocyte growth factor (HGF), which is known to be up-regulated in dermal
fibroblasts (FB) after UV-irradiation. In contrast, IL-33, the agonist of sST2, was not secreted by KC.
To investigate the biological activity of KC-derived sST2, we analyzed its effect on IL-33 stimulated
peripheral blood mononuclear cells (PBMC). IL-33, in combination with IL-12, is known to induce
IFN-gamma production in these cells. We show here that pre-incubation of IL-33 with either recom-
binant sST2 or supernatants of UVB or HGF-treated KC strongly inhibited IL-33 induced IFN-gamma
release. In summary, we have demonstrated that high amounts of biologically active sST2 are
secreted by KC after exposure to UVB or HGF. We therefore suggest that the UV-induced secre-
tion of sST2 by KC might contribute to the immunosuppression observed in UV irradiated skin.
S130 Journal of Investigative Dermatology (2009), Volume 129
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Anti-aging effects of Unikamide-AA on photoaged skin in hairless mice is mediated through
the transforming growth factor-β/Smad signaling
M Kwon,1 S Jeong,1 H Kim,2 B Park1 and S Lee2,3 1 Research Division, NeoPharm Co., Ltd.,
Daejeon, Korea, South, 2 Department of Dermatology, Yonsei University College of
Medicine, Seoul, Korea, South and 3 Human Barrier Research Institute, Yonsei University
College of Medicine, Seoul, Korea, South
Transforming growth factor-β (TGF-β) plays important role in regulation of dermal collagen syn-
thesis, and type I procollagen synthesis is known to be decreased after UV irradiation through the
TGF-β/Smad signaling. In this study, we have investigated the anti-aging effects of Unikamide-AA,
a newly synthesized anti-aging molecules, through the stimulation of the TGF-β/Smad signaling
and inhibition of MMPs, thereby protecting against from UV-induced photoaging in hairless mice.
Photoaging was induced in hairless mice by chronic application of UVA and UVB three times a
day for 10 weeks. After UV irradiation, Unikamide-AA was topically applied on the irradiated site
twice a day for 2 weeks. Topical application of 625IU of retinol was used as a positive control.
After 2 weeks treatment, 1% of Unikamide-AA resulted in a 1.5 times increase of dermal thick-
ness without affecting transepidermal water loss, and collagen density was also increased, com-
pared with vehicle treated skin. By Western blotting, increased amount of dermal collagen and
decreased expression of MMP-13 was also observed. In order to verify that the TGF-β/Smad sig-
naling is involved in the anti-aging effects of Unikamide-AA, in vitro experiments using cultured
human fibroblast were performed. Treatment of Unikamide-AA on cultured fibroblast stimulated
the proliferation of fibroblast, as well as collagen synthesis. Potential involvement of TGF-β/Smad
signaling was observed by real-time RT-PCR and Western blotting, which resulted in an increase
of TGF-β and Smad-3. These results suggest that Unikamide-AA exert its anti-aging effects, includ-
ing the increase of collagen synthesis and decrease of matrix metalloproteinase, through the stim-
ulation of the TGF-β/Smad signaling in UVB-irradiated human fibroblast and photoaging hairless
mice. As a conclusion, Unikamide-AA can be used as an anti-aging agent for photo-aged skin.
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Melanin dispersion to basal keratinocytes may play a role in UV-induced long-lasting pig-
mentation in human skin
SG Coelho,1 SA Miller,2 BZ Zmudzka,2 JZ Beer2 and VJ Hearing1 1 Laboratory of Cell Biology,
National Cancer Institute, National Institutes of Health, Bethesda, MD and 2 Center for
Devices and Radiological Health, Food and Drug Administration, Silver Spring, MD
Human skin has the ability to remain pigmented for extended amounts of time after acute or repeated
UV exposures. The frequency of such long-lasting pigmentation (LLP) has been reported by us, yet
the mechanism of this prolonged melanogenic response remains to be elucidated. It has been sug-
gested that delayed hyperpigmentation in solar lentigos results from melanin accumulation in basal
keratinocytes that leads to slower cell differentiation. We hypothesized that melanin dispersion to
basal keratinocytes might explain the LLP phenomenon. We evaluated epidermal skin samples
from 6 subjects collected ≥ 9 months after a single, low UV exposure. To assess if LLP may increase
carcinogenic risk, we assessed several melanogenic markers. None of the three melanogenic mark-
ers (tyrosinase, MITF and MART1) indicated quantifiable differences in melanocyte numbers between
the LLP and unexposed, adjacent skin. However, 3 of the 6 subjects developed visible pigmenta-
tion and showed an increase in melanin content at the LLP sites. Our preliminary observations sug-
gest that LLP might also result from the slower proliferation of undifferentiated keratinocytes in the
basal layer due to the accrual of melanin in keratinocytes not expressing the cell proliferation
marker, PCNA. However, 2 out of 3 subjects with visible LLP showed increased numbers of PCNA
positive cells in the LLP sites compared to the controls. The fact that such a low single UV dose,
received in some cases more than 5 years ago, can produce LLP raises the question of whether a
mild sunburn-inducing dose is sufficient to create an environment with the potential to initiate UV-
induced skin cancers.
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Protein kinase C δ is critical for UV radiation induced cell cycle checkpoint activation
EL LaGory1 and MF Denning1,2 1 Molecular and Cellular Biochemistry, Loyola University
Chicago, Maywood, IL and 2 Department of Pathology, Loyola University Chicago,
Maywood, IL
Protein kinase C delta (PKCδ) is a key participant in the apoptotic response to UV radiation and
functions as a tumor suppressor gene in cutaneous squamous cell carcinomas. Following expo-
sure to apoptotic doses of UV radiation, PKCδ is cleaved by caspase-3, generating a constitutively
active catalytic fragment. Work in our lab demonstrated that cleavage of PKCδ is both necessary
and sufficient for UV-induced apoptosis in keratinocytes (KC). Tumor suppressor proteins are also
often involved in limiting cellular proliferation by triggering cell cycle checkpoints. We found that
in addition to inducing apoptosis, retroviral expression of the PKCδ catalytic fragment (PKCδ-cat)
resulted in a pronounced G2/M cell cycle arrest in both primary human KCs as well as HaCaT
cells. Consistent with induction of the G2/M checkpoint, keratinocytes expressing the PKCδ-cat
contained elevated levels of phosphorylated Cdk1 (Tyr15). To assess the role of PKCδ in the cell
cycle response to UV irradiation, we exposed wild type or PKCδ null mouse embryo fibroblasts
(MEF) to UV radiation. Strikingly, we found that while wild type MEFs underwent a pronounced
G2/M arrest, Cdk1 phosphorylation, and induction of apoptosis following UVB exposure, PKCδ
null MEFs were relatively resistant to these effects. Treatment with the ATM/ATR inhibitor caffeine
induced massive apoptosis in UV irradiated wild type MEFs, however caffeine plus UV had little
effect on the cell cycle profile or survival of PKCδ null MEFs. The sensitivity of UV irradiated wild
type MEFs to ATM/ATR inhibition reflects an override of the G2/M checkpoint, resulting in cell
death, while the resistance of PKCδ null MEFs to caffeine plus UV is a manifestation of the criti-
cal role of PKCδ in UV-induced apoptosis. The function of PKCδ in the UV-induced cell cycle
checkpoint response of KCs may be a critical component of its tumor suppressor function in squa-
mous cell carcinomas.
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Human skin fibroblasts under post-menopausal conditions are more sensitive to UVA-induced
MMP-1 expression
J Jian,1 Q Yang,1 X Huang,1 E Pelle,1,2 N Pernodet2 and D Maes2 1 Environmental Medicine,
New York University School of Medicine, New York, NY and 2 Skin Biology, Estee Lauder
Research Laboratories, Melville, NY
During and after menopause, many women experience skin thinning and wrinkle formation. Matrix
metalloproteinase-1 (MMP-1) and estrogen deficiency contribute to this aging process. Because of
menstruation cessation and a decrease in ovarian function, women at peri- and post-menopausal
stages experience not only a reduction in estrogen but also a concurrent increase in iron. In the
present study, we have tested a hypothesis that increased iron, in the form of ferritin, plays an impor-
tant role in skin photoaging, particularly in post-menopausal women. Based on the observation of
an inverse but concurrent change in estrogen and iron, an in vitro cell culture model of high estro-
gen and low iron or low estrogen and high iron to mimic pre- and post-menopausal conditions
was developed. We found that UVA at 50 kJ/m2 significantly induced MMP-1 activity, a 12.6-fold
and a 44.6-fold increase over the baseline (without UVA exposure) in fibroblasts grown under pre-
and post-menopausal conditions, respectively. Interestingly, deferoxamine, an iron chelator, inhib-
ited MMP-1 induction through the UVA-activated ERK pathway, suggesting that increased iron mod-
ulates MMP-1 expression. Since UVA did not significantly increase MMP-1 induction in normal
human epidermal keratinocytes (NHEK), we then investigated whether factors released from UVA-
exposed NHEK could stimulate MMP-1 expression in fibroblasts. We found that medium from
irradiated NHEK cells grown under post-menopausal conditions that was transferred to fibroblasts
increased MMP-1 expression. Quantitative real-time PCR showed that the cytokine, TNF-α, appeared
to be released from NHEK cells which then enhanced MMP-1 expression in fibroblasts. Further,
the addition of neutralizing TNF-α antibody to the UVA-exposed NHEK media completely blocked
MMP-1 expression. In summary, our results suggest that, in addition to estrogen deficiency, increased
iron as a result of menopause may sensitize post-menopausal skin to UV exposure.
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Impact of the arylhydrocarbon receptor ligand resveratrol on UV-induced immunosuppres-
sion after in vivo and in vitro administration
W Schuller, T Schwarz and A Schwarz Dermatology, UK-SH, Kiel, Germany
Ultraviolet B radiation (UV) suppresses the immune system in an antigen-specific fashion via induc-
tion of regulatory T cells (Treg). Recently it was shown that low doses of resveratrol exert immunomod-
ulating effects. Resveratrol binds to the cytosolic arylhydrocarbon receptor (AhR). The AhR was
identified as a molecular target for UV and participates in UV-induced signal transduction. Hence,
we were interested whether resveratrol influences Treg function in vivo and in vitro. To address
this issue, the murine contact hypersensitivity (CHS) model was utilized. Mice which were hap-
ten-sensitized through skin exposed to UVB (4x150 mJ/cm2) did not respond with an ear swelling
response upon challenge, indicating UV-induced immunosuppression. In contrast, after addi-
tional i.p. injection of resveratrol (150 μM, 200 μl) before sensitization revealed an almost normal
CHS response. Administration of resveratrol alone did not influence CHS reaction. To investigate
the impact on UV-Treg, adoptive transfer experiments were performed. Injection of lymphocytes
from donors, which were hapten-sensitized through UVB-exposed skin, rendered naive recipient
mice unresponsive to the hapten. In contrast, recipients of Treg obtained from mice, which in
addition had received resveratrol i.p., were not suppressed in their CHS response. This suggests
that resveratrol suppressed development of UV-Treg. To elucidate the underlying mechanism, serum
samples from mice were analysed for TGFb1 using an ELISA. Mice that were injected with resver-
atrol i.p. showed decreased serum levels of TGFb1. Moreover UV-Treg cells were isolated from
hapten-sensitized mice and incubated with resveratrol in vitro for 24 hours. Again, i.v. injection of
Treg in naïve mice revealed suppressed CHS response. Hence, pre-incubation of Tregs with low
concentrations of resveratrol (50μM) increased ear swelling response. Subsequent adoptive trans-
fer experiments confirmed the impact of resveratrol on UV-Treg function. These data suggest that
AhR ligands may influence the immunosuppressive effects of UV-induced Treg.
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UV irradiation induces Snail expression by MAPK/AP-1 signaling cascade in human ker-
atinocytes
Y Li, Y Liu, Y Xu, S Kang, TM Johnson, JJ Voorhees and GJ Fisher Dept. of Dermatology,
University of Michigan, Ann Arbor, MI
Snail/Slug family of transcription repressors are key regulators of cellular functions, including adhe-
sion, mobility and apoptosis. Snail is a potent inducer of epithelial-to-mesenchymal transition (EMT).
Snail expression is low in normal tissue, whereas elevated expression triggers EMT during tumor
invasion, wound healing, and embryo development. We have investigated regulation of Snail/Slug
by ultraviolet (UV) irradiation, in human skin in vivo and cultured primary adult human keratinocytes.
Exposure of human skin to solar-simulated UV irradiation (twice minimal erythema dose) enhanced
Snail mRNA expression. Snail gene expression was increased 4.7-fold at 4 hours, peaked at 8 hours
(5.9-fold) and returned to basal at 48 hours (n=8, p<0.01). In contrast, expression of Slug was not
altered. UV irradiation (50mJ/cm2) also induced Snail expression in cultured keratinocytes with
similar kinetics as observed in vivo. Snail induction in keratinocytes was significantly reduced by
specific inhibitors of ERK, p38 or JNK, indicating each of the three major MAP Kinases participates
in Snail regulation. AP-1 transcription complex is a downstream target of MAP Kinase signaling
and controls expression of many genes that respond to UV irradiation. Inhibition of AP-1 activity
by over-expression of dominant-negative c-Jun significantly reduced (51%, n=4, p<0.05) Snail
induction. Analysis of the Snail promoter revealed the presence of an AP-1 binding site, conserved
in both human and mouse. EMSA demonstrated that UV irradiation specifically induced protein-
binding to the AP-1 site. Mutation of the AP-1 binding site completely blocked protein binding
and inhibited UV irradiation-induced Snail promoter activity by 97% (n=3, p<0.001). Taken together,
these data demonstrate that UV irradiation induces Snail in a MAPK/AP-1 dependent manner, in
human keratinocytes. Given the key role of Snail in EMT, UV irradiation induction of Snail is likely
a critical mediator of sun-induced skin cancer.
www.jidonline.org   S131
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Early critical events after photodynamic therapy with the silicon phthalocyanine Pc 4: Evi-
dence for photodamage to ER proteins and Ca2+ depletion
M Lam,1 ME Rodriguez,1 SJ Howell,2 L Xue,3 MC Davis,4 CW Distelhorst,4 ME Kenney,5
NL Oleinick,3 TS McCormick,1 KD Cooper1,6 and ED Baron1,6 1 Dermatology, CWRU,
Cleveland, OH, 2 Ophthalmology - VSRC, CWRU, Cleveland, OH, 3 Radiation Oncology,
CWRU, Cleveland, OH, 4 Hematology Oncology, CWRU, Cleveland, OH, 5 Chemistry,
CWRU, Cleveland, OH and 6 Dermatology, CVAMC, Cleveland, OH
Photodynamic therapy (PDT), a promising treatment for cancer and certain noncancerous condi-
tions, employs a combination of a photosensitizing chemical and visible light. PDT generates sin-
glet oxygen and other reactive oxygen species and induces apoptosis in lymphoid and epithelial
cells. The mechanisms initiating apoptosis after PDT are not fully characterized. To further dissect
the pathways of PDT-induced apoptosis, we investigated the involvement of the endoplasmic retic-
ulum (ER) using the silicon phthalocyanine Pc 4. As detected by confocal microscopy, Pc 4 local-
izes primarily to cytosolic membranes, specifically, of the mitochondria and ER. Photoactivation
of Pc 4-loaded cells is known to damage two anti-apoptotic proteins of the mitochondria, Bcl-2
and Bcl-xL, as determined by western blot analysis. Here, we demonstrate an instantaneous PDT-
induced photodamage to the ER-membrane inositol 1,4,5-trisphosphate receptor (IP3R) as well as
the sarcoplasmic ER Ca2+ ATPase (SERCA) pump. The SERCA pump normally maintains the essen-
tial concentration of ER luminal Ca2+. As a result of photodamage to the pump, a transient increase
of intracellular free Ca2+ ion was detected within minutes when MCF-7 cells were exposed to
PDT with Pc 4. This event was inhibited upon pre-treatment with the intracellular Ca2+ chelator
BAPTA-AM. These findings suggest that the release of intracellular Ca2+ may be a critical event in
initiating apoptotic death during Pc 4-PDT as free Ca2+ ion could enter PDT-damaged mitochon-
dria and potentiate the mitochondrial events triggered by the simultaneous photodamage to that
organelle. Furthermore, the immediate loss of ER proteins after Pc 4-PDT might be a useful clini-
cal marker that could predict tissue response to PDT.
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Role of mast cells in platelet-activating factor-mediated ultraviolet B radiation-induced sys-
temic immune suppression
Y Yao, M Al-Hassani, R Kapur and JB Travers Indiana University School of Medicine,
Indianapolis, IN
Recent studies have implicated the lipid mediator platelet-activating factor (PAF) and mast cell
(MC)-derived histamine in mediating ultraviolet B radiation (UVB)-induced systemic immunosup-
pression known to be a major cause for skin cancers. Our previous bone marrow (BM) chimeric
mice studies revealed that PAF-receptor (PAF-R)-expressing BM-derived cells are necessary for UVB-
induced systemic immunosuppression as measured by the inhibition of delayed type contact hyper-
sensitivity (CHS) to the chemical DNFB. In the present study, we demonstrate MC as the direct tar-
get for PAF. The inhibition of CHS by the metabolically stable PAF-R agonist CPAF was completely
abolished in MC-deficient (Wsh) mice. However, the immunosuppressive effect of histamine was
not affected by PAF-R-deficiency. In addition, ongoing studies reveal that reconstitution of PAF-R-
deficient (PAF-R-/-) or Wsh mice with PAF-R+/+ but not PAF-R-/- BM-derived MC by subcutaneous
injection restored their responsiveness to UVB-induced inhibition of CHS. These studies indicate
an important role for MC as a target for UVB-generated PAF resulting in systemic immunosup-
pression.
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Synergistic upregulation of TNF-α in response to UVB and IL-1α is mediated by NF-κB
MM Bashir2,1 and VP Werth2,1 1 VA Medical Center, University of Pennsylvania, Philadelphia,
PA and 2 Dermatology, University of Pennsylvania, Philadelphia, PA
Cytokines are important immune modulators whose expression can be effected by ultraviolet (UV),
especially UVB exposure. Ultraviolet B (UVB) radiation is a potent inducer of cutaneous cytokines,
including tumor necrosis factor α (TNF-α), that play a key role in inflammatory responses in skin.
Further evaluation of this upregulation showed it was due to enhanced transcription, mediated by
an AP-1 binding site in the TNF-α promoter [Bashir et al, 127:S57 (Abstract #340), 2007]. We
have previously reported that UVB and IL-1α synergistically enhanced the expression of TNF-α in
human keratinocytes, but the mechanism for this was previously unknown. In this present study,
we investigated the molecular mechanism for the synergistic upregulation of hTNF-a by UVB and
IL-1α treatment of neonatal HK. Several lines of evidence suggest that UVB is also responsible for
the activation of NF-κB, a family of transcription factors, in skin. NF-κB activation requires the
phosphorylation of IκB by the IκB kinase (IKK) complex, which consists of two kinases, IKKα and
IKKβ, and a regulatory subunit, IKKγ (also known as NEMO). To determine the role of NF-κB in the
synergistic upregulation of TNF-α production by the combination of UVB plus IL-1α, we trans-
fected neonatal HK with dominant negative (DN) constructs of IKKα and IKKβ and, as a control,
an empty plasmid. The control HK exhibited a robust, synergistic induction of TNFα mRNA in
response to UVB plus IL-1α. The DN IKKα construct reduced this response by 40% (p<0.05), and
the DN IKKβ construct reduced it by 18% (p<0.05 compared to control). Studies with the 1.2 Kb
TNFα promoter construct did not show a synergistic IL-1α effect, suggesting that the effect of IL-
1α mediated NF-κB activation is outside of this construct. In conclusion, our results clearly indi-
cated synergistic upregulation of TNF-α in neonatal HK by UVB and IL-1α is mediated through
NF-κB, while the UVB effect is through AP-1. We also show that IKKα is the primary pathway for
synergy between UVB and IL-1α in neonatal HK.
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Skin microbiota rescues melanocyte from UVB apoptosis
Y Lai, PF Kotol, RL Gallo and A Di Nardo Medicine-Dermatology section, UCSD, La Jolla, CA
Advances in microbiology and immunology have recently suggested that host cells sense and
react to resident bacteria and may be beneficial to the host. We thereby hypothesized that resident
bacteria express TLR ligands to modify the skin’s response to UV-B damage and decrease apopto-
sis. In the present study we investigated the effects of Toll-like receptor (TLR) ligands, as a surro-
gate for intact bacteria, on the UV response of melanocytes. By Real-time RT-PCR we proved that
normal human melanocytes (NHM) are responsive to TLR2 and 3 ligands and show an increase of
IL-6 and TNF-alpha expression. Since melanocytes are in contact with bacterial products in vivo
during sun exposure, we studied how TLR stimulation modifies melanocyte response to UV radi-
ation. NHM were treated with TLR3, TLR2, TLR2/6, or TLR7 ligands for 24 hours and irradiated
with 10mJ/cm2 with a UV lamp (Spectroline EB-280C, Westbury NY). After another 24 hours, the
cells were harvested, double stained with annexin V and propidium Iodide, and immediately ana-
lyzed by flow cytometry. The cells pretreated with LTA and SE presented a 54% and 83% reduc-
tion in the percentage of Annexin V positive cells; this effect was not visible in the absence of a
UVB stimulus. To evaluate the protective effect of LTA and SE, we increased UVB to15 mJ/cm2.
The data of SubG0 population, representative of cells going to apoptosis, showed Pam3CSK4 (TLR1/2
ligand), LTA (TLR2/2 ligand) and Malp2 (TLR2/6 ligand) rescued cells from entering the SubG0 state
in the cell cycle. These scavenger effects on cells were not due to increased medium absorbance
during irradiation by spectroscopy. Take together, our findings demonstrate that resident bacteria
express TLR ligands that modify the skin’s response to UV-B damage and decrease apoptosis. This
discovery could change the conceptual basis for formulation of cleansers and sunscreens, and refine
the role of certain resident cutaneous bacteria as being beneficial to the skin.
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Functional melanocortin 1 receptor activates signaling pathways that inhibit UV-induced
genotoxicity in human melanocytes by enhancing DNA repair
A Kadekaro,1 R Starner,1 V Swope,1 P Cassidy,2 S Leachman,2 A Koshoffer,1 R Boissy1 and
Z Abdel-Malek1 1 Dermatology, University of Cincinnati, Cincinnati, OH and 2 Dermatology,
University of Utah, Salt Lake City, UT
The melanocortin 1 receptor gene (MC1R) is a bona fide melanoma susceptibility gene that codes
for a Gs-protein coupled receptor with seven transmembrane domains. It is established that some
allelic variants of the MC1R (RHC alleles) are strongly associated with red hair phenotype and
increased melanoma risk. However, the increased melanoma susceptibility is not strictly depend-
ent on pigmentary phenotype. We have discovered that activation of the MC1R by its ligand α-
melanocyte stimulating hormone (MSH) enhanced the repair of DNA photoproducts and reduced
the generation of reactive oxygen species in UV-irradiated human melanocytes (HM). Activation
of DNA repair pathways and reduction of oxidative stress were mediated by augmenting UV-induced
phosphorylation of the MAP kinases p38 and JNK, as well as accumulation and phosphorylation
of p53. The antioxidant effects of MSH were immediate, exemplified by inhibition of generation
of reactive oxygen species, and latent, due to induction of antioxidant genes. These effects were
absent in HM expressing 2 RHC alleles, which expressed non functional MC1R and had a com-
promised nucleotide excision repair capacity and sustained high levels of hydrogen peroxide as
well as unrepaired 8-oxodG. To confirm that the aberrant response of these HM to UV was indeed
due to loss of function of MC1R, we stably transfected one strain that expressed 2 RHC alleles with
the wild type MC1R, and found that this normalized the response to MSH and UV. Additionally,
we treated HM expressing functional MC1R with agouti signal protein, the physiological antago-
nist of the MC1R, and found that it blocked the functional coupling of MSH to the MC1R, and its
effects on DNA repair, oxidative stress and apoptosis following UV exposure. These results pro-
vide compelling evidence for the significance of the MC1R and MSH in the UV stress response,
and in protecting HM from UV-induced genotoxicity.
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On the evolution of stress response system: An update on the cutaneous hypothalamic-pitu-
itary-adrenal (HPA) axis
A Slominski1 and DJ Tobin2 1 Pathology and Laboratory Medicine, University of Tennessee
Health Science Center, Memphis, TN and 2 Centre for Skin Sciences, School of Life Sciences,
University of Bradford, Bradford, United Kingdom
More than decade ago we have proposed that mammalian skin expresses a homologue of the HPA
axis to regulate local response to stress. Since then independent laboratories have firmly estab-
lished expression of the HPA axis elements in skin cells including CRF, POMC with its products
ACTH, α-MSH, β-End as well as corresponding CRF1, MC2, and opiate receptors, and key enzymes
of corticosteroid synthesis with production of corticosterone and cortisol in situ. The expression of
these elements is non-random, but instead is organized into functional, cell type-specific regula-
tory loops with a structural hierarchy similar/identical to that found centrally. The common ecto-
dermal origin of the brain and epidermis, the central (brain and pituitary) expression of the cytokines
and growth factors and their ability to modify CRF/ POMC function, and the capability of CRF and
POMC peptides to act as growth factors/cytokines (a function developed first at the periphery) are
allowing us to propose a new theory on the integumental origin of the HPA axis. Thus, the pri-
mordial HPA may have developed first in the integument for the regulation of its defense against
the hostile environment and pathogens. During evolution, its main algorithm
CRF>CRF1>POMC>ACTH>COR has been adapted and perfected by the brain to form the HPA
axis, which has separated anatomically and functionally from the immune system and skin. The
retained cutaneous HPA is an evolutionary record of the parental system and its deregulation leads
to the inflammatory, pigmentary and neoplastic disorders and pathology of adnexal structures.
S132 Journal of Investigative Dermatology (2009), Volume 129
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The IGF-1/IGF-1R signaling axis in the skin: a new paradigm for aging-associated skin can-
cer
D Lewis, J Travers and D Spandau Indiana University School of Medicine, Indianapolis, IN
The incidence of UVB-induced skin cancer increases dramatically with age, becoming most com-
mon in individuals over 60 years old. Recent in vitro and epidemiological data suggests one pos-
sible mechanism is dependent on the functional status of the insulin-like growth factor-1 receptor
(IGF-1R) signaling network. When the epidermal IGF-1R is functionally active, UVB exposure
results in an appropriate senescent response by keratinocytes. If the IGF-1R is functionally inac-
tive at the time of UVB-irradiation, the keratinocytes do not become senescent, do not repair
UVB-damaged DNA, and they can continue to proliferate with the potential of converting the dam-
aged DNA into initiating carcinogenic mutations. In the skin, the majority of the IGF-1 supplied
to the epidermis is produced by dermal fibroblasts because keratinocytes do not produce IGF-1.
Therefore, we hypothesize that geriatric skin responds inappropriately to UVB exposure due to
the silencing of IGF-1 expression in senescent fibroblasts and the resulting reduced activation of
the IGF-1R in keratinocytes. To test our hypothesis, the expression of IGF-1, activation of the IGF-
1R, and the keratinocyte UVB response was compared in young adult (20-28 yrs old) or geriatric
individuals (>65 yrs old) using immunohistochemisty, quantitative RT-PCR analyses, and DNA-
damage assays. Analyses of IGF-1 in samples of geriatric individuals showed a significant reduc-
tion in IGF-1 levels when compared to young adults. Accordingly, activated IGF-1R levels were
high in young adult compared to its virtual absence in geriatric individuals. The epidermis from
geriatric subjects was sixty-fold more likely to respond inappropriately to UVB irradiation than
young adult epidermis. Finally, the inappropriate response of geriatric skin to UVB irradiation was
prevented by IGF-1 treatment prior to irradiation. In conclusion, the age-related decrease in IGF-
1 expression, IGF-1R inactivation and inappropriate UVB response are major components in the
development of non-melanoma skin cancer seen in geriatric patients.
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Photodynamic therapy with the silicon phthalocyanine Pc 4 induces Bcl-2 photodamage and
reduction of CD45RB in the epidermis of Mycosis fungoides patients
M Deng,1 AH Hsia,1 M Lam,1 Y Liu,2 LY Xue,3 ME Kenney,2 NL Oleinick,3 KD Cooper1,4 and
ED Baron1,4 1 Derm, UH Case Med Ctr, Cleve, OH, 2 Chem, CWRU, Cleve, OH, 3 Rad Onc,
UH Case Med Ctr, Cleve, OH and 4 Derm, Stokes VA Med Ctr, Cleve, OH
Mycosis fungoides (MF) is a primary cutaneous T-cell lymphoma characterized by malignant epi-
dermotrophic T cells that are largely CD45RB+ and CD45RO-. In vitro studies using photody-
namic therapy with the silicon phthalocyanine Pc 4 indicated increased killing of Jurkat T cells
relative to keratinocytes. In addition, a previous study of Pc 4-PDT showed preferential killing of
malignant T cells to normal T cells in Sezary Syndrome peripheral blood. Pc 4-PDT cell killing
involves photodamage to the anti-apoptotic protein Bcl-2. The purpose of this study was to eval-
uate skin biopsies from MF patients after a single Pc 4-PDT treatment for damage to Bcl-2 and to
analyze for preferential killing of malignant T cells, analogous to previous studies. Tissue samples
from treated and untreated MF lesions from a Phase I clinical trial on Pc 4-PDT were obtained from
6 patients. The biopsies were evaluated for Bcl-2 expression by Western blot. Paraffin sections
were stained with antibodies against CD45RB and CD45RO. Bcl-2 expression in treated lesions
collected from patients who showed clinical response was significantly decreased compared to
untreated lesions. Interestingly, clinically non-responsive patients showed no difference in Bcl-2
expression between treated and untreated lesions. In addition, CD45RB stained surface area was
significantly reduced in treated lesions compared to corresponding untreated lesions (p=0.0078).
Treated lesions stained with CD45RO showed marginal significance upon Pc 4-PDT (p=0.056).
On average, the reduction of CD45RB in the epidermis was 2.1 times higher than that of CD45RO.
The ratio of reduction of CD45RB to CD45RO approached significance (p=0.069). In conclusion,
clinical responders, but not non-responders, showed molecular evidence of Bcl-2 damage with
Pc4-PDT. In addition, Pc 4-PDT also reduces T cell markers CD45RB and CD45RO with a more
pronounced reduction of CD45RB.
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Mutations in genes regulating melanosome formation influence multi-drug resistance in
melanomas and melanocytes.
ML Wei,1,2 T Xie,1 T Nguyen1 and M Hupe2 1 Dermatology, University of California, San
Francisco, CA and 2 Veterans Administration Medical Center, San Francisco, CA
The development of an effective treatment for metastatic melanomas has proven to be elusive due
to the broad treatment resistance exhibited by these tumors. Unlike other, more common cancers,
the incidence of melanomas continues to rise. Thus, the development of novel effective therapies
and improvement of existing modalities is urgently needed. Using a panel of congenic human
melanoma cells and primary mouse melanocytes, we have discovered that mutations in genes
that regulate melanosomes, intracellular organelles found in melanomas and melanocytes, that
cause significant impairment of melanosome formation also influence drug resistance to cis-platin,
etoposide and vinblastine. Electron microscopy was used to determine melanosome developmental
stage; cell death and proliferation were assessed using light microscopy and a colorimetric assay
using 3-(4,5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT). We found that muta-
tions in genes that regulate a) trafficking to the melanosome (Pldn, Dtnbp1, Vps33a), b) melanosome
structure (PMEL) and c) melanosome content (Tyr) all cause significant disruption of melanosome
morphology and also result in increased sensitivity to chemotherapeutic agents. In contrast, a muta-
tion in a melanosome regulatory gene (Hps1) that does not affect melanosome morphology but
does affect rate of melanosome formation, does not influence chemosensitivity. Thus, we conclude
that genes that regulate melanosomes play a fundamental role in the multi-drug resistance observed
in melanomas.
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Effect of UVB irradiation on intracellular sodium level and chloride channel CFTR expres-
sion in normal human keratinocytes and skin biopsies
T Chen,1 L Singleton,2 I Imbert,3 A Perrin,3 C Gondran,3 R McMullen,4 C Dal Farra4 and
N Domloge3 1 Johnson & Johnson, Skillman, NJ, 2 Neutrogena, Los Angeles, CA, 3 ISP
Vincience, Sophia Antipolis, France and 4 ISP, Wayne, NJ
Ionic fluxes are important for the maintenance of electrolyte balance and sweat secretion, which
are susceptible to variations in external events. Until now, it was not known whether UV stress
could impact ionic fluxes in the skin. The aim of this study is to examine the effects of UVB irra-
diation on intracellular sodium level and the expression of chloride channel CFTR (cystic fibrosis
transmembrane conductance regulator) in normal human keratinocytes and human skin biopsies.
The effect of UVB irradiation on intracellular sodium level was evaluated in normal human ker-
atinocytes (NHK) irradiated with increasing UVB doses from 0 – 100 mJ/cm2, immediately fol-
lowed by CoroNaTM Green staining and fluorescence quantification. The effect of UVB irradia-
tion on the expression of chloride channel CFTR in NHK and skin biopsies was evaluated by
immuno-fluorescence staining and image analysis.Our results indicate an UVB-dose dependent
increase in intracellular sodium level. Immuno-fluorescence staining confirms that CFTR channel
is localized in cell cytoplasm and nucleus. In human skin biopsies, CFTR is localized in the dif-
ferent layers of the epidermis and dermis. Preliminary results show that CFTR expression is up-reg-
ulated upon UVB exposure. Pre-treatment with a marine extract prevented UVB-induced sodium
influx and augmented CFTR expression. These results show that UVB irradiation can increase mem-
brane permeability of small electrolytes such as sodium in human keratinocytes, and suggest that
CFTR may be involved in membrane electrostatic maintenance and homeostatic repair in response
to UVB induced barrier changes in human skin.
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Expression of Sirtuins in keratinocyte responses to photodamage and in actinic keratoses (AK)
and squamous cell carcinoma (SCC)
EL Jacobson and CA Benavente Pharmacology & Toxicology, Arizona Cancer
Center/University of Arizona, Tucson, AZ
Sirtuins (SIRTs) are NAD-dependent deacetylases that link the energy status of the cell (NAD) with
responses to environmental and metabolic stresses. Skin is frequently exposed to the DNA dam-
aging effects of UV irradiation whose causative effects in skin carcinogenesis are well established.
Thus, cellular defense mechanisms following UV irradiation are critically important in skin car-
cinogenesis cancer prevention. We have quantified by qPCR the expression of all seven SIRT fam-
ily member mRNAs and the relative protein expression by Western blot analyses in human skin
fibroblasts, normal keratinocytes, immortalized keratinocytes, and an epidermoid carcinoma cell
line. Following photodamage, SIRT1 and SIRT4 are upregulated and SIRTs 3, 5-7 are downregu-
lated. Limiting NAD availability by niacin restriction in immortalized keratinocytes results in upreg-
ulation of SIRT2 and SIRT4 and leads to a severe sensitivity to photodamage, which is reflected in
increased DNA damage and cell death. Photodamage in niacin restricted cells stimulates additional
gene expression changes upregulating SIRT1, SIRT4, SIRT7, and downregulating SIRT3. Niacin
repletion completely restores NAD and reverses the increased sensitivity to photodamage demon-
strating that niacin is a critical regulator of cellular responses to photodamage. In immortalized and
malignant cell lines, SIRT mRNA levels do not correlate with protein levels, suggesting that alter-
ations in regulation of protein synthesis and/or turnover of SIRT proteins have occurred relative to
normal human keratinocytes. The expression of all SIRTs is significantly upregulated in SCCs and
all but SIRT1 and SIRT4 are upregulated in AKs, relative to adjacent normal skin of the same sub-
ject. These data support the hypothesis that SIRTs play important roles in response to photodam-
age, have altered expression in human skin cancer, and thus may be target(s) for skin cancer pre-
vention.
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Downregulation of Rap1GAP via promoter hypermethylation promotes melanoma cell pro-
liferation, survival and migration
L Gao,1 Z Hong,1 L Yuan,3 H Zhao2 and L Cornelius1 1 Department of Medicine, Division of
Dermatology, Washington University School of Medicine, St.Louis, MO, 2 Department of
Pathology, Washington University School of Medicine, St.Louis, MO and 3 Department of
Nerosurgery, Washington University School of Medicine, St.Louis, MO
Current therapies for melanoma are relatively ineffective, highlighting the need for continued inves-
tigation into the molecular mechanisms contributing to disease. Previously, we demonstrated that
activation of Rap1 promotes melanoma cell proliferation and migration through the MAP kinase
pathway and integrin activation. We now show that expression of Rap1GAP, a specific negative
regulator of Rap1, is decreased in human melanoma tumors and cell lines. Overexpression of
Rap1GAP in melanoma cells blocks Rap1 activation, ERK phosphorylation, and inhibits melanoma
cell proliferation and survival. In addition, overexpression of Rap1GAP inhibits focal adhesion for-
mation and decreases melanoma cell migration. We further demonstrate that Rap1GAP downreg-
ulation is due to its promoter methylation, a mechanism of gene silencing in tumors and that treat-
ment of melanoma cells with the demethylating agent 5-aza-2’-deoxycytidine re-induces Rap1GAP
expression, decreased Rap1 activity, ERK phosphorylation, cell proliferation and survival. These
changes are significantly blunted in cells transfected by siRNA-mediated Rap1GAP knockdown.
We conclude that downregulation of Rap1GAP via promoter hypermethylation promotes melanoma
cell proliferation, survival and migration.
www.jidonline.org   S133
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Characterization and immunohistochemical evaluation of senile lentigines
CB Lin,1 Y Hu,1 N Chen,1 D Cassarino2 and M Seiberg1 1 Skin Biology, The Johnson & Johnson
Skin Research Center, CPPW, a unit of Johnson & Johnson Consumer Companies, Inc,
Skillman, NJ and 2 Pathology and Laboratory Medicine, University of California, Los Angeles,
Los Angeles, CA
Senile lentigines (SLs) are clinically characterized as macular hyperpigmented lesions that are asso-
ciated with sun exposure and age. Histopathologically, SLs are defined by a hyperpigmented basal
layer and by elongated rete ridges. We retrospectively selected skin samples characterized with
SLs, using dermatopathological assessment of F&M stained sections, and classified the different,
progressive stages of SLs based on the level of melanin deposition and on the development of the
elongated rete ridges. Early-stage SLs accumulate less melanin and their rete ridges are less elon-
gated. The late-stage lesions have massive accumulation of melanin in the basal layer and they
contain many long, finger-like “stems” of rete ridges that protrude into the dermis. Protein levels
of the proliferation marker Ki67, tyrosinase (TYR), Stem cell factor (SCF), keratinocyte Growth Fac-
tor (KGF), and KGF receptor (KGFR), were analyzed in sections of normal human skins and SLs,
and were correlated to the stage and progression status of the lesions. Immunohistological exam-
ination of TYR protein levels revealed an increased number of melanocytes at the basal layer and
the rete ridges of SLs, regardless of their stage, as compared to normal human skins. The levels of
KGF, KGFR, SCF and Ki67 varied with the SLs progression stages, with different proteins peaking
at different stages. Interestingly, the latest-stage SLs express the lowest levels of these four proteins,
suggesting a lower bioactive status of the advanced stage lesions, which may be dormant or qui-
escent. The expression patterns of these genes, during the different stages of SLs development, might
clue on the molecular and cellular mechanisms involved in SLs formation and maintenance.
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The Role of KGF and IL-1a in Melanogenesis: A possible mechanism for the initiation of hyper-
pigmentary lesions
N Chen, Y Hu, W Li, M Eisinger, M Seiberg and LB Connie Skin Biology, The Johnson & Johnson
Skin Research Center, Consumer Product Worldwide, a unit of Johnson & Johnson Consumer
Companies, Inc., Skillman, NJ
The molecular mechanisms involved in the initiation of hyperpigmentary lesions, and in particu-
lar of senile lentigines (SLs), are not yet completely understood. We found that Keratinocyte Growth
Factor (KGF), alone or in combination with Interleukin 1a (IL-1a), induces pigment deposition in
keratinocytes of pigmented epidermal equivalents and of human skin explants. We also found that
KGF is expressed in cultured melanocytes and could be induced by UVB, and that KGF-treated
primary melanocytes express tyrosinase (TYR) at higher levels than untreated controls. Furthermore,
we demonstrated the KGF-induced pigmentary changes using human skins grafted onto immuno-
deficient mice and pigmented Yucatan swine. In both model systems, the topical treatment with
KGF and IL-1a resulted in the creation of hyperpigmentary lesions with elongated rete ridges, which
resemble human SLs histological features. In summary, KGF, and its combination with IL-1a increase
melanin deposition in vitro and induce hyperpigmentary lesions with elongated rete ridges in
vivo. We suggest that the combination of KGF and IL-1a might be involved in the initiation of hyper-
pigmentary lesion formation.
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PTHrP up-regulation is involved in EGF-induced cell migration in murine B16 melanoma
cells
C Ji,1 B Yang,1 Z Bi1 and Y Wan2 1 The First Affiliated Hospital of Nanjing Medical University,
Nanjing, China and 2 Providence College, Providence, RI
Parathyroid hormone-related protein (PTHrP) is a major pathogenic factor for hypercalcemia in
several malignancies including renal cell carcinoma, squamous cell carcinoma, and bladder car-
cinoma. Hypercalcemia does occur in patients with melanoma, but few studies have described a
direct connection to PTHrP. We demonstrate that PTHrP is over-expressed in murine B16 melanoma
cells. Furthermore, treatment of this cell line with exogenous epidermal growth factor or EGF up-
regulates PTHrP mRNA level and migration. Specific PTHrP siRNA knockdown inhibits PTHrP-
induced cell migration. An EGFR inhibitor, PD153035, blocks EGF-induced PTHrP mRNA expres-
sion and cell migration. Further studies have shown that ERK pathway is involved in EGFR-mediated
PTHrP mRNA expression and cell migration. Our findings suggest that PTHrP play an important
role in melanoma progression and may lead to new directions in the future treatment.
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Inhibitory effects of ellagic acid on melanogenesis and melanin transfer in human melanocytes
in vitro
H Ma, G Zhao, W Liu, Y Li and D Li Department of Dermatology, General Hospital of Air
Force, Chinese PLA, Beijing, China
Down-regulation of melanin synthesis and\or melanin transfer are\is required for recovery of pig-
mentary disorders. It has been reported that ellagic acid is a potential inhibitor of tyrosinase and
suppressed UV-induced skin pigmentation of brownish guinea pigs. However, little is known about
the skin-whitening effects of ellagic acid on human melanocytes. Our present investigations, employ-
ing monolayer cultures of human epidermal melanocytes and co-cultures of human melanocytes
and keratinocytes, were aimed at testing whether the ellagic acid would inhibit melanogenesis
and melanin transfer of melanocytes in vitro. Results from both culture systems indicated that
melanin synthesis and tyrosinase activity were clearly suppressed by ellagic acid in a dose-depend-
ent manner. The levels of tyrosinase mRNA expression and protein expression were also reduced
by ellagic acid. We further studied the inhibitory effects of ellagic acid on melanin transfer in
melanocytes-keratinocytes co-culture system with Flow Cytometer technique. Ellagic acid, just like
nicotinamide, inhibited melanin transfer in a dose-dependence manner. More than 70% of inhi-
bition of melanin transfer was observed at concentration of 1μg/ml of ellagic acid and the increased
melanin transfer induced by SLIGRL was also reduced by ellagic acid. But, ellagic acid did not
influence the level of PAR-2 mRNA and protein expression in co-culture cells. We propose that
ellagic acid may be useful for skin-whitening cosmetic and the depigmenting effect of ellagic acid
might be due to its down-regulation of melanogenesis and melanin transfer.
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Diffuse reflectance spectrometry for skin phototype determination
M Martínez-Escanamé,1 F Gonzalez,2 R Muñoz,1 B Torres-Alvarez1 and B Moncada1 1
Dermatology, University of San Luis Potosi, San Luis Potosi, Mexico and 2 Institute for
Research in Optical Sciences, University of San Luis Potosi, San Luis Potosi, Mexico
Fitzpatrick skin phototype classification scheme has become the standard method for assessing
the reaction of the skin to solar stimuli, this method can be easily biased by different factors, such
as ethnicity, which might induce errors in the subject’s susceptibility to skin cancer or in deter-
mining the required dose for laser treatment limiting therefore its utility. In this work diffuse reflectance
spectrometry (DRS) is used to determine constitutive skin color from the upper volar arm as an
objective way of measuring skin pigmentation. A melanin index was developed that accounts for
skin pigmentation, this melanin index was obtained for thirty five subjects of Hispanic origin and
for six patients with vitiligo. The results show that least for Hispanic individuals there is a clear clin-
ical distinction between subjects with skin phototype I and their DRS determined melanin index,
however subjects with skin phototypes II-VI have a large melanin index overlap, indicating that
clinical assessment of skin phototype can be improved by using diffuse reflectance spectrometry.
804
Survivin promotes melanocyte migration through upregulation of α5 integrin
J McKenzie,1 T Liu1 and D Grossman1,2 1 Huntsman Cancer Inst., Univ. of Utah, Salt Lake City,
UT and 2 Dept. of Dermatology, Univ. of Utah, Salt Lake City, UT
Expression of the apoptosis inhibitor Survivin in melanoma tumors correlates with poor survival in
patients with advanced disease. In previous studies, we found that transgenic mice with melanocyte-
specific expression of Survivin were predisposed to the development of UV-induced melanoma
and tumor metastasis. To understand the basis for its promotion of metastasis, we investigated how
Survivin may contribute to metastatic phenotype. Survivin expression in melanocytes did not impart
resistance to anoikis (on Polyhema-coated plates) or alter markers of EMT (E-cadherin, fibronectin,
β-catenin). However, we observed enhanced migration on fibronectin and laminin (Transwell assay,
2-fold), and enhanced invasion (Matrigel, 7-fold) in vitro. Similar results were obtained in several
human melanoma cell lines, which also exhibited enhanced migration on fibronectin (2-6-fold)
and enhanced invasion (5-fold) following over-expression of Survivin. These activities in melanocytes
were associated with Akt phosphorylation and activation of the MAPK pathway. Transcriptional
profiling of Survivin-expressing melanocytes revealed significant differential expression of 828
genes (>1.5-fold), including a metastasis gene signature characterized by upregulation of multiple
genes involved in cytokine and extracellular matrix interaction, glycan biosynthesis and TGF-β sig-
naling, and downregulation of genes regulating the adherens junction and melanogenesis. Among
these changes was striking upregulation of α5 integrin (a component of the fibronectin receptor),
which was highly expressed in Survivin-expressing melanocytes and in multiple melanoma cell
lines with Survivin over-expression. Antibody against α5 integrin completely blocked Survivin-
enhanced melanocyte migration on fibronectin, but did not effect migration on laminin. These stud-
ies demonstrate that Survivin expression in normal melanocytes and melanoma cells is sufficient
to enhance both migratory and invasive capabilities, and that Survivin may promote melanocyte
migration through expression of α5 integrin.
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Plexin B1 is a potential tumor suppressor receptor for melanoma
L Stevens, L McClelland, A Fricke and G Scott Dermatology, U. Rochester, Rochester, NY
Semaphorins are proteins critical for neuronal pathfinding and axon guidance in the developing
nervous system. Plexins are a family of transmembrane receptors that bind to secreted and mem-
brane bound semaphorins. Because semaphorins regulate cell migration and motility in virtually
all cell types examined, there is keen interest in the possible role of semaphorins in tumor pro-
gression. Further, Plexin B1 couples with the hepatocyte growth factor receptor, c-Met, in other
cell types, suggesting a potential role for Plexin B1 in modulating c-Met activation in melanocytic
cells. The purpose of this study is to examine the function of Plexin B1, the receptor for Sema-
phorin 4D (Sema4D) in melanocytes, and to define the effect of loss of Plexin B1 in human
melanoma. Our data show that Sema4D rapidly stimulates the adhesion and dendricity of human
melanocytes, an integrin dependent process. Human melanocytes express the Sema4D receptor,
Plexin B1, but Plexin B1 is lost at the protein and message level in 6 human melanoma cell lines
tested. Tissue microarrays (TMAs) of nevi, primary melanoma and metastatic melanoma were
stained for Plexin B1 and expression of Plexin B1 was retained in nevi and primary melanoma,
but was almost completely absent in metastatic melanoma in vivo. To define the significance of
loss of Plexin B1 in melanoma, Plexin B1 was introduced into 2 human melanoma cell lines
(YUMAC and YUSIK) using Lentiviral vectors. Introduction of Plexin B1 into YUMAC cells, which
produce Sema4D, resulted in decreased migration, adhesion and growth, compared with LacZ
expressing controls, suggesting that autocrine loops of Sema4D and Plexin B1 inhibit melanoma
motility and proliferation. Introduction of Plexin B1 into YUSIK cells, which do not produce Sema4D,
also resulted in decreased migration in response to recombinant Sema4D. YUSIK cells expressing
Plexin B1 grow at a significantly slower rate than LacZ expressing cells, and display prominent
membrane blebbing, suggesting that Plexin B1 stimulates apoptosis. We propose that Plexin B1
may facilitate melanoma progression through enhanced growth and migration.
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Gli2, a TGF-beta inducibe target, promotes melanoma invasion and metastasis
V Alexaki,1 D Javelaud,1 L Van Kempen,2 KS Mohammad,3 S Dennler,1 F Luciani,4 K Hoek,5
P Juarez,3 JS Goydos,6 PJ Fournier,3 C Sibon,7 C Bertolotto,8 F Verrecchia,1 S Saule,4 V Delmas,4
R Ballotti,8 L Larue,4 P Saiag,7 TA Guise3 and A Mauviel1 1 U697, INSERM, Paris, France, 2,
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 3 Medicine,
University of Virginia, Charlottesville, VA, 4 UMR146 CNRS, Institut Curie, Orsay, France, 5
Dermatology, University of Zurich, Zurich, Switzerland, 6 Surgery, UMDNJ-RWJMS, New
Brunswick, NJ, 7 Dermatology, Hopital Ambroise Paré, Boulogne, France and 8 U895,
INSERM, Nice, France
Cutaneous melanomas, which represent about 4% of skin cancers, are responsible for up to 80%
of deaths from cutaneous malignancies. The TGF-β/SMAD pathway, which can exert both tumor
suppressor and pro-oncogenic activities, is often constitutively active in melanoma and a marker
of poor prognosis. Our work demonstrates that GLI2, a mediator of the Sonic Hedgehog pathway
recently identified as a TGF-β/SMAD target, is upregulated in the most aggressive melanoma cell
lines, and promotes melanoma migration and invasion by controlling a mesenchymal transition
characterized by loss of expression of E-cadherin and increased MMP secretion. GLI2 expression
is heterogeneous within human melanoma lesions, associates with tumor regions in which E-cad-
herin is lost, and is increased in the most aggressive tumors when compared to less aggressive
tumors. Further, GLI2 knockdown in melanoma cells that express high levels of GLI2 significantly
inhibits the development of experimental bone metastases in mice. Together, our data provide func-
tional evidence for a direct role for GLI2 in driving melanoma invasion and metastasis, and sug-
gest that high GLI2 expression in tumors may be a marker for melanoma metastasis.
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Retrospective analysis of lentigo maligna and lentigo maligna melanoma treated with mod-
ified Mohs micrographic surgery
SF Ibrahim,1 G Scott1,2 and MD Brown1 1 Dermatology, Univeristy of Rochester, Rochester, NY
and 2 Pathology, Univeristy of Rochester, Rochester, NY
Lentigo maligna (LM)is a form of melanoma in situ that carries a significant risk for progression to
invasive melanoma. Management of these lesions can be challenging because of ill-defined mar-
gins and sub-clinical extension. Surgical excision remains the modality of choice, however, cur-
rent recommendations for margin width may be inadequate. Staged excision with complete periph-
eral margin mapping provides meticulous margin control and reduces rates of recurrence. We
reviewed cases of LM with a focus on patient and tumor characteristics to determine whether any
specific parameters might serve as clues to predict adequate margin width for future cases. This
study and others may provide valuable information to redefine recommended surgical margins for
LM. 186 patients underwent the modified Mohs surgery procedure for primary, biopsy-proven LM
during a 3 year period. The average age was 69, with 69% being male. 85% of lesions occurred
on the head and neck. The average number of stages needed to achieve clear margins was 1.5
(range 1–6). 61% of cases required only a single stage and clear margins were obtained within 2
stages 90% of the time. Interestingly, undiagnosed lentigo maligna melanoma (LMM) was detected
in 22 (11.8%) of specimens with a mean depth of invasion of 0.39 +/- 0.26mm. The average mar-
gin needed to clear all lesions was 7.91 +/- 4.25 mm (5 – 36mm). The average margin needed for
lesions of LM was 7.68 +/- 3.25 mm (5–17mm), and 9.64 +/- 8.7mm (range 5–36mm) for LMM.
Although there was a slight trend for larger lesions to require wider total margins, there was no
reliable means by which to predict total margin based upon any of the above parameters. Our
results are in accordance with previous studies that validate the value of modified Mohs surgery
for the management of LM and LMM. The width of margins needed to clear these lesions sur-
passes those of currently recommended standards, and occult invasive disease is present in a sub-
stantial portion of patients.
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Doxycycline (Dox)-inducible expression of CXC chemokine receptor-4 (CXCR4) in B16
melanoma cells reveals roles for CXCR4 in lung and lymph node (LN) metastasis
H Zhang, V Lee and S Hwang Dermatology Branch, NIH/NCI, Bethesda, MD
The chemokine receptor CXCR4 is broadly expressed by many cancers and was previously shown
to be involved in melanoma lung metastasis. To determine where and when CXCR4 expression on
cancer cells alters melanoma metastasis, we established several B16 murine melanoma cell lines
(iCXCR4-B16 cells) from single cell clones that displayed stable, dose-dependent, Dox-inducible
expression of CXCR4 (confirmed by flow cytometry). >8 fold induction of CXCR4 could be achieved
depending on the cell line tested. These cell lines were co-transduced with luciferase to facilitate
quantification in vivo. iCXCR4-B16 cells were injected into mouse ear skin and footpad (to initi-
ate primary tumors) and tail vein (to initiate lung metastases) in C57BL/6 mice. In the tail vein injec-
tion model, sustained (17 days) Dox induction increased the number of B16 cells present in lungs
by 4.8-fold (p<0.005) compared to no treatment. In response to initial treatment with Dox that was
removed after 6 days, the number of B16 cells in the lung similarly increased 5.6-fold, suggesting
that CXCR4 expression was not essential for maintenance of lung metastases. At 21 and 31 days
following inoculation, adding Dox to the diet of mice injected in footpad or in ear skin, respec-
tively, with iCXCR4-B16 cells resulted in significantly increased (>10 fold) draining LN metastasis
in popliteal or cervical draining LN. With ear injections, no visible tumors formed in the ear skin
with or without Dox at day 31 after inoculation. Surprisingly, addition of Dox did not induce tumors
in the ear. With footpad injections, small tumors of similar size in both groups were present at day
21 when Dox was added to one group. Thus, the development of versatile, CXCR4-inducible
melanoma cell lines revealed that early CXCR4 expression is critical for lung metastases. By con-
trast, induction of CXCR4 appears to have dramatic effect on LN metastases, but not primary tumors,
even weeks after inoculation in the skin.
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Melanoma cells induce synthesis of hyaluronic acid by stromal fibroblasts leading to tumor
cell proliferation, spreading and motility
A Willenberg, JC Simon and U Anderegg Dermatology, University of Leipzig, Leipzig, Germany
Tumor-Stroma-Interactions are thought to be essential for growth and metastasis of solid tumors.
Stromal fibroblasts (FB) are stimulated by soluble mediators from tumor cells leading to modified
expression of proteases and matrix components. We found huge amounts of hyaluronic acid (HA)
in the stroma of malignant melanoma (MM) that might support MM cell proliferation and motility.
Here we analyzed the HA metabolism of FB and MM cells and investigated putative mediators
that might be involved in the communication of tumor and stroma cells leading to HA deposition.
Finally, we demonstrate the functional impact of stromal HA on MM cell proliferation and motil-
ity. MM-cells synthesize only little amounts of HA-synthetases (HAS) and consequently MM cell
supernatants contain very low concentrations of HA. In contrast, FB constitutively express HAS2
and HAS3 and secrete 1000 times more HA than MM cell lines. Medium transfer experiments
showed that MM cells secrete soluble mediators that induce HAS1 and HAS2 expression and HA
secretion by FB. MM lines differ in their capacity to degrade HA thus modifying the net amount of
HA that is deposited in co-cultures. We demonstrate that FB produce the HA found in many tumors
under the control of MM-derived mediators. MM secrete TGFβ1 that induces HAS expression in
FB. Using siRNA techniques we blocked TGFβ1 expression in MM cells leading to decreased expres-
sion of HAS1-mRNA in exposed FB. However, the induction of HA synthesis was not blocked by
TGFβ-siRNA indicating that additional MM-derived mediators seem to be involved in the induc-
tion of HA-synthesis by FB. We show that MM cells proliferate twofold more when growing on HA
synthesizing FB feeder layers and that blocking HA synthesis in FB significantly reduces this effect.
The FB-derived HA increases the random motility of MM cells and supports colony forming. In
summary, HA deposition found in MM is realized by FB that are stimulated by soluble mediators
like TGFβ from MM cells. This HA deposition in turn promotes motility and growth of tumor cells.
810
Interferon signaling alterations in CCR7-expressing B16 murine melanoma cells that show
diminished recruitment of intratumoral CD8+ T cells
L Fang and ST Hwang Dermatology Branch, National Cancer Institute, Bethesda, MD
Cancers suppress host anti-tumor immune responses in a number of ways, but the role of tumor-
associated chemokine receptors such as CCR7, which augments lymph node metastasis, in this
process is unclear. At higher tumor cell inoculums, empty vector-transduced B16 cells (pLNCX2-
B16) and CCR7-transduced B16 cells (CCR7-B16) form tumors of similar size after footpad injec-
tion. Interestingly, intratumoral CD45+ leukocytes and CD8+ T cells are diminished by >5 and 15
fold in CCR7-B16 (vs. pLNCX2-B16) tumors. To explore the mechanism underlying the reduction
in intratumoral leukocytes in CCR7-B16 tumors, Affymetrix microarrays were used to assess mRNA
profiles of freshly isolated tumor cells that had been depleted (by > 99%) of CD45+ leukocytes
with magnetic beads. Three independent analyses of CD45+ cell-depleted pLNCX2-B16 and CCR7-
B16 tumor cells showed that 3 major groups of genes linked to interferon (IFN) signaling pathways
were downregulated in CCR7-B16 tumor cells: STAT1 and two potent chemokines (CCL5 and
CXCL10) were downregulated by 15-, 14-, and 3-fold, respectively, and MHC I and II genes were
reduced by 6- to 318- fold in CCR7-B16 tumor cells. Microarray results were confirmed by West-
ern blot or quantitative RT-PCR. Exposure of CCR7-B16 cells to CCR7 ligand in vitro did not pre-
vent these cells from up-regulating STAT1 to the same degree as pLNCX2-B16 cells following
treatment with IFN-γ, suggesting that the in vivo tumor environment provided additional signals
that blocked IFN signaling in CCR7-B16 cells. After injection into footpads, IFN-γ-treated CCR7-
B16 cells formed tumors that were ~2.5 fold smaller compared to tumors from mice injected with
untreated cells (p=0.001). In summary, isolated CCR7-B16 tumor cells show a number of differ-
ences in STAT1, chemokine, and MHC I and II expression compared to pLNCX2-B16 tumor cells,
suggesting that CCR7 signaling in vivo may contribute to suppression of host anti-tumor immune
responses.
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Effect of nrf2 on the pigmentation
T Yoon,1 S Jung,2 T Choi,2 J Kim,2 M Kim,2 S Kim,1 J Lee2 and C Kim2 1 Department of
Dermatology, Gyeongsang National University Hospital, Jinju, Korea, South and 2
Department of Dermatology, Chungnam National University, Daejeon, Korea, South
Nrf2 is a redox-sensitive basic leucine zipper transcription factor, which is essential for the ARE
(antioxidant responsive element)-mediated induction of phase II detoxifying genes. In normal state,
Nrf2 is negatively regulated by the Keap1, which targets the Nrf2 to proteasomal degradation. How-
ever, in response to oxidative stress, Nrf2 dissociates from Keap1 and then binds to the AREs in the
promoters of various phase II detoxifying genes. Since it has been well established that UV-induced
oxidative stress is the trigger for the pigmentation process in melanocytes, we investigate the effect
of Nrf2 on the melanogenesis using adenoviral gene delivery system. When melanoma cell line
MNT-1 was transduced with adenovirus expressing GFP-tagged Nrf2, unexpectedly the pigmen-
tation was inhibited in terms of tyrosinase activity and total melanin content. Consistents with, the
protein level for tyrosinase was markedly decreased by overexpression of Nrf2. However, protein
levels for MITF, Trp1 and Trp2 were not affected significantly by Nrf2. Interestingly, the mRNA lev-
els for tyrosinase was not decreased significantly, suggesting that Nrf2-mediated downregualtion
of tyrosinase was at the translational and/or posttranslational levels. To delineate the mechanism
underlying this phenomenon, we next examined the activation status of several intracellular sig-
naling cascades. Interestingly, overexpression of Nrf2 led to the phosphorylation of Akt, which has
been known to reduce tyrosinase level. Together, these results suggest that Nrf2 play a negative
role in melanogenesis through the modulation of intracellular signaling pathway.
812
Knockdown of flotillin-2 by siRNA inhibits melanoma cell growth in vitro and in vivo
P Hazarika,1 P Richards,1 PE Vivas-Mejia,2 X Zhang1 and M Duvic1 1 Dermatology, UT MD
Anderson Cancer Center, Houston, TX and 2 Experimental Therapeutics, UT MD Anderson
Cancer Center, Houston, TX
Flotillin-2 (flot-2) is a 41.7 kDa, highly conserved, lipid raft associated protein that induces filopo-
dia formation [J Cell Biochem 75:147-59, 1999]. We have previously demonstrated that Flot-2
interacts with thrombin receptor, PAR-1, a G protein coupled receptor and over-expression of flot-
2 enhanced sensitivity to thrombin activation including cell proliferation, actin cytoskeleton reor-
ganization and Matrigel invasion. Flot-2 over-expression transformed SB2 melanoma cells from
non-tumorigenic, non-metastatic to a highly tumorigenic and metastatic phenotype in a nude mouse
xenograft model [Cancer Res 64: 7361-9, 2004]. High flotillin-2 expression is associated with lymph
node metastasis and Breslow depth in melanoma (Melanoma Research 16:461-463, 2006). The
aim of this study was to investigate the effects of suppressing flot-2 in human melanoma cell lines
in-vitro and in vivo. WM2664 melanoma cells were transfected with flot-2 siRNA or control siRNA.
After 48 hours of transfection, cell proliferation was measured by MTT assay and in vitro invasion
was assessed by Matrigel invasion assay. Flot-2 siRNA treatment resulted in decreased cell prolif-
eration (40%) and Matrigel invasion (80%). Athymic nude mice were injected subcutaneously with
1x106 WM2664 melanoma cells and after one week, Flot-2 siRNA or control siRNA incorporated
into neutral liposome [1,2-dioleoyl-sn-glycero-3-phosphatidyl choline(DOPC)] were injected into
tail vein of mice (N=10), twice weekly for 4 weeks. Tumor volumes were measured twice weekly.
Tumor growth was decreased in flot-2 siRNA treated group compared to control siRNA treated
group (mean tumor volume 255 mm3 vs 552 mm3, p=< .04). After 4 weeks of therapy, the mice
were sacrificed to harvest the tumors and individual tumor weights were recorded. Tumor weights
were decreased in flot-2 siRNA treated group (mean tumor weight 0.32g vs 0.63g, p= < .05). Our
data suggest that flot-2 may serve as a target for therapeutic intervention in melanoma patients.
813
Bayesian recognition of dermoscopic structures in skin lesions
P Wighton,1,2,3 TK Lee,1,2,3 H Lui,2,3 DI McLean2 and MS Atkins1 1 School of Computing
Science, Simon Fraser University, Burnaby, BC, Canada, 2 Photomedicine Institute,
Department of Dermatology and Skin Science, University of British Columbia and Vancouver
Coastal Health Research Institute, Vancouver, BC, Canada and 3 Cancer Control Research
Program and Cancer Imaging Department, BC Cancer Research Centre, Vancouver, BC,
Canada
The purpose of this research is to develop a generic framework for the automatic classification and
visualization of dermoscopic structures in skin lesions. We formulate the framework and test is
efficacy at classifying and visualizing pigmentary networks. Our dataset is a selection of images
from Argenziano et. al.’s Interactive Atlas of Dermoscopy. The dataset was created by considering
a subset of images for which the illumination and magnification was constant. From this set, images
were removed if the entire lesion was not visible, or was heavily occluded by either hair or oil.
The final dataset consisted of 94 images. Each image is labeled as having an absent, regular or irreg-
ular pigment network. We begin by computing several pixel-wise measurements of each image
such as L*a*b*, filter bank convolutions, wavelet decompositions, etc. A total of 52 measurements
are made at each pixel. Linear discriminant analysis is then used to reduce the dimensionality while
maintaining saliency. Bayesian methods are used to estimate the probability that a given pixel is
indicative of an absent, regular and irregular pigment network respectively. Maximum likelihood
estimation is then used to assign a label to each image. Visualizations of where regular and irreg-
ular pigment networks are found within the lesion are also constructed. Leave-one-out cross vali-
dation was used to evaluate the method. The framework can correctly identify the presence of a
pigment network with 87% accuracy. It can also identify the type of pigment network with a 72%
accuracy. Convincing visualizations of the location and type of pigment network are also gener-
ated. In conclusion, our Bayesian based framework seems to be a promising technique for the auto-
matic identification and visualization of dermoscopic structures in skin lesions.
814
High throughput integrated analyses for the tyrosinase-induced melanogenesis: Microarray,
proteomics and interactomics studies
Y Park,1 D Park,2 J Bhak,2 D Lee1 and J Yang1 1 Dermatology, Sungkyunkwan University
Samsung Medical Center, Seoul, Korea, South and 2 Korean Bioinformation Center, Daejeon,
Korea, South
Tyrosinase is a key enzyme in producing melanin pigment. We aimed to detect the genes that have
shown altered expression levels in the tyrosinase-mediated melanogenesis by using high-through-
put screening methods. The tyrosinase gene was overexpressed in HEK293 cells, and then a DNA
microarray coupled with proteomic tools was applied to detect the dysregulated genes and pro-
teins in highly pigmented cells. The candidate genes were obtained from the significance analysis
of microarray (SAM), and these data were compared to the yeast two-hybridization results. Com-
putational prediction via protein-protein interaction (PPI) mapping suggested the existence of hub
genes in melanogenesis. The results of SAM showed that more than 700 genes were up- and
down-regulated compared to the control samples. From a proteomic study, we detected 33 dys-
regulated proteins. PPI mapping using bioinformatic tools revealed 66 genes that formed an inter-
action hub. The approach of combining the expression data analysis and predicted protein inter-
action partners performed in large scales can bring valuable and more reliable gene targets for
understanding pigmentation. Most importantly, RNA binding motif protein 9 is newly detected as
a putative critical melanogenesis-associated gene in this study.
815
The effect of trifluoroethanol on tyrosinase activity and conformation: Inhibition kinetics
and computational simulations
Y Park,1 D Park,2 J Bhak,2 D Lee1 and J Yang1 1 Dermatology, Samsung Medical Center, Seoul,
Korea, South and 2 Korean Bioinformatics Center, Daejeon, Korea, South
We studied the inhibitory effects of trifluoroethanol (TFE) on the activity and conformation of tyrosi-
nase. TFE increased the degree of secondary structure of tyrosinase, which directly resulted in
enzyme inactivation. A reciprocal study showed that TFE inhibited tyrosinase in a slope-parabolic
mixed-type inhibition manner (KI = 0.5 ± 0.096 M). Time-interval kinetic studies showed that the
inhibition was best described as first-order with biphasic processes. Intrinsic and ANS-binding flu-
orescences were also measured to gain more insight into the supposed structural changes; these
showed that TFE induced a conspicuous tertiary structural change in tyrosinase by exposing
hydrophobic surfaces. We also predicted the tertiary structure of tyrosinase and simulated its
docking with TFE. The docking simulation was successful with significant scores (binding energy
for Autodock4: -4.75 kcal/mol; for Dock6: -23.07 kcal/mol) and suggested that the TRP173 residue
was mainly responsible for the interaction with TFE. Our results provide insight into the structure
of tyrosinase and allow us to describe a new inhibition strategy that works by inducing conforma-
tional changes rather than targeting the active site of the protein.
816
Expression of human endogenous retrovirus k (HERV-K) mRNA and production of putative
viral particles by melanoma cell lines
S Singh,1,2 CB Bunker,1 S Kaye,2 M Tristem,3 ME Gore4 and MO McClure1 1 Dermatology,
Chelsea and Westminster Hospital, Imperial College (IC), London, United Kingdom, 2
Infectious Diseases, IC, London, United Kingdom, 3 Biological Sciences, IC, London, United
Kingdom and 4 Cancer Medicine, Royal Marsden Hospital, London, United Kingdom
The human endogenous retrovirus K (HERV-K) provirus family is fixed in the human genome and
has been implicated in the pathogenesis of melanoma (MM). The aims of this study were to quan-
tify the expression of full-length and spliced HERV-K mRNA in human MM cell lines, to charac-
terise expressed sequences and to determine whether MM cells release virus particles. A real-time
quantitative PCR methodology was developed to quantify the expression of full-length (pol and
unspliced env) and spliced (env, rec and np9) HERV-K mRNA in the human MM cell lines A375
and WM2664, and the human embryonic kidney cell line 293T. Expressed HERV-K env sequences
from A375 cells were cloned for sequence and phylogenetic analysis. Viral pellets were obtained
from MM cell line supernatants by ultracentrifugation and analysed by PCR for HERV-K viral RNA.
Full-length and np9 mRNA were expressed in all three cell lines investigated, but at higher levels
in the MM cell lines. In all cell lines, the relative expression of pol was lower than that of unspliced
env. Spliced env and rec mRNA were expressed in A375 cells only. In all cases the relative expres-
sion was less than 1, thus HERV-K genes were expressed at lower levels than the housekeeping
gene hprt. Sequence analysis of expressed env cDNA clones derived from A375 cells revealed that
independent isolates had nucleotide sequence differences. Putative viral particles were detected
in A375 cell supernatants and sequence analysis revealed that these particles contain sequences
with homology to the env region of HERV-K 101 and 109. Expression of HERV-K mRNA in MM
cell lines has previously been demonstrated by our group and other researchers, but this is the first
study to quantify and characterise expressed sequences.
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Quantification of human endogenous retrovirus k (HERV-K) expression in primary melanoma,
normal skin and benign naevi
S Singh,1,2 S Kaye,2 ND Francis,3 D Peston,3 ME Gore,4 MO McClure2 and CB Bunker1 1
Dermatology, Chelsea and Westminster Hospital, Imperial College (IC), London, United
Kingdom, 2 Infectious Diseases, IC, London, United Kingdom, 3 Histopathology, IC, London,
United Kingdom and 4 Cancer Medicine, Royal Marsden Hospital, London, United Kingdom
Human endogenous retroviruses (HERVs), remnants of ancestral exogenous retroviral infections
fixed in the germ-line DNA, have been implicated in melanomagenesis. The HERV-K provirus fam-
ily is the most likely to be pathogenic because some members have open reading frames for all
viral genes. Genes for two potentially oncogenic proteins, Rec and Np9, have been described in
the HERV-K genome. In this study the expression of HERV-K mRNA in archival primary melanoma
(MM), normal skin (NS) and benign naevi (BN) has been investigated by real-time quantitative PCR.
The MM group comprised in situ (n=6), superficial spreading (n=12), nodular (n=7), acral (n=9)
and lentigo maligna (n=5) sub-types. Full-length HERV-K mRNA expression was observed at high
levels in all tissues (pol: n=47 and unspliced env: n=40). There were no differences in relative
expression between MM, BN and NS (pol: p=0.267 and unspliced env: p=0.823). No differences
were observed between lesion site (pol: p=0.970 and unspliced env: p=0.796) and males and
females (pol: p=0.418 and unspliced env: p=0.766). However, the relative expression of pol
increased with the Breslow thickness of MM (n=19; p=0.458). np9 was expressed in 14/39 MM,
4/16 BN and 9/31 NS and there was no difference in relative expression between the groups
(p=0.964). Spliced env was expressed in 8/39 MM, but only 1/16 BN and 0/31 NS (p=0.003). rec
was expressed in 9/39 MM but not in BN, nor in NS (p=0.009) nor in surrounding extra-lesional
skin in 5 rec-positive cases. rec-positive MM were all histologically in vertical growth phase and
thicker than rec-negative MM (median Breslow 2.1mm v 1.05mm). This is the first detailed study
of HERV-K mRNA expression in primary MM, BN and NS. Expression of the potentially oncogenic
rec mRNA in some primary MM, but not in BN or NS merits further evaluation.
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Modulation of skin pigmentation by modulation of the PAR2 receptor
M Bonnans,1 F Labarrade,1 C Plaza,1 J Botto,1 C Gondran,1 F Portolan,1 C Dal Farra2 and
N Domloge1 1 Vincience, ISP Global Skin Research Center, ISP, Sophia-Antipolis, France and
2 ISP Corporate Research Center, ISP, Wayne, NJ
Protease-activated receptor-2 (PAR2) belongs to the large superfamily of G-protein-coupled recep-
tors, is implicated in melanosome transfer, and can thus modulate cutaneous pigmentation. In this
domain, we used IV08.006, a designed molecule to act selectively on PAR2 receptor, and tested
its ability to modulate skin pigmentation. Through immunofluorescence (IF) staining of the PAR2
receptor, we observed an increase in PAR2 expression in NHK treated with 1% of IV08.006 for 48
hours. This result was confirmed by Western blot. The effect of PAR2 modulation on melanosome
uptake was evaluated by looking at fluorescent microsphere ingestion by NHK. For this purpose,
NHK were pretreated, or not, with the PAR2-inducing agent for 48 h. Fluorescent microspheres
were added to the culture medium for the last 16 hours. Fluorescence observation and quantifi-
cation were then performed, and showed that microsphere ingestion was significantly increased
in NHK where PAR2 was up-regulated. As this activity has been previously linked with actin
cytoskeleton reorganization, we performed actin staining on NHK. This study showed cytoskele-
tal modifications in PAR2-induced NHK, in association with extended membrane protrusions. This
observation corroborated the phagocytosis mechanism implicated in the ingestion of melanosomes
by keratinocytes. Furthermore, we investigated the effect of the association of IV08.006 with a
previously described tanning compound on skin pigmentation. IF studies on normal human ex
vivo skin showed that PAR2 is similarly up-regulated in skin samples treated with the PAR2 enhancer.
Melanin intensity was revealed by Fontana-Masson staining of human skin sections, after 48
hours of treatment. The association of the two compounds enhanced skin pigmentation to a greater
extent, compared to the effect observed with the tanning compound alone. In conclusion, these
studies show that enhancing melanin transfer by PAR2 activation can be a useful approach to boost-
ing skin tanning.
821
Photoprotective roles of endothelin-1/stem cell factor induced heme oxygenase-1 expres-
sion in cultured human melanocytes
E Akasaka,1 H Nakano,1 K Sato-Jin,1 K Kimura,1 D Rokunohe,1 D Sawamura1 and G Imokawa2,1
1 Department of Dermatology, Hirosaki University Graduate School of Medicine, Hirosaki,
Japan and 2 School of Bioscience and Biotechnology, Tokyo University of Technology, Tokyo,
Japan
Melanocytes protect the skin from the solar damage. Endothelin-1 (ET-1), stem cell factor (SCF),
and alpha-melanocyte stimulating hormone (α-MSH) are cytokines secreted by UVB-exposed
kerationcytes, playing pivotal roles in regulating the melanogenesis in normal human melanocytes
(NHM). It has recently been reported that ET-1 or α-MSH promotes survival of NHM against the
sun damage and inhibits the UVB-induced apoptosis. However, the signaling mechanisms involved
in the photoprotective effects are poorly understood. In this study, we demonstrated that expres-
sion of heme oxygenase-1 (HO-1), an anti-oxidative protein, is up-regulated by ET-1 or SCF, but
not by α-MSH in NHM. Furthermore, ET-1 and SCF synergistically increased HO-1 expression. In
addition, the ET-1/SCF-induced HO-1 expression was abolished by MEK and PI3K inhibitors. We
then determined whether ET-1 and/or SCF elicit photoprotective effects against UVB irradiation.
Treatment with ET-1, but not with SCF, significantly suppressed the UVB-induced cell death, and
the photoprotective effect was significantly up-regulated by concomitant addition of ET-1 and SCF
compared with ET-1 alone. Moreover, overexpression of HO-1 was able to promote cell survival
of UVB-exposed pigment cells and a pharmacological HO-1 inhibitor diminished the photopro-
tective effect. Taken together, these results indicate that ET-1/SCF augments cellular antioxidant
potential through HO-1 induction via the Raf/MEK/ERK and PI3K/Akt signaling pathways, thereby
protecting melanocytes from UVB induced oxidative stress.
820
Narrow-band UVB stimulates the migration and functional development in Vitiligo IgG
Antibody treated melanoblast cells
H Yu1 and C Wu2 1 Dermatology, Kaohsiung Medical University, Kaohsiung, Taiwan and 2
Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung,
Taiwan
Vitiligo is characterized by the destruction of melanocytes. Currently, the autoimmune component
is believed to play an important role in the pathogenesis of the disease due to strong associations
of vitiligo with multiple autoimmune diseases and the presence of autoantibodies in vitiligo. Our
previous studies revealed that in addition to anti-melanocyte IgG antibodies, non-cytotoxic anti-
keratinocyte IgG antibodies exist in vitiligo. Furthermore, we demonstrated that the anti-keratinocyte
IgG antibodies displayed a UVB protective effect in vitiligo skin. The inactivated melanocytes
(melanoblasts, MBs) residing in the outer root sheath of hair follicle serve as the pigment cell reser-
voir for repigmentation. Narrow-band UVB (NBUVB) has been considered to be an effective and
well-tolerated treatment for vitiligo. Accumulating results from clinical observations demonstrated
that narrow-band UVB mostly resulted in follicular pattern of repigmentation, suggesting that MBs
were essential in NBUVB irradiation-induced repigmentation. We investigated the effects of NBUVB
on vitiligo IgG antibodies treated NCCmelan5 cells, a neural crest derived mouse melanoblast cell,
in terms of proliferation, migration, and melanin formation in this study. Our results showed that
NBUVB irradiation increased the proliferation of vitiligo IgG antibodies treated NCCmelan5. In
addition, NBUVB enhanced the mobility of vitiligo IgG antibodies treated NCCmelan5 via enhanced
phosphorylated focal adhesion kinase (phosphorylated p125FAK) expression. The melanogenesis
and tyrosinase expression in vitiligo IgG antibodies treated NCCmelan5 were promoted by NBUVB.
In conclusion, our findings provided in vitro evidence demonstrating the interaction between
NBUVB irradiation and vitiligo IgG antibodies on proliferation, migration and functional devel-
opment in NCCmelan5 cells. Furthermore, our study provides a theoretical basis explaining the
effectiveness of NBUVB in treating vitiligo.
818
Improvement of keratinocyte-melanocyte interactions by PAR2 receptor activation
F Labarrade,1 M Bonnans,1 C Serre,1 C Plaza,1 J Botto,1 C Dal Farra2 and N Domloge1 1
Vincience, ISP Global Skin Research Center, ISP, Sophia-Antipolis, France and 2 ISP Corporate
Research Center, ISP, Wayne, NJ
Protease-Activated Receptors (PARs) are G-protein-coupled receptors, activated by proteolysis of
the extra cellular N-terminus, thus exposing the specific agonist ligand. The purpose of this study
was to investigate the activation mechanism of PAR2 and its possible functions in the skin pig-
mentation process. First, we investigated the expression of PAR1 to PAR4 mRNAs in different skin
cell types, by RT-PCR studies. PAR2 mRNA was highly expressed in primary human keratinocytes
but no transcript was observed in human fibroblasts or melanocytes. Next, we analyzed the activ-
ity of the MAP kinase signaling pathway in relation to PAR2 stimulation. Normal human keratinocytes
in culture were treated with IV08.006, a molecule designed to act selectively on the PAR2 recep-
tor. In this study, MAP kinase ERK1/2 phosphorylation was observed ten minutes after PAR2 acti-
vation. During the pigmentation process, melanosomes are transferred to keratinocytes via
melanocyte dendrites. Hence, we investigated whether PAR2 activation with IV08.006 could
enhance the interactions between melanocytes and keratinocytes, and therefore melanosome
uptake. For this purpose, normal human keratinocytes and melanocytes were cultured in two sep-
arate compartments of a silicon culture insert. Cell migration and contact formation between the
two cell types were visualized 24 hours after insert removal. This experiment was performed in the
presence of IV08.006. Our data suggested that PAR2 activation led to an increase in keratinocyte-
melanocyte contacts and improved melanocyte dendrite elongation. Finally, DNA microarray analy-
sis of transcript levels revealed gene expression patterns 6h and 48h after PAR2 stimulation. In
conclusion, these studies show that activation of PAR2 improves interactions between keratinocytes
and melanocytes, favoring enhancement of pigmentation.
822
MKK6 increases the melanocyte dendricity through the regulation of Rho family GPTases
J Lee,1 M Kim,1 J Kim,1 T Choi,1 S Jung,1 Y Kim,1 Y Lee,1 Y Lee,1 C Kim1 and T Yoon2 1 Chungnam
National University, Daejeon, Korea, South and 2 Gyeongsang National University, Jinju,
Korea, South
Dendrite formation requires actin polymerization, and Rho family GPTases including RhoA, Rac1
and Cdc42 are well implicated in this process. It has been documented that RhoA regulates the
formation of the actin stress fibers though bundling of pre-existing filaments, whereas Rac1 and
Cdc42 are required for the formation of lamellipodia and filopodia, respectively, via de novo actin
polymerization. In other systems, Rac1 and Cdc42 are shown to be related with the p38 MAPK
pathway. To investigate the involvement of p38 MAPK in melanocyte dendrite formation, we
made the recombinant adenovirus expressing MKK6, an upstream MAPKK for p38 MAPK. Inter-
estingly, the activation of p38 MAPK by overexpression of MKK6 resulted in increase of dendrite
number in normal human melanocytes cultured in vitro. When MKK6 was overexpressed in
melanoma cell line SK-mel-24, dendrite length was dramatically increased. To examine whether
the activation of p38 MAPK by MKK6 expression affects the Rho family GTPases, we perfomed
Western blot analysis against RhoA, Cdc42 and Rac1. As expected, overexpression of MKK6 led
to the upregulation of Cdc42 and Rac1, while RhoA was slightly decreased by MKK6 overexpres-
sion. These results suggest that activation of p38 MAPK pathway by MKK6 is an important step to
regulate Rho family GPTases, thereby influencing the dendricity of melanocytes.
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The effect of yeast ferment filtrate on melanogenesis via suppressing expression of tyrosinase
related proteins, Pmel-17 and melanin polymerization
T Hakozaki,1 T Laughlin,1 K Wakamatsu2 and RE Boissy3 1 Procter & Gamble Company,
Cincinnati, OH, 2 Department of Chemistry, Fujita Health University School of Health
Sciences, Toyoake, Japan and 3 Department of Dermatology, University of Cincinnati College
of Medicine, Cincinnati, OH
Skin pigmentation results in part from melanization of melanosomes in melanocytes. We investi-
gated the effect of yeast ferment filtrate (YFF), which has been reported to suppress generation of
reactive oxygen species in skin, on the catalytic activity of purified tyrosinase, melanogenesis in
cultured melanocytes, formation of melanin polymer(s) and pigmentation of a skin equivalent
model. In cultured B16 cells, human melanocytes and skin equivalent model (Melanoderm™,
MEL300B), YFF effectively suppressed melanin synthesis measured spectrophotometirically in all
models, while it did not inhibit catalytic activity of mushroom tyrosinase. Instead, YFF suppressed
the expression of TRP-1 and TRP-2 by 44-49% respectively measured by RT-PCR, and also reduced
production of Pmel-17 protein measured by immuno-blotting in B16 cells. We also evaluated
melanin polymer formation by natural oxidation from dopachrome, 5,6-dihydroxyindole (DHI) and
5,6-dihydroxyindole-2-carboxylic acid (DHICA) under UVA exposure respectively in the chemi-
cal solution with formed melanin measured by 450nm absorbance. In these assays, YFF effectively
suppressed eu-melanin polymer formation from both DHI and dopachrome in a dose dependent
manner, while it did not affect formation from DHICA. Microscopic observation of melanosome
maturation indicated that less stage IV melanosomes occurred in the dendrites of YFF-treated human
melanocytes, which supports inhibitory effect on melanin polymerization. As a conclusion, the
data suggested that YFF suppresses melanogenesis at multiple endpoints: TRP-1/2 expressions,
Pmel17 production and eu-melanin polymer formation from DHI pathway selectively.
824
IL-12/23 suppresses the growth of melanocytic nevi in mice
AM Holzer, TH Nasti, N Yusuf, SK Katiyar, M Athar and CA Elmets Dermatology, University of
Alabama at Birmingham, Birmingham, AL
In C3H/HeN mice, topical application of the polyaromatic hydrocarbon dimethylbenz[a]anthracene
(DMBA) is a stimulus for the development of melanocytic nevi. To determine the effect of IL-12
and IL-23 on the growth of nevi, we treated mutant mice with a deficiency in the p40 subunit of
the IL-12/23 molecule on a C3H/HeN background with a single topical application of 100 μl of a
0.1% solution of DMBA followed by biweekly topical application of 100 μl of a 40 nmol solution
of the phorbol ester 12-O-tetradecanoylphorbol-13 acetate (TPA). Comparison was made to wild-
type C3H/HeN mice that had normal IL-12/23 activity. Both strains began developing nevi after a
latency period of seven weeks. The nevi of the IL-12/23 p40 deficient mice, however, demonstrated
a consistently larger size and comprised a total larger area (mean 36.24 mm2, standard deviation
11.74 mm2) throughout the 17 weeks of the study than those of their wild-type counterparts (mean
19.74 mm2, standard deviation 7.78 mm2; p = 0.01). In no case did the nevi develop into inva-
sive melanomas. These results provide evidence that IL-12/23 has an important immunomodula-
tory effect on the growth of melanocytic nevi in mice.
825
Both Erk1 and Erk2 regulate melanoma cell survival
J Qin,1 H Xin2 and BJ Nickoloff1 1 Department of Pathology, Loyola University, Maywood, IL
and 2 Oncology Institute, Loyola University, Maywood, IL
Since the majority of melanomas contain activating B-Raf mutations, there is a therapeutic inter-
est in targeting Ras/Raf/MEK/Erk signaling pathways. As distinct roles for Erk1 and Erk2 in melanoma
are unclear, specific shRNAs were used to selectively reduce Erk1 and Erk2 protein levels and the
responses of A375 melanoma cells were examined. Knockdown of one Erk member led to com-
pensatory increased phosphorylation of the other Erk member. Knocking down either isoform
(Erk1 or Erk2) reduced melanoma cell proliferation by 40-60% (MTT assay) at 3 days after shRNA
treatment compared to scrambled control shRNA treated cells, and reducing both Erks led to 80%
growth inhibition. Similar patterns of inhibition were observed in colony formation using anchor-
age dependent and independent assays. Erk1 knockdown led to apoptosis of A375 cells started at
day 4 detected by sub-G0 DNA content (FACS), but a delayed (day 6) apoptotic response was
observed in cells with reduced Erk2 levels. By day 8, the majority of melanoma cells underwent
apoptosis with either knockdown of Erk1 or Erk2, proceeded by upregulation of pro-apoptotic
proteins Bid, Bim and Bax (Western blotting). The combined knockdown of both Erks revealed an
additive effects for inducing melanoma cell death. Furthermore, knockdown of either Erk1 or Erk2
significantly enhance A375 cell sensitivity to TRAIL induced apoptosis, which was accompanied
by increased cell surface expression of DR4 but not DR5. These results confirm and extend the
importance of Ras/Raf/MEK/Erk pathway in melanoma survival, and further studies are indicated
to determine the potential therapeutic implications for killing melanoma cells in patients by tar-
geting Erk1 and/or Erk2.
826
Development of a human endothelialized reconstructed skin by tissue engineering to study
melanoma biology
L Gibot, S Chabaud, V Moulin and F Auger Laboratoire d’Organogenèse Expérimentale
(LOEX), Centre de recherche FRSQ du CHA, Université Laval, Hôpital Saint Sacrement,
Quebec, QC, Canada
Despite their usefulness in the study of melanoma biology, monolayer cell cultures do not faith-
fully reflect the in situ phenotype of these cancer cells. Important features for a robust in vitro
melanoma model are: tumorigenesis in the context of a physiological environment, amenable to
biological and molecular manipulations, easy to perform experiments and to evaluate outcome.
The LOEX has developed a biopolymer-based endothelialized reconstructed skin model (BP-ERS)
by tissue engineering (TE) which can be used to achieve this goal. It involves co-culture of primary
human cells in a three-dimensional matrix of collagen and glycosaminoglycans cross-linked by
chitosan (sponge). It mimics the two main layers of skin: a dermis with fibroblasts and endothelial
cells that spontaneously form a network of capillary-like structures, and a differentiated epidermis
made with keratinocytes. Considering these features, the BP-ERS seems very well suited to study
melanoma development, progression and biology in vitro. However, we observed that melanoma
cell lines seeded alone onto the sponge displayed initial apoptotic responses that were later over-
come. After assessing each of the sponge components’ cytotoxicity by flow cytometry, caspase-3
activity levels and PARP cleavage, chitosan was identified as the pro-apoptotic agent in our melanoma
cell lines. Further investigations might potentially bring to light an adaptive or resistance mecha-
nism that would be relevant to melanoma treatment. The LOEX has also developed a self-assem-
bled ERS closer to the physiology of native human skin, in which cells secrete their own extracel-
lular environment. This skin model, in which three-dimensional cell-matrix and cell-cell interactions
can be investigated, promises to be a versatile and efficient model to study not only the origin and
mechanisms of melanoma, but also their progression.
827
Increased risk of second primary cancers after diagnosis of melanoma
PT Bradford,1 DM Freedman,2 AM Goldstein1 and MA Tucker1 1 Genetic Epidemiology Branch,
Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes
of Health, Bethesda, MD and 2 Radiation Epidemiology Branch, Division of Cancer
Epidemiology and Genetics, National Cancer Institute, National Institutes of Health,
Bethesda, MD
The purpose of this study was to quantify the risk of subsequent primary cancers in patients with
cutaneous malignant melanoma (CMM). The study evaluated whites who survived at least 2 months
after CMM diagnosis and were reported to 1 of 9 population-based cancer registries in the Sur-
veillance, Epidemiology, and End Results Program between 1973 and 2004. Of the 79,910 patients
diagnosed with an initial CMM, 9,156 (11.4%) developed 1 or more subsequent primary tumors.
These included 7,943 patients (9.9%) with a total of 2 primary cancers, 1,040 (1.3%) with a total
of 3, and 173 (0.2%) with 4 or more primary cancers. The overall risk of developing a subsequent
primary cancer was increased by 28% (observed-to-expected [O/E] ratio = 1.28, 95% confidence
interval [CI] = 1.26-1.30). This excess was due primarily to subsequent primary CMM (O/E=8.99,
95% CI 8.64-9.35), with 24% of the subsequent cancers being primary CMMs. Patients <30 years
of age with an initial CMM had a markedly higher relative risk of developing subsequent CMM
(O/E=14.44, 95% CI 12.40-16.71). Patients with their first CMM diagnosed on the head and neck
had an increased relative risk (O/E=10.04, 95% CI 9.21-10.92) of developing a subsequent CMM,
with females having the highest risk (O/E=14.04, 95% CI 12.00-16.33). Risks of subsequent can-
cers did not vary substantially by the histologic type of the primary CMM, though risks were low-
est for patients diagnosed initially with acral lentiginous melanoma. Patients with primary tumors
diagnosed in the most recent calendar period (1995-2004), had the highest relative risk for devel-
oping a subsequent CMM (O/E=12.08, 95% CI 11.28-12.92). Patients with CMM have approxi-
mately a 9-fold increased risk of developing a subsequent CMM compared to the general popula-
tion and should remain under active surveillance for future CMMs.
828
Genetic instability in metastatic melanoma from a patient with xeroderma pigmentosum
Y Wang,1 JJ DiGiovanna,1,3 C Lee,2 SB Jere,2 M Raffeld,2 ES Jaffe2 and KH Kraemer1 1 Basic
Research Laboratory, NCI, Bethesda, MD, 2 Lab of Pathology, NCI, Bethesda, MD and 3
Dermatology, Warren Alpert Med School of Brown Univ, Providence, RI
Patients with xeroderma pigmentosum (XP), a rare genetic disease with defective DNA repair,
have a more than 1000-fold increase in melanoma frequency. We are attempting to determine if
genetic instability plays a role in melanomas in XP patients. A 25y/o white male with XP (XP4BE)
was admitted to the NIH Clinical Center in 1969. A large tumor had been excised from his nose
at age 9 years. He subsequently developed more than 100 skin cancers including basal cell car-
cinomas and squamous cell carcinomas of sun exposed skin. A malignant melanoma of the right
post-auricular area had been excised at age 23 years and evidence of spread was found in 2 of 35
cervical nodes. This lesion metastasized widely. He died at age 27 in 1971 and an autopsy was
performed at NIH that revealed metastatic tumor in virtually every organ. The paraffin blocks from
this autopsy were recently retrieved, sectioned and stained. We analyzed 7 metastatic lesions (CNS,
muscle, liver, kidney, pancreas, and scalp) and normal tissue using laser capture microdissection
for isolation of DNA. Samples from 6/7 (86%) of the melanomas showed base substitution muta-
tions in the PTEN tumor suppressor gene. No insertions or deletions were observed. Fifteen base
substitution mutations were detected and 14 of these were different from each other. Individual
lesions showed 1 to 4 different PTEN base substitution mutations. There was 1 nonsense mutation,
12 missense mutations and 2 mutations that did not alter the amino acid sequence. Multiple tumor
samples from the same patient had different mutations indicating the presence of different clonal
populations of tumor cells in different metastatic lesions. This is evidence of marked genomic insta-
bility in these metastatic lesions. These mutations may affect melanoma development and pro-
gression toward metastasis.
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Monobenzyl ether of hydroquinone affects melanosomal protein expression
V Hariharan, M Reust, J Klarquist and IC Le Poole Pathology, Microbiology and
Immunology/Oncology Institute, Loyola University Chicago, Chicago, IL
Monobenzyl ether of hydroquinone (MBEH) is a topical depigmenting agent. Earlier studies revealed
that MBEH induces necrotic melanocyte death, whereas 4-tertiary butyl phenol (4-TBP) induces
apoptosis, suggesting that both reagents follow different mechanisms of action. Yet both chemi-
cals may serve as alternative substrates for melanogenesis. This apparent contradiction prompted
the current studies to correlate expression of melanosomal markers and sensitivity to 4-TBP and
MBEH. Sensitivity of 9 melanocyte cultures to MBEH did not correlate with cellular melanin con-
tent. FACS analysis of melanosomal marker expression was performed following 72 hrs exposure
to 125 μM of either agent. 4-TBP treated melanocytes downregulated expression of TRP-1, tyrosi-
nase and TRP-2 by 37%, 20% and 23% respectively. By contrast, MBEH treatment induced upreg-
ulation of TRP-1, tyrosinase and TRP-2 by 13%, 67% and 81% respectively, further confirming
markedly different mechanisms of action. The in vivo relevance of these findings was evaluated
by immunohistochemistry of organotypic skin cultures. Six mm skin biopsies topically treated with
250mM of 4-TBP or MBEH or vehicle alone were snap frozen after 24 hours. Whereas expression
in response to 4-TBP was markedly reduced, MBEH enhanced expression of melanosomal mark-
ers TRP-1, TRP-2 and tyrosinase, with no significant changes in the expression of MART-1 or gp-
100. The observed increase in expression of melanosomal enzymes by MBEH supports the con-
cept that melanosomal enzymes partake in enzymatic conversion of MBEH, potentially mediating
melanocyte death. As melanin content reflects tyrosinase activity within the cell, TRP-1 and TRP-
2 are currently considered prime candidates defining melanocyte sensitivity to MBEH.
831
Repetitive ultraviolet irradiation induces fibroblast to secrete stem cell factor and senes-
cence
J Shin,1 J Kim2 and E Kim2 1 Dermatology, Inha University School of Medicine, Incheon,
Korea, South and 2 Biological Engineering, Inha University, Incheon, Korea, South
Melasma, which is an acquired hyperpigmentation disorder induced by multiple factors includ-
ing chronic sun light exposure, is recurrent disease even after epidermal chemical peel. However,
deep reticular dermal peel, like phenol peel, can result in no recurrence. Therefore, it is suggested
that dermal factor has a role in the pathogenesis of melasma. We suspected that changes of fibrob-
lasts in the dermis by chronic sun light exposure may lead melanocytes to synthesize pigments in
the epidermis. This study is aimed at finding out the effects of repetitive ultraviolet radiation (UVR)
on fibroblasts. We irradiated UVA (356nm, 100mJ/cm2) or UVB (312nm, 20mJ/cm2) with a portable
UV lamp to cultured human fibroblast cell line (CCD-986sk) 5 times per 24 hrs. After each irradi-
ation, the supernatant medium was isolated from each dish and measured for the stem cell factor
(SCF) and hepatocyte growth factor (HGF) by ELISAkit assay. Finally, the irradiated fibroblasts
were stained with Senescence associated-β-galactosidase (SA-β-gal). In results, irradiated fibrob-
lasts secreted SCF rather than HGF, and the amount of SCF was dependent on the number of UVR.
Irradiated fibroblasts stained positively for SA-β-gal. This was also increased by UVR repetition.
UVA or UVB showed similar results. In conclusion, repetitive UVR induces fibroblast to secrete
SCF. This increased secretion of SCF is likely associated with fibroblast senescence by UVR. SCF
is well-known melanocyte growth and stimulating factor. Therefore, it is suggested that fibroblast
senescence and increased secretion of SCF may be related to the pathogenesis of chronic recur-
ring hyperpigmentation disorder, like melasma.
833
Genome-wide RNAi-based functional genomics identifies novel genes and pathways that
regulate melanoma chemoresistance
J Aruri,1 H Ho,2 MA White3 and AK Ganesan1,2 1 Department of Dermatology, University of
California, Irvine, Irvine, CA, 2 Department of Biological Chemistry, University of California,
Irvine, Irvine, CA and 3 Department of Cell Biology, University of Texas, Southwestern,
Dallas, TX
Melanoma, a cancer highly resistant to chemotherapy, has increased in incidence and prevalence
over the last several decades. Identification of genes that regulate melanoma chemoresistance
could lead to the identification of more effective chemotherapy regimens. RNA-mediated inter-
ference (RNAi) based functional genomics is a method to identify genes that regulate melanoma
chemoresistance that operate outside of our preconceived mechanistic understanding of cancer
chemoresistance. In this study, we coupled a dacarbazine-based synthetic lethal screening format
with a genome-wide arrayed synthetic library of small interfering RNAs to identify central regula-
tors of melanoma chemoresistance. Targets identified in the initial screen underwent secondary
screening in other cell lines using a cisplatin-based synthetic lethal screening format. 14 genes
were identified that sensitized melanoma cells to both dacarbazine and cisplatin in multiple cell
lines. While the validated gene list did contain genes predicted to regulate chemoresistance (DNA
repair genes, apoptosis inhibitors), the screen also identified components of the molecular machin-
ery known to regulate the actin cytoskeleton, a biological pathway not previously known to impact
melanoma chemoresistance. Secondary validation studies determined that regulators of the actin
cytoskeleton sensitized melanoma cells to chemotherapy-induced apoptosis and pharmacologic
inhibition of stress fiber formation sensitized melanoma cells to chemotherapy. Analysis of pub-
lished melanoma genomic data revealed that several actin cytoskeleton regulators identified in our
screen are either overexpressed or genetically amplified in melanoma cells. In summary, these
studies illustrate the power of functional genomics to identify novel pathways and pharmacologic
agents that impact cancer chemoresistance.
832
Initiation of the unfolded protein response in melanocytes and melanoma
SG Bis, KE Knoll, MS Lolis, SJ Orlow and P Manga The Ronald O. Perelman Department of
Dermatology, New York University School of Medicine, New York, NY
Melanoma has proven refractory to most current chemotherapies, thus novel targets are continu-
ally being explored. Recent studies suggest that activation of the unfolded protein response (UPR)
following thapsigargin treatment sensitizes melanoma cells to TRAIL-induced apoptosis. Three UPR
pathways, triggered by accumulation of unfolded proteins in the Endoplasmic Reticulum (ER), are
initiated by IRE1, PERK or ATF6 respectively. In this study, we investigated the response of normal
melanocytes to thapsigargin in order to establish baseline response in this cell type with the even-
tual goal of identifying novel targets for melanoma therapies. Wild-type mouse melanocytes (melan-
a cells) were treated with thapsigargin and tunicamycin over a 24 hour time period in order to
induce ER stress. Cells were harvested at 6, 12 and 24 hours. The PERK and IRE-1 branches of the
UPR were assessed by Western blot and RT-PCR analysis. Activation of the ATF6 branch was mon-
itored via cleavage of recombinant, HA-tagged ATF6 protein. Expression of IRE1 protein was upreg-
ulated within six hours of treatment. A second marker of IRE1 pathway activation was observed in
the splicing of XBP1 mRNA. PERK and CHOP, which acts downstream of PERK, were phosphory-
lated and the ATF6-fusion protein cleaved within 6-12 hours of treatment. Upregulation of the ER
chaperone BiP, a hallmark of the UPR, was also observed. UPR activation was also assessed in a
panel of human melanoma cell lines, which expressed UPR markers to varying degrees. These data
indicate that wild-type melanocytes respond to ER stress by upregulating all three UPR pathways,
while some melanoma cells display signs of chronic ER stress in the absence of external stimuli.
830
Identification of miRNAs involved in melanoma tumorigenesis
NB Goldstein, M Fujita, DA Norris and YG Shellman Dermatology, UC Denver, School of
Medicine, Aurora, CO
MicroRNAs (miRNAs) are a recently discovered class of short RNAs that repress gene expression,
and emerging evidence demonstrates the importance of miRNAs in diverse and essential biologi-
cal processes. Thus, our current understanding of the molecular mechanisms behind many dis-
eases is incomplete without addressing the functional significance of miRNAs. To study which
miRNA(s) might play a role in melanoma tumorigenesis, we performed a miRNA microarray analy-
sis to compare the miRNA expression profiles of human melanomas to those of normal melanocytes.
We identified several candidate miRNAs that are differentially expressed in melanomas compared
to melanocytes. Interestingly, several of these miRNAs have been shown by others to be respon-
sive to TPA treatment, and as such, they might regulate cell differentiation. Quantitative RT-PCR
confirmed that miR-181a was significantly down-regulated in human melanoma cells compared
to melanocytes, indicating that miR-181a may act as a tumor suppressor in these cells. Using Tar-
getScan target prediction software, we identified Mcl-1 (a member of the Bcl-2 pro-survival fam-
ily) as a potential target of miR-181a. Mcl-1 has emerged as a central factor in controlling resist-
ance of melanoma cells to chemotherapy, especially drugs that disrupt the balance of anti-apoptotic
molecules. Preliminary studies demonstrated low expression levels of miR-181a and high expres-
sion of the Mcl-1 protein in a panel of human melanoma cells compared to melanocytes. In addi-
tion, transfecting synthetic miR-181a mimic into 1205Lu melanoma cells down regulated Mcl-1
protein expression, induced cell death, and inhibited cell growth. Currently, we are exploring the
therapeutic potential of this miRNA alone or in combination of other drugs for melanoma. In sum-
mary, our study suggests that miR-181a might act as a tumor suppressor in melanocytic cells.
834
Hypopigmentary effect of platycodin D through inhibition of melanin synthesis and den-
drite growth in melanocytes
E Jung, J Lee, S Huh, J Lee, Y Kim and D Park BioSpectrum, Gunpo, Korea, South
Platycodin D (PD), a major constituent of triterpene saponins in Platycodon grandiflorum, is known
to have diverse effects including anti-inflammatory, anti-cancer anti-allergic and cholesterol-low-
ing activities, augmentation of immune response and stimulation of skin cell apoptosis. This study
investigated the depigmenting action mechanisms of PD in normal human epidermal melanocytes.
Increased production and accumulation of melanins characterize a large number of skin diseases
such as freckle, melasma, postinflammatory melanoderma and solar lentigo. Epidermal and der-
mal hyperpigmentation can be dependent on either increased melanin synthesis or melanocyte
dendricity. Melanocyte dendricity is important for skin pigmentation because melanosomes are
transferred on dendritic processes to keratinocytes. PD exhibited a strong hypopigmentary effect
in melanocytes and significantly inhibited melanin synthesis at low concentration (2 μM) through
downregulation of cAMP production, phosphorylation of CRE binding protein (CREB) and microph-
thalmia-associated transcription factor (MITF) expression and also the subsequent downregulation
of tyrosinase and TRP-2 protein. In addition, PD induced significant morphological changes in
melanocytes and dendrite retraction. Since the members of small GTP-binding proteins are regu-
lators of dendrite formation, we examined the effects of PD on the small GTPases by using GTPase
inhibitors and pull-down assay for cellular GTP-Rho, Rac and CDC42. PD stimulated the increase
of GTP-bound Rho content and a Rho inhibitor (C3 exoenzyme) and a Rho kinase inhibitor (Y27632)
blocked dendrite retraction induced by PD. These results suggest that PD inhibit melanocyte den-
dricity via activating Rho signal pathway. In in vitro melanocyte-keratinocyte co-culture system,
melanosome transfer from melanocytes to keratinocyte was reduced by PD. Together, this study
suggest that PD may be an effective inhibitor of hyperpigmentation caused by UV irradiation or
pigmented skin disorders through downregulation of melanin synthesis and melanocyte dendric-
ity.
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Clinical and pathological characteristics of melanoma in African American patients
DT Alexandrescu,1 LC Kauffman,2 FD Kabigting,1 CA Dasanu,3 H Farzanmehr4 and F Nelson1 1
Division of Dermatology, University of California at San Diego, San Diego, CA, 2
Dermatopathology and Dermatology, Georgetown Dermatology, Washington, DC, 3
Department of Hematology/Oncology, St Francis Medical Center, Hartford, CT and 4
Department of Pathology, Washington Hospital Center, Washington, DC
Melanoma development in African American patients is a rare occurrence. Clinical diagnosis is
frequently delayed, contributing to an advanced presentation. We analyzed histologically the biopsy
specimens from 68 African American patients with cutaneous melanoma. All slides were read by
an experienced pathologist (CLK) using multiple morphological criteria. The mean Breslow dept
of invasion was 3.3 mm, and 70% of tumors presented a vertical growth phase. Histological fac-
tors predicting survival with are: presence of ulceration (log rank 6.69, p=0.0097), Breslow dept
(log rank 3.92, p=0.04), Clark level (log rank 8.54, p=0.03), number of mitoses (log rank 13.17,
p=0.0003), neurotropism (log rank 5.02, p=0.025), microvascular density (8.62, p=0.034), and
lymph node involvement (log rank 8.99, p=0.0027). In a multivariate model, the factors most closely
associated with survival are, in the order of importance, Clark level, microvascular density under
the tumor, presence of residual melanoma, number of mitoses, Breslow depth, and presence of
neurotropism. The overall survival of African American patients was significantly decreased com-
pared to a general melanoma population seen in a Pigmented Lesion Clinic (OS 46.0 mo vs. 80.0
mo, log rank 23.02, p<0.00001). A progressively diminished average survival was correlated with
advancement in the Breslow depth (129.25 mo vs. 80.00 mo vs. 68.80 mo vs. 48.20 mo for depths
of 0-1, 1.01-2.00, 2.01-4.00, and >4.01 mm, respectively [log rank 3.92, p=0.04]). Certain histo-
logical predictors of survival in melanoma confirm their prognostic value in African Americans.
However, few histological features behave differently from the known standard, pointing towards
a possibly different biological behavior of melanoma in pigmented skin.
836
Melanoma costs – a dynamic model comparing estimated overall costs of various clinical
stages
DT Alexandrescu,1 LC Kauffman2 and FP Nelson1 1 Division of Dermatology, University of
California at San Diego, San Diego, CA and 2 Dermatology and Dermatopathology,
Georgetown Dermatology, Washington, DC
Melanoma incidence is rapidly increasing with an annual percentage change (APC) of 2.8%. Early
detection of melanoma is reflected in an increase of thin lesions by an APC of 2.8% in men and
3.3% in women. We developed a dynamic model estimating the economic burden of melanoma,
which considers the costs of screening, diagnostic procedures, adjuvant, curative, palliative and
end-of-life treatment, medical follow-up through physician visits, non-invasive and invasive pro-
cedures, as well as costs associated with years of life lost and loss of productivity. The model begins
with a melanoma of predetermined TNM staging, and summates the impact of projected natural
outcomes and the standard responses triggered by these evolutions. Costs of false-positive proce-
dures and follow-up protocols are also considered. There is a cost decrement by diagnosing
melanoma at an earlier stage. The greater cost of more advanced stages comprises a large com-
ponent from the workup and treatment for metastatic disease. The 5-year cost of treating stage IV
melanoma reaches $159,808.19, which represents 3,438% more than the costs for melanoma in-
situ ($4,648.29). The cost of stage IIIC or stage IV is almost 23 times the cost of stage IA disease.
Stage III costs are high due to an increased rate of metastatic progression, and elevated surveil-
lance expenses. Our analysis demonstrates the economical impact of detecting earlier melanoma
lesions by showing the cost differences between progressive tumor and TNM stages. The higher
than previously estimated costs of melanoma care reported in our analysis are the result of a com-
prehensive consideration of all the costs after diagnosis, including hospitalization and newer treat-
ments, complex medications, complications of the baseline disease, the follow-up plan including
expensive tests, and effect of medical inflation. The higher costs of advanced-stage melanoma war-
rant an increased emphasis on early diagnosis and treatment.
837
Delays in treatment accompany an advanced presentation of melanoma in African Ameri-
can patients
FP Nelson,1 LC Kauffman,2 H Farzanmehr,3 B Sanderson,4 FD Kabigting,1 CA Dasanu5 and
DT Alexandrescu1 1 Division of Dermatology, University of California at San Diego, San
Diego, CA, 2 Georgetown Dermatology, Washington, DC, 3 Pathology, WHC, Washington,
DC, 4 Melanoma Ctr, WHC, Washington, DC and 5 Oncology, St Francis Med Ctr, Hartford,
CT
Although uncommon, malignant melanoma in minority ethnic populations represents an aggres-
sive disease, with more deeply invasive lesions and more advanced stage of disease at diagnosis.
These factors may contribute to an associated shorter survival when compared with the general
melanoma patient population. The role of ethnicity as an independent prognostic indicator of the
outcome is currently under investigation, with conflicting results emerging from the previous stud-
ies. We analyzed the objective parameters associated with melanoma ability to metastasize, and
the delays in administering therapeutic interventions in 67 consecutive African American and 306
consecutive Caucasian patients managed in a typical pigmented lesion clinic. African American
patients developed regional disease and metastatic disease more than the Caucasian patients (23.1%
vs. 11.7% and 40.0% vs. 4.7%, respectively). Case distribution by Breslow depth was skewed
towards an advanced thickness of the lesion in African Americans (T1 25.7%, T2 8.6%, T3 17.1%,
T4 48.6%) than in Caucasians (T1 47.4%, T2 33.1%, T3 11.7%, T4 7.8%). The average time from
melanoma biopsy to re-excision (wide local excision) was significantly higher in African Ameri-
cans than in Caucasians (68.15 days vs. 44.74 days, t=3.557, p=0.0004). The unfavorable prog-
nosis of melanoma in African American patients may be related to an advanced stage at presenta-
tion, as well as delayed therapeutic interventions. More effective therapeutic plans need to be
designed and implemented along with the already advocated strategies for early diagnosis.
838
Acral melanoma in African American patients: Clinico-biological parameters and impact on
survival
CL Kauffman,1 FP Nelson,2 FD Kabigting,2 H Farzanmehr,3 GL Peck,4 B Sanderson,4 CA Dasanu5
and DT Alexandrescu2 1 Georgetown Dermatology, Washington, DC, 2 Dermatology,
University of California at San Diego, San Diego, CA, 3 Pathology, WHC, Washington, DC, 4
Melanoma Center, WHC, Washington, DC and 5 Oncology, St Francis Med Ctr, Washington,
CT
Melanoma assumes a different anatomical distribution in African-Americans than in Caucasians,
the most common sites involved being the acral regions. Plantar distribution was found to account
for 73% of all cutaneous melanomas in Black South African patients, compared with only 2.1% in
Caucasians. We sought to delineate the clinical and histological properties of acral melanoma in
African Americans, compared to similar cases in Caucasians, and with non-acral melanomas in
African Americans, and to analyze the potential impact on patient survival (OS) of this anatomic
location. A search for consecutive cases encountered during the past 20 years identified 25 acral
tumors over 67 (37.3%) melanomas in African Americans and 21/306 (6.8%) cases in Caucasians.
Acral melanomas associated more intratumoral fibrosis (p=0.03), fewer precursor lesions (p<0.0001),
and less necrosis (p=0.007) than non-acral cases. Compared to acral melanomas in Caucasians,
there is a greater mean host response (p=0.001) and a trend toward a higher Breslow depth (p=0.06).
Survival of African Americans with acral melanoma appeared to be similar or better than the non-
acral melanomas in African Americans (median OS 58.00 mo vs. 44.00 mo, log rank 0.85, p=0.356),
which may be explained by the lower median Breslow score (2.88 vs. 3.00 mm). Conversely, in
Caucasians there is a much better overall survival in non-acral melanoma than in acral lesions
(80.00 mo vs. 24.00 mo, log rank=6.68, p=0.0098). OS of acral melanomas in African Americans
was similar with that of Caucasians when analyzed in matched pairs. Acral melanoma in African
American patients does not represent by itself a prognostic factor for decreased survival. The spe-
cific histological profile of acral melanoma may be the result of a different spectrum of etiological
factors.
839
Autophagy regulates melanoma glycogen synthase kinase-3-dependent survival
R Lo,1 R Nazarian,1 Y Zong,3 A Ribas2 and O Witte3 1 Dermatology/Medicine, UCLA, Los
Angeles, CA, 2 Hematology & Oncology/Medicine, UCLA, Los Angeles, CA and 3 Howard
Hughes Medical Institute, UCLA, Los Angeles, CA
Although nuclear β-catenin signaling has been shown to promote melanocyte transformation, its
role in established melanoma remains unclear. Because of the heterogeneity of patient-derived
melanoma cell lines, we took advantage of human melanocytes transformed by engineered onco-
genes to test whether addition of a mutant, stabilized β-catenin can modulate the transformation
phenotype. This uncovered an unexpected anti-oncogenic role of β-catenin signaling in artifi-
cially transformed human epidermal melanocytes. Tracing the canonical β-catenin pathway iden-
tified glycogen synthase kinase-3 (GSK-3), a negative regulator of β-catenin, as a molecular target
whose pharmacologic blockade led to variable melanoma growth inhibition in vitro and in vivo.
Indeed, exposure of human melanoma cells to GSK-3 inhibitor (GSK-3i) led to rapid nuclear β-
catenin accumulation and transcriptional activity. Importantly, the growth inhibitory effect of
GSK-3i in susceptible melanoma cells can be reversed, at least partially, by stable expression of a
dominant-negative TCF-4. Additionally, genome-wide expression profiling of GSK-3i-sensitive and
-resistant melanoma cells followed by functional validation revealed the state of cellular autophagy
as a key regulator of human melanoma susceptibility to GSK-3 targeted inhibition. Thus, the growth
of melanoma cells displays variable sensitivities to GSK-3 inhibition, and survival of melanoma in
response to acute GSK-3 inhibition may be partially mediated by enhanced cellular autophagy.
840
NP-003, newly synthesized PAR-2 specific antagonist, has an inhibitory effect on skin pig-
mentation
S Jeong,1 J Jeon,1 M Kwon,1 J Bae,1 H Kim,2 H Kwak,1 B Park1 and S Lee2,3 1 Research Division,
Neopharm Co., Ltd., Daejeon, Korea, South, 2 Department of Dermatology, Yonsei University
College of Medicine, Seoul, Korea, South and 3 Human Barrier Research Institute, Yonsei
University College of Medicine, Seoul, Korea, South
Protease-activated receptor (PAR)-2 mediated signaling is known to be involved in the melanosome
transfer between melanocyte and keratinocyte and previous report also suggested that topical appli-
cation of protease inhibitors can prevent the UV-induced skin pigmentation. While these results
proposed the potential application of PAR-2 specific antagonist as a whitening agent, lack of PAR-
2 antagonist has made it unclear. Recently, we have reported that the newly synthesized molecule,
NP-003 has an antagonistic activity against PAR-2. In this study, we have investigated whether the
NP-003 has an inhibitory effect on pigmentation process in vitro and in vivo. Co-culture model of
human melanocyte and keratinocyte was used for in vitro experiments. UV irradiation signifi-
cantly increased the PAR-2 expressions in cultured keratinocyte and melanosome formation in cul-
tured melanocytes. While the UV irradiation stimulated the melanosome transfer from the
melanocytes to the surrounding keratinocytes, treatment of NP-003 significantly inhibited the
melanosome transfer, which was observed by confocal LASER microscopy and FACS analysis. For
an in vivo confirmation, UV light was irradiated onto the brown guinea pigs once a week for 3
weeks and skin pigmentation was induced. After UV irradiation, NP-003 was topically applied onto
the irradiated site twice a day for 5 weeks. Skin pigmentation was visually accessed during the
treatment period and histological observation was performed after treatment. Both the visual obser-
vation and F&M staining also showed the inhibitory effects of NP-003 on the UV-induced skin pig-
mentation. These results suggest that PAR-2 signaling is involved in skin pigmentation and NP-003,
as a PAR-2 specific antagonist can be used a potential anti-pigmenting agent.
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Multiple pagetoid Spitz nevi
K Harris,1 SR Florell,1,3 J Papenfuss,2 W Kohlmann,3 GM Bowen1,3 and SA Leachman1,3 1
University of Utah, Salt Lake City, UT, 2 Midwest Dermatology Clinic, PA, Norfolk, NE and 3
Huntsman Cancer Institute, Salt Lake City, UT
We have identified limited reports of isolated pagetoid Spitz nevi and no reports of multiple page-
toid Spitz nevi through PubMed, yet interest in identifying the molecular etiology of spitzoid tumors
continues to grow. We report a thirty-four-year-old woman with 9 pagetoid Spitz nevi. She ini-
tially sought removal of a pigmented patch on her left leg that she found unsightly. The lesion was
biopsied and showed a symmetric, incompletely circumscribed junctional melanocytic lesion com-
posed of epitheliod melanocytes. Melanocytes were distributed mainly in single cell array with
pagetoid scatter to the upper reaches of the epidermis. A few melanocytic theques and rare Kamino
bodies were present. The lesion was interpreted as a melanoma-in-situ and excised with 5mm mar-
gins. Subsequently eight clinically bland appearing tan-to-brown macules on the lower extremi-
ties, head and upper extremity were biopsied. All showed similar pagetoid histology. All were diag-
nosed as melanoma-in-situ or pre-malignant melanocytic dysplasia. Following excision of the 9
lesions, she was referred to our tertiary center for recommendations regarding her multiple recur-
rent in-situ melanomas. Review of the biopsies was consistent with the limited reports of isolated
pagetoid Spitz nevi: circumscribed melanocytic lesions composed of few junctional nests and
extensive pagetoid spread of epitheloid melanocytes singly and in nests with mild cytologic ayt-
pia and minimal architectural disorder. To our knowledge this is the first reported case of multiple
pagetoid Spitz nevi. Serendipitous identification of such unusual cases now offers the opportunity
to uncover molecular defects through the use of high-throughput screening technologies. Com-
parative genomic hybridization is being conducted to explore molecular pathology of this case of
multiple pagetoid Spitz nevi. Dermatologists should be aware of pagetoid Spitz nevi to avoid mor-
bidity associated with the diagnosis of melanoma and multiple excisions.
843
A novel player in the regulation of human pigmentation : Golgi-located N-acetylglucosaminyl
1-phosphotransferase (GNPTA) is involved in POMC processing and melanin production in
situ and in vitro
S Tiede,1 T Braulke,2 S Pohl2 and R Paus1,3 1 Dermatology, University of Lübeck, Lübeck,
Germany, 2 Biochemistry, Children’s Hospital, University of Hamburg, Hamburg, Germany
and 3 School of Translational Medicine, University of Manchester, Manchester, United
Kingdom
The phosphorylation of mannose residues on lysosomal enzymes, essential for lysosomal target-
ing, is catalyzed by the N-acetylglucosaminyl 1-phosphotransferase (PT), composed of three sub-
units, encoded by two seperate genes (GNPTA and GNPTG). Defects in the PT genes prevent or
impair the formation of mannose 6-phosphate recognition marker followed by missorting of lyso-
somal enzymes and intracellular reduced levels of lysosomal enzyme activities characteristic for
mucolipidosis type II (I-cell disease) or type III (pseudo Hurler-polydystrophy). Beside the severe
metabolic and skeletal phenotype this patients show a thickening of the skin and bright-blonde
hairs. Until now, GNPTA has only been known to play a role in the above mentioned endoso-
mal/lysosomal pathway. Here, we provide evidence that the PT is also involved in proopiome-
lanocortin (POMC) processing in normal human hair follicle (HF) epithelium. GNPTA knock-down
by lipofectamine mediated siRNA transfection in organ-cultured adult human scalp HFs substan-
tially reduced POMC mRNA and protein expression and strongly reduced intrafollicular melanin
production (as shown by Masson-Fontana histochemistry and melanin content/cell). GNPTA knock-
down also significantly inhibited melanin production, reduces the gp100 mRNA and protein level
in isolated, cultured primary human HF melanocytes. This effect was not just due to a non-spe-
cific blockade of the M6P-receptor-mediated transport of proteins to the endosomal/lysosomal
compartment, because incubation with NH4Cl did not change POMC gene activity, but resulted
in a reduced intracellular ACTH protein level in HF melanocytes. In summary, our study identi-
fies this golgi-located PT as a novel player in the regulation of human pigmentation, namely in
POMC processing and melanin production within human HF and their melanocytes.
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AP-1 inhibition identifies cooperation of INK4 and Cip/Kip signaling pathways to suppress
human melanoma
A Jalili,1 C Wagner,1 KD Mertz,1 M Pashenkov,2 M Lupien,3 M Goiser,1 J Brunet,4 S Ramaswamy,5
TR Golub,4 G Stingl1 and SN Wagner1 1 Department of Dermatology, Division of Immunology,
Allergy and Infectious Diseases, Vienna, Austria, 2 Laboratory of Clinical Immunology,
Institute of Immunology, Moscow, Russia, 3 The Dana-Farber Cancer Institute, Boston, MA,
4 The Broad Institute of MIT and Harvard University, Cambridge, MA and 5 Department of
Medicine, Massachusetts General Hospital Center for Cancer Research, Charlestown, MA
In the past years, cell biologic analyses have uncovered serious gaps in our understanding of
genes and pathways that function to constrain transformation of melanocytes into melanomas. In
melanoma, oncogenic BRAF/NRAS mutations induce activation of AP-1, a fundamental regulator
of cell proliferation and oncogenic transformation. Though of fundamental importance, the effects
of AP-1 activity are largely unknown in human melanoma. We used the human melanoma cells
LOXIMVI and UACC257 to establish lines allowing inducible expression of a c-Jun (AP-1) domi-
nant negative mutant. Using these cell lines in cell cycle analyses, proliferation and colony for-
mation assays in vitro, and an in vivo model of the disease, we show that AP-1 activity critically
controls cell cycle progression at G1 and accelerates proliferation of melanoma cells. Western blot
analysis and RNA interference of genes involved in cell cycle progression at G1 identified repres-
sion of p18INK4c by AP-1. A series of functional studies employing promoter reporter assays, ChIP,
immunofluorescence, and (Co-)IP confirmed that p18ink4c is a direct target of AP-1. Co-transfec-
tion and RNA interference in Western blot and promoter reporter analyses revealed also indirect
repression of p21Cip1 by AP-1 via Tbx2. Finally, in silico analysis of generated mRNA expression
profiles from human melanoma samples identified c-Jun and JunD as potential heterodimeriza-
tion partners, an observation supported by functional studies. These results identify for the first time
p18INK4c as an important melanoma suppressor gene that, in cooperation with p21Cip1, can
effectively repress AP-1-mediated oncogenic signals in human melanoma.
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Development of a non-invasive genomic-based assay to detect melanoma
W Wachsman,1,2 L Walls,1,2 T Palmer3 and S Chang3 1 Research Service, VA San Diego
Healthcare System, San Diego, CA, 2 Division of Hematology-Oncology and Moores Cancer
Center, UCSD, La Jolla, CA and 3 DermTech International, La Jolla, CA
The current gold standard for detection and diagnosis of melanoma is histopathologic evaluation
of a skin biopsy. Due to its subjective nature, discordant readings between expert dermatopathol-
ogists are reported to occur in 10-35% of potential melanoma cases. This is especially true when
trying to differentiate between a lentigo maligna and solar lentigo. The goal of this study is to develop
a more objective means for melanoma detection by use of the Epidermal Genetic Information
Retrieval (EGIR) technology that non-invasively samples stratum corneum by means of tape strip-
ping. Pigmented lesions thought suspicious for melanoma were tape stripped and then biopsied as
per standard of care. RNA isolated from the tape by EGIR was amplified and assayed on the Affymetrix
U133 plus 2.0 GeneChip. Supervised analysis of the training dataset, identified 7199 differentially
expressed genes (p< 0.05, FDR < 0.05) that separated in situ and invasive superficial spreading
melanoma and lentigo maligna from atypical nevi. Using the TreeNet® algorithm, we further ana-
lyzed these differentially expressed genes and discovered a 19-gene classifier that discriminated
melanoma from atypical nevi. This classifier was tested with an independent set of sample data
and found to be 100% sensitive and 88% specific for detection of melanoma (PPV=78%,
NPV=100%). Step-sectioning and re-review of 11 of the specimens of atypical nevi, called posi-
tive for melanoma by the EGIR assay, revealed the presence of melanoma in one. In addition, pre-
liminary work has identified a 32-gene classifier that accurately discriminates solar lentigines from
both lentigo maligna and lentigo maligna melanoma. These results indicate that the non-invasive
EGIR technology can be used to form the bases of assays for melanoma detection in the clinical
setting. Our findings also suggest that assays of EGIR-harvested stratum corneum may be a more
sensitive means for melanoma detection than histopathologic evaluation of biopsy specimens.
842
Induction of pigmentation in human melanoma cells stimulates NFκB activity and affects the
responsiveness to vitamin D3 derivatives.
Z Janjetovic,1 RC Tuckey,2 LM Pfeffer1 and AT Slominski1 1 Pathology and Laboratory Medicine,
Cancer Center, University of Tennessee Health Science Center, Memphis, TN and 2 School
of Biomedical, Biomolecular and Chemical Sciences, University of Western Australia,
Crawley, WA, Australia
Melanoma is a highly aggressive tumor with a high mortality once the metastatic process started.
Constitutive activation of nuclear factor-κB (NFκB) is a hallmark of various forms of cancer, includ-
ing malignant melanoma, which is almost universally resistant to chemotherapy. Melanogenesis
is a metabolic pathway characteristic for melanocytes that can affect the behavior of melanoma
cells and responsiveness to therapy. Since the vitamin D receptor (VDR) is a potential target for
melanoma therapy, we examined whether induction of melanin synthesis can affect both NFκB
activity and cellular responsiveness to the vitamin D derivatives. These studies were performed in
a human melanoma line in which production of melanin pigment is dependent on precursors to
melanogenesis levels in medium. Proliferation of these cells was inhibited by the hydroxyvitamin
D3 derivatives including the classical calcitriol and a novel one 20-hydroxyvitamin D3 (20(OH)D3)
derivative. Induction of pigmentation stimulated endogenous NFκB activity, and reduced VDR
expression at mRNA and protein levels. Hydroxyderivatives of vitamin D3 induced a significant
increase in mRNA and protein levels for IκBα (NFκB-cytosolic inhibitor) in non-pigmented cells,
being without effect in pigmented cells. Immunofluorescence analysis showed that 1,25(OH)2D3
and 20(OH)D3 treatment dramatically shifted NFκB localization from the nucleus into the cyto-
plasm in amelanotic cells. These data indicate that classical and novel vitamin D3 agonists can
inhibit growth of melanoma cells via inhibiting NFκB activity and this effect is affected by the
presence or absence of melanin pigment and/or active melanogenesis.
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The inflammasome, a molecular platform processing IL-1β, mediates secretion of biologi-
cally-active IL-1β from human melanoma cells
M Okamoto,1 DA Norris,1 CA Dinarello2 and M Fujita1 1 Dermatology, University of Colorado
Denver, Aurora, CO and 2 Medichine, University of Colorado Denver, Aurora, CO
IL-1β is a pleiotropic pro-inflammatory cytokine involved in cell growth, differentiation, tissue
repair, and regulation of immune response. Although IL-1β has been studied in monocytes and
macrophages, little has been known about the role of IL-1β and its regulation in non-immuno-
cytes. Previously, we have reported that advanced-stage human melanoma constitutively produces
and secretes IL-1β and that melanoma-derived IL-1β is biologically active to induce other cytokines
and chemokines in vitro. In the present study, we investigated the mechanism of IL-1β secretion
and its biological role in the tumor microenvironment. Several mechanisms control the produc-
tion and activity of IL-1β, including the conversion of inactive pro-IL-1β to active IL-1β by cas-
pase/inflammasome dependent pathway. The inflammasome is a large multi-protein complex whose
assembly and activation is responsible for the recruitment and activation of caspases 1/5. By West-
ern blotting, we found that melanoma cells that secreted IL-1β expressed all components of inflam-
masome and that IL-1α stimulation induced caspase activation and secretion of inflammasome
components in the supernatant. Immunoprecipitation using ASC, a key adaptor protein of inflam-
masome, showed the assembly of inflammasome components such as NALP1 and NALP3 together
with ASC. IL-1β secretion from human melanoma cells was significantly reduced by knocking down
of ASC or NALP1 with siRNA transfection or by inhibiting caspase activity with caspase inhibitors.
Furthermore, supernatant from melanoma cells induced macrophage chemotaxis and angiogene-
sis assessed by tube formation using HUVEC cells, both of which were inhibited by caspase inhibitors
or IL-1 receptor blockade. Our findings indicate that the inflammasome mediates the secretion of
biologically-active IL-1β from human melanoma cells, which contributes to inflammation and
tumor progression by orchestrating other cytokines/chemokines, recruiting macrophages and
facilitating angiogenesis.
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Aldo-ketoreductase 1C2, a keratinocyte UV inducible enzyme, contributes to prostaglandin
F2α synthesis in the skin and is a potential mediator of post-inflammatory pigmentation
A Mantel, G Scott, J VanBuskirk, A Fricke and A Pentland Dermatology, University of Rochester,
Rochester, NY
Tanning occurs after exposure to ultraviolet radiation (UVR) and involves increased melanin pro-
duction, tyrosinase activity and melanocyte dendricity. Prostaglandin F2α (PGF2α) is a lipid medi-
ator synthesized de novo from the cyclooxygenase product prostaglandin H2 by hormone-metab-
olizing aldo-ketoreductase (AKR) 1C3. Synthesis can also occur via metabolism of prostaglandin
E2 (PGE2) by the hormone metabolizing enzymes AKR1C1 and AKR1C2. We have previously shown
that the activation of the prostaglandin F receptor (FP) in melanocytes increases tyrosinase activ-
ity, expression and melanocyte dendricity. In order to better understand the role of PGF2α in the
signaling interactions between keratinocytes and melanocytes after UVR, the expression of FP recep-
tor, PGF2α secretion, COX-2 and the F-synthases AKR1C2 and AKR1C3 were investigated. Primary
keratinocytes were treated with 60mj/cm2 of UVB and were compared with untreated cells (con-
trol), and protein and supernatants were collected at intervals. UVB exposure increased PGF2α
secretion 5 fold over normal keratinocytes and was accompanied by COX-2 and AKR1C2 upreg-
ulation. Western blotting showed that FP receptor expression was significantly greater in melanocytes
than keratinocytes. In contrast, keratinocytes had much higher expression levels of AKR1C3 com-
pared with melanocytes. AKR1C2 was undetectable under normal conditions in both cell types
and was induced after UV exposure only in keratinocytes. Addition of PGE2 to keratinocytes resulted
in elevation of PGF2α, suggesting AKR1C2 metabolism of PGE2 to PGF2α. Our data support a
model whereby keratinocytes upregulate PGF2α synthesis through the activity of COX-2 and
AKR1C2 enzymes. Because PGF2α stimulates dendrite formation and pigmentation in melanocytes,
the capacity of keratinocytes to metabolize pro-inflammatory PGE2 into tan-promoting PGF2α sug-
gests an underlying mechanism for post-inflammatory hyperpigmentation. AKRs involved in PGF2α
synthesis may also play a role in melasma.
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Synergy of skin lightening actives evaluated by a combined in silico and in vitro approach
DJ Moore,1 G Menon,1 J Botto,2 C Dal Farra,1 A Chakraborty,3 N Domloge2 and S Vali4 1 R&D,
ISP, Wayne, NJ, 2 ISP-Vincience, Sophia Antipolis, France, 3 Yale University, New Haven, CT
and 4 CellWorks, Bangalore, India
To investigate a combined approach to evaluating synergistic effects of two compounds designed
for skin lightening activity, in vitro data on inhibition of tyrosinase was used to simulate the effects
on UV induced pigmentation in a virtual co-culture system of keratinocytes and melanocytes
using an in silico platform of Cellworks Group. This systems biology approach was tested for pre-
dictive effects of two compounds (alone and combined) on Tyrosinase, Trp1 and Trp 2. Separately,
in vitro evaluation of the effects on tyrosinase, Trp1 and Trp 2 activity, and total melanin secretion
was performed on B16 cells. The results from these studies were compared for all three enzymatic
endpoints. UV induced increase in total melanin concentration in the virtual cell system was
decreased 54% and 46% by compounds A and B, respectively at 1.0 uM doses. Compound A
decreases the concentration of both eumelanin (55%) and pheomelanin (53%), while compound
B decreased eumelanin concentration (67 %), with negligible effects on pheomelanin (1.17 %)
content. Co-application of the two compounds showed synergy in all parameters. (total melanin -
74%; Eumelanin -83% and Pheomelanin -53% compared to controls). Expressed as a percentage
of control, compound A was predicted to inhibit Tyrosinase at 47% ; Trp 1 at 60 % and Trp 2 at
89%. Compound B was more effective on Tyrosinase (71%) and Trp 1 (93%), while less effective
on Trp 2 (18%). In vitro results showed both compounds were effective in reducing the melanin
content in 3 days. Decrease in melanin secreted into the medium (a surrogate for melanin trans-
fer in the co-cultures) was more pronounced in samples treated with compound A. The enzyme
assays on treated B16 cells revealed that trends for the enzymes matched the predicted range, which
will be discussed in the poster. This work shows that combining in silico and in vitro studies pro-
vide logical, time- and cost effective means of measuring skin lightening effects of new compounds.
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The prognostic relevance of the expression of mTOR signalling pathway markers in melanoma
patients
J Valencak,1 K Schmid,2 P Mastan,1 M Gonzalez Inchaurraga,3 P Zampieri,3 M Raderer,4
W Sieghart,5 R Knobler,1 H Pehamberger1 and H Kittler1 1 Dept of Dermatology, Medical
University of Vienna, Vienna, Austria, 2 Clinical Inst of Pathology, Medical University of
Vienna, Vienna, Austria, 3 Dept of Dermatology, Hospital F. Tappeiner, Merano, Italy, 4 Dept
of Int Medicine I, Medical University of Vienna, Vienna, Austria and 5 Dept of Int Medicine
IV, Medical University of Vienna, Vienna, Austria
The PI3K-Akt-mTOR signalling pathway is suggested to be associated with melanoma progression.
We sought to determine if activation of mTOR (mammalian Target of Rapamycin) correlates in a
negative manner with melanoma patients’ survival. 126 patients with melanoma were eligible for
analysis. The primary tumor specimens were analysed by immunohistochemistry for the phos-
phorylated forms of p70S6K (p70 ribosomal S6 kinase), mTOR and PTEN (phosphatase and tensin
homologue deleted from chromosome 10). Retrospective analysis of clinical data was performed
with a mean follow-up of 5.5 years (SD: 3.8 years). The results were correlated with clinico-patho-
logical and prognostic variables as well as overall and disease free survival. Our results showed
that P-mTOR, p-PTEN, p-p70S6K were highly expressed in 69.8%, 74.6%, 36.5% of patients respec-
tively. P-mTOR was associated with neither disease free nor overall survival. P-p70S6K was asso-
ciated with positive disease free and overall survival in univariate and multivariate analysis. Strong
p-PTEN expression correlated with longer survival but statistical significance could not be reached.
There was a significant positive correlation between p-PTEN and p-mTOR, but not between p-
p70S6K and p-mTOR and p-PTEN. We conclude that mTOR expression does not associate with
survival implying that melanoma may not be a target for mTOR directed therapy. However the high
expression of p70S6K associated with better disease free survival supports the hypothesis that an
alternate pathway might be responsible for the activation of p70S6K which appears to have an
antiproliferative effect.
850
Melanin detection in human skin biopsies using multispectral imaging
K Kalleberg, K Gossage, S Wong and C Bosko Unilever R&D, Trumbull, CT
In this poster, we compare the sensitivity of melanin detection between multispectral imaging and
the traditional Fontana Masson stain in human skin biopsy samples. In the Fontana Masson stain,
the phenolic groups of melanin reduce the silver ions of the stain which results in deposits of metal-
lic silver at the site of the reduction. This causes the melanin to be stained black and allows for its
visual detection. Multispectral imaging on the other hand, uses a spectral camera to detect and
separate the various stains and colors of samples according to their differing spectra. Melanin pro-
duced in melanocytes is transferred to surrounding basal keratinocytes where a majority of the
melanin can be stained by Fontana Masson stain. The melanin granules that migrate upward through
epidermis and especially to the stratum corneum are much more difficult for the stain to detect.
Multispectral imaging was observed to detect the melanin granules that were not visible by Fontana
Masson staining throughout all layers of the viable epidermis and the stratum corneum. Thus, mul-
tispectral imaging is more sensitive than Fontana Masson stain for detecting melanin in histology
samples.
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ALDH activity defines tumor-initiating cells in human melanoma
K Dallaglio,1,2 M Okamoto,1 DR Roop1,2 and M Fujita1,2 1 Charles C. Gates Regenerative
Medicine and Stem Cell Biology Program, University of Colorado Denver, Aurora, CO and 2
Dermatology, University of Colorado Denver, Aurora, CO
Recent studies suggest that cancer is driven by a population of cancer-initiating cells. These cells
have been identified in hematological cancers and several solid tumors. However, due to the lim-
ited availability of known surrogate markers, studying melanoma-initiating cells is still challeng-
ing. One approach to identify these cells is to focus on physiological properties. They involve
identification of “Side Population (SP)” cells exhibiting the ability to efflux Hoechst dye 33342, and
assessment of aldehyde dehydrogenase (ALDH), a detoxifying enzyme, highly expressed in stem
cells and in several human cancers. Here we provide evidence for the existence of a tumor-initi-
ating subpopulation in human melanoma. First, we analyzed the expression of SP and ALDH in
human melanoma cell lines and melanoma tissues. SP cells accounted for 0.1% to 2% of entire
population from all melanoma samples. In contrast, the number of ALDH+ cells ranged from 0.3%
in primary melanoma tissues to 30% in metastatic melanoma cell lines and was correlated with
aggressiveness of melanoma cells. Second, using a xenograft model, we demonstrated that ALDH+
subpopulation in human melanoma had a higher tumorigenic capacity than ALDH- subpopula-
tion both in nude and NOD/SCID mouse models and that the secondary tumors from ALDH+ sub-
population recapitulated the heterogeneity of the original tumors. Third, the size of tumors from
SP and that from non-SP subpopulations were indistinguishable. Lastly, we found that the ALDH+
subpopulation generated a tumor in mice from as few as 50 cells. Our findings indicate that can-
cer-initiating cells can be identified by using methodologies to analyze physiologic properties of
stem cells. Here we demonstrate that cancer-initiating cells do exist in human melanoma and that
they are substantially enriched in the ALDH+ subpopulation. The isolation and characterization
of melanoma-initiating cells will provide an important tool for the discovery of new therapeutic
targets against human melanoma.
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Hyperactivation of oncogenic BRAF triggers autophagy and inhibits melanoma tumor growth
N Maddodi,1 W Huang,2 K Kim,3 JB Longley1 and V Setaluri1 1 Dermatology, University of
Wisconsin-Madison, Madison, WI, 2 Pathology, University of Wisconsin-Madison, Madison,
WI and 3 Biostatistics, University of Wisconsin-Madison, Madison, WI
Activating mutations in BRAF gene are found frequently in many human neoplasms including
melanomas. Oncogenic BRAF induces a biphasic cellular response triggering an initial prolifera-
tive burst followed by a senescence-like arrest. Although loss or inactivation of tumor suppres-
sor(s) has been proposed as a potential mechanism involved in overcoming senescence, there is
increasing evidence that activation levels of BRAF play a role in the differential cellular response
including reactivation of senescence and proliferative arrest in tumor cells. In this study, we gen-
erated human metastatic melanoma cells that overexpress activated BRAF either constitutively or
inducible by tamoxifen. Chronic high levels of activated BRAF induce hyperactivation of ERK,
senescence-like phenotype and autophagic response resulting in growth inhibition in vitro and in
vivo. Cell death induced by high BRAF levels is rescued, partially, by downregulation of BRAF
protein or pharmacological inhibition of autophagy, but not by inhibition of MAP kinase or apop-
totic pathways. Increased BRAF activation also induces expression of microtubule associated pro-
tein 2 (MAP2), a marker of terminal neuronal differentiation. Induction of MAP2 requires both
high levels of BRAF and MAP kinase activation. Automated quantitative immunohistochemical
analysis using tissue microarray showed a significant positive correlation between levels of BRAF
protein and autophagy marker LC3 in human melanoma specimens and cell lines. These data show
dosage-dependent effects of oncogenic BRAF on trans-differentiation and autophagy-associated
growth arrest of melanoma.
S142 Journal of Investigative Dermatology (2009), Volume 129
ABSTRACTS
853
The dedifferentiating role of agouti signaling protein in murine melanocytes via the Mc1r
assessed by microarray
E Le Pape,1 T Passeron,1 A Giubellino,2 JC Valencia,1 R Wolber3 and VJ Hearing1 1 LCB, NIH,
Bethesda, MD, 2 UOB, NIH, Bethesda, MD and 3 Skin Research, Beiersdorf AG, Hamburg,
Germany
The G-protein coupled melanocortin receptor 1 (Mc1r) is an important positive regulator of melano-
genesis and contributes to protecting the skin from UV induced-carcinogenic effects. Mc1r acti-
vation is enhanced by α-melanocyte stimulating hormone (αMSH), and is inhibited by the natu-
ral agonist inverse, Agouti Signaling Protein (ASP), which has been associated with lighter skin
and hair phenotypes. We determined in this study the gene expression profiles of murine melan-
a melanocytes treated with ASP or αMSH over a 4-day time course using oligonucleotide microar-
rays. As expected, the 2 ligands displayed opposing effects, and we found significant reductions
in expression of numerous melanogenic proteins elicited by ASP, which correlates with its inhibi-
tion of pigmentation. In addition, ASP modulated the expression of genes involved in morpho-
genesis, cell adhesion and communication. Based on those observations, we investigated the effect
of ASP on the migratory potential of melanocytic cells in vitro and found an increased migration
and invasiveness of melanocytes cultured in presence of ASP. This study raises novel interesting
hypotheses concerning the roles of ASP in the skin and possibly in the development of melanoma.
These results demonstrate the role of ASP in the dedifferentiation of melanocytes, through the down-
regulation of various melanogenic proteins and provide insights into the pleiotropic molecular
effects of MC1R signaling that may function during development and may affect skin cancer risk.
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Yearly exposure of infant skin to solar ultraviolet radiation incurs partially irreversible changes
in skin pigmentation
M Mack,1 NK Tierney,1 E Ruvolo,2 GN Stamatas,3 N Kollias2 and K Martin1 1 Baby Care Science
& Technology, Johnson & Johnson Consumer Products Worldwide, Skillman, NJ, 2 Models &
Methods Development, Johnson & Johnson Consumer Products Worldwide, Skillman, NJ and
3 Baby Care Science & Technology, Johnson & Johnson Consumer France, Issy-les-
Moulineaux, France
Development of pigment in the skin is one of the natural processes that infants undergo following
the transition from the womb to the terrestrial environment. Seasonal variations in skin color due
to sun exposure and the associated cumulative photoaging are well known in adults; however, the
extent to which these changes occur in infants and the adaptive capacity of infant skin to respond
to these changes is not well documented or understood. This study explored the skin’s pigmentary
and vascular responses to incidental sun exposure over the first two summers of life by following
two groups of infants (using daily sun protection lotion or following their habitual routine) and
one group of adults over one year. Infant and adult skin exhibited cyclical pigmentary and vascu-
lar changes; after summer, the skin became darker and more yellow, and apparent concentrations
of deoxy-hemoglobin and melanin increased. In the spring, the skin’s ability to return to pre-sum-
mer levels depended on the age and sun protection routine. In infants experiencing the first sum-
mer of life, skin protected either due to body site location or use of sun protection lotion returned
to the pre-summer state, whereas apparent concentration of melanin in the exposed skin of the
infants following their habitual routine remained elevated. Protection of the skin from UVR, espe-
cially in the first summer of life, may prevent or delay the onset of irreversible changes due to sun
exposure.
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Antagonism of endothelin B receptors leads to hypopigmentation
SK Wong, S Arcella and J Nip Unilever R&D, Trumbull, CT
Endothelins (ET-1, ET-2, ET-3) are endogenous peptides secreted from endothelial cells in the car-
diovascular system to regulate vasoconstriction. In the skin, ET-1 is secreted from the keratinocytes
in response to ultraviolet light. The secreted peptide acts as a cytokine to the melanocytes and
induces proliferation and melanogenesis. There are two receptors for ET-1, endothelin A receptor
(ETAR) and endothelin B receptor (ETBR). Null mutation at the ETBR locus in both human and
rodents leads to hypopigmentation. However it is not determined if the effect is due to develop-
mental defect, or the receptor mediates pigmentation post-development. Previous literature data
suggest that ETBR is the main receptor for endothelin in the melanocytes, but the direct link between
ETBR and pigmentation has not been established. In this poster, using the melanoderm assay, we
present evidence that activation of ETBR by ET-1 and ET-3 (specific agonist for ETBR) leads to hyper-
pigmentation. The hyperpigmentation was reversed by the ETBR-specific antagonist BQ-788 with
functional Ki similar to its functional Ki towards ETBR. These data provide pharmacological evi-
dence to support the use of ETBR antagonists for skin lightening.
856
Inhibition of cell proliferation by BMI-1 depletion in human melanoma cells
BM Zhao and TJ Hornyak Dermatology Branch, NCI, Bethesda, MD
The B lymphoma Mo-MLV insertion region 1 (BMI-1) protein is a member of the polycomb group
of proteins which function as epigenetic gene repressors. BMI-1 is an oncogene which is overex-
pressed in many human tumors, such as colon cancer, prostate carcinomas, breast carcinomas,
human medulloblastomas and non-small-cell lung cancer. In this study, we are examining func-
tional roles for BMI-1 in malignant melanoma. Using Western blotting of cultured cell lysates and
immunofluorescence on human tissues specimens, we show that BMI-1 is widely expressed in
human melanoma cell lines and in vivo in normal human melanocytes, melanocytic nevi and
metastatic melanomas. Using siRNA targeting BMI-1, we are able to effectively knockdown BMI-
1 mRNA and protein expression and inhibit cell proliferation in human SK-Mel-2 and SK-Mel-147
melanoma cells. To determine the long term effects of depletion of BMI-1 in human melanoma
cells, we stably depleted BMI-1 expression in SK-Mel-147 cells using lentivirally-delivered shRNA.
Our preliminary results suggest that depletion of BMI-1 causes a G1 phase cell cycle arrest in SK-
Mel-147 cells. We are currently conducting experiments to determine if BMI-1 expression is func-
tionally required for melanoma tumor growth in vivo.
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Comparison of the effect of 30 compounds on the activity of human and mushroom tyrosi-
nases
L Shore, S Madison, J Bajor and C Bosko Unilever R&D, Trumbull, CT
Melanin is produced within the melanocytes located at the basal layer of the epidermis and the
quantity produced contributes to overall skin color. Biochemically, melanin is derived from tyro-
sine in which the key rate limiting enzyme in the pathway is tyrosinase. Inhibitors of tyrosinase
have been well documented to reduce overall melanin synthesis and hence pigmentation. Typi-
cally, mushroom tyrosinase, available commercially, is used for in vitro screening of inhibitors as
human tyrosinase is difficult to purify and stabilize. However, the correlation of inhibitors of
mushroom to that of human tyrosinase has not been well documented. A pilot set of 30 compounds
with diverse chemical structures were tested at final concentrations ranging from 0.5 to 1000 μM
using both mushroom tyrosinase (obtained from Sigma) and human tyrosinase (extracted from
normal human melanocytes) with dihydroxy phenylalanine (L-DOPA) as the substrate. Kojic acid
was used as an internal reference inhibitor which inhibits both mushroom and human tyrosinase.
The following observations were obtained: 1) 12 compounds significantly inhibited the activity of
both mushroom and human tyrosinase however the IC50 against the different enzyme varied by
as much as 30 fold, 2) 10 compounds did not significantly inhibit either enzyme, 3) 7 compounds
decreased the activity of mushroom tyrosinase but not human tyrosinase, and 4) 1 compound
slightly decreased the activity of human tyrosinase but not mushroom tyrosinase. Overall, the
inhibitory activity obtained with mushroom tyrosinase was greater than that obtained with human
tyrosinase. In conclusion, the results obtained using this limited test set suggest using mushroom
tyrosinase for initial screening may result in a high rate of false positives and that the human enzyme
is more suitable for identifying inhibitors of the human enzyme.
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Development and optimization of a serological assay for cytoplasmic melanoma-associated
antigen, a potential early marker of response to treatment in resected melanoma
N Habib,1 M Lolis,1 S Ferrone2 and J Bystryn1 1 Ronald O. Perelman Department of
Dermatology, New York University School of Medicine, New York, NY and 2 University of
Pittsburgh, Pittsburgh, PA
Cytoplasmic melanoma-associated antigen (CYT-MAA) is present in the serum of patients with
resected melanoma. We have previously shown that serum levels of this antigen decrease with
adjuvant therapy and that this decrease is associated with improved clinical outcome. Thus, CYT-
MAA has potential to provide an early marker of response to treatment in melanoma. There is crit-
ical need for such a marker, as presently the only way to judge response to adjuvant therapy is to
wait for disease recurrence. We report our development, optimization, and validation of an assay
to measure CYT-MAA. Serum levels of CYT-MAA were measured with a bead-based double sand-
wich ELISA. Different concentrations of capture and reporter antibody, serum, and microspheres
were used to optimize the assay conditions and to yield the highest sensitivity index. Following
optimization, the assay was validated using samples of low, medium, and high concentration of a
standard source of CYT-MAA. Analytic reproducibility, precision, and accuracy were measured.
Specificity and sensitivity of the assay were determined using known positive (melanoma) and neg-
ative (control) samples. ROC curves were constructed to determine an optimal cut-off value of CYT-
MAA for positive sera. The assays were run in duplicates in two separate experiments to determine
concordance of detection. The CYT-MAA assay was highly reproducible (coefficient of variance
<0.2; intra-class correlation coefficient >60%), accurate (accuracy >85%), and specific (speci-
ficity >80%). The concordance of detection of CYT-MAA in two separate assays was >90%. In sum-
mary, we have optimized an assay for CYT-MAA which appears to be a valuable tool to determine
early response to therapy in resected melanoma.
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A role for keratinocyte p53 in formation of pigmented lesions
N Box,1 T Terzian,1 R Stiegmann,1 L Crane,1 G Lozano2 and D Roop1 1 Dermatology, University
of Colorado at Denver, Aurora, CO and 2 Cancer Genetics, MD Anderson Cancer Center,
Houston, TX
Ultraviolet light UV has long been recognized to play a role in the development of pigmented
lesions, although the mechanism explaining this interaction is not well understood. p53 in ker-
atinocytes is a major target of UV irradiation and is a master regulator of the skin sunburn response.
Recently p53 has been shown to stimulate expression and release of a-MSH, KITLG and ET1 from
keratinocytes after UV exposure. These paracrine factors are critical mediators of the skin tanning
response, including increased melanocyte pigment synthesis and recruitment of melanocytes to
the burned skin area. We hypothesize that p53 activation in keratinocytes provides a strong sig-
naling environment that assists in establishing and promoting pigmented lesions at the very earli-
est stages of their development. In support of this idea, we studied melanocytic nevus formation
in a cohort of 1200 Colorado children ascertained for nevus formation. In children with fair skin,
robust tanning capacity is required for optimal nevus formation. In children with impaired a-MSH
signaling due to loss-of-function MC1R variants, few melanocytic nevi are observed. Furthermore,
we have modeled the p53 dependent skin tanning response using the Sooty Foot Ataxia (SFA) mouse
that carries a ribosomal protein haploinsufficiency allele. The SFA mouse presents with hyperpig-
mented footpads, ears and tail. These phenotypes are a result of increased melanogenesis and
melanocyte number due to hyperactive p53 in keratinocytes. We showed that Mdm2 and Mdm4,
two of the known major negative regulators of p53 are key modulators of p53 activation in ker-
atinocytes. We performed DMBA and UV carcinogenesis studies on SFA mice and observed an
increase in pigmented lesions with some of these lesions undergoing conversion to melanoma. This
mouse model strongly supports the idea that skin tanning and pigmented lesion formation are inti-
mately linked, largely through the action of keratinocyte p53.
860
Clinical and dermoscopic changes in melanocytic nevi in a population-based cohort of chil-
dren
A Scope Dermatology, Memorial Sloan-Kettering Cancer Center, New York, NY
The purpose of the study was to describe the changes in melanocytic nevi of pre-adolescent chil-
dren using longitudinal data from a population-based cohort. High resolution overview photogra-
phy of the back was obtained during 5th grade (age 10-11) and 8th grade (age 13-14) in all 10
schools of Framingham, MA. At 5th grade, close-up clinical and dermoscopic images of up to 4
index back nevi were obtained (the largest nevus on the upper and lower back and one randomly-
selected nevus from the upper and lower back) and repeated at 8th grade. Side-by-side compar-
isons of images were made. Of 443 children imaged at 5th grade, 366 children, 62% males and
38% females, had repeated imaging at 8th grade, with retention rate of 83%. In general, back nevus
counts increased. The median increase in back nevus counts was 2 (range of -2 to +26). Of the 8th
graders, 274 students (75%) had at least one new back nevus, and 103 (28%) at least one nevus
that disappeared or became significantly smaller. Of 962 index nevi available for evaluation of der-
moscopic pattern at 8th grade, 15% were reticular, 30% globular, 8% complex, and 45% homog-
enous (i.e. without pattern). Of these nevi, 68% had retained the same dermoscopic classification
from baseline evaluation. During follow-up, we did see homogenous nevi develop a dermoscopic
pattern (27%), as well as patterned nevi become homogenous (19%). Only 1.1% (n=11) of nevi
assessed as globular at baseline transformed into reticular nevi at follow-up, and just 0.3% (n=3)
of reticular nevi at baseline transformed into globular pattern at follow-up. Twelve of the index nevi
disappeared at follow up; none showed evidence of halo or regression on baseline or follow-up
dermoscopic images. In conclusion, nevus involution is common in childhood, despite overall
increase in nevus counts. Most globular and reticular nevi remain stable in pattern during longi-
tudinal follow-up, supporting the hypothesis that these dermoscopic patterns identify distinct nevus
subsets in childhood.
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In-vitro effects of EGCG and vorinostat on human melanoma
M Nihal1 and GS Wood1,2 1 Dermatology, University of Wisconsin, Madison, WI and 2
Dermatology, Wm. S. Middleton VAMC, Madison, WI
Our recent work has shown that epigallocatechin-3-gallate (EGCG), the major polyphenolic antiox-
idant present in green tea, resulted in a significant decrease in the viability and growth of metasta-
tic melanoma Hs-294T cells and amelanotic melanoma A-375 cells in conjunction with i) induc-
tion of apoptosis, and ii) inhibition of clonogenic survival of these cells, iii) down-modulation of
anti-apoptotic protein Bcl-2, iv) up-regulation of pro-apoptotic Bax, v) activation of caspases -3, -
7, and -9, vi) decrease in cyclin D1 and cdk2, and vii) induction of cyclin kinase inhibitors (ckis)
p16/INK4a, p21 WAF-1/CIP-1and p27/ KIP-1. Because some histone deacetylase inhibitors (HDACIs)
are active against human melanomas, we determined the effects of the HDACI, vorinostat, on
growth, viability, cellular proliferation markers, apoptosis, cell cycle modulation, Bcl2 expression
and transcript, caspase3 activation and PARP cleavage. We also determined the effects of combi-
nation treatments with EGCG and vorinostat. Our results indicate that the effects of vorinostat on
human melanoma lines in vitro generally paralleled those of EGCG. Furthermore, the combina-
tion of both agents produced alterations that were often statistically significantly greater than
either agent alone. Our preclinical findings suggest that the combination of EGCG and vorinostat
may have potential for the chemoprevention and treatment of melanoma.
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Vascular endothelial growth factor (VEGF) signaling regulates melanogenesis in human
melanocytes via intracellular calcium elevation
H Kim,1,3 S Jeong,2 J Kim,1,3,4 G Nam5 and S Lee1,3 1 Dermatology, Yonsei University College of
Medicine, Seoul, Korea, South, 2 Research Division, NeoPharm Co., Ltd., Daejeon, Korea,
South, 3 Human Barrier Research Institute, Yonsei University College of Medicine, Seoul,
Korea, South, 4 Brain Korea 21 Project for Medical science,Yonsei University, Seoul, Korea,
South and 5 Skin Research Institute, AMOREPACIFIC Corporation/R&D Center, Yongin,
Korea, South
VEGF(vascular endothelial growth factor) is a major angiogenetic factor and expressed and secreted
by epidermal keratinocytes. Downregulation of thrombospondin-1 and upregulation of vascular
endothelial growth factor in the epidermis after acute ultraviolet B irradiation. Melanocyte also
expressed the VEGF receptors suggesting paracrine effects of keratinocyte derived VEGF on MCs.
We want to know that VEGF directly induces the melanogensis and what signaling cascades are
related. We evaluated the effecs of VEGF treatment on melanogenesis(expression of tyrosinase
and MITF), proliferation and dendricity using confocal microscopy and EM findings. We also see
the VEGF directly regulate the intracellular calcium levels in melanocyte. After the UV treatment,
we added the Avastin (VEGF inhibitor, Bevacizumab) for examining the VEGF effects on
melanogesesis . VEGF directly induces the melanogenesis in melanocyte and antagonist treatment
confirms the melanogenic effects of VEGF. The VEGF can regulate the intracellulat calcium levels.
We suggested that the VEGF is new melanogenic effector on melanocyte using calcium signaling
cascades.
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Novel small molecule kinase inhibitors with potent and specific anti-melanoma activity
NK Haass,1,2,3 KS Smalley,3,4 JT Lee,3 W Weninger1,2 and M Herlyn3 1 Centenary Institute of
Cancer Medicine and Cell Biology, University of Sydney, Newtown, NSW, Australia, 2
Discipline of Dermatology, University of Sydney, Sydney, NSW, Australia, 3 The Wistar
Institute, Philadelphia, PA and 4 Moffitt Cancer Center, Tampa, FL
Melanoma is highly resistant to conventional therapy. As preclinical studies in vitro often poorly
predict the outcome of clinical studies we have developed a novel cell culture model which bet-
ter compares to the in vivo situation: melanoma cells grown as three-dimensional spheroids are
implanted into collagen to mimic the tumor architecture and microenvironment. Here we discuss
the anti-melanoma activity of the MEK inhibitor AZD6244 and the B-RafV600E inhibitor PLX4720
in our novel 3D spheroid and angiogenesis models, and a xenograft model. The use of intravital
multi-photon microscopy allows in vivo real-time imaging of the interactions of melanoma cells
with their microenvironment as well as their drug response. MEK inhibition with AZD6244 causes
G1-phase cell cycle arrest and is cytostatic as a monotherapy in melanoma, but cytotoxic when
combined with docetaxel in vitro. AZD6244 has a minor effect on angiogenesis, but a direct effect
on melanoma cell proliferation. AZD6244 decreases phospho-ERK in vivo and fully inhibits tumor
growth and causes tumor regression when combined with docetaxel in vivo. Specific B-RafV600E
inhibition with PLX4720 in vitro blocks proliferation through induction of cell cycle arrest and leads
to apoptosis exclusively in melanoma cells harboring the B-RafV600E mutation. Specifically in B-
RafV600E-dependent tumor xenografs, orally dosed PLX4720 causes significant tumor growth delays
and tumor regression. This efficacy is achieved without toxicity to untransformed cells in vitro or
to treated mice. For the first time we show here inhibitors that directly target the MAPK pathway
in melanoma to correlate in vitro and in vivo data. Given their potency and specificity these novel
drugs are important candidates as novel small molecule therapeutics targeting the MAPK pathway
in melanoma.
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ERK but not AKT pathway mediates FOXO3a induces apoptosis in melanoma cells by a novel
phytosphingosine-derivate
H Yoo and T Kim , Catholic Research Institute of Medical Science, College of Medicine, Seoul,
Korea, South
The forkhead transcription factors of class O (FoxO) subfamily are emerging as a shared compo-
nent among pathways regulating diverse cellular functions, including the cell cycle, apoptosis,
stress resistance, and metabolism. The FoxO transcription factors are believed to function in vari-
ous pathological processes ranging from cancer. Here we report a novel mechanism on FoxO3a
regulation of PACHASTRISSAMINE (PA), anhydro-phytosphingosine, isolated from the marine
sponge. Treatment with the PA sufficiently suppressed cell growth and induced apoptosis as shown
by TUNEL staining. PA also increased the protein expression of FoxO3a in HaCaT cells. Interest-
ingly, phosphorylated-AKT expression was increased by its treatment but Erk activity was decreased.
These changes were confirmed in other melanoma cell lines sensitive to the antiproliferative effects
of PA. Furthermore, treatment with the PA sufficiently suppressed beta-catenin-induced FoxO3a
degradation and FoxO3a transcriptional activity. The I.V. administration of PA at 200ug/head
every fourth daily for 2 weeks to lung metastasis model mice (C57BL6) suppressed tumor growth
in association with decreased proliferation and increased apoptosis in tumor cells. Our finding indi-
cated that the PA may inhibit epidermal hyperplasia and melanoma growth by regulating FoxO3a
expression.
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Endothelin-1 regulates MITF expression and function in melanocytes
BR Litzner,1,2 JP Scheschuk1 and PE Burnett1,3 1 Division of Dermatology, Vanderbilt University
Medical Center, Nashville, TN, 2 Department of Pathology, Vanderbilt University Medical
Center, Nashville, TN and 3 Medical Service, VA Tennessee Valley Healthcare System,
Nashville, TN
The endothelins (ETs) are a family of molecules composed of three 21 amino acid peptides: ET-1,
ET-2 and ET-3. They produce their physiologic effect by binding to two different G-protein cou-
pled receptors (GPCRs), EdnrA and EdnrB. Interest in their role in the skin came when studies
demonstrated that Waardenburg’s syndrome (a syndrome involving hypopigmentation and hear-
ing deficits) is caused by mutations in ET-3 or EdnrB, as well as the transcription factor MITF. This
observation suggested that signaling through the ET pathway was necessary for melanocyte via-
bility during development and that the endothelin pathway may regulate MITF function. Our study
seeks to determine the mechanism by which endothelin signaling can regulate MITF expression
and function. We studied the protein phosphatase and MAP kinase pathways using normal human
epidermal melanocytes in cell culture. The downstream effects of activating or inhibiting various
segments of the pathway were assayed using reverse transcriptase PCR and western blot analysis.
We demonstrate that ET-1, signaling through EdnrB, in human melanocytes leads to protein kinase
C activation and eventually to phosphorylation and activation of MITF, a transcription factor known
to be the key regulator of melanocyte differentiation and proliferation. In addition, we show acti-
vation of CREB leads to transcriptional upregulation of MITF. In addition, ET-1 regulates protein
phosphatase activity and thereby MITF phosphorylation. In conclusion, ET-1 signaling through PKC
and MAP kinase regulates MITF expression and function through several different mechanisms.
Further investigation into the relationship between these molecules and the downstream implica-
tions of their interaction will be necessary for an improved understanding of Waardenburg’s syn-
drome and melanocyte biology.
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Is melanoma in African American patients biologically more aggressive? Analysis of survival
in a prognostic factor-matched population
DT Alexandrescu,1 FP Nelson,1 A Bidulescu,2 H Farzanmehr,3 GL Peck4 and LC Kauffman5 1
Dermatology, University of California at San Diego, San Diego, CA, 2 Clinical Epidemiology,
Morehouse Schl of Medicine, Atlanta, GA, 3 Pathology, WHC, Washington, DC, 4 Melanoma
Center, WHC, Washington, DC and 5 Georgetown Dermatology, Washington, DC
Despite being 16 times less common than in Caucasians, melanoma presents in African Ameri-
cans at an advanced stage. Postulated reasons for this late presentation consist of a decreased sus-
picion, a high frequency of tumors in unexpected sites, and a propensity to neglect dark lesions
on pigmented skin. 67 cases of melanoma in African Americans were matched with the same num-
ber of melanomas in Caucasians. Matching parameters were age (61.46 vs. 61.88 yr), Breslow
depth (median 2.50 vs. 2.44 mm), year of diagnosis (+/- 5 years), and gender. The difference in
Overall Survival (OS) between unmatched (consecutive clinic cases) in African Americans and
Caucasians (46.0 mo vs. 80.0 mo, log rank 23.02, p<0.00001) decreased, but remained statisti-
cally significant in matched patient groups (OS 46.0 vs. 76 mo log rank 4.28, p=0.03). The decreased
survival in matched compared with unmatched Caucasian cases correlated with a higher frequency
of adverse histological prognostic factors. While no difference was seen between survival of African
Americans and Caucasians for T3 and T4 lesions (OS 76 mo vs. 76 mo), more superficial T1 and
T2 tumors appeared to have a better prognosis in Caucasians ( OS 80.0 vs. 66.0 mo). In conclu-
sion, in a relatively small patient population, restricted by the rarity of melanoma in African Amer-
icans, the intrinsic properties of the tumor appear to lead to a decreased survival compared to Cau-
casians. This biological behavior manifests even after correction for adverse prognostic influences,
indicating that additional factors may play an independent role. Contrary to the common belief,
the more superficial lesions may confer a worse prognosis for African Americans, while the more
advanced melanomas may share a similarily unfavorable couse with that seen in Caucasians.
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Unscheduled melanogenesis in response to oncogenic Hedgehog signaling in skin
SH Yang, M Verhaegen, V Grachtchouk, A Wang, J Liu, L Syu, J Ferris and AA Dlugosz
Dermatology, University of Michigan, Ann Arbor, MI
Periodic activation of the Hedgehog (Hh) pathway controls proliferation of hair follicle epithelium
during the anagen growth phase, while sustained Hh signaling leads to the formation of basaloid
skin tumors, including basal cell carcinoma (BCC) and basaloid follicular hamartoma. In addition
to modulating epithelial cell function, physiologic Hh signaling is temporally linked to melano-
genesis during anagen, and pathologic Hh signaling leads to grossly apparent pigment in some
human BCCs, suggesting that activation of the Hh pathway in keratinocytes may influence
melanocyte behavior in a paracrine fashion. We have begun to explore the link between epithe-
lial Hh signaling and melanogenesis using mice expressing the oncogenic Hh pathway effector
SMO*. These mice develop pigmented basaloid follicular hamartomas covering much of their body,
including hairless volar skin. SMO*-expressing volar skin contains a dramatically increased num-
ber of melanocytic cells detected by histochemical staining for β-galactosidase in mice also car-
rying the melanocyte-specific Dct-lacZ reporter transgene. In keeping with the gross hyperpig-
mentation, skin from SMO*-expressing mice contained elevated levels of mRNAs encoding the
melanocyte lineage markers Tyr, Trp1, Trp2/Dct, Pmel17, and Mitf. We also examined the expres-
sion level of secreted factors previously shown to enhance melanogenesis, and found elevated
expression of Et1, Et3, Scf, and bFGF in SMO*-expressing skin. Our results reveal that oncogenic
Hh signaling in cutaneous epithelium has a profound stimulatory effect on cells of the melanocyte
lineage, which is associated with coordinate upregulation of multiple melanocyte mitogens. Mod-
ulation of melanocytes by epithelial cells with elevated Hh signaling provides a powerful model
for dissecting paracrine effects of tumor cells on neighboring cell populations.
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Deacetylation of ganglioside GM3 drives melanoma metastasis in vivo and distinguishes the
metastatic phenotype
X Wang, J Liu, P Sun, Q Yan, A Hui, E Yoo and AS Paller Dermatology, Northwestern University,
Chicago, IL
Melanoma-related deaths have steadily increased in the past 25 years due to an increased preva-
lence of melanoma and the lack of effective therapy for metastases. We have recently discovered
that active cleavage of the C-5 acetyl group from GM3, the predominant ganglioside of eukaryotic
cells, promotes melanoma metastasis. This de-N-acetyl derivative of GM3 (d-GM3) is strongly
expressed in highly metastatic melanoma cells (C8161, WM1205 and M14), but not in poorly inva-
sive melanoma cells (A375P and WM3211), pigmented nevi, or normal melanocytes. We have
shown that purified d-GM3 increases proliferation, migration and invasion of poorly invasive
melanoma cells. Depletion of GM3, and thereby d-GM3, prevents metastatic C8161 cell invasion;
replenishing d-GM3, but not GM3, increases invasiveness. Given the limited expression of d-
GM3 and its immunologic distinction from GM3, we hypothesized that targeting d-GM3 could
reduce melanoma metastasis in vivo. We first explored the possibility that d-GM3 expresses in
human metastatic melanomas and found it is present in 100% of 45 specimens, but not in normal
tissues, nevi, or most primary melanomas. Inoculation of d-GM3 positive C8161 cells subcuta-
neously into nude mice leads to 10-fold larger tumors than those of inoculated d-GM3 negative
A375P cells. 48-days after tumor inoculation, all C8161 melanomas metastasize to lung, 67% to
liver, while A375P cells do not metastasize. Blockade of d-GM3 by its specific antibody, DH5,
reduces lung metastases to 33% and eliminates metastases to the liver, in comparison with mice
treated with IgG antibody. uPAR signaling activation increases melanoma invasiveness. We also
now show that d-GM3 increases uPA activity in A375P cells, activates uPAR signaling and pro-
motes MMP-2 activation and expression. These data suggest that GM3 deacetylation promotes
melanoma growth and metastasis in vivo, at least in part through activation of uPAR signaling. The
specificity of d-GM3 to metastatic cells positions it as both a marker of more aggressive tumors
and a target for melanoma treatment.
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